data_4a52_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4a52 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 3.1 mppt? . . . . . 0 CA--C 1.512 -0.495 0 CA-C-O 120.28 0.086 . . . . 2.54 111.114 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 50' ' ' GLY . 20.0 mt -85.2 168.26 14.94 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.721 0.638 . . . . 1.1000000000000001 110.958 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.509 HD11 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -76.87 149.48 36.11 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 123.273 0.629 . . . . 1.05 112.57 -167.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.505 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.2 148.94 36.52 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.091 -0.959 . . . . 1.01 111.427 167.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.656 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 74.3 t80 -134.42 148.43 50.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.705 -1.589 . . . . 1.1200000000000001 107.753 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.89 114.46 15.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.152 -1.425 . . . . 1.72 107.152 175.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -77.51 158.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.801 -0.636 . . . . 0.38 111.262 -168.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -112.44 153.1 27.89 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.846 -0.798 . . . . 3.0600000000000001 108.846 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.538 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.24 116.18 1.91 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.64 -0.709 . . . . 2.1699999999999999 112.396 -172.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.93 -11.57 20.51 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.476 -0.783 . . . . 0.63 113.013 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.521 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 78.9 m-20 -63.13 153.97 32.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.633 0.605 . . . . 2.1699999999999999 112.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.4 p -134.05 155.0 50.79 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.858 -0.61 . . . . 1.27 112.385 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.579 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.3 tp -48.64 -58.99 3.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.68 0.992 . . . . 1.0800000000000001 113.68 -173.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.659 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.9 t-20 -65.25 -43.13 92.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.533 1.159 . . . . 1.55 110.164 -169.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.827 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 13.9 m -57.98 -43.13 86.36 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 112.381 -2.19 . . . . 1.8200000000000001 110.484 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.51 -41.1 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 123.738 0.815 . . . . 1.0600000000000001 112.566 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.29 -64.41 0.87 Allowed 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.588 -0.278 . . . . 0.97999999999999998 111.388 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.27 -4.46 50.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.875 -1.13 . . . . 1.0700000000000001 111.843 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.827 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.8 t0 -65.54 -34.31 77.95 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.618 -0.882 . . . . 1.6299999999999999 108.618 157.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.5 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.9 m-85 -95.15 16.92 15.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.777 0.322 . . . . 0.25 111.83 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 55.14 48.41 19.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.619 -0.719 . . . . 4.2000000000000002 110.552 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 39.1 pt -147.22 -176.34 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.526 -0.916 . . . . 1.02 108.526 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -100.07 145.04 28.41 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.297 -0.865 . . . . 1.1599999999999999 109.374 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.659 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 13.5 p -60.75 -35.85 77.44 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.41 0.624 . . . . 1.05 109.331 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.02 -32.71 74.14 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.488 -1.233 . . . . 1.05 111.514 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -37.51 42.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.095 0.474 . . . . 1.03 109.749 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 18.3 tp -73.63 -19.25 60.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.499 -0.773 . . . . 1.05 109.077 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.571 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.79 35.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.3 0.571 . . . . 1.0600000000000001 111.419 172.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 64.9 mt-30 -57.04 -44.33 82.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.511 1.148 . . . . 1.26 109.598 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.39 42.18 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.327 -1.76 . . . . 1.01 112.37 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 30.7 m-80 -143.28 72.56 17.97 Favored Pre-proline 0 CA--C 1.513 -0.466 0 CA-C-O 121.075 0.464 . . . . 0.20000000000000001 110.014 -171.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.669 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.6 Cg_endo -57.87 -9.05 5.21 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.289 2.659 . . . . 0.29999999999999999 113.876 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -63.62 -33.54 75.83 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.073 0.939 . . . . 1.3600000000000001 109.363 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -80.97 -6.53 58.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.059 -1.428 . . . . 1.26 114.508 -171.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.669 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -49.73 -40.64 41.39 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.634 1.207 . . . . 1.8899999999999999 109.919 177.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.61 -46.36 11.61 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 112.755 -2.02 . . . . 1.1000000000000001 111.815 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -166.89 39.11 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.439 -0.886 . . . . 0.29999999999999999 114.163 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mp -113.98 158.97 20.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.67 -1.265 . . . . 1.0800000000000001 110.214 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.592 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.05 135.32 39.31 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.905 -0.589 . . . . 1.1699999999999999 110.923 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -46.91 126.69 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.338 0.866 . . . . 1.1699999999999999 113.338 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.8 -10.52 51.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 114.539 -1.21 . . . . 0.38 112.192 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.592 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.5 tt0 -64.28 152.31 41.4 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.572 0.701 . . . . 1.1899999999999999 110.552 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.7 m -118.47 134.74 54.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.452 -1.249 . . . . 1.22 109.113 -172.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.422 ' CG1' ' HB3' ' A' ' 7' ' ' TYR . 22.2 pt -137.08 153.93 30.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.213 0.53 . . . . 1.0600000000000001 110.508 -175.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.535 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.4 t -98.81 148.99 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.292 -0.867 . . . . 0.20999999999999999 110.407 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 16.5 mm -118.16 88.09 31.2 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 114.903 -1.044 . . . . 1.01 108.356 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HA ' HD12 ' A' ' 4' ' ' LEU . 28.7 Cg_endo -60.04 140.59 93.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.095 2.53 . . . . 0.23000000000000001 112.43 -174.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.593 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 84.01 -7.79 69.43 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.636 -0.711 . . . . 0.29999999999999999 112.528 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.63 128.67 25.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.487 -0.931 . . . . 1.0800000000000001 108.487 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.567 ' CD ' HD21 ' A' ' 51' ' ' LEU . 71.8 Cg_endo -69.36 169.24 18.86 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.695 2.93 . . . . 0.34000000000000002 114.241 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 3.2 t70 -90.91 136.88 27.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.621 -1.172 . . . . 0.71999999999999997 111.603 -172.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD3' HD11 ' A' ' 5' ' ' LEU . 73.2 Cg_endo -76.74 -1.9 12.07 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.02 2.48 . . . . 0.33000000000000002 112.893 -173.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -96.13 -28.75 14.44 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 120.714 0.292 . . . . 2.29 111.031 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 3' ' ' LYS . 34.7 p -65.19 -34.6 78.76 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.606 -1.257 . . . . 2.0600000000000001 107.606 168.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.583 HD11 ' HG2' ' A' ' 158' ' ' PRO . 96.4 mt -78.15 126.37 83.65 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 113.053 -1.885 . . . . 1.0900000000000001 111.016 176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.47 96.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 120.92 1.08 . . . . 0.22 110.248 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 73' ' ' SER . 82.9 m-85 -158.87 136.77 10.39 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.463 -1.31 . . . . 0.80000000000000004 107.463 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 26.2 t-80 -141.75 108.18 5.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.603 -1.258 . . . . 3.5800000000000001 107.603 -169.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.0 mt -95.11 109.83 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.974 -1.012 . . . . 1.0600000000000001 110.317 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.53 95.42 5.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.181 -0.918 . . . . 1.1200000000000001 110.013 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -114.34 97.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.362 -1.29 . . . . 0.68000000000000005 109.325 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.472 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 32.0 m -92.05 130.37 37.8 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.898 -1.046 . . . . 1.3300000000000001 108.584 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.493 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.9 mm -60.2 -34.96 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.768 0.794 . . . . 1.77 109.042 177.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.38 91.24 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.475 -1.238 . . . . 0.93999999999999995 111.337 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.472 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.11 -24.35 64.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.265 0.555 . . . . 1.22 112.217 176.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 30.4 mttt 55.39 18.06 2.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.159 0.984 . . . . 2.9399999999999999 112.798 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -141.26 140.58 33.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.78 0.8 . . . . 1.0600000000000001 110.982 175.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.448 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -94.06 117.58 30.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.267 -1.333 . . . . 1.0900000000000001 109.516 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 m -101.05 126.27 47.72 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.439 -0.504 . . . . 1.0900000000000001 111.189 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -82.74 147.73 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.126 -1.805 . . . . 1.0800000000000001 106.126 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 20.0 m -150.94 130.82 13.28 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 120.238 1.381 . . . . 0.93000000000000005 112.329 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.9 tp -122.02 125.2 45.75 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.921 -1.036 . . . . 1.1399999999999999 110.697 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 66.06 35.14 6.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.539 0.685 . . . . 0.52000000000000002 109.321 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.3 m120 82.19 2.0 1.33 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.183 -1.371 . . . . 1.8400000000000001 111.719 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -131.52 140.46 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 118.756 -1.178 . . . . 3.8500000000000001 113.623 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -54.4 148.28 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 113.017 -1.901 . . . . 0.40999999999999998 112.788 -177.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.528 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.3 mtp -98.51 -42.74 7.17 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 112.734 -2.03 . . . . 1.0900000000000001 108.275 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 179.32 159.47 0.67 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.226 -2.261 . . . . 2.6200000000000001 110.135 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.499 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 11.8 m -119.14 133.26 55.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.588 0.232 . . . . 1.1000000000000001 111.238 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 1.608 ' HE1' ' CE2' ' A' ' 82' ' ' TYR . 48.6 m-85 -117.38 145.44 36.09 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.541 . . . . 1.0600000000000001 109.538 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -82.09 144.34 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.308 2.005 . . . . 0.85999999999999999 111.722 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.45 173.27 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.675 -0.491 . . . . 1.2 109.675 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 121.38 0.61 . . . . 1.4099999999999999 110.966 177.502 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.66 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 4.4 m-85 . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 107.841 -1.17 . . . . 2.3500000000000001 107.841 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.652 ' HA ' ' O ' ' A' ' 161' ' ' THR . 60.6 m-85 -130.67 140.49 50.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.113 0.482 . . . . 0.92000000000000004 110.879 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.483 HD13 HD13 ' A' ' 125' ' ' ILE . 19.0 mm -59.76 104.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.194 -1.039 . . . . 1.0600000000000001 108.194 166.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.5 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.5 tt -103.01 -24.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 120.221 -0.592 . . . . 1.04 112.191 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 6.5 t-20 -155.23 157.73 37.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.133 1.16 . . . . 2.3500000000000001 114.133 -172.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.31 133.73 26.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 111.767 -2.47 . . . . 1.54 110.262 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.579 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 33.5 tp60 -106.27 141.79 37.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.069 -0.969 . . . . 1.8899999999999999 111.386 -173.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 17.7 ttt180 -54.69 150.76 9.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.075 -1.875 . . . . 3.46 112.434 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -45.19 100.36 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.507 0 O-C-N 124.931 1.395 . . . . 3.3500000000000001 111.58 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -55.37 -50.02 14.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.886 3.058 . . . . 0.97999999999999998 112.242 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.26 -13.16 23.71 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.02 -0.991 . . . . 1.0800000000000001 112.256 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.75 -170.44 13.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.829 -0.7 . . . . 1.1599999999999999 112.773 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.64 18.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 124.69 3.593 . . . . 1.46 114.61 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.622 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 1.4 t80 -72.36 -16.13 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.256 0.55 . . . . 2.1000000000000001 109.655 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.88 42.71 2.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 1.1100000000000001 114.061 170.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.435 ' O ' ' HD2' ' A' ' 114' ' ' TYR . . . 73.59 -39.05 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.307 0.854 . . . . 1.45 113.307 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.3 OUTLIER -151.55 144.79 24.69 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 122.719 0.408 . . . . 1.5 109.93 -174.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.579 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 47.8 t-105 -117.07 104.44 11.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.873 -0.417 . . . . 2.6000000000000001 109.873 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.3 mp -105.95 137.1 44.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.546 0.688 . . . . 1.3100000000000001 110.707 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.1 m -105.09 145.18 30.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.334 -0.848 . . . . 1.3100000000000001 112.266 -170.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.53 -174.67 3.1 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.907 -1.146 . . . . 1.8600000000000001 107.907 171.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.47 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 33.7 m . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 113.764 1.024 . . . . 1.95 113.764 -172.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 40.0 mt . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 108.976 -0.75 . . . . 1.05 108.976 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -140.93 -167.65 2.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.752 0.787 . . . . 1.25 112.65 -172.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.453 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.62 179.86 16.05 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.586 -1.188 . . . . 0.46000000000000002 113.221 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -144.65 174.6 10.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.49 0.662 . . . . 1.21 111.563 -165.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -110.85 -13.23 14.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.923 -1.035 . . . . 1.8600000000000001 109.557 162.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -124.39 101.6 34.13 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.72 -0.673 . . . . 1.8200000000000001 109.633 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -92.22 3.6 3.82 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.213 2.609 . . . . 0.64000000000000001 113.682 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.07 -19.24 40.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.33 0.586 . . . . 1.3200000000000001 110.458 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -87.7 -7.12 57.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.57 -0.741 . . . . 1.8899999999999999 110.223 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.4 mm . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.238 -0.892 . . . . 1.21 111.369 -174.134 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.425 ' HE3' ' HB2' ' A' ' 145' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 109.784 -0.45 . . . . 1.8700000000000001 109.784 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.545 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 30.4 m-70 -66.84 152.69 45.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.251 -0.648 . . . . 3.25 109.251 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -50.5 -61.55 2.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.302 0.376 . . . . 2.4199999999999999 111.101 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.19 -28.54 70.12 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.89 -0.506 . . . . 2.5699999999999998 111.63 -175.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.545 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 1.5 m-20 -67.12 -41.96 85.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 1.05 110.777 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.705 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 13.5 p -77.03 -16.38 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.32000000000000001 110.716 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -89.15 -39.68 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 119.109 -0.472 . . . . 1.1299999999999999 110.679 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -43.69 -68.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.402 1.001 . . . . 1.3799999999999999 111.825 163.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.451 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -49.96 -43.11 49.9 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.638 -0.71 . . . . 1.3400000000000001 110.271 177.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.705 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -54.16 -52.8 60.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.406 -1.27 . . . . 1.02 112.25 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.8 p -77.44 -15.94 59.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.548 -1.206 . . . . 1.9099999999999999 111.214 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.5 -48.62 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.731 -0.47 . . . . 1.04 109.731 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.455 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 25.8 m -77.48 118.87 74.85 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-O 121.946 0.879 . . . . 0.20999999999999999 110.559 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.583 ' HG2' HD11 ' A' ' 57' ' ' ILE . 35.3 Cg_endo -83.6 -177.85 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.177 2.585 . . . . 0.51000000000000001 112.533 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.714 ' O ' HD22 ' A' ' 51' ' ' LEU . 15.0 m120 -61.56 3.84 0.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.977 -1.01 . . . . 1.02 113.52 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.94 58.13 0.46 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.64000000000000001 112.379 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.652 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.78 135.92 33.41 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 122.547 -0.384 . . . . 1.0700000000000001 110.452 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -83.88 125.51 32.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.79 -0.187 . . . . 2.3399999999999999 110.546 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 4.2 p -138.15 127.43 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.439 0.637 . . . . 0.46000000000000002 111.28 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.7 m -118.22 140.36 49.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.654 -0.703 . . . . 1.26 111.721 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.17 110.25 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 118.919 -1.112 . . . . 1.1699999999999999 110.524 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.593 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.476 -0.784 . . . . 1.1899999999999999 111.354 -170.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.5 mptp? . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.632 -0.507 . . . . 2.54 109.632 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.551 HD12 ' H ' ' A' ' 50' ' ' GLY . 15.7 mt -99.4 170.81 8.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.425 -0.352 . . . . 1.1000000000000001 111.458 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.538 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.2 tp -77.86 150.95 34.1 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.334 0.654 . . . . 1.05 112.358 -170.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.538 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.86 149.47 40.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.055 0.931 . . . . 1.01 112.295 169.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 78.7 t80 -133.1 147.73 52.15 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 113.595 -1.639 . . . . 1.1200000000000001 107.596 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.68 113.65 16.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.036 -1.468 . . . . 1.72 107.036 175.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.48 156.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.066 0.46 . . . . 0.38 111.89 -166.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -104.96 146.71 28.66 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.491 -0.777 . . . . 3.0600000000000001 109.23 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.539 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 3.2 tt0 -50.55 106.18 0.12 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.846 -1.07 . . . . 2.1699999999999999 112.894 -173.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.15 15.17 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.407 -0.815 . . . . 0.63 112.812 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.508 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 17.3 m-20 -62.36 154.57 27.64 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.345 0.498 . . . . 2.1699999999999999 112.345 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.448 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.2 p -131.64 155.37 47.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.008 0.433 . . . . 1.27 111.989 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.581 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.7 tp -49.03 -60.12 3.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.098 1.147 . . . . 1.0800000000000001 114.098 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.733 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 3.1 t-20 -65.21 -38.72 91.3 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.011 0.91 . . . . 1.55 110.572 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 t -58.61 -50.36 74.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 113.154 -1.839 . . . . 1.8200000000000001 109.19 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -67.72 -38.48 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 O-C-N 123.584 0.553 . . . . 1.0600000000000001 111.975 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -60.16 4.07 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.97999999999999998 110.994 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.79 58.57 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.67 -1.212 . . . . 1.0700000000000001 112.15 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.532 ' HB3' ' O ' ' A' ' 119' ' ' SER . 11.3 m-20 -62.61 -34.33 76.81 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.859 -1.163 . . . . 1.6299999999999999 107.859 156.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -99.98 17.54 20.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.396 0.517 . . . . 0.25 112.396 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 50.44 53.77 12.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 4.2000000000000002 111.13 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 37.1 pt -147.77 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.045 -0.724 . . . . 1.02 109.045 -173.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -98.78 144.17 28.31 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.333 -0.849 . . . . 1.1599999999999999 109.57 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.733 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.9 p -62.89 -37.15 85.79 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.564 0.697 . . . . 1.05 109.21 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.14 -27.89 69.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.104 -1.407 . . . . 1.05 111.343 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.89 -37.52 26.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.231 0.538 . . . . 1.03 109.862 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.3 tp -73.8 -19.83 60.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.205 -0.907 . . . . 1.05 109.009 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.649 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.98 -37.74 38.65 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.332 0.586 . . . . 1.0600000000000001 111.235 172.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.5 mt-30 -56.89 -42.85 80.62 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.25 1.024 . . . . 1.26 109.686 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.65 -20.58 35.99 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.536 -1.666 . . . . 1.01 112.523 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 31.7 m-80 -142.04 72.16 23.09 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.009 0.433 . . . . 0.20000000000000001 109.994 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.6 -9.36 5.27 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.586 2.857 . . . . 0.29999999999999999 113.954 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -63.78 -33.63 76.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.028 0.918 . . . . 1.3600000000000001 109.845 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -80.6 -4.75 55.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.206 -1.361 . . . . 1.26 114.46 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.649 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -50.52 -39.41 48.69 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 122.561 1.172 . . . . 1.8899999999999999 110.035 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.491 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -86.57 -45.87 10.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 112.921 -1.945 . . . . 1.1000000000000001 111.523 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 176.08 -167.55 39.3 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.155 -1.021 . . . . 0.29999999999999999 114.295 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.3 mp -115.86 157.92 23.73 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.511 -1.345 . . . . 1.0800000000000001 110.571 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.609 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 48.8 m -130.34 134.74 47.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.74 -0.664 . . . . 1.1699999999999999 110.394 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -48.99 129.95 17.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.98 0.733 . . . . 1.1699999999999999 112.98 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 -13.82 35.89 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 114.792 -1.095 . . . . 0.38 112.054 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.609 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.2 tt0 -63.02 152.38 37.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.744 0.783 . . . . 1.1899999999999999 110.323 175.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.428 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 31.1 m -119.42 131.88 55.72 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.365 -1.289 . . . . 1.22 109.403 -171.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.0 pt -133.46 155.82 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.248 0.547 . . . . 1.0600000000000001 110.522 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.516 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.4 t -101.38 148.73 6.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.239 -0.891 . . . . 0.20999999999999999 110.176 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.435 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 16.8 mm -117.17 87.69 24.52 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.767 -1.106 . . . . 1.01 108.099 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.523 ' HA ' HD12 ' A' ' 4' ' ' LEU . 21.7 Cg_endo -58.63 145.82 93.94 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.387 2.725 . . . . 0.23000000000000001 112.627 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.551 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 78.61 -6.16 54.33 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.911 -0.586 . . . . 0.29999999999999999 112.831 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -116.06 125.41 28.62 Favored Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.707 -0.849 . . . . 1.0800000000000001 108.707 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.565 ' CD ' HD21 ' A' ' 51' ' ' LEU . 55.6 Cg_endo -64.92 174.2 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.616 2.878 . . . . 0.34000000000000002 113.752 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.412 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 1.8 t70 -91.13 140.43 25.87 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 114.88 -1.054 . . . . 0.71999999999999997 111.686 -170.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.484 ' HD3' HD11 ' A' ' 5' ' ' LEU . 63.0 Cg_endo -84.09 -7.58 10.12 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.316 2.677 . . . . 0.33000000000000002 113.474 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 55' ' ' TYR . 74.2 m-85 -90.65 -29.27 17.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.924 0.392 . . . . 2.29 110.437 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -80.69 -13.73 58.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.749 0.785 . . . . 2.0600000000000001 109.02 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 158' ' ' PRO . 66.8 mt -85.91 126.95 64.18 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 114.679 -1.146 . . . . 1.0900000000000001 109.839 171.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' O ' HD13 ' A' ' 74' ' ' LEU . 18.2 Cg_endo -101.61 94.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.948 0 CA-C-N 119.972 1.026 . . . . 0.22 110.659 170.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.796 ' HA ' ' O ' ' A' ' 73' ' ' SER . 92.6 m-85 -158.56 139.65 13.09 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.981 -1.463 . . . . 0.80000000000000004 107.236 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 55.9 m-70 -139.19 117.77 12.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.916 -1.513 . . . . 3.5800000000000001 106.916 -176.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.423 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 79.6 mt -98.88 109.34 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.085 -0.646 . . . . 1.0600000000000001 110.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.65 98.94 7.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.918 0.865 . . . . 1.1200000000000001 110.896 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.499 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.3 p -121.01 98.44 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.012 -1.449 . . . . 0.68000000000000005 110.606 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.477 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 68.8 m -92.03 115.49 28.12 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.419 -1.326 . . . . 1.3300000000000001 107.419 170.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 mt -54.05 -26.0 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 121.122 0.487 . . . . 1.77 110.167 172.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.58 -48.43 62.64 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.795 -0.717 . . . . 0.93999999999999995 112.237 169.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -63.34 -22.48 66.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.451 0.643 . . . . 1.22 110.849 171.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 64' ' ' SER . 9.0 tmtt? 64.35 11.03 6.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.6 -1.182 . . . . 2.9399999999999999 112.603 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.455 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -145.12 143.43 30.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.591 0.71 . . . . 1.0600000000000001 112.183 176.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.499 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.8 tt -95.72 122.27 38.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.197 -1.365 . . . . 1.0900000000000001 109.952 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.26 125.74 50.07 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.487 -0.485 . . . . 1.0900000000000001 111.61 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -83.21 150.62 26.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.426 -1.694 . . . . 1.0800000000000001 106.426 175.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.796 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 1.4 m -150.84 128.5 11.55 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.335 1.425 . . . . 0.93000000000000005 111.786 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 58' ' ' PRO . 21.0 tp -115.01 126.91 55.29 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.496 -0.775 . . . . 1.1399999999999999 110.222 174.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.58 35.29 11.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.392 0.615 . . . . 0.52000000000000002 109.666 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.39 7.77 5.17 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.02 -0.991 . . . . 1.8400000000000001 112.367 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -129.89 138.26 50.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.755 -1.178 . . . . 3.8500000000000001 113.649 170.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -54.71 150.06 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 113.551 -1.659 . . . . 0.40999999999999998 112.963 -172.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.514 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 3.6 mtp -103.36 -41.15 6.11 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.745 -2.025 . . . . 1.0900000000000001 108.476 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -175.29 170.28 3.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 112.868 -1.969 . . . . 2.6200000000000001 111.1 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.455 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 16.0 m -131.02 129.42 42.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.684 -0.235 . . . . 1.1000000000000001 110.93 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.504 ' CD1' ' HE1' ' A' ' 145' ' ' MET . 85.7 m-85 -115.77 150.43 44.86 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 122.32 0.248 . . . . 1.0600000000000001 110.948 -175.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -84.92 141.07 8.23 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.838 2.359 . . . . 0.85999999999999999 112.1 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.46 -177.12 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.057 -0.519 . . . . 1.2 110.412 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.617 -0.512 . . . . 1.4099999999999999 109.617 176.295 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.627 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 19.6 m-85 . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.269 0.557 . . . . 2.3500000000000001 110.531 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.628 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 65.2 m-85 -131.46 141.26 49.76 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.255 -0.884 . . . . 0.92000000000000004 109.969 172.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.465 HD13 HD13 ' A' ' 125' ' ' ILE . 24.0 mm -59.87 114.36 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 N-CA-C 107.47 -1.307 . . . . 1.0600000000000001 107.47 165.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.91 -27.41 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.551 -0.86 . . . . 1.04 112.018 -176.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.686 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 60.0 t30 -172.41 -172.64 0.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.663 1.22 . . . . 2.3500000000000001 113.481 -175.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.686 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.3 ptt180 -155.45 131.71 10.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 111.693 -2.503 . . . . 1.54 109.711 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.74 157.34 17.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.58 1.181 . . . . 1.8899999999999999 112.227 -171.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 106' ' ' ASN . 37.0 ttt180 -53.93 154.78 3.81 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 112.485 -2.143 . . . . 3.46 112.473 170.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 105' ' ' ARG . 9.3 p30 -44.03 105.72 0.46 Allowed Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 112.925 -1.943 . . . . 3.3500000000000001 111.346 175.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.424 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 88.7 Cg_exo -56.75 -53.31 5.26 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.653 2.902 . . . . 0.97999999999999998 112.309 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.62 37.68 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.206 -0.906 . . . . 1.0800000000000001 112.599 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.85 -170.37 24.36 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.915 -0.66 . . . . 1.1599999999999999 111.89 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.15 49.56 0.34 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.992 3.128 . . . . 1.46 113.127 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.653 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -93.85 -21.1 19.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.059 0.456 . . . . 2.1000000000000001 110.026 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.523 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 46.62 2.04 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.53 -0.759 . . . . 1.1100000000000001 113.986 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.62 -24.53 0.21 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.192 0.812 . . . . 1.45 113.192 170.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.615 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -154.43 151.33 28.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.261 -0.274 . . . . 1.5 110.261 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -118.02 100.25 7.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.788 -0.819 . . . . 2.6000000000000001 108.788 165.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.5 mp -101.85 139.24 37.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.801 0.81 . . . . 1.3100000000000001 110.32 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.0 m -106.68 144.96 32.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.916 -1.038 . . . . 1.3100000000000001 112.378 -168.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 73.0 mt -102.24 -176.84 3.23 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.648 -1.16 . . . . 1.8600000000000001 108.464 173.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.532 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 49.6 m . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 111.803 0.297 . . . . 1.95 111.803 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.585 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 23.1 mt . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.254 -0.647 . . . . 1.05 109.254 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -153.51 -162.22 1.42 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.405 0.621 . . . . 1.25 111.498 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.523 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.63 179.57 16.38 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.158 -1.02 . . . . 0.46000000000000002 112.779 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -135.13 174.83 10.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.453 0.644 . . . . 1.21 111.185 -167.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -107.74 -23.0 12.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.92 -1.036 . . . . 1.8600000000000001 108.994 168.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.41 104.63 28.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 114.756 -1.111 . . . . 1.8200000000000001 109.616 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.8 Cg_endo -89.97 4.5 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.213 2.609 . . . . 0.64000000000000001 113.185 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.84 -21.91 29.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.389 0.614 . . . . 1.3200000000000001 109.453 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.2 t -76.76 -18.18 58.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.079 -0.964 . . . . 1.8899999999999999 109.317 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 23.4 mm . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.096 -0.957 . . . . 1.21 110.275 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.504 ' HE1' ' CD1' ' A' ' 82' ' ' TYR . 4.9 mtp . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.79 0.329 . . . . 1.8700000000000001 110.581 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -78.4 161.46 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.106 -0.701 . . . . 3.25 109.106 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -52.42 -68.13 0.19 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.398 0.436 . . . . 2.4199999999999999 110.987 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -58.12 -30.89 66.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.098 0.407 . . . . 2.5699999999999998 112.098 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -67.07 -41.5 86.31 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.906 0.384 . . . . 1.05 110.975 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 7.3 p -78.38 -15.27 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 0.32000000000000001 110.637 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.39 -41.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 118.749 -0.643 . . . . 1.1299999999999999 110.414 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -44.36 -68.72 0.17 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.543 1.065 . . . . 1.3799999999999999 112.244 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.444 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -49.94 -43.46 49.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.927 -0.579 . . . . 1.3400000000000001 110.169 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -53.17 -54.66 32.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.074 -1.421 . . . . 1.02 111.929 -171.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -79.95 -14.4 58.63 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.574 -1.194 . . . . 1.9099999999999999 110.779 -170.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.65 -48.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.987 -0.375 . . . . 1.04 109.987 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.1 m -76.33 119.35 76.93 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-O 121.672 0.748 . . . . 0.20999999999999999 110.294 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.554 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.8 Cg_endo -83.1 -178.07 3.63 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.154 2.569 . . . . 0.51000000000000001 112.872 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.616 ' O ' HD22 ' A' ' 51' ' ' LEU . 21.6 m120 -61.44 0.06 0.34 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.104 -0.953 . . . . 1.02 113.142 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.84 58.02 0.52 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.767 -0.73 . . . . 0.64000000000000001 112.519 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.542 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 3.5 m -95.26 133.98 38.54 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.327 -0.513 . . . . 1.0700000000000001 110.206 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.7 134.17 34.36 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 2.3399999999999999 110.353 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.4 p -140.57 123.73 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.024 -0.989 . . . . 0.46000000000000002 110.79 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.463 ' C ' HD11 ' A' ' 165' ' ' ILE . 93.0 m -118.09 141.57 48.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.494 -0.775 . . . . 1.26 111.782 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.463 HD11 ' C ' ' A' ' 164' ' ' THR . 2.9 mp -125.13 123.31 65.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 118.845 -1.142 . . . . 1.1699999999999999 112.258 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 107.989 -1.115 . . . . 1.1899999999999999 107.989 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.6 mptp? . . . . . 0 CA--C 1.52 -0.207 0 N-CA-C 109.929 -0.397 . . . . 2.54 109.929 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.588 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.6 mt -100.11 169.92 8.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.188 0.305 . . . . 1.1000000000000001 111.439 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.6 tp -75.86 150.23 37.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 123.076 0.55 . . . . 1.05 112.17 -170.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.501 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.38 149.26 38.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 122.11 0.957 . . . . 1.01 111.921 167.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 67.8 t80 -132.84 149.41 52.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.538 -1.665 . . . . 1.1200000000000001 107.863 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.578 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.1 119.67 25.81 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.628 -1.619 . . . . 1.72 106.628 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.99 158.56 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-O 121.227 0.537 . . . . 0.38 111.554 -170.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -110.16 155.44 21.95 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.554 -0.906 . . . . 3.0600000000000001 108.554 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.465 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 47.7 tt0 -52.53 122.34 8.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 2.1699999999999999 112.14 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.99 -9.08 36.68 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.99 -1.004 . . . . 0.63 112.724 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.526 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 94.7 m-20 -67.42 151.23 47.77 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.935 0.398 . . . . 2.1699999999999999 112.058 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -132.6 157.33 45.05 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 112.282 0.475 . . . . 1.27 112.282 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.9 tp -49.96 -59.75 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.95 1.092 . . . . 1.0800000000000001 113.95 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.713 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.4 t-20 -65.83 -38.3 88.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.298 1.047 . . . . 1.55 110.476 -168.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 t -57.09 -54.93 41.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 113.143 -1.844 . . . . 1.8200000000000001 109.233 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.72 -38.76 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 115.531 -0.759 . . . . 1.0600000000000001 112.086 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.86 -63.73 1.11 Allowed 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 116.048 -0.523 . . . . 0.97999999999999998 111.279 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.66 -3.93 54.83 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.803 -1.159 . . . . 1.0700000000000001 112.011 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -66.97 -27.34 67.37 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.81 -0.811 . . . . 1.6299999999999999 108.81 156.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -103.07 18.31 21.99 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.861 -0.524 . . . . 0.25 111.968 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 50.34 54.81 10.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.195 -0.911 . . . . 4.2000000000000002 110.918 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 37.1 pt -148.26 -173.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.597 -0.89 . . . . 1.02 108.597 -173.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -100.96 143.63 30.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.29 -0.868 . . . . 1.1599999999999999 109.319 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.713 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.8 p -61.05 -35.27 76.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.453 0.645 . . . . 1.05 109.503 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.94 -30.69 71.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.482 -1.236 . . . . 1.05 111.396 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.78 30.5 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.224 0.535 . . . . 1.03 109.631 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 15.0 tp -73.17 -19.3 61.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.417 -0.81 . . . . 1.05 109.022 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.572 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.61 36.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.315 0.578 . . . . 1.0600000000000001 111.237 172.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 51.6 mt-30 -58.01 -42.52 85.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.227 1.013 . . . . 1.26 109.727 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.69 -20.71 38.94 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 113.478 -1.692 . . . . 1.01 112.489 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.637 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 30.9 m-80 -143.43 73.48 17.5 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.20000000000000001 109.949 -172.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.726 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.7 Cg_endo -57.36 -12.05 9.73 Favored 'Trans proline' 0 C--O 1.221 -0.372 0 C-N-CA 123.573 2.849 . . . . 0.29999999999999999 114.003 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -62.47 -34.23 76.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.106 0.955 . . . . 1.3600000000000001 109.119 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.3 mt -78.44 -6.7 56.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.117 -1.402 . . . . 1.26 114.448 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.726 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -50.99 -42.55 60.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 120.019 1.281 . . . . 1.8899999999999999 109.478 176.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.84 15.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 112.894 -1.957 . . . . 1.1000000000000001 111.601 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.86 -164.4 35.81 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.264 -0.969 . . . . 0.29999999999999999 114.243 176.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.85 158.96 23.11 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.274 -1.463 . . . . 1.0800000000000001 109.905 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 93.2 m -136.53 135.63 38.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.912 -0.585 . . . . 1.1699999999999999 110.77 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -45.27 126.61 6.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.267 0.84 . . . . 1.1699999999999999 113.267 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.578 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.57 -12.52 46.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.588 -1.187 . . . . 0.38 112.388 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.565 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.7 tt0 -63.2 152.08 38.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.597 0.713 . . . . 1.1899999999999999 110.455 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.441 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 49.9 m -119.87 132.27 55.51 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.668 -1.151 . . . . 1.22 109.612 -171.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.403 ' CG1' ' HB3' ' A' ' 7' ' ' TYR . 18.9 pt -132.91 160.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.156 0.503 . . . . 1.0600000000000001 110.319 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.637 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 21.7 t -107.05 148.45 11.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.221 -0.899 . . . . 0.20999999999999999 109.943 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 15.0 mm -116.66 88.5 25.02 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.957 -1.019 . . . . 1.01 108.277 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' HD12 ' A' ' 4' ' ' LEU . 27.5 Cg_endo -59.3 142.66 99.43 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.304 2.669 . . . . 0.23000000000000001 113.02 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.588 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 81.29 -7.56 60.43 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.447 -0.797 . . . . 0.29999999999999999 112.9 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.652 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.48 126.15 28.06 Favored Pre-proline 0 C--O 1.218 -0.567 0 N-CA-C 108.936 -0.764 . . . . 1.0800000000000001 108.936 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.544 ' CD ' HD21 ' A' ' 51' ' ' LEU . 48.8 Cg_endo -64.48 176.56 2.67 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.939 3.093 . . . . 0.34000000000000002 114.198 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.571 ' HB3' HG21 ' A' ' 56' ' ' THR . 4.3 t70 -90.74 141.99 27.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.84 -1.073 . . . . 0.71999999999999997 110.646 -170.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.498 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 63.1 Cg_endo -86.81 -4.61 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.352 2.702 . . . . 0.33000000000000002 112.158 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 55' ' ' TYR . 67.6 m-85 -95.06 -28.67 14.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 2.29 110.59 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.571 HG21 ' HB3' ' A' ' 53' ' ' ASP . 14.9 t -79.43 -14.1 59.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.024 -1.102 . . . . 2.0600000000000001 108.024 172.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.572 HD11 ' HG2' ' A' ' 158' ' ' PRO . 71.8 mt -91.54 126.22 55.03 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.118 -1.401 . . . . 1.0900000000000001 109.77 170.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -103.13 95.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.146 0 CA-C-N 120.036 1.048 . . . . 0.22 110.117 166.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -158.96 138.66 11.78 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.645 -1.613 . . . . 0.80000000000000004 106.645 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.573 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 12.6 t60 -147.69 121.83 9.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 3.5800000000000001 108.147 -169.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.4 mt -103.39 111.13 31.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 114.643 -1.162 . . . . 1.0600000000000001 110.853 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.27 94.29 4.86 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.077 0.941 . . . . 1.1200000000000001 110.14 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.502 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -116.95 98.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 113.82 -1.537 . . . . 0.68000000000000005 109.819 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.494 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 38.7 m -90.19 113.13 24.86 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.672 -1.233 . . . . 1.3300000000000001 107.672 175.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 mm -46.46 -37.49 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.111 -0.495 . . . . 1.77 109.845 170.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.31 -42.05 99.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.076 -1.059 . . . . 0.93999999999999995 112.247 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.494 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.97 -23.96 62.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.051 1.13 . . . . 1.22 114.051 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.6 mptt 61.83 11.4 4.06 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.819 0.848 . . . . 2.9399999999999999 112.866 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.62 137.42 31.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.143 0.973 . . . . 1.0600000000000001 112.232 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.502 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.97 119.87 34.23 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.455 -1.702 . . . . 1.0900000000000001 109.621 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.96 124.53 47.74 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.104 -0.639 . . . . 1.0900000000000001 111.538 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.587 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -83.26 134.73 34.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.168 -1.79 . . . . 1.0800000000000001 106.168 175.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.573 ' OG ' ' HB3' ' A' ' 60' ' ' HIS . 33.6 p -143.39 125.75 15.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 120.943 1.701 . . . . 0.93000000000000005 113.334 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 tp -110.48 124.42 51.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.351 -1.295 . . . . 1.1399999999999999 110.116 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.46 33.12 7.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.602 0.715 . . . . 0.52000000000000002 109.077 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 m120 77.5 4.48 3.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.23 -1.35 . . . . 1.8400000000000001 111.6 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -129.27 138.08 51.43 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.689 -1.205 . . . . 3.8500000000000001 113.504 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -57.22 148.66 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 113.054 -1.884 . . . . 0.40999999999999998 112.975 -172.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.587 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.2 mtp -100.4 -41.91 6.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.581 -2.099 . . . . 1.0900000000000001 108.393 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? 179.98 160.19 0.85 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.442 -2.163 . . . . 2.6200000000000001 110.39 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -121.65 133.23 54.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.385 0.136 . . . . 1.1000000000000001 110.789 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 73.0 m-85 -118.81 149.13 45.92 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 120.831 0.348 . . . . 1.0600000000000001 111.623 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 9.9 Cg_endo -80.36 141.49 14.3 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.752 2.301 . . . . 0.85999999999999999 111.738 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.48 173.82 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.442 -0.577 . . . . 1.2 109.442 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.135 0.493 . . . . 1.4099999999999999 111.653 -177.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.631 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 15.7 m-85 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.734 -0.469 . . . . 2.3500000000000001 109.734 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.622 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 65.8 m-85 -135.69 141.07 44.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.592 -0.731 . . . . 0.92000000000000004 109.75 172.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 23.7 mm -59.56 116.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 107.469 -1.308 . . . . 1.0600000000000001 107.469 167.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.9 tt -103.18 -28.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.361 -0.936 . . . . 1.04 112.026 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -172.36 -169.96 0.67 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 114.923 1.453 . . . . 2.3500000000000001 114.923 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.501 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.3 ptp180 -151.92 131.12 12.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 111.634 -2.53 . . . . 1.54 109.378 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.27 156.81 17.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.245 1.021 . . . . 1.8899999999999999 111.531 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -53.18 152.26 4.48 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.562 -2.108 . . . . 3.46 112.42 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -44.98 104.85 0.41 Allowed Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 113.854 -1.521 . . . . 3.3500000000000001 111.48 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -55.19 -51.19 10.72 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.971 3.114 . . . . 0.97999999999999998 112.291 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.76 -20.2 34.5 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.999 -1.0 . . . . 1.0800000000000001 112.181 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -103.43 -169.84 25.74 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.193 -0.527 . . . . 1.1599999999999999 112.174 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.98 15.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 124.434 3.423 . . . . 1.46 114.094 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -67.93 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.949 0.404 . . . . 2.1000000000000001 110.64 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.436 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 45.58 2.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 1.1100000000000001 114.186 170.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.06 -22.57 0.26 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.305 0.854 . . . . 1.45 113.305 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -157.84 151.95 24.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.732 0.301 . . . . 1.5 110.373 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -120.92 102.43 8.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 2.6000000000000001 109.583 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -106.59 137.28 44.88 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.236 0.541 . . . . 1.3100000000000001 110.413 176.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.2 m -106.15 145.17 31.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.507 -0.77 . . . . 1.3100000000000001 112.726 -170.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.37 -174.19 3.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.703 -1.221 . . . . 1.8600000000000001 107.703 170.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 52.9 m . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 118.806 0.73 . . . . 1.95 112.08 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.632 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 47.2 mt . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 107.905 -1.146 . . . . 1.05 107.905 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -138.98 -162.83 1.37 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.35 0.595 . . . . 1.25 111.542 -173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.436 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.92 178.28 16.39 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.844 -1.17 . . . . 0.46000000000000002 113.654 -175.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.4 t -144.54 176.41 9.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.487 0.661 . . . . 1.21 111.263 -167.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -108.06 -15.15 14.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.72 -1.127 . . . . 1.8600000000000001 109.715 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.13 103.73 29.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.555 -0.748 . . . . 1.8200000000000001 109.976 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -90.52 4.58 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.168 2.579 . . . . 0.64000000000000001 112.9 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.46 -16.25 46.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.322 0.582 . . . . 1.3200000000000001 110.324 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -98.19 7.15 46.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.652 -0.704 . . . . 1.8899999999999999 109.912 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 26.2 mm . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.384 -0.825 . . . . 1.21 111.244 -176.006 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.425 ' HE3' ' HB3' ' A' ' 149' ' ' ASP . 10.8 ptm . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.082 -0.34 . . . . 1.8700000000000001 110.082 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.524 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 22.1 m170 -73.52 154.53 39.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.939 -0.393 . . . . 3.25 109.939 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -50.31 -68.05 0.2 Allowed 'General case' 0 C--O 1.221 -0.412 0 O-C-N 123.318 0.386 . . . . 2.4199999999999999 111.43 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -60.41 -29.41 68.96 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.782 -0.574 . . . . 2.5699999999999998 111.699 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.524 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 2.2 m-20 -66.72 -41.95 87.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.732 0.301 . . . . 1.05 110.956 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.689 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 12.3 p -75.86 -18.93 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 116.311 -0.404 . . . . 0.32000000000000001 110.615 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -86.89 -39.94 13.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 119.014 -0.517 . . . . 1.1299999999999999 110.154 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -45.33 -66.26 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.52 1.054 . . . . 1.3799999999999999 111.949 165.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.2 tp -53.17 -42.69 66.44 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.838 -0.619 . . . . 1.3400000000000001 110.107 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -52.32 -54.84 26.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.384 -1.28 . . . . 1.02 111.735 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 32.8 t -75.46 -16.46 60.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.822 -1.081 . . . . 1.9099999999999999 110.491 -172.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.2 mt -90.94 -53.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.787 -0.449 . . . . 1.04 109.787 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.7 m -77.45 114.79 43.82 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 122.194 0.997 . . . . 0.20999999999999999 110.212 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.572 ' HG2' HD11 ' A' ' 57' ' ' ILE . 54.6 Cg_endo -81.13 -179.12 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.911 2.407 . . . . 0.51000000000000001 112.715 -173.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.652 ' O ' HD22 ' A' ' 51' ' ' LEU . 17.1 m120 -59.63 -0.24 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.827 -1.079 . . . . 1.02 113.404 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.23 59.02 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.834 -0.698 . . . . 0.64000000000000001 112.435 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -95.03 134.89 37.21 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.523 -0.398 . . . . 1.0700000000000001 110.219 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 131.83 34.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.859 0.362 . . . . 2.3399999999999999 110.499 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.8 p -140.24 123.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.579 -0.737 . . . . 0.46000000000000002 111.471 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.2 m -111.6 138.53 48.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.805 -0.634 . . . . 1.26 111.074 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.0 mp -122.37 117.2 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 118.461 -1.296 . . . . 1.1699999999999999 111.059 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.625 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 123.263 1.506 . . . . 1.1899999999999999 110.154 -175.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 121.037 0.446 . . . . 2.54 111.223 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.583 HD12 ' H ' ' A' ' 50' ' ' GLY . 15.4 mt -97.95 168.63 10.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.088 -0.96 . . . . 1.1000000000000001 110.886 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 6' ' ' THR . 2.3 tp -80.71 151.42 28.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.411 0.684 . . . . 1.05 112.407 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.507 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -117.3 151.33 37.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.997 0.903 . . . . 1.01 112.364 169.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.648 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 78.4 t80 -134.56 148.74 50.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.701 -1.59 . . . . 1.1200000000000001 107.917 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.623 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -127.33 121.15 30.25 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.012 -1.477 . . . . 1.72 107.012 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -83.06 158.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.243 0.544 . . . . 0.38 112.011 -170.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -109.43 150.37 28.18 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.838 -0.801 . . . . 3.0600000000000001 108.838 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.97 114.1 1.21 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.89 -0.595 . . . . 2.1699999999999999 112.004 -174.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -10.07 21.65 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.677 -0.773 . . . . 0.63 112.944 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.478 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 9.6 m-20 -62.62 154.51 28.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.028 0.414 . . . . 2.1699999999999999 111.82 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.412 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -132.53 152.0 51.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 1.27 112.153 -177.492 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.586 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.4 tp -48.04 -57.76 5.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.425 0.898 . . . . 1.0800000000000001 113.425 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.676 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.5 t-20 -66.05 -39.5 90.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 1.55 110.308 -169.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -59.4 -47.62 84.75 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 113.106 -1.861 . . . . 1.8200000000000001 109.902 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -69.64 -39.36 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.513 -0.767 . . . . 1.0600000000000001 112.205 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.0 -57.79 11.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.97999999999999998 110.934 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.6 -4.35 57.54 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.683 -1.207 . . . . 1.0700000000000001 112.147 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 42.2 m-20 -61.85 -36.38 81.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.902 -1.148 . . . . 1.6299999999999999 107.902 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.478 ' CD1' HD11 ' A' ' 101' ' ' ILE . 2.2 m-85 -99.75 15.82 25.61 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.899 0.703 . . . . 0.25 112.899 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.05 50.99 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 4.2000000000000002 110.684 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 36.8 pt -146.65 -174.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.692 -0.855 . . . . 1.02 108.692 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -100.2 143.76 30.01 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.231 -0.895 . . . . 1.1599999999999999 109.293 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.676 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.4 p -60.97 -35.09 75.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 121.4 0.619 . . . . 1.05 109.399 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.95 -31.51 72.72 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.507 -1.224 . . . . 1.05 111.657 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.85 -37.89 39.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.406 0.622 . . . . 1.03 109.574 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.4 tp -73.97 -20.47 60.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.042 -0.981 . . . . 1.05 109.066 175.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.558 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.91 -39.13 43.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.431 0.634 . . . . 1.0600000000000001 111.582 172.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 55.2 mt-30 -59.18 -42.23 90.34 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.163 0.983 . . . . 1.26 109.649 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.53 -18.89 43.47 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.535 -1.666 . . . . 1.01 112.32 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.552 HD22 ' H ' ' A' ' 47' ' ' VAL . 29.7 m-80 -143.77 71.9 17.11 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.20000000000000001 109.881 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.62 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 12.2 Cg_endo -55.64 -13.56 8.4 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 123.696 2.931 . . . . 0.29999999999999999 114.318 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -61.9 -35.72 79.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.02 0.914 . . . . 1.3600000000000001 109.798 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.635 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -76.76 -6.64 53.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.341 -1.3 . . . . 1.26 114.362 -170.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -49.23 -40.68 34.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.527 1.156 . . . . 1.8899999999999999 110.485 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.41 -45.65 11.67 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.054 -1.885 . . . . 1.1000000000000001 111.627 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.3 -163.87 34.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.479 -0.867 . . . . 0.29999999999999999 114.238 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.97 158.04 26.53 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.444 -1.378 . . . . 1.0800000000000001 110.512 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.571 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 71.3 m -133.22 136.48 45.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.873 -0.603 . . . . 1.1699999999999999 110.964 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -44.73 126.17 5.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 1.1699999999999999 113.312 173.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.623 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.84 -12.49 48.23 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.558 -1.201 . . . . 0.38 112.16 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.571 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.9 tt0 -62.75 150.81 40.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.741 0.781 . . . . 1.1899999999999999 110.294 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.8 m -120.42 130.85 54.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.328 -1.305 . . . . 1.22 109.544 -170.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.86 148.65 31.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.338 0.589 . . . . 1.0600000000000001 110.697 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.552 ' H ' HD22 ' A' ' 33' ' ' ASN . 13.2 t -94.1 149.02 4.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.078 -0.965 . . . . 0.20999999999999999 110.383 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 18.9 mm -117.44 87.72 26.06 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 114.771 -1.104 . . . . 1.01 108.384 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' HD12 ' A' ' 4' ' ' LEU . 28.2 Cg_endo -59.38 143.82 99.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.214 2.609 . . . . 0.23000000000000001 112.737 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.583 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 80.46 -7.6 56.95 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.569 -0.741 . . . . 0.29999999999999999 112.977 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.708 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -115.92 127.1 27.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.711 -0.848 . . . . 1.0800000000000001 108.711 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.2 Cg_endo -66.47 174.91 5.65 Favored 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 123.793 2.996 . . . . 0.34000000000000002 114.005 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 10.6 t70 -90.45 141.53 27.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.263 -0.88 . . . . 0.71999999999999997 110.734 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HD3' HD13 ' A' ' 5' ' ' LEU . 90.5 Cg_endo -83.84 -9.51 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.33000000000000002 112.438 -175.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' A' ' 55' ' ' TYR . 64.0 m-85 -95.09 -27.08 15.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 2.29 110.25 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 53' ' ' ASP . 30.6 p -68.14 -32.34 72.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.591 -1.263 . . . . 2.0600000000000001 107.591 170.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.594 HD11 ' HG2' ' A' ' 158' ' ' PRO . 89.5 mt -76.27 127.86 83.93 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 113.242 -1.799 . . . . 1.0900000000000001 110.476 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -101.84 95.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.856 0 C-N-CA 120.846 1.031 . . . . 0.22 110.479 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.648 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.4 m-85 -158.38 139.25 12.98 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.952 -1.499 . . . . 0.80000000000000004 106.952 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 34.2 t-80 -145.27 107.15 4.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.789 -1.189 . . . . 3.5800000000000001 107.789 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 163' ' ' VAL . 69.9 mt -94.93 109.64 22.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.254 -1.339 . . . . 1.0600000000000001 110.302 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.94 94.73 5.09 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.987 0.898 . . . . 1.1200000000000001 110.175 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 p -110.35 97.3 5.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.183 -1.372 . . . . 0.68000000000000005 109.256 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.445 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 67.1 m -93.43 108.52 20.18 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.756 -1.111 . . . . 1.3300000000000001 108.074 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -46.38 -32.2 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.293 0.637 . . . . 1.77 112.613 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.16 -44.91 93.3 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.155 -1.022 . . . . 0.93999999999999995 111.476 172.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -69.82 -23.28 63.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.768 -0.716 . . . . 1.22 111.754 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttt 59.97 16.94 6.2 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.042 0.937 . . . . 2.9399999999999999 113.056 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.59 140.32 37.01 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.919 0.866 . . . . 1.0600000000000001 111.404 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.42 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.6 tt -95.67 120.17 35.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.029 -1.441 . . . . 1.0900000000000001 109.7 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -101.79 125.82 48.54 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.147 -0.621 . . . . 1.0900000000000001 111.289 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -83.37 147.45 27.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.559 -1.645 . . . . 1.0800000000000001 106.559 175.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 24.3 m -150.96 132.77 15.01 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 120.407 1.458 . . . . 0.93000000000000005 112.712 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp -120.42 125.9 49.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.989 -1.005 . . . . 1.1399999999999999 110.731 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 65.7 34.53 7.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.52000000000000002 109.393 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.7 m120 79.87 3.46 2.06 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.377 -1.283 . . . . 1.8400000000000001 111.754 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -130.9 139.07 50.06 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 118.803 -1.159 . . . . 3.8500000000000001 113.75 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -52.76 149.69 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 113.112 -1.858 . . . . 0.40999999999999998 112.884 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.487 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.9 mtp -98.91 -43.98 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.643 -2.071 . . . . 1.0900000000000001 108.263 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? 179.26 154.71 0.47 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.33 -2.214 . . . . 2.6200000000000001 110.332 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.1 m -115.11 135.57 54.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.464 0.173 . . . . 1.1000000000000001 110.754 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.632 ' CG ' ' HE1' ' A' ' 145' ' ' MET . 88.2 m-85 -125.34 131.97 24.19 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 1.0600000000000001 110.608 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.58 146.37 79.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.793 2.328 . . . . 0.85999999999999999 111.748 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.39 179.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.218 -0.66 . . . . 1.2 109.218 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.816 0 C-N-CA 119.199 -1.0 . . . . 1.4099999999999999 109.877 174.702 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.63 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 17.8 m-85 . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 107.431 -1.322 . . . . 2.3500000000000001 107.431 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.755 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.3 m-85 -127.19 136.45 52.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.925 -0.31 . . . . 0.92000000000000004 110.477 175.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.468 HD13 HD13 ' A' ' 125' ' ' ILE . 11.7 mm -58.1 108.18 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 108.042 -1.096 . . . . 1.0600000000000001 108.042 169.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.478 HD11 ' CD1' ' A' ' 22' ' ' PHE . 2.0 tt -108.4 -27.31 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 112.813 0.672 . . . . 1.04 112.813 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 26.2 t-20 -156.33 161.2 40.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 122.675 1.226 . . . . 2.3500000000000001 114.046 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.625 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 134.14 36.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 111.678 -2.51 . . . . 1.54 109.177 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 16.0 tm0? -114.66 145.23 42.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.022 0.915 . . . . 1.8899999999999999 111.055 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -50.1 154.37 1.18 Allowed 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 112.828 -1.987 . . . . 3.46 112.391 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -43.84 100.32 0.23 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 CA-C-O 121.557 0.694 . . . . 3.3500000000000001 111.185 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.45 ' HG3' ' OE1' ' A' ' 104' ' ' GLN . 90.2 Cg_exo -55.99 -51.01 10.54 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.18 3.253 . . . . 0.97999999999999998 112.794 -173.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.89 16.87 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.146 -0.934 . . . . 1.0800000000000001 112.15 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -106.13 -171.15 23.22 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.697 -0.763 . . . . 1.1599999999999999 112.347 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.93 33.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 124.621 3.547 . . . . 1.46 114.422 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -77.61 -32.19 53.35 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.068 0.461 . . . . 2.1000000000000001 110.695 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.471 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.82 42.78 2.79 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.598 -0.728 . . . . 1.1100000000000001 113.333 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.83 -17.07 0.54 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.53 0.937 . . . . 1.45 113.53 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.628 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -156.87 131.38 8.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 110.042 -0.355 . . . . 1.5 110.042 176.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.9 t-105 -99.23 101.17 12.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.743 -0.836 . . . . 2.6000000000000001 108.743 167.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.765 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.3 mp -106.95 135.64 48.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.281 0.562 . . . . 1.3100000000000001 110.168 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.3 m -106.36 144.42 33.07 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.625 -0.716 . . . . 1.3100000000000001 112.175 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -177.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.415 -1.328 . . . . 1.8600000000000001 107.415 164.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--N 1.318 -0.778 0 N-CA-C 112.445 0.535 . . . . 1.95 112.445 -175.52 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.765 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 43.0 mt . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.687 -0.857 . . . . 1.05 108.687 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -144.34 -163.81 1.76 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.789 -0.765 . . . . 1.25 112.148 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.471 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.05 -174.94 15.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.929 -1.129 . . . . 0.46000000000000002 113.541 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -141.9 173.66 11.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.454 0.645 . . . . 1.21 111.333 -165.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.88 -18.59 14.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.131 -0.941 . . . . 1.8600000000000001 108.645 164.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -127.26 101.66 24.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.891 -1.05 . . . . 1.8200000000000001 110.3 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.1 Cg_endo -92.14 3.83 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.138 2.558 . . . . 0.64000000000000001 112.801 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.01 -30.29 24.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.01 0.433 . . . . 1.3200000000000001 110.254 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 m -85.52 -2.66 58.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 1.8899999999999999 110.384 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 8.0 mm . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 115.476 -0.784 . . . . 1.21 110.12 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.632 ' HE1' ' CG ' ' A' ' 82' ' ' TYR . 7.3 mtp . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.243 0.544 . . . . 1.8700000000000001 111.14 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -73.83 146.46 44.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.082 -0.963 . . . . 3.25 108.739 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -52.16 -65.33 0.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.219 0.451 . . . . 2.4199999999999999 112.219 -171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -59.22 -25.05 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.65 -0.656 . . . . 2.5699999999999998 111.476 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.61 -35.78 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 1.05 110.765 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.692 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 10.8 p -77.94 -17.01 14.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.691 0 CA-C-N 116.529 -0.305 . . . . 0.32000000000000001 110.25 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.9 -39.11 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 119.073 -0.489 . . . . 1.1299999999999999 109.914 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -44.72 -69.48 0.13 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 119.148 0.885 . . . . 1.3799999999999999 112.178 163.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.44 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -50.36 -44.34 54.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.68 -0.691 . . . . 1.3400000000000001 110.303 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -55.65 -50.04 71.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.141 -1.39 . . . . 1.02 112.109 -171.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 p -77.58 -17.21 58.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.724 -1.126 . . . . 1.9099999999999999 111.111 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.42 -46.2 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.933 -0.576 . . . . 1.04 109.528 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.47 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 30.6 m -76.51 120.95 83.88 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-O 121.669 0.747 . . . . 0.20999999999999999 110.459 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.594 ' HG2' HD11 ' A' ' 57' ' ' ILE . 27.4 Cg_endo -85.59 -177.71 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.384 2.723 . . . . 0.51000000000000001 112.841 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.708 ' O ' HD22 ' A' ' 51' ' ' LEU . 15.7 m120 -60.09 3.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.775 -1.102 . . . . 1.02 113.895 -175.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -149.65 57.8 0.46 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.635 -0.793 . . . . 0.64000000000000001 112.641 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.755 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.71 134.26 34.55 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.472 -0.428 . . . . 1.0700000000000001 111.173 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -84.39 128.5 34.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.055 -0.521 . . . . 2.3399999999999999 110.622 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 3.2 p -141.83 129.58 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.542 0.526 . . . . 0.46000000000000002 111.347 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.9 m -122.95 143.86 49.63 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.515 0.561 . . . . 1.26 112.515 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.92 115.86 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.19 -1.004 . . . . 1.1699999999999999 112.352 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.612 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 114.958 -1.019 . . . . 1.1899999999999999 109.73 -172.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.232 -0.655 . . . . 2.54 109.232 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.576 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.1 mt -90.73 167.72 12.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.211 -0.449 . . . . 1.1000000000000001 111.069 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.537 HD11 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -74.19 148.57 41.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.216 0.531 . . . . 1.05 111.65 -170.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.525 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.38 148.67 37.31 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.794 0.806 . . . . 1.01 111.257 168.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.664 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 69.1 t80 -134.04 148.03 51.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.009 -1.45 . . . . 1.1200000000000001 107.61 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.8 tt0 -127.84 111.21 13.37 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.657 -1.609 . . . . 1.72 106.657 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.471 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -72.18 157.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.219 0.533 . . . . 0.38 111.39 -165.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -107.64 148.43 29.35 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.461 -0.79 . . . . 3.0600000000000001 109.291 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.513 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -46.53 116.96 1.44 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 2.1699999999999999 112.631 -173.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.35 -8.94 38.39 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.967 -1.015 . . . . 0.63 113.514 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 83.1 m-20 -61.46 155.03 22.8 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.973 0.731 . . . . 2.1699999999999999 112.973 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.453 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.2 p -134.32 159.11 41.99 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.949 -0.569 . . . . 1.27 111.73 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.6 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 46.6 tp -52.68 -57.71 9.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.948 1.092 . . . . 1.0800000000000001 113.948 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.724 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 2.0 t30 -66.71 -43.19 84.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 122.309 1.052 . . . . 1.55 110.558 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 37.5 t -57.77 -47.96 81.03 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 112.988 -1.915 . . . . 1.8200000000000001 109.797 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.511 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -68.75 -40.65 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.795 -0.639 . . . . 1.0600000000000001 111.89 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.28 -65.55 0.59 Allowed 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.97999999999999998 111.541 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.89 -4.73 55.87 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.768 -1.173 . . . . 1.0700000000000001 112.273 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -67.62 -27.28 66.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.93 -0.767 . . . . 1.6299999999999999 108.93 157.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.429 ' HD1' ' CD1' ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.6 15.37 26.87 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.804 -0.56 . . . . 0.25 112.146 172.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 56.28 50.94 12.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.495 -0.775 . . . . 4.2000000000000002 110.662 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 39.3 pt -149.14 -173.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.909 -0.775 . . . . 1.02 108.909 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.04 147.61 23.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.415 -0.811 . . . . 1.1599999999999999 110.017 172.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.724 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.4 p -62.56 -36.46 82.71 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.654 -0.869 . . . . 1.05 108.654 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -28.83 68.74 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.665 -1.152 . . . . 1.05 111.539 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.22 30.84 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.524 -0.547 . . . . 1.03 109.524 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 12.7 tp -71.98 -20.42 61.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.563 -0.744 . . . . 1.05 109.007 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.662 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -38.36 40.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.47 0.652 . . . . 1.0600000000000001 111.381 172.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -59.25 -42.46 91.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.998 0.904 . . . . 1.26 109.84 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.95 -16.26 51.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.843 -1.526 . . . . 1.01 112.01 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 33.2 m-80 -139.99 69.94 35.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.624 -0.51 . . . . 0.20000000000000001 109.624 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.46 -21.9 19.77 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 124.533 3.489 . . . . 0.29999999999999999 115.422 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -69.64 -34.12 73.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 119.458 1.026 . . . . 1.3600000000000001 110.293 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.602 ' CD2' ' HB3' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -65.05 -6.7 9.42 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.422 -1.263 . . . . 1.26 113.635 -172.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.662 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.12 -40.68 24.34 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.475 1.131 . . . . 1.8899999999999999 110.351 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.54 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -82.37 -46.15 13.93 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.98 -1.918 . . . . 1.1000000000000001 111.642 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.41 -161.78 31.82 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.118 -1.039 . . . . 0.29999999999999999 114.396 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.456 HD21 ' HB ' ' A' ' 9' ' ' VAL . 6.5 mp -118.6 158.27 25.78 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.704 -1.748 . . . . 1.0800000000000001 110.542 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 98.7 m -133.6 133.69 42.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.799 -0.637 . . . . 1.1699999999999999 110.55 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -47.22 127.15 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.789 0.662 . . . . 1.1699999999999999 112.789 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.47 52.9 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.796 -1.093 . . . . 0.38 112.506 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.1 tt0 -65.28 152.66 43.2 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.643 0.735 . . . . 1.1899999999999999 110.219 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 42.0 m -119.24 131.76 55.84 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.61 -1.177 . . . . 1.22 109.542 -171.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.2 pt -136.49 151.34 28.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.339 0.59 . . . . 1.0600000000000001 110.698 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.538 ' H ' HD22 ' A' ' 33' ' ' ASN . 5.3 t -94.56 148.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.156 -0.929 . . . . 0.20999999999999999 110.703 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 15.7 mm -117.44 88.74 29.63 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 114.599 -1.182 . . . . 1.01 108.418 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.545 ' HA ' HD12 ' A' ' 4' ' ' LEU . 24.6 Cg_endo -59.02 143.8 99.65 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.186 2.591 . . . . 0.23000000000000001 112.769 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.576 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 80.83 -6.88 60.68 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.29999999999999999 113.035 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.708 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.9 tt -116.65 129.97 24.88 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.334 -0.987 . . . . 1.0800000000000001 108.334 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.573 ' CD ' HD21 ' A' ' 51' ' ' LEU . 73.2 Cg_endo -69.45 171.08 14.76 Favored 'Trans proline' 0 N--CA 1.475 0.41 0 C-N-CA 123.583 2.855 . . . . 0.34000000000000002 113.906 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 3.1 t70 -91.6 138.05 25.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 0.71999999999999997 112.297 -171.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HD3' HD11 ' A' ' 5' ' ' LEU . 69.4 Cg_endo -84.4 -4.27 10.15 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 123.684 2.923 . . . . 0.33000000000000002 113.351 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.661 ' HD1' ' CD2' ' A' ' 55' ' ' TYR . 58.3 m-85 -94.96 -25.15 16.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.853 0.359 . . . . 2.29 110.9 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.7 t -86.06 -13.0 48.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.448 0.642 . . . . 2.0600000000000001 109.42 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.59 HD11 ' HG2' ' A' ' 158' ' ' PRO . 81.3 mt -85.61 124.42 71.3 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.198 -0.91 . . . . 1.0900000000000001 110.034 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -101.25 95.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.811 0.968 . . . . 0.22 110.109 169.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -158.37 137.13 11.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.55 -1.648 . . . . 0.80000000000000004 106.55 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 71.8 t60 -144.19 109.89 5.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.851 -1.166 . . . . 3.5800000000000001 107.851 -167.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 70.2 mt -95.14 107.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.394 -1.276 . . . . 1.0600000000000001 109.864 -177.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.5 94.24 4.9 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.048 0.927 . . . . 1.1200000000000001 110.244 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -113.95 98.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 113.825 -1.534 . . . . 0.68000000000000005 109.202 178.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.474 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 55.2 m -91.0 123.76 34.72 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.805 -1.183 . . . . 1.3300000000000001 107.805 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 5.8 mt -60.6 -26.98 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.571 0.7 . . . . 1.77 110.214 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.53 -47.08 64.44 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 114.96 -1.018 . . . . 0.93999999999999995 111.477 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.474 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -66.36 -23.92 66.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.114 0.483 . . . . 1.22 111.908 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 2.7 mtpt 59.13 12.48 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.256 1.023 . . . . 2.9399999999999999 113.169 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.98 143.23 38.44 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.647 0.736 . . . . 1.0600000000000001 110.902 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.47 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.6 tt -96.8 119.1 34.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.319 -1.31 . . . . 1.0900000000000001 109.635 -177.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -102.59 126.51 49.69 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.244 -0.582 . . . . 1.0900000000000001 111.317 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.551 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.71 141.9 32.07 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.436 -1.69 . . . . 1.0800000000000001 106.436 175.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.5 m -145.98 128.81 16.33 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.481 1.491 . . . . 0.93000000000000005 112.377 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -118.07 125.49 50.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.982 -1.008 . . . . 1.1399999999999999 110.291 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.49 33.36 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.13 -0.692 . . . . 0.52000000000000002 109.13 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.6 m120 77.57 3.88 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.374 -1.285 . . . . 1.8400000000000001 111.592 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -130.47 138.52 50.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 118.779 -1.168 . . . . 3.8500000000000001 113.368 170.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -53.2 150.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 113.107 -1.86 . . . . 0.40999999999999998 112.957 -174.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.551 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.8 mtp -99.03 -43.88 6.51 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.543 -2.117 . . . . 1.0900000000000001 108.21 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -177.52 157.6 1.29 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.427 -2.169 . . . . 2.6200000000000001 109.863 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -117.59 130.65 56.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.723 0.297 . . . . 1.1000000000000001 110.8 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -114.99 143.11 29.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.355 -0.384 . . . . 1.0600000000000001 110.337 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -81.67 140.61 11.82 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.298 1.999 . . . . 0.85999999999999999 111.156 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.27 -172.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.323 -0.399 . . . . 1.2 111.085 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 1.4099999999999999 110.03 175.394 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.617 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 19.1 m-85 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 107.61 -1.256 . . . . 2.3500000000000001 107.61 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 161' ' ' THR . 46.9 m-85 -128.78 139.07 52.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.761 0.315 . . . . 0.92000000000000004 110.221 173.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.466 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 16.3 mm -58.66 104.59 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.273 -1.01 . . . . 1.0600000000000001 108.273 169.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.429 ' CD1' ' HD1' ' A' ' 22' ' ' PHE . 2.5 tt -93.17 -25.86 4.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.009 -0.676 . . . . 1.04 112.337 -170.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -169.4 -179.51 3.49 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 114.936 1.458 . . . . 2.3500000000000001 114.936 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.9 175.8 10.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 111.079 -2.782 . . . . 1.54 108.517 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.78 155.27 39.84 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.462 1.125 . . . . 1.8899999999999999 113.311 -164.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -52.54 149.73 5.62 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.64 -2.073 . . . . 3.46 111.109 166.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.14 107.03 0.71 Allowed Pre-proline 0 CA--C 1.514 -0.407 0 CA-C-N 115.825 -0.625 . . . . 3.3500000000000001 111.928 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -59.2 -51.62 6.29 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 123.627 2.885 . . . . 0.97999999999999998 112.896 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.45 -21.64 44.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.2 -0.909 . . . . 1.0800000000000001 111.575 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -93.79 -170.1 38.57 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.357 -0.449 . . . . 1.1599999999999999 112.137 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.3 21.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 124.648 3.565 . . . . 1.46 114.69 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.666 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -75.73 -18.5 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.369 . . . . 2.1000000000000001 111.136 179.041 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 82.51 49.42 5.18 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.78 -0.646 . . . . 1.1100000000000001 113.326 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.93 -20.56 0.37 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.222 0.823 . . . . 1.45 113.222 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -155.77 144.54 20.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 1.5 110.861 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -111.87 102.16 10.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.342 -0.614 . . . . 2.6000000000000001 109.342 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.664 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -106.47 137.01 45.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.537 0.685 . . . . 1.3100000000000001 109.839 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.9 m -106.75 144.46 33.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.412 -0.813 . . . . 1.3100000000000001 112.272 -171.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.98 -175.04 4.21 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.19 -1.411 . . . . 1.8600000000000001 107.19 169.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.316 -0.871 0 C-N-CA 119.775 -0.77 . . . . 1.95 111.861 -178.323 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.664 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 27.8 mt . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 108.78 -0.822 . . . . 1.05 108.78 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -139.68 -163.27 1.47 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.329 0.585 . . . . 1.25 111.441 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.03 163.51 14.47 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.058 -1.068 . . . . 0.46000000000000002 113.597 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.7 t -120.45 170.87 8.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.711 -0.745 . . . . 1.21 111.608 -168.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.98 -22.21 13.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.926 -1.034 . . . . 1.8600000000000001 108.586 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -124.88 104.56 30.05 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 114.837 -1.074 . . . . 1.8200000000000001 109.642 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.58 4.22 7.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.96 2.44 . . . . 0.64000000000000001 112.783 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.21 -11.0 47.97 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.98 -0.748 . . . . 1.3200000000000001 108.98 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.7 m -78.52 -26.65 45.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.011 -0.995 . . . . 1.8899999999999999 109.439 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 27.1 mm . . . . . 0 N--CA 1.451 -0.383 0 CA-C-N 115.354 -0.839 . . . . 1.21 110.041 175.915 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 111.721 0.267 . . . . 1.8700000000000001 111.721 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -67.33 148.1 52.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.493 -0.188 . . . . 3.25 110.493 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -50.8 -68.09 0.2 Allowed 'General case' 0 C--O 1.221 -0.408 0 O-C-N 123.529 0.518 . . . . 2.4199999999999999 110.962 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.383 0.512 . . . . 2.5699999999999998 112.383 -173.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.55 -37.99 62.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.579 0.228 . . . . 1.05 111.14 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.737 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 9.5 p -75.85 -15.2 15.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 110.11 -0.33 . . . . 0.32000000000000001 110.11 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -89.79 -39.65 12.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.101 -0.476 . . . . 1.1299999999999999 110.582 172.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -44.44 -68.63 0.18 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.574 1.079 . . . . 1.3799999999999999 112.137 164.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.407 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.4 tp -50.0 -43.11 50.41 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.904 0.753 . . . . 1.3400000000000001 110.092 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -53.24 -53.67 47.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.296 -1.32 . . . . 1.02 112.464 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.2 t -76.74 -16.99 59.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.843 -1.072 . . . . 1.9099999999999999 110.618 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.7 mt -91.28 -49.58 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.768 -0.456 . . . . 1.04 109.768 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.423 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 22.5 m -77.98 116.27 57.26 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-O 121.855 0.835 . . . . 0.20999999999999999 110.119 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.59 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -83.01 -178.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.052 2.501 . . . . 0.51000000000000001 112.327 -175.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.708 ' O ' HD22 ' A' ' 51' ' ' LEU . 14.2 m120 -64.93 7.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.905 -1.043 . . . . 1.02 113.337 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -146.64 53.98 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.941 -0.647 . . . . 0.64000000000000001 112.156 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.0 m -88.17 135.8 33.27 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.47 -0.429 . . . . 1.0700000000000001 110.863 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 162' ' ' ARG . 9.0 mtm180 -84.75 122.08 28.6 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.783 -0.644 . . . . 2.3399999999999999 110.351 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 3.6 p -134.74 127.74 49.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.46000000000000002 111.594 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 m -118.67 140.06 50.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.474 -0.785 . . . . 1.26 111.902 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -124.65 114.71 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 118.887 -1.125 . . . . 1.1699999999999999 110.75 174.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.622 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.878 0 CA-C-N 114.917 -1.038 . . . . 1.1899999999999999 110.268 -173.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 108.428 -0.953 . . . . 2.54 108.428 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.603 HD12 ' H ' ' A' ' 50' ' ' GLY . 19.8 mt -99.2 172.37 7.41 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.396 0.435 . . . . 1.1000000000000001 111.756 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.3 tp -75.86 150.73 37.57 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.176 0.59 . . . . 1.05 111.84 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.526 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.06 150.58 35.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.978 0.894 . . . . 1.01 111.927 167.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.666 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 68.1 t80 -133.16 149.62 52.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.656 -1.611 . . . . 1.1200000000000001 108.014 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.88 116.38 19.33 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 106.405 -1.702 . . . . 1.72 106.405 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.48 158.03 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.446 0.641 . . . . 0.38 111.786 -169.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.63 152.04 26.07 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.145 -0.934 . . . . 3.0600000000000001 108.804 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.498 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.6 111.3 0.57 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 2.1699999999999999 111.795 -174.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -9.17 20.56 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.141 -0.936 . . . . 0.63 113.015 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.473 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 74.8 m-20 -66.48 147.13 53.73 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.327 0.563 . . . . 2.1699999999999999 112.25 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.485 ' O ' HD12 ' A' ' 18' ' ' ILE . 2.0 p -134.44 163.75 28.99 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.257 0.466 . . . . 1.27 112.257 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -49.94 -62.06 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.367 1.247 . . . . 1.0800000000000001 114.367 -171.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.701 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.2 t-20 -64.99 -41.14 95.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.49 1.138 . . . . 1.55 110.305 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.9 t -57.42 -48.15 79.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.472 -2.149 . . . . 1.8200000000000001 109.858 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -70.15 -40.4 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 123.668 0.787 . . . . 1.0600000000000001 112.456 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.33 -65.07 0.67 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.397 -0.365 . . . . 0.97999999999999998 111.535 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.85 -5.06 54.73 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.743 -1.183 . . . . 1.0700000000000001 111.83 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 17' ' ' SER . 17.3 t70 -65.19 -32.88 74.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.329 -0.989 . . . . 1.6299999999999999 108.329 158.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.4 m-85 -97.83 14.96 25.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.196 0.443 . . . . 0.25 112.196 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 58.46 47.93 12.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 4.2000000000000002 110.741 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 39.1 pt -147.89 -175.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.918 -0.771 . . . . 1.02 108.918 -173.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 146.22 26.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.362 -0.835 . . . . 1.1599999999999999 109.467 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.701 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 10.3 p -62.17 -37.39 85.09 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.933 -0.766 . . . . 1.05 108.933 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.559 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.75 -30.29 71.4 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.192 -1.367 . . . . 1.05 111.281 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.93 -37.94 33.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 1.03 109.778 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.1 tp -73.69 -20.09 60.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 1.05 109.206 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.609 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.93 -38.82 44.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.65 0.738 . . . . 1.0600000000000001 111.435 172.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 57.4 mt-30 -59.53 -41.9 91.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.288 1.042 . . . . 1.26 109.744 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.42 -20.74 39.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.565 -1.652 . . . . 1.01 112.315 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 26.8 m-80 -142.34 73.25 21.25 Favored Pre-proline 0 CA--C 1.513 -0.449 0 CA-C-O 121.196 0.522 . . . . 0.20000000000000001 110.099 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.703 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.3 Cg_endo -58.37 -10.03 7.9 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 123.239 2.626 . . . . 0.29999999999999999 113.926 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -62.59 -31.06 71.81 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.972 0.892 . . . . 1.3600000000000001 109.564 173.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 3.2 mt -83.14 -7.01 59.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.679 1.363 . . . . 1.26 114.679 -172.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.703 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -49.54 -40.92 39.86 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 120.03 1.286 . . . . 1.8899999999999999 110.151 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 -46.64 12.84 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.886 -1.961 . . . . 1.1000000000000001 111.511 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.42 -165.93 37.61 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.295 -0.955 . . . . 0.29999999999999999 114.472 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 15' ' ' LEU . 4.5 mp -113.71 158.47 20.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.412 -1.394 . . . . 1.0800000000000001 110.252 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -136.97 134.16 36.39 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.786 -0.643 . . . . 1.1699999999999999 110.65 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -49.05 129.36 17.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.475 0.655 . . . . 1.1699999999999999 112.736 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.578 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 83.2 -11.49 54.76 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.561 -1.199 . . . . 0.38 112.766 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.634 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -61.48 158.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.194 0.521 . . . . 1.1899999999999999 110.134 172.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.472 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 58.7 p -123.24 137.85 54.77 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.96 -1.018 . . . . 1.22 110.468 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' THR . 12.3 pt -135.13 171.6 17.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.287 0.565 . . . . 1.0600000000000001 111.266 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.582 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 19.1 t -114.2 149.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.731 -1.122 . . . . 0.20999999999999999 109.533 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 18.4 mm -118.27 88.29 32.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.183 -0.917 . . . . 1.01 108.711 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.47 139.88 92.38 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.387 2.725 . . . . 0.23000000000000001 113.203 -173.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.603 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 83.22 -7.37 67.8 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.424 -0.807 . . . . 0.29999999999999999 112.867 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.57 124.27 30.22 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.578 -0.897 . . . . 1.0800000000000001 108.578 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.54 ' CD ' HD21 ' A' ' 51' ' ' LEU . 57.0 Cg_endo -65.31 176.34 3.36 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.75 2.967 . . . . 0.34000000000000002 113.939 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.6 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 3.2 t70 -89.6 140.97 28.26 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.801 -1.091 . . . . 0.71999999999999997 110.139 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.6 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 88.0 Cg_endo -81.86 -1.16 10.74 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.367 2.711 . . . . 0.33000000000000002 111.725 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -28.83 14.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.898 -0.592 . . . . 2.29 110.772 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 53' ' ' ASP . 34.1 p -69.41 -28.4 66.12 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 122.617 1.199 . . . . 2.0600000000000001 107.905 170.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.585 HD11 ' HG2' ' A' ' 158' ' ' PRO . 96.8 mt -84.16 124.75 73.81 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.899 -1.955 . . . . 1.0900000000000001 110.648 175.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -101.57 95.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 CA-C-N 119.841 0.979 . . . . 0.22 109.847 166.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -157.74 131.75 8.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.925 -1.509 . . . . 0.80000000000000004 106.925 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 3.5 m-70 -140.48 113.55 8.38 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.436 -1.32 . . . . 3.5800000000000001 107.436 -164.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.456 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.7 mt -102.23 111.22 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.723 -0.671 . . . . 1.0600000000000001 111.307 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.96 98.86 7.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.227 -0.897 . . . . 1.1200000000000001 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -116.55 99.71 8.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.174 -1.375 . . . . 0.68000000000000005 109.559 177.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.452 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 54.2 m -94.46 133.08 38.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.071 -0.968 . . . . 1.3300000000000001 109.199 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -35.63 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.595 0.712 . . . . 1.77 110.676 176.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.85 -43.4 97.67 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.905 -1.043 . . . . 0.93999999999999995 110.956 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -71.32 -25.27 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.825 0.676 . . . . 1.22 112.825 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 mttt 54.03 17.07 1.28 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.913 0.885 . . . . 2.9399999999999999 112.961 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.42 141.59 35.5 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.525 0.678 . . . . 1.0600000000000001 111.051 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.466 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.2 tt -96.25 117.47 30.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.473 -1.239 . . . . 1.0900000000000001 109.675 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 m -100.73 127.51 47.12 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.17 -0.468 . . . . 1.0900000000000001 111.227 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -81.94 146.84 29.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.275 -1.75 . . . . 1.0800000000000001 106.275 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 36.5 m -150.31 127.02 10.95 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 120.351 1.432 . . . . 0.93000000000000005 112.442 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.07 125.25 53.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.492 -1.231 . . . . 1.1399999999999999 110.088 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 4.7 t-20 60.73 42.25 13.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.152 0.501 . . . . 0.52000000000000002 110.166 174.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.7 m-20 74.64 -1.46 3.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.993 -1.003 . . . . 1.8400000000000001 112.731 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -128.69 135.76 49.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 117.845 -1.542 . . . . 3.8500000000000001 114.115 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -56.55 149.17 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 112.7 -2.045 . . . . 0.40999999999999998 113.027 -170.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.55 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.2 mtp -101.02 -43.03 6.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.581 -2.1 . . . . 1.0900000000000001 108.566 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.81 159.1 0.57 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.617 -2.083 . . . . 2.6200000000000001 110.342 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.497 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.1 m -117.07 135.55 53.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.392 0.139 . . . . 1.1000000000000001 111.165 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -124.08 135.03 25.88 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-O 120.792 0.329 . . . . 1.0600000000000001 110.778 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -62.49 145.27 95.53 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.385 2.723 . . . . 0.85999999999999999 113.268 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.94 169.38 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.091 -0.504 . . . . 1.2 109.675 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.297 0.57 . . . . 1.4099999999999999 110.902 175.249 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.649 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 7.1 m-85 . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 109.76 -0.459 . . . . 2.3500000000000001 109.76 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 95.6 m-85 -139.02 143.33 38.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.92000000000000004 110.385 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.474 HD13 HD13 ' A' ' 125' ' ' ILE . 22.6 mm -59.96 126.08 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.54 -1.281 . . . . 1.0600000000000001 107.54 164.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.472 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -124.02 -23.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.653 -0.819 . . . . 1.04 112.808 -174.25 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 15.7 t-20 -161.3 161.34 30.56 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.328 1.233 . . . . 2.3500000000000001 114.328 -173.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 1.0 OUTLIER -147.0 128.74 15.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 111.579 -2.555 . . . . 1.54 109.515 174.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.669 ' HB3' ' CD1' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -109.26 161.54 15.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.562 1.172 . . . . 1.8899999999999999 111.542 -171.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.553 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 9.4 ttm180 -49.79 152.67 1.45 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.929 -2.396 . . . . 3.46 112.544 171.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.553 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-20 -45.26 114.72 2.33 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-N 114.556 -1.202 . . . . 3.3500000000000001 111.628 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.502 ' HG3' ' NE1' ' A' ' 115' ' ' TRP . 85.3 Cg_exo -51.19 -48.16 22.44 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 C-N-CA 124.082 3.188 . . . . 0.97999999999999998 112.441 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.59 -4.26 59.7 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.441 -1.254 . . . . 1.0800000000000001 112.025 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -139.52 -171.55 12.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.989 -0.624 . . . . 1.1599999999999999 112.736 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.64 20.15 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.724 3.616 . . . . 1.46 114.973 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.65 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 46.6 t80 -74.55 -11.2 60.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.216 0.531 . . . . 2.1000000000000001 110.21 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.89 38.16 3.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.705 -0.76 . . . . 1.1100000000000001 114.31 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 73.25 -23.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.541 1.311 . . . . 1.45 114.541 166.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.635 ' HE2' ' CE1' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -152.16 148.96 28.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.832 0.349 . . . . 1.5 111.175 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.669 ' CD1' ' HB3' ' A' ' 104' ' ' GLN . 0.1 OUTLIER -110.4 101.6 10.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.489 -0.93 . . . . 2.6000000000000001 108.489 171.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -111.44 138.18 48.27 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.073 -0.651 . . . . 1.3100000000000001 110.252 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.0 t -107.32 151.34 25.61 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.717 -0.674 . . . . 1.3100000000000001 111.951 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.8 -174.1 2.51 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.275 -1.38 . . . . 1.8600000000000001 107.275 172.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.485 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 32.4 t . . . . . 0 C--N 1.316 -0.856 0 C-N-CA 119.678 -0.809 . . . . 1.95 110.716 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.779 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 32.3 mt . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 108.051 -1.092 . . . . 1.05 108.051 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -140.69 -162.13 1.31 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.978 -0.689 . . . . 1.25 111.443 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.62 -172.36 14.63 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.679 -1.248 . . . . 0.46000000000000002 113.13 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -154.7 178.15 10.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.209 0.528 . . . . 1.21 110.336 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -111.66 -12.79 13.85 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.425 -0.807 . . . . 1.8600000000000001 109.57 169.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -125.26 101.99 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.61 -0.723 . . . . 1.8200000000000001 109.782 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.52 4.04 4.62 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.053 2.502 . . . . 0.64000000000000001 113.148 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.13 54.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.521 0.677 . . . . 1.3200000000000001 109.57 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -100.13 3.28 43.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.003 -0.999 . . . . 1.8899999999999999 109.53 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 1.21 110.256 -179.807 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.435 ' SD ' ' HB3' ' A' ' 149' ' ' ASP . 1.7 ttm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.778 0.323 . . . . 1.8700000000000001 111.063 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -71.73 154.19 41.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.306 -0.627 . . . . 3.25 109.306 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -51.52 -68.69 0.15 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.288 0.477 . . . . 2.4199999999999999 112.288 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -60.15 -26.29 66.18 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 121.644 -0.66 . . . . 2.5699999999999998 112.315 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.435 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 62.9 m-20 -78.08 -34.33 50.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.523 -0.308 . . . . 1.05 111.639 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.689 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 11.6 p -74.97 -15.82 15.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.32000000000000001 109.651 175.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.403 ' HA ' ' CB ' ' A' ' 154' ' ' ALA . 2.5 mp -88.59 -37.34 10.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.178 -0.464 . . . . 1.1299999999999999 110.33 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -43.43 -71.8 0.07 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.375 0.989 . . . . 1.3799999999999999 112.098 162.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.03 -42.42 38.18 Favored 'General case' 0 C--O 1.222 -0.343 0 O-C-N 123.747 0.654 . . . . 1.3400000000000001 110.147 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -52.43 -54.66 29.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.298 -1.319 . . . . 1.02 112.033 -172.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.6 p -77.82 -14.81 59.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.313 -1.312 . . . . 1.9099999999999999 111.619 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.14 -51.83 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.82 -0.437 . . . . 1.04 109.82 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.8 m -77.13 118.06 69.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-O 121.952 0.882 . . . . 0.20999999999999999 110.229 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.585 ' HG2' HD11 ' A' ' 57' ' ' ILE . 41.1 Cg_endo -83.88 -178.42 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.022 2.481 . . . . 0.51000000000000001 112.832 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.606 ' O ' HD22 ' A' ' 51' ' ' LEU . 15.4 m120 -59.84 -0.46 0.2 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.621 -1.172 . . . . 1.02 113.641 -174.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.59 57.46 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.64000000000000001 112.235 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -94.46 132.78 38.75 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.441 -0.446 . . . . 1.0700000000000001 109.951 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -84.54 140.28 31.53 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.676 -0.41 . . . . 2.3399999999999999 109.995 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.456 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.4 p -145.48 126.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.584 -0.735 . . . . 0.46000000000000002 110.744 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.446 ' C ' HD11 ' A' ' 165' ' ' ILE . 92.0 m -116.51 144.19 44.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.813 -0.63 . . . . 1.26 111.646 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.446 HD11 ' C ' ' A' ' 164' ' ' THR . 3.3 mp -125.96 114.17 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 118.819 -1.152 . . . . 1.1699999999999999 110.58 173.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.155 -1.384 . . . . 1.1899999999999999 108.698 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 1.8 mppt? . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 109.64 -0.504 . . . . 2.54 109.64 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.605 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.6 mt -100.92 168.32 9.7 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.143 0.277 . . . . 1.1000000000000001 111.374 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.547 HD11 ' HD3' ' A' ' 54' ' ' PRO . 2.6 tp -78.16 149.81 33.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.303 0.641 . . . . 1.05 112.189 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.546 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -116.18 149.46 39.06 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.953 0.882 . . . . 1.01 112.123 169.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 65.3 t80 -133.9 149.86 51.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.761 -1.563 . . . . 1.1200000000000001 107.498 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -129.86 116.07 18.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.163 -1.421 . . . . 1.72 107.163 174.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -77.17 158.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.203 0.525 . . . . 0.38 111.885 -166.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HZ1' ' HB3' ' A' ' 10' ' ' LYS . 9.2 mtpm? -104.94 152.66 22.4 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.417 -0.811 . . . . 3.0600000000000001 108.947 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.516 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -53.0 119.69 4.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.962 -0.563 . . . . 2.1699999999999999 111.694 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.03 -10.42 37.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.63 113.15 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.487 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 80.9 m-20 -59.33 154.52 16.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.814 0.672 . . . . 2.1699999999999999 112.814 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -133.95 150.79 51.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.972 -0.558 . . . . 1.27 112.071 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.588 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.1 tp -48.33 -58.7 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.674 0.99 . . . . 1.0800000000000001 113.674 -172.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.686 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.0 t-20 -64.69 -42.4 95.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.546 1.165 . . . . 1.55 110.233 -169.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -59.06 -45.65 90.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.428 -2.169 . . . . 1.8200000000000001 110.031 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -70.43 -41.14 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.715 -0.675 . . . . 1.0600000000000001 111.867 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -66.22 0.48 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.23 -0.441 . . . . 0.97999999999999998 111.812 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -4.6 48.27 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.989 -1.084 . . . . 1.0700000000000001 112.352 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.51 -29.67 69.15 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.16 -0.682 . . . . 1.6299999999999999 109.16 158.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.41 10.49 36.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.034 0.445 . . . . 0.25 111.961 173.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 59.95 50.3 6.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.256 -0.883 . . . . 4.2000000000000002 110.513 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 39.6 pt -147.7 -174.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.608 -0.886 . . . . 1.02 108.608 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.2 m -101.07 147.7 25.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.559 -0.746 . . . . 1.1599999999999999 109.755 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.686 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -61.74 -36.09 79.98 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.745 -0.661 . . . . 1.05 109.251 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.39 71.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.502 -1.227 . . . . 1.05 111.677 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -37.54 37.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.196 -0.602 . . . . 1.03 109.451 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 16.3 tp -74.17 -19.75 60.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.433 -0.803 . . . . 1.05 109.115 176.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.62 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.08 -38.68 35.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.454 0.645 . . . . 1.0600000000000001 111.652 173.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -58.89 -43.17 90.9 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 122.223 1.011 . . . . 1.26 109.834 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.53 44.08 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.576 -1.647 . . . . 1.01 111.929 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 32.8 m-80 -142.6 72.85 20.27 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.20000000000000001 109.75 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.3 Cg_endo -54.91 -16.53 11.97 Favored 'Trans proline' 0 C--N 1.333 -0.273 0 C-N-CA 123.598 2.865 . . . . 0.29999999999999999 113.991 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -61.12 -32.65 72.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.068 0.937 . . . . 1.3600000000000001 109.727 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.63 -4.47 51.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.295 -1.32 . . . . 1.26 114.484 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.62 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.92 -41.24 45.68 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 119.883 1.219 . . . . 1.8899999999999999 109.856 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.539 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.63 -45.3 11.85 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.946 -1.933 . . . . 1.1000000000000001 111.597 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.84 -166.31 37.49 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.324 -0.941 . . . . 0.29999999999999999 113.781 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD21 ' HB ' ' A' ' 9' ' ' VAL . 6.8 mp -115.92 158.23 23.33 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.591 -1.304 . . . . 1.0800000000000001 110.364 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.6 m -131.27 133.68 45.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.994 -0.548 . . . . 1.1699999999999999 110.643 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.516 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -46.55 127.93 9.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.108 0.781 . . . . 1.1699999999999999 113.108 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.77 -11.04 48.98 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.33 -1.304 . . . . 0.38 112.322 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 41' ' ' THR . 5.6 tt0 -65.06 152.12 44.3 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.526 0.679 . . . . 1.1899999999999999 110.355 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.1 p -116.04 133.71 55.74 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.691 -1.14 . . . . 1.22 109.758 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.412 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 21.7 pt -136.12 144.03 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.464 0.649 . . . . 1.0600000000000001 110.54 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.543 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.9 t -90.72 150.09 3.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.805 -1.089 . . . . 0.20999999999999999 110.39 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 17.2 mm -117.95 87.1 26.94 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 114.849 -1.069 . . . . 1.01 108.245 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.538 ' HA ' HD12 ' A' ' 4' ' ' LEU . 28.4 Cg_endo -59.79 142.51 98.78 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.488 2.792 . . . . 0.23000000000000001 113.023 -172.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.605 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 82.44 -7.78 63.64 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.56 -0.746 . . . . 0.29999999999999999 112.69 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.572 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.2 tt -115.45 127.13 27.06 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.771 -0.826 . . . . 1.0800000000000001 108.771 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 55.3 Cg_endo -64.97 174.04 5.2 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.817 3.011 . . . . 0.34000000000000002 113.7 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 4.9 t70 -95.75 138.73 21.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.428 -0.805 . . . . 0.71999999999999997 111.996 -168.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HD3' HD11 ' A' ' 5' ' ' LEU . 97.3 Cg_endo -77.74 -9.76 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.388 2.725 . . . . 0.33000000000000002 113.271 -172.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' A' ' 55' ' ' TYR . 67.7 m-85 -94.98 -25.32 16.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 2.29 110.444 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.442 HG22 ' HB2' ' A' ' 3' ' ' LYS . 21.9 p -68.4 -31.79 71.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.3 1.048 . . . . 2.0600000000000001 108.233 169.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.588 HD11 ' HG2' ' A' ' 158' ' ' PRO . 95.5 mt -77.25 126.87 84.52 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 113.362 -1.745 . . . . 1.0900000000000001 110.854 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -102.15 95.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 121.084 1.19 . . . . 0.22 110.53 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.3 m-85 -158.42 133.34 8.41 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.886 -1.524 . . . . 0.80000000000000004 106.886 172.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 10.8 m-70 -138.91 109.05 6.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.729 -1.582 . . . . 3.5800000000000001 106.729 -168.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -94.65 109.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.126 -0.943 . . . . 1.0600000000000001 110.135 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.73 96.42 5.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.046 0.927 . . . . 1.1200000000000001 110.396 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.0 OUTLIER -115.74 97.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.028 -1.442 . . . . 0.68000000000000005 109.741 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.465 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -89.29 128.13 35.84 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.994 -1.003 . . . . 1.3300000000000001 108.494 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.5 mm -57.91 -35.26 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.611 -0.885 . . . . 1.77 108.611 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.54 -43.68 91.72 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 114.355 -1.293 . . . . 0.93999999999999995 111.828 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.96 -23.91 63.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.404 0.52 . . . . 1.22 112.404 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 58.14 15.32 3.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.07 0.948 . . . . 2.9399999999999999 112.857 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.49 143.26 33.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.556 0.694 . . . . 1.0600000000000001 111.462 175.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.413 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 4.7 tt -94.45 122.68 37.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.362 -1.29 . . . . 1.0900000000000001 109.766 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -103.36 123.77 47.43 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.041 -0.664 . . . . 1.0900000000000001 111.267 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -82.76 141.47 32.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.323 -1.732 . . . . 1.0800000000000001 106.323 176.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 2.4 m -144.6 125.91 14.77 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 120.456 1.48 . . . . 0.93000000000000005 112.483 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.3 tp -112.53 127.81 56.17 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 1.1399999999999999 110.085 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 7.3 t-20 63.13 32.89 14.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.385 0.612 . . . . 0.52000000000000002 109.519 173.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.7 m-20 79.86 1.44 2.12 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.536 -1.211 . . . . 1.8400000000000001 112.493 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -129.15 138.73 51.95 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.707 -1.197 . . . . 3.8500000000000001 113.698 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -54.01 147.94 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 113.329 -1.76 . . . . 0.40999999999999998 113.553 -170.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.505 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.8 mtp -99.68 -44.45 6.11 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 112.087 -2.324 . . . . 1.0900000000000001 108.121 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 34.4 tptt -176.89 164.75 2.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 112.491 -2.14 . . . . 2.6200000000000001 110.661 -176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 m -124.16 134.41 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.893 -0.14 . . . . 1.1000000000000001 111.304 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.602 ' CG ' ' HE2' ' A' ' 145' ' ' MET . 44.3 m-85 -124.51 134.62 25.71 Favored Pre-proline 0 CA--C 1.521 -0.154 0 CA-C-O 121.027 0.441 . . . . 1.0600000000000001 111.637 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -63.78 146.64 92.18 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.985 2.456 . . . . 0.85999999999999999 111.967 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.52 -178.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.834 -0.432 . . . . 1.2 109.834 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.666 0.746 . . . . 1.4099999999999999 111.575 -178.469 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.663 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 33.5 m-85 . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 121.103 0.478 . . . . 2.3500000000000001 110.445 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.678 ' HA ' ' O ' ' A' ' 161' ' ' THR . 37.1 m-85 -124.5 143.64 50.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.506 -0.77 . . . . 0.92000000000000004 109.716 170.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.35 121.77 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.393 -1.336 . . . . 1.0600000000000001 107.393 164.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -109.49 -45.7 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.024 -0.67 . . . . 1.04 111.275 -173.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.407 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 5.6 t-20 -153.32 173.39 15.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 118.665 -1.214 . . . . 2.3500000000000001 113.975 -170.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.597 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -139.18 128.18 23.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 111.948 -2.387 . . . . 1.54 109.194 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.2 149.11 23.89 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.237 1.018 . . . . 1.8899999999999999 111.46 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -52.6 151.2 4.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.859 -1.973 . . . . 3.46 112.765 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.67 107.14 0.62 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 113.694 -1.594 . . . . 3.3500000000000001 111.589 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -53.08 -50.19 14.92 Favored 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 124.416 3.411 . . . . 0.97999999999999998 112.727 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.12 -20.31 12.88 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.164 -0.925 . . . . 1.0800000000000001 112.46 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.41 -170.01 13.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.053 -0.594 . . . . 1.1599999999999999 112.085 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.95 33.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 124.578 3.519 . . . . 1.46 114.093 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.656 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 4.4 t80 -86.31 -8.07 58.01 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.17 0.51 . . . . 2.1000000000000001 110.12 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.58 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 100.89 32.57 5.3 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 115.517 0.967 . . . . 1.1100000000000001 115.517 168.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 70.09 -21.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.207 1.188 . . . . 1.45 114.207 168.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.592 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -157.2 128.73 6.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.119 -0.697 . . . . 1.5 109.119 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -101.76 100.07 10.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.526 -0.916 . . . . 2.6000000000000001 108.526 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.707 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.4 mp -101.78 136.31 41.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.615 0.722 . . . . 1.3100000000000001 109.756 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.8 m -106.5 152.05 24.17 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.239 -0.891 . . . . 1.3100000000000001 111.626 -171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.425 HD21 ' CD2' ' A' ' 98' ' ' PHE . 1.5 tp -101.39 165.03 11.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.86 -1.064 . . . . 1.8600000000000001 108.729 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.46 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 30.5 t . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.401 . . . . 1.95 111.975 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 55.4 mt . . . . . 0 CA--C 1.513 -0.449 0 CA-C-O 121.181 0.515 . . . . 1.05 109.646 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -152.11 -162.34 1.49 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.191 0.519 . . . . 1.25 110.718 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.58 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.4 171.12 14.52 Favored Glycine 0 C--N 1.311 -0.843 0 C-N-CA 119.838 -1.172 . . . . 0.46000000000000002 112.98 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -129.66 173.03 11.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.724 0.773 . . . . 1.21 111.809 -168.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -108.92 -20.65 12.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.382 -1.281 . . . . 1.8600000000000001 109.078 165.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -124.79 103.6 30.99 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.261 -0.881 . . . . 1.8200000000000001 109.696 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.8 3.77 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.294 2.662 . . . . 0.64000000000000001 113.926 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.65 -13.16 59.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.58 0.705 . . . . 1.3200000000000001 110.211 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.7 m -96.26 6.97 47.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.185 -0.916 . . . . 1.8899999999999999 109.943 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 23.8 mm . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.394 -0.821 . . . . 1.21 110.376 -177.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.602 ' HE2' ' CG ' ' A' ' 82' ' ' TYR . 1.2 mpp? . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 109.669 -0.493 . . . . 1.8700000000000001 109.669 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.488 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 48.8 m80 -70.53 166.14 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.983 -0.377 . . . . 3.25 109.983 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -54.26 -69.04 0.14 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 111.893 0.331 . . . . 2.4199999999999999 111.893 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.01 -27.3 66.77 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.564 -0.71 . . . . 2.5699999999999998 111.236 -176.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.488 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 3.1 m-20 -63.67 -46.82 83.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.923 -0.58 . . . . 1.05 110.545 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.663 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 12.1 p -77.35 -17.44 14.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-N 115.754 -0.657 . . . . 0.32000000000000001 111.078 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.46 -39.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 118.969 -0.538 . . . . 1.1299999999999999 110.443 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -44.45 -69.97 0.12 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.705 1.139 . . . . 1.3799999999999999 112.244 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.414 HD13 ' HG ' ' A' ' 72' ' ' LEU . 1.5 tp -49.82 -43.79 48.87 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.469 -0.787 . . . . 1.3400000000000001 110.287 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -53.54 -48.36 69.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.256 -1.338 . . . . 1.02 111.819 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 35.0 t -79.63 -19.98 47.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.579 -1.191 . . . . 1.9099999999999999 110.85 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 -48.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.782 -0.451 . . . . 1.04 109.782 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 m -77.45 116.47 58.14 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-O 121.802 0.811 . . . . 0.20999999999999999 109.93 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.588 ' HG2' HD11 ' A' ' 57' ' ' ILE . 32.3 Cg_endo -84.46 -178.35 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.099 2.533 . . . . 0.51000000000000001 112.442 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.572 ' O ' HD22 ' A' ' 51' ' ' LEU . 19.4 m120 -63.27 5.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.743 -1.117 . . . . 1.02 113.349 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.19 58.2 0.47 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.89 -0.671 . . . . 0.64000000000000001 112.56 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -92.75 136.71 33.0 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.447 -0.443 . . . . 1.0700000000000001 110.671 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -83.85 129.52 34.93 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.642 -0.423 . . . . 2.3399999999999999 110.301 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 4.4 p -136.37 127.3 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.23 0.538 . . . . 0.46000000000000002 111.19 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.4 m -119.23 134.64 55.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.768 -0.651 . . . . 1.26 111.689 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -121.82 108.68 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 119.32 -0.952 . . . . 1.1699999999999999 110.673 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.591 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.662 0 CA-C-N 115.061 -0.972 . . . . 1.1899999999999999 111.177 -168.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.8 mptt . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 110.135 -0.32 . . . . 2.54 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 50' ' ' GLY . 18.5 mt -89.15 168.9 11.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.092 -0.504 . . . . 1.1000000000000001 110.629 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.3 tp -77.39 150.08 35.12 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 122.988 0.515 . . . . 1.05 112.119 -169.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.547 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.12 150.43 36.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.891 0.853 . . . . 1.01 111.67 167.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.642 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 69.2 t80 -135.48 151.82 50.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.717 -1.583 . . . . 1.1200000000000001 108.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.613 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -131.67 118.74 20.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.61 -1.256 . . . . 1.72 107.61 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.53 159.34 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 123.333 0.653 . . . . 0.38 112.011 -169.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -108.37 152.07 25.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.711 -0.677 . . . . 3.0600000000000001 109.198 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.48 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -50.54 119.4 3.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 2.1699999999999999 112.175 -175.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.67 -4.2 42.8 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.028 -0.987 . . . . 0.63 113.144 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.498 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 7.3 m-20 -65.62 156.81 31.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.535 0.668 . . . . 2.1699999999999999 112.529 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.96 148.16 52.5 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.829 0.677 . . . . 1.27 112.829 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.601 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.0 tp -46.5 -58.91 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.771 1.026 . . . . 1.0800000000000001 113.771 -173.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.666 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 20.3 t-20 -64.73 -40.28 95.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.583 1.183 . . . . 1.55 110.328 -170.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.768 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 10.9 m -60.87 -42.75 98.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 112.602 -2.09 . . . . 1.8200000000000001 110.398 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -73.38 -39.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 O-C-N 123.831 0.707 . . . . 1.0600000000000001 112.332 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.1 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.396 -0.365 . . . . 0.97999999999999998 111.522 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.75 52.31 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.902 -1.119 . . . . 1.0700000000000001 111.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.2 t0 -60.7 -42.63 97.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.461 -1.311 . . . . 1.6299999999999999 107.461 157.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.7 m-85 -93.55 16.78 12.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.5 0.556 . . . . 0.25 112.5 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HG2' HD11 ' A' ' 101' ' ' ILE . 7.0 mmm180 53.82 51.86 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 4.2000000000000002 111.002 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 35.7 pt -147.26 -172.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.928 -0.768 . . . . 1.02 108.928 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.97 148.01 23.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 1.1599999999999999 109.682 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.666 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 23.3 p -63.39 -35.74 81.4 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.683 -0.858 . . . . 1.05 108.683 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.14 -32.58 74.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.303 -1.317 . . . . 1.05 111.38 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.05 -37.58 38.62 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.273 0.559 . . . . 1.03 109.634 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 12.6 tp -74.18 -18.8 60.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.401 -0.818 . . . . 1.05 109.027 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.663 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.28 34.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.462 0.649 . . . . 1.0600000000000001 111.424 172.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 60.3 mt-30 -57.08 -46.26 82.67 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 122.248 1.023 . . . . 1.26 109.458 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.0 47.97 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.18 -1.827 . . . . 1.01 112.202 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 29.1 m-80 -142.96 72.71 18.67 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-O 121.153 0.502 . . . . 0.20000000000000001 109.903 -173.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.476 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 17.8 Cg_endo -57.24 -11.42 8.03 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 123.7 2.933 . . . . 0.29999999999999999 114.187 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 t -62.86 -34.19 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.049 0.928 . . . . 1.3600000000000001 109.915 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.7 mt -78.27 -4.99 50.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.438 -1.255 . . . . 1.26 114.372 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.663 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -51.08 -39.44 56.08 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 122.342 1.068 . . . . 1.8899999999999999 110.049 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.551 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -83.98 -46.47 12.02 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.987 -1.915 . . . . 1.1000000000000001 111.437 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.28 -164.09 34.4 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.502 -0.856 . . . . 0.29999999999999999 114.008 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mp -118.16 157.41 26.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.401 -1.4 . . . . 1.0800000000000001 110.088 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -134.15 136.8 44.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.704 -0.68 . . . . 1.1699999999999999 110.428 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -46.02 126.89 7.92 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.282 0.845 . . . . 1.1699999999999999 113.282 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.613 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.52 -11.78 49.78 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.528 -1.215 . . . . 0.38 112.002 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.565 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 3.7 tt0 -63.09 150.25 43.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.766 0.793 . . . . 1.1899999999999999 110.466 175.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 22.9 m -118.45 134.51 55.01 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.231 -1.35 . . . . 1.22 109.13 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.0 pt -137.14 151.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.445 0.64 . . . . 1.0600000000000001 110.513 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.527 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 16.7 t -96.75 149.21 4.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.013 -0.994 . . . . 0.20999999999999999 110.074 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 20.1 mm -117.65 88.84 31.05 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 108.309 -0.997 . . . . 1.01 108.309 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.521 ' HA ' HD12 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.83 142.14 98.05 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.014 2.476 . . . . 0.23000000000000001 112.717 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.595 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 82.06 -6.91 65.08 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.525 -0.761 . . . . 0.29999999999999999 112.995 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.9 127.74 26.44 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 108.737 -0.838 . . . . 1.0800000000000001 108.737 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.545 ' CD ' HD21 ' A' ' 51' ' ' LEU . 73.5 Cg_endo -68.56 174.31 8.59 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.819 3.013 . . . . 0.34000000000000002 113.93 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.551 ' CG ' ' HD2' ' A' ' 54' ' ' PRO . 9.6 t70 -89.57 142.48 29.47 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.881 -1.054 . . . . 0.71999999999999997 110.185 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 84.2 Cg_endo -80.96 -6.2 13.13 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.225 2.617 . . . . 0.33000000000000002 111.973 -174.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 55' ' ' TYR . 60.6 m-85 -95.85 -25.62 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 2.29 111.099 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 53' ' ' ASP . 28.6 p -70.49 -27.06 63.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.495 1.14 . . . . 2.0600000000000001 108.028 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.593 HD11 ' HG2' ' A' ' 158' ' ' PRO . 96.9 mt -81.98 129.23 65.32 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 112.936 -1.938 . . . . 1.0900000000000001 110.66 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -102.75 95.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 121.112 1.208 . . . . 0.22 110.761 165.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 73' ' ' SER . 86.8 m-85 -158.3 129.3 6.39 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.869 -1.53 . . . . 0.80000000000000004 106.869 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 31.4 m-70 -136.69 105.13 5.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.983 -1.488 . . . . 3.5800000000000001 106.983 -165.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.424 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 80.6 mt -94.15 113.42 28.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.282 -0.872 . . . . 1.0600000000000001 110.703 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.6 95.19 5.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.366 -0.834 . . . . 1.1200000000000001 110.752 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -110.18 112.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.431 -1.259 . . . . 0.68000000000000005 109.479 177.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 49.5 m -107.38 135.63 48.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.836 -0.62 . . . . 1.3300000000000001 110.629 -175.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 1.2 mt -57.32 -38.96 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.772 0.796 . . . . 1.77 110.269 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.21 -45.73 69.06 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.32 -1.309 . . . . 0.93999999999999995 111.717 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 64' ' ' SER . . . -74.41 -24.65 59.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.347 0.594 . . . . 1.22 112.052 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 32.7 mttt 53.41 24.53 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.283 1.033 . . . . 2.9399999999999999 111.732 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.462 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.5 OUTLIER -141.63 143.78 33.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.93 0.872 . . . . 1.0600000000000001 110.934 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.8 tt -98.6 117.94 34.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.82 -1.536 . . . . 1.0900000000000001 109.147 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -100.16 125.37 46.28 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.378 -0.529 . . . . 1.0900000000000001 110.67 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -83.01 147.88 27.91 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.789 -1.56 . . . . 1.0800000000000001 106.789 177.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.607 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 25.5 m -151.4 129.39 11.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 120.316 1.416 . . . . 0.93000000000000005 112.729 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 tp -117.3 129.39 55.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.917 -1.038 . . . . 1.1399999999999999 110.755 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 63.4 35.56 12.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.377 0.608 . . . . 0.52000000000000002 109.679 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 77.48 2.75 3.09 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.595 -1.184 . . . . 1.8400000000000001 111.784 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -129.95 138.74 51.03 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.41 -1.316 . . . . 3.8500000000000001 114.032 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.53 149.36 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 113.162 -1.835 . . . . 0.40999999999999998 112.822 -173.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.516 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -99.48 -45.57 5.77 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 112.675 -2.057 . . . . 1.0900000000000001 108.38 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.53 157.61 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 112.805 -1.998 . . . . 2.6200000000000001 110.388 -175.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.462 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.3 m -116.44 136.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.788 0.327 . . . . 1.1000000000000001 111.661 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -116.89 153.27 49.35 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.088 -0.505 . . . . 1.0600000000000001 110.192 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.11 143.09 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.59 2.193 . . . . 0.85999999999999999 111.424 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.96 179.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.672 -0.24 . . . . 1.2 110.59 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.485 0.66 . . . . 1.4099999999999999 111.64 177.353 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.63 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 33.4 m-85 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.085 0.469 . . . . 2.3500000000000001 111.185 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.632 ' HA ' ' O ' ' A' ' 161' ' ' THR . 48.9 m-85 -128.62 138.52 52.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.476 -0.784 . . . . 0.92000000000000004 109.897 171.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.433 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 21.7 mm -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.926 -1.139 . . . . 1.0600000000000001 107.926 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.54 HD13 ' CD1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -111.55 -33.54 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.897 -0.721 . . . . 1.04 112.666 -177.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 28.5 p-10 -166.47 -167.77 1.07 Allowed 'General case' 0 N--CA 1.46 0.062 0 CA-C-O 122.383 1.087 . . . . 2.3500000000000001 113.846 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -156.84 141.6 16.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 112.391 -2.186 . . . . 1.54 111.501 178.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.62 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 23.5 tp60 -109.92 142.18 41.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.142 -0.936 . . . . 1.8899999999999999 110.957 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -53.25 150.0 6.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.645 -1.616 . . . . 3.46 112.115 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.81 103.17 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 114.448 -1.251 . . . . 3.3500000000000001 111.434 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.42 -49.77 15.77 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.151 3.234 . . . . 0.97999999999999998 112.362 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.29 -16.01 20.1 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.995 -1.002 . . . . 1.0800000000000001 112.393 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -119.97 -170.38 14.35 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.012 -0.613 . . . . 1.1599999999999999 112.675 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.28 16.17 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.633 3.556 . . . . 1.46 114.99 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.653 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 2.3 t80 -66.66 -24.6 66.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.597 . . . . 2.1000000000000001 109.933 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 127' ' ' GLY . . . 99.63 60.52 0.85 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.331 -0.849 . . . . 1.1100000000000001 114.934 168.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 151' ' ' ILE . . . 72.96 -57.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.941 1.089 . . . . 1.45 113.941 166.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -146.79 137.31 23.76 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.59 -0.522 . . . . 1.5 109.59 -173.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.62 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 76.2 t-105 -103.74 101.04 10.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.272 -0.64 . . . . 2.6000000000000001 109.272 169.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.4 mp -104.51 109.23 21.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.585 0.707 . . . . 1.3100000000000001 109.769 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.501 ' HB3' ' CG2' ' A' ' 101' ' ' ILE . 3.5 t -79.01 146.3 33.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 1.3100000000000001 111.069 -168.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -92.88 177.02 6.21 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.591 -1.262 . . . . 1.8600000000000001 107.591 171.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 36.0 t . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 111.869 0.322 . . . . 1.95 111.869 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.491 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 21.1 mt . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.075 -0.713 . . . . 1.05 109.075 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -152.09 -164.99 2.1 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.399 0.618 . . . . 1.25 111.341 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.431 ' O ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.07 -178.62 15.74 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.666 -1.152 . . . . 0.46000000000000002 112.873 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.6 t -145.48 178.23 8.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.139 -0.531 . . . . 1.21 110.927 -165.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -108.98 -16.82 14.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.983 -1.008 . . . . 1.8600000000000001 109.255 165.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -124.98 100.71 33.13 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 115.744 -0.662 . . . . 1.8200000000000001 109.854 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 44.8 Cg_endo -92.78 4.64 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.584 2.856 . . . . 0.64000000000000001 113.166 175.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.22 -20.99 50.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.976 0.417 . . . . 1.3200000000000001 110.437 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 p -93.95 -4.83 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.598 0.714 . . . . 1.8899999999999999 110.11 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 9.0 mm . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.239 -0.891 . . . . 1.21 110.461 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 29.1 mtp . . . . . 0 C--O 1.234 0.256 0 N-CA-C 109.964 -0.384 . . . . 1.8700000000000001 109.964 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -79.0 153.27 30.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.919 -0.771 . . . . 3.25 108.919 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -52.08 -65.0 0.63 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.504 0.187 . . . . 2.4199999999999999 111.504 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -60.74 -30.44 69.99 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.703 -0.623 . . . . 2.5699999999999998 111.342 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -64.38 -43.54 94.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.179 0.514 . . . . 1.05 110.25 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.707 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 9.4 p -77.59 -17.42 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.509 -0.769 . . . . 0.32000000000000001 110.993 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 113' ' ' ALA . 3.0 mp -88.98 -40.86 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 119.022 -0.513 . . . . 1.1299999999999999 110.649 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -44.03 -69.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.633 1.106 . . . . 1.3799999999999999 112.027 162.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.493 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -48.31 -42.52 31.26 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 123.813 0.695 . . . . 1.3400000000000001 110.232 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -53.6 -57.02 12.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.427 -1.26 . . . . 1.02 112.465 -171.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 t -77.05 -14.99 59.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.825 -1.079 . . . . 1.9099999999999999 110.487 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.48 -50.28 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 109.976 -0.379 . . . . 1.04 109.976 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.422 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 28.3 m -75.96 116.71 58.1 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 121.939 0.876 . . . . 0.20999999999999999 110.379 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.593 ' HG2' HD11 ' A' ' 57' ' ' ILE . 40.2 Cg_endo -81.97 -177.43 3.53 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.199 2.599 . . . . 0.51000000000000001 112.581 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.614 ' O ' HD22 ' A' ' 51' ' ' LEU . 16.5 m120 -59.11 0.65 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.58 -1.191 . . . . 1.02 113.839 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.18 58.41 0.45 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.738 -0.744 . . . . 0.64000000000000001 112.677 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.6 m -90.32 136.83 32.81 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.376 -0.484 . . . . 1.0700000000000001 110.53 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -84.76 131.92 34.5 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.55 -0.46 . . . . 2.3399999999999999 109.983 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.424 ' HA ' ' HB ' ' A' ' 61' ' ' ILE . 2.4 p -138.91 124.81 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.363 -0.835 . . . . 0.46000000000000002 110.858 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.403 ' C ' HD11 ' A' ' 165' ' ' ILE . 89.8 m -116.92 140.5 49.38 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.682 -0.69 . . . . 1.26 111.636 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.1 mp -120.4 110.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.811 -1.156 . . . . 1.1699999999999999 110.593 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.321 -0.649 0 CA-C-N 114.372 -1.285 . . . . 1.1899999999999999 109.071 -172.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.276 -0.639 . . . . 2.54 109.276 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.606 HD12 ' H ' ' A' ' 50' ' ' GLY . 17.8 mt -91.79 168.86 11.15 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.382 0.426 . . . . 1.1000000000000001 111.05 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.552 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.8 tp -76.42 150.31 36.76 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 123.42 0.688 . . . . 1.05 112.297 -168.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.552 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.57 150.05 35.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.137 0.97 . . . . 1.01 111.92 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 70.0 t80 -136.63 149.8 48.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.448 -1.705 . . . . 1.1200000000000001 108.083 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.55 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.82 121.7 28.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.194 -1.41 . . . . 1.72 107.194 176.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -82.46 158.65 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.181 0.515 . . . . 0.38 112.119 -170.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -106.18 150.28 26.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.843 -0.799 . . . . 3.0600000000000001 108.843 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.502 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 1.2 tt0 -53.97 112.73 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.541 0.526 . . . . 2.1699999999999999 111.967 -175.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.0 -8.67 18.72 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.673 -0.775 . . . . 0.63 112.837 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.493 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 55.7 m-20 -62.26 154.84 26.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.067 0.433 . . . . 2.1699999999999999 111.946 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.424 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.1 p -132.11 152.95 50.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 1.27 111.892 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.0 tp -49.86 -58.5 5.26 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.99 1.107 . . . . 1.0800000000000001 113.99 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.646 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.6 t-20 -65.07 -42.01 94.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.569 1.176 . . . . 1.55 109.979 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.737 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 5.8 m -60.34 -39.45 87.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 112.51 -2.132 . . . . 1.8200000000000001 110.769 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.8 -41.18 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 123.296 0.638 . . . . 1.0600000000000001 112.176 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.62 -61.94 2.08 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.511 -0.313 . . . . 0.97999999999999998 111.284 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.12 54.38 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.798 -1.161 . . . . 1.0700000000000001 112.136 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.9 t70 -61.89 -34.84 76.75 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.654 -1.239 . . . . 1.6299999999999999 107.654 156.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' CD1' HD11 ' A' ' 101' ' ' ILE . 2.4 m-85 -99.35 17.81 19.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.248 0.462 . . . . 0.25 112.248 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 52.11 51.92 15.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.356 -0.838 . . . . 4.2000000000000002 110.954 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 35.5 pt -146.86 -174.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.644 -0.872 . . . . 1.02 108.644 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -100.81 144.7 29.46 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.429 -0.805 . . . . 1.1599999999999999 109.258 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.646 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 25.3 p -61.77 -34.81 76.54 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.48 0.657 . . . . 1.05 109.251 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.86 -29.4 70.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.34 -1.3 . . . . 1.05 111.511 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.82 -38.11 26.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.391 0.615 . . . . 1.03 109.791 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 16.7 tp -73.31 -16.93 61.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.214 -0.903 . . . . 1.05 108.958 174.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.58 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -82.1 -38.52 24.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.37 0.605 . . . . 1.0600000000000001 111.578 173.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.4 mt-30 -57.92 -43.42 86.25 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.169 0.985 . . . . 1.26 109.636 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.59 -19.77 41.23 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.354 -1.748 . . . . 1.01 112.402 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 32.7 m-80 -143.34 72.66 17.85 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.148 0.499 . . . . 0.20000000000000001 109.922 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.639 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.8 Cg_endo -57.36 -11.32 8.11 Favored 'Trans proline' 0 C--N 1.333 -0.283 0 C-N-CA 123.649 2.9 . . . . 0.29999999999999999 114.478 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -63.31 -34.43 77.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.913 0.864 . . . . 1.3600000000000001 109.573 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -78.35 -6.62 55.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.332 -1.303 . . . . 1.26 114.415 -170.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -49.94 -42.56 48.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 119.78 1.173 . . . . 1.8899999999999999 110.22 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.28 -45.95 12.31 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 112.881 -1.963 . . . . 1.1000000000000001 111.439 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -164.81 36.16 Favored Glycine 0 CA--C 1.492 -1.355 0 C-N-CA 120.265 -0.969 . . . . 0.29999999999999999 114.358 176.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.43 157.86 23.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.966 -1.617 . . . . 1.0800000000000001 110.447 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 96.3 m -133.89 133.86 42.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.641 -0.709 . . . . 1.1699999999999999 110.519 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -44.61 126.49 5.54 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.416 0.895 . . . . 1.1699999999999999 113.416 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.55 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.31 -10.66 53.65 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.391 -1.277 . . . . 0.38 112.129 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -63.99 150.91 44.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.776 0.798 . . . . 1.1899999999999999 110.315 175.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 44.7 m -118.2 133.86 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.212 -1.358 . . . . 1.22 109.049 -171.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.446 HD11 HD13 ' A' ' 29' ' ' LEU . 15.0 pt -135.89 151.14 28.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.244 0.545 . . . . 1.0600000000000001 110.312 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.489 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.1 t -96.03 149.09 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.121 -0.945 . . . . 0.20999999999999999 110.119 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 19.4 mm -117.24 87.31 23.51 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.84 -1.073 . . . . 1.01 108.386 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HA ' HD12 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.59 140.26 92.97 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.119 2.546 . . . . 0.23000000000000001 112.626 -173.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.606 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 85.3 -8.24 72.07 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.323 -0.853 . . . . 0.29999999999999999 113.015 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.538 HD21 ' CD ' ' A' ' 52' ' ' PRO . 2.9 tt -117.55 127.43 26.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.585 -0.894 . . . . 1.0800000000000001 108.585 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.538 ' CD ' HD21 ' A' ' 51' ' ' LEU . 62.0 Cg_endo -67.78 173.58 8.89 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.725 2.95 . . . . 0.34000000000000002 113.818 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.555 ' HB3' HG21 ' A' ' 56' ' ' THR . 11.9 t70 -90.3 142.05 28.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.034 -0.985 . . . . 0.71999999999999997 110.576 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.498 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 60.3 Cg_endo -86.21 -8.31 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.73 2.953 . . . . 0.33000000000000002 112.444 -174.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.658 ' HE1' ' CE2' ' A' ' 55' ' ' TYR . 59.0 m-85 -92.01 -13.52 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 2.29 109.486 177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.555 HG21 ' HB3' ' A' ' 53' ' ' ASP . 12.3 p -84.92 -29.5 25.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.944 -1.132 . . . . 2.0600000000000001 107.944 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.649 HD11 ' HG2' ' A' ' 158' ' ' PRO . 43.5 mt -83.02 131.74 52.94 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 113.496 -1.684 . . . . 1.0900000000000001 110.887 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.68 96.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 121.046 1.164 . . . . 0.22 110.525 167.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.497 ' HD2' ' CG2' ' A' ' 57' ' ' ILE . 84.1 m-85 -157.3 132.49 8.97 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.604 -1.258 . . . . 0.80000000000000004 107.604 171.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 29.1 m170 -135.96 103.73 5.47 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.487 -1.672 . . . . 3.5800000000000001 106.487 -167.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 64.5 mt -94.71 112.43 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 120.237 -0.585 . . . . 1.0600000000000001 110.521 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.33 95.8 5.35 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.378 -0.828 . . . . 1.1200000000000001 110.811 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -115.75 104.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.503 -1.226 . . . . 0.68000000000000005 110.645 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.497 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 50.9 m -98.96 113.52 25.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.213 -1.032 . . . . 1.3300000000000001 108.213 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 mt -54.62 -32.43 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-O 120.905 0.383 . . . . 1.77 111.779 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.09 -45.62 95.0 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.071 -1.061 . . . . 0.93999999999999995 111.305 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -70.43 -23.45 62.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.461 0.648 . . . . 1.22 111.959 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.7 mttt 62.35 18.93 10.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.734 1.214 . . . . 2.9399999999999999 112.999 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.423 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.94 140.17 31.0 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.284 1.04 . . . . 1.0600000000000001 112.63 177.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.547 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -97.19 118.7 34.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.028 -1.897 . . . . 1.0900000000000001 109.269 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -100.86 125.14 47.36 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.349 -0.54 . . . . 1.0900000000000001 110.489 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -83.8 143.92 29.64 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.966 -1.864 . . . . 1.0800000000000001 105.966 176.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.583 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 47.7 m -148.65 129.52 14.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 120.189 1.359 . . . . 0.93000000000000005 112.895 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -114.46 126.53 55.06 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.608 -1.178 . . . . 1.1399999999999999 110.438 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.5 t-20 63.7 36.31 10.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.52000000000000002 109.54 172.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.1 m-20 76.81 2.73 3.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.591 -1.186 . . . . 1.8400000000000001 112.409 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -130.42 137.79 50.01 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 118.081 -1.448 . . . . 3.8500000000000001 114.269 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -53.17 149.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-N 113.122 -1.854 . . . . 0.40999999999999998 113.59 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.542 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.8 mtp -103.3 -40.35 6.44 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.407 -2.179 . . . . 1.0900000000000001 108.732 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.52 165.87 2.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.677 -2.056 . . . . 2.6200000000000001 110.723 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.423 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 8.6 m -125.49 130.52 51.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.419 0.152 . . . . 1.1000000000000001 110.947 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.453 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 15.7 m-85 -120.68 134.35 24.23 Favored Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.759 0.314 . . . . 1.0600000000000001 110.966 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.69 143.53 74.78 Favored 'Trans proline' 0 N--CA 1.472 0.213 0 C-N-CA 123.168 2.579 . . . . 0.85999999999999999 112.76 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.24 179.36 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.329 -0.396 . . . . 1.2 110.782 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 110.091 -0.337 . . . . 1.4099999999999999 110.091 179.555 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.654 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 7.2 m-85 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.71 0.291 . . . . 2.3500000000000001 110.505 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 161' ' ' THR . 66.5 m-85 -131.17 139.83 49.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.92000000000000004 110.252 172.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.586 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 34.0 mm -63.22 116.68 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 N-CA-C 108.752 -0.833 . . . . 1.0600000000000001 108.752 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.457 HD11 ' CD1' ' A' ' 22' ' ' PHE . 3.7 tt -108.32 -19.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 119.237 -0.985 . . . . 1.04 112.507 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.461 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 6.2 t-20 179.0 -168.39 0.09 Allowed 'General case' 0 C--N 1.351 0.669 0 CA-C-O 122.73 1.252 . . . . 2.3500000000000001 114.096 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.461 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.6 ptp180 -156.78 144.17 18.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.621 -2.536 . . . . 1.54 110.021 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.98 157.21 22.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 122.067 0.937 . . . . 1.8899999999999999 111.172 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -52.32 150.21 4.9 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.521 -2.127 . . . . 3.46 112.05 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -48.33 110.3 1.4 Allowed Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 115.118 -0.946 . . . . 3.3500000000000001 111.039 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.17 -48.25 22.63 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 123.762 2.975 . . . . 0.97999999999999998 111.858 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 111.3 -20.39 23.42 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.849 -1.069 . . . . 1.0800000000000001 112.625 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -105.93 -170.07 23.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.971 -0.633 . . . . 1.1599999999999999 111.946 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.82 35.51 0.1 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.188 3.259 . . . . 1.46 113.561 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.489 ' H ' ' C ' ' A' ' 109' ' ' GLY . 11.4 t80 -86.89 -16.89 34.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.21 0.529 . . . . 2.1000000000000001 109.804 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.548 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.89 38.0 3.75 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.653 -0.703 . . . . 1.1100000000000001 114.071 173.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.441 ' HB1' ' ND2' ' A' ' 147' ' ' ASN . . . 74.38 -36.71 0.34 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.121 1.156 . . . . 1.45 114.121 168.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.626 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -148.37 144.55 27.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.975 0.417 . . . . 1.5 110.949 -173.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -115.49 100.21 7.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.661 . . . . 2.6000000000000001 109.373 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -101.72 145.72 28.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.206 0.527 . . . . 1.3100000000000001 110.535 176.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 74.4 m -106.71 137.12 45.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.662 -0.699 . . . . 1.3100000000000001 112.412 -170.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 tp -107.68 -171.29 1.84 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.086 -0.961 . . . . 1.8600000000000001 108.987 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.7 t . . . . . 0 CA--C 1.543 0.685 0 CA-C-N 118.675 0.67 . . . . 1.95 111.18 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.638 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 12.0 mt . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 107.363 -1.347 . . . . 1.05 107.363 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -137.96 -163.92 1.53 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.697 -0.801 . . . . 1.25 112.463 -173.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.548 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.9 -177.0 15.31 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.377 -1.283 . . . . 0.46000000000000002 112.479 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -141.07 175.88 9.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.494 0.664 . . . . 1.21 111.594 -166.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -111.04 -17.78 13.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.827 -1.079 . . . . 1.8600000000000001 109.311 166.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -125.45 102.94 29.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.296 -0.866 . . . . 1.8200000000000001 109.727 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -91.79 3.48 4.07 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.171 2.581 . . . . 0.64000000000000001 113.564 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.86 57.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.869 0.366 . . . . 1.3200000000000001 111.117 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 -3.02 50.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 1.8899999999999999 110.152 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.9 mm . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 1.21 111.255 -175.545 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 10.8 mtm . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.769 0.319 . . . . 1.8700000000000001 110.679 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -67.73 150.51 48.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 3.25 110.046 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.441 ' ND2' ' HB1' ' A' ' 113' ' ' ALA . 3.4 m-20 -51.63 -67.77 0.22 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 123.412 0.445 . . . . 2.4199999999999999 111.589 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.43 -24.5 67.86 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.862 -0.524 . . . . 2.5699999999999998 111.963 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.59 -38.41 74.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.731 0.3 . . . . 1.05 110.975 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.71 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 12.0 p -80.26 -14.9 13.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 116.587 -0.279 . . . . 0.32000000000000001 110.521 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.402 ' HA ' ' CB ' ' A' ' 154' ' ' ALA . 2.5 mp -89.16 -38.96 12.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 118.851 -0.595 . . . . 1.1299999999999999 110.911 173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -44.09 -68.6 0.18 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.854 1.206 . . . . 1.3799999999999999 111.601 163.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.488 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -49.83 -42.47 47.33 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.589 -0.732 . . . . 1.3400000000000001 110.059 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -54.64 -57.66 10.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.237 -1.347 . . . . 1.02 112.107 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.0 t -75.32 -14.57 60.5 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.475 -1.239 . . . . 1.9099999999999999 110.63 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.437 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 80.9 mt -93.06 -47.77 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.32 -0.4 . . . . 1.04 110.365 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.9 m -76.88 110.61 12.37 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 122.038 0.923 . . . . 0.20999999999999999 111.073 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.649 ' HG2' HD11 ' A' ' 57' ' ' ILE . 13.9 Cg_endo -82.16 -179.31 4.62 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.698 2.265 . . . . 0.51000000000000001 113.254 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 8.7 m120 -66.73 110.54 3.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.74 -1.118 . . . . 1.02 108.254 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.89 2.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.284 -0.96 . . . . 0.64000000000000001 113.314 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.586 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 18.9 m -93.2 136.29 33.6 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.839 -0.8 . . . . 1.0700000000000001 109.819 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -84.72 134.16 34.35 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.952 -0.388 . . . . 2.3399999999999999 109.952 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.44 ' HA ' ' HB ' ' A' ' 61' ' ' ILE . 3.2 p -140.51 125.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.421 -0.809 . . . . 0.46000000000000002 111.424 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.4 m -114.01 129.7 56.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.303 -0.862 . . . . 1.26 111.557 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.8 mp -119.25 122.3 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 118.135 -1.426 . . . . 1.1699999999999999 109.578 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 122.087 0.946 . . . . 1.1899999999999999 109.932 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.157 0 N-CA-C 109.754 -0.461 . . . . 2.54 109.754 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.607 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.2 mt -100.69 169.15 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 1.1000000000000001 111.948 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.572 HD11 ' HD3' ' A' ' 54' ' ' PRO . 3.4 tp -79.62 153.02 29.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 123.643 0.777 . . . . 1.05 112.206 -169.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -116.58 153.05 32.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.866 0.841 . . . . 1.01 111.858 166.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.653 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 68.2 t80 -136.6 150.5 48.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.029 -1.441 . . . . 1.1200000000000001 108.07 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.635 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.47 119.42 24.87 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.714 -1.587 . . . . 1.72 106.714 174.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -81.08 158.88 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 112.782 0.66 . . . . 0.38 112.782 -167.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -99.26 150.14 22.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.019 -0.992 . . . . 3.0600000000000001 109.43 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.532 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 2.1 tt0 -53.84 109.17 0.43 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.258 -0.883 . . . . 2.1699999999999999 111.618 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -9.82 22.43 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.64 -0.79 . . . . 0.63 112.748 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.497 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 82.4 m-20 -59.7 154.21 18.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.021 0.41 . . . . 2.1699999999999999 111.545 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.423 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.7 p -133.39 153.63 51.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.102 0.477 . . . . 1.27 112.115 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.5 tp -49.44 -59.9 3.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.795 1.035 . . . . 1.0800000000000001 113.795 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.685 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.6 t-20 -65.02 -40.13 94.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.22 1.009 . . . . 1.55 110.456 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.0 t -59.72 -51.46 69.66 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 113.221 -1.809 . . . . 1.8200000000000001 109.358 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.497 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.64 -39.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.924 -0.58 . . . . 1.0600000000000001 111.433 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -65.2 0.66 Allowed 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.97999999999999998 111.635 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.12 -5.3 55.74 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 118.84 -1.144 . . . . 1.0700000000000001 112.269 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.094 -0.706 . . . . 1.6299999999999999 109.094 158.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.458 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.4 m-85 -97.05 13.94 27.36 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.089 0.403 . . . . 0.25 112.089 173.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 58.15 49.19 11.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 4.2000000000000002 110.096 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 42.0 pt -147.7 -175.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.691 -0.855 . . . . 1.02 108.691 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 m -99.52 146.0 26.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.538 -0.755 . . . . 1.1599999999999999 109.337 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.685 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.1 p -60.66 -38.08 83.68 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.01 -0.737 . . . . 1.05 109.01 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.55 69.0 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.47 -1.241 . . . . 1.05 111.654 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 49' ' ' PRO . . . -80.72 -38.13 29.36 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.078 -0.712 . . . . 1.03 109.078 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 12.8 tp -73.69 -18.54 61.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.333 -0.849 . . . . 1.05 109.044 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.606 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.9 -39.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.484 0.659 . . . . 1.0600000000000001 111.563 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -57.92 -42.9 85.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 122.372 1.082 . . . . 1.26 109.648 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.43 -17.25 49.51 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.512 -1.676 . . . . 1.01 112.016 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.604 HD22 ' H ' ' A' ' 47' ' ' VAL . 33.6 m-80 -144.45 72.22 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.102 0.477 . . . . 0.20000000000000001 110.115 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.9 Cg_endo -55.06 -10.54 2.92 Favored 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 124.216 3.277 . . . . 0.29999999999999999 114.387 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.38 -37.77 87.99 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.894 0.854 . . . . 1.3600000000000001 110.78 173.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.652 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 6.3 mt -76.55 -6.09 50.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.749 1.389 . . . . 1.26 114.749 -169.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.606 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -50.7 -39.72 52.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.527 1.156 . . . . 1.8899999999999999 109.942 -177.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.95 -45.26 12.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.694 -2.048 . . . . 1.1000000000000001 111.453 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.64 -165.28 35.98 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.576 -0.821 . . . . 0.29999999999999999 114.187 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.449 HD21 ' HB ' ' A' ' 9' ' ' VAL . 5.8 mp -117.33 158.13 24.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.501 -1.35 . . . . 1.0800000000000001 110.593 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.639 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 68.3 m -134.25 134.12 41.6 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.756 -0.656 . . . . 1.1699999999999999 111.101 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -47.5 129.06 13.17 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.446 0.906 . . . . 1.1699999999999999 113.446 175.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.635 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 81.84 -12.77 40.39 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 114.38 -1.282 . . . . 0.38 111.865 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.639 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.6 tt0 -64.7 151.63 44.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.715 0.769 . . . . 1.1899999999999999 110.307 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 41.1 m -118.0 133.68 55.69 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.257 -1.338 . . . . 1.22 109.277 -172.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 29' ' ' LEU . 19.2 pt -136.28 148.05 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.389 0.614 . . . . 1.0600000000000001 110.503 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 ' H ' HD22 ' A' ' 33' ' ' ASN . 14.8 t -93.1 149.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.087 -0.96 . . . . 0.20999999999999999 110.342 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 17.1 mm -118.01 88.94 33.06 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 1.01 108.61 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HA ' HD12 ' A' ' 4' ' ' LEU . 31.1 Cg_endo -61.73 140.64 87.13 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.0 2.466 . . . . 0.23000000000000001 112.468 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.607 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 82.76 -7.26 66.36 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.45 -0.796 . . . . 0.29999999999999999 112.692 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.734 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -115.24 125.33 29.01 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.777 -0.823 . . . . 1.0800000000000001 108.777 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.546 ' CD ' HD21 ' A' ' 51' ' ' LEU . 57.1 Cg_endo -65.39 174.2 5.47 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 124.064 3.176 . . . . 0.34000000000000002 114.129 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.474 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 6.9 t70 -95.74 137.16 21.93 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.776 -1.102 . . . . 0.71999999999999997 111.877 -170.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.572 ' HD3' HD11 ' A' ' 5' ' ' LEU . 71.3 Cg_endo -82.25 -8.36 11.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.496 2.797 . . . . 0.33000000000000002 113.552 -174.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 55' ' ' TYR . 51.3 m-85 -95.21 -22.25 17.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.089 0.471 . . . . 2.29 110.942 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -85.5 -6.8 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.069 0.938 . . . . 2.0600000000000001 108.942 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.588 HD11 ' HG2' ' A' ' 158' ' ' PRO . 87.1 mt -95.8 127.46 41.19 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.446 -1.252 . . . . 1.0900000000000001 110.226 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -102.12 96.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.147 1.231 . . . . 0.22 110.698 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.472 ' HB2' HG21 ' A' ' 161' ' ' THR . 89.2 m-85 -157.4 131.49 8.26 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.241 -1.392 . . . . 0.80000000000000004 107.241 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 18.3 m170 -136.08 103.21 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.706 -1.59 . . . . 3.5800000000000001 106.706 -165.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 55.6 mt -94.53 112.32 26.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.569 -0.742 . . . . 1.0600000000000001 110.537 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.97 96.83 6.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.102 -0.954 . . . . 1.1200000000000001 110.361 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -119.09 106.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.543 -1.208 . . . . 0.68000000000000005 110.361 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.522 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 24.1 m -101.06 125.94 47.71 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.542 -0.754 . . . . 1.3300000000000001 109.805 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 mt -47.01 -35.64 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.137 0.494 . . . . 1.77 110.83 166.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.47 -49.16 46.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.469 -0.872 . . . . 0.93999999999999995 111.514 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -68.92 -24.65 64.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 1.22 112.186 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 2.9 tppt? 55.67 18.69 2.95 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.489 1.138 . . . . 2.9399999999999999 112.055 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.443 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.69 140.25 34.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.968 0.889 . . . . 1.0600000000000001 111.15 173.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.471 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -96.89 118.57 33.61 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.9 -1.5 . . . . 1.0900000000000001 109.275 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.0 m -101.13 123.82 45.88 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.194 -0.602 . . . . 1.0900000000000001 111.17 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.518 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.95 131.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.767 -1.938 . . . . 1.0800000000000001 105.767 176.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 12.0 m -136.86 130.72 32.18 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 120.735 1.607 . . . . 0.93000000000000005 112.761 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.15 126.89 55.14 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.278 -0.874 . . . . 1.1399999999999999 110.322 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.0 t-20 63.7 35.65 11.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.383 0.611 . . . . 0.52000000000000002 109.463 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.3 m-20 78.52 -0.04 2.53 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.548 -1.206 . . . . 1.8400000000000001 112.613 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -129.99 139.42 51.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.082 -1.447 . . . . 3.8500000000000001 113.793 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -51.89 149.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 112.891 -1.959 . . . . 0.40999999999999998 113.737 -172.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.518 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.6 mtp -101.56 -42.04 6.38 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.234 -2.257 . . . . 1.0900000000000001 108.22 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -176.64 160.78 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.508 -2.133 . . . . 2.6200000000000001 110.373 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.443 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 9.5 m -122.78 132.6 54.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.527 -0.175 . . . . 1.1000000000000001 110.527 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.57 156.04 53.85 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 110.346 -0.242 . . . . 1.0600000000000001 110.346 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.36 143.45 11.11 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.7 2.267 . . . . 0.85999999999999999 111.842 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.37 173.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.482 -0.326 . . . . 1.2 110.148 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.352 . . . . 1.4099999999999999 110.804 176.262 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.644 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 6.7 m-85 . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 107.998 -1.112 . . . . 2.3500000000000001 107.998 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.7 m-85 -132.56 137.96 47.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.719 0.295 . . . . 0.92000000000000004 110.499 172.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 17.2 mm -58.73 116.5 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.562 -1.273 . . . . 1.0600000000000001 107.562 165.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.458 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.2 tt -102.09 -34.39 3.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.042 -0.663 . . . . 1.04 111.985 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.639 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 59.1 t30 -166.21 -177.83 4.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 122.819 1.295 . . . . 2.3500000000000001 113.846 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.639 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.7 ptt180 -155.65 131.27 9.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 111.476 -2.602 . . . . 1.54 110.187 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.2 153.7 20.66 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 121.925 0.869 . . . . 1.8899999999999999 110.76 -173.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -51.47 152.71 2.51 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.352 -1.749 . . . . 3.46 113.25 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -44.69 110.84 1.12 Allowed Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 112.331 -2.213 . . . . 3.3500000000000001 110.69 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -54.15 -50.34 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.499 2.799 . . . . 0.97999999999999998 111.827 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.65 -20.35 20.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.088 -0.96 . . . . 1.0800000000000001 112.683 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -132.94 -169.53 12.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.082 -0.58 . . . . 1.1599999999999999 112.123 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.77 37.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.906 3.737 . . . . 1.46 114.487 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.649 ' HE2' ' CE1' ' A' ' 111' ' ' PHE . 52.1 t80 -82.06 -18.04 44.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.695 -0.483 . . . . 2.1000000000000001 109.695 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.56 52.3 0.99 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.599 -0.728 . . . . 1.1100000000000001 114.415 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB2' HD12 ' A' ' 151' ' ' ILE . . . 71.71 -63.08 0.44 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.258 1.207 . . . . 1.45 114.258 164.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.595 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -142.41 138.28 30.99 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.541 -0.299 . . . . 1.5 110.204 -172.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.44 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 51.4 t-105 -98.35 99.35 10.54 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.976 -0.75 . . . . 2.6000000000000001 108.976 169.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.613 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.5 mp -109.34 135.28 50.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.628 0.727 . . . . 1.3100000000000001 110.659 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 m -107.58 149.17 28.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.278 -0.874 . . . . 1.3100000000000001 112.047 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 tp -102.17 -173.78 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.916 -1.038 . . . . 1.8600000000000001 108.573 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.481 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 48.0 t . . . . . 0 C--N 1.323 -0.57 0 C-N-CA 120.627 -0.429 . . . . 1.95 112.101 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.613 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 7.4 mt . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 106.522 -1.659 . . . . 1.05 106.522 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.479 ' HE1' ' O ' ' A' ' 111' ' ' PHE . 7.1 t-80 -134.9 179.31 6.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.883 -0.727 . . . . 1.25 111.715 -166.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -123.54 176.46 16.73 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.775 -1.102 . . . . 0.46000000000000002 111.537 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.8 t -148.07 171.77 15.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.154 0.502 . . . . 1.21 111.07 -168.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.38 -15.41 17.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.209 -0.905 . . . . 1.8600000000000001 109.523 166.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -125.33 101.34 31.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.673 -0.694 . . . . 1.8200000000000001 109.873 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -90.65 4.88 4.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.171 2.581 . . . . 0.64000000000000001 112.762 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.66 0.54 42.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.038 0.447 . . . . 1.3200000000000001 110.849 -170.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.6 p -111.22 -2.31 15.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.661 0.743 . . . . 1.8899999999999999 109.711 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 20.9 mm . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.967 -1.015 . . . . 1.21 110.772 -175.588 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.4 mtp . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.05 0.452 . . . . 1.8700000000000001 110.599 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -71.38 146.22 48.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.457 -0.942 . . . . 3.25 108.457 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -50.21 -67.78 0.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 112.508 0.558 . . . . 2.4199999999999999 112.508 -171.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -23.13 65.58 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.441 -0.787 . . . . 2.5699999999999998 112.018 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.81 -40.57 63.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.865 -0.607 . . . . 1.05 111.055 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.721 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 8.9 p -75.77 -17.94 15.58 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 110.285 -0.265 . . . . 0.32000000000000001 110.285 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.439 HD12 ' HB2' ' A' ' 113' ' ' ALA . 2.6 mp -87.12 -39.46 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 118.985 -0.531 . . . . 1.1299999999999999 110.61 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -43.7 -70.15 0.11 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.534 1.061 . . . . 1.3799999999999999 111.964 162.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.472 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -48.8 -44.79 39.47 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.626 -0.716 . . . . 1.3400000000000001 110.139 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.721 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -53.88 -55.2 28.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.244 -1.344 . . . . 1.02 112.337 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.473 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 33.1 t -77.42 -14.72 59.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.592 -1.186 . . . . 1.9099999999999999 110.9 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.54 -47.16 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.863 -0.421 . . . . 1.04 109.863 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.475 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 32.6 m -76.12 120.11 80.23 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.885 0.85 . . . . 0.20999999999999999 110.595 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.588 ' HG2' HD11 ' A' ' 57' ' ' ILE . 41.2 Cg_endo -83.43 -178.69 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.955 2.437 . . . . 0.51000000000000001 112.538 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.734 ' O ' HD22 ' A' ' 51' ' ' LEU . 19.9 m120 -62.3 4.25 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.503 -1.226 . . . . 1.02 113.366 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.3 54.84 0.52 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.64000000000000001 112.446 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.728 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -89.72 131.17 35.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.438 -0.448 . . . . 1.0700000000000001 110.837 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.37 138.9 31.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.472 -0.491 . . . . 2.3399999999999999 110.342 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 3.8 p -146.71 127.7 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.377 -0.829 . . . . 0.46000000000000002 111.13 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.404 ' C ' HD11 ' A' ' 165' ' ' ILE . 7.1 m -111.67 133.38 53.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 1.26 111.1 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.7 mp -119.18 110.13 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 117.832 -1.547 . . . . 1.1699999999999999 110.558 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.576 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.747 0 CA-C-N 114.896 -1.047 . . . . 1.1899999999999999 110.312 -171.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.6 mptt . . . . . 0 CA--C 1.518 -0.286 0 N-CA-C 109.864 -0.421 . . . . 2.54 109.864 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.57 HD12 ' H ' ' A' ' 50' ' ' GLY . 15.7 mt -93.49 167.22 11.84 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.367 0.417 . . . . 1.1000000000000001 111.332 175.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 6' ' ' THR . 2.5 tp -77.11 151.2 35.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.488 0.715 . . . . 1.05 111.902 -170.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.554 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.8 150.14 38.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 122.1 0.952 . . . . 1.01 112.168 169.081 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.649 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 62.8 t80 -133.67 150.29 51.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.754 -1.567 . . . . 1.1200000000000001 107.86 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -129.93 114.97 16.52 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.071 -1.455 . . . . 1.72 107.071 175.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.4 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 0.9 OUTLIER -74.32 157.15 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.342 0.591 . . . . 0.38 112.359 -166.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -102.8 149.04 24.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.001 -0.999 . . . . 3.0600000000000001 108.978 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.491 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -52.53 117.94 3.24 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.874 -0.603 . . . . 2.1699999999999999 111.369 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.67 -10.26 32.56 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.516 -0.766 . . . . 0.63 112.446 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.498 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 54.6 m-20 -62.24 147.55 47.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.997 0.427 . . . . 2.1699999999999999 111.827 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.19 149.38 50.47 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.892 -0.594 . . . . 1.27 111.908 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.2 tp -46.16 -60.42 2.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.868 1.062 . . . . 1.0800000000000001 113.868 -173.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.659 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.7 t-20 -64.41 -38.96 92.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.751 1.262 . . . . 1.55 110.15 -171.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.764 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 19.3 m -62.07 -40.93 97.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.636 -2.075 . . . . 1.8200000000000001 111.002 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.28 -39.74 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.013 0.925 . . . . 1.0600000000000001 112.736 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.81 -62.1 1.98 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.61 -0.268 . . . . 0.97999999999999998 111.203 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.38 -4.65 52.01 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.814 -1.155 . . . . 1.0700000000000001 111.789 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.764 ' HB2' ' O ' ' A' ' 17' ' ' SER . 12.1 t70 -63.68 -32.42 73.9 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.135 -1.061 . . . . 1.6299999999999999 108.135 158.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' A' ' 101' ' ' ILE . 2.0 m-85 -102.53 16.49 26.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 112.354 0.502 . . . . 0.25 112.354 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 54.46 52.02 13.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.206 -0.906 . . . . 4.2000000000000002 110.644 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 34.9 pt -147.99 -171.35 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.971 -0.752 . . . . 1.02 108.971 -172.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.85 147.47 24.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.668 -0.697 . . . . 1.1599999999999999 109.917 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.659 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 15.8 p -63.0 -35.88 81.68 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.725 -0.843 . . . . 1.05 108.725 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.9 68.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.196 -1.366 . . . . 1.05 111.619 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.79 -38.43 25.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.368 0.604 . . . . 1.03 109.551 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 13.6 tp -73.88 -18.82 60.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 1.05 109.084 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.65 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.25 -39.34 33.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.616 0.722 . . . . 1.0600000000000001 111.444 171.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -61.03 -40.3 93.06 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.128 -0.942 . . . . 1.26 110.009 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.74 36.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.881 -1.509 . . . . 1.01 112.085 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 29.7 m-80 -142.02 71.57 23.43 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.039 0.447 . . . . 0.20000000000000001 109.825 -173.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.501 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.33 -10.26 6.21 Favored 'Trans proline' 0 C--O 1.218 -0.475 0 C-N-CA 123.484 2.789 . . . . 0.29999999999999999 114.07 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -62.63 -33.83 75.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.09 0.947 . . . . 1.3600000000000001 109.75 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -78.78 -4.51 49.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.262 -1.335 . . . . 1.26 114.233 -172.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.65 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.64 -40.11 26.6 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 122.414 1.102 . . . . 1.8899999999999999 110.249 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.557 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.46 -46.51 10.82 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.997 -1.911 . . . . 1.1000000000000001 111.565 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.52 -164.52 34.89 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.978 -1.106 . . . . 0.29999999999999999 114.264 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -116.38 159.56 21.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.262 -1.469 . . . . 1.0800000000000001 110.396 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.1 m -138.44 135.09 34.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.916 -0.584 . . . . 1.1699999999999999 110.871 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -48.0 129.32 14.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.662 0.744 . . . . 1.1699999999999999 112.857 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.5 -13.64 39.88 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.46 -1.246 . . . . 0.38 112.179 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.8 tt0 -64.59 151.3 45.04 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.628 0.728 . . . . 1.1899999999999999 110.272 174.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.444 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 46.1 m -117.91 133.18 56.18 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.495 -1.23 . . . . 1.22 109.276 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.22 148.97 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.277 0.561 . . . . 1.0600000000000001 110.511 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.471 ' H ' HD22 ' A' ' 33' ' ' ASN . 14.2 t -93.41 149.61 4.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.136 -0.938 . . . . 0.20999999999999999 110.099 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 21.7 mm -117.64 88.58 30.08 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.05 -0.977 . . . . 1.01 108.584 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.57 ' HA ' HD12 ' A' ' 4' ' ' LEU . 23.7 Cg_endo -59.06 143.28 99.86 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.053 2.502 . . . . 0.23000000000000001 112.585 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.57 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 80.22 -6.59 59.67 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.694 -0.685 . . . . 0.29999999999999999 112.996 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.691 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -116.73 126.39 27.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.752 -0.833 . . . . 1.0800000000000001 108.752 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.549 ' CD ' HD21 ' A' ' 51' ' ' LEU . 61.6 Cg_endo -66.86 171.01 11.7 Favored 'Trans proline' 0 N--CA 1.477 0.517 0 C-N-CA 123.644 2.896 . . . . 0.34000000000000002 114.029 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -90.95 138.89 25.9 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.573 -1.194 . . . . 0.71999999999999997 111.82 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.525 ' HD3' HD11 ' A' ' 5' ' ' LEU . 66.3 Cg_endo -83.17 -4.94 11.19 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.529 2.819 . . . . 0.33000000000000002 113.771 -173.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.34 -29.3 14.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.613 0.244 . . . . 2.29 111.235 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -80.38 -17.53 51.62 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.825 -0.805 . . . . 2.0600000000000001 108.825 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.523 HD11 ' HG2' ' A' ' 158' ' ' PRO . 87.2 mt -81.44 123.31 81.2 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.974 -1.012 . . . . 1.0900000000000001 109.224 169.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -100.83 94.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 120.023 1.044 . . . . 0.22 110.13 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -158.78 129.79 6.23 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.558 -1.645 . . . . 0.80000000000000004 106.558 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.661 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 42.9 m170 -134.02 106.56 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.198 -1.779 . . . . 3.5800000000000001 106.198 -165.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -95.06 110.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.908 -0.717 . . . . 1.0600000000000001 110.904 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.13 94.21 4.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.277 -0.874 . . . . 1.1200000000000001 110.442 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.532 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -119.36 97.76 5.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.317 -1.31 . . . . 0.68000000000000005 110.432 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.49 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 48.9 m -89.33 112.26 23.31 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.529 -1.286 . . . . 1.3300000000000001 107.529 173.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.4 mm -42.34 -43.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.901 -0.59 . . . . 1.77 110.03 169.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.94 -46.33 91.07 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.661 -1.257 . . . . 0.93999999999999995 111.746 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -66.83 -23.87 66.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.629 0.603 . . . . 1.22 112.629 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 62.63 13.08 6.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.034 0.753 . . . . 2.9399999999999999 113.034 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.25 138.89 33.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.225 1.012 . . . . 1.0600000000000001 111.796 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.532 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -98.45 120.63 39.21 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.241 -1.8 . . . . 1.0900000000000001 109.282 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -102.1 124.23 47.34 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.593 -0.843 . . . . 1.0900000000000001 110.826 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.572 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -85.21 129.92 34.71 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.728 -1.953 . . . . 1.0800000000000001 105.728 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.661 ' OG ' ' HB2' ' A' ' 60' ' ' HIS . 13.7 p -139.23 128.88 24.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 121.37 1.895 . . . . 0.93000000000000005 114.03 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 tp -113.97 127.49 55.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.346 -1.297 . . . . 1.1399999999999999 110.338 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 11.5 t-20 63.44 35.9 11.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.217 0.532 . . . . 0.52000000000000002 109.675 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.6 m-20 79.96 -1.02 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.835 -1.075 . . . . 1.8400000000000001 112.697 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -131.2 138.78 49.55 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.391 -1.324 . . . . 3.8500000000000001 113.832 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -50.31 149.31 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 113.004 -1.907 . . . . 0.40999999999999998 113.298 -176.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.572 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.6 mtp -97.95 -46.03 6.06 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 112.116 -2.311 . . . . 1.0900000000000001 107.525 174.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -177.87 157.56 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.576 -2.102 . . . . 2.6200000000000001 110.479 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -115.69 132.15 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.508 0.195 . . . . 1.1000000000000001 110.886 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.45 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 69.5 m-85 -115.63 147.27 38.54 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.617 -0.265 . . . . 1.0600000000000001 110.398 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -86.92 141.71 6.32 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.489 2.126 . . . . 0.85999999999999999 111.793 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.44 -177.51 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.332 -0.395 . . . . 1.2 110.807 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 CA-C-O 120.842 0.353 . . . . 1.4099999999999999 111.168 -178.269 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.642 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 13.6 m-85 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.085 0.469 . . . . 2.3500000000000001 110.452 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 161' ' ' THR . 69.0 m-85 -136.84 139.27 41.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.92000000000000004 109.838 171.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.471 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 26.0 mm -60.23 118.79 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.997 -1.112 . . . . 1.0600000000000001 107.997 167.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 22' ' ' PHE . 2.8 tt -114.46 -22.68 4.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 119.814 -0.754 . . . . 1.04 112.287 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.603 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 66.0 t30 -167.67 178.62 5.23 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 122.86 1.314 . . . . 2.3500000000000001 114.325 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.603 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 2.1 ptt180 -151.18 131.8 13.94 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 111.387 -2.642 . . . . 1.54 110.447 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.577 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 5.5 tp60 -109.45 145.37 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.981 0.896 . . . . 1.8899999999999999 111.623 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.577 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 61.3 ttt180 -54.92 150.24 10.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.431 -1.713 . . . . 3.46 111.487 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.04 106.22 0.54 Allowed Pre-proline 0 CA--C 1.511 -0.52 0 CA-C-N 115.602 -0.726 . . . . 3.3500000000000001 111.624 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.01 -48.84 20.01 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.781 2.988 . . . . 0.97999999999999998 111.69 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.87 -21.1 14.07 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.961 -1.018 . . . . 1.0800000000000001 112.624 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -101.75 -169.89 27.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.956 -0.64 . . . . 1.1599999999999999 112.13 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.44 31.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.231 3.288 . . . . 1.46 113.533 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.614 ' CE1' ' HB2' ' A' ' 115' ' ' TRP . 1.1 t80 -72.51 -33.45 66.93 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.308 -0.627 . . . . 2.1000000000000001 109.308 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.28 60.64 0.78 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.119 -0.946 . . . . 1.1100000000000001 114.485 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' HB3' HD12 ' A' ' 151' ' ' ILE . . . 74.51 -45.09 0.57 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.182 1.178 . . . . 1.45 114.182 166.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.634 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -150.41 145.79 26.28 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.21 -0.293 . . . . 1.5 110.21 -176.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.614 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 24.1 t-105 -116.01 101.06 8.42 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.258 -0.645 . . . . 2.6000000000000001 109.258 166.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.5 mp -100.66 127.79 46.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.792 0.806 . . . . 1.3100000000000001 110.536 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.4 m -87.44 133.72 33.7 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.22 -0.9 . . . . 1.3100000000000001 111.672 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.55 -179.42 6.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.233 -1.395 . . . . 1.8600000000000001 107.233 168.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.473 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 40.8 t . . . . . 0 C--N 1.321 -0.642 0 C-N-CA 120.392 -0.523 . . . . 1.95 110.037 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.588 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 17.2 mt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.477 -0.564 . . . . 1.05 109.477 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -155.43 -163.97 1.65 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.507 0.67 . . . . 1.25 111.729 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -121.91 179.25 16.27 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.014 -1.089 . . . . 0.46000000000000002 113.123 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 t -136.09 173.29 11.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.215 -0.493 . . . . 1.21 110.797 -168.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -104.22 -18.45 14.48 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.358 -0.837 . . . . 1.8600000000000001 108.873 166.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -128.01 103.68 20.95 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 1.8200000000000001 110.366 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.403 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 53.4 Cg_endo -91.21 4.07 4.25 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.143 2.562 . . . . 0.64000000000000001 112.928 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.23 -18.67 33.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.284 0.564 . . . . 1.3200000000000001 110.337 -172.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 m -89.26 -12.92 39.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 1.8899999999999999 109.922 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 5.3 mm . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.238 -0.892 . . . . 1.21 111.373 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.45 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 8.3 mtm . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.759 0.314 . . . . 1.8700000000000001 110.198 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.427 ' HD2' ' OD1' ' A' ' 147' ' ' ASN . 1.9 t60 -67.58 145.33 54.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.155 -0.683 . . . . 3.25 109.155 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.427 ' OD1' ' HD2' ' A' ' 146' ' ' HIS . 30.5 p-10 -49.33 -66.43 0.4 Allowed 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.296 0.48 . . . . 2.4199999999999999 112.296 -174.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -62.95 -23.35 67.36 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.834 -0.541 . . . . 2.5699999999999998 111.603 -174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 1.5 m-20 -69.19 -43.14 74.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 1.05 110.9 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.671 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 14.3 p -77.68 -20.53 13.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 CA-C-N 116.555 -0.293 . . . . 0.32000000000000001 111.036 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.401 HD12 ' HB3' ' A' ' 113' ' ' ALA . 3.1 mp -84.79 -40.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 118.907 -0.568 . . . . 1.1299999999999999 110.437 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -43.63 -68.7 0.17 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.608 1.095 . . . . 1.3799999999999999 111.931 163.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.469 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -50.55 -44.03 56.38 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.726 -0.67 . . . . 1.3400000000000001 110.375 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.671 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -53.69 -54.28 40.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.377 -1.283 . . . . 1.02 112.157 -171.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.6 p -77.76 -13.73 59.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.223 -1.353 . . . . 1.9099999999999999 111.443 -172.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -93.51 -46.82 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.907 0.384 . . . . 1.04 110.227 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.401 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 24.4 m -76.61 122.64 86.96 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-O 121.586 0.708 . . . . 0.20999999999999999 110.077 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.523 ' HG2' HD11 ' A' ' 57' ' ' ILE . 34.8 Cg_endo -84.08 -178.51 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.89 2.394 . . . . 0.51000000000000001 112.557 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.691 ' O ' HD22 ' A' ' 51' ' ' LEU . 11.7 m120 -59.73 -0.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.021 . . . . 1.02 113.604 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.46 56.3 0.53 Allowed Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.822 -0.704 . . . . 0.64000000000000001 112.734 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.505 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 2.5 m -92.68 139.43 30.57 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 122.29 -0.535 . . . . 1.0700000000000001 110.733 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -85.1 134.6 34.19 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.151 -0.314 . . . . 2.3399999999999999 110.151 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.95 128.03 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.544 0.687 . . . . 0.46000000000000002 111.646 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.1 m -113.37 132.56 55.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.526 -0.761 . . . . 1.26 111.167 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.27 116.67 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 118.788 -1.165 . . . . 1.1699999999999999 110.184 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.662 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 122.185 0.993 . . . . 1.1899999999999999 111.171 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 5.8 mtmt . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.734 -0.469 . . . . 2.54 109.734 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.635 HD12 ' H ' ' A' ' 50' ' ' GLY . 15.7 mt -100.26 164.55 11.9 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.783 -0.644 . . . . 1.1000000000000001 111.389 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.538 ' HG ' ' N ' ' A' ' 6' ' ' THR . 2.7 tp -75.51 149.77 38.33 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.906 -0.588 . . . . 1.05 111.973 -169.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.538 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.39 149.91 38.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.015 0.912 . . . . 1.01 112.148 169.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.656 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 73.9 t80 -134.98 148.34 49.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.671 -1.604 . . . . 1.1200000000000001 107.661 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.75 115.72 17.71 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.175 -1.417 . . . . 1.72 107.175 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -77.82 158.47 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.886 -0.597 . . . . 0.38 111.843 -166.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -104.66 153.58 21.06 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.859 -0.793 . . . . 3.0600000000000001 108.859 -176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.539 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 16.8 tt0 -54.42 109.11 0.45 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.855 -0.611 . . . . 2.1699999999999999 112.243 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.56 -7.01 18.16 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.397 -0.82 . . . . 0.63 112.723 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.523 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 87.5 m-20 -63.01 152.93 35.48 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.101 0.451 . . . . 2.1699999999999999 111.973 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.405 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.9 p -132.27 155.05 49.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.01 0.433 . . . . 1.27 111.982 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.593 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 50.1 tp -49.12 -59.16 3.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.009 1.114 . . . . 1.0800000000000001 114.009 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.659 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 13.3 t-20 -64.54 -43.21 94.7 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 122.452 1.12 . . . . 1.55 110.481 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.722 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 21.1 t -57.45 -42.31 82.23 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 112.467 -2.151 . . . . 1.8200000000000001 110.289 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.94 -41.31 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 123.528 0.731 . . . . 1.0600000000000001 112.488 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.86 -64.83 0.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.529 -0.305 . . . . 0.97999999999999998 111.665 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.36 -3.89 48.38 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.067 -1.053 . . . . 1.0700000000000001 111.826 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.722 ' HB2' ' O ' ' A' ' 17' ' ' SER . 53.6 t0 -62.18 -42.76 99.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.971 -1.122 . . . . 1.6299999999999999 107.971 156.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.2 m-85 -89.93 16.28 8.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.123 0.416 . . . . 0.25 112.123 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 54.47 51.29 14.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.288 -0.869 . . . . 4.2000000000000002 110.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 38.6 pt -147.82 -173.62 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.826 -0.805 . . . . 1.02 108.826 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -100.87 146.09 27.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.48 -0.782 . . . . 1.1599999999999999 109.759 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.659 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -62.34 -35.78 80.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.452 0.644 . . . . 1.05 109.435 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.67 67.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.57 -1.195 . . . . 1.05 111.673 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.25 -38.7 24.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.302 0.572 . . . . 1.03 109.472 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.4 tp -73.48 -19.47 60.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.334 -0.848 . . . . 1.05 109.162 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.662 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.36 34.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.618 0.723 . . . . 1.0600000000000001 111.45 173.327 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.2 -39.32 94.31 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.002 0.906 . . . . 1.26 110.047 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 -19.65 38.28 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.052 -1.431 . . . . 1.01 111.861 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 29.9 m-80 -142.55 72.31 20.62 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 0.20000000000000001 109.709 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.594 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.2 Cg_endo -54.52 -19.42 17.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 123.545 2.83 . . . . 0.29999999999999999 113.9 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -59.85 -30.82 69.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.925 0.869 . . . . 1.3600000000000001 110.431 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.8 mt -79.78 -3.72 48.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.309 -1.314 . . . . 1.26 114.238 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.662 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.67 -39.62 37.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.442 1.115 . . . . 1.8899999999999999 110.082 -177.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.553 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.22 -45.94 11.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.875 -1.966 . . . . 1.1000000000000001 111.733 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.33 -165.06 35.81 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.393 -0.908 . . . . 0.29999999999999999 113.963 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -115.08 158.22 22.45 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.232 -1.484 . . . . 1.0800000000000001 109.977 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.559 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.1 m -134.67 136.39 42.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.893 -0.594 . . . . 1.1699999999999999 110.553 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -45.75 127.64 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.272 0.841 . . . . 1.1699999999999999 113.272 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.33 -10.93 46.94 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.33 -1.305 . . . . 0.38 112.265 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.559 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -64.23 151.81 42.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.477 0.656 . . . . 1.1899999999999999 110.455 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.429 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 55.4 p -115.48 136.71 52.8 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.882 -1.054 . . . . 1.22 109.484 -173.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -137.36 149.37 25.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.414 0.626 . . . . 1.0600000000000001 110.382 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.488 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.8 t -96.48 149.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.973 -1.012 . . . . 0.20999999999999999 110.121 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 17.2 mm -117.9 87.47 27.85 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.155 -0.929 . . . . 1.01 108.702 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HA ' HD12 ' A' ' 4' ' ' LEU . 23.8 Cg_endo -59.14 141.41 98.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.248 2.632 . . . . 0.23000000000000001 113.018 -173.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.635 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 83.52 -7.89 67.14 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.557 -0.747 . . . . 0.29999999999999999 112.855 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -116.34 127.44 26.75 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.719 -0.845 . . . . 1.0800000000000001 108.719 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.6 Cg_endo -65.91 171.87 9.27 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.674 2.916 . . . . 0.34000000000000002 113.8 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 9.5 t70 -94.94 138.0 22.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.063 -0.971 . . . . 0.71999999999999997 111.522 -170.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 77.6 Cg_endo -75.32 -7.95 19.29 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 123.296 2.664 . . . . 0.33000000000000002 113.288 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -33.5 16.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.063 -0.255 . . . . 2.29 110.618 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.5 p -63.4 -31.82 73.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.426 1.107 . . . . 2.0600000000000001 108.31 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.584 HD11 ' HG2' ' A' ' 158' ' ' PRO . 95.1 mt -77.27 126.02 85.65 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.082 -1.872 . . . . 1.0900000000000001 110.857 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -100.97 95.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.946 0 C-N-CA 120.753 0.969 . . . . 0.22 110.257 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 73' ' ' SER . 94.3 m-85 -157.68 138.08 12.8 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.909 -1.515 . . . . 0.80000000000000004 106.909 171.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 55.5 t-80 -144.56 104.07 4.01 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.429 -1.323 . . . . 3.5800000000000001 107.429 -170.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 68.8 mt -94.8 109.25 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.037 -1.438 . . . . 1.0600000000000001 110.176 -174.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.05 102.74 11.17 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.19 -0.913 . . . . 1.1200000000000001 110.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.491 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -122.14 102.57 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.005 -1.452 . . . . 0.68000000000000005 109.988 178.48 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.51 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 30.2 t -95.0 135.67 36.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.183 -0.917 . . . . 1.3300000000000001 108.9 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -33.61 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.491 0.662 . . . . 1.77 109.95 170.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.04 -48.1 74.69 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 114.95 -1.023 . . . . 0.93999999999999995 111.368 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.51 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -69.08 -25.12 64.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.873 0.694 . . . . 1.22 112.873 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 57.18 12.71 1.39 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.871 0.869 . . . . 2.9399999999999999 112.982 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.43 142.27 35.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.575 0.702 . . . . 1.0600000000000001 111.349 177.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.491 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -98.07 118.42 34.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.499 -1.228 . . . . 1.0900000000000001 109.936 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 m -101.51 125.4 48.15 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.438 -0.505 . . . . 1.0900000000000001 111.35 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -83.16 134.89 34.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.47 -1.678 . . . . 1.0800000000000001 106.47 177.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 13.4 m -138.32 129.33 27.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.716 1.598 . . . . 0.93000000000000005 112.346 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.14 124.25 49.86 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.079 -0.964 . . . . 1.1399999999999999 110.01 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.57 37.51 3.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.843 -1.169 . . . . 0.52000000000000002 107.843 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m120 83.92 -14.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.679 -1.601 . . . . 1.8400000000000001 111.569 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -127.23 141.27 51.77 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 117.675 -1.61 . . . . 3.8500000000000001 114.613 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -56.55 148.75 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 112.291 -2.232 . . . . 0.40999999999999998 113.957 -165.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.52 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.0 mtp -100.49 -43.73 6.11 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.721 -2.49 . . . . 1.0900000000000001 107.804 175.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.471 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 33.3 tptt -179.92 161.34 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.497 -2.138 . . . . 2.6200000000000001 111.102 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.469 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 15.2 m -118.39 137.43 53.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 122.422 -0.174 . . . . 1.1000000000000001 110.908 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 82' ' ' TYR . 19.6 m-85 -126.03 137.81 30.88 Favored Pre-proline 0 N--CA 1.457 -0.107 0 CA-C-O 120.702 0.287 . . . . 1.0600000000000001 110.267 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.39 146.09 93.09 Favored 'Trans proline' 0 N--CA 1.471 0.184 0 C-N-CA 123.187 2.592 . . . . 0.85999999999999999 112.772 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.58 179.75 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.67 -0.493 . . . . 1.2 109.67 176.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.55 0.691 . . . . 1.4099999999999999 111.411 179.376 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.657 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 29.7 m-85 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.518 -0.919 . . . . 2.3500000000000001 108.518 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.629 ' HA ' ' O ' ' A' ' 161' ' ' THR . 42.4 m-85 -129.86 139.71 51.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.766 0.317 . . . . 0.92000000000000004 110.19 169.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 18.6 mm -59.4 115.58 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.681 -1.229 . . . . 1.0600000000000001 107.681 166.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' A' ' 22' ' ' PHE . 2.6 tt -99.31 -30.03 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.622 -0.831 . . . . 1.04 112.068 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.469 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 7.0 t-20 -178.8 -165.06 0.08 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.599 1.19 . . . . 2.3500000000000001 113.775 176.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.586 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 9.9 mtt180 -148.2 132.86 17.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 111.969 -2.378 . . . . 1.54 108.871 -173.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.457 ' HG2' ' N ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -101.76 158.91 15.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.274 1.035 . . . . 1.8899999999999999 111.423 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.713 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 2.5 ttt180 -49.74 152.93 1.35 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 112.865 -1.971 . . . . 3.46 112.003 169.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.713 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.03 112.93 1.9 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 114.062 -1.426 . . . . 3.3500000000000001 110.861 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -57.44 -50.75 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.141 2.56 . . . . 0.97999999999999998 111.559 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.08 45.57 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.777 -1.101 . . . . 1.0800000000000001 112.469 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -107.32 -169.21 22.05 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.328 -0.463 . . . . 1.1599999999999999 112.09 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.6 36.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 124.576 3.517 . . . . 1.46 114.402 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.631 ' HE2' ' CE1' ' A' ' 111' ' ' PHE . 8.7 t80 -93.1 -12.05 31.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.76 0.314 . . . . 2.1000000000000001 110.977 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.59 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.51 33.4 5.37 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.408 -0.901 . . . . 1.1100000000000001 114.497 171.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.39 -22.5 0.25 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.943 1.09 . . . . 1.45 113.943 168.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.597 ' HE2' ' CE1' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -152.98 143.99 23.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.011 -0.366 . . . . 1.5 110.011 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -109.94 100.77 9.67 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.799 -0.815 . . . . 2.6000000000000001 108.799 166.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.799 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.1 mp -104.82 137.1 43.12 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.42 0.629 . . . . 1.3100000000000001 109.549 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.9 m -106.16 143.45 34.26 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.231 -0.895 . . . . 1.3100000000000001 112.064 -170.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.83 -174.79 3.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.702 -1.222 . . . . 1.8600000000000001 107.702 171.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.318 -0.802 0 N-CA-C 112.218 0.451 . . . . 1.95 112.218 -177.772 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.799 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 41.7 mt . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 108.476 -0.935 . . . . 1.05 108.476 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -140.9 -162.71 1.41 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.045 -0.662 . . . . 1.25 111.463 -175.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.59 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.3 175.89 16.22 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.087 -1.054 . . . . 0.46000000000000002 113.449 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -141.1 177.9 7.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.946 -0.627 . . . . 1.21 109.849 -172.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 -4.71 9.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.317 -0.856 . . . . 1.8600000000000001 110.116 167.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -126.31 101.69 27.82 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 109.178 -0.675 . . . . 1.8200000000000001 109.178 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -92.5 3.57 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.636 2.89 . . . . 0.64000000000000001 114.015 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.11 -19.34 59.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.131 0.491 . . . . 1.3200000000000001 111.693 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.2 m -91.66 -18.24 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.116 0.484 . . . . 1.8899999999999999 110.456 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.3 mm . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.637 -0.71 . . . . 1.21 111.12 -176.358 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.51 ' HE2' ' CG ' ' A' ' 82' ' ' TYR . 10.5 mtp . . . . . 0 C--O 1.232 0.172 0 N-CA-C 110.196 -0.298 . . . . 1.8700000000000001 110.196 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -79.13 158.89 27.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.597 -0.52 . . . . 3.25 109.597 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -52.05 -68.13 0.19 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 123.333 0.396 . . . . 2.4199999999999999 111.73 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -62.55 -24.54 67.58 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.728 -0.607 . . . . 2.5699999999999998 111.821 -175.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.27 -43.05 71.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.331 -0.395 . . . . 1.05 110.704 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.692 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 7.3 p -77.3 -19.8 14.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.374 -0.375 . . . . 0.32000000000000001 111.047 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.61 -39.53 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 118.987 -0.53 . . . . 1.1299999999999999 109.849 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -43.35 -70.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.257 0.935 . . . . 1.3799999999999999 112.107 163.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.45 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -49.81 -42.96 48.21 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 123.853 0.721 . . . . 1.3400000000000001 110.323 178.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.692 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -54.12 -56.68 15.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.3 -1.318 . . . . 1.02 111.884 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.2 t -76.41 -11.53 59.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.803 -1.09 . . . . 1.9099999999999999 110.626 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 92.9 mt -93.03 -47.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.751 -0.463 . . . . 1.04 109.751 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 27.0 m -77.17 119.16 76.36 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 121.996 0.903 . . . . 0.20999999999999999 110.81 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.584 ' HG2' HD11 ' A' ' 57' ' ' ILE . 33.1 Cg_endo -84.09 -177.71 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.017 2.478 . . . . 0.51000000000000001 113.013 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.651 ' O ' HD22 ' A' ' 51' ' ' LEU . 17.5 m120 -59.11 1.21 0.07 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.568 -1.196 . . . . 1.02 113.978 -176.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.08 55.92 0.47 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.729 . . . . 0.64000000000000001 112.173 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.1 m -84.83 137.03 33.41 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.543 -0.386 . . . . 1.0700000000000001 110.657 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.4 ' HG2' ' HE1' ' A' ' 99' ' ' TYR . 64.0 mtm180 -83.06 125.87 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.097 -0.335 . . . . 2.3399999999999999 110.097 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 61' ' ' ILE . 2.7 p -139.49 123.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.401 0.62 . . . . 0.46000000000000002 111.103 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.432 ' C ' HD11 ' A' ' 165' ' ' ILE . 62.5 m -113.44 137.12 51.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.699 -0.682 . . . . 1.26 111.813 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.432 HD11 ' C ' ' A' ' 164' ' ' THR . 3.2 mp -126.35 113.34 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 118.387 -1.325 . . . . 1.1699999999999999 111.08 172.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 113.468 -1.697 . . . . 1.1899999999999999 109.618 -174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.9 mptp? . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.777 -0.453 . . . . 2.54 109.777 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.565 HD12 ' H ' ' A' ' 50' ' ' GLY . 15.5 mt -97.05 168.16 10.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.017 -0.538 . . . . 1.1000000000000001 111.147 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.8 tp -75.88 150.23 37.64 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 123.336 0.654 . . . . 1.05 111.886 -169.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.529 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.46 149.13 36.78 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.17 0.986 . . . . 1.01 111.978 167.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 77.9 t80 -135.18 150.84 50.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.277 -1.783 . . . . 1.1200000000000001 108.068 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.598 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.1 tm0? -129.41 120.96 26.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.359 -1.349 . . . . 1.72 107.359 174.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -81.41 159.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 123.327 0.651 . . . . 0.38 111.968 -171.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -107.84 151.14 26.15 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.071 -0.715 . . . . 3.0600000000000001 109.071 -176.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.503 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 4.9 tt0 -54.3 113.76 1.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.339 -0.846 . . . . 2.1699999999999999 111.949 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.75 -5.79 25.97 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.679 -0.772 . . . . 0.63 112.797 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 32.7 m-20 -66.6 156.26 35.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.661 0.615 . . . . 2.1699999999999999 112.661 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -133.86 154.64 50.9 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 116.048 -0.524 . . . . 1.27 112.273 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.581 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.54 -58.68 4.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.767 1.025 . . . . 1.0800000000000001 113.767 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.642 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.2 p30 -63.19 -41.83 99.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.794 1.283 . . . . 1.55 110.941 -171.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.787 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 3.2 m -61.83 -39.76 92.95 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.162 -2.29 . . . . 1.8200000000000001 110.878 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.45 -38.99 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 123.638 0.775 . . . . 1.0600000000000001 112.694 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.411 ' HB3' ' HA ' ' A' ' 26' ' ' THR . . . -57.15 -61.29 2.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.465 -0.334 . . . . 0.97999999999999998 111.2 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.32 -4.79 54.81 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.677 -1.209 . . . . 1.0700000000000001 111.774 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.787 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.0 t70 -61.95 -35.43 78.41 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.609 -1.256 . . . . 1.6299999999999999 107.609 157.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.9 m-85 -100.73 17.29 22.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.854 0.687 . . . . 0.25 112.854 176.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 53.95 52.49 12.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.563 -0.744 . . . . 4.2000000000000002 110.856 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 34.0 pt -149.85 -173.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.984 -0.747 . . . . 1.02 108.984 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 146.97 24.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.589 -0.732 . . . . 1.1599999999999999 109.71 173.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.642 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 17.9 p -60.89 -36.6 79.64 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.503 -0.925 . . . . 1.05 108.503 175.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.64 70.55 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.441 -1.254 . . . . 1.05 111.733 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.21 -37.57 28.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.888 -0.507 . . . . 1.03 109.761 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.0 tp -74.47 -19.66 60.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.382 -0.826 . . . . 1.05 109.188 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.6 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.28 -39.02 41.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.723 0.773 . . . . 1.0600000000000001 111.608 173.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -60.62 -41.39 94.76 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.971 -1.013 . . . . 1.26 109.745 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.54 -20.53 39.81 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.717 -1.583 . . . . 1.01 112.169 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 25.4 m-80 -141.88 72.3 23.77 Favored Pre-proline 0 CA--C 1.513 -0.447 0 CA-C-O 121.132 0.492 . . . . 0.20000000000000001 109.836 -173.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.686 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.6 Cg_endo -57.51 -11.94 9.9 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.415 2.743 . . . . 0.29999999999999999 113.887 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -61.9 -32.77 73.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.965 0.888 . . . . 1.3600000000000001 109.375 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.75 -6.87 59.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.785 1.402 . . . . 1.26 114.785 -171.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -50.58 -40.91 53.6 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 120.08 1.309 . . . . 1.8899999999999999 110.241 179.254 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.81 -46.29 12.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.965 -1.925 . . . . 1.1000000000000001 111.437 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.43 -163.5 34.15 Favored Glycine 0 CA--C 1.495 -1.214 0 C-N-CA 120.402 -0.904 . . . . 0.29999999999999999 114.029 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.89 158.31 25.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.215 -1.493 . . . . 1.0800000000000001 110.436 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.582 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.7 m -131.74 135.58 46.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.713 -0.676 . . . . 1.1699999999999999 110.339 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -46.13 127.71 8.83 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.994 0.739 . . . . 1.1699999999999999 112.994 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.598 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 81.79 -10.43 51.83 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.815 -1.084 . . . . 0.38 112.174 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.582 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.0 tt0 -64.25 151.33 43.91 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.771 0.796 . . . . 1.1899999999999999 110.188 175.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 39.5 m -117.79 134.14 55.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.235 -1.348 . . . . 1.22 109.023 -171.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.404 HD13 HD13 ' A' ' 29' ' ' LEU . 22.8 pt -135.88 149.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.319 0.581 . . . . 1.0600000000000001 110.584 -175.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.481 ' H ' HD22 ' A' ' 33' ' ' ASN . 13.5 t -94.64 149.37 4.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.998 -1.001 . . . . 0.20999999999999999 110.249 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.441 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 21.4 mm -117.58 88.36 29.09 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.993 -1.003 . . . . 1.01 108.434 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.556 ' HA ' HD12 ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.45 143.4 97.88 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.248 2.632 . . . . 0.23000000000000001 112.723 -173.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.565 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 79.14 -8.29 46.59 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.496 -0.775 . . . . 0.29999999999999999 112.882 -176.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -113.54 124.82 30.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.551 -0.907 . . . . 1.0800000000000001 108.551 177.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.55 ' CD ' HD21 ' A' ' 51' ' ' LEU . 59.2 Cg_endo -66.17 174.35 6.11 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.6 2.867 . . . . 0.34000000000000002 113.631 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.565 ' CG ' ' HD2' ' A' ' 54' ' ' PRO . 13.6 t70 -89.12 142.0 29.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.043 -0.98 . . . . 0.71999999999999997 109.967 -173.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 83.2 Cg_endo -81.19 -13.58 11.19 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.223 2.615 . . . . 0.33000000000000002 112.087 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.653 ' HD1' ' CD2' ' A' ' 55' ' ' TYR . 72.2 m-85 -96.91 -10.33 26.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.08 0.467 . . . . 2.29 111.182 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -81.22 -22.37 38.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.076 -1.453 . . . . 2.0600000000000001 107.076 166.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.622 HD11 ' HG2' ' A' ' 158' ' ' PRO . 64.4 mt -87.68 132.56 40.16 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 113.005 -1.907 . . . . 1.0900000000000001 110.219 173.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -103.89 96.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 121.208 1.272 . . . . 0.22 110.546 165.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 73' ' ' SER . 84.0 m-85 -157.97 130.99 7.45 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.5 -1.296 . . . . 0.80000000000000004 107.5 172.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 13.0 m170 -135.75 103.68 5.5 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.981 -1.489 . . . . 3.5800000000000001 106.981 -166.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -94.3 109.39 22.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.458 -0.792 . . . . 1.0600000000000001 110.541 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.11 97.01 6.24 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.385 -0.825 . . . . 1.1200000000000001 110.579 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.474 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -113.43 98.56 7.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.319 -1.309 . . . . 0.68000000000000005 109.808 178.125 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.469 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 43.0 m -94.59 121.1 35.8 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.615 -1.175 . . . . 1.3300000000000001 108.752 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.2 mt -57.82 -26.79 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.352 0.596 . . . . 1.77 111.601 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.49 70.53 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.722 -0.752 . . . . 0.93999999999999995 111.269 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.19 -24.46 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.14 0.495 . . . . 1.22 112.335 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.9 mttt 58.26 18.38 5.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.367 1.067 . . . . 2.9399999999999999 112.318 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.522 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.67 141.27 31.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.92 0.866 . . . . 1.0600000000000001 111.516 176.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.474 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.96 118.52 31.94 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.895 -1.502 . . . . 1.0900000000000001 109.318 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -99.68 124.28 44.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.39 -0.524 . . . . 1.0900000000000001 111.095 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.469 ' C ' ' HG3' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.07 133.52 35.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.804 -1.924 . . . . 1.0800000000000001 105.804 175.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.6 m -138.76 130.78 28.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 120.544 1.52 . . . . 0.93000000000000005 112.743 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.77 126.61 53.36 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.14 -0.936 . . . . 1.1399999999999999 110.432 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 64.61 37.91 7.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.453 0.644 . . . . 0.52000000000000002 109.357 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 73.98 2.34 4.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.562 -1.199 . . . . 1.8400000000000001 112.567 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -130.8 138.0 49.7 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.618 -1.233 . . . . 3.8500000000000001 113.703 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -52.04 148.64 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-N 113.292 -1.776 . . . . 0.40999999999999998 113.587 -172.085 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.469 ' HG3' ' C ' ' A' ' 72' ' ' LEU . 3.7 mtp -96.98 -46.12 6.32 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.191 -2.277 . . . . 1.0900000000000001 107.576 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.5 tptp 179.2 159.01 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.474 -2.148 . . . . 2.6200000000000001 109.767 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.522 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 18.5 m -117.03 136.22 53.12 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.379 -0.2 . . . . 1.1000000000000001 110.946 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CG ' ' HE2' ' A' ' 145' ' ' MET . 17.5 m-85 -120.54 133.42 24.04 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 109.986 -0.376 . . . . 1.0600000000000001 109.986 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.76 146.57 92.15 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.868 2.378 . . . . 0.85999999999999999 112.447 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 177.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.056 -0.72 . . . . 1.2 109.056 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.118 0.485 . . . . 1.4099999999999999 110.072 173.433 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.65 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 13.1 m-85 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.973 0.416 . . . . 2.3500000000000001 110.017 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.62 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 72.3 m-85 -134.06 140.42 46.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.923 -0.58 . . . . 0.92000000000000004 110.09 172.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.487 HD13 HD13 ' A' ' 125' ' ' ILE . 27.2 mm -60.46 126.61 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.239 -1.022 . . . . 1.0600000000000001 108.239 167.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.493 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.7 tt -124.7 -21.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.047 -0.661 . . . . 1.04 112.41 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 21.9 t-20 -159.65 160.86 34.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.635 1.207 . . . . 2.3500000000000001 114.088 -173.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 127.49 15.37 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 111.632 -2.531 . . . . 1.54 108.806 172.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.64 158.54 16.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.446 1.117 . . . . 1.8899999999999999 111.821 -171.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.602 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 21.9 ttm180 -52.42 155.59 2.05 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.175 -2.284 . . . . 3.46 111.793 167.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.602 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 6.6 p30 -45.13 109.89 0.99 Allowed Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.163 -1.38 . . . . 3.3500000000000001 111.519 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.37 -51.51 5.24 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.4 2.733 . . . . 0.97999999999999998 112.12 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.61 -10.31 70.87 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.096 -0.957 . . . . 1.0800000000000001 111.959 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -107.78 -168.72 21.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.412 -0.423 . . . . 1.1599999999999999 112.085 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.54 18.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 124.073 3.182 . . . . 1.46 113.945 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.653 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -69.26 -18.56 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 2.1000000000000001 111.385 -177.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.573 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 94.19 41.38 4.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 1.1100000000000001 113.4 174.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 77.08 -27.58 0.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.237 0.828 . . . . 1.45 113.237 171.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.618 ' HE2' ' CE1' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -152.64 146.5 25.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.95 0.405 . . . . 1.5 110.769 -178.178 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -115.88 101.58 8.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 2.6000000000000001 109.545 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -103.63 141.69 35.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.406 0.622 . . . . 1.3100000000000001 110.462 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.7 m -106.15 140.3 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.488 -0.778 . . . . 1.3100000000000001 111.818 -171.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.56 -178.41 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.676 -1.231 . . . . 1.8600000000000001 107.676 172.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 C--O 1.221 -0.421 0 CA-C-N 118.439 0.563 . . . . 1.95 111.037 177.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.622 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 7.3 mt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 108.499 -0.926 . . . . 1.05 108.499 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -140.13 -164.44 1.71 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.505 -0.878 . . . . 1.25 111.796 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.573 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.04 179.52 16.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.724 -1.125 . . . . 0.46000000000000002 113.968 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -139.39 174.22 10.73 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.293 0.568 . . . . 1.21 111.068 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -104.38 -21.29 13.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.971 -1.013 . . . . 1.8600000000000001 108.9 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -127.22 104.36 22.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.755 -1.111 . . . . 1.8200000000000001 109.672 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.69 5.41 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.499 2.799 . . . . 0.64000000000000001 112.794 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.46 59.57 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.258 0.552 . . . . 1.3200000000000001 110.363 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 m -85.33 -17.32 37.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 1.8899999999999999 109.576 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.407 -0.815 . . . . 1.21 111.017 -175.101 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.526 ' HE2' ' CG ' ' A' ' 82' ' ' TYR . 11.7 ptm . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 112.719 0.637 . . . . 1.8700000000000001 112.719 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -64.58 133.81 53.07 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.669 -0.696 . . . . 3.25 111.051 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -52.64 -63.54 1.11 Allowed 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 113.038 0.755 . . . . 2.4199999999999999 113.038 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.549 ' HZ2' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -63.04 -23.76 67.6 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.321 -0.862 . . . . 2.5699999999999998 112.115 -174.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.03 -33.8 57.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 1.05 111.193 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.738 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 14.8 p -79.71 -16.3 13.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 110.016 -0.365 . . . . 0.32000000000000001 110.016 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.458 ' HA ' ' CB ' ' A' ' 154' ' ' ALA . 2.8 mp -88.38 -37.14 10.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.897 -0.409 . . . . 1.1299999999999999 109.897 171.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -43.46 -70.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.878 0.763 . . . . 1.3799999999999999 111.784 159.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' A' ' 150' ' ' VAL . 2.9 pp -54.7 -36.0 64.22 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.474 0.484 . . . . 1.3400000000000001 110.479 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -55.22 -51.92 65.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.6 0.714 . . . . 1.02 112.059 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 p -77.52 -15.57 59.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.77 -1.104 . . . . 1.9099999999999999 110.91 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.401 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 58.2 mt -93.86 -49.01 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.06 -0.518 . . . . 1.04 110.5 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 m -76.83 111.97 19.53 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-O 121.776 0.798 . . . . 0.20999999999999999 110.253 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.622 ' HG2' HD11 ' A' ' 57' ' ' ILE . 6.8 Cg_endo -77.85 -179.89 5.87 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.467 2.111 . . . . 0.51000000000000001 112.804 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.664 ' O ' HD22 ' A' ' 51' ' ' LEU . 12.2 m120 -62.03 1.54 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.153 -1.385 . . . . 1.02 113.611 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.418 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -145.1 58.4 0.51 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.145 -0.55 . . . . 0.64000000000000001 112.133 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.458 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 9.4 m -96.34 136.72 36.44 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.514 -0.403 . . . . 1.0700000000000001 110.27 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.589 HH11 ' HH ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -85.69 135.36 33.8 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.365 -0.534 . . . . 2.3399999999999999 110.386 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.0 122.75 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.022 -0.99 . . . . 0.46000000000000002 110.788 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.405 ' C ' HD13 ' A' ' 165' ' ' ILE . 87.1 m -113.75 138.39 50.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.716 -0.674 . . . . 1.26 111.426 -177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.405 HD13 ' C ' ' A' ' 164' ' ' THR . 2.9 mp -119.8 110.98 30.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 118.751 -1.18 . . . . 1.1699999999999999 109.999 172.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.861 0 CA-C-N 114.425 -1.261 . . . . 1.1899999999999999 109.568 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.6 OUTLIER . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 108.984 -0.747 . . . . 2.54 108.984 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.5 mt -99.94 171.66 7.71 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.164 0.431 . . . . 1.1000000000000001 112.164 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.534 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.7 tp -76.15 152.89 36.58 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.59 0.756 . . . . 1.05 112.512 -168.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.534 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.29 148.14 39.55 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.21 1.005 . . . . 1.01 111.88 165.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.657 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 71.7 t80 -134.34 149.14 50.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.096 -1.865 . . . . 1.1200000000000001 107.612 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -130.03 114.41 15.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.208 -1.404 . . . . 1.72 107.208 175.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.76 155.92 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 121.203 0.525 . . . . 0.38 112.031 -166.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -98.53 151.35 20.72 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.096 -0.956 . . . . 3.0600000000000001 109.593 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -52.17 116.41 2.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 2.1699999999999999 111.398 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.05 -7.16 35.22 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.09 -0.959 . . . . 0.63 112.956 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 71.6 m-20 -61.29 149.11 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.362 0.505 . . . . 2.1699999999999999 112.362 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.428 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -130.83 152.33 50.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.916 -0.583 . . . . 1.27 111.719 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.3 tp -48.43 -59.9 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 1.0800000000000001 113.896 -170.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.707 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 7.1 t-20 -65.39 -39.85 92.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.132 0.968 . . . . 1.55 110.211 -170.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.719 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 23.3 m -59.59 -41.74 90.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.928 -1.942 . . . . 1.8200000000000001 110.728 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.95 -40.36 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.515 0.726 . . . . 1.0600000000000001 112.589 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.84 -63.65 1.11 Allowed 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.533 -0.303 . . . . 0.97999999999999998 111.188 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -79.95 -3.56 48.72 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.818 -1.153 . . . . 1.0700000000000001 112.035 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.719 ' HB2' ' O ' ' A' ' 17' ' ' SER . 13.6 t70 -64.47 -33.41 75.81 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.348 -0.982 . . . . 1.6299999999999999 108.348 157.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' HD13 ' A' ' 101' ' ' ILE . 1.9 m-85 -100.19 17.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.96 0.41 . . . . 0.25 111.998 173.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 2.3 mpt_? 53.79 52.18 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.407 -0.815 . . . . 4.2000000000000002 110.764 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 38.5 pt -148.2 -173.27 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.059 -0.719 . . . . 1.02 109.059 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -98.91 144.39 28.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.522 -0.763 . . . . 1.1599999999999999 109.665 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.707 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 7.1 p -62.55 -37.97 88.2 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.618 0.723 . . . . 1.05 109.221 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.19 -27.41 68.67 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.164 -1.38 . . . . 1.05 111.284 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -38.71 26.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.467 0.651 . . . . 1.03 109.589 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.7 tp -72.06 -19.44 61.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 1.05 108.911 174.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.613 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.51 -37.23 32.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.307 0.575 . . . . 1.0600000000000001 111.243 172.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.0 mt-30 -56.57 -43.26 79.82 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.353 1.073 . . . . 1.26 109.808 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.97 -18.93 35.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.404 -1.725 . . . . 1.01 112.801 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 31.7 m-80 -143.82 73.76 16.71 Favored Pre-proline 0 CA--C 1.513 -0.479 0 CA-C-O 121.137 0.494 . . . . 0.20000000000000001 109.961 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.655 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.1 Cg_endo -57.18 -14.02 14.04 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 123.568 2.845 . . . . 0.29999999999999999 114.098 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.99 -33.56 74.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.104 0.954 . . . . 1.3600000000000001 109.672 175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -79.18 -6.0 55.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.225 -1.352 . . . . 1.26 114.375 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.655 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -49.25 -41.11 36.66 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 119.778 1.172 . . . . 1.8899999999999999 110.295 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.1 -46.53 11.85 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.766 -2.016 . . . . 1.1000000000000001 111.733 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.39 -163.89 34.73 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 120.369 -0.919 . . . . 0.29999999999999999 114.383 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.65 157.38 27.53 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 112.945 -1.627 . . . . 1.0800000000000001 110.686 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.585 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 84.8 m -135.17 132.32 37.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.464 -0.789 . . . . 1.1699999999999999 110.18 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -48.61 128.64 15.43 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.313 0.577 . . . . 1.1699999999999999 112.339 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.09 -13.5 54.15 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 114.734 -1.121 . . . . 0.38 112.432 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.7 tt0 -65.85 151.98 45.46 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.426 0.632 . . . . 1.1899999999999999 110.358 173.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.5 m -117.92 134.35 55.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.589 -1.187 . . . . 1.22 109.463 -171.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.421 HD11 HD13 ' A' ' 29' ' ' LEU . 16.4 pt -136.84 149.79 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.423 0.63 . . . . 1.0600000000000001 110.576 -175.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.513 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 16.9 t -95.65 148.94 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.08 -0.964 . . . . 0.20999999999999999 110.333 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 19.9 mm -117.25 89.33 30.66 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 114.835 -1.075 . . . . 1.01 108.812 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.589 ' HA ' HD12 ' A' ' 4' ' ' LEU . 20.9 Cg_endo -59.3 140.48 94.78 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.277 2.652 . . . . 0.23000000000000001 112.767 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.595 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 82.77 -6.87 67.9 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.701 -0.681 . . . . 0.29999999999999999 113.033 -176.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.543 HD21 ' CD ' ' A' ' 52' ' ' PRO . 2.7 tt -116.49 124.87 28.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.444 -0.947 . . . . 1.0800000000000001 108.444 175.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.543 ' CD ' HD21 ' A' ' 51' ' ' LEU . 58.9 Cg_endo -65.86 174.22 5.95 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.728 2.952 . . . . 0.34000000000000002 113.898 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -90.56 137.55 27.21 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 114.743 -1.117 . . . . 0.71999999999999997 111.604 -171.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD3' HD11 ' A' ' 5' ' ' LEU . 62.3 Cg_endo -83.94 -9.7 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.457 2.771 . . . . 0.33000000000000002 113.344 -174.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.633 ' HE2' ' CE1' ' A' ' 55' ' ' TYR . 61.4 m-85 -95.67 -15.42 22.71 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.994 0.426 . . . . 2.29 110.729 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -91.62 -5.31 54.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.623 0.725 . . . . 2.0600000000000001 109.174 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.621 HD12 ' HG2' ' A' ' 158' ' ' PRO . 45.0 mt -98.28 137.73 20.8 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 115.24 -0.891 . . . . 1.0900000000000001 109.605 171.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' O ' ' CG ' ' A' ' 59' ' ' TYR . 10.6 Cg_endo -104.13 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.243 0 CA-C-N 120.153 1.09 . . . . 0.22 110.038 163.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 58' ' ' PRO . 70.7 m-85 -156.94 133.47 9.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.142 -1.429 . . . . 0.80000000000000004 107.142 169.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -148.18 111.26 4.86 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.555 -0.905 . . . . 3.5800000000000001 108.555 -160.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.598 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 50.1 mt -98.63 118.25 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.798 -1.092 . . . . 1.0600000000000001 111.019 -175.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.59 92.98 4.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.797 0.808 . . . . 1.1200000000000001 110.07 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 70' ' ' LEU . 1.1 p -111.36 101.78 13.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.438 -1.256 . . . . 0.68000000000000005 108.94 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.446 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.2 m -96.0 116.08 28.4 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.466 -0.939 . . . . 1.3300000000000001 108.466 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mm -45.47 -36.5 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 1.77 110.876 170.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.419 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . -63.9 -43.83 96.96 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.372 -0.918 . . . . 0.93999999999999995 111.683 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -71.17 -23.2 62.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.872 -0.664 . . . . 1.22 112.73 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' A' ' 66' ' ' GLY . 6.2 mptt 58.71 14.98 3.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.882 0.873 . . . . 2.9399999999999999 112.583 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.467 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.21 139.56 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.897 0.856 . . . . 1.0600000000000001 111.442 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.439 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -93.67 114.01 26.22 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.744 -1.571 . . . . 1.0900000000000001 108.737 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -98.5 122.19 41.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.06 -0.656 . . . . 1.0900000000000001 110.432 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.583 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -81.87 127.14 32.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.823 -1.917 . . . . 1.0800000000000001 105.823 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.1 m -131.8 127.34 36.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 120.341 1.428 . . . . 0.93000000000000005 111.976 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -113.17 122.69 48.27 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.004 -0.998 . . . . 1.1399999999999999 109.559 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 68.51 36.75 2.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.772 -0.825 . . . . 0.52000000000000002 108.772 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 73.75 1.87 4.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.275 -1.329 . . . . 1.8400000000000001 112.295 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -130.38 138.14 50.23 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 118.148 -1.421 . . . . 3.8500000000000001 113.805 173.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.25 148.21 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 112.84 -1.982 . . . . 0.40999999999999998 113.585 -171.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.583 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -98.96 -44.43 6.33 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 111.921 -2.4 . . . . 1.0900000000000001 107.998 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -178.96 160.77 1.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.235 -2.257 . . . . 2.6200000000000001 109.491 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.467 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.7 m -118.93 131.07 56.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.518 0.199 . . . . 1.1000000000000001 110.662 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 1.632 ' HE2' ' CE1' ' A' ' 82' ' ' TYR . 30.6 m-85 -118.11 141.2 29.0 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 109.294 -0.632 . . . . 1.0600000000000001 109.294 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -80.94 144.13 14.9 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.196 1.93 . . . . 0.85999999999999999 111.783 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.66 178.07 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.89 -0.411 . . . . 1.2 109.89 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.199 0.524 . . . . 1.4099999999999999 111.367 -178.845 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.643 ' HD1' ' CD2' ' A' ' 98' ' ' PHE . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 109.803 -0.443 . . . . 2.3500000000000001 109.803 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.628 ' HE1' ' CE2' ' A' ' 99' ' ' TYR . 37.0 m-85 -137.13 138.56 40.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.179 -0.675 . . . . 0.92000000000000004 109.179 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.491 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 26.8 mm -60.64 107.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.994 -0.743 . . . . 1.0600000000000001 108.994 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 22' ' ' PHE . 2.4 tt -104.36 -31.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.629 -0.714 . . . . 1.04 112.401 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.656 ' ND2' ' H ' ' A' ' 103' ' ' ARG . 4.0 t-20 -168.65 175.52 6.09 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 123.028 1.394 . . . . 2.3500000000000001 114.224 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.674 ' HB3' ' CE1' ' A' ' 114' ' ' TYR . 5.6 mtt180 -137.0 126.98 25.89 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.07 -2.787 . . . . 1.54 107.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.74 150.45 20.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.179 0.99 . . . . 1.8899999999999999 111.081 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.588 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 27.0 ttm180 -51.78 156.81 1.33 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.95 -1.932 . . . . 3.46 111.863 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.588 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 8.4 p30 -43.23 105.12 0.41 Allowed Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 122.745 1.259 . . . . 3.3500000000000001 111.312 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -58.3 -54.68 2.8 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.775 2.983 . . . . 0.97999999999999998 112.949 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.96 72.38 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.445 -0.798 . . . . 1.0800000000000001 111.848 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.89 -169.87 13.67 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.973 -0.451 . . . . 1.1599999999999999 111.973 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.5 32.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 124.419 3.413 . . . . 1.46 114.369 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.653 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -88.11 -12.18 44.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.19 0.519 . . . . 2.1000000000000001 110.938 178.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 72.31 51.99 11.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.146 -0.934 . . . . 1.1100000000000001 114.018 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.81 -13.6 0.92 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.958 1.096 . . . . 1.45 113.958 167.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.626 ' HE2' ' CE1' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -161.99 142.57 10.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.656 0.265 . . . . 1.5 110.553 175.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -113.37 101.27 9.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.81 . . . . 2.6000000000000001 108.814 168.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.618 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.6 mm? -92.71 110.3 21.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.447 0.641 . . . . 1.3100000000000001 109.806 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.5 m -65.86 140.98 58.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.945 -1.025 . . . . 1.3100000000000001 111.983 -174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.903 HD13 ' CE1' ' A' ' 98' ' ' PHE . 1.4 tp -109.43 161.46 15.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.452 -0.573 . . . . 1.8600000000000001 109.452 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.412 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 5.6 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.303 0.573 . . . . 1.95 109.877 174.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.618 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 47.7 mt . . . . . 0 N--CA 1.442 -0.864 0 N-CA-C 107.555 -1.276 . . . . 1.05 107.555 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -143.69 -163.4 1.65 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.825 -0.75 . . . . 1.25 111.846 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.39 168.45 14.33 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.697 -1.138 . . . . 0.46000000000000002 112.68 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.9 t -127.65 177.54 6.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.53 0.681 . . . . 1.21 111.888 -165.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -106.98 -18.45 13.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.614 -1.175 . . . . 1.8600000000000001 109.456 166.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -125.3 103.88 29.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.401 -0.818 . . . . 1.8200000000000001 109.732 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -87.78 4.2 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.979 2.453 . . . . 0.64000000000000001 112.892 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.74 -21.59 23.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.086 0.47 . . . . 1.3200000000000001 110.132 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.8 m -90.23 13.21 15.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 1.8899999999999999 110.357 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 20.4 mm . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 1.21 110.387 178.786 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.746 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 36.0 mtm . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.429 0.633 . . . . 1.8700000000000001 112.241 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.523 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 14.6 t-80 -72.77 148.19 44.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.125 -0.943 . . . . 3.25 109.212 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -50.31 -63.29 1.16 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 112.672 0.619 . . . . 2.4199999999999999 112.672 -172.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -64.53 -21.06 66.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.429 -0.794 . . . . 2.5699999999999998 111.945 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.1 m-20 -73.27 -39.51 65.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.207 -0.451 . . . . 1.05 110.659 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.675 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 10.4 p -80.99 -17.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.005 -0.543 . . . . 0.32000000000000001 110.79 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.02 -40.54 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.871 -0.585 . . . . 1.1299999999999999 110.24 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -44.11 -69.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.411 1.005 . . . . 1.3799999999999999 112.093 165.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.405 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.4 tp -52.07 -42.76 63.42 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.647 -0.706 . . . . 1.3400000000000001 110.581 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -52.98 -51.55 61.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.475 -1.238 . . . . 1.02 111.605 -173.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 -18.04 53.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.739 -1.119 . . . . 1.9099999999999999 111.244 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.412 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 62.2 mt -90.8 -50.35 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.924 -0.399 . . . . 1.04 109.924 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.1 m -78.13 110.7 14.32 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-O 122.192 0.996 . . . . 0.20999999999999999 110.226 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.621 ' HG2' HD12 ' A' ' 57' ' ' ILE . 24.4 Cg_endo -88.22 -179.08 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.386 2.724 . . . . 0.51000000000000001 112.669 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -65.17 108.92 2.02 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.27 -1.011 . . . . 1.02 108.27 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.522 ' O ' HD11 ' A' ' 57' ' ' ILE . . . 108.11 37.37 2.16 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.375 -0.917 . . . . 0.64000000000000001 113.496 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.498 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 26.1 m -90.61 131.69 36.18 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.65 -0.912 . . . . 1.0700000000000001 110.394 172.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -85.98 136.62 33.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.251 -0.431 . . . . 2.3399999999999999 109.892 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 1.9 p -148.71 137.19 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.716 -0.674 . . . . 0.46000000000000002 111.515 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.8 m -119.02 141.49 48.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 1.26 112.055 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.94 116.32 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 C-N-CA 118.539 -1.264 . . . . 1.1699999999999999 111.715 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.618 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 114.255 -1.339 . . . . 1.1899999999999999 110.799 -170.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 4.0 mptp? . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 109.735 -0.469 . . . . 2.54 109.735 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 50' ' ' GLY . 17.8 mt -97.43 170.04 9.33 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.524 0.515 . . . . 1.1000000000000001 111.634 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.3 tp -77.69 150.31 34.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.376 0.67 . . . . 1.05 112.144 -170.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -114.84 149.39 37.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.093 0.949 . . . . 1.01 111.879 168.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.666 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 70.8 t80 -135.19 151.11 50.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.546 -1.661 . . . . 1.1200000000000001 107.844 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -128.74 113.85 15.85 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.944 -1.502 . . . . 1.72 106.944 173.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.5 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 1.3 m -71.83 158.04 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 121.141 0.496 . . . . 0.38 111.771 -166.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -111.17 145.09 39.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.328 -0.851 . . . . 3.0600000000000001 109.487 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.489 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -54.82 121.45 8.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.067 -0.97 . . . . 2.1699999999999999 111.82 -173.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.77 -8.21 17.01 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.149 -0.78 . . . . 0.63 111.149 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -40.42 142.37 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.198 1.555 . . . . 2.1699999999999999 115.198 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 134.72 45.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.013 -0.994 . . . . 1.27 111.342 163.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.583 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.8 tp -41.37 -56.34 2.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.195 -0.911 . . . . 1.0800000000000001 113.457 -174.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.679 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.6 -38.11 88.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.432 1.11 . . . . 1.55 110.322 -171.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -64.41 -42.35 96.13 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 112.953 -1.93 . . . . 1.8200000000000001 110.263 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.26 -41.07 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.045 0.45 . . . . 1.0600000000000001 111.228 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -59.56 4.98 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.995 -0.548 . . . . 0.97999999999999998 111.396 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.78 -3.86 57.19 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 118.936 -1.106 . . . . 1.0700000000000001 112.153 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -61.1 -37.8 84.02 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.987 -1.116 . . . . 1.6299999999999999 107.987 155.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.499 ' CD1' HD11 ' A' ' 101' ' ' ILE . 3.7 m-85 -98.06 27.91 4.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.404 0.52 . . . . 0.25 112.404 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.612 ' HD2' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.2 67.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.902 1.281 . . . . 4.2000000000000002 113.729 -169.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 33.0 pt -146.92 -172.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.094 -1.076 . . . . 1.02 108.094 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 m -101.72 145.0 29.72 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.732 -0.667 . . . . 1.1599999999999999 109.38 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.679 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.3 p -61.4 -35.61 77.99 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.679 -0.692 . . . . 1.05 109.256 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.52 67.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.344 -1.298 . . . . 1.05 111.646 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.25 -39.15 19.62 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.463 -0.569 . . . . 1.03 109.463 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 12.9 tp -72.88 -17.53 61.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.228 -0.896 . . . . 1.05 108.738 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.606 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -81.13 -37.89 28.1 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.484 0.659 . . . . 1.0600000000000001 111.557 172.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -58.52 -43.13 89.05 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.306 1.051 . . . . 1.26 109.59 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.91 -20.96 41.0 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.64 -1.618 . . . . 1.01 111.995 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 31.9 m-80 -142.52 72.77 20.68 Favored Pre-proline 0 CA--C 1.514 -0.414 0 CA-C-O 121.237 0.542 . . . . 0.20000000000000001 109.993 -172.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.627 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.2 Cg_endo -56.62 -13.11 10.01 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 123.649 2.899 . . . . 0.29999999999999999 114.122 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 t -62.24 -32.37 73.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.047 0.927 . . . . 1.3600000000000001 109.754 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.2 mt -81.34 -6.65 59.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.345 -1.298 . . . . 1.26 114.402 -171.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -49.85 -44.45 49.59 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.471 1.129 . . . . 1.8899999999999999 110.274 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.11 -45.85 15.83 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.937 -1.938 . . . . 1.1000000000000001 110.551 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.42 -170.33 43.33 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.491 -0.862 . . . . 0.29999999999999999 113.809 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.426 ' HG ' HD23 ' A' ' 36' ' ' LEU . 6.7 mp -111.79 159.58 18.16 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.373 -1.414 . . . . 1.0800000000000001 109.764 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 77.1 m -128.43 132.27 48.45 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.859 -0.61 . . . . 1.1699999999999999 109.887 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -48.56 129.38 16.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.406 0.622 . . . . 1.1699999999999999 112.241 174.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.35 -11.81 53.77 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.853 -1.067 . . . . 0.38 112.704 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.1 tt0 -66.08 153.66 41.68 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.537 0.684 . . . . 1.1899999999999999 110.378 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.429 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 49.8 m -115.3 135.42 54.17 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.5 -1.227 . . . . 1.22 109.029 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 29' ' ' LEU . 18.6 pt -137.28 151.16 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.358 0.599 . . . . 1.0600000000000001 110.504 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.503 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 15.4 t -96.89 149.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.07 -0.968 . . . . 0.20999999999999999 110.028 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.437 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 19.8 mm -117.64 88.41 29.54 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.024 -0.989 . . . . 1.01 108.529 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.563 ' HA ' HD12 ' A' ' 4' ' ' LEU . 26.3 Cg_endo -59.68 142.8 99.4 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.199 2.599 . . . . 0.23000000000000001 112.564 -174.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.592 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 80.57 -6.95 59.64 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.874 -0.603 . . . . 0.29999999999999999 112.621 -176.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.7 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.18 125.27 28.71 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 108.54 -0.911 . . . . 1.0800000000000001 108.54 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.536 ' CD ' HD21 ' A' ' 51' ' ' LEU . 60.2 Cg_endo -66.38 172.62 8.76 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.715 2.943 . . . . 0.34000000000000002 114.017 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 4.9 t70 -91.19 136.66 26.95 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.665 -1.152 . . . . 0.71999999999999997 111.721 -170.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.495 ' HD3' HD11 ' A' ' 5' ' ' LEU . 68.8 Cg_endo -81.97 -6.94 12.28 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.332 2.688 . . . . 0.33000000000000002 113.381 -174.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -28.06 16.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.015 0.436 . . . . 2.29 110.297 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -84.37 -12.93 53.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.985 -0.746 . . . . 2.0600000000000001 108.985 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.567 HD11 ' HG2' ' A' ' 158' ' ' PRO . 84.0 mt -86.21 125.95 66.49 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.989 -1.005 . . . . 1.0900000000000001 109.295 169.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -101.47 95.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.14 0 CA-C-N 119.876 0.991 . . . . 0.22 110.225 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 73' ' ' SER . 82.1 m-85 -158.55 129.45 6.26 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.016 -1.476 . . . . 0.80000000000000004 107.016 172.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 14.8 m170 -137.84 104.18 5.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.756 -1.572 . . . . 3.5800000000000001 106.756 -164.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -94.34 108.4 20.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.584 -0.734 . . . . 1.0600000000000001 110.331 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.6 97.35 6.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.14 -0.936 . . . . 1.1200000000000001 110.67 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.427 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.6 OUTLIER -112.22 98.38 6.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.964 -1.471 . . . . 0.68000000000000005 109.304 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.8 m -94.43 123.16 37.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.734 -1.121 . . . . 1.3300000000000001 108.843 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mt -59.75 -31.87 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.064 -0.517 . . . . 1.77 111.802 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.91 -40.54 97.3 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.715 -0.755 . . . . 0.93999999999999995 111.301 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.35 -23.96 59.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.941 -0.63 . . . . 1.22 112.342 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.9 mttt 55.7 19.47 3.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.157 0.983 . . . . 2.9399999999999999 112.776 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.465 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.27 140.85 35.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.716 0.77 . . . . 1.0600000000000001 111.308 177.349 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.427 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.5 tt -94.31 119.27 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.157 -1.383 . . . . 1.0900000000000001 109.367 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -101.97 124.8 48.2 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.443 -0.503 . . . . 1.0900000000000001 111.093 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.543 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.62 139.52 33.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.237 -1.764 . . . . 1.0800000000000001 106.237 176.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.594 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 19.4 m -143.05 128.91 19.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 120.508 1.503 . . . . 0.93000000000000005 112.672 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.89 125.4 50.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.906 -1.043 . . . . 1.1399999999999999 110.457 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 61.84 40.68 12.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.029 0.443 . . . . 0.52000000000000002 109.867 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 81.68 -7.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.798 -1.092 . . . . 1.8400000000000001 112.21 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -128.52 139.22 52.42 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 118.282 -1.367 . . . . 3.8500000000000001 114.025 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.71 149.85 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 112.873 -1.967 . . . . 0.40999999999999998 112.891 -174.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.543 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.0 mtp -100.16 -44.06 6.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.5 -2.137 . . . . 1.0900000000000001 108.43 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 179.7 159.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.54 -2.118 . . . . 2.6200000000000001 110.156 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.465 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.4 m -121.06 137.6 54.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.526 0.203 . . . . 1.1000000000000001 111.309 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.616 ' CG ' ' HE1' ' A' ' 145' ' ' MET . 98.4 m-85 -127.82 135.94 28.24 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.905 0.383 . . . . 1.0600000000000001 111.374 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.22 143.86 90.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.935 2.424 . . . . 0.85999999999999999 112.181 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.7 -175.58 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 1.2 110.028 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.399 0 N-CA-C 109.71 -0.478 . . . . 1.4099999999999999 109.71 173.611 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.657 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 29.1 m-85 . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.643 -0.873 . . . . 2.3500000000000001 108.643 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.612 ' HD2' ' CD1' ' A' ' 99' ' ' TYR . 80.7 m-85 -134.14 138.07 44.96 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.931 0.396 . . . . 0.92000000000000004 110.738 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.465 HD13 HD13 ' A' ' 125' ' ' ILE . 26.5 mm -59.55 124.77 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 107.428 -1.323 . . . . 1.0600000000000001 107.428 166.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.612 ' CD1' ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -118.09 -22.09 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.893 -0.723 . . . . 1.04 112.174 -176.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.656 ' ND2' ' H ' ' A' ' 103' ' ' ARG . 3.1 t-20 -167.81 177.11 5.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 123.081 1.42 . . . . 2.3500000000000001 114.122 -175.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.656 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 4.3 ptt180 -152.19 123.93 7.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 110.824 -2.898 . . . . 1.54 108.684 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 161.25 14.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.382 1.087 . . . . 1.8899999999999999 111.666 -168.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -52.56 155.08 2.31 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 112.626 -2.079 . . . . 3.46 112.662 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -44.0 110.3 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 113.119 -1.855 . . . . 3.3500000000000001 111.02 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -54.56 -47.88 24.39 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.386 2.724 . . . . 0.97999999999999998 111.668 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.71 -21.34 38.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.641 -1.163 . . . . 1.0800000000000001 112.74 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -112.81 -170.27 17.86 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.999 -0.619 . . . . 1.1599999999999999 112.199 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.9 34.24 0.1 Allowed 'Trans proline' 0 N--CA 1.478 0.578 0 C-N-CA 124.473 3.449 . . . . 1.46 113.888 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.632 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 50.1 t80 -83.15 -18.03 40.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.08 0.467 . . . . 2.1000000000000001 110.244 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.608 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.18 57.44 0.96 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.768 -0.73 . . . . 1.1100000000000001 114.856 170.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.27 -45.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.262 1.208 . . . . 1.45 114.262 165.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.629 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -140.68 162.87 34.37 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.903 -0.406 . . . . 1.5 109.903 -176.106 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 1.8 t90 -127.27 99.63 5.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 2.6000000000000001 108.433 172.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.3 mp -108.99 139.05 44.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.777 0.799 . . . . 1.3100000000000001 110.89 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.1 m -107.7 148.62 29.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.822 -1.081 . . . . 1.3100000000000001 113.115 -169.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 67.9 mt -104.86 -174.35 2.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.533 -1.212 . . . . 1.8600000000000001 108.441 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.0 m . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 112.555 0.576 . . . . 1.95 112.555 -176.859 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.649 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 25.5 mt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.271 -0.64 . . . . 1.05 109.271 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -155.21 -161.46 1.19 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.337 0.589 . . . . 1.25 110.578 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.608 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -119.31 177.1 16.31 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 119.612 -1.28 . . . . 0.46000000000000002 112.877 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.9 t -137.07 172.84 12.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.135 0.493 . . . . 1.21 110.254 -170.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.68 -19.66 14.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 1.8600000000000001 109.0 165.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -125.39 104.41 28.46 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.339 -0.846 . . . . 1.8200000000000001 110.124 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.49 4.98 4.41 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.259 2.639 . . . . 0.64000000000000001 112.887 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.28 -22.8 28.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.039 0.447 . . . . 1.3200000000000001 110.651 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.2 p -85.32 -16.94 38.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.538 0.685 . . . . 1.8899999999999999 110.047 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.9 mm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.168 -0.923 . . . . 1.21 110.672 178.61 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.616 ' HE1' ' CG ' ' A' ' 82' ' ' TYR . 35.8 mtp . . . . . 0 CA--C 1.519 -0.242 0 N-CA-C 109.783 -0.451 . . . . 1.8700000000000001 109.783 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.548 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 4.0 t-80 -78.57 154.71 30.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.265 -1.013 . . . . 3.25 108.265 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -48.87 -67.39 0.27 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.428 0.529 . . . . 2.4199999999999999 112.428 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 149' ' ' ASP . 3.8 ptpp? -59.7 -28.2 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.72 -0.612 . . . . 2.5699999999999998 111.582 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.548 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 6.7 m-20 -72.44 -40.15 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 1.05 110.714 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.709 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 9.4 p -74.83 -18.52 16.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.524 -0.307 . . . . 0.32000000000000001 110.246 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -86.82 -39.84 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.947 -0.549 . . . . 1.1299999999999999 110.435 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -44.39 -69.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.688 1.131 . . . . 1.3799999999999999 112.834 162.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.453 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -50.52 -42.35 54.89 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.953 -0.567 . . . . 1.3400000000000001 110.242 179.088 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -55.74 -53.82 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.348 -1.296 . . . . 1.02 112.038 -172.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.553 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 12.1 p -76.55 -13.57 60.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.407 -1.269 . . . . 1.9099999999999999 111.093 -172.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.65 -49.16 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.15 -0.477 . . . . 1.04 110.053 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.1 m -77.55 117.14 63.61 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-O 122.059 0.933 . . . . 0.20999999999999999 110.81 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.567 ' HG2' HD11 ' A' ' 57' ' ' ILE . 42.2 Cg_endo -83.05 -178.52 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.876 2.384 . . . . 0.51000000000000001 112.785 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.7 ' O ' HD22 ' A' ' 51' ' ' LEU . 16.9 m120 -58.32 -2.63 0.2 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.509 -1.223 . . . . 1.02 113.53 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.01 55.91 0.56 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.813 -0.708 . . . . 0.64000000000000001 112.568 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.556 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 4.9 m -93.91 136.59 34.04 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.565 -0.374 . . . . 1.0700000000000001 110.305 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.79 142.2 29.12 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.462 -0.495 . . . . 2.3399999999999999 110.291 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.2 p -143.66 123.75 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 0.46000000000000002 110.846 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.3 m -112.7 139.63 48.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 1.26 112.007 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.65 114.17 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 118.542 -1.263 . . . . 1.1699999999999999 111.194 171.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.992 0 CA-C-N 113.886 -1.506 . . . . 1.1899999999999999 109.848 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.1 mptt . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.01 -0.737 . . . . 2.54 109.01 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.617 HD12 ' H ' ' A' ' 50' ' ' GLY . 17.5 mt -92.38 167.87 11.69 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.269 0.356 . . . . 1.1000000000000001 111.163 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.0 tp -75.89 149.05 37.84 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 122.929 0.492 . . . . 1.05 111.851 -169.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.519 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.04 150.04 34.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.969 0.89 . . . . 1.01 111.365 167.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.658 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 57.5 t80 -134.64 150.36 50.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.727 -1.579 . . . . 1.1200000000000001 108.0 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.578 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.41 120.93 27.9 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.001 -1.481 . . . . 1.72 107.001 175.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.51 158.79 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 112.579 0.585 . . . . 0.38 112.579 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -103.37 150.82 23.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.409 -0.814 . . . . 3.0600000000000001 109.261 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.502 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -52.61 109.44 0.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.336 0.589 . . . . 2.1699999999999999 112.005 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.23 -9.68 15.26 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.338 -0.846 . . . . 0.63 112.766 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.508 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 67.1 m-20 -61.43 152.55 29.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.844 0.322 . . . . 2.1699999999999999 110.814 176.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -133.49 155.99 48.57 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.253 0.464 . . . . 1.27 112.253 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.582 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -50.3 -58.33 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.545 0.943 . . . . 1.0800000000000001 113.545 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.675 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.9 t-20 -66.08 -41.81 90.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.27 1.033 . . . . 1.55 110.687 -169.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 26.3 m -55.89 -52.29 64.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 112.958 -1.928 . . . . 1.8200000000000001 109.754 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -66.48 -40.01 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.373 -0.831 . . . . 1.0600000000000001 111.942 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -66.06 0.51 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.087 -0.506 . . . . 0.97999999999999998 112.108 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.35 -4.87 56.99 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 118.996 -1.081 . . . . 1.0700000000000001 112.133 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.1 m-20 -66.21 -31.52 72.4 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.99 -0.745 . . . . 1.6299999999999999 108.99 156.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.502 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.6 m-85 -96.48 15.21 22.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.033 -0.417 . . . . 0.25 112.068 173.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.57 51.48 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.607 -0.724 . . . . 4.2000000000000002 110.609 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 37.4 pt -149.4 -172.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.721 -0.844 . . . . 1.02 108.721 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.96 147.49 24.94 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.678 -0.692 . . . . 1.1599999999999999 109.909 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.675 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.7 p -61.5 -36.41 80.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.539 -0.911 . . . . 1.05 108.539 175.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.29 -28.64 69.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.478 -1.237 . . . . 1.05 111.664 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.72 -38.7 25.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.513 -0.551 . . . . 1.03 109.513 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.589 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.0 tp -73.3 -19.44 61.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.412 -0.813 . . . . 1.05 109.081 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.608 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -39.69 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.657 0.742 . . . . 1.0600000000000001 111.549 172.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.12 -40.6 96.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 114.994 -1.003 . . . . 1.26 110.03 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.24 -19.25 43.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.998 -1.455 . . . . 1.01 111.819 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 33.0 m-80 -142.13 71.57 22.89 Favored Pre-proline 0 CA--C 1.515 -0.374 0 CA-C-O 121.025 0.441 . . . . 0.20000000000000001 109.903 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.689 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.23 -12.54 10.42 Favored 'Trans proline' 0 C--O 1.22 -0.4 0 C-N-CA 123.301 2.667 . . . . 0.29999999999999999 113.946 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -61.69 -32.31 72.5 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.061 0.934 . . . . 1.3600000000000001 110.035 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.1 mt -81.1 -6.36 58.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.206 -1.361 . . . . 1.26 114.551 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.689 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -51.69 -40.66 60.51 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.77 1.272 . . . . 1.8899999999999999 109.503 177.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.97 -46.69 14.72 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 112.763 -2.017 . . . . 1.1000000000000001 111.562 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.54 -162.69 33.76 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.271 -0.966 . . . . 0.29999999999999999 114.364 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.88 158.21 24.37 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.188 -1.506 . . . . 1.0800000000000001 109.881 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 89.2 m -137.31 135.47 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 1.1699999999999999 110.792 -177.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -45.48 126.66 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.404 0.89 . . . . 1.1699999999999999 113.404 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.578 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.4 -12.48 45.47 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 114.613 -1.176 . . . . 0.38 112.083 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 4.1 tt0 -63.47 151.81 40.16 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.817 0.817 . . . . 1.1899999999999999 110.263 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.9 m -117.41 135.51 53.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.133 -1.394 . . . . 1.22 109.096 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.429 HD11 HD13 ' A' ' 29' ' ' LEU . 16.8 pt -136.71 146.42 28.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.296 0.57 . . . . 1.0600000000000001 110.533 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.441 ' H ' HD22 ' A' ' 33' ' ' ASN . 7.2 t -91.61 149.1 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.051 -0.977 . . . . 0.20999999999999999 110.409 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 19.2 mm -118.07 87.54 29.03 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-N 114.959 -1.019 . . . . 1.01 108.701 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' HD12 ' A' ' 4' ' ' LEU . 24.8 Cg_endo -59.08 139.78 92.16 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.209 2.606 . . . . 0.23000000000000001 112.709 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.617 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 84.18 -7.59 70.91 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.29999999999999999 112.93 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.81 128.78 25.78 Favored Pre-proline 0 C--O 1.218 -0.566 0 N-CA-C 108.566 -0.902 . . . . 1.0800000000000001 108.566 177.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.566 ' CD ' HD21 ' A' ' 51' ' ' LEU . 73.4 Cg_endo -68.92 171.72 13.04 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.75 2.967 . . . . 0.34000000000000002 114.167 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.559 ' HB3' HG21 ' A' ' 56' ' ' THR . 9.1 t70 -90.08 141.76 28.17 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.71999999999999997 110.232 -172.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 62.9 Cg_endo -85.27 -7.13 9.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.323 2.682 . . . . 0.33000000000000002 111.992 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 55' ' ' TYR . 57.5 m-85 -95.67 -24.52 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.29 110.239 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.559 HG21 ' HB3' ' A' ' 53' ' ' ASP . 13.1 t -87.25 -15.41 38.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.678 -0.86 . . . . 2.0600000000000001 108.678 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.583 HD11 ' HG2' ' A' ' 158' ' ' PRO . 61.7 mt -87.21 126.2 63.44 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 114.503 -1.226 . . . . 1.0900000000000001 108.964 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -101.16 93.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.175 0 CA-C-N 120.52 1.221 . . . . 0.22 110.106 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -159.03 131.52 6.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.238 -1.764 . . . . 0.80000000000000004 106.238 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 23.3 m-70 -140.33 107.8 5.57 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.095 -1.446 . . . . 3.5800000000000001 107.095 -164.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.5 mt -94.61 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.054 -0.975 . . . . 1.0600000000000001 110.398 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.39 94.59 5.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.0 0.905 . . . . 1.1200000000000001 110.337 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -115.6 100.02 9.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.039 -1.437 . . . . 0.68000000000000005 110.291 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 38.6 t -90.32 121.58 32.44 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.239 -1.393 . . . . 1.3300000000000001 107.239 173.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.3 mm -62.26 -26.88 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.957 0.884 . . . . 1.77 108.936 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.89 -46.0 84.72 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.297 -0.954 . . . . 0.93999999999999995 111.377 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -67.27 -23.99 65.74 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.606 0.595 . . . . 1.22 112.606 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.7 mttt 61.54 13.17 4.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.885 0.874 . . . . 2.9399999999999999 112.544 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.489 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -141.13 137.35 32.7 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.1 0.953 . . . . 1.0600000000000001 112.118 177.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.476 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.3 tt -93.96 118.93 32.16 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.346 -1.752 . . . . 1.0900000000000001 109.121 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 m -102.6 125.08 49.2 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.055 -0.658 . . . . 1.0900000000000001 111.233 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.587 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -84.6 129.75 34.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.509 -1.663 . . . . 1.0800000000000001 106.509 177.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 15.6 m -135.58 126.45 27.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 120.905 1.684 . . . . 0.93000000000000005 112.81 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.0 tp -113.03 126.5 55.56 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.774 -1.103 . . . . 1.1399999999999999 109.876 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 63.05 40.05 9.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.088 -0.708 . . . . 0.52000000000000002 109.088 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 83.35 -21.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.725 1.21 . . . . 1.8400000000000001 111.949 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -121.92 139.06 54.12 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 117.295 -1.762 . . . . 3.8500000000000001 114.779 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.92 149.53 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 112.546 -2.115 . . . . 0.40999999999999998 113.882 -167.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.587 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.5 mtp -100.74 -42.97 6.28 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 112.076 -2.329 . . . . 1.0900000000000001 108.18 175.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 2.6 tppt? -178.37 164.69 1.74 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 112.464 -2.153 . . . . 2.6200000000000001 109.931 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.489 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 12.1 m -126.24 134.39 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.514 0.197 . . . . 1.1000000000000001 110.798 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 1.628 ' HE2' ' CE1' ' A' ' 82' ' ' TYR . 19.5 m-85 -123.31 145.87 47.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 109.534 -0.543 . . . . 1.0600000000000001 109.534 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -83.86 148.31 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.44 2.093 . . . . 0.85999999999999999 112.037 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.69 179.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.296 -0.411 . . . . 1.2 110.192 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.86 0.362 . . . . 1.4099999999999999 110.251 179.035 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.593 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 21.4 m-85 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.857 -0.423 . . . . 2.3500000000000001 109.857 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.7 m-85 -140.03 141.7 36.27 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.061 -0.348 . . . . 0.92000000000000004 110.061 174.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 125' ' ' ILE . 23.9 mm -60.16 121.17 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.9 -1.148 . . . . 1.0600000000000001 107.9 167.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.502 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.8 tt -122.92 -25.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.094 -0.642 . . . . 1.04 112.161 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 9.1 t-20 -150.69 154.22 37.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.478 1.288 . . . . 2.3500000000000001 114.478 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.56 119.85 11.55 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 111.487 -2.597 . . . . 1.54 108.904 172.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.432 ' HG2' ' N ' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -97.59 159.87 14.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.386 1.088 . . . . 1.8899999999999999 112.042 -168.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.432 ' N ' ' HG2' ' A' ' 104' ' ' GLN . 18.3 ttm180 -50.69 149.73 3.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 112.352 -2.204 . . . . 3.46 111.646 168.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -48.21 106.32 0.59 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 114.976 -1.011 . . . . 3.3500000000000001 112.233 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.7 -49.9 13.32 Favored 'Trans proline' 0 CA--C 1.519 -0.261 0 C-N-CA 123.723 2.949 . . . . 0.97999999999999998 112.43 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 16.75 49.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.237 -0.892 . . . . 1.0800000000000001 112.394 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -138.67 -168.95 11.43 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.085 -0.579 . . . . 1.1599999999999999 112.15 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.96 16.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.938 3.092 . . . . 1.46 113.115 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.531 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -70.57 -21.38 62.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.079 -0.509 . . . . 2.1000000000000001 110.503 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.45 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.32 37.01 4.19 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.584 -0.735 . . . . 1.1100000000000001 113.874 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.36 -19.0 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.762 0.653 . . . . 1.45 112.762 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.624 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -159.21 152.47 22.41 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 122.86 0.464 . . . . 1.5 110.02 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.408 ' CE3' ' HE1' ' A' ' 111' ' ' PHE . 33.7 t-105 -120.24 105.48 10.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.6000000000000001 109.634 170.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -107.84 138.52 43.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.6 0.714 . . . . 1.3100000000000001 111.101 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.9 m -106.76 146.25 31.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.326 -0.852 . . . . 1.3100000000000001 112.347 -171.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.88 -173.49 3.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.85 -0.796 . . . . 1.8600000000000001 108.85 169.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.444 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.9 t . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.42 0.526 . . . . 1.95 112.42 -172.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.608 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 40.3 mt . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 108.213 -1.032 . . . . 1.05 108.213 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.456 ' O ' ' HG2' ' A' ' 145' ' ' MET . 12.6 p80 -138.95 -166.96 2.12 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.306 -0.957 . . . . 1.25 111.954 -176.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.45 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.72 161.54 14.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.356 -1.293 . . . . 0.46000000000000002 112.988 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.7 t -127.25 178.22 6.18 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.951 -0.625 . . . . 1.21 110.569 -170.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -105.21 -16.64 14.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.318 -0.856 . . . . 1.8600000000000001 109.662 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -126.92 100.69 27.23 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.842 -0.617 . . . . 1.8200000000000001 110.152 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -91.6 4.31 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.197 2.598 . . . . 0.64000000000000001 113.267 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.97 27.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.253 0.549 . . . . 1.3200000000000001 110.251 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.1 t -82.19 -26.98 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.736 . . . . 1.8899999999999999 109.732 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 134' ' ' ILE . 6.6 mm . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.18 -0.918 . . . . 1.21 111.552 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.489 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 15.4 ptm . . . . . 0 C--O 1.234 0.243 0 CA-C-O 120.506 0.193 . . . . 1.8700000000000001 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -77.06 145.5 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.505 -0.316 . . . . 3.25 110.493 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -49.89 -67.15 0.28 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.336 0.398 . . . . 2.4199999999999999 111.898 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -26.32 65.45 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.572 -0.705 . . . . 2.5699999999999998 111.853 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.44 -36.72 63.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.745 -0.207 . . . . 1.05 110.812 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.714 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 13.4 p -75.44 -18.65 15.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 116.61 -0.268 . . . . 0.32000000000000001 110.377 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.418 ' HA ' ' CB ' ' A' ' 154' ' ' ALA . 3.2 mp -88.83 -41.44 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 119.27 -0.395 . . . . 1.1299999999999999 110.243 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -41.03 -69.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 119.019 0.827 . . . . 1.3799999999999999 112.191 162.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.428 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.1 tp -50.55 -43.11 56.04 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.859 -0.61 . . . . 1.3400000000000001 110.334 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.714 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -54.02 -52.52 60.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.703 -1.135 . . . . 1.02 112.366 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.5 t -78.47 -14.67 59.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.668 -1.151 . . . . 1.9099999999999999 110.961 -172.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.01 -48.78 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.028 0.442 . . . . 1.04 109.815 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.2 m -76.91 119.51 77.77 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-O 121.714 0.769 . . . . 0.20999999999999999 109.819 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.583 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.3 Cg_endo -82.3 -178.89 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.664 2.243 . . . . 0.51000000000000001 112.257 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.698 ' O ' HD22 ' A' ' 51' ' ' LEU . 9.6 m120 -59.67 -0.66 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.682 -1.144 . . . . 1.02 113.52 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 158' ' ' PRO . . . -144.95 56.2 0.54 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.02 -0.61 . . . . 0.64000000000000001 112.237 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.514 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 3.1 m -94.01 133.99 36.88 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.524 -0.398 . . . . 1.0700000000000001 110.075 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -86.64 142.49 28.21 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.186 -0.605 . . . . 2.3399999999999999 110.849 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.1 p -147.31 127.42 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.025 -0.989 . . . . 0.46000000000000002 110.917 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.4 m -113.3 142.13 46.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.516 -0.766 . . . . 1.26 111.38 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.0 mp -125.34 119.34 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 118.791 -1.164 . . . . 1.1699999999999999 111.148 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.44 -0.936 0 CA-C-N 113.952 -1.476 . . . . 1.1899999999999999 107.768 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 109.538 -0.542 . . . . 2.54 109.538 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.4 mt -99.35 172.92 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.21 -0.45 . . . . 1.1000000000000001 111.338 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.5 tp -77.67 152.33 33.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.201 0.6 . . . . 1.05 111.748 -170.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.543 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.17 150.13 36.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.115 0.959 . . . . 1.01 111.847 166.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.668 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 87.1 t80 -133.6 142.77 48.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.611 -1.631 . . . . 1.1200000000000001 107.719 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.3 tm0? -125.79 113.53 17.4 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.862 -1.533 . . . . 1.72 106.862 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.413 ' HB ' HD21 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -76.81 158.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 113.193 0.812 . . . . 0.38 113.193 -164.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.567 ' HB3' ' HZ2' ' A' ' 10' ' ' LYS . 9.9 mtpm? -95.44 148.11 22.81 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.105 -0.952 . . . . 3.0600000000000001 109.599 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.522 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 6.4 tt0 -52.19 109.38 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 2.1699999999999999 111.554 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.9 -9.44 23.31 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.692 -0.766 . . . . 0.63 112.957 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 71.4 m-20 -59.75 154.44 18.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.294 0.547 . . . . 2.1699999999999999 111.757 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.4 p -133.04 152.91 51.92 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.439 0.533 . . . . 1.27 112.439 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.579 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.99 -59.04 3.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.776 1.028 . . . . 1.0800000000000001 113.776 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.666 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 16.5 t-20 -64.84 -41.2 95.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.615 1.198 . . . . 1.55 110.578 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.565 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 43.9 t -59.22 -48.51 81.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.353 -2.203 . . . . 1.8200000000000001 109.991 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -68.01 -40.71 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.064 -0.516 . . . . 1.0600000000000001 111.936 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.57 -63.9 1.05 Allowed 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.18 -0.464 . . . . 0.97999999999999998 111.559 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.56 -4.64 54.78 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.877 -1.129 . . . . 1.0700000000000001 112.181 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -68.29 -30.25 69.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.947 -0.76 . . . . 1.6299999999999999 108.947 157.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.475 ' CD1' HD11 ' A' ' 101' ' ' ILE . 2.4 m-85 -96.44 15.61 20.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.996 0.369 . . . . 0.25 111.996 172.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 55.43 49.62 16.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.661 -0.699 . . . . 4.2000000000000002 110.579 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 37.4 pt -148.2 -173.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.858 -0.793 . . . . 1.02 108.858 -173.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -100.6 146.19 27.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.167 -0.924 . . . . 1.1599999999999999 109.737 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.666 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.3 p -61.37 -37.14 82.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.983 -0.747 . . . . 1.05 108.983 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -28.91 70.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.389 -1.278 . . . . 1.05 111.543 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.22 -38.06 27.59 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.492 -0.559 . . . . 1.03 109.492 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.575 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.3 tp -74.32 -17.84 60.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.317 -0.856 . . . . 1.05 109.201 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.582 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.94 -39.1 26.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.681 0.753 . . . . 1.0600000000000001 111.825 173.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -60.57 -40.95 93.56 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.947 -1.024 . . . . 1.26 109.764 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.35 -21.14 39.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.633 -1.622 . . . . 1.01 111.985 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 28.3 m-80 -142.36 72.87 21.37 Favored Pre-proline 0 CA--C 1.513 -0.46 0 CA-C-O 121.163 0.506 . . . . 0.20000000000000001 109.89 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.645 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 19.1 Cg_endo -58.36 -9.04 5.99 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.592 2.861 . . . . 0.29999999999999999 114.157 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -63.34 -34.89 78.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.949 0.881 . . . . 1.3600000000000001 109.478 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.21 -6.72 57.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.205 -1.361 . . . . 1.26 114.521 -170.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.645 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -49.13 -40.73 33.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.575 1.179 . . . . 1.8899999999999999 110.181 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.06 -46.85 10.78 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 112.747 -2.024 . . . . 1.1000000000000001 111.624 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.64 -164.08 34.81 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.43 -0.89 . . . . 0.29999999999999999 114.172 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 9' ' ' VAL . 5.6 mp -118.4 157.74 26.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.474 -1.363 . . . . 1.0800000000000001 110.624 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 81.5 m -135.09 135.48 41.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.694 -0.684 . . . . 1.1699999999999999 110.912 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.522 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -47.37 128.9 12.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.576 0.954 . . . . 1.1699999999999999 113.576 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.493 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 80.49 -11.62 37.83 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.386 -1.279 . . . . 0.38 112.26 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.9 tt0 -63.74 152.22 39.87 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.555 0.693 . . . . 1.1899999999999999 110.237 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 30.8 m -119.5 133.37 55.71 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.41 -1.268 . . . . 1.22 109.436 -171.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.446 HD11 HD13 ' A' ' 29' ' ' LEU . 19.5 pt -135.37 155.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.157 0.504 . . . . 1.0600000000000001 110.397 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.513 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.8 t -99.68 149.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.283 -0.871 . . . . 0.20999999999999999 110.398 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.436 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 17.5 mm -117.57 88.72 30.26 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.118 -0.946 . . . . 1.01 108.516 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . 24.1 Cg_endo -59.67 139.49 89.07 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.188 2.592 . . . . 0.23000000000000001 112.876 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.582 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 83.38 -7.29 68.76 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.172 -0.922 . . . . 0.29999999999999999 112.812 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.08 124.98 29.46 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.902 -0.777 . . . . 1.0800000000000001 108.902 177.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.54 ' CD ' HD21 ' A' ' 51' ' ' LEU . 59.9 Cg_endo -66.23 174.19 6.39 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.729 2.953 . . . . 0.34000000000000002 114.028 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 2.5 t70 -90.82 138.33 26.4 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.71999999999999997 111.699 -171.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 92.7 Cg_endo -81.17 -5.84 12.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.219 2.613 . . . . 0.33000000000000002 113.429 -174.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 55' ' ' TYR . 67.6 m-85 -95.15 -28.51 15.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.65 0.262 . . . . 2.29 111.038 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t -78.99 -24.42 43.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.667 -0.864 . . . . 2.0600000000000001 108.667 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.564 HD11 ' HG2' ' A' ' 158' ' ' PRO . 77.5 mt -74.24 123.59 89.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 114.859 -1.064 . . . . 1.0900000000000001 109.711 170.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' O ' HD13 ' A' ' 74' ' ' LEU . 18.1 Cg_endo -101.06 94.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 119.839 0.978 . . . . 0.22 110.148 169.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 73' ' ' SER . 84.1 m-85 -159.1 139.45 12.25 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.546 -1.65 . . . . 0.80000000000000004 106.546 172.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.525 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 35.1 t60 -147.43 118.73 7.82 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.878 -1.156 . . . . 3.5800000000000001 107.878 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -106.51 113.02 42.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.032 -0.985 . . . . 1.0600000000000001 111.087 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.89 106.87 16.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.107 -0.951 . . . . 1.1200000000000001 110.106 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -113.37 119.85 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 114.59 -1.186 . . . . 0.68000000000000005 110.017 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.525 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 16.5 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.015 -1.074 . . . . 1.3300000000000001 109.937 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.2 mt -61.43 -28.78 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.808 0.813 . . . . 1.77 109.798 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.32 -47.25 59.26 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.658 -1.156 . . . . 0.93999999999999995 111.615 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -74.94 -26.11 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.237 0.828 . . . . 1.22 113.237 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 tttt 49.35 29.27 2.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.112 0.958 . . . . 2.9399999999999999 112.179 -175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -143.98 139.61 29.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.381 -0.827 . . . . 1.0600000000000001 110.989 170.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 tt -97.03 120.06 36.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.907 -1.497 . . . . 1.0900000000000001 109.495 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -100.45 123.18 44.34 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.003 -0.679 . . . . 1.0900000000000001 110.711 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.562 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.73 143.57 30.8 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.449 -1.685 . . . . 1.0800000000000001 106.449 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 31.2 p -149.72 127.47 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 120.499 1.499 . . . . 0.93000000000000005 113.147 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 58' ' ' PRO . 13.3 tp -112.19 125.91 54.64 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.151 -1.386 . . . . 1.1399999999999999 110.076 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 8.9 t-20 68.87 31.02 4.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.513 -0.921 . . . . 0.52000000000000002 108.513 172.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 34.9 m-80 79.14 2.1 2.37 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.167 -1.378 . . . . 1.8400000000000001 111.763 176.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -129.76 142.09 50.76 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 118.874 -1.13 . . . . 3.8500000000000001 113.987 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -58.45 150.06 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 113.219 -1.81 . . . . 0.40999999999999998 113.314 -168.223 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.562 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -100.47 -43.73 6.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.464 -2.153 . . . . 1.0900000000000001 108.4 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 4.7 tppt? 179.5 161.05 0.81 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.746 -2.025 . . . . 2.6200000000000001 110.451 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.499 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 22.8 m -118.05 132.0 56.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.675 0.274 . . . . 1.1000000000000001 110.957 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -113.22 152.01 44.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 1.0600000000000001 110.297 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -83.86 138.84 8.31 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.508 2.139 . . . . 0.85999999999999999 111.943 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.35 172.74 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.325 -0.62 . . . . 1.2 109.325 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 1.4099999999999999 111.478 176.209 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 7.1 m-85 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.72 -0.474 . . . . 2.3500000000000001 109.72 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' A' ' 99' ' ' TYR . 62.2 m-85 -139.26 138.64 36.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.781 -0.645 . . . . 0.92000000000000004 110.315 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.52 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 27.7 mm -60.51 127.63 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 107.987 -1.116 . . . . 1.0600000000000001 107.987 167.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.475 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -118.17 -31.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.512 -0.875 . . . . 1.04 112.341 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.453 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 1.8 t-20 -166.78 -175.07 2.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 118.084 -1.447 . . . . 2.3500000000000001 114.289 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.453 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.9 ptp180 -156.81 133.86 10.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 111.211 -2.722 . . . . 1.54 110.125 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.8 155.36 24.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.275 1.036 . . . . 1.8899999999999999 111.708 -172.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.27 155.35 3.81 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 112.291 -2.231 . . . . 3.46 112.92 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -43.58 102.93 0.3 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 112.947 -1.933 . . . . 3.3500000000000001 111.674 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.83 -54.04 2.71 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 124.114 3.209 . . . . 0.97999999999999998 113.0 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.73 -20.6 26.87 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.543 -0.753 . . . . 1.0800000000000001 111.907 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -87.82 -169.59 45.49 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.375 -0.44 . . . . 1.1599999999999999 112.493 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.03 6.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.167 3.245 . . . . 1.46 113.949 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.659 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 32.6 m-85 -53.42 -35.95 60.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.138 0.494 . . . . 2.1000000000000001 109.749 171.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.9 -2.58 16.76 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.337 -0.847 . . . . 1.1100000000000001 114.697 168.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . . . -175.57 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.828 0.814 . . . . 1.45 112.628 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.594 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -151.63 158.32 43.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.344 -0.389 . . . . 1.5 111.514 -171.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.427 ' CE3' ' HD2' ' A' ' 126' ' ' HIS . 9.7 t-105 -117.77 100.44 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.359 -0.608 . . . . 2.6000000000000001 109.359 171.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mp -105.3 141.12 37.38 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.727 0.775 . . . . 1.3100000000000001 111.351 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 56.3 m -105.83 142.79 34.95 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.934 -1.03 . . . . 1.3100000000000001 111.979 -169.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.87 -174.49 2.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.468 -0.938 . . . . 1.8600000000000001 108.468 173.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 118.973 0.806 . . . . 1.95 112.788 -176.792 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.488 HD13 HD13 ' A' ' 100' ' ' ILE . 30.8 mt . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 121.918 0.866 . . . . 1.05 109.441 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.427 ' HD2' ' CE3' ' A' ' 115' ' ' TRP . 14.9 t-80 -130.26 173.09 11.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.635 -1.166 . . . . 1.25 111.527 -160.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.2 -171.7 14.63 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 0.46000000000000002 111.311 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 t -159.48 174.52 14.55 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.933 -1.107 . . . . 1.21 112.679 -163.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.18 -20.57 13.76 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.914 -1.494 . . . . 1.8600000000000001 108.884 167.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.78 103.21 21.76 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.152 -0.931 . . . . 1.8200000000000001 110.232 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.52 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 64.8 Cg_endo -90.63 4.94 4.35 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.975 2.45 . . . . 0.64000000000000001 112.553 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.5 40.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.248 0.547 . . . . 1.3200000000000001 109.977 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.0 m -91.25 13.8 16.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.324 -0.853 . . . . 1.8899999999999999 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 18.8 mm . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 1.21 110.711 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.9 mtp . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 121.096 0.474 . . . . 1.8700000000000001 111.362 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 149' ' ' ASP . 37.6 m80 -66.45 176.11 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.167 -0.924 . . . . 3.25 109.143 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -82.4 -63.5 1.36 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.017 -1.105 . . . . 2.4199999999999999 108.017 -172.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -66.69 -22.15 66.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.616 . . . . 2.5699999999999998 111.323 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 146' ' ' HIS . 31.2 m-20 -67.93 -41.83 81.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.893 0.378 . . . . 1.05 110.831 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.728 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 8.5 p -79.52 -13.01 13.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.32000000000000001 110.521 -177.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.546 ' CD1' ' HB3' ' A' ' 113' ' ' ALA . 3.3 mp -92.34 -40.52 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 119.254 -0.403 . . . . 1.1299999999999999 110.849 168.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -42.32 -70.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.356 0.98 . . . . 1.3799999999999999 111.912 162.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.463 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -50.07 -41.96 48.99 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.738 0.649 . . . . 1.3400000000000001 110.181 177.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.728 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -52.23 -55.47 20.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.622 -1.172 . . . . 1.02 111.727 -172.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 28.7 t -77.01 -16.66 59.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.686 -1.143 . . . . 1.9099999999999999 110.863 -172.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.24 -50.07 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 1.04 109.969 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.3 m -77.51 115.78 52.43 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 122.046 0.927 . . . . 0.20999999999999999 110.38 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.564 ' HG2' HD11 ' A' ' 57' ' ' ILE . 45.6 Cg_endo -80.82 -178.28 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.834 2.356 . . . . 0.51000000000000001 112.578 -172.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.62 ' O ' HD22 ' A' ' 51' ' ' LEU . 19.2 m120 -55.91 -5.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.669 -1.151 . . . . 1.02 113.57 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.18 57.26 0.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.937 -0.649 . . . . 0.64000000000000001 112.168 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.52 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 3.8 m -90.72 140.32 29.89 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.405 -0.467 . . . . 1.0700000000000001 110.608 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.478 ' HG2' ' CE2' ' A' ' 99' ' ' TYR . 60.4 mtm180 -83.53 125.15 31.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.51 . . . . 2.3399999999999999 109.86 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.5 p -136.16 126.65 41.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.389 0.614 . . . . 0.46000000000000002 111.419 -177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.5 m -117.29 140.49 49.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.384 -0.826 . . . . 1.26 111.975 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.7 mp -129.14 115.82 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 122.342 1.067 . . . . 1.1699999999999999 111.397 172.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.948 0 CA-C-N 113.527 -1.67 . . . . 1.1899999999999999 110.26 -173.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.56 ' HE2' ' H ' ' A' ' 3' ' ' LYS . 1.8 mppt? . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 108.845 -0.798 . . . . 2.54 108.845 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.6 mt -95.91 170.89 8.98 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.071 0.232 . . . . 1.1000000000000001 111.15 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.0 tp -77.62 150.11 34.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 123.215 0.606 . . . . 1.05 112.173 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.528 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -115.07 149.25 37.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.012 0.911 . . . . 1.01 111.754 168.006 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 68.5 t80 -133.72 150.3 51.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.61 -1.632 . . . . 1.1200000000000001 107.911 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.3 tm0? -131.59 117.13 18.3 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.151 -1.426 . . . . 1.72 107.151 174.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.58 158.83 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 123.234 0.614 . . . . 0.38 111.226 -169.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.557 ' HB3' ' HZ2' ' A' ' 10' ' ' LYS . 8.5 mtpm? -110.27 156.72 20.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.111 -0.7 . . . . 3.0600000000000001 109.111 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.513 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 19.7 tm0? -49.82 117.94 2.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.826 -0.625 . . . . 2.1699999999999999 112.571 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.54 -6.44 35.94 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.63 113.428 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.507 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 20.9 m-20 -70.66 157.09 38.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.473 0.637 . . . . 2.1699999999999999 112.436 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.438 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -134.7 162.29 32.76 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.549 0.574 . . . . 1.27 112.549 -176.337 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.9 tp -51.75 -60.73 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.937 1.088 . . . . 1.0800000000000001 113.937 -173.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.652 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.8 t-20 -63.75 -43.37 96.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.614 1.197 . . . . 1.55 110.403 -169.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 31.3 m -60.46 -39.17 86.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 112.494 -2.139 . . . . 1.8200000000000001 110.989 -177.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.507 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.35 -40.87 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 123.012 0.525 . . . . 1.0600000000000001 112.327 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.55 -61.66 2.27 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.487 -0.324 . . . . 0.97999999999999998 111.242 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.14 -3.33 54.62 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.01 -1.076 . . . . 1.0700000000000001 112.136 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 17' ' ' SER . 4.0 t70 -62.13 -39.64 93.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.85 -1.167 . . . . 1.6299999999999999 107.85 155.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.504 ' CD1' HD11 ' A' ' 101' ' ' ILE . 4.6 m-85 -93.13 24.9 3.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.087 -0.506 . . . . 0.25 111.969 174.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.564 ' HD2' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER 23.74 69.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.96 1.304 . . . . 4.2000000000000002 113.515 -168.41 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.8 pt -147.66 -169.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.066 -1.087 . . . . 1.02 108.066 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.22 146.88 25.18 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.943 -0.571 . . . . 1.1599999999999999 109.736 171.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.652 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.6 p -61.25 -35.56 77.58 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.499 -0.926 . . . . 1.05 108.499 174.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.66 71.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.604 -1.18 . . . . 1.05 111.77 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.03 -38.24 32.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.874 -0.516 . . . . 1.03 109.725 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.4 tp -73.68 -19.08 60.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.423 -0.808 . . . . 1.05 109.133 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.613 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -78.83 -40.37 32.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 1.0600000000000001 111.832 173.396 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -59.68 -40.59 88.33 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.072 -0.967 . . . . 1.26 109.746 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.11 -20.29 41.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.673 -1.603 . . . . 1.01 112.214 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.624 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 23.8 m-80 -143.52 73.12 17.46 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.165 0.507 . . . . 0.20000000000000001 109.941 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.702 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.8 Cg_endo -57.08 -11.32 7.42 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 123.574 2.849 . . . . 0.29999999999999999 113.809 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.6 t -62.67 -32.83 73.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.988 0.899 . . . . 1.3600000000000001 109.392 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.82 -7.08 59.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.568 1.321 . . . . 1.26 114.568 -172.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.702 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -53.06 -39.84 63.56 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 120.19 1.359 . . . . 1.8899999999999999 109.599 177.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.78 -47.4 12.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.769 -2.014 . . . . 1.1000000000000001 111.334 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.03 -166.54 38.68 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.91 -1.138 . . . . 0.29999999999999999 114.567 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 15' ' ' LEU . 5.6 mp -114.88 158.91 21.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.335 -1.432 . . . . 1.0800000000000001 110.152 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.575 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.84 136.2 38.57 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.797 -0.638 . . . . 1.1699999999999999 110.499 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -46.93 127.46 10.08 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 113.115 0.783 . . . . 1.1699999999999999 113.115 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.22 -11.13 51.23 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.607 -1.179 . . . . 0.38 112.312 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.575 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -63.31 151.11 41.63 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.697 0.76 . . . . 1.1899999999999999 110.298 175.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.467 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 35.6 m -118.88 131.59 56.07 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.32 -1.309 . . . . 1.22 109.265 -171.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.438 ' CG1' ' HB3' ' A' ' 7' ' ' TYR . 21.2 pt -132.81 159.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.095 0.474 . . . . 1.0600000000000001 110.345 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.624 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 26.1 t -106.63 148.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.292 -0.867 . . . . 0.20999999999999999 109.808 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.421 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 16.9 mm -116.97 88.69 27.19 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.31 -0.996 . . . . 1.01 108.31 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.541 ' HA ' HD12 ' A' ' 4' ' ' LEU . 24.3 Cg_endo -59.05 142.32 99.23 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.129 2.553 . . . . 0.23000000000000001 112.617 -173.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.592 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 81.37 -7.08 61.93 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.492 -0.776 . . . . 0.29999999999999999 112.811 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -114.62 126.07 28.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.742 -0.836 . . . . 1.0800000000000001 108.742 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.55 ' CD ' HD21 ' A' ' 51' ' ' LEU . 57.5 Cg_endo -65.58 174.3 5.55 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.849 3.033 . . . . 0.34000000000000002 113.656 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.579 ' HB3' HG21 ' A' ' 56' ' ' THR . 14.1 t70 -91.31 141.73 26.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.158 -0.928 . . . . 0.71999999999999997 110.9 -169.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.5 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 96.5 Cg_endo -83.57 -7.11 10.73 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.616 2.877 . . . . 0.33000000000000002 112.17 -175.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.67 ' HE1' ' CE2' ' A' ' 55' ' ' TYR . 62.1 m-85 -94.84 -27.31 15.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.831 -0.433 . . . . 2.29 109.831 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.579 HG21 ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -70.23 -35.06 73.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.497 -1.298 . . . . 2.0600000000000001 107.497 170.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.585 HD11 ' HG2' ' A' ' 158' ' ' PRO . 85.0 mt -74.34 126.43 88.96 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 113.327 -1.761 . . . . 1.0900000000000001 110.524 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -102.94 95.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.905 1.07 . . . . 0.22 110.257 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 73' ' ' SER . 77.2 m-85 -158.33 129.57 6.49 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.403 -1.332 . . . . 0.80000000000000004 107.403 172.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m-70 -137.7 110.13 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.158 -1.423 . . . . 3.5800000000000001 107.158 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.0 mt -94.94 111.4 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.383 0.611 . . . . 1.0600000000000001 110.539 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.27 93.06 4.23 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.857 0.837 . . . . 1.1200000000000001 110.399 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -112.88 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.414 -1.266 . . . . 0.68000000000000005 109.647 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.469 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 35.4 t -92.77 124.96 37.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.849 -1.167 . . . . 1.3300000000000001 107.849 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.98 -28.59 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.345 0.593 . . . . 1.77 110.796 172.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.45 -45.05 88.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.881 -0.888 . . . . 0.93999999999999995 110.881 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -70.25 -24.08 63.01 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.644 0.609 . . . . 1.22 112.644 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.5 mttt 58.57 14.26 2.97 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.818 0.847 . . . . 2.9399999999999999 112.894 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.446 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.42 138.9 35.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.973 0.892 . . . . 1.0600000000000001 111.249 177.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.421 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -92.74 117.9 30.49 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.881 -1.509 . . . . 1.0900000000000001 108.881 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.61 125.4 48.26 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.938 -0.705 . . . . 1.0900000000000001 110.925 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -82.43 142.62 31.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.095 -1.817 . . . . 1.0800000000000001 106.095 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 26.1 m -147.48 128.2 14.28 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 120.445 1.475 . . . . 0.93000000000000005 112.969 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -111.41 126.88 55.41 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.588 -1.187 . . . . 1.1399999999999999 110.147 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.1 t-20 61.89 35.45 16.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 0.52000000000000002 110.285 173.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.2 m-20 78.35 1.59 2.68 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.112 -0.949 . . . . 1.8400000000000001 112.404 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -128.51 137.36 51.73 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 118.283 -1.367 . . . . 3.8500000000000001 113.446 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.19 147.93 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 112.987 -1.915 . . . . 0.40999999999999998 113.17 -171.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.514 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -97.8 -44.72 6.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.25 -2.25 . . . . 1.0900000000000001 107.943 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 26.0 tptt -179.04 160.21 1.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.325 -2.216 . . . . 2.6200000000000001 110.484 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.446 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.5 m -116.11 131.44 56.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.689 -0.232 . . . . 1.1000000000000001 111.403 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -113.71 146.86 36.37 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 110.487 -0.19 . . . . 1.0600000000000001 110.487 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.95 143.19 12.88 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.506 2.137 . . . . 0.85999999999999999 111.305 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.75 172.23 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.768 -0.456 . . . . 1.2 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.92 0.391 . . . . 1.4099999999999999 110.08 175.666 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.643 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 2.7 m-85 . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 108.301 -1.0 . . . . 2.3500000000000001 108.301 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.642 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 89.4 m-85 -135.9 139.1 43.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.464 -0.495 . . . . 0.92000000000000004 111.685 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 26.6 mm -60.62 126.19 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 107.578 -1.267 . . . . 1.0600000000000001 107.578 164.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.564 ' CD1' ' HD2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -125.46 -27.93 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 120.118 -0.633 . . . . 1.04 112.51 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 3.6 t30 -151.61 158.8 43.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.82 1.045 . . . . 2.3500000000000001 113.82 -168.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.69 133.91 20.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.397 -2.183 . . . . 1.54 110.198 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 13.3 tp60 -111.92 142.57 44.14 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.806 0.813 . . . . 1.8899999999999999 110.709 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -54.23 151.44 7.26 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 112.937 -1.938 . . . . 3.46 113.254 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -45.36 101.98 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 114.121 -1.399 . . . . 3.3500000000000001 111.998 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -56.79 -51.39 9.11 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 124.242 3.294 . . . . 0.97999999999999998 112.839 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.39 -0.86 29.46 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.353 -0.839 . . . . 1.0800000000000001 112.436 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.16 -170.34 11.99 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.939 -0.648 . . . . 1.1599999999999999 112.098 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.29 49.14 0.16 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.465 3.443 . . . . 1.46 113.945 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.666 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 1.6 t80 -107.42 -15.56 14.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.392 -0.596 . . . . 2.1000000000000001 109.392 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.92 35.37 4.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.806 -0.712 . . . . 1.1100000000000001 114.516 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.415 ' O ' ' HD2' ' A' ' 114' ' ' TYR . . . 72.72 -36.42 0.36 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.468 0.914 . . . . 1.45 113.468 172.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.64 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -152.83 137.57 16.99 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.366 -0.605 . . . . 1.5 109.366 -176.043 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 61.9 t-105 -110.34 102.35 11.01 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.485 -0.561 . . . . 2.6000000000000001 109.485 171.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.2 mp -102.03 144.41 30.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.763 0.792 . . . . 1.3100000000000001 110.54 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 102' ' ' ASN . 34.8 m -107.84 144.32 35.21 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.08 -0.964 . . . . 1.3100000000000001 112.794 -169.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.8 tp -106.81 -171.78 1.95 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.836 -1.529 . . . . 1.8600000000000001 107.899 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 118.772 0.715 . . . . 1.95 111.836 178.388 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 100' ' ' ILE . 4.0 mt . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 106.338 -1.727 . . . . 1.05 106.338 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' A' ' 145' ' ' MET . 10.3 p80 -149.48 -165.06 2.17 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.467 -0.893 . . . . 1.25 112.272 -172.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.401 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.17 175.39 16.35 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.636 -1.165 . . . . 0.46000000000000002 113.01 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.0 t -136.69 171.68 14.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.464 0.649 . . . . 1.21 111.986 -165.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -104.81 -18.17 14.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.877 -1.056 . . . . 1.8600000000000001 108.702 165.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -124.21 102.8 33.45 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.268 -0.878 . . . . 1.8200000000000001 109.661 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -90.07 4.29 4.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.165 2.577 . . . . 0.64000000000000001 112.846 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.48 -12.37 58.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.338 0.59 . . . . 1.3200000000000001 109.805 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.6 m -93.53 5.9 50.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.298 -0.865 . . . . 1.8899999999999999 109.271 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 31.2 mm . . . . . 0 N--CA 1.45 -0.473 0 CA-C-N 115.095 -0.957 . . . . 1.21 110.487 -179.044 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 126' ' ' HIS . 20.4 ptm . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 112.253 0.464 . . . . 1.8700000000000001 112.253 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.435 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 14.3 m80 -67.54 138.61 56.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 3.25 109.826 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -52.3 -64.67 0.74 Allowed 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.18 0.3 . . . . 2.4199999999999999 111.401 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -59.57 -27.29 66.12 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.91 -0.494 . . . . 2.5699999999999998 111.809 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.435 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 2.3 m-20 -70.31 -43.68 69.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 1.05 110.68 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.716 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 11.2 p -73.68 -15.79 16.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.32000000000000001 110.37 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.416 ' HA ' ' CB ' ' A' ' 154' ' ' ALA . 2.7 mp -90.18 -40.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 119.181 -0.438 . . . . 1.1299999999999999 110.551 172.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -43.16 -67.75 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.348 0.976 . . . . 1.3799999999999999 112.014 163.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.6 tp -49.35 -43.79 44.14 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.592 -0.731 . . . . 1.3400000000000001 109.894 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.716 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -53.66 -50.85 64.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.118 -1.401 . . . . 1.02 112.421 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 17.1 t -78.74 -18.64 53.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.758 -1.11 . . . . 1.9099999999999999 110.71 -173.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.16 -50.46 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.838 -0.43 . . . . 1.04 109.838 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.8 m -77.12 114.88 43.96 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 122.057 0.932 . . . . 0.20999999999999999 109.985 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.585 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.4 Cg_endo -82.12 -178.11 3.89 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.169 2.579 . . . . 0.51000000000000001 112.609 -174.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.616 ' O ' HD22 ' A' ' 51' ' ' LEU . 20.6 m120 -59.2 -1.71 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.591 -1.186 . . . . 1.02 113.364 -174.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.42 59.08 0.5 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.947 -0.644 . . . . 0.64000000000000001 112.414 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.2 m -95.69 134.85 38.12 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.535 -0.391 . . . . 1.0700000000000001 110.393 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -84.88 140.24 31.29 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.098 -0.334 . . . . 2.3399999999999999 110.098 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 3.7 p -145.55 130.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.811 -0.631 . . . . 0.46000000000000002 111.271 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 20.0 m -116.82 138.18 51.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.811 -0.631 . . . . 1.26 111.789 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 mp -122.18 109.84 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 118.997 -1.081 . . . . 1.1699999999999999 110.619 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.548 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 114.526 -1.215 . . . . 1.1899999999999999 109.358 -170.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.417 -0.586 . . . . 2.54 109.417 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 50' ' ' GLY . 18.9 mt -91.96 170.63 9.7 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.94 -0.573 . . . . 1.1000000000000001 110.854 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.496 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.6 tp -76.49 149.07 36.81 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 122.983 0.513 . . . . 1.05 111.866 -170.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.496 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.59 149.18 36.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.166 0.984 . . . . 1.01 111.67 168.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.665 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 77.3 t80 -134.54 147.53 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.304 -1.771 . . . . 1.1200000000000001 107.521 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.56 112.01 14.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.288 -1.745 . . . . 1.72 106.288 174.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 1.6 m -71.42 157.68 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 115.714 -0.675 . . . . 0.38 111.961 -165.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -108.27 147.77 30.94 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.113 -0.948 . . . . 3.0600000000000001 109.387 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.461 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.58 131.22 29.42 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.888 0.742 . . . . 2.1699999999999999 112.349 -174.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -4.59 39.69 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.371 -0.831 . . . . 0.63 111.44 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -45.11 143.63 1.53 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.915 1.45 . . . . 2.1699999999999999 114.915 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.23 140.1 46.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.978 -1.01 . . . . 1.27 111.674 164.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.593 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.5 tp -42.31 -55.28 3.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.315 -0.857 . . . . 1.0800000000000001 113.174 -175.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.648 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 17.3 t-20 -65.43 -42.97 91.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.584 1.183 . . . . 1.55 110.375 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 15.1 m -62.95 -38.06 89.54 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 112.477 -2.147 . . . . 1.8200000000000001 110.878 -176.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 1.5 mp -76.08 -39.62 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 O-C-N 123.713 0.633 . . . . 1.0600000000000001 112.2 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.02 -59.59 4.85 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.611 -0.268 . . . . 0.97999999999999998 110.998 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 -4.65 56.83 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.527 -1.269 . . . . 1.0700000000000001 111.848 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.77 ' HB2' ' O ' ' A' ' 17' ' ' SER . 8.3 t70 -61.3 -29.24 69.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.567 -1.272 . . . . 1.6299999999999999 107.567 157.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -109.06 19.13 19.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.999 0.74 . . . . 0.25 112.999 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? 49.57 54.95 10.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.486 -0.779 . . . . 4.2000000000000002 111.266 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.473 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 33.5 pt -148.18 -172.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.721 -0.844 . . . . 1.02 108.721 -173.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.58 146.78 24.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.66 -0.7 . . . . 1.1599999999999999 109.684 173.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.648 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.1 p -62.69 -35.19 78.89 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.793 -0.818 . . . . 1.05 108.793 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.16 -28.88 68.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.362 -1.29 . . . . 1.05 111.665 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.38 26.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.241 -0.651 . . . . 1.03 109.241 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.581 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 16.5 tp -72.46 -17.85 61.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.144 -0.935 . . . . 1.05 108.772 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.586 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.05 -37.51 33.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.393 0.616 . . . . 1.0600000000000001 111.16 171.234 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -56.39 -46.28 80.18 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.636 1.208 . . . . 1.26 110.278 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.69 43.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 112.998 -1.91 . . . . 1.01 112.317 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.581 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 34.3 m-80 -142.51 73.1 20.59 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.20000000000000001 110.108 -172.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.723 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.6 Cg_endo -57.24 -13.55 12.95 Favored 'Trans proline' 0 C--O 1.22 -0.419 0 C-N-CA 123.437 2.758 . . . . 0.29999999999999999 114.325 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.48 -31.59 71.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.932 0.872 . . . . 1.3600000000000001 109.718 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.66 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -81.0 -6.69 59.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.469 1.285 . . . . 1.26 114.469 -171.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.723 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -50.86 -41.48 58.03 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.806 1.185 . . . . 1.8899999999999999 110.147 179.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.62 -46.32 13.44 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.829 -1.987 . . . . 1.1000000000000001 111.136 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.01 -170.32 43.4 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.49 -0.862 . . . . 0.29999999999999999 113.952 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 15' ' ' LEU . 5.3 mp -110.03 161.71 15.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.558 -1.321 . . . . 1.0800000000000001 109.724 177.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.3 m -135.61 134.12 38.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.872 -0.603 . . . . 1.1699999999999999 110.428 176.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -49.44 129.25 18.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.314 0.578 . . . . 1.1699999999999999 112.281 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.18 -12.9 57.11 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.802 -1.09 . . . . 0.38 112.647 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.598 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.6 tt0 -65.88 152.7 43.88 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.641 0.734 . . . . 1.1899999999999999 110.306 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 50.7 m -117.02 130.68 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.501 -1.227 . . . . 1.22 109.603 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.436 HD11 HD13 ' A' ' 29' ' ' LEU . 20.6 pt -134.46 145.51 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.516 0.674 . . . . 1.0600000000000001 110.526 -174.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.497 ' H ' HD22 ' A' ' 33' ' ' ASN . 12.5 t -91.02 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.866 -1.061 . . . . 0.20999999999999999 110.192 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 21.8 mm -117.47 88.53 29.09 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-N 115.083 -0.962 . . . . 1.01 108.425 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HA ' HD12 ' A' ' 4' ' ' LEU . 22.8 Cg_endo -58.74 141.36 97.71 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.221 2.614 . . . . 0.23000000000000001 112.967 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.595 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 84.6 -7.6 72.58 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.381 -0.827 . . . . 0.29999999999999999 113.115 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.562 HD21 ' CD ' ' A' ' 52' ' ' PRO . 2.7 tt -118.53 128.39 26.0 Favored Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.641 -0.874 . . . . 1.0800000000000001 108.641 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.562 ' CD ' HD21 ' A' ' 51' ' ' LEU . 59.8 Cg_endo -67.33 175.12 6.22 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.563 2.842 . . . . 0.34000000000000002 113.825 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' HB3' HG21 ' A' ' 56' ' ' THR . 10.9 t70 -89.46 142.11 29.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.71999999999999997 110.56 -171.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.504 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 75.0 Cg_endo -84.28 -4.58 10.26 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.576 2.851 . . . . 0.33000000000000002 112.363 -174.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.657 ' HD2' ' CD1' ' A' ' 55' ' ' TYR . 68.9 m-85 -94.79 -26.53 16.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.741 -0.466 . . . . 2.29 109.741 174.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 53' ' ' ASP . 19.1 p -72.99 -28.76 62.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.561 1.172 . . . . 2.0600000000000001 107.844 171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.584 HD11 ' HG2' ' A' ' 158' ' ' PRO . 93.0 mt -80.68 124.35 81.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 113.065 -1.88 . . . . 1.0900000000000001 109.868 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -101.8 96.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 120.779 0.986 . . . . 0.22 110.235 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.9 m-85 -157.74 133.23 9.01 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.387 -1.338 . . . . 0.80000000000000004 107.387 172.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 9.7 m-70 -137.08 103.82 5.25 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.259 -1.756 . . . . 3.5800000000000001 106.259 -167.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.453 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.1 mt -92.96 106.43 17.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.705 0.764 . . . . 1.0600000000000001 109.595 -177.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.86 96.1 5.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.716 -1.129 . . . . 1.1200000000000001 110.623 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -114.82 96.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 113.743 -1.571 . . . . 0.68000000000000005 108.712 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.502 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 51.1 m -95.18 122.57 38.0 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.209 -1.36 . . . . 1.3300000000000001 108.383 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.587 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 3.1 mm -47.3 -34.48 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.428 0.632 . . . . 1.77 110.117 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.55 -47.33 35.05 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.17 -0.923 . . . . 0.93999999999999995 112.336 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -64.37 -24.25 67.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.317 0.58 . . . . 1.22 112.392 174.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 17.9 mttt 54.97 17.63 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.773 1.229 . . . . 2.9399999999999999 113.414 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.32 142.46 31.32 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.318 0.58 . . . . 1.0600000000000001 111.02 171.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.526 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.5 tt -90.98 118.21 30.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.169 -0.923 . . . . 1.0900000000000001 109.411 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -105.0 125.77 51.33 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.392 -0.523 . . . . 1.0900000000000001 111.691 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.505 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.76 136.82 34.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.129 -1.804 . . . . 1.0800000000000001 106.129 176.055 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 13.3 m -141.78 129.35 21.44 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 120.493 1.497 . . . . 0.93000000000000005 112.758 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.26 126.59 53.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.045 -0.98 . . . . 1.1399999999999999 110.539 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.9 t-20 63.74 37.79 9.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.423 0.63 . . . . 0.52000000000000002 109.827 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.4 m-20 76.25 0.57 3.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.672 -1.149 . . . . 1.8400000000000001 112.525 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.49 138.54 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.279 -1.368 . . . . 3.8500000000000001 113.751 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -53.89 147.23 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 113.053 -1.885 . . . . 0.40999999999999998 112.863 -172.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.505 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -96.47 -45.66 6.67 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.338 -2.21 . . . . 1.0900000000000001 107.565 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 30.2 tptt -176.77 159.33 1.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.216 -2.265 . . . . 2.6200000000000001 110.298 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.6 m -119.43 134.81 55.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.397 -0.121 . . . . 1.1000000000000001 111.051 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -120.22 127.14 26.48 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 120.924 0.392 . . . . 1.0600000000000001 110.876 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -57.46 137.82 83.25 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 124.16 3.24 . . . . 0.85999999999999999 113.813 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 168.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.818 -0.353 . . . . 1.2 110.371 177.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.314 0 CA-C-O 121.549 0.69 . . . . 1.4099999999999999 111.39 179.025 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 13.3 m-85 . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 107.205 -1.405 . . . . 2.3500000000000001 107.205 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 161' ' ' THR . 84.6 m-85 -130.37 135.9 48.52 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.277 -0.569 . . . . 0.92000000000000004 111.021 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 26.8 mm -60.26 121.06 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 107.346 -1.353 . . . . 1.0600000000000001 107.346 164.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 3.1 tt -109.04 -22.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.487 -0.885 . . . . 1.04 112.099 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 21.1 p-10 -178.5 -165.7 0.09 Allowed 'General case' 0 C--N 1.348 0.531 0 N-CA-C 114.024 1.12 . . . . 2.3500000000000001 114.024 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 103' ' ' ARG . 5.3 ptp180 -150.73 139.66 20.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 112.683 -2.053 . . . . 1.54 111.68 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.697 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 24.7 tp60 -107.12 145.0 33.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.604 -1.18 . . . . 1.8899999999999999 111.407 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.697 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 34.3 ttm180 -56.64 150.15 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.167 -1.833 . . . . 3.46 111.506 170.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -46.07 104.01 0.38 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 123.89 0.744 . . . . 3.3500000000000001 111.736 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 87.9 Cg_exo -56.35 -51.64 8.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.815 3.01 . . . . 0.97999999999999998 111.874 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.75 -21.59 13.83 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.02 -0.991 . . . . 1.0800000000000001 112.578 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -100.27 -169.49 29.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.96 -0.638 . . . . 1.1599999999999999 112.311 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.52 32.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.256 3.304 . . . . 1.46 113.754 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -85.92 -20.92 28.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.142 0.496 . . . . 2.1000000000000001 109.933 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.427 ' HA3' ' CA ' ' A' ' 127' ' ' GLY . . . 96.33 42.55 3.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.519 -0.764 . . . . 1.1100000000000001 114.019 170.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.69 -33.62 0.23 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.419 0.896 . . . . 1.45 113.419 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.629 ' HE2' ' CE1' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -150.17 127.0 11.04 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.816 -0.439 . . . . 1.5 109.816 -174.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 34.0 t-105 -100.48 100.39 11.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.158 -0.682 . . . . 2.6000000000000001 109.158 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.734 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.2 mp -101.09 141.27 34.22 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 1.3100000000000001 109.016 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.1 m -106.93 144.09 34.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.644 0.609 . . . . 1.3100000000000001 112.644 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.3 tp -97.97 -174.19 2.8 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.786 -1.191 . . . . 1.8600000000000001 107.786 172.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--N 1.314 -0.951 0 C-N-CA 120.586 -0.445 . . . . 1.95 110.741 175.35 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.734 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 9.2 mt . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.541 -0.911 . . . . 1.05 108.541 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -136.95 -161.76 1.2 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.527 0.68 . . . . 1.25 111.27 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.427 ' CA ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.1 155.8 16.08 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.815 -1.183 . . . . 0.46000000000000002 113.569 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.447 HG22 ' CA ' ' A' ' 131' ' ' PRO . 3.8 t -98.37 172.5 7.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.028 -1.086 . . . . 1.21 110.592 -171.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.93 -13.35 13.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.351 -0.841 . . . . 1.8600000000000001 109.075 160.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 133' ' ' SER . 24.1 t30 -124.75 101.12 33.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.185 -0.916 . . . . 1.8200000000000001 109.414 171.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.447 ' CA ' HG22 ' A' ' 128' ' ' THR . 81.1 Cg_endo -90.49 3.29 4.82 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.785 2.323 . . . . 0.64000000000000001 113.039 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -94.8 -2.02 51.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.383 0.611 . . . . 1.3200000000000001 109.546 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.45 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 33.3 t -90.23 -12.69 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.262 -0.881 . . . . 1.8899999999999999 109.555 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.6 mm . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.672 -0.695 . . . . 1.21 109.963 177.831 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.507 ' CG ' ' HB ' ' A' ' 150' ' ' VAL . 5.1 ptm . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 113.279 0.844 . . . . 1.8700000000000001 113.279 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.435 ' HD2' ' OD1' ' A' ' 147' ' ' ASN . 2.6 t60 -71.12 153.93 42.14 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.851 -0.796 . . . . 3.25 108.851 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.435 ' OD1' ' HD2' ' A' ' 146' ' ' HIS . 29.8 p-10 -54.21 -69.91 0.11 Allowed 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.268 0.47 . . . . 2.4199999999999999 112.268 -172.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -61.39 -20.35 62.95 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.567 -0.708 . . . . 2.5699999999999998 111.405 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -74.26 -45.3 48.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.667 -0.697 . . . . 1.05 110.354 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 13.2 p -72.05 -18.37 19.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.32000000000000001 110.945 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.68 -36.68 11.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 119.116 -0.469 . . . . 1.1299999999999999 110.297 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -45.05 -70.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 119.441 1.018 . . . . 1.3799999999999999 112.337 162.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.439 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -49.45 -40.88 38.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.877 -0.601 . . . . 1.3400000000000001 110.316 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -55.99 -55.6 30.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.169 -1.378 . . . . 1.02 111.997 -172.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.9 p -75.08 -12.91 60.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.7 -1.136 . . . . 1.9099999999999999 110.919 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.89 -49.87 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.881 -0.6 . . . . 1.04 110.098 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.15 115.69 51.05 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 122.096 0.95 . . . . 0.20999999999999999 110.541 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.584 ' HG2' HD11 ' A' ' 57' ' ' ILE . 38.4 Cg_endo -82.78 -177.34 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.184 2.589 . . . . 0.51000000000000001 112.971 -173.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.552 ' O ' HD22 ' A' ' 51' ' ' LEU . 12.0 m120 -57.63 -2.13 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.708 -1.133 . . . . 1.02 113.898 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.57 57.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.64000000000000001 112.537 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.2 m -92.69 134.62 34.85 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.612 -0.346 . . . . 1.0700000000000001 110.479 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 138.81 31.73 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.904 0.383 . . . . 2.3399999999999999 110.389 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.5 p -145.63 127.39 8.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.339 -0.846 . . . . 0.46000000000000002 110.911 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.3 m -116.34 143.0 46.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.854 -0.612 . . . . 1.26 111.652 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 3.1 mp -124.34 107.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 119.252 -0.979 . . . . 1.1699999999999999 109.77 172.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.574 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 1.1899999999999999 111.148 -168.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.522 ' HE2' ' CG2' ' A' ' 56' ' ' THR . 4.1 mppt? . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 109.89 -0.411 . . . . 2.54 109.89 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.587 HD12 ' H ' ' A' ' 50' ' ' GLY . 18.1 mt -95.21 172.6 8.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.855 -0.611 . . . . 1.1000000000000001 111.192 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.2 tp -75.49 149.2 38.51 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.103 0.478 . . . . 1.05 111.77 -170.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.515 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.29 147.82 38.47 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.143 0.973 . . . . 1.01 111.6 167.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.661 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 81.1 t80 -133.91 146.7 50.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.205 -1.816 . . . . 1.1200000000000001 107.571 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.6 tt0 -127.33 111.35 13.8 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 1.72 106.66 176.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.414 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 1.2 m -70.64 157.44 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 121.37 0.605 . . . . 0.38 111.856 -165.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.31 147.09 33.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.128 -0.942 . . . . 3.0600000000000001 109.44 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.497 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -53.13 130.82 35.5 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.838 0.712 . . . . 2.1699999999999999 112.15 -173.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.81 -4.85 39.51 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.491 -0.777 . . . . 0.63 111.672 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -43.5 146.17 0.53 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.004 1.483 . . . . 2.1699999999999999 115.004 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.35 139.9 45.97 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.014 -0.994 . . . . 1.27 111.928 162.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.571 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.5 tp -43.11 -55.76 3.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.499 -0.773 . . . . 1.0800000000000001 113.031 -175.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.682 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.2 -40.06 93.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.261 1.029 . . . . 1.55 110.268 -171.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -59.81 -49.88 75.97 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 112.924 -1.944 . . . . 1.8200000000000001 109.534 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.84 -39.35 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 O-C-N 123.522 0.514 . . . . 1.0600000000000001 111.35 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.41 -62.67 1.61 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.887 -0.597 . . . . 0.97999999999999998 111.612 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.27 -4.27 56.84 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.996 -1.081 . . . . 1.0700000000000001 112.292 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.56 -33.58 74.11 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.285 -1.005 . . . . 1.6299999999999999 108.285 155.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.522 ' HA ' HD11 ' A' ' 101' ' ' ILE . 2.6 m-85 -101.47 27.39 6.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.099 0.407 . . . . 0.25 112.099 175.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.578 ' HD2' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.13 68.62 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.836 1.255 . . . . 4.2000000000000002 113.805 -168.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 34.6 pt -147.42 -173.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.856 -1.164 . . . . 1.02 107.856 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -101.09 145.68 28.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.764 -0.653 . . . . 1.1599999999999999 109.409 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.682 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.7 p -61.93 -35.24 77.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.54 0.686 . . . . 1.05 109.208 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.1 -30.18 71.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.282 -1.326 . . . . 1.05 111.334 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.14 -38.54 27.01 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.394 0.616 . . . . 1.03 109.692 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 13.9 tp -72.74 -18.22 61.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.432 -0.804 . . . . 1.05 108.963 175.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.616 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.58 -37.58 35.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 1.0600000000000001 111.223 171.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.0 mt-30 -56.96 -47.43 80.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.285 1.04 . . . . 1.26 109.501 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.56 -18.37 51.91 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.361 -1.745 . . . . 1.01 112.178 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 31.3 m-80 -143.15 72.52 18.22 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.153 0.501 . . . . 0.20000000000000001 109.903 -173.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.749 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.68 -13.0 12.85 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 123.322 2.681 . . . . 0.29999999999999999 113.781 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -31.78 70.67 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 122.045 0.926 . . . . 1.3600000000000001 109.897 174.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.652 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -82.67 -6.45 59.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.159 -1.382 . . . . 1.26 114.527 -172.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.749 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -50.6 -42.28 55.71 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 119.778 1.172 . . . . 1.8899999999999999 109.907 178.04 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.19 -47.04 15.29 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 112.99 -1.914 . . . . 1.1000000000000001 111.172 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.12 -166.82 39.04 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-O 122.162 0.868 . . . . 0.29999999999999999 113.989 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 15' ' ' LEU . 5.1 mp -113.76 160.34 18.78 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.392 -1.404 . . . . 1.0800000000000001 109.871 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.586 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.0 m -136.02 135.36 39.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.901 -0.591 . . . . 1.1699999999999999 110.231 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -49.12 129.98 18.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.438 0.637 . . . . 1.1699999999999999 112.451 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.99 -13.03 46.54 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.804 -1.089 . . . . 0.38 112.534 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.586 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -64.34 152.71 40.53 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.507 0.67 . . . . 1.1899999999999999 110.288 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.445 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 45.8 m -117.81 132.32 56.46 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.741 -1.118 . . . . 1.22 109.512 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.4 pt -135.77 155.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.354 0.597 . . . . 1.0600000000000001 110.633 -175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.527 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.5 t -100.08 149.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.0 -1.0 . . . . 0.20999999999999999 110.189 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 18.0 mm -117.57 87.8 27.1 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 1.01 108.257 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 4' ' ' LEU . 20.4 Cg_endo -57.89 143.45 95.83 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.303 2.669 . . . . 0.23000000000000001 112.937 -173.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.587 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 81.2 -7.22 60.96 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.667 -0.697 . . . . 0.29999999999999999 113.07 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.543 HD21 ' CD ' ' A' ' 52' ' ' PRO . 2.9 tt -116.15 126.47 27.6 Favored Pre-proline 0 C--O 1.219 -0.539 0 N-CA-C 108.457 -0.942 . . . . 1.0800000000000001 108.457 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.543 ' CD ' HD21 ' A' ' 51' ' ' LEU . 60.1 Cg_endo -66.45 174.88 5.67 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.72 2.947 . . . . 0.34000000000000002 113.618 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.554 ' HB3' HG21 ' A' ' 56' ' ' THR . 8.9 t70 -89.63 141.75 28.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.71999999999999997 110.355 -172.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 90.2 Cg_endo -82.49 -3.88 11.48 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.423 2.749 . . . . 0.33000000000000002 112.169 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 55' ' ' TYR . 77.3 m-85 -95.68 -25.44 16.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 2.29 110.14 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 53' ' ' ASP . 22.7 p -74.05 -28.32 61.35 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.737 -1.208 . . . . 2.0600000000000001 107.737 171.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.574 HD11 ' HG2' ' A' ' 158' ' ' PRO . 97.0 mt -80.93 128.6 70.78 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 113.234 -1.803 . . . . 1.0900000000000001 109.659 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -103.6 96.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.942 0 CA-C-N 120.1 1.071 . . . . 0.22 110.681 166.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -157.7 132.81 8.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.587 -1.264 . . . . 0.80000000000000004 107.587 172.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 2.7 m-70 -139.08 104.98 5.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.483 -1.302 . . . . 3.5800000000000001 107.483 -164.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.448 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.7 mt -96.35 114.4 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.722 -0.672 . . . . 1.0600000000000001 111.169 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.84 97.01 6.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.202 -0.908 . . . . 1.1200000000000001 110.808 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -120.79 100.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.396 -1.275 . . . . 0.68000000000000005 110.253 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.524 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.9 m -94.76 134.51 37.28 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.23 -0.895 . . . . 1.3300000000000001 109.298 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.538 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 6.0 mm -59.39 -33.44 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.867 0.842 . . . . 1.77 109.433 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.33 40.97 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.314 -1.312 . . . . 0.93999999999999995 112.068 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -68.16 -24.86 65.03 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.177 0.513 . . . . 1.22 112.18 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 26.8 mttt 55.74 16.94 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.295 1.038 . . . . 2.9399999999999999 113.544 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.98 142.37 31.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 1.0600000000000001 110.839 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.49 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.2 tt -96.37 120.25 36.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.467 -1.242 . . . . 1.0900000000000001 109.658 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 m -101.12 122.34 43.42 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.078 -0.649 . . . . 1.0900000000000001 111.019 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.44 131.76 35.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 106.22 -1.77 . . . . 1.0800000000000001 106.22 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -137.28 126.89 25.24 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.677 1.581 . . . . 0.93000000000000005 112.703 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -113.06 126.22 55.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.089 -0.959 . . . . 1.1399999999999999 110.288 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 66.86 35.31 4.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.499 0.666 . . . . 0.52000000000000002 109.326 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.4 t30 75.7 -0.28 3.23 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.215 -1.357 . . . . 1.8400000000000001 112.21 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -128.93 140.6 51.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.125 -1.43 . . . . 3.8500000000000001 113.944 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -56.14 148.09 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 113.41 -1.723 . . . . 0.40999999999999998 113.371 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.533 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -96.94 -46.42 6.22 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.013 -2.358 . . . . 1.0900000000000001 107.594 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 21.0 tptp -178.77 155.68 0.81 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.397 -2.183 . . . . 2.6200000000000001 110.462 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -111.48 131.57 55.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.483 -0.192 . . . . 1.1000000000000001 110.483 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.85 135.85 24.5 Favored Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.033 0.444 . . . . 1.0600000000000001 111.6 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -64.04 140.96 74.88 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.272 2.648 . . . . 0.85999999999999999 112.613 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 -179.64 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.803 -0.814 . . . . 1.2 108.803 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.083 0.468 . . . . 1.4099999999999999 110.662 175.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.642 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 2.4 m-85 . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 108.181 -1.044 . . . . 2.3500000000000001 108.181 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.5 m-85 -136.31 138.68 41.96 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.213 -0.595 . . . . 0.92000000000000004 111.639 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.482 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 26.8 mm -59.93 106.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.19 -1.411 . . . . 1.0600000000000001 107.19 163.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.578 ' CD1' ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -94.87 -24.03 4.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.829 -0.749 . . . . 1.04 111.587 -176.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -172.01 -174.75 1.35 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 122.784 1.278 . . . . 2.3500000000000001 114.227 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.469 ' NH1' ' HA ' ' A' ' 155' ' ' SER . 2.8 ptt180 -149.9 137.7 20.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 111.374 -2.648 . . . . 1.54 110.575 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.614 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 29.2 tp60 -105.83 144.37 32.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.842 -1.072 . . . . 1.8899999999999999 110.386 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.586 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 23.8 ttm180 -53.37 155.28 2.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.748 -2.024 . . . . 3.46 112.085 172.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.586 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.4 109.87 1.1 Allowed Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 114.955 -1.021 . . . . 3.3500000000000001 110.498 175.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.15 -52.07 5.58 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.325 2.683 . . . . 0.97999999999999998 111.958 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.33 -20.24 25.89 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.197 -0.91 . . . . 1.0800000000000001 112.168 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -115.27 -169.94 16.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.94 -0.648 . . . . 1.1599999999999999 112.621 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.31 9.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 124.598 3.532 . . . . 1.46 114.557 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 115' ' ' TRP . 3.8 t80 -62.27 -27.37 68.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.421 0.629 . . . . 2.1000000000000001 109.959 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.78 55.36 0.94 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.1100000000000001 114.427 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.404 ' O ' ' HD2' ' A' ' 114' ' ' TYR . . . 73.38 -46.98 0.65 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.389 1.255 . . . . 1.45 114.389 166.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.614 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -151.84 147.06 26.17 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 122.638 0.375 . . . . 1.5 110.445 -174.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.614 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 47.0 t-105 -118.56 102.58 9.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.975 -0.38 . . . . 2.6000000000000001 109.975 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.65 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -107.45 139.78 41.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.561 0.696 . . . . 1.3100000000000001 110.222 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.3 m -107.66 148.52 29.26 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.51 0.93 . . . . 1.3100000000000001 113.51 -168.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 70.4 mt -103.09 -172.62 2.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.416 -1.266 . . . . 1.8600000000000001 107.981 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 p . . . . . 0 C--N 1.324 -0.521 0 C-N-CA 119.422 -0.911 . . . . 1.95 110.244 173.347 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.65 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 20.4 mt . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.085 -0.709 . . . . 1.05 109.085 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -145.45 -163.15 1.66 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.283 -0.567 . . . . 1.25 111.117 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.55 173.76 16.1 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.171 -1.014 . . . . 0.46000000000000002 113.016 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -137.21 174.68 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.432 0.634 . . . . 1.21 111.375 -167.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -104.44 -17.87 14.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.199 -0.909 . . . . 1.8600000000000001 109.604 165.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -125.39 103.08 29.36 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.827 -0.624 . . . . 1.8200000000000001 110.238 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.53 4.43 4.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.203 2.602 . . . . 0.64000000000000001 113.545 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.49 -22.66 54.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.189 0.519 . . . . 1.3200000000000001 110.818 -171.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -88.28 -6.56 57.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 1.8899999999999999 110.303 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 30.4 mm . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.663 0.744 . . . . 1.21 110.176 179.312 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.8 ptm . . . . . 0 C--O 1.232 0.177 0 N-CA-C 111.858 0.318 . . . . 1.8700000000000001 111.858 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -61.43 144.23 54.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.474 -0.33 . . . . 3.25 110.156 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -51.98 -64.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.025 0.203 . . . . 2.4199999999999999 111.536 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -62.68 -26.66 68.77 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.747 -0.596 . . . . 2.5699999999999998 111.462 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.47 -42.23 71.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.451 -0.341 . . . . 1.05 110.526 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.682 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 12.8 p -75.8 -17.44 15.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.32000000000000001 110.577 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.33 -37.99 11.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 119.289 -0.386 . . . . 1.1299999999999999 110.306 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -43.64 -70.23 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.078 0.854 . . . . 1.3799999999999999 111.954 161.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.414 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -50.03 -41.2 47.01 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.465 -0.789 . . . . 1.3400000000000001 110.29 178.248 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.682 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -54.41 -51.57 64.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.662 -1.154 . . . . 1.02 111.719 -173.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.469 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 14.9 m -77.94 -13.42 59.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.393 -1.276 . . . . 1.9099999999999999 111.387 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.48 -50.85 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.156 -0.474 . . . . 1.04 110.08 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.9 m -78.59 115.37 51.1 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-O 121.943 0.878 . . . . 0.20999999999999999 110.536 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.574 ' HG2' HD11 ' A' ' 57' ' ' ILE . 33.5 Cg_endo -84.6 -177.17 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.375 2.717 . . . . 0.51000000000000001 112.935 -174.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.528 ' O ' HD22 ' A' ' 51' ' ' LEU . 15.5 m120 -56.09 -2.35 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.636 -1.165 . . . . 1.02 114.016 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.2 57.2 0.5 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.633 -0.794 . . . . 0.64000000000000001 112.477 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.4 m -92.16 133.14 36.06 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.018 -0.364 . . . . 1.0700000000000001 110.018 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.22 133.9 34.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.469 -0.492 . . . . 2.3399999999999999 110.089 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.5 p -143.84 130.78 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 0.46000000000000002 111.234 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.403 ' C ' HD13 ' A' ' 165' ' ' ILE . 29.6 m -115.55 140.45 49.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.855 -0.612 . . . . 1.26 111.647 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.403 HD13 ' C ' ' A' ' 164' ' ' THR . 2.9 mp -123.82 110.29 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 118.957 -1.097 . . . . 1.1699999999999999 110.217 171.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 114.897 -1.047 . . . . 1.1899999999999999 110.566 -172.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.543 -0.623 . . . . 3.3799999999999999 111.543 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -87.36 134.86 33.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.216 0.531 . . . . 4.6799999999999997 110.475 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 3.1 mppt? -74.25 157.31 36.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.95 -1.023 . . . . 2.54 111.114 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 50' ' ' GLY . 20.0 mt -85.2 168.26 14.94 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.721 0.638 . . . . 1.1000000000000001 110.958 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.509 HD11 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -76.87 149.48 36.11 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 123.273 0.629 . . . . 1.05 112.57 -167.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.505 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.2 148.94 36.52 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.091 -0.959 . . . . 1.01 111.427 167.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.656 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 74.3 t80 -134.42 148.43 50.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.705 -1.589 . . . . 1.1200000000000001 107.753 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.89 114.46 15.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.152 -1.425 . . . . 1.72 107.152 175.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -77.51 158.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.801 -0.636 . . . . 0.38 111.262 -168.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -112.44 153.1 27.89 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.846 -0.798 . . . . 3.0600000000000001 108.846 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.538 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.24 116.18 1.91 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.64 -0.709 . . . . 2.1699999999999999 112.396 -172.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.93 -11.57 20.51 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.476 -0.783 . . . . 0.63 113.013 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.521 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 78.9 m-20 -63.13 153.97 32.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.633 0.605 . . . . 2.1699999999999999 112.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.4 p -134.05 155.0 50.79 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.858 -0.61 . . . . 1.27 112.385 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.579 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.3 tp -48.64 -58.99 3.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.68 0.992 . . . . 1.0800000000000001 113.68 -173.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.659 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.9 t-20 -65.25 -43.13 92.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.533 1.159 . . . . 1.55 110.164 -169.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.827 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 13.9 m -57.98 -43.13 86.36 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 112.381 -2.19 . . . . 1.8200000000000001 110.484 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.51 -41.1 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 123.738 0.815 . . . . 1.0600000000000001 112.566 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.29 -64.41 0.87 Allowed 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.588 -0.278 . . . . 0.97999999999999998 111.388 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.27 -4.46 50.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.875 -1.13 . . . . 1.0700000000000001 111.843 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.827 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.8 t0 -65.54 -34.31 77.95 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.618 -0.882 . . . . 1.6299999999999999 108.618 157.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.5 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.9 m-85 -95.15 16.92 15.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.777 0.322 . . . . 0.25 111.83 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 55.14 48.41 19.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.619 -0.719 . . . . 4.2000000000000002 110.552 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 39.1 pt -147.22 -176.34 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.526 -0.916 . . . . 1.02 108.526 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -100.07 145.04 28.41 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.297 -0.865 . . . . 1.1599999999999999 109.374 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.659 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 13.5 p -60.75 -35.85 77.44 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.41 0.624 . . . . 1.05 109.331 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.02 -32.71 74.14 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.488 -1.233 . . . . 1.05 111.514 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -37.51 42.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.095 0.474 . . . . 1.03 109.749 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 18.3 tp -73.63 -19.25 60.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.499 -0.773 . . . . 1.05 109.077 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.571 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.79 35.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.3 0.571 . . . . 1.0600000000000001 111.419 172.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 64.9 mt-30 -57.04 -44.33 82.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.511 1.148 . . . . 1.26 109.598 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.39 42.18 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.327 -1.76 . . . . 1.01 112.37 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 30.7 m-80 -143.28 72.56 17.97 Favored Pre-proline 0 CA--C 1.513 -0.466 0 CA-C-O 121.075 0.464 . . . . 0.20000000000000001 110.014 -171.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.669 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.6 Cg_endo -57.87 -9.05 5.21 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.289 2.659 . . . . 0.29999999999999999 113.876 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -63.62 -33.54 75.83 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.073 0.939 . . . . 1.3600000000000001 109.363 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -80.97 -6.53 58.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.059 -1.428 . . . . 1.26 114.508 -171.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.669 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -49.73 -40.64 41.39 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.634 1.207 . . . . 1.8899999999999999 109.919 177.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.61 -46.36 11.61 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 112.755 -2.02 . . . . 1.1000000000000001 111.815 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -166.89 39.11 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.439 -0.886 . . . . 0.29999999999999999 114.163 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mp -113.98 158.97 20.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.67 -1.265 . . . . 1.0800000000000001 110.214 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.592 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.05 135.32 39.31 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.905 -0.589 . . . . 1.1699999999999999 110.923 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -46.91 126.69 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.338 0.866 . . . . 1.1699999999999999 113.338 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.8 -10.52 51.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 114.539 -1.21 . . . . 0.38 112.192 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.592 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.5 tt0 -64.28 152.31 41.4 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.572 0.701 . . . . 1.1899999999999999 110.552 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.7 m -118.47 134.74 54.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.452 -1.249 . . . . 1.22 109.113 -172.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.422 ' CG1' ' HB3' ' A' ' 7' ' ' TYR . 22.2 pt -137.08 153.93 30.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.213 0.53 . . . . 1.0600000000000001 110.508 -175.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.535 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.4 t -98.81 148.99 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.292 -0.867 . . . . 0.20999999999999999 110.407 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 16.5 mm -118.16 88.09 31.2 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 114.903 -1.044 . . . . 1.01 108.356 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HA ' HD12 ' A' ' 4' ' ' LEU . 28.7 Cg_endo -60.04 140.59 93.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.095 2.53 . . . . 0.23000000000000001 112.43 -174.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.593 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 84.01 -7.79 69.43 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.636 -0.711 . . . . 0.29999999999999999 112.528 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.63 128.67 25.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.487 -0.931 . . . . 1.0800000000000001 108.487 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.567 ' CD ' HD21 ' A' ' 51' ' ' LEU . 71.8 Cg_endo -69.36 169.24 18.86 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.695 2.93 . . . . 0.34000000000000002 114.241 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 3.2 t70 -90.91 136.88 27.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.621 -1.172 . . . . 0.71999999999999997 111.603 -172.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD3' HD11 ' A' ' 5' ' ' LEU . 73.2 Cg_endo -76.74 -1.9 12.07 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.02 2.48 . . . . 0.33000000000000002 112.893 -173.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -96.13 -28.75 14.44 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 120.714 0.292 . . . . 2.29 111.031 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 3' ' ' LYS . 34.7 p -65.19 -34.6 78.76 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.606 -1.257 . . . . 2.0600000000000001 107.606 168.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.583 HD11 ' HG2' ' A' ' 158' ' ' PRO . 96.4 mt -78.15 126.37 83.65 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 113.053 -1.885 . . . . 1.0900000000000001 111.016 176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.47 96.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 120.92 1.08 . . . . 0.22 110.248 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 73' ' ' SER . 82.9 m-85 -158.87 136.77 10.39 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.463 -1.31 . . . . 0.80000000000000004 107.463 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 26.2 t-80 -141.75 108.18 5.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.603 -1.258 . . . . 3.5800000000000001 107.603 -169.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.0 mt -95.11 109.83 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.974 -1.012 . . . . 1.0600000000000001 110.317 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.53 95.42 5.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.181 -0.918 . . . . 1.1200000000000001 110.013 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -114.34 97.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.362 -1.29 . . . . 0.68000000000000005 109.325 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.472 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 32.0 m -92.05 130.37 37.8 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.898 -1.046 . . . . 1.3300000000000001 108.584 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.493 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.9 mm -60.2 -34.96 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.768 0.794 . . . . 1.77 109.042 177.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.38 91.24 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.475 -1.238 . . . . 0.93999999999999995 111.337 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.472 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.11 -24.35 64.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.265 0.555 . . . . 1.22 112.217 176.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 30.4 mttt 55.39 18.06 2.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.159 0.984 . . . . 2.9399999999999999 112.798 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -141.26 140.58 33.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.78 0.8 . . . . 1.0600000000000001 110.982 175.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.448 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -94.06 117.58 30.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.267 -1.333 . . . . 1.0900000000000001 109.516 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 m -101.05 126.27 47.72 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.439 -0.504 . . . . 1.0900000000000001 111.189 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -82.74 147.73 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.126 -1.805 . . . . 1.0800000000000001 106.126 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 20.0 m -150.94 130.82 13.28 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 120.238 1.381 . . . . 0.93000000000000005 112.329 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.9 tp -122.02 125.2 45.75 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.921 -1.036 . . . . 1.1399999999999999 110.697 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 66.06 35.14 6.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.539 0.685 . . . . 0.52000000000000002 109.321 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.3 m120 82.19 2.0 1.33 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.183 -1.371 . . . . 1.8400000000000001 111.719 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -131.52 140.46 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 118.756 -1.178 . . . . 3.8500000000000001 113.623 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -54.4 148.28 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 113.017 -1.901 . . . . 0.40999999999999998 112.788 -177.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.528 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.3 mtp -98.51 -42.74 7.17 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 112.734 -2.03 . . . . 1.0900000000000001 108.275 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 179.32 159.47 0.67 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.226 -2.261 . . . . 2.6200000000000001 110.135 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.499 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 11.8 m -119.14 133.26 55.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.588 0.232 . . . . 1.1000000000000001 111.238 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 1.608 ' HE1' ' CE2' ' A' ' 82' ' ' TYR . 48.6 m-85 -117.38 145.44 36.09 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.541 . . . . 1.0600000000000001 109.538 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -82.09 144.34 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.308 2.005 . . . . 0.85999999999999999 111.722 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.45 173.27 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.675 -0.491 . . . . 1.2 109.675 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' HB1' ' H ' ' A' ' 142' ' ' CYS . . . -86.3 118.63 25.86 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.38 0.61 . . . . 1.4099999999999999 110.966 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' CG2' ' HA ' ' A' ' 65' ' ' ILE . 1.3 t -111.18 -47.34 6.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.735 -1.121 . . . . 1.6699999999999999 110.444 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.34 -173.42 15.31 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.663 -0.699 . . . . 3.0800000000000001 111.471 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -118.12 -18.2 9.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.01 0.433 . . . . 7.6200000000000001 110.118 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.4 tt -158.19 71.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 122.192 0.996 . . . . 6.7199999999999998 109.674 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.4 tp -134.57 100.85 4.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.442 -0.799 . . . . 7.6299999999999999 110.2 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 92' ' ' GLN . 17.3 p -96.99 -154.96 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.057 -0.52 . . . . 5.5099999999999998 111.451 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' H ' ' HB ' ' A' ' 91' ' ' THR . 0.0 OUTLIER 73.01 98.32 0.07 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.328 0.651 . . . . 5.3899999999999997 109.778 -178.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.473 HG23 ' HB2' ' A' ' 167' ' ' ARG . 16.5 p -75.39 113.11 22.65 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.22 -0.446 . . . . 2.5600000000000001 111.129 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HD3' HH11 ' A' ' 167' ' ' ARG . 6.2 Cg_exo -74.46 91.48 0.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.283 1.988 . . . . 3.6600000000000001 110.923 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 p -76.05 70.3 2.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.584 0.707 . . . . 4.1699999999999999 111.576 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.09 165.39 30.28 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.44 -0.8 . . . . 2.6899999999999999 111.323 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.82 145.87 44.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.058 0.456 . . . . 2.2999999999999998 110.329 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.66 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 4.4 m-85 -120.67 170.48 9.39 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.841 -1.17 . . . . 2.3500000000000001 107.841 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.652 ' HA ' ' O ' ' A' ' 161' ' ' THR . 60.6 m-85 -130.67 140.49 50.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.113 0.482 . . . . 0.92000000000000004 110.879 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.483 HD13 HD13 ' A' ' 125' ' ' ILE . 19.0 mm -59.76 104.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.194 -1.039 . . . . 1.0600000000000001 108.194 166.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.5 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.5 tt -103.01 -24.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 120.221 -0.592 . . . . 1.04 112.191 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 6.5 t-20 -155.23 157.73 37.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.133 1.16 . . . . 2.3500000000000001 114.133 -172.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.31 133.73 26.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 111.767 -2.47 . . . . 1.54 110.262 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.579 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 33.5 tp60 -106.27 141.79 37.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.069 -0.969 . . . . 1.8899999999999999 111.386 -173.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 17.7 ttt180 -54.69 150.76 9.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.075 -1.875 . . . . 3.46 112.434 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -45.19 100.36 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.507 0 O-C-N 124.931 1.395 . . . . 3.3500000000000001 111.58 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -55.37 -50.02 14.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.886 3.058 . . . . 0.97999999999999998 112.242 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.26 -13.16 23.71 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.02 -0.991 . . . . 1.0800000000000001 112.256 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.75 -170.44 13.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.829 -0.7 . . . . 1.1599999999999999 112.773 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.64 18.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 124.69 3.593 . . . . 1.46 114.61 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.622 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 1.4 t80 -72.36 -16.13 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.256 0.55 . . . . 2.1000000000000001 109.655 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.88 42.71 2.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 1.1100000000000001 114.061 170.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.435 ' O ' ' HD2' ' A' ' 114' ' ' TYR . . . 73.59 -39.05 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.307 0.854 . . . . 1.45 113.307 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.3 OUTLIER -151.55 144.79 24.69 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 122.719 0.408 . . . . 1.5 109.93 -174.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.598 ' CH2' ' H25' ' A' 1142 ' ' IM2 . 47.8 t-105 -117.07 104.44 11.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.873 -0.417 . . . . 2.6000000000000001 109.873 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.3 mp -105.95 137.1 44.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.546 0.688 . . . . 1.3100000000000001 110.707 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.1 m -105.09 145.18 30.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.334 -0.848 . . . . 1.3100000000000001 112.266 -170.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -96.53 -174.67 3.1 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.907 -1.146 . . . . 1.8600000000000001 107.907 171.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.47 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 33.7 m -106.66 3.38 26.73 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.764 1.024 . . . . 1.95 113.764 -172.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.404 ' HZ2' ' CG ' ' A' ' 13' ' ' ASP . 18.2 tttp -130.93 98.7 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.127 -1.029 . . . . 3.3999999999999999 112.908 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.439 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 96.9 mt-30 45.08 -107.04 0.12 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.444 1.276 . . . . 5.5800000000000001 114.444 171.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -91.8 49.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.349 0.595 . . . . 6.7300000000000004 111.438 -167.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.41 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 68.8 m-85 -136.54 130.93 33.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.854 -0.612 . . . . 5.1500000000000004 110.107 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.583 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -155.09 156.73 27.13 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.971 -0.633 . . . . 1.1899999999999999 111.724 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 40.0 mt -109.0 112.32 39.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.976 -0.75 . . . . 1.05 108.976 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 8.9 p80 -140.93 -167.65 2.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.752 0.787 . . . . 1.25 112.65 -172.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.453 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.62 179.86 16.05 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.586 -1.188 . . . . 0.46000000000000002 113.221 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -144.65 174.6 10.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.49 0.662 . . . . 1.21 111.563 -165.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -110.85 -13.23 14.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.923 -1.035 . . . . 1.8600000000000001 109.557 162.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -124.39 101.6 34.13 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.72 -0.673 . . . . 1.8200000000000001 109.633 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -92.22 3.6 3.82 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.213 2.609 . . . . 0.64000000000000001 113.682 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.07 -19.24 40.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.33 0.586 . . . . 1.3200000000000001 110.458 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -87.7 -7.12 57.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.57 -0.741 . . . . 1.8899999999999999 110.223 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.483 HD13 ' CG ' ' A' ' 144' ' ' ARG . 13.4 mm -79.74 104.85 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.238 -0.892 . . . . 1.21 111.369 -174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.41 -11.02 71.17 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.726 -1.125 . . . . 1.6799999999999999 112.153 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -127.52 12.25 6.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.134 0.42 . . . . 4.8799999999999999 112.134 -172.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.08 164.83 36.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.057 0.456 . . . . 4.4699999999999998 111.375 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.5 m -92.22 63.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 4.6799999999999997 111.016 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.3 m -79.98 50.7 1.24 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.96 -0.564 . . . . 5.9100000000000001 111.886 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.536 ' HD3' ' H41' ' A' 1142 ' ' IM2 . 21.3 ptmt 37.26 47.02 0.64 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.507 1.123 . . . . 8.5999999999999996 113.415 177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 57.48 63.7 5.06 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.995 -0.548 . . . . 4.1900000000000004 114.024 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.449 ' H ' ' HB1' ' A' ' 85' ' ' ALA . 89.3 m -108.48 126.64 53.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 2.9199999999999999 109.906 174.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 29.3 mt -96.21 73.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.6 0.714 . . . . 2.0699999999999998 109.565 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 40.1 ptt180 -129.59 151.88 49.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.482 -0.781 . . . . 3.98 110.448 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.425 ' HE3' ' HB2' ' A' ' 145' ' ' MET . 0.5 OUTLIER -141.56 -162.32 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.784 -0.45 . . . . 1.8700000000000001 109.784 178.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.545 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 30.4 m-70 -66.84 152.69 45.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.251 -0.648 . . . . 3.25 109.251 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -50.5 -61.55 2.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.302 0.376 . . . . 2.4199999999999999 111.101 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.19 -28.54 70.12 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.89 -0.506 . . . . 2.5699999999999998 111.63 -175.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.545 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 1.5 m-20 -67.12 -41.96 85.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 1.05 110.777 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.705 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 13.5 p -77.03 -16.38 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.32000000000000001 110.716 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -89.15 -39.68 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 119.109 -0.472 . . . . 1.1299999999999999 110.679 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -43.69 -68.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.402 1.001 . . . . 1.3799999999999999 111.825 163.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.451 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -49.96 -43.11 49.9 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.638 -0.71 . . . . 1.3400000000000001 110.271 177.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.705 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -54.16 -52.8 60.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.406 -1.27 . . . . 1.02 112.25 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.8 p -77.44 -15.94 59.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.548 -1.206 . . . . 1.9099999999999999 111.214 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.5 -48.62 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.731 -0.47 . . . . 1.04 109.731 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.455 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 25.8 m -77.48 118.87 74.85 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-O 121.946 0.879 . . . . 0.20999999999999999 110.559 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.583 ' HG2' HD11 ' A' ' 57' ' ' ILE . 35.3 Cg_endo -83.6 -177.85 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.177 2.585 . . . . 0.51000000000000001 112.533 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.714 ' O ' HD22 ' A' ' 51' ' ' LEU . 15.0 m120 -61.56 3.84 0.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.977 -1.01 . . . . 1.02 113.52 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.94 58.13 0.46 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.64000000000000001 112.379 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.652 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.78 135.92 33.41 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 122.547 -0.384 . . . . 1.0700000000000001 110.452 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -83.88 125.51 32.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.79 -0.187 . . . . 2.3399999999999999 110.546 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 4.2 p -138.15 127.43 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.439 0.637 . . . . 0.46000000000000002 111.28 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.7 m -118.22 140.36 49.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.654 -0.703 . . . . 1.26 111.721 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.17 110.25 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 118.919 -1.112 . . . . 1.1699999999999999 110.524 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.593 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.51 139.93 30.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.476 -0.784 . . . . 1.1899999999999999 111.354 -170.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.482 HH11 ' HD3' ' A' ' 94' ' ' PRO . 5.4 mpt_? -77.81 -16.07 58.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.939 -1.028 . . . . 3.7999999999999998 110.912 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.69 -96.32 0.84 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.004 -0.617 . . . . 3.6499999999999999 112.377 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.478 -0.773 . . . . 5.9699999999999998 110.397 -177.341 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.598 ' H25' ' CH2' ' A' ' 115' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 111.912 -0.475 . . . . 3.3799999999999999 111.912 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 63.64 -173.63 0.16 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.462 0.649 . . . . 4.6799999999999997 111.46 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.5 mptp? -71.04 148.19 47.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.38 -0.827 . . . . 2.54 109.632 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.551 HD12 ' H ' ' A' ' 50' ' ' GLY . 15.7 mt -99.4 170.81 8.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.425 -0.352 . . . . 1.1000000000000001 111.458 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.538 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.2 tp -77.86 150.95 34.1 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.334 0.654 . . . . 1.05 112.358 -170.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.538 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.86 149.47 40.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.055 0.931 . . . . 1.01 112.295 169.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 78.7 t80 -133.1 147.73 52.15 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 113.595 -1.639 . . . . 1.1200000000000001 107.596 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.68 113.65 16.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.036 -1.468 . . . . 1.72 107.036 175.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.48 156.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.066 0.46 . . . . 0.38 111.89 -166.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -104.96 146.71 28.66 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.491 -0.777 . . . . 3.0600000000000001 109.23 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.539 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 3.2 tt0 -50.55 106.18 0.12 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.846 -1.07 . . . . 2.1699999999999999 112.894 -173.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.15 15.17 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.407 -0.815 . . . . 0.63 112.812 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.508 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 17.3 m-20 -62.36 154.57 27.64 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.345 0.498 . . . . 2.1699999999999999 112.345 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.448 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.2 p -131.64 155.37 47.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.008 0.433 . . . . 1.27 111.989 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.581 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.7 tp -49.03 -60.12 3.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.098 1.147 . . . . 1.0800000000000001 114.098 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.733 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 3.1 t-20 -65.21 -38.72 91.3 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.011 0.91 . . . . 1.55 110.572 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 t -58.61 -50.36 74.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 113.154 -1.839 . . . . 1.8200000000000001 109.19 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -67.72 -38.48 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 O-C-N 123.584 0.553 . . . . 1.0600000000000001 111.975 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -60.16 4.07 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.97999999999999998 110.994 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.79 58.57 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.67 -1.212 . . . . 1.0700000000000001 112.15 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.532 ' HB3' ' O ' ' A' ' 119' ' ' SER . 11.3 m-20 -62.61 -34.33 76.81 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.859 -1.163 . . . . 1.6299999999999999 107.859 156.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -99.98 17.54 20.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.396 0.517 . . . . 0.25 112.396 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 50.44 53.77 12.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 4.2000000000000002 111.13 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 37.1 pt -147.77 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.045 -0.724 . . . . 1.02 109.045 -173.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -98.78 144.17 28.31 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.333 -0.849 . . . . 1.1599999999999999 109.57 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.733 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.9 p -62.89 -37.15 85.79 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.564 0.697 . . . . 1.05 109.21 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.14 -27.89 69.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.104 -1.407 . . . . 1.05 111.343 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.89 -37.52 26.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.231 0.538 . . . . 1.03 109.862 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.3 tp -73.8 -19.83 60.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.205 -0.907 . . . . 1.05 109.009 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.649 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.98 -37.74 38.65 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.332 0.586 . . . . 1.0600000000000001 111.235 172.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.5 mt-30 -56.89 -42.85 80.62 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.25 1.024 . . . . 1.26 109.686 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.65 -20.58 35.99 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.536 -1.666 . . . . 1.01 112.523 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 31.7 m-80 -142.04 72.16 23.09 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.009 0.433 . . . . 0.20000000000000001 109.994 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.6 -9.36 5.27 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.586 2.857 . . . . 0.29999999999999999 113.954 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -63.78 -33.63 76.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.028 0.918 . . . . 1.3600000000000001 109.845 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -80.6 -4.75 55.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.206 -1.361 . . . . 1.26 114.46 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.649 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -50.52 -39.41 48.69 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 122.561 1.172 . . . . 1.8899999999999999 110.035 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.491 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -86.57 -45.87 10.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 112.921 -1.945 . . . . 1.1000000000000001 111.523 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 176.08 -167.55 39.3 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.155 -1.021 . . . . 0.29999999999999999 114.295 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.3 mp -115.86 157.92 23.73 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.511 -1.345 . . . . 1.0800000000000001 110.571 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.609 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 48.8 m -130.34 134.74 47.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.74 -0.664 . . . . 1.1699999999999999 110.394 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -48.99 129.95 17.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.98 0.733 . . . . 1.1699999999999999 112.98 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 -13.82 35.89 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 114.792 -1.095 . . . . 0.38 112.054 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.609 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.2 tt0 -63.02 152.38 37.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.744 0.783 . . . . 1.1899999999999999 110.323 175.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.428 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 31.1 m -119.42 131.88 55.72 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.365 -1.289 . . . . 1.22 109.403 -171.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.0 pt -133.46 155.82 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.248 0.547 . . . . 1.0600000000000001 110.522 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.516 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.4 t -101.38 148.73 6.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.239 -0.891 . . . . 0.20999999999999999 110.176 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.435 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 16.8 mm -117.17 87.69 24.52 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.767 -1.106 . . . . 1.01 108.099 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.523 ' HA ' HD12 ' A' ' 4' ' ' LEU . 21.7 Cg_endo -58.63 145.82 93.94 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.387 2.725 . . . . 0.23000000000000001 112.627 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.551 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 78.61 -6.16 54.33 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.911 -0.586 . . . . 0.29999999999999999 112.831 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -116.06 125.41 28.62 Favored Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.707 -0.849 . . . . 1.0800000000000001 108.707 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.565 ' CD ' HD21 ' A' ' 51' ' ' LEU . 55.6 Cg_endo -64.92 174.2 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.616 2.878 . . . . 0.34000000000000002 113.752 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 1.8 t70 -91.13 140.43 25.87 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 114.88 -1.054 . . . . 0.71999999999999997 111.686 -170.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.484 ' HD3' HD11 ' A' ' 5' ' ' LEU . 63.0 Cg_endo -84.09 -7.58 10.12 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.316 2.677 . . . . 0.33000000000000002 113.474 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 55' ' ' TYR . 74.2 m-85 -90.65 -29.27 17.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.924 0.392 . . . . 2.29 110.437 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -80.69 -13.73 58.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.749 0.785 . . . . 2.0600000000000001 109.02 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 158' ' ' PRO . 66.8 mt -85.91 126.95 64.18 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 114.679 -1.146 . . . . 1.0900000000000001 109.839 171.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' O ' HD13 ' A' ' 74' ' ' LEU . 18.2 Cg_endo -101.61 94.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.948 0 CA-C-N 119.972 1.026 . . . . 0.22 110.659 170.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.796 ' HA ' ' O ' ' A' ' 73' ' ' SER . 92.6 m-85 -158.56 139.65 13.09 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.981 -1.463 . . . . 0.80000000000000004 107.236 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 55.9 m-70 -139.19 117.77 12.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.916 -1.513 . . . . 3.5800000000000001 106.916 -176.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.423 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 79.6 mt -98.88 109.34 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.085 -0.646 . . . . 1.0600000000000001 110.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.65 98.94 7.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.918 0.865 . . . . 1.1200000000000001 110.896 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.499 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.3 p -121.01 98.44 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.012 -1.449 . . . . 0.68000000000000005 110.606 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.477 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 68.8 m -92.03 115.49 28.12 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.419 -1.326 . . . . 1.3300000000000001 107.419 170.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.785 ' CG2' ' HB2' ' A' ' 167' ' ' ARG . 16.4 mt -54.05 -26.0 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 121.122 0.487 . . . . 1.77 110.167 172.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.504 ' CA ' ' HD3' ' A' ' 88' ' ' LYS . . . -66.58 -48.43 62.64 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.795 -0.717 . . . . 0.93999999999999995 112.237 169.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -63.34 -22.48 66.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.451 0.643 . . . . 1.22 110.849 171.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HA ' ' CG1' ' A' ' 86' ' ' VAL . 9.0 tmtt? 64.35 11.03 6.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.6 -1.182 . . . . 2.9399999999999999 112.603 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.455 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -145.12 143.43 30.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.591 0.71 . . . . 1.0600000000000001 112.183 176.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.499 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.8 tt -95.72 122.27 38.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.197 -1.365 . . . . 1.0900000000000001 109.952 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.26 125.74 50.07 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.487 -0.485 . . . . 1.0900000000000001 111.61 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -83.21 150.62 26.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.426 -1.694 . . . . 1.0800000000000001 106.426 175.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.796 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 1.4 m -150.84 128.5 11.55 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.335 1.425 . . . . 0.93000000000000005 111.786 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 58' ' ' PRO . 21.0 tp -115.01 126.91 55.29 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.496 -0.775 . . . . 1.1399999999999999 110.222 174.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.58 35.29 11.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.392 0.615 . . . . 0.52000000000000002 109.666 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.39 7.77 5.17 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.02 -0.991 . . . . 1.8400000000000001 112.367 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -129.89 138.26 50.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.755 -1.178 . . . . 3.8500000000000001 113.649 170.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -54.71 150.06 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 113.551 -1.659 . . . . 0.40999999999999998 112.963 -172.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.514 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 3.6 mtp -103.36 -41.15 6.11 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.745 -2.025 . . . . 1.0900000000000001 108.476 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -175.29 170.28 3.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 112.868 -1.969 . . . . 2.6200000000000001 111.1 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.455 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 16.0 m -131.02 129.42 42.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.684 -0.235 . . . . 1.1000000000000001 110.93 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.504 ' CD1' ' HE1' ' A' ' 145' ' ' MET . 85.7 m-85 -115.77 150.43 44.86 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 122.32 0.248 . . . . 1.0600000000000001 110.948 -175.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -84.92 141.07 8.23 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.838 2.359 . . . . 0.85999999999999999 112.1 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.46 -177.12 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.057 -0.519 . . . . 1.2 110.412 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.479 ' HB1' ' H ' ' A' ' 142' ' ' CYS . . . -84.66 138.9 32.41 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.617 -0.512 . . . . 1.4099999999999999 109.617 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 68' ' ' LYS . 17.0 m -143.7 -163.8 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.844 0.683 . . . . 1.6699999999999999 112.844 -165.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 146.3 92.76 0.12 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.81 -0.916 . . . . 3.0800000000000001 110.81 -173.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.504 ' HD3' ' CA ' ' A' ' 66' ' ' GLY . 32.3 ttpt -98.26 -72.46 0.65 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.134 0.42 . . . . 7.6200000000000001 112.134 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.474 ' HB ' ' OG ' ' A' ' 169' ' ' SER . 3.8 mp 65.2 -84.63 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.219 0.608 . . . . 6.7199999999999998 111.921 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.5 mt -126.77 -106.3 0.32 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.289 0.848 . . . . 7.6299999999999999 113.289 -176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 91.4 m -147.46 134.62 20.48 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.503 0.557 . . . . 5.5099999999999998 112.503 -171.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -178.13 -66.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.172 0.589 . . . . 5.3899999999999997 110.183 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.664 HG21 ' N ' ' A' ' 167' ' ' ARG . 45.5 p 51.76 89.47 0.1 OUTLIER Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 123.869 0.867 . . . . 2.5600000000000001 113.295 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -72.2 63.25 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.523 2.149 . . . . 3.6600000000000001 109.846 167.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.5 m -58.01 109.29 0.71 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.002 -0.999 . . . . 4.1699999999999999 112.247 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.07 108.08 2.65 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.308 -1.117 . . . . 2.6899999999999999 110.308 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -77.02 124.74 28.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.397 0.618 . . . . 2.2999999999999998 109.917 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.627 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 19.6 m-85 -124.44 172.47 9.14 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.989 -1.005 . . . . 2.3500000000000001 110.531 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.628 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 65.2 m-85 -131.46 141.26 49.76 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.255 -0.884 . . . . 0.92000000000000004 109.969 172.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.465 HD13 HD13 ' A' ' 125' ' ' ILE . 24.0 mm -59.87 114.36 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 N-CA-C 107.47 -1.307 . . . . 1.0600000000000001 107.47 165.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.91 -27.41 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.551 -0.86 . . . . 1.04 112.018 -176.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.686 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 60.0 t30 -172.41 -172.64 0.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.663 1.22 . . . . 2.3500000000000001 113.481 -175.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.686 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.3 ptt180 -155.45 131.71 10.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 111.693 -2.503 . . . . 1.54 109.711 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.74 157.34 17.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.58 1.181 . . . . 1.8899999999999999 112.227 -171.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 106' ' ' ASN . 37.0 ttt180 -53.93 154.78 3.81 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 112.485 -2.143 . . . . 3.46 112.473 170.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 105' ' ' ARG . 9.3 p30 -44.03 105.72 0.46 Allowed Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 112.925 -1.943 . . . . 3.3500000000000001 111.346 175.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.424 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 88.7 Cg_exo -56.75 -53.31 5.26 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.653 2.902 . . . . 0.97999999999999998 112.309 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.62 37.68 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.206 -0.906 . . . . 1.0800000000000001 112.599 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.85 -170.37 24.36 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.915 -0.66 . . . . 1.1599999999999999 111.89 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.15 49.56 0.34 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.992 3.128 . . . . 1.46 113.127 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.653 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -93.85 -21.1 19.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.059 0.456 . . . . 2.1000000000000001 110.026 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.523 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 46.62 2.04 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.53 -0.759 . . . . 1.1100000000000001 113.986 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.62 -24.53 0.21 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.192 0.812 . . . . 1.45 113.192 170.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.615 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -154.43 151.33 28.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.261 -0.274 . . . . 1.5 110.261 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -118.02 100.25 7.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.788 -0.819 . . . . 2.6000000000000001 108.788 165.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.5 mp -101.85 139.24 37.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.801 0.81 . . . . 1.3100000000000001 110.32 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.0 m -106.68 144.96 32.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.916 -1.038 . . . . 1.3100000000000001 112.378 -168.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 73.0 mt -102.24 -176.84 3.23 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.648 -1.16 . . . . 1.8600000000000001 108.464 173.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.532 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 49.6 m -76.61 2.58 13.64 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.803 0.297 . . . . 1.95 111.803 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -128.36 146.89 50.64 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.599 -0.519 . . . . 3.3999999999999999 109.599 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.403 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 12.0 pt20 -84.53 2.33 41.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.679 0.276 . . . . 5.5800000000000001 111.013 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -89.15 -29.31 19.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.783 0.325 . . . . 6.7300000000000004 110.887 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -128.85 146.71 50.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.406 -0.361 . . . . 5.1500000000000004 110.736 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.36 150.77 22.45 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.095 -0.574 . . . . 1.1899999999999999 111.69 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.585 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 23.1 mt -93.19 115.07 31.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.254 -0.647 . . . . 1.05 109.254 176.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.527 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 7.9 p80 -153.51 -162.22 1.42 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.405 0.621 . . . . 1.25 111.498 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.523 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.63 179.57 16.38 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.158 -1.02 . . . . 0.46000000000000002 112.779 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -135.13 174.83 10.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.453 0.644 . . . . 1.21 111.185 -167.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -107.74 -23.0 12.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.92 -1.036 . . . . 1.8600000000000001 108.994 168.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.41 104.63 28.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 114.756 -1.111 . . . . 1.8200000000000001 109.616 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.8 Cg_endo -89.97 4.5 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.213 2.609 . . . . 0.64000000000000001 113.185 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.84 -21.91 29.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.389 0.614 . . . . 1.3200000000000001 109.453 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.2 t -76.76 -18.18 58.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.079 -0.964 . . . . 1.8899999999999999 109.317 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 144' ' ' ARG . 23.4 mm -70.92 106.17 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.096 -0.957 . . . . 1.21 110.275 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.18 -135.29 7.8 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.667 -0.778 . . . . 1.6799999999999999 112.464 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -86.46 4.33 40.14 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.728 0.27 . . . . 4.8799999999999999 111.728 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.7 -55.5 26.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.702 0.287 . . . . 4.4699999999999998 111.272 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.52 155.37 8.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.181 -0.463 . . . . 4.6799999999999997 109.932 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 14.7 p -84.0 -143.49 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.199 -0.455 . . . . 5.9100000000000001 111.02 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 139' ' ' SER . 4.2 mptp? 69.44 114.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.167 0.587 . . . . 8.5999999999999996 110.416 -174.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.54 96.85 0.03 OUTLIER Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.934 -0.576 . . . . 4.1900000000000004 113.457 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.479 ' H ' ' HB1' ' A' ' 85' ' ' ALA . 77.7 m -128.53 105.48 8.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.109 0.48 . . . . 2.9199999999999999 110.388 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.8 mt -95.13 79.91 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.416 0.627 . . . . 2.0699999999999998 110.08 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 81.7 mtm180 -128.67 150.29 50.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.407 -0.815 . . . . 3.98 110.523 -175.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.504 ' HE1' ' CD1' ' A' ' 82' ' ' TYR . 4.9 mtp -145.26 -165.68 2.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.37 -0.377 . . . . 1.8700000000000001 110.581 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -78.4 161.46 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.106 -0.701 . . . . 3.25 109.106 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -52.42 -68.13 0.19 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.398 0.436 . . . . 2.4199999999999999 110.987 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -58.12 -30.89 66.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.098 0.407 . . . . 2.5699999999999998 112.098 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -67.07 -41.5 86.31 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.906 0.384 . . . . 1.05 110.975 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 7.3 p -78.38 -15.27 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 0.32000000000000001 110.637 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.39 -41.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 118.749 -0.643 . . . . 1.1299999999999999 110.414 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -44.36 -68.72 0.17 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.543 1.065 . . . . 1.3799999999999999 112.244 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.444 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -49.94 -43.46 49.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.927 -0.579 . . . . 1.3400000000000001 110.169 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -53.17 -54.66 32.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.074 -1.421 . . . . 1.02 111.929 -171.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -79.95 -14.4 58.63 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.574 -1.194 . . . . 1.9099999999999999 110.779 -170.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.65 -48.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.987 -0.375 . . . . 1.04 109.987 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.1 m -76.33 119.35 76.93 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-O 121.672 0.748 . . . . 0.20999999999999999 110.294 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.554 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.8 Cg_endo -83.1 -178.07 3.63 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.154 2.569 . . . . 0.51000000000000001 112.872 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.616 ' O ' HD22 ' A' ' 51' ' ' LEU . 21.6 m120 -61.44 0.06 0.34 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.104 -0.953 . . . . 1.02 113.142 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.84 58.02 0.52 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.767 -0.73 . . . . 0.64000000000000001 112.519 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.542 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 3.5 m -95.26 133.98 38.54 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.327 -0.513 . . . . 1.0700000000000001 110.206 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.7 134.17 34.36 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 2.3399999999999999 110.353 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.4 p -140.57 123.73 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.024 -0.989 . . . . 0.46000000000000002 110.79 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.463 ' C ' HD11 ' A' ' 165' ' ' ILE . 93.0 m -118.09 141.57 48.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.494 -0.775 . . . . 1.26 111.782 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.463 HD11 ' C ' ' A' ' 164' ' ' THR . 2.9 mp -125.13 123.31 65.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 118.845 -1.142 . . . . 1.1699999999999999 112.258 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.17 118.41 10.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.989 -1.115 . . . . 1.1899999999999999 107.989 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.785 ' HB2' ' CG2' ' A' ' 65' ' ' ILE . 2.0 ptt180 -99.0 -49.74 4.42 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 115.602 1.704 . . . . 3.7999999999999998 115.602 -169.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.671 ' N ' ' HG2' ' A' ' 167' ' ' ARG . . . 132.45 -141.65 13.03 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 108.589 -1.804 . . . . 3.6499999999999999 108.589 -161.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.474 ' OG ' ' HB ' ' A' ' 89' ' ' ILE . 24.1 p . . . . . 0 C--O 1.252 1.19 0 CA-C-N 118.7 1.25 . . . . 5.9699999999999998 110.885 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.627 ' O32' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.975 -0.45 . . . . 3.3799999999999999 111.975 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.9 OUTLIER 63.81 -177.18 0.16 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.317 0.579 . . . . 4.6799999999999997 111.539 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.6 mptp? -71.87 142.87 49.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.532 -0.758 . . . . 2.54 109.929 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.588 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.6 mt -100.11 169.92 8.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.188 0.305 . . . . 1.1000000000000001 111.439 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.6 tp -75.86 150.23 37.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 123.076 0.55 . . . . 1.05 112.17 -170.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.501 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.38 149.26 38.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 122.11 0.957 . . . . 1.01 111.921 167.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 67.8 t80 -132.84 149.41 52.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.538 -1.665 . . . . 1.1200000000000001 107.863 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.578 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.1 119.67 25.81 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.628 -1.619 . . . . 1.72 106.628 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.99 158.56 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-O 121.227 0.537 . . . . 0.38 111.554 -170.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -110.16 155.44 21.95 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.554 -0.906 . . . . 3.0600000000000001 108.554 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.465 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 47.7 tt0 -52.53 122.34 8.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 2.1699999999999999 112.14 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.99 -9.08 36.68 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.99 -1.004 . . . . 0.63 112.724 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.526 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 94.7 m-20 -67.42 151.23 47.77 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.935 0.398 . . . . 2.1699999999999999 112.058 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -132.6 157.33 45.05 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 112.282 0.475 . . . . 1.27 112.282 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.9 tp -49.96 -59.75 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.95 1.092 . . . . 1.0800000000000001 113.95 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.713 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.4 t-20 -65.83 -38.3 88.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.298 1.047 . . . . 1.55 110.476 -168.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 t -57.09 -54.93 41.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 113.143 -1.844 . . . . 1.8200000000000001 109.233 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.72 -38.76 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 115.531 -0.759 . . . . 1.0600000000000001 112.086 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.86 -63.73 1.11 Allowed 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 116.048 -0.523 . . . . 0.97999999999999998 111.279 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.66 -3.93 54.83 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.803 -1.159 . . . . 1.0700000000000001 112.011 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -66.97 -27.34 67.37 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.81 -0.811 . . . . 1.6299999999999999 108.81 156.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -103.07 18.31 21.99 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.861 -0.524 . . . . 0.25 111.968 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 50.34 54.81 10.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.195 -0.911 . . . . 4.2000000000000002 110.918 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 37.1 pt -148.26 -173.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.597 -0.89 . . . . 1.02 108.597 -173.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -100.96 143.63 30.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.29 -0.868 . . . . 1.1599999999999999 109.319 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.713 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.8 p -61.05 -35.27 76.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.453 0.645 . . . . 1.05 109.503 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.94 -30.69 71.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.482 -1.236 . . . . 1.05 111.396 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.78 30.5 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.224 0.535 . . . . 1.03 109.631 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 15.0 tp -73.17 -19.3 61.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.417 -0.81 . . . . 1.05 109.022 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.572 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.61 36.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.315 0.578 . . . . 1.0600000000000001 111.237 172.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 51.6 mt-30 -58.01 -42.52 85.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.227 1.013 . . . . 1.26 109.727 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.69 -20.71 38.94 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 113.478 -1.692 . . . . 1.01 112.489 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.637 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 30.9 m-80 -143.43 73.48 17.5 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.20000000000000001 109.949 -172.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.726 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.7 Cg_endo -57.36 -12.05 9.73 Favored 'Trans proline' 0 C--O 1.221 -0.372 0 C-N-CA 123.573 2.849 . . . . 0.29999999999999999 114.003 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -62.47 -34.23 76.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.106 0.955 . . . . 1.3600000000000001 109.119 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.3 mt -78.44 -6.7 56.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.117 -1.402 . . . . 1.26 114.448 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.726 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -50.99 -42.55 60.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 120.019 1.281 . . . . 1.8899999999999999 109.478 176.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.84 15.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 112.894 -1.957 . . . . 1.1000000000000001 111.601 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.86 -164.4 35.81 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.264 -0.969 . . . . 0.29999999999999999 114.243 176.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.85 158.96 23.11 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.274 -1.463 . . . . 1.0800000000000001 109.905 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 93.2 m -136.53 135.63 38.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.912 -0.585 . . . . 1.1699999999999999 110.77 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -45.27 126.61 6.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.267 0.84 . . . . 1.1699999999999999 113.267 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.578 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.57 -12.52 46.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.588 -1.187 . . . . 0.38 112.388 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.565 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.7 tt0 -63.2 152.08 38.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.597 0.713 . . . . 1.1899999999999999 110.455 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.441 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 49.9 m -119.87 132.27 55.51 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.668 -1.151 . . . . 1.22 109.612 -171.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.403 ' CG1' ' HB3' ' A' ' 7' ' ' TYR . 18.9 pt -132.91 160.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.156 0.503 . . . . 1.0600000000000001 110.319 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.637 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 21.7 t -107.05 148.45 11.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.221 -0.899 . . . . 0.20999999999999999 109.943 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 15.0 mm -116.66 88.5 25.02 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.957 -1.019 . . . . 1.01 108.277 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' HD12 ' A' ' 4' ' ' LEU . 27.5 Cg_endo -59.3 142.66 99.43 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.304 2.669 . . . . 0.23000000000000001 113.02 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.588 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 81.29 -7.56 60.43 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.447 -0.797 . . . . 0.29999999999999999 112.9 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.652 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.48 126.15 28.06 Favored Pre-proline 0 C--O 1.218 -0.567 0 N-CA-C 108.936 -0.764 . . . . 1.0800000000000001 108.936 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.544 ' CD ' HD21 ' A' ' 51' ' ' LEU . 48.8 Cg_endo -64.48 176.56 2.67 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.939 3.093 . . . . 0.34000000000000002 114.198 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.571 ' HB3' HG21 ' A' ' 56' ' ' THR . 4.3 t70 -90.74 141.99 27.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.84 -1.073 . . . . 0.71999999999999997 110.646 -170.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.498 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 63.1 Cg_endo -86.81 -4.61 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.352 2.702 . . . . 0.33000000000000002 112.158 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 55' ' ' TYR . 67.6 m-85 -95.06 -28.67 14.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 2.29 110.59 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.571 HG21 ' HB3' ' A' ' 53' ' ' ASP . 14.9 t -79.43 -14.1 59.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.024 -1.102 . . . . 2.0600000000000001 108.024 172.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.572 HD11 ' HG2' ' A' ' 158' ' ' PRO . 71.8 mt -91.54 126.22 55.03 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.118 -1.401 . . . . 1.0900000000000001 109.77 170.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -103.13 95.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.146 0 CA-C-N 120.036 1.048 . . . . 0.22 110.117 166.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -158.96 138.66 11.78 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.645 -1.613 . . . . 0.80000000000000004 106.645 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.573 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 12.6 t60 -147.69 121.83 9.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 3.5800000000000001 108.147 -169.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.4 mt -103.39 111.13 31.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 114.643 -1.162 . . . . 1.0600000000000001 110.853 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.27 94.29 4.86 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.077 0.941 . . . . 1.1200000000000001 110.14 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.502 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -116.95 98.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 113.82 -1.537 . . . . 0.68000000000000005 109.819 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.494 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 38.7 m -90.19 113.13 24.86 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.672 -1.233 . . . . 1.3300000000000001 107.672 175.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.668 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 2.6 mm -46.46 -37.49 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.111 -0.495 . . . . 1.77 109.845 170.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.31 -42.05 99.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.076 -1.059 . . . . 0.93999999999999995 112.247 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.494 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.97 -23.96 62.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.051 1.13 . . . . 1.22 114.051 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HG3' ' CG1' ' A' ' 86' ' ' VAL . 7.6 mptt 61.83 11.4 4.06 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.819 0.848 . . . . 2.9399999999999999 112.866 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.62 137.42 31.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.143 0.973 . . . . 1.0600000000000001 112.232 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.502 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.97 119.87 34.23 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.455 -1.702 . . . . 1.0900000000000001 109.621 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.96 124.53 47.74 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.104 -0.639 . . . . 1.0900000000000001 111.538 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.587 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -83.26 134.73 34.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.168 -1.79 . . . . 1.0800000000000001 106.168 175.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.573 ' OG ' ' HB3' ' A' ' 60' ' ' HIS . 33.6 p -143.39 125.75 15.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 120.943 1.701 . . . . 0.93000000000000005 113.334 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 tp -110.48 124.42 51.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.351 -1.295 . . . . 1.1399999999999999 110.116 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.46 33.12 7.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.602 0.715 . . . . 0.52000000000000002 109.077 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 m120 77.5 4.48 3.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.23 -1.35 . . . . 1.8400000000000001 111.6 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -129.27 138.08 51.43 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.689 -1.205 . . . . 3.8500000000000001 113.504 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -57.22 148.66 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 113.054 -1.884 . . . . 0.40999999999999998 112.975 -172.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.587 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.2 mtp -100.4 -41.91 6.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.581 -2.099 . . . . 1.0900000000000001 108.393 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? 179.98 160.19 0.85 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.442 -2.163 . . . . 2.6200000000000001 110.39 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -121.65 133.23 54.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.385 0.136 . . . . 1.1000000000000001 110.789 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 73.0 m-85 -118.81 149.13 45.92 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 120.831 0.348 . . . . 1.0600000000000001 111.623 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 9.9 Cg_endo -80.36 141.49 14.3 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.752 2.301 . . . . 0.85999999999999999 111.738 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.48 173.82 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.442 -0.577 . . . . 1.2 109.442 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.71 132.94 34.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.135 0.493 . . . . 1.4099999999999999 111.653 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.453 ' CG1' ' HG3' ' A' ' 68' ' ' LYS . 10.8 t -146.81 152.3 13.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.996 -1.002 . . . . 1.6699999999999999 110.326 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.99 57.06 0.23 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.013 -0.613 . . . . 3.0800000000000001 112.094 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HB3' ' HG ' ' A' ' 169' ' ' SER . 37.9 mmtm -150.67 158.29 43.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.857 0.329 . . . . 7.6200000000000001 111.482 -175.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.476 ' O ' ' HA3' ' A' ' 168' ' ' GLY . 4.6 mp -119.11 -85.48 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 116.29 -0.414 . . . . 6.7199999999999998 111.943 -174.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.493 ' HA ' ' C ' ' A' ' 168' ' ' GLY . 61.3 tp -155.38 115.28 3.72 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.436 0.532 . . . . 7.6299999999999999 112.436 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.584 ' N ' ' HA ' ' A' ' 169' ' ' SER . 17.2 m -165.68 -61.62 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.335 0.654 . . . . 5.5099999999999998 111.011 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.614 ' H ' ' HA ' ' A' ' 169' ' ' SER . 16.7 mm100 -125.71 -68.17 0.84 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.958 1.095 . . . . 5.3899999999999997 113.958 -169.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.733 ' CG2' ' HA ' ' A' ' 166' ' ' ASN . 2.9 m 61.47 67.52 1.35 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 117.879 0.309 . . . . 2.5600000000000001 110.513 -165.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.18 -11.37 10.96 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.938 2.425 . . . . 3.6600000000000001 112.251 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.8 m -65.85 127.62 32.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.668 -0.697 . . . . 4.1699999999999999 111.103 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.77 173.61 49.28 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.805 -0.712 . . . . 2.6899999999999999 111.96 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.39 143.06 31.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.786 -0.45 . . . . 2.2999999999999998 109.786 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.631 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 15.7 m-85 -123.6 -178.94 4.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.125 -0.488 . . . . 2.3500000000000001 109.734 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.622 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 65.8 m-85 -135.69 141.07 44.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.592 -0.731 . . . . 0.92000000000000004 109.75 172.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 23.7 mm -59.56 116.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 107.469 -1.308 . . . . 1.0600000000000001 107.469 167.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.9 tt -103.18 -28.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.361 -0.936 . . . . 1.04 112.026 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -172.36 -169.96 0.67 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 114.923 1.453 . . . . 2.3500000000000001 114.923 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.501 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.3 ptp180 -151.92 131.12 12.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 111.634 -2.53 . . . . 1.54 109.378 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.27 156.81 17.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.245 1.021 . . . . 1.8899999999999999 111.531 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -53.18 152.26 4.48 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.562 -2.108 . . . . 3.46 112.42 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -44.98 104.85 0.41 Allowed Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 113.854 -1.521 . . . . 3.3500000000000001 111.48 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -55.19 -51.19 10.72 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.971 3.114 . . . . 0.97999999999999998 112.291 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.76 -20.2 34.5 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.999 -1.0 . . . . 1.0800000000000001 112.181 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -103.43 -169.84 25.74 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.193 -0.527 . . . . 1.1599999999999999 112.174 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.98 15.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 124.434 3.423 . . . . 1.46 114.094 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -67.93 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.949 0.404 . . . . 2.1000000000000001 110.64 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.436 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 45.58 2.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 1.1100000000000001 114.186 170.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.06 -22.57 0.26 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.305 0.854 . . . . 1.45 113.305 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -157.84 151.95 24.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.732 0.301 . . . . 1.5 110.373 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -120.92 102.43 8.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 2.6000000000000001 109.583 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -106.59 137.28 44.88 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.236 0.541 . . . . 1.3100000000000001 110.413 176.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.2 m -106.15 145.17 31.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.507 -0.77 . . . . 1.3100000000000001 112.726 -170.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.37 -174.19 3.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.703 -1.221 . . . . 1.8600000000000001 107.703 170.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 52.9 m -85.61 -101.9 0.06 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.806 0.73 . . . . 1.95 112.08 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 121' ' ' GLN . 36.2 ttpt -72.13 142.69 49.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.087 -0.338 . . . . 3.3999999999999999 110.087 -174.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 120' ' ' LYS . 2.3 mp0 71.0 125.43 0.03 OUTLIER 'General case' 0 C--O 1.233 0.184 0 O-C-N 124.093 0.871 . . . . 5.5800000000000001 109.044 -170.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -74.1 64.43 1.04 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.45 0.643 . . . . 6.7300000000000004 112.048 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -113.88 163.88 14.51 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.554 -0.906 . . . . 5.1500000000000004 108.554 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.435 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -155.64 163.88 31.88 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.958 -1.115 . . . . 1.1899999999999999 112.935 -176.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.632 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 47.2 mt -91.97 107.12 18.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.905 -1.146 . . . . 1.05 107.905 172.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.466 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 9.2 p80 -138.98 -162.83 1.37 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.35 0.595 . . . . 1.25 111.542 -173.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.436 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.92 178.28 16.39 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.844 -1.17 . . . . 0.46000000000000002 113.654 -175.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.453 ' HA ' ' NH2' ' A' ' 144' ' ' ARG . 7.4 t -144.54 176.41 9.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.487 0.661 . . . . 1.21 111.263 -167.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -108.06 -15.15 14.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.72 -1.127 . . . . 1.8600000000000001 109.715 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.13 103.73 29.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.555 -0.748 . . . . 1.8200000000000001 109.976 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -90.52 4.58 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.168 2.579 . . . . 0.64000000000000001 112.9 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.46 -16.25 46.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.322 0.582 . . . . 1.3200000000000001 110.324 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -98.19 7.15 46.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.652 -0.704 . . . . 1.8899999999999999 109.912 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 26.2 mm -102.83 119.67 51.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.384 -0.825 . . . . 1.21 111.244 -176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.64 53.76 2.21 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.416 -0.897 . . . . 1.6799999999999999 113.004 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.542 ' HB2' ' HZ3' ' A' ' 136' ' ' LYS . 0.3 OUTLIER -160.53 149.45 16.95 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.035 -0.357 . . . . 4.8799999999999999 110.035 178.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -87.11 102.8 14.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.031 -0.531 . . . . 4.4699999999999998 110.497 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.1 p -154.78 -47.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.167 -0.47 . . . . 4.6799999999999997 110.948 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 65.5 m -158.87 147.67 18.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.05 -0.352 . . . . 5.9100000000000001 110.05 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -80.89 77.92 7.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.441 -0.578 . . . . 8.5999999999999996 109.441 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.47 -139.84 0.77 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.969 -0.634 . . . . 4.1900000000000004 111.805 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 64.4 m -110.43 168.31 9.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.22 0.534 . . . . 2.9199999999999999 111.363 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 31.7 mt -89.44 80.14 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.378 -0.828 . . . . 2.0699999999999998 110.123 -174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 46.9 mtp180 -118.4 156.3 29.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 3.98 110.58 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.425 ' HE3' ' HB3' ' A' ' 149' ' ' ASP . 10.8 ptm -151.95 -168.22 3.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.204 -0.453 . . . . 1.8700000000000001 110.082 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.524 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 22.1 m170 -73.52 154.53 39.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.939 -0.393 . . . . 3.25 109.939 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -50.31 -68.05 0.2 Allowed 'General case' 0 C--O 1.221 -0.412 0 O-C-N 123.318 0.386 . . . . 2.4199999999999999 111.43 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -60.41 -29.41 68.96 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.782 -0.574 . . . . 2.5699999999999998 111.699 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.524 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 2.2 m-20 -66.72 -41.95 87.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.732 0.301 . . . . 1.05 110.956 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.689 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 12.3 p -75.86 -18.93 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 116.311 -0.404 . . . . 0.32000000000000001 110.615 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -86.89 -39.94 13.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 119.014 -0.517 . . . . 1.1299999999999999 110.154 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -45.33 -66.26 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.52 1.054 . . . . 1.3799999999999999 111.949 165.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.2 tp -53.17 -42.69 66.44 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.838 -0.619 . . . . 1.3400000000000001 110.107 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -52.32 -54.84 26.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.384 -1.28 . . . . 1.02 111.735 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 32.8 t -75.46 -16.46 60.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.822 -1.081 . . . . 1.9099999999999999 110.491 -172.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.2 mt -90.94 -53.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.787 -0.449 . . . . 1.04 109.787 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.7 m -77.45 114.79 43.82 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 122.194 0.997 . . . . 0.20999999999999999 110.212 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.572 ' HG2' HD11 ' A' ' 57' ' ' ILE . 54.6 Cg_endo -81.13 -179.12 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.911 2.407 . . . . 0.51000000000000001 112.715 -173.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.652 ' O ' HD22 ' A' ' 51' ' ' LEU . 17.1 m120 -59.63 -0.24 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.827 -1.079 . . . . 1.02 113.404 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.23 59.02 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.834 -0.698 . . . . 0.64000000000000001 112.435 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -95.03 134.89 37.21 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.523 -0.398 . . . . 1.0700000000000001 110.219 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 131.83 34.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.859 0.362 . . . . 2.3399999999999999 110.499 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.8 p -140.24 123.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.579 -0.737 . . . . 0.46000000000000002 111.471 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.2 m -111.6 138.53 48.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.805 -0.634 . . . . 1.26 111.074 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.0 mp -122.37 117.2 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 118.461 -1.296 . . . . 1.1699999999999999 111.059 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.733 ' HA ' ' CG2' ' A' ' 93' ' ' THR . 0.0 OUTLIER -141.3 121.26 13.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 123.263 1.506 . . . . 1.1899999999999999 110.154 -175.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.676 ' H ' HG21 ' A' ' 93' ' ' THR . 3.4 ptm180 -101.53 -47.46 4.65 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 111.751 -2.477 . . . . 3.7999999999999998 114.162 -166.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.493 ' C ' ' HA ' ' A' ' 90' ' ' LEU . . . 117.3 -77.3 0.29 Allowed Glycine 0 N--CA 1.418 -2.506 0 N-CA-C 109.196 -1.561 . . . . 3.6499999999999999 109.196 -163.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.614 ' HA ' ' H ' ' A' ' 92' ' ' GLN . 80.2 p . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.562 -0.733 . . . . 5.9699999999999998 110.747 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.545 ' O31' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.387 -0.285 . . . . 3.3799999999999999 112.387 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -135.73 -169.2 2.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.557 -0.534 . . . . 4.6799999999999997 109.557 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.33 147.17 21.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.92 -0.582 . . . . 2.54 111.223 173.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.583 HD12 ' H ' ' A' ' 50' ' ' GLY . 15.4 mt -97.95 168.63 10.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.088 -0.96 . . . . 1.1000000000000001 110.886 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 6' ' ' THR . 2.3 tp -80.71 151.42 28.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.411 0.684 . . . . 1.05 112.407 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.507 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -117.3 151.33 37.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.997 0.903 . . . . 1.01 112.364 169.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.648 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 78.4 t80 -134.56 148.74 50.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.701 -1.59 . . . . 1.1200000000000001 107.917 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.623 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -127.33 121.15 30.25 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.012 -1.477 . . . . 1.72 107.012 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -83.06 158.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.243 0.544 . . . . 0.38 112.011 -170.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -109.43 150.37 28.18 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.838 -0.801 . . . . 3.0600000000000001 108.838 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.97 114.1 1.21 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.89 -0.595 . . . . 2.1699999999999999 112.004 -174.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -10.07 21.65 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.677 -0.773 . . . . 0.63 112.944 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.478 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 9.6 m-20 -62.62 154.51 28.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.028 0.414 . . . . 2.1699999999999999 111.82 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.412 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -132.53 152.0 51.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 1.27 112.153 -177.492 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.586 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.4 tp -48.04 -57.76 5.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.425 0.898 . . . . 1.0800000000000001 113.425 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.676 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.5 t-20 -66.05 -39.5 90.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 1.55 110.308 -169.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -59.4 -47.62 84.75 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 113.106 -1.861 . . . . 1.8200000000000001 109.902 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -69.64 -39.36 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.513 -0.767 . . . . 1.0600000000000001 112.205 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.0 -57.79 11.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.97999999999999998 110.934 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.6 -4.35 57.54 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.683 -1.207 . . . . 1.0700000000000001 112.147 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 42.2 m-20 -61.85 -36.38 81.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.902 -1.148 . . . . 1.6299999999999999 107.902 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.478 ' CD1' HD11 ' A' ' 101' ' ' ILE . 2.2 m-85 -99.75 15.82 25.61 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.899 0.703 . . . . 0.25 112.899 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.05 50.99 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 4.2000000000000002 110.684 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 36.8 pt -146.65 -174.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.692 -0.855 . . . . 1.02 108.692 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -100.2 143.76 30.01 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.231 -0.895 . . . . 1.1599999999999999 109.293 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.676 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.4 p -60.97 -35.09 75.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 121.4 0.619 . . . . 1.05 109.399 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.95 -31.51 72.72 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.507 -1.224 . . . . 1.05 111.657 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.85 -37.89 39.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.406 0.622 . . . . 1.03 109.574 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.4 tp -73.97 -20.47 60.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.042 -0.981 . . . . 1.05 109.066 175.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.558 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.91 -39.13 43.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.431 0.634 . . . . 1.0600000000000001 111.582 172.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 55.2 mt-30 -59.18 -42.23 90.34 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.163 0.983 . . . . 1.26 109.649 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.53 -18.89 43.47 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.535 -1.666 . . . . 1.01 112.32 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.552 HD22 ' H ' ' A' ' 47' ' ' VAL . 29.7 m-80 -143.77 71.9 17.11 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.20000000000000001 109.881 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.62 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 12.2 Cg_endo -55.64 -13.56 8.4 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 123.696 2.931 . . . . 0.29999999999999999 114.318 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -61.9 -35.72 79.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.02 0.914 . . . . 1.3600000000000001 109.798 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.635 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -76.76 -6.64 53.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.341 -1.3 . . . . 1.26 114.362 -170.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -49.23 -40.68 34.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.527 1.156 . . . . 1.8899999999999999 110.485 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.41 -45.65 11.67 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.054 -1.885 . . . . 1.1000000000000001 111.627 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.3 -163.87 34.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.479 -0.867 . . . . 0.29999999999999999 114.238 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.97 158.04 26.53 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.444 -1.378 . . . . 1.0800000000000001 110.512 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.571 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 71.3 m -133.22 136.48 45.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.873 -0.603 . . . . 1.1699999999999999 110.964 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -44.73 126.17 5.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 1.1699999999999999 113.312 173.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.623 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.84 -12.49 48.23 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.558 -1.201 . . . . 0.38 112.16 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.571 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.9 tt0 -62.75 150.81 40.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.741 0.781 . . . . 1.1899999999999999 110.294 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.8 m -120.42 130.85 54.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.328 -1.305 . . . . 1.22 109.544 -170.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.86 148.65 31.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.338 0.589 . . . . 1.0600000000000001 110.697 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.552 ' H ' HD22 ' A' ' 33' ' ' ASN . 13.2 t -94.1 149.02 4.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.078 -0.965 . . . . 0.20999999999999999 110.383 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 18.9 mm -117.44 87.72 26.06 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 114.771 -1.104 . . . . 1.01 108.384 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' HD12 ' A' ' 4' ' ' LEU . 28.2 Cg_endo -59.38 143.82 99.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.214 2.609 . . . . 0.23000000000000001 112.737 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.583 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 80.46 -7.6 56.95 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.569 -0.741 . . . . 0.29999999999999999 112.977 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.708 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -115.92 127.1 27.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.711 -0.848 . . . . 1.0800000000000001 108.711 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.2 Cg_endo -66.47 174.91 5.65 Favored 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 123.793 2.996 . . . . 0.34000000000000002 114.005 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 10.6 t70 -90.45 141.53 27.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.263 -0.88 . . . . 0.71999999999999997 110.734 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HD3' HD13 ' A' ' 5' ' ' LEU . 90.5 Cg_endo -83.84 -9.51 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.33000000000000002 112.438 -175.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' A' ' 55' ' ' TYR . 64.0 m-85 -95.09 -27.08 15.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 2.29 110.25 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 53' ' ' ASP . 30.6 p -68.14 -32.34 72.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.591 -1.263 . . . . 2.0600000000000001 107.591 170.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.594 HD11 ' HG2' ' A' ' 158' ' ' PRO . 89.5 mt -76.27 127.86 83.93 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 113.242 -1.799 . . . . 1.0900000000000001 110.476 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -101.84 95.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.856 0 C-N-CA 120.846 1.031 . . . . 0.22 110.479 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.648 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.4 m-85 -158.38 139.25 12.98 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.952 -1.499 . . . . 0.80000000000000004 106.952 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 34.2 t-80 -145.27 107.15 4.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.789 -1.189 . . . . 3.5800000000000001 107.789 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 163' ' ' VAL . 69.9 mt -94.93 109.64 22.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.254 -1.339 . . . . 1.0600000000000001 110.302 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.94 94.73 5.09 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.987 0.898 . . . . 1.1200000000000001 110.175 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 p -110.35 97.3 5.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.183 -1.372 . . . . 0.68000000000000005 109.256 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.445 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 67.1 m -93.43 108.52 20.18 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.756 -1.111 . . . . 1.3300000000000001 108.074 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.432 ' CG2' ' HG3' ' A' ' 167' ' ' ARG . 0.9 OUTLIER -46.38 -32.2 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.293 0.637 . . . . 1.77 112.613 174.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.16 -44.91 93.3 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.155 -1.022 . . . . 0.93999999999999995 111.476 172.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -69.82 -23.28 63.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.768 -0.716 . . . . 1.22 111.754 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.401 ' HE2' ' CG1' ' A' ' 86' ' ' VAL . 52.4 mttt 59.97 16.94 6.2 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.042 0.937 . . . . 2.9399999999999999 113.056 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.59 140.32 37.01 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.919 0.866 . . . . 1.0600000000000001 111.404 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.42 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.6 tt -95.67 120.17 35.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.029 -1.441 . . . . 1.0900000000000001 109.7 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -101.79 125.82 48.54 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.147 -0.621 . . . . 1.0900000000000001 111.289 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -83.37 147.45 27.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.559 -1.645 . . . . 1.0800000000000001 106.559 175.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 24.3 m -150.96 132.77 15.01 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 120.407 1.458 . . . . 0.93000000000000005 112.712 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp -120.42 125.9 49.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.989 -1.005 . . . . 1.1399999999999999 110.731 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 65.7 34.53 7.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.52000000000000002 109.393 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.7 m120 79.87 3.46 2.06 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.377 -1.283 . . . . 1.8400000000000001 111.754 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -130.9 139.07 50.06 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 118.803 -1.159 . . . . 3.8500000000000001 113.75 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -52.76 149.69 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 113.112 -1.858 . . . . 0.40999999999999998 112.884 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.487 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.9 mtp -98.91 -43.98 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.643 -2.071 . . . . 1.0900000000000001 108.263 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? 179.26 154.71 0.47 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.33 -2.214 . . . . 2.6200000000000001 110.332 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.1 m -115.11 135.57 54.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.464 0.173 . . . . 1.1000000000000001 110.754 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.632 ' CG ' ' HE1' ' A' ' 145' ' ' MET . 88.2 m-85 -125.34 131.97 24.19 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 1.0600000000000001 110.608 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.58 146.37 79.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.793 2.328 . . . . 0.85999999999999999 111.748 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.39 179.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.218 -0.66 . . . . 1.2 109.218 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.27 114.64 23.24 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 119.199 -1.0 . . . . 1.4099999999999999 109.877 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' CG1' ' HE2' ' A' ' 68' ' ' LYS . 8.5 t -102.67 92.46 2.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.532 -1.655 . . . . 1.6699999999999999 106.532 164.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.432 ' CA ' ' HB ' ' A' ' 138' ' ' VAL . . . 152.85 107.4 0.32 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.179 -1.01 . . . . 3.0800000000000001 113.478 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 140' ' ' LYS . 17.4 tppt? -171.18 -53.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.831 0.348 . . . . 7.6200000000000001 110.068 173.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.413 ' C ' HD23 ' A' ' 90' ' ' LEU . 18.7 mm -105.03 -108.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.344 -0.389 . . . . 6.7199999999999998 110.562 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.413 HD23 ' C ' ' A' ' 89' ' ' ILE . 2.5 mm? -136.03 174.56 10.48 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.02 0.438 . . . . 7.6299999999999999 110.881 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 m -80.46 85.29 5.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.696 -0.684 . . . . 5.5099999999999998 109.897 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.611 ' C ' ' HD2' ' A' ' 94' ' ' PRO . 47.8 tt0 -74.0 -94.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.792 -0.64 . . . . 5.3899999999999997 111.184 -176.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.561 HG23 ' HB2' ' A' ' 167' ' ' ARG 0.272 60.5 p 107.9 -48.21 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 127.089 2.155 . . . . 2.5600000000000001 112.834 -178.144 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.611 ' HD2' ' C ' ' A' ' 92' ' ' GLN . 30.5 Cg_endo -65.49 74.73 0.28 Allowed 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 121.528 1.485 . . . . 3.6600000000000001 111.755 173.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 165' ' ' ILE . 23.9 m -128.71 112.93 14.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.341 -0.845 . . . . 4.1699999999999999 109.412 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.86 -178.4 34.15 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.662 -0.78 . . . . 2.6899999999999999 112.128 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.59 145.82 38.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.107 0.48 . . . . 2.2999999999999998 110.164 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.63 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 17.8 m-85 -119.33 167.61 11.73 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.431 -1.322 . . . . 2.3500000000000001 107.431 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.755 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.3 m-85 -127.19 136.45 52.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.925 -0.31 . . . . 0.92000000000000004 110.477 175.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.468 HD13 HD13 ' A' ' 125' ' ' ILE . 11.7 mm -58.1 108.18 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 108.042 -1.096 . . . . 1.0600000000000001 108.042 169.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.478 HD11 ' CD1' ' A' ' 22' ' ' PHE . 2.0 tt -108.4 -27.31 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 112.813 0.672 . . . . 1.04 112.813 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 26.2 t-20 -156.33 161.2 40.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 122.675 1.226 . . . . 2.3500000000000001 114.046 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.625 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 134.14 36.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 111.678 -2.51 . . . . 1.54 109.177 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 16.0 tm0? -114.66 145.23 42.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.022 0.915 . . . . 1.8899999999999999 111.055 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -50.1 154.37 1.18 Allowed 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 112.828 -1.987 . . . . 3.46 112.391 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -43.84 100.32 0.23 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 CA-C-O 121.557 0.694 . . . . 3.3500000000000001 111.185 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.45 ' HG3' ' OE1' ' A' ' 104' ' ' GLN . 90.2 Cg_exo -55.99 -51.01 10.54 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.18 3.253 . . . . 0.97999999999999998 112.794 -173.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.89 16.87 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.146 -0.934 . . . . 1.0800000000000001 112.15 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -106.13 -171.15 23.22 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.697 -0.763 . . . . 1.1599999999999999 112.347 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.93 33.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 124.621 3.547 . . . . 1.46 114.422 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -77.61 -32.19 53.35 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.068 0.461 . . . . 2.1000000000000001 110.695 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.471 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.82 42.78 2.79 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.598 -0.728 . . . . 1.1100000000000001 113.333 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.83 -17.07 0.54 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.53 0.937 . . . . 1.45 113.53 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.628 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -156.87 131.38 8.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 110.042 -0.355 . . . . 1.5 110.042 176.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.9 t-105 -99.23 101.17 12.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.743 -0.836 . . . . 2.6000000000000001 108.743 167.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.765 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.3 mp -106.95 135.64 48.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.281 0.562 . . . . 1.3100000000000001 110.168 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.3 m -106.36 144.42 33.07 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.625 -0.716 . . . . 1.3100000000000001 112.175 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 123' ' ' TYR . 0.1 OUTLIER -86.36 -177.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.415 -1.328 . . . . 1.8600000000000001 107.415 164.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.7 m -88.62 4.65 46.27 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.445 0.535 . . . . 1.95 112.445 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 33.2 tptt -129.15 115.59 17.92 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 119.766 -0.773 . . . . 3.3999999999999999 112.295 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 51.42 -144.12 0.6 Allowed 'General case' 0 C--N 1.332 -0.184 0 O-C-N 124.088 0.868 . . . . 5.5800000000000001 112.202 174.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -86.69 9.52 18.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.739 0.274 . . . . 6.7300000000000004 111.739 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 78.8 m-85 -70.41 123.77 22.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.081 -0.711 . . . . 5.1500000000000004 109.081 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.416 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -154.0 162.03 30.28 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.245 -0.979 . . . . 1.1899999999999999 112.76 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.765 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 43.0 mt -95.14 117.01 38.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.687 -0.857 . . . . 1.05 108.687 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 8.8 p80 -144.34 -163.81 1.76 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.789 -0.765 . . . . 1.25 112.148 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.471 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.05 -174.94 15.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.929 -1.129 . . . . 0.46000000000000002 113.541 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.449 ' HA ' ' NH2' ' A' ' 144' ' ' ARG . 5.2 t -141.9 173.66 11.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.454 0.645 . . . . 1.21 111.333 -165.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.88 -18.59 14.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.131 -0.941 . . . . 1.8600000000000001 108.645 164.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -127.26 101.66 24.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.891 -1.05 . . . . 1.8200000000000001 110.3 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.1 Cg_endo -92.14 3.83 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.138 2.558 . . . . 0.64000000000000001 112.801 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.01 -30.29 24.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.01 0.433 . . . . 1.3200000000000001 110.254 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 m -85.52 -2.66 58.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 1.8899999999999999 110.384 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 8.0 mm -67.37 114.76 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.476 -0.784 . . . . 1.21 110.12 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.18 96.25 1.7 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.102 -0.799 . . . . 1.6799999999999999 111.102 -172.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -151.58 -170.77 3.74 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.634 -0.333 . . . . 4.8799999999999999 110.995 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.418 ' O ' ' HB ' ' A' ' 138' ' ' VAL . . . -84.61 -174.81 5.48 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.189 -0.301 . . . . 4.4699999999999998 110.189 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.432 ' HB ' ' CA ' ' A' ' 87' ' ' GLY . 40.6 t 76.79 168.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.588 -0.893 . . . . 4.6799999999999997 108.588 -172.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.1 t -124.76 156.1 38.25 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.677 -0.64 . . . . 5.9100000000000001 111.041 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 88.9 tttt 57.02 85.75 0.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.404 -0.816 . . . . 8.5999999999999996 111.63 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 88' ' ' LYS . . . -113.55 -148.3 10.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.747 -0.739 . . . . 4.1900000000000004 112.244 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 95.7 m -102.54 146.25 28.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.504 . . . . 2.9199999999999999 110.114 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 23.8 mt -96.82 73.15 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.438 0.637 . . . . 2.0699999999999998 109.869 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 9.7 ptm180 -123.89 148.97 46.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 3.98 110.558 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.632 ' HE1' ' CG ' ' A' ' 82' ' ' TYR . 7.3 mtp -136.39 -167.31 2.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.243 0.544 . . . . 1.8700000000000001 111.14 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -73.83 146.46 44.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.082 -0.963 . . . . 3.25 108.739 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -52.16 -65.33 0.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.219 0.451 . . . . 2.4199999999999999 112.219 -171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -59.22 -25.05 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.65 -0.656 . . . . 2.5699999999999998 111.476 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.61 -35.78 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 1.05 110.765 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.692 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 10.8 p -77.94 -17.01 14.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.691 0 CA-C-N 116.529 -0.305 . . . . 0.32000000000000001 110.25 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -85.9 -39.11 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 119.073 -0.489 . . . . 1.1299999999999999 109.914 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -44.72 -69.48 0.13 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 119.148 0.885 . . . . 1.3799999999999999 112.178 163.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.44 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -50.36 -44.34 54.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.68 -0.691 . . . . 1.3400000000000001 110.303 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -55.65 -50.04 71.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.141 -1.39 . . . . 1.02 112.109 -171.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 p -77.58 -17.21 58.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.724 -1.126 . . . . 1.9099999999999999 111.111 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.42 -46.2 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.933 -0.576 . . . . 1.04 109.528 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.47 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 30.6 m -76.51 120.95 83.88 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-O 121.669 0.747 . . . . 0.20999999999999999 110.459 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.594 ' HG2' HD11 ' A' ' 57' ' ' ILE . 27.4 Cg_endo -85.59 -177.71 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.384 2.723 . . . . 0.51000000000000001 112.841 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.708 ' O ' HD22 ' A' ' 51' ' ' LEU . 15.7 m120 -60.09 3.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.775 -1.102 . . . . 1.02 113.895 -175.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -149.65 57.8 0.46 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.635 -0.793 . . . . 0.64000000000000001 112.641 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.755 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.71 134.26 34.55 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.472 -0.428 . . . . 1.0700000000000001 111.173 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -84.39 128.5 34.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.055 -0.521 . . . . 2.3399999999999999 110.622 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 3.2 p -141.83 129.58 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.542 0.526 . . . . 0.46000000000000002 111.347 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.9 m -122.95 143.86 49.63 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.515 0.561 . . . . 1.26 112.515 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.4 ' O ' ' HB ' ' A' ' 95' ' ' THR . 0.0 OUTLIER -125.92 115.86 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.19 -1.004 . . . . 1.1699999999999999 112.352 177.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.612 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.46 141.01 30.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.958 -1.019 . . . . 1.1899999999999999 109.73 -172.103 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.561 ' HB2' HG23 ' A' ' 93' ' ' THR . 5.5 mpt_? -93.34 -39.26 11.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.848 -1.069 . . . . 3.7999999999999998 111.586 -172.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.37 -57.46 4.42 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.891 -0.595 . . . . 3.6499999999999999 112.271 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.38 -0.819 . . . . 5.9699999999999998 109.718 178.502 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.685 H621 ' N4 ' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 111.698 -0.561 . . . . 3.3799999999999999 111.698 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 61.25 -175.54 0.12 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.601 0.715 . . . . 4.6799999999999997 111.705 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt -66.87 155.12 39.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.234 -0.894 . . . . 2.54 109.232 169.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.576 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.1 mt -90.73 167.72 12.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.211 -0.449 . . . . 1.1000000000000001 111.069 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.537 HD11 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -74.19 148.57 41.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.216 0.531 . . . . 1.05 111.65 -170.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.525 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.38 148.67 37.31 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.794 0.806 . . . . 1.01 111.257 168.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.664 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 69.1 t80 -134.04 148.03 51.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.009 -1.45 . . . . 1.1200000000000001 107.61 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.8 tt0 -127.84 111.21 13.37 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.657 -1.609 . . . . 1.72 106.657 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.471 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -72.18 157.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.219 0.533 . . . . 0.38 111.39 -165.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HE2' ' HA3' ' A' ' 96' ' ' GLY . 87.7 mttt -107.64 148.43 29.35 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.461 -0.79 . . . . 3.0600000000000001 109.291 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.513 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -46.53 116.96 1.44 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 2.1699999999999999 112.631 -173.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.35 -8.94 38.39 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.967 -1.015 . . . . 0.63 113.514 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 83.1 m-20 -61.46 155.03 22.8 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.973 0.731 . . . . 2.1699999999999999 112.973 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.453 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.2 p -134.32 159.11 41.99 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.949 -0.569 . . . . 1.27 111.73 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.6 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 46.6 tp -52.68 -57.71 9.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.948 1.092 . . . . 1.0800000000000001 113.948 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.724 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 2.0 t30 -66.71 -43.19 84.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 122.309 1.052 . . . . 1.55 110.558 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 37.5 t -57.77 -47.96 81.03 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 112.988 -1.915 . . . . 1.8200000000000001 109.797 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.511 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -68.75 -40.65 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.795 -0.639 . . . . 1.0600000000000001 111.89 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.28 -65.55 0.59 Allowed 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.97999999999999998 111.541 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.89 -4.73 55.87 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.768 -1.173 . . . . 1.0700000000000001 112.273 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -67.62 -27.28 66.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.93 -0.767 . . . . 1.6299999999999999 108.93 157.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.429 ' HD1' ' CD1' ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.6 15.37 26.87 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.804 -0.56 . . . . 0.25 112.146 172.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 56.28 50.94 12.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.495 -0.775 . . . . 4.2000000000000002 110.662 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 39.3 pt -149.14 -173.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.909 -0.775 . . . . 1.02 108.909 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.04 147.61 23.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.415 -0.811 . . . . 1.1599999999999999 110.017 172.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.724 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.4 p -62.56 -36.46 82.71 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.654 -0.869 . . . . 1.05 108.654 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -28.83 68.74 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.665 -1.152 . . . . 1.05 111.539 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.22 30.84 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.524 -0.547 . . . . 1.03 109.524 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 12.7 tp -71.98 -20.42 61.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.563 -0.744 . . . . 1.05 109.007 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.662 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -38.36 40.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.47 0.652 . . . . 1.0600000000000001 111.381 172.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -59.25 -42.46 91.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.998 0.904 . . . . 1.26 109.84 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.95 -16.26 51.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.843 -1.526 . . . . 1.01 112.01 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 33.2 m-80 -139.99 69.94 35.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.624 -0.51 . . . . 0.20000000000000001 109.624 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.46 -21.9 19.77 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 124.533 3.489 . . . . 0.29999999999999999 115.422 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -69.64 -34.12 73.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 119.458 1.026 . . . . 1.3600000000000001 110.293 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.602 ' CD2' ' HB3' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -65.05 -6.7 9.42 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.422 -1.263 . . . . 1.26 113.635 -172.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.662 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.12 -40.68 24.34 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.475 1.131 . . . . 1.8899999999999999 110.351 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.54 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -82.37 -46.15 13.93 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.98 -1.918 . . . . 1.1000000000000001 111.642 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.41 -161.78 31.82 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.118 -1.039 . . . . 0.29999999999999999 114.396 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.456 HD21 ' HB ' ' A' ' 9' ' ' VAL . 6.5 mp -118.6 158.27 25.78 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.704 -1.748 . . . . 1.0800000000000001 110.542 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 98.7 m -133.6 133.69 42.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.799 -0.637 . . . . 1.1699999999999999 110.55 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -47.22 127.15 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.789 0.662 . . . . 1.1699999999999999 112.789 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.47 52.9 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.796 -1.093 . . . . 0.38 112.506 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.1 tt0 -65.28 152.66 43.2 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.643 0.735 . . . . 1.1899999999999999 110.219 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 42.0 m -119.24 131.76 55.84 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.61 -1.177 . . . . 1.22 109.542 -171.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.2 pt -136.49 151.34 28.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.339 0.59 . . . . 1.0600000000000001 110.698 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.538 ' H ' HD22 ' A' ' 33' ' ' ASN . 5.3 t -94.56 148.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.156 -0.929 . . . . 0.20999999999999999 110.703 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 15.7 mm -117.44 88.74 29.63 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 114.599 -1.182 . . . . 1.01 108.418 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.545 ' HA ' HD12 ' A' ' 4' ' ' LEU . 24.6 Cg_endo -59.02 143.8 99.65 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.186 2.591 . . . . 0.23000000000000001 112.769 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.576 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 80.83 -6.88 60.68 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.29999999999999999 113.035 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.708 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.9 tt -116.65 129.97 24.88 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.334 -0.987 . . . . 1.0800000000000001 108.334 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.573 ' CD ' HD21 ' A' ' 51' ' ' LEU . 73.2 Cg_endo -69.45 171.08 14.76 Favored 'Trans proline' 0 N--CA 1.475 0.41 0 C-N-CA 123.583 2.855 . . . . 0.34000000000000002 113.906 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 3.1 t70 -91.6 138.05 25.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 0.71999999999999997 112.297 -171.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HD3' HD11 ' A' ' 5' ' ' LEU . 69.4 Cg_endo -84.4 -4.27 10.15 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 123.684 2.923 . . . . 0.33000000000000002 113.351 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.661 ' HD1' ' CD2' ' A' ' 55' ' ' TYR . 58.3 m-85 -94.96 -25.15 16.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.853 0.359 . . . . 2.29 110.9 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.7 t -86.06 -13.0 48.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.448 0.642 . . . . 2.0600000000000001 109.42 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.59 HD11 ' HG2' ' A' ' 158' ' ' PRO . 81.3 mt -85.61 124.42 71.3 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.198 -0.91 . . . . 1.0900000000000001 110.034 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -101.25 95.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.811 0.968 . . . . 0.22 110.109 169.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -158.37 137.13 11.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.55 -1.648 . . . . 0.80000000000000004 106.55 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 71.8 t60 -144.19 109.89 5.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.851 -1.166 . . . . 3.5800000000000001 107.851 -167.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 70.2 mt -95.14 107.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.394 -1.276 . . . . 1.0600000000000001 109.864 -177.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.5 94.24 4.9 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.048 0.927 . . . . 1.1200000000000001 110.244 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -113.95 98.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 113.825 -1.534 . . . . 0.68000000000000005 109.202 178.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.474 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 55.2 m -91.0 123.76 34.72 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.805 -1.183 . . . . 1.3300000000000001 107.805 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 5.8 mt -60.6 -26.98 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.571 0.7 . . . . 1.77 110.214 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.53 -47.08 64.44 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 114.96 -1.018 . . . . 0.93999999999999995 111.477 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.474 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -66.36 -23.92 66.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.114 0.483 . . . . 1.22 111.908 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 2.7 mtpt 59.13 12.48 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.256 1.023 . . . . 2.9399999999999999 113.169 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.98 143.23 38.44 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.647 0.736 . . . . 1.0600000000000001 110.902 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.47 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.6 tt -96.8 119.1 34.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.319 -1.31 . . . . 1.0900000000000001 109.635 -177.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -102.59 126.51 49.69 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.244 -0.582 . . . . 1.0900000000000001 111.317 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.551 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.71 141.9 32.07 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.436 -1.69 . . . . 1.0800000000000001 106.436 175.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.5 m -145.98 128.81 16.33 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.481 1.491 . . . . 0.93000000000000005 112.377 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -118.07 125.49 50.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.982 -1.008 . . . . 1.1399999999999999 110.291 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.49 33.36 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.13 -0.692 . . . . 0.52000000000000002 109.13 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.6 m120 77.57 3.88 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.374 -1.285 . . . . 1.8400000000000001 111.592 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -130.47 138.52 50.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 118.779 -1.168 . . . . 3.8500000000000001 113.368 170.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -53.2 150.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 113.107 -1.86 . . . . 0.40999999999999998 112.957 -174.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.551 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.8 mtp -99.03 -43.88 6.51 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.543 -2.117 . . . . 1.0900000000000001 108.21 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -177.52 157.6 1.29 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.427 -2.169 . . . . 2.6200000000000001 109.863 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -117.59 130.65 56.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.723 0.297 . . . . 1.1000000000000001 110.8 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -114.99 143.11 29.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.355 -0.384 . . . . 1.0600000000000001 110.337 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -81.67 140.61 11.82 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.298 1.999 . . . . 0.85999999999999999 111.156 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.27 -172.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.323 -0.399 . . . . 1.2 111.085 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.05 130.34 34.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 1.4099999999999999 110.03 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -152.85 32.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 1.6699999999999999 111.173 -172.147 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.86 -170.68 38.63 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.702 -0.761 . . . . 3.0800000000000001 112.869 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.428 ' HG2' ' CB ' ' A' ' 137' ' ' ALA . 74.0 mmtt 60.43 87.03 0.09 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.214 0.606 . . . . 7.6200000000000001 111.221 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 tp -74.61 80.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 122.053 0.93 . . . . 6.7199999999999998 110.432 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 92' ' ' GLN . 66.1 mt -90.63 -6.18 54.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.581 -0.736 . . . . 7.6299999999999999 110.46 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.433 ' C ' ' HD3' ' A' ' 167' ' ' ARG . 23.4 m 74.52 -20.22 0.33 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.689 -0.687 . . . . 5.5099999999999998 111.807 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 90' ' ' LEU . 24.8 mt-30 -68.36 119.73 13.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.041 0.448 . . . . 5.3899999999999997 111.108 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.527 HG21 ' HG2' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -88.13 118.2 69.31 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.75 -0.659 . . . . 2.5600000000000001 110.126 173.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.51 113.74 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.333 2.022 . . . . 3.6600000000000001 111.087 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.3 m -92.95 128.5 38.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.911 -0.586 . . . . 4.1699999999999999 111.004 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA3' ' HE2' ' A' ' 10' ' ' LYS . . . 90.9 142.41 10.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.975 -0.631 . . . . 2.6899999999999999 111.982 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.11 169.29 18.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.344 0.592 . . . . 2.2999999999999998 111.355 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.617 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 19.1 m-85 -123.98 172.38 9.0 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.61 -1.256 . . . . 2.3500000000000001 107.61 169.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 161' ' ' THR . 46.9 m-85 -128.78 139.07 52.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.761 0.315 . . . . 0.92000000000000004 110.221 173.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.466 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 16.3 mm -58.66 104.59 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.273 -1.01 . . . . 1.0600000000000001 108.273 169.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.429 ' CD1' ' HD1' ' A' ' 22' ' ' PHE . 2.5 tt -93.17 -25.86 4.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.009 -0.676 . . . . 1.04 112.337 -170.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -169.4 -179.51 3.49 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 114.936 1.458 . . . . 2.3500000000000001 114.936 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.9 175.8 10.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 111.079 -2.782 . . . . 1.54 108.517 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.78 155.27 39.84 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.462 1.125 . . . . 1.8899999999999999 113.311 -164.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -52.54 149.73 5.62 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.64 -2.073 . . . . 3.46 111.109 166.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.14 107.03 0.71 Allowed Pre-proline 0 CA--C 1.514 -0.407 0 CA-C-N 115.825 -0.625 . . . . 3.3500000000000001 111.928 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -59.2 -51.62 6.29 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 123.627 2.885 . . . . 0.97999999999999998 112.896 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.45 -21.64 44.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.2 -0.909 . . . . 1.0800000000000001 111.575 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -93.79 -170.1 38.57 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.357 -0.449 . . . . 1.1599999999999999 112.137 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.3 21.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 124.648 3.565 . . . . 1.46 114.69 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.666 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -75.73 -18.5 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.369 . . . . 2.1000000000000001 111.136 179.041 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 82.51 49.42 5.18 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.78 -0.646 . . . . 1.1100000000000001 113.326 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.93 -20.56 0.37 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.222 0.823 . . . . 1.45 113.222 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -155.77 144.54 20.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 1.5 110.861 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -111.87 102.16 10.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.342 -0.614 . . . . 2.6000000000000001 109.342 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.664 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -106.47 137.01 45.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.537 0.685 . . . . 1.3100000000000001 109.839 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.9 m -106.75 144.46 33.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.412 -0.813 . . . . 1.3100000000000001 112.272 -171.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.98 -175.04 4.21 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.19 -1.411 . . . . 1.8600000000000001 107.19 169.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.2 m -80.23 -67.61 0.75 Allowed 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.775 -0.77 . . . . 1.95 111.861 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -86.79 151.37 23.42 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.092 0.775 . . . . 3.3999999999999999 113.092 -170.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 64.3 -169.93 0.19 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.571 -1.195 . . . . 5.5800000000000001 111.412 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -96.3 44.92 1.07 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.149 0.499 . . . . 6.7300000000000004 109.711 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 1.639 ' HE1' ' CE2' ' A' ' 123' ' ' TYR . 76.0 m-85 -115.74 140.61 49.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.772 -0.649 . . . . 5.1500000000000004 109.993 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -154.64 163.41 31.21 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.704 -0.76 . . . . 1.1899999999999999 112.209 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.664 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 27.8 mt -91.72 107.19 18.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.78 -0.822 . . . . 1.05 108.78 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.664 ' CE1' ' HB3' ' A' ' 144' ' ' ARG . 10.0 p80 -139.68 -163.27 1.47 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.329 0.585 . . . . 1.25 111.441 -174.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.03 163.51 14.47 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.058 -1.068 . . . . 0.46000000000000002 113.597 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 5.7 t -120.45 170.87 8.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.711 -0.745 . . . . 1.21 111.608 -168.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.98 -22.21 13.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.926 -1.034 . . . . 1.8600000000000001 108.586 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -124.88 104.56 30.05 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 114.837 -1.074 . . . . 1.8200000000000001 109.642 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.58 4.22 7.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.96 2.44 . . . . 0.64000000000000001 112.783 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.21 -11.0 47.97 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.98 -0.748 . . . . 1.3200000000000001 108.98 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.7 m -78.52 -26.65 45.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.011 -0.995 . . . . 1.8899999999999999 109.439 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 144' ' ' ARG . 27.1 mm -60.84 117.36 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.354 -0.839 . . . . 1.21 110.041 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 122.88 -29.79 5.27 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.051 -0.819 . . . . 1.6799999999999999 111.051 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -104.7 -156.7 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.289 -0.263 . . . . 4.8799999999999999 110.289 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.428 ' CB ' ' HG2' ' A' ' 88' ' ' LYS . . . -99.44 -74.08 0.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.218 0.451 . . . . 4.4699999999999998 112.218 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 137' ' ' ALA . 93.7 t 70.45 103.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 123.615 0.572 . . . . 4.6799999999999997 109.564 -170.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m 65.94 -89.81 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.271 -0.877 . . . . 5.9100000000000001 110.289 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.58 -0.34 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.257 0.551 . . . . 8.5999999999999996 109.774 174.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 135.35 115.46 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.593 -0.731 . . . . 4.1900000000000004 111.513 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.585 ' SG ' ' HD2' ' A' ' 144' ' ' ARG . 0.5 OUTLIER -113.1 110.1 19.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 2.9199999999999999 111.42 -178.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 19.9 mt -86.11 66.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.08 0.467 . . . . 2.0699999999999998 110.156 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.664 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 1.7 ptm180 -127.6 104.79 8.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.569 0.699 . . . . 3.98 111.844 -176.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.7 ptm -107.83 -165.16 1.02 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.211 -0.904 . . . . 1.8700000000000001 111.721 -172.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -67.33 148.1 52.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.493 -0.188 . . . . 3.25 110.493 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -50.8 -68.09 0.2 Allowed 'General case' 0 C--O 1.221 -0.408 0 O-C-N 123.529 0.518 . . . . 2.4199999999999999 110.962 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.383 0.512 . . . . 2.5699999999999998 112.383 -173.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.55 -37.99 62.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.579 0.228 . . . . 1.05 111.14 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.737 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 9.5 p -75.85 -15.2 15.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 110.11 -0.33 . . . . 0.32000000000000001 110.11 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -89.79 -39.65 12.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.101 -0.476 . . . . 1.1299999999999999 110.582 172.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -44.44 -68.63 0.18 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.574 1.079 . . . . 1.3799999999999999 112.137 164.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.407 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.4 tp -50.0 -43.11 50.41 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.904 0.753 . . . . 1.3400000000000001 110.092 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -53.24 -53.67 47.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.296 -1.32 . . . . 1.02 112.464 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.2 t -76.74 -16.99 59.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.843 -1.072 . . . . 1.9099999999999999 110.618 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.7 mt -91.28 -49.58 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.768 -0.456 . . . . 1.04 109.768 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.423 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 22.5 m -77.98 116.27 57.26 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-O 121.855 0.835 . . . . 0.20999999999999999 110.119 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.59 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -83.01 -178.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.052 2.501 . . . . 0.51000000000000001 112.327 -175.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.708 ' O ' HD22 ' A' ' 51' ' ' LEU . 14.2 m120 -64.93 7.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.905 -1.043 . . . . 1.02 113.337 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -146.64 53.98 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.941 -0.647 . . . . 0.64000000000000001 112.156 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.0 m -88.17 135.8 33.27 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.47 -0.429 . . . . 1.0700000000000001 110.863 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 162' ' ' ARG . 9.0 mtm180 -84.75 122.08 28.6 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.783 -0.644 . . . . 2.3399999999999999 110.351 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.427 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 3.6 p -134.74 127.74 49.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.46000000000000002 111.594 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 m -118.67 140.06 50.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.474 -0.785 . . . . 1.26 111.902 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -124.65 114.71 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 118.887 -1.125 . . . . 1.1699999999999999 110.75 174.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.622 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.65 127.85 17.66 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.917 -1.038 . . . . 1.1899999999999999 110.268 -173.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.527 ' HG2' HG21 ' A' ' 93' ' ' THR . 6.0 ptm180 -94.24 -22.86 18.14 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.811 -1.086 . . . . 3.7999999999999998 111.856 -175.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.5 -128.4 8.47 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.248 -0.887 . . . . 3.6499999999999999 110.999 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.769 -0.634 . . . . 5.9699999999999998 109.906 177.764 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.739 ' O62' ' H12' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.737 -0.545 . . . . 3.3799999999999999 111.737 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -142.16 174.31 10.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.049 0.452 . . . . 4.6799999999999997 110.114 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.21 143.75 27.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.428 -0.953 . . . . 2.54 108.428 167.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.603 HD12 ' H ' ' A' ' 50' ' ' GLY . 19.8 mt -99.2 172.37 7.41 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.396 0.435 . . . . 1.1000000000000001 111.756 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.3 tp -75.86 150.73 37.57 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.176 0.59 . . . . 1.05 111.84 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.526 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.06 150.58 35.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.978 0.894 . . . . 1.01 111.927 167.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.666 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 68.1 t80 -133.16 149.62 52.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.656 -1.611 . . . . 1.1200000000000001 108.014 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.88 116.38 19.33 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 106.405 -1.702 . . . . 1.72 106.405 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.48 158.03 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.446 0.641 . . . . 0.38 111.786 -169.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.63 152.04 26.07 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.145 -0.934 . . . . 3.0600000000000001 108.804 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.498 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.6 111.3 0.57 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 2.1699999999999999 111.795 -174.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -9.17 20.56 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.141 -0.936 . . . . 0.63 113.015 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.473 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 74.8 m-20 -66.48 147.13 53.73 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.327 0.563 . . . . 2.1699999999999999 112.25 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.485 ' O ' HD12 ' A' ' 18' ' ' ILE . 2.0 p -134.44 163.75 28.99 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.257 0.466 . . . . 1.27 112.257 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -49.94 -62.06 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.367 1.247 . . . . 1.0800000000000001 114.367 -171.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.701 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.2 t-20 -64.99 -41.14 95.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.49 1.138 . . . . 1.55 110.305 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.9 t -57.42 -48.15 79.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.472 -2.149 . . . . 1.8200000000000001 109.858 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -70.15 -40.4 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 123.668 0.787 . . . . 1.0600000000000001 112.456 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.33 -65.07 0.67 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.397 -0.365 . . . . 0.97999999999999998 111.535 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.85 -5.06 54.73 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.743 -1.183 . . . . 1.0700000000000001 111.83 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 17' ' ' SER . 17.3 t70 -65.19 -32.88 74.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.329 -0.989 . . . . 1.6299999999999999 108.329 158.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.4 m-85 -97.83 14.96 25.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.196 0.443 . . . . 0.25 112.196 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 58.46 47.93 12.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 4.2000000000000002 110.741 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 39.1 pt -147.89 -175.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.918 -0.771 . . . . 1.02 108.918 -173.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 146.22 26.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.362 -0.835 . . . . 1.1599999999999999 109.467 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.701 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 10.3 p -62.17 -37.39 85.09 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.933 -0.766 . . . . 1.05 108.933 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.559 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.75 -30.29 71.4 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.192 -1.367 . . . . 1.05 111.281 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.93 -37.94 33.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 1.03 109.778 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.1 tp -73.69 -20.09 60.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 1.05 109.206 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.609 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.93 -38.82 44.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.65 0.738 . . . . 1.0600000000000001 111.435 172.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 57.4 mt-30 -59.53 -41.9 91.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.288 1.042 . . . . 1.26 109.744 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.42 -20.74 39.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.565 -1.652 . . . . 1.01 112.315 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 26.8 m-80 -142.34 73.25 21.25 Favored Pre-proline 0 CA--C 1.513 -0.449 0 CA-C-O 121.196 0.522 . . . . 0.20000000000000001 110.099 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.703 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.3 Cg_endo -58.37 -10.03 7.9 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 123.239 2.626 . . . . 0.29999999999999999 113.926 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -62.59 -31.06 71.81 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.972 0.892 . . . . 1.3600000000000001 109.564 173.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 3.2 mt -83.14 -7.01 59.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.679 1.363 . . . . 1.26 114.679 -172.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.703 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -49.54 -40.92 39.86 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 120.03 1.286 . . . . 1.8899999999999999 110.151 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 -46.64 12.84 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.886 -1.961 . . . . 1.1000000000000001 111.511 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.42 -165.93 37.61 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.295 -0.955 . . . . 0.29999999999999999 114.472 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 15' ' ' LEU . 4.5 mp -113.71 158.47 20.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.412 -1.394 . . . . 1.0800000000000001 110.252 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -136.97 134.16 36.39 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.786 -0.643 . . . . 1.1699999999999999 110.65 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -49.05 129.36 17.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.475 0.655 . . . . 1.1699999999999999 112.736 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.578 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 83.2 -11.49 54.76 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.561 -1.199 . . . . 0.38 112.766 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.634 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -61.48 158.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.194 0.521 . . . . 1.1899999999999999 110.134 172.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.472 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 58.7 p -123.24 137.85 54.77 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.96 -1.018 . . . . 1.22 110.468 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' THR . 12.3 pt -135.13 171.6 17.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.287 0.565 . . . . 1.0600000000000001 111.266 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.582 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 19.1 t -114.2 149.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.731 -1.122 . . . . 0.20999999999999999 109.533 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 18.4 mm -118.27 88.29 32.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.183 -0.917 . . . . 1.01 108.711 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.47 139.88 92.38 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.387 2.725 . . . . 0.23000000000000001 113.203 -173.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.603 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 83.22 -7.37 67.8 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.424 -0.807 . . . . 0.29999999999999999 112.867 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.57 124.27 30.22 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.578 -0.897 . . . . 1.0800000000000001 108.578 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.54 ' CD ' HD21 ' A' ' 51' ' ' LEU . 57.0 Cg_endo -65.31 176.34 3.36 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.75 2.967 . . . . 0.34000000000000002 113.939 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.6 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 3.2 t70 -89.6 140.97 28.26 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.801 -1.091 . . . . 0.71999999999999997 110.139 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.6 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 88.0 Cg_endo -81.86 -1.16 10.74 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.367 2.711 . . . . 0.33000000000000002 111.725 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -28.83 14.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.898 -0.592 . . . . 2.29 110.772 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 53' ' ' ASP . 34.1 p -69.41 -28.4 66.12 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 122.617 1.199 . . . . 2.0600000000000001 107.905 170.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.585 HD11 ' HG2' ' A' ' 158' ' ' PRO . 96.8 mt -84.16 124.75 73.81 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.899 -1.955 . . . . 1.0900000000000001 110.648 175.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -101.57 95.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 CA-C-N 119.841 0.979 . . . . 0.22 109.847 166.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -157.74 131.75 8.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.925 -1.509 . . . . 0.80000000000000004 106.925 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 3.5 m-70 -140.48 113.55 8.38 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.436 -1.32 . . . . 3.5800000000000001 107.436 -164.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.456 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.7 mt -102.23 111.22 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.723 -0.671 . . . . 1.0600000000000001 111.307 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.96 98.86 7.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.227 -0.897 . . . . 1.1200000000000001 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -116.55 99.71 8.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.174 -1.375 . . . . 0.68000000000000005 109.559 177.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.452 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 54.2 m -94.46 133.08 38.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.071 -0.968 . . . . 1.3300000000000001 109.199 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.617 ' HB ' ' CB ' ' A' ' 167' ' ' ARG . 0.9 OUTLIER -59.87 -35.63 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.595 0.712 . . . . 1.77 110.676 176.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.85 -43.4 97.67 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.905 -1.043 . . . . 0.93999999999999995 110.956 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -71.32 -25.27 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.825 0.676 . . . . 1.22 112.825 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 mttt 54.03 17.07 1.28 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.913 0.885 . . . . 2.9399999999999999 112.961 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.42 141.59 35.5 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.525 0.678 . . . . 1.0600000000000001 111.051 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.2 tt -96.25 117.47 30.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.473 -1.239 . . . . 1.0900000000000001 109.675 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 m -100.73 127.51 47.12 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.17 -0.468 . . . . 1.0900000000000001 111.227 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -81.94 146.84 29.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.275 -1.75 . . . . 1.0800000000000001 106.275 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 36.5 m -150.31 127.02 10.95 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 120.351 1.432 . . . . 0.93000000000000005 112.442 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.07 125.25 53.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.492 -1.231 . . . . 1.1399999999999999 110.088 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 4.7 t-20 60.73 42.25 13.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.152 0.501 . . . . 0.52000000000000002 110.166 174.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.7 m-20 74.64 -1.46 3.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.993 -1.003 . . . . 1.8400000000000001 112.731 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -128.69 135.76 49.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 117.845 -1.542 . . . . 3.8500000000000001 114.115 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -56.55 149.17 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 112.7 -2.045 . . . . 0.40999999999999998 113.027 -170.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.55 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.2 mtp -101.02 -43.03 6.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.581 -2.1 . . . . 1.0900000000000001 108.566 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.81 159.1 0.57 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.617 -2.083 . . . . 2.6200000000000001 110.342 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.497 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.1 m -117.07 135.55 53.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.392 0.139 . . . . 1.1000000000000001 111.165 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -124.08 135.03 25.88 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-O 120.792 0.329 . . . . 1.0600000000000001 110.778 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -62.49 145.27 95.53 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.385 2.723 . . . . 0.85999999999999999 113.268 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.94 169.38 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.091 -0.504 . . . . 1.2 109.675 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.471 ' HB1' ' H ' ' A' ' 142' ' ' CYS . . . -88.27 127.75 35.47 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.297 0.57 . . . . 1.4099999999999999 110.902 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 65' ' ' ILE . 1.2 t -109.06 -28.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.774 -1.103 . . . . 1.6699999999999999 111.781 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 138' ' ' VAL . . . 84.47 -126.93 7.87 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.375 -0.917 . . . . 3.0800000000000001 111.246 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -176.16 -35.09 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.457 0.169 . . . . 7.6200000000000001 111.457 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 tp -143.82 -24.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.163 -0.615 . . . . 6.7199999999999998 112.26 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 20.4 tp -83.13 21.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.45 0.643 . . . . 7.6299999999999999 111.036 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.9 m -152.71 114.42 4.32 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.136 -0.691 . . . . 5.5099999999999998 109.136 175.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -84.61 171.33 12.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.97 -0.559 . . . . 5.3899999999999997 110.492 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.608 HG21 ' H ' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -54.16 -56.53 25.18 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 111.663 0.246 . . . . 2.5600000000000001 111.663 177.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HD3' ' HB ' ' A' ' 93' ' ' THR . 2.7 Cg_exo -76.32 75.79 4.15 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.486 2.124 . . . . 3.6600000000000001 111.928 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 m -80.96 -26.45 36.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.347 -0.612 . . . . 4.1699999999999999 109.347 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.95 156.74 14.51 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.386 -0.825 . . . . 2.6899999999999999 111.928 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -88.93 129.6 35.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 2.2999999999999998 109.688 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.649 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 7.1 m-85 -118.74 177.55 4.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.535 -0.757 . . . . 2.3500000000000001 109.76 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 95.6 m-85 -139.02 143.33 38.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.92000000000000004 110.385 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.474 HD13 HD13 ' A' ' 125' ' ' ILE . 22.6 mm -59.96 126.08 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.54 -1.281 . . . . 1.0600000000000001 107.54 164.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.472 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -124.02 -23.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.653 -0.819 . . . . 1.04 112.808 -174.25 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 15.7 t-20 -161.3 161.34 30.56 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.328 1.233 . . . . 2.3500000000000001 114.328 -173.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 1.0 OUTLIER -147.0 128.74 15.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 111.579 -2.555 . . . . 1.54 109.515 174.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.669 ' HB3' ' CD1' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -109.26 161.54 15.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.562 1.172 . . . . 1.8899999999999999 111.542 -171.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.553 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 9.4 ttm180 -49.79 152.67 1.45 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.929 -2.396 . . . . 3.46 112.544 171.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.553 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-20 -45.26 114.72 2.33 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-N 114.556 -1.202 . . . . 3.3500000000000001 111.628 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.502 ' HG3' ' NE1' ' A' ' 115' ' ' TRP . 85.3 Cg_exo -51.19 -48.16 22.44 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 C-N-CA 124.082 3.188 . . . . 0.97999999999999998 112.441 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.59 -4.26 59.7 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.441 -1.254 . . . . 1.0800000000000001 112.025 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -139.52 -171.55 12.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.989 -0.624 . . . . 1.1599999999999999 112.736 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.64 20.15 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.724 3.616 . . . . 1.46 114.973 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.65 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 46.6 t80 -74.55 -11.2 60.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.216 0.531 . . . . 2.1000000000000001 110.21 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.89 38.16 3.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.705 -0.76 . . . . 1.1100000000000001 114.31 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 73.25 -23.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.541 1.311 . . . . 1.45 114.541 166.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.635 ' HE2' ' CE1' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -152.16 148.96 28.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.832 0.349 . . . . 1.5 111.175 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.669 ' CD1' ' HB3' ' A' ' 104' ' ' GLN . 0.1 OUTLIER -110.4 101.6 10.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.489 -0.93 . . . . 2.6000000000000001 108.489 171.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.779 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -111.44 138.18 48.27 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.073 -0.651 . . . . 1.3100000000000001 110.252 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.0 t -107.32 151.34 25.61 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.717 -0.674 . . . . 1.3100000000000001 111.951 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.463 ' N ' ' HA2' ' A' ' 124' ' ' GLY . 1.0 OUTLIER -101.8 -174.1 2.51 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.275 -1.38 . . . . 1.8600000000000001 107.275 172.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.485 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 32.4 t -80.78 -76.78 0.22 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.678 -0.809 . . . . 1.95 110.716 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.503 ' HB2' ' HZ2' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -126.56 149.2 49.56 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.113 0.412 . . . . 3.3999999999999999 112.113 -170.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 72.16 -60.96 0.51 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.179 0.992 . . . . 5.5800000000000001 113.404 169.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -79.67 10.97 3.45 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.83 0.307 . . . . 6.7300000000000004 111.83 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 1.667 ' HD2' ' CD1' ' A' ' 123' ' ' TYR . 68.4 m-85 64.03 -87.33 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.944 0.777 . . . . 5.1500000000000004 112.377 173.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.463 ' HA2' ' N ' ' A' ' 118' ' ' LEU . . . -156.24 162.33 31.35 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.258 -0.972 . . . . 1.1899999999999999 113.574 -175.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.779 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 32.3 mt -93.26 106.39 17.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.051 -1.092 . . . . 1.05 108.051 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.573 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 9.9 p80 -140.69 -162.13 1.31 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.978 -0.689 . . . . 1.25 111.443 -172.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.62 -172.36 14.63 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.679 -1.248 . . . . 0.46000000000000002 113.13 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -154.7 178.15 10.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.209 0.528 . . . . 1.21 110.336 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -111.66 -12.79 13.85 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.425 -0.807 . . . . 1.8600000000000001 109.57 169.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -125.26 101.99 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.61 -0.723 . . . . 1.8200000000000001 109.782 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.52 4.04 4.62 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.053 2.502 . . . . 0.64000000000000001 113.148 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.13 54.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.521 0.677 . . . . 1.3200000000000001 109.57 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -100.13 3.28 43.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.003 -0.999 . . . . 1.8899999999999999 109.53 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 144' ' ' ARG . 16.7 mm -95.71 122.88 47.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 1.21 110.256 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.53 -8.55 74.55 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.544 -1.022 . . . . 1.6799999999999999 110.544 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -151.38 80.98 1.3 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.904 -0.406 . . . . 4.8799999999999999 109.904 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.07 147.02 25.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.435 -0.348 . . . . 4.4699999999999998 110.646 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 33.4 m -111.75 148.42 14.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.448 -0.342 . . . . 4.6799999999999997 111.187 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.5 m 67.7 159.5 0.15 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.646 -0.707 . . . . 5.9100000000000001 111.744 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.699 ' HZ2' ' H26' ' A' 1142 ' ' IM2 . 0.4 OUTLIER 71.82 -61.57 0.49 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.571 -0.741 . . . . 8.5999999999999996 112.04 175.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.18 82.74 0.24 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.79 -0.719 . . . . 4.1900000000000004 112.733 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.471 ' H ' ' HB1' ' A' ' 85' ' ' ALA . 69.0 m -110.13 165.3 11.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 2.9199999999999999 110.489 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 52.0 mt -124.44 83.83 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.587 0.708 . . . . 2.0699999999999998 110.014 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 21.6 mtp180 -119.03 161.35 20.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.484 -0.78 . . . . 3.98 109.248 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.435 ' SD ' ' HB3' ' A' ' 149' ' ' ASP . 1.7 ttm -152.83 -165.35 2.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.778 0.323 . . . . 1.8700000000000001 111.063 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -71.73 154.19 41.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.306 -0.627 . . . . 3.25 109.306 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -51.52 -68.69 0.15 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.288 0.477 . . . . 2.4199999999999999 112.288 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -60.15 -26.29 66.18 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 121.644 -0.66 . . . . 2.5699999999999998 112.315 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.435 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 62.9 m-20 -78.08 -34.33 50.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.523 -0.308 . . . . 1.05 111.639 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.689 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 11.6 p -74.97 -15.82 15.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.32000000000000001 109.651 175.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.403 ' HA ' ' CB ' ' A' ' 154' ' ' ALA . 2.5 mp -88.59 -37.34 10.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.178 -0.464 . . . . 1.1299999999999999 110.33 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -43.43 -71.8 0.07 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.375 0.989 . . . . 1.3799999999999999 112.098 162.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.03 -42.42 38.18 Favored 'General case' 0 C--O 1.222 -0.343 0 O-C-N 123.747 0.654 . . . . 1.3400000000000001 110.147 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -52.43 -54.66 29.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.298 -1.319 . . . . 1.02 112.033 -172.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.6 p -77.82 -14.81 59.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.313 -1.312 . . . . 1.9099999999999999 111.619 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.14 -51.83 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.82 -0.437 . . . . 1.04 109.82 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.8 m -77.13 118.06 69.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-O 121.952 0.882 . . . . 0.20999999999999999 110.229 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.585 ' HG2' HD11 ' A' ' 57' ' ' ILE . 41.1 Cg_endo -83.88 -178.42 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.022 2.481 . . . . 0.51000000000000001 112.832 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.606 ' O ' HD22 ' A' ' 51' ' ' LEU . 15.4 m120 -59.84 -0.46 0.2 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.621 -1.172 . . . . 1.02 113.641 -174.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.59 57.46 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.64000000000000001 112.235 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -94.46 132.78 38.75 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.441 -0.446 . . . . 1.0700000000000001 109.951 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -84.54 140.28 31.53 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.676 -0.41 . . . . 2.3399999999999999 109.995 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.456 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.4 p -145.48 126.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.584 -0.735 . . . . 0.46000000000000002 110.744 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.446 ' C ' HD11 ' A' ' 165' ' ' ILE . 92.0 m -116.51 144.19 44.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.813 -0.63 . . . . 1.26 111.646 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.446 HD11 ' C ' ' A' ' 164' ' ' THR . 3.3 mp -125.96 114.17 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 118.819 -1.152 . . . . 1.1699999999999999 110.58 173.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.31 135.82 25.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.155 -1.384 . . . . 1.1899999999999999 108.698 -175.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.617 ' CB ' ' HB ' ' A' ' 65' ' ' ILE . 8.0 ptm180 -92.37 -24.99 18.72 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.143 0.423 . . . . 3.7999999999999998 112.143 -177.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.504 ' H ' HG21 ' A' ' 93' ' ' THR . . . -177.47 -127.97 1.11 Allowed Glycine 0 C--N 1.309 -0.935 0 N-CA-C 111.464 -0.654 . . . . 3.6499999999999999 111.464 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.249 1.052 0 N-CA-C 109.507 -0.553 . . . . 5.9699999999999998 109.507 177.463 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.699 ' H26' ' HZ2' ' A' ' 140' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.613 -0.595 . . . . 3.3799999999999999 111.613 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.408 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 9.9 mpt_? -101.0 177.96 4.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.099 0.476 . . . . 4.6799999999999997 110.672 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 1.8 mppt? -62.43 147.08 49.72 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.326 -0.852 . . . . 2.54 109.64 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.605 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.6 mt -100.92 168.32 9.7 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.143 0.277 . . . . 1.1000000000000001 111.374 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.547 HD11 ' HD3' ' A' ' 54' ' ' PRO . 2.6 tp -78.16 149.81 33.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.303 0.641 . . . . 1.05 112.189 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.546 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -116.18 149.46 39.06 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.953 0.882 . . . . 1.01 112.123 169.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 65.3 t80 -133.9 149.86 51.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.761 -1.563 . . . . 1.1200000000000001 107.498 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -129.86 116.07 18.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.163 -1.421 . . . . 1.72 107.163 174.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -77.17 158.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.203 0.525 . . . . 0.38 111.885 -166.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HZ1' ' HB3' ' A' ' 10' ' ' LYS . 9.2 mtpm? -104.94 152.66 22.4 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.417 -0.811 . . . . 3.0600000000000001 108.947 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.516 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -53.0 119.69 4.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.962 -0.563 . . . . 2.1699999999999999 111.694 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.03 -10.42 37.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.63 113.15 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.487 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 80.9 m-20 -59.33 154.52 16.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.814 0.672 . . . . 2.1699999999999999 112.814 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -133.95 150.79 51.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.972 -0.558 . . . . 1.27 112.071 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.588 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.1 tp -48.33 -58.7 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.674 0.99 . . . . 1.0800000000000001 113.674 -172.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.686 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.0 t-20 -64.69 -42.4 95.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.546 1.165 . . . . 1.55 110.233 -169.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -59.06 -45.65 90.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.428 -2.169 . . . . 1.8200000000000001 110.031 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -70.43 -41.14 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.715 -0.675 . . . . 1.0600000000000001 111.867 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -66.22 0.48 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.23 -0.441 . . . . 0.97999999999999998 111.812 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -4.6 48.27 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.989 -1.084 . . . . 1.0700000000000001 112.352 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.51 -29.67 69.15 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.16 -0.682 . . . . 1.6299999999999999 109.16 158.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.41 10.49 36.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.034 0.445 . . . . 0.25 111.961 173.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 59.95 50.3 6.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.256 -0.883 . . . . 4.2000000000000002 110.513 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 39.6 pt -147.7 -174.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.608 -0.886 . . . . 1.02 108.608 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.2 m -101.07 147.7 25.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.559 -0.746 . . . . 1.1599999999999999 109.755 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.686 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -61.74 -36.09 79.98 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.745 -0.661 . . . . 1.05 109.251 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.39 71.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.502 -1.227 . . . . 1.05 111.677 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -37.54 37.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.196 -0.602 . . . . 1.03 109.451 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 16.3 tp -74.17 -19.75 60.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.433 -0.803 . . . . 1.05 109.115 176.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.62 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.08 -38.68 35.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.454 0.645 . . . . 1.0600000000000001 111.652 173.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -58.89 -43.17 90.9 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 122.223 1.011 . . . . 1.26 109.834 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.53 44.08 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.576 -1.647 . . . . 1.01 111.929 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 32.8 m-80 -142.6 72.85 20.27 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.20000000000000001 109.75 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.3 Cg_endo -54.91 -16.53 11.97 Favored 'Trans proline' 0 C--N 1.333 -0.273 0 C-N-CA 123.598 2.865 . . . . 0.29999999999999999 113.991 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -61.12 -32.65 72.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.068 0.937 . . . . 1.3600000000000001 109.727 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.63 -4.47 51.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.295 -1.32 . . . . 1.26 114.484 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.62 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.92 -41.24 45.68 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 119.883 1.219 . . . . 1.8899999999999999 109.856 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.539 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.63 -45.3 11.85 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.946 -1.933 . . . . 1.1000000000000001 111.597 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.84 -166.31 37.49 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.324 -0.941 . . . . 0.29999999999999999 113.781 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD21 ' HB ' ' A' ' 9' ' ' VAL . 6.8 mp -115.92 158.23 23.33 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.591 -1.304 . . . . 1.0800000000000001 110.364 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.6 m -131.27 133.68 45.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.994 -0.548 . . . . 1.1699999999999999 110.643 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.516 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -46.55 127.93 9.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.108 0.781 . . . . 1.1699999999999999 113.108 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.77 -11.04 48.98 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.33 -1.304 . . . . 0.38 112.322 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 41' ' ' THR . 5.6 tt0 -65.06 152.12 44.3 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.526 0.679 . . . . 1.1899999999999999 110.355 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.1 p -116.04 133.71 55.74 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.691 -1.14 . . . . 1.22 109.758 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.412 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 21.7 pt -136.12 144.03 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.464 0.649 . . . . 1.0600000000000001 110.54 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.543 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.9 t -90.72 150.09 3.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.805 -1.089 . . . . 0.20999999999999999 110.39 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 17.2 mm -117.95 87.1 26.94 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 114.849 -1.069 . . . . 1.01 108.245 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.538 ' HA ' HD12 ' A' ' 4' ' ' LEU . 28.4 Cg_endo -59.79 142.51 98.78 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.488 2.792 . . . . 0.23000000000000001 113.023 -172.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.605 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 82.44 -7.78 63.64 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.56 -0.746 . . . . 0.29999999999999999 112.69 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.572 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.2 tt -115.45 127.13 27.06 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.771 -0.826 . . . . 1.0800000000000001 108.771 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 55.3 Cg_endo -64.97 174.04 5.2 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.817 3.011 . . . . 0.34000000000000002 113.7 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 4.9 t70 -95.75 138.73 21.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.428 -0.805 . . . . 0.71999999999999997 111.996 -168.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HD3' HD11 ' A' ' 5' ' ' LEU . 97.3 Cg_endo -77.74 -9.76 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.388 2.725 . . . . 0.33000000000000002 113.271 -172.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' A' ' 55' ' ' TYR . 67.7 m-85 -94.98 -25.32 16.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 2.29 110.444 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.442 HG22 ' HB2' ' A' ' 3' ' ' LYS . 21.9 p -68.4 -31.79 71.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.3 1.048 . . . . 2.0600000000000001 108.233 169.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.588 HD11 ' HG2' ' A' ' 158' ' ' PRO . 95.5 mt -77.25 126.87 84.52 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 113.362 -1.745 . . . . 1.0900000000000001 110.854 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -102.15 95.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 121.084 1.19 . . . . 0.22 110.53 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.3 m-85 -158.42 133.34 8.41 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.886 -1.524 . . . . 0.80000000000000004 106.886 172.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 10.8 m-70 -138.91 109.05 6.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.729 -1.582 . . . . 3.5800000000000001 106.729 -168.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -94.65 109.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.126 -0.943 . . . . 1.0600000000000001 110.135 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.73 96.42 5.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.046 0.927 . . . . 1.1200000000000001 110.396 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.0 OUTLIER -115.74 97.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.028 -1.442 . . . . 0.68000000000000005 109.741 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.465 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -89.29 128.13 35.84 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.994 -1.003 . . . . 1.3300000000000001 108.494 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.445 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 15.5 mm -57.91 -35.26 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.611 -0.885 . . . . 1.77 108.611 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.54 -43.68 91.72 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 114.355 -1.293 . . . . 0.93999999999999995 111.828 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.96 -23.91 63.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.404 0.52 . . . . 1.22 112.404 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.593 ' HE2' ' CG1' ' A' ' 86' ' ' VAL . 32.4 mttt 58.14 15.32 3.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.07 0.948 . . . . 2.9399999999999999 112.857 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.49 143.26 33.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.556 0.694 . . . . 1.0600000000000001 111.462 175.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.494 ' CD1' HD12 ' A' ' 143' ' ' ILE . 4.7 tt -94.45 122.68 37.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.362 -1.29 . . . . 1.0900000000000001 109.766 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -103.36 123.77 47.43 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.041 -0.664 . . . . 1.0900000000000001 111.267 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -82.76 141.47 32.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.323 -1.732 . . . . 1.0800000000000001 106.323 176.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 2.4 m -144.6 125.91 14.77 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 120.456 1.48 . . . . 0.93000000000000005 112.483 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.3 tp -112.53 127.81 56.17 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 1.1399999999999999 110.085 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 7.3 t-20 63.13 32.89 14.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.385 0.612 . . . . 0.52000000000000002 109.519 173.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.7 m-20 79.86 1.44 2.12 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.536 -1.211 . . . . 1.8400000000000001 112.493 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -129.15 138.73 51.95 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.707 -1.197 . . . . 3.8500000000000001 113.698 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -54.01 147.94 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 113.329 -1.76 . . . . 0.40999999999999998 113.553 -170.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.505 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.8 mtp -99.68 -44.45 6.11 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 112.087 -2.324 . . . . 1.0900000000000001 108.121 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 34.4 tptt -176.89 164.75 2.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 112.491 -2.14 . . . . 2.6200000000000001 110.661 -176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 m -124.16 134.41 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.893 -0.14 . . . . 1.1000000000000001 111.304 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.602 ' CG ' ' HE2' ' A' ' 145' ' ' MET . 44.3 m-85 -124.51 134.62 25.71 Favored Pre-proline 0 CA--C 1.521 -0.154 0 CA-C-O 121.027 0.441 . . . . 1.0600000000000001 111.637 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -63.78 146.64 92.18 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.985 2.456 . . . . 0.85999999999999999 111.967 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.52 -178.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.834 -0.432 . . . . 1.2 109.834 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.84 119.04 24.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.666 0.746 . . . . 1.4099999999999999 111.575 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.593 ' CG1' ' HE2' ' A' ' 68' ' ' LYS . 8.8 t -140.98 137.43 34.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.344 -1.298 . . . . 1.6699999999999999 108.872 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.42 -117.25 2.88 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.471 -0.871 . . . . 3.0800000000000001 112.032 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.425 ' HG2' ' H ' ' A' ' 90' ' ' LEU . 56.7 tttp -91.93 135.0 34.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.733 -0.469 . . . . 7.6200000000000001 109.733 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.9 pt -67.8 -10.25 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.93 0.345 . . . . 6.7199999999999998 111.93 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.425 ' H ' ' HG2' ' A' ' 88' ' ' LYS . 29.4 tp -84.88 44.33 1.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.449 0.643 . . . . 7.6299999999999999 110.229 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -117.66 156.02 28.92 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.958 -0.564 . . . . 5.5099999999999998 110.529 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -78.57 135.45 37.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.012 0.434 . . . . 5.3899999999999997 110.756 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.541 HG23 ' H ' ' A' ' 167' ' ' ARG . 37.8 p -61.01 122.76 71.67 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.805 -0.634 . . . . 2.5600000000000001 110.118 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -86.0 18.03 1.65 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.572 2.181 . . . . 3.6600000000000001 113.746 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.1 p 49.17 37.79 11.79 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.217 0.607 . . . . 4.1699999999999999 111.091 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.44 94.25 1.84 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.565 -0.743 . . . . 2.6899999999999999 112.63 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.59 117.01 24.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.7 -0.852 . . . . 2.2999999999999998 108.7 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.663 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 33.5 m-85 -134.62 179.24 6.41 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.736 -0.665 . . . . 2.3500000000000001 110.445 -171.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.678 ' HA ' ' O ' ' A' ' 161' ' ' THR . 37.1 m-85 -124.5 143.64 50.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.506 -0.77 . . . . 0.92000000000000004 109.716 170.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.35 121.77 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.393 -1.336 . . . . 1.0600000000000001 107.393 164.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -109.49 -45.7 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.024 -0.67 . . . . 1.04 111.275 -173.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.407 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 5.6 t-20 -153.32 173.39 15.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 118.665 -1.214 . . . . 2.3500000000000001 113.975 -170.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.597 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -139.18 128.18 23.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 111.948 -2.387 . . . . 1.54 109.194 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.2 149.11 23.89 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.237 1.018 . . . . 1.8899999999999999 111.46 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -52.6 151.2 4.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.859 -1.973 . . . . 3.46 112.765 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.67 107.14 0.62 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 113.694 -1.594 . . . . 3.3500000000000001 111.589 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -53.08 -50.19 14.92 Favored 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 124.416 3.411 . . . . 0.97999999999999998 112.727 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.12 -20.31 12.88 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.164 -0.925 . . . . 1.0800000000000001 112.46 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.41 -170.01 13.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.053 -0.594 . . . . 1.1599999999999999 112.085 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.95 33.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 124.578 3.519 . . . . 1.46 114.093 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.656 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 4.4 t80 -86.31 -8.07 58.01 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.17 0.51 . . . . 2.1000000000000001 110.12 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.58 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 100.89 32.57 5.3 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 115.517 0.967 . . . . 1.1100000000000001 115.517 168.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 70.09 -21.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.207 1.188 . . . . 1.45 114.207 168.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.592 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -157.2 128.73 6.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.119 -0.697 . . . . 1.5 109.119 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -101.76 100.07 10.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.526 -0.916 . . . . 2.6000000000000001 108.526 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.707 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.4 mp -101.78 136.31 41.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.615 0.722 . . . . 1.3100000000000001 109.756 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.8 m -106.5 152.05 24.17 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.239 -0.891 . . . . 1.3100000000000001 111.626 -171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.425 HD21 ' CD2' ' A' ' 98' ' ' PHE . 1.5 tp -101.39 165.03 11.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.86 -1.064 . . . . 1.8600000000000001 108.729 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.46 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 30.5 t -53.25 -32.05 46.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.401 . . . . 1.95 111.975 -175.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 122' ' ' HIS . 16.6 tptm -126.99 160.01 32.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.506 -0.554 . . . . 3.3999999999999999 109.506 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -73.11 45.94 0.17 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.623 0.725 . . . . 5.5800000000000001 110.861 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.451 ' H ' ' C ' ' A' ' 120' ' ' LYS . 23.6 m-70 -138.66 119.79 14.57 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.287 -1.005 . . . . 6.7300000000000004 108.287 175.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 1.669 ' HE2' ' CE1' ' A' ' 123' ' ' TYR . 61.1 m-85 67.44 147.11 0.05 OUTLIER 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.968 0.792 . . . . 5.1500000000000004 110.969 -171.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.2 126.8 1.99 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.469 -0.653 . . . . 1.1899999999999999 111.469 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 55.4 mt -91.3 113.36 26.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.181 0.515 . . . . 1.05 109.646 -175.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.562 ' CE1' ' HD3' ' A' ' 144' ' ' ARG . 7.4 p80 -152.11 -162.34 1.49 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.191 0.519 . . . . 1.25 110.718 -177.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.58 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.4 171.12 14.52 Favored Glycine 0 C--N 1.311 -0.843 0 C-N-CA 119.838 -1.172 . . . . 0.46000000000000002 112.98 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -129.66 173.03 11.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.724 0.773 . . . . 1.21 111.809 -168.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -108.92 -20.65 12.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.382 -1.281 . . . . 1.8600000000000001 109.078 165.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -124.79 103.6 30.99 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.261 -0.881 . . . . 1.8200000000000001 109.696 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.8 3.77 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.294 2.662 . . . . 0.64000000000000001 113.926 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.65 -13.16 59.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.58 0.705 . . . . 1.3200000000000001 110.211 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.447 ' HB3' ' OG ' ' A' ' 139' ' ' SER . 21.7 m -96.26 6.97 47.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.185 -0.916 . . . . 1.8899999999999999 109.943 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 23.8 mm -97.55 116.4 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.394 -0.821 . . . . 1.21 110.376 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.92 -55.91 1.86 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.796 -0.716 . . . . 1.6799999999999999 112.45 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -102.0 43.86 1.04 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.718 0.294 . . . . 4.8799999999999999 110.958 -177.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -173.0 146.03 1.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 4.4699999999999998 110.178 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.95 -34.45 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.236 0.541 . . . . 4.6799999999999997 110.831 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.447 ' OG ' ' HB3' ' A' ' 133' ' ' SER . 26.2 m 52.81 27.47 5.42 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.813 -1.085 . . . . 5.9100000000000001 113.462 171.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.1 mttp 62.04 19.46 10.81 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.447 0.467 . . . . 8.5999999999999996 111.879 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 142' ' ' CYS . . . 103.58 -158.36 17.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.541 -0.838 . . . . 4.1900000000000004 112.38 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 141' ' ' GLY . 70.0 m 80.56 171.4 0.14 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.557 0.743 . . . . 2.9199999999999999 110.664 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 8.1 tt -153.96 92.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.775 0.798 . . . . 2.0699999999999998 110.534 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.562 ' HD3' ' CE1' ' A' ' 126' ' ' HIS . 34.2 ptt180 -142.87 163.1 33.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.887 -0.597 . . . . 3.98 111.864 -172.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.602 ' HE2' ' CG ' ' A' ' 82' ' ' TYR . 1.2 mpp? -144.35 -161.12 1.22 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.779 -0.646 . . . . 1.8700000000000001 109.669 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.488 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 48.8 m80 -70.53 166.14 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.983 -0.377 . . . . 3.25 109.983 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -54.26 -69.04 0.14 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 111.893 0.331 . . . . 2.4199999999999999 111.893 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.01 -27.3 66.77 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.564 -0.71 . . . . 2.5699999999999998 111.236 -176.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.488 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 3.1 m-20 -63.67 -46.82 83.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.923 -0.58 . . . . 1.05 110.545 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.663 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 12.1 p -77.35 -17.44 14.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-N 115.754 -0.657 . . . . 0.32000000000000001 111.078 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.46 -39.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 118.969 -0.538 . . . . 1.1299999999999999 110.443 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -44.45 -69.97 0.12 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.705 1.139 . . . . 1.3799999999999999 112.244 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.414 HD13 ' HG ' ' A' ' 72' ' ' LEU . 1.5 tp -49.82 -43.79 48.87 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.469 -0.787 . . . . 1.3400000000000001 110.287 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -53.54 -48.36 69.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.256 -1.338 . . . . 1.02 111.819 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 35.0 t -79.63 -19.98 47.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.579 -1.191 . . . . 1.9099999999999999 110.85 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 -48.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.782 -0.451 . . . . 1.04 109.782 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 m -77.45 116.47 58.14 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-O 121.802 0.811 . . . . 0.20999999999999999 109.93 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.588 ' HG2' HD11 ' A' ' 57' ' ' ILE . 32.3 Cg_endo -84.46 -178.35 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.099 2.533 . . . . 0.51000000000000001 112.442 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.572 ' O ' HD22 ' A' ' 51' ' ' LEU . 19.4 m120 -63.27 5.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.743 -1.117 . . . . 1.02 113.349 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.19 58.2 0.47 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.89 -0.671 . . . . 0.64000000000000001 112.56 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -92.75 136.71 33.0 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.447 -0.443 . . . . 1.0700000000000001 110.671 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -83.85 129.52 34.93 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.642 -0.423 . . . . 2.3399999999999999 110.301 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 4.4 p -136.37 127.3 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.23 0.538 . . . . 0.46000000000000002 111.19 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.4 m -119.23 134.64 55.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.768 -0.651 . . . . 1.26 111.689 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -121.82 108.68 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 119.32 -0.952 . . . . 1.1699999999999999 110.673 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.591 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.2 136.27 27.95 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.061 -0.972 . . . . 1.1899999999999999 111.177 -168.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.541 ' H ' HG23 ' A' ' 93' ' ' THR . 5.1 mpt_? -70.35 -32.52 70.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.091 -1.413 . . . . 3.7999999999999998 111.348 176.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.11 -129.48 7.22 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.161 -0.775 . . . . 3.6499999999999999 111.161 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.251 1.148 0 C-N-CA 122.749 0.419 . . . . 5.9699999999999998 111.114 177.323 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.447 ' O31' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.671 -0.572 . . . . 3.3799999999999999 111.671 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.441 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -94.53 135.76 35.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.011 -0.366 . . . . 4.6799999999999997 110.011 179.409 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.8 mptt -62.22 153.43 30.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.983 -0.553 . . . . 2.54 110.135 175.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 50' ' ' GLY . 18.5 mt -89.15 168.9 11.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.092 -0.504 . . . . 1.1000000000000001 110.629 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.3 tp -77.39 150.08 35.12 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 122.988 0.515 . . . . 1.05 112.119 -169.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.547 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.12 150.43 36.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.891 0.853 . . . . 1.01 111.67 167.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.642 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 69.2 t80 -135.48 151.82 50.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.717 -1.583 . . . . 1.1200000000000001 108.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.613 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -131.67 118.74 20.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.61 -1.256 . . . . 1.72 107.61 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.53 159.34 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 123.333 0.653 . . . . 0.38 112.011 -169.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -108.37 152.07 25.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.711 -0.677 . . . . 3.0600000000000001 109.198 -176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.48 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -50.54 119.4 3.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 2.1699999999999999 112.175 -175.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.67 -4.2 42.8 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.028 -0.987 . . . . 0.63 113.144 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.498 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 7.3 m-20 -65.62 156.81 31.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.535 0.668 . . . . 2.1699999999999999 112.529 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.96 148.16 52.5 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.829 0.677 . . . . 1.27 112.829 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.601 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.0 tp -46.5 -58.91 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.771 1.026 . . . . 1.0800000000000001 113.771 -173.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.666 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 20.3 t-20 -64.73 -40.28 95.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.583 1.183 . . . . 1.55 110.328 -170.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.768 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 10.9 m -60.87 -42.75 98.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 112.602 -2.09 . . . . 1.8200000000000001 110.398 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -73.38 -39.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 O-C-N 123.831 0.707 . . . . 1.0600000000000001 112.332 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.1 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.396 -0.365 . . . . 0.97999999999999998 111.522 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.75 52.31 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.902 -1.119 . . . . 1.0700000000000001 111.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.2 t0 -60.7 -42.63 97.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.461 -1.311 . . . . 1.6299999999999999 107.461 157.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.7 m-85 -93.55 16.78 12.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.5 0.556 . . . . 0.25 112.5 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HG2' HD11 ' A' ' 101' ' ' ILE . 7.0 mmm180 53.82 51.86 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 4.2000000000000002 111.002 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 35.7 pt -147.26 -172.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.928 -0.768 . . . . 1.02 108.928 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.97 148.01 23.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 1.1599999999999999 109.682 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.666 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 23.3 p -63.39 -35.74 81.4 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.683 -0.858 . . . . 1.05 108.683 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.14 -32.58 74.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.303 -1.317 . . . . 1.05 111.38 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.05 -37.58 38.62 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.273 0.559 . . . . 1.03 109.634 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 12.6 tp -74.18 -18.8 60.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.401 -0.818 . . . . 1.05 109.027 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.663 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.28 34.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.462 0.649 . . . . 1.0600000000000001 111.424 172.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 60.3 mt-30 -57.08 -46.26 82.67 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 122.248 1.023 . . . . 1.26 109.458 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.0 47.97 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.18 -1.827 . . . . 1.01 112.202 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 29.1 m-80 -142.96 72.71 18.67 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-O 121.153 0.502 . . . . 0.20000000000000001 109.903 -173.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.476 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 17.8 Cg_endo -57.24 -11.42 8.03 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 123.7 2.933 . . . . 0.29999999999999999 114.187 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 t -62.86 -34.19 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.049 0.928 . . . . 1.3600000000000001 109.915 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.7 mt -78.27 -4.99 50.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.438 -1.255 . . . . 1.26 114.372 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.663 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -51.08 -39.44 56.08 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 122.342 1.068 . . . . 1.8899999999999999 110.049 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.551 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -83.98 -46.47 12.02 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.987 -1.915 . . . . 1.1000000000000001 111.437 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.28 -164.09 34.4 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.502 -0.856 . . . . 0.29999999999999999 114.008 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mp -118.16 157.41 26.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.401 -1.4 . . . . 1.0800000000000001 110.088 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -134.15 136.8 44.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.704 -0.68 . . . . 1.1699999999999999 110.428 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -46.02 126.89 7.92 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.282 0.845 . . . . 1.1699999999999999 113.282 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.613 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.52 -11.78 49.78 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.528 -1.215 . . . . 0.38 112.002 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.565 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 3.7 tt0 -63.09 150.25 43.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.766 0.793 . . . . 1.1899999999999999 110.466 175.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 22.9 m -118.45 134.51 55.01 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.231 -1.35 . . . . 1.22 109.13 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.0 pt -137.14 151.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.445 0.64 . . . . 1.0600000000000001 110.513 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.527 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 16.7 t -96.75 149.21 4.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.013 -0.994 . . . . 0.20999999999999999 110.074 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 20.1 mm -117.65 88.84 31.05 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 108.309 -0.997 . . . . 1.01 108.309 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.521 ' HA ' HD12 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.83 142.14 98.05 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.014 2.476 . . . . 0.23000000000000001 112.717 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.595 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 82.06 -6.91 65.08 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.525 -0.761 . . . . 0.29999999999999999 112.995 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.9 127.74 26.44 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 108.737 -0.838 . . . . 1.0800000000000001 108.737 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.545 ' CD ' HD21 ' A' ' 51' ' ' LEU . 73.5 Cg_endo -68.56 174.31 8.59 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.819 3.013 . . . . 0.34000000000000002 113.93 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.551 ' CG ' ' HD2' ' A' ' 54' ' ' PRO . 9.6 t70 -89.57 142.48 29.47 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.881 -1.054 . . . . 0.71999999999999997 110.185 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 84.2 Cg_endo -80.96 -6.2 13.13 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.225 2.617 . . . . 0.33000000000000002 111.973 -174.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 55' ' ' TYR . 60.6 m-85 -95.85 -25.62 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 2.29 111.099 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 53' ' ' ASP . 28.6 p -70.49 -27.06 63.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.495 1.14 . . . . 2.0600000000000001 108.028 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.593 HD11 ' HG2' ' A' ' 158' ' ' PRO . 96.9 mt -81.98 129.23 65.32 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 112.936 -1.938 . . . . 1.0900000000000001 110.66 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -102.75 95.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 121.112 1.208 . . . . 0.22 110.761 165.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 73' ' ' SER . 86.8 m-85 -158.3 129.3 6.39 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.869 -1.53 . . . . 0.80000000000000004 106.869 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 31.4 m-70 -136.69 105.13 5.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.983 -1.488 . . . . 3.5800000000000001 106.983 -165.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.424 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 80.6 mt -94.15 113.42 28.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.282 -0.872 . . . . 1.0600000000000001 110.703 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.6 95.19 5.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.366 -0.834 . . . . 1.1200000000000001 110.752 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -110.18 112.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.431 -1.259 . . . . 0.68000000000000005 109.479 177.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 49.5 m -107.38 135.63 48.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.836 -0.62 . . . . 1.3300000000000001 110.629 -175.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 1.2 mt -57.32 -38.96 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.772 0.796 . . . . 1.77 110.269 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.21 -45.73 69.06 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.32 -1.309 . . . . 0.93999999999999995 111.717 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 64' ' ' SER . . . -74.41 -24.65 59.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.347 0.594 . . . . 1.22 112.052 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 32.7 mttt 53.41 24.53 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.283 1.033 . . . . 2.9399999999999999 111.732 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.462 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.5 OUTLIER -141.63 143.78 33.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.93 0.872 . . . . 1.0600000000000001 110.934 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.8 tt -98.6 117.94 34.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.82 -1.536 . . . . 1.0900000000000001 109.147 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -100.16 125.37 46.28 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.378 -0.529 . . . . 1.0900000000000001 110.67 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -83.01 147.88 27.91 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.789 -1.56 . . . . 1.0800000000000001 106.789 177.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.607 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 25.5 m -151.4 129.39 11.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 120.316 1.416 . . . . 0.93000000000000005 112.729 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 tp -117.3 129.39 55.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.917 -1.038 . . . . 1.1399999999999999 110.755 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 63.4 35.56 12.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.377 0.608 . . . . 0.52000000000000002 109.679 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 77.48 2.75 3.09 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.595 -1.184 . . . . 1.8400000000000001 111.784 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -129.95 138.74 51.03 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.41 -1.316 . . . . 3.8500000000000001 114.032 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.53 149.36 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 113.162 -1.835 . . . . 0.40999999999999998 112.822 -173.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.516 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -99.48 -45.57 5.77 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 112.675 -2.057 . . . . 1.0900000000000001 108.38 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.53 157.61 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 112.805 -1.998 . . . . 2.6200000000000001 110.388 -175.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.462 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.3 m -116.44 136.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.788 0.327 . . . . 1.1000000000000001 111.661 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -116.89 153.27 49.35 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.088 -0.505 . . . . 1.0600000000000001 110.192 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.11 143.09 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.59 2.193 . . . . 0.85999999999999999 111.424 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.517 ' HB ' ' CG1' ' A' ' 143' ' ' ILE . 0.1 OUTLIER -145.96 179.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.672 -0.24 . . . . 1.2 110.59 -178.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.01 158.88 19.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.485 0.66 . . . . 1.4099999999999999 111.64 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.6 m -134.72 141.79 42.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.87 -1.059 . . . . 1.6699999999999999 108.796 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.93 176.59 19.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.821 -1.18 . . . . 3.0800000000000001 113.43 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.4 tttp 59.32 62.12 1.88 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.158 0.504 . . . . 7.6200000000000001 110.237 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 mm -81.09 64.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.314 0.578 . . . . 6.7199999999999998 111.106 -174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.2 mt -141.65 -62.42 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.597 -0.729 . . . . 7.6299999999999999 109.884 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 92' ' ' GLN . 15.0 t -178.68 -175.17 0.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.602 -0.726 . . . . 5.5099999999999998 109.14 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 57.2 tp60 74.1 126.27 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.83 0.706 . . . . 5.3899999999999997 111.983 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.631 HG23 ' H ' ' A' ' 167' ' ' ARG . 18.3 p -81.88 109.94 17.61 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.349 -0.841 . . . . 2.5600000000000001 109.462 172.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 92' ' ' GLN . 32.9 Cg_exo -60.84 134.44 53.64 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.741 1.627 . . . . 3.6600000000000001 110.863 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.2 m -77.23 62.94 2.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.63 0.729 . . . . 4.1699999999999999 109.686 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.01 66.52 0.42 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.487 -0.779 . . . . 2.6899999999999999 112.345 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -94.43 121.54 36.08 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.336 -0.616 . . . . 2.2999999999999998 109.336 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.63 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 33.4 m-85 -132.3 177.84 7.27 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.067 -0.97 . . . . 2.3500000000000001 111.185 -174.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.632 ' HA ' ' O ' ' A' ' 161' ' ' THR . 48.9 m-85 -128.62 138.52 52.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.476 -0.784 . . . . 0.92000000000000004 109.897 171.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.433 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 21.7 mm -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.926 -1.139 . . . . 1.0600000000000001 107.926 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.54 HD13 ' CD1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -111.55 -33.54 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.897 -0.721 . . . . 1.04 112.666 -177.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 28.5 p-10 -166.47 -167.77 1.07 Allowed 'General case' 0 N--CA 1.46 0.062 0 CA-C-O 122.383 1.087 . . . . 2.3500000000000001 113.846 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -156.84 141.6 16.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 112.391 -2.186 . . . . 1.54 111.501 178.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.62 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 23.5 tp60 -109.92 142.18 41.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.142 -0.936 . . . . 1.8899999999999999 110.957 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -53.25 150.0 6.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.645 -1.616 . . . . 3.46 112.115 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.81 103.17 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 114.448 -1.251 . . . . 3.3500000000000001 111.434 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.42 -49.77 15.77 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.151 3.234 . . . . 0.97999999999999998 112.362 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.29 -16.01 20.1 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.995 -1.002 . . . . 1.0800000000000001 112.393 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -119.97 -170.38 14.35 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.012 -0.613 . . . . 1.1599999999999999 112.675 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.28 16.17 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.633 3.556 . . . . 1.46 114.99 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.653 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 2.3 t80 -66.66 -24.6 66.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.597 . . . . 2.1000000000000001 109.933 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 127' ' ' GLY . . . 99.63 60.52 0.85 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.331 -0.849 . . . . 1.1100000000000001 114.934 168.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 151' ' ' ILE . . . 72.96 -57.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.941 1.089 . . . . 1.45 113.941 166.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -146.79 137.31 23.76 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.59 -0.522 . . . . 1.5 109.59 -173.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.62 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 76.2 t-105 -103.74 101.04 10.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.272 -0.64 . . . . 2.6000000000000001 109.272 169.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.4 mp -104.51 109.23 21.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.585 0.707 . . . . 1.3100000000000001 109.769 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.501 ' HB3' ' CG2' ' A' ' 101' ' ' ILE . 3.5 t -79.01 146.3 33.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 1.3100000000000001 111.069 -168.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -92.88 177.02 6.21 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.591 -1.262 . . . . 1.8600000000000001 107.591 171.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 36.0 t -79.89 8.74 6.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.869 0.322 . . . . 1.95 111.869 -172.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -130.57 128.8 41.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.847 -0.427 . . . . 3.3999999999999999 109.847 170.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -71.26 52.65 0.18 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.373 0.606 . . . . 5.5800000000000001 111.272 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -149.79 -27.8 0.25 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.763 -0.653 . . . . 6.7300000000000004 109.643 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 99.6 m-85 -123.96 143.71 50.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 5.1500000000000004 109.64 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.57 151.67 23.31 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.358 -0.925 . . . . 1.1899999999999999 112.248 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.491 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 21.1 mt -91.67 116.6 33.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.075 -0.713 . . . . 1.05 109.075 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.494 ' CE1' ' HG3' ' A' ' 144' ' ' ARG . 7.1 p80 -152.09 -164.99 2.1 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.399 0.618 . . . . 1.25 111.341 -175.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.431 ' O ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.07 -178.62 15.74 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.666 -1.152 . . . . 0.46000000000000002 112.873 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.6 t -145.48 178.23 8.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.139 -0.531 . . . . 1.21 110.927 -165.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -108.98 -16.82 14.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.983 -1.008 . . . . 1.8600000000000001 109.255 165.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -124.98 100.71 33.13 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 115.744 -0.662 . . . . 1.8200000000000001 109.854 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 44.8 Cg_endo -92.78 4.64 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.584 2.856 . . . . 0.64000000000000001 113.166 175.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.22 -20.99 50.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.976 0.417 . . . . 1.3200000000000001 110.437 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 p -93.95 -4.83 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.598 0.714 . . . . 1.8899999999999999 110.11 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 9.0 mm -76.91 111.91 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.239 -0.891 . . . . 1.21 110.461 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.83 7.35 74.76 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.695 -0.684 . . . . 1.6799999999999999 111.549 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.404 ' HB2' ' HE3' ' A' ' 136' ' ' LYS . 35.9 ttmt -123.83 127.31 47.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.691 0.281 . . . . 4.8799999999999999 110.659 -174.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 64.65 -97.44 0.06 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.504 -0.771 . . . . 4.4699999999999998 111.8 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.9 t -137.42 -78.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.495 -0.187 . . . . 4.6799999999999997 110.495 -175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.8 t 58.06 37.73 26.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.231 0.538 . . . . 5.9100000000000001 111.02 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.35 162.33 15.15 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.365 0.506 . . . . 8.5999999999999996 112.365 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.36 -67.44 0.22 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.019 -0.61 . . . . 4.1900000000000004 111.974 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 59.9 m -108.19 146.37 32.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.268 -0.641 . . . . 2.9199999999999999 109.268 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.517 ' CG1' ' HB ' ' A' ' 84' ' ' ILE . 20.3 tt -84.71 -60.01 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 119.169 -0.443 . . . . 2.0699999999999998 110.478 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.494 ' HG3' ' CE1' ' A' ' 126' ' ' HIS . 37.1 mtt180 59.6 147.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.251 1.575 . . . . 3.98 115.251 170.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 144' ' ' ARG . 29.1 mtp -151.44 -166.93 2.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.786 -1.097 . . . . 1.8700000000000001 109.964 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -79.0 153.27 30.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.919 -0.771 . . . . 3.25 108.919 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -52.08 -65.0 0.63 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.504 0.187 . . . . 2.4199999999999999 111.504 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -60.74 -30.44 69.99 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.703 -0.623 . . . . 2.5699999999999998 111.342 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -64.38 -43.54 94.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.179 0.514 . . . . 1.05 110.25 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.707 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 9.4 p -77.59 -17.42 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.509 -0.769 . . . . 0.32000000000000001 110.993 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 113' ' ' ALA . 3.0 mp -88.98 -40.86 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 119.022 -0.513 . . . . 1.1299999999999999 110.649 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -44.03 -69.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.633 1.106 . . . . 1.3799999999999999 112.027 162.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.493 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -48.31 -42.52 31.26 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 123.813 0.695 . . . . 1.3400000000000001 110.232 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -53.6 -57.02 12.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.427 -1.26 . . . . 1.02 112.465 -171.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 t -77.05 -14.99 59.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.825 -1.079 . . . . 1.9099999999999999 110.487 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.48 -50.28 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 109.976 -0.379 . . . . 1.04 109.976 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.422 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 28.3 m -75.96 116.71 58.1 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 121.939 0.876 . . . . 0.20999999999999999 110.379 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.593 ' HG2' HD11 ' A' ' 57' ' ' ILE . 40.2 Cg_endo -81.97 -177.43 3.53 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.199 2.599 . . . . 0.51000000000000001 112.581 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.614 ' O ' HD22 ' A' ' 51' ' ' LEU . 16.5 m120 -59.11 0.65 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.58 -1.191 . . . . 1.02 113.839 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.18 58.41 0.45 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.738 -0.744 . . . . 0.64000000000000001 112.677 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.6 m -90.32 136.83 32.81 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.376 -0.484 . . . . 1.0700000000000001 110.53 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -84.76 131.92 34.5 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.55 -0.46 . . . . 2.3399999999999999 109.983 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.424 ' HA ' ' HB ' ' A' ' 61' ' ' ILE . 2.4 p -138.91 124.81 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.363 -0.835 . . . . 0.46000000000000002 110.858 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.403 ' C ' HD11 ' A' ' 165' ' ' ILE . 89.8 m -116.92 140.5 49.38 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.682 -0.69 . . . . 1.26 111.636 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.1 mp -120.4 110.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.811 -1.156 . . . . 1.1699999999999999 110.593 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -143.78 146.96 33.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.372 -1.285 . . . . 1.1899999999999999 109.071 -172.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.631 ' H ' HG23 ' A' ' 93' ' ' THR . 7.9 ptm180 -92.85 -31.8 14.86 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.558 0.577 . . . . 3.7999999999999998 112.558 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -160.29 -132.38 1.34 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.037 -0.601 . . . . 3.6499999999999999 111.77 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.25 1.088 0 C-N-CA 122.929 0.491 . . . . 5.9699999999999998 111.057 -179.513 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.61 ' O62' ' H12' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 111.582 -0.607 . . . . 3.3799999999999999 111.582 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 63.78 177.84 0.17 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.91 0.862 . . . . 4.6799999999999997 112.303 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -77.8 153.95 32.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.821 -1.081 . . . . 2.54 109.276 172.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.606 HD12 ' H ' ' A' ' 50' ' ' GLY . 17.8 mt -91.79 168.86 11.15 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.382 0.426 . . . . 1.1000000000000001 111.05 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.552 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.8 tp -76.42 150.31 36.76 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 123.42 0.688 . . . . 1.05 112.297 -168.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.552 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.57 150.05 35.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.137 0.97 . . . . 1.01 111.92 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 70.0 t80 -136.63 149.8 48.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.448 -1.705 . . . . 1.1200000000000001 108.083 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.55 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.82 121.7 28.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.194 -1.41 . . . . 1.72 107.194 176.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -82.46 158.65 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.181 0.515 . . . . 0.38 112.119 -170.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -106.18 150.28 26.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.843 -0.799 . . . . 3.0600000000000001 108.843 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.502 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 1.2 tt0 -53.97 112.73 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.541 0.526 . . . . 2.1699999999999999 111.967 -175.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.0 -8.67 18.72 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.673 -0.775 . . . . 0.63 112.837 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.493 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 55.7 m-20 -62.26 154.84 26.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.067 0.433 . . . . 2.1699999999999999 111.946 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.424 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.1 p -132.11 152.95 50.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 1.27 111.892 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.0 tp -49.86 -58.5 5.26 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.99 1.107 . . . . 1.0800000000000001 113.99 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.646 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.6 t-20 -65.07 -42.01 94.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.569 1.176 . . . . 1.55 109.979 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.737 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 5.8 m -60.34 -39.45 87.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 112.51 -2.132 . . . . 1.8200000000000001 110.769 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.8 -41.18 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 123.296 0.638 . . . . 1.0600000000000001 112.176 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.62 -61.94 2.08 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.511 -0.313 . . . . 0.97999999999999998 111.284 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.12 54.38 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.798 -1.161 . . . . 1.0700000000000001 112.136 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.9 t70 -61.89 -34.84 76.75 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.654 -1.239 . . . . 1.6299999999999999 107.654 156.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' CD1' HD11 ' A' ' 101' ' ' ILE . 2.4 m-85 -99.35 17.81 19.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.248 0.462 . . . . 0.25 112.248 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 52.11 51.92 15.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.356 -0.838 . . . . 4.2000000000000002 110.954 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 35.5 pt -146.86 -174.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.644 -0.872 . . . . 1.02 108.644 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -100.81 144.7 29.46 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.429 -0.805 . . . . 1.1599999999999999 109.258 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.646 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 25.3 p -61.77 -34.81 76.54 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.48 0.657 . . . . 1.05 109.251 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.86 -29.4 70.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.34 -1.3 . . . . 1.05 111.511 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.82 -38.11 26.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.391 0.615 . . . . 1.03 109.791 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 16.7 tp -73.31 -16.93 61.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.214 -0.903 . . . . 1.05 108.958 174.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.58 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -82.1 -38.52 24.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.37 0.605 . . . . 1.0600000000000001 111.578 173.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.4 mt-30 -57.92 -43.42 86.25 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.169 0.985 . . . . 1.26 109.636 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.59 -19.77 41.23 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.354 -1.748 . . . . 1.01 112.402 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 32.7 m-80 -143.34 72.66 17.85 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.148 0.499 . . . . 0.20000000000000001 109.922 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.639 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.8 Cg_endo -57.36 -11.32 8.11 Favored 'Trans proline' 0 C--N 1.333 -0.283 0 C-N-CA 123.649 2.9 . . . . 0.29999999999999999 114.478 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -63.31 -34.43 77.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.913 0.864 . . . . 1.3600000000000001 109.573 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -78.35 -6.62 55.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.332 -1.303 . . . . 1.26 114.415 -170.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -49.94 -42.56 48.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 119.78 1.173 . . . . 1.8899999999999999 110.22 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.28 -45.95 12.31 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 112.881 -1.963 . . . . 1.1000000000000001 111.439 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -164.81 36.16 Favored Glycine 0 CA--C 1.492 -1.355 0 C-N-CA 120.265 -0.969 . . . . 0.29999999999999999 114.358 176.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.43 157.86 23.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.966 -1.617 . . . . 1.0800000000000001 110.447 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 96.3 m -133.89 133.86 42.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.641 -0.709 . . . . 1.1699999999999999 110.519 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -44.61 126.49 5.54 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.416 0.895 . . . . 1.1699999999999999 113.416 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.55 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.31 -10.66 53.65 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.391 -1.277 . . . . 0.38 112.129 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -63.99 150.91 44.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.776 0.798 . . . . 1.1899999999999999 110.315 175.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 44.7 m -118.2 133.86 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.212 -1.358 . . . . 1.22 109.049 -171.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.446 HD11 HD13 ' A' ' 29' ' ' LEU . 15.0 pt -135.89 151.14 28.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.244 0.545 . . . . 1.0600000000000001 110.312 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.489 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.1 t -96.03 149.09 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.121 -0.945 . . . . 0.20999999999999999 110.119 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 19.4 mm -117.24 87.31 23.51 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.84 -1.073 . . . . 1.01 108.386 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HA ' HD12 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.59 140.26 92.97 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.119 2.546 . . . . 0.23000000000000001 112.626 -173.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.606 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 85.3 -8.24 72.07 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.323 -0.853 . . . . 0.29999999999999999 113.015 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.538 HD21 ' CD ' ' A' ' 52' ' ' PRO . 2.9 tt -117.55 127.43 26.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.585 -0.894 . . . . 1.0800000000000001 108.585 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.538 ' CD ' HD21 ' A' ' 51' ' ' LEU . 62.0 Cg_endo -67.78 173.58 8.89 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.725 2.95 . . . . 0.34000000000000002 113.818 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.555 ' HB3' HG21 ' A' ' 56' ' ' THR . 11.9 t70 -90.3 142.05 28.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.034 -0.985 . . . . 0.71999999999999997 110.576 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.498 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 60.3 Cg_endo -86.21 -8.31 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.73 2.953 . . . . 0.33000000000000002 112.444 -174.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.658 ' HE1' ' CE2' ' A' ' 55' ' ' TYR . 59.0 m-85 -92.01 -13.52 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 2.29 109.486 177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.555 HG21 ' HB3' ' A' ' 53' ' ' ASP . 12.3 p -84.92 -29.5 25.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.944 -1.132 . . . . 2.0600000000000001 107.944 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.649 HD11 ' HG2' ' A' ' 158' ' ' PRO . 43.5 mt -83.02 131.74 52.94 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 113.496 -1.684 . . . . 1.0900000000000001 110.887 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.68 96.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 121.046 1.164 . . . . 0.22 110.525 167.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.497 ' HD2' ' CG2' ' A' ' 57' ' ' ILE . 84.1 m-85 -157.3 132.49 8.97 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.604 -1.258 . . . . 0.80000000000000004 107.604 171.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 29.1 m170 -135.96 103.73 5.47 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.487 -1.672 . . . . 3.5800000000000001 106.487 -167.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 64.5 mt -94.71 112.43 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 120.237 -0.585 . . . . 1.0600000000000001 110.521 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.33 95.8 5.35 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.378 -0.828 . . . . 1.1200000000000001 110.811 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -115.75 104.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.503 -1.226 . . . . 0.68000000000000005 110.645 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.497 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 50.9 m -98.96 113.52 25.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.213 -1.032 . . . . 1.3300000000000001 108.213 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.495 ' CG2' ' H ' ' A' ' 87' ' ' GLY . 2.1 mt -54.62 -32.43 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-O 120.905 0.383 . . . . 1.77 111.779 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' HA2' ' HG3' ' A' ' 88' ' ' LYS . . . -59.09 -45.62 95.0 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.071 -1.061 . . . . 0.93999999999999995 111.305 170.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -70.43 -23.45 62.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.461 0.648 . . . . 1.22 111.959 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.479 ' HA ' ' CG2' ' A' ' 86' ' ' VAL . 35.7 mttt 62.35 18.93 10.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.734 1.214 . . . . 2.9399999999999999 112.999 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.423 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.94 140.17 31.0 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.284 1.04 . . . . 1.0600000000000001 112.63 177.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.547 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -97.19 118.7 34.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.028 -1.897 . . . . 1.0900000000000001 109.269 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -100.86 125.14 47.36 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.349 -0.54 . . . . 1.0900000000000001 110.489 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -83.8 143.92 29.64 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.966 -1.864 . . . . 1.0800000000000001 105.966 176.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.583 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 47.7 m -148.65 129.52 14.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 120.189 1.359 . . . . 0.93000000000000005 112.895 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -114.46 126.53 55.06 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.608 -1.178 . . . . 1.1399999999999999 110.438 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.5 t-20 63.7 36.31 10.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.52000000000000002 109.54 172.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.1 m-20 76.81 2.73 3.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.591 -1.186 . . . . 1.8400000000000001 112.409 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -130.42 137.79 50.01 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 118.081 -1.448 . . . . 3.8500000000000001 114.269 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -53.17 149.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-N 113.122 -1.854 . . . . 0.40999999999999998 113.59 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.542 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.8 mtp -103.3 -40.35 6.44 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.407 -2.179 . . . . 1.0900000000000001 108.732 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.52 165.87 2.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.677 -2.056 . . . . 2.6200000000000001 110.723 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.423 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 8.6 m -125.49 130.52 51.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.419 0.152 . . . . 1.1000000000000001 110.947 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.453 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 15.7 m-85 -120.68 134.35 24.23 Favored Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.759 0.314 . . . . 1.0600000000000001 110.966 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.69 143.53 74.78 Favored 'Trans proline' 0 N--CA 1.472 0.213 0 C-N-CA 123.168 2.579 . . . . 0.85999999999999999 112.76 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.24 179.36 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.329 -0.396 . . . . 1.2 110.782 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.94 150.68 25.51 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 110.091 -0.337 . . . . 1.4099999999999999 110.091 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.479 ' CG2' ' HA ' ' A' ' 68' ' ' LYS . 2.1 t -149.28 145.15 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 114.261 1.208 . . . . 1.6699999999999999 114.261 -159.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.495 ' H ' ' CG2' ' A' ' 65' ' ' ILE . . . -127.28 82.32 0.35 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.695 -1.362 . . . . 3.0800000000000001 109.695 163.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HD2' ' HE3' ' A' ' 68' ' ' LYS . 51.7 tttp -80.01 153.99 28.49 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.717 0.636 . . . . 7.6200000000000001 112.717 -167.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.8 tp -168.39 -43.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.694 -0.685 . . . . 6.7199999999999998 110.855 168.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.409 ' HB3' ' H ' ' A' ' 91' ' ' THR . 0.2 OUTLIER -160.24 -95.34 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.153 -0.342 . . . . 7.6299999999999999 111.242 175.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.655 ' N ' ' HA2' ' A' ' 168' ' ' GLY . 15.1 t -153.05 161.51 42.42 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.128 -0.358 . . . . 5.5099999999999998 111.158 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 91' ' ' THR . 44.3 mt-30 76.95 127.9 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.084 0.953 . . . . 5.3899999999999997 112.655 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.627 ' HB ' ' CD ' ' A' ' 94' ' ' PRO . 0.6 OUTLIER -84.7 -160.84 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 107.954 -1.128 . . . . 2.5600000000000001 107.954 169.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.627 ' CD ' ' HB ' ' A' ' 93' ' ' THR . 22.7 Cg_exo -71.33 30.91 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 CA-C-N 120.631 1.261 . . . . 3.6600000000000001 111.797 161.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.54 ' H ' ' C ' ' A' ' 93' ' ' THR . 28.7 m 65.56 83.42 0.17 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.454 0.702 . . . . 4.1699999999999999 111.196 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -138.64 114.81 1.08 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.432 -0.889 . . . . 2.6899999999999999 112.924 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' HG2' HG21 ' A' ' 164' ' ' THR . 32.1 mt-10 -119.39 140.08 50.96 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.33 -0.618 . . . . 2.2999999999999998 109.33 174.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.654 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 7.2 m-85 -126.64 178.55 5.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.416 -0.356 . . . . 2.3500000000000001 110.505 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 161' ' ' THR . 66.5 m-85 -131.17 139.83 49.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.92000000000000004 110.252 172.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.586 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 34.0 mm -63.22 116.68 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 N-CA-C 108.752 -0.833 . . . . 1.0600000000000001 108.752 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.457 HD11 ' CD1' ' A' ' 22' ' ' PHE . 3.7 tt -108.32 -19.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 119.237 -0.985 . . . . 1.04 112.507 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.461 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 6.2 t-20 179.0 -168.39 0.09 Allowed 'General case' 0 C--N 1.351 0.669 0 CA-C-O 122.73 1.252 . . . . 2.3500000000000001 114.096 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.461 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.6 ptp180 -156.78 144.17 18.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.621 -2.536 . . . . 1.54 110.021 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.98 157.21 22.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 122.067 0.937 . . . . 1.8899999999999999 111.172 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -52.32 150.21 4.9 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.521 -2.127 . . . . 3.46 112.05 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -48.33 110.3 1.4 Allowed Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 115.118 -0.946 . . . . 3.3500000000000001 111.039 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.17 -48.25 22.63 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 123.762 2.975 . . . . 0.97999999999999998 111.858 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 111.3 -20.39 23.42 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.849 -1.069 . . . . 1.0800000000000001 112.625 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -105.93 -170.07 23.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.971 -0.633 . . . . 1.1599999999999999 111.946 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.82 35.51 0.1 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.188 3.259 . . . . 1.46 113.561 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.489 ' H ' ' C ' ' A' ' 109' ' ' GLY . 11.4 t80 -86.89 -16.89 34.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.21 0.529 . . . . 2.1000000000000001 109.804 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.548 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.89 38.0 3.75 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.653 -0.703 . . . . 1.1100000000000001 114.071 173.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.441 ' HB1' ' ND2' ' A' ' 147' ' ' ASN . . . 74.38 -36.71 0.34 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.121 1.156 . . . . 1.45 114.121 168.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.626 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -148.37 144.55 27.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.975 0.417 . . . . 1.5 110.949 -173.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -115.49 100.21 7.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.661 . . . . 2.6000000000000001 109.373 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -101.72 145.72 28.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.206 0.527 . . . . 1.3100000000000001 110.535 176.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 74.4 m -106.71 137.12 45.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.662 -0.699 . . . . 1.3100000000000001 112.412 -170.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 tp -107.68 -171.29 1.84 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.086 -0.961 . . . . 1.8600000000000001 108.987 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.7 t -87.57 -98.02 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.675 0.67 . . . . 1.95 111.18 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -89.34 159.7 17.23 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.908 0.707 . . . . 3.3999999999999999 112.908 -171.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 57.92 -88.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.753 -1.112 . . . . 5.5800000000000001 112.545 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -82.38 63.64 6.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.72 -1.215 . . . . 6.7300000000000004 107.72 176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -71.9 22.04 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.202 0.816 . . . . 5.1500000000000004 113.202 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.89 122.4 1.22 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 119.654 -1.26 . . . . 1.1899999999999999 113.951 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.638 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 12.0 mt -92.99 107.36 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.363 -1.347 . . . . 1.05 107.363 165.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 12.6 p80 -137.96 -163.92 1.53 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.697 -0.801 . . . . 1.25 112.463 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.548 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.9 -177.0 15.31 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.377 -1.283 . . . . 0.46000000000000002 112.479 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -141.07 175.88 9.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.494 0.664 . . . . 1.21 111.594 -166.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -111.04 -17.78 13.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.827 -1.079 . . . . 1.8600000000000001 109.311 166.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -125.45 102.94 29.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.296 -0.866 . . . . 1.8200000000000001 109.727 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -91.79 3.48 4.07 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.171 2.581 . . . . 0.64000000000000001 113.564 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.86 57.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.869 0.366 . . . . 1.3200000000000001 111.117 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 -3.02 50.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 1.8899999999999999 110.152 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.9 mm -79.48 118.41 26.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 1.21 111.255 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.46 3.09 56.51 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.484 -0.78 . . . . 1.6799999999999999 111.548 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -121.56 149.36 43.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.994 -0.373 . . . . 4.8799999999999999 109.994 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.24 62.04 5.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.176 0.512 . . . . 4.4699999999999998 110.517 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 95.9 t -82.6 -54.63 9.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.872 -0.604 . . . . 4.6799999999999997 110.875 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.5 m -152.93 153.03 32.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.195 -0.457 . . . . 5.9100000000000001 110.325 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -89.65 67.73 7.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.101 -0.499 . . . . 8.5999999999999996 110.3 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -95.48 -130.57 6.24 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.919 -0.658 . . . . 4.1900000000000004 112.642 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 47.3 m -103.22 -164.59 1.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.644 -0.502 . . . . 2.9199999999999999 109.644 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.451 ' CG2' ' HA ' ' A' ' 125' ' ' ILE . 2.5 tt -116.34 119.85 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.692 0.758 . . . . 2.0699999999999998 110.151 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 34.8 ptt180 -150.51 153.65 36.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.937 -0.574 . . . . 3.98 110.273 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 10.8 mtm -145.71 -165.03 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.769 0.319 . . . . 1.8700000000000001 110.679 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -67.73 150.51 48.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 3.25 110.046 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.441 ' ND2' ' HB1' ' A' ' 113' ' ' ALA . 3.4 m-20 -51.63 -67.77 0.22 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 123.412 0.445 . . . . 2.4199999999999999 111.589 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.43 -24.5 67.86 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.862 -0.524 . . . . 2.5699999999999998 111.963 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.59 -38.41 74.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.731 0.3 . . . . 1.05 110.975 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.71 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 12.0 p -80.26 -14.9 13.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 116.587 -0.279 . . . . 0.32000000000000001 110.521 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.402 ' HA ' ' CB ' ' A' ' 154' ' ' ALA . 2.5 mp -89.16 -38.96 12.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 118.851 -0.595 . . . . 1.1299999999999999 110.911 173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -44.09 -68.6 0.18 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.854 1.206 . . . . 1.3799999999999999 111.601 163.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.488 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -49.83 -42.47 47.33 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.589 -0.732 . . . . 1.3400000000000001 110.059 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -54.64 -57.66 10.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.237 -1.347 . . . . 1.02 112.107 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.0 t -75.32 -14.57 60.5 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.475 -1.239 . . . . 1.9099999999999999 110.63 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.437 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 80.9 mt -93.06 -47.77 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.32 -0.4 . . . . 1.04 110.365 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.9 m -76.88 110.61 12.37 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 122.038 0.923 . . . . 0.20999999999999999 111.073 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.649 ' HG2' HD11 ' A' ' 57' ' ' ILE . 13.9 Cg_endo -82.16 -179.31 4.62 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.698 2.265 . . . . 0.51000000000000001 113.254 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 8.7 m120 -66.73 110.54 3.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.74 -1.118 . . . . 1.02 108.254 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.89 2.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.284 -0.96 . . . . 0.64000000000000001 113.314 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.586 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 18.9 m -93.2 136.29 33.6 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.839 -0.8 . . . . 1.0700000000000001 109.819 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -84.72 134.16 34.35 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.952 -0.388 . . . . 2.3399999999999999 109.952 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.44 ' HA ' ' HB ' ' A' ' 61' ' ' ILE . 3.2 p -140.51 125.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.421 -0.809 . . . . 0.46000000000000002 111.424 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.418 HG21 ' HG2' ' A' ' 97' ' ' GLU . 52.4 m -114.01 129.7 56.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.303 -0.862 . . . . 1.26 111.557 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.8 mp -119.25 122.3 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 118.135 -1.426 . . . . 1.1699999999999999 109.578 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.529 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.1 OUTLIER -142.54 122.51 13.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.087 0.946 . . . . 1.1899999999999999 109.932 177.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.445 ' CG ' ' N ' ' A' ' 168' ' ' GLY . 31.6 ptt180 -98.18 -48.85 4.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.323 -1.762 . . . . 3.7999999999999998 114.301 -165.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.655 ' HA2' ' N ' ' A' ' 91' ' ' THR . . . 138.84 101.38 0.52 Allowed Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.968 -0.853 . . . . 3.6499999999999999 110.968 -163.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 64.7 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.954 -0.546 . . . . 5.9699999999999998 109.777 177.911 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.493 ' O32' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.99 -0.444 . . . . 3.3799999999999999 111.99 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.41 175.5 9.87 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.12 -0.326 . . . . 4.6799999999999997 110.12 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -70.32 151.7 44.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.754 -0.461 . . . . 2.54 109.754 176.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.607 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.2 mt -100.69 169.15 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 1.1000000000000001 111.948 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.572 HD11 ' HD3' ' A' ' 54' ' ' PRO . 3.4 tp -79.62 153.02 29.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 123.643 0.777 . . . . 1.05 112.206 -169.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -116.58 153.05 32.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.866 0.841 . . . . 1.01 111.858 166.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.653 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 68.2 t80 -136.6 150.5 48.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.029 -1.441 . . . . 1.1200000000000001 108.07 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.635 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.47 119.42 24.87 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.714 -1.587 . . . . 1.72 106.714 174.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -81.08 158.88 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 112.782 0.66 . . . . 0.38 112.782 -167.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -99.26 150.14 22.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.019 -0.992 . . . . 3.0600000000000001 109.43 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.532 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 2.1 tt0 -53.84 109.17 0.43 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.258 -0.883 . . . . 2.1699999999999999 111.618 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -9.82 22.43 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.64 -0.79 . . . . 0.63 112.748 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.497 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 82.4 m-20 -59.7 154.21 18.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.021 0.41 . . . . 2.1699999999999999 111.545 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.423 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.7 p -133.39 153.63 51.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.102 0.477 . . . . 1.27 112.115 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.5 tp -49.44 -59.9 3.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.795 1.035 . . . . 1.0800000000000001 113.795 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.685 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.6 t-20 -65.02 -40.13 94.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.22 1.009 . . . . 1.55 110.456 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.0 t -59.72 -51.46 69.66 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 113.221 -1.809 . . . . 1.8200000000000001 109.358 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.497 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.64 -39.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.924 -0.58 . . . . 1.0600000000000001 111.433 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -65.2 0.66 Allowed 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.97999999999999998 111.635 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.12 -5.3 55.74 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 118.84 -1.144 . . . . 1.0700000000000001 112.269 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.094 -0.706 . . . . 1.6299999999999999 109.094 158.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.458 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.4 m-85 -97.05 13.94 27.36 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.089 0.403 . . . . 0.25 112.089 173.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 58.15 49.19 11.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 4.2000000000000002 110.096 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 42.0 pt -147.7 -175.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.691 -0.855 . . . . 1.02 108.691 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 m -99.52 146.0 26.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.538 -0.755 . . . . 1.1599999999999999 109.337 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.685 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.1 p -60.66 -38.08 83.68 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.01 -0.737 . . . . 1.05 109.01 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.55 69.0 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.47 -1.241 . . . . 1.05 111.654 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 49' ' ' PRO . . . -80.72 -38.13 29.36 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.078 -0.712 . . . . 1.03 109.078 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 12.8 tp -73.69 -18.54 61.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.333 -0.849 . . . . 1.05 109.044 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.606 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.9 -39.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.484 0.659 . . . . 1.0600000000000001 111.563 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -57.92 -42.9 85.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 122.372 1.082 . . . . 1.26 109.648 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.43 -17.25 49.51 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.512 -1.676 . . . . 1.01 112.016 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.604 HD22 ' H ' ' A' ' 47' ' ' VAL . 33.6 m-80 -144.45 72.22 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.102 0.477 . . . . 0.20000000000000001 110.115 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.9 Cg_endo -55.06 -10.54 2.92 Favored 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 124.216 3.277 . . . . 0.29999999999999999 114.387 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.38 -37.77 87.99 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.894 0.854 . . . . 1.3600000000000001 110.78 173.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.652 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 6.3 mt -76.55 -6.09 50.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.749 1.389 . . . . 1.26 114.749 -169.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.606 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -50.7 -39.72 52.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.527 1.156 . . . . 1.8899999999999999 109.942 -177.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.95 -45.26 12.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.694 -2.048 . . . . 1.1000000000000001 111.453 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.64 -165.28 35.98 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.576 -0.821 . . . . 0.29999999999999999 114.187 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.449 HD21 ' HB ' ' A' ' 9' ' ' VAL . 5.8 mp -117.33 158.13 24.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.501 -1.35 . . . . 1.0800000000000001 110.593 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.639 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 68.3 m -134.25 134.12 41.6 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.756 -0.656 . . . . 1.1699999999999999 111.101 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -47.5 129.06 13.17 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.446 0.906 . . . . 1.1699999999999999 113.446 175.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.635 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 81.84 -12.77 40.39 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 114.38 -1.282 . . . . 0.38 111.865 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.639 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.6 tt0 -64.7 151.63 44.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.715 0.769 . . . . 1.1899999999999999 110.307 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 41.1 m -118.0 133.68 55.69 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.257 -1.338 . . . . 1.22 109.277 -172.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 29' ' ' LEU . 19.2 pt -136.28 148.05 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.389 0.614 . . . . 1.0600000000000001 110.503 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 ' H ' HD22 ' A' ' 33' ' ' ASN . 14.8 t -93.1 149.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.087 -0.96 . . . . 0.20999999999999999 110.342 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 17.1 mm -118.01 88.94 33.06 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 1.01 108.61 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HA ' HD12 ' A' ' 4' ' ' LEU . 31.1 Cg_endo -61.73 140.64 87.13 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.0 2.466 . . . . 0.23000000000000001 112.468 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.607 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 82.76 -7.26 66.36 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.45 -0.796 . . . . 0.29999999999999999 112.692 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.734 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -115.24 125.33 29.01 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.777 -0.823 . . . . 1.0800000000000001 108.777 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.546 ' CD ' HD21 ' A' ' 51' ' ' LEU . 57.1 Cg_endo -65.39 174.2 5.47 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 124.064 3.176 . . . . 0.34000000000000002 114.129 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.474 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 6.9 t70 -95.74 137.16 21.93 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.776 -1.102 . . . . 0.71999999999999997 111.877 -170.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.572 ' HD3' HD11 ' A' ' 5' ' ' LEU . 71.3 Cg_endo -82.25 -8.36 11.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.496 2.797 . . . . 0.33000000000000002 113.552 -174.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 55' ' ' TYR . 51.3 m-85 -95.21 -22.25 17.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.089 0.471 . . . . 2.29 110.942 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -85.5 -6.8 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.069 0.938 . . . . 2.0600000000000001 108.942 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.588 HD11 ' HG2' ' A' ' 158' ' ' PRO . 87.1 mt -95.8 127.46 41.19 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.446 -1.252 . . . . 1.0900000000000001 110.226 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -102.12 96.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.147 1.231 . . . . 0.22 110.698 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.472 ' HB2' HG21 ' A' ' 161' ' ' THR . 89.2 m-85 -157.4 131.49 8.26 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.241 -1.392 . . . . 0.80000000000000004 107.241 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 18.3 m170 -136.08 103.21 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.706 -1.59 . . . . 3.5800000000000001 106.706 -165.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 55.6 mt -94.53 112.32 26.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.569 -0.742 . . . . 1.0600000000000001 110.537 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.97 96.83 6.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.102 -0.954 . . . . 1.1200000000000001 110.361 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -119.09 106.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.543 -1.208 . . . . 0.68000000000000005 110.361 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.522 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 24.1 m -101.06 125.94 47.71 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.542 -0.754 . . . . 1.3300000000000001 109.805 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 mt -47.01 -35.64 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.137 0.494 . . . . 1.77 110.83 166.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.47 -49.16 46.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.469 -0.872 . . . . 0.93999999999999995 111.514 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -68.92 -24.65 64.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 1.22 112.186 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 2.9 tppt? 55.67 18.69 2.95 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.489 1.138 . . . . 2.9399999999999999 112.055 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.443 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.69 140.25 34.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.968 0.889 . . . . 1.0600000000000001 111.15 173.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.471 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -96.89 118.57 33.61 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.9 -1.5 . . . . 1.0900000000000001 109.275 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.0 m -101.13 123.82 45.88 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.194 -0.602 . . . . 1.0900000000000001 111.17 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.518 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.95 131.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.767 -1.938 . . . . 1.0800000000000001 105.767 176.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 12.0 m -136.86 130.72 32.18 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 120.735 1.607 . . . . 0.93000000000000005 112.761 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.15 126.89 55.14 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.278 -0.874 . . . . 1.1399999999999999 110.322 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.0 t-20 63.7 35.65 11.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.383 0.611 . . . . 0.52000000000000002 109.463 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.3 m-20 78.52 -0.04 2.53 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.548 -1.206 . . . . 1.8400000000000001 112.613 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -129.99 139.42 51.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.082 -1.447 . . . . 3.8500000000000001 113.793 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -51.89 149.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 112.891 -1.959 . . . . 0.40999999999999998 113.737 -172.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.518 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.6 mtp -101.56 -42.04 6.38 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.234 -2.257 . . . . 1.0900000000000001 108.22 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -176.64 160.78 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.508 -2.133 . . . . 2.6200000000000001 110.373 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.443 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 9.5 m -122.78 132.6 54.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.527 -0.175 . . . . 1.1000000000000001 110.527 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.57 156.04 53.85 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 110.346 -0.242 . . . . 1.0600000000000001 110.346 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.36 143.45 11.11 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.7 2.267 . . . . 0.85999999999999999 111.842 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.37 173.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.482 -0.326 . . . . 1.2 110.148 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.5 149.86 24.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.352 . . . . 1.4099999999999999 110.804 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.511 ' CG1' ' HA ' ' A' ' 68' ' ' LYS . 16.9 m -136.06 6.32 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.99 -0.55 . . . . 1.6699999999999999 110.75 -170.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.25 71.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.746 . . . . 3.0800000000000001 113.151 -173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -162.04 154.05 19.11 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.44 -0.948 . . . . 7.6200000000000001 108.44 175.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt 67.23 95.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 O-C-N 123.557 0.536 . . . . 6.7199999999999998 110.025 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.56 7.08 46.58 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.21 -0.306 . . . . 7.6299999999999999 111.284 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.1 p -73.77 -72.71 0.25 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.079 0.466 . . . . 5.5099999999999998 110.778 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -151.79 -159.05 0.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.661 . . . . 5.3899999999999997 109.565 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.682 HG21 ' H ' ' A' ' 167' ' ' ARG . 28.9 p -60.23 122.51 67.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 109.064 -0.717 . . . . 2.5600000000000001 109.064 169.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -42.02 -65.77 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.586 2.857 . . . . 3.6600000000000001 113.8 -172.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -153.0 -170.85 3.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.105 -0.702 . . . . 4.1699999999999999 109.105 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.464 ' H ' HG23 ' A' ' 95' ' ' THR . . . -86.79 -104.92 0.81 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.423 -0.894 . . . . 2.6899999999999999 111.982 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' HG2' ' HG1' ' A' ' 164' ' ' THR . 46.5 mt-10 -113.64 149.83 34.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.507 0.67 . . . . 2.2999999999999998 111.442 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.644 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 6.7 m-85 -125.27 178.25 5.68 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.998 -1.112 . . . . 2.3500000000000001 107.998 175.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.7 m-85 -132.56 137.96 47.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.719 0.295 . . . . 0.92000000000000004 110.499 172.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 17.2 mm -58.73 116.5 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.562 -1.273 . . . . 1.0600000000000001 107.562 165.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.458 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.2 tt -102.09 -34.39 3.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.042 -0.663 . . . . 1.04 111.985 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.639 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 59.1 t30 -166.21 -177.83 4.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 122.819 1.295 . . . . 2.3500000000000001 113.846 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.639 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.7 ptt180 -155.65 131.27 9.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 111.476 -2.602 . . . . 1.54 110.187 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.2 153.7 20.66 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 121.925 0.869 . . . . 1.8899999999999999 110.76 -173.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -51.47 152.71 2.51 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.352 -1.749 . . . . 3.46 113.25 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -44.69 110.84 1.12 Allowed Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 112.331 -2.213 . . . . 3.3500000000000001 110.69 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -54.15 -50.34 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.499 2.799 . . . . 0.97999999999999998 111.827 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.65 -20.35 20.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.088 -0.96 . . . . 1.0800000000000001 112.683 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -132.94 -169.53 12.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.082 -0.58 . . . . 1.1599999999999999 112.123 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.77 37.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.906 3.737 . . . . 1.46 114.487 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.649 ' HE2' ' CE1' ' A' ' 111' ' ' PHE . 52.1 t80 -82.06 -18.04 44.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.695 -0.483 . . . . 2.1000000000000001 109.695 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.56 52.3 0.99 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.599 -0.728 . . . . 1.1100000000000001 114.415 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB2' HD12 ' A' ' 151' ' ' ILE . . . 71.71 -63.08 0.44 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.258 1.207 . . . . 1.45 114.258 164.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.595 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -142.41 138.28 30.99 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.541 -0.299 . . . . 1.5 110.204 -172.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.44 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 51.4 t-105 -98.35 99.35 10.54 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.976 -0.75 . . . . 2.6000000000000001 108.976 169.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.613 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.5 mp -109.34 135.28 50.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.628 0.727 . . . . 1.3100000000000001 110.659 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 m -107.58 149.17 28.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.278 -0.874 . . . . 1.3100000000000001 112.047 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.467 ' HB2' ' N ' ' A' ' 124' ' ' GLY . 1.5 tp -102.17 -173.78 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.916 -1.038 . . . . 1.8600000000000001 108.573 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.481 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 48.0 t -86.3 -79.89 0.25 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.627 -0.429 . . . . 1.95 112.101 -175.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -128.29 159.49 35.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.791 0.293 . . . . 3.3999999999999999 111.791 -171.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.87 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.272 0.983 . . . . 5.5800000000000001 112.633 169.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.6 t60 62.26 57.36 1.99 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.853 0.835 . . . . 6.7300000000000004 108.862 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 1.621 ' HE2' ' CE1' ' A' ' 123' ' ' TYR . 5.0 p90 -97.9 95.72 7.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.069 -0.969 . . . . 5.1500000000000004 112.178 -169.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.467 ' N ' ' HB2' ' A' ' 118' ' ' LEU . . . -156.32 148.04 17.45 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.271 -0.966 . . . . 1.1899999999999999 114.235 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.613 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 7.4 mt -147.74 107.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.522 -1.659 . . . . 1.05 106.522 163.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.491 ' HB3' ' HG2' ' A' ' 144' ' ' ARG . 7.1 t-80 -134.9 179.31 6.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.883 -0.727 . . . . 1.25 111.715 -166.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -123.54 176.46 16.73 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.775 -1.102 . . . . 0.46000000000000002 111.537 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.8 t -148.07 171.77 15.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.154 0.502 . . . . 1.21 111.07 -168.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.38 -15.41 17.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.209 -0.905 . . . . 1.8600000000000001 109.523 166.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -125.33 101.34 31.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.673 -0.694 . . . . 1.8200000000000001 109.873 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -90.65 4.88 4.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.171 2.581 . . . . 0.64000000000000001 112.762 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.66 0.54 42.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.038 0.447 . . . . 1.3200000000000001 110.849 -170.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.6 p -111.22 -2.31 15.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.661 0.743 . . . . 1.8899999999999999 109.711 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 20.9 mm -92.57 126.67 45.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.967 -1.015 . . . . 1.21 110.772 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.37 -134.87 13.22 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.502 -0.856 . . . . 1.6799999999999999 112.171 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -76.02 87.72 2.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.269 0.557 . . . . 4.8799999999999999 110.345 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -160.76 -63.12 0.06 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.372 -0.831 . . . . 4.4699999999999998 109.942 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.83 172.41 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.749 -0.659 . . . . 4.6799999999999997 110.113 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.404 ' OG ' ' HD2' ' A' ' 140' ' ' LYS . 7.7 p -91.05 -58.72 2.37 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.669 -0.241 . . . . 5.9100000000000001 110.942 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HD2' ' OG ' ' A' ' 139' ' ' SER . 11.4 mptt -72.03 141.05 49.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 8.5999999999999996 110.982 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.29 174.76 26.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.048 -0.596 . . . . 4.1900000000000004 111.701 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.0 t -99.32 159.8 14.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.8 0.3 . . . . 2.9199999999999999 110.537 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.3 tt -75.24 80.64 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 122.267 1.032 . . . . 2.0699999999999998 110.902 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.491 ' HG2' ' HB3' ' A' ' 126' ' ' HIS . 54.0 mtt180 -118.39 172.02 7.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.898 -1.046 . . . . 3.98 109.742 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.4 mtp -147.85 179.75 7.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.452 . . . . 1.8700000000000001 110.599 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -71.38 146.22 48.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.457 -0.942 . . . . 3.25 108.457 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -50.21 -67.78 0.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 112.508 0.558 . . . . 2.4199999999999999 112.508 -171.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -23.13 65.58 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.441 -0.787 . . . . 2.5699999999999998 112.018 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.81 -40.57 63.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.865 -0.607 . . . . 1.05 111.055 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.721 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 8.9 p -75.77 -17.94 15.58 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 110.285 -0.265 . . . . 0.32000000000000001 110.285 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.439 HD12 ' HB2' ' A' ' 113' ' ' ALA . 2.6 mp -87.12 -39.46 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 118.985 -0.531 . . . . 1.1299999999999999 110.61 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -43.7 -70.15 0.11 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.534 1.061 . . . . 1.3799999999999999 111.964 162.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.472 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -48.8 -44.79 39.47 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.626 -0.716 . . . . 1.3400000000000001 110.139 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.721 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -53.88 -55.2 28.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.244 -1.344 . . . . 1.02 112.337 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.473 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 33.1 t -77.42 -14.72 59.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.592 -1.186 . . . . 1.9099999999999999 110.9 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.54 -47.16 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.863 -0.421 . . . . 1.04 109.863 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.475 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 32.6 m -76.12 120.11 80.23 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.885 0.85 . . . . 0.20999999999999999 110.595 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.588 ' HG2' HD11 ' A' ' 57' ' ' ILE . 41.2 Cg_endo -83.43 -178.69 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.955 2.437 . . . . 0.51000000000000001 112.538 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.734 ' O ' HD22 ' A' ' 51' ' ' LEU . 19.9 m120 -62.3 4.25 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.503 -1.226 . . . . 1.02 113.366 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.3 54.84 0.52 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.64000000000000001 112.446 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.728 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -89.72 131.17 35.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.438 -0.448 . . . . 1.0700000000000001 110.837 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.37 138.9 31.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.472 -0.491 . . . . 2.3399999999999999 110.342 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 3.8 p -146.71 127.7 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.377 -0.829 . . . . 0.46000000000000002 111.13 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.427 ' HG1' ' HG2' ' A' ' 97' ' ' GLU . 7.1 m -111.67 133.38 53.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 1.26 111.1 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.7 mp -119.18 110.13 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 117.832 -1.547 . . . . 1.1699999999999999 110.558 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.576 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.17 141.74 31.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.896 -1.047 . . . . 1.1899999999999999 110.312 -171.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.682 ' H ' HG21 ' A' ' 93' ' ' THR . 7.5 ptm180 -92.38 -32.68 14.86 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.43 -0.805 . . . . 3.7999999999999998 111.922 -175.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.93 -59.58 3.06 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 121.18 -0.533 . . . . 3.6499999999999999 113.54 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.375 -0.821 . . . . 5.9699999999999998 110.453 -178.355 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.518 ' O31' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.887 -0.485 . . . . 3.3799999999999999 111.887 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -137.77 179.57 6.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.677 0.275 . . . . 4.6799999999999997 110.74 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.6 mptt -61.31 154.9 22.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.714 -0.676 . . . . 2.54 109.864 172.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.57 HD12 ' H ' ' A' ' 50' ' ' GLY . 15.7 mt -93.49 167.22 11.84 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.367 0.417 . . . . 1.1000000000000001 111.332 175.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 6' ' ' THR . 2.5 tp -77.11 151.2 35.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.488 0.715 . . . . 1.05 111.902 -170.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.554 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.8 150.14 38.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 122.1 0.952 . . . . 1.01 112.168 169.081 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.649 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 62.8 t80 -133.67 150.29 51.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.754 -1.567 . . . . 1.1200000000000001 107.86 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -129.93 114.97 16.52 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.071 -1.455 . . . . 1.72 107.071 175.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.4 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 0.9 OUTLIER -74.32 157.15 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.342 0.591 . . . . 0.38 112.359 -166.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -102.8 149.04 24.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.001 -0.999 . . . . 3.0600000000000001 108.978 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.491 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -52.53 117.94 3.24 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.874 -0.603 . . . . 2.1699999999999999 111.369 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.67 -10.26 32.56 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.516 -0.766 . . . . 0.63 112.446 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.498 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 54.6 m-20 -62.24 147.55 47.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.997 0.427 . . . . 2.1699999999999999 111.827 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.19 149.38 50.47 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.892 -0.594 . . . . 1.27 111.908 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.2 tp -46.16 -60.42 2.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.868 1.062 . . . . 1.0800000000000001 113.868 -173.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.659 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.7 t-20 -64.41 -38.96 92.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.751 1.262 . . . . 1.55 110.15 -171.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.764 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 19.3 m -62.07 -40.93 97.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.636 -2.075 . . . . 1.8200000000000001 111.002 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.28 -39.74 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.013 0.925 . . . . 1.0600000000000001 112.736 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.81 -62.1 1.98 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.61 -0.268 . . . . 0.97999999999999998 111.203 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.38 -4.65 52.01 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.814 -1.155 . . . . 1.0700000000000001 111.789 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.764 ' HB2' ' O ' ' A' ' 17' ' ' SER . 12.1 t70 -63.68 -32.42 73.9 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.135 -1.061 . . . . 1.6299999999999999 108.135 158.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' A' ' 101' ' ' ILE . 2.0 m-85 -102.53 16.49 26.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 112.354 0.502 . . . . 0.25 112.354 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 54.46 52.02 13.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.206 -0.906 . . . . 4.2000000000000002 110.644 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 34.9 pt -147.99 -171.35 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.971 -0.752 . . . . 1.02 108.971 -172.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.85 147.47 24.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.668 -0.697 . . . . 1.1599999999999999 109.917 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.659 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 15.8 p -63.0 -35.88 81.68 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.725 -0.843 . . . . 1.05 108.725 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.9 68.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.196 -1.366 . . . . 1.05 111.619 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.79 -38.43 25.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.368 0.604 . . . . 1.03 109.551 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 13.6 tp -73.88 -18.82 60.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 1.05 109.084 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.65 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.25 -39.34 33.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.616 0.722 . . . . 1.0600000000000001 111.444 171.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -61.03 -40.3 93.06 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.128 -0.942 . . . . 1.26 110.009 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.74 36.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.881 -1.509 . . . . 1.01 112.085 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 29.7 m-80 -142.02 71.57 23.43 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.039 0.447 . . . . 0.20000000000000001 109.825 -173.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.501 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.33 -10.26 6.21 Favored 'Trans proline' 0 C--O 1.218 -0.475 0 C-N-CA 123.484 2.789 . . . . 0.29999999999999999 114.07 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -62.63 -33.83 75.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.09 0.947 . . . . 1.3600000000000001 109.75 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -78.78 -4.51 49.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.262 -1.335 . . . . 1.26 114.233 -172.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.65 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.64 -40.11 26.6 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 122.414 1.102 . . . . 1.8899999999999999 110.249 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.557 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.46 -46.51 10.82 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.997 -1.911 . . . . 1.1000000000000001 111.565 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.52 -164.52 34.89 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.978 -1.106 . . . . 0.29999999999999999 114.264 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -116.38 159.56 21.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.262 -1.469 . . . . 1.0800000000000001 110.396 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.1 m -138.44 135.09 34.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.916 -0.584 . . . . 1.1699999999999999 110.871 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -48.0 129.32 14.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.662 0.744 . . . . 1.1699999999999999 112.857 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.5 -13.64 39.88 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.46 -1.246 . . . . 0.38 112.179 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.8 tt0 -64.59 151.3 45.04 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.628 0.728 . . . . 1.1899999999999999 110.272 174.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.444 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 46.1 m -117.91 133.18 56.18 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.495 -1.23 . . . . 1.22 109.276 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.22 148.97 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.277 0.561 . . . . 1.0600000000000001 110.511 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.471 ' H ' HD22 ' A' ' 33' ' ' ASN . 14.2 t -93.41 149.61 4.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.136 -0.938 . . . . 0.20999999999999999 110.099 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 21.7 mm -117.64 88.58 30.08 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.05 -0.977 . . . . 1.01 108.584 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.57 ' HA ' HD12 ' A' ' 4' ' ' LEU . 23.7 Cg_endo -59.06 143.28 99.86 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.053 2.502 . . . . 0.23000000000000001 112.585 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.57 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 80.22 -6.59 59.67 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.694 -0.685 . . . . 0.29999999999999999 112.996 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.691 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -116.73 126.39 27.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.752 -0.833 . . . . 1.0800000000000001 108.752 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.549 ' CD ' HD21 ' A' ' 51' ' ' LEU . 61.6 Cg_endo -66.86 171.01 11.7 Favored 'Trans proline' 0 N--CA 1.477 0.517 0 C-N-CA 123.644 2.896 . . . . 0.34000000000000002 114.029 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -90.95 138.89 25.9 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.573 -1.194 . . . . 0.71999999999999997 111.82 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.525 ' HD3' HD11 ' A' ' 5' ' ' LEU . 66.3 Cg_endo -83.17 -4.94 11.19 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.529 2.819 . . . . 0.33000000000000002 113.771 -173.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.34 -29.3 14.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.613 0.244 . . . . 2.29 111.235 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -80.38 -17.53 51.62 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.825 -0.805 . . . . 2.0600000000000001 108.825 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.523 HD11 ' HG2' ' A' ' 158' ' ' PRO . 87.2 mt -81.44 123.31 81.2 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.974 -1.012 . . . . 1.0900000000000001 109.224 169.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -100.83 94.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 120.023 1.044 . . . . 0.22 110.13 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -158.78 129.79 6.23 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.558 -1.645 . . . . 0.80000000000000004 106.558 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.661 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 42.9 m170 -134.02 106.56 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.198 -1.779 . . . . 3.5800000000000001 106.198 -165.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -95.06 110.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.908 -0.717 . . . . 1.0600000000000001 110.904 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.13 94.21 4.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.277 -0.874 . . . . 1.1200000000000001 110.442 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.532 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -119.36 97.76 5.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.317 -1.31 . . . . 0.68000000000000005 110.432 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.49 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 48.9 m -89.33 112.26 23.31 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.529 -1.286 . . . . 1.3300000000000001 107.529 173.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.67 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 1.4 mm -42.34 -43.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.901 -0.59 . . . . 1.77 110.03 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 89' ' ' ILE . . . -56.94 -46.33 91.07 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.661 -1.257 . . . . 0.93999999999999995 111.746 175.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -66.83 -23.87 66.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.629 0.603 . . . . 1.22 112.629 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.514 ' HE2' ' CG1' ' A' ' 86' ' ' VAL . 81.6 mttt 62.63 13.08 6.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.034 0.753 . . . . 2.9399999999999999 113.034 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.25 138.89 33.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.225 1.012 . . . . 1.0600000000000001 111.796 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.532 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -98.45 120.63 39.21 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.241 -1.8 . . . . 1.0900000000000001 109.282 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -102.1 124.23 47.34 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.593 -0.843 . . . . 1.0900000000000001 110.826 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.572 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -85.21 129.92 34.71 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.728 -1.953 . . . . 1.0800000000000001 105.728 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.661 ' OG ' ' HB2' ' A' ' 60' ' ' HIS . 13.7 p -139.23 128.88 24.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 121.37 1.895 . . . . 0.93000000000000005 114.03 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 tp -113.97 127.49 55.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.346 -1.297 . . . . 1.1399999999999999 110.338 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 11.5 t-20 63.44 35.9 11.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.217 0.532 . . . . 0.52000000000000002 109.675 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.6 m-20 79.96 -1.02 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.835 -1.075 . . . . 1.8400000000000001 112.697 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -131.2 138.78 49.55 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.391 -1.324 . . . . 3.8500000000000001 113.832 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -50.31 149.31 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 113.004 -1.907 . . . . 0.40999999999999998 113.298 -176.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.572 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.6 mtp -97.95 -46.03 6.06 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 112.116 -2.311 . . . . 1.0900000000000001 107.525 174.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -177.87 157.56 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.576 -2.102 . . . . 2.6200000000000001 110.479 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -115.69 132.15 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.508 0.195 . . . . 1.1000000000000001 110.886 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.45 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 69.5 m-85 -115.63 147.27 38.54 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.617 -0.265 . . . . 1.0600000000000001 110.398 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -86.92 141.71 6.32 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.489 2.126 . . . . 0.85999999999999999 111.793 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.44 -177.51 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.332 -0.395 . . . . 1.2 110.807 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.06 133.49 34.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.842 0.353 . . . . 1.4099999999999999 111.168 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.514 ' CG1' ' HE2' ' A' ' 68' ' ' LYS . 21.1 t -150.31 157.4 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.575 -0.739 . . . . 1.6699999999999999 110.984 -175.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.417 ' N ' ' CG1' ' A' ' 86' ' ' VAL . . . -77.49 -108.28 0.16 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.363 -0.446 . . . . 3.0800000000000001 112.273 170.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -144.19 -32.31 0.43 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.751 0.649 . . . . 7.6200000000000001 112.751 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.42 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 1.1 pp -63.53 170.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.977 0.732 . . . . 6.7199999999999998 112.977 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 90' ' ' LEU . 51.8 tp -149.39 79.05 1.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.106 -0.497 . . . . 7.6299999999999999 112.088 -173.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.572 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 6.3 m -158.29 -97.56 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 O-C-N 122.367 -0.208 . . . . 5.5099999999999998 111.028 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.502 ' HA ' ' HB2' ' A' ' 166' ' ' ASN . 48.5 mt-30 -138.71 154.61 48.58 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.956 -0.465 . . . . 5.3899999999999997 111.852 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' A' ' 166' ' ' ASN . 0.5 OUTLIER -71.59 176.4 2.22 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 109.608 -0.516 . . . . 2.5600000000000001 109.608 174.07 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.81 -68.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 120.855 1.037 . . . . 3.6600000000000001 109.886 163.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 p -155.73 121.36 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.834 -0.802 . . . . 4.1699999999999999 108.834 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.52 87.41 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 119.195 -1.479 . . . . 2.6899999999999999 114.754 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -124.75 130.87 53.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.1 0.476 . . . . 2.2999999999999998 109.76 168.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.642 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 13.6 m-85 -128.79 -175.65 3.61 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.478 -0.783 . . . . 2.3500000000000001 110.452 -178.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 161' ' ' THR . 69.0 m-85 -136.84 139.27 41.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.92000000000000004 109.838 171.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.471 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 26.0 mm -60.23 118.79 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.997 -1.112 . . . . 1.0600000000000001 107.997 167.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 22' ' ' PHE . 2.8 tt -114.46 -22.68 4.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 119.814 -0.754 . . . . 1.04 112.287 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.603 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 66.0 t30 -167.67 178.62 5.23 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 122.86 1.314 . . . . 2.3500000000000001 114.325 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.603 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 2.1 ptt180 -151.18 131.8 13.94 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 111.387 -2.642 . . . . 1.54 110.447 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.577 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 5.5 tp60 -109.45 145.37 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.981 0.896 . . . . 1.8899999999999999 111.623 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.577 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 61.3 ttt180 -54.92 150.24 10.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.431 -1.713 . . . . 3.46 111.487 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.04 106.22 0.54 Allowed Pre-proline 0 CA--C 1.511 -0.52 0 CA-C-N 115.602 -0.726 . . . . 3.3500000000000001 111.624 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.01 -48.84 20.01 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.781 2.988 . . . . 0.97999999999999998 111.69 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.87 -21.1 14.07 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.961 -1.018 . . . . 1.0800000000000001 112.624 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -101.75 -169.89 27.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.956 -0.64 . . . . 1.1599999999999999 112.13 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.44 31.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.231 3.288 . . . . 1.46 113.533 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.614 ' CE1' ' HB2' ' A' ' 115' ' ' TRP . 1.1 t80 -72.51 -33.45 66.93 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.308 -0.627 . . . . 2.1000000000000001 109.308 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.28 60.64 0.78 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.119 -0.946 . . . . 1.1100000000000001 114.485 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' HB3' HD12 ' A' ' 151' ' ' ILE . . . 74.51 -45.09 0.57 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.182 1.178 . . . . 1.45 114.182 166.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.634 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -150.41 145.79 26.28 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.21 -0.293 . . . . 1.5 110.21 -176.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.614 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 24.1 t-105 -116.01 101.06 8.42 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.258 -0.645 . . . . 2.6000000000000001 109.258 166.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.5 mp -100.66 127.79 46.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.792 0.806 . . . . 1.3100000000000001 110.536 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.4 m -87.44 133.72 33.7 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.22 -0.9 . . . . 1.3100000000000001 111.672 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.55 -179.42 6.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.233 -1.395 . . . . 1.8600000000000001 107.233 168.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.473 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 40.8 t -68.31 -85.24 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.392 -0.523 . . . . 1.95 110.037 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.604 ' HA ' ' OD1' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -66.05 119.42 11.37 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.937 -0.394 . . . . 3.3999999999999999 109.937 -176.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.511 ' HG3' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -68.61 43.5 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.293 1.22 . . . . 5.5800000000000001 114.293 -172.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -114.45 -15.38 12.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.469 -0.567 . . . . 6.7300000000000004 109.469 171.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -136.19 151.93 50.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.329 -0.851 . . . . 5.1500000000000004 109.834 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -153.16 145.96 13.93 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.974 -0.85 . . . . 1.1899999999999999 110.974 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.588 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 17.2 mt -93.4 120.76 43.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.477 -0.564 . . . . 1.05 109.477 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 7.9 p80 -155.43 -163.97 1.65 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.507 0.67 . . . . 1.25 111.729 -176.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -121.91 179.25 16.27 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.014 -1.089 . . . . 0.46000000000000002 113.123 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 t -136.09 173.29 11.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.215 -0.493 . . . . 1.21 110.797 -168.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -104.22 -18.45 14.48 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.358 -0.837 . . . . 1.8600000000000001 108.873 166.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -128.01 103.68 20.95 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 1.8200000000000001 110.366 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.403 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 53.4 Cg_endo -91.21 4.07 4.25 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.143 2.562 . . . . 0.64000000000000001 112.928 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.23 -18.67 33.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.284 0.564 . . . . 1.3200000000000001 110.337 -172.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 m -89.26 -12.92 39.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 1.8899999999999999 109.922 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 5.3 mm -65.8 116.55 5.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.238 -0.892 . . . . 1.21 111.373 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.54 -38.99 2.99 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.417 -0.811 . . . . 1.6799999999999999 113.516 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -125.22 3.91 7.83 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.719 0.637 . . . . 4.8799999999999999 112.719 -171.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -150.78 167.37 27.64 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.052 -0.259 . . . . 4.4699999999999998 111.321 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.0 t 50.93 69.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 123.955 0.784 . . . . 4.6799999999999997 110.985 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.1 m -81.18 21.09 0.76 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.681 -0.691 . . . . 5.9100000000000001 111.759 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.08 -44.81 71.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.215 0.531 . . . . 8.5999999999999996 110.05 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 142' ' ' CYS . . . 146.6 -151.16 23.46 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.33 -0.708 . . . . 4.1900000000000004 111.33 -176.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 141' ' ' GLY . 1.2 m 75.98 104.15 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.261 0.624 . . . . 2.9199999999999999 109.666 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 38.7 mt -85.71 64.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.945 0.879 . . . . 2.0699999999999998 109.599 -176.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 29.7 ptt180 -102.7 149.96 23.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.884 -1.053 . . . . 3.98 110.437 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.45 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 8.3 mtm -140.74 -166.27 2.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.759 0.314 . . . . 1.8700000000000001 110.198 -177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.427 ' HD2' ' OD1' ' A' ' 147' ' ' ASN . 1.9 t60 -67.58 145.33 54.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.155 -0.683 . . . . 3.25 109.155 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.427 ' OD1' ' HD2' ' A' ' 146' ' ' HIS . 30.5 p-10 -49.33 -66.43 0.4 Allowed 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.296 0.48 . . . . 2.4199999999999999 112.296 -174.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -62.95 -23.35 67.36 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.834 -0.541 . . . . 2.5699999999999998 111.603 -174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 1.5 m-20 -69.19 -43.14 74.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 1.05 110.9 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.671 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 14.3 p -77.68 -20.53 13.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 CA-C-N 116.555 -0.293 . . . . 0.32000000000000001 111.036 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.401 HD12 ' HB3' ' A' ' 113' ' ' ALA . 3.1 mp -84.79 -40.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 118.907 -0.568 . . . . 1.1299999999999999 110.437 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -43.63 -68.7 0.17 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.608 1.095 . . . . 1.3799999999999999 111.931 163.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.469 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -50.55 -44.03 56.38 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.726 -0.67 . . . . 1.3400000000000001 110.375 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.671 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -53.69 -54.28 40.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.377 -1.283 . . . . 1.02 112.157 -171.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.6 p -77.76 -13.73 59.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.223 -1.353 . . . . 1.9099999999999999 111.443 -172.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -93.51 -46.82 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.907 0.384 . . . . 1.04 110.227 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.401 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 24.4 m -76.61 122.64 86.96 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-O 121.586 0.708 . . . . 0.20999999999999999 110.077 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.523 ' HG2' HD11 ' A' ' 57' ' ' ILE . 34.8 Cg_endo -84.08 -178.51 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.89 2.394 . . . . 0.51000000000000001 112.557 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.691 ' O ' HD22 ' A' ' 51' ' ' LEU . 11.7 m120 -59.73 -0.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.021 . . . . 1.02 113.604 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.46 56.3 0.53 Allowed Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.822 -0.704 . . . . 0.64000000000000001 112.734 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.505 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 2.5 m -92.68 139.43 30.57 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 122.29 -0.535 . . . . 1.0700000000000001 110.733 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -85.1 134.6 34.19 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.151 -0.314 . . . . 2.3399999999999999 110.151 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.95 128.03 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.544 0.687 . . . . 0.46000000000000002 111.646 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.1 m -113.37 132.56 55.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.526 -0.761 . . . . 1.26 111.167 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.27 116.67 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 118.788 -1.165 . . . . 1.1699999999999999 110.184 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.662 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.3 122.56 13.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.185 0.993 . . . . 1.1899999999999999 111.171 -175.571 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.67 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 6.1 ptm180 -100.52 -62.86 1.19 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 116.275 1.954 . . . . 3.7999999999999998 116.275 -165.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.572 ' HA2' ' HB ' ' A' ' 91' ' ' THR . . . 141.98 -6.6 2.33 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 119.64 -1.266 . . . . 3.6499999999999999 112.318 -169.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 167' ' ' ARG . 58.3 p . . . . . 0 C--O 1.253 1.266 0 CA-C-O 118.015 -0.993 . . . . 5.9699999999999998 109.543 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.733 ' S21' ' H25' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.145 -0.382 . . . . 3.3799999999999999 112.145 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -93.58 -172.32 2.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.823 -0.436 . . . . 4.6799999999999997 109.823 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 5.8 mtmt -58.51 141.41 51.96 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.586 -0.734 . . . . 2.54 109.734 166.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.635 HD12 ' H ' ' A' ' 50' ' ' GLY . 15.7 mt -100.26 164.55 11.9 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.783 -0.644 . . . . 1.1000000000000001 111.389 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.538 ' HG ' ' N ' ' A' ' 6' ' ' THR . 2.7 tp -75.51 149.77 38.33 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.906 -0.588 . . . . 1.05 111.973 -169.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.538 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.39 149.91 38.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.015 0.912 . . . . 1.01 112.148 169.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.656 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 73.9 t80 -134.98 148.34 49.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.671 -1.604 . . . . 1.1200000000000001 107.661 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.75 115.72 17.71 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.175 -1.417 . . . . 1.72 107.175 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -77.82 158.47 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.886 -0.597 . . . . 0.38 111.843 -166.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -104.66 153.58 21.06 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.859 -0.793 . . . . 3.0600000000000001 108.859 -176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.539 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 16.8 tt0 -54.42 109.11 0.45 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.855 -0.611 . . . . 2.1699999999999999 112.243 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.56 -7.01 18.16 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.397 -0.82 . . . . 0.63 112.723 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.523 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 87.5 m-20 -63.01 152.93 35.48 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.101 0.451 . . . . 2.1699999999999999 111.973 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.405 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.9 p -132.27 155.05 49.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.01 0.433 . . . . 1.27 111.982 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.593 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 50.1 tp -49.12 -59.16 3.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.009 1.114 . . . . 1.0800000000000001 114.009 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.659 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 13.3 t-20 -64.54 -43.21 94.7 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 122.452 1.12 . . . . 1.55 110.481 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.722 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 21.1 t -57.45 -42.31 82.23 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 112.467 -2.151 . . . . 1.8200000000000001 110.289 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.94 -41.31 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 123.528 0.731 . . . . 1.0600000000000001 112.488 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.86 -64.83 0.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.529 -0.305 . . . . 0.97999999999999998 111.665 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.36 -3.89 48.38 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.067 -1.053 . . . . 1.0700000000000001 111.826 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.722 ' HB2' ' O ' ' A' ' 17' ' ' SER . 53.6 t0 -62.18 -42.76 99.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.971 -1.122 . . . . 1.6299999999999999 107.971 156.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.2 m-85 -89.93 16.28 8.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.123 0.416 . . . . 0.25 112.123 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 54.47 51.29 14.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.288 -0.869 . . . . 4.2000000000000002 110.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 38.6 pt -147.82 -173.62 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.826 -0.805 . . . . 1.02 108.826 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -100.87 146.09 27.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.48 -0.782 . . . . 1.1599999999999999 109.759 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.659 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -62.34 -35.78 80.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.452 0.644 . . . . 1.05 109.435 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.67 67.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.57 -1.195 . . . . 1.05 111.673 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.25 -38.7 24.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.302 0.572 . . . . 1.03 109.472 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.4 tp -73.48 -19.47 60.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.334 -0.848 . . . . 1.05 109.162 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.662 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.36 34.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.618 0.723 . . . . 1.0600000000000001 111.45 173.327 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.2 -39.32 94.31 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.002 0.906 . . . . 1.26 110.047 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 -19.65 38.28 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.052 -1.431 . . . . 1.01 111.861 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 29.9 m-80 -142.55 72.31 20.62 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 0.20000000000000001 109.709 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.594 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.2 Cg_endo -54.52 -19.42 17.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 123.545 2.83 . . . . 0.29999999999999999 113.9 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -59.85 -30.82 69.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.925 0.869 . . . . 1.3600000000000001 110.431 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.8 mt -79.78 -3.72 48.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.309 -1.314 . . . . 1.26 114.238 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.662 ' CA ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.67 -39.62 37.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.442 1.115 . . . . 1.8899999999999999 110.082 -177.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.553 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.22 -45.94 11.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.875 -1.966 . . . . 1.1000000000000001 111.733 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.33 -165.06 35.81 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.393 -0.908 . . . . 0.29999999999999999 113.963 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -115.08 158.22 22.45 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.232 -1.484 . . . . 1.0800000000000001 109.977 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.559 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.1 m -134.67 136.39 42.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.893 -0.594 . . . . 1.1699999999999999 110.553 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -45.75 127.64 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.272 0.841 . . . . 1.1699999999999999 113.272 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.33 -10.93 46.94 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.33 -1.305 . . . . 0.38 112.265 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.559 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -64.23 151.81 42.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.477 0.656 . . . . 1.1899999999999999 110.455 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.429 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 55.4 p -115.48 136.71 52.8 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.882 -1.054 . . . . 1.22 109.484 -173.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -137.36 149.37 25.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.414 0.626 . . . . 1.0600000000000001 110.382 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.8 t -96.48 149.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.973 -1.012 . . . . 0.20999999999999999 110.121 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 17.2 mm -117.9 87.47 27.85 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.155 -0.929 . . . . 1.01 108.702 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HA ' HD12 ' A' ' 4' ' ' LEU . 23.8 Cg_endo -59.14 141.41 98.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.248 2.632 . . . . 0.23000000000000001 113.018 -173.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.635 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 83.52 -7.89 67.14 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.557 -0.747 . . . . 0.29999999999999999 112.855 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -116.34 127.44 26.75 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.719 -0.845 . . . . 1.0800000000000001 108.719 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.6 Cg_endo -65.91 171.87 9.27 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.674 2.916 . . . . 0.34000000000000002 113.8 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 9.5 t70 -94.94 138.0 22.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.063 -0.971 . . . . 0.71999999999999997 111.522 -170.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 77.6 Cg_endo -75.32 -7.95 19.29 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 123.296 2.664 . . . . 0.33000000000000002 113.288 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -33.5 16.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.063 -0.255 . . . . 2.29 110.618 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.5 p -63.4 -31.82 73.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.426 1.107 . . . . 2.0600000000000001 108.31 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.584 HD11 ' HG2' ' A' ' 158' ' ' PRO . 95.1 mt -77.27 126.02 85.65 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.082 -1.872 . . . . 1.0900000000000001 110.857 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -100.97 95.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.946 0 C-N-CA 120.753 0.969 . . . . 0.22 110.257 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 73' ' ' SER . 94.3 m-85 -157.68 138.08 12.8 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.909 -1.515 . . . . 0.80000000000000004 106.909 171.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 55.5 t-80 -144.56 104.07 4.01 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.429 -1.323 . . . . 3.5800000000000001 107.429 -170.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 68.8 mt -94.8 109.25 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.037 -1.438 . . . . 1.0600000000000001 110.176 -174.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.05 102.74 11.17 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.19 -0.913 . . . . 1.1200000000000001 110.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.491 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -122.14 102.57 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.005 -1.452 . . . . 0.68000000000000005 109.988 178.48 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.51 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 30.2 t -95.0 135.67 36.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.183 -0.917 . . . . 1.3300000000000001 108.9 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.643 ' HB ' ' CB ' ' A' ' 167' ' ' ARG . 1.0 OUTLIER -59.64 -33.61 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.491 0.662 . . . . 1.77 109.95 170.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.04 -48.1 74.69 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 114.95 -1.023 . . . . 0.93999999999999995 111.368 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.51 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -69.08 -25.12 64.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.873 0.694 . . . . 1.22 112.873 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 57.18 12.71 1.39 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.871 0.869 . . . . 2.9399999999999999 112.982 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.43 142.27 35.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.575 0.702 . . . . 1.0600000000000001 111.349 177.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.491 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -98.07 118.42 34.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.499 -1.228 . . . . 1.0900000000000001 109.936 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 m -101.51 125.4 48.15 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.438 -0.505 . . . . 1.0900000000000001 111.35 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -83.16 134.89 34.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.47 -1.678 . . . . 1.0800000000000001 106.47 177.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 13.4 m -138.32 129.33 27.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.716 1.598 . . . . 0.93000000000000005 112.346 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.14 124.25 49.86 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.079 -0.964 . . . . 1.1399999999999999 110.01 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.57 37.51 3.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.843 -1.169 . . . . 0.52000000000000002 107.843 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m120 83.92 -14.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.679 -1.601 . . . . 1.8400000000000001 111.569 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -127.23 141.27 51.77 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 117.675 -1.61 . . . . 3.8500000000000001 114.613 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -56.55 148.75 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 112.291 -2.232 . . . . 0.40999999999999998 113.957 -165.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.52 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.0 mtp -100.49 -43.73 6.11 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.721 -2.49 . . . . 1.0900000000000001 107.804 175.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.471 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 33.3 tptt -179.92 161.34 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.497 -2.138 . . . . 2.6200000000000001 111.102 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.469 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 15.2 m -118.39 137.43 53.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 122.422 -0.174 . . . . 1.1000000000000001 110.908 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 82' ' ' TYR . 19.6 m-85 -126.03 137.81 30.88 Favored Pre-proline 0 N--CA 1.457 -0.107 0 CA-C-O 120.702 0.287 . . . . 1.0600000000000001 110.267 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.39 146.09 93.09 Favored 'Trans proline' 0 N--CA 1.471 0.184 0 C-N-CA 123.187 2.592 . . . . 0.85999999999999999 112.772 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.406 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -139.58 179.75 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.67 -0.493 . . . . 1.2 109.67 176.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.34 141.67 29.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.55 0.691 . . . . 1.4099999999999999 111.411 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' A' ' 65' ' ' ILE . 2.5 t -153.73 -35.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.112 -1.404 . . . . 1.6699999999999999 108.585 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.11 -134.94 13.17 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.392 -1.083 . . . . 3.0800000000000001 110.392 -175.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.601 ' HG3' ' H ' ' A' ' 89' ' ' ILE . 51.6 pttt -82.06 -62.98 1.48 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.089 -0.708 . . . . 7.6200000000000001 109.089 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.601 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 71.0 mt -157.29 96.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.437 -0.949 . . . . 6.7199999999999998 108.437 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.82 94.39 0.82 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.089 0.471 . . . . 7.6299999999999999 110.156 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.9 p -77.89 56.43 1.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.723 -0.671 . . . . 5.5099999999999998 112.222 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -127.47 -21.19 3.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.253 -0.431 . . . . 5.3899999999999997 110.962 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.458 ' CG2' ' H ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER 43.21 67.6 3.55 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 109.513 -0.551 . . . . 2.5600000000000001 109.513 -170.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HG3' ' O32' ' A' 1142 ' ' IM2 . 18.7 Cg_exo -18.01 -72.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.073 1 C-N-CA 125.496 4.131 . . . . 3.6600000000000001 115.437 -162.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.4 p -146.73 -76.82 0.19 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.418 0.628 . . . . 4.1699999999999999 110.246 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.9 -85.68 0.07 OUTLIER Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.243 -0.89 . . . . 2.6899999999999999 111.362 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -124.97 140.54 52.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.276 0.56 . . . . 2.2999999999999998 111.605 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.657 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 29.7 m-85 -125.87 177.1 6.5 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.939 -1.028 . . . . 2.3500000000000001 108.518 171.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.629 ' HA ' ' O ' ' A' ' 161' ' ' THR . 42.4 m-85 -129.86 139.71 51.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.766 0.317 . . . . 0.92000000000000004 110.19 169.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 18.6 mm -59.4 115.58 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.681 -1.229 . . . . 1.0600000000000001 107.681 166.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' A' ' 22' ' ' PHE . 2.6 tt -99.31 -30.03 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.622 -0.831 . . . . 1.04 112.068 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.469 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 7.0 t-20 -178.8 -165.06 0.08 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.599 1.19 . . . . 2.3500000000000001 113.775 176.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.586 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 9.9 mtt180 -148.2 132.86 17.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 111.969 -2.378 . . . . 1.54 108.871 -173.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.457 ' HG2' ' N ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -101.76 158.91 15.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.274 1.035 . . . . 1.8899999999999999 111.423 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.713 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 2.5 ttt180 -49.74 152.93 1.35 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 112.865 -1.971 . . . . 3.46 112.003 169.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.713 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.03 112.93 1.9 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 114.062 -1.426 . . . . 3.3500000000000001 110.861 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -57.44 -50.75 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.141 2.56 . . . . 0.97999999999999998 111.559 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.08 45.57 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.777 -1.101 . . . . 1.0800000000000001 112.469 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -107.32 -169.21 22.05 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.328 -0.463 . . . . 1.1599999999999999 112.09 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.6 36.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 124.576 3.517 . . . . 1.46 114.402 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.631 ' HE2' ' CE1' ' A' ' 111' ' ' PHE . 8.7 t80 -93.1 -12.05 31.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.76 0.314 . . . . 2.1000000000000001 110.977 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.59 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.51 33.4 5.37 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.408 -0.901 . . . . 1.1100000000000001 114.497 171.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.39 -22.5 0.25 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.943 1.09 . . . . 1.45 113.943 168.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.597 ' HE2' ' CE1' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -152.98 143.99 23.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.011 -0.366 . . . . 1.5 110.011 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -109.94 100.77 9.67 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.799 -0.815 . . . . 2.6000000000000001 108.799 166.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.799 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.1 mp -104.82 137.1 43.12 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.42 0.629 . . . . 1.3100000000000001 109.549 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.9 m -106.16 143.45 34.26 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.231 -0.895 . . . . 1.3100000000000001 112.064 -170.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.83 -174.79 3.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.702 -1.222 . . . . 1.8600000000000001 107.702 171.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.505 ' O ' ' HE2' ' A' ' 120' ' ' LYS . 20.1 m -95.33 18.91 11.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.218 0.451 . . . . 1.95 112.218 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' A' ' 119' ' ' SER . 0.0 OUTLIER -130.56 97.61 4.43 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 119.914 -0.714 . . . . 3.3999999999999999 112.398 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 54.05 -103.09 0.16 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.566 0.746 . . . . 5.5800000000000001 112.868 169.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -110.88 5.65 20.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.415 -0.357 . . . . 6.7300000000000004 111.068 -174.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -79.63 131.3 35.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.975 -0.38 . . . . 5.1500000000000004 109.975 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.501 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -155.93 160.43 30.03 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.854 -0.689 . . . . 1.1899999999999999 112.035 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.799 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 41.7 mt -92.56 107.39 18.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.476 -0.935 . . . . 1.05 108.476 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.54 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 9.2 p80 -140.9 -162.71 1.41 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.045 -0.662 . . . . 1.25 111.463 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.59 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.3 175.89 16.22 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.087 -1.054 . . . . 0.46000000000000002 113.449 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -141.1 177.9 7.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.946 -0.627 . . . . 1.21 109.849 -172.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 -4.71 9.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.317 -0.856 . . . . 1.8600000000000001 110.116 167.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -126.31 101.69 27.82 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 109.178 -0.675 . . . . 1.8200000000000001 109.178 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -92.5 3.57 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.636 2.89 . . . . 0.64000000000000001 114.015 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.11 -19.34 59.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.131 0.491 . . . . 1.3200000000000001 111.693 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.2 m -91.66 -18.24 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.116 0.484 . . . . 1.8899999999999999 110.456 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.3 mm -68.44 110.2 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.637 -0.71 . . . . 1.21 111.12 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 84' ' ' ILE . . . 105.32 1.63 41.1 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.791 -0.718 . . . . 1.6799999999999999 112.983 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -150.03 -54.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.229 0.514 . . . . 4.8799999999999999 112.309 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.64 158.11 17.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.275 0.559 . . . . 4.4699999999999998 111.874 -171.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.9 m -93.34 1.8 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.485 -0.779 . . . . 4.6799999999999997 109.984 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.3 m -67.86 95.28 0.51 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.189 -0.914 . . . . 5.9100000000000001 112.275 -173.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 56.02 58.33 4.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.64 -0.709 . . . . 8.5999999999999996 111.649 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.3 133.23 2.27 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.27 -0.967 . . . . 4.1900000000000004 112.749 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 63.9 m -120.66 -75.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.015 0.436 . . . . 2.9199999999999999 109.875 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 10.1 mt -122.09 76.17 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.518 . . . . 2.0699999999999998 109.822 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 89.2 mtt180 -129.85 147.33 51.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.838 -0.619 . . . . 3.98 110.124 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.51 ' HE2' ' CG ' ' A' ' 82' ' ' TYR . 10.5 mtp -139.36 -166.39 2.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.451 -0.34 . . . . 1.8700000000000001 110.196 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -79.13 158.89 27.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.597 -0.52 . . . . 3.25 109.597 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -52.05 -68.13 0.19 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 123.333 0.396 . . . . 2.4199999999999999 111.73 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -62.55 -24.54 67.58 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.728 -0.607 . . . . 2.5699999999999998 111.821 -175.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.27 -43.05 71.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.331 -0.395 . . . . 1.05 110.704 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.692 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 7.3 p -77.3 -19.8 14.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.374 -0.375 . . . . 0.32000000000000001 111.047 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.61 -39.53 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 118.987 -0.53 . . . . 1.1299999999999999 109.849 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -43.35 -70.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.257 0.935 . . . . 1.3799999999999999 112.107 163.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.45 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -49.81 -42.96 48.21 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 123.853 0.721 . . . . 1.3400000000000001 110.323 178.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.692 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -54.12 -56.68 15.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.3 -1.318 . . . . 1.02 111.884 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.2 t -76.41 -11.53 59.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.803 -1.09 . . . . 1.9099999999999999 110.626 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 92.9 mt -93.03 -47.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.751 -0.463 . . . . 1.04 109.751 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 27.0 m -77.17 119.16 76.36 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 121.996 0.903 . . . . 0.20999999999999999 110.81 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.584 ' HG2' HD11 ' A' ' 57' ' ' ILE . 33.1 Cg_endo -84.09 -177.71 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.017 2.478 . . . . 0.51000000000000001 113.013 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.651 ' O ' HD22 ' A' ' 51' ' ' LEU . 17.5 m120 -59.11 1.21 0.07 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.568 -1.196 . . . . 1.02 113.978 -176.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.08 55.92 0.47 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.729 . . . . 0.64000000000000001 112.173 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.1 m -84.83 137.03 33.41 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.543 -0.386 . . . . 1.0700000000000001 110.657 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.4 ' HG2' ' HE1' ' A' ' 99' ' ' TYR . 64.0 mtm180 -83.06 125.87 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.097 -0.335 . . . . 2.3399999999999999 110.097 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 61' ' ' ILE . 2.7 p -139.49 123.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.401 0.62 . . . . 0.46000000000000002 111.103 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.432 ' C ' HD11 ' A' ' 165' ' ' ILE . 62.5 m -113.44 137.12 51.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.699 -0.682 . . . . 1.26 111.813 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.432 HD11 ' C ' ' A' ' 164' ' ' THR . 3.2 mp -126.35 113.34 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 118.387 -1.325 . . . . 1.1699999999999999 111.08 172.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.5 135.91 25.51 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 113.468 -1.697 . . . . 1.1899999999999999 109.618 -174.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.643 ' CB ' ' HB ' ' A' ' 65' ' ' ILE . 3.9 ptt180 -92.47 -30.81 15.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.619 0.723 . . . . 3.7999999999999998 109.893 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -133.77 137.81 9.61 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.738 -1.119 . . . . 3.6499999999999999 111.093 170.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.72 -0.657 . . . . 5.9699999999999998 110.04 179.305 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.548 ' O31' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.907 -0.477 . . . . 3.3799999999999999 111.907 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 67.04 175.89 0.25 Allowed 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.304 0.641 . . . . 4.6799999999999997 111.687 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.9 mptp? -69.4 154.19 42.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.349 -0.841 . . . . 2.54 109.777 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.565 HD12 ' H ' ' A' ' 50' ' ' GLY . 15.5 mt -97.05 168.16 10.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.017 -0.538 . . . . 1.1000000000000001 111.147 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.8 tp -75.88 150.23 37.64 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 123.336 0.654 . . . . 1.05 111.886 -169.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.529 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.46 149.13 36.78 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.17 0.986 . . . . 1.01 111.978 167.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 77.9 t80 -135.18 150.84 50.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.277 -1.783 . . . . 1.1200000000000001 108.068 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.598 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.1 tm0? -129.41 120.96 26.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.359 -1.349 . . . . 1.72 107.359 174.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -81.41 159.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 123.327 0.651 . . . . 0.38 111.968 -171.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -107.84 151.14 26.15 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.071 -0.715 . . . . 3.0600000000000001 109.071 -176.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.503 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 4.9 tt0 -54.3 113.76 1.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.339 -0.846 . . . . 2.1699999999999999 111.949 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.75 -5.79 25.97 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.679 -0.772 . . . . 0.63 112.797 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 32.7 m-20 -66.6 156.26 35.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.661 0.615 . . . . 2.1699999999999999 112.661 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -133.86 154.64 50.9 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 116.048 -0.524 . . . . 1.27 112.273 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.581 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.54 -58.68 4.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.767 1.025 . . . . 1.0800000000000001 113.767 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.642 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.2 p30 -63.19 -41.83 99.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.794 1.283 . . . . 1.55 110.941 -171.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.787 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 3.2 m -61.83 -39.76 92.95 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.162 -2.29 . . . . 1.8200000000000001 110.878 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.45 -38.99 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 123.638 0.775 . . . . 1.0600000000000001 112.694 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.411 ' HB3' ' HA ' ' A' ' 26' ' ' THR . . . -57.15 -61.29 2.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.465 -0.334 . . . . 0.97999999999999998 111.2 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.32 -4.79 54.81 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.677 -1.209 . . . . 1.0700000000000001 111.774 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.787 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.0 t70 -61.95 -35.43 78.41 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.609 -1.256 . . . . 1.6299999999999999 107.609 157.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.9 m-85 -100.73 17.29 22.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.854 0.687 . . . . 0.25 112.854 176.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 121' ' ' GLN . 2.5 mpt_? 53.95 52.49 12.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.563 -0.744 . . . . 4.2000000000000002 110.856 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 34.0 pt -149.85 -173.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.984 -0.747 . . . . 1.02 108.984 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 146.97 24.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.589 -0.732 . . . . 1.1599999999999999 109.71 173.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.642 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 17.9 p -60.89 -36.6 79.64 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.503 -0.925 . . . . 1.05 108.503 175.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.64 70.55 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.441 -1.254 . . . . 1.05 111.733 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.21 -37.57 28.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.888 -0.507 . . . . 1.03 109.761 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.0 tp -74.47 -19.66 60.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.382 -0.826 . . . . 1.05 109.188 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.6 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.28 -39.02 41.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.723 0.773 . . . . 1.0600000000000001 111.608 173.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -60.62 -41.39 94.76 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.971 -1.013 . . . . 1.26 109.745 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.54 -20.53 39.81 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.717 -1.583 . . . . 1.01 112.169 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 25.4 m-80 -141.88 72.3 23.77 Favored Pre-proline 0 CA--C 1.513 -0.447 0 CA-C-O 121.132 0.492 . . . . 0.20000000000000001 109.836 -173.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.686 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.6 Cg_endo -57.51 -11.94 9.9 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.415 2.743 . . . . 0.29999999999999999 113.887 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -61.9 -32.77 73.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.965 0.888 . . . . 1.3600000000000001 109.375 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.75 -6.87 59.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.785 1.402 . . . . 1.26 114.785 -171.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -50.58 -40.91 53.6 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 120.08 1.309 . . . . 1.8899999999999999 110.241 179.254 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.81 -46.29 12.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.965 -1.925 . . . . 1.1000000000000001 111.437 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.43 -163.5 34.15 Favored Glycine 0 CA--C 1.495 -1.214 0 C-N-CA 120.402 -0.904 . . . . 0.29999999999999999 114.029 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.89 158.31 25.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.215 -1.493 . . . . 1.0800000000000001 110.436 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.582 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.7 m -131.74 135.58 46.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.713 -0.676 . . . . 1.1699999999999999 110.339 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -46.13 127.71 8.83 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.994 0.739 . . . . 1.1699999999999999 112.994 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.598 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 81.79 -10.43 51.83 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.815 -1.084 . . . . 0.38 112.174 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.582 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.0 tt0 -64.25 151.33 43.91 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.771 0.796 . . . . 1.1899999999999999 110.188 175.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 39.5 m -117.79 134.14 55.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.235 -1.348 . . . . 1.22 109.023 -171.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.404 HD13 HD13 ' A' ' 29' ' ' LEU . 22.8 pt -135.88 149.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.319 0.581 . . . . 1.0600000000000001 110.584 -175.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.481 ' H ' HD22 ' A' ' 33' ' ' ASN . 13.5 t -94.64 149.37 4.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.998 -1.001 . . . . 0.20999999999999999 110.249 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.441 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 21.4 mm -117.58 88.36 29.09 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.993 -1.003 . . . . 1.01 108.434 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.556 ' HA ' HD12 ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.45 143.4 97.88 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.248 2.632 . . . . 0.23000000000000001 112.723 -173.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.565 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 79.14 -8.29 46.59 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.496 -0.775 . . . . 0.29999999999999999 112.882 -176.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -113.54 124.82 30.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.551 -0.907 . . . . 1.0800000000000001 108.551 177.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.55 ' CD ' HD21 ' A' ' 51' ' ' LEU . 59.2 Cg_endo -66.17 174.35 6.11 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.6 2.867 . . . . 0.34000000000000002 113.631 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.565 ' CG ' ' HD2' ' A' ' 54' ' ' PRO . 13.6 t70 -89.12 142.0 29.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.043 -0.98 . . . . 0.71999999999999997 109.967 -173.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 83.2 Cg_endo -81.19 -13.58 11.19 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.223 2.615 . . . . 0.33000000000000002 112.087 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.653 ' HD1' ' CD2' ' A' ' 55' ' ' TYR . 72.2 m-85 -96.91 -10.33 26.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.08 0.467 . . . . 2.29 111.182 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -81.22 -22.37 38.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.076 -1.453 . . . . 2.0600000000000001 107.076 166.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.622 HD11 ' HG2' ' A' ' 158' ' ' PRO . 64.4 mt -87.68 132.56 40.16 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 113.005 -1.907 . . . . 1.0900000000000001 110.219 173.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -103.89 96.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 121.208 1.272 . . . . 0.22 110.546 165.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 73' ' ' SER . 84.0 m-85 -157.97 130.99 7.45 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.5 -1.296 . . . . 0.80000000000000004 107.5 172.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 13.0 m170 -135.75 103.68 5.5 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.981 -1.489 . . . . 3.5800000000000001 106.981 -166.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -94.3 109.39 22.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.458 -0.792 . . . . 1.0600000000000001 110.541 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.11 97.01 6.24 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.385 -0.825 . . . . 1.1200000000000001 110.579 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.474 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -113.43 98.56 7.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.319 -1.309 . . . . 0.68000000000000005 109.808 178.125 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.469 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 43.0 m -94.59 121.1 35.8 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.615 -1.175 . . . . 1.3300000000000001 108.752 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.515 HD13 ' CZ ' ' A' ' 167' ' ' ARG . 8.2 mt -57.82 -26.79 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.352 0.596 . . . . 1.77 111.601 175.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.49 70.53 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.722 -0.752 . . . . 0.93999999999999995 111.269 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.19 -24.46 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.14 0.495 . . . . 1.22 112.335 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HA ' ' CG1' ' A' ' 86' ' ' VAL . 35.9 mttt 58.26 18.38 5.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.367 1.067 . . . . 2.9399999999999999 112.318 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.522 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.67 141.27 31.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.92 0.866 . . . . 1.0600000000000001 111.516 176.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.474 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.96 118.52 31.94 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.895 -1.502 . . . . 1.0900000000000001 109.318 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -99.68 124.28 44.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.39 -0.524 . . . . 1.0900000000000001 111.095 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.469 ' C ' ' HG3' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.07 133.52 35.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.804 -1.924 . . . . 1.0800000000000001 105.804 175.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.6 m -138.76 130.78 28.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 120.544 1.52 . . . . 0.93000000000000005 112.743 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.77 126.61 53.36 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.14 -0.936 . . . . 1.1399999999999999 110.432 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 64.61 37.91 7.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.453 0.644 . . . . 0.52000000000000002 109.357 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 73.98 2.34 4.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.562 -1.199 . . . . 1.8400000000000001 112.567 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -130.8 138.0 49.7 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.618 -1.233 . . . . 3.8500000000000001 113.703 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -52.04 148.64 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-N 113.292 -1.776 . . . . 0.40999999999999998 113.587 -172.085 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.469 ' HG3' ' C ' ' A' ' 72' ' ' LEU . 3.7 mtp -96.98 -46.12 6.32 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.191 -2.277 . . . . 1.0900000000000001 107.576 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.5 tptp 179.2 159.01 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.474 -2.148 . . . . 2.6200000000000001 109.767 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.522 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 18.5 m -117.03 136.22 53.12 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.379 -0.2 . . . . 1.1000000000000001 110.946 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CG ' ' HE2' ' A' ' 145' ' ' MET . 17.5 m-85 -120.54 133.42 24.04 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 109.986 -0.376 . . . . 1.0600000000000001 109.986 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.76 146.57 92.15 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.868 2.378 . . . . 0.85999999999999999 112.447 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 177.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.056 -0.72 . . . . 1.2 109.056 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 142' ' ' CYS . . . -88.19 153.45 21.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.118 0.485 . . . . 1.4099999999999999 110.072 173.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.467 ' CG1' ' HA ' ' A' ' 68' ' ' LYS . 3.3 m -122.55 98.27 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.717 -0.674 . . . . 1.6699999999999999 111.982 -171.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.03 84.36 0.92 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.726 -0.67 . . . . 3.0800000000000001 111.904 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -82.72 2.96 31.18 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.803 0.297 . . . . 7.6200000000000001 111.803 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.2 tp -81.8 -35.11 13.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.771 0.32 . . . . 6.7199999999999998 111.13 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.99 123.26 28.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.302 . . . . 7.6299999999999999 110.777 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -89.63 64.63 6.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.387 0.613 . . . . 5.5099999999999998 110.773 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -123.72 84.56 2.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.165 -0.47 . . . . 5.3899999999999997 110.326 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.627 ' CG2' ' HB2' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -80.75 -62.7 0.36 Allowed Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 112.885 0.698 . . . . 2.5600000000000001 112.885 -175.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.568 ' HD3' ' OG1' ' A' ' 93' ' ' THR . 74.9 Cg_endo -91.0 -6.83 3.89 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.957 1.771 . . . . 3.6600000000000001 113.707 -173.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.9 t -102.65 13.47 34.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.976 0.417 . . . . 4.1699999999999999 111.239 -176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -105.33 52.8 0.69 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.451 -0.881 . . . . 2.6899999999999999 112.465 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.39 128.18 53.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.366 0.603 . . . . 2.2999999999999998 110.598 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.65 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 13.1 m-85 -127.0 178.78 5.77 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.033 -0.985 . . . . 2.3500000000000001 110.017 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.62 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 72.3 m-85 -134.06 140.42 46.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.923 -0.58 . . . . 0.92000000000000004 110.09 172.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.487 HD13 HD13 ' A' ' 125' ' ' ILE . 27.2 mm -60.46 126.61 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.239 -1.022 . . . . 1.0600000000000001 108.239 167.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.493 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.7 tt -124.7 -21.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.047 -0.661 . . . . 1.04 112.41 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 21.9 t-20 -159.65 160.86 34.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.635 1.207 . . . . 2.3500000000000001 114.088 -173.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 127.49 15.37 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 111.632 -2.531 . . . . 1.54 108.806 172.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.64 158.54 16.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.446 1.117 . . . . 1.8899999999999999 111.821 -171.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.602 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 21.9 ttm180 -52.42 155.59 2.05 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.175 -2.284 . . . . 3.46 111.793 167.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.602 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 6.6 p30 -45.13 109.89 0.99 Allowed Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.163 -1.38 . . . . 3.3500000000000001 111.519 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.37 -51.51 5.24 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.4 2.733 . . . . 0.97999999999999998 112.12 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.61 -10.31 70.87 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.096 -0.957 . . . . 1.0800000000000001 111.959 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -107.78 -168.72 21.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.412 -0.423 . . . . 1.1599999999999999 112.085 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.54 18.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 124.073 3.182 . . . . 1.46 113.945 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.653 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -69.26 -18.56 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 2.1000000000000001 111.385 -177.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.573 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 94.19 41.38 4.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 1.1100000000000001 113.4 174.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 77.08 -27.58 0.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.237 0.828 . . . . 1.45 113.237 171.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.618 ' HE2' ' CE1' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -152.64 146.5 25.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.95 0.405 . . . . 1.5 110.769 -178.178 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -115.88 101.58 8.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 2.6000000000000001 109.545 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -103.63 141.69 35.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.406 0.622 . . . . 1.3100000000000001 110.462 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.7 m -106.15 140.3 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.488 -0.778 . . . . 1.3100000000000001 111.818 -171.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.56 -178.41 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.676 -1.231 . . . . 1.8600000000000001 107.676 172.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.9 m -56.93 -58.04 9.89 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 118.439 0.563 . . . . 1.95 111.037 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.403 ' HA ' ' OD1' ' A' ' 21' ' ' ASP . 25.5 mmmt -70.12 127.0 31.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.067 0.461 . . . . 3.3999999999999999 109.884 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 21' ' ' ASP . 23.3 tm0? -56.4 -30.12 62.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.148 -0.933 . . . . 5.5800000000000001 112.071 -174.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -90.13 11.47 20.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.853 0.316 . . . . 6.7300000000000004 111.853 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -133.02 135.79 45.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.945 0.402 . . . . 5.1500000000000004 110.464 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.2 158.0 28.07 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.007 -1.092 . . . . 1.1899999999999999 112.882 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.622 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 7.3 mt -92.73 109.43 21.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.499 -0.926 . . . . 1.05 108.499 172.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 144' ' ' ARG . 9.9 p80 -140.13 -164.44 1.71 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.505 -0.878 . . . . 1.25 111.796 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.573 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.04 179.52 16.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.724 -1.125 . . . . 0.46000000000000002 113.968 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -139.39 174.22 10.73 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.293 0.568 . . . . 1.21 111.068 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -104.38 -21.29 13.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.971 -1.013 . . . . 1.8600000000000001 108.9 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -127.22 104.36 22.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.755 -1.111 . . . . 1.8200000000000001 109.672 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.69 5.41 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.499 2.799 . . . . 0.64000000000000001 112.794 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.46 59.57 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.258 0.552 . . . . 1.3200000000000001 110.363 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 m -85.33 -17.32 37.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 1.8899999999999999 109.576 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 36.6 mm -81.5 115.55 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.407 -0.815 . . . . 1.21 111.017 -175.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.29 29.76 59.72 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.577 -0.738 . . . . 1.6799999999999999 111.571 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -154.56 -38.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.772 0.32 . . . . 4.8799999999999999 110.57 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -85.38 154.11 22.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.944 0.402 . . . . 4.4699999999999998 110.865 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.57 -12.45 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.66 -0.7 . . . . 4.6799999999999997 110.476 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.0 p -152.55 38.13 0.54 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.128 0.49 . . . . 5.9100000000000001 111.271 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -151.96 133.71 14.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.414 -0.357 . . . . 8.5999999999999996 110.65 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 144' ' ' ARG . . . 89.99 -33.8 4.33 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.112 -0.566 . . . . 4.1900000000000004 113.371 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.48 ' HA ' ' HB1' ' A' ' 85' ' ' ALA . 29.9 p 39.05 -91.85 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.848 0.859 . . . . 2.9199999999999999 113.088 -171.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.404 ' N ' ' SG ' ' A' ' 142' ' ' CYS . 15.6 mt -124.11 65.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 121.493 -0.755 . . . . 2.0699999999999998 111.345 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.553 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 10.3 ptm180 -132.49 90.98 2.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.961 0.886 . . . . 3.98 110.475 175.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.526 ' HE2' ' CG ' ' A' ' 82' ' ' TYR . 11.7 ptm -100.29 -165.44 1.22 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.951 -1.022 . . . . 1.8700000000000001 112.719 -168.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -64.58 133.81 53.07 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.669 -0.696 . . . . 3.25 111.051 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -52.64 -63.54 1.11 Allowed 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 113.038 0.755 . . . . 2.4199999999999999 113.038 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.549 ' HZ2' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -63.04 -23.76 67.6 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.321 -0.862 . . . . 2.5699999999999998 112.115 -174.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.03 -33.8 57.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 1.05 111.193 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.738 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 14.8 p -79.71 -16.3 13.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 110.016 -0.365 . . . . 0.32000000000000001 110.016 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.458 ' HA ' ' CB ' ' A' ' 154' ' ' ALA . 2.8 mp -88.38 -37.14 10.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.897 -0.409 . . . . 1.1299999999999999 109.897 171.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -43.46 -70.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.878 0.763 . . . . 1.3799999999999999 111.784 159.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' A' ' 150' ' ' VAL . 2.9 pp -54.7 -36.0 64.22 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.474 0.484 . . . . 1.3400000000000001 110.479 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -55.22 -51.92 65.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.6 0.714 . . . . 1.02 112.059 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 p -77.52 -15.57 59.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.77 -1.104 . . . . 1.9099999999999999 110.91 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.401 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 58.2 mt -93.86 -49.01 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.06 -0.518 . . . . 1.04 110.5 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 m -76.83 111.97 19.53 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-O 121.776 0.798 . . . . 0.20999999999999999 110.253 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.622 ' HG2' HD11 ' A' ' 57' ' ' ILE . 6.8 Cg_endo -77.85 -179.89 5.87 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.467 2.111 . . . . 0.51000000000000001 112.804 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.664 ' O ' HD22 ' A' ' 51' ' ' LEU . 12.2 m120 -62.03 1.54 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.153 -1.385 . . . . 1.02 113.611 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.418 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -145.1 58.4 0.51 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.145 -0.55 . . . . 0.64000000000000001 112.133 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.458 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 9.4 m -96.34 136.72 36.44 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.514 -0.403 . . . . 1.0700000000000001 110.27 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.589 HH11 ' HH ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -85.69 135.36 33.8 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.365 -0.534 . . . . 2.3399999999999999 110.386 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.0 122.75 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.022 -0.99 . . . . 0.46000000000000002 110.788 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.405 ' C ' HD13 ' A' ' 165' ' ' ILE . 87.1 m -113.75 138.39 50.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.716 -0.674 . . . . 1.26 111.426 -177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.405 HD13 ' C ' ' A' ' 164' ' ' THR . 2.9 mp -119.8 110.98 30.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 118.751 -1.18 . . . . 1.1699999999999999 109.999 172.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.25 139.06 33.67 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.425 -1.261 . . . . 1.1899999999999999 109.568 -173.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.627 ' HB2' ' CG2' ' A' ' 93' ' ' THR . 12.2 mpt_? -81.27 -9.72 59.72 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.236 -1.347 . . . . 3.7999999999999998 110.568 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 175.71 -81.56 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.313 -0.858 . . . . 3.6499999999999999 111.371 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.529 -0.748 . . . . 5.9699999999999998 109.799 177.859 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.608 ' O32' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.718 -0.553 . . . . 3.3799999999999999 111.718 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -79.1 169.38 18.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.064 0.459 . . . . 4.6799999999999997 110.853 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.6 OUTLIER -72.93 153.62 40.9 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.984 -0.747 . . . . 2.54 108.984 172.189 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.5 mt -99.94 171.66 7.71 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.164 0.431 . . . . 1.1000000000000001 112.164 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.534 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.7 tp -76.15 152.89 36.58 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.59 0.756 . . . . 1.05 112.512 -168.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.534 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.29 148.14 39.55 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.21 1.005 . . . . 1.01 111.88 165.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.657 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 71.7 t80 -134.34 149.14 50.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.096 -1.865 . . . . 1.1200000000000001 107.612 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -130.03 114.41 15.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.208 -1.404 . . . . 1.72 107.208 175.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.76 155.92 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 121.203 0.525 . . . . 0.38 112.031 -166.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -98.53 151.35 20.72 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.096 -0.956 . . . . 3.0600000000000001 109.593 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -52.17 116.41 2.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 2.1699999999999999 111.398 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.05 -7.16 35.22 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.09 -0.959 . . . . 0.63 112.956 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 71.6 m-20 -61.29 149.11 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.362 0.505 . . . . 2.1699999999999999 112.362 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.428 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -130.83 152.33 50.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.916 -0.583 . . . . 1.27 111.719 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.3 tp -48.43 -59.9 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 1.0800000000000001 113.896 -170.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.707 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 7.1 t-20 -65.39 -39.85 92.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.132 0.968 . . . . 1.55 110.211 -170.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.719 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 23.3 m -59.59 -41.74 90.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.928 -1.942 . . . . 1.8200000000000001 110.728 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.95 -40.36 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.515 0.726 . . . . 1.0600000000000001 112.589 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.84 -63.65 1.11 Allowed 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.533 -0.303 . . . . 0.97999999999999998 111.188 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -79.95 -3.56 48.72 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.818 -1.153 . . . . 1.0700000000000001 112.035 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.719 ' HB2' ' O ' ' A' ' 17' ' ' SER . 13.6 t70 -64.47 -33.41 75.81 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.348 -0.982 . . . . 1.6299999999999999 108.348 157.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' HD13 ' A' ' 101' ' ' ILE . 1.9 m-85 -100.19 17.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.96 0.41 . . . . 0.25 111.998 173.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 2.3 mpt_? 53.79 52.18 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.407 -0.815 . . . . 4.2000000000000002 110.764 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 38.5 pt -148.2 -173.27 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.059 -0.719 . . . . 1.02 109.059 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -98.91 144.39 28.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.522 -0.763 . . . . 1.1599999999999999 109.665 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.707 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 7.1 p -62.55 -37.97 88.2 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.618 0.723 . . . . 1.05 109.221 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.19 -27.41 68.67 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.164 -1.38 . . . . 1.05 111.284 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -38.71 26.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.467 0.651 . . . . 1.03 109.589 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.7 tp -72.06 -19.44 61.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 1.05 108.911 174.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.613 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.51 -37.23 32.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.307 0.575 . . . . 1.0600000000000001 111.243 172.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.0 mt-30 -56.57 -43.26 79.82 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.353 1.073 . . . . 1.26 109.808 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.97 -18.93 35.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.404 -1.725 . . . . 1.01 112.801 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 31.7 m-80 -143.82 73.76 16.71 Favored Pre-proline 0 CA--C 1.513 -0.479 0 CA-C-O 121.137 0.494 . . . . 0.20000000000000001 109.961 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.655 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.1 Cg_endo -57.18 -14.02 14.04 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 123.568 2.845 . . . . 0.29999999999999999 114.098 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.99 -33.56 74.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.104 0.954 . . . . 1.3600000000000001 109.672 175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -79.18 -6.0 55.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.225 -1.352 . . . . 1.26 114.375 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.655 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -49.25 -41.11 36.66 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 119.778 1.172 . . . . 1.8899999999999999 110.295 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.1 -46.53 11.85 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.766 -2.016 . . . . 1.1000000000000001 111.733 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.39 -163.89 34.73 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 120.369 -0.919 . . . . 0.29999999999999999 114.383 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.65 157.38 27.53 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 112.945 -1.627 . . . . 1.0800000000000001 110.686 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.585 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 84.8 m -135.17 132.32 37.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.464 -0.789 . . . . 1.1699999999999999 110.18 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -48.61 128.64 15.43 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.313 0.577 . . . . 1.1699999999999999 112.339 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.09 -13.5 54.15 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 114.734 -1.121 . . . . 0.38 112.432 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.7 tt0 -65.85 151.98 45.46 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.426 0.632 . . . . 1.1899999999999999 110.358 173.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.5 m -117.92 134.35 55.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.589 -1.187 . . . . 1.22 109.463 -171.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.421 HD11 HD13 ' A' ' 29' ' ' LEU . 16.4 pt -136.84 149.79 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.423 0.63 . . . . 1.0600000000000001 110.576 -175.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.513 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 16.9 t -95.65 148.94 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.08 -0.964 . . . . 0.20999999999999999 110.333 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 19.9 mm -117.25 89.33 30.66 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 114.835 -1.075 . . . . 1.01 108.812 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.589 ' HA ' HD12 ' A' ' 4' ' ' LEU . 20.9 Cg_endo -59.3 140.48 94.78 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.277 2.652 . . . . 0.23000000000000001 112.767 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.595 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 82.77 -6.87 67.9 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.701 -0.681 . . . . 0.29999999999999999 113.033 -176.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.543 HD21 ' CD ' ' A' ' 52' ' ' PRO . 2.7 tt -116.49 124.87 28.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.444 -0.947 . . . . 1.0800000000000001 108.444 175.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.543 ' CD ' HD21 ' A' ' 51' ' ' LEU . 58.9 Cg_endo -65.86 174.22 5.95 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.728 2.952 . . . . 0.34000000000000002 113.898 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -90.56 137.55 27.21 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 114.743 -1.117 . . . . 0.71999999999999997 111.604 -171.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD3' HD11 ' A' ' 5' ' ' LEU . 62.3 Cg_endo -83.94 -9.7 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.457 2.771 . . . . 0.33000000000000002 113.344 -174.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.633 ' HE2' ' CE1' ' A' ' 55' ' ' TYR . 61.4 m-85 -95.67 -15.42 22.71 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.994 0.426 . . . . 2.29 110.729 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -91.62 -5.31 54.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.623 0.725 . . . . 2.0600000000000001 109.174 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.621 HD12 ' HG2' ' A' ' 158' ' ' PRO . 45.0 mt -98.28 137.73 20.8 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 115.24 -0.891 . . . . 1.0900000000000001 109.605 171.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' O ' ' CG ' ' A' ' 59' ' ' TYR . 10.6 Cg_endo -104.13 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.243 0 CA-C-N 120.153 1.09 . . . . 0.22 110.038 163.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 58' ' ' PRO . 70.7 m-85 -156.94 133.47 9.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.142 -1.429 . . . . 0.80000000000000004 107.142 169.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -148.18 111.26 4.86 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.555 -0.905 . . . . 3.5800000000000001 108.555 -160.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.598 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 50.1 mt -98.63 118.25 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.798 -1.092 . . . . 1.0600000000000001 111.019 -175.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.59 92.98 4.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.797 0.808 . . . . 1.1200000000000001 110.07 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 70' ' ' LEU . 1.1 p -111.36 101.78 13.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.438 -1.256 . . . . 0.68000000000000005 108.94 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.446 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.2 m -96.0 116.08 28.4 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.466 -0.939 . . . . 1.3300000000000001 108.466 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 1.2 mm -45.47 -36.5 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 1.77 110.876 170.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . -63.9 -43.83 96.96 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.372 -0.918 . . . . 0.93999999999999995 111.683 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -71.17 -23.2 62.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.872 -0.664 . . . . 1.22 112.73 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' A' ' 66' ' ' GLY . 6.2 mptt 58.71 14.98 3.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.882 0.873 . . . . 2.9399999999999999 112.583 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.467 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.21 139.56 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.897 0.856 . . . . 1.0600000000000001 111.442 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.439 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -93.67 114.01 26.22 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.744 -1.571 . . . . 1.0900000000000001 108.737 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -98.5 122.19 41.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.06 -0.656 . . . . 1.0900000000000001 110.432 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.583 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -81.87 127.14 32.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.823 -1.917 . . . . 1.0800000000000001 105.823 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.1 m -131.8 127.34 36.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 120.341 1.428 . . . . 0.93000000000000005 111.976 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -113.17 122.69 48.27 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.004 -0.998 . . . . 1.1399999999999999 109.559 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 68.51 36.75 2.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.772 -0.825 . . . . 0.52000000000000002 108.772 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 73.75 1.87 4.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.275 -1.329 . . . . 1.8400000000000001 112.295 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -130.38 138.14 50.23 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 118.148 -1.421 . . . . 3.8500000000000001 113.805 173.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.25 148.21 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 112.84 -1.982 . . . . 0.40999999999999998 113.585 -171.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.583 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -98.96 -44.43 6.33 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 111.921 -2.4 . . . . 1.0900000000000001 107.998 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -178.96 160.77 1.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.235 -2.257 . . . . 2.6200000000000001 109.491 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.467 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.7 m -118.93 131.07 56.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.518 0.199 . . . . 1.1000000000000001 110.662 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 1.632 ' HE2' ' CE1' ' A' ' 82' ' ' TYR . 30.6 m-85 -118.11 141.2 29.0 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 109.294 -0.632 . . . . 1.0600000000000001 109.294 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -80.94 144.13 14.9 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.196 1.93 . . . . 0.85999999999999999 111.783 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.66 178.07 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.89 -0.411 . . . . 1.2 109.89 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.95 119.01 24.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.199 0.524 . . . . 1.4099999999999999 111.367 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.1 112.89 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.027 -0.988 . . . . 1.6699999999999999 109.619 175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.93 138.35 9.95 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.206 -0.758 . . . . 3.0800000000000001 111.206 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -93.85 64.73 3.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.481 0.658 . . . . 7.6200000000000001 111.84 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.0 pt -101.15 -139.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.63 -0.714 . . . . 6.7199999999999998 109.626 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.79 76.6 0.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.302 -0.629 . . . . 7.6299999999999999 109.302 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.468 ' HB ' ' O32' ' A' 1142 ' ' IM2 . 5.1 t -170.48 152.36 3.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.386 -0.824 . . . . 5.5099999999999998 109.405 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.576 ' HG2' ' H ' ' A' ' 93' ' ' THR . 6.2 tt0 -136.44 -148.31 0.28 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.36 -0.607 . . . . 5.3899999999999997 109.36 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.576 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 13.0 p -66.08 117.68 45.11 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 122.793 0.437 . . . . 2.5600000000000001 109.826 174.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.1 107.77 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.263 1.975 . . . . 3.6600000000000001 111.627 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.9 t -85.0 43.51 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.677 0.751 . . . . 4.1699999999999999 111.474 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.02 122.51 0.93 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.471 -0.871 . . . . 2.6899999999999999 112.582 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -76.73 153.55 34.94 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.119 -0.326 . . . . 2.2999999999999998 110.119 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.643 ' HD1' ' CD2' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -113.29 176.99 4.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.092 -0.504 . . . . 2.3500000000000001 109.803 176.362 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.628 ' HE1' ' CE2' ' A' ' 99' ' ' TYR . 37.0 m-85 -137.13 138.56 40.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.179 -0.675 . . . . 0.92000000000000004 109.179 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.491 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 26.8 mm -60.64 107.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.994 -0.743 . . . . 1.0600000000000001 108.994 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 22' ' ' PHE . 2.4 tt -104.36 -31.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.629 -0.714 . . . . 1.04 112.401 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.656 ' ND2' ' H ' ' A' ' 103' ' ' ARG . 4.0 t-20 -168.65 175.52 6.09 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 123.028 1.394 . . . . 2.3500000000000001 114.224 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.674 ' HB3' ' CE1' ' A' ' 114' ' ' TYR . 5.6 mtt180 -137.0 126.98 25.89 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.07 -2.787 . . . . 1.54 107.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.74 150.45 20.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.179 0.99 . . . . 1.8899999999999999 111.081 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.588 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 27.0 ttm180 -51.78 156.81 1.33 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.95 -1.932 . . . . 3.46 111.863 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.588 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 8.4 p30 -43.23 105.12 0.41 Allowed Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 122.745 1.259 . . . . 3.3500000000000001 111.312 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -58.3 -54.68 2.8 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.775 2.983 . . . . 0.97999999999999998 112.949 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.96 72.38 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.445 -0.798 . . . . 1.0800000000000001 111.848 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.89 -169.87 13.67 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.973 -0.451 . . . . 1.1599999999999999 111.973 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.5 32.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 124.419 3.413 . . . . 1.46 114.369 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.653 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -88.11 -12.18 44.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.19 0.519 . . . . 2.1000000000000001 110.938 178.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 72.31 51.99 11.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.146 -0.934 . . . . 1.1100000000000001 114.018 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.81 -13.6 0.92 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.958 1.096 . . . . 1.45 113.958 167.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.626 ' HE2' ' CE1' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -161.99 142.57 10.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.656 0.265 . . . . 1.5 110.553 175.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.712 ' CZ3' ' HA3' ' A' ' 124' ' ' GLY . 24.5 t-105 -113.37 101.27 9.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.81 . . . . 2.6000000000000001 108.814 168.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.618 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.6 mm? -92.71 110.3 21.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.447 0.641 . . . . 1.3100000000000001 109.806 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.5 m -65.86 140.98 58.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.945 -1.025 . . . . 1.3100000000000001 111.983 -174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.903 HD13 ' CE1' ' A' ' 98' ' ' PHE . 1.4 tp -109.43 161.46 15.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.452 -0.573 . . . . 1.8600000000000001 109.452 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.412 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 5.6 m -93.92 29.55 2.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.303 0.573 . . . . 1.95 109.877 174.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 96.65 4.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.882 -0.599 . . . . 3.3999999999999999 109.899 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 53.97 -131.49 2.02 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.36 0.412 . . . . 5.5800000000000001 110.986 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -104.67 18.24 22.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.678 0.275 . . . . 6.7300000000000004 110.777 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 94.1 m-85 -72.88 154.7 40.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.141 -0.688 . . . . 5.1500000000000004 109.141 173.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.712 ' HA3' ' CZ3' ' A' ' 115' ' ' TRP . . . -156.91 162.65 31.83 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.259 -0.972 . . . . 1.1899999999999999 113.065 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.618 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 47.7 mt -92.87 108.84 20.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 107.555 -1.276 . . . . 1.05 107.555 169.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.594 ' CE1' ' HB3' ' A' ' 144' ' ' ARG . 12.7 p80 -143.69 -163.4 1.65 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.825 -0.75 . . . . 1.25 111.846 -175.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.39 168.45 14.33 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.697 -1.138 . . . . 0.46000000000000002 112.68 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 6.9 t -127.65 177.54 6.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.53 0.681 . . . . 1.21 111.888 -165.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -106.98 -18.45 13.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.614 -1.175 . . . . 1.8600000000000001 109.456 166.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -125.3 103.88 29.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.401 -0.818 . . . . 1.8200000000000001 109.732 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -87.78 4.2 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.979 2.453 . . . . 0.64000000000000001 112.892 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.74 -21.59 23.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.086 0.47 . . . . 1.3200000000000001 110.132 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.8 m -90.23 13.21 15.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 1.8899999999999999 110.357 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 20.4 mm -99.24 113.53 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 1.21 110.387 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.79 -83.31 0.35 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.574 -0.739 . . . . 1.6799999999999999 111.594 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -108.43 72.66 0.84 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.321 0.582 . . . . 4.8799999999999999 110.602 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -163.21 146.16 10.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.762 -0.654 . . . . 4.4699999999999998 110.194 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.1 t -101.44 69.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.453 0.644 . . . . 4.6799999999999997 110.314 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.0 m -90.91 138.53 31.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.517 -0.765 . . . . 5.9100000000000001 110.751 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.99 -40.99 97.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.771 -0.65 . . . . 8.5999999999999996 109.566 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -78.8 111.03 3.16 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.71 -0.956 . . . . 4.1900000000000004 110.71 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 84.3 m -106.04 168.2 9.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.624 0.25 . . . . 2.9199999999999999 111.518 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.8 mt 49.36 54.54 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.453 -0.794 . . . . 2.0699999999999998 111.944 171.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.594 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 15.5 ptt180 -131.26 96.8 4.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 3.98 110.176 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.746 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 36.0 mtm -99.58 -165.45 1.23 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.429 0.633 . . . . 1.8700000000000001 112.241 -170.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.523 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 14.6 t-80 -72.77 148.19 44.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.125 -0.943 . . . . 3.25 109.212 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -50.31 -63.29 1.16 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 112.672 0.619 . . . . 2.4199999999999999 112.672 -172.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -64.53 -21.06 66.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.429 -0.794 . . . . 2.5699999999999998 111.945 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.1 m-20 -73.27 -39.51 65.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.207 -0.451 . . . . 1.05 110.659 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.675 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 10.4 p -80.99 -17.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.005 -0.543 . . . . 0.32000000000000001 110.79 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.02 -40.54 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.871 -0.585 . . . . 1.1299999999999999 110.24 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -44.11 -69.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.411 1.005 . . . . 1.3799999999999999 112.093 165.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.405 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.4 tp -52.07 -42.76 63.42 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.647 -0.706 . . . . 1.3400000000000001 110.581 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -52.98 -51.55 61.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.475 -1.238 . . . . 1.02 111.605 -173.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 -18.04 53.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.739 -1.119 . . . . 1.9099999999999999 111.244 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.412 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 62.2 mt -90.8 -50.35 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.924 -0.399 . . . . 1.04 109.924 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.1 m -78.13 110.7 14.32 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-O 122.192 0.996 . . . . 0.20999999999999999 110.226 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.621 ' HG2' HD12 ' A' ' 57' ' ' ILE . 24.4 Cg_endo -88.22 -179.08 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.386 2.724 . . . . 0.51000000000000001 112.669 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -65.17 108.92 2.02 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.27 -1.011 . . . . 1.02 108.27 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.522 ' O ' HD11 ' A' ' 57' ' ' ILE . . . 108.11 37.37 2.16 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.375 -0.917 . . . . 0.64000000000000001 113.496 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.498 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 26.1 m -90.61 131.69 36.18 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.65 -0.912 . . . . 1.0700000000000001 110.394 172.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -85.98 136.62 33.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.251 -0.431 . . . . 2.3399999999999999 109.892 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 1.9 p -148.71 137.19 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.716 -0.674 . . . . 0.46000000000000002 111.515 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.8 m -119.02 141.49 48.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 1.26 112.055 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.94 116.32 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 C-N-CA 118.539 -1.264 . . . . 1.1699999999999999 111.715 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.618 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER -145.35 145.18 31.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.255 -1.339 . . . . 1.1899999999999999 110.799 -170.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.474 ' H ' HG23 ' A' ' 93' ' ' THR . 4.9 ttt180 -93.11 -35.1 13.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.867 -1.06 . . . . 3.7999999999999998 110.578 -174.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 162.24 108.07 0.22 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.458 -0.877 . . . . 3.6499999999999999 112.228 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.652 -0.69 . . . . 5.9699999999999998 110.095 179.223 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.511 ' O31' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.661 -0.575 . . . . 3.3799999999999999 111.661 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.72 160.51 30.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.649 -0.501 . . . . 4.6799999999999997 109.649 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 4.0 mptp? -66.63 148.51 51.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.735 -0.469 . . . . 2.54 109.735 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 50' ' ' GLY . 17.8 mt -97.43 170.04 9.33 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.524 0.515 . . . . 1.1000000000000001 111.634 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.3 tp -77.69 150.31 34.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.376 0.67 . . . . 1.05 112.144 -170.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -114.84 149.39 37.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.093 0.949 . . . . 1.01 111.879 168.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.666 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 70.8 t80 -135.19 151.11 50.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.546 -1.661 . . . . 1.1200000000000001 107.844 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -128.74 113.85 15.85 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.944 -1.502 . . . . 1.72 106.944 173.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.5 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 1.3 m -71.83 158.04 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 121.141 0.496 . . . . 0.38 111.771 -166.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HE2' ' HA3' ' A' ' 96' ' ' GLY . 79.1 mttt -111.17 145.09 39.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.328 -0.851 . . . . 3.0600000000000001 109.487 -174.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -54.82 121.45 8.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.067 -0.97 . . . . 2.1699999999999999 111.82 -173.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.77 -8.21 17.01 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.149 -0.78 . . . . 0.63 111.149 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -40.42 142.37 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.198 1.555 . . . . 2.1699999999999999 115.198 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 134.72 45.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.013 -0.994 . . . . 1.27 111.342 163.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.583 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.8 tp -41.37 -56.34 2.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.195 -0.911 . . . . 1.0800000000000001 113.457 -174.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.679 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.6 -38.11 88.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.432 1.11 . . . . 1.55 110.322 -171.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -64.41 -42.35 96.13 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 112.953 -1.93 . . . . 1.8200000000000001 110.263 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.26 -41.07 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.045 0.45 . . . . 1.0600000000000001 111.228 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -59.56 4.98 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.995 -0.548 . . . . 0.97999999999999998 111.396 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.78 -3.86 57.19 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 118.936 -1.106 . . . . 1.0700000000000001 112.153 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -61.1 -37.8 84.02 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.987 -1.116 . . . . 1.6299999999999999 107.987 155.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.499 ' CD1' HD11 ' A' ' 101' ' ' ILE . 3.7 m-85 -98.06 27.91 4.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.404 0.52 . . . . 0.25 112.404 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.612 ' HD2' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.2 67.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.902 1.281 . . . . 4.2000000000000002 113.729 -169.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 33.0 pt -146.92 -172.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.094 -1.076 . . . . 1.02 108.094 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 m -101.72 145.0 29.72 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.732 -0.667 . . . . 1.1599999999999999 109.38 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.679 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.3 p -61.4 -35.61 77.99 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.679 -0.692 . . . . 1.05 109.256 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.52 67.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.344 -1.298 . . . . 1.05 111.646 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.25 -39.15 19.62 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.463 -0.569 . . . . 1.03 109.463 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 12.9 tp -72.88 -17.53 61.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.228 -0.896 . . . . 1.05 108.738 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.606 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -81.13 -37.89 28.1 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.484 0.659 . . . . 1.0600000000000001 111.557 172.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -58.52 -43.13 89.05 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.306 1.051 . . . . 1.26 109.59 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.91 -20.96 41.0 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.64 -1.618 . . . . 1.01 111.995 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 31.9 m-80 -142.52 72.77 20.68 Favored Pre-proline 0 CA--C 1.514 -0.414 0 CA-C-O 121.237 0.542 . . . . 0.20000000000000001 109.993 -172.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.627 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.2 Cg_endo -56.62 -13.11 10.01 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 123.649 2.899 . . . . 0.29999999999999999 114.122 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 t -62.24 -32.37 73.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.047 0.927 . . . . 1.3600000000000001 109.754 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.2 mt -81.34 -6.65 59.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.345 -1.298 . . . . 1.26 114.402 -171.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -49.85 -44.45 49.59 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.471 1.129 . . . . 1.8899999999999999 110.274 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.11 -45.85 15.83 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.937 -1.938 . . . . 1.1000000000000001 110.551 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.42 -170.33 43.33 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.491 -0.862 . . . . 0.29999999999999999 113.809 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.426 ' HG ' HD23 ' A' ' 36' ' ' LEU . 6.7 mp -111.79 159.58 18.16 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.373 -1.414 . . . . 1.0800000000000001 109.764 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 77.1 m -128.43 132.27 48.45 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.859 -0.61 . . . . 1.1699999999999999 109.887 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -48.56 129.38 16.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.406 0.622 . . . . 1.1699999999999999 112.241 174.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.35 -11.81 53.77 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.853 -1.067 . . . . 0.38 112.704 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.1 tt0 -66.08 153.66 41.68 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.537 0.684 . . . . 1.1899999999999999 110.378 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.429 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 49.8 m -115.3 135.42 54.17 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.5 -1.227 . . . . 1.22 109.029 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 29' ' ' LEU . 18.6 pt -137.28 151.16 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.358 0.599 . . . . 1.0600000000000001 110.504 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.503 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 15.4 t -96.89 149.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.07 -0.968 . . . . 0.20999999999999999 110.028 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.437 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 19.8 mm -117.64 88.41 29.54 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.024 -0.989 . . . . 1.01 108.529 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.563 ' HA ' HD12 ' A' ' 4' ' ' LEU . 26.3 Cg_endo -59.68 142.8 99.4 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.199 2.599 . . . . 0.23000000000000001 112.564 -174.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.592 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 80.57 -6.95 59.64 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.874 -0.603 . . . . 0.29999999999999999 112.621 -176.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.7 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.18 125.27 28.71 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 108.54 -0.911 . . . . 1.0800000000000001 108.54 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.536 ' CD ' HD21 ' A' ' 51' ' ' LEU . 60.2 Cg_endo -66.38 172.62 8.76 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.715 2.943 . . . . 0.34000000000000002 114.017 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 4.9 t70 -91.19 136.66 26.95 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.665 -1.152 . . . . 0.71999999999999997 111.721 -170.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.495 ' HD3' HD11 ' A' ' 5' ' ' LEU . 68.8 Cg_endo -81.97 -6.94 12.28 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.332 2.688 . . . . 0.33000000000000002 113.381 -174.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -28.06 16.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.015 0.436 . . . . 2.29 110.297 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -84.37 -12.93 53.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.985 -0.746 . . . . 2.0600000000000001 108.985 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.567 HD11 ' HG2' ' A' ' 158' ' ' PRO . 84.0 mt -86.21 125.95 66.49 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.989 -1.005 . . . . 1.0900000000000001 109.295 169.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -101.47 95.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.14 0 CA-C-N 119.876 0.991 . . . . 0.22 110.225 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 73' ' ' SER . 82.1 m-85 -158.55 129.45 6.26 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.016 -1.476 . . . . 0.80000000000000004 107.016 172.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 14.8 m170 -137.84 104.18 5.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.756 -1.572 . . . . 3.5800000000000001 106.756 -164.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -94.34 108.4 20.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.584 -0.734 . . . . 1.0600000000000001 110.331 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.6 97.35 6.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.14 -0.936 . . . . 1.1200000000000001 110.67 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.6 OUTLIER -112.22 98.38 6.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.964 -1.471 . . . . 0.68000000000000005 109.304 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.8 m -94.43 123.16 37.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.734 -1.121 . . . . 1.3300000000000001 108.843 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.581 ' HB ' ' CB ' ' A' ' 167' ' ' ARG . 1.2 mt -59.75 -31.87 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.064 -0.517 . . . . 1.77 111.802 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.91 -40.54 97.3 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.715 -0.755 . . . . 0.93999999999999995 111.301 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.35 -23.96 59.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.941 -0.63 . . . . 1.22 112.342 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.9 mttt 55.7 19.47 3.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.157 0.983 . . . . 2.9399999999999999 112.776 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.465 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.27 140.85 35.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.716 0.77 . . . . 1.0600000000000001 111.308 177.349 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.427 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.5 tt -94.31 119.27 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.157 -1.383 . . . . 1.0900000000000001 109.367 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -101.97 124.8 48.2 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.443 -0.503 . . . . 1.0900000000000001 111.093 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.543 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.62 139.52 33.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.237 -1.764 . . . . 1.0800000000000001 106.237 176.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.594 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 19.4 m -143.05 128.91 19.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 120.508 1.503 . . . . 0.93000000000000005 112.672 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.89 125.4 50.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.906 -1.043 . . . . 1.1399999999999999 110.457 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 61.84 40.68 12.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.029 0.443 . . . . 0.52000000000000002 109.867 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 81.68 -7.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.798 -1.092 . . . . 1.8400000000000001 112.21 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -128.52 139.22 52.42 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 118.282 -1.367 . . . . 3.8500000000000001 114.025 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.71 149.85 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 112.873 -1.967 . . . . 0.40999999999999998 112.891 -174.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.543 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.0 mtp -100.16 -44.06 6.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.5 -2.137 . . . . 1.0900000000000001 108.43 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 179.7 159.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.54 -2.118 . . . . 2.6200000000000001 110.156 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.465 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.4 m -121.06 137.6 54.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.526 0.203 . . . . 1.1000000000000001 111.309 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.616 ' CG ' ' HE1' ' A' ' 145' ' ' MET . 98.4 m-85 -127.82 135.94 28.24 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.905 0.383 . . . . 1.0600000000000001 111.374 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.22 143.86 90.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.935 2.424 . . . . 0.85999999999999999 112.181 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.7 -175.58 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 1.2 110.028 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.46 141.74 28.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.71 -0.478 . . . . 1.4099999999999999 109.71 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.427 ' CG2' ' HA ' ' A' ' 65' ' ' ILE . 1.1 t -130.6 137.66 55.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.713 -0.676 . . . . 1.6699999999999999 110.582 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.3 83.19 0.76 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.588 -0.733 . . . . 3.0800000000000001 113.253 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -67.5 -34.2 76.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.189 0.519 . . . . 7.6200000000000001 109.663 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -85.36 -27.17 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.571 -0.74 . . . . 6.7199999999999998 110.247 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.9 mt -75.58 94.32 3.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.789 -0.641 . . . . 7.6299999999999999 110.443 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -81.68 61.76 5.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.536 0.684 . . . . 5.5099999999999998 109.926 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -165.77 139.4 4.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.227 -0.897 . . . . 5.3899999999999997 109.883 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.596 HG23 ' H ' ' A' ' 167' ' ' ARG . 11.0 p -85.62 110.01 26.45 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.008 -0.738 . . . . 2.5600000000000001 109.008 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -47.89 100.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.865 2.377 . . . . 3.6600000000000001 112.19 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.2 m -72.65 127.63 33.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.933 -0.576 . . . . 4.1699999999999999 111.407 -173.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.465 ' HA3' ' HE2' ' A' ' 10' ' ' LYS . . . 93.6 133.81 6.86 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.834 -0.621 . . . . 2.6899999999999999 112.406 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.39 169.5 18.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.339 0.59 . . . . 2.2999999999999998 111.393 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.657 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 29.1 m-85 -123.79 175.5 6.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.186 -0.916 . . . . 2.3500000000000001 108.643 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.612 ' HD2' ' CD1' ' A' ' 99' ' ' TYR . 80.7 m-85 -134.14 138.07 44.96 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.931 0.396 . . . . 0.92000000000000004 110.738 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.465 HD13 HD13 ' A' ' 125' ' ' ILE . 26.5 mm -59.55 124.77 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 107.428 -1.323 . . . . 1.0600000000000001 107.428 166.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.612 ' CD1' ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -118.09 -22.09 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.893 -0.723 . . . . 1.04 112.174 -176.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.656 ' ND2' ' H ' ' A' ' 103' ' ' ARG . 3.1 t-20 -167.81 177.11 5.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 123.081 1.42 . . . . 2.3500000000000001 114.122 -175.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.656 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 4.3 ptt180 -152.19 123.93 7.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 110.824 -2.898 . . . . 1.54 108.684 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 161.25 14.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.382 1.087 . . . . 1.8899999999999999 111.666 -168.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -52.56 155.08 2.31 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 112.626 -2.079 . . . . 3.46 112.662 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -44.0 110.3 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 113.119 -1.855 . . . . 3.3500000000000001 111.02 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -54.56 -47.88 24.39 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.386 2.724 . . . . 0.97999999999999998 111.668 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.71 -21.34 38.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.641 -1.163 . . . . 1.0800000000000001 112.74 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -112.81 -170.27 17.86 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.999 -0.619 . . . . 1.1599999999999999 112.199 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.9 34.24 0.1 Allowed 'Trans proline' 0 N--CA 1.478 0.578 0 C-N-CA 124.473 3.449 . . . . 1.46 113.888 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.632 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 50.1 t80 -83.15 -18.03 40.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.08 0.467 . . . . 2.1000000000000001 110.244 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.608 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.18 57.44 0.96 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.768 -0.73 . . . . 1.1100000000000001 114.856 170.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.27 -45.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.262 1.208 . . . . 1.45 114.262 165.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.629 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -140.68 162.87 34.37 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.903 -0.406 . . . . 1.5 109.903 -176.106 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 1.8 t90 -127.27 99.63 5.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 2.6000000000000001 108.433 172.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.3 mp -108.99 139.05 44.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.777 0.799 . . . . 1.3100000000000001 110.89 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 72.1 m -107.7 148.62 29.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.822 -1.081 . . . . 1.3100000000000001 113.115 -169.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 67.9 mt -104.86 -174.35 2.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.533 -1.212 . . . . 1.8600000000000001 108.441 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.0 m -72.34 -69.39 0.4 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.555 0.576 . . . . 1.95 112.555 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -124.36 149.77 46.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.869 0.322 . . . . 3.3999999999999999 111.869 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.434 ' HG3' ' H ' ' A' ' 122' ' ' HIS . 3.1 tp60 77.15 173.85 0.21 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 114.98 -1.009 . . . . 5.5800000000000001 111.068 173.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.434 ' H ' ' HG3' ' A' ' 121' ' ' GLN . 23.4 m-70 -82.09 42.29 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 6.7300000000000004 111.653 -173.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -110.63 128.66 55.78 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.861 -0.792 . . . . 5.1500000000000004 108.861 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.443 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -147.64 152.22 24.36 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.616 -0.802 . . . . 1.1899999999999999 111.609 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.649 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 25.5 mt -92.97 116.07 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.271 -0.64 . . . . 1.05 109.271 175.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 8.1 p80 -155.21 -161.46 1.19 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.337 0.589 . . . . 1.25 110.578 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.608 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -119.31 177.1 16.31 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 119.612 -1.28 . . . . 0.46000000000000002 112.877 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.9 t -137.07 172.84 12.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.135 0.493 . . . . 1.21 110.254 -170.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.68 -19.66 14.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 1.8600000000000001 109.0 165.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -125.39 104.41 28.46 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.339 -0.846 . . . . 1.8200000000000001 110.124 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.49 4.98 4.41 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.259 2.639 . . . . 0.64000000000000001 112.887 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.28 -22.8 28.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.039 0.447 . . . . 1.3200000000000001 110.651 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.2 p -85.32 -16.94 38.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.538 0.685 . . . . 1.8899999999999999 110.047 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 144' ' ' ARG . 11.9 mm -64.97 117.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.168 -0.923 . . . . 1.21 110.672 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.68 -5.11 47.16 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.724 -0.671 . . . . 1.6799999999999999 111.944 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -132.74 -49.41 0.89 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.765 0.317 . . . . 4.8799999999999999 111.647 -175.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.21 140.89 48.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.293 -0.412 . . . . 4.4699999999999998 111.334 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.4 t -117.2 -58.61 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 4.6799999999999997 111.135 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.7 p -70.33 -43.99 69.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.287 -0.415 . . . . 5.9100000000000001 110.591 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.81 -31.82 22.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.43 0.633 . . . . 8.5999999999999996 109.807 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.6 129.61 19.58 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.256 -0.884 . . . . 4.1900000000000004 113.22 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 64.6 m -122.65 -176.67 3.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.318 -0.623 . . . . 2.9199999999999999 109.318 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 27.7 mt -81.02 73.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.482 0.658 . . . . 2.0699999999999998 109.906 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 95.9 mtt180 -116.22 154.05 30.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.515 -0.766 . . . . 3.98 110.432 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.616 ' HE1' ' CG ' ' A' ' 82' ' ' TYR . 35.8 mtp -136.96 -173.34 3.42 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.926 -0.579 . . . . 1.8700000000000001 109.783 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.548 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 4.0 t-80 -78.57 154.71 30.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.265 -1.013 . . . . 3.25 108.265 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -48.87 -67.39 0.27 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.428 0.529 . . . . 2.4199999999999999 112.428 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 149' ' ' ASP . 3.8 ptpp? -59.7 -28.2 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.72 -0.612 . . . . 2.5699999999999998 111.582 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.548 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 6.7 m-20 -72.44 -40.15 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 1.05 110.714 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.709 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 9.4 p -74.83 -18.52 16.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.524 -0.307 . . . . 0.32000000000000001 110.246 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -86.82 -39.84 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.947 -0.549 . . . . 1.1299999999999999 110.435 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -44.39 -69.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.688 1.131 . . . . 1.3799999999999999 112.834 162.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.453 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -50.52 -42.35 54.89 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.953 -0.567 . . . . 1.3400000000000001 110.242 179.088 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -55.74 -53.82 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.348 -1.296 . . . . 1.02 112.038 -172.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.553 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 12.1 p -76.55 -13.57 60.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.407 -1.269 . . . . 1.9099999999999999 111.093 -172.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.65 -49.16 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.15 -0.477 . . . . 1.04 110.053 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.1 m -77.55 117.14 63.61 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-O 122.059 0.933 . . . . 0.20999999999999999 110.81 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.567 ' HG2' HD11 ' A' ' 57' ' ' ILE . 42.2 Cg_endo -83.05 -178.52 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.876 2.384 . . . . 0.51000000000000001 112.785 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.7 ' O ' HD22 ' A' ' 51' ' ' LEU . 16.9 m120 -58.32 -2.63 0.2 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.509 -1.223 . . . . 1.02 113.53 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.01 55.91 0.56 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.813 -0.708 . . . . 0.64000000000000001 112.568 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.556 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 4.9 m -93.91 136.59 34.04 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.565 -0.374 . . . . 1.0700000000000001 110.305 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.79 142.2 29.12 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.462 -0.495 . . . . 2.3399999999999999 110.291 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.2 p -143.66 123.75 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 0.46000000000000002 110.846 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.3 m -112.7 139.63 48.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 1.26 112.007 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.65 114.17 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 118.542 -1.263 . . . . 1.1699999999999999 111.194 171.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.0 127.41 16.85 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.886 -1.506 . . . . 1.1899999999999999 109.848 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.596 ' H ' HG23 ' A' ' 93' ' ' THR . 5.4 ptt180 -92.91 -29.78 15.73 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.694 -0.685 . . . . 3.7999999999999998 111.556 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -128.33 86.84 0.32 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.679 -0.772 . . . . 3.6499999999999999 112.007 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.337 -0.84 . . . . 5.9699999999999998 109.31 179.033 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.478 ' O32' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.693 -0.563 . . . . 3.3799999999999999 111.693 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -77.62 165.76 23.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.988 -0.375 . . . . 4.6799999999999997 109.988 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.1 mptt -65.38 150.95 47.43 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.01 -0.737 . . . . 2.54 109.01 173.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.617 HD12 ' H ' ' A' ' 50' ' ' GLY . 17.5 mt -92.38 167.87 11.69 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.269 0.356 . . . . 1.1000000000000001 111.163 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.0 tp -75.89 149.05 37.84 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 122.929 0.492 . . . . 1.05 111.851 -169.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.519 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.04 150.04 34.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.969 0.89 . . . . 1.01 111.365 167.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.658 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 57.5 t80 -134.64 150.36 50.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.727 -1.579 . . . . 1.1200000000000001 108.0 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.578 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.41 120.93 27.9 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.001 -1.481 . . . . 1.72 107.001 175.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.51 158.79 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 112.579 0.585 . . . . 0.38 112.579 -169.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -103.37 150.82 23.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.409 -0.814 . . . . 3.0600000000000001 109.261 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.502 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -52.61 109.44 0.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.336 0.589 . . . . 2.1699999999999999 112.005 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.23 -9.68 15.26 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.338 -0.846 . . . . 0.63 112.766 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.508 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 67.1 m-20 -61.43 152.55 29.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.844 0.322 . . . . 2.1699999999999999 110.814 176.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -133.49 155.99 48.57 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.253 0.464 . . . . 1.27 112.253 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.582 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -50.3 -58.33 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.545 0.943 . . . . 1.0800000000000001 113.545 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.675 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.9 t-20 -66.08 -41.81 90.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.27 1.033 . . . . 1.55 110.687 -169.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 26.3 m -55.89 -52.29 64.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 112.958 -1.928 . . . . 1.8200000000000001 109.754 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -66.48 -40.01 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.373 -0.831 . . . . 1.0600000000000001 111.942 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.98 -66.06 0.51 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.087 -0.506 . . . . 0.97999999999999998 112.108 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.35 -4.87 56.99 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 118.996 -1.081 . . . . 1.0700000000000001 112.133 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.1 m-20 -66.21 -31.52 72.4 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.99 -0.745 . . . . 1.6299999999999999 108.99 156.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.502 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.6 m-85 -96.48 15.21 22.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.033 -0.417 . . . . 0.25 112.068 173.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.57 51.48 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.607 -0.724 . . . . 4.2000000000000002 110.609 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 37.4 pt -149.4 -172.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.721 -0.844 . . . . 1.02 108.721 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.96 147.49 24.94 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.678 -0.692 . . . . 1.1599999999999999 109.909 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.675 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.7 p -61.5 -36.41 80.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.539 -0.911 . . . . 1.05 108.539 175.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.29 -28.64 69.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.478 -1.237 . . . . 1.05 111.664 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.72 -38.7 25.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.513 -0.551 . . . . 1.03 109.513 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.589 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.0 tp -73.3 -19.44 61.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.412 -0.813 . . . . 1.05 109.081 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.608 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -39.69 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.657 0.742 . . . . 1.0600000000000001 111.549 172.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.12 -40.6 96.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 114.994 -1.003 . . . . 1.26 110.03 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.24 -19.25 43.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.998 -1.455 . . . . 1.01 111.819 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 33.0 m-80 -142.13 71.57 22.89 Favored Pre-proline 0 CA--C 1.515 -0.374 0 CA-C-O 121.025 0.441 . . . . 0.20000000000000001 109.903 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.689 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.23 -12.54 10.42 Favored 'Trans proline' 0 C--O 1.22 -0.4 0 C-N-CA 123.301 2.667 . . . . 0.29999999999999999 113.946 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -61.69 -32.31 72.5 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.061 0.934 . . . . 1.3600000000000001 110.035 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.1 mt -81.1 -6.36 58.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.206 -1.361 . . . . 1.26 114.551 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.689 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -51.69 -40.66 60.51 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.77 1.272 . . . . 1.8899999999999999 109.503 177.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.97 -46.69 14.72 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 112.763 -2.017 . . . . 1.1000000000000001 111.562 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.54 -162.69 33.76 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.271 -0.966 . . . . 0.29999999999999999 114.364 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.88 158.21 24.37 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.188 -1.506 . . . . 1.0800000000000001 109.881 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 89.2 m -137.31 135.47 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 1.1699999999999999 110.792 -177.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -45.48 126.66 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.404 0.89 . . . . 1.1699999999999999 113.404 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.578 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.4 -12.48 45.47 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 114.613 -1.176 . . . . 0.38 112.083 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 4.1 tt0 -63.47 151.81 40.16 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.817 0.817 . . . . 1.1899999999999999 110.263 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.9 m -117.41 135.51 53.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.133 -1.394 . . . . 1.22 109.096 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.429 HD11 HD13 ' A' ' 29' ' ' LEU . 16.8 pt -136.71 146.42 28.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.296 0.57 . . . . 1.0600000000000001 110.533 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.441 ' H ' HD22 ' A' ' 33' ' ' ASN . 7.2 t -91.61 149.1 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.051 -0.977 . . . . 0.20999999999999999 110.409 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 19.2 mm -118.07 87.54 29.03 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-N 114.959 -1.019 . . . . 1.01 108.701 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' HD12 ' A' ' 4' ' ' LEU . 24.8 Cg_endo -59.08 139.78 92.16 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.209 2.606 . . . . 0.23000000000000001 112.709 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.617 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 84.18 -7.59 70.91 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.29999999999999999 112.93 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.81 128.78 25.78 Favored Pre-proline 0 C--O 1.218 -0.566 0 N-CA-C 108.566 -0.902 . . . . 1.0800000000000001 108.566 177.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.566 ' CD ' HD21 ' A' ' 51' ' ' LEU . 73.4 Cg_endo -68.92 171.72 13.04 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.75 2.967 . . . . 0.34000000000000002 114.167 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.559 ' HB3' HG21 ' A' ' 56' ' ' THR . 9.1 t70 -90.08 141.76 28.17 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.71999999999999997 110.232 -172.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 62.9 Cg_endo -85.27 -7.13 9.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.323 2.682 . . . . 0.33000000000000002 111.992 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 55' ' ' TYR . 57.5 m-85 -95.67 -24.52 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.29 110.239 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.559 HG21 ' HB3' ' A' ' 53' ' ' ASP . 13.1 t -87.25 -15.41 38.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.678 -0.86 . . . . 2.0600000000000001 108.678 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.583 HD11 ' HG2' ' A' ' 158' ' ' PRO . 61.7 mt -87.21 126.2 63.44 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 114.503 -1.226 . . . . 1.0900000000000001 108.964 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -101.16 93.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.175 0 CA-C-N 120.52 1.221 . . . . 0.22 110.106 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -159.03 131.52 6.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.238 -1.764 . . . . 0.80000000000000004 106.238 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 23.3 m-70 -140.33 107.8 5.57 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.095 -1.446 . . . . 3.5800000000000001 107.095 -164.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.5 mt -94.61 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.054 -0.975 . . . . 1.0600000000000001 110.398 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.39 94.59 5.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.0 0.905 . . . . 1.1200000000000001 110.337 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -115.6 100.02 9.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.039 -1.437 . . . . 0.68000000000000005 110.291 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 38.6 t -90.32 121.58 32.44 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.239 -1.393 . . . . 1.3300000000000001 107.239 173.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.562 ' CG2' ' HB2' ' A' ' 167' ' ' ARG . 33.3 mm -62.26 -26.88 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.957 0.884 . . . . 1.77 108.936 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.89 -46.0 84.72 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.297 -0.954 . . . . 0.93999999999999995 111.377 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -67.27 -23.99 65.74 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.606 0.595 . . . . 1.22 112.606 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HA ' ' CG2' ' A' ' 86' ' ' VAL . 40.7 mttt 61.54 13.17 4.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.885 0.874 . . . . 2.9399999999999999 112.544 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.489 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -141.13 137.35 32.7 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.1 0.953 . . . . 1.0600000000000001 112.118 177.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.476 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.3 tt -93.96 118.93 32.16 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.346 -1.752 . . . . 1.0900000000000001 109.121 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 m -102.6 125.08 49.2 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.055 -0.658 . . . . 1.0900000000000001 111.233 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.587 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -84.6 129.75 34.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.509 -1.663 . . . . 1.0800000000000001 106.509 177.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 15.6 m -135.58 126.45 27.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 120.905 1.684 . . . . 0.93000000000000005 112.81 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.0 tp -113.03 126.5 55.56 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.774 -1.103 . . . . 1.1399999999999999 109.876 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 63.05 40.05 9.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.088 -0.708 . . . . 0.52000000000000002 109.088 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 83.35 -21.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.725 1.21 . . . . 1.8400000000000001 111.949 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -121.92 139.06 54.12 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 117.295 -1.762 . . . . 3.8500000000000001 114.779 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.92 149.53 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 112.546 -2.115 . . . . 0.40999999999999998 113.882 -167.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.587 ' SD ' HD23 ' A' ' 72' ' ' LEU . 3.5 mtp -100.74 -42.97 6.28 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 112.076 -2.329 . . . . 1.0900000000000001 108.18 175.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 2.6 tppt? -178.37 164.69 1.74 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 112.464 -2.153 . . . . 2.6200000000000001 109.931 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.489 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 12.1 m -126.24 134.39 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.514 0.197 . . . . 1.1000000000000001 110.798 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 1.628 ' HE2' ' CE1' ' A' ' 82' ' ' TYR . 19.5 m-85 -123.31 145.87 47.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 109.534 -0.543 . . . . 1.0600000000000001 109.534 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -83.86 148.31 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.44 2.093 . . . . 0.85999999999999999 112.037 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.69 179.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.296 -0.411 . . . . 1.2 110.192 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.2 139.87 31.33 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.86 0.362 . . . . 1.4099999999999999 110.251 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.467 ' CG2' ' HA ' ' A' ' 68' ' ' LYS . 2.1 t -135.69 149.45 28.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.948 -0.569 . . . . 1.6699999999999999 112.506 -169.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.16 -91.46 1.25 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.933 -0.576 . . . . 3.0800000000000001 113.099 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.558 ' HG3' ' H ' ' A' ' 89' ' ' ILE . 17.7 tptm -158.47 179.85 8.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.07 0.435 . . . . 7.6200000000000001 110.428 -173.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.558 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 31.3 pt -131.88 132.67 61.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.132 0.419 . . . . 6.7199999999999998 112.132 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.54 ' N ' ' HA ' ' A' ' 169' ' ' SER . 21.5 mt -156.66 -82.53 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.554 0.742 . . . . 7.6299999999999999 110.593 173.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -173.86 77.65 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.753 0.649 . . . . 5.5099999999999998 112.753 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.69 ' HB2' ' O ' ' A' ' 169' ' ' SER . 19.9 mm-40 -150.34 -81.63 0.11 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.761 0.652 . . . . 5.3899999999999997 112.761 176.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.663 HG23 ' N ' ' A' ' 167' ' ' ARG . 60.6 p 61.81 127.55 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 124.446 1.098 . . . . 2.5600000000000001 112.159 -174.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.77 152.82 37.71 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.264 1.976 . . . . 3.6600000000000001 112.075 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.4 m -98.46 134.78 40.96 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.57 -0.529 . . . . 4.1699999999999999 109.57 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.66 91.4 0.19 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.107 -1.044 . . . . 2.6899999999999999 111.723 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -77.63 148.99 34.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.869 -0.419 . . . . 2.2999999999999998 109.869 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.593 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 21.4 m-85 -113.33 174.31 5.97 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.189 -0.46 . . . . 2.3500000000000001 109.857 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.7 m-85 -140.03 141.7 36.27 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.061 -0.348 . . . . 0.92000000000000004 110.061 174.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 125' ' ' ILE . 23.9 mm -60.16 121.17 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.9 -1.148 . . . . 1.0600000000000001 107.9 167.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.502 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.8 tt -122.92 -25.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.094 -0.642 . . . . 1.04 112.161 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 9.1 t-20 -150.69 154.22 37.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.478 1.288 . . . . 2.3500000000000001 114.478 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.56 119.85 11.55 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 111.487 -2.597 . . . . 1.54 108.904 172.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.432 ' HG2' ' N ' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -97.59 159.87 14.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.386 1.088 . . . . 1.8899999999999999 112.042 -168.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.432 ' N ' ' HG2' ' A' ' 104' ' ' GLN . 18.3 ttm180 -50.69 149.73 3.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 112.352 -2.204 . . . . 3.46 111.646 168.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -48.21 106.32 0.59 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 114.976 -1.011 . . . . 3.3500000000000001 112.233 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.7 -49.9 13.32 Favored 'Trans proline' 0 CA--C 1.519 -0.261 0 C-N-CA 123.723 2.949 . . . . 0.97999999999999998 112.43 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 16.75 49.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.237 -0.892 . . . . 1.0800000000000001 112.394 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -138.67 -168.95 11.43 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.085 -0.579 . . . . 1.1599999999999999 112.15 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.96 16.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.938 3.092 . . . . 1.46 113.115 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.531 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -70.57 -21.38 62.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.079 -0.509 . . . . 2.1000000000000001 110.503 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.45 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.32 37.01 4.19 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.584 -0.735 . . . . 1.1100000000000001 113.874 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.36 -19.0 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.762 0.653 . . . . 1.45 112.762 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.624 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -159.21 152.47 22.41 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 122.86 0.464 . . . . 1.5 110.02 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.408 ' CE3' ' HE1' ' A' ' 111' ' ' PHE . 33.7 t-105 -120.24 105.48 10.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.6000000000000001 109.634 170.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -107.84 138.52 43.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.6 0.714 . . . . 1.3100000000000001 111.101 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.9 m -106.76 146.25 31.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.326 -0.852 . . . . 1.3100000000000001 112.347 -171.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.88 -173.49 3.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.85 -0.796 . . . . 1.8600000000000001 108.85 169.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.444 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.9 t -60.88 -80.08 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.42 0.526 . . . . 1.95 112.42 -172.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 21.8 pttm -125.39 160.44 29.4 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.191 -0.318 . . . . 3.3999999999999999 111.086 -177.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 6.6 tp-100 75.28 156.56 0.18 Allowed 'General case' 0 N--CA 1.461 0.09 0 O-C-N 124.296 0.997 . . . . 5.5800000000000001 109.179 -175.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.544 ' ND1' ' N26' ' A' 1142 ' ' IM2 . 84.2 m-70 -74.52 58.67 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.2 0.524 . . . . 6.7300000000000004 111.49 -175.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -116.55 139.48 50.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.296 -0.865 . . . . 5.1500000000000004 108.709 172.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.66 161.06 30.01 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.118 -1.039 . . . . 1.1899999999999999 112.368 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.608 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 40.3 mt -93.26 107.35 19.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.213 -1.032 . . . . 1.05 108.213 173.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.456 ' O ' ' HG2' ' A' ' 145' ' ' MET . 12.6 p80 -138.95 -166.96 2.12 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.306 -0.957 . . . . 1.25 111.954 -176.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.45 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.72 161.54 14.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.356 -1.293 . . . . 0.46000000000000002 112.988 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.7 t -127.25 178.22 6.18 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.951 -0.625 . . . . 1.21 110.569 -170.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -105.21 -16.64 14.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.318 -0.856 . . . . 1.8600000000000001 109.662 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -126.92 100.69 27.23 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.842 -0.617 . . . . 1.8200000000000001 110.152 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -91.6 4.31 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.197 2.598 . . . . 0.64000000000000001 113.267 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.97 27.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.253 0.549 . . . . 1.3200000000000001 110.251 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.1 t -82.19 -26.98 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.736 . . . . 1.8899999999999999 109.732 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 144' ' ' ARG . 6.6 mm -60.35 107.94 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.18 -0.918 . . . . 1.21 111.552 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.65 32.75 85.24 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 114.9 -1.045 . . . . 1.6799999999999999 112.771 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -153.19 -36.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.16 0.43 . . . . 4.8799999999999999 112.16 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.56 160.81 39.57 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.242 -0.286 . . . . 4.4699999999999998 111.52 -175.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.9 t 72.57 -60.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 123.859 0.724 . . . . 4.6799999999999997 111.2 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.1 m 66.01 170.43 0.23 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.882 0.473 . . . . 5.9100000000000001 111.663 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 53.63 77.99 0.16 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.799 -0.637 . . . . 8.5999999999999996 111.414 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.37 -152.97 6.35 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 4.1900000000000004 112.109 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 56.7 m -111.34 177.09 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.393 0.616 . . . . 2.9199999999999999 111.161 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.8 mt -86.04 94.49 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.386 -0.825 . . . . 2.0699999999999998 111.428 -170.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.532 ' HB2' HD12 ' A' ' 134' ' ' ILE . 35.4 mtm180 -119.04 151.64 37.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.404 -0.816 . . . . 3.98 109.339 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.489 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 15.4 ptm -152.42 -167.18 2.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.506 0.193 . . . . 1.8700000000000001 111.094 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -77.06 145.5 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.505 -0.316 . . . . 3.25 110.493 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -49.89 -67.15 0.28 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.336 0.398 . . . . 2.4199999999999999 111.898 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -26.32 65.45 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.572 -0.705 . . . . 2.5699999999999998 111.853 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.44 -36.72 63.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.745 -0.207 . . . . 1.05 110.812 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.714 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 13.4 p -75.44 -18.65 15.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 116.61 -0.268 . . . . 0.32000000000000001 110.377 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.418 ' HA ' ' CB ' ' A' ' 154' ' ' ALA . 3.2 mp -88.83 -41.44 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 119.27 -0.395 . . . . 1.1299999999999999 110.243 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -41.03 -69.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 119.019 0.827 . . . . 1.3799999999999999 112.191 162.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.428 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.1 tp -50.55 -43.11 56.04 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.859 -0.61 . . . . 1.3400000000000001 110.334 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.714 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -54.02 -52.52 60.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.703 -1.135 . . . . 1.02 112.366 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.5 t -78.47 -14.67 59.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.668 -1.151 . . . . 1.9099999999999999 110.961 -172.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.01 -48.78 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.028 0.442 . . . . 1.04 109.815 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.2 m -76.91 119.51 77.77 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-O 121.714 0.769 . . . . 0.20999999999999999 109.819 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.583 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.3 Cg_endo -82.3 -178.89 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.664 2.243 . . . . 0.51000000000000001 112.257 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.698 ' O ' HD22 ' A' ' 51' ' ' LEU . 9.6 m120 -59.67 -0.66 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.682 -1.144 . . . . 1.02 113.52 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 158' ' ' PRO . . . -144.95 56.2 0.54 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.02 -0.61 . . . . 0.64000000000000001 112.237 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.514 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 3.1 m -94.01 133.99 36.88 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.524 -0.398 . . . . 1.0700000000000001 110.075 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -86.64 142.49 28.21 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.186 -0.605 . . . . 2.3399999999999999 110.849 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.1 p -147.31 127.42 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.025 -0.989 . . . . 0.46000000000000002 110.917 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.4 m -113.3 142.13 46.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.516 -0.766 . . . . 1.26 111.38 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.0 mp -125.34 119.34 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 118.791 -1.164 . . . . 1.1699999999999999 111.148 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.79 120.56 11.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.952 -1.476 . . . . 1.1899999999999999 107.768 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.663 ' N ' HG23 ' A' ' 93' ' ' THR . 0.0 OUTLIER -96.55 -50.94 4.53 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 114.165 1.172 . . . . 3.7999999999999998 114.165 -169.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.622 ' N ' ' HG2' ' A' ' 167' ' ' ARG . . . 125.42 -61.74 0.61 Allowed Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 109.993 -1.243 . . . . 3.6499999999999999 109.993 -170.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.69 ' O ' ' HB2' ' A' ' 92' ' ' GLN . 12.9 t . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.343 -0.837 . . . . 5.9699999999999998 112.643 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.544 ' N26' ' ND1' ' A' ' 122' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.763 -0.535 . . . . 3.3799999999999999 111.763 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -107.66 170.47 7.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.947 -0.39 . . . . 4.6799999999999997 109.947 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -71.39 148.66 46.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.538 -0.542 . . . . 2.54 109.538 176.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.4 mt -99.35 172.92 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.21 -0.45 . . . . 1.1000000000000001 111.338 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.5 tp -77.67 152.33 33.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.201 0.6 . . . . 1.05 111.748 -170.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.543 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.17 150.13 36.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.115 0.959 . . . . 1.01 111.847 166.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.668 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 87.1 t80 -133.6 142.77 48.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.611 -1.631 . . . . 1.1200000000000001 107.719 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.3 tm0? -125.79 113.53 17.4 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.862 -1.533 . . . . 1.72 106.862 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.413 ' HB ' HD21 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -76.81 158.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 113.193 0.812 . . . . 0.38 113.193 -164.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.567 ' HB3' ' HZ2' ' A' ' 10' ' ' LYS . 9.9 mtpm? -95.44 148.11 22.81 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.105 -0.952 . . . . 3.0600000000000001 109.599 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.522 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 6.4 tt0 -52.19 109.38 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 2.1699999999999999 111.554 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.9 -9.44 23.31 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.692 -0.766 . . . . 0.63 112.957 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 71.4 m-20 -59.75 154.44 18.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.294 0.547 . . . . 2.1699999999999999 111.757 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.4 p -133.04 152.91 51.92 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.439 0.533 . . . . 1.27 112.439 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.579 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.99 -59.04 3.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.776 1.028 . . . . 1.0800000000000001 113.776 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.666 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 16.5 t-20 -64.84 -41.2 95.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.615 1.198 . . . . 1.55 110.578 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.565 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 43.9 t -59.22 -48.51 81.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.353 -2.203 . . . . 1.8200000000000001 109.991 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -68.01 -40.71 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.064 -0.516 . . . . 1.0600000000000001 111.936 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.57 -63.9 1.05 Allowed 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.18 -0.464 . . . . 0.97999999999999998 111.559 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.56 -4.64 54.78 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.877 -1.129 . . . . 1.0700000000000001 112.181 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -68.29 -30.25 69.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.947 -0.76 . . . . 1.6299999999999999 108.947 157.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.475 ' CD1' HD11 ' A' ' 101' ' ' ILE . 2.4 m-85 -96.44 15.61 20.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.996 0.369 . . . . 0.25 111.996 172.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 55.43 49.62 16.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.661 -0.699 . . . . 4.2000000000000002 110.579 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 37.4 pt -148.2 -173.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.858 -0.793 . . . . 1.02 108.858 -173.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -100.6 146.19 27.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.167 -0.924 . . . . 1.1599999999999999 109.737 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.666 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.3 p -61.37 -37.14 82.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.983 -0.747 . . . . 1.05 108.983 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -28.91 70.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.389 -1.278 . . . . 1.05 111.543 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.22 -38.06 27.59 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.492 -0.559 . . . . 1.03 109.492 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.575 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.3 tp -74.32 -17.84 60.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.317 -0.856 . . . . 1.05 109.201 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.582 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.94 -39.1 26.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.681 0.753 . . . . 1.0600000000000001 111.825 173.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -60.57 -40.95 93.56 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.947 -1.024 . . . . 1.26 109.764 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.35 -21.14 39.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.633 -1.622 . . . . 1.01 111.985 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 28.3 m-80 -142.36 72.87 21.37 Favored Pre-proline 0 CA--C 1.513 -0.46 0 CA-C-O 121.163 0.506 . . . . 0.20000000000000001 109.89 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.645 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 19.1 Cg_endo -58.36 -9.04 5.99 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.592 2.861 . . . . 0.29999999999999999 114.157 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -63.34 -34.89 78.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.949 0.881 . . . . 1.3600000000000001 109.478 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.21 -6.72 57.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.205 -1.361 . . . . 1.26 114.521 -170.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.645 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -49.13 -40.73 33.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.575 1.179 . . . . 1.8899999999999999 110.181 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.06 -46.85 10.78 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 112.747 -2.024 . . . . 1.1000000000000001 111.624 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.64 -164.08 34.81 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.43 -0.89 . . . . 0.29999999999999999 114.172 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 9' ' ' VAL . 5.6 mp -118.4 157.74 26.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.474 -1.363 . . . . 1.0800000000000001 110.624 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 81.5 m -135.09 135.48 41.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.694 -0.684 . . . . 1.1699999999999999 110.912 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.522 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -47.37 128.9 12.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.576 0.954 . . . . 1.1699999999999999 113.576 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.493 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 80.49 -11.62 37.83 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.386 -1.279 . . . . 0.38 112.26 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.9 tt0 -63.74 152.22 39.87 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.555 0.693 . . . . 1.1899999999999999 110.237 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 30.8 m -119.5 133.37 55.71 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.41 -1.268 . . . . 1.22 109.436 -171.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.446 HD11 HD13 ' A' ' 29' ' ' LEU . 19.5 pt -135.37 155.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.157 0.504 . . . . 1.0600000000000001 110.397 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.513 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.8 t -99.68 149.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.283 -0.871 . . . . 0.20999999999999999 110.398 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.436 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 17.5 mm -117.57 88.72 30.26 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.118 -0.946 . . . . 1.01 108.516 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . 24.1 Cg_endo -59.67 139.49 89.07 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.188 2.592 . . . . 0.23000000000000001 112.876 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.582 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 83.38 -7.29 68.76 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.172 -0.922 . . . . 0.29999999999999999 112.812 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.08 124.98 29.46 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.902 -0.777 . . . . 1.0800000000000001 108.902 177.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.54 ' CD ' HD21 ' A' ' 51' ' ' LEU . 59.9 Cg_endo -66.23 174.19 6.39 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.729 2.953 . . . . 0.34000000000000002 114.028 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 2.5 t70 -90.82 138.33 26.4 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.71999999999999997 111.699 -171.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 92.7 Cg_endo -81.17 -5.84 12.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.219 2.613 . . . . 0.33000000000000002 113.429 -174.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 55' ' ' TYR . 67.6 m-85 -95.15 -28.51 15.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.65 0.262 . . . . 2.29 111.038 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t -78.99 -24.42 43.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.667 -0.864 . . . . 2.0600000000000001 108.667 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.564 HD11 ' HG2' ' A' ' 158' ' ' PRO . 77.5 mt -74.24 123.59 89.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 114.859 -1.064 . . . . 1.0900000000000001 109.711 170.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' O ' HD13 ' A' ' 74' ' ' LEU . 18.1 Cg_endo -101.06 94.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 119.839 0.978 . . . . 0.22 110.148 169.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 73' ' ' SER . 84.1 m-85 -159.1 139.45 12.25 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.546 -1.65 . . . . 0.80000000000000004 106.546 172.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.525 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 35.1 t60 -147.43 118.73 7.82 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.878 -1.156 . . . . 3.5800000000000001 107.878 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -106.51 113.02 42.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.032 -0.985 . . . . 1.0600000000000001 111.087 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.89 106.87 16.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.107 -0.951 . . . . 1.1200000000000001 110.106 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -113.37 119.85 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 114.59 -1.186 . . . . 0.68000000000000005 110.017 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.525 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 16.5 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.015 -1.074 . . . . 1.3300000000000001 109.937 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.468 ' HA ' ' CG1' ' A' ' 86' ' ' VAL . 17.2 mt -61.43 -28.78 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.808 0.813 . . . . 1.77 109.798 172.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.32 -47.25 59.26 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.658 -1.156 . . . . 0.93999999999999995 111.615 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -74.94 -26.11 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.237 0.828 . . . . 1.22 113.237 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.541 ' HA ' ' CG1' ' A' ' 86' ' ' VAL . 59.0 tttt 49.35 29.27 2.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.112 0.958 . . . . 2.9399999999999999 112.179 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -143.98 139.61 29.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.381 -0.827 . . . . 1.0600000000000001 110.989 170.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 tt -97.03 120.06 36.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.907 -1.497 . . . . 1.0900000000000001 109.495 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -100.45 123.18 44.34 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.003 -0.679 . . . . 1.0900000000000001 110.711 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.562 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.73 143.57 30.8 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.449 -1.685 . . . . 1.0800000000000001 106.449 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 31.2 p -149.72 127.47 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 120.499 1.499 . . . . 0.93000000000000005 113.147 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 58' ' ' PRO . 13.3 tp -112.19 125.91 54.64 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.151 -1.386 . . . . 1.1399999999999999 110.076 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 8.9 t-20 68.87 31.02 4.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.513 -0.921 . . . . 0.52000000000000002 108.513 172.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 34.9 m-80 79.14 2.1 2.37 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.167 -1.378 . . . . 1.8400000000000001 111.763 176.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -129.76 142.09 50.76 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 118.874 -1.13 . . . . 3.8500000000000001 113.987 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -58.45 150.06 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 113.219 -1.81 . . . . 0.40999999999999998 113.314 -168.223 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.562 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -100.47 -43.73 6.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.464 -2.153 . . . . 1.0900000000000001 108.4 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 4.7 tppt? 179.5 161.05 0.81 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.746 -2.025 . . . . 2.6200000000000001 110.451 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.499 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 22.8 m -118.05 132.0 56.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.675 0.274 . . . . 1.1000000000000001 110.957 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -113.22 152.01 44.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 1.0600000000000001 110.297 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -83.86 138.84 8.31 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.508 2.139 . . . . 0.85999999999999999 111.943 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.35 172.74 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.325 -0.62 . . . . 1.2 109.325 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.85 158.95 17.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 1.4099999999999999 111.478 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 68' ' ' LYS . 26.7 m -142.25 170.33 12.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.309 -0.859 . . . . 1.6699999999999999 109.362 -174.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.95 -130.87 0.44 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.737 -0.744 . . . . 3.0800000000000001 112.354 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -100.68 -93.33 0.28 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.745 -0.268 . . . . 7.6200000000000001 110.706 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pt -136.5 -78.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.439 0.533 . . . . 6.7199999999999998 112.439 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.9 tt -116.16 139.05 50.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 7.6299999999999999 111.212 -172.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.409 HG23 ' HG2' ' A' ' 92' ' ' GLN . 47.3 m -157.07 -86.27 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.518 . . . . 5.5099999999999998 110.121 174.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.409 ' HG2' HG23 ' A' ' 91' ' ' THR . 3.6 pt20 -168.4 18.84 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.04 0.385 . . . . 5.3899999999999997 112.04 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.656 HG21 ' H ' ' A' ' 167' ' ' ARG . 79.7 p 56.14 130.29 0.01 OUTLIER Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 124.08 0.952 . . . . 2.5600000000000001 111.76 -172.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.411 ' C ' ' HG1' ' A' ' 95' ' ' THR . 90.8 Cg_endo -76.79 27.69 0.43 Allowed 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.574 2.183 . . . . 3.6600000000000001 114.235 -170.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.411 ' HG1' ' C ' ' A' ' 94' ' ' PRO . 21.7 p 45.51 48.62 10.96 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.474 0.654 . . . . 4.1699999999999999 110.645 -174.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -85.27 52.86 4.71 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.294 -0.866 . . . . 2.6899999999999999 113.938 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -92.18 103.76 16.21 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.228 -0.656 . . . . 2.2999999999999998 109.228 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 7.1 m-85 -124.57 -178.6 4.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.517 -0.765 . . . . 2.3500000000000001 109.72 -176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' A' ' 99' ' ' TYR . 62.2 m-85 -139.26 138.64 36.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.781 -0.645 . . . . 0.92000000000000004 110.315 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.52 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 27.7 mm -60.51 127.63 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 107.987 -1.116 . . . . 1.0600000000000001 107.987 167.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.475 HD11 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -118.17 -31.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.512 -0.875 . . . . 1.04 112.341 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.453 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 1.8 t-20 -166.78 -175.07 2.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 118.084 -1.447 . . . . 2.3500000000000001 114.289 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.453 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.9 ptp180 -156.81 133.86 10.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 111.211 -2.722 . . . . 1.54 110.125 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.8 155.36 24.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.275 1.036 . . . . 1.8899999999999999 111.708 -172.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.27 155.35 3.81 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 112.291 -2.231 . . . . 3.46 112.92 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -43.58 102.93 0.3 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 112.947 -1.933 . . . . 3.3500000000000001 111.674 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.83 -54.04 2.71 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 124.114 3.209 . . . . 0.97999999999999998 113.0 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.73 -20.6 26.87 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.543 -0.753 . . . . 1.0800000000000001 111.907 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -87.82 -169.59 45.49 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.375 -0.44 . . . . 1.1599999999999999 112.493 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.03 6.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.167 3.245 . . . . 1.46 113.949 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.659 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 32.6 m-85 -53.42 -35.95 60.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.138 0.494 . . . . 2.1000000000000001 109.749 171.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.9 -2.58 16.76 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.337 -0.847 . . . . 1.1100000000000001 114.697 168.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . . . -175.57 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.828 0.814 . . . . 1.45 112.628 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.594 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -151.63 158.32 43.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.344 -0.389 . . . . 1.5 111.514 -171.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.427 ' CE3' ' HD2' ' A' ' 126' ' ' HIS . 9.7 t-105 -117.77 100.44 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.359 -0.608 . . . . 2.6000000000000001 109.359 171.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mp -105.3 141.12 37.38 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.727 0.775 . . . . 1.3100000000000001 111.351 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 56.3 m -105.83 142.79 34.95 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.934 -1.03 . . . . 1.3100000000000001 111.979 -169.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.87 -174.49 2.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.468 -0.938 . . . . 1.8600000000000001 108.468 173.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.3 p -100.71 -44.75 5.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.973 0.806 . . . . 1.95 112.788 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 98' ' ' PHE . 87.7 mttt -122.34 160.69 24.84 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.362 -0.211 . . . . 3.3999999999999999 111.329 -173.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 67.5 179.3 0.23 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.698 0.761 . . . . 5.5800000000000001 112.545 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -84.09 40.46 0.76 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.253 -0.885 . . . . 6.7300000000000004 110.779 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -116.69 141.07 48.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.12 -0.491 . . . . 5.1500000000000004 110.583 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.64 154.46 25.54 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 109.978 -1.249 . . . . 1.1899999999999999 109.978 175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.488 HD13 HD13 ' A' ' 100' ' ' ILE . 30.8 mt -92.94 112.05 25.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.918 0.866 . . . . 1.05 109.441 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.427 ' HD2' ' CE3' ' A' ' 115' ' ' TRP . 14.9 t-80 -130.26 173.09 11.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.635 -1.166 . . . . 1.25 111.527 -160.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.2 -171.7 14.63 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 0.46000000000000002 111.311 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 t -159.48 174.52 14.55 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.933 -1.107 . . . . 1.21 112.679 -163.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.18 -20.57 13.76 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.914 -1.494 . . . . 1.8600000000000001 108.884 167.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.78 103.21 21.76 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.152 -0.931 . . . . 1.8200000000000001 110.232 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.52 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 64.8 Cg_endo -90.63 4.94 4.35 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.975 2.45 . . . . 0.64000000000000001 112.553 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.5 40.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.248 0.547 . . . . 1.3200000000000001 109.977 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.0 m -91.25 13.8 16.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.324 -0.853 . . . . 1.8899999999999999 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 18.8 mm -108.08 115.48 49.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 1.21 110.711 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.52 -36.66 3.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.775 . . . . 1.6799999999999999 112.953 176.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -121.22 116.68 25.37 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.536 -0.542 . . . . 4.8799999999999999 109.536 179.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 66.18 170.59 0.23 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.01 0.819 . . . . 4.4699999999999998 111.645 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t 67.15 138.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.696 0.76 . . . . 4.6799999999999997 111.814 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 12.4 t -109.49 -145.73 0.4 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.53 -0.759 . . . . 5.9100000000000001 110.223 -176.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.516 ' HZ1' ' HB2' ' A' ' 140' ' ' LYS . 0.1 OUTLIER 72.66 108.78 0.07 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.542 0.687 . . . . 8.5999999999999996 111.078 -178.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.47 89.62 1.03 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.554 -0.748 . . . . 4.1900000000000004 112.629 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.845 ' SG ' ' H12' ' A' 1142 ' ' IM2 . 50.5 t -118.54 -33.9 4.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.952 -0.388 . . . . 2.9199999999999999 109.952 174.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.0 mt 75.38 81.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.846 0.832 . . . . 2.0699999999999998 111.442 173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.503 ' NH2' ' N26' ' A' 1142 ' ' IM2 . 39.4 mtt180 -118.97 162.56 18.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.413 -0.958 . . . . 3.98 108.413 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.9 mtp -145.4 -169.28 3.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.096 0.474 . . . . 1.8700000000000001 111.362 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 149' ' ' ASP . 37.6 m80 -66.45 176.11 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.167 -0.924 . . . . 3.25 109.143 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -82.4 -63.5 1.36 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.017 -1.105 . . . . 2.4199999999999999 108.017 -172.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -66.69 -22.15 66.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.616 . . . . 2.5699999999999998 111.323 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 146' ' ' HIS . 31.2 m-20 -67.93 -41.83 81.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.893 0.378 . . . . 1.05 110.831 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.728 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 8.5 p -79.52 -13.01 13.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.32000000000000001 110.521 -177.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.546 ' CD1' ' HB3' ' A' ' 113' ' ' ALA . 3.3 mp -92.34 -40.52 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 119.254 -0.403 . . . . 1.1299999999999999 110.849 168.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -42.32 -70.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.356 0.98 . . . . 1.3799999999999999 111.912 162.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.463 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -50.07 -41.96 48.99 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.738 0.649 . . . . 1.3400000000000001 110.181 177.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.728 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -52.23 -55.47 20.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.622 -1.172 . . . . 1.02 111.727 -172.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 28.7 t -77.01 -16.66 59.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.686 -1.143 . . . . 1.9099999999999999 110.863 -172.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.24 -50.07 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 1.04 109.969 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.3 m -77.51 115.78 52.43 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 122.046 0.927 . . . . 0.20999999999999999 110.38 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.564 ' HG2' HD11 ' A' ' 57' ' ' ILE . 45.6 Cg_endo -80.82 -178.28 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.834 2.356 . . . . 0.51000000000000001 112.578 -172.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.62 ' O ' HD22 ' A' ' 51' ' ' LEU . 19.2 m120 -55.91 -5.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.669 -1.151 . . . . 1.02 113.57 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.18 57.26 0.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.937 -0.649 . . . . 0.64000000000000001 112.168 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.52 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 3.8 m -90.72 140.32 29.89 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.405 -0.467 . . . . 1.0700000000000001 110.608 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.478 ' HG2' ' CE2' ' A' ' 99' ' ' TYR . 60.4 mtm180 -83.53 125.15 31.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.51 . . . . 2.3399999999999999 109.86 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.5 p -136.16 126.65 41.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.389 0.614 . . . . 0.46000000000000002 111.419 -177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.5 m -117.29 140.49 49.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.384 -0.826 . . . . 1.26 111.975 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.7 mp -129.14 115.82 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 122.342 1.067 . . . . 1.1699999999999999 111.397 172.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -143.78 137.77 28.29 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.527 -1.67 . . . . 1.1899999999999999 110.26 -173.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.656 ' H ' HG21 ' A' ' 93' ' ' THR . 8.6 ptm180 -91.99 -11.56 35.71 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.098 -0.956 . . . . 3.7999999999999998 111.342 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.66 -57.24 0.52 Allowed Glycine 0 C--N 1.308 -1.022 0 CA-C-N 114.459 -1.246 . . . . 3.6499999999999999 110.949 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.248 0.98 0 N-CA-C 109.123 -0.695 . . . . 5.9699999999999998 109.123 173.194 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.845 ' H12' ' SG ' ' A' ' 142' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.908 -0.477 . . . . 3.3799999999999999 111.908 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.417 ' HD3' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -110.97 178.15 4.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.214 0.531 . . . . 4.6799999999999997 110.756 178.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.56 ' HE2' ' H ' ' A' ' 3' ' ' LYS . 1.8 mppt? -73.27 143.01 47.2 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.288 -0.869 . . . . 2.54 108.845 174.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 50' ' ' GLY . 16.6 mt -95.91 170.89 8.98 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.071 0.232 . . . . 1.1000000000000001 111.15 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.0 tp -77.62 150.11 34.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 123.215 0.606 . . . . 1.05 112.173 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.528 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -115.07 149.25 37.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.012 0.911 . . . . 1.01 111.754 168.006 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 68.5 t80 -133.72 150.3 51.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.61 -1.632 . . . . 1.1200000000000001 107.911 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.3 tm0? -131.59 117.13 18.3 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.151 -1.426 . . . . 1.72 107.151 174.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.58 158.83 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 123.234 0.614 . . . . 0.38 111.226 -169.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.557 ' HB3' ' HZ2' ' A' ' 10' ' ' LYS . 8.5 mtpm? -110.27 156.72 20.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.111 -0.7 . . . . 3.0600000000000001 109.111 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.513 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 19.7 tm0? -49.82 117.94 2.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.826 -0.625 . . . . 2.1699999999999999 112.571 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.54 -6.44 35.94 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.63 113.428 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.507 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . 20.9 m-20 -70.66 157.09 38.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.473 0.637 . . . . 2.1699999999999999 112.436 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.438 ' O ' HD12 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -134.7 162.29 32.76 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.549 0.574 . . . . 1.27 112.549 -176.337 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.9 tp -51.75 -60.73 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.937 1.088 . . . . 1.0800000000000001 113.937 -173.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.652 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.8 t-20 -63.75 -43.37 96.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.614 1.197 . . . . 1.55 110.403 -169.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.751 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 31.3 m -60.46 -39.17 86.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 112.494 -2.139 . . . . 1.8200000000000001 110.989 -177.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.507 ' CD1' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.35 -40.87 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 123.012 0.525 . . . . 1.0600000000000001 112.327 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.55 -61.66 2.27 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.487 -0.324 . . . . 0.97999999999999998 111.242 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.14 -3.33 54.62 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.01 -1.076 . . . . 1.0700000000000001 112.136 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 17' ' ' SER . 4.0 t70 -62.13 -39.64 93.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.85 -1.167 . . . . 1.6299999999999999 107.85 155.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.504 ' CD1' HD11 ' A' ' 101' ' ' ILE . 4.6 m-85 -93.13 24.9 3.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.087 -0.506 . . . . 0.25 111.969 174.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.564 ' HD2' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER 23.74 69.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.96 1.304 . . . . 4.2000000000000002 113.515 -168.41 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.8 pt -147.66 -169.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.066 -1.087 . . . . 1.02 108.066 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.22 146.88 25.18 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.943 -0.571 . . . . 1.1599999999999999 109.736 171.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.652 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.6 p -61.25 -35.56 77.58 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.499 -0.926 . . . . 1.05 108.499 174.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.66 71.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.604 -1.18 . . . . 1.05 111.77 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.03 -38.24 32.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.874 -0.516 . . . . 1.03 109.725 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 14.4 tp -73.68 -19.08 60.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.423 -0.808 . . . . 1.05 109.133 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.613 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -78.83 -40.37 32.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 1.0600000000000001 111.832 173.396 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -59.68 -40.59 88.33 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.072 -0.967 . . . . 1.26 109.746 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.11 -20.29 41.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.673 -1.603 . . . . 1.01 112.214 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.624 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 23.8 m-80 -143.52 73.12 17.46 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.165 0.507 . . . . 0.20000000000000001 109.941 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.702 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.8 Cg_endo -57.08 -11.32 7.42 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 123.574 2.849 . . . . 0.29999999999999999 113.809 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.6 t -62.67 -32.83 73.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.988 0.899 . . . . 1.3600000000000001 109.392 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.82 -7.08 59.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.568 1.321 . . . . 1.26 114.568 -172.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.702 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -53.06 -39.84 63.56 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 120.19 1.359 . . . . 1.8899999999999999 109.599 177.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.78 -47.4 12.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.769 -2.014 . . . . 1.1000000000000001 111.334 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.03 -166.54 38.68 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.91 -1.138 . . . . 0.29999999999999999 114.567 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 15' ' ' LEU . 5.6 mp -114.88 158.91 21.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.335 -1.432 . . . . 1.0800000000000001 110.152 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.575 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.84 136.2 38.57 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.797 -0.638 . . . . 1.1699999999999999 110.499 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -46.93 127.46 10.08 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 113.115 0.783 . . . . 1.1699999999999999 113.115 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.22 -11.13 51.23 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.607 -1.179 . . . . 0.38 112.312 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.575 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -63.31 151.11 41.63 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.697 0.76 . . . . 1.1899999999999999 110.298 175.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.467 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 35.6 m -118.88 131.59 56.07 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.32 -1.309 . . . . 1.22 109.265 -171.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.438 ' CG1' ' HB3' ' A' ' 7' ' ' TYR . 21.2 pt -132.81 159.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.095 0.474 . . . . 1.0600000000000001 110.345 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.624 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 26.1 t -106.63 148.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.292 -0.867 . . . . 0.20999999999999999 109.808 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.421 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 16.9 mm -116.97 88.69 27.19 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.31 -0.996 . . . . 1.01 108.31 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.541 ' HA ' HD12 ' A' ' 4' ' ' LEU . 24.3 Cg_endo -59.05 142.32 99.23 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.129 2.553 . . . . 0.23000000000000001 112.617 -173.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.592 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 81.37 -7.08 61.93 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.492 -0.776 . . . . 0.29999999999999999 112.811 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD22 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -114.62 126.07 28.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.742 -0.836 . . . . 1.0800000000000001 108.742 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.55 ' CD ' HD21 ' A' ' 51' ' ' LEU . 57.5 Cg_endo -65.58 174.3 5.55 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.849 3.033 . . . . 0.34000000000000002 113.656 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.579 ' HB3' HG21 ' A' ' 56' ' ' THR . 14.1 t70 -91.31 141.73 26.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.158 -0.928 . . . . 0.71999999999999997 110.9 -169.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.5 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 96.5 Cg_endo -83.57 -7.11 10.73 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.616 2.877 . . . . 0.33000000000000002 112.17 -175.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.67 ' HE1' ' CE2' ' A' ' 55' ' ' TYR . 62.1 m-85 -94.84 -27.31 15.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.831 -0.433 . . . . 2.29 109.831 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.579 HG21 ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -70.23 -35.06 73.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.497 -1.298 . . . . 2.0600000000000001 107.497 170.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.585 HD11 ' HG2' ' A' ' 158' ' ' PRO . 85.0 mt -74.34 126.43 88.96 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 113.327 -1.761 . . . . 1.0900000000000001 110.524 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -102.94 95.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.905 1.07 . . . . 0.22 110.257 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 73' ' ' SER . 77.2 m-85 -158.33 129.57 6.49 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.403 -1.332 . . . . 0.80000000000000004 107.403 172.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m-70 -137.7 110.13 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.158 -1.423 . . . . 3.5800000000000001 107.158 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.0 mt -94.94 111.4 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.383 0.611 . . . . 1.0600000000000001 110.539 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.27 93.06 4.23 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.857 0.837 . . . . 1.1200000000000001 110.399 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -112.88 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.414 -1.266 . . . . 0.68000000000000005 109.647 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.469 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 35.4 t -92.77 124.96 37.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.849 -1.167 . . . . 1.3300000000000001 107.849 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.473 HD13 ' NH1' ' A' ' 167' ' ' ARG . 1.0 OUTLIER -58.98 -28.59 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.345 0.593 . . . . 1.77 110.796 172.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.45 -45.05 88.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.881 -0.888 . . . . 0.93999999999999995 110.881 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -70.25 -24.08 63.01 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.644 0.609 . . . . 1.22 112.644 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.5 mttt 58.57 14.26 2.97 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.818 0.847 . . . . 2.9399999999999999 112.894 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.446 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.42 138.9 35.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.973 0.892 . . . . 1.0600000000000001 111.249 177.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.421 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -92.74 117.9 30.49 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.881 -1.509 . . . . 1.0900000000000001 108.881 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.61 125.4 48.26 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.938 -0.705 . . . . 1.0900000000000001 110.925 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -82.43 142.62 31.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.095 -1.817 . . . . 1.0800000000000001 106.095 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 26.1 m -147.48 128.2 14.28 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 120.445 1.475 . . . . 0.93000000000000005 112.969 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -111.41 126.88 55.41 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.588 -1.187 . . . . 1.1399999999999999 110.147 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.1 t-20 61.89 35.45 16.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 0.52000000000000002 110.285 173.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.2 m-20 78.35 1.59 2.68 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.112 -0.949 . . . . 1.8400000000000001 112.404 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -128.51 137.36 51.73 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 118.283 -1.367 . . . . 3.8500000000000001 113.446 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.19 147.93 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 112.987 -1.915 . . . . 0.40999999999999998 113.17 -171.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.514 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -97.8 -44.72 6.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.25 -2.25 . . . . 1.0900000000000001 107.943 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 26.0 tptt -179.04 160.21 1.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.325 -2.216 . . . . 2.6200000000000001 110.484 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.446 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.5 m -116.11 131.44 56.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.689 -0.232 . . . . 1.1000000000000001 111.403 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -113.71 146.86 36.37 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 110.487 -0.19 . . . . 1.0600000000000001 110.487 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.95 143.19 12.88 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.506 2.137 . . . . 0.85999999999999999 111.305 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.75 172.23 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.768 -0.456 . . . . 1.2 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.56 127.65 34.51 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.92 0.391 . . . . 1.4099999999999999 110.08 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -114.02 -57.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.572 -0.74 . . . . 1.6699999999999999 111.55 -177.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.63 -56.08 2.52 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.347 -0.454 . . . . 3.0800000000000001 113.0 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt 58.04 82.69 0.13 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.462 0.705 . . . . 7.6200000000000001 110.729 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 tp -76.22 -24.27 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.985 -0.552 . . . . 6.7199999999999998 110.34 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 91' ' ' THR . 34.0 tp -176.25 172.92 2.23 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.867 -0.79 . . . . 7.6299999999999999 108.867 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.427 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 15.0 p -52.13 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.528 0.518 . . . . 5.5099999999999998 111.114 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 65.26 -66.66 0.14 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.88 0.696 . . . . 5.3899999999999997 112.88 172.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.52 HG23 ' H ' ' A' ' 167' ' ' ARG . 22.1 p 49.26 83.58 0.22 Allowed Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 123.917 0.887 . . . . 2.5600000000000001 111.965 -174.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.98 103.83 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.892 2.395 . . . . 3.6600000000000001 112.142 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.5 p -82.56 73.25 9.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.753 -0.658 . . . . 4.1699999999999999 111.659 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.88 153.04 21.54 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.05 -0.595 . . . . 2.6899999999999999 111.664 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.84 147.48 34.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.303 0.573 . . . . 2.2999999999999998 111.133 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.643 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 2.7 m-85 -121.56 172.5 8.05 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.301 -1.0 . . . . 2.3500000000000001 108.301 -177.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.642 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 89.4 m-85 -135.9 139.1 43.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.464 -0.495 . . . . 0.92000000000000004 111.685 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 26.6 mm -60.62 126.19 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 107.578 -1.267 . . . . 1.0600000000000001 107.578 164.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.564 ' CD1' ' HD2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -125.46 -27.93 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 120.118 -0.633 . . . . 1.04 112.51 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 3.6 t30 -151.61 158.8 43.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.82 1.045 . . . . 2.3500000000000001 113.82 -168.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.69 133.91 20.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.397 -2.183 . . . . 1.54 110.198 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 13.3 tp60 -111.92 142.57 44.14 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.806 0.813 . . . . 1.8899999999999999 110.709 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -54.23 151.44 7.26 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 112.937 -1.938 . . . . 3.46 113.254 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -45.36 101.98 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 114.121 -1.399 . . . . 3.3500000000000001 111.998 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -56.79 -51.39 9.11 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 124.242 3.294 . . . . 0.97999999999999998 112.839 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.39 -0.86 29.46 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.353 -0.839 . . . . 1.0800000000000001 112.436 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.16 -170.34 11.99 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.939 -0.648 . . . . 1.1599999999999999 112.098 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.29 49.14 0.16 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.465 3.443 . . . . 1.46 113.945 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.666 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 1.6 t80 -107.42 -15.56 14.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.392 -0.596 . . . . 2.1000000000000001 109.392 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.92 35.37 4.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.806 -0.712 . . . . 1.1100000000000001 114.516 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.415 ' O ' ' HD2' ' A' ' 114' ' ' TYR . . . 72.72 -36.42 0.36 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.468 0.914 . . . . 1.45 113.468 172.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.64 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -152.83 137.57 16.99 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.366 -0.605 . . . . 1.5 109.366 -176.043 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 61.9 t-105 -110.34 102.35 11.01 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.485 -0.561 . . . . 2.6000000000000001 109.485 171.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.2 mp -102.03 144.41 30.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.763 0.792 . . . . 1.3100000000000001 110.54 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 102' ' ' ASN . 34.8 m -107.84 144.32 35.21 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.08 -0.964 . . . . 1.3100000000000001 112.794 -169.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.414 ' CB ' ' HB2' ' A' ' 123' ' ' TYR . 6.8 tp -106.81 -171.78 1.95 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.836 -1.529 . . . . 1.8600000000000001 107.899 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.1 t -129.29 41.87 3.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.772 0.715 . . . . 1.95 111.836 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.638 ' HD2' ' CZ ' ' A' ' 98' ' ' PHE . 57.6 tttp -129.73 95.91 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.045 -0.41 . . . . 3.3999999999999999 111.012 172.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 42.07 -93.52 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.135 0.897 . . . . 5.5800000000000001 112.55 174.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -83.12 69.66 9.92 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.555 -0.906 . . . . 6.7300000000000004 108.555 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.414 ' HB2' ' CB ' ' A' ' 118' ' ' LEU . 33.3 p90 -71.57 137.42 48.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.703 -1.135 . . . . 5.1500000000000004 112.114 -172.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.32 138.96 6.12 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.253 -1.451 . . . . 1.1899999999999999 116.015 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 100' ' ' ILE . 4.0 mt -151.49 107.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.338 -1.727 . . . . 1.05 106.338 159.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.692 ' CE1' ' HB3' ' A' ' 144' ' ' ARG . 10.3 p80 -149.48 -165.06 2.17 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.467 -0.893 . . . . 1.25 112.272 -172.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.401 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.17 175.39 16.35 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.636 -1.165 . . . . 0.46000000000000002 113.01 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.611 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 5.0 t -136.69 171.68 14.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.464 0.649 . . . . 1.21 111.986 -165.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.535 ' H ' ' C25' ' A' 1142 ' ' IM2 . 4.3 m-20 -104.81 -18.17 14.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.877 -1.056 . . . . 1.8600000000000001 108.702 165.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -124.21 102.8 33.45 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.268 -0.878 . . . . 1.8200000000000001 109.661 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -90.07 4.29 4.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.165 2.577 . . . . 0.64000000000000001 112.846 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.48 -12.37 58.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.338 0.59 . . . . 1.3200000000000001 109.805 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.6 m -93.53 5.9 50.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.298 -0.865 . . . . 1.8899999999999999 109.271 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 31.2 mm -98.56 115.57 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.095 -0.957 . . . . 1.21 110.487 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 106.45 -56.81 0.49 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.076 -1.21 . . . . 1.6799999999999999 110.076 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -100.56 97.63 8.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.244 -0.651 . . . . 4.8799999999999999 109.244 172.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.29 109.4 4.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.199 0.523 . . . . 4.4699999999999998 111.612 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.3 86.2 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.49 -0.777 . . . . 4.6799999999999997 110.49 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 t 66.08 -83.46 0.03 OUTLIER 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.346 -0.843 . . . . 5.9100000000000001 111.502 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -76.39 104.45 6.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.039 0.447 . . . . 8.5999999999999996 111.007 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.21 99.81 0.74 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.698 -0.763 . . . . 4.1900000000000004 112.049 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 3.9 t -121.22 130.5 53.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.209 -0.293 . . . . 2.9199999999999999 110.209 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 16.9 tt -86.24 64.53 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 122.436 1.112 . . . . 2.0699999999999998 111.003 -173.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.692 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 16.4 ptt180 -107.62 88.04 2.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.631 -1.168 . . . . 3.98 110.075 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 126' ' ' HIS . 20.4 ptm -92.94 -166.75 1.59 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.588 -0.733 . . . . 1.8700000000000001 112.253 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.435 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 14.3 m80 -67.54 138.61 56.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 3.25 109.826 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -52.3 -64.67 0.74 Allowed 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.18 0.3 . . . . 2.4199999999999999 111.401 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -59.57 -27.29 66.12 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.91 -0.494 . . . . 2.5699999999999998 111.809 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.435 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 2.3 m-20 -70.31 -43.68 69.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 1.05 110.68 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.716 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 11.2 p -73.68 -15.79 16.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.32000000000000001 110.37 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.416 ' HA ' ' CB ' ' A' ' 154' ' ' ALA . 2.7 mp -90.18 -40.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 119.181 -0.438 . . . . 1.1299999999999999 110.551 172.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -43.16 -67.75 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.348 0.976 . . . . 1.3799999999999999 112.014 163.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.6 tp -49.35 -43.79 44.14 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.592 -0.731 . . . . 1.3400000000000001 109.894 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.716 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -53.66 -50.85 64.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.118 -1.401 . . . . 1.02 112.421 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 17.1 t -78.74 -18.64 53.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.758 -1.11 . . . . 1.9099999999999999 110.71 -173.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.16 -50.46 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.838 -0.43 . . . . 1.04 109.838 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.8 m -77.12 114.88 43.96 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 122.057 0.932 . . . . 0.20999999999999999 109.985 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.585 ' HG2' HD11 ' A' ' 57' ' ' ILE . 46.4 Cg_endo -82.12 -178.11 3.89 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.169 2.579 . . . . 0.51000000000000001 112.609 -174.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.616 ' O ' HD22 ' A' ' 51' ' ' LEU . 20.6 m120 -59.2 -1.71 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.591 -1.186 . . . . 1.02 113.364 -174.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.42 59.08 0.5 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.947 -0.644 . . . . 0.64000000000000001 112.414 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.2 m -95.69 134.85 38.12 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.535 -0.391 . . . . 1.0700000000000001 110.393 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -84.88 140.24 31.29 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.098 -0.334 . . . . 2.3399999999999999 110.098 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 3.7 p -145.55 130.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.811 -0.631 . . . . 0.46000000000000002 111.271 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 20.0 m -116.82 138.18 51.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.811 -0.631 . . . . 1.26 111.789 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.9 mp -122.18 109.84 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 118.997 -1.081 . . . . 1.1699999999999999 110.619 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.548 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.72 156.7 44.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.526 -1.215 . . . . 1.1899999999999999 109.358 -170.187 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.52 ' H ' HG23 ' A' ' 93' ' ' THR . 3.1 mpt_? -91.37 -8.32 48.34 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.017 -0.538 . . . . 3.7999999999999998 110.84 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.21 -69.24 1.84 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.677 -0.692 . . . . 3.6499999999999999 112.617 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.714 -0.66 . . . . 5.9699999999999998 110.126 -177.358 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.535 ' C25' ' H ' ' A' ' 129' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.727 -0.549 . . . . 3.3799999999999999 111.727 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -97.72 160.8 14.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.823 0.311 . . . . 4.6799999999999997 110.503 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt -65.3 153.45 41.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.417 -0.586 . . . . 2.54 109.417 172.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 50' ' ' GLY . 18.9 mt -91.96 170.63 9.7 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.94 -0.573 . . . . 1.1000000000000001 110.854 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.496 ' HG ' ' N ' ' A' ' 6' ' ' THR . 3.6 tp -76.49 149.07 36.81 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 122.983 0.513 . . . . 1.05 111.866 -170.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.496 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.59 149.18 36.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.166 0.984 . . . . 1.01 111.67 168.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.665 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 77.3 t80 -134.54 147.53 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.304 -1.771 . . . . 1.1200000000000001 107.521 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.56 112.01 14.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.288 -1.745 . . . . 1.72 106.288 174.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 1.6 m -71.42 157.68 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 115.714 -0.675 . . . . 0.38 111.961 -165.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -108.27 147.77 30.94 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.113 -0.948 . . . . 3.0600000000000001 109.387 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.461 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.58 131.22 29.42 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.888 0.742 . . . . 2.1699999999999999 112.349 -174.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -4.59 39.69 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.371 -0.831 . . . . 0.63 111.44 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -45.11 143.63 1.53 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.915 1.45 . . . . 2.1699999999999999 114.915 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.23 140.1 46.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.978 -1.01 . . . . 1.27 111.674 164.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.593 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.5 tp -42.31 -55.28 3.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.315 -0.857 . . . . 1.0800000000000001 113.174 -175.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.648 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 17.3 t-20 -65.43 -42.97 91.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.584 1.183 . . . . 1.55 110.375 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 15.1 m -62.95 -38.06 89.54 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 112.477 -2.147 . . . . 1.8200000000000001 110.878 -176.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 1.5 mp -76.08 -39.62 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 O-C-N 123.713 0.633 . . . . 1.0600000000000001 112.2 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.02 -59.59 4.85 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.611 -0.268 . . . . 0.97999999999999998 110.998 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 -4.65 56.83 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.527 -1.269 . . . . 1.0700000000000001 111.848 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.77 ' HB2' ' O ' ' A' ' 17' ' ' SER . 8.3 t70 -61.3 -29.24 69.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.567 -1.272 . . . . 1.6299999999999999 107.567 157.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -109.06 19.13 19.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.999 0.74 . . . . 0.25 112.999 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? 49.57 54.95 10.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.486 -0.779 . . . . 4.2000000000000002 111.266 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.473 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 33.5 pt -148.18 -172.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.721 -0.844 . . . . 1.02 108.721 -173.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.58 146.78 24.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.66 -0.7 . . . . 1.1599999999999999 109.684 173.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.648 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.1 p -62.69 -35.19 78.89 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.793 -0.818 . . . . 1.05 108.793 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.16 -28.88 68.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.362 -1.29 . . . . 1.05 111.665 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.38 26.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.241 -0.651 . . . . 1.03 109.241 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.581 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 16.5 tp -72.46 -17.85 61.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.144 -0.935 . . . . 1.05 108.772 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.586 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.05 -37.51 33.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.393 0.616 . . . . 1.0600000000000001 111.16 171.234 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -56.39 -46.28 80.18 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.636 1.208 . . . . 1.26 110.278 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.69 43.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 112.998 -1.91 . . . . 1.01 112.317 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.581 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 34.3 m-80 -142.51 73.1 20.59 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.20000000000000001 110.108 -172.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.723 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.6 Cg_endo -57.24 -13.55 12.95 Favored 'Trans proline' 0 C--O 1.22 -0.419 0 C-N-CA 123.437 2.758 . . . . 0.29999999999999999 114.325 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.48 -31.59 71.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.932 0.872 . . . . 1.3600000000000001 109.718 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.66 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -81.0 -6.69 59.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.469 1.285 . . . . 1.26 114.469 -171.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.723 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -50.86 -41.48 58.03 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.806 1.185 . . . . 1.8899999999999999 110.147 179.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.62 -46.32 13.44 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.829 -1.987 . . . . 1.1000000000000001 111.136 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.01 -170.32 43.4 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.49 -0.862 . . . . 0.29999999999999999 113.952 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 15' ' ' LEU . 5.3 mp -110.03 161.71 15.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.558 -1.321 . . . . 1.0800000000000001 109.724 177.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.3 m -135.61 134.12 38.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.872 -0.603 . . . . 1.1699999999999999 110.428 176.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -49.44 129.25 18.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.314 0.578 . . . . 1.1699999999999999 112.281 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.18 -12.9 57.11 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.802 -1.09 . . . . 0.38 112.647 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.598 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.6 tt0 -65.88 152.7 43.88 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.641 0.734 . . . . 1.1899999999999999 110.306 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 50.7 m -117.02 130.68 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.501 -1.227 . . . . 1.22 109.603 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.436 HD11 HD13 ' A' ' 29' ' ' LEU . 20.6 pt -134.46 145.51 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.516 0.674 . . . . 1.0600000000000001 110.526 -174.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.497 ' H ' HD22 ' A' ' 33' ' ' ASN . 12.5 t -91.02 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.866 -1.061 . . . . 0.20999999999999999 110.192 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 21.8 mm -117.47 88.53 29.09 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-N 115.083 -0.962 . . . . 1.01 108.425 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HA ' HD12 ' A' ' 4' ' ' LEU . 22.8 Cg_endo -58.74 141.36 97.71 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.221 2.614 . . . . 0.23000000000000001 112.967 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.595 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 84.6 -7.6 72.58 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.381 -0.827 . . . . 0.29999999999999999 113.115 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.562 HD21 ' CD ' ' A' ' 52' ' ' PRO . 2.7 tt -118.53 128.39 26.0 Favored Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.641 -0.874 . . . . 1.0800000000000001 108.641 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.562 ' CD ' HD21 ' A' ' 51' ' ' LEU . 59.8 Cg_endo -67.33 175.12 6.22 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.563 2.842 . . . . 0.34000000000000002 113.825 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.519 ' HB3' HG21 ' A' ' 56' ' ' THR . 10.9 t70 -89.46 142.11 29.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.71999999999999997 110.56 -171.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.504 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 75.0 Cg_endo -84.28 -4.58 10.26 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.576 2.851 . . . . 0.33000000000000002 112.363 -174.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.657 ' HD2' ' CD1' ' A' ' 55' ' ' TYR . 68.9 m-85 -94.79 -26.53 16.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.741 -0.466 . . . . 2.29 109.741 174.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 53' ' ' ASP . 19.1 p -72.99 -28.76 62.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.561 1.172 . . . . 2.0600000000000001 107.844 171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.584 HD11 ' HG2' ' A' ' 158' ' ' PRO . 93.0 mt -80.68 124.35 81.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 113.065 -1.88 . . . . 1.0900000000000001 109.868 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -101.8 96.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 120.779 0.986 . . . . 0.22 110.235 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.9 m-85 -157.74 133.23 9.01 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.387 -1.338 . . . . 0.80000000000000004 107.387 172.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 9.7 m-70 -137.08 103.82 5.25 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.259 -1.756 . . . . 3.5800000000000001 106.259 -167.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.453 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.1 mt -92.96 106.43 17.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.705 0.764 . . . . 1.0600000000000001 109.595 -177.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.86 96.1 5.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.716 -1.129 . . . . 1.1200000000000001 110.623 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -114.82 96.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 113.743 -1.571 . . . . 0.68000000000000005 108.712 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.502 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 51.1 m -95.18 122.57 38.0 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.209 -1.36 . . . . 1.3300000000000001 108.383 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.587 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 3.1 mm -47.3 -34.48 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.428 0.632 . . . . 1.77 110.117 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.55 -47.33 35.05 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.17 -0.923 . . . . 0.93999999999999995 112.336 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -64.37 -24.25 67.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.317 0.58 . . . . 1.22 112.392 174.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 17.9 mttt 54.97 17.63 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.773 1.229 . . . . 2.9399999999999999 113.414 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.32 142.46 31.32 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.318 0.58 . . . . 1.0600000000000001 111.02 171.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.526 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.5 tt -90.98 118.21 30.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.169 -0.923 . . . . 1.0900000000000001 109.411 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -105.0 125.77 51.33 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.392 -0.523 . . . . 1.0900000000000001 111.691 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.505 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.76 136.82 34.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.129 -1.804 . . . . 1.0800000000000001 106.129 176.055 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 13.3 m -141.78 129.35 21.44 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 120.493 1.497 . . . . 0.93000000000000005 112.758 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.26 126.59 53.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.045 -0.98 . . . . 1.1399999999999999 110.539 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.9 t-20 63.74 37.79 9.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.423 0.63 . . . . 0.52000000000000002 109.827 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.4 m-20 76.25 0.57 3.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.672 -1.149 . . . . 1.8400000000000001 112.525 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.49 138.54 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.279 -1.368 . . . . 3.8500000000000001 113.751 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -53.89 147.23 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 113.053 -1.885 . . . . 0.40999999999999998 112.863 -172.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.505 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -96.47 -45.66 6.67 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.338 -2.21 . . . . 1.0900000000000001 107.565 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 30.2 tptt -176.77 159.33 1.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.216 -2.265 . . . . 2.6200000000000001 110.298 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.6 m -119.43 134.81 55.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.397 -0.121 . . . . 1.1000000000000001 111.051 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -120.22 127.14 26.48 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 120.924 0.392 . . . . 1.0600000000000001 110.876 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -57.46 137.82 83.25 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 124.16 3.24 . . . . 0.85999999999999999 113.813 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.619 ' HB ' ' H26' ' A' 1142 ' ' IM2 . 0.2 OUTLIER -138.12 168.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.818 -0.353 . . . . 1.2 110.371 177.394 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.534 ' HB2' ' H51' ' A' 1142 ' ' IM2 . . . -85.98 137.43 32.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.549 0.69 . . . . 1.4099999999999999 111.39 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.13 19.66 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.571 -1.195 . . . . 1.6699999999999999 110.104 -175.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.1 69.39 3.11 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.438 -0.801 . . . . 3.0800000000000001 112.102 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -147.38 138.71 23.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.33 -0.989 . . . . 7.6200000000000001 108.33 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.6 tp -52.44 129.05 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.211 0.529 . . . . 6.7199999999999998 111.151 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.0 mt -83.41 58.44 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.986 -0.552 . . . . 7.6299999999999999 110.592 -175.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.8 m -68.55 -54.74 14.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.51 -0.768 . . . . 5.5099999999999998 111.693 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -151.18 150.49 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.865 0.364 . . . . 5.3899999999999997 110.644 -175.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 167' ' ' ARG . 10.6 p -78.21 117.35 65.61 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.894 -0.593 . . . . 2.5600000000000001 110.583 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 166' ' ' ASN . 46.4 Cg_exo -57.87 129.82 35.28 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.39 2.06 . . . . 3.6600000000000001 111.904 175.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.3 p -87.26 156.98 19.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.98 -0.555 . . . . 4.1699999999999999 111.779 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.03 -168.31 48.73 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.098 -0.573 . . . . 2.6899999999999999 112.669 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.9 168.24 20.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.789 -0.448 . . . . 2.2999999999999998 109.789 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 13.3 m-85 -116.59 167.68 10.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.205 -1.405 . . . . 2.3500000000000001 107.205 171.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 161' ' ' THR . 84.6 m-85 -130.37 135.9 48.52 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.277 -0.569 . . . . 0.92000000000000004 111.021 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 26.8 mm -60.26 121.06 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 107.346 -1.353 . . . . 1.0600000000000001 107.346 164.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 3.1 tt -109.04 -22.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.487 -0.885 . . . . 1.04 112.099 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 21.1 p-10 -178.5 -165.7 0.09 Allowed 'General case' 0 C--N 1.348 0.531 0 N-CA-C 114.024 1.12 . . . . 2.3500000000000001 114.024 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 103' ' ' ARG . 5.3 ptp180 -150.73 139.66 20.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 112.683 -2.053 . . . . 1.54 111.68 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.697 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 24.7 tp60 -107.12 145.0 33.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.604 -1.18 . . . . 1.8899999999999999 111.407 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.697 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 34.3 ttm180 -56.64 150.15 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.167 -1.833 . . . . 3.46 111.506 170.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -46.07 104.01 0.38 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 123.89 0.744 . . . . 3.3500000000000001 111.736 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 87.9 Cg_exo -56.35 -51.64 8.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.815 3.01 . . . . 0.97999999999999998 111.874 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.75 -21.59 13.83 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.02 -0.991 . . . . 1.0800000000000001 112.578 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -100.27 -169.49 29.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.96 -0.638 . . . . 1.1599999999999999 112.311 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.52 32.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.256 3.304 . . . . 1.46 113.754 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -85.92 -20.92 28.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.142 0.496 . . . . 2.1000000000000001 109.933 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.427 ' HA3' ' CA ' ' A' ' 127' ' ' GLY . . . 96.33 42.55 3.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.519 -0.764 . . . . 1.1100000000000001 114.019 170.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.69 -33.62 0.23 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.419 0.896 . . . . 1.45 113.419 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.629 ' HE2' ' CE1' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -150.17 127.0 11.04 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.816 -0.439 . . . . 1.5 109.816 -174.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 34.0 t-105 -100.48 100.39 11.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.158 -0.682 . . . . 2.6000000000000001 109.158 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.734 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.2 mp -101.09 141.27 34.22 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 1.3100000000000001 109.016 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.1 m -106.93 144.09 34.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.644 0.609 . . . . 1.3100000000000001 112.644 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.3 tp -97.97 -174.19 2.8 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.786 -1.191 . . . . 1.8600000000000001 107.786 172.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t -75.04 -67.61 0.63 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.586 -0.445 . . . . 1.95 110.741 175.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.554 ' NZ ' ' HA ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -64.91 110.66 2.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.937 0.718 . . . . 3.3999999999999999 112.937 -165.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 55.89 -136.96 1.14 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.146 -0.934 . . . . 5.5800000000000001 111.998 173.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -90.27 15.74 9.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.949 0.404 . . . . 6.7300000000000004 110.539 -176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 1.639 ' HD1' ' CD2' ' A' ' 123' ' ' TYR . 29.6 m-85 -66.07 134.26 52.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.751 -0.462 . . . . 5.1500000000000004 109.751 174.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.32 158.43 28.66 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.782 -0.723 . . . . 1.1899999999999999 111.881 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.734 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 9.2 mt -93.59 106.0 17.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 108.541 -0.911 . . . . 1.05 108.541 174.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.517 ' NE2' ' HG2' ' A' ' 144' ' ' ARG . 18.4 p80 -136.95 -161.76 1.2 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.527 0.68 . . . . 1.25 111.27 -172.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.427 ' CA ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.1 155.8 16.08 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.815 -1.183 . . . . 0.46000000000000002 113.569 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.447 HG22 ' CA ' ' A' ' 131' ' ' PRO . 3.8 t -98.37 172.5 7.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.028 -1.086 . . . . 1.21 110.592 -171.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.93 -13.35 13.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.351 -0.841 . . . . 1.8600000000000001 109.075 160.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 133' ' ' SER . 24.1 t30 -124.75 101.12 33.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.185 -0.916 . . . . 1.8200000000000001 109.414 171.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 139' ' ' SER . 81.1 Cg_endo -90.49 3.29 4.82 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.785 2.323 . . . . 0.64000000000000001 113.039 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -94.8 -2.02 51.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.383 0.611 . . . . 1.3200000000000001 109.546 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.45 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 33.3 t -90.23 -12.69 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.262 -0.881 . . . . 1.8899999999999999 109.555 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.476 HD13 ' O ' ' A' ' 144' ' ' ARG . 14.6 mm -60.11 130.65 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.672 -0.695 . . . . 1.21 109.963 177.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.25 -121.3 15.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.778 -0.725 . . . . 1.6799999999999999 111.596 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -107.65 -63.83 1.27 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.142 -0.688 . . . . 4.8799999999999999 109.142 170.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -134.13 29.0 3.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.648 -0.706 . . . . 4.4699999999999998 110.332 176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.19 -176.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.932 -0.766 . . . . 4.6799999999999997 108.932 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 131' ' ' PRO . 64.1 m -147.63 170.1 18.22 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.564 -0.455 . . . . 5.9100000000000001 112.021 -177.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.4 pttm 42.78 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.589 1.156 . . . . 8.5999999999999996 112.908 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 142' ' ' CYS . . . 173.25 -177.65 45.57 Favored Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 115.27 -0.877 . . . . 4.1900000000000004 111.329 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.57 ' C ' ' H ' ' A' ' 144' ' ' ARG . 42.2 t 79.73 167.87 0.18 Allowed 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.461 -0.57 . . . . 2.9199999999999999 109.461 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.56 ' HB ' ' HA ' ' A' ' 125' ' ' ILE . 22.4 pt -76.06 24.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.496 0.665 . . . . 2.0699999999999998 110.397 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 142' ' ' CYS . 98.9 mtt180 -153.83 66.25 0.73 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.876 1.271 . . . . 3.98 108.494 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.507 ' CG ' ' HB ' ' A' ' 150' ' ' VAL . 5.1 ptm -107.48 -167.44 1.26 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.279 0.844 . . . . 1.8700000000000001 113.279 -166.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.435 ' HD2' ' OD1' ' A' ' 147' ' ' ASN . 2.6 t60 -71.12 153.93 42.14 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.851 -0.796 . . . . 3.25 108.851 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.435 ' OD1' ' HD2' ' A' ' 146' ' ' HIS . 29.8 p-10 -54.21 -69.91 0.11 Allowed 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.268 0.47 . . . . 2.4199999999999999 112.268 -172.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -61.39 -20.35 62.95 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.567 -0.708 . . . . 2.5699999999999998 111.405 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -74.26 -45.3 48.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.667 -0.697 . . . . 1.05 110.354 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 13.2 p -72.05 -18.37 19.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.32000000000000001 110.945 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.68 -36.68 11.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 119.116 -0.469 . . . . 1.1299999999999999 110.297 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -45.05 -70.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 119.441 1.018 . . . . 1.3799999999999999 112.337 162.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.439 HD11 ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -49.45 -40.88 38.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.877 -0.601 . . . . 1.3400000000000001 110.316 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 150' ' ' VAL . . . -55.99 -55.6 30.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.169 -1.378 . . . . 1.02 111.997 -172.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.9 p -75.08 -12.91 60.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.7 -1.136 . . . . 1.9099999999999999 110.919 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.89 -49.87 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.881 -0.6 . . . . 1.04 110.098 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.15 115.69 51.05 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 122.096 0.95 . . . . 0.20999999999999999 110.541 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.584 ' HG2' HD11 ' A' ' 57' ' ' ILE . 38.4 Cg_endo -82.78 -177.34 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.184 2.589 . . . . 0.51000000000000001 112.971 -173.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.552 ' O ' HD22 ' A' ' 51' ' ' LEU . 12.0 m120 -57.63 -2.13 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.708 -1.133 . . . . 1.02 113.898 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.57 57.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.64000000000000001 112.537 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.2 m -92.69 134.62 34.85 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.612 -0.346 . . . . 1.0700000000000001 110.479 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 138.81 31.73 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.904 0.383 . . . . 2.3399999999999999 110.389 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.5 p -145.63 127.39 8.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.339 -0.846 . . . . 0.46000000000000002 110.911 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.3 m -116.34 143.0 46.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.854 -0.612 . . . . 1.26 111.652 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 3.1 mp -124.34 107.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 119.252 -0.979 . . . . 1.1699999999999999 109.77 172.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.574 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.46 145.21 32.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 1.1899999999999999 111.148 -168.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.513 ' H ' HG23 ' A' ' 93' ' ' THR . 4.5 mpt_? -81.36 -10.24 59.58 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.007 -0.997 . . . . 3.7999999999999998 111.274 177.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.02 -62.58 4.52 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.98 -0.629 . . . . 3.6499999999999999 111.964 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.726 -0.654 . . . . 5.9699999999999998 110.384 179.415 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.632 H221 ' N26' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 112.39 -0.284 . . . . 3.3799999999999999 112.39 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.18 167.86 27.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.9 -0.407 . . . . 4.6799999999999997 109.9 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.522 ' HE2' ' CG2' ' A' ' 56' ' ' THR . 4.1 mppt? -78.9 150.14 32.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.89 -0.411 . . . . 2.54 109.89 174.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.587 HD12 ' H ' ' A' ' 50' ' ' GLY . 18.1 mt -95.21 172.6 8.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.855 -0.611 . . . . 1.1000000000000001 111.192 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 6' ' ' THR . 4.2 tp -75.49 149.2 38.51 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.103 0.478 . . . . 1.05 111.77 -170.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.515 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.29 147.82 38.47 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.143 0.973 . . . . 1.01 111.6 167.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.661 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 81.1 t80 -133.91 146.7 50.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.205 -1.816 . . . . 1.1200000000000001 107.571 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.6 tt0 -127.33 111.35 13.8 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 1.72 106.66 176.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.414 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 1.2 m -70.64 157.44 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 121.37 0.605 . . . . 0.38 111.856 -165.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.31 147.09 33.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.128 -0.942 . . . . 3.0600000000000001 109.44 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.497 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -53.13 130.82 35.5 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.838 0.712 . . . . 2.1699999999999999 112.15 -173.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.81 -4.85 39.51 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.491 -0.777 . . . . 0.63 111.672 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -43.5 146.17 0.53 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.004 1.483 . . . . 2.1699999999999999 115.004 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.35 139.9 45.97 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.014 -0.994 . . . . 1.27 111.928 162.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.571 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.5 tp -43.11 -55.76 3.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.499 -0.773 . . . . 1.0800000000000001 113.031 -175.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.682 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.2 -40.06 93.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.261 1.029 . . . . 1.55 110.268 -171.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -59.81 -49.88 75.97 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 112.924 -1.944 . . . . 1.8200000000000001 109.534 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.84 -39.35 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 O-C-N 123.522 0.514 . . . . 1.0600000000000001 111.35 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.41 -62.67 1.61 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.887 -0.597 . . . . 0.97999999999999998 111.612 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.27 -4.27 56.84 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.996 -1.081 . . . . 1.0700000000000001 112.292 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.56 -33.58 74.11 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.285 -1.005 . . . . 1.6299999999999999 108.285 155.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.522 ' HA ' HD11 ' A' ' 101' ' ' ILE . 2.6 m-85 -101.47 27.39 6.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.099 0.407 . . . . 0.25 112.099 175.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.578 ' HD2' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.13 68.62 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.836 1.255 . . . . 4.2000000000000002 113.805 -168.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 34.6 pt -147.42 -173.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.856 -1.164 . . . . 1.02 107.856 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -101.09 145.68 28.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.764 -0.653 . . . . 1.1599999999999999 109.409 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.682 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.7 p -61.93 -35.24 77.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.54 0.686 . . . . 1.05 109.208 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.1 -30.18 71.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.282 -1.326 . . . . 1.05 111.334 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.14 -38.54 27.01 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.394 0.616 . . . . 1.03 109.692 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 13.9 tp -72.74 -18.22 61.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.432 -0.804 . . . . 1.05 108.963 175.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.616 HD13 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.58 -37.58 35.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 1.0600000000000001 111.223 171.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.0 mt-30 -56.96 -47.43 80.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.285 1.04 . . . . 1.26 109.501 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.56 -18.37 51.91 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.361 -1.745 . . . . 1.01 112.178 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 31.3 m-80 -143.15 72.52 18.22 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.153 0.501 . . . . 0.20000000000000001 109.903 -173.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.749 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.68 -13.0 12.85 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 123.322 2.681 . . . . 0.29999999999999999 113.781 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -31.78 70.67 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 122.045 0.926 . . . . 1.3600000000000001 109.897 174.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.652 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -82.67 -6.45 59.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.159 -1.382 . . . . 1.26 114.527 -172.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.749 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -50.6 -42.28 55.71 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 119.778 1.172 . . . . 1.8899999999999999 109.907 178.04 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.19 -47.04 15.29 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 112.99 -1.914 . . . . 1.1000000000000001 111.172 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.12 -166.82 39.04 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-O 122.162 0.868 . . . . 0.29999999999999999 113.989 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 15' ' ' LEU . 5.1 mp -113.76 160.34 18.78 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.392 -1.404 . . . . 1.0800000000000001 109.871 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.586 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.0 m -136.02 135.36 39.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.901 -0.591 . . . . 1.1699999999999999 110.231 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -49.12 129.98 18.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.438 0.637 . . . . 1.1699999999999999 112.451 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.99 -13.03 46.54 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.804 -1.089 . . . . 0.38 112.534 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.586 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -64.34 152.71 40.53 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.507 0.67 . . . . 1.1899999999999999 110.288 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.445 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 45.8 m -117.81 132.32 56.46 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.741 -1.118 . . . . 1.22 109.512 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.4 pt -135.77 155.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.354 0.597 . . . . 1.0600000000000001 110.633 -175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.527 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.5 t -100.08 149.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.0 -1.0 . . . . 0.20999999999999999 110.189 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 18.0 mm -117.57 87.8 27.1 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 1.01 108.257 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 4' ' ' LEU . 20.4 Cg_endo -57.89 143.45 95.83 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.303 2.669 . . . . 0.23000000000000001 112.937 -173.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.587 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 81.2 -7.22 60.96 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.667 -0.697 . . . . 0.29999999999999999 113.07 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.543 HD21 ' CD ' ' A' ' 52' ' ' PRO . 2.9 tt -116.15 126.47 27.6 Favored Pre-proline 0 C--O 1.219 -0.539 0 N-CA-C 108.457 -0.942 . . . . 1.0800000000000001 108.457 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.543 ' CD ' HD21 ' A' ' 51' ' ' LEU . 60.1 Cg_endo -66.45 174.88 5.67 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.72 2.947 . . . . 0.34000000000000002 113.618 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.554 ' HB3' HG21 ' A' ' 56' ' ' THR . 8.9 t70 -89.63 141.75 28.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.71999999999999997 110.355 -172.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 90.2 Cg_endo -82.49 -3.88 11.48 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.423 2.749 . . . . 0.33000000000000002 112.169 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 55' ' ' TYR . 77.3 m-85 -95.68 -25.44 16.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 2.29 110.14 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 53' ' ' ASP . 22.7 p -74.05 -28.32 61.35 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.737 -1.208 . . . . 2.0600000000000001 107.737 171.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.574 HD11 ' HG2' ' A' ' 158' ' ' PRO . 97.0 mt -80.93 128.6 70.78 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 113.234 -1.803 . . . . 1.0900000000000001 109.659 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -103.6 96.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.942 0 CA-C-N 120.1 1.071 . . . . 0.22 110.681 166.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -157.7 132.81 8.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.587 -1.264 . . . . 0.80000000000000004 107.587 172.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 2.7 m-70 -139.08 104.98 5.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.483 -1.302 . . . . 3.5800000000000001 107.483 -164.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.7 mt -96.35 114.4 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.722 -0.672 . . . . 1.0600000000000001 111.169 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.84 97.01 6.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.202 -0.908 . . . . 1.1200000000000001 110.808 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -120.79 100.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.396 -1.275 . . . . 0.68000000000000005 110.253 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.524 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.9 m -94.76 134.51 37.28 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.23 -0.895 . . . . 1.3300000000000001 109.298 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.538 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 6.0 mm -59.39 -33.44 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.867 0.842 . . . . 1.77 109.433 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.33 40.97 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.314 -1.312 . . . . 0.93999999999999995 112.068 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -68.16 -24.86 65.03 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.177 0.513 . . . . 1.22 112.18 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 26.8 mttt 55.74 16.94 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.295 1.038 . . . . 2.9399999999999999 113.544 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.98 142.37 31.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 1.0600000000000001 110.839 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.49 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.2 tt -96.37 120.25 36.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.467 -1.242 . . . . 1.0900000000000001 109.658 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 m -101.12 122.34 43.42 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.078 -0.649 . . . . 1.0900000000000001 111.019 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD23 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.44 131.76 35.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 106.22 -1.77 . . . . 1.0800000000000001 106.22 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -137.28 126.89 25.24 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.677 1.581 . . . . 0.93000000000000005 112.703 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -113.06 126.22 55.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.089 -0.959 . . . . 1.1399999999999999 110.288 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 66.86 35.31 4.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.499 0.666 . . . . 0.52000000000000002 109.326 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.4 t30 75.7 -0.28 3.23 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.215 -1.357 . . . . 1.8400000000000001 112.21 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -128.93 140.6 51.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.125 -1.43 . . . . 3.8500000000000001 113.944 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -56.14 148.09 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 113.41 -1.723 . . . . 0.40999999999999998 113.371 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.533 ' SD ' HD23 ' A' ' 72' ' ' LEU . 4.1 mtp -96.94 -46.42 6.22 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.013 -2.358 . . . . 1.0900000000000001 107.594 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 21.0 tptp -178.77 155.68 0.81 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.397 -2.183 . . . . 2.6200000000000001 110.462 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -111.48 131.57 55.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.483 -0.192 . . . . 1.1000000000000001 110.483 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.85 135.85 24.5 Favored Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.033 0.444 . . . . 1.0600000000000001 111.6 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -64.04 140.96 74.88 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.272 2.648 . . . . 0.85999999999999999 112.613 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 -179.64 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.803 -0.814 . . . . 1.2 108.803 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.96 147.35 26.27 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.083 0.468 . . . . 1.4099999999999999 110.662 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.512 ' CG1' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -143.5 120.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.438 -0.801 . . . . 1.6699999999999999 110.948 -176.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.36 -148.47 9.22 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.621 -0.718 . . . . 3.0800000000000001 112.535 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -68.24 139.18 56.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.798 0.332 . . . . 7.6200000000000001 110.62 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.4 pt -94.06 55.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.414 0.626 . . . . 6.7199999999999998 110.858 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 91' ' ' THR . 31.1 tp -89.2 176.56 6.91 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.127 -0.694 . . . . 7.6299999999999999 109.127 176.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.482 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 6.5 t -72.63 17.41 0.11 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.25 0.548 . . . . 5.5099999999999998 111.665 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.462 ' H ' ' C ' ' A' ' 90' ' ' LEU . 43.2 mt-30 -84.39 55.64 3.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.226 0.536 . . . . 5.3899999999999997 109.609 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.486 HG23 ' HB2' ' A' ' 167' ' ' ARG . 21.2 p -75.93 112.69 21.55 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.937 -0.574 . . . . 2.5600000000000001 110.587 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 92' ' ' GLN . 33.8 Cg_exo -60.97 118.27 5.12 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.282 1.988 . . . . 3.6600000000000001 111.431 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.0 p -81.84 158.23 24.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.098 -0.501 . . . . 4.1699999999999999 110.793 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.47 164.93 39.65 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.678 -0.772 . . . . 2.6899999999999999 112.087 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -111.07 157.8 19.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.226 0.536 . . . . 2.2999999999999998 110.932 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.642 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 2.4 m-85 -119.52 171.22 8.51 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.181 -1.044 . . . . 2.3500000000000001 108.181 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.5 m-85 -136.31 138.68 41.96 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.213 -0.595 . . . . 0.92000000000000004 111.639 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.482 ' HB ' ' HB ' ' A' ' 161' ' ' THR . 26.8 mm -59.93 106.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.19 -1.411 . . . . 1.0600000000000001 107.19 163.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.578 ' CD1' ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -94.87 -24.03 4.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.829 -0.749 . . . . 1.04 111.587 -176.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -172.01 -174.75 1.35 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 122.784 1.278 . . . . 2.3500000000000001 114.227 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.469 ' NH1' ' HA ' ' A' ' 155' ' ' SER . 2.8 ptt180 -149.9 137.7 20.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 111.374 -2.648 . . . . 1.54 110.575 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.614 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 29.2 tp60 -105.83 144.37 32.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.842 -1.072 . . . . 1.8899999999999999 110.386 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.586 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 23.8 ttm180 -53.37 155.28 2.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.748 -2.024 . . . . 3.46 112.085 172.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.586 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.4 109.87 1.1 Allowed Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 114.955 -1.021 . . . . 3.3500000000000001 110.498 175.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.15 -52.07 5.58 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.325 2.683 . . . . 0.97999999999999998 111.958 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.33 -20.24 25.89 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.197 -0.91 . . . . 1.0800000000000001 112.168 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -115.27 -169.94 16.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.94 -0.648 . . . . 1.1599999999999999 112.621 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.31 9.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 124.598 3.532 . . . . 1.46 114.557 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.61 ' HA ' ' H26' ' A' 1142 ' ' IM2 . 3.8 t80 -62.27 -27.37 68.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.421 0.629 . . . . 2.1000000000000001 109.959 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.78 55.36 0.94 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.1100000000000001 114.427 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.404 ' O ' ' HD2' ' A' ' 114' ' ' TYR . . . 73.38 -46.98 0.65 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.389 1.255 . . . . 1.45 114.389 166.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.614 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -151.84 147.06 26.17 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 122.638 0.375 . . . . 1.5 110.445 -174.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.614 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 47.0 t-105 -118.56 102.58 9.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.975 -0.38 . . . . 2.6000000000000001 109.975 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.65 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -107.45 139.78 41.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.561 0.696 . . . . 1.3100000000000001 110.222 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.3 m -107.66 148.52 29.26 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.51 0.93 . . . . 1.3100000000000001 113.51 -168.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 70.4 mt -103.09 -172.62 2.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.416 -1.266 . . . . 1.8600000000000001 107.981 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 p -78.65 -94.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.422 -0.911 . . . . 1.95 110.244 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -131.08 113.6 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.195 0.443 . . . . 3.3999999999999999 112.195 176.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -156.89 3.12 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 5.5800000000000001 110.832 172.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 62.46 24.96 14.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.036 0.922 . . . . 6.7300000000000004 108.983 -169.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -136.0 156.63 48.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.821 -1.081 . . . . 5.1500000000000004 110.355 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.506 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -149.25 157.13 27.12 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.106 -1.198 . . . . 1.1899999999999999 110.106 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.65 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 20.4 mt -92.67 107.52 19.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.085 -0.709 . . . . 1.05 109.085 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.597 ' CE1' ' HB3' ' A' ' 144' ' ' ARG . 7.7 p80 -145.45 -163.15 1.66 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.283 -0.567 . . . . 1.25 111.117 -176.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.55 173.76 16.1 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.171 -1.014 . . . . 0.46000000000000002 113.016 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.4 ' HB ' ' HG3' ' A' ' 144' ' ' ARG . 5.2 t -137.21 174.68 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.432 0.634 . . . . 1.21 111.375 -167.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -104.44 -17.87 14.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.199 -0.909 . . . . 1.8600000000000001 109.604 165.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -125.39 103.08 29.36 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.827 -0.624 . . . . 1.8200000000000001 110.238 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.53 4.43 4.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.203 2.602 . . . . 0.64000000000000001 113.545 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.49 -22.66 54.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.189 0.519 . . . . 1.3200000000000001 110.818 -171.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -88.28 -6.56 57.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 1.8899999999999999 110.303 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 30.4 mm -81.49 104.69 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 121.663 0.744 . . . . 1.21 110.176 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.89 -153.79 25.07 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 114.785 -1.098 . . . . 1.6799999999999999 110.676 -176.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -77.74 73.46 4.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.104 0.478 . . . . 4.8799999999999999 110.638 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -143.33 137.79 29.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.661 -0.7 . . . . 4.4699999999999998 110.482 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.0 p -116.85 73.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 122.251 1.024 . . . . 4.6799999999999997 110.339 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.3 m -153.07 110.07 3.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.295 -0.866 . . . . 5.9100000000000001 109.636 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt 58.02 42.4 22.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.271 0.558 . . . . 8.5999999999999996 109.587 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.58 114.93 7.04 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.229 -0.896 . . . . 4.1900000000000004 113.665 -172.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.408 ' HA ' ' O7 ' ' A' 1142 ' ' IM2 . 90.4 m -128.0 149.72 50.24 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.789 -0.449 . . . . 2.9199999999999999 109.789 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 40.7 mt -90.23 62.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.724 0.773 . . . . 2.0699999999999998 109.307 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 6.3 ptm180 -124.28 94.3 4.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.793 0.806 . . . . 3.98 111.35 -176.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.8 ptm -90.86 -166.51 1.6 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.874 -1.057 . . . . 1.8700000000000001 111.858 -171.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -61.43 144.23 54.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.474 -0.33 . . . . 3.25 110.156 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -51.98 -64.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.025 0.203 . . . . 2.4199999999999999 111.536 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -62.68 -26.66 68.77 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.747 -0.596 . . . . 2.5699999999999998 111.462 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.47 -42.23 71.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.451 -0.341 . . . . 1.05 110.526 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.682 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 12.8 p -75.8 -17.44 15.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.32000000000000001 110.577 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.33 -37.99 11.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 119.289 -0.386 . . . . 1.1299999999999999 110.306 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -43.64 -70.23 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.078 0.854 . . . . 1.3799999999999999 111.954 161.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.414 HD11 ' HG ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -50.03 -41.2 47.01 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.465 -0.789 . . . . 1.3400000000000001 110.29 178.248 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.682 ' HB1' ' O ' ' A' ' 150' ' ' VAL . . . -54.41 -51.57 64.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.662 -1.154 . . . . 1.02 111.719 -173.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.469 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 14.9 m -77.94 -13.42 59.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.393 -1.276 . . . . 1.9099999999999999 111.387 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.48 -50.85 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.156 -0.474 . . . . 1.04 110.08 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 18.9 m -78.59 115.37 51.1 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-O 121.943 0.878 . . . . 0.20999999999999999 110.536 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.574 ' HG2' HD11 ' A' ' 57' ' ' ILE . 33.5 Cg_endo -84.6 -177.17 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.375 2.717 . . . . 0.51000000000000001 112.935 -174.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.528 ' O ' HD22 ' A' ' 51' ' ' LEU . 15.5 m120 -56.09 -2.35 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.636 -1.165 . . . . 1.02 114.016 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.2 57.2 0.5 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.633 -0.794 . . . . 0.64000000000000001 112.477 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.4 m -92.16 133.14 36.06 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.018 -0.364 . . . . 1.0700000000000001 110.018 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.22 133.9 34.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.469 -0.492 . . . . 2.3399999999999999 110.089 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.5 p -143.84 130.78 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 0.46000000000000002 111.234 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.403 ' C ' HD13 ' A' ' 165' ' ' ILE . 29.6 m -115.55 140.45 49.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.855 -0.612 . . . . 1.26 111.647 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.403 HD13 ' C ' ' A' ' 164' ' ' THR . 2.9 mp -123.82 110.29 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 118.957 -1.097 . . . . 1.1699999999999999 110.217 171.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.81 140.01 31.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.897 -1.047 . . . . 1.1899999999999999 110.566 -172.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.522 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.1 mpt_? -72.88 -16.31 61.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.114 -0.948 . . . . 3.7999999999999998 111.584 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.78 89.2 0.54 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.663 -0.779 . . . . 3.6499999999999999 111.758 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.262 -0.875 . . . . 5.9699999999999998 109.913 179.322 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1142 ' ' IM2 . . . . . 0.61 ' H26' ' HA ' ' A' ' 111' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 3' ' ' LYS . 3.1 mppt? . . . . . 0 CA--C 1.512 -0.495 0 CA-C-O 120.28 0.086 . . . . 2.1 111.114 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 49' ' ' PRO . 20.0 mt -85.2 168.26 14.94 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.721 0.638 . . . . 0.26 110.958 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.869 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -76.87 149.48 36.11 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 123.273 0.629 . . . . 0.23 112.57 -167.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.528 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.2 148.94 36.52 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.091 -0.959 . . . . 0.26 111.427 167.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 45' ' ' SER . 74.3 t80 -134.42 148.43 50.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.705 -1.589 . . . . 0.39 107.753 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.89 114.46 15.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.152 -1.425 . . . . 1.07 107.152 175.472 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.442 HG11 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -77.51 158.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.801 -0.636 . . . . 0.38 111.262 -168.33 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -112.44 153.1 27.89 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.846 -0.798 . . . . 2.59 108.846 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.676 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.24 116.18 1.91 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.64 -0.709 . . . . 1.74 112.396 -172.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.93 -11.57 20.51 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.476 -0.783 . . . . 0.57 113.013 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.584 ' HB3' HD11 ' A' ' 18' ' ' ILE . 78.9 m-20 -63.13 153.97 32.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.633 0.605 . . . . 2.17 112.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.551 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.4 p -134.05 155.0 50.79 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.858 -0.61 . . . . 0.5 112.385 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.3 tp -48.64 -58.99 3.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.68 0.992 . . . . 0.27 113.68 -173.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.656 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.9 t-20 -65.25 -43.13 92.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.533 1.159 . . . . 1.21 110.164 -169.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.83 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 13.9 m -57.98 -43.13 86.36 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 112.381 -2.19 . . . . 1.24 110.484 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.584 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.51 -41.1 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 123.738 0.815 . . . . 0.3 112.566 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.678 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.29 -64.41 0.87 Allowed 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.588 -0.278 . . . . 0.23 111.388 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.27 -4.46 50.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.875 -1.13 . . . . 0.39 111.843 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.83 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.8 t0 -65.54 -34.31 77.95 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.618 -0.882 . . . . 1.63 108.618 157.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.673 ' CD1' HD12 ' A' ' 101' ' ' ILE . 1.9 m-85 -95.15 16.92 15.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.777 0.322 . . . . 0.24 111.83 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 55.14 48.41 19.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.619 -0.719 . . . . 3.55 110.552 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.678 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.1 pt -147.22 -176.34 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.526 -0.916 . . . . 0.27 108.526 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -100.07 145.04 28.41 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.297 -0.865 . . . . 0.81 109.374 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.656 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 13.5 p -60.75 -35.85 77.44 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.41 0.624 . . . . 0.27 109.331 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.569 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.02 -32.71 74.14 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.488 -1.233 . . . . 0.26 111.514 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -37.51 42.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.095 0.474 . . . . 0.23 109.749 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 46' ' ' ILE . 18.3 tp -73.63 -19.25 60.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.499 -0.773 . . . . 0.17 109.077 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.737 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.79 35.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.3 0.571 . . . . 0.19 111.419 172.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 64.9 mt-30 -57.04 -44.33 82.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.511 1.148 . . . . 1.07 109.598 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.39 42.18 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.327 -1.76 . . . . 0.17 112.37 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.7 m120 -143.28 72.56 17.97 Favored Pre-proline 0 CA--C 1.513 -0.466 0 CA-C-O 121.075 0.464 . . . . 0.19 110.014 -171.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.691 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.6 Cg_endo -57.87 -9.05 5.21 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.289 2.659 . . . . 0.3 113.876 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -63.62 -33.54 75.83 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.073 0.939 . . . . 1.17 109.363 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.646 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -80.97 -6.53 58.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.059 -1.428 . . . . 0.53 114.508 -171.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.737 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.73 -40.64 41.39 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.634 1.207 . . . . 1.23 109.919 177.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.61 -46.36 11.61 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 112.755 -2.02 . . . . 0.4 111.815 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -166.89 39.11 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.439 -0.886 . . . . 0.3 114.163 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 18' ' ' ILE . 5.3 mp -113.98 158.97 20.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.67 -1.265 . . . . 0.31 110.214 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.623 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.05 135.32 39.31 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.905 -0.589 . . . . 0.39 110.923 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.676 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.91 126.69 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.338 0.866 . . . . 0.47 113.338 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.8 -10.52 51.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 114.539 -1.21 . . . . 0.36 112.192 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.5 tt0 -64.28 152.31 41.4 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.572 0.701 . . . . 1.19 110.552 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.7 m -118.47 134.74 54.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.452 -1.249 . . . . 0.89 109.113 -172.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 HD11 ' A' ' 29' ' ' LEU . 22.2 pt -137.08 153.93 30.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.213 0.53 . . . . 0.22 110.508 -175.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.533 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.4 t -98.81 148.99 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.292 -0.867 . . . . 0.21 110.407 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.5 mm -118.16 88.09 31.2 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 114.903 -1.044 . . . . 0.17 108.356 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.703 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.7 Cg_endo -60.04 140.59 93.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.095 2.53 . . . . 0.23 112.43 -174.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.534 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.01 -7.79 69.43 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.636 -0.711 . . . . 0.3 112.528 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.759 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.63 128.67 25.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.487 -0.931 . . . . 0.25 108.487 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.655 ' HD2' HD23 ' A' ' 51' ' ' LEU . 71.8 Cg_endo -69.36 169.24 18.86 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.695 2.93 . . . . 0.31 114.241 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 3.2 t70 -90.91 136.88 27.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.621 -1.172 . . . . 0.72 111.603 -172.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.869 ' HD3' HD12 ' A' ' 5' ' ' LEU . 73.2 Cg_endo -76.74 -1.9 12.07 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.02 2.48 . . . . 0.27 112.893 -173.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -96.13 -28.75 14.44 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 120.714 0.292 . . . . 2.11 111.031 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.7 p -65.19 -34.6 78.76 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.606 -1.257 . . . . 1.47 107.606 168.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.752 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.4 mt -78.15 126.37 83.65 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 113.053 -1.885 . . . . 0.26 111.016 176.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.47 96.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 120.92 1.08 . . . . 0.2 110.248 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.435 ' HD2' HG23 ' A' ' 57' ' ' ILE . 82.9 m-85 -158.87 136.77 10.39 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.463 -1.31 . . . . 0.26 107.463 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 26.2 t-80 -141.75 108.18 5.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.603 -1.258 . . . . 2.84 107.603 -169.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.0 mt -95.11 109.83 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.974 -1.012 . . . . 0.32 110.317 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.53 95.42 5.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.181 -0.918 . . . . 0.34 110.013 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.479 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -114.34 97.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.362 -1.29 . . . . 0.68 109.325 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 32.0 m -92.05 130.37 37.8 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.898 -1.046 . . . . 1.05 108.584 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.9 mm -60.2 -34.96 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.768 0.794 . . . . 1.29 109.042 177.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.38 91.24 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.475 -1.238 . . . . 0.88 111.337 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.489 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.11 -24.35 64.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.265 0.555 . . . . 0.74 112.217 176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 30.4 mttt 55.39 18.06 2.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.159 0.984 . . . . 2.51 112.798 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.518 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -141.26 140.58 33.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.78 0.8 . . . . 0.45 110.982 175.254 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.479 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -94.06 117.58 30.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.267 -1.333 . . . . 0.33 109.516 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 m -101.05 126.27 47.72 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.439 -0.504 . . . . 0.4 111.189 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.559 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -82.74 147.73 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.126 -1.805 . . . . 0.33 106.126 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 20.0 m -150.94 130.82 13.28 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 120.238 1.381 . . . . 0.75 112.329 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.9 tp -122.02 125.2 45.75 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.921 -1.036 . . . . 0.35 110.697 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 66.06 35.14 6.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.539 0.685 . . . . 0.52 109.321 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 82.19 2.0 1.33 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.183 -1.371 . . . . 1.84 111.719 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -131.52 140.46 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 118.756 -1.178 . . . . 3.19 113.623 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.4 148.28 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 113.017 -1.901 . . . . 0.41 112.788 -177.302 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.55 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.3 mtp -98.51 -42.74 7.17 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 112.734 -2.03 . . . . 0.35 108.275 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 179.32 159.47 0.67 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.226 -2.261 . . . . 2.07 110.135 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.518 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 11.8 m -119.14 133.26 55.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.588 0.232 . . . . 0.37 111.238 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 48.6 m-85 -117.38 145.44 36.09 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.541 . . . . 0.97 109.538 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.44 ' HB2' HG22 ' A' ' 134' ' ' ILE . 10.2 Cg_endo -82.09 144.34 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.308 2.005 . . . . 0.6 111.722 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.45 173.27 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.675 -0.491 . . . . 0.64 109.675 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 121.38 0.61 . . . . 0.83 110.966 177.502 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.566 ' HB2' HG13 ' A' ' 163' ' ' VAL . 4.4 m-85 . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 107.841 -1.17 . . . . 1.93 107.841 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 161' ' ' THR . 60.6 m-85 -130.67 140.49 50.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.113 0.482 . . . . 0.58 110.879 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.837 HD11 HD12 ' A' ' 125' ' ' ILE . 19.0 mm -59.76 104.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.194 -1.039 . . . . 0.41 108.194 166.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.673 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.5 tt -103.01 -24.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 120.221 -0.592 . . . . 0.37 112.191 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 6.5 t-20 -155.23 157.73 37.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.133 1.16 . . . . 1.99 114.133 -172.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.31 133.73 26.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 111.767 -2.47 . . . . 1.19 110.262 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 33.5 tp60 -106.27 141.79 37.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.069 -0.969 . . . . 1.67 111.386 -173.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.515 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 17.7 ttt180 -54.69 150.76 9.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.075 -1.875 . . . . 3.06 112.434 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -45.19 100.36 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.507 0 O-C-N 124.931 1.395 . . . . 2.61 111.58 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -55.37 -50.02 14.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.886 3.058 . . . . 0.98 112.242 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.26 -13.16 23.71 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.02 -0.991 . . . . 1.08 112.256 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.75 -170.44 13.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.829 -0.7 . . . . 1.05 112.773 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.64 18.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 124.69 3.593 . . . . 1.3 114.61 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 115' ' ' TRP . 1.4 t80 -72.36 -16.13 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.256 0.55 . . . . 1.38 109.655 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.88 42.71 2.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 1.11 114.061 170.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 114' ' ' TYR . . . 73.59 -39.05 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.307 0.854 . . . . 0.81 113.307 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -151.55 144.79 24.69 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 122.719 0.408 . . . . 1.12 109.93 -174.393 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 47.8 t-105 -117.07 104.44 11.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.873 -0.417 . . . . 2.19 109.873 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.3 mp -105.95 137.1 44.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.546 0.688 . . . . 0.61 110.707 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.1 m -105.09 145.18 30.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.334 -0.848 . . . . 0.94 112.266 -170.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.517 HD11 HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -96.53 -174.67 3.1 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.907 -1.146 . . . . 1.08 107.907 171.051 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.556 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 33.7 m . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 113.764 1.024 . . . . 1.5 113.764 -172.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 HD11 ' A' ' 100' ' ' ILE . 40.0 mt . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 108.976 -0.75 . . . . 0.48 108.976 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -140.93 -167.65 2.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.752 0.787 . . . . 1.25 112.65 -172.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.469 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.62 179.86 16.05 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.586 -1.188 . . . . 0.46 113.221 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -144.65 174.6 10.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.49 0.662 . . . . 0.5 111.563 -165.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -110.85 -13.23 14.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.923 -1.035 . . . . 1.86 109.557 162.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -124.39 101.6 34.13 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.72 -0.673 . . . . 1.77 109.633 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -92.22 3.6 3.82 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.213 2.609 . . . . 0.59 113.682 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.07 -19.24 40.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.33 0.586 . . . . 0.78 110.458 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -87.7 -7.12 57.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.57 -0.741 . . . . 1.45 110.223 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.44 HG22 ' HB2' ' A' ' 83' ' ' PRO . 13.4 mm . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.238 -0.892 . . . . 0.7 111.369 -174.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 109.784 -0.45 . . . . 1.13 109.784 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.555 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 30.4 m-70 -66.84 152.69 45.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.251 -0.648 . . . . 2.51 109.251 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.554 ' O ' HG12 ' A' ' 150' ' ' VAL . 1.9 m-20 -50.5 -61.55 2.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.302 0.376 . . . . 1.77 111.101 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.19 -28.54 70.12 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.89 -0.506 . . . . 2.13 111.63 -175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 1.5 m-20 -67.12 -41.96 85.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 1.05 110.777 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.5 p -77.03 -16.38 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.32 110.716 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -89.15 -39.68 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 119.109 -0.472 . . . . 0.37 110.679 173.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -43.69 -68.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.402 1.001 . . . . 1.38 111.825 163.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -49.96 -43.11 49.9 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.638 -0.71 . . . . 0.74 110.271 177.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.16 -52.8 60.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.406 -1.27 . . . . 0.22 112.25 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.8 p -77.44 -15.94 59.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.548 -1.206 . . . . 1.33 111.214 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.5 -48.62 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.731 -0.47 . . . . 0.23 109.731 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.8 m -77.48 118.87 74.85 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-O 121.946 0.879 . . . . 0.21 110.559 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.752 ' HG2' HD13 ' A' ' 57' ' ' ILE . 35.3 Cg_endo -83.6 -177.85 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.177 2.585 . . . . 0.34 112.533 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.759 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.0 m120 -61.56 3.84 0.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.977 -1.01 . . . . 1.02 113.52 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.94 58.13 0.46 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.28 112.379 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.78 135.92 33.41 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 122.547 -0.384 . . . . 0.3 110.452 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -83.88 125.51 32.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.79 -0.187 . . . . 1.96 110.546 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 98' ' ' PHE . 4.2 p -138.15 127.43 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.439 0.637 . . . . 0.46 111.28 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.4 ' C ' HD12 ' A' ' 165' ' ' ILE . 31.7 m -118.22 140.36 49.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.654 -0.703 . . . . 0.56 111.721 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.422 HG13 HG13 ' A' ' 63' ' ' VAL . 2.7 mp -122.17 110.25 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 118.919 -1.112 . . . . 0.96 110.524 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.476 -0.784 . . . . 1.19 111.354 -170.161 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.5 mptp? . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.632 -0.507 . . . . 2.1 109.632 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -99.4 170.81 8.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.425 -0.352 . . . . 0.26 111.458 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.568 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.2 tp -77.86 150.95 34.1 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.334 0.654 . . . . 0.23 112.358 -170.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.552 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.86 149.47 40.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.055 0.931 . . . . 0.26 112.295 169.101 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.7 t80 -133.1 147.73 52.15 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 113.595 -1.639 . . . . 0.39 107.596 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.68 113.65 16.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.036 -1.468 . . . . 1.07 107.036 175.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -73.48 156.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.066 0.46 . . . . 0.38 111.89 -166.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -104.96 146.71 28.66 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.491 -0.777 . . . . 2.59 109.23 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.931 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 26.4 tt0 -50.55 106.18 0.12 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.846 -1.07 . . . . 1.74 112.894 -173.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.15 15.17 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.407 -0.815 . . . . 0.57 112.812 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.591 ' HB3' HD11 ' A' ' 18' ' ' ILE . 17.3 m-20 -62.36 154.57 27.64 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.345 0.498 . . . . 2.17 112.345 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.611 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -131.64 155.37 47.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.008 0.433 . . . . 0.5 111.989 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.7 tp -49.03 -60.12 3.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.098 1.147 . . . . 0.27 114.098 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.727 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 3.1 t-20 -65.21 -38.72 91.3 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.011 0.91 . . . . 1.21 110.572 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 t -58.61 -50.36 74.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 113.154 -1.839 . . . . 1.24 109.19 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -67.72 -38.48 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 O-C-N 123.584 0.553 . . . . 0.3 111.975 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.48 -60.16 4.07 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.23 110.994 175.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.79 58.57 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.67 -1.212 . . . . 0.39 112.15 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 11.3 m-20 -62.61 -34.33 76.81 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.859 -1.163 . . . . 1.63 107.859 156.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.694 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.3 m-85 -99.98 17.54 20.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.396 0.517 . . . . 0.24 112.396 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 50.44 53.77 12.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 3.55 111.13 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.1 pt -147.77 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.045 -0.724 . . . . 0.27 109.045 -173.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -98.78 144.17 28.31 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.333 -0.849 . . . . 0.81 109.57 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.727 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.9 p -62.89 -37.15 85.79 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.564 0.697 . . . . 0.27 109.21 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.14 -27.89 69.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.104 -1.407 . . . . 0.26 111.343 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.89 -37.52 26.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.231 0.538 . . . . 0.23 109.862 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 HD12 ' A' ' 46' ' ' ILE . 14.3 tp -73.8 -19.83 60.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.205 -0.907 . . . . 0.17 109.009 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.747 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.98 -37.74 38.65 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.332 0.586 . . . . 0.19 111.235 172.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.5 mt-30 -56.89 -42.85 80.62 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.25 1.024 . . . . 1.07 109.686 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.65 -20.58 35.99 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.536 -1.666 . . . . 0.17 112.523 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.7 m120 -142.04 72.16 23.09 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.009 0.433 . . . . 0.19 109.994 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.6 -9.36 5.27 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.586 2.857 . . . . 0.3 113.954 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -63.78 -33.63 76.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.028 0.918 . . . . 1.17 109.845 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -80.6 -4.75 55.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.206 -1.361 . . . . 0.53 114.46 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.747 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -50.52 -39.41 48.69 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 122.561 1.172 . . . . 1.23 110.035 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.57 -45.87 10.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 112.921 -1.945 . . . . 0.4 111.523 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 176.08 -167.55 39.3 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.155 -1.021 . . . . 0.3 114.295 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 18' ' ' ILE . 6.3 mp -115.86 157.92 23.73 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.511 -1.345 . . . . 0.31 110.571 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 48.8 m -130.34 134.74 47.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.74 -0.664 . . . . 0.39 110.394 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.931 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.99 129.95 17.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.98 0.733 . . . . 0.47 112.98 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 -13.82 35.89 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 114.792 -1.095 . . . . 0.36 112.054 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.64 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.2 tt0 -63.02 152.38 37.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.744 0.783 . . . . 1.19 110.323 175.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 31.1 m -119.42 131.88 55.72 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.365 -1.289 . . . . 0.89 109.403 -171.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.691 HD12 HD11 ' A' ' 29' ' ' LEU . 23.0 pt -133.46 155.82 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.248 0.547 . . . . 0.22 110.522 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.425 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.4 t -101.38 148.73 6.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.239 -0.891 . . . . 0.21 110.176 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.528 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.8 mm -117.17 87.69 24.52 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.767 -1.106 . . . . 0.17 108.099 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.692 ' HA ' HD13 ' A' ' 4' ' ' LEU . 21.7 Cg_endo -58.63 145.82 93.94 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.387 2.725 . . . . 0.23 112.627 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 78.61 -6.16 54.33 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.911 -0.586 . . . . 0.3 112.831 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.72 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -116.06 125.41 28.62 Favored Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.707 -0.849 . . . . 0.25 108.707 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HD2' HD23 ' A' ' 51' ' ' LEU . 55.6 Cg_endo -64.92 174.2 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.616 2.878 . . . . 0.31 113.752 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 1.8 t70 -91.13 140.43 25.87 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 114.88 -1.054 . . . . 0.72 111.686 -170.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.568 ' HD3' HD12 ' A' ' 5' ' ' LEU . 63.0 Cg_endo -84.09 -7.58 10.12 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.316 2.677 . . . . 0.27 113.474 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.65 -29.27 17.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.924 0.392 . . . . 2.11 110.437 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -80.69 -13.73 58.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.749 0.785 . . . . 1.47 109.02 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.794 HD13 ' HG2' ' A' ' 158' ' ' PRO . 66.8 mt -85.91 126.95 64.18 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 114.679 -1.146 . . . . 0.26 109.839 171.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -101.61 94.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.948 0 CA-C-N 119.972 1.026 . . . . 0.2 110.659 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.803 ' HA ' ' O ' ' A' ' 73' ' ' SER . 92.6 m-85 -158.56 139.65 13.09 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.981 -1.463 . . . . 0.26 107.236 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 55.9 m-70 -139.19 117.77 12.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.916 -1.513 . . . . 2.84 106.916 -176.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 79.6 mt -98.88 109.34 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.085 -0.646 . . . . 0.32 110.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.65 98.94 7.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.918 0.865 . . . . 0.34 110.896 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.3 p -121.01 98.44 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.012 -1.449 . . . . 0.68 110.606 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 68' ' ' LYS . 68.8 m -92.03 115.49 28.12 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.419 -1.326 . . . . 1.05 107.419 170.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 mt -54.05 -26.0 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 121.122 0.487 . . . . 1.29 110.167 172.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.58 -48.43 62.64 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.795 -0.717 . . . . 0.88 112.237 169.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.34 -22.48 66.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.451 0.643 . . . . 0.74 110.849 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 64' ' ' SER . 9.0 tmtt? 64.35 11.03 6.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.6 -1.182 . . . . 2.51 112.603 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.471 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -145.12 143.43 30.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.591 0.71 . . . . 0.45 112.183 176.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.526 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.8 tt -95.72 122.27 38.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.197 -1.365 . . . . 0.33 109.952 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.26 125.74 50.07 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.487 -0.485 . . . . 0.4 111.61 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.555 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.21 150.62 26.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.426 -1.694 . . . . 0.33 106.426 175.229 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.803 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 1.4 m -150.84 128.5 11.55 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.335 1.425 . . . . 0.75 111.786 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.0 tp -115.01 126.91 55.29 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.496 -0.775 . . . . 0.35 110.222 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.58 35.29 11.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.392 0.615 . . . . 0.52 109.666 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.39 7.77 5.17 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.02 -0.991 . . . . 1.84 112.367 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -129.89 138.26 50.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.755 -1.178 . . . . 3.19 113.649 170.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.71 150.06 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 113.551 -1.659 . . . . 0.41 112.963 -172.039 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.531 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 3.6 mtp -103.36 -41.15 6.11 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.745 -2.025 . . . . 0.35 108.476 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 2.8 tppt? -175.29 170.28 3.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 112.868 -1.969 . . . . 2.07 111.1 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.471 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 16.0 m -131.02 129.42 42.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.684 -0.235 . . . . 0.37 110.93 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.77 150.43 44.86 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 122.32 0.248 . . . . 0.97 110.948 -175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -84.92 141.07 8.23 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.838 2.359 . . . . 0.6 112.1 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.46 -177.12 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.057 -0.519 . . . . 0.64 110.412 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.83 109.617 176.295 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 163' ' ' VAL . 19.6 m-85 . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.269 0.557 . . . . 1.93 110.531 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' THR . 65.2 m-85 -131.46 141.26 49.76 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.255 -0.884 . . . . 0.58 109.969 172.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 125' ' ' ILE . 24.0 mm -59.87 114.36 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 N-CA-C 107.47 -1.307 . . . . 0.41 107.47 165.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.59 HD12 ' HD1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -106.91 -27.41 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.551 -0.86 . . . . 0.37 112.018 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.578 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 60.0 t30 -172.41 -172.64 0.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.663 1.22 . . . . 1.99 113.481 -175.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.578 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.3 ptt180 -155.45 131.71 10.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 111.693 -2.503 . . . . 1.19 109.711 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -103.74 157.34 17.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.58 1.181 . . . . 1.67 112.227 -171.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 106' ' ' ASN . 37.0 ttt180 -53.93 154.78 3.81 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 112.485 -2.143 . . . . 3.06 112.473 170.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 105' ' ' ARG . 9.3 p30 -44.03 105.72 0.46 Allowed Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 112.925 -1.943 . . . . 2.61 111.346 175.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 88.7 Cg_exo -56.75 -53.31 5.26 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.653 2.902 . . . . 0.98 112.309 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.62 37.68 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.206 -0.906 . . . . 1.08 112.599 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.85 -170.37 24.36 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.915 -0.66 . . . . 1.05 111.89 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.15 49.56 0.34 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.992 3.128 . . . . 1.3 113.127 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.441 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -93.85 -21.1 19.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.059 0.456 . . . . 1.38 110.026 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.54 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 46.62 2.04 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.53 -0.759 . . . . 1.11 113.986 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.62 -24.53 0.21 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.192 0.812 . . . . 0.81 113.192 170.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -154.43 151.33 28.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.261 -0.274 . . . . 1.12 110.261 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -118.02 100.25 7.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.788 -0.819 . . . . 2.19 108.788 165.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.5 mp -101.85 139.24 37.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.801 0.81 . . . . 0.61 110.32 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.401 ' HB2' HG23 ' A' ' 101' ' ' ILE . 68.0 m -106.68 144.96 32.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.916 -1.038 . . . . 0.94 112.378 -168.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.574 HD22 HG11 ' A' ' 163' ' ' VAL . 73.0 mt -102.24 -176.84 3.23 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.648 -1.16 . . . . 1.08 108.464 173.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 49.6 m . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 111.803 0.297 . . . . 1.5 111.803 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.789 HD12 HD11 ' A' ' 100' ' ' ILE . 23.1 mt . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.254 -0.647 . . . . 0.48 109.254 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -153.51 -162.22 1.42 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.405 0.621 . . . . 1.25 111.498 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.54 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.63 179.57 16.38 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.158 -1.02 . . . . 0.46 112.779 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -135.13 174.83 10.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.453 0.644 . . . . 0.5 111.185 -167.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -107.74 -23.0 12.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.92 -1.036 . . . . 1.86 108.994 168.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.41 104.63 28.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 114.756 -1.111 . . . . 1.77 109.616 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.418 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.8 Cg_endo -89.97 4.5 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.213 2.609 . . . . 0.59 113.185 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.84 -21.91 29.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.389 0.614 . . . . 0.78 109.453 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.2 t -76.76 -18.18 58.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.079 -0.964 . . . . 1.45 109.317 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 23.4 mm . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.096 -0.957 . . . . 0.7 110.275 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.9 mtp . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.79 0.329 . . . . 1.13 110.581 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -78.4 161.46 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.106 -0.701 . . . . 2.51 109.106 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.633 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.5 m-20 -52.42 -68.13 0.19 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.398 0.436 . . . . 1.77 110.987 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -58.12 -30.89 66.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.098 0.407 . . . . 2.13 112.098 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -67.07 -41.5 86.31 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.906 0.384 . . . . 1.05 110.975 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 7.3 p -78.38 -15.27 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 0.32 110.637 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.467 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.7 mp -87.39 -41.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 118.749 -0.643 . . . . 0.37 110.414 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -44.36 -68.72 0.17 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.543 1.065 . . . . 1.38 112.244 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.687 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.8 OUTLIER -49.94 -43.46 49.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.927 -0.579 . . . . 0.74 110.169 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.17 -54.66 32.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.074 -1.421 . . . . 0.22 111.929 -171.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -79.95 -14.4 58.63 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.574 -1.194 . . . . 1.33 110.779 -170.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.65 -48.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.987 -0.375 . . . . 0.23 109.987 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 153' ' ' LEU . 23.1 m -76.33 119.35 76.93 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-O 121.672 0.748 . . . . 0.21 110.294 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.794 ' HG2' HD13 ' A' ' 57' ' ' ILE . 43.8 Cg_endo -83.1 -178.07 3.63 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.154 2.569 . . . . 0.34 112.872 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.72 ' O ' HD21 ' A' ' 51' ' ' LEU . 21.6 m120 -61.44 0.06 0.34 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.104 -0.953 . . . . 1.02 113.142 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.84 58.02 0.52 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.767 -0.73 . . . . 0.28 112.519 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.5 m -95.26 133.98 38.54 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.327 -0.513 . . . . 0.3 110.206 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 162' ' ' ARG . 0.0 OUTLIER -84.7 134.17 34.36 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 1.96 110.353 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.574 HG11 HD22 ' A' ' 118' ' ' LEU . 2.4 p -140.57 123.73 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.024 -0.989 . . . . 0.46 110.79 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.463 ' C ' HD12 ' A' ' 165' ' ' ILE . 93.0 m -118.09 141.57 48.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.494 -0.775 . . . . 0.56 111.782 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.506 HG13 HG13 ' A' ' 63' ' ' VAL . 2.9 mp -125.13 123.31 65.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 118.845 -1.142 . . . . 0.96 112.258 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 107.989 -1.115 . . . . 1.19 107.989 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.6 mptp? . . . . . 0 CA--C 1.52 -0.207 0 N-CA-C 109.929 -0.397 . . . . 2.1 109.929 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -100.11 169.92 8.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.188 0.305 . . . . 0.26 111.439 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.587 HD23 HG13 ' A' ' 48' ' ' ILE . 4.6 tp -75.86 150.23 37.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 123.076 0.55 . . . . 0.23 112.17 -170.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.515 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.38 149.26 38.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 122.11 0.957 . . . . 0.26 111.921 167.434 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 45' ' ' SER . 67.8 t80 -132.84 149.41 52.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.538 -1.665 . . . . 0.39 107.863 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.592 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.1 119.67 25.81 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.628 -1.619 . . . . 1.07 106.628 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.448 HG11 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -79.99 158.56 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-O 121.227 0.537 . . . . 0.38 111.554 -170.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -110.16 155.44 21.95 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.554 -0.906 . . . . 2.59 108.554 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.628 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 47.7 tt0 -52.53 122.34 8.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 1.74 112.14 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.99 -9.08 36.68 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.99 -1.004 . . . . 0.57 112.724 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.68 ' HB3' HD11 ' A' ' 18' ' ' ILE . 94.7 m-20 -67.42 151.23 47.77 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.935 0.398 . . . . 2.17 112.058 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.563 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 p -132.6 157.33 45.05 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 112.282 0.475 . . . . 0.5 112.282 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.579 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.9 tp -49.96 -59.75 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.95 1.092 . . . . 0.27 113.95 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.4 t-20 -65.83 -38.3 88.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.298 1.047 . . . . 1.21 110.476 -168.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 t -57.09 -54.93 41.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 113.143 -1.844 . . . . 1.24 109.233 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.68 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.72 -38.76 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 115.531 -0.759 . . . . 0.3 112.086 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.86 -63.73 1.11 Allowed 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 116.048 -0.523 . . . . 0.23 111.279 177.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.66 -3.93 54.83 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.803 -1.159 . . . . 0.39 112.011 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 23.6 m-20 -66.97 -27.34 67.37 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.81 -0.811 . . . . 1.63 108.81 156.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.1 m-85 -103.07 18.31 21.99 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.861 -0.524 . . . . 0.24 111.968 171.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 50.34 54.81 10.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.195 -0.911 . . . . 3.55 110.918 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.1 pt -148.26 -173.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.597 -0.89 . . . . 0.27 108.597 -173.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -100.96 143.63 30.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.29 -0.868 . . . . 0.81 109.319 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.71 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.8 p -61.05 -35.27 76.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.453 0.645 . . . . 0.27 109.503 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.94 -30.69 71.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.482 -1.236 . . . . 0.26 111.396 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.78 30.5 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.224 0.535 . . . . 0.23 109.631 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.674 HD11 HD12 ' A' ' 46' ' ' ILE . 15.0 tp -73.17 -19.3 61.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.417 -0.81 . . . . 0.17 109.022 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.748 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.61 36.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.315 0.578 . . . . 0.19 111.237 172.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 51.6 mt-30 -58.01 -42.52 85.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.227 1.013 . . . . 1.07 109.727 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.69 -20.71 38.94 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 113.478 -1.692 . . . . 0.17 112.489 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.1 m120 -143.43 73.48 17.5 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.19 109.949 -172.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.751 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.7 Cg_endo -57.36 -12.05 9.73 Favored 'Trans proline' 0 C--O 1.221 -0.372 0 C-N-CA 123.573 2.849 . . . . 0.3 114.003 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -62.47 -34.23 76.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.106 0.955 . . . . 1.17 109.119 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.3 mt -78.44 -6.7 56.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.117 -1.402 . . . . 0.53 114.448 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -50.99 -42.55 60.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 120.019 1.281 . . . . 1.23 109.478 176.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.84 15.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 112.894 -1.957 . . . . 0.4 111.601 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.86 -164.4 35.81 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.264 -0.969 . . . . 0.3 114.243 176.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' CD2' HG12 ' A' ' 18' ' ' ILE . 5.6 mp -116.85 158.96 23.11 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.274 -1.463 . . . . 0.31 109.905 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.597 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 93.2 m -136.53 135.63 38.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.912 -0.585 . . . . 0.39 110.77 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.27 126.61 6.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.267 0.84 . . . . 0.47 113.267 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.592 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.57 -12.52 46.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.588 -1.187 . . . . 0.36 112.388 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.597 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.7 tt0 -63.2 152.08 38.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.597 0.713 . . . . 1.19 110.455 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 49.9 m -119.87 132.27 55.51 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.668 -1.151 . . . . 0.89 109.612 -171.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.674 HD12 HD11 ' A' ' 29' ' ' LEU . 18.9 pt -132.91 160.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.156 0.503 . . . . 0.22 110.319 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.05 148.45 11.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.221 -0.899 . . . . 0.21 109.943 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.587 HG13 HD23 ' A' ' 5' ' ' LEU . 15.0 mm -116.66 88.5 25.02 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.957 -1.019 . . . . 0.17 108.277 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.725 ' HA ' HD13 ' A' ' 4' ' ' LEU . 27.5 Cg_endo -59.3 142.66 99.43 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.304 2.669 . . . . 0.23 113.02 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.479 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.29 -7.56 60.43 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.447 -0.797 . . . . 0.3 112.9 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.722 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.48 126.15 28.06 Favored Pre-proline 0 C--O 1.218 -0.567 0 N-CA-C 108.936 -0.764 . . . . 0.25 108.936 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD23 ' A' ' 51' ' ' LEU . 48.8 Cg_endo -64.48 176.56 2.67 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.939 3.093 . . . . 0.31 114.198 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.761 ' HB3' HG22 ' A' ' 56' ' ' THR . 4.3 t70 -90.74 141.99 27.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.84 -1.073 . . . . 0.72 110.646 -170.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.484 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 63.1 Cg_endo -86.81 -4.61 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.352 2.702 . . . . 0.27 112.158 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -95.06 -28.67 14.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 2.11 110.59 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.761 HG22 ' HB3' ' A' ' 53' ' ' ASP . 14.9 t -79.43 -14.1 59.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.024 -1.102 . . . . 1.47 108.024 172.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.8 HD13 ' HG2' ' A' ' 158' ' ' PRO . 71.8 mt -91.54 126.22 55.03 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.118 -1.401 . . . . 0.26 109.77 170.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -103.13 95.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.146 0 CA-C-N 120.036 1.048 . . . . 0.2 110.117 166.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.424 ' HD2' HG23 ' A' ' 57' ' ' ILE . 74.8 m-85 -158.96 138.66 11.78 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.645 -1.613 . . . . 0.26 106.645 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.571 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 12.6 t60 -147.69 121.83 9.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 2.84 108.147 -169.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.4 mt -103.39 111.13 31.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 114.643 -1.162 . . . . 0.32 110.853 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.27 94.29 4.86 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.077 0.941 . . . . 0.34 110.14 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -116.95 98.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 113.82 -1.537 . . . . 0.68 109.819 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.507 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 38.7 m -90.19 113.13 24.86 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.672 -1.233 . . . . 1.05 107.672 175.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.571 ' CG1' HG23 ' A' ' 165' ' ' ILE . 2.6 mm -46.46 -37.49 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.845 170.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.31 -42.05 99.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.076 -1.059 . . . . 0.88 112.247 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.507 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.97 -23.96 62.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.051 1.13 . . . . 0.74 114.051 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.6 mptt 61.83 11.4 4.06 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.819 0.848 . . . . 2.51 112.866 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.407 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -141.62 137.42 31.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.143 0.973 . . . . 0.45 112.232 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.523 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.97 119.87 34.23 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.455 -1.702 . . . . 0.33 109.621 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.96 124.53 47.74 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.104 -0.639 . . . . 0.4 111.538 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.602 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -83.26 134.73 34.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.168 -1.79 . . . . 0.33 106.168 175.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 33.6 p -143.39 125.75 15.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 120.943 1.701 . . . . 0.75 113.334 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 tp -110.48 124.42 51.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.351 -1.295 . . . . 0.35 110.116 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.46 33.12 7.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.602 0.715 . . . . 0.52 109.077 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 77.5 4.48 3.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.23 -1.35 . . . . 1.84 111.6 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -129.27 138.08 51.43 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.689 -1.205 . . . . 3.19 113.504 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -57.22 148.66 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 113.054 -1.884 . . . . 0.41 112.975 -172.004 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.602 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.2 mtp -100.4 -41.91 6.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.581 -2.099 . . . . 0.35 108.393 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? 179.98 160.19 0.85 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.442 -2.163 . . . . 2.07 110.39 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.407 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.0 m -121.65 133.23 54.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.385 0.136 . . . . 0.37 110.789 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.447 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 73.0 m-85 -118.81 149.13 45.92 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 120.831 0.348 . . . . 0.97 111.623 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 9.9 Cg_endo -80.36 141.49 14.3 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.752 2.301 . . . . 0.6 111.738 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.48 173.82 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.442 -0.577 . . . . 0.64 109.442 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.135 0.493 . . . . 0.83 111.653 -177.951 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.517 ' HB3' ' H ' ' A' ' 119' ' ' SER . 15.7 m-85 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.734 -0.469 . . . . 1.93 109.734 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 161' ' ' THR . 65.8 m-85 -135.69 141.07 44.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.592 -0.731 . . . . 0.58 109.75 172.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 125' ' ' ILE . 23.7 mm -59.56 116.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 107.469 -1.308 . . . . 0.41 107.469 167.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.574 HD12 ' HD1' ' A' ' 22' ' ' PHE . 2.9 tt -103.18 -28.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.361 -0.936 . . . . 0.37 112.026 -175.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -172.36 -169.96 0.67 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 114.923 1.453 . . . . 1.99 114.923 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.538 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.3 ptp180 -151.92 131.12 12.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 111.634 -2.53 . . . . 1.19 109.378 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -102.27 156.81 17.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.245 1.021 . . . . 1.67 111.531 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -53.18 152.26 4.48 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.562 -2.108 . . . . 3.06 112.42 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -44.98 104.85 0.41 Allowed Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 113.854 -1.521 . . . . 2.61 111.48 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -55.19 -51.19 10.72 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.971 3.114 . . . . 0.98 112.291 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.76 -20.2 34.5 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.999 -1.0 . . . . 1.08 112.181 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -103.43 -169.84 25.74 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.193 -0.527 . . . . 1.05 112.174 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.98 15.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 124.434 3.423 . . . . 1.3 114.094 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -67.93 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.949 0.404 . . . . 1.38 110.64 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 45.58 2.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 1.11 114.186 170.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.06 -22.57 0.26 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.305 0.854 . . . . 0.81 113.305 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.462 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -157.84 151.95 24.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.732 0.301 . . . . 1.12 110.373 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -120.92 102.43 8.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 2.19 109.583 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -106.59 137.28 44.88 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.236 0.541 . . . . 0.61 110.413 176.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.2 m -106.15 145.17 31.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.507 -0.77 . . . . 0.94 112.726 -170.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -92.37 -174.19 3.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.703 -1.221 . . . . 1.08 107.703 170.039 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.517 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 52.9 m . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 118.806 0.73 . . . . 1.5 112.08 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 100' ' ' ILE . 47.2 mt . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 107.905 -1.146 . . . . 0.48 107.905 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.434 ' HA ' HG21 ' A' ' 150' ' ' VAL . 9.2 p80 -138.98 -162.83 1.37 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.35 0.595 . . . . 1.25 111.542 -173.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.453 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.92 178.28 16.39 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.844 -1.17 . . . . 0.46 113.654 -175.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.4 t -144.54 176.41 9.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.487 0.661 . . . . 0.5 111.263 -167.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -108.06 -15.15 14.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.72 -1.127 . . . . 1.86 109.715 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.13 103.73 29.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.555 -0.748 . . . . 1.77 109.976 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -90.52 4.58 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.168 2.579 . . . . 0.59 112.9 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.46 -16.25 46.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.322 0.582 . . . . 0.78 110.324 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -98.19 7.15 46.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.652 -0.704 . . . . 1.45 109.912 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 26.2 mm . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.384 -0.825 . . . . 0.7 111.244 -176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.473 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 10.8 ptm . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.082 -0.34 . . . . 1.13 110.082 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.529 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 22.1 m170 -73.52 154.53 39.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.939 -0.393 . . . . 2.51 109.939 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HG12 ' A' ' 150' ' ' VAL . 74.7 m-20 -50.31 -68.05 0.2 Allowed 'General case' 0 C--O 1.221 -0.412 0 O-C-N 123.318 0.386 . . . . 1.77 111.43 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -60.41 -29.41 68.96 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.782 -0.574 . . . . 2.13 111.699 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.529 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 2.2 m-20 -66.72 -41.95 87.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.732 0.301 . . . . 1.05 110.956 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.3 p -75.86 -18.93 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 116.311 -0.404 . . . . 0.32 110.615 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.534 HD12 HG13 ' A' ' 150' ' ' VAL . 2.8 mp -86.89 -39.94 13.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 119.014 -0.517 . . . . 0.37 110.154 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -45.33 -66.26 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.52 1.054 . . . . 1.38 111.949 165.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.631 ' O ' HG22 ' A' ' 157' ' ' VAL . 2.2 tp -53.17 -42.69 66.44 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.838 -0.619 . . . . 0.74 110.107 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.32 -54.84 26.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.384 -1.28 . . . . 0.22 111.735 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 32.8 t -75.46 -16.46 60.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.822 -1.081 . . . . 1.33 110.491 -172.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.2 mt -90.94 -53.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.787 -0.449 . . . . 0.23 109.787 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 153' ' ' LEU . 18.7 m -77.45 114.79 43.82 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 122.194 0.997 . . . . 0.21 110.212 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.8 ' HG2' HD13 ' A' ' 57' ' ' ILE . 54.6 Cg_endo -81.13 -179.12 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.911 2.407 . . . . 0.34 112.715 -173.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.722 ' O ' HD21 ' A' ' 51' ' ' LEU . 17.1 m120 -59.63 -0.24 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.827 -1.079 . . . . 1.02 113.404 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.23 59.02 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.834 -0.698 . . . . 0.28 112.435 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -95.03 134.89 37.21 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.523 -0.398 . . . . 0.3 110.219 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 131.83 34.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.859 0.362 . . . . 1.96 110.499 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.506 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.8 p -140.24 123.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.579 -0.737 . . . . 0.46 111.471 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.2 m -111.6 138.53 48.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.805 -0.634 . . . . 0.56 111.074 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.571 HG23 ' CG1' ' A' ' 65' ' ' ILE . 2.0 mp -122.37 117.2 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 118.461 -1.296 . . . . 0.96 111.059 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 123.263 1.506 . . . . 1.19 110.154 -175.748 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 121.037 0.446 . . . . 2.1 111.223 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.4 mt -97.95 168.63 10.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.088 -0.96 . . . . 0.26 110.886 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 48' ' ' ILE . 2.3 tp -80.71 151.42 28.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.411 0.684 . . . . 0.23 112.407 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.519 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -117.3 151.33 37.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.997 0.903 . . . . 0.26 112.364 169.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.4 t80 -134.56 148.74 50.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.701 -1.59 . . . . 0.39 107.917 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.638 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -127.33 121.15 30.25 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.012 -1.477 . . . . 1.07 107.012 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -83.06 158.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.243 0.544 . . . . 0.38 112.011 -170.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' N ' HG23 ' A' ' 9' ' ' VAL . 53.9 mtpt -109.43 150.37 28.18 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.838 -0.801 . . . . 2.59 108.838 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.97 114.1 1.21 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.89 -0.595 . . . . 1.74 112.004 -174.599 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -10.07 21.65 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.677 -0.773 . . . . 0.57 112.944 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.575 ' HB3' HD11 ' A' ' 18' ' ' ILE . 9.6 m-20 -62.62 154.51 28.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.028 0.414 . . . . 2.17 111.82 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.555 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -132.53 152.0 51.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.5 112.153 -177.492 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.4 tp -48.04 -57.76 5.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.425 0.898 . . . . 0.27 113.425 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.67 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.5 t-20 -66.05 -39.5 90.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 1.21 110.308 -169.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -59.4 -47.62 84.75 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 113.106 -1.861 . . . . 1.24 109.902 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -69.64 -39.36 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.513 -0.767 . . . . 0.3 112.205 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.0 -57.79 11.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.23 110.934 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.6 -4.35 57.54 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.683 -1.207 . . . . 0.39 112.147 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 42.2 m-20 -61.85 -36.38 81.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.902 -1.148 . . . . 1.63 107.902 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.669 ' CD1' HD12 ' A' ' 101' ' ' ILE . 2.2 m-85 -99.75 15.82 25.61 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.899 0.703 . . . . 0.24 112.899 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.05 50.99 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 3.55 110.684 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 19' ' ' ALA . 36.8 pt -146.65 -174.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.692 -0.855 . . . . 0.27 108.692 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -100.2 143.76 30.01 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.231 -0.895 . . . . 0.81 109.293 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.67 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.4 p -60.97 -35.09 75.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 121.4 0.619 . . . . 0.27 109.399 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.95 -31.51 72.72 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.507 -1.224 . . . . 0.26 111.657 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.85 -37.89 39.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.406 0.622 . . . . 0.23 109.574 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.671 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.97 -20.47 60.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.042 -0.981 . . . . 0.17 109.066 175.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.735 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.91 -39.13 43.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.431 0.634 . . . . 0.19 111.582 172.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 55.2 mt-30 -59.18 -42.23 90.34 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.163 0.983 . . . . 1.07 109.649 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.53 -18.89 43.47 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.535 -1.666 . . . . 0.17 112.32 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.1 m120 -143.77 71.9 17.11 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.19 109.881 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.643 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 12.2 Cg_endo -55.64 -13.56 8.4 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 123.696 2.931 . . . . 0.3 114.318 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -61.9 -35.72 79.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.02 0.914 . . . . 1.17 109.798 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -76.76 -6.64 53.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.341 -1.3 . . . . 0.53 114.362 -170.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.735 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -49.23 -40.68 34.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.527 1.156 . . . . 1.23 110.485 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.41 -45.65 11.67 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.054 -1.885 . . . . 0.4 111.627 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.651 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.3 -163.87 34.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.479 -0.867 . . . . 0.3 114.238 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.3 mp -118.97 158.04 26.53 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.444 -1.378 . . . . 0.31 110.512 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 71.3 m -133.22 136.48 45.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.873 -0.603 . . . . 0.39 110.964 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -44.73 126.17 5.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 0.47 113.312 173.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.638 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.84 -12.49 48.23 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.558 -1.201 . . . . 0.36 112.16 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.603 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.9 tt0 -62.75 150.81 40.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.741 0.781 . . . . 1.19 110.294 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.8 m -120.42 130.85 54.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.328 -1.305 . . . . 0.89 109.544 -170.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.671 HD12 HD11 ' A' ' 29' ' ' LEU . 21.3 pt -132.86 148.65 31.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.338 0.589 . . . . 0.22 110.697 -173.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.454 ' H ' HD22 ' A' ' 33' ' ' ASN . 13.2 t -94.1 149.02 4.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.078 -0.965 . . . . 0.21 110.383 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 18.9 mm -117.44 87.72 26.06 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 114.771 -1.104 . . . . 0.17 108.384 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.708 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.2 Cg_endo -59.38 143.82 99.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.214 2.609 . . . . 0.23 112.737 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.502 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.46 -7.6 56.95 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.569 -0.741 . . . . 0.3 112.977 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.758 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -115.92 127.1 27.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.711 -0.848 . . . . 0.25 108.711 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.2 Cg_endo -66.47 174.91 5.65 Favored 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 123.793 2.996 . . . . 0.31 114.005 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.703 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.6 t70 -90.45 141.53 27.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.263 -0.88 . . . . 0.72 110.734 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HD3' HD12 ' A' ' 5' ' ' LEU . 90.5 Cg_endo -83.84 -9.51 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.27 112.438 -175.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -95.09 -27.08 15.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 2.11 110.25 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.6 p -68.14 -32.34 72.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.591 -1.263 . . . . 1.47 107.591 170.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.768 HD13 ' HG2' ' A' ' 158' ' ' PRO . 89.5 mt -76.27 127.86 83.93 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 113.242 -1.799 . . . . 0.26 110.476 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -101.84 95.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.856 0 C-N-CA 120.846 1.031 . . . . 0.2 110.479 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.4 m-85 -158.38 139.25 12.98 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.952 -1.499 . . . . 0.26 106.952 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 34.2 t-80 -145.27 107.15 4.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.789 -1.189 . . . . 2.84 107.789 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 69.9 mt -94.93 109.64 22.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.254 -1.339 . . . . 0.32 110.302 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.94 94.73 5.09 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.987 0.898 . . . . 0.34 110.175 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 p -110.35 97.3 5.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.183 -1.372 . . . . 0.68 109.256 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 m -93.43 108.52 20.18 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.756 -1.111 . . . . 1.05 108.074 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.42 ' CG1' HG22 ' A' ' 165' ' ' ILE . 0.9 OUTLIER -46.38 -32.2 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.293 0.637 . . . . 1.29 112.613 174.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.16 -44.91 93.3 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.155 -1.022 . . . . 0.88 111.476 172.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.82 -23.28 63.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.768 -0.716 . . . . 0.74 111.754 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttt 59.97 16.94 6.2 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.042 0.937 . . . . 2.51 113.056 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.59 140.32 37.01 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.919 0.866 . . . . 0.45 111.404 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.441 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.6 tt -95.67 120.17 35.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.029 -1.441 . . . . 0.33 109.7 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -101.79 125.82 48.54 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.147 -0.621 . . . . 0.4 111.289 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.604 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.37 147.45 27.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.559 -1.645 . . . . 0.33 106.559 175.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.653 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 24.3 m -150.96 132.77 15.01 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 120.407 1.458 . . . . 0.75 112.712 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp -120.42 125.9 49.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.989 -1.005 . . . . 0.35 110.731 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 65.7 34.53 7.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.52 109.393 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 79.87 3.46 2.06 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.377 -1.283 . . . . 1.84 111.754 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -130.9 139.07 50.06 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 118.803 -1.159 . . . . 3.19 113.75 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -52.76 149.69 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 113.112 -1.858 . . . . 0.41 112.884 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.505 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.9 mtp -98.91 -43.98 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.643 -2.071 . . . . 0.35 108.263 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? 179.26 154.71 0.47 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.33 -2.214 . . . . 2.07 110.332 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.1 m -115.11 135.57 54.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.464 0.173 . . . . 0.37 110.754 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -125.34 131.97 24.19 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.97 110.608 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.58 146.37 79.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.793 2.328 . . . . 0.6 111.748 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.39 179.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.218 -0.66 . . . . 0.64 109.218 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.816 0 C-N-CA 119.199 -1.0 . . . . 0.83 109.877 174.702 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.57 ' HB2' HG13 ' A' ' 163' ' ' VAL . 17.8 m-85 . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 107.431 -1.322 . . . . 1.93 107.431 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.769 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.3 m-85 -127.19 136.45 52.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.925 -0.31 . . . . 0.58 110.477 175.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.85 HD11 HD12 ' A' ' 125' ' ' ILE . 11.7 mm -58.1 108.18 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 108.042 -1.096 . . . . 0.41 108.042 169.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.669 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.0 tt -108.4 -27.31 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 112.813 0.672 . . . . 0.37 112.813 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 26.2 t-20 -156.33 161.2 40.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 122.675 1.226 . . . . 1.99 114.046 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.82 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 134.14 36.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 111.678 -2.51 . . . . 1.19 109.177 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 16.0 tm0? -114.66 145.23 42.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.022 0.915 . . . . 1.67 111.055 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -50.1 154.37 1.18 Allowed 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 112.828 -1.987 . . . . 3.06 112.391 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -43.84 100.32 0.23 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 CA-C-O 121.557 0.694 . . . . 2.61 111.185 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HG3' ' OE1' ' A' ' 104' ' ' GLN . 90.2 Cg_exo -55.99 -51.01 10.54 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.18 3.253 . . . . 0.98 112.794 -173.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.89 16.87 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.146 -0.934 . . . . 1.08 112.15 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -106.13 -171.15 23.22 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.697 -0.763 . . . . 1.05 112.347 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.93 33.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 124.621 3.547 . . . . 1.3 114.422 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -77.61 -32.19 53.35 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.068 0.461 . . . . 1.38 110.695 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.488 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.82 42.78 2.79 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.598 -0.728 . . . . 1.11 113.333 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.83 -17.07 0.54 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.53 0.937 . . . . 0.81 113.53 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -156.87 131.38 8.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 110.042 -0.355 . . . . 1.12 110.042 176.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.9 t-105 -99.23 101.17 12.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.743 -0.836 . . . . 2.19 108.743 167.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.82 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.3 mp -106.95 135.64 48.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.281 0.562 . . . . 0.61 110.168 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.3 m -106.36 144.42 33.07 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.625 -0.716 . . . . 0.94 112.175 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.423 ' CD1' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -86.36 -177.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.415 -1.328 . . . . 1.08 107.415 164.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 21.7 m . . . . . 0 C--N 1.318 -0.778 0 N-CA-C 112.445 0.535 . . . . 1.5 112.445 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.85 HD12 HD11 ' A' ' 100' ' ' ILE . 43.0 mt . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.687 -0.857 . . . . 0.48 108.687 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -144.34 -163.81 1.76 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.789 -0.765 . . . . 1.25 112.148 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.488 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.05 -174.94 15.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.929 -1.129 . . . . 0.46 113.541 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -141.9 173.66 11.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.454 0.645 . . . . 0.5 111.333 -165.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.88 -18.59 14.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.131 -0.941 . . . . 1.86 108.645 164.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -127.26 101.66 24.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.891 -1.05 . . . . 1.77 110.3 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.1 Cg_endo -92.14 3.83 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.138 2.558 . . . . 0.59 112.801 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.01 -30.29 24.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.01 0.433 . . . . 0.78 110.254 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 m -85.52 -2.66 58.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 1.45 110.384 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 8.0 mm . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 115.476 -0.784 . . . . 0.7 110.12 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.3 mtp . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.243 0.544 . . . . 1.13 111.14 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -73.83 146.46 44.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.082 -0.963 . . . . 2.51 108.739 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.617 ' O ' HG12 ' A' ' 150' ' ' VAL . 4.4 m-20 -52.16 -65.33 0.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.219 0.451 . . . . 1.77 112.219 -171.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -59.22 -25.05 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.65 -0.656 . . . . 2.13 111.476 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.61 -35.78 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 1.05 110.765 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 10.8 p -77.94 -17.01 14.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.691 0 CA-C-N 116.529 -0.305 . . . . 0.32 110.25 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.447 HD12 HG13 ' A' ' 150' ' ' VAL . 2.3 mp -85.9 -39.11 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 119.073 -0.489 . . . . 0.37 109.914 172.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -44.72 -69.48 0.13 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 119.148 0.885 . . . . 1.38 112.178 163.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.706 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -50.36 -44.34 54.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.74 110.303 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.65 -50.04 71.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.141 -1.39 . . . . 0.22 112.109 -171.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 p -77.58 -17.21 58.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.724 -1.126 . . . . 1.33 111.111 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.42 -46.2 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.933 -0.576 . . . . 0.23 109.528 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 153' ' ' LEU . 30.6 m -76.51 120.95 83.88 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-O 121.669 0.747 . . . . 0.21 110.459 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.768 ' HG2' HD13 ' A' ' 57' ' ' ILE . 27.4 Cg_endo -85.59 -177.71 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.384 2.723 . . . . 0.34 112.841 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.758 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.7 m120 -60.09 3.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.775 -1.102 . . . . 1.02 113.895 -175.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -149.65 57.8 0.46 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.635 -0.793 . . . . 0.28 112.641 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.769 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.71 134.26 34.55 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.472 -0.428 . . . . 0.3 111.173 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -84.39 128.5 34.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.055 -0.521 . . . . 1.96 110.622 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 98' ' ' PHE . 3.2 p -141.83 129.58 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.542 0.526 . . . . 0.46 111.347 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.9 m -122.95 143.86 49.63 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.515 0.561 . . . . 0.56 112.515 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.42 HG22 ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -125.92 115.86 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.19 -1.004 . . . . 0.96 112.352 177.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 114.958 -1.019 . . . . 1.19 109.73 -172.103 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.232 -0.655 . . . . 2.1 109.232 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.767 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.1 mt -90.73 167.72 12.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.211 -0.449 . . . . 0.26 111.069 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.671 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -74.19 148.57 41.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.216 0.531 . . . . 0.23 111.65 -170.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.38 148.67 37.31 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.794 0.806 . . . . 0.26 111.257 168.007 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.462 ' CE2' ' HA ' ' A' ' 9' ' ' VAL . 69.1 t80 -134.04 148.03 51.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.009 -1.45 . . . . 0.39 107.61 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.8 tt0 -127.84 111.21 13.37 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.657 -1.609 . . . . 1.07 106.657 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -72.18 157.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.219 0.533 . . . . 0.38 111.39 -165.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -107.64 148.43 29.35 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.461 -0.79 . . . . 2.59 109.291 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.955 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 19.3 tm0? -46.53 116.96 1.44 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 1.74 112.631 -173.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.35 -8.94 38.39 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.967 -1.015 . . . . 0.57 113.514 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.546 ' HB3' HD11 ' A' ' 18' ' ' ILE . 83.1 m-20 -61.46 155.03 22.8 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.973 0.731 . . . . 2.17 112.973 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.592 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -134.32 159.11 41.99 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.949 -0.569 . . . . 0.5 111.73 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 46.6 tp -52.68 -57.71 9.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.948 1.092 . . . . 0.27 113.948 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.706 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 2.0 t30 -66.71 -43.19 84.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 122.309 1.052 . . . . 1.21 110.558 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.569 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 37.5 t -57.77 -47.96 81.03 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 112.988 -1.915 . . . . 1.24 109.797 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 14' ' ' THR . 1.6 mp -68.75 -40.65 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.795 -0.639 . . . . 0.3 111.89 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.708 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.28 -65.55 0.59 Allowed 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.23 111.541 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.89 -4.73 55.87 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.768 -1.173 . . . . 0.39 112.273 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -67.62 -27.28 66.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.93 -0.767 . . . . 1.63 108.93 157.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -99.6 15.37 26.87 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.804 -0.56 . . . . 0.24 112.146 172.245 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 56.28 50.94 12.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.495 -0.775 . . . . 3.55 110.662 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.708 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.3 pt -149.14 -173.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.909 -0.775 . . . . 0.27 108.909 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.04 147.61 23.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.415 -0.811 . . . . 0.81 110.017 172.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.706 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.4 p -62.56 -36.46 82.71 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.654 -0.869 . . . . 0.27 108.654 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -28.83 68.74 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.665 -1.152 . . . . 0.26 111.539 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 49' ' ' PRO . . . -80.37 -38.22 30.84 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.524 -0.547 . . . . 0.23 109.524 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 46' ' ' ILE . 12.7 tp -71.98 -20.42 61.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.563 -0.744 . . . . 0.17 109.007 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.684 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -38.36 40.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.47 0.652 . . . . 0.19 111.381 172.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.25 -42.46 91.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.998 0.904 . . . . 1.07 109.84 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.95 -16.26 51.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.843 -1.526 . . . . 0.17 112.01 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 33.2 m-80 -139.99 69.94 35.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.624 -0.51 . . . . 0.19 109.624 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.46 -21.9 19.77 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 124.533 3.489 . . . . 0.3 115.422 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -69.64 -34.12 73.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 119.458 1.026 . . . . 1.17 110.293 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.629 ' CD2' ' HB3' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -65.05 -6.7 9.42 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.422 -1.263 . . . . 0.53 113.635 -172.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.684 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.12 -40.68 24.34 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.475 1.131 . . . . 1.23 110.351 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.37 -46.15 13.93 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.98 -1.918 . . . . 0.4 111.642 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.41 -161.78 31.82 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.118 -1.039 . . . . 0.3 114.396 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.5 mp -118.6 158.27 25.78 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.704 -1.748 . . . . 0.31 110.542 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 98.7 m -133.6 133.69 42.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.799 -0.637 . . . . 0.39 110.55 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.955 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.22 127.15 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.789 0.662 . . . . 0.47 112.789 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.47 52.9 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.796 -1.093 . . . . 0.36 112.506 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.631 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.1 tt0 -65.28 152.66 43.2 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.643 0.735 . . . . 1.19 110.219 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 42.0 m -119.24 131.76 55.84 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.61 -1.177 . . . . 0.89 109.542 -171.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.718 HD12 HD11 ' A' ' 29' ' ' LEU . 25.2 pt -136.49 151.34 28.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.339 0.59 . . . . 0.22 110.698 -174.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.615 ' H ' HD21 ' A' ' 33' ' ' ASN . 5.3 t -94.56 148.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.156 -0.929 . . . . 0.21 110.703 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.598 ' CG1' HD23 ' A' ' 5' ' ' LEU . 15.7 mm -117.44 88.74 29.63 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 114.599 -1.182 . . . . 0.17 108.418 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.6 Cg_endo -59.02 143.8 99.65 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.186 2.591 . . . . 0.23 112.769 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.46 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.83 -6.88 60.68 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.3 113.035 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.752 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.9 tt -116.65 129.97 24.88 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.334 -0.987 . . . . 0.25 108.334 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.721 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.2 Cg_endo -69.45 171.08 14.76 Favored 'Trans proline' 0 N--CA 1.475 0.41 0 C-N-CA 123.583 2.855 . . . . 0.31 113.906 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 3.1 t70 -91.6 138.05 25.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 0.72 112.297 -171.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.671 ' HD3' HD12 ' A' ' 5' ' ' LEU . 69.4 Cg_endo -84.4 -4.27 10.15 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 123.684 2.923 . . . . 0.27 113.351 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -94.96 -25.15 16.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.853 0.359 . . . . 2.11 110.9 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.7 t -86.06 -13.0 48.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.448 0.642 . . . . 1.47 109.42 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HG2' ' A' ' 158' ' ' PRO . 81.3 mt -85.61 124.42 71.3 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.198 -0.91 . . . . 0.26 110.034 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -101.25 95.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.811 0.968 . . . . 0.2 110.109 169.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -158.37 137.13 11.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.55 -1.648 . . . . 0.26 106.55 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 71.8 t60 -144.19 109.89 5.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.851 -1.166 . . . . 2.84 107.851 -167.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 70.2 mt -95.14 107.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.394 -1.276 . . . . 0.32 109.864 -177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.5 94.24 4.9 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.048 0.927 . . . . 0.34 110.244 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.492 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -113.95 98.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 113.825 -1.534 . . . . 0.68 109.202 178.043 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.491 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 55.2 m -91.0 123.76 34.72 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.805 -1.183 . . . . 1.05 107.805 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 5.8 mt -60.6 -26.98 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.571 0.7 . . . . 1.29 110.214 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.53 -47.08 64.44 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 114.96 -1.018 . . . . 0.88 111.477 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -66.36 -23.92 66.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.114 0.483 . . . . 0.74 111.908 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 2.7 mtpt 59.13 12.48 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.256 1.023 . . . . 2.51 113.169 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.98 143.23 38.44 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.647 0.736 . . . . 0.45 110.902 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.6 tt -96.8 119.1 34.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.319 -1.31 . . . . 0.33 109.635 -177.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -102.59 126.51 49.69 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.244 -0.582 . . . . 0.4 111.317 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.566 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.71 141.9 32.07 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.436 -1.69 . . . . 0.33 106.436 175.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.5 m -145.98 128.81 16.33 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.481 1.491 . . . . 0.75 112.377 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -118.07 125.49 50.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.982 -1.008 . . . . 0.35 110.291 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.49 33.36 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.13 -0.692 . . . . 0.52 109.13 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 77.57 3.88 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.374 -1.285 . . . . 1.84 111.592 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -130.47 138.52 50.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 118.779 -1.168 . . . . 3.19 113.368 170.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -53.2 150.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 113.107 -1.86 . . . . 0.41 112.957 -174.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.566 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -99.03 -43.88 6.51 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.543 -2.117 . . . . 0.35 108.21 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -177.52 157.6 1.29 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.427 -2.169 . . . . 2.07 109.863 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -117.59 130.65 56.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.723 0.297 . . . . 0.37 110.8 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 74.9 m-85 -114.99 143.11 29.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.355 -0.384 . . . . 0.97 110.337 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 18.8 Cg_endo -81.67 140.61 11.82 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.298 1.999 . . . . 0.6 111.156 175.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.27 -172.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.323 -0.399 . . . . 0.64 111.085 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 0.83 110.03 175.394 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.516 ' HB2' HG13 ' A' ' 163' ' ' VAL . 19.1 m-85 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 107.61 -1.256 . . . . 1.93 107.61 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 161' ' ' THR . 46.9 m-85 -128.78 139.07 52.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.761 0.315 . . . . 0.58 110.221 173.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.69 HD11 HD12 ' A' ' 125' ' ' ILE . 16.3 mm -58.66 104.59 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.273 -1.01 . . . . 0.41 108.273 169.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.558 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.5 tt -93.17 -25.86 4.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.009 -0.676 . . . . 0.37 112.337 -170.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -169.4 -179.51 3.49 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 114.936 1.458 . . . . 1.99 114.936 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.9 175.8 10.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 111.079 -2.782 . . . . 1.19 108.517 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.78 155.27 39.84 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.462 1.125 . . . . 1.67 113.311 -164.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -52.54 149.73 5.62 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.64 -2.073 . . . . 3.06 111.109 166.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -50.14 107.03 0.71 Allowed Pre-proline 0 CA--C 1.514 -0.407 0 CA-C-N 115.825 -0.625 . . . . 2.61 111.928 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -59.2 -51.62 6.29 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 123.627 2.885 . . . . 0.98 112.896 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.45 -21.64 44.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.2 -0.909 . . . . 1.08 111.575 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -93.79 -170.1 38.57 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.357 -0.449 . . . . 1.05 112.137 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.3 21.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 124.648 3.565 . . . . 1.3 114.69 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -75.73 -18.5 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.369 . . . . 1.38 111.136 179.041 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 82.51 49.42 5.18 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.78 -0.646 . . . . 1.11 113.326 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.93 -20.56 0.37 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.222 0.823 . . . . 0.81 113.222 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.522 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -155.77 144.54 20.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 1.12 110.861 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -111.87 102.16 10.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.342 -0.614 . . . . 2.19 109.342 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -106.47 137.01 45.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.537 0.685 . . . . 0.61 109.839 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.412 ' HB2' HG23 ' A' ' 101' ' ' ILE . 72.9 m -106.75 144.46 33.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.412 -0.813 . . . . 0.94 112.272 -171.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -90.98 -175.04 4.21 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.19 -1.411 . . . . 1.08 107.19 169.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.316 -0.871 0 C-N-CA 119.775 -0.77 . . . . 1.5 111.861 -178.323 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.69 HD12 HD11 ' A' ' 100' ' ' ILE . 27.8 mt . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 108.78 -0.822 . . . . 0.48 108.78 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -139.68 -163.27 1.47 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.329 0.585 . . . . 1.25 111.441 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.03 163.51 14.47 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.058 -1.068 . . . . 0.46 113.597 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.7 t -120.45 170.87 8.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.711 -0.745 . . . . 0.5 111.608 -168.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.98 -22.21 13.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.926 -1.034 . . . . 1.86 108.586 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -124.88 104.56 30.05 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 114.837 -1.074 . . . . 1.77 109.642 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.58 4.22 7.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.96 2.44 . . . . 0.59 112.783 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.21 -11.0 47.97 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.98 -0.748 . . . . 0.78 108.98 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.7 m -78.52 -26.65 45.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.011 -0.995 . . . . 1.45 109.439 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 27.1 mm . . . . . 0 N--CA 1.451 -0.383 0 CA-C-N 115.354 -0.839 . . . . 0.7 110.041 175.915 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.41 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 9.7 ptm . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 111.721 0.267 . . . . 1.13 111.721 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -67.33 148.1 52.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.493 -0.188 . . . . 2.51 110.493 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.619 ' O ' HG12 ' A' ' 150' ' ' VAL . 13.8 m-80 -50.8 -68.09 0.2 Allowed 'General case' 0 C--O 1.221 -0.408 0 O-C-N 123.529 0.518 . . . . 1.77 110.962 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.383 0.512 . . . . 2.13 112.383 -173.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.55 -37.99 62.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.579 0.228 . . . . 1.05 111.14 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.5 p -75.85 -15.2 15.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 110.11 -0.33 . . . . 0.32 110.11 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.522 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -89.79 -39.65 12.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.101 -0.476 . . . . 0.37 110.582 172.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -44.44 -68.63 0.18 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.574 1.079 . . . . 1.38 112.137 164.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.4 tp -50.0 -43.11 50.41 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.904 0.753 . . . . 0.74 110.092 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.24 -53.67 47.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.296 -1.32 . . . . 0.22 112.464 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.2 t -76.74 -16.99 59.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.843 -1.072 . . . . 1.33 110.618 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.7 mt -91.28 -49.58 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.768 -0.456 . . . . 0.23 109.768 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 22.5 m -77.98 116.27 57.26 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-O 121.855 0.835 . . . . 0.21 110.119 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.788 ' HG2' HD13 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -83.01 -178.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.052 2.501 . . . . 0.34 112.327 -175.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.752 ' O ' HD21 ' A' ' 51' ' ' LEU . 14.2 m120 -64.93 7.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.905 -1.043 . . . . 1.02 113.337 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -146.64 53.98 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.941 -0.647 . . . . 0.28 112.156 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.0 m -88.17 135.8 33.27 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.47 -0.429 . . . . 0.3 110.863 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 162' ' ' ARG . 9.0 mtm180 -84.75 122.08 28.6 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.783 -0.644 . . . . 1.96 110.351 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 98' ' ' PHE . 3.6 p -134.74 127.74 49.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.46 111.594 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 m -118.67 140.06 50.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.474 -0.785 . . . . 0.56 111.902 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -124.65 114.71 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 118.887 -1.125 . . . . 0.96 110.75 174.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 . . . . . 0 N--CA 1.441 -0.878 0 CA-C-N 114.917 -1.038 . . . . 1.19 110.268 -173.345 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 108.428 -0.953 . . . . 2.1 108.428 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.803 HD13 ' HA ' ' A' ' 49' ' ' PRO . 19.8 mt -99.2 172.37 7.41 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.396 0.435 . . . . 0.26 111.756 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD23 HG13 ' A' ' 48' ' ' ILE . 4.3 tp -75.86 150.73 37.57 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.176 0.59 . . . . 0.23 111.84 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.539 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.06 150.58 35.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.978 0.894 . . . . 0.26 111.927 167.452 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.1 t80 -133.16 149.62 52.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.656 -1.611 . . . . 0.39 108.014 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.647 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.88 116.38 19.33 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 106.405 -1.702 . . . . 1.07 106.405 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.48 158.03 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.446 0.641 . . . . 0.38 111.786 -169.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.63 152.04 26.07 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.145 -0.934 . . . . 2.59 108.804 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.796 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.6 tt0 -51.6 111.3 0.57 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 1.74 111.795 -174.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -9.17 20.56 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.141 -0.936 . . . . 0.57 113.015 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.608 ' HB3' HD11 ' A' ' 18' ' ' ILE . 74.8 m-20 -66.48 147.13 53.73 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.327 0.563 . . . . 2.17 112.25 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.643 ' O ' HD13 ' A' ' 18' ' ' ILE . 2.0 p -134.44 163.75 28.99 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.257 0.466 . . . . 0.5 112.257 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.597 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -49.94 -62.06 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.367 1.247 . . . . 0.27 114.367 -171.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.697 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.2 t-20 -64.99 -41.14 95.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.49 1.138 . . . . 1.21 110.305 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.768 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.9 t -57.42 -48.15 79.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.472 -2.149 . . . . 1.24 109.858 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -70.15 -40.4 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 123.668 0.787 . . . . 0.3 112.456 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.687 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.33 -65.07 0.67 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.397 -0.365 . . . . 0.23 111.535 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.85 -5.06 54.73 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.743 -1.183 . . . . 0.39 111.83 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' SER . 17.3 t70 -65.19 -32.88 74.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.329 -0.989 . . . . 1.63 108.329 158.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.599 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.4 m-85 -97.83 14.96 25.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.196 0.443 . . . . 0.24 112.196 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 58.46 47.93 12.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 3.55 110.741 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.1 pt -147.89 -175.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.918 -0.771 . . . . 0.27 108.918 -173.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 146.22 26.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.362 -0.835 . . . . 0.81 109.467 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.697 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 10.3 p -62.17 -37.39 85.09 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.933 -0.766 . . . . 0.27 108.933 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.556 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.75 -30.29 71.4 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.192 -1.367 . . . . 0.26 111.281 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.93 -37.94 33.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 0.23 109.778 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.742 HD11 HD12 ' A' ' 46' ' ' ILE . 14.1 tp -73.69 -20.09 60.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 0.17 109.206 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.744 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.93 -38.82 44.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.65 0.738 . . . . 0.19 111.435 172.435 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 57.4 mt-30 -59.53 -41.9 91.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.288 1.042 . . . . 1.07 109.744 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.42 -20.74 39.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.565 -1.652 . . . . 0.17 112.315 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 12.6 m120 -142.34 73.25 21.25 Favored Pre-proline 0 CA--C 1.513 -0.449 0 CA-C-O 121.196 0.522 . . . . 0.19 110.099 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.726 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.3 Cg_endo -58.37 -10.03 7.9 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 123.239 2.626 . . . . 0.3 113.926 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -62.59 -31.06 71.81 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.972 0.892 . . . . 1.17 109.564 173.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 3.2 mt -83.14 -7.01 59.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.679 1.363 . . . . 0.53 114.679 -172.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.744 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -49.54 -40.92 39.86 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 120.03 1.286 . . . . 1.23 110.151 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 -46.64 12.84 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.886 -1.961 . . . . 0.4 111.511 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.42 -165.93 37.61 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.295 -0.955 . . . . 0.3 114.472 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.466 HD23 HG11 ' A' ' 9' ' ' VAL . 4.5 mp -113.71 158.47 20.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.412 -1.394 . . . . 0.31 110.252 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.687 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -136.97 134.16 36.39 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.786 -0.643 . . . . 0.39 110.65 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.796 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.05 129.36 17.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.475 0.655 . . . . 0.47 112.736 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.594 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 83.2 -11.49 54.76 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.561 -1.199 . . . . 0.36 112.766 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.888 ' OE1' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -61.48 158.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.194 0.521 . . . . 1.19 110.134 172.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.492 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 58.7 p -123.24 137.85 54.77 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.96 -1.018 . . . . 0.89 110.468 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.888 HG23 ' OE1' ' A' ' 44' ' ' GLN . 12.3 pt -135.13 171.6 17.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.287 0.565 . . . . 0.22 111.266 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 19.1 t -114.2 149.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.731 -1.122 . . . . 0.21 109.533 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.55 HG13 HD23 ' A' ' 5' ' ' LEU . 18.4 mm -118.27 88.29 32.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.183 -0.917 . . . . 0.17 108.711 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.803 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.47 139.88 92.38 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.387 2.725 . . . . 0.23 113.203 -173.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.469 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.22 -7.37 67.8 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.424 -0.807 . . . . 0.3 112.867 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.691 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.57 124.27 30.22 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.578 -0.897 . . . . 0.25 108.578 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD23 ' A' ' 51' ' ' LEU . 57.0 Cg_endo -65.31 176.34 3.36 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.75 2.967 . . . . 0.31 113.939 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.638 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.2 t70 -89.6 140.97 28.26 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.801 -1.091 . . . . 0.72 110.139 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.598 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 88.0 Cg_endo -81.86 -1.16 10.74 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.367 2.711 . . . . 0.27 111.725 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -28.83 14.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.898 -0.592 . . . . 2.11 110.772 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 53' ' ' ASP . 34.1 p -69.41 -28.4 66.12 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 122.617 1.199 . . . . 1.47 107.905 170.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.804 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.8 mt -84.16 124.75 73.81 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.899 -1.955 . . . . 0.26 110.648 175.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -101.57 95.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 CA-C-N 119.841 0.979 . . . . 0.2 109.847 166.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' HD2' HG23 ' A' ' 57' ' ' ILE . 80.8 m-85 -157.74 131.75 8.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.925 -1.509 . . . . 0.26 106.925 172.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 3.5 m-70 -140.48 113.55 8.38 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.436 -1.32 . . . . 2.84 107.436 -164.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.7 mt -102.23 111.22 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.723 -0.671 . . . . 0.32 111.307 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.96 98.86 7.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.227 -0.897 . . . . 0.34 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 165' ' ' ILE . 0.4 OUTLIER -116.55 99.71 8.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.174 -1.375 . . . . 0.68 109.559 177.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 54.2 m -94.46 133.08 38.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.071 -0.968 . . . . 1.05 109.199 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -35.63 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.595 0.712 . . . . 1.29 110.676 176.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.85 -43.4 97.67 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.905 -1.043 . . . . 0.88 110.956 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -71.32 -25.27 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.825 0.676 . . . . 0.74 112.825 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 mttt 54.03 17.07 1.28 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.913 0.885 . . . . 2.51 112.961 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.42 141.59 35.5 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.525 0.678 . . . . 0.45 111.051 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.486 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.2 tt -96.25 117.47 30.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.473 -1.239 . . . . 0.33 109.675 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 m -100.73 127.51 47.12 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.17 -0.468 . . . . 0.4 111.227 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.557 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -81.94 146.84 29.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.275 -1.75 . . . . 0.33 106.275 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 36.5 m -150.31 127.02 10.95 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 120.351 1.432 . . . . 0.75 112.442 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.07 125.25 53.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.492 -1.231 . . . . 0.35 110.088 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 4.7 t-20 60.73 42.25 13.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.152 0.501 . . . . 0.52 110.166 174.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.7 m-20 74.64 -1.46 3.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.993 -1.003 . . . . 1.84 112.731 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -128.69 135.76 49.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 117.845 -1.542 . . . . 3.19 114.115 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -56.55 149.17 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 112.7 -2.045 . . . . 0.41 113.027 -170.404 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.557 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.2 mtp -101.02 -43.03 6.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.581 -2.1 . . . . 0.35 108.566 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 178.81 159.1 0.57 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.617 -2.083 . . . . 2.07 110.342 -177.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.512 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.1 m -117.07 135.55 53.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.392 0.139 . . . . 0.37 111.165 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -124.08 135.03 25.88 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-O 120.792 0.329 . . . . 0.97 110.778 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -62.49 145.27 95.53 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.385 2.723 . . . . 0.6 113.268 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.94 169.38 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.091 -0.504 . . . . 0.64 109.675 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.297 0.57 . . . . 0.83 110.902 175.249 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.632 ' HB2' HG13 ' A' ' 163' ' ' VAL . 7.1 m-85 . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 109.76 -0.459 . . . . 1.93 109.76 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 161' ' ' THR . 95.6 m-85 -139.02 143.33 38.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.58 110.385 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.79 HD11 HD12 ' A' ' 125' ' ' ILE . 22.6 mm -59.96 126.08 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.54 -1.281 . . . . 0.41 107.54 164.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -124.02 -23.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.653 -0.819 . . . . 0.37 112.808 -174.25 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 15.7 t-20 -161.3 161.34 30.56 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.328 1.233 . . . . 1.99 114.328 -173.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 1.0 OUTLIER -147.0 128.74 15.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 111.579 -2.555 . . . . 1.19 109.515 174.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.686 ' HB3' ' CD1' ' A' ' 115' ' ' TRP . 7.4 tm0? -109.26 161.54 15.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.562 1.172 . . . . 1.67 111.542 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.55 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 9.4 ttm180 -49.79 152.67 1.45 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.929 -2.396 . . . . 3.06 112.544 171.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.55 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-20 -45.26 114.72 2.33 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-N 114.556 -1.202 . . . . 2.61 111.628 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HG3' ' NE1' ' A' ' 115' ' ' TRP . 85.3 Cg_exo -51.19 -48.16 22.44 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 C-N-CA 124.082 3.188 . . . . 0.98 112.441 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.59 -4.26 59.7 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.441 -1.254 . . . . 1.08 112.025 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -139.52 -171.55 12.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.989 -0.624 . . . . 1.05 112.736 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.64 20.15 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.724 3.616 . . . . 1.3 114.973 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 109' ' ' GLY . 46.6 t80 -74.55 -11.2 60.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.216 0.531 . . . . 1.38 110.21 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.89 38.16 3.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.705 -0.76 . . . . 1.11 114.31 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 73.25 -23.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.541 1.311 . . . . 0.81 114.541 166.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.542 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -152.16 148.96 28.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.832 0.349 . . . . 1.12 111.175 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.686 ' CD1' ' HB3' ' A' ' 104' ' ' GLN . 0.1 OUTLIER -110.4 101.6 10.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.489 -0.93 . . . . 2.19 108.489 171.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.782 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -111.44 138.18 48.27 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.073 -0.651 . . . . 0.61 110.252 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 101' ' ' ILE . 10.0 t -107.32 151.34 25.61 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.717 -0.674 . . . . 0.94 111.951 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.447 HD11 HG11 ' A' ' 163' ' ' VAL . 1.0 OUTLIER -101.8 -174.1 2.51 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.275 -1.38 . . . . 1.08 107.275 172.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.575 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 32.4 t . . . . . 0 C--N 1.316 -0.856 0 C-N-CA 119.678 -0.809 . . . . 1.5 110.716 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.79 HD12 HD11 ' A' ' 100' ' ' ILE . 32.3 mt . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 108.051 -1.092 . . . . 0.48 108.051 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -140.69 -162.13 1.31 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.978 -0.689 . . . . 1.25 111.443 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.62 -172.36 14.63 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.679 -1.248 . . . . 0.46 113.13 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -154.7 178.15 10.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.209 0.528 . . . . 0.5 110.336 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -111.66 -12.79 13.85 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.425 -0.807 . . . . 1.86 109.57 169.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -125.26 101.99 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.61 -0.723 . . . . 1.77 109.782 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.52 4.04 4.62 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.053 2.502 . . . . 0.59 113.148 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.13 54.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.521 0.677 . . . . 0.78 109.57 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -100.13 3.28 43.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.003 -0.999 . . . . 1.45 109.53 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 0.7 110.256 -179.807 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' A' ' 149' ' ' ASP . 1.7 ttm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.778 0.323 . . . . 1.13 111.063 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -71.73 154.19 41.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.306 -0.627 . . . . 2.51 109.306 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.618 ' O ' HG12 ' A' ' 150' ' ' VAL . 5.4 p30 -51.52 -68.69 0.15 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.288 0.477 . . . . 1.77 112.288 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -60.15 -26.29 66.18 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 121.644 -0.66 . . . . 2.13 112.315 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.453 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 62.9 m-20 -78.08 -34.33 50.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.523 -0.308 . . . . 1.05 111.639 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.649 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 11.6 p -74.97 -15.82 15.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.32 109.651 175.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.542 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.5 mp -88.59 -37.34 10.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.178 -0.464 . . . . 0.37 110.33 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -43.43 -71.8 0.07 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.375 0.989 . . . . 1.38 112.098 162.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.5 tp -49.03 -42.42 38.18 Favored 'General case' 0 C--O 1.222 -0.343 0 O-C-N 123.747 0.654 . . . . 0.74 110.147 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.43 -54.66 29.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.298 -1.319 . . . . 0.22 112.033 -172.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.6 p -77.82 -14.81 59.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.313 -1.312 . . . . 1.33 111.619 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.14 -51.83 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.82 -0.437 . . . . 0.23 109.82 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.8 m -77.13 118.06 69.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-O 121.952 0.882 . . . . 0.21 110.229 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.804 ' HG2' HD13 ' A' ' 57' ' ' ILE . 41.1 Cg_endo -83.88 -178.42 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.022 2.481 . . . . 0.34 112.832 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.691 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.4 m120 -59.84 -0.46 0.2 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.621 -1.172 . . . . 1.02 113.641 -174.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.59 57.46 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.28 112.235 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -94.46 132.78 38.75 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.441 -0.446 . . . . 0.3 109.951 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -84.54 140.28 31.53 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.676 -0.41 . . . . 1.96 109.995 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.4 p -145.48 126.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.584 -0.735 . . . . 0.46 110.744 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.453 ' C ' HD12 ' A' ' 165' ' ' ILE . 92.0 m -116.51 144.19 44.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.813 -0.63 . . . . 0.56 111.646 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.507 HG13 HG13 ' A' ' 63' ' ' VAL . 3.3 mp -125.96 114.17 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 118.819 -1.152 . . . . 0.96 110.58 173.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.155 -1.384 . . . . 1.19 108.698 -175.856 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 1.8 mppt? . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 109.64 -0.504 . . . . 2.1 109.64 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -100.92 168.32 9.7 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.143 0.277 . . . . 0.26 111.374 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.702 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.6 tp -78.16 149.81 33.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.303 0.641 . . . . 0.23 112.189 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.565 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -116.18 149.46 39.06 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.953 0.882 . . . . 0.26 112.123 169.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' SER . 65.3 t80 -133.9 149.86 51.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.761 -1.563 . . . . 0.39 107.498 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -129.86 116.07 18.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.163 -1.421 . . . . 1.07 107.163 174.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -77.17 158.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.203 0.525 . . . . 0.38 111.885 -166.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -104.94 152.66 22.4 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.417 -0.811 . . . . 2.59 108.947 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.717 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 18.8 tm0? -53.0 119.69 4.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.962 -0.563 . . . . 1.74 111.694 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.03 -10.42 37.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.57 113.15 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.543 ' HB3' HD11 ' A' ' 18' ' ' ILE . 80.9 m-20 -59.33 154.52 16.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.814 0.672 . . . . 2.17 112.814 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.521 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -133.95 150.79 51.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.972 -0.558 . . . . 0.5 112.071 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.598 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.1 tp -48.33 -58.7 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.674 0.99 . . . . 0.27 113.674 -172.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.674 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.0 t-20 -64.69 -42.4 95.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.546 1.165 . . . . 1.21 110.233 -169.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -59.06 -45.65 90.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.428 -2.169 . . . . 1.24 110.031 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -70.43 -41.14 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.715 -0.675 . . . . 0.3 111.867 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.684 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.58 -66.22 0.48 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.23 -0.441 . . . . 0.23 111.812 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -4.6 48.27 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.989 -1.084 . . . . 0.39 112.352 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.51 -29.67 69.15 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.16 -0.682 . . . . 1.63 109.16 158.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD1' HG13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -95.41 10.49 36.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.034 0.445 . . . . 0.24 111.961 173.384 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 59.95 50.3 6.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.256 -0.883 . . . . 3.55 110.513 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.684 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.6 pt -147.7 -174.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.608 -0.886 . . . . 0.27 108.608 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.2 m -101.07 147.7 25.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.559 -0.746 . . . . 0.81 109.755 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.674 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -61.74 -36.09 79.98 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.745 -0.661 . . . . 0.27 109.251 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.39 71.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.502 -1.227 . . . . 0.26 111.677 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -37.54 37.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.196 -0.602 . . . . 0.23 109.451 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 46' ' ' ILE . 16.3 tp -74.17 -19.75 60.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.433 -0.803 . . . . 0.17 109.115 176.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.711 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.08 -38.68 35.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.454 0.645 . . . . 0.19 111.652 173.592 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -58.89 -43.17 90.9 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 122.223 1.011 . . . . 1.07 109.834 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.53 44.08 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.576 -1.647 . . . . 0.17 111.929 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.565 ' ND2' ' HA ' ' A' ' 46' ' ' ILE . 14.6 m120 -142.6 72.85 20.27 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.19 109.75 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.46 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.3 Cg_endo -54.91 -16.53 11.97 Favored 'Trans proline' 0 C--N 1.333 -0.273 0 C-N-CA 123.598 2.865 . . . . 0.3 113.991 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -61.12 -32.65 72.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.068 0.937 . . . . 1.17 109.727 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.664 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.63 -4.47 51.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.295 -1.32 . . . . 0.53 114.484 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.711 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.92 -41.24 45.68 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 119.883 1.219 . . . . 1.23 109.856 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.63 -45.3 11.85 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.946 -1.933 . . . . 0.4 111.597 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.84 -166.31 37.49 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.324 -0.941 . . . . 0.3 113.781 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.8 mp -115.92 158.23 23.33 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.591 -1.304 . . . . 0.31 110.364 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.626 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.6 m -131.27 133.68 45.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.994 -0.548 . . . . 0.39 110.643 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.55 127.93 9.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.108 0.781 . . . . 0.47 113.108 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.77 -11.04 48.98 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.33 -1.304 . . . . 0.36 112.322 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.626 ' HB3' ' O ' ' A' ' 41' ' ' THR . 5.6 tt0 -65.06 152.12 44.3 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.526 0.679 . . . . 1.19 110.355 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 69.1 p -116.04 133.71 55.74 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.691 -1.14 . . . . 0.89 109.758 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 29' ' ' LEU . 21.7 pt -136.12 144.03 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.464 0.649 . . . . 0.22 110.54 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.478 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.9 t -90.72 150.09 3.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.805 -1.089 . . . . 0.21 110.39 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.607 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.2 mm -117.95 87.1 26.94 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 114.849 -1.069 . . . . 0.17 108.245 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.699 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.4 Cg_endo -59.79 142.51 98.78 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.488 2.792 . . . . 0.23 113.023 -172.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.534 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.44 -7.78 63.64 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.56 -0.746 . . . . 0.3 112.69 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.644 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.2 tt -115.45 127.13 27.06 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.771 -0.826 . . . . 0.25 108.771 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 55.3 Cg_endo -64.97 174.04 5.2 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.817 3.011 . . . . 0.31 113.7 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 4.9 t70 -95.75 138.73 21.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.428 -0.805 . . . . 0.72 111.996 -168.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HD3' HD12 ' A' ' 5' ' ' LEU . 97.3 Cg_endo -77.74 -9.76 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.388 2.725 . . . . 0.27 113.271 -172.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -94.98 -25.32 16.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 2.11 110.444 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 3' ' ' LYS . 21.9 p -68.4 -31.79 71.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.3 1.048 . . . . 1.47 108.233 169.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.831 HD13 ' HG2' ' A' ' 158' ' ' PRO . 95.5 mt -77.25 126.87 84.52 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 113.362 -1.745 . . . . 0.26 110.854 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -102.15 95.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 121.084 1.19 . . . . 0.2 110.53 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.3 m-85 -158.42 133.34 8.41 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.886 -1.524 . . . . 0.26 106.886 172.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 10.8 m-70 -138.91 109.05 6.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.729 -1.582 . . . . 2.84 106.729 -168.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -94.65 109.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.126 -0.943 . . . . 0.32 110.135 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.73 96.42 5.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.046 0.927 . . . . 0.34 110.396 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.0 OUTLIER -115.74 97.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.028 -1.442 . . . . 0.68 109.741 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -89.29 128.13 35.84 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.994 -1.003 . . . . 1.05 108.494 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.5 mm -57.91 -35.26 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.611 -0.885 . . . . 1.29 108.611 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.54 -43.68 91.72 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 114.355 -1.293 . . . . 0.88 111.828 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.96 -23.91 63.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.404 0.52 . . . . 0.74 112.404 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 58.14 15.32 3.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.07 0.948 . . . . 2.51 112.857 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.49 143.26 33.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.556 0.694 . . . . 0.45 111.462 175.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.434 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 4.7 tt -94.45 122.68 37.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.362 -1.29 . . . . 0.33 109.766 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -103.36 123.77 47.43 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.041 -0.664 . . . . 0.4 111.267 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.535 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.76 141.47 32.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.323 -1.732 . . . . 0.33 106.323 176.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 2.4 m -144.6 125.91 14.77 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 120.456 1.48 . . . . 0.75 112.483 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.3 tp -112.53 127.81 56.17 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 0.35 110.085 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 7.3 t-20 63.13 32.89 14.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.385 0.612 . . . . 0.52 109.519 173.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.7 m-20 79.86 1.44 2.12 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.536 -1.211 . . . . 1.84 112.493 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -129.15 138.73 51.95 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.707 -1.197 . . . . 3.19 113.698 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.01 147.94 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 113.329 -1.76 . . . . 0.41 113.553 -170.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.535 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -99.68 -44.45 6.11 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 112.087 -2.324 . . . . 0.35 108.121 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 34.4 tptt -176.89 164.75 2.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 112.491 -2.14 . . . . 2.07 110.661 -176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 m -124.16 134.41 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.893 -0.14 . . . . 0.37 111.304 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -124.51 134.62 25.71 Favored Pre-proline 0 CA--C 1.521 -0.154 0 CA-C-O 121.027 0.441 . . . . 0.97 111.637 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.4 ' HB2' HG22 ' A' ' 134' ' ' ILE . 25.6 Cg_endo -63.78 146.64 92.18 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.985 2.456 . . . . 0.6 111.967 174.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.52 -178.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.834 -0.432 . . . . 0.64 109.834 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.666 0.746 . . . . 0.83 111.575 -178.469 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 118' ' ' LEU . 33.5 m-85 . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 121.103 0.478 . . . . 1.93 110.445 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.673 ' HA ' ' O ' ' A' ' 161' ' ' THR . 37.1 m-85 -124.5 143.64 50.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.506 -0.77 . . . . 0.58 109.716 170.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.681 HD11 HD12 ' A' ' 125' ' ' ILE . 13.3 mm -59.35 121.77 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.393 -1.336 . . . . 0.41 107.393 164.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.611 HG13 ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -109.49 -45.7 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.024 -0.67 . . . . 0.37 111.275 -173.436 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 101' ' ' ILE . 5.6 t-20 -153.32 173.39 15.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 118.665 -1.214 . . . . 1.99 113.975 -170.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.751 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -139.18 128.18 23.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 111.948 -2.387 . . . . 1.19 109.194 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -100.2 149.11 23.89 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.237 1.018 . . . . 1.67 111.46 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -52.6 151.2 4.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.859 -1.973 . . . . 3.06 112.765 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -45.67 107.14 0.62 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 113.694 -1.594 . . . . 2.61 111.589 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -53.08 -50.19 14.92 Favored 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 124.416 3.411 . . . . 0.98 112.727 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.12 -20.31 12.88 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.164 -0.925 . . . . 1.08 112.46 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.41 -170.01 13.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.053 -0.594 . . . . 1.05 112.085 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.95 33.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 124.578 3.519 . . . . 1.3 114.093 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.413 ' H ' ' C ' ' A' ' 109' ' ' GLY . 4.4 t80 -86.31 -8.07 58.01 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.17 0.51 . . . . 1.38 110.12 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.604 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 100.89 32.57 5.3 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 115.517 0.967 . . . . 1.11 115.517 168.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 70.09 -21.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.207 1.188 . . . . 0.81 114.207 168.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -157.2 128.73 6.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.119 -0.697 . . . . 1.12 109.119 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -101.76 100.07 10.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.526 -0.916 . . . . 2.19 108.526 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.751 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.4 mp -101.78 136.31 41.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.615 0.722 . . . . 0.61 109.756 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 101' ' ' ILE . 68.8 m -106.5 152.05 24.17 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.239 -0.891 . . . . 0.94 111.626 -171.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.642 HD11 HG11 ' A' ' 163' ' ' VAL . 1.5 tp -101.39 165.03 11.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.86 -1.064 . . . . 1.08 108.729 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.56 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 30.5 t . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.401 . . . . 1.5 111.975 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 55.4 mt . . . . . 0 CA--C 1.513 -0.449 0 CA-C-O 121.181 0.515 . . . . 0.48 109.646 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -152.11 -162.34 1.49 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.191 0.519 . . . . 1.25 110.718 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.604 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.4 171.12 14.52 Favored Glycine 0 C--N 1.311 -0.843 0 C-N-CA 119.838 -1.172 . . . . 0.46 112.98 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -129.66 173.03 11.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.724 0.773 . . . . 0.5 111.809 -168.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -108.92 -20.65 12.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.382 -1.281 . . . . 1.86 109.078 165.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -124.79 103.6 30.99 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.261 -0.881 . . . . 1.77 109.696 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.8 3.77 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.294 2.662 . . . . 0.59 113.926 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.65 -13.16 59.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.58 0.705 . . . . 0.78 110.211 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.7 m -96.26 6.97 47.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.185 -0.916 . . . . 1.45 109.943 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 83' ' ' PRO . 23.8 mm . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.394 -0.821 . . . . 0.7 110.376 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.2 mpp? . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 109.669 -0.493 . . . . 1.13 109.669 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.489 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 48.8 m80 -70.53 166.14 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.983 -0.377 . . . . 2.51 109.983 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.594 ' O ' HG12 ' A' ' 150' ' ' VAL . 21.1 p-10 -54.26 -69.04 0.14 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 111.893 0.331 . . . . 1.77 111.893 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.01 -27.3 66.77 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.564 -0.71 . . . . 2.13 111.236 -176.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.489 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 3.1 m-20 -63.67 -46.82 83.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.923 -0.58 . . . . 1.05 110.545 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.1 p -77.35 -17.44 14.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-N 115.754 -0.657 . . . . 0.32 111.078 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.445 HD12 HG13 ' A' ' 150' ' ' VAL . 2.4 mp -85.46 -39.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 118.969 -0.538 . . . . 0.37 110.443 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -44.45 -69.97 0.12 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.705 1.139 . . . . 1.38 112.244 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.705 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.5 tp -49.82 -43.79 48.87 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.469 -0.787 . . . . 0.74 110.287 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.54 -48.36 69.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.256 -1.338 . . . . 0.22 111.819 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 35.0 t -79.63 -19.98 47.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.579 -1.191 . . . . 1.33 110.85 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 -48.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.782 -0.451 . . . . 0.23 109.782 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.4 m -77.45 116.47 58.14 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-O 121.802 0.811 . . . . 0.21 109.93 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.831 ' HG2' HD13 ' A' ' 57' ' ' ILE . 32.3 Cg_endo -84.46 -178.35 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.099 2.533 . . . . 0.34 112.442 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.644 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.4 m120 -63.27 5.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.743 -1.117 . . . . 1.02 113.349 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.19 58.2 0.47 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.89 -0.671 . . . . 0.28 112.56 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -92.75 136.71 33.0 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.447 -0.443 . . . . 0.3 110.671 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -83.85 129.52 34.93 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.642 -0.423 . . . . 1.96 110.301 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.642 HG11 HD11 ' A' ' 118' ' ' LEU . 4.4 p -136.37 127.3 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.23 0.538 . . . . 0.46 111.19 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.4 ' O ' HG13 ' A' ' 63' ' ' VAL . 10.4 m -119.23 134.64 55.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.768 -0.651 . . . . 0.56 111.689 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -121.82 108.68 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 119.32 -0.952 . . . . 0.96 110.673 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 . . . . . 0 N--CA 1.446 -0.662 0 CA-C-N 115.061 -0.972 . . . . 1.19 111.177 -168.681 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.8 mptt . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 110.135 -0.32 . . . . 2.1 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.5 mt -89.15 168.9 11.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.092 -0.504 . . . . 0.26 110.629 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.617 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.3 tp -77.39 150.08 35.12 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 122.988 0.515 . . . . 0.23 112.119 -169.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.12 150.43 36.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.891 0.853 . . . . 0.26 111.67 167.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' SER . 69.2 t80 -135.48 151.82 50.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.717 -1.583 . . . . 0.39 108.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -131.67 118.74 20.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.61 -1.256 . . . . 1.07 107.61 174.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.532 HG11 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -80.53 159.34 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 123.333 0.653 . . . . 0.38 112.011 -169.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.409 ' N ' HG23 ' A' ' 9' ' ' VAL . 89.3 mttt -108.37 152.07 25.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.711 -0.677 . . . . 2.59 109.198 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.664 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 19.6 tm0? -50.54 119.4 3.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 1.74 112.175 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.67 -4.2 42.8 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.028 -0.987 . . . . 0.57 113.144 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.624 ' HB3' HD11 ' A' ' 18' ' ' ILE . 7.3 m-20 -65.62 156.81 31.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.535 0.668 . . . . 2.17 112.529 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.523 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -131.96 148.16 52.5 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.829 0.677 . . . . 0.5 112.829 -176.105 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.609 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.0 tp -46.5 -58.91 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.771 1.026 . . . . 0.27 113.771 -173.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.654 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 20.3 t-20 -64.73 -40.28 95.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.583 1.183 . . . . 1.21 110.328 -170.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.781 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 10.9 m -60.87 -42.75 98.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 112.602 -2.09 . . . . 1.24 110.398 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -73.38 -39.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 O-C-N 123.831 0.707 . . . . 0.3 112.332 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.689 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.1 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.396 -0.365 . . . . 0.23 111.522 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.75 52.31 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.902 -1.119 . . . . 0.39 111.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.781 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.2 t0 -60.7 -42.63 97.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.461 -1.311 . . . . 1.63 107.461 157.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.7 m-85 -93.55 16.78 12.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.5 0.556 . . . . 0.24 112.5 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HG2' HD13 ' A' ' 101' ' ' ILE . 7.0 mmm180 53.82 51.86 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 3.55 111.002 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.689 HG12 ' O ' ' A' ' 19' ' ' ALA . 35.7 pt -147.26 -172.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.928 -0.768 . . . . 0.27 108.928 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.97 148.01 23.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 0.81 109.682 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.654 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 23.3 p -63.39 -35.74 81.4 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.683 -0.858 . . . . 0.27 108.683 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.14 -32.58 74.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.303 -1.317 . . . . 0.26 111.38 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.05 -37.58 38.62 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.273 0.559 . . . . 0.23 109.634 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 46' ' ' ILE . 12.6 tp -74.18 -18.8 60.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.401 -0.818 . . . . 0.17 109.027 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.743 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.28 34.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.462 0.649 . . . . 0.19 111.424 172.437 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 60.3 mt-30 -57.08 -46.26 82.67 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 122.248 1.023 . . . . 1.07 109.458 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.0 47.97 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.18 -1.827 . . . . 0.17 112.202 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.1 m120 -142.96 72.71 18.67 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-O 121.153 0.502 . . . . 0.19 109.903 -173.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.492 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 17.8 Cg_endo -57.24 -11.42 8.03 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 123.7 2.933 . . . . 0.3 114.187 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 t -62.86 -34.19 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.049 0.928 . . . . 1.17 109.915 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.7 mt -78.27 -4.99 50.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.438 -1.255 . . . . 0.53 114.372 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.743 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -51.08 -39.44 56.08 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 122.342 1.068 . . . . 1.23 110.049 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.98 -46.47 12.02 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.987 -1.915 . . . . 0.4 111.437 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.28 -164.09 34.4 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.502 -0.856 . . . . 0.3 114.008 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.532 HD23 HG11 ' A' ' 9' ' ' VAL . 6.0 mp -118.16 157.41 26.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.401 -1.4 . . . . 0.31 110.088 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.582 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -134.15 136.8 44.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.704 -0.68 . . . . 0.39 110.428 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.02 126.89 7.92 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.282 0.845 . . . . 0.47 113.282 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' HA2' ' OE1' ' A' ' 8' ' ' GLN . . . 82.52 -11.78 49.78 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.528 -1.215 . . . . 0.36 112.002 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -63.09 150.25 43.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.766 0.793 . . . . 1.19 110.466 175.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 22.9 m -118.45 134.51 55.01 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.231 -1.35 . . . . 0.89 109.13 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 29' ' ' LEU . 18.0 pt -137.14 151.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.445 0.64 . . . . 0.22 110.513 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.445 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.7 t -96.75 149.21 4.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.013 -0.994 . . . . 0.21 110.074 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.603 ' CG1' HD23 ' A' ' 5' ' ' LEU . 20.1 mm -117.65 88.84 31.05 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 108.309 -0.997 . . . . 0.17 108.309 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.742 ' HA ' HD13 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.83 142.14 98.05 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.014 2.476 . . . . 0.23 112.717 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.48 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.06 -6.91 65.08 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.525 -0.761 . . . . 0.3 112.995 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.681 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.9 127.74 26.44 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 108.737 -0.838 . . . . 0.25 108.737 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.5 Cg_endo -68.56 174.31 8.59 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.819 3.013 . . . . 0.31 113.93 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.6 t70 -89.57 142.48 29.47 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.881 -1.054 . . . . 0.72 110.185 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HD3' HD12 ' A' ' 5' ' ' LEU . 84.2 Cg_endo -80.96 -6.2 13.13 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.225 2.617 . . . . 0.27 111.973 -174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -95.85 -25.62 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 2.11 111.099 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 53' ' ' ASP . 28.6 p -70.49 -27.06 63.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.495 1.14 . . . . 1.47 108.028 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.9 mt -81.98 129.23 65.32 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 112.936 -1.938 . . . . 0.26 110.66 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -102.75 95.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 121.112 1.208 . . . . 0.2 110.761 165.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' SER . 86.8 m-85 -158.3 129.3 6.39 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.869 -1.53 . . . . 0.26 106.869 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 31.4 m-70 -136.69 105.13 5.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.983 -1.488 . . . . 2.84 106.983 -165.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 80.6 mt -94.15 113.42 28.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.282 -0.872 . . . . 0.32 110.703 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.6 95.19 5.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.366 -0.834 . . . . 0.34 110.752 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -110.18 112.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.431 -1.259 . . . . 0.68 109.479 177.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.626 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 49.5 m -107.38 135.63 48.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.836 -0.62 . . . . 1.05 110.629 -175.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 1.2 mt -57.32 -38.96 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.772 0.796 . . . . 1.29 110.269 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.21 -45.73 69.06 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.32 -1.309 . . . . 0.88 111.717 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -74.41 -24.65 59.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.347 0.594 . . . . 0.74 112.052 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 32.7 mttt 53.41 24.53 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.283 1.033 . . . . 2.51 111.732 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.472 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.5 OUTLIER -141.63 143.78 33.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.93 0.872 . . . . 0.45 110.934 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.8 tt -98.6 117.94 34.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.82 -1.536 . . . . 0.33 109.147 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -100.16 125.37 46.28 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.378 -0.529 . . . . 0.4 110.67 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.01 147.88 27.91 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.789 -1.56 . . . . 0.33 106.789 177.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 25.5 m -151.4 129.39 11.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 120.316 1.416 . . . . 0.75 112.729 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 tp -117.3 129.39 55.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.917 -1.038 . . . . 0.35 110.755 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 63.4 35.56 12.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.377 0.608 . . . . 0.52 109.679 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 77.48 2.75 3.09 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.595 -1.184 . . . . 1.84 111.784 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -129.95 138.74 51.03 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.41 -1.316 . . . . 3.19 114.032 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.53 149.36 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 113.162 -1.835 . . . . 0.41 112.822 -173.074 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -99.48 -45.57 5.77 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 112.675 -2.057 . . . . 0.35 108.38 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 179.53 157.61 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 112.805 -1.998 . . . . 2.07 110.388 -175.374 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.472 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.3 m -116.44 136.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.788 0.327 . . . . 0.37 111.661 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -116.89 153.27 49.35 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.088 -0.505 . . . . 0.97 110.192 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.11 143.09 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.59 2.193 . . . . 0.6 111.424 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 85' ' ' ALA . 0.1 OUTLIER -145.96 179.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.672 -0.24 . . . . 0.64 110.59 -178.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' HG12 ' A' ' 84' ' ' ILE . . . . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.485 0.66 . . . . 0.83 111.64 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.596 ' HB3' ' H ' ' A' ' 119' ' ' SER . 33.4 m-85 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.085 0.469 . . . . 1.93 111.185 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' A' ' 161' ' ' THR . 48.9 m-85 -128.62 138.52 52.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.476 -0.784 . . . . 0.58 109.897 171.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 125' ' ' ILE . 21.7 mm -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.926 -1.139 . . . . 0.41 107.926 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.593 HD12 ' CD1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -111.55 -33.54 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.897 -0.721 . . . . 0.37 112.666 -177.15 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 28.5 p-10 -166.47 -167.77 1.07 Allowed 'General case' 0 N--CA 1.46 0.062 0 CA-C-O 122.383 1.087 . . . . 1.99 113.846 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -156.84 141.6 16.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 112.391 -2.186 . . . . 1.19 111.501 178.101 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 23.5 tp60 -109.92 142.18 41.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.142 -0.936 . . . . 1.67 110.957 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -53.25 150.0 6.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.645 -1.616 . . . . 3.06 112.115 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -45.81 103.17 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 114.448 -1.251 . . . . 2.61 111.434 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.42 -49.77 15.77 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.151 3.234 . . . . 0.98 112.362 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.29 -16.01 20.1 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.995 -1.002 . . . . 1.08 112.393 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.97 -170.38 14.35 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.012 -0.613 . . . . 1.05 112.675 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.28 16.17 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.633 3.556 . . . . 1.3 114.99 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -66.66 -24.6 66.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.597 . . . . 1.38 109.933 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 127' ' ' GLY . . . 99.63 60.52 0.85 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.331 -0.849 . . . . 1.11 114.934 168.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.54 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 72.96 -57.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.941 1.089 . . . . 0.81 113.941 166.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -146.79 137.31 23.76 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.59 -0.522 . . . . 1.12 109.59 -173.104 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 76.2 t-105 -103.74 101.04 10.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.272 -0.64 . . . . 2.19 109.272 169.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.4 mp -104.51 109.23 21.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.585 0.707 . . . . 0.61 109.769 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.506 ' HB3' ' CG2' ' A' ' 101' ' ' ILE . 3.5 t -79.01 146.3 33.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 0.94 111.069 -168.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -92.88 177.02 6.21 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.591 -1.262 . . . . 1.08 107.591 171.223 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 36.0 t . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 111.869 0.322 . . . . 1.5 111.869 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.754 HD12 HD11 ' A' ' 100' ' ' ILE . 21.1 mt . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.075 -0.713 . . . . 0.48 109.075 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -152.09 -164.99 2.1 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.399 0.618 . . . . 1.25 111.341 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.443 ' O ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.07 -178.62 15.74 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.666 -1.152 . . . . 0.46 112.873 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.6 t -145.48 178.23 8.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.139 -0.531 . . . . 0.5 110.927 -165.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -108.98 -16.82 14.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.983 -1.008 . . . . 1.86 109.255 165.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -124.98 100.71 33.13 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 115.744 -0.662 . . . . 1.77 109.854 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.54 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 44.8 Cg_endo -92.78 4.64 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.584 2.856 . . . . 0.59 113.166 175.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.22 -20.99 50.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.976 0.417 . . . . 0.78 110.437 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 p -93.95 -4.83 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.598 0.714 . . . . 1.45 110.11 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 9.0 mm . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.239 -0.891 . . . . 0.7 110.461 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 29.1 mtp . . . . . 0 C--O 1.234 0.256 0 N-CA-C 109.964 -0.384 . . . . 1.13 109.964 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -79.0 153.27 30.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.919 -0.771 . . . . 2.51 108.919 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.64 ' O ' HG12 ' A' ' 150' ' ' VAL . 21.7 p-10 -52.08 -65.0 0.63 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.504 0.187 . . . . 1.77 111.504 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -60.74 -30.44 69.99 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.703 -0.623 . . . . 2.13 111.342 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -64.38 -43.54 94.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.179 0.514 . . . . 1.05 110.25 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.4 p -77.59 -17.42 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.509 -0.769 . . . . 0.32 110.993 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.54 HD11 ' HB1' ' A' ' 113' ' ' ALA . 3.0 mp -88.98 -40.86 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 119.022 -0.513 . . . . 0.37 110.649 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -44.03 -69.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.633 1.106 . . . . 1.38 112.027 162.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.744 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.8 OUTLIER -48.31 -42.52 31.26 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 123.813 0.695 . . . . 0.74 110.232 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.6 -57.02 12.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.427 -1.26 . . . . 0.22 112.465 -171.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 t -77.05 -14.99 59.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.825 -1.079 . . . . 1.33 110.487 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.48 -50.28 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 109.976 -0.379 . . . . 0.23 109.976 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 153' ' ' LEU . 28.3 m -75.96 116.71 58.1 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 121.939 0.876 . . . . 0.21 110.379 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.788 ' HG2' HD13 ' A' ' 57' ' ' ILE . 40.2 Cg_endo -81.97 -177.43 3.53 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.199 2.599 . . . . 0.34 112.581 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.681 ' O ' HD21 ' A' ' 51' ' ' LEU . 16.5 m120 -59.11 0.65 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.58 -1.191 . . . . 1.02 113.839 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.18 58.41 0.45 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.738 -0.744 . . . . 0.28 112.677 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.6 m -90.32 136.83 32.81 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.376 -0.484 . . . . 0.3 110.53 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -84.76 131.92 34.5 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.55 -0.46 . . . . 1.96 109.983 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.4 p -138.91 124.81 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.363 -0.835 . . . . 0.46 110.858 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.412 ' C ' HD12 ' A' ' 165' ' ' ILE . 89.8 m -116.92 140.5 49.38 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.682 -0.69 . . . . 0.56 111.636 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.1 mp -120.4 110.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.811 -1.156 . . . . 0.96 110.593 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' SER . 3.7 p30 . . . . . 0 C--N 1.321 -0.649 0 CA-C-N 114.372 -1.285 . . . . 1.19 109.071 -172.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.276 -0.639 . . . . 2.1 109.276 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.8 mt -91.79 168.86 11.15 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.382 0.426 . . . . 0.26 111.05 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.556 HD23 ' CG1' ' A' ' 48' ' ' ILE . 3.8 tp -76.42 150.31 36.76 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 123.42 0.688 . . . . 0.23 112.297 -168.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.551 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.57 150.05 35.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.137 0.97 . . . . 0.26 111.92 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 45' ' ' SER . 70.0 t80 -136.63 149.8 48.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.448 -1.705 . . . . 0.39 108.083 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.82 121.7 28.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.194 -1.41 . . . . 1.07 107.194 176.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -82.46 158.65 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.181 0.515 . . . . 0.38 112.119 -170.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -106.18 150.28 26.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.843 -0.799 . . . . 2.59 108.843 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.647 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 15.0 tt0 -53.97 112.73 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.541 0.526 . . . . 1.74 111.967 -175.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.0 -8.67 18.72 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.673 -0.775 . . . . 0.57 112.837 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.567 ' HB3' HD11 ' A' ' 18' ' ' ILE . 55.7 m-20 -62.26 154.84 26.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.067 0.433 . . . . 2.17 111.946 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.562 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 p -132.11 152.95 50.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.5 111.892 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.0 tp -49.86 -58.5 5.26 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.99 1.107 . . . . 0.27 113.99 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.6 t-20 -65.07 -42.01 94.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.569 1.176 . . . . 1.21 109.979 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.755 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 5.8 m -60.34 -39.45 87.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 112.51 -2.132 . . . . 1.24 110.769 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.567 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.8 -41.18 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 123.296 0.638 . . . . 0.3 112.176 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.62 -61.94 2.08 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.511 -0.313 . . . . 0.23 111.284 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.12 54.38 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.798 -1.161 . . . . 0.39 112.136 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.755 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.9 t70 -61.89 -34.84 76.75 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.654 -1.239 . . . . 1.63 107.654 156.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.4 m-85 -99.35 17.81 19.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.248 0.462 . . . . 0.24 112.248 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 52.11 51.92 15.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.356 -0.838 . . . . 3.55 110.954 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 19' ' ' ALA . 35.5 pt -146.86 -174.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.644 -0.872 . . . . 0.27 108.644 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -100.81 144.7 29.46 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.429 -0.805 . . . . 0.81 109.258 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.644 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 25.3 p -61.77 -34.81 76.54 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.48 0.657 . . . . 0.27 109.251 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.86 -29.4 70.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.34 -1.3 . . . . 0.26 111.511 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.82 -38.11 26.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.391 0.615 . . . . 0.23 109.791 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.672 HD11 HD12 ' A' ' 46' ' ' ILE . 16.7 tp -73.31 -16.93 61.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.214 -0.903 . . . . 0.17 108.958 174.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.769 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -82.1 -38.52 24.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.37 0.605 . . . . 0.19 111.578 173.077 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.4 mt-30 -57.92 -43.42 86.25 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.169 0.985 . . . . 1.07 109.636 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.59 -19.77 41.23 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.354 -1.748 . . . . 0.17 112.402 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 15.3 m120 -143.34 72.66 17.85 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.148 0.499 . . . . 0.19 109.922 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.663 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.8 Cg_endo -57.36 -11.32 8.11 Favored 'Trans proline' 0 C--N 1.333 -0.283 0 C-N-CA 123.649 2.9 . . . . 0.3 114.478 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -63.31 -34.43 77.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.913 0.864 . . . . 1.17 109.573 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -78.35 -6.62 55.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.332 -1.303 . . . . 0.53 114.415 -170.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.769 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.94 -42.56 48.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 119.78 1.173 . . . . 1.23 110.22 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.28 -45.95 12.31 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 112.881 -1.963 . . . . 0.4 111.439 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -164.81 36.16 Favored Glycine 0 CA--C 1.492 -1.355 0 C-N-CA 120.265 -0.969 . . . . 0.3 114.358 176.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.5 mp -115.43 157.86 23.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.966 -1.617 . . . . 0.31 110.447 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.62 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 96.3 m -133.89 133.86 42.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.641 -0.709 . . . . 0.39 110.519 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.647 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -44.61 126.49 5.54 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.416 0.895 . . . . 0.47 113.416 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.568 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.31 -10.66 53.65 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.391 -1.277 . . . . 0.36 112.129 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.62 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -63.99 150.91 44.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.776 0.798 . . . . 1.19 110.315 175.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 44.7 m -118.2 133.86 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.212 -1.358 . . . . 0.89 109.049 -171.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.672 HD12 HD11 ' A' ' 29' ' ' LEU . 15.0 pt -135.89 151.14 28.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.244 0.545 . . . . 0.22 110.312 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.49 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.1 t -96.03 149.09 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.121 -0.945 . . . . 0.21 110.119 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.556 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.4 mm -117.24 87.31 23.51 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.84 -1.073 . . . . 0.17 108.386 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.699 ' HA ' HD13 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.59 140.26 92.97 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.119 2.546 . . . . 0.23 112.626 -173.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.554 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 85.3 -8.24 72.07 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.323 -0.853 . . . . 0.3 113.015 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.606 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.9 tt -117.55 127.43 26.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.585 -0.894 . . . . 0.25 108.585 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD23 ' A' ' 51' ' ' LEU . 62.0 Cg_endo -67.78 173.58 8.89 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.725 2.95 . . . . 0.31 113.818 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.785 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.9 t70 -90.3 142.05 28.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.034 -0.985 . . . . 0.72 110.576 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.548 ' HD3' HD12 ' A' ' 5' ' ' LEU . 60.3 Cg_endo -86.21 -8.31 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.73 2.953 . . . . 0.27 112.444 -174.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -92.01 -13.52 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 2.11 109.486 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 53' ' ' ASP . 12.3 p -84.92 -29.5 25.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.944 -1.132 . . . . 1.47 107.944 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.662 HD13 ' HG2' ' A' ' 158' ' ' PRO . 43.5 mt -83.02 131.74 52.94 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 113.496 -1.684 . . . . 0.26 110.887 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.68 96.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 121.046 1.164 . . . . 0.2 110.525 167.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.499 ' HD2' ' CG2' ' A' ' 57' ' ' ILE . 84.1 m-85 -157.3 132.49 8.97 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.604 -1.258 . . . . 0.26 107.604 171.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.646 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 0.9 OUTLIER -135.96 103.73 5.47 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.487 -1.672 . . . . 2.84 106.487 -167.183 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 64.5 mt -94.71 112.43 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 120.237 -0.585 . . . . 0.32 110.521 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.33 95.8 5.35 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.378 -0.828 . . . . 0.34 110.811 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 165' ' ' ILE . 0.3 OUTLIER -115.75 104.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.503 -1.226 . . . . 0.68 110.645 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -98.96 113.52 25.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.213 -1.032 . . . . 1.05 108.213 174.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 mt -54.62 -32.43 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-O 120.905 0.383 . . . . 1.29 111.779 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.09 -45.62 95.0 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.071 -1.061 . . . . 0.88 111.305 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.43 -23.45 62.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.461 0.648 . . . . 0.74 111.959 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.7 mttt 62.35 18.93 10.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.734 1.214 . . . . 2.51 112.999 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.441 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.94 140.17 31.0 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.284 1.04 . . . . 0.45 112.63 177.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.572 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -97.19 118.7 34.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.028 -1.897 . . . . 0.33 109.269 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -100.86 125.14 47.36 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.349 -0.54 . . . . 0.4 110.489 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.604 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.8 143.92 29.64 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.966 -1.864 . . . . 0.33 105.966 176.333 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 47.7 m -148.65 129.52 14.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 120.189 1.359 . . . . 0.75 112.895 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -114.46 126.53 55.06 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.608 -1.178 . . . . 0.35 110.438 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.5 t-20 63.7 36.31 10.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.52 109.54 172.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.1 m-20 76.81 2.73 3.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.591 -1.186 . . . . 1.84 112.409 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -130.42 137.79 50.01 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 118.081 -1.448 . . . . 3.19 114.269 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.17 149.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-N 113.122 -1.854 . . . . 0.41 113.59 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.553 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -103.3 -40.35 6.44 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.407 -2.179 . . . . 0.35 108.732 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.52 165.87 2.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.677 -2.056 . . . . 2.07 110.723 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.441 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 8.6 m -125.49 130.52 51.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.419 0.152 . . . . 0.37 110.947 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.473 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 15.7 m-85 -120.68 134.35 24.23 Favored Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.759 0.314 . . . . 0.97 110.966 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.69 143.53 74.78 Favored 'Trans proline' 0 N--CA 1.472 0.213 0 C-N-CA 123.168 2.579 . . . . 0.6 112.76 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.24 179.36 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.329 -0.396 . . . . 0.64 110.782 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 110.091 -0.337 . . . . 0.83 110.091 179.555 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.506 ' HB3' ' H ' ' A' ' 119' ' ' SER . 7.2 m-85 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.71 0.291 . . . . 1.93 110.505 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 161' ' ' THR . 66.5 m-85 -131.17 139.83 49.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.58 110.252 172.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.596 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 34.0 mm -63.22 116.68 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 N-CA-C 108.752 -0.833 . . . . 0.41 108.752 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 3.7 tt -108.32 -19.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 119.237 -0.985 . . . . 0.37 112.507 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 6.2 t-20 179.0 -168.39 0.09 Allowed 'General case' 0 C--N 1.351 0.669 0 CA-C-O 122.73 1.252 . . . . 1.99 114.096 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.6 ptp180 -156.78 144.17 18.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.621 -2.536 . . . . 1.19 110.021 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.98 157.21 22.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 122.067 0.937 . . . . 1.67 111.172 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -52.32 150.21 4.9 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.521 -2.127 . . . . 3.06 112.05 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -48.33 110.3 1.4 Allowed Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 115.118 -0.946 . . . . 2.61 111.039 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.17 -48.25 22.63 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 123.762 2.975 . . . . 0.98 111.858 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 111.3 -20.39 23.42 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.849 -1.069 . . . . 1.08 112.625 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -105.93 -170.07 23.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.971 -0.633 . . . . 1.05 111.946 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.82 35.51 0.1 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.188 3.259 . . . . 1.3 113.561 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 109' ' ' GLY . 11.4 t80 -86.89 -16.89 34.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.21 0.529 . . . . 1.38 109.804 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.563 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.89 38.0 3.75 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.653 -0.703 . . . . 1.11 114.071 173.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB2' ' ND2' ' A' ' 147' ' ' ASN . . . 74.38 -36.71 0.34 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.121 1.156 . . . . 0.81 114.121 168.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.545 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -148.37 144.55 27.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.975 0.417 . . . . 1.12 110.949 -173.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -115.49 100.21 7.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.661 . . . . 2.19 109.373 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -101.72 145.72 28.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.206 0.527 . . . . 0.61 110.535 176.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.479 ' HB2' HG23 ' A' ' 101' ' ' ILE . 74.4 m -106.71 137.12 45.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.662 -0.699 . . . . 0.94 112.412 -170.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.564 HD11 HG11 ' A' ' 163' ' ' VAL . 2.2 tp -107.68 -171.29 1.84 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.086 -0.961 . . . . 1.08 108.987 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.506 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.7 t . . . . . 0 CA--C 1.543 0.685 0 CA-C-N 118.675 0.67 . . . . 1.5 111.18 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.637 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 12.0 mt . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 107.363 -1.347 . . . . 0.48 107.363 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -137.96 -163.92 1.53 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.697 -0.801 . . . . 1.25 112.463 -173.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.563 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.9 -177.0 15.31 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.377 -1.283 . . . . 0.46 112.479 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -141.07 175.88 9.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.494 0.664 . . . . 0.5 111.594 -166.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -111.04 -17.78 13.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.827 -1.079 . . . . 1.86 109.311 166.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -125.45 102.94 29.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.296 -0.866 . . . . 1.77 109.727 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.412 ' HA ' HG12 ' A' ' 134' ' ' ILE . 44.3 Cg_endo -91.79 3.48 4.07 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.171 2.581 . . . . 0.59 113.564 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.86 57.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.869 0.366 . . . . 0.78 111.117 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 -3.02 50.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 1.45 110.152 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 131' ' ' PRO . 10.9 mm . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.7 111.255 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 10.8 mtm . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.769 0.319 . . . . 1.13 110.679 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -67.73 150.51 48.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 2.51 110.046 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.595 ' O ' HG12 ' A' ' 150' ' ' VAL . 3.4 m-20 -51.63 -67.77 0.22 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 123.412 0.445 . . . . 1.77 111.589 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.43 -24.5 67.86 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.862 -0.524 . . . . 2.13 111.963 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.59 -38.41 74.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.731 0.3 . . . . 1.05 110.975 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.0 p -80.26 -14.9 13.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 116.587 -0.279 . . . . 0.32 110.521 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.545 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.5 mp -89.16 -38.96 12.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 118.851 -0.595 . . . . 0.37 110.911 173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -44.09 -68.6 0.18 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.854 1.206 . . . . 1.38 111.601 163.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.701 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -49.83 -42.47 47.33 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.589 -0.732 . . . . 0.74 110.059 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.64 -57.66 10.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.237 -1.347 . . . . 0.22 112.107 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.0 t -75.32 -14.57 60.5 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.475 -1.239 . . . . 1.33 110.63 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.438 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 80.9 mt -93.06 -47.77 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.32 -0.4 . . . . 0.23 110.365 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.9 m -76.88 110.61 12.37 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 122.038 0.923 . . . . 0.21 111.073 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.662 ' HG2' HD13 ' A' ' 57' ' ' ILE . 13.9 Cg_endo -82.16 -179.31 4.62 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.698 2.265 . . . . 0.34 113.254 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.425 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 8.7 m120 -66.73 110.54 3.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.74 -1.118 . . . . 1.02 108.254 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.89 2.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.284 -0.96 . . . . 0.28 113.314 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.596 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 18.9 m -93.2 136.29 33.6 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.839 -0.8 . . . . 0.3 109.819 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -84.72 134.16 34.35 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.952 -0.388 . . . . 1.96 109.952 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.564 HG11 HD11 ' A' ' 118' ' ' LEU . 3.2 p -140.51 125.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.421 -0.809 . . . . 0.46 111.424 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.4 m -114.01 129.7 56.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.303 -0.862 . . . . 0.56 111.557 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.608 HG13 HG13 ' A' ' 63' ' ' VAL . 2.8 mp -119.25 122.3 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 118.135 -1.426 . . . . 0.96 109.578 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 122.087 0.946 . . . . 1.19 109.932 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.157 0 N-CA-C 109.754 -0.461 . . . . 2.1 109.754 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.779 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.2 mt -100.69 169.15 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 0.26 111.948 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.693 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.4 tp -79.62 153.02 29.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 123.643 0.777 . . . . 0.23 112.206 -169.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.571 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -116.58 153.05 32.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.866 0.841 . . . . 0.26 111.858 166.204 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.2 t80 -136.6 150.5 48.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.029 -1.441 . . . . 0.39 108.07 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.654 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.47 119.42 24.87 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.714 -1.587 . . . . 1.07 106.714 174.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -81.08 158.88 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 112.782 0.66 . . . . 0.38 112.782 -167.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.407 ' N ' HG23 ' A' ' 9' ' ' VAL . 8.5 mtmp? -99.26 150.14 22.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.019 -0.992 . . . . 2.59 109.43 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.791 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.1 tt0 -53.84 109.17 0.43 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.258 -0.883 . . . . 1.74 111.618 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -9.82 22.43 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.64 -0.79 . . . . 0.57 112.748 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 18' ' ' ILE . 82.4 m-20 -59.7 154.21 18.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.021 0.41 . . . . 2.17 111.545 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.556 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.7 p -133.39 153.63 51.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.102 0.477 . . . . 0.5 112.115 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.5 tp -49.44 -59.9 3.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.795 1.035 . . . . 0.27 113.795 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.681 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.6 t-20 -65.02 -40.13 94.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.22 1.009 . . . . 1.21 110.456 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.0 t -59.72 -51.46 69.66 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 113.221 -1.809 . . . . 1.24 109.358 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.64 -39.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.924 -0.58 . . . . 0.3 111.433 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.666 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.98 -65.2 0.66 Allowed 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.23 111.635 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.12 -5.3 55.74 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 118.84 -1.144 . . . . 0.39 112.269 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.094 -0.706 . . . . 1.63 109.094 158.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.618 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.4 m-85 -97.05 13.94 27.36 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.089 0.403 . . . . 0.24 112.089 173.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 58.15 49.19 11.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 3.55 110.096 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 19' ' ' ALA . 42.0 pt -147.7 -175.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.691 -0.855 . . . . 0.27 108.691 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 m -99.52 146.0 26.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.538 -0.755 . . . . 0.81 109.337 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.681 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.1 p -60.66 -38.08 83.68 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.01 -0.737 . . . . 0.27 109.01 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.55 69.0 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.47 -1.241 . . . . 0.26 111.654 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 49' ' ' PRO . . . -80.72 -38.13 29.36 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.078 -0.712 . . . . 0.23 109.078 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.712 HD11 HD12 ' A' ' 46' ' ' ILE . 12.8 tp -73.69 -18.54 61.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.333 -0.849 . . . . 0.17 109.044 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.737 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.9 -39.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.484 0.659 . . . . 0.19 111.563 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -57.92 -42.9 85.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 122.372 1.082 . . . . 1.07 109.648 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.43 -17.25 49.51 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.512 -1.676 . . . . 0.17 112.016 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.8 m120 -144.45 72.22 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.102 0.477 . . . . 0.19 110.115 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.53 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.9 Cg_endo -55.06 -10.54 2.92 Favored 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 124.216 3.277 . . . . 0.3 114.387 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.38 -37.77 87.99 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.894 0.854 . . . . 1.17 110.78 173.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 6.3 mt -76.55 -6.09 50.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.749 1.389 . . . . 0.53 114.749 -169.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.737 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -50.7 -39.72 52.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.527 1.156 . . . . 1.23 109.942 -177.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.95 -45.26 12.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.694 -2.048 . . . . 0.4 111.453 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.64 -165.28 35.98 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.576 -0.821 . . . . 0.3 114.187 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.8 mp -117.33 158.13 24.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.501 -1.35 . . . . 0.31 110.593 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.672 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 68.3 m -134.25 134.12 41.6 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.756 -0.656 . . . . 0.39 111.101 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.791 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.5 129.06 13.17 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.446 0.906 . . . . 0.47 113.446 175.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.654 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 81.84 -12.77 40.39 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 114.38 -1.282 . . . . 0.36 111.865 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.672 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.6 tt0 -64.7 151.63 44.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.715 0.769 . . . . 1.19 110.307 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 41.1 m -118.0 133.68 55.69 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.257 -1.338 . . . . 0.89 109.277 -172.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 29' ' ' LEU . 19.2 pt -136.28 148.05 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.389 0.614 . . . . 0.22 110.503 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 t -93.1 149.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.087 -0.96 . . . . 0.21 110.342 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.602 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.1 mm -118.01 88.94 33.06 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 0.17 108.61 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.779 ' HA ' HD13 ' A' ' 4' ' ' LEU . 31.1 Cg_endo -61.73 140.64 87.13 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.0 2.466 . . . . 0.23 112.468 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.483 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.76 -7.26 66.36 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.45 -0.796 . . . . 0.3 112.692 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -115.24 125.33 29.01 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.777 -0.823 . . . . 0.25 108.777 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.586 ' CD ' HD23 ' A' ' 51' ' ' LEU . 57.1 Cg_endo -65.39 174.2 5.47 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 124.064 3.176 . . . . 0.31 114.129 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.479 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 6.9 t70 -95.74 137.16 21.93 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.776 -1.102 . . . . 0.72 111.877 -170.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.693 ' HD3' HD12 ' A' ' 5' ' ' LEU . 71.3 Cg_endo -82.25 -8.36 11.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.496 2.797 . . . . 0.27 113.552 -174.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -95.21 -22.25 17.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.089 0.471 . . . . 2.11 110.942 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -85.5 -6.8 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.069 0.938 . . . . 1.47 108.942 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.808 HD13 ' HG2' ' A' ' 158' ' ' PRO . 87.1 mt -95.8 127.46 41.19 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.446 -1.252 . . . . 0.26 110.226 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -102.12 96.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.147 1.231 . . . . 0.2 110.698 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.52 ' HB2' HG23 ' A' ' 161' ' ' THR . 89.2 m-85 -157.4 131.49 8.26 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.241 -1.392 . . . . 0.26 107.241 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.541 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 0.3 OUTLIER -136.08 103.21 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.706 -1.59 . . . . 2.84 106.706 -165.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 55.6 mt -94.53 112.32 26.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.569 -0.742 . . . . 0.32 110.537 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.97 96.83 6.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.102 -0.954 . . . . 0.34 110.361 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.548 HG13 HG13 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -119.09 106.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.543 -1.208 . . . . 0.68 110.361 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.536 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 24.1 m -101.06 125.94 47.71 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.542 -0.754 . . . . 1.05 109.805 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 mt -47.01 -35.64 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.137 0.494 . . . . 1.29 110.83 166.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.47 -49.16 46.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.469 -0.872 . . . . 0.88 111.514 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -68.92 -24.65 64.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 0.74 112.186 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.58 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 2.9 tppt? 55.67 18.69 2.95 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.489 1.138 . . . . 2.51 112.055 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.69 140.25 34.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.968 0.889 . . . . 0.45 111.15 173.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -96.89 118.57 33.61 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.9 -1.5 . . . . 0.33 109.275 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.0 m -101.13 123.82 45.88 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.194 -0.602 . . . . 0.4 111.17 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.95 131.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.767 -1.938 . . . . 0.33 105.767 176.436 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 12.0 m -136.86 130.72 32.18 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 120.735 1.607 . . . . 0.75 112.761 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.15 126.89 55.14 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.278 -0.874 . . . . 0.35 110.322 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.0 t-20 63.7 35.65 11.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.383 0.611 . . . . 0.52 109.463 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.3 m-20 78.52 -0.04 2.53 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.548 -1.206 . . . . 1.84 112.613 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -129.99 139.42 51.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.082 -1.447 . . . . 3.19 113.793 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -51.89 149.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 112.891 -1.959 . . . . 0.41 113.737 -172.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.536 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.6 mtp -101.56 -42.04 6.38 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.234 -2.257 . . . . 0.35 108.22 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -176.64 160.78 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.508 -2.133 . . . . 2.07 110.373 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 9.5 m -122.78 132.6 54.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.527 -0.175 . . . . 0.37 110.527 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.57 156.04 53.85 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 110.346 -0.242 . . . . 0.97 110.346 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HB2' HG22 ' A' ' 134' ' ' ILE . 9.7 Cg_endo -83.36 143.45 11.11 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.7 2.267 . . . . 0.6 111.842 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.37 173.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.482 -0.326 . . . . 0.64 110.148 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.352 . . . . 0.83 110.804 176.262 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.579 ' HB2' HG13 ' A' ' 163' ' ' VAL . 6.7 m-85 . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 107.998 -1.112 . . . . 1.93 107.998 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.717 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.7 m-85 -132.56 137.96 47.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.719 0.295 . . . . 0.58 110.499 172.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.737 HD11 HD12 ' A' ' 125' ' ' ILE . 17.2 mm -58.73 116.5 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.562 -1.273 . . . . 0.41 107.562 165.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.629 HG13 HD11 ' A' ' 51' ' ' LEU . 1.2 tt -102.09 -34.39 3.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.042 -0.663 . . . . 0.37 111.985 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.547 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 59.1 t30 -166.21 -177.83 4.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 122.819 1.295 . . . . 1.99 113.846 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.547 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.7 ptt180 -155.65 131.27 9.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 111.476 -2.602 . . . . 1.19 110.187 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -104.2 153.7 20.66 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 121.925 0.869 . . . . 1.67 110.76 -173.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -51.47 152.71 2.51 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.352 -1.749 . . . . 3.06 113.25 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -44.69 110.84 1.12 Allowed Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 112.331 -2.213 . . . . 2.61 110.69 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -54.15 -50.34 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.499 2.799 . . . . 0.98 111.827 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.65 -20.35 20.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.088 -0.96 . . . . 1.08 112.683 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -132.94 -169.53 12.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.082 -0.58 . . . . 1.05 112.123 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.77 37.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.906 3.737 . . . . 1.3 114.487 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.481 ' O ' ' HE1' ' A' ' 126' ' ' HIS . 52.1 t80 -82.06 -18.04 44.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.695 -0.483 . . . . 1.38 109.695 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.56 52.3 0.99 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.599 -0.728 . . . . 1.11 114.415 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 71.71 -63.08 0.44 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.258 1.207 . . . . 0.81 114.258 164.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -142.41 138.28 30.99 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.541 -0.299 . . . . 1.12 110.204 -172.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 51.4 t-105 -98.35 99.35 10.54 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.976 -0.75 . . . . 2.19 108.976 169.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.5 mp -109.34 135.28 50.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.628 0.727 . . . . 0.61 110.659 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 101' ' ' ILE . 29.5 m -107.58 149.17 28.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.278 -0.874 . . . . 0.94 112.047 -175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.639 HD11 HG11 ' A' ' 163' ' ' VAL . 1.5 tp -102.17 -173.78 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.916 -1.038 . . . . 1.08 108.573 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.556 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 48.0 t . . . . . 0 C--N 1.323 -0.57 0 C-N-CA 120.627 -0.429 . . . . 1.5 112.101 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.737 HD12 HD11 ' A' ' 100' ' ' ILE . 7.4 mt . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 106.522 -1.659 . . . . 0.48 106.522 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.481 ' HE1' ' O ' ' A' ' 111' ' ' PHE . 7.1 t-80 -134.9 179.31 6.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.883 -0.727 . . . . 1.25 111.715 -166.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -123.54 176.46 16.73 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.775 -1.102 . . . . 0.46 111.537 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.8 t -148.07 171.77 15.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.154 0.502 . . . . 0.5 111.07 -168.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -101.38 -15.41 17.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.209 -0.905 . . . . 1.86 109.523 166.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -125.33 101.34 31.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.673 -0.694 . . . . 1.77 109.873 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -90.65 4.88 4.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.171 2.581 . . . . 0.59 112.762 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.66 0.54 42.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.038 0.447 . . . . 0.78 110.849 -170.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.6 p -111.22 -2.31 15.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.661 0.743 . . . . 1.45 109.711 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 83' ' ' PRO . 20.9 mm . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.967 -1.015 . . . . 0.7 110.772 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.4 mtp . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.05 0.452 . . . . 1.13 110.599 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -71.38 146.22 48.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.457 -0.942 . . . . 2.51 108.457 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.554 ' O ' HG12 ' A' ' 150' ' ' VAL . 27.3 p-10 -50.21 -67.78 0.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 112.508 0.558 . . . . 1.77 112.508 -171.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -23.13 65.58 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.441 -0.787 . . . . 2.13 112.018 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.81 -40.57 63.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.865 -0.607 . . . . 1.05 111.055 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 8.9 p -75.77 -17.94 15.58 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 110.285 -0.265 . . . . 0.32 110.285 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.6 mp -87.12 -39.46 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 118.985 -0.531 . . . . 0.37 110.61 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -43.7 -70.15 0.11 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.534 1.061 . . . . 1.38 111.964 162.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.732 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -48.8 -44.79 39.47 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.626 -0.716 . . . . 0.74 110.139 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.88 -55.2 28.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.244 -1.344 . . . . 0.22 112.337 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.481 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 33.1 t -77.42 -14.72 59.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.592 -1.186 . . . . 1.33 110.9 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.54 -47.16 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.863 -0.421 . . . . 0.23 109.863 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 153' ' ' LEU . 32.6 m -76.12 120.11 80.23 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.885 0.85 . . . . 0.21 110.595 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.808 ' HG2' HD13 ' A' ' 57' ' ' ILE . 41.2 Cg_endo -83.43 -178.69 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.955 2.437 . . . . 0.34 112.538 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.739 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.9 m120 -62.3 4.25 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.503 -1.226 . . . . 1.02 113.366 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.3 54.84 0.52 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.28 112.446 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.717 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -89.72 131.17 35.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.438 -0.448 . . . . 0.3 110.837 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.37 138.9 31.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.472 -0.491 . . . . 1.96 110.342 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 118' ' ' LEU . 3.8 p -146.71 127.7 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.377 -0.829 . . . . 0.46 111.13 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.407 ' C ' HD12 ' A' ' 165' ' ' ILE . 7.1 m -111.67 133.38 53.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 0.56 111.1 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.548 HG13 HG13 ' A' ' 63' ' ' VAL . 2.7 mp -119.18 110.13 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 117.832 -1.547 . . . . 0.96 110.558 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 64' ' ' SER . 37.2 p-10 . . . . . 0 C--N 1.319 -0.747 0 CA-C-N 114.896 -1.047 . . . . 1.19 110.312 -171.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.6 mptt . . . . . 0 CA--C 1.518 -0.286 0 N-CA-C 109.864 -0.421 . . . . 2.1 109.864 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -93.49 167.22 11.84 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.367 0.417 . . . . 0.26 111.332 175.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.653 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.5 tp -77.11 151.2 35.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.488 0.715 . . . . 0.23 111.902 -170.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.8 150.14 38.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 122.1 0.952 . . . . 0.26 112.168 169.081 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' SER . 62.8 t80 -133.67 150.29 51.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.754 -1.567 . . . . 0.39 107.86 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -129.93 114.97 16.52 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.071 -1.455 . . . . 1.07 107.071 175.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.41 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.32 157.15 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.342 0.591 . . . . 0.38 112.359 -166.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -102.8 149.04 24.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.001 -0.999 . . . . 2.59 108.978 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.679 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.5 tm0? -52.53 117.94 3.24 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.874 -0.603 . . . . 1.74 111.369 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.67 -10.26 32.56 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.516 -0.766 . . . . 0.57 112.446 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.58 ' HB3' HD11 ' A' ' 18' ' ' ILE . 54.6 m-20 -62.24 147.55 47.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.997 0.427 . . . . 2.17 111.827 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.534 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -128.19 149.38 50.47 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.892 -0.594 . . . . 0.5 111.908 -178.033 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.605 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.2 tp -46.16 -60.42 2.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.868 1.062 . . . . 0.27 113.868 -173.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.652 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.7 t-20 -64.41 -38.96 92.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.751 1.262 . . . . 1.21 110.15 -171.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.78 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 19.3 m -62.07 -40.93 97.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.636 -2.075 . . . . 1.24 111.002 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.28 -39.74 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.013 0.925 . . . . 0.3 112.736 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.7 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.81 -62.1 1.98 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.61 -0.268 . . . . 0.23 111.203 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.38 -4.65 52.01 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.814 -1.155 . . . . 0.39 111.789 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.78 ' HB2' ' O ' ' A' ' 17' ' ' SER . 12.1 t70 -63.68 -32.42 73.9 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.135 -1.061 . . . . 1.63 108.135 158.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.653 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.0 m-85 -102.53 16.49 26.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 112.354 0.502 . . . . 0.24 112.354 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 54.46 52.02 13.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.206 -0.906 . . . . 3.55 110.644 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.7 HG12 ' O ' ' A' ' 19' ' ' ALA . 34.9 pt -147.99 -171.35 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.971 -0.752 . . . . 0.27 108.971 -172.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.85 147.47 24.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.668 -0.697 . . . . 0.81 109.917 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.652 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 15.8 p -63.0 -35.88 81.68 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.725 -0.843 . . . . 0.27 108.725 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.9 68.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.196 -1.366 . . . . 0.26 111.619 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.79 -38.43 25.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.368 0.604 . . . . 0.23 109.551 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.646 HD11 HD12 ' A' ' 46' ' ' ILE . 13.6 tp -73.88 -18.82 60.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 0.17 109.084 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.716 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.25 -39.34 33.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.616 0.722 . . . . 0.19 111.444 171.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -61.03 -40.3 93.06 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.128 -0.942 . . . . 1.07 110.009 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.74 36.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.881 -1.509 . . . . 0.17 112.085 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.0 m120 -142.02 71.57 23.43 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.039 0.447 . . . . 0.19 109.825 -173.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.519 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.33 -10.26 6.21 Favored 'Trans proline' 0 C--O 1.218 -0.475 0 C-N-CA 123.484 2.789 . . . . 0.3 114.07 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -62.63 -33.83 75.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.09 0.947 . . . . 1.17 109.75 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -78.78 -4.51 49.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.262 -1.335 . . . . 0.53 114.233 -172.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.716 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.64 -40.11 26.6 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 122.414 1.102 . . . . 1.23 110.249 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.46 -46.51 10.82 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.997 -1.911 . . . . 0.4 111.565 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.52 -164.52 34.89 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.978 -1.106 . . . . 0.3 114.264 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 18' ' ' ILE . 5.5 mp -116.38 159.56 21.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.262 -1.469 . . . . 0.31 110.396 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.1 m -138.44 135.09 34.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.916 -0.584 . . . . 0.39 110.871 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.0 129.32 14.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.662 0.744 . . . . 0.47 112.857 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.5 -13.64 39.88 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.46 -1.246 . . . . 0.36 112.179 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.617 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -64.59 151.3 45.04 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.628 0.728 . . . . 1.19 110.272 174.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 46.1 m -117.91 133.18 56.18 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.495 -1.23 . . . . 0.89 109.276 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.646 HD12 HD11 ' A' ' 29' ' ' LEU . 19.7 pt -135.22 148.97 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.277 0.561 . . . . 0.22 110.511 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.476 ' H ' HD22 ' A' ' 33' ' ' ASN . 14.2 t -93.41 149.61 4.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.136 -0.938 . . . . 0.21 110.099 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.518 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.7 mm -117.64 88.58 30.08 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.05 -0.977 . . . . 0.17 108.584 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.756 ' HA ' HD13 ' A' ' 4' ' ' LEU . 23.7 Cg_endo -59.06 143.28 99.86 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.053 2.502 . . . . 0.23 112.585 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.484 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.22 -6.59 59.67 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.694 -0.685 . . . . 0.3 112.996 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.718 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -116.73 126.39 27.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.752 -0.833 . . . . 0.25 108.752 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.648 ' HD2' HD23 ' A' ' 51' ' ' LEU . 61.6 Cg_endo -66.86 171.01 11.7 Favored 'Trans proline' 0 N--CA 1.477 0.517 0 C-N-CA 123.644 2.896 . . . . 0.31 114.029 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 2.0 t70 -90.95 138.89 25.9 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.573 -1.194 . . . . 0.72 111.82 -171.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HD3' HD12 ' A' ' 5' ' ' LEU . 66.3 Cg_endo -83.17 -4.94 11.19 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.529 2.819 . . . . 0.27 113.771 -173.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.34 -29.3 14.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.613 0.244 . . . . 2.11 111.235 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -80.38 -17.53 51.62 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.825 -0.805 . . . . 1.47 108.825 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.725 HD13 ' HG2' ' A' ' 158' ' ' PRO . 87.2 mt -81.44 123.31 81.2 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.974 -1.012 . . . . 0.26 109.224 169.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -100.83 94.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 120.023 1.044 . . . . 0.2 110.13 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' HD2' HG23 ' A' ' 57' ' ' ILE . 86.5 m-85 -158.78 129.79 6.23 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.558 -1.645 . . . . 0.26 106.558 172.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.682 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 2.5 m-70 -134.02 106.56 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.198 -1.779 . . . . 2.84 106.198 -165.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -95.06 110.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.908 -0.717 . . . . 0.32 110.904 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.13 94.21 4.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.277 -0.874 . . . . 0.34 110.442 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.555 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -119.36 97.76 5.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.317 -1.31 . . . . 0.68 110.432 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.9 m -89.33 112.26 23.31 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.529 -1.286 . . . . 1.05 107.529 173.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.581 ' CG1' HG23 ' A' ' 165' ' ' ILE . 1.4 mm -42.34 -43.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.901 -0.59 . . . . 1.29 110.03 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.94 -46.33 91.07 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.661 -1.257 . . . . 0.88 111.746 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -66.83 -23.87 66.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.629 0.603 . . . . 0.74 112.629 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 62.63 13.08 6.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.034 0.753 . . . . 2.51 113.034 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.25 138.89 33.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.225 1.012 . . . . 0.45 111.796 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.555 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -98.45 120.63 39.21 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.241 -1.8 . . . . 0.33 109.282 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -102.1 124.23 47.34 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.593 -0.843 . . . . 0.4 110.826 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -85.21 129.92 34.71 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.728 -1.953 . . . . 0.33 105.728 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.682 ' OG ' ' HB2' ' A' ' 60' ' ' HIS . 13.7 p -139.23 128.88 24.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 121.37 1.895 . . . . 0.75 114.03 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 tp -113.97 127.49 55.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.346 -1.297 . . . . 0.35 110.338 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 11.5 t-20 63.44 35.9 11.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.217 0.532 . . . . 0.52 109.675 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.6 m-20 79.96 -1.02 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.835 -1.075 . . . . 1.84 112.697 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -131.2 138.78 49.55 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.391 -1.324 . . . . 3.19 113.832 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -50.31 149.31 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 113.004 -1.907 . . . . 0.41 113.298 -176.346 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.579 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.6 mtp -97.95 -46.03 6.06 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 112.116 -2.311 . . . . 0.35 107.525 174.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -177.87 157.56 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.576 -2.102 . . . . 2.07 110.479 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -115.69 132.15 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.508 0.195 . . . . 0.37 110.886 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.46 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 69.5 m-85 -115.63 147.27 38.54 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.617 -0.265 . . . . 0.97 110.398 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -86.92 141.71 6.32 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.489 2.126 . . . . 0.6 111.793 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.44 -177.51 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.332 -0.395 . . . . 0.64 110.807 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 CA-C-O 120.842 0.353 . . . . 0.83 111.168 -178.269 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.556 ' HB3' ' H ' ' A' ' 119' ' ' SER . 13.6 m-85 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.085 0.469 . . . . 1.93 110.452 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 161' ' ' THR . 69.0 m-85 -136.84 139.27 41.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.58 109.838 171.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 125' ' ' ILE . 26.0 mm -60.23 118.79 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.997 -1.112 . . . . 0.41 107.997 167.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.8 tt -114.46 -22.68 4.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 119.814 -0.754 . . . . 0.37 112.287 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 66.0 t30 -167.67 178.62 5.23 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 122.86 1.314 . . . . 1.99 114.325 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 114' ' ' TYR . 2.1 ptt180 -151.18 131.8 13.94 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 111.387 -2.642 . . . . 1.19 110.447 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 5.5 tp60 -109.45 145.37 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.981 0.896 . . . . 1.67 111.623 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.586 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 61.3 ttt180 -54.92 150.24 10.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.431 -1.713 . . . . 3.06 111.487 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -46.04 106.22 0.54 Allowed Pre-proline 0 CA--C 1.511 -0.52 0 CA-C-N 115.602 -0.726 . . . . 2.61 111.624 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.01 -48.84 20.01 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.781 2.988 . . . . 0.98 111.69 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.87 -21.1 14.07 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.961 -1.018 . . . . 1.08 112.624 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -101.75 -169.89 27.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.956 -0.64 . . . . 1.05 112.13 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.44 31.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.231 3.288 . . . . 1.3 113.533 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.606 ' CE1' ' HB2' ' A' ' 115' ' ' TRP . 1.1 t80 -72.51 -33.45 66.93 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.308 -0.627 . . . . 1.38 109.308 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.28 60.64 0.78 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.119 -0.946 . . . . 1.11 114.485 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.51 -45.09 0.57 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.182 1.178 . . . . 0.81 114.182 166.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -150.41 145.79 26.28 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.21 -0.293 . . . . 1.12 110.21 -176.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.606 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 24.1 t-105 -116.01 101.06 8.42 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.258 -0.645 . . . . 2.19 109.258 166.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.5 mp -100.66 127.79 46.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.792 0.806 . . . . 0.61 110.536 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.421 ' HB2' HG23 ' A' ' 101' ' ' ILE . 62.4 m -87.44 133.72 33.7 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.22 -0.9 . . . . 0.94 111.672 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -88.55 -179.42 6.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.233 -1.395 . . . . 1.08 107.233 168.294 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.556 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 40.8 t . . . . . 0 C--N 1.321 -0.642 0 C-N-CA 120.392 -0.523 . . . . 1.5 110.037 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 100' ' ' ILE . 17.2 mt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.477 -0.564 . . . . 0.48 109.477 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -155.43 -163.97 1.65 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.507 0.67 . . . . 1.25 111.729 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -121.91 179.25 16.27 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.014 -1.089 . . . . 0.46 113.123 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 t -136.09 173.29 11.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.215 -0.493 . . . . 0.5 110.797 -168.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -104.22 -18.45 14.48 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.358 -0.837 . . . . 1.86 108.873 166.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -128.01 103.68 20.95 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 1.77 110.366 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.405 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 53.4 Cg_endo -91.21 4.07 4.25 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.143 2.562 . . . . 0.59 112.928 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.23 -18.67 33.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.284 0.564 . . . . 0.78 110.337 -172.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 m -89.26 -12.92 39.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 1.45 109.922 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 134' ' ' ILE . 5.3 mm . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.238 -0.892 . . . . 0.7 111.373 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 8.3 mtm . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.759 0.314 . . . . 1.13 110.198 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 10.8 t-80 -67.58 145.33 54.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.155 -0.683 . . . . 2.51 109.155 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.519 ' O ' HG12 ' A' ' 150' ' ' VAL . 30.5 p-10 -49.33 -66.43 0.4 Allowed 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.296 0.48 . . . . 1.77 112.296 -174.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -62.95 -23.35 67.36 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.834 -0.541 . . . . 2.13 111.603 -174.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 1.5 m-20 -69.19 -43.14 74.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 1.05 110.9 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 14.3 p -77.68 -20.53 13.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 CA-C-N 116.555 -0.293 . . . . 0.32 111.036 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.497 HD11 ' HB1' ' A' ' 113' ' ' ALA . 3.1 mp -84.79 -40.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 118.907 -0.568 . . . . 0.37 110.437 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -43.63 -68.7 0.17 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.608 1.095 . . . . 1.38 111.931 163.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.678 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -50.55 -44.03 56.38 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.726 -0.67 . . . . 0.74 110.375 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.69 -54.28 40.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.377 -1.283 . . . . 0.22 112.157 -171.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.6 p -77.76 -13.73 59.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.223 -1.353 . . . . 1.33 111.443 -172.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -93.51 -46.82 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.907 0.384 . . . . 0.23 110.227 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 153' ' ' LEU . 24.4 m -76.61 122.64 86.96 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-O 121.586 0.708 . . . . 0.21 110.077 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.725 ' HG2' HD13 ' A' ' 57' ' ' ILE . 34.8 Cg_endo -84.08 -178.51 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.89 2.394 . . . . 0.34 112.557 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.718 ' O ' HD21 ' A' ' 51' ' ' LEU . 11.7 m120 -59.73 -0.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.021 . . . . 1.02 113.604 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.46 56.3 0.53 Allowed Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.822 -0.704 . . . . 0.28 112.734 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 2.5 m -92.68 139.43 30.57 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 122.29 -0.535 . . . . 0.3 110.733 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -85.1 134.6 34.19 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.151 -0.314 . . . . 1.96 110.151 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.95 128.03 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.544 0.687 . . . . 0.46 111.646 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.1 m -113.37 132.56 55.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.526 -0.761 . . . . 0.56 111.167 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.581 HG23 ' CG1' ' A' ' 65' ' ' ILE . 1.9 mp -120.27 116.67 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 118.788 -1.165 . . . . 0.96 110.184 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 122.185 0.993 . . . . 1.19 111.171 -175.571 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.664 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 5.8 mtmt . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.734 -0.469 . . . . 2.1 109.734 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -100.26 164.55 11.9 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.783 -0.644 . . . . 0.26 111.389 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.82 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.7 tp -75.51 149.77 38.33 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.906 -0.588 . . . . 0.23 111.973 -169.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.39 149.91 38.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.015 0.912 . . . . 0.26 112.148 169.619 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -134.98 148.34 49.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.671 -1.604 . . . . 0.39 107.661 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.75 115.72 17.71 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.175 -1.417 . . . . 1.07 107.175 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -77.82 158.47 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.886 -0.597 . . . . 0.38 111.843 -166.339 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.416 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.6 ptmt -104.66 153.58 21.06 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.859 -0.793 . . . . 2.59 108.859 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.77 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 16.8 tt0 -54.42 109.11 0.45 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.855 -0.611 . . . . 1.74 112.243 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.56 -7.01 18.16 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.397 -0.82 . . . . 0.57 112.723 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.602 ' HB3' HD11 ' A' ' 18' ' ' ILE . 87.5 m-20 -63.01 152.93 35.48 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.101 0.451 . . . . 2.17 111.973 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.557 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.9 p -132.27 155.05 49.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.01 0.433 . . . . 0.5 111.982 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.605 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 50.1 tp -49.12 -59.16 3.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.009 1.114 . . . . 0.27 114.009 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.657 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 13.3 t-20 -64.54 -43.21 94.7 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 122.452 1.12 . . . . 1.21 110.481 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 21.1 t -57.45 -42.31 82.23 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 112.467 -2.151 . . . . 1.24 110.289 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.94 -41.31 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 123.528 0.731 . . . . 0.3 112.488 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.683 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.86 -64.83 0.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.529 -0.305 . . . . 0.23 111.665 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.36 -3.89 48.38 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.067 -1.053 . . . . 0.39 111.826 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.741 ' HB2' ' O ' ' A' ' 17' ' ' SER . 53.6 t0 -62.18 -42.76 99.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.971 -1.122 . . . . 1.63 107.971 156.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.633 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.2 m-85 -89.93 16.28 8.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.123 0.416 . . . . 0.24 112.123 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 54.47 51.29 14.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.288 -0.869 . . . . 3.55 110.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 19' ' ' ALA . 38.6 pt -147.82 -173.62 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.826 -0.805 . . . . 0.27 108.826 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -100.87 146.09 27.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.48 -0.782 . . . . 0.81 109.759 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.657 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -62.34 -35.78 80.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.452 0.644 . . . . 0.27 109.435 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.67 67.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.57 -1.195 . . . . 0.26 111.673 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.25 -38.7 24.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.302 0.572 . . . . 0.23 109.472 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.48 -19.47 60.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.334 -0.848 . . . . 0.17 109.162 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.718 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.36 34.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.618 0.723 . . . . 0.19 111.45 173.327 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.2 -39.32 94.31 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.002 0.906 . . . . 1.07 110.047 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 -19.65 38.28 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.052 -1.431 . . . . 0.17 111.861 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.5 m120 -142.55 72.31 20.62 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 0.19 109.709 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.611 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.2 Cg_endo -54.52 -19.42 17.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 123.545 2.83 . . . . 0.3 113.9 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -59.85 -30.82 69.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.925 0.869 . . . . 1.17 110.431 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.8 mt -79.78 -3.72 48.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.309 -1.314 . . . . 0.53 114.238 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.718 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.67 -39.62 37.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.442 1.115 . . . . 1.23 110.082 -177.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.22 -45.94 11.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.875 -1.966 . . . . 0.4 111.733 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.33 -165.06 35.81 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.393 -0.908 . . . . 0.3 113.963 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.476 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.2 mp -115.08 158.22 22.45 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.232 -1.484 . . . . 0.31 109.977 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.1 m -134.67 136.39 42.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.893 -0.594 . . . . 0.39 110.553 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.77 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.75 127.64 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.272 0.841 . . . . 0.47 113.272 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.33 -10.93 46.94 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.33 -1.305 . . . . 0.36 112.265 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -64.23 151.81 42.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.477 0.656 . . . . 1.19 110.455 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 55.4 p -115.48 136.71 52.8 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.882 -1.054 . . . . 0.89 109.484 -173.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 29' ' ' LEU . 19.6 pt -137.36 149.37 25.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.414 0.626 . . . . 0.22 110.382 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.528 ' H ' HD22 ' A' ' 33' ' ' ASN . 12.8 t -96.48 149.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.973 -1.012 . . . . 0.21 110.121 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.574 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.2 mm -117.9 87.47 27.85 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.155 -0.929 . . . . 0.17 108.702 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.748 ' HA ' HD13 ' A' ' 4' ' ' LEU . 23.8 Cg_endo -59.14 141.41 98.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.248 2.632 . . . . 0.23 113.018 -173.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.52 -7.89 67.14 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.557 -0.747 . . . . 0.3 112.855 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -116.34 127.44 26.75 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.719 -0.845 . . . . 0.25 108.719 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.6 Cg_endo -65.91 171.87 9.27 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.674 2.916 . . . . 0.31 113.8 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.515 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 9.5 t70 -94.94 138.0 22.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.063 -0.971 . . . . 0.72 111.522 -170.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.82 ' HD3' HD12 ' A' ' 5' ' ' LEU . 77.6 Cg_endo -75.32 -7.95 19.29 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 123.296 2.664 . . . . 0.27 113.288 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -33.5 16.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.063 -0.255 . . . . 2.11 110.618 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.423 HG21 ' HG3' ' A' ' 3' ' ' LYS . 23.5 p -63.4 -31.82 73.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.426 1.107 . . . . 1.47 108.31 172.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.759 HD13 ' HG2' ' A' ' 158' ' ' PRO . 95.1 mt -77.27 126.02 85.65 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.082 -1.872 . . . . 0.26 110.857 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -100.97 95.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.946 0 C-N-CA 120.753 0.969 . . . . 0.2 110.257 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 73' ' ' SER . 94.3 m-85 -157.68 138.08 12.8 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.909 -1.515 . . . . 0.26 106.909 171.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 55.5 t-80 -144.56 104.07 4.01 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.429 -1.323 . . . . 2.84 107.429 -170.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 68.8 mt -94.8 109.25 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.037 -1.438 . . . . 0.32 110.176 -174.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.05 102.74 11.17 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.19 -0.913 . . . . 0.34 110.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.692 HG13 HG13 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -122.14 102.57 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.005 -1.452 . . . . 0.68 109.988 178.48 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.522 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 30.2 t -95.0 135.67 36.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.183 -0.917 . . . . 1.05 108.9 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -33.61 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.491 0.662 . . . . 1.29 109.95 170.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.04 -48.1 74.69 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 114.95 -1.023 . . . . 0.88 111.368 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -69.08 -25.12 64.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.873 0.694 . . . . 0.74 112.873 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 57.18 12.71 1.39 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.871 0.869 . . . . 2.51 112.982 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.43 142.27 35.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.575 0.702 . . . . 0.45 111.349 177.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.517 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -98.07 118.42 34.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.499 -1.228 . . . . 0.33 109.936 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 m -101.51 125.4 48.15 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.438 -0.505 . . . . 0.4 111.35 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.16 134.89 34.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.47 -1.678 . . . . 0.33 106.47 177.316 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.4 m -138.32 129.33 27.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.716 1.598 . . . . 0.75 112.346 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.14 124.25 49.86 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.079 -0.964 . . . . 0.35 110.01 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.57 37.51 3.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.843 -1.169 . . . . 0.52 107.843 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 83.92 -14.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.679 -1.601 . . . . 1.84 111.569 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -127.23 141.27 51.77 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 117.675 -1.61 . . . . 3.19 114.613 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -56.55 148.75 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 112.291 -2.232 . . . . 0.41 113.957 -165.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.0 mtp -100.49 -43.73 6.11 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.721 -2.49 . . . . 0.35 107.804 175.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 33.3 tptt -179.92 161.34 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.497 -2.138 . . . . 2.07 111.102 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.485 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 15.2 m -118.39 137.43 53.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 122.422 -0.174 . . . . 0.37 110.908 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -126.03 137.81 30.88 Favored Pre-proline 0 N--CA 1.457 -0.107 0 CA-C-O 120.702 0.287 . . . . 0.97 110.267 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HB2' HG22 ' A' ' 134' ' ' ILE . 27.8 Cg_endo -63.39 146.09 93.09 Favored 'Trans proline' 0 N--CA 1.471 0.184 0 C-N-CA 123.187 2.592 . . . . 0.6 112.772 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.58 179.75 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.67 -0.493 . . . . 0.64 109.67 176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.55 0.691 . . . . 0.83 111.411 179.376 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.522 ' HB2' HG13 ' A' ' 163' ' ' VAL . 29.7 m-85 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.518 -0.919 . . . . 1.93 108.518 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.639 ' HA ' ' O ' ' A' ' 161' ' ' THR . 42.4 m-85 -129.86 139.71 51.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.766 0.317 . . . . 0.58 110.19 169.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.828 HD11 HD12 ' A' ' 125' ' ' ILE . 18.6 mm -59.4 115.58 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.681 -1.229 . . . . 0.41 107.681 166.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.557 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.6 tt -99.31 -30.03 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.622 -0.831 . . . . 0.37 112.068 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -178.8 -165.06 0.08 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.599 1.19 . . . . 1.99 113.775 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.781 ' HG2' HD23 ' A' ' 116' ' ' LEU . 9.9 mtt180 -148.2 132.86 17.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 111.969 -2.378 . . . . 1.19 108.871 -173.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -101.76 158.91 15.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.274 1.035 . . . . 1.67 111.423 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.712 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 2.5 ttt180 -49.74 152.93 1.35 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 112.865 -1.971 . . . . 3.06 112.003 169.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.712 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.03 112.93 1.9 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 114.062 -1.426 . . . . 2.61 110.861 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -57.44 -50.75 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.141 2.56 . . . . 0.98 111.559 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.08 45.57 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.777 -1.101 . . . . 1.08 112.469 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.32 -169.21 22.05 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.328 -0.463 . . . . 1.05 112.09 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.6 36.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 124.576 3.517 . . . . 1.3 114.402 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -93.1 -12.05 31.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.76 0.314 . . . . 1.38 110.977 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.614 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.51 33.4 5.37 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.408 -0.901 . . . . 1.11 114.497 171.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.39 -22.5 0.25 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.943 1.09 . . . . 0.81 113.943 168.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -152.98 143.99 23.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.011 -0.366 . . . . 1.12 110.011 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -109.94 100.77 9.67 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.799 -0.815 . . . . 2.19 108.799 166.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.804 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.1 mp -104.82 137.1 43.12 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.42 0.629 . . . . 0.61 109.549 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.9 m -106.16 143.45 34.26 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.231 -0.895 . . . . 0.94 112.064 -170.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.6 OUTLIER -94.83 -174.79 3.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.702 -1.222 . . . . 1.08 107.702 171.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.318 -0.802 0 N-CA-C 112.218 0.451 . . . . 1.5 112.218 -177.772 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 100' ' ' ILE . 41.7 mt . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 108.476 -0.935 . . . . 0.48 108.476 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -140.9 -162.71 1.41 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.045 -0.662 . . . . 1.25 111.463 -175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.614 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.3 175.89 16.22 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.087 -1.054 . . . . 0.46 113.449 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -141.1 177.9 7.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.946 -0.627 . . . . 0.5 109.849 -172.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 -4.71 9.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.317 -0.856 . . . . 1.86 110.116 167.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -126.31 101.69 27.82 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 109.178 -0.675 . . . . 1.77 109.178 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -92.5 3.57 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.636 2.89 . . . . 0.59 114.015 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.11 -19.34 59.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.131 0.491 . . . . 0.78 111.693 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.2 m -91.66 -18.24 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.116 0.484 . . . . 1.45 110.456 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 83' ' ' PRO . 25.3 mm . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.637 -0.71 . . . . 0.7 111.12 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.5 mtp . . . . . 0 C--O 1.232 0.172 0 N-CA-C 110.196 -0.298 . . . . 1.13 110.196 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -79.13 158.89 27.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.597 -0.52 . . . . 2.51 109.597 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.556 ' O ' HG12 ' A' ' 150' ' ' VAL . 23.1 p-10 -52.05 -68.13 0.19 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 123.333 0.396 . . . . 1.77 111.73 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -62.55 -24.54 67.58 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.728 -0.607 . . . . 2.13 111.821 -175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.27 -43.05 71.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.331 -0.395 . . . . 1.05 110.704 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 7.3 p -77.3 -19.8 14.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.374 -0.375 . . . . 0.32 111.047 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.402 HD12 HG13 ' A' ' 150' ' ' VAL . 2.6 mp -84.61 -39.53 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 118.987 -0.53 . . . . 0.37 109.849 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -43.35 -70.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.257 0.935 . . . . 1.38 112.107 163.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.671 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -49.81 -42.96 48.21 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 123.853 0.721 . . . . 0.74 110.323 178.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.12 -56.68 15.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.3 -1.318 . . . . 0.22 111.884 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.2 t -76.41 -11.53 59.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.803 -1.09 . . . . 1.33 110.626 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 92.9 mt -93.03 -47.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.751 -0.463 . . . . 0.23 109.751 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 153' ' ' LEU . 27.0 m -77.17 119.16 76.36 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 121.996 0.903 . . . . 0.21 110.81 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.759 ' HG2' HD13 ' A' ' 57' ' ' ILE . 33.1 Cg_endo -84.09 -177.71 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.017 2.478 . . . . 0.34 113.013 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.692 ' O ' HD21 ' A' ' 51' ' ' LEU . 17.5 m120 -59.11 1.21 0.07 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.568 -1.196 . . . . 1.02 113.978 -176.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.08 55.92 0.47 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.729 . . . . 0.28 112.173 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.1 m -84.83 137.03 33.41 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.543 -0.386 . . . . 0.3 110.657 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HG2' ' HE1' ' A' ' 99' ' ' TYR . 64.0 mtm180 -83.06 125.87 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.097 -0.335 . . . . 1.96 110.097 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.7 p -139.49 123.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.401 0.62 . . . . 0.46 111.103 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.444 ' C ' HD12 ' A' ' 165' ' ' ILE . 62.5 m -113.44 137.12 51.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.699 -0.682 . . . . 0.56 111.813 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.692 HG13 HG13 ' A' ' 63' ' ' VAL . 3.2 mp -126.35 113.34 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 118.387 -1.325 . . . . 0.96 111.08 172.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 64' ' ' SER . 3.2 p30 . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 113.468 -1.697 . . . . 1.19 109.618 -174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.9 mptp? . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.777 -0.453 . . . . 2.1 109.777 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.5 mt -97.05 168.16 10.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.017 -0.538 . . . . 0.26 111.147 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.551 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.8 tp -75.88 150.23 37.64 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 123.336 0.654 . . . . 0.23 111.886 -169.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.46 149.13 36.78 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.17 0.986 . . . . 0.26 111.978 167.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' SER . 77.9 t80 -135.18 150.84 50.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.277 -1.783 . . . . 0.39 108.068 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -129.41 120.96 26.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.359 -1.349 . . . . 1.07 107.359 174.572 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -81.41 159.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 123.327 0.651 . . . . 0.38 111.968 -171.159 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.1 ptmt -107.84 151.14 26.15 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.071 -0.715 . . . . 2.59 109.071 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.701 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 4.9 tt0 -54.3 113.76 1.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.339 -0.846 . . . . 1.74 111.949 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.75 -5.79 25.97 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.679 -0.772 . . . . 0.57 112.797 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.695 ' HB3' HD11 ' A' ' 18' ' ' ILE . 32.7 m-20 -66.6 156.26 35.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.661 0.615 . . . . 2.17 112.661 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.564 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -133.86 154.64 50.9 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 116.048 -0.524 . . . . 0.5 112.273 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.592 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.54 -58.68 4.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.767 1.025 . . . . 0.27 113.767 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.2 p30 -63.19 -41.83 99.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.794 1.283 . . . . 1.21 110.941 -171.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.794 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 3.2 m -61.83 -39.76 92.95 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.162 -2.29 . . . . 1.24 110.878 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.45 -38.99 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 123.638 0.775 . . . . 0.3 112.694 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.679 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.15 -61.29 2.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.465 -0.334 . . . . 0.23 111.2 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.32 -4.79 54.81 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.677 -1.209 . . . . 0.39 111.774 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.794 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.0 t70 -61.95 -35.43 78.41 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.609 -1.256 . . . . 1.63 107.609 157.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.665 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.9 m-85 -100.73 17.29 22.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.854 0.687 . . . . 0.24 112.854 176.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 53.95 52.49 12.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.563 -0.744 . . . . 3.55 110.856 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 19' ' ' ALA . 34.0 pt -149.85 -173.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.984 -0.747 . . . . 0.27 108.984 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 146.97 24.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.589 -0.732 . . . . 0.81 109.71 173.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 17.9 p -60.89 -36.6 79.64 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.503 -0.925 . . . . 0.27 108.503 175.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.64 70.55 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.441 -1.254 . . . . 0.26 111.733 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.21 -37.57 28.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.888 -0.507 . . . . 0.23 109.761 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.62 HD11 HD12 ' A' ' 46' ' ' ILE . 14.0 tp -74.47 -19.66 60.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.382 -0.826 . . . . 0.17 109.188 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.753 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.28 -39.02 41.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.723 0.773 . . . . 0.19 111.608 173.099 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -60.62 -41.39 94.76 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.971 -1.013 . . . . 1.07 109.745 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.54 -20.53 39.81 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.717 -1.583 . . . . 0.17 112.169 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 13.2 m120 -141.88 72.3 23.77 Favored Pre-proline 0 CA--C 1.513 -0.447 0 CA-C-O 121.132 0.492 . . . . 0.19 109.836 -173.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.708 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.6 Cg_endo -57.51 -11.94 9.9 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.415 2.743 . . . . 0.3 113.887 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -61.9 -32.77 73.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.965 0.888 . . . . 1.17 109.375 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.68 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.75 -6.87 59.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.785 1.402 . . . . 0.53 114.785 -171.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.753 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -50.58 -40.91 53.6 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 120.08 1.309 . . . . 1.23 110.241 179.254 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.81 -46.29 12.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.965 -1.925 . . . . 0.4 111.437 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.68 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.43 -163.5 34.15 Favored Glycine 0 CA--C 1.495 -1.214 0 C-N-CA 120.402 -0.904 . . . . 0.3 114.029 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 9' ' ' VAL . 6.6 mp -117.89 158.31 25.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.215 -1.493 . . . . 0.31 110.436 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.616 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.7 m -131.74 135.58 46.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.713 -0.676 . . . . 0.39 110.339 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.701 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.13 127.71 8.83 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.994 0.739 . . . . 0.47 112.994 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.458 ' HA2' ' OE1' ' A' ' 8' ' ' GLN . . . 81.79 -10.43 51.83 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.815 -1.084 . . . . 0.36 112.174 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.616 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.0 tt0 -64.25 151.33 43.91 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.771 0.796 . . . . 1.19 110.188 175.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 39.5 m -117.79 134.14 55.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.235 -1.348 . . . . 0.89 109.023 -171.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 29' ' ' LEU . 22.8 pt -135.88 149.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.319 0.581 . . . . 0.22 110.584 -175.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.553 ' H ' HD22 ' A' ' 33' ' ' ASN . 13.5 t -94.64 149.37 4.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.998 -1.001 . . . . 0.21 110.249 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.527 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.4 mm -117.58 88.36 29.09 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.993 -1.003 . . . . 0.17 108.434 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.766 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.45 143.4 97.88 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.248 2.632 . . . . 0.23 112.723 -173.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.451 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 79.14 -8.29 46.59 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.496 -0.775 . . . . 0.3 112.882 -176.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.727 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -113.54 124.82 30.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.551 -0.907 . . . . 0.25 108.551 177.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.659 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.2 Cg_endo -66.17 174.35 6.11 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.6 2.867 . . . . 0.31 113.631 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.6 t70 -89.12 142.0 29.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.043 -0.98 . . . . 0.72 109.967 -173.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 83.2 Cg_endo -81.19 -13.58 11.19 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.223 2.615 . . . . 0.27 112.087 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -96.91 -10.33 26.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.08 0.467 . . . . 2.11 111.182 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -81.22 -22.37 38.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.076 -1.453 . . . . 1.47 107.076 166.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.62 HD13 ' HG2' ' A' ' 158' ' ' PRO . 64.4 mt -87.68 132.56 40.16 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 113.005 -1.907 . . . . 0.26 110.219 173.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -103.89 96.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 121.208 1.272 . . . . 0.2 110.546 165.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.464 ' HD2' ' CG2' ' A' ' 57' ' ' ILE . 84.0 m-85 -157.97 130.99 7.45 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.5 -1.296 . . . . 0.26 107.5 172.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 0.3 OUTLIER -135.75 103.68 5.5 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.981 -1.489 . . . . 2.84 106.981 -166.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 76.2 mt -94.3 109.39 22.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.458 -0.792 . . . . 0.32 110.541 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.11 97.01 6.24 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.385 -0.825 . . . . 0.34 110.579 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.496 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -113.43 98.56 7.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.319 -1.309 . . . . 0.68 109.808 178.125 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 43.0 m -94.59 121.1 35.8 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.615 -1.175 . . . . 1.05 108.752 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.2 mt -57.82 -26.79 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.352 0.596 . . . . 1.29 111.601 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.49 70.53 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.722 -0.752 . . . . 0.88 111.269 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.19 -24.46 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.14 0.495 . . . . 0.74 112.335 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.9 mttt 58.26 18.38 5.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.367 1.067 . . . . 2.51 112.318 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.67 141.27 31.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.92 0.866 . . . . 0.45 111.516 176.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.496 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.96 118.52 31.94 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.895 -1.502 . . . . 0.33 109.318 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -99.68 124.28 44.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.39 -0.524 . . . . 0.4 111.095 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.494 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.07 133.52 35.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.804 -1.924 . . . . 0.33 105.804 175.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.6 m -138.76 130.78 28.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 120.544 1.52 . . . . 0.75 112.743 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.77 126.61 53.36 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.14 -0.936 . . . . 0.35 110.432 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 64.61 37.91 7.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.453 0.644 . . . . 0.52 109.357 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 73.98 2.34 4.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.562 -1.199 . . . . 1.84 112.567 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -130.8 138.0 49.7 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.618 -1.233 . . . . 3.19 113.703 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -52.04 148.64 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-N 113.292 -1.776 . . . . 0.41 113.587 -172.085 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.494 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.7 mtp -96.98 -46.12 6.32 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.191 -2.277 . . . . 0.35 107.576 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 6.5 tptp 179.2 159.01 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.474 -2.148 . . . . 2.07 109.767 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.536 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 18.5 m -117.03 136.22 53.12 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.379 -0.2 . . . . 0.37 110.946 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.54 133.42 24.04 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 109.986 -0.376 . . . . 0.97 109.986 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.76 146.57 92.15 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.868 2.378 . . . . 0.6 112.447 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 177.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.056 -0.72 . . . . 0.64 109.056 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.118 0.485 . . . . 0.83 110.072 173.433 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 163' ' ' VAL . 13.1 m-85 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.973 0.416 . . . . 1.93 110.017 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' THR . 72.3 m-85 -134.06 140.42 46.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.923 -0.58 . . . . 0.58 110.09 172.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 125' ' ' ILE . 27.2 mm -60.46 126.61 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.239 -1.022 . . . . 0.41 108.239 167.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.7 tt -124.7 -21.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.047 -0.661 . . . . 0.37 112.41 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 21.9 t-20 -159.65 160.86 34.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.635 1.207 . . . . 1.99 114.088 -173.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 127.49 15.37 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 111.632 -2.531 . . . . 1.19 108.806 172.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.64 158.54 16.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.446 1.117 . . . . 1.67 111.821 -171.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.593 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 21.9 ttm180 -52.42 155.59 2.05 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.175 -2.284 . . . . 3.06 111.793 167.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.593 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 6.6 p30 -45.13 109.89 0.99 Allowed Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.163 -1.38 . . . . 2.61 111.519 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.37 -51.51 5.24 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.4 2.733 . . . . 0.98 112.12 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.61 -10.31 70.87 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.096 -0.957 . . . . 1.08 111.959 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -107.78 -168.72 21.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.412 -0.423 . . . . 1.05 112.085 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.54 18.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 124.073 3.182 . . . . 1.3 113.945 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -69.26 -18.56 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 1.38 111.385 -177.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.591 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 94.19 41.38 4.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 1.11 113.4 174.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 77.08 -27.58 0.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.237 0.828 . . . . 0.81 113.237 171.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.551 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -152.64 146.5 25.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.95 0.405 . . . . 1.12 110.769 -178.178 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -115.88 101.58 8.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 2.19 109.545 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -103.63 141.69 35.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.406 0.622 . . . . 0.61 110.462 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 101' ' ' ILE . 50.7 m -106.15 140.3 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.488 -0.778 . . . . 0.94 111.818 -171.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -95.56 -178.41 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.676 -1.231 . . . . 1.08 107.676 172.436 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 58.9 m . . . . . 0 C--O 1.221 -0.421 0 CA-C-N 118.439 0.563 . . . . 1.5 111.037 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 100' ' ' ILE . 7.3 mt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 108.499 -0.926 . . . . 0.48 108.499 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -140.13 -164.44 1.71 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.505 -0.878 . . . . 1.25 111.796 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.591 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.04 179.52 16.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.724 -1.125 . . . . 0.46 113.968 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -139.39 174.22 10.73 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.293 0.568 . . . . 0.5 111.068 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -104.38 -21.29 13.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.971 -1.013 . . . . 1.86 108.9 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -127.22 104.36 22.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.755 -1.111 . . . . 1.77 109.672 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.69 5.41 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.499 2.799 . . . . 0.59 112.794 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.46 59.57 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.258 0.552 . . . . 0.78 110.363 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 m -85.33 -17.32 37.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 1.45 109.576 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.407 -0.815 . . . . 0.7 111.017 -175.101 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.7 ptm . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 112.719 0.637 . . . . 1.13 112.719 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -64.58 133.81 53.07 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.669 -0.696 . . . . 2.51 111.051 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.623 ' O ' HG12 ' A' ' 150' ' ' VAL . 10.9 p30 -52.64 -63.54 1.11 Allowed 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 113.038 0.755 . . . . 1.77 113.038 -172.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -23.76 67.6 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.321 -0.862 . . . . 2.13 112.115 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.03 -33.8 57.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 1.05 111.193 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 14.8 p -79.71 -16.3 13.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 110.016 -0.365 . . . . 0.32 110.016 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.571 HD12 HG13 ' A' ' 150' ' ' VAL . 2.8 mp -88.38 -37.14 10.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.897 -0.409 . . . . 0.37 109.897 171.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -43.46 -70.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.878 0.763 . . . . 1.38 111.784 159.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.712 ' O ' HG22 ' A' ' 157' ' ' VAL . 2.9 pp -54.7 -36.0 64.22 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.474 0.484 . . . . 0.74 110.479 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.22 -51.92 65.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.6 0.714 . . . . 0.22 112.059 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 p -77.52 -15.57 59.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.77 -1.104 . . . . 1.33 110.91 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.2 mt -93.86 -49.01 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.06 -0.518 . . . . 0.23 110.5 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.2 m -76.83 111.97 19.53 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-O 121.776 0.798 . . . . 0.21 110.253 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.62 ' HG2' HD13 ' A' ' 57' ' ' ILE . 6.8 Cg_endo -77.85 -179.89 5.87 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.467 2.111 . . . . 0.34 112.804 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.727 ' O ' HD21 ' A' ' 51' ' ' LEU . 12.2 m120 -62.03 1.54 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.153 -1.385 . . . . 1.02 113.611 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.408 ' O ' HD12 ' A' ' 57' ' ' ILE . . . -145.1 58.4 0.51 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.145 -0.55 . . . . 0.28 112.133 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.465 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 9.4 m -96.34 136.72 36.44 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.514 -0.403 . . . . 0.3 110.27 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 135.36 33.8 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.365 -0.534 . . . . 1.96 110.386 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.2 p -139.0 122.75 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.022 -0.99 . . . . 0.46 110.788 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.409 ' C ' HD12 ' A' ' 165' ' ' ILE . 87.1 m -113.75 138.39 50.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.716 -0.674 . . . . 0.56 111.426 -177.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.489 HG13 HG13 ' A' ' 63' ' ' VAL . 2.9 mp -119.8 110.98 30.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 118.751 -1.18 . . . . 0.96 109.999 172.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--N 1.316 -0.861 0 CA-C-N 114.425 -1.261 . . . . 1.19 109.568 -173.296 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.6 OUTLIER . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 108.984 -0.747 . . . . 2.1 108.984 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.789 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.5 mt -99.94 171.66 7.71 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.164 0.431 . . . . 0.26 112.164 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.594 HD12 ' HD3' ' A' ' 54' ' ' PRO . 4.7 tp -76.15 152.89 36.58 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.59 0.756 . . . . 0.23 112.512 -168.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.29 148.14 39.55 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.21 1.005 . . . . 0.26 111.88 165.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 45' ' ' SER . 71.7 t80 -134.34 149.14 50.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.096 -1.865 . . . . 0.39 107.612 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -130.03 114.41 15.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.208 -1.404 . . . . 1.07 107.208 175.848 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.2 m -72.76 155.92 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 121.203 0.525 . . . . 0.38 112.031 -166.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -98.53 151.35 20.72 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.096 -0.956 . . . . 2.59 109.593 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.798 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -52.17 116.41 2.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 1.74 111.398 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.05 -7.16 35.22 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.09 -0.959 . . . . 0.57 112.956 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.55 ' CB ' HD11 ' A' ' 18' ' ' ILE . 71.6 m-20 -61.29 149.11 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.362 0.505 . . . . 2.17 112.362 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.575 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -130.83 152.33 50.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.916 -0.583 . . . . 0.5 111.719 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.586 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.3 tp -48.43 -59.9 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 0.27 113.896 -170.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.694 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 7.1 t-20 -65.39 -39.85 92.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.132 0.968 . . . . 1.21 110.211 -170.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.737 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 23.3 m -59.59 -41.74 90.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.928 -1.942 . . . . 1.24 110.728 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -74.95 -40.36 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.515 0.726 . . . . 0.3 112.589 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -55.84 -63.65 1.11 Allowed 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.533 -0.303 . . . . 0.23 111.188 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -79.95 -3.56 48.72 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.818 -1.153 . . . . 0.39 112.035 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 17' ' ' SER . 13.6 t70 -64.47 -33.41 75.81 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.348 -0.982 . . . . 1.63 108.348 157.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.679 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.9 m-85 -100.19 17.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.96 0.41 . . . . 0.24 111.998 173.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 2.3 mpt_? 53.79 52.18 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.407 -0.815 . . . . 3.55 110.764 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 38.5 pt -148.2 -173.27 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.059 -0.719 . . . . 0.27 109.059 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -98.91 144.39 28.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.522 -0.763 . . . . 0.81 109.665 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.694 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 7.1 p -62.55 -37.97 88.2 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.618 0.723 . . . . 0.27 109.221 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.19 -27.41 68.67 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.164 -1.38 . . . . 0.26 111.284 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -38.71 26.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.467 0.651 . . . . 0.23 109.589 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.702 HD11 HD12 ' A' ' 46' ' ' ILE . 14.7 tp -72.06 -19.44 61.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 0.17 108.911 174.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.789 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.51 -37.23 32.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.307 0.575 . . . . 0.19 111.243 172.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.0 mt-30 -56.57 -43.26 79.82 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.353 1.073 . . . . 1.07 109.808 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.97 -18.93 35.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.404 -1.725 . . . . 0.17 112.801 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.6 m120 -143.82 73.76 16.71 Favored Pre-proline 0 CA--C 1.513 -0.479 0 CA-C-O 121.137 0.494 . . . . 0.19 109.961 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.679 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.1 Cg_endo -57.18 -14.02 14.04 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 123.568 2.845 . . . . 0.3 114.098 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.99 -33.56 74.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.104 0.954 . . . . 1.17 109.672 175.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -79.18 -6.0 55.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.225 -1.352 . . . . 0.53 114.375 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.789 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -49.25 -41.11 36.66 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 119.778 1.172 . . . . 1.23 110.295 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.1 -46.53 11.85 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.766 -2.016 . . . . 0.4 111.733 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.39 -163.89 34.73 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 120.369 -0.919 . . . . 0.3 114.383 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.8 mp -118.65 157.38 27.53 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 112.945 -1.627 . . . . 0.31 110.686 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 84.8 m -135.17 132.32 37.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.464 -0.789 . . . . 0.39 110.18 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.61 128.64 15.43 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.313 0.577 . . . . 0.47 112.339 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.09 -13.5 54.15 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 114.734 -1.121 . . . . 0.36 112.432 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.617 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -65.85 151.98 45.46 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.426 0.632 . . . . 1.19 110.358 173.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.5 m -117.92 134.35 55.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.589 -1.187 . . . . 0.89 109.463 -171.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 29' ' ' LEU . 16.4 pt -136.84 149.79 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.423 0.63 . . . . 0.22 110.576 -175.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.505 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 16.9 t -95.65 148.94 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.08 -0.964 . . . . 0.21 110.333 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.504 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.9 mm -117.25 89.33 30.66 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 114.835 -1.075 . . . . 0.17 108.812 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.789 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.9 Cg_endo -59.3 140.48 94.78 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.277 2.652 . . . . 0.23 112.767 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.77 -6.87 67.9 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.701 -0.681 . . . . 0.3 113.033 -176.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.7 tt -116.49 124.87 28.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.444 -0.947 . . . . 0.25 108.444 175.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD23 ' A' ' 51' ' ' LEU . 58.9 Cg_endo -65.86 174.22 5.95 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.728 2.952 . . . . 0.31 113.898 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.493 ' O ' HG13 ' A' ' 57' ' ' ILE . 3.8 t70 -90.56 137.55 27.21 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 114.743 -1.117 . . . . 0.72 111.604 -171.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.594 ' HD3' HD12 ' A' ' 5' ' ' LEU . 62.3 Cg_endo -83.94 -9.7 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.457 2.771 . . . . 0.27 113.344 -174.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -95.67 -15.42 22.71 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.994 0.426 . . . . 2.11 110.729 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -91.62 -5.31 54.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.623 0.725 . . . . 1.47 109.174 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.799 HD13 ' HG2' ' A' ' 158' ' ' PRO . 45.0 mt -98.28 137.73 20.8 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 115.24 -0.891 . . . . 0.26 109.605 171.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' O ' ' CG ' ' A' ' 59' ' ' TYR . 10.6 Cg_endo -104.13 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.243 0 CA-C-N 120.153 1.09 . . . . 0.2 110.038 163.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 58' ' ' PRO . 70.7 m-85 -156.94 133.47 9.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.142 -1.429 . . . . 0.26 107.142 169.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -148.18 111.26 4.86 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.555 -0.905 . . . . 2.84 108.555 -160.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 50.1 mt -98.63 118.25 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.798 -1.092 . . . . 0.32 111.019 -175.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.59 92.98 4.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.797 0.808 . . . . 0.34 110.07 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 70' ' ' LEU . 1.1 p -111.36 101.78 13.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.438 -1.256 . . . . 0.68 108.94 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.464 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.2 m -96.0 116.08 28.4 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.466 -0.939 . . . . 1.05 108.466 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mm -45.47 -36.5 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 1.29 110.876 170.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . -63.9 -43.83 96.96 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.372 -0.918 . . . . 0.88 111.683 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -71.17 -23.2 62.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.872 -0.664 . . . . 0.74 112.73 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 66' ' ' GLY . 6.2 mptt 58.71 14.98 3.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.882 0.873 . . . . 2.51 112.583 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.484 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.21 139.56 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.897 0.856 . . . . 0.45 111.442 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.459 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -93.67 114.01 26.22 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.744 -1.571 . . . . 0.33 108.737 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -98.5 122.19 41.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.06 -0.656 . . . . 0.4 110.432 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.595 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -81.87 127.14 32.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.823 -1.917 . . . . 0.33 105.823 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.1 m -131.8 127.34 36.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 120.341 1.428 . . . . 0.75 111.976 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -113.17 122.69 48.27 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.004 -0.998 . . . . 0.35 109.559 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 68.51 36.75 2.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.772 -0.825 . . . . 0.52 108.772 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 73.75 1.87 4.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.275 -1.329 . . . . 1.84 112.295 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -130.38 138.14 50.23 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 118.148 -1.421 . . . . 3.19 113.805 173.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.25 148.21 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 112.84 -1.982 . . . . 0.41 113.585 -171.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -98.96 -44.43 6.33 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 111.921 -2.4 . . . . 0.35 107.998 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 4.3 tppt? -178.96 160.77 1.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.235 -2.257 . . . . 2.07 109.491 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.484 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.7 m -118.93 131.07 56.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.518 0.199 . . . . 0.37 110.662 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.769 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 30.6 m-85 -118.11 141.2 29.0 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 109.294 -0.632 . . . . 0.97 109.294 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HB2' HG22 ' A' ' 134' ' ' ILE . 11.4 Cg_endo -80.94 144.13 14.9 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.196 1.93 . . . . 0.6 111.783 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.66 178.07 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.89 -0.411 . . . . 0.64 109.89 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.199 0.524 . . . . 0.83 111.367 -178.845 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.854 ' CE1' HG11 ' A' ' 163' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 109.803 -0.443 . . . . 1.93 109.803 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.487 ' HE2' ' HG3' ' A' ' 162' ' ' ARG . 37.0 m-85 -137.13 138.56 40.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.179 -0.675 . . . . 0.58 109.179 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.493 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 26.8 mm -60.64 107.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.994 -0.743 . . . . 0.41 108.994 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.626 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.4 tt -104.36 -31.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.629 -0.714 . . . . 0.37 112.401 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 66.5 t30 -168.65 175.52 6.09 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 123.028 1.394 . . . . 1.99 114.224 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.699 ' HB3' ' CE1' ' A' ' 114' ' ' TYR . 5.6 mtt180 -137.0 126.98 25.89 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.07 -2.787 . . . . 1.19 107.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.74 150.45 20.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.179 0.99 . . . . 1.67 111.081 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.578 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 27.0 ttm180 -51.78 156.81 1.33 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.95 -1.932 . . . . 3.06 111.863 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.578 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 8.4 p30 -43.23 105.12 0.41 Allowed Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 122.745 1.259 . . . . 2.61 111.312 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -58.3 -54.68 2.8 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.775 2.983 . . . . 0.98 112.949 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.96 72.38 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.445 -0.798 . . . . 1.08 111.848 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.89 -169.87 13.67 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.973 -0.451 . . . . 1.05 111.973 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.5 32.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 124.419 3.413 . . . . 1.3 114.369 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -88.11 -12.18 44.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.19 0.519 . . . . 1.38 110.938 178.059 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 72.31 51.99 11.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.146 -0.934 . . . . 1.11 114.018 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.81 -13.6 0.92 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.958 1.096 . . . . 0.81 113.958 167.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.699 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -161.99 142.57 10.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.656 0.265 . . . . 1.12 110.553 175.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -113.37 101.27 9.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.81 . . . . 2.19 108.814 168.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.645 HD12 ' HG2' ' A' ' 103' ' ' ARG . 1.6 mm? -92.71 110.3 21.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.447 0.641 . . . . 0.61 109.806 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.509 ' HB2' HG23 ' A' ' 101' ' ' ILE . 68.5 m -65.86 140.98 58.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.945 -1.025 . . . . 0.94 111.983 -174.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.654 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 1.4 tp -109.43 161.46 15.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.452 -0.573 . . . . 1.08 109.452 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.49 ' H ' ' HB2' ' A' ' 98' ' ' PHE . 5.6 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.303 0.573 . . . . 1.5 109.877 174.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.616 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 47.7 mt . . . . . 0 N--CA 1.442 -0.864 0 N-CA-C 107.555 -1.276 . . . . 0.48 107.555 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -143.69 -163.4 1.65 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.825 -0.75 . . . . 1.25 111.846 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.39 168.45 14.33 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.697 -1.138 . . . . 0.46 112.68 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.9 t -127.65 177.54 6.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.53 0.681 . . . . 0.5 111.888 -165.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -106.98 -18.45 13.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.614 -1.175 . . . . 1.86 109.456 166.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -125.3 103.88 29.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.401 -0.818 . . . . 1.77 109.732 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -87.78 4.2 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.979 2.453 . . . . 0.59 112.892 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.74 -21.59 23.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.086 0.47 . . . . 0.78 110.132 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.8 m -90.23 13.21 15.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 1.45 110.357 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' PRO . 20.4 mm . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.7 110.387 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.769 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 36.0 mtm . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.429 0.633 . . . . 1.13 112.241 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.523 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 14.6 t-80 -72.77 148.19 44.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.125 -0.943 . . . . 2.51 109.212 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.549 ' O ' HG12 ' A' ' 150' ' ' VAL . 31.9 p-10 -50.31 -63.29 1.16 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 112.672 0.619 . . . . 1.77 112.672 -172.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -64.53 -21.06 66.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.429 -0.794 . . . . 2.13 111.945 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.1 m-20 -73.27 -39.51 65.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.207 -0.451 . . . . 1.05 110.659 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 10.4 p -80.99 -17.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.005 -0.543 . . . . 0.32 110.79 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.443 HD12 HG13 ' A' ' 150' ' ' VAL . 2.5 mp -86.02 -40.54 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.871 -0.585 . . . . 0.37 110.24 171.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -44.11 -69.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.411 1.005 . . . . 1.38 112.093 165.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.656 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.4 tp -52.07 -42.76 63.42 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.647 -0.706 . . . . 0.74 110.581 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.98 -51.55 61.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.475 -1.238 . . . . 0.22 111.605 -173.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 -18.04 53.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.739 -1.119 . . . . 1.33 111.244 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.417 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 62.2 mt -90.8 -50.35 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.924 -0.399 . . . . 0.23 109.924 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 153' ' ' LEU . 16.1 m -78.13 110.7 14.32 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-O 122.192 0.996 . . . . 0.21 110.226 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.799 ' HG2' HD13 ' A' ' 57' ' ' ILE . 24.4 Cg_endo -88.22 -179.08 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.386 2.724 . . . . 0.34 112.669 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 8.6 m120 -65.17 108.92 2.02 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.27 -1.011 . . . . 1.02 108.27 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.455 ' O ' HD12 ' A' ' 57' ' ' ILE . . . 108.11 37.37 2.16 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.375 -0.917 . . . . 0.28 113.496 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.494 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 26.1 m -90.61 131.69 36.18 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.65 -0.912 . . . . 0.3 110.394 172.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -85.98 136.62 33.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.251 -0.431 . . . . 1.96 109.892 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 98' ' ' PHE . 1.9 p -148.71 137.19 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.716 -0.674 . . . . 0.46 111.515 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.8 m -119.02 141.49 48.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 0.56 112.055 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.43 HG12 HG13 ' A' ' 63' ' ' VAL . 1.2 mt -125.94 116.32 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 C-N-CA 118.539 -1.264 . . . . 0.96 111.715 173.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 114.255 -1.339 . . . . 1.19 110.799 -170.046 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 4.0 mptp? . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 109.735 -0.469 . . . . 2.1 109.735 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.8 mt -97.43 170.04 9.33 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.524 0.515 . . . . 0.26 111.634 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.672 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.3 tp -77.69 150.31 34.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.376 0.67 . . . . 0.23 112.144 -170.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.547 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -114.84 149.39 37.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.093 0.949 . . . . 0.26 111.879 168.285 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.495 ' CE2' ' HA ' ' A' ' 9' ' ' VAL . 70.8 t80 -135.19 151.11 50.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.546 -1.661 . . . . 0.39 107.844 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -128.74 113.85 15.85 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.944 -1.502 . . . . 1.07 106.944 173.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.543 HG11 HD23 ' A' ' 40' ' ' LEU . 1.3 m -71.83 158.04 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 121.141 0.496 . . . . 0.38 111.771 -166.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' N ' HG23 ' A' ' 9' ' ' VAL . 79.1 mttt -111.17 145.09 39.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.328 -0.851 . . . . 2.59 109.487 -174.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 7.2 tt0 -54.82 121.45 8.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.067 -0.97 . . . . 1.74 111.82 -173.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.77 -8.21 17.01 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.149 -0.78 . . . . 0.57 111.149 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -40.42 142.37 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.198 1.555 . . . . 2.17 115.198 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 134.72 45.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.013 -0.994 . . . . 0.5 111.342 163.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.8 tp -41.37 -56.34 2.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.195 -0.911 . . . . 0.27 113.457 -174.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.675 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.6 -38.11 88.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.432 1.11 . . . . 1.21 110.322 -171.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -64.41 -42.35 96.13 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 112.953 -1.93 . . . . 1.24 110.263 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -70.26 -41.07 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.045 0.45 . . . . 0.3 111.228 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.5 -59.56 4.98 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.995 -0.548 . . . . 0.23 111.396 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.78 -3.86 57.19 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 118.936 -1.106 . . . . 0.39 112.153 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 5.2 m-20 -61.1 -37.8 84.02 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.987 -1.116 . . . . 1.63 107.987 155.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.79 ' O ' HG23 ' A' ' 24' ' ' ILE . 3.7 m-85 -98.06 27.91 4.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.404 0.52 . . . . 0.24 112.404 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.765 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.2 67.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.902 1.281 . . . . 3.55 113.729 -169.1 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 22' ' ' PHE . 33.0 pt -146.92 -172.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.094 -1.076 . . . . 0.27 108.094 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 m -101.72 145.0 29.72 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.732 -0.667 . . . . 0.81 109.38 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.675 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.3 p -61.4 -35.61 77.99 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.679 -0.692 . . . . 0.27 109.256 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.52 67.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.344 -1.298 . . . . 0.26 111.646 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.25 -39.15 19.62 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.463 -0.569 . . . . 0.23 109.463 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 46' ' ' ILE . 12.9 tp -72.88 -17.53 61.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.228 -0.896 . . . . 0.17 108.738 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.78 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -81.13 -37.89 28.1 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.484 0.659 . . . . 0.19 111.557 172.394 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -58.52 -43.13 89.05 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.306 1.051 . . . . 1.07 109.59 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.91 -20.96 41.0 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.64 -1.618 . . . . 0.17 111.995 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.568 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.8 m120 -142.52 72.77 20.68 Favored Pre-proline 0 CA--C 1.514 -0.414 0 CA-C-O 121.237 0.542 . . . . 0.19 109.993 -172.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.652 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.2 Cg_endo -56.62 -13.11 10.01 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 123.649 2.899 . . . . 0.3 114.122 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 t -62.24 -32.37 73.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.047 0.927 . . . . 1.17 109.754 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.2 mt -81.34 -6.65 59.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.345 -1.298 . . . . 0.53 114.402 -171.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.78 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -49.85 -44.45 49.59 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.471 1.129 . . . . 1.23 110.274 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.11 -45.85 15.83 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.937 -1.938 . . . . 0.4 110.551 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.42 -170.33 43.33 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.491 -0.862 . . . . 0.3 113.809 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 18' ' ' ILE . 6.7 mp -111.79 159.58 18.16 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.373 -1.414 . . . . 0.31 109.764 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.653 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 77.1 m -128.43 132.27 48.45 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.859 -0.61 . . . . 0.39 109.887 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.56 129.38 16.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.406 0.622 . . . . 0.47 112.241 174.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.35 -11.81 53.77 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.853 -1.067 . . . . 0.36 112.704 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.1 tt0 -66.08 153.66 41.68 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.537 0.684 . . . . 1.19 110.378 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 49.8 m -115.3 135.42 54.17 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.5 -1.227 . . . . 0.89 109.029 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.677 HD12 HD11 ' A' ' 29' ' ' LEU . 18.6 pt -137.28 151.16 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.358 0.599 . . . . 0.22 110.504 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.444 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 15.4 t -96.89 149.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.07 -0.968 . . . . 0.21 110.028 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.549 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.8 mm -117.64 88.41 29.54 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.024 -0.989 . . . . 0.17 108.529 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.776 ' HA ' HD13 ' A' ' 4' ' ' LEU . 26.3 Cg_endo -59.68 142.8 99.4 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.199 2.599 . . . . 0.23 112.564 -174.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.45 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.57 -6.95 59.64 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.874 -0.603 . . . . 0.3 112.621 -176.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.75 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.18 125.27 28.71 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 108.54 -0.911 . . . . 0.25 108.54 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD23 ' A' ' 51' ' ' LEU . 60.2 Cg_endo -66.38 172.62 8.76 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.715 2.943 . . . . 0.31 114.017 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 4.9 t70 -91.19 136.66 26.95 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.665 -1.152 . . . . 0.72 111.721 -170.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.672 ' HD3' HD12 ' A' ' 5' ' ' LEU . 68.8 Cg_endo -81.97 -6.94 12.28 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.332 2.688 . . . . 0.27 113.381 -174.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -28.06 16.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.015 0.436 . . . . 2.11 110.297 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -84.37 -12.93 53.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.985 -0.746 . . . . 1.47 108.985 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.764 HD13 ' HG2' ' A' ' 158' ' ' PRO . 84.0 mt -86.21 125.95 66.49 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.989 -1.005 . . . . 0.26 109.295 169.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -101.47 95.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.14 0 CA-C-N 119.876 0.991 . . . . 0.2 110.225 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 73' ' ' SER . 82.1 m-85 -158.55 129.45 6.26 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.016 -1.476 . . . . 0.26 107.016 172.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 0.3 OUTLIER -137.84 104.18 5.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.756 -1.572 . . . . 2.84 106.756 -164.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -94.34 108.4 20.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.584 -0.734 . . . . 0.32 110.331 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.6 97.35 6.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.14 -0.936 . . . . 0.34 110.67 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 164' ' ' THR . 0.6 OUTLIER -112.22 98.38 6.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.964 -1.471 . . . . 0.68 109.304 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.8 m -94.43 123.16 37.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.734 -1.121 . . . . 1.05 108.843 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mt -59.75 -31.87 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.064 -0.517 . . . . 1.29 111.802 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.91 -40.54 97.3 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.715 -0.755 . . . . 0.88 111.301 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.35 -23.96 59.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.941 -0.63 . . . . 0.74 112.342 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.9 mttt 55.7 19.47 3.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.157 0.983 . . . . 2.51 112.776 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.27 140.85 35.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.716 0.77 . . . . 0.45 111.308 177.349 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.444 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.5 tt -94.31 119.27 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.157 -1.383 . . . . 0.33 109.367 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -101.97 124.8 48.2 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.443 -0.503 . . . . 0.4 111.093 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.558 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.62 139.52 33.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.237 -1.764 . . . . 0.33 106.237 176.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 19.4 m -143.05 128.91 19.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 120.508 1.503 . . . . 0.75 112.672 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.89 125.4 50.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.906 -1.043 . . . . 0.35 110.457 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 61.84 40.68 12.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.029 0.443 . . . . 0.52 109.867 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 81.68 -7.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.798 -1.092 . . . . 1.84 112.21 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -128.52 139.22 52.42 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 118.282 -1.367 . . . . 3.19 114.025 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.71 149.85 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 112.873 -1.967 . . . . 0.41 112.891 -174.564 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.558 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.0 mtp -100.16 -44.06 6.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.5 -2.137 . . . . 0.35 108.43 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 179.7 159.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.54 -2.118 . . . . 2.07 110.156 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.479 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.4 m -121.06 137.6 54.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.526 0.203 . . . . 0.37 111.309 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -127.82 135.94 28.24 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.905 0.383 . . . . 0.97 111.374 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.22 143.86 90.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.935 2.424 . . . . 0.6 112.181 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.7 -175.58 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 0.64 110.028 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.399 0 N-CA-C 109.71 -0.478 . . . . 0.83 109.71 173.611 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.544 ' HB2' HG13 ' A' ' 163' ' ' VAL . 29.1 m-85 . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.643 -0.873 . . . . 1.93 108.643 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 161' ' ' THR . 80.7 m-85 -134.14 138.07 44.96 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.931 0.396 . . . . 0.58 110.738 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 125' ' ' ILE . 26.5 mm -59.55 124.77 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 107.428 -1.323 . . . . 0.41 107.428 166.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.765 HD11 ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -118.09 -22.09 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.893 -0.723 . . . . 0.37 112.174 -176.765 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.455 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 65.9 t30 -167.81 177.11 5.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 123.081 1.42 . . . . 1.99 114.122 -175.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.566 ' NH1' ' HA ' ' A' ' 155' ' ' SER . 4.3 ptt180 -152.19 123.93 7.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 110.824 -2.898 . . . . 1.19 108.684 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -106.07 161.25 14.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.382 1.087 . . . . 1.67 111.666 -168.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -52.56 155.08 2.31 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 112.626 -2.079 . . . . 3.06 112.662 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -44.0 110.3 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 113.119 -1.855 . . . . 2.61 111.02 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -54.56 -47.88 24.39 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.386 2.724 . . . . 0.98 111.668 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.71 -21.34 38.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.641 -1.163 . . . . 1.08 112.74 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -112.81 -170.27 17.86 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.999 -0.619 . . . . 1.05 112.199 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.9 34.24 0.1 Allowed 'Trans proline' 0 N--CA 1.478 0.578 0 C-N-CA 124.473 3.449 . . . . 1.3 113.888 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 109' ' ' GLY . 50.1 t80 -83.15 -18.03 40.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.08 0.467 . . . . 1.38 110.244 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.62 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.18 57.44 0.96 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.768 -0.73 . . . . 1.11 114.856 170.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.27 -45.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.262 1.208 . . . . 0.81 114.262 165.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.68 162.87 34.37 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.903 -0.406 . . . . 1.12 109.903 -176.106 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 1.8 t90 -127.27 99.63 5.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 2.19 108.433 172.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.653 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.3 mp -108.99 139.05 44.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.777 0.799 . . . . 0.61 110.89 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.514 ' HB2' HG23 ' A' ' 101' ' ' ILE . 72.1 m -107.7 148.62 29.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.822 -1.081 . . . . 0.94 113.115 -169.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.522 HD22 HG11 ' A' ' 163' ' ' VAL . 67.9 mt -104.86 -174.35 2.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.533 -1.212 . . . . 1.08 108.441 173.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.0 m . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 112.555 0.576 . . . . 1.5 112.555 -176.859 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 100' ' ' ILE . 25.5 mt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.271 -0.64 . . . . 0.48 109.271 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -155.21 -161.46 1.19 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.337 0.589 . . . . 1.25 110.578 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.62 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -119.31 177.1 16.31 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 119.612 -1.28 . . . . 0.46 112.877 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.9 t -137.07 172.84 12.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.135 0.493 . . . . 0.5 110.254 -170.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -102.68 -19.66 14.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 1.86 109.0 165.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -125.39 104.41 28.46 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.339 -0.846 . . . . 1.77 110.124 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.49 4.98 4.41 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.259 2.639 . . . . 0.59 112.887 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.28 -22.8 28.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.039 0.447 . . . . 0.78 110.651 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.2 p -85.32 -16.94 38.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.538 0.685 . . . . 1.45 110.047 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 134' ' ' ILE . 11.9 mm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.168 -0.923 . . . . 0.7 110.672 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 35.8 mtp . . . . . 0 CA--C 1.519 -0.242 0 N-CA-C 109.783 -0.451 . . . . 1.13 109.783 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.558 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 4.0 t-80 -78.57 154.71 30.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.265 -1.013 . . . . 2.51 108.265 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.557 ' O ' HG12 ' A' ' 150' ' ' VAL . 22.7 p-10 -48.87 -67.39 0.27 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.428 0.529 . . . . 1.77 112.428 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 149' ' ' ASP . 3.8 ptpp? -59.7 -28.2 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.72 -0.612 . . . . 2.13 111.582 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.558 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 6.7 m-20 -72.44 -40.15 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 1.05 110.714 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.4 p -74.83 -18.52 16.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.524 -0.307 . . . . 0.32 110.246 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.49 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.8 mp -86.82 -39.84 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.947 -0.549 . . . . 0.37 110.435 174.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -44.39 -69.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.688 1.131 . . . . 1.38 112.834 162.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.675 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -50.52 -42.35 54.89 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.74 110.242 179.088 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.74 -53.82 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.348 -1.296 . . . . 0.22 112.038 -172.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.566 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 12.1 p -76.55 -13.57 60.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.407 -1.269 . . . . 1.33 111.093 -172.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.65 -49.16 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.15 -0.477 . . . . 0.23 110.053 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.1 m -77.55 117.14 63.61 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-O 122.059 0.933 . . . . 0.21 110.81 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.764 ' HG2' HD13 ' A' ' 57' ' ' ILE . 42.2 Cg_endo -83.05 -178.52 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.876 2.384 . . . . 0.34 112.785 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.75 ' O ' HD21 ' A' ' 51' ' ' LEU . 16.9 m120 -58.32 -2.63 0.2 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.509 -1.223 . . . . 1.02 113.53 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.01 55.91 0.56 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.813 -0.708 . . . . 0.28 112.568 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.546 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 4.9 m -93.91 136.59 34.04 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.565 -0.374 . . . . 0.3 110.305 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.79 142.2 29.12 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.462 -0.495 . . . . 1.96 110.291 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.2 p -143.66 123.75 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 0.46 110.846 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.466 ' O ' HG13 ' A' ' 63' ' ' VAL . 23.3 m -112.7 139.63 48.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.56 112.007 -176.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -125.65 114.17 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 118.542 -1.263 . . . . 0.96 111.194 171.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--N 1.313 -0.992 0 CA-C-N 113.886 -1.506 . . . . 1.19 109.848 -175.781 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.1 mptt . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.01 -0.737 . . . . 2.1 109.01 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.765 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.5 mt -92.38 167.87 11.69 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.269 0.356 . . . . 0.26 111.163 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.58 ' HB2' HD22 ' A' ' 51' ' ' LEU . 4.0 tp -75.89 149.05 37.84 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 122.929 0.492 . . . . 0.23 111.851 -169.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.04 150.04 34.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.969 0.89 . . . . 0.26 111.365 167.56 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' SER . 57.5 t80 -134.64 150.36 50.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.727 -1.579 . . . . 0.39 108.0 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.41 120.93 27.9 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.001 -1.481 . . . . 1.07 107.001 175.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -82.51 158.79 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 112.579 0.585 . . . . 0.38 112.579 -169.73 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -103.37 150.82 23.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.409 -0.814 . . . . 2.59 109.261 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -52.61 109.44 0.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.336 0.589 . . . . 1.74 112.005 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.23 -9.68 15.26 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.338 -0.846 . . . . 0.57 112.766 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.652 ' HB3' HD11 ' A' ' 18' ' ' ILE . 67.1 m-20 -61.43 152.55 29.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.844 0.322 . . . . 2.17 110.814 176.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.56 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -133.49 155.99 48.57 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.253 0.464 . . . . 0.5 112.253 -177.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.595 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -50.3 -58.33 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.545 0.943 . . . . 0.27 113.545 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.668 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.9 t-20 -66.08 -41.81 90.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.27 1.033 . . . . 1.21 110.687 -169.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 26.3 m -55.89 -52.29 64.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 112.958 -1.928 . . . . 1.24 109.754 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -66.48 -40.01 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.373 -0.831 . . . . 0.3 111.942 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.683 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.98 -66.06 0.51 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.087 -0.506 . . . . 0.23 112.108 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.35 -4.87 56.99 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 118.996 -1.081 . . . . 0.39 112.133 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.1 m-20 -66.21 -31.52 72.4 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.99 -0.745 . . . . 1.63 108.99 156.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD1' HD12 ' A' ' 101' ' ' ILE . 1.6 m-85 -96.48 15.21 22.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.033 -0.417 . . . . 0.24 112.068 173.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.57 51.48 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.607 -0.724 . . . . 3.55 110.609 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.4 pt -149.4 -172.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.721 -0.844 . . . . 0.27 108.721 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.96 147.49 24.94 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.678 -0.692 . . . . 0.81 109.909 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.668 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.7 p -61.5 -36.41 80.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.539 -0.911 . . . . 0.27 108.539 175.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.29 -28.64 69.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.478 -1.237 . . . . 0.26 111.664 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.72 -38.7 25.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.513 -0.551 . . . . 0.23 109.513 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 46' ' ' ILE . 14.0 tp -73.3 -19.44 61.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.412 -0.813 . . . . 0.17 109.081 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.702 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -39.69 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.657 0.742 . . . . 0.19 111.549 172.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.12 -40.6 96.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 114.994 -1.003 . . . . 1.07 110.03 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.24 -19.25 43.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.998 -1.455 . . . . 0.17 111.819 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 33.0 m-80 -142.13 71.57 22.89 Favored Pre-proline 0 CA--C 1.515 -0.374 0 CA-C-O 121.025 0.441 . . . . 0.19 109.903 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.712 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.23 -12.54 10.42 Favored 'Trans proline' 0 C--O 1.22 -0.4 0 C-N-CA 123.301 2.667 . . . . 0.3 113.946 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -61.69 -32.31 72.5 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.061 0.934 . . . . 1.17 110.035 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.1 mt -81.1 -6.36 58.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.206 -1.361 . . . . 0.53 114.551 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.712 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -51.69 -40.66 60.51 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.77 1.272 . . . . 1.23 109.503 177.766 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.97 -46.69 14.72 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 112.763 -2.017 . . . . 0.4 111.562 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.54 -162.69 33.76 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.271 -0.966 . . . . 0.3 114.364 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.1 mp -116.88 158.21 24.37 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.188 -1.506 . . . . 0.31 109.881 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 89.2 m -137.31 135.47 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 0.39 110.792 -177.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.646 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.48 126.66 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.404 0.89 . . . . 0.47 113.404 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.591 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.4 -12.48 45.47 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 114.613 -1.176 . . . . 0.36 112.083 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.597 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 4.1 tt0 -63.47 151.81 40.16 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.817 0.817 . . . . 1.19 110.263 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.9 m -117.41 135.51 53.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.133 -1.394 . . . . 0.89 109.096 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 29' ' ' LEU . 16.8 pt -136.71 146.42 28.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.296 0.57 . . . . 0.22 110.533 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.519 ' H ' HD21 ' A' ' 33' ' ' ASN . 7.2 t -91.61 149.1 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.051 -0.977 . . . . 0.21 110.409 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.579 HG13 HD23 ' A' ' 5' ' ' LEU . 19.2 mm -118.07 87.54 29.03 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-N 114.959 -1.019 . . . . 0.17 108.701 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.765 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.8 Cg_endo -59.08 139.78 92.16 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.209 2.606 . . . . 0.23 112.709 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.518 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.18 -7.59 70.91 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.3 112.93 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.75 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.81 128.78 25.78 Favored Pre-proline 0 C--O 1.218 -0.566 0 N-CA-C 108.566 -0.902 . . . . 0.25 108.566 177.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.697 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.4 Cg_endo -68.92 171.72 13.04 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.75 2.967 . . . . 0.31 114.167 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.745 ' HB3' HG22 ' A' ' 56' ' ' THR . 9.1 t70 -90.08 141.76 28.17 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.72 110.232 -172.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD3' HD12 ' A' ' 5' ' ' LEU . 62.9 Cg_endo -85.27 -7.13 9.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.323 2.682 . . . . 0.27 111.992 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -95.67 -24.52 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.11 110.239 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.745 HG22 ' HB3' ' A' ' 53' ' ' ASP . 13.1 t -87.25 -15.41 38.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.678 -0.86 . . . . 1.47 108.678 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.747 HD13 ' HG2' ' A' ' 158' ' ' PRO . 61.7 mt -87.21 126.2 63.44 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 114.503 -1.226 . . . . 0.26 108.964 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -101.16 93.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.175 0 CA-C-N 120.52 1.221 . . . . 0.2 110.106 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.414 ' HD2' HG23 ' A' ' 57' ' ' ILE . 78.0 m-85 -159.03 131.52 6.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.238 -1.764 . . . . 0.26 106.238 173.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 23.3 m-70 -140.33 107.8 5.57 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.095 -1.446 . . . . 2.84 107.095 -164.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.5 mt -94.61 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.054 -0.975 . . . . 0.32 110.398 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.39 94.59 5.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.0 0.905 . . . . 0.34 110.337 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -115.6 100.02 9.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.039 -1.437 . . . . 0.68 110.291 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.523 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 38.6 t -90.32 121.58 32.44 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.239 -1.393 . . . . 1.05 107.239 173.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 165' ' ' ILE . 33.3 mm -62.26 -26.88 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.957 0.884 . . . . 1.29 108.936 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.89 -46.0 84.72 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.297 -0.954 . . . . 0.88 111.377 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -67.27 -23.99 65.74 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.606 0.595 . . . . 0.74 112.606 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.7 mttt 61.54 13.17 4.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.885 0.874 . . . . 2.51 112.544 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.506 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -141.13 137.35 32.7 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.1 0.953 . . . . 0.45 112.118 177.339 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.5 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.3 tt -93.96 118.93 32.16 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.346 -1.752 . . . . 0.33 109.121 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 m -102.6 125.08 49.2 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.055 -0.658 . . . . 0.4 111.233 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.595 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -84.6 129.75 34.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.509 -1.663 . . . . 0.33 106.509 177.18 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 15.6 m -135.58 126.45 27.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 120.905 1.684 . . . . 0.75 112.81 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.0 tp -113.03 126.5 55.56 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.774 -1.103 . . . . 0.35 109.876 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 63.05 40.05 9.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.088 -0.708 . . . . 0.52 109.088 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 83.35 -21.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.725 1.21 . . . . 1.84 111.949 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -121.92 139.06 54.12 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 117.295 -1.762 . . . . 3.19 114.779 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.92 149.53 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 112.546 -2.115 . . . . 0.41 113.882 -167.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.5 mtp -100.74 -42.97 6.28 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 112.076 -2.329 . . . . 0.35 108.18 175.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 2.6 tppt? -178.37 164.69 1.74 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 112.464 -2.153 . . . . 2.07 109.931 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.506 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 12.1 m -126.24 134.39 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.514 0.197 . . . . 0.37 110.798 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 19.5 m-85 -123.31 145.87 47.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 109.534 -0.543 . . . . 0.97 109.534 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 27.3 Cg_endo -83.86 148.31 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.44 2.093 . . . . 0.6 112.037 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.69 179.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.296 -0.411 . . . . 0.64 110.192 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.86 0.362 . . . . 0.83 110.251 179.035 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.599 ' HB2' HG13 ' A' ' 163' ' ' VAL . 21.4 m-85 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.857 -0.423 . . . . 1.93 109.857 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.7 m-85 -140.03 141.7 36.27 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.061 -0.348 . . . . 0.58 110.061 174.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.721 HD11 HD12 ' A' ' 125' ' ' ILE . 23.9 mm -60.16 121.17 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.9 -1.148 . . . . 0.41 107.9 167.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.652 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.8 tt -122.92 -25.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.094 -0.642 . . . . 0.37 112.161 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 9.1 t-20 -150.69 154.22 37.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.478 1.288 . . . . 1.99 114.478 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.56 119.85 11.55 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 111.487 -2.597 . . . . 1.19 108.904 172.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 105' ' ' ARG . 1.3 tt0 -97.59 159.87 14.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.386 1.088 . . . . 1.67 112.042 -168.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 18.3 ttm180 -50.69 149.73 3.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 112.352 -2.204 . . . . 3.06 111.646 168.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.403 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 19.3 m-80 -48.21 106.32 0.59 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 114.976 -1.011 . . . . 2.61 112.233 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.7 -49.9 13.32 Favored 'Trans proline' 0 CA--C 1.519 -0.261 0 C-N-CA 123.723 2.949 . . . . 0.98 112.43 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 16.75 49.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.237 -0.892 . . . . 1.08 112.394 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -138.67 -168.95 11.43 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.085 -0.579 . . . . 1.05 112.15 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.96 16.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.938 3.092 . . . . 1.3 113.115 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -70.57 -21.38 62.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.079 -0.509 . . . . 1.38 110.503 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.32 37.01 4.19 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.584 -0.735 . . . . 1.11 113.874 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.36 -19.0 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.762 0.653 . . . . 0.81 112.762 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.498 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -159.21 152.47 22.41 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 122.86 0.464 . . . . 1.12 110.02 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.401 ' CE3' ' HE1' ' A' ' 111' ' ' PHE . 33.7 t-105 -120.24 105.48 10.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.19 109.634 170.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.3 mp -107.84 138.52 43.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.6 0.714 . . . . 0.61 111.101 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.9 m -106.76 146.25 31.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.326 -0.852 . . . . 0.94 112.347 -171.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.88 -173.49 3.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.85 -0.796 . . . . 1.08 108.85 169.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.496 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.9 t . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.42 0.526 . . . . 1.5 112.42 -172.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.721 HD12 HD11 ' A' ' 100' ' ' ILE . 40.3 mt . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 108.213 -1.032 . . . . 0.48 108.213 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.468 ' O ' ' HG2' ' A' ' 145' ' ' MET . 12.6 p80 -138.95 -166.96 2.12 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.306 -0.957 . . . . 1.25 111.954 -176.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.468 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.72 161.54 14.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.356 -1.293 . . . . 0.46 112.988 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.7 t -127.25 178.22 6.18 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.951 -0.625 . . . . 0.5 110.569 -170.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -105.21 -16.64 14.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.318 -0.856 . . . . 1.86 109.662 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -126.92 100.69 27.23 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.842 -0.617 . . . . 1.77 110.152 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -91.6 4.31 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.197 2.598 . . . . 0.59 113.267 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.97 27.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.253 0.549 . . . . 0.78 110.251 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.1 t -82.19 -26.98 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.736 . . . . 1.45 109.732 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.455 HD13 ' HA ' ' A' ' 134' ' ' ILE . 6.6 mm . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.18 -0.918 . . . . 0.7 111.552 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.54 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 15.4 ptm . . . . . 0 C--O 1.234 0.243 0 CA-C-O 120.506 0.193 . . . . 1.13 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -77.06 145.5 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.505 -0.316 . . . . 2.51 110.493 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.653 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.4 m-20 -49.89 -67.15 0.28 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.336 0.398 . . . . 1.77 111.898 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -26.32 65.45 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.572 -0.705 . . . . 2.13 111.853 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.44 -36.72 63.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.745 -0.207 . . . . 1.05 110.812 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.4 p -75.44 -18.65 15.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 116.61 -0.268 . . . . 0.32 110.377 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.568 HD12 HG13 ' A' ' 150' ' ' VAL . 3.2 mp -88.83 -41.44 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 119.27 -0.395 . . . . 0.37 110.243 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -41.03 -69.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 119.019 0.827 . . . . 1.38 112.191 162.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.703 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.1 tp -50.55 -43.11 56.04 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.859 -0.61 . . . . 0.74 110.334 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.02 -52.52 60.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.703 -1.135 . . . . 0.22 112.366 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.5 t -78.47 -14.67 59.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.668 -1.151 . . . . 1.33 110.961 -172.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.01 -48.78 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.028 0.442 . . . . 0.23 109.815 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.2 m -76.91 119.51 77.77 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-O 121.714 0.769 . . . . 0.21 109.819 178.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.747 ' HG2' HD13 ' A' ' 57' ' ' ILE . 46.3 Cg_endo -82.3 -178.89 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.664 2.243 . . . . 0.34 112.257 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.75 ' O ' HD21 ' A' ' 51' ' ' LEU . 9.6 m120 -59.67 -0.66 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.682 -1.144 . . . . 1.02 113.52 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.95 56.2 0.54 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.02 -0.61 . . . . 0.28 112.237 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.492 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 3.1 m -94.01 133.99 36.88 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.524 -0.398 . . . . 0.3 110.075 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -86.64 142.49 28.21 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.186 -0.605 . . . . 1.96 110.849 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.599 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.1 p -147.31 127.42 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.025 -0.989 . . . . 0.46 110.917 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.4 m -113.3 142.13 46.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.516 -0.766 . . . . 0.56 111.38 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.583 HG23 HG12 ' A' ' 65' ' ' ILE . 2.0 mp -125.34 119.34 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 118.791 -1.164 . . . . 0.96 111.148 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.44 -0.936 0 CA-C-N 113.952 -1.476 . . . . 1.19 107.768 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 109.538 -0.542 . . . . 2.1 109.538 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.4 mt -99.35 172.92 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.21 -0.45 . . . . 0.26 111.338 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.605 HD12 ' HD3' ' A' ' 54' ' ' PRO . 4.5 tp -77.67 152.33 33.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.201 0.6 . . . . 0.23 111.748 -170.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.17 150.13 36.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.115 0.959 . . . . 0.26 111.847 166.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' SER . 87.1 t80 -133.6 142.77 48.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.611 -1.631 . . . . 0.39 107.719 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -125.79 113.53 17.4 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.862 -1.533 . . . . 1.07 106.862 178.631 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -76.81 158.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 113.193 0.812 . . . . 0.38 113.193 -164.499 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -95.44 148.11 22.81 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.105 -0.952 . . . . 2.59 109.599 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.831 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 6.4 tt0 -52.19 109.38 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 1.74 111.554 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.9 -9.44 23.31 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.692 -0.766 . . . . 0.57 112.957 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.582 ' HB3' HD11 ' A' ' 18' ' ' ILE . 71.4 m-20 -59.75 154.44 18.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.294 0.547 . . . . 2.17 111.757 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.4 p -133.04 152.91 51.92 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.439 0.533 . . . . 0.5 112.439 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.99 -59.04 3.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.776 1.028 . . . . 0.27 113.776 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.66 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 16.5 t-20 -64.84 -41.2 95.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.615 1.198 . . . . 1.21 110.578 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 43.9 t -59.22 -48.51 81.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.353 -2.203 . . . . 1.24 109.991 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.582 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -68.01 -40.71 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.064 -0.516 . . . . 0.3 111.936 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.671 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.57 -63.9 1.05 Allowed 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.18 -0.464 . . . . 0.23 111.559 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.56 -4.64 54.78 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.877 -1.129 . . . . 0.39 112.181 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -68.29 -30.25 69.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.947 -0.76 . . . . 1.63 108.947 157.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.658 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.4 m-85 -96.44 15.61 20.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.996 0.369 . . . . 0.24 111.996 172.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 55.43 49.62 16.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.661 -0.699 . . . . 3.55 110.579 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.671 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.4 pt -148.2 -173.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.858 -0.793 . . . . 0.27 108.858 -173.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -100.6 146.19 27.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.167 -0.924 . . . . 0.81 109.737 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.66 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.3 p -61.37 -37.14 82.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.983 -0.747 . . . . 0.27 108.983 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -28.91 70.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.389 -1.278 . . . . 0.26 111.543 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.22 -38.06 27.59 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.492 -0.559 . . . . 0.23 109.492 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 46' ' ' ILE . 14.3 tp -74.32 -17.84 60.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.317 -0.856 . . . . 0.17 109.201 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.742 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.94 -39.1 26.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.681 0.753 . . . . 0.19 111.825 173.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -60.57 -40.95 93.56 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.947 -1.024 . . . . 1.07 109.764 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.35 -21.14 39.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.633 -1.622 . . . . 0.17 111.985 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 13.6 m120 -142.36 72.87 21.37 Favored Pre-proline 0 CA--C 1.513 -0.46 0 CA-C-O 121.163 0.506 . . . . 0.19 109.89 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.668 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 19.1 Cg_endo -58.36 -9.04 5.99 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.592 2.861 . . . . 0.3 114.157 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -63.34 -34.89 78.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.949 0.881 . . . . 1.17 109.478 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.21 -6.72 57.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.205 -1.361 . . . . 0.53 114.521 -170.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.742 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -49.13 -40.73 33.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.575 1.179 . . . . 1.23 110.181 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.06 -46.85 10.78 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 112.747 -2.024 . . . . 0.4 111.624 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.64 -164.08 34.81 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.43 -0.89 . . . . 0.3 114.172 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.459 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.6 mp -118.4 157.74 26.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.474 -1.363 . . . . 0.31 110.624 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.657 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 81.5 m -135.09 135.48 41.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.694 -0.684 . . . . 0.39 110.912 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.37 128.9 12.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.576 0.954 . . . . 0.47 113.576 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.49 -11.62 37.83 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.386 -1.279 . . . . 0.36 112.26 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.657 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.9 tt0 -63.74 152.22 39.87 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.555 0.693 . . . . 1.19 110.237 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 30.8 m -119.5 133.37 55.71 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.41 -1.268 . . . . 0.89 109.436 -171.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.718 HD12 HD11 ' A' ' 29' ' ' LEU . 19.5 pt -135.37 155.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.157 0.504 . . . . 0.22 110.397 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.476 ' H ' HD22 ' A' ' 33' ' ' ASN . 14.8 t -99.68 149.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.283 -0.871 . . . . 0.21 110.398 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.552 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.5 mm -117.57 88.72 30.26 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.118 -0.946 . . . . 0.17 108.516 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.778 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.1 Cg_endo -59.67 139.49 89.07 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.188 2.592 . . . . 0.23 112.876 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.495 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.38 -7.29 68.76 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.172 -0.922 . . . . 0.3 112.812 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.08 124.98 29.46 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.902 -0.777 . . . . 0.25 108.902 177.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.611 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.9 Cg_endo -66.23 174.19 6.39 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.729 2.953 . . . . 0.31 114.028 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 2.5 t70 -90.82 138.33 26.4 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.72 111.699 -171.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HD3' HD12 ' A' ' 5' ' ' LEU . 92.7 Cg_endo -81.17 -5.84 12.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.219 2.613 . . . . 0.27 113.429 -174.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -95.15 -28.51 15.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.65 0.262 . . . . 2.11 111.038 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t -78.99 -24.42 43.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.667 -0.864 . . . . 1.47 108.667 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.751 HD13 ' HG2' ' A' ' 158' ' ' PRO . 77.5 mt -74.24 123.59 89.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 114.859 -1.064 . . . . 0.26 109.711 170.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -101.06 94.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 119.839 0.978 . . . . 0.2 110.148 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HD2' HG23 ' A' ' 57' ' ' ILE . 84.1 m-85 -159.1 139.45 12.25 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.546 -1.65 . . . . 0.26 106.546 172.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.523 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 35.1 t60 -147.43 118.73 7.82 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.878 -1.156 . . . . 2.84 107.878 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 67.8 mt -106.51 113.02 42.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.032 -0.985 . . . . 0.32 111.087 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.89 106.87 16.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.107 -0.951 . . . . 0.34 110.106 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -113.37 119.85 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 114.59 -1.186 . . . . 0.68 110.017 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.619 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 16.5 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.015 -1.074 . . . . 1.05 109.937 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.2 mt -61.43 -28.78 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.808 0.813 . . . . 1.29 109.798 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.32 -47.25 59.26 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.658 -1.156 . . . . 0.88 111.615 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -74.94 -26.11 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.237 0.828 . . . . 0.74 113.237 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 tttt 49.35 29.27 2.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.112 0.958 . . . . 2.51 112.179 -175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.514 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -143.98 139.61 29.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.381 -0.827 . . . . 0.45 110.989 170.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 tt -97.03 120.06 36.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.907 -1.497 . . . . 0.33 109.495 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -100.45 123.18 44.34 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.003 -0.679 . . . . 0.4 110.711 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.573 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.73 143.57 30.8 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.449 -1.685 . . . . 0.33 106.449 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 31.2 p -149.72 127.47 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 120.499 1.499 . . . . 0.75 113.147 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 tp -112.19 125.91 54.64 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.151 -1.386 . . . . 0.35 110.076 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 8.9 t-20 68.87 31.02 4.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.513 -0.921 . . . . 0.52 108.513 172.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 17.3 m120 79.14 2.1 2.37 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.167 -1.378 . . . . 1.84 111.763 176.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -129.76 142.09 50.76 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 118.874 -1.13 . . . . 3.19 113.987 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -58.45 150.06 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 113.219 -1.81 . . . . 0.41 113.314 -168.223 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.573 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -100.47 -43.73 6.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.464 -2.153 . . . . 0.35 108.4 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 4.7 tppt? 179.5 161.05 0.81 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.746 -2.025 . . . . 2.07 110.451 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.514 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 22.8 m -118.05 132.0 56.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.675 0.274 . . . . 0.37 110.957 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 79.7 m-85 -113.22 152.01 44.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 0.97 110.297 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HB2' HG22 ' A' ' 134' ' ' ILE . 12.3 Cg_endo -83.86 138.84 8.31 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.508 2.139 . . . . 0.6 111.943 177.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.35 172.74 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.325 -0.62 . . . . 0.64 109.325 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 0.83 111.478 176.209 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.512 ' HB2' HG13 ' A' ' 163' ' ' VAL . 7.1 m-85 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.72 -0.474 . . . . 1.93 109.72 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.513 ' CE2' ' HG2' ' A' ' 162' ' ' ARG . 62.2 m-85 -139.26 138.64 36.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.781 -0.645 . . . . 0.58 110.315 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 125' ' ' ILE . 27.7 mm -60.51 127.63 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 107.987 -1.116 . . . . 0.41 107.987 167.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.619 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -118.17 -31.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.512 -0.875 . . . . 0.37 112.341 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -166.78 -175.07 2.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 118.084 -1.447 . . . . 1.99 114.289 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 103' ' ' ARG . 4.9 ptp180 -156.81 133.86 10.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 111.211 -2.722 . . . . 1.19 110.125 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -112.8 155.36 24.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.275 1.036 . . . . 1.67 111.708 -172.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.27 155.35 3.81 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 112.291 -2.231 . . . . 3.06 112.92 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -43.58 102.93 0.3 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 112.947 -1.933 . . . . 2.61 111.674 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.83 -54.04 2.71 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 124.114 3.209 . . . . 0.98 113.0 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.73 -20.6 26.87 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.543 -0.753 . . . . 1.08 111.907 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -87.82 -169.59 45.49 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.375 -0.44 . . . . 1.05 112.493 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.03 6.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.167 3.245 . . . . 1.3 113.949 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.41 ' H ' ' C ' ' A' ' 109' ' ' GLY . 32.6 m-85 -53.42 -35.95 60.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.138 0.494 . . . . 1.38 109.749 171.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.9 -2.58 16.76 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.337 -0.847 . . . . 1.11 114.697 168.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB1' ' CD1' ' A' ' 151' ' ' ILE . . . -175.57 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.828 0.814 . . . . 0.81 112.628 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.532 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -151.63 158.32 43.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.344 -0.389 . . . . 1.12 111.514 -171.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CE3' ' HD2' ' A' ' 126' ' ' HIS . 9.7 t-105 -117.77 100.44 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.359 -0.608 . . . . 2.19 109.359 171.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.46 ' CD1' HG22 ' A' ' 150' ' ' VAL . 3.8 mp -105.3 141.12 37.38 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.727 0.775 . . . . 0.61 111.351 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.513 ' HB2' HG23 ' A' ' 101' ' ' ILE . 56.3 m -105.83 142.79 34.95 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.934 -1.03 . . . . 0.94 111.979 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -102.87 -174.49 2.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.468 -0.938 . . . . 1.08 108.468 173.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 118.973 0.806 . . . . 1.5 112.788 -176.792 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 100' ' ' ILE . 30.8 mt . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 121.918 0.866 . . . . 0.48 109.441 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.428 ' HD2' ' CE3' ' A' ' 115' ' ' TRP . 14.9 t-80 -130.26 173.09 11.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.635 -1.166 . . . . 1.25 111.527 -160.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.2 -171.7 14.63 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 0.46 111.311 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 t -159.48 174.52 14.55 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.933 -1.107 . . . . 0.5 112.679 -163.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -104.18 -20.57 13.76 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.914 -1.494 . . . . 1.86 108.884 167.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.78 103.21 21.76 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.152 -0.931 . . . . 1.77 110.232 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.521 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 64.8 Cg_endo -90.63 4.94 4.35 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.975 2.45 . . . . 0.59 112.553 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.5 40.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.248 0.547 . . . . 0.78 109.977 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.0 m -91.25 13.8 16.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.324 -0.853 . . . . 1.45 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 18.8 mm . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 0.7 110.711 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.405 ' HA ' HG21 ' A' ' 134' ' ' ILE . 38.9 mtp . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 121.096 0.474 . . . . 1.13 111.362 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 149' ' ' ASP . 37.6 m80 -66.45 176.11 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.167 -0.924 . . . . 2.51 109.143 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 150' ' ' VAL . 3.8 m120 -82.4 -63.5 1.36 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.017 -1.105 . . . . 1.77 108.017 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -66.69 -22.15 66.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.616 . . . . 2.13 111.323 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 146' ' ' HIS . 31.2 m-20 -67.93 -41.83 81.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.893 0.378 . . . . 1.05 110.831 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 8.5 p -79.52 -13.01 13.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.32 110.521 -177.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.581 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 3.3 mp -92.34 -40.52 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 119.254 -0.403 . . . . 0.37 110.849 168.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -42.32 -70.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.356 0.98 . . . . 1.38 111.912 162.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.0 OUTLIER -50.07 -41.96 48.99 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.738 0.649 . . . . 0.74 110.181 177.623 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.23 -55.47 20.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.622 -1.172 . . . . 0.22 111.727 -172.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 28.7 t -77.01 -16.66 59.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.686 -1.143 . . . . 1.33 110.863 -172.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.24 -50.07 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 0.23 109.969 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.3 m -77.51 115.78 52.43 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 122.046 0.927 . . . . 0.21 110.38 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.751 ' HG2' HD13 ' A' ' 57' ' ' ILE . 45.6 Cg_endo -80.82 -178.28 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.834 2.356 . . . . 0.34 112.578 -172.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.694 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.2 m120 -55.91 -5.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.669 -1.151 . . . . 1.02 113.57 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.18 57.26 0.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.937 -0.649 . . . . 0.28 112.168 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.528 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 3.8 m -90.72 140.32 29.89 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.405 -0.467 . . . . 0.3 110.608 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.513 ' HG2' ' CE2' ' A' ' 99' ' ' TYR . 60.4 mtm180 -83.53 125.15 31.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.51 . . . . 1.96 109.86 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -136.16 126.65 41.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.389 0.614 . . . . 0.46 111.419 -177.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.5 m -117.29 140.49 49.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.384 -0.826 . . . . 0.56 111.975 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.7 mp -129.14 115.82 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 122.342 1.067 . . . . 0.96 111.397 172.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.8 OUTLIER . . . . . 0 C--N 1.314 -0.948 0 CA-C-N 113.527 -1.67 . . . . 1.19 110.26 -173.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 1.8 mppt? . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 108.845 -0.798 . . . . 2.1 108.845 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -95.91 170.89 8.98 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.071 0.232 . . . . 0.26 111.15 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.544 HD23 ' CG1' ' A' ' 48' ' ' ILE . 4.0 tp -77.62 150.11 34.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 123.215 0.606 . . . . 0.23 112.173 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.541 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -115.07 149.25 37.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.012 0.911 . . . . 0.26 111.754 168.006 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.5 t80 -133.72 150.3 51.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.61 -1.632 . . . . 0.39 107.911 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -131.59 117.13 18.3 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.151 -1.426 . . . . 1.07 107.151 174.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG11 HD23 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -78.58 158.83 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 123.234 0.614 . . . . 0.38 111.226 -169.473 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 10' ' ' LYS . 8.5 mtpm? -110.27 156.72 20.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.111 -0.7 . . . . 2.59 109.111 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.849 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 19.7 tm0? -49.82 117.94 2.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.826 -0.625 . . . . 1.74 112.571 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.54 -6.44 35.94 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.57 113.428 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.704 ' HB3' HD11 ' A' ' 18' ' ' ILE . 20.9 m-20 -70.66 157.09 38.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.473 0.637 . . . . 2.17 112.436 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.615 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -134.7 162.29 32.76 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.549 0.574 . . . . 0.5 112.549 -176.337 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.9 tp -51.75 -60.73 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.937 1.088 . . . . 0.27 113.937 -173.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.647 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.8 t-20 -63.75 -43.37 96.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.614 1.197 . . . . 1.21 110.403 -169.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.768 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 31.3 m -60.46 -39.17 86.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 112.494 -2.139 . . . . 1.24 110.989 -177.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.35 -40.87 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 123.012 0.525 . . . . 0.3 112.327 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.682 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.55 -61.66 2.27 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.487 -0.324 . . . . 0.23 111.242 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.14 -3.33 54.62 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.01 -1.076 . . . . 0.39 112.136 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' SER . 4.0 t70 -62.13 -39.64 93.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.85 -1.167 . . . . 1.63 107.85 155.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.766 ' O ' HG23 ' A' ' 24' ' ' ILE . 4.6 m-85 -93.13 24.9 3.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.087 -0.506 . . . . 0.24 111.969 174.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.647 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 23.74 69.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.96 1.304 . . . . 3.55 113.515 -168.41 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 22' ' ' PHE . 29.8 pt -147.66 -169.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.066 -1.087 . . . . 0.27 108.066 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.22 146.88 25.18 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.943 -0.571 . . . . 0.81 109.736 171.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.647 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.6 p -61.25 -35.56 77.58 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.499 -0.926 . . . . 0.27 108.499 174.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.66 71.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.604 -1.18 . . . . 0.26 111.77 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.03 -38.24 32.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.874 -0.516 . . . . 0.23 109.725 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.68 -19.08 60.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.423 -0.808 . . . . 0.17 109.133 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.764 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -78.83 -40.37 32.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 0.19 111.832 173.396 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -59.68 -40.59 88.33 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.072 -0.967 . . . . 1.07 109.746 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.11 -20.29 41.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.673 -1.603 . . . . 0.17 112.214 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 11.1 m120 -143.52 73.12 17.46 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.165 0.507 . . . . 0.19 109.941 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.724 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.8 Cg_endo -57.08 -11.32 7.42 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 123.574 2.849 . . . . 0.3 113.809 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.6 t -62.67 -32.83 73.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.988 0.899 . . . . 1.17 109.392 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.82 -7.08 59.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.568 1.321 . . . . 0.53 114.568 -172.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.764 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -53.06 -39.84 63.56 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 120.19 1.359 . . . . 1.23 109.599 177.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.78 -47.4 12.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.769 -2.014 . . . . 0.4 111.334 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.03 -166.54 38.68 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.91 -1.138 . . . . 0.3 114.567 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.577 ' CD2' HG12 ' A' ' 18' ' ' ILE . 5.6 mp -114.88 158.91 21.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.335 -1.432 . . . . 0.31 110.152 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.605 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.84 136.2 38.57 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.797 -0.638 . . . . 0.39 110.499 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.849 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.93 127.46 10.08 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 113.115 0.783 . . . . 0.47 113.115 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.22 -11.13 51.23 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.607 -1.179 . . . . 0.36 112.312 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -63.31 151.11 41.63 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.697 0.76 . . . . 1.19 110.298 175.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 35.6 m -118.88 131.59 56.07 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.32 -1.309 . . . . 0.89 109.265 -171.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 29' ' ' LEU . 21.2 pt -132.81 159.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.095 0.474 . . . . 0.22 110.345 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.1 t -106.63 148.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.292 -0.867 . . . . 0.21 109.808 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.544 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.9 mm -116.97 88.69 27.19 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.31 -0.996 . . . . 0.17 108.31 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.709 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.3 Cg_endo -59.05 142.32 99.23 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.129 2.553 . . . . 0.23 112.617 -173.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.514 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.37 -7.08 61.93 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.492 -0.776 . . . . 0.3 112.811 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.712 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -114.62 126.07 28.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.742 -0.836 . . . . 0.25 108.742 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 51' ' ' LEU . 57.5 Cg_endo -65.58 174.3 5.55 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.849 3.033 . . . . 0.31 113.656 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.1 t70 -91.31 141.73 26.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.158 -0.928 . . . . 0.72 110.9 -169.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 96.5 Cg_endo -83.57 -7.11 10.73 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.616 2.877 . . . . 0.27 112.17 -175.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 62.1 m-85 -94.84 -27.31 15.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.831 -0.433 . . . . 2.11 109.831 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -70.23 -35.06 73.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.497 -1.298 . . . . 1.47 107.497 170.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.8 HD13 ' HG2' ' A' ' 158' ' ' PRO . 85.0 mt -74.34 126.43 88.96 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 113.327 -1.761 . . . . 0.26 110.524 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -102.94 95.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.905 1.07 . . . . 0.2 110.257 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.451 ' HD2' HG23 ' A' ' 57' ' ' ILE . 77.2 m-85 -158.33 129.57 6.49 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.403 -1.332 . . . . 0.26 107.403 172.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m-70 -137.7 110.13 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.158 -1.423 . . . . 2.84 107.158 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.0 mt -94.94 111.4 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.383 0.611 . . . . 0.32 110.539 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.27 93.06 4.23 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.857 0.837 . . . . 0.34 110.399 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -112.88 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.414 -1.266 . . . . 0.68 109.647 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 35.4 t -92.77 124.96 37.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.849 -1.167 . . . . 1.05 107.849 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.465 HG13 HG23 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -58.98 -28.59 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.345 0.593 . . . . 1.29 110.796 172.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.45 -45.05 88.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.881 -0.888 . . . . 0.88 110.881 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.481 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -70.25 -24.08 63.01 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.644 0.609 . . . . 0.74 112.644 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.5 mttt 58.57 14.26 2.97 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.818 0.847 . . . . 2.51 112.894 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.458 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.42 138.9 35.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.973 0.892 . . . . 0.45 111.249 177.723 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.445 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -92.74 117.9 30.49 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.881 -1.509 . . . . 0.33 108.881 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.61 125.4 48.26 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.938 -0.705 . . . . 0.4 110.925 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.43 142.62 31.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.095 -1.817 . . . . 0.33 106.095 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 26.1 m -147.48 128.2 14.28 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 120.445 1.475 . . . . 0.75 112.969 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -111.41 126.88 55.41 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.588 -1.187 . . . . 0.35 110.147 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.1 t-20 61.89 35.45 16.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 0.52 110.285 173.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.2 m-20 78.35 1.59 2.68 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.112 -0.949 . . . . 1.84 112.404 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 77' ' ' ARG . 5.5 ttt180 -128.51 137.36 51.73 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 118.283 -1.367 . . . . 3.19 113.446 172.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.19 147.93 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 112.987 -1.915 . . . . 0.41 113.17 -171.752 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.533 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -97.8 -44.72 6.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.25 -2.25 . . . . 0.35 107.943 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 26.0 tptt -179.04 160.21 1.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.325 -2.216 . . . . 2.07 110.484 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.458 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.5 m -116.11 131.44 56.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.689 -0.232 . . . . 0.37 111.403 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -113.71 146.86 36.37 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 110.487 -0.19 . . . . 0.97 110.487 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.95 143.19 12.88 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.506 2.137 . . . . 0.6 111.305 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.75 172.23 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.768 -0.456 . . . . 0.64 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.92 0.391 . . . . 0.83 110.08 175.666 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.506 ' HB2' HG13 ' A' ' 163' ' ' VAL . 2.7 m-85 . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 108.301 -1.0 . . . . 1.93 108.301 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 161' ' ' THR . 89.4 m-85 -135.9 139.1 43.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.464 -0.495 . . . . 0.58 111.685 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.73 HD11 HD12 ' A' ' 125' ' ' ILE . 26.6 mm -60.62 126.19 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 107.578 -1.267 . . . . 0.41 107.578 164.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -125.46 -27.93 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 120.118 -0.633 . . . . 0.37 112.51 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 3.6 t30 -151.61 158.8 43.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.82 1.045 . . . . 1.99 113.82 -168.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.69 133.91 20.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.397 -2.183 . . . . 1.19 110.198 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 13.3 tp60 -111.92 142.57 44.14 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.806 0.813 . . . . 1.67 110.709 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -54.23 151.44 7.26 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 112.937 -1.938 . . . . 3.06 113.254 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -45.36 101.98 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 114.121 -1.399 . . . . 2.61 111.998 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.402 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 85.7 Cg_exo -56.79 -51.39 9.11 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 124.242 3.294 . . . . 0.98 112.839 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.39 -0.86 29.46 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.353 -0.839 . . . . 1.08 112.436 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.16 -170.34 11.99 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.939 -0.648 . . . . 1.05 112.098 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.29 49.14 0.16 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.465 3.443 . . . . 1.3 113.945 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.402 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 1.6 t80 -107.42 -15.56 14.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.392 -0.596 . . . . 1.38 109.392 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.427 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.92 35.37 4.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.806 -0.712 . . . . 1.11 114.516 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.406 ' O ' ' HD1' ' A' ' 114' ' ' TYR . . . 72.72 -36.42 0.36 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.468 0.914 . . . . 0.81 113.468 172.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -152.83 137.57 16.99 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.366 -0.605 . . . . 1.12 109.366 -176.043 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 61.9 t-105 -110.34 102.35 11.01 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.485 -0.561 . . . . 2.19 109.485 171.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.2 mp -102.03 144.41 30.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.763 0.792 . . . . 0.61 110.54 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.588 ' HB2' HG23 ' A' ' 101' ' ' ILE . 34.8 m -107.84 144.32 35.21 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.08 -0.964 . . . . 0.94 112.794 -169.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.716 HD11 HG11 ' A' ' 163' ' ' VAL . 6.8 tp -106.81 -171.78 1.95 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.836 -1.529 . . . . 1.08 107.899 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 118.772 0.715 . . . . 1.5 111.836 178.388 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 100' ' ' ILE . 4.0 mt . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 106.338 -1.727 . . . . 0.48 106.338 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' A' ' 145' ' ' MET . 10.3 p80 -149.48 -165.06 2.17 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.467 -0.893 . . . . 1.25 112.272 -172.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.427 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.17 175.39 16.35 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.636 -1.165 . . . . 0.46 113.01 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.0 t -136.69 171.68 14.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.464 0.649 . . . . 0.5 111.986 -165.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -104.81 -18.17 14.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.877 -1.056 . . . . 1.86 108.702 165.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -124.21 102.8 33.45 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.268 -0.878 . . . . 1.77 109.661 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -90.07 4.29 4.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.165 2.577 . . . . 0.59 112.846 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.48 -12.37 58.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.338 0.59 . . . . 0.78 109.805 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.6 m -93.53 5.9 50.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.298 -0.865 . . . . 1.45 109.271 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 145' ' ' MET . 31.2 mm . . . . . 0 N--CA 1.45 -0.473 0 CA-C-N 115.095 -0.957 . . . . 0.7 110.487 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 126' ' ' HIS . 20.4 ptm . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 112.253 0.464 . . . . 1.13 112.253 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.439 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 14.3 m80 -67.54 138.61 56.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 2.51 109.826 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.643 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.4 m-20 -52.3 -64.67 0.74 Allowed 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.18 0.3 . . . . 1.77 111.401 -175.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -59.57 -27.29 66.12 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.91 -0.494 . . . . 2.13 111.809 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.439 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 2.3 m-20 -70.31 -43.68 69.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 1.05 110.68 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 11.2 p -73.68 -15.79 16.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.32 110.37 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -90.18 -40.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 119.181 -0.438 . . . . 0.37 110.551 172.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -43.16 -67.75 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.348 0.976 . . . . 1.38 112.014 163.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.694 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.6 tp -49.35 -43.79 44.14 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.592 -0.731 . . . . 0.74 109.894 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.66 -50.85 64.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.118 -1.401 . . . . 0.22 112.421 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 17.1 t -78.74 -18.64 53.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.758 -1.11 . . . . 1.33 110.71 -173.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.16 -50.46 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.838 -0.43 . . . . 0.23 109.838 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.8 m -77.12 114.88 43.96 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 122.057 0.932 . . . . 0.21 109.985 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.8 ' HG2' HD13 ' A' ' 57' ' ' ILE . 46.4 Cg_endo -82.12 -178.11 3.89 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.169 2.579 . . . . 0.34 112.609 -174.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.712 ' O ' HD21 ' A' ' 51' ' ' LEU . 20.6 m120 -59.2 -1.71 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.591 -1.186 . . . . 1.02 113.364 -174.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.42 59.08 0.5 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.947 -0.644 . . . . 0.28 112.414 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.2 m -95.69 134.85 38.12 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.535 -0.391 . . . . 0.3 110.393 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -84.88 140.24 31.29 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.098 -0.334 . . . . 1.96 110.098 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.716 HG11 HD11 ' A' ' 118' ' ' LEU . 3.7 p -145.55 130.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.811 -0.631 . . . . 0.46 111.271 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.404 ' C ' HD12 ' A' ' 165' ' ' ILE . 20.0 m -116.82 138.18 51.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.811 -0.631 . . . . 0.56 111.789 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.465 HG23 HG13 ' A' ' 65' ' ' ILE . 2.9 mp -122.18 109.84 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 118.997 -1.081 . . . . 0.96 110.619 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 114.526 -1.215 . . . . 1.19 109.358 -170.187 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.417 -0.586 . . . . 2.1 109.417 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.784 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.9 mt -91.96 170.63 9.7 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.94 -0.573 . . . . 0.26 110.854 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.539 HD23 ' CG1' ' A' ' 48' ' ' ILE . 3.6 tp -76.49 149.07 36.81 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 122.983 0.513 . . . . 0.23 111.866 -170.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.51 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.59 149.18 36.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.166 0.984 . . . . 0.26 111.67 168.125 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 45' ' ' SER . 77.3 t80 -134.54 147.53 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.304 -1.771 . . . . 0.39 107.521 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.56 112.01 14.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.288 -1.745 . . . . 1.07 106.288 174.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 40' ' ' LEU . 1.6 m -71.42 157.68 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 115.714 -0.675 . . . . 0.38 111.961 -165.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -108.27 147.77 30.94 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.113 -0.948 . . . . 2.59 109.387 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.5 tm0? -51.58 131.22 29.42 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.888 0.742 . . . . 1.74 112.349 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -4.59 39.69 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.371 -0.831 . . . . 0.57 111.44 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -45.11 143.63 1.53 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.915 1.45 . . . . 2.17 114.915 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.23 140.1 46.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.978 -1.01 . . . . 0.5 111.674 164.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.5 tp -42.31 -55.28 3.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.315 -0.857 . . . . 0.27 113.174 -175.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 17.3 t-20 -65.43 -42.97 91.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.584 1.183 . . . . 1.21 110.375 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.786 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 15.1 m -62.95 -38.06 89.54 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 112.477 -2.147 . . . . 1.24 110.878 -176.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -76.08 -39.62 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 O-C-N 123.713 0.633 . . . . 0.3 112.2 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.718 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.02 -59.59 4.85 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.611 -0.268 . . . . 0.23 110.998 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 -4.65 56.83 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.527 -1.269 . . . . 0.39 111.848 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.786 ' HB2' ' O ' ' A' ' 17' ' ' SER . 8.3 t70 -61.3 -29.24 69.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.567 -1.272 . . . . 1.63 107.567 157.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.692 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.8 m-85 -109.06 19.13 19.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.999 0.74 . . . . 0.24 112.999 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? 49.57 54.95 10.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.486 -0.779 . . . . 3.55 111.266 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 19' ' ' ALA . 33.5 pt -148.18 -172.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.721 -0.844 . . . . 0.27 108.721 -173.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.58 146.78 24.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.66 -0.7 . . . . 0.81 109.684 173.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.644 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.1 p -62.69 -35.19 78.89 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.793 -0.818 . . . . 0.27 108.793 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.16 -28.88 68.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.362 -1.29 . . . . 0.26 111.665 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.38 26.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.241 -0.651 . . . . 0.23 109.241 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 16.5 tp -72.46 -17.85 61.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.144 -0.935 . . . . 0.17 108.772 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.757 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.05 -37.51 33.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.393 0.616 . . . . 0.19 111.16 171.234 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -56.39 -46.28 80.18 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.636 1.208 . . . . 1.07 110.278 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.69 43.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 112.998 -1.91 . . . . 0.17 112.317 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 15.7 m120 -142.51 73.1 20.59 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.19 110.108 -172.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.747 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.6 Cg_endo -57.24 -13.55 12.95 Favored 'Trans proline' 0 C--O 1.22 -0.419 0 C-N-CA 123.437 2.758 . . . . 0.3 114.325 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.48 -31.59 71.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.932 0.872 . . . . 1.17 109.718 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.675 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -81.0 -6.69 59.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.469 1.285 . . . . 0.53 114.469 -171.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.757 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -50.86 -41.48 58.03 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.806 1.185 . . . . 1.23 110.147 179.538 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.62 -46.32 13.44 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.829 -1.987 . . . . 0.4 111.136 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.01 -170.32 43.4 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.49 -0.862 . . . . 0.3 113.952 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 9' ' ' VAL . 5.3 mp -110.03 161.71 15.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.558 -1.321 . . . . 0.31 109.724 177.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.3 m -135.61 134.12 38.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.872 -0.603 . . . . 0.39 110.428 176.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.44 129.25 18.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.314 0.578 . . . . 0.47 112.281 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.18 -12.9 57.11 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.802 -1.09 . . . . 0.36 112.647 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.6 tt0 -65.88 152.7 43.88 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.641 0.734 . . . . 1.19 110.306 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.498 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 50.7 m -117.02 130.68 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.501 -1.227 . . . . 0.89 109.603 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 29' ' ' LEU . 20.6 pt -134.46 145.51 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.516 0.674 . . . . 0.22 110.526 -174.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.558 ' H ' HD22 ' A' ' 33' ' ' ASN . 12.5 t -91.02 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.866 -1.061 . . . . 0.21 110.192 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.8 mm -117.47 88.53 29.09 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-N 115.083 -0.962 . . . . 0.17 108.425 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.784 ' HA ' HD13 ' A' ' 4' ' ' LEU . 22.8 Cg_endo -58.74 141.36 97.71 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.221 2.614 . . . . 0.23 112.967 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.495 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.6 -7.6 72.58 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.381 -0.827 . . . . 0.3 113.115 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.636 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.7 tt -118.53 128.39 26.0 Favored Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.641 -0.874 . . . . 0.25 108.641 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.636 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.8 Cg_endo -67.33 175.12 6.22 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.563 2.842 . . . . 0.31 113.825 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.771 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.9 t70 -89.46 142.11 29.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.72 110.56 -171.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.503 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 75.0 Cg_endo -84.28 -4.58 10.26 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.576 2.851 . . . . 0.27 112.363 -174.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -94.79 -26.53 16.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.741 -0.466 . . . . 2.11 109.741 174.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.771 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.1 p -72.99 -28.76 62.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.561 1.172 . . . . 1.47 107.844 171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.755 HD13 ' HG2' ' A' ' 158' ' ' PRO . 93.0 mt -80.68 124.35 81.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 113.065 -1.88 . . . . 0.26 109.868 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -101.8 96.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 120.779 0.986 . . . . 0.2 110.235 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.489 ' HB2' HG23 ' A' ' 161' ' ' THR . 89.9 m-85 -157.74 133.23 9.01 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.387 -1.338 . . . . 0.26 107.387 172.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 9.7 m-70 -137.08 103.82 5.25 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.259 -1.756 . . . . 2.84 106.259 -167.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.1 mt -92.96 106.43 17.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.705 0.764 . . . . 0.32 109.595 -177.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.86 96.1 5.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.716 -1.129 . . . . 0.34 110.623 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.557 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -114.82 96.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 113.743 -1.571 . . . . 0.68 108.712 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.51 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.1 m -95.18 122.57 38.0 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.209 -1.36 . . . . 1.05 108.383 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 3.1 mm -47.3 -34.48 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.428 0.632 . . . . 1.29 110.117 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.55 -47.33 35.05 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.17 -0.923 . . . . 0.88 112.336 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.51 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -64.37 -24.25 67.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.317 0.58 . . . . 0.74 112.392 174.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 17.9 mttt 54.97 17.63 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.773 1.229 . . . . 2.51 113.414 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.414 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -143.32 142.46 31.32 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.318 0.58 . . . . 0.45 111.02 171.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.557 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.5 tt -90.98 118.21 30.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.169 -0.923 . . . . 0.33 109.411 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -105.0 125.77 51.33 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.392 -0.523 . . . . 0.4 111.691 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.543 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.76 136.82 34.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.129 -1.804 . . . . 0.33 106.129 176.055 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.648 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 13.3 m -141.78 129.35 21.44 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 120.493 1.497 . . . . 0.75 112.758 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.26 126.59 53.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.045 -0.98 . . . . 0.35 110.539 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.9 t-20 63.74 37.79 9.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.423 0.63 . . . . 0.52 109.827 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.4 m-20 76.25 0.57 3.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.672 -1.149 . . . . 1.84 112.525 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.49 138.54 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.279 -1.368 . . . . 3.19 113.751 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -53.89 147.23 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 113.053 -1.885 . . . . 0.41 112.863 -172.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.52 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -96.47 -45.66 6.67 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.338 -2.21 . . . . 0.35 107.565 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 30.2 tptt -176.77 159.33 1.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.216 -2.265 . . . . 2.07 110.298 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.414 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 3.6 m -119.43 134.81 55.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.397 -0.121 . . . . 0.37 111.051 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -120.22 127.14 26.48 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 120.924 0.392 . . . . 0.97 110.876 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 69' ' ' THR . 7.7 Cg_endo -57.46 137.82 83.25 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 124.16 3.24 . . . . 0.6 113.813 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 168.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.818 -0.353 . . . . 0.64 110.371 177.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.314 0 CA-C-O 121.549 0.69 . . . . 0.83 111.39 179.025 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.642 ' HB2' HG13 ' A' ' 163' ' ' VAL . 13.3 m-85 . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 107.205 -1.405 . . . . 1.93 107.205 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 161' ' ' THR . 84.6 m-85 -130.37 135.9 48.52 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.277 -0.569 . . . . 0.58 111.021 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.804 HD11 HD12 ' A' ' 125' ' ' ILE . 26.8 mm -60.26 121.06 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 107.346 -1.353 . . . . 0.41 107.346 164.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.629 HD12 ' HD1' ' A' ' 22' ' ' PHE . 3.1 tt -109.04 -22.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.487 -0.885 . . . . 0.37 112.099 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 21.1 p-10 -178.5 -165.7 0.09 Allowed 'General case' 0 C--N 1.348 0.531 0 N-CA-C 114.024 1.12 . . . . 1.99 114.024 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 103' ' ' ARG . 5.3 ptp180 -150.73 139.66 20.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 112.683 -2.053 . . . . 1.19 111.68 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 24.7 tp60 -107.12 145.0 33.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.604 -1.18 . . . . 1.67 111.407 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.707 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 34.3 ttm180 -56.64 150.15 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.167 -1.833 . . . . 3.06 111.506 170.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -46.07 104.01 0.38 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 123.89 0.744 . . . . 2.61 111.736 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.425 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 87.9 Cg_exo -56.35 -51.64 8.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.815 3.01 . . . . 0.98 111.874 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.75 -21.59 13.83 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.02 -0.991 . . . . 1.08 112.578 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -100.27 -169.49 29.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.96 -0.638 . . . . 1.05 112.311 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.52 32.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.256 3.304 . . . . 1.3 113.754 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -85.92 -20.92 28.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.142 0.496 . . . . 1.38 109.933 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.439 ' HA3' ' CA ' ' A' ' 127' ' ' GLY . . . 96.33 42.55 3.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.519 -0.764 . . . . 1.11 114.019 170.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.69 -33.62 0.23 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.419 0.896 . . . . 0.81 113.419 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.559 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -150.17 127.0 11.04 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.816 -0.439 . . . . 1.12 109.816 -174.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 34.0 t-105 -100.48 100.39 11.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.158 -0.682 . . . . 2.19 109.158 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.2 mp -101.09 141.27 34.22 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 0.61 109.016 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.1 m -106.93 144.09 34.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.644 0.609 . . . . 0.94 112.644 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.598 HD11 HG11 ' A' ' 163' ' ' VAL . 2.3 tp -97.97 -174.19 2.8 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.786 -1.191 . . . . 1.08 107.786 172.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--N 1.314 -0.951 0 C-N-CA 120.586 -0.445 . . . . 1.5 110.741 175.35 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.804 HD12 HD11 ' A' ' 100' ' ' ILE . 9.2 mt . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.541 -0.911 . . . . 0.48 108.541 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -136.95 -161.76 1.2 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.527 0.68 . . . . 1.25 111.27 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.439 ' CA ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.1 155.8 16.08 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.815 -1.183 . . . . 0.46 113.569 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.441 HG21 ' CA ' ' A' ' 131' ' ' PRO . 3.8 t -98.37 172.5 7.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.028 -1.086 . . . . 0.5 110.592 -171.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.93 -13.35 13.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.351 -0.841 . . . . 1.86 109.075 160.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 133' ' ' SER . 24.1 t30 -124.75 101.12 33.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.185 -0.916 . . . . 1.77 109.414 171.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.441 ' CA ' HG21 ' A' ' 128' ' ' THR . 81.1 Cg_endo -90.49 3.29 4.82 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.785 2.323 . . . . 0.59 113.039 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -94.8 -2.02 51.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.383 0.611 . . . . 0.78 109.546 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.468 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 33.3 t -90.23 -12.69 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.262 -0.881 . . . . 1.45 109.555 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.6 mm . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.672 -0.695 . . . . 0.7 109.963 177.831 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.528 ' CG ' ' HB ' ' A' ' 150' ' ' VAL . 5.1 ptm . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 113.279 0.844 . . . . 1.13 113.279 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -71.12 153.93 42.14 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.851 -0.796 . . . . 2.51 108.851 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.573 ' O ' HG12 ' A' ' 150' ' ' VAL . 29.8 p-10 -54.21 -69.91 0.11 Allowed 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.268 0.47 . . . . 1.77 112.268 -172.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -61.39 -20.35 62.95 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.567 -0.708 . . . . 2.13 111.405 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -74.26 -45.3 48.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.667 -0.697 . . . . 1.05 110.354 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.601 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.2 p -72.05 -18.37 19.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.32 110.945 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.583 HD12 HG13 ' A' ' 150' ' ' VAL . 1.9 mp -84.68 -36.68 11.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 119.116 -0.469 . . . . 0.37 110.297 177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -45.05 -70.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 119.441 1.018 . . . . 1.38 112.337 162.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.677 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -49.45 -40.88 38.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.74 110.316 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.99 -55.6 30.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.169 -1.378 . . . . 0.22 111.997 -172.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.9 p -75.08 -12.91 60.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.7 -1.136 . . . . 1.33 110.919 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.89 -49.87 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.881 -0.6 . . . . 0.23 110.098 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.2 m -77.15 115.69 51.05 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 122.096 0.95 . . . . 0.21 110.541 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.755 ' HG2' HD13 ' A' ' 57' ' ' ILE . 38.4 Cg_endo -82.78 -177.34 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.184 2.589 . . . . 0.34 112.971 -173.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.631 ' O ' HD21 ' A' ' 51' ' ' LEU . 12.0 m120 -57.63 -2.13 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.708 -1.133 . . . . 1.02 113.898 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.57 57.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.28 112.537 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.2 m -92.69 134.62 34.85 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.612 -0.346 . . . . 0.3 110.479 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 138.81 31.73 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.904 0.383 . . . . 1.96 110.389 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -145.63 127.39 8.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.339 -0.846 . . . . 0.46 110.911 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 63' ' ' VAL . 3.3 m -116.34 143.0 46.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.854 -0.612 . . . . 0.56 111.652 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.465 HG13 HG13 ' A' ' 63' ' ' VAL . 3.1 mp -124.34 107.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 119.252 -0.979 . . . . 0.96 109.77 172.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 1.19 111.148 -168.503 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.533 ' HE2' ' CG2' ' A' ' 56' ' ' THR . 4.1 mppt? . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 109.89 -0.411 . . . . 2.1 109.89 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.1 mt -95.21 172.6 8.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.855 -0.611 . . . . 0.26 111.192 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.548 HD23 ' CG1' ' A' ' 48' ' ' ILE . 4.2 tp -75.49 149.2 38.51 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.103 0.478 . . . . 0.23 111.77 -170.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.529 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.29 147.82 38.47 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.143 0.973 . . . . 0.26 111.6 167.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' SER . 81.1 t80 -133.91 146.7 50.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.205 -1.816 . . . . 0.39 107.571 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.6 tt0 -127.33 111.35 13.8 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 1.07 106.66 176.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.549 HG11 HD23 ' A' ' 40' ' ' LEU . 1.2 m -70.64 157.44 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 121.37 0.605 . . . . 0.38 111.856 -165.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.31 147.09 33.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.128 -0.942 . . . . 2.59 109.44 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.658 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 3.8 tt0 -53.13 130.82 35.5 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.838 0.712 . . . . 1.74 112.15 -173.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.81 -4.85 39.51 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.491 -0.777 . . . . 0.57 111.672 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -43.5 146.17 0.53 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.004 1.483 . . . . 2.17 115.004 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.35 139.9 45.97 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.014 -0.994 . . . . 0.5 111.928 162.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.582 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.5 tp -43.11 -55.76 3.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.499 -0.773 . . . . 0.27 113.031 -175.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.679 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.2 -40.06 93.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.261 1.029 . . . . 1.21 110.268 -171.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -59.81 -49.88 75.97 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 112.924 -1.944 . . . . 1.24 109.534 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -65.84 -39.35 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 O-C-N 123.522 0.514 . . . . 0.3 111.35 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.68 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.41 -62.67 1.61 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.887 -0.597 . . . . 0.23 111.612 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.27 -4.27 56.84 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.996 -1.081 . . . . 0.39 112.292 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.56 -33.58 74.11 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.285 -1.005 . . . . 1.63 108.285 155.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.6 m-85 -101.47 27.39 6.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.099 0.407 . . . . 0.24 112.099 175.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.694 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.13 68.62 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.836 1.255 . . . . 3.55 113.805 -168.406 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.772 HG23 ' O ' ' A' ' 22' ' ' PHE . 34.6 pt -147.42 -173.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.856 -1.164 . . . . 0.27 107.856 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -101.09 145.68 28.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.764 -0.653 . . . . 0.81 109.409 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.679 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.7 p -61.93 -35.24 77.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.54 0.686 . . . . 0.27 109.208 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.1 -30.18 71.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.282 -1.326 . . . . 0.26 111.334 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.14 -38.54 27.01 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.394 0.616 . . . . 0.23 109.692 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.693 HD11 HD12 ' A' ' 46' ' ' ILE . 13.9 tp -72.74 -18.22 61.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.432 -0.804 . . . . 0.17 108.963 175.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.738 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.58 -37.58 35.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.19 111.223 171.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.0 mt-30 -56.96 -47.43 80.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.285 1.04 . . . . 1.07 109.501 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.56 -18.37 51.91 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.361 -1.745 . . . . 0.17 112.178 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 15.1 m120 -143.15 72.52 18.22 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.153 0.501 . . . . 0.19 109.903 -173.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.774 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.68 -13.0 12.85 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 123.322 2.681 . . . . 0.3 113.781 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -31.78 70.67 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 122.045 0.926 . . . . 1.17 109.897 174.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.668 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -82.67 -6.45 59.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.159 -1.382 . . . . 0.53 114.527 -172.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.774 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -50.6 -42.28 55.71 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 119.778 1.172 . . . . 1.23 109.907 178.04 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.19 -47.04 15.29 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 112.99 -1.914 . . . . 0.4 111.172 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.668 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.12 -166.82 39.04 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-O 122.162 0.868 . . . . 0.3 113.989 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.549 HD23 HG11 ' A' ' 9' ' ' VAL . 5.1 mp -113.76 160.34 18.78 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.392 -1.404 . . . . 0.31 109.871 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.0 m -136.02 135.36 39.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.901 -0.591 . . . . 0.39 110.231 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.12 129.98 18.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.438 0.637 . . . . 0.47 112.451 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.99 -13.03 46.54 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.804 -1.089 . . . . 0.36 112.534 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.613 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -64.34 152.71 40.53 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.507 0.67 . . . . 1.19 110.288 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 45.8 m -117.81 132.32 56.46 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.741 -1.118 . . . . 0.89 109.512 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.693 HD12 HD11 ' A' ' 29' ' ' LEU . 17.4 pt -135.77 155.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.354 0.597 . . . . 0.22 110.633 -175.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.488 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.5 t -100.08 149.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.0 -1.0 . . . . 0.21 110.189 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.548 ' CG1' HD23 ' A' ' 5' ' ' LEU . 18.0 mm -117.57 87.8 27.1 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 0.17 108.257 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.742 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.4 Cg_endo -57.89 143.45 95.83 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.303 2.669 . . . . 0.23 112.937 -173.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.485 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.2 -7.22 60.96 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.667 -0.697 . . . . 0.3 113.07 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.9 tt -116.15 126.47 27.6 Favored Pre-proline 0 C--O 1.219 -0.539 0 N-CA-C 108.457 -0.942 . . . . 0.25 108.457 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD2' HD23 ' A' ' 51' ' ' LEU . 60.1 Cg_endo -66.45 174.88 5.67 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.72 2.947 . . . . 0.31 113.618 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.753 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.9 t70 -89.63 141.75 28.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.72 110.355 -172.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.511 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 90.2 Cg_endo -82.49 -3.88 11.48 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.423 2.749 . . . . 0.27 112.169 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.68 -25.44 16.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 2.11 110.14 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.753 HG23 ' HB3' ' A' ' 53' ' ' ASP . 22.7 p -74.05 -28.32 61.35 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.737 -1.208 . . . . 1.47 107.737 171.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.798 HD13 ' HG2' ' A' ' 158' ' ' PRO . 97.0 mt -80.93 128.6 70.78 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 113.234 -1.803 . . . . 0.26 109.659 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -103.6 96.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.942 0 CA-C-N 120.1 1.071 . . . . 0.2 110.681 166.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HD2' HG23 ' A' ' 57' ' ' ILE . 80.3 m-85 -157.7 132.81 8.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.587 -1.264 . . . . 0.26 107.587 172.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.585 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 2.7 m-70 -139.08 104.98 5.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.483 -1.302 . . . . 2.84 107.483 -164.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.7 mt -96.35 114.4 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.722 -0.672 . . . . 0.32 111.169 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.84 97.01 6.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.202 -0.908 . . . . 0.34 110.808 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -120.79 100.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.396 -1.275 . . . . 0.68 110.253 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.537 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.9 m -94.76 134.51 37.28 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.23 -0.895 . . . . 1.05 109.298 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.557 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 6.0 mm -59.39 -33.44 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.867 0.842 . . . . 1.29 109.433 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.33 40.97 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.314 -1.312 . . . . 0.88 112.068 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -68.16 -24.86 65.03 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.177 0.513 . . . . 0.74 112.18 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 26.8 mttt 55.74 16.94 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.295 1.038 . . . . 2.51 113.544 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.98 142.37 31.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 0.45 110.839 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.516 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.2 tt -96.37 120.25 36.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.467 -1.242 . . . . 0.33 109.658 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 m -101.12 122.34 43.42 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.078 -0.649 . . . . 0.4 111.019 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.549 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.44 131.76 35.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 106.22 -1.77 . . . . 0.33 106.22 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -137.28 126.89 25.24 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.677 1.581 . . . . 0.75 112.703 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -113.06 126.22 55.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.089 -0.959 . . . . 0.35 110.288 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 66.86 35.31 4.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.499 0.666 . . . . 0.52 109.326 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.4 t30 75.7 -0.28 3.23 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.215 -1.357 . . . . 1.84 112.21 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -128.93 140.6 51.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.125 -1.43 . . . . 3.19 113.944 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -56.14 148.09 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 113.41 -1.723 . . . . 0.41 113.371 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.549 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -96.94 -46.42 6.22 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.013 -2.358 . . . . 0.35 107.594 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 21.0 tptp -178.77 155.68 0.81 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.397 -2.183 . . . . 2.07 110.462 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -111.48 131.57 55.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.483 -0.192 . . . . 0.37 110.483 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.85 135.85 24.5 Favored Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.97 111.6 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -64.04 140.96 74.88 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.272 2.648 . . . . 0.6 112.613 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 -179.64 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.803 -0.814 . . . . 0.64 108.803 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.083 0.468 . . . . 0.83 110.662 175.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 163' ' ' VAL . 2.4 m-85 . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 108.181 -1.044 . . . . 1.93 108.181 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.5 m-85 -136.31 138.68 41.96 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.213 -0.595 . . . . 0.58 111.639 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.73 HD11 HD12 ' A' ' 125' ' ' ILE . 26.8 mm -59.93 106.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.19 -1.411 . . . . 0.41 107.19 163.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.694 HD11 ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -94.87 -24.03 4.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.829 -0.749 . . . . 0.37 111.587 -176.28 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -172.01 -174.75 1.35 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 122.784 1.278 . . . . 1.99 114.227 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.504 ' NH1' ' HA ' ' A' ' 155' ' ' SER . 2.8 ptt180 -149.9 137.7 20.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 111.374 -2.648 . . . . 1.19 110.575 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.642 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 29.2 tp60 -105.83 144.37 32.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.842 -1.072 . . . . 1.67 110.386 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.576 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 23.8 ttm180 -53.37 155.28 2.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.748 -2.024 . . . . 3.06 112.085 172.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.576 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.4 109.87 1.1 Allowed Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 114.955 -1.021 . . . . 2.61 110.498 175.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.15 -52.07 5.58 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.325 2.683 . . . . 0.98 111.958 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.33 -20.24 25.89 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.197 -0.91 . . . . 1.08 112.168 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -115.27 -169.94 16.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.94 -0.648 . . . . 1.05 112.621 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.31 9.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 124.598 3.532 . . . . 1.3 114.557 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 115' ' ' TRP . 3.8 t80 -62.27 -27.37 68.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.421 0.629 . . . . 1.38 109.959 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.78 55.36 0.94 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.11 114.427 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 73.38 -46.98 0.65 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.389 1.255 . . . . 0.81 114.389 166.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.567 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -151.84 147.06 26.17 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 122.638 0.375 . . . . 1.12 110.445 -174.586 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.642 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 47.0 t-105 -118.56 102.58 9.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.975 -0.38 . . . . 2.19 109.975 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -107.45 139.78 41.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.561 0.696 . . . . 0.61 110.222 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 101' ' ' ILE . 58.3 m -107.66 148.52 29.26 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.51 0.93 . . . . 0.94 113.51 -168.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.48 HD22 HG11 ' A' ' 163' ' ' VAL . 70.4 mt -103.09 -172.62 2.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.416 -1.266 . . . . 1.08 107.981 173.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 p . . . . . 0 C--N 1.324 -0.521 0 C-N-CA 119.422 -0.911 . . . . 1.5 110.244 173.347 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 100' ' ' ILE . 20.4 mt . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.085 -0.709 . . . . 0.48 109.085 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -145.45 -163.15 1.66 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.283 -0.567 . . . . 1.25 111.117 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.55 173.76 16.1 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.171 -1.014 . . . . 0.46 113.016 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -137.21 174.68 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.432 0.634 . . . . 0.5 111.375 -167.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -104.44 -17.87 14.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.199 -0.909 . . . . 1.86 109.604 165.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -125.39 103.08 29.36 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.827 -0.624 . . . . 1.77 110.238 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.53 4.43 4.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.203 2.602 . . . . 0.59 113.545 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.49 -22.66 54.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.189 0.519 . . . . 0.78 110.818 -171.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -88.28 -6.56 57.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 1.45 110.303 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 134' ' ' ILE . 30.4 mm . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.663 0.744 . . . . 0.7 110.176 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.428 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 7.8 ptm . . . . . 0 C--O 1.232 0.177 0 N-CA-C 111.858 0.318 . . . . 1.13 111.858 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -61.43 144.23 54.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.474 -0.33 . . . . 2.51 110.156 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.563 ' O ' HG12 ' A' ' 150' ' ' VAL . 25.3 p-10 -51.98 -64.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.025 0.203 . . . . 1.77 111.536 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -62.68 -26.66 68.77 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.747 -0.596 . . . . 2.13 111.462 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.47 -42.23 71.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.451 -0.341 . . . . 1.05 110.526 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.625 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.8 p -75.8 -17.44 15.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.32 110.577 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.567 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -88.33 -37.99 11.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 119.289 -0.386 . . . . 0.37 110.306 174.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -43.64 -70.23 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.078 0.854 . . . . 1.38 111.954 161.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.664 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.0 OUTLIER -50.03 -41.2 47.01 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.465 -0.789 . . . . 0.74 110.29 178.248 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.41 -51.57 64.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.662 -1.154 . . . . 0.22 111.719 -173.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.504 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 14.9 m -77.94 -13.42 59.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.393 -1.276 . . . . 1.33 111.387 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.48 -50.85 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.156 -0.474 . . . . 0.23 110.08 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 153' ' ' LEU . 18.9 m -78.59 115.37 51.1 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-O 121.943 0.878 . . . . 0.21 110.536 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.798 ' HG2' HD13 ' A' ' 57' ' ' ILE . 33.5 Cg_endo -84.6 -177.17 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.375 2.717 . . . . 0.34 112.935 -174.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.616 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.5 m120 -56.09 -2.35 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.636 -1.165 . . . . 1.02 114.016 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.2 57.2 0.5 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.633 -0.794 . . . . 0.28 112.477 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.4 m -92.16 133.14 36.06 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.018 -0.364 . . . . 0.3 110.018 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.22 133.9 34.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.469 -0.492 . . . . 1.96 110.089 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -143.84 130.78 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 0.46 111.234 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.402 ' C ' HD12 ' A' ' 165' ' ' ILE . 29.6 m -115.55 140.45 49.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.855 -0.612 . . . . 0.56 111.647 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 164' ' ' THR . 2.9 mp -123.82 110.29 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 118.957 -1.097 . . . . 0.96 110.217 171.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p30 . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 114.897 -1.047 . . . . 1.19 110.566 -172.759 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.543 -0.623 . . . . 2.92 111.543 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -87.36 134.86 33.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.216 0.531 . . . . 4.1 110.475 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 3.1 mppt? -74.25 157.31 36.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.95 -1.023 . . . . 2.1 111.114 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 49' ' ' PRO . 20.0 mt -85.2 168.26 14.94 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.721 0.638 . . . . 0.26 110.958 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.869 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -76.87 149.48 36.11 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 123.273 0.629 . . . . 0.23 112.57 -167.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.528 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.2 148.94 36.52 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.091 -0.959 . . . . 0.26 111.427 167.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 45' ' ' SER . 74.3 t80 -134.42 148.43 50.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.705 -1.589 . . . . 0.39 107.753 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.89 114.46 15.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.152 -1.425 . . . . 1.07 107.152 175.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.442 HG11 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -77.51 158.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.801 -0.636 . . . . 0.38 111.262 -168.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -112.44 153.1 27.89 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.846 -0.798 . . . . 2.59 108.846 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.676 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.24 116.18 1.91 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.64 -0.709 . . . . 1.74 112.396 -172.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.93 -11.57 20.51 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.476 -0.783 . . . . 0.57 113.013 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.584 ' HB3' HD11 ' A' ' 18' ' ' ILE . 78.9 m-20 -63.13 153.97 32.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.633 0.605 . . . . 2.17 112.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.551 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.4 p -134.05 155.0 50.79 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.858 -0.61 . . . . 0.5 112.385 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.3 tp -48.64 -58.99 3.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.68 0.992 . . . . 0.27 113.68 -173.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.656 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.9 t-20 -65.25 -43.13 92.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.533 1.159 . . . . 1.21 110.164 -169.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.83 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 13.9 m -57.98 -43.13 86.36 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 112.381 -2.19 . . . . 1.24 110.484 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.584 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.51 -41.1 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 123.738 0.815 . . . . 0.3 112.566 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.678 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.29 -64.41 0.87 Allowed 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.588 -0.278 . . . . 0.23 111.388 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.27 -4.46 50.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.875 -1.13 . . . . 0.39 111.843 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.83 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.8 t0 -65.54 -34.31 77.95 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.618 -0.882 . . . . 1.63 108.618 157.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.673 ' CD1' HD12 ' A' ' 101' ' ' ILE . 1.9 m-85 -95.15 16.92 15.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.777 0.322 . . . . 0.24 111.83 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 55.14 48.41 19.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.619 -0.719 . . . . 3.55 110.552 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.678 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.1 pt -147.22 -176.34 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.526 -0.916 . . . . 0.27 108.526 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -100.07 145.04 28.41 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.297 -0.865 . . . . 0.81 109.374 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.656 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 13.5 p -60.75 -35.85 77.44 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.41 0.624 . . . . 0.27 109.331 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.569 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.02 -32.71 74.14 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.488 -1.233 . . . . 0.26 111.514 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -37.51 42.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.095 0.474 . . . . 0.23 109.749 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 46' ' ' ILE . 18.3 tp -73.63 -19.25 60.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.499 -0.773 . . . . 0.17 109.077 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.737 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.79 35.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.3 0.571 . . . . 0.19 111.419 172.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 64.9 mt-30 -57.04 -44.33 82.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.511 1.148 . . . . 1.07 109.598 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.39 42.18 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.327 -1.76 . . . . 0.17 112.37 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.7 m120 -143.28 72.56 17.97 Favored Pre-proline 0 CA--C 1.513 -0.466 0 CA-C-O 121.075 0.464 . . . . 0.19 110.014 -171.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.691 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.6 Cg_endo -57.87 -9.05 5.21 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.289 2.659 . . . . 0.3 113.876 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -63.62 -33.54 75.83 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.073 0.939 . . . . 1.17 109.363 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.646 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -80.97 -6.53 58.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.059 -1.428 . . . . 0.53 114.508 -171.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.737 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.73 -40.64 41.39 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.634 1.207 . . . . 1.23 109.919 177.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.61 -46.36 11.61 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 112.755 -2.02 . . . . 0.4 111.815 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -166.89 39.11 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.439 -0.886 . . . . 0.3 114.163 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 18' ' ' ILE . 5.3 mp -113.98 158.97 20.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.67 -1.265 . . . . 0.31 110.214 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.623 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.05 135.32 39.31 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.905 -0.589 . . . . 0.39 110.923 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.676 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.91 126.69 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.338 0.866 . . . . 0.47 113.338 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.8 -10.52 51.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 114.539 -1.21 . . . . 0.36 112.192 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.5 tt0 -64.28 152.31 41.4 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.572 0.701 . . . . 1.19 110.552 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.7 m -118.47 134.74 54.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.452 -1.249 . . . . 0.89 109.113 -172.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 HD11 ' A' ' 29' ' ' LEU . 22.2 pt -137.08 153.93 30.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.213 0.53 . . . . 0.22 110.508 -175.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.533 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.4 t -98.81 148.99 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.292 -0.867 . . . . 0.21 110.407 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.5 mm -118.16 88.09 31.2 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 114.903 -1.044 . . . . 0.17 108.356 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.703 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.7 Cg_endo -60.04 140.59 93.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.095 2.53 . . . . 0.23 112.43 -174.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.534 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.01 -7.79 69.43 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.636 -0.711 . . . . 0.3 112.528 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.759 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.63 128.67 25.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.487 -0.931 . . . . 0.25 108.487 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.655 ' HD2' HD23 ' A' ' 51' ' ' LEU . 71.8 Cg_endo -69.36 169.24 18.86 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.695 2.93 . . . . 0.31 114.241 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 3.2 t70 -90.91 136.88 27.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.621 -1.172 . . . . 0.72 111.603 -172.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.869 ' HD3' HD12 ' A' ' 5' ' ' LEU . 73.2 Cg_endo -76.74 -1.9 12.07 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.02 2.48 . . . . 0.27 112.893 -173.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -96.13 -28.75 14.44 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 120.714 0.292 . . . . 2.11 111.031 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 3' ' ' LYS . 34.7 p -65.19 -34.6 78.76 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.606 -1.257 . . . . 1.47 107.606 168.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.752 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.4 mt -78.15 126.37 83.65 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 113.053 -1.885 . . . . 0.26 111.016 176.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.47 96.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 120.92 1.08 . . . . 0.2 110.248 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.435 ' HD2' HG23 ' A' ' 57' ' ' ILE . 82.9 m-85 -158.87 136.77 10.39 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.463 -1.31 . . . . 0.26 107.463 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 26.2 t-80 -141.75 108.18 5.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.603 -1.258 . . . . 2.84 107.603 -169.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.0 mt -95.11 109.83 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.974 -1.012 . . . . 0.32 110.317 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.53 95.42 5.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.181 -0.918 . . . . 0.34 110.013 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.479 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -114.34 97.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.362 -1.29 . . . . 0.68 109.325 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 32.0 m -92.05 130.37 37.8 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.898 -1.046 . . . . 1.05 108.584 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.558 HG21 ' NE ' ' A' ' 167' ' ' ARG . 9.9 mm -60.2 -34.96 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.768 0.794 . . . . 1.29 109.042 177.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.38 91.24 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.475 -1.238 . . . . 0.88 111.337 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.489 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.11 -24.35 64.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.265 0.555 . . . . 0.74 112.217 176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.643 ' HA ' HG21 ' A' ' 86' ' ' VAL . 30.4 mttt 55.39 18.06 2.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.159 0.984 . . . . 2.51 112.798 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.518 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -141.26 140.58 33.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.78 0.8 . . . . 0.45 110.982 175.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.479 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -94.06 117.58 30.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.267 -1.333 . . . . 0.33 109.516 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 m -101.05 126.27 47.72 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.439 -0.504 . . . . 0.4 111.189 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.559 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -82.74 147.73 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.126 -1.805 . . . . 0.33 106.126 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 20.0 m -150.94 130.82 13.28 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 120.238 1.381 . . . . 0.75 112.329 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.9 tp -122.02 125.2 45.75 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.921 -1.036 . . . . 0.35 110.697 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 66.06 35.14 6.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.539 0.685 . . . . 0.52 109.321 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 82.19 2.0 1.33 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.183 -1.371 . . . . 1.84 111.719 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -131.52 140.46 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 118.756 -1.178 . . . . 3.19 113.623 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.4 148.28 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 113.017 -1.901 . . . . 0.41 112.788 -177.302 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.55 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.3 mtp -98.51 -42.74 7.17 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 112.734 -2.03 . . . . 0.35 108.275 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 179.32 159.47 0.67 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.226 -2.261 . . . . 2.07 110.135 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.518 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 11.8 m -119.14 133.26 55.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.588 0.232 . . . . 0.37 111.238 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 48.6 m-85 -117.38 145.44 36.09 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.541 . . . . 0.97 109.538 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.44 ' HB2' HG22 ' A' ' 134' ' ' ILE . 10.2 Cg_endo -82.09 144.34 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.308 2.005 . . . . 0.6 111.722 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.45 173.27 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.675 -0.491 . . . . 0.64 109.675 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.541 ' HB3' ' H ' ' A' ' 142' ' ' CYS . . . -86.3 118.63 25.86 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.38 0.61 . . . . 0.83 110.966 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 68' ' ' LYS . 1.3 t -111.18 -47.34 6.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.735 -1.121 . . . . 1.67 110.444 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.34 -173.42 15.31 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.663 -0.699 . . . . 3.08 111.471 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -118.12 -18.2 9.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.01 0.433 . . . . 7.26 110.118 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.4 tt -158.19 71.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 122.192 0.996 . . . . 6.29 109.674 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.4 tp -134.57 100.85 4.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.442 -0.799 . . . . 7.27 110.2 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' A' ' 92' ' ' GLN . 17.3 p -96.99 -154.96 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.057 -0.52 . . . . 5.18 111.451 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' H ' ' HB ' ' A' ' 91' ' ' THR . 0.0 OUTLIER 73.01 98.32 0.07 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.328 0.651 . . . . 4.81 109.778 -178.109 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 167' ' ' ARG . 16.5 p -75.39 113.11 22.65 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.22 -0.446 . . . . 2.11 111.129 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HD3' HH11 ' A' ' 167' ' ' ARG . 6.2 Cg_exo -74.46 91.48 0.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.283 1.988 . . . . 3.21 110.923 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 p -76.05 70.3 2.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.584 0.707 . . . . 3.59 111.576 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.09 165.39 30.28 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.44 -0.8 . . . . 2.1 111.323 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.82 145.87 44.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.058 0.456 . . . . 2.3 110.329 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.566 ' HB2' HG13 ' A' ' 163' ' ' VAL . 4.4 m-85 -120.67 170.48 9.39 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.841 -1.17 . . . . 1.93 107.841 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 161' ' ' THR . 60.6 m-85 -130.67 140.49 50.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.113 0.482 . . . . 0.58 110.879 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.837 HD11 HD12 ' A' ' 125' ' ' ILE . 19.0 mm -59.76 104.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.194 -1.039 . . . . 0.41 108.194 166.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.673 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.5 tt -103.01 -24.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 120.221 -0.592 . . . . 0.37 112.191 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 6.5 t-20 -155.23 157.73 37.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.133 1.16 . . . . 1.99 114.133 -172.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.31 133.73 26.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 111.767 -2.47 . . . . 1.19 110.262 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 33.5 tp60 -106.27 141.79 37.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.069 -0.969 . . . . 1.67 111.386 -173.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.515 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 17.7 ttt180 -54.69 150.76 9.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.075 -1.875 . . . . 3.06 112.434 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -45.19 100.36 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.507 0 O-C-N 124.931 1.395 . . . . 2.61 111.58 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -55.37 -50.02 14.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.886 3.058 . . . . 0.98 112.242 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.26 -13.16 23.71 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.02 -0.991 . . . . 1.08 112.256 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.75 -170.44 13.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.829 -0.7 . . . . 1.05 112.773 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.64 18.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 124.69 3.593 . . . . 1.3 114.61 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 115' ' ' TRP . 1.4 t80 -72.36 -16.13 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.256 0.55 . . . . 1.38 109.655 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.88 42.71 2.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 1.11 114.061 170.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 114' ' ' TYR . . . 73.59 -39.05 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.307 0.854 . . . . 0.81 113.307 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -151.55 144.79 24.69 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 122.719 0.408 . . . . 1.12 109.93 -174.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 47.8 t-105 -117.07 104.44 11.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.873 -0.417 . . . . 2.19 109.873 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.3 mp -105.95 137.1 44.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.546 0.688 . . . . 0.61 110.707 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.1 m -105.09 145.18 30.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.334 -0.848 . . . . 0.94 112.266 -170.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.517 HD11 HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -96.53 -174.67 3.1 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.907 -1.146 . . . . 1.08 107.907 171.051 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.556 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 33.7 m -106.66 3.38 26.73 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.764 1.024 . . . . 1.5 113.764 -172.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -130.93 98.7 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.127 -1.029 . . . . 2.97 112.908 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.483 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 96.9 mt-30 45.08 -107.04 0.12 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.444 1.276 . . . . 5.06 114.444 171.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -91.8 49.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.349 0.595 . . . . 5.95 111.438 -167.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.499 ' HB3' HD23 ' A' ' 118' ' ' LEU . 68.8 m-85 -136.54 130.93 33.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.854 -0.612 . . . . 4.83 110.107 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -155.09 156.73 27.13 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.971 -0.633 . . . . 0.95 111.724 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 HD11 ' A' ' 100' ' ' ILE . 40.0 mt -109.0 112.32 39.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.976 -0.75 . . . . 0.48 108.976 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 8.9 p80 -140.93 -167.65 2.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.752 0.787 . . . . 1.25 112.65 -172.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.469 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.62 179.86 16.05 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.586 -1.188 . . . . 0.46 113.221 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -144.65 174.6 10.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.49 0.662 . . . . 0.5 111.563 -165.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -110.85 -13.23 14.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.923 -1.035 . . . . 1.86 109.557 162.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -124.39 101.6 34.13 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.72 -0.673 . . . . 1.77 109.633 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -92.22 3.6 3.82 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.213 2.609 . . . . 0.59 113.682 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.07 -19.24 40.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.33 0.586 . . . . 0.78 110.458 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -87.7 -7.12 57.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.57 -0.741 . . . . 1.45 110.223 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.539 HD11 ' HE ' ' A' ' 144' ' ' ARG . 13.4 mm -79.74 104.85 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.238 -0.892 . . . . 0.7 111.369 -174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.41 -11.02 71.17 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.726 -1.125 . . . . 1.68 112.153 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -127.52 12.25 6.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.134 0.42 . . . . 4.39 112.134 -172.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.08 164.83 36.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.057 0.456 . . . . 3.94 111.375 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.5 m -92.22 63.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 4.68 111.016 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.3 m -79.98 50.7 1.24 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.96 -0.564 . . . . 5.68 111.886 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt 37.26 47.02 0.64 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.507 1.123 . . . . 8.3 113.415 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 57.48 63.7 5.06 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.995 -0.548 . . . . 3.85 114.024 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.541 ' H ' ' HB3' ' A' ' 85' ' ' ALA . 89.3 m -108.48 126.64 53.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 2.51 109.906 174.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 29.3 mt -96.21 73.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.6 0.714 . . . . 1.44 109.565 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.539 ' HE ' HD11 ' A' ' 134' ' ' ILE . 40.1 ptt180 -129.59 151.88 49.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.482 -0.781 . . . . 3.36 110.448 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.56 -162.32 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.784 -0.45 . . . . 1.13 109.784 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.555 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 30.4 m-70 -66.84 152.69 45.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.251 -0.648 . . . . 2.51 109.251 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.554 ' O ' HG12 ' A' ' 150' ' ' VAL . 1.9 m-20 -50.5 -61.55 2.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.302 0.376 . . . . 1.77 111.101 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.19 -28.54 70.12 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.89 -0.506 . . . . 2.13 111.63 -175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 1.5 m-20 -67.12 -41.96 85.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 1.05 110.777 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.5 p -77.03 -16.38 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.32 110.716 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -89.15 -39.68 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 119.109 -0.472 . . . . 0.37 110.679 173.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -43.69 -68.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.402 1.001 . . . . 1.38 111.825 163.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -49.96 -43.11 49.9 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.638 -0.71 . . . . 0.74 110.271 177.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.16 -52.8 60.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.406 -1.27 . . . . 0.22 112.25 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.8 p -77.44 -15.94 59.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.548 -1.206 . . . . 1.33 111.214 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.5 -48.62 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.731 -0.47 . . . . 0.23 109.731 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.8 m -77.48 118.87 74.85 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-O 121.946 0.879 . . . . 0.21 110.559 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.752 ' HG2' HD13 ' A' ' 57' ' ' ILE . 35.3 Cg_endo -83.6 -177.85 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.177 2.585 . . . . 0.34 112.533 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.759 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.0 m120 -61.56 3.84 0.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.977 -1.01 . . . . 1.02 113.52 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.94 58.13 0.46 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.28 112.379 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.78 135.92 33.41 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 122.547 -0.384 . . . . 0.3 110.452 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -83.88 125.51 32.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.79 -0.187 . . . . 1.96 110.546 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 98' ' ' PHE . 4.2 p -138.15 127.43 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.439 0.637 . . . . 0.46 111.28 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.4 ' C ' HD12 ' A' ' 165' ' ' ILE . 31.7 m -118.22 140.36 49.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.654 -0.703 . . . . 0.56 111.721 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.422 HG13 HG13 ' A' ' 63' ' ' VAL . 2.7 mp -122.17 110.25 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 118.919 -1.112 . . . . 0.96 110.524 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -143.51 139.93 30.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.476 -0.784 . . . . 1.19 111.354 -170.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.579 ' HB2' HG22 ' A' ' 93' ' ' THR . 5.4 mpt_? -77.81 -16.07 58.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.939 -1.028 . . . . 3.42 110.912 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.69 -96.32 0.84 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.004 -0.617 . . . . 3.65 112.377 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.478 -0.773 . . . . 5.97 110.397 -177.341 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.596 ' H25' ' CH2' ' A' ' 115' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 111.912 -0.475 . . . . 2.92 111.912 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 63.64 -173.63 0.16 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.462 0.649 . . . . 4.1 111.46 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.5 mptp? -71.04 148.19 47.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.38 -0.827 . . . . 2.1 109.632 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -99.4 170.81 8.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.425 -0.352 . . . . 0.26 111.458 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.568 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.2 tp -77.86 150.95 34.1 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.334 0.654 . . . . 0.23 112.358 -170.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.552 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.86 149.47 40.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.055 0.931 . . . . 0.26 112.295 169.101 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.7 t80 -133.1 147.73 52.15 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 113.595 -1.639 . . . . 0.39 107.596 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.68 113.65 16.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.036 -1.468 . . . . 1.07 107.036 175.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -73.48 156.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.066 0.46 . . . . 0.38 111.89 -166.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -104.96 146.71 28.66 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.491 -0.777 . . . . 2.59 109.23 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.931 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 26.4 tt0 -50.55 106.18 0.12 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.846 -1.07 . . . . 1.74 112.894 -173.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.15 15.17 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.407 -0.815 . . . . 0.57 112.812 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.591 ' HB3' HD11 ' A' ' 18' ' ' ILE . 17.3 m-20 -62.36 154.57 27.64 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.345 0.498 . . . . 2.17 112.345 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.611 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -131.64 155.37 47.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.008 0.433 . . . . 0.5 111.989 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.7 tp -49.03 -60.12 3.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.098 1.147 . . . . 0.27 114.098 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.727 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 3.1 t-20 -65.21 -38.72 91.3 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.011 0.91 . . . . 1.21 110.572 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 t -58.61 -50.36 74.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 113.154 -1.839 . . . . 1.24 109.19 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -67.72 -38.48 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 O-C-N 123.584 0.553 . . . . 0.3 111.975 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.48 -60.16 4.07 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.23 110.994 175.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.79 58.57 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.67 -1.212 . . . . 0.39 112.15 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 11.3 m-20 -62.61 -34.33 76.81 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.859 -1.163 . . . . 1.63 107.859 156.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.694 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.3 m-85 -99.98 17.54 20.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.396 0.517 . . . . 0.24 112.396 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 50.44 53.77 12.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 3.55 111.13 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.1 pt -147.77 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.045 -0.724 . . . . 0.27 109.045 -173.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -98.78 144.17 28.31 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.333 -0.849 . . . . 0.81 109.57 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.727 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.9 p -62.89 -37.15 85.79 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.564 0.697 . . . . 0.27 109.21 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.14 -27.89 69.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.104 -1.407 . . . . 0.26 111.343 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.89 -37.52 26.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.231 0.538 . . . . 0.23 109.862 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 HD12 ' A' ' 46' ' ' ILE . 14.3 tp -73.8 -19.83 60.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.205 -0.907 . . . . 0.17 109.009 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.747 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.98 -37.74 38.65 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.332 0.586 . . . . 0.19 111.235 172.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.5 mt-30 -56.89 -42.85 80.62 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.25 1.024 . . . . 1.07 109.686 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.65 -20.58 35.99 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.536 -1.666 . . . . 0.17 112.523 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.7 m120 -142.04 72.16 23.09 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.009 0.433 . . . . 0.19 109.994 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.6 -9.36 5.27 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.586 2.857 . . . . 0.3 113.954 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -63.78 -33.63 76.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.028 0.918 . . . . 1.17 109.845 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -80.6 -4.75 55.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.206 -1.361 . . . . 0.53 114.46 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.747 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -50.52 -39.41 48.69 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 122.561 1.172 . . . . 1.23 110.035 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.57 -45.87 10.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 112.921 -1.945 . . . . 0.4 111.523 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 176.08 -167.55 39.3 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.155 -1.021 . . . . 0.3 114.295 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 18' ' ' ILE . 6.3 mp -115.86 157.92 23.73 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.511 -1.345 . . . . 0.31 110.571 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 48.8 m -130.34 134.74 47.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.74 -0.664 . . . . 0.39 110.394 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.931 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.99 129.95 17.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.98 0.733 . . . . 0.47 112.98 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 -13.82 35.89 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 114.792 -1.095 . . . . 0.36 112.054 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.64 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.2 tt0 -63.02 152.38 37.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.744 0.783 . . . . 1.19 110.323 175.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 31.1 m -119.42 131.88 55.72 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.365 -1.289 . . . . 0.89 109.403 -171.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.691 HD12 HD11 ' A' ' 29' ' ' LEU . 23.0 pt -133.46 155.82 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.248 0.547 . . . . 0.22 110.522 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.425 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.4 t -101.38 148.73 6.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.239 -0.891 . . . . 0.21 110.176 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.528 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.8 mm -117.17 87.69 24.52 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.767 -1.106 . . . . 0.17 108.099 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.692 ' HA ' HD13 ' A' ' 4' ' ' LEU . 21.7 Cg_endo -58.63 145.82 93.94 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.387 2.725 . . . . 0.23 112.627 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 78.61 -6.16 54.33 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.911 -0.586 . . . . 0.3 112.831 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.72 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -116.06 125.41 28.62 Favored Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.707 -0.849 . . . . 0.25 108.707 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HD2' HD23 ' A' ' 51' ' ' LEU . 55.6 Cg_endo -64.92 174.2 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.616 2.878 . . . . 0.31 113.752 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 1.8 t70 -91.13 140.43 25.87 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 114.88 -1.054 . . . . 0.72 111.686 -170.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.568 ' HD3' HD12 ' A' ' 5' ' ' LEU . 63.0 Cg_endo -84.09 -7.58 10.12 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.316 2.677 . . . . 0.27 113.474 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.65 -29.27 17.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.924 0.392 . . . . 2.11 110.437 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -80.69 -13.73 58.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.749 0.785 . . . . 1.47 109.02 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.794 HD13 ' HG2' ' A' ' 158' ' ' PRO . 66.8 mt -85.91 126.95 64.18 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 114.679 -1.146 . . . . 0.26 109.839 171.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -101.61 94.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.948 0 CA-C-N 119.972 1.026 . . . . 0.2 110.659 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.803 ' HA ' ' O ' ' A' ' 73' ' ' SER . 92.6 m-85 -158.56 139.65 13.09 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.981 -1.463 . . . . 0.26 107.236 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 55.9 m-70 -139.19 117.77 12.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.916 -1.513 . . . . 2.84 106.916 -176.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 79.6 mt -98.88 109.34 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.085 -0.646 . . . . 0.32 110.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.65 98.94 7.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.918 0.865 . . . . 0.34 110.896 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.3 p -121.01 98.44 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.012 -1.449 . . . . 0.68 110.606 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 68' ' ' LYS . 68.8 m -92.03 115.49 28.12 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.419 -1.326 . . . . 1.05 107.419 170.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.807 ' CG2' ' HB2' ' A' ' 167' ' ' ARG . 16.4 mt -54.05 -26.0 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 121.122 0.487 . . . . 1.29 110.167 172.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' CA ' ' HD3' ' A' ' 88' ' ' LYS . . . -66.58 -48.43 62.64 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.795 -0.717 . . . . 0.88 112.237 169.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.34 -22.48 66.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.451 0.643 . . . . 0.74 110.849 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.839 ' HA ' HG11 ' A' ' 86' ' ' VAL . 9.0 tmtt? 64.35 11.03 6.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.6 -1.182 . . . . 2.51 112.603 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.471 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -145.12 143.43 30.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.591 0.71 . . . . 0.45 112.183 176.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.526 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.8 tt -95.72 122.27 38.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.197 -1.365 . . . . 0.33 109.952 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.26 125.74 50.07 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.487 -0.485 . . . . 0.4 111.61 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.555 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.21 150.62 26.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.426 -1.694 . . . . 0.33 106.426 175.229 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.803 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 1.4 m -150.84 128.5 11.55 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.335 1.425 . . . . 0.75 111.786 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.0 tp -115.01 126.91 55.29 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.496 -0.775 . . . . 0.35 110.222 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.58 35.29 11.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.392 0.615 . . . . 0.52 109.666 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.39 7.77 5.17 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.02 -0.991 . . . . 1.84 112.367 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -129.89 138.26 50.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.755 -1.178 . . . . 3.19 113.649 170.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.71 150.06 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 113.551 -1.659 . . . . 0.41 112.963 -172.039 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.531 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 3.6 mtp -103.36 -41.15 6.11 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.745 -2.025 . . . . 0.35 108.476 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 2.8 tppt? -175.29 170.28 3.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 112.868 -1.969 . . . . 2.07 111.1 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.471 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 16.0 m -131.02 129.42 42.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.684 -0.235 . . . . 0.37 110.93 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.77 150.43 44.86 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 122.32 0.248 . . . . 0.97 110.948 -175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -84.92 141.07 8.23 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.838 2.359 . . . . 0.6 112.1 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.46 -177.12 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.057 -0.519 . . . . 0.64 110.412 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.66 ' HB3' ' H ' ' A' ' 142' ' ' CYS . . . -84.66 138.9 32.41 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.83 109.617 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.839 HG11 ' HA ' ' A' ' 68' ' ' LYS . 17.0 m -143.7 -163.8 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.844 0.683 . . . . 1.67 112.844 -165.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 86' ' ' VAL . . . 146.3 92.76 0.12 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.81 -0.916 . . . . 3.08 110.81 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.51 ' HD3' ' CA ' ' A' ' 66' ' ' GLY . 32.3 ttpt -98.26 -72.46 0.65 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.134 0.42 . . . . 7.26 112.134 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.475 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.8 mp 65.2 -84.63 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.219 0.608 . . . . 6.29 111.921 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 89' ' ' ILE . 71.5 mt -126.77 -106.3 0.32 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.289 0.848 . . . . 7.27 113.289 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 91.4 m -147.46 134.62 20.48 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.503 0.557 . . . . 5.18 112.503 -171.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -178.13 -66.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.172 0.589 . . . . 4.81 110.183 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.758 HG22 ' H ' ' A' ' 167' ' ' ARG . 45.5 p 51.76 89.47 0.1 OUTLIER Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 123.869 0.867 . . . . 2.11 113.295 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -72.2 63.25 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.523 2.149 . . . . 3.21 109.846 167.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.5 m -58.01 109.29 0.71 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.002 -0.999 . . . . 3.59 112.247 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.07 108.08 2.65 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.308 -1.117 . . . . 2.1 110.308 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -77.02 124.74 28.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.397 0.618 . . . . 2.3 109.917 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 163' ' ' VAL . 19.6 m-85 -124.44 172.47 9.14 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.989 -1.005 . . . . 1.93 110.531 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' THR . 65.2 m-85 -131.46 141.26 49.76 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.255 -0.884 . . . . 0.58 109.969 172.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 125' ' ' ILE . 24.0 mm -59.87 114.36 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 N-CA-C 107.47 -1.307 . . . . 0.41 107.47 165.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.59 HD12 ' HD1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -106.91 -27.41 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.551 -0.86 . . . . 0.37 112.018 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.578 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 60.0 t30 -172.41 -172.64 0.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.663 1.22 . . . . 1.99 113.481 -175.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.578 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.3 ptt180 -155.45 131.71 10.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 111.693 -2.503 . . . . 1.19 109.711 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -103.74 157.34 17.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.58 1.181 . . . . 1.67 112.227 -171.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 106' ' ' ASN . 37.0 ttt180 -53.93 154.78 3.81 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 112.485 -2.143 . . . . 3.06 112.473 170.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 105' ' ' ARG . 9.3 p30 -44.03 105.72 0.46 Allowed Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 112.925 -1.943 . . . . 2.61 111.346 175.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 88.7 Cg_exo -56.75 -53.31 5.26 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.653 2.902 . . . . 0.98 112.309 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.62 37.68 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.206 -0.906 . . . . 1.08 112.599 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.85 -170.37 24.36 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.915 -0.66 . . . . 1.05 111.89 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.15 49.56 0.34 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.992 3.128 . . . . 1.3 113.127 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.441 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -93.85 -21.1 19.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.059 0.456 . . . . 1.38 110.026 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.54 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 46.62 2.04 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.53 -0.759 . . . . 1.11 113.986 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.62 -24.53 0.21 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.192 0.812 . . . . 0.81 113.192 170.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -154.43 151.33 28.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.261 -0.274 . . . . 1.12 110.261 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -118.02 100.25 7.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.788 -0.819 . . . . 2.19 108.788 165.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.5 mp -101.85 139.24 37.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.801 0.81 . . . . 0.61 110.32 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.401 ' HB2' HG23 ' A' ' 101' ' ' ILE . 68.0 m -106.68 144.96 32.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.916 -1.038 . . . . 0.94 112.378 -168.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.574 HD22 HG11 ' A' ' 163' ' ' VAL . 73.0 mt -102.24 -176.84 3.23 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.648 -1.16 . . . . 1.08 108.464 173.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 49.6 m -76.61 2.58 13.64 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.803 0.297 . . . . 1.5 111.803 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 11.9 tptt -128.36 146.89 50.64 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.599 -0.519 . . . . 2.97 109.599 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.409 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 12.0 pt20 -84.53 2.33 41.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.679 0.276 . . . . 5.06 111.013 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -89.15 -29.31 19.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.783 0.325 . . . . 5.95 110.887 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -128.85 146.71 50.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.406 -0.361 . . . . 4.83 110.736 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.36 150.77 22.45 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.095 -0.574 . . . . 0.95 111.69 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.789 HD12 HD11 ' A' ' 100' ' ' ILE . 23.1 mt -93.19 115.07 31.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.254 -0.647 . . . . 0.48 109.254 176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.532 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 7.9 p80 -153.51 -162.22 1.42 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.405 0.621 . . . . 1.25 111.498 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.54 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.63 179.57 16.38 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.158 -1.02 . . . . 0.46 112.779 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -135.13 174.83 10.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.453 0.644 . . . . 0.5 111.185 -167.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -107.74 -23.0 12.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.92 -1.036 . . . . 1.86 108.994 168.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.41 104.63 28.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 114.756 -1.111 . . . . 1.77 109.616 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.418 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.8 Cg_endo -89.97 4.5 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.213 2.609 . . . . 0.59 113.185 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.84 -21.91 29.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.389 0.614 . . . . 0.78 109.453 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.2 t -76.76 -18.18 58.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.079 -0.964 . . . . 1.45 109.317 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 144' ' ' ARG . 23.4 mm -70.92 106.17 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.096 -0.957 . . . . 0.7 110.275 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.18 -135.29 7.8 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.667 -0.778 . . . . 1.68 112.464 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -86.46 4.33 40.14 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.728 0.27 . . . . 4.39 111.728 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.7 -55.5 26.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.702 0.287 . . . . 3.94 111.272 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.52 155.37 8.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.181 -0.463 . . . . 4.68 109.932 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 14.7 p -84.0 -143.49 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.199 -0.455 . . . . 5.68 111.02 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 139' ' ' SER . 4.2 mptp? 69.44 114.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.167 0.587 . . . . 8.3 110.416 -174.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.54 96.85 0.03 OUTLIER Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.934 -0.576 . . . . 3.85 113.457 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.66 ' H ' ' HB3' ' A' ' 85' ' ' ALA . 77.7 m -128.53 105.48 8.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.109 0.48 . . . . 2.51 110.388 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.491 HG21 HG12 ' A' ' 125' ' ' ILE . 13.8 mt -95.13 79.91 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.416 0.627 . . . . 1.44 110.08 -175.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 81.7 mtm180 -128.67 150.29 50.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.407 -0.815 . . . . 3.36 110.523 -175.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.9 mtp -145.26 -165.68 2.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.37 -0.377 . . . . 1.13 110.581 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -78.4 161.46 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.106 -0.701 . . . . 2.51 109.106 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.633 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.5 m-20 -52.42 -68.13 0.19 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.398 0.436 . . . . 1.77 110.987 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -58.12 -30.89 66.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.098 0.407 . . . . 2.13 112.098 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -67.07 -41.5 86.31 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.906 0.384 . . . . 1.05 110.975 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 7.3 p -78.38 -15.27 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 0.32 110.637 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.467 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.7 mp -87.39 -41.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 118.749 -0.643 . . . . 0.37 110.414 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -44.36 -68.72 0.17 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.543 1.065 . . . . 1.38 112.244 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.687 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.8 OUTLIER -49.94 -43.46 49.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.927 -0.579 . . . . 0.74 110.169 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.17 -54.66 32.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.074 -1.421 . . . . 0.22 111.929 -171.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -79.95 -14.4 58.63 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.574 -1.194 . . . . 1.33 110.779 -170.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.65 -48.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.987 -0.375 . . . . 0.23 109.987 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 153' ' ' LEU . 23.1 m -76.33 119.35 76.93 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-O 121.672 0.748 . . . . 0.21 110.294 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.794 ' HG2' HD13 ' A' ' 57' ' ' ILE . 43.8 Cg_endo -83.1 -178.07 3.63 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.154 2.569 . . . . 0.34 112.872 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.72 ' O ' HD21 ' A' ' 51' ' ' LEU . 21.6 m120 -61.44 0.06 0.34 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.104 -0.953 . . . . 1.02 113.142 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.84 58.02 0.52 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.767 -0.73 . . . . 0.28 112.519 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.5 m -95.26 133.98 38.54 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.327 -0.513 . . . . 0.3 110.206 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 162' ' ' ARG . 0.0 OUTLIER -84.7 134.17 34.36 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 1.96 110.353 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.574 HG11 HD22 ' A' ' 118' ' ' LEU . 2.4 p -140.57 123.73 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.024 -0.989 . . . . 0.46 110.79 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.463 ' C ' HD12 ' A' ' 165' ' ' ILE . 93.0 m -118.09 141.57 48.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.494 -0.775 . . . . 0.56 111.782 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.506 HG13 HG13 ' A' ' 63' ' ' VAL . 2.9 mp -125.13 123.31 65.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 118.845 -1.142 . . . . 0.96 112.258 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.17 118.41 10.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.989 -1.115 . . . . 1.19 107.989 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.807 ' HB2' ' CG2' ' A' ' 65' ' ' ILE . 2.0 ptt180 -99.0 -49.74 4.42 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 115.602 1.704 . . . . 3.42 115.602 -169.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.674 ' N ' ' HG2' ' A' ' 167' ' ' ARG . . . 132.45 -141.65 13.03 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 108.589 -1.804 . . . . 3.65 108.589 -161.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 89' ' ' ILE . 24.1 p . . . . . 0 C--O 1.252 1.19 0 CA-C-N 118.7 1.25 . . . . 5.97 110.885 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.701 H622 ' H41' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.975 -0.45 . . . . 2.92 111.975 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.9 OUTLIER 63.81 -177.18 0.16 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.317 0.579 . . . . 4.1 111.539 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.6 mptp? -71.87 142.87 49.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.532 -0.758 . . . . 2.1 109.929 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -100.11 169.92 8.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.188 0.305 . . . . 0.26 111.439 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.587 HD23 HG13 ' A' ' 48' ' ' ILE . 4.6 tp -75.86 150.23 37.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 123.076 0.55 . . . . 0.23 112.17 -170.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.515 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.38 149.26 38.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 122.11 0.957 . . . . 0.26 111.921 167.434 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 45' ' ' SER . 67.8 t80 -132.84 149.41 52.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.538 -1.665 . . . . 0.39 107.863 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.592 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.1 119.67 25.81 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.628 -1.619 . . . . 1.07 106.628 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.448 HG11 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -79.99 158.56 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-O 121.227 0.537 . . . . 0.38 111.554 -170.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -110.16 155.44 21.95 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.554 -0.906 . . . . 2.59 108.554 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.628 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 47.7 tt0 -52.53 122.34 8.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 1.74 112.14 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.99 -9.08 36.68 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.99 -1.004 . . . . 0.57 112.724 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.68 ' HB3' HD11 ' A' ' 18' ' ' ILE . 94.7 m-20 -67.42 151.23 47.77 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.935 0.398 . . . . 2.17 112.058 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.563 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 p -132.6 157.33 45.05 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 112.282 0.475 . . . . 0.5 112.282 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.579 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.9 tp -49.96 -59.75 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.95 1.092 . . . . 0.27 113.95 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.4 t-20 -65.83 -38.3 88.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.298 1.047 . . . . 1.21 110.476 -168.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 t -57.09 -54.93 41.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 113.143 -1.844 . . . . 1.24 109.233 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.68 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.72 -38.76 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 115.531 -0.759 . . . . 0.3 112.086 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.86 -63.73 1.11 Allowed 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 116.048 -0.523 . . . . 0.23 111.279 177.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.66 -3.93 54.83 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.803 -1.159 . . . . 0.39 112.011 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 23.6 m-20 -66.97 -27.34 67.37 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.81 -0.811 . . . . 1.63 108.81 156.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.1 m-85 -103.07 18.31 21.99 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.861 -0.524 . . . . 0.24 111.968 171.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 50.34 54.81 10.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.195 -0.911 . . . . 3.55 110.918 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.1 pt -148.26 -173.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.597 -0.89 . . . . 0.27 108.597 -173.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -100.96 143.63 30.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.29 -0.868 . . . . 0.81 109.319 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.71 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.8 p -61.05 -35.27 76.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.453 0.645 . . . . 0.27 109.503 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.94 -30.69 71.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.482 -1.236 . . . . 0.26 111.396 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.78 30.5 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.224 0.535 . . . . 0.23 109.631 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.674 HD11 HD12 ' A' ' 46' ' ' ILE . 15.0 tp -73.17 -19.3 61.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.417 -0.81 . . . . 0.17 109.022 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.748 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.61 36.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.315 0.578 . . . . 0.19 111.237 172.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 51.6 mt-30 -58.01 -42.52 85.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.227 1.013 . . . . 1.07 109.727 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.69 -20.71 38.94 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 113.478 -1.692 . . . . 0.17 112.489 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.1 m120 -143.43 73.48 17.5 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.19 109.949 -172.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.751 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.7 Cg_endo -57.36 -12.05 9.73 Favored 'Trans proline' 0 C--O 1.221 -0.372 0 C-N-CA 123.573 2.849 . . . . 0.3 114.003 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -62.47 -34.23 76.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.106 0.955 . . . . 1.17 109.119 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.3 mt -78.44 -6.7 56.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.117 -1.402 . . . . 0.53 114.448 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -50.99 -42.55 60.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 120.019 1.281 . . . . 1.23 109.478 176.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.84 15.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 112.894 -1.957 . . . . 0.4 111.601 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.86 -164.4 35.81 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.264 -0.969 . . . . 0.3 114.243 176.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' CD2' HG12 ' A' ' 18' ' ' ILE . 5.6 mp -116.85 158.96 23.11 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.274 -1.463 . . . . 0.31 109.905 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.597 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 93.2 m -136.53 135.63 38.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.912 -0.585 . . . . 0.39 110.77 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.27 126.61 6.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.267 0.84 . . . . 0.47 113.267 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.592 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.57 -12.52 46.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.588 -1.187 . . . . 0.36 112.388 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.597 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.7 tt0 -63.2 152.08 38.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.597 0.713 . . . . 1.19 110.455 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 49.9 m -119.87 132.27 55.51 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.668 -1.151 . . . . 0.89 109.612 -171.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.674 HD12 HD11 ' A' ' 29' ' ' LEU . 18.9 pt -132.91 160.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.156 0.503 . . . . 0.22 110.319 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.05 148.45 11.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.221 -0.899 . . . . 0.21 109.943 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.587 HG13 HD23 ' A' ' 5' ' ' LEU . 15.0 mm -116.66 88.5 25.02 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.957 -1.019 . . . . 0.17 108.277 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.725 ' HA ' HD13 ' A' ' 4' ' ' LEU . 27.5 Cg_endo -59.3 142.66 99.43 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.304 2.669 . . . . 0.23 113.02 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.479 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.29 -7.56 60.43 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.447 -0.797 . . . . 0.3 112.9 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.722 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.48 126.15 28.06 Favored Pre-proline 0 C--O 1.218 -0.567 0 N-CA-C 108.936 -0.764 . . . . 0.25 108.936 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD23 ' A' ' 51' ' ' LEU . 48.8 Cg_endo -64.48 176.56 2.67 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.939 3.093 . . . . 0.31 114.198 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.761 ' HB3' HG22 ' A' ' 56' ' ' THR . 4.3 t70 -90.74 141.99 27.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.84 -1.073 . . . . 0.72 110.646 -170.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.484 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 63.1 Cg_endo -86.81 -4.61 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.352 2.702 . . . . 0.27 112.158 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -95.06 -28.67 14.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 2.11 110.59 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.761 HG22 ' HB3' ' A' ' 53' ' ' ASP . 14.9 t -79.43 -14.1 59.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.024 -1.102 . . . . 1.47 108.024 172.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.8 HD13 ' HG2' ' A' ' 158' ' ' PRO . 71.8 mt -91.54 126.22 55.03 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.118 -1.401 . . . . 0.26 109.77 170.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -103.13 95.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.146 0 CA-C-N 120.036 1.048 . . . . 0.2 110.117 166.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.424 ' HD2' HG23 ' A' ' 57' ' ' ILE . 74.8 m-85 -158.96 138.66 11.78 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.645 -1.613 . . . . 0.26 106.645 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.571 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 12.6 t60 -147.69 121.83 9.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 2.84 108.147 -169.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.4 mt -103.39 111.13 31.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 114.643 -1.162 . . . . 0.32 110.853 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.27 94.29 4.86 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.077 0.941 . . . . 0.34 110.14 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -116.95 98.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 113.82 -1.537 . . . . 0.68 109.819 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.507 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 38.7 m -90.19 113.13 24.86 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.672 -1.233 . . . . 1.05 107.672 175.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.67 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 2.6 mm -46.46 -37.49 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.845 170.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.31 -42.05 99.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.076 -1.059 . . . . 0.88 112.247 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.507 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.97 -23.96 62.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.051 1.13 . . . . 0.74 114.051 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.637 ' HA ' HG21 ' A' ' 86' ' ' VAL . 7.6 mptt 61.83 11.4 4.06 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.819 0.848 . . . . 2.51 112.866 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.407 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -141.62 137.42 31.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.143 0.973 . . . . 0.45 112.232 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.523 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.97 119.87 34.23 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.455 -1.702 . . . . 0.33 109.621 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.96 124.53 47.74 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.104 -0.639 . . . . 0.4 111.538 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.602 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -83.26 134.73 34.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.168 -1.79 . . . . 0.33 106.168 175.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 33.6 p -143.39 125.75 15.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 120.943 1.701 . . . . 0.75 113.334 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 tp -110.48 124.42 51.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.351 -1.295 . . . . 0.35 110.116 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.46 33.12 7.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.602 0.715 . . . . 0.52 109.077 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 77.5 4.48 3.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.23 -1.35 . . . . 1.84 111.6 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -129.27 138.08 51.43 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.689 -1.205 . . . . 3.19 113.504 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -57.22 148.66 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 113.054 -1.884 . . . . 0.41 112.975 -172.004 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.602 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.2 mtp -100.4 -41.91 6.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.581 -2.099 . . . . 0.35 108.393 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? 179.98 160.19 0.85 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.442 -2.163 . . . . 2.07 110.39 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.407 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.0 m -121.65 133.23 54.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.385 0.136 . . . . 0.37 110.789 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.447 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 73.0 m-85 -118.81 149.13 45.92 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 120.831 0.348 . . . . 0.97 111.623 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 9.9 Cg_endo -80.36 141.49 14.3 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.752 2.301 . . . . 0.6 111.738 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.48 173.82 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.442 -0.577 . . . . 0.64 109.442 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.71 132.94 34.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.135 0.493 . . . . 0.83 111.653 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.652 HG22 HG23 ' A' ' 65' ' ' ILE . 10.8 t -146.81 152.3 13.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.996 -1.002 . . . . 1.67 110.326 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.99 57.06 0.23 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.013 -0.613 . . . . 3.08 112.094 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -150.67 158.29 43.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.857 0.329 . . . . 7.26 111.482 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.488 ' O ' ' HA3' ' A' ' 168' ' ' GLY . 4.6 mp -119.11 -85.48 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 116.29 -0.414 . . . . 6.29 111.943 -174.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.516 ' HA ' ' C ' ' A' ' 168' ' ' GLY . 61.3 tp -155.38 115.28 3.72 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.436 0.532 . . . . 7.27 112.436 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.588 ' N ' ' HA ' ' A' ' 169' ' ' SER . 17.2 m -165.68 -61.62 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.335 0.654 . . . . 5.18 111.011 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.602 ' H ' ' HA ' ' A' ' 169' ' ' SER . 16.7 mm100 -125.71 -68.17 0.84 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.958 1.095 . . . . 4.81 113.958 -169.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.841 HG23 ' H ' ' A' ' 167' ' ' ARG . 2.9 m 61.47 67.52 1.35 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 117.879 0.309 . . . . 2.11 110.513 -165.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.18 -11.37 10.96 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.938 2.425 . . . . 3.21 112.251 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.8 m -65.85 127.62 32.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.668 -0.697 . . . . 3.59 111.103 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.77 173.61 49.28 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.805 -0.712 . . . . 2.1 111.96 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.39 143.06 31.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.786 -0.45 . . . . 2.3 109.786 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.517 ' HB3' ' H ' ' A' ' 119' ' ' SER . 15.7 m-85 -123.6 -178.94 4.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.125 -0.488 . . . . 1.93 109.734 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 161' ' ' THR . 65.8 m-85 -135.69 141.07 44.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.592 -0.731 . . . . 0.58 109.75 172.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 125' ' ' ILE . 23.7 mm -59.56 116.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 107.469 -1.308 . . . . 0.41 107.469 167.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.574 HD12 ' HD1' ' A' ' 22' ' ' PHE . 2.9 tt -103.18 -28.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.361 -0.936 . . . . 0.37 112.026 -175.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -172.36 -169.96 0.67 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 114.923 1.453 . . . . 1.99 114.923 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.538 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.3 ptp180 -151.92 131.12 12.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 111.634 -2.53 . . . . 1.19 109.378 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -102.27 156.81 17.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.245 1.021 . . . . 1.67 111.531 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -53.18 152.26 4.48 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.562 -2.108 . . . . 3.06 112.42 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -44.98 104.85 0.41 Allowed Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 113.854 -1.521 . . . . 2.61 111.48 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -55.19 -51.19 10.72 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.971 3.114 . . . . 0.98 112.291 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.76 -20.2 34.5 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.999 -1.0 . . . . 1.08 112.181 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -103.43 -169.84 25.74 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.193 -0.527 . . . . 1.05 112.174 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.98 15.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 124.434 3.423 . . . . 1.3 114.094 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -67.93 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.949 0.404 . . . . 1.38 110.64 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 45.58 2.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 1.11 114.186 170.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.06 -22.57 0.26 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.305 0.854 . . . . 0.81 113.305 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.462 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -157.84 151.95 24.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.732 0.301 . . . . 1.12 110.373 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -120.92 102.43 8.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 2.19 109.583 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -106.59 137.28 44.88 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.236 0.541 . . . . 0.61 110.413 176.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.2 m -106.15 145.17 31.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.507 -0.77 . . . . 0.94 112.726 -170.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -92.37 -174.19 3.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.703 -1.221 . . . . 1.08 107.703 170.039 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.517 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 52.9 m -85.61 -101.9 0.06 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.806 0.73 . . . . 1.5 112.08 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 121' ' ' GLN . 36.2 ttpt -72.13 142.69 49.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.087 -0.338 . . . . 2.97 110.087 -174.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 120' ' ' LYS . 2.3 mp0 71.0 125.43 0.03 OUTLIER 'General case' 0 C--O 1.233 0.184 0 O-C-N 124.093 0.871 . . . . 5.06 109.044 -170.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -74.1 64.43 1.04 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.45 0.643 . . . . 5.95 112.048 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -113.88 163.88 14.51 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.554 -0.906 . . . . 4.83 108.554 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -155.64 163.88 31.88 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.958 -1.115 . . . . 0.95 112.935 -176.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 100' ' ' ILE . 47.2 mt -91.97 107.12 18.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.905 -1.146 . . . . 0.48 107.905 172.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 9.2 p80 -138.98 -162.83 1.37 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.35 0.595 . . . . 1.25 111.542 -173.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.453 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.92 178.28 16.39 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.844 -1.17 . . . . 0.46 113.654 -175.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.455 ' HA ' ' NH2' ' A' ' 144' ' ' ARG . 7.4 t -144.54 176.41 9.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.487 0.661 . . . . 0.5 111.263 -167.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -108.06 -15.15 14.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.72 -1.127 . . . . 1.86 109.715 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.13 103.73 29.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.555 -0.748 . . . . 1.77 109.976 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -90.52 4.58 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.168 2.579 . . . . 0.59 112.9 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.46 -16.25 46.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.322 0.582 . . . . 0.78 110.324 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -98.19 7.15 46.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.652 -0.704 . . . . 1.45 109.912 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 26.2 mm -102.83 119.67 51.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.384 -0.825 . . . . 0.7 111.244 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.64 53.76 2.21 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.416 -0.897 . . . . 1.68 113.004 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.53 149.45 16.95 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.035 -0.357 . . . . 4.39 110.035 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.421 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . . . -87.11 102.8 14.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.031 -0.531 . . . . 3.94 110.497 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.1 p -154.78 -47.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.167 -0.47 . . . . 4.68 110.948 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 65.5 m -158.87 147.67 18.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.05 -0.352 . . . . 5.68 110.05 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -80.89 77.92 7.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.441 -0.578 . . . . 8.3 109.441 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.47 -139.84 0.77 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.969 -0.634 . . . . 3.85 111.805 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 64.4 m -110.43 168.31 9.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.22 0.534 . . . . 2.51 111.363 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 31.7 mt -89.44 80.14 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.378 -0.828 . . . . 1.44 110.123 -174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 46.9 mtp180 -118.4 156.3 29.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 3.36 110.58 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.473 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 10.8 ptm -151.95 -168.22 3.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.204 -0.453 . . . . 1.13 110.082 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.529 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 22.1 m170 -73.52 154.53 39.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.939 -0.393 . . . . 2.51 109.939 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HG12 ' A' ' 150' ' ' VAL . 74.7 m-20 -50.31 -68.05 0.2 Allowed 'General case' 0 C--O 1.221 -0.412 0 O-C-N 123.318 0.386 . . . . 1.77 111.43 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -60.41 -29.41 68.96 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.782 -0.574 . . . . 2.13 111.699 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.529 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 2.2 m-20 -66.72 -41.95 87.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.732 0.301 . . . . 1.05 110.956 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.3 p -75.86 -18.93 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 116.311 -0.404 . . . . 0.32 110.615 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.534 HD12 HG13 ' A' ' 150' ' ' VAL . 2.8 mp -86.89 -39.94 13.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 119.014 -0.517 . . . . 0.37 110.154 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -45.33 -66.26 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.52 1.054 . . . . 1.38 111.949 165.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.631 ' O ' HG22 ' A' ' 157' ' ' VAL . 2.2 tp -53.17 -42.69 66.44 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.838 -0.619 . . . . 0.74 110.107 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.32 -54.84 26.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.384 -1.28 . . . . 0.22 111.735 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 32.8 t -75.46 -16.46 60.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.822 -1.081 . . . . 1.33 110.491 -172.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.2 mt -90.94 -53.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.787 -0.449 . . . . 0.23 109.787 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 153' ' ' LEU . 18.7 m -77.45 114.79 43.82 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 122.194 0.997 . . . . 0.21 110.212 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.8 ' HG2' HD13 ' A' ' 57' ' ' ILE . 54.6 Cg_endo -81.13 -179.12 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.911 2.407 . . . . 0.34 112.715 -173.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.722 ' O ' HD21 ' A' ' 51' ' ' LEU . 17.1 m120 -59.63 -0.24 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.827 -1.079 . . . . 1.02 113.404 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.23 59.02 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.834 -0.698 . . . . 0.28 112.435 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -95.03 134.89 37.21 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.523 -0.398 . . . . 0.3 110.219 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 131.83 34.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.859 0.362 . . . . 1.96 110.499 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.506 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.8 p -140.24 123.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.579 -0.737 . . . . 0.46 111.471 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.2 m -111.6 138.53 48.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.805 -0.634 . . . . 0.56 111.074 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.571 HG23 ' CG1' ' A' ' 65' ' ' ILE . 2.0 mp -122.37 117.2 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 118.461 -1.296 . . . . 0.96 111.059 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.742 ' HA ' ' CG2' ' A' ' 93' ' ' THR . 23.9 p-10 -141.3 121.26 13.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 123.263 1.506 . . . . 1.19 110.154 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.841 ' H ' HG23 ' A' ' 93' ' ' THR . 3.4 ptm180 -101.53 -47.46 4.65 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 111.751 -2.477 . . . . 3.42 114.162 -166.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.516 ' C ' ' HA ' ' A' ' 90' ' ' LEU . . . 117.3 -77.3 0.29 Allowed Glycine 0 N--CA 1.418 -2.506 0 N-CA-C 109.196 -1.561 . . . . 3.65 109.196 -163.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.602 ' HA ' ' H ' ' A' ' 92' ' ' GLN . 80.2 p . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.562 -0.733 . . . . 5.97 110.747 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.545 ' S21' ' O31' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.387 -0.285 . . . . 2.92 112.387 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 3' ' ' LYS . 9.3 ptp180 -135.73 -169.2 2.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.557 -0.534 . . . . 4.1 109.557 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.33 147.17 21.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.92 -0.582 . . . . 2.1 111.223 173.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.4 mt -97.95 168.63 10.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.088 -0.96 . . . . 0.26 110.886 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 48' ' ' ILE . 2.3 tp -80.71 151.42 28.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.411 0.684 . . . . 0.23 112.407 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.519 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -117.3 151.33 37.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.997 0.903 . . . . 0.26 112.364 169.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.4 t80 -134.56 148.74 50.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.701 -1.59 . . . . 0.39 107.917 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.638 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -127.33 121.15 30.25 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.012 -1.477 . . . . 1.07 107.012 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -83.06 158.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.243 0.544 . . . . 0.38 112.011 -170.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' N ' HG23 ' A' ' 9' ' ' VAL . 53.9 mtpt -109.43 150.37 28.18 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.838 -0.801 . . . . 2.59 108.838 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.97 114.1 1.21 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.89 -0.595 . . . . 1.74 112.004 -174.599 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -10.07 21.65 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.677 -0.773 . . . . 0.57 112.944 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.575 ' HB3' HD11 ' A' ' 18' ' ' ILE . 9.6 m-20 -62.62 154.51 28.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.028 0.414 . . . . 2.17 111.82 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.555 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -132.53 152.0 51.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.5 112.153 -177.492 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.4 tp -48.04 -57.76 5.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.425 0.898 . . . . 0.27 113.425 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.67 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.5 t-20 -66.05 -39.5 90.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 1.21 110.308 -169.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -59.4 -47.62 84.75 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 113.106 -1.861 . . . . 1.24 109.902 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -69.64 -39.36 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.513 -0.767 . . . . 0.3 112.205 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.0 -57.79 11.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.23 110.934 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.6 -4.35 57.54 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.683 -1.207 . . . . 0.39 112.147 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 42.2 m-20 -61.85 -36.38 81.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.902 -1.148 . . . . 1.63 107.902 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.669 ' CD1' HD12 ' A' ' 101' ' ' ILE . 2.2 m-85 -99.75 15.82 25.61 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.899 0.703 . . . . 0.24 112.899 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.05 50.99 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 3.55 110.684 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 19' ' ' ALA . 36.8 pt -146.65 -174.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.692 -0.855 . . . . 0.27 108.692 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -100.2 143.76 30.01 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.231 -0.895 . . . . 0.81 109.293 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.67 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.4 p -60.97 -35.09 75.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 121.4 0.619 . . . . 0.27 109.399 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.95 -31.51 72.72 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.507 -1.224 . . . . 0.26 111.657 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.85 -37.89 39.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.406 0.622 . . . . 0.23 109.574 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.671 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.97 -20.47 60.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.042 -0.981 . . . . 0.17 109.066 175.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.735 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.91 -39.13 43.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.431 0.634 . . . . 0.19 111.582 172.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 55.2 mt-30 -59.18 -42.23 90.34 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.163 0.983 . . . . 1.07 109.649 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.53 -18.89 43.47 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.535 -1.666 . . . . 0.17 112.32 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.1 m120 -143.77 71.9 17.11 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.19 109.881 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.643 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 12.2 Cg_endo -55.64 -13.56 8.4 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 123.696 2.931 . . . . 0.3 114.318 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -61.9 -35.72 79.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.02 0.914 . . . . 1.17 109.798 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -76.76 -6.64 53.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.341 -1.3 . . . . 0.53 114.362 -170.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.735 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -49.23 -40.68 34.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.527 1.156 . . . . 1.23 110.485 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.41 -45.65 11.67 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.054 -1.885 . . . . 0.4 111.627 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.651 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.3 -163.87 34.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.479 -0.867 . . . . 0.3 114.238 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.3 mp -118.97 158.04 26.53 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.444 -1.378 . . . . 0.31 110.512 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 71.3 m -133.22 136.48 45.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.873 -0.603 . . . . 0.39 110.964 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -44.73 126.17 5.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 0.47 113.312 173.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.638 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.84 -12.49 48.23 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.558 -1.201 . . . . 0.36 112.16 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.603 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.9 tt0 -62.75 150.81 40.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.741 0.781 . . . . 1.19 110.294 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.8 m -120.42 130.85 54.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.328 -1.305 . . . . 0.89 109.544 -170.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.671 HD12 HD11 ' A' ' 29' ' ' LEU . 21.3 pt -132.86 148.65 31.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.338 0.589 . . . . 0.22 110.697 -173.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.454 ' H ' HD22 ' A' ' 33' ' ' ASN . 13.2 t -94.1 149.02 4.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.078 -0.965 . . . . 0.21 110.383 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 18.9 mm -117.44 87.72 26.06 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 114.771 -1.104 . . . . 0.17 108.384 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.708 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.2 Cg_endo -59.38 143.82 99.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.214 2.609 . . . . 0.23 112.737 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.502 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.46 -7.6 56.95 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.569 -0.741 . . . . 0.3 112.977 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.758 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -115.92 127.1 27.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.711 -0.848 . . . . 0.25 108.711 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.2 Cg_endo -66.47 174.91 5.65 Favored 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 123.793 2.996 . . . . 0.31 114.005 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.703 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.6 t70 -90.45 141.53 27.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.263 -0.88 . . . . 0.72 110.734 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HD3' HD12 ' A' ' 5' ' ' LEU . 90.5 Cg_endo -83.84 -9.51 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.27 112.438 -175.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -95.09 -27.08 15.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 2.11 110.25 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.6 p -68.14 -32.34 72.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.591 -1.263 . . . . 1.47 107.591 170.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.768 HD13 ' HG2' ' A' ' 158' ' ' PRO . 89.5 mt -76.27 127.86 83.93 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 113.242 -1.799 . . . . 0.26 110.476 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -101.84 95.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.856 0 C-N-CA 120.846 1.031 . . . . 0.2 110.479 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.4 m-85 -158.38 139.25 12.98 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.952 -1.499 . . . . 0.26 106.952 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 34.2 t-80 -145.27 107.15 4.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.789 -1.189 . . . . 2.84 107.789 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 69.9 mt -94.93 109.64 22.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.254 -1.339 . . . . 0.32 110.302 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.94 94.73 5.09 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.987 0.898 . . . . 0.34 110.175 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 p -110.35 97.3 5.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.183 -1.372 . . . . 0.68 109.256 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 m -93.43 108.52 20.18 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.756 -1.111 . . . . 1.05 108.074 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.653 HG23 HG13 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -46.38 -32.2 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.293 0.637 . . . . 1.29 112.613 174.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.16 -44.91 93.3 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.155 -1.022 . . . . 0.88 111.476 172.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.82 -23.28 63.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.768 -0.716 . . . . 0.74 111.754 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HA ' HG21 ' A' ' 86' ' ' VAL . 52.4 mttt 59.97 16.94 6.2 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.042 0.937 . . . . 2.51 113.056 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.59 140.32 37.01 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.919 0.866 . . . . 0.45 111.404 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.441 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.6 tt -95.67 120.17 35.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.029 -1.441 . . . . 0.33 109.7 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -101.79 125.82 48.54 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.147 -0.621 . . . . 0.4 111.289 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.604 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.37 147.45 27.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.559 -1.645 . . . . 0.33 106.559 175.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.653 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 24.3 m -150.96 132.77 15.01 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 120.407 1.458 . . . . 0.75 112.712 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp -120.42 125.9 49.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.989 -1.005 . . . . 0.35 110.731 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 65.7 34.53 7.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.52 109.393 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 79.87 3.46 2.06 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.377 -1.283 . . . . 1.84 111.754 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -130.9 139.07 50.06 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 118.803 -1.159 . . . . 3.19 113.75 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -52.76 149.69 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 113.112 -1.858 . . . . 0.41 112.884 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.505 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.9 mtp -98.91 -43.98 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.643 -2.071 . . . . 0.35 108.263 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? 179.26 154.71 0.47 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.33 -2.214 . . . . 2.07 110.332 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.1 m -115.11 135.57 54.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.464 0.173 . . . . 0.37 110.754 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -125.34 131.97 24.19 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.97 110.608 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.58 146.37 79.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.793 2.328 . . . . 0.6 111.748 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.39 179.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.218 -0.66 . . . . 0.64 109.218 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.481 ' HB3' ' H ' ' A' ' 142' ' ' CYS . . . -86.27 114.64 23.24 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 119.199 -1.0 . . . . 0.83 109.877 174.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.653 HG13 HG23 ' A' ' 65' ' ' ILE . 8.5 t -102.67 92.46 2.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.532 -1.655 . . . . 1.67 106.532 164.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.468 ' HA3' ' HB ' ' A' ' 138' ' ' VAL . . . 152.85 107.4 0.32 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.179 -1.01 . . . . 3.08 113.478 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 140' ' ' LYS . 17.4 tppt? -171.18 -53.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.831 0.348 . . . . 7.26 110.068 173.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.429 ' C ' HD22 ' A' ' 90' ' ' LEU . 18.7 mm -105.03 -108.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.344 -0.389 . . . . 6.29 110.562 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.429 HD22 ' C ' ' A' ' 89' ' ' ILE . 2.5 mm? -136.03 174.56 10.48 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.02 0.438 . . . . 7.27 110.881 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 m -80.46 85.29 5.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.696 -0.684 . . . . 5.18 109.897 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.628 ' C ' ' HD2' ' A' ' 94' ' ' PRO . 47.8 tt0 -74.0 -94.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.792 -0.64 . . . . 4.81 111.184 -176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.571 HG22 ' HB2' ' A' ' 167' ' ' ARG 0.272 60.5 p 107.9 -48.21 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 127.089 2.155 . . . . 2.11 112.834 -178.144 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.628 ' HD2' ' C ' ' A' ' 92' ' ' GLN . 30.5 Cg_endo -65.49 74.73 0.28 Allowed 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 121.528 1.485 . . . . 3.21 111.755 173.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 165' ' ' ILE . 23.9 m -128.71 112.93 14.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.341 -0.845 . . . . 3.59 109.412 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.86 -178.4 34.15 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.662 -0.78 . . . . 2.1 112.128 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.59 145.82 38.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.107 0.48 . . . . 2.3 110.164 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.57 ' HB2' HG13 ' A' ' 163' ' ' VAL . 17.8 m-85 -119.33 167.61 11.73 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.431 -1.322 . . . . 1.93 107.431 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.769 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.3 m-85 -127.19 136.45 52.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.925 -0.31 . . . . 0.58 110.477 175.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.85 HD11 HD12 ' A' ' 125' ' ' ILE . 11.7 mm -58.1 108.18 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 108.042 -1.096 . . . . 0.41 108.042 169.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.669 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.0 tt -108.4 -27.31 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 112.813 0.672 . . . . 0.37 112.813 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 26.2 t-20 -156.33 161.2 40.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 122.675 1.226 . . . . 1.99 114.046 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.82 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 134.14 36.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 111.678 -2.51 . . . . 1.19 109.177 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 16.0 tm0? -114.66 145.23 42.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.022 0.915 . . . . 1.67 111.055 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -50.1 154.37 1.18 Allowed 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 112.828 -1.987 . . . . 3.06 112.391 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -43.84 100.32 0.23 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 CA-C-O 121.557 0.694 . . . . 2.61 111.185 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HG3' ' OE1' ' A' ' 104' ' ' GLN . 90.2 Cg_exo -55.99 -51.01 10.54 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.18 3.253 . . . . 0.98 112.794 -173.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.89 16.87 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.146 -0.934 . . . . 1.08 112.15 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -106.13 -171.15 23.22 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.697 -0.763 . . . . 1.05 112.347 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.93 33.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 124.621 3.547 . . . . 1.3 114.422 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -77.61 -32.19 53.35 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.068 0.461 . . . . 1.38 110.695 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.82 42.78 2.79 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.598 -0.728 . . . . 1.11 113.333 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.83 -17.07 0.54 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.53 0.937 . . . . 0.81 113.53 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -156.87 131.38 8.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 110.042 -0.355 . . . . 1.12 110.042 176.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.9 t-105 -99.23 101.17 12.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.743 -0.836 . . . . 2.19 108.743 167.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.82 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.3 mp -106.95 135.64 48.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.281 0.562 . . . . 0.61 110.168 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.3 m -106.36 144.42 33.07 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.625 -0.716 . . . . 0.94 112.175 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 123' ' ' TYR . 0.1 OUTLIER -86.36 -177.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.415 -1.328 . . . . 1.08 107.415 164.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 21.7 m -88.62 4.65 46.27 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.445 0.535 . . . . 1.5 112.445 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.47 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 33.2 tptt -129.15 115.59 17.92 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 119.766 -0.773 . . . . 2.97 112.295 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 51.42 -144.12 0.6 Allowed 'General case' 0 C--N 1.332 -0.184 0 O-C-N 124.088 0.868 . . . . 5.06 112.202 174.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -86.69 9.52 18.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.739 0.274 . . . . 5.95 111.739 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 78.8 m-85 -70.41 123.77 22.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.081 -0.711 . . . . 4.83 109.081 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.414 ' HA2' HD22 ' A' ' 118' ' ' LEU . . . -154.0 162.03 30.28 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.245 -0.979 . . . . 0.95 112.76 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.85 HD12 HD11 ' A' ' 100' ' ' ILE . 43.0 mt -95.14 117.01 38.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.687 -0.857 . . . . 0.48 108.687 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.559 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 8.8 p80 -144.34 -163.81 1.76 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.789 -0.765 . . . . 1.25 112.148 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.488 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.05 -174.94 15.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.929 -1.129 . . . . 0.46 113.541 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.457 ' HA ' ' NH2' ' A' ' 144' ' ' ARG . 5.2 t -141.9 173.66 11.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.454 0.645 . . . . 0.5 111.333 -165.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.88 -18.59 14.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.131 -0.941 . . . . 1.86 108.645 164.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -127.26 101.66 24.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.891 -1.05 . . . . 1.77 110.3 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.1 Cg_endo -92.14 3.83 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.138 2.558 . . . . 0.59 112.801 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.01 -30.29 24.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.01 0.433 . . . . 0.78 110.254 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 m -85.52 -2.66 58.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 1.45 110.384 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 8.0 mm -67.37 114.76 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.476 -0.784 . . . . 0.7 110.12 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.18 96.25 1.7 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.102 -0.799 . . . . 1.68 111.102 -172.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -151.58 -170.77 3.74 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.634 -0.333 . . . . 4.39 110.995 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 138' ' ' VAL . . . -84.61 -174.81 5.48 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.189 -0.301 . . . . 3.94 110.189 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.468 ' HB ' ' HA3' ' A' ' 87' ' ' GLY . 40.6 t 76.79 168.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.588 -0.893 . . . . 4.68 108.588 -172.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 138' ' ' VAL . 8.1 t -124.76 156.1 38.25 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.677 -0.64 . . . . 5.68 111.041 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 88.9 tttt 57.02 85.75 0.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.404 -0.816 . . . . 8.3 111.63 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 88' ' ' LYS . . . -113.55 -148.3 10.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.747 -0.739 . . . . 3.85 112.244 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.481 ' H ' ' HB3' ' A' ' 85' ' ' ALA . 95.7 m -102.54 146.25 28.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.504 . . . . 2.51 110.114 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.505 ' CG2' HG12 ' A' ' 125' ' ' ILE . 23.8 mt -96.82 73.15 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.438 0.637 . . . . 1.44 109.869 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 9.7 ptm180 -123.89 148.97 46.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 3.36 110.558 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.3 mtp -136.39 -167.31 2.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.243 0.544 . . . . 1.13 111.14 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -73.83 146.46 44.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.082 -0.963 . . . . 2.51 108.739 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.617 ' O ' HG12 ' A' ' 150' ' ' VAL . 4.4 m-20 -52.16 -65.33 0.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.219 0.451 . . . . 1.77 112.219 -171.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -59.22 -25.05 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.65 -0.656 . . . . 2.13 111.476 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.61 -35.78 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 1.05 110.765 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 10.8 p -77.94 -17.01 14.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.691 0 CA-C-N 116.529 -0.305 . . . . 0.32 110.25 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.447 HD12 HG13 ' A' ' 150' ' ' VAL . 2.3 mp -85.9 -39.11 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 119.073 -0.489 . . . . 0.37 109.914 172.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -44.72 -69.48 0.13 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 119.148 0.885 . . . . 1.38 112.178 163.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.706 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -50.36 -44.34 54.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.74 110.303 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.65 -50.04 71.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.141 -1.39 . . . . 0.22 112.109 -171.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 p -77.58 -17.21 58.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.724 -1.126 . . . . 1.33 111.111 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.42 -46.2 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.933 -0.576 . . . . 0.23 109.528 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 153' ' ' LEU . 30.6 m -76.51 120.95 83.88 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-O 121.669 0.747 . . . . 0.21 110.459 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.768 ' HG2' HD13 ' A' ' 57' ' ' ILE . 27.4 Cg_endo -85.59 -177.71 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.384 2.723 . . . . 0.34 112.841 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.758 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.7 m120 -60.09 3.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.775 -1.102 . . . . 1.02 113.895 -175.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -149.65 57.8 0.46 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.635 -0.793 . . . . 0.28 112.641 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.769 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.71 134.26 34.55 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.472 -0.428 . . . . 0.3 111.173 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -84.39 128.5 34.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.055 -0.521 . . . . 1.96 110.622 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 98' ' ' PHE . 3.2 p -141.83 129.58 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.542 0.526 . . . . 0.46 111.347 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.9 m -122.95 143.86 49.63 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.515 0.561 . . . . 0.56 112.515 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.42 HG22 ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -125.92 115.86 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.19 -1.004 . . . . 0.96 112.352 177.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -143.46 141.01 30.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.958 -1.019 . . . . 1.19 109.73 -172.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.571 ' HB2' HG22 ' A' ' 93' ' ' THR . 5.5 mpt_? -93.34 -39.26 11.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.848 -1.069 . . . . 3.42 111.586 -172.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.37 -57.46 4.42 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.891 -0.595 . . . . 3.65 112.271 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.38 -0.819 . . . . 5.97 109.718 178.502 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.69 ' N4 ' H623 ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 111.698 -0.561 . . . . 2.92 111.698 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 61.25 -175.54 0.12 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.601 0.715 . . . . 4.1 111.705 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt -66.87 155.12 39.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.234 -0.894 . . . . 2.1 109.232 169.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.767 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.1 mt -90.73 167.72 12.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.211 -0.449 . . . . 0.26 111.069 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.671 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -74.19 148.57 41.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.216 0.531 . . . . 0.23 111.65 -170.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.38 148.67 37.31 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.794 0.806 . . . . 0.26 111.257 168.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.462 ' CE2' ' HA ' ' A' ' 9' ' ' VAL . 69.1 t80 -134.04 148.03 51.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.009 -1.45 . . . . 0.39 107.61 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.8 tt0 -127.84 111.21 13.37 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.657 -1.609 . . . . 1.07 106.657 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -72.18 157.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.219 0.533 . . . . 0.38 111.39 -165.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HE2' ' HA3' ' A' ' 96' ' ' GLY . 87.7 mttt -107.64 148.43 29.35 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.461 -0.79 . . . . 2.59 109.291 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.955 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 19.3 tm0? -46.53 116.96 1.44 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 1.74 112.631 -173.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.35 -8.94 38.39 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.967 -1.015 . . . . 0.57 113.514 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.546 ' HB3' HD11 ' A' ' 18' ' ' ILE . 83.1 m-20 -61.46 155.03 22.8 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.973 0.731 . . . . 2.17 112.973 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.592 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -134.32 159.11 41.99 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.949 -0.569 . . . . 0.5 111.73 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 46.6 tp -52.68 -57.71 9.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.948 1.092 . . . . 0.27 113.948 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.706 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 2.0 t30 -66.71 -43.19 84.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 122.309 1.052 . . . . 1.21 110.558 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.569 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 37.5 t -57.77 -47.96 81.03 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 112.988 -1.915 . . . . 1.24 109.797 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 14' ' ' THR . 1.6 mp -68.75 -40.65 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.795 -0.639 . . . . 0.3 111.89 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.708 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.28 -65.55 0.59 Allowed 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.23 111.541 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.89 -4.73 55.87 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.768 -1.173 . . . . 0.39 112.273 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -67.62 -27.28 66.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.93 -0.767 . . . . 1.63 108.93 157.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -99.6 15.37 26.87 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.804 -0.56 . . . . 0.24 112.146 172.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 56.28 50.94 12.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.495 -0.775 . . . . 3.55 110.662 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.708 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.3 pt -149.14 -173.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.909 -0.775 . . . . 0.27 108.909 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.04 147.61 23.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.415 -0.811 . . . . 0.81 110.017 172.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.706 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.4 p -62.56 -36.46 82.71 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.654 -0.869 . . . . 0.27 108.654 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -28.83 68.74 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.665 -1.152 . . . . 0.26 111.539 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 49' ' ' PRO . . . -80.37 -38.22 30.84 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.524 -0.547 . . . . 0.23 109.524 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 46' ' ' ILE . 12.7 tp -71.98 -20.42 61.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.563 -0.744 . . . . 0.17 109.007 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.684 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -38.36 40.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.47 0.652 . . . . 0.19 111.381 172.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.25 -42.46 91.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.998 0.904 . . . . 1.07 109.84 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.95 -16.26 51.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.843 -1.526 . . . . 0.17 112.01 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 33.2 m-80 -139.99 69.94 35.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.624 -0.51 . . . . 0.19 109.624 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.46 -21.9 19.77 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 124.533 3.489 . . . . 0.3 115.422 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -69.64 -34.12 73.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 119.458 1.026 . . . . 1.17 110.293 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.629 ' CD2' ' HB3' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -65.05 -6.7 9.42 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.422 -1.263 . . . . 0.53 113.635 -172.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.684 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.12 -40.68 24.34 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.475 1.131 . . . . 1.23 110.351 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.37 -46.15 13.93 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.98 -1.918 . . . . 0.4 111.642 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.41 -161.78 31.82 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.118 -1.039 . . . . 0.3 114.396 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.5 mp -118.6 158.27 25.78 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.704 -1.748 . . . . 0.31 110.542 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 98.7 m -133.6 133.69 42.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.799 -0.637 . . . . 0.39 110.55 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.955 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.22 127.15 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.789 0.662 . . . . 0.47 112.789 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.47 52.9 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.796 -1.093 . . . . 0.36 112.506 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.631 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.1 tt0 -65.28 152.66 43.2 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.643 0.735 . . . . 1.19 110.219 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 42.0 m -119.24 131.76 55.84 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.61 -1.177 . . . . 0.89 109.542 -171.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.718 HD12 HD11 ' A' ' 29' ' ' LEU . 25.2 pt -136.49 151.34 28.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.339 0.59 . . . . 0.22 110.698 -174.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.615 ' H ' HD21 ' A' ' 33' ' ' ASN . 5.3 t -94.56 148.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.156 -0.929 . . . . 0.21 110.703 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.598 ' CG1' HD23 ' A' ' 5' ' ' LEU . 15.7 mm -117.44 88.74 29.63 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 114.599 -1.182 . . . . 0.17 108.418 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.6 Cg_endo -59.02 143.8 99.65 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.186 2.591 . . . . 0.23 112.769 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.46 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.83 -6.88 60.68 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.3 113.035 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.752 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.9 tt -116.65 129.97 24.88 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.334 -0.987 . . . . 0.25 108.334 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.721 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.2 Cg_endo -69.45 171.08 14.76 Favored 'Trans proline' 0 N--CA 1.475 0.41 0 C-N-CA 123.583 2.855 . . . . 0.31 113.906 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 3.1 t70 -91.6 138.05 25.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 0.72 112.297 -171.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.671 ' HD3' HD12 ' A' ' 5' ' ' LEU . 69.4 Cg_endo -84.4 -4.27 10.15 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 123.684 2.923 . . . . 0.27 113.351 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -94.96 -25.15 16.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.853 0.359 . . . . 2.11 110.9 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.7 t -86.06 -13.0 48.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.448 0.642 . . . . 1.47 109.42 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HG2' ' A' ' 158' ' ' PRO . 81.3 mt -85.61 124.42 71.3 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.198 -0.91 . . . . 0.26 110.034 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -101.25 95.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.811 0.968 . . . . 0.2 110.109 169.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -158.37 137.13 11.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.55 -1.648 . . . . 0.26 106.55 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 71.8 t60 -144.19 109.89 5.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.851 -1.166 . . . . 2.84 107.851 -167.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 70.2 mt -95.14 107.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.394 -1.276 . . . . 0.32 109.864 -177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.5 94.24 4.9 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.048 0.927 . . . . 0.34 110.244 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.492 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -113.95 98.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 113.825 -1.534 . . . . 0.68 109.202 178.043 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.491 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 55.2 m -91.0 123.76 34.72 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.805 -1.183 . . . . 1.05 107.805 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 167' ' ' ARG . 5.8 mt -60.6 -26.98 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.571 0.7 . . . . 1.29 110.214 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.53 -47.08 64.44 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 114.96 -1.018 . . . . 0.88 111.477 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -66.36 -23.92 66.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.114 0.483 . . . . 0.74 111.908 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.609 ' HA ' HG11 ' A' ' 86' ' ' VAL . 2.7 mtpt 59.13 12.48 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.256 1.023 . . . . 2.51 113.169 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.98 143.23 38.44 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.647 0.736 . . . . 0.45 110.902 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.6 tt -96.8 119.1 34.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.319 -1.31 . . . . 0.33 109.635 -177.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -102.59 126.51 49.69 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.244 -0.582 . . . . 0.4 111.317 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.566 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.71 141.9 32.07 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.436 -1.69 . . . . 0.33 106.436 175.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.5 m -145.98 128.81 16.33 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.481 1.491 . . . . 0.75 112.377 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -118.07 125.49 50.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.982 -1.008 . . . . 0.35 110.291 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.49 33.36 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.13 -0.692 . . . . 0.52 109.13 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 77.57 3.88 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.374 -1.285 . . . . 1.84 111.592 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -130.47 138.52 50.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 118.779 -1.168 . . . . 3.19 113.368 170.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -53.2 150.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 113.107 -1.86 . . . . 0.41 112.957 -174.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.566 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -99.03 -43.88 6.51 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.543 -2.117 . . . . 0.35 108.21 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -177.52 157.6 1.29 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.427 -2.169 . . . . 2.07 109.863 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -117.59 130.65 56.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.723 0.297 . . . . 0.37 110.8 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 74.9 m-85 -114.99 143.11 29.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.355 -0.384 . . . . 0.97 110.337 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 18.8 Cg_endo -81.67 140.61 11.82 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.298 1.999 . . . . 0.6 111.156 175.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.27 -172.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.323 -0.399 . . . . 0.64 111.085 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.05 130.34 34.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 0.83 110.03 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -152.85 32.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 1.67 111.173 -172.147 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.86 -170.68 38.63 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.702 -0.761 . . . . 3.08 112.869 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HG2' ' CB ' ' A' ' 137' ' ' ALA . 74.0 mmtt 60.43 87.03 0.09 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.214 0.606 . . . . 7.26 111.221 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 tp -74.61 80.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 122.053 0.93 . . . . 6.29 110.432 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.1 mt -90.63 -6.18 54.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.581 -0.736 . . . . 7.27 110.46 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.448 ' C ' ' HD3' ' A' ' 167' ' ' ARG . 23.4 m 74.52 -20.22 0.33 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.689 -0.687 . . . . 5.18 111.807 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -68.36 119.73 13.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.041 0.448 . . . . 4.81 111.108 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.558 HG23 ' HG2' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -88.13 118.2 69.31 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.75 -0.659 . . . . 2.11 110.126 173.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.51 113.74 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.333 2.022 . . . . 3.21 111.087 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.3 m -92.95 128.5 38.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.911 -0.586 . . . . 3.59 111.004 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.418 ' HA3' ' HE2' ' A' ' 10' ' ' LYS . . . 90.9 142.41 10.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.975 -0.631 . . . . 2.1 111.982 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.11 169.29 18.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.344 0.592 . . . . 2.3 111.355 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.516 ' HB2' HG13 ' A' ' 163' ' ' VAL . 19.1 m-85 -123.98 172.38 9.0 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.61 -1.256 . . . . 1.93 107.61 169.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 161' ' ' THR . 46.9 m-85 -128.78 139.07 52.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.761 0.315 . . . . 0.58 110.221 173.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.69 HD11 HD12 ' A' ' 125' ' ' ILE . 16.3 mm -58.66 104.59 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.273 -1.01 . . . . 0.41 108.273 169.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.558 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.5 tt -93.17 -25.86 4.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.009 -0.676 . . . . 0.37 112.337 -170.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -169.4 -179.51 3.49 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 114.936 1.458 . . . . 1.99 114.936 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.9 175.8 10.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 111.079 -2.782 . . . . 1.19 108.517 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.78 155.27 39.84 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.462 1.125 . . . . 1.67 113.311 -164.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -52.54 149.73 5.62 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.64 -2.073 . . . . 3.06 111.109 166.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -50.14 107.03 0.71 Allowed Pre-proline 0 CA--C 1.514 -0.407 0 CA-C-N 115.825 -0.625 . . . . 2.61 111.928 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -59.2 -51.62 6.29 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 123.627 2.885 . . . . 0.98 112.896 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.45 -21.64 44.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.2 -0.909 . . . . 1.08 111.575 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -93.79 -170.1 38.57 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.357 -0.449 . . . . 1.05 112.137 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.3 21.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 124.648 3.565 . . . . 1.3 114.69 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -75.73 -18.5 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.369 . . . . 1.38 111.136 179.041 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 82.51 49.42 5.18 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.78 -0.646 . . . . 1.11 113.326 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.93 -20.56 0.37 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.222 0.823 . . . . 0.81 113.222 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.522 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -155.77 144.54 20.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 1.12 110.861 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -111.87 102.16 10.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.342 -0.614 . . . . 2.19 109.342 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -106.47 137.01 45.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.537 0.685 . . . . 0.61 109.839 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.412 ' HB2' HG23 ' A' ' 101' ' ' ILE . 72.9 m -106.75 144.46 33.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.412 -0.813 . . . . 0.94 112.272 -171.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -90.98 -175.04 4.21 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.19 -1.411 . . . . 1.08 107.19 169.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.2 m -80.23 -67.61 0.75 Allowed 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.775 -0.77 . . . . 1.5 111.861 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -86.79 151.37 23.42 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.092 0.775 . . . . 2.97 113.092 -170.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 64.3 -169.93 0.19 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.571 -1.195 . . . . 5.06 111.412 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -96.3 44.92 1.07 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.149 0.499 . . . . 5.95 109.711 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -115.74 140.61 49.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.772 -0.649 . . . . 4.83 109.993 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -154.64 163.41 31.21 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.704 -0.76 . . . . 0.95 112.209 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.69 HD12 HD11 ' A' ' 100' ' ' ILE . 27.8 mt -91.72 107.19 18.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.78 -0.822 . . . . 0.48 108.78 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.531 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 54.2 p-80 -139.68 -163.27 1.47 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.329 0.585 . . . . 1.25 111.441 -174.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.03 163.51 14.47 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.058 -1.068 . . . . 0.46 113.597 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 5.7 t -120.45 170.87 8.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.711 -0.745 . . . . 0.5 111.608 -168.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.98 -22.21 13.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.926 -1.034 . . . . 1.86 108.586 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -124.88 104.56 30.05 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 114.837 -1.074 . . . . 1.77 109.642 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.58 4.22 7.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.96 2.44 . . . . 0.59 112.783 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.21 -11.0 47.97 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.98 -0.748 . . . . 0.78 108.98 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.404 ' HB3' HG21 ' A' ' 138' ' ' VAL . 15.7 m -78.52 -26.65 45.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.011 -0.995 . . . . 1.45 109.439 175.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 144' ' ' ARG . 27.1 mm -60.84 117.36 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.354 -0.839 . . . . 0.7 110.041 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 122.88 -29.79 5.27 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.051 -0.819 . . . . 1.68 111.051 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -104.7 -156.7 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.289 -0.263 . . . . 4.39 110.289 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.447 ' CB ' ' HG2' ' A' ' 88' ' ' LYS . . . -99.44 -74.08 0.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.218 0.451 . . . . 3.94 112.218 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 137' ' ' ALA . 93.7 t 70.45 103.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 123.615 0.572 . . . . 4.68 109.564 -170.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m 65.94 -89.81 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.271 -0.877 . . . . 5.68 110.289 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.58 -0.34 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.257 0.551 . . . . 8.3 109.774 174.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 135.35 115.46 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.593 -0.731 . . . . 3.85 111.513 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.601 ' SG ' ' HD2' ' A' ' 144' ' ' ARG . 0.5 OUTLIER -113.1 110.1 19.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 2.51 111.42 -178.001 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 19.9 mt -86.11 66.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.08 0.467 . . . . 1.44 110.156 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.601 ' HD2' ' SG ' ' A' ' 142' ' ' CYS . 1.7 ptm180 -127.6 104.79 8.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.569 0.699 . . . . 3.36 111.844 -176.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.41 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 9.7 ptm -107.83 -165.16 1.02 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.211 -0.904 . . . . 1.13 111.721 -172.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -67.33 148.1 52.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.493 -0.188 . . . . 2.51 110.493 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.619 ' O ' HG12 ' A' ' 150' ' ' VAL . 13.8 m-80 -50.8 -68.09 0.2 Allowed 'General case' 0 C--O 1.221 -0.408 0 O-C-N 123.529 0.518 . . . . 1.77 110.962 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.383 0.512 . . . . 2.13 112.383 -173.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.55 -37.99 62.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.579 0.228 . . . . 1.05 111.14 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.5 p -75.85 -15.2 15.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 110.11 -0.33 . . . . 0.32 110.11 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.522 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -89.79 -39.65 12.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.101 -0.476 . . . . 0.37 110.582 172.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -44.44 -68.63 0.18 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.574 1.079 . . . . 1.38 112.137 164.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.4 tp -50.0 -43.11 50.41 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.904 0.753 . . . . 0.74 110.092 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.24 -53.67 47.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.296 -1.32 . . . . 0.22 112.464 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.2 t -76.74 -16.99 59.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.843 -1.072 . . . . 1.33 110.618 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.7 mt -91.28 -49.58 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.768 -0.456 . . . . 0.23 109.768 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 22.5 m -77.98 116.27 57.26 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-O 121.855 0.835 . . . . 0.21 110.119 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.788 ' HG2' HD13 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -83.01 -178.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.052 2.501 . . . . 0.34 112.327 -175.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.752 ' O ' HD21 ' A' ' 51' ' ' LEU . 14.2 m120 -64.93 7.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.905 -1.043 . . . . 1.02 113.337 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -146.64 53.98 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.941 -0.647 . . . . 0.28 112.156 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.0 m -88.17 135.8 33.27 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.47 -0.429 . . . . 0.3 110.863 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 162' ' ' ARG . 9.0 mtm180 -84.75 122.08 28.6 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.783 -0.644 . . . . 1.96 110.351 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 98' ' ' PHE . 3.6 p -134.74 127.74 49.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.46 111.594 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 m -118.67 140.06 50.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.474 -0.785 . . . . 0.56 111.902 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -124.65 114.71 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 118.887 -1.125 . . . . 0.96 110.75 174.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.499 ' HA ' HG22 ' A' ' 93' ' ' THR . 29.5 p-10 -143.65 127.85 17.66 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.917 -1.038 . . . . 1.19 110.268 -173.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.558 ' HG2' HG23 ' A' ' 93' ' ' THR . 6.0 ptm180 -94.24 -22.86 18.14 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.811 -1.086 . . . . 3.42 111.856 -175.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.5 -128.4 8.47 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.248 -0.887 . . . . 3.65 110.999 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.769 -0.634 . . . . 5.97 109.906 177.764 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.729 ' H11' ' O62' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.737 -0.545 . . . . 2.92 111.737 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -142.16 174.31 10.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.049 0.452 . . . . 4.1 110.114 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.21 143.75 27.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.428 -0.953 . . . . 2.1 108.428 167.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.803 HD13 ' HA ' ' A' ' 49' ' ' PRO . 19.8 mt -99.2 172.37 7.41 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.396 0.435 . . . . 0.26 111.756 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD23 HG13 ' A' ' 48' ' ' ILE . 4.3 tp -75.86 150.73 37.57 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.176 0.59 . . . . 0.23 111.84 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.539 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.06 150.58 35.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.978 0.894 . . . . 0.26 111.927 167.452 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.1 t80 -133.16 149.62 52.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.656 -1.611 . . . . 0.39 108.014 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.647 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.88 116.38 19.33 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 106.405 -1.702 . . . . 1.07 106.405 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.48 158.03 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.446 0.641 . . . . 0.38 111.786 -169.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.63 152.04 26.07 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.145 -0.934 . . . . 2.59 108.804 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.796 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.6 tt0 -51.6 111.3 0.57 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 1.74 111.795 -174.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -9.17 20.56 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.141 -0.936 . . . . 0.57 113.015 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.608 ' HB3' HD11 ' A' ' 18' ' ' ILE . 74.8 m-20 -66.48 147.13 53.73 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.327 0.563 . . . . 2.17 112.25 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.643 ' O ' HD13 ' A' ' 18' ' ' ILE . 2.0 p -134.44 163.75 28.99 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.257 0.466 . . . . 0.5 112.257 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.597 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -49.94 -62.06 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.367 1.247 . . . . 0.27 114.367 -171.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.697 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.2 t-20 -64.99 -41.14 95.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.49 1.138 . . . . 1.21 110.305 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.768 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.9 t -57.42 -48.15 79.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.472 -2.149 . . . . 1.24 109.858 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -70.15 -40.4 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 123.668 0.787 . . . . 0.3 112.456 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.687 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.33 -65.07 0.67 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.397 -0.365 . . . . 0.23 111.535 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.85 -5.06 54.73 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.743 -1.183 . . . . 0.39 111.83 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' SER . 17.3 t70 -65.19 -32.88 74.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.329 -0.989 . . . . 1.63 108.329 158.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.599 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.4 m-85 -97.83 14.96 25.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.196 0.443 . . . . 0.24 112.196 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 58.46 47.93 12.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 3.55 110.741 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.1 pt -147.89 -175.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.918 -0.771 . . . . 0.27 108.918 -173.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 146.22 26.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.362 -0.835 . . . . 0.81 109.467 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.697 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 10.3 p -62.17 -37.39 85.09 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.933 -0.766 . . . . 0.27 108.933 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.556 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.75 -30.29 71.4 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.192 -1.367 . . . . 0.26 111.281 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.93 -37.94 33.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 0.23 109.778 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.742 HD11 HD12 ' A' ' 46' ' ' ILE . 14.1 tp -73.69 -20.09 60.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 0.17 109.206 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.744 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.93 -38.82 44.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.65 0.738 . . . . 0.19 111.435 172.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 57.4 mt-30 -59.53 -41.9 91.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.288 1.042 . . . . 1.07 109.744 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.42 -20.74 39.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.565 -1.652 . . . . 0.17 112.315 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 12.6 m120 -142.34 73.25 21.25 Favored Pre-proline 0 CA--C 1.513 -0.449 0 CA-C-O 121.196 0.522 . . . . 0.19 110.099 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.726 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.3 Cg_endo -58.37 -10.03 7.9 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 123.239 2.626 . . . . 0.3 113.926 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -62.59 -31.06 71.81 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.972 0.892 . . . . 1.17 109.564 173.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 3.2 mt -83.14 -7.01 59.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.679 1.363 . . . . 0.53 114.679 -172.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.744 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -49.54 -40.92 39.86 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 120.03 1.286 . . . . 1.23 110.151 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 -46.64 12.84 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.886 -1.961 . . . . 0.4 111.511 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.42 -165.93 37.61 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.295 -0.955 . . . . 0.3 114.472 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.466 HD23 HG11 ' A' ' 9' ' ' VAL . 4.5 mp -113.71 158.47 20.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.412 -1.394 . . . . 0.31 110.252 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.687 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -136.97 134.16 36.39 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.786 -0.643 . . . . 0.39 110.65 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.796 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.05 129.36 17.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.475 0.655 . . . . 0.47 112.736 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.594 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 83.2 -11.49 54.76 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.561 -1.199 . . . . 0.36 112.766 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.888 ' OE1' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -61.48 158.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.194 0.521 . . . . 1.19 110.134 172.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.492 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 58.7 p -123.24 137.85 54.77 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.96 -1.018 . . . . 0.89 110.468 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.888 HG23 ' OE1' ' A' ' 44' ' ' GLN . 12.3 pt -135.13 171.6 17.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.287 0.565 . . . . 0.22 111.266 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 19.1 t -114.2 149.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.731 -1.122 . . . . 0.21 109.533 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.55 HG13 HD23 ' A' ' 5' ' ' LEU . 18.4 mm -118.27 88.29 32.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.183 -0.917 . . . . 0.17 108.711 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.803 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.47 139.88 92.38 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.387 2.725 . . . . 0.23 113.203 -173.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.469 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.22 -7.37 67.8 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.424 -0.807 . . . . 0.3 112.867 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.691 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.57 124.27 30.22 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.578 -0.897 . . . . 0.25 108.578 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD23 ' A' ' 51' ' ' LEU . 57.0 Cg_endo -65.31 176.34 3.36 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.75 2.967 . . . . 0.31 113.939 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.638 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.2 t70 -89.6 140.97 28.26 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.801 -1.091 . . . . 0.72 110.139 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.598 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 88.0 Cg_endo -81.86 -1.16 10.74 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.367 2.711 . . . . 0.27 111.725 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -28.83 14.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.898 -0.592 . . . . 2.11 110.772 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 53' ' ' ASP . 34.1 p -69.41 -28.4 66.12 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 122.617 1.199 . . . . 1.47 107.905 170.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.804 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.8 mt -84.16 124.75 73.81 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.899 -1.955 . . . . 0.26 110.648 175.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -101.57 95.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 CA-C-N 119.841 0.979 . . . . 0.2 109.847 166.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' HD2' HG23 ' A' ' 57' ' ' ILE . 80.8 m-85 -157.74 131.75 8.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.925 -1.509 . . . . 0.26 106.925 172.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 3.5 m-70 -140.48 113.55 8.38 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.436 -1.32 . . . . 2.84 107.436 -164.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.7 mt -102.23 111.22 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.723 -0.671 . . . . 0.32 111.307 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.96 98.86 7.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.227 -0.897 . . . . 0.34 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 165' ' ' ILE . 0.4 OUTLIER -116.55 99.71 8.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.174 -1.375 . . . . 0.68 109.559 177.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 54.2 m -94.46 133.08 38.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.071 -0.968 . . . . 1.05 109.199 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.658 HG23 HG13 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -59.87 -35.63 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.595 0.712 . . . . 1.29 110.676 176.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' H ' ' HA ' ' A' ' 167' ' ' ARG . . . -63.85 -43.4 97.67 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.905 -1.043 . . . . 0.88 110.956 175.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -71.32 -25.27 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.825 0.676 . . . . 0.74 112.825 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 mttt 54.03 17.07 1.28 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.913 0.885 . . . . 2.51 112.961 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.42 141.59 35.5 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.525 0.678 . . . . 0.45 111.051 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.486 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.2 tt -96.25 117.47 30.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.473 -1.239 . . . . 0.33 109.675 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 m -100.73 127.51 47.12 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.17 -0.468 . . . . 0.4 111.227 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.557 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -81.94 146.84 29.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.275 -1.75 . . . . 0.33 106.275 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 36.5 m -150.31 127.02 10.95 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 120.351 1.432 . . . . 0.75 112.442 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.07 125.25 53.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.492 -1.231 . . . . 0.35 110.088 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 4.7 t-20 60.73 42.25 13.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.152 0.501 . . . . 0.52 110.166 174.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.7 m-20 74.64 -1.46 3.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.993 -1.003 . . . . 1.84 112.731 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -128.69 135.76 49.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 117.845 -1.542 . . . . 3.19 114.115 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -56.55 149.17 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 112.7 -2.045 . . . . 0.41 113.027 -170.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.557 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.2 mtp -101.02 -43.03 6.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.581 -2.1 . . . . 0.35 108.566 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 178.81 159.1 0.57 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.617 -2.083 . . . . 2.07 110.342 -177.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.512 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.1 m -117.07 135.55 53.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.392 0.139 . . . . 0.37 111.165 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -124.08 135.03 25.88 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-O 120.792 0.329 . . . . 0.97 110.778 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -62.49 145.27 95.53 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.385 2.723 . . . . 0.6 113.268 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.94 169.38 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.091 -0.504 . . . . 0.64 109.675 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.537 ' HB3' ' H ' ' A' ' 142' ' ' CYS . . . -88.27 127.75 35.47 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.297 0.57 . . . . 0.83 110.902 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.658 HG13 HG23 ' A' ' 65' ' ' ILE . 1.2 t -109.06 -28.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.774 -1.103 . . . . 1.67 111.781 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 138' ' ' VAL . . . 84.47 -126.93 7.87 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.375 -0.917 . . . . 3.08 111.246 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -176.16 -35.09 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.457 0.169 . . . . 7.26 111.457 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 tp -143.82 -24.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.163 -0.615 . . . . 6.29 112.26 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 20.4 tp -83.13 21.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.45 0.643 . . . . 7.27 111.036 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.9 m -152.71 114.42 4.32 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.136 -0.691 . . . . 5.18 109.136 175.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -84.61 171.33 12.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.97 -0.559 . . . . 4.81 110.492 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.659 HG23 ' H ' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -54.16 -56.53 25.18 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 111.663 0.246 . . . . 2.11 111.663 177.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' A' ' 93' ' ' THR . 2.7 Cg_exo -76.32 75.79 4.15 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.486 2.124 . . . . 3.21 111.928 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 m -80.96 -26.45 36.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.347 -0.612 . . . . 3.59 109.347 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.95 156.74 14.51 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.386 -0.825 . . . . 2.1 111.928 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -88.93 129.6 35.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 2.3 109.688 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.632 ' HB2' HG13 ' A' ' 163' ' ' VAL . 7.1 m-85 -118.74 177.55 4.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.535 -0.757 . . . . 1.93 109.76 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 161' ' ' THR . 95.6 m-85 -139.02 143.33 38.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.58 110.385 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.79 HD11 HD12 ' A' ' 125' ' ' ILE . 22.6 mm -59.96 126.08 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.54 -1.281 . . . . 0.41 107.54 164.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -124.02 -23.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.653 -0.819 . . . . 0.37 112.808 -174.25 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 15.7 t-20 -161.3 161.34 30.56 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.328 1.233 . . . . 1.99 114.328 -173.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 1.0 OUTLIER -147.0 128.74 15.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 111.579 -2.555 . . . . 1.19 109.515 174.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.686 ' HB3' ' CD1' ' A' ' 115' ' ' TRP . 7.4 tm0? -109.26 161.54 15.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.562 1.172 . . . . 1.67 111.542 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.55 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 9.4 ttm180 -49.79 152.67 1.45 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.929 -2.396 . . . . 3.06 112.544 171.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.55 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-20 -45.26 114.72 2.33 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-N 114.556 -1.202 . . . . 2.61 111.628 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HG3' ' NE1' ' A' ' 115' ' ' TRP . 85.3 Cg_exo -51.19 -48.16 22.44 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 C-N-CA 124.082 3.188 . . . . 0.98 112.441 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.59 -4.26 59.7 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.441 -1.254 . . . . 1.08 112.025 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -139.52 -171.55 12.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.989 -0.624 . . . . 1.05 112.736 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.64 20.15 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.724 3.616 . . . . 1.3 114.973 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 109' ' ' GLY . 46.6 t80 -74.55 -11.2 60.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.216 0.531 . . . . 1.38 110.21 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.89 38.16 3.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.705 -0.76 . . . . 1.11 114.31 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 73.25 -23.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.541 1.311 . . . . 0.81 114.541 166.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.542 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -152.16 148.96 28.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.832 0.349 . . . . 1.12 111.175 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.686 ' CD1' ' HB3' ' A' ' 104' ' ' GLN . 0.1 OUTLIER -110.4 101.6 10.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.489 -0.93 . . . . 2.19 108.489 171.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.782 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -111.44 138.18 48.27 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.073 -0.651 . . . . 0.61 110.252 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 101' ' ' ILE . 10.0 t -107.32 151.34 25.61 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.717 -0.674 . . . . 0.94 111.951 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.48 ' N ' ' HA2' ' A' ' 124' ' ' GLY . 1.0 OUTLIER -101.8 -174.1 2.51 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.275 -1.38 . . . . 1.08 107.275 172.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.575 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 32.4 t -80.78 -76.78 0.22 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.678 -0.809 . . . . 1.5 110.716 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.464 ' HE2' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -126.56 149.2 49.56 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.113 0.412 . . . . 2.97 112.113 -170.176 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 72.16 -60.96 0.51 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.179 0.992 . . . . 5.06 113.404 169.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -79.67 10.97 3.45 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.83 0.307 . . . . 5.95 111.83 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 64.03 -87.33 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.944 0.777 . . . . 4.83 112.377 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.48 ' HA2' ' N ' ' A' ' 118' ' ' LEU . . . -156.24 162.33 31.35 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.258 -0.972 . . . . 0.95 113.574 -175.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.79 HD12 HD11 ' A' ' 100' ' ' ILE . 32.3 mt -93.26 106.39 17.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.051 -1.092 . . . . 0.48 108.051 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.577 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 9.9 p80 -140.69 -162.13 1.31 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.978 -0.689 . . . . 1.25 111.443 -172.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.62 -172.36 14.63 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.679 -1.248 . . . . 0.46 113.13 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -154.7 178.15 10.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.209 0.528 . . . . 0.5 110.336 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -111.66 -12.79 13.85 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.425 -0.807 . . . . 1.86 109.57 169.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -125.26 101.99 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.61 -0.723 . . . . 1.77 109.782 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.52 4.04 4.62 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.053 2.502 . . . . 0.59 113.148 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.13 54.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.521 0.677 . . . . 0.78 109.57 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -100.13 3.28 43.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.003 -0.999 . . . . 1.45 109.53 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 144' ' ' ARG . 16.7 mm -95.71 122.88 47.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 0.7 110.256 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.53 -8.55 74.55 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.544 -1.022 . . . . 1.68 110.544 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -151.38 80.98 1.3 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.904 -0.406 . . . . 4.39 109.904 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.07 147.02 25.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.435 -0.348 . . . . 3.94 110.646 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 33.4 m -111.75 148.42 14.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.448 -0.342 . . . . 4.68 111.187 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.5 m 67.7 159.5 0.15 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.646 -0.707 . . . . 5.68 111.744 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.611 ' HB2' ' N26' ' A' 1142 ' ' IM2 . 0.4 OUTLIER 71.82 -61.57 0.49 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.571 -0.741 . . . . 8.3 112.04 175.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.18 82.74 0.24 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.79 -0.719 . . . . 3.85 112.733 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.537 ' H ' ' HB3' ' A' ' 85' ' ' ALA . 69.0 m -110.13 165.3 11.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 2.51 110.489 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.559 ' CG2' HG12 ' A' ' 125' ' ' ILE . 52.0 mt -124.44 83.83 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.587 0.708 . . . . 1.44 110.014 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 21.6 mtp180 -119.03 161.35 20.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.484 -0.78 . . . . 3.36 109.248 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' A' ' 149' ' ' ASP . 1.7 ttm -152.83 -165.35 2.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.778 0.323 . . . . 1.13 111.063 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -71.73 154.19 41.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.306 -0.627 . . . . 2.51 109.306 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.618 ' O ' HG12 ' A' ' 150' ' ' VAL . 5.4 p30 -51.52 -68.69 0.15 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.288 0.477 . . . . 1.77 112.288 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -60.15 -26.29 66.18 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 121.644 -0.66 . . . . 2.13 112.315 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.453 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 62.9 m-20 -78.08 -34.33 50.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.523 -0.308 . . . . 1.05 111.639 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.649 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 11.6 p -74.97 -15.82 15.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.32 109.651 175.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.542 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.5 mp -88.59 -37.34 10.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.178 -0.464 . . . . 0.37 110.33 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -43.43 -71.8 0.07 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.375 0.989 . . . . 1.38 112.098 162.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.5 tp -49.03 -42.42 38.18 Favored 'General case' 0 C--O 1.222 -0.343 0 O-C-N 123.747 0.654 . . . . 0.74 110.147 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.43 -54.66 29.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.298 -1.319 . . . . 0.22 112.033 -172.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.6 p -77.82 -14.81 59.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.313 -1.312 . . . . 1.33 111.619 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.14 -51.83 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.82 -0.437 . . . . 0.23 109.82 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.8 m -77.13 118.06 69.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-O 121.952 0.882 . . . . 0.21 110.229 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.804 ' HG2' HD13 ' A' ' 57' ' ' ILE . 41.1 Cg_endo -83.88 -178.42 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.022 2.481 . . . . 0.34 112.832 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.691 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.4 m120 -59.84 -0.46 0.2 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.621 -1.172 . . . . 1.02 113.641 -174.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.59 57.46 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.28 112.235 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -94.46 132.78 38.75 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.441 -0.446 . . . . 0.3 109.951 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -84.54 140.28 31.53 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.676 -0.41 . . . . 1.96 109.995 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.4 p -145.48 126.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.584 -0.735 . . . . 0.46 110.744 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.453 ' C ' HD12 ' A' ' 165' ' ' ILE . 92.0 m -116.51 144.19 44.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.813 -0.63 . . . . 0.56 111.646 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.507 HG13 HG13 ' A' ' 63' ' ' VAL . 3.3 mp -125.96 114.17 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 118.819 -1.152 . . . . 0.96 110.58 173.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -144.31 135.82 25.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.155 -1.384 . . . . 1.19 108.698 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.659 ' H ' HG23 ' A' ' 93' ' ' THR . 8.0 ptm180 -92.37 -24.99 18.72 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.143 0.423 . . . . 3.42 112.143 -177.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.538 ' H ' HG23 ' A' ' 93' ' ' THR . . . -177.47 -127.97 1.11 Allowed Glycine 0 C--N 1.309 -0.935 0 N-CA-C 111.464 -0.654 . . . . 3.65 111.464 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.249 1.052 0 N-CA-C 109.507 -0.553 . . . . 5.97 109.507 177.463 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.611 ' N26' ' HB2' ' A' ' 140' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.613 -0.595 . . . . 2.92 111.613 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 9.9 mpt_? -101.0 177.96 4.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.099 0.476 . . . . 4.1 110.672 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.62 ' HE2' ' H ' ' A' ' 3' ' ' LYS . 1.8 mppt? -62.43 147.08 49.72 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.326 -0.852 . . . . 2.1 109.64 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -100.92 168.32 9.7 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.143 0.277 . . . . 0.26 111.374 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.702 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.6 tp -78.16 149.81 33.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.303 0.641 . . . . 0.23 112.189 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.565 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -116.18 149.46 39.06 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.953 0.882 . . . . 0.26 112.123 169.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' SER . 65.3 t80 -133.9 149.86 51.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.761 -1.563 . . . . 0.39 107.498 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -129.86 116.07 18.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.163 -1.421 . . . . 1.07 107.163 174.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -77.17 158.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.203 0.525 . . . . 0.38 111.885 -166.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -104.94 152.66 22.4 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.417 -0.811 . . . . 2.59 108.947 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.717 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 18.8 tm0? -53.0 119.69 4.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.962 -0.563 . . . . 1.74 111.694 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.03 -10.42 37.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.57 113.15 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.543 ' HB3' HD11 ' A' ' 18' ' ' ILE . 80.9 m-20 -59.33 154.52 16.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.814 0.672 . . . . 2.17 112.814 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.521 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -133.95 150.79 51.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.972 -0.558 . . . . 0.5 112.071 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.598 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.1 tp -48.33 -58.7 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.674 0.99 . . . . 0.27 113.674 -172.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.674 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.0 t-20 -64.69 -42.4 95.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.546 1.165 . . . . 1.21 110.233 -169.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -59.06 -45.65 90.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.428 -2.169 . . . . 1.24 110.031 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -70.43 -41.14 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.715 -0.675 . . . . 0.3 111.867 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.684 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.58 -66.22 0.48 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.23 -0.441 . . . . 0.23 111.812 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -4.6 48.27 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.989 -1.084 . . . . 0.39 112.352 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.51 -29.67 69.15 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.16 -0.682 . . . . 1.63 109.16 158.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD1' HG13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -95.41 10.49 36.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.034 0.445 . . . . 0.24 111.961 173.384 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 59.95 50.3 6.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.256 -0.883 . . . . 3.55 110.513 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.684 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.6 pt -147.7 -174.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.608 -0.886 . . . . 0.27 108.608 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.2 m -101.07 147.7 25.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.559 -0.746 . . . . 0.81 109.755 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.674 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -61.74 -36.09 79.98 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.745 -0.661 . . . . 0.27 109.251 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.39 71.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.502 -1.227 . . . . 0.26 111.677 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -37.54 37.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.196 -0.602 . . . . 0.23 109.451 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 46' ' ' ILE . 16.3 tp -74.17 -19.75 60.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.433 -0.803 . . . . 0.17 109.115 176.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.711 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.08 -38.68 35.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.454 0.645 . . . . 0.19 111.652 173.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -58.89 -43.17 90.9 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 122.223 1.011 . . . . 1.07 109.834 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.53 44.08 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.576 -1.647 . . . . 0.17 111.929 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.565 ' ND2' ' HA ' ' A' ' 46' ' ' ILE . 14.6 m120 -142.6 72.85 20.27 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.19 109.75 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.3 Cg_endo -54.91 -16.53 11.97 Favored 'Trans proline' 0 C--N 1.333 -0.273 0 C-N-CA 123.598 2.865 . . . . 0.3 113.991 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -61.12 -32.65 72.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.068 0.937 . . . . 1.17 109.727 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.664 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.63 -4.47 51.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.295 -1.32 . . . . 0.53 114.484 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.711 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.92 -41.24 45.68 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 119.883 1.219 . . . . 1.23 109.856 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.63 -45.3 11.85 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.946 -1.933 . . . . 0.4 111.597 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.84 -166.31 37.49 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.324 -0.941 . . . . 0.3 113.781 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.8 mp -115.92 158.23 23.33 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.591 -1.304 . . . . 0.31 110.364 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.626 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.6 m -131.27 133.68 45.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.994 -0.548 . . . . 0.39 110.643 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.55 127.93 9.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.108 0.781 . . . . 0.47 113.108 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.77 -11.04 48.98 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.33 -1.304 . . . . 0.36 112.322 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.626 ' HB3' ' O ' ' A' ' 41' ' ' THR . 5.6 tt0 -65.06 152.12 44.3 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.526 0.679 . . . . 1.19 110.355 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 69.1 p -116.04 133.71 55.74 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.691 -1.14 . . . . 0.89 109.758 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 29' ' ' LEU . 21.7 pt -136.12 144.03 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.464 0.649 . . . . 0.22 110.54 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.478 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.9 t -90.72 150.09 3.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.805 -1.089 . . . . 0.21 110.39 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.607 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.2 mm -117.95 87.1 26.94 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 114.849 -1.069 . . . . 0.17 108.245 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.699 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.4 Cg_endo -59.79 142.51 98.78 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.488 2.792 . . . . 0.23 113.023 -172.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.534 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.44 -7.78 63.64 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.56 -0.746 . . . . 0.3 112.69 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.644 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.2 tt -115.45 127.13 27.06 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.771 -0.826 . . . . 0.25 108.771 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 55.3 Cg_endo -64.97 174.04 5.2 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.817 3.011 . . . . 0.31 113.7 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 4.9 t70 -95.75 138.73 21.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.428 -0.805 . . . . 0.72 111.996 -168.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HD3' HD12 ' A' ' 5' ' ' LEU . 97.3 Cg_endo -77.74 -9.76 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.388 2.725 . . . . 0.27 113.271 -172.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -94.98 -25.32 16.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 2.11 110.444 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 3' ' ' LYS . 21.9 p -68.4 -31.79 71.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.3 1.048 . . . . 1.47 108.233 169.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.831 HD13 ' HG2' ' A' ' 158' ' ' PRO . 95.5 mt -77.25 126.87 84.52 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 113.362 -1.745 . . . . 0.26 110.854 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -102.15 95.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 121.084 1.19 . . . . 0.2 110.53 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.3 m-85 -158.42 133.34 8.41 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.886 -1.524 . . . . 0.26 106.886 172.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 10.8 m-70 -138.91 109.05 6.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.729 -1.582 . . . . 2.84 106.729 -168.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -94.65 109.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.126 -0.943 . . . . 0.32 110.135 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.73 96.42 5.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.046 0.927 . . . . 0.34 110.396 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.0 OUTLIER -115.74 97.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.028 -1.442 . . . . 0.68 109.741 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -89.29 128.13 35.84 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.994 -1.003 . . . . 1.05 108.494 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.598 HG21 ' HE ' ' A' ' 167' ' ' ARG . 15.5 mm -57.91 -35.26 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.611 -0.885 . . . . 1.29 108.611 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.54 -43.68 91.72 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 114.355 -1.293 . . . . 0.88 111.828 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.96 -23.91 63.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.404 0.52 . . . . 0.74 112.404 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HE2' ' CG1' ' A' ' 86' ' ' VAL . 32.4 mttt 58.14 15.32 3.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.07 0.948 . . . . 2.51 112.857 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.49 143.26 33.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.556 0.694 . . . . 0.45 111.462 175.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.509 ' CD1' HD11 ' A' ' 143' ' ' ILE . 4.7 tt -94.45 122.68 37.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.362 -1.29 . . . . 0.33 109.766 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -103.36 123.77 47.43 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.041 -0.664 . . . . 0.4 111.267 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.535 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.76 141.47 32.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.323 -1.732 . . . . 0.33 106.323 176.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 2.4 m -144.6 125.91 14.77 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 120.456 1.48 . . . . 0.75 112.483 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.3 tp -112.53 127.81 56.17 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 0.35 110.085 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 7.3 t-20 63.13 32.89 14.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.385 0.612 . . . . 0.52 109.519 173.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.7 m-20 79.86 1.44 2.12 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.536 -1.211 . . . . 1.84 112.493 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -129.15 138.73 51.95 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.707 -1.197 . . . . 3.19 113.698 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.01 147.94 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 113.329 -1.76 . . . . 0.41 113.553 -170.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.535 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -99.68 -44.45 6.11 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 112.087 -2.324 . . . . 0.35 108.121 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 34.4 tptt -176.89 164.75 2.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 112.491 -2.14 . . . . 2.07 110.661 -176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 m -124.16 134.41 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.893 -0.14 . . . . 0.37 111.304 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -124.51 134.62 25.71 Favored Pre-proline 0 CA--C 1.521 -0.154 0 CA-C-O 121.027 0.441 . . . . 0.97 111.637 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.4 ' HB2' HG22 ' A' ' 134' ' ' ILE . 25.6 Cg_endo -63.78 146.64 92.18 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.985 2.456 . . . . 0.6 111.967 174.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.52 -178.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.834 -0.432 . . . . 0.64 109.834 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.84 119.04 24.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.666 0.746 . . . . 0.83 111.575 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.598 ' CG1' ' HE2' ' A' ' 68' ' ' LYS . 8.8 t -140.98 137.43 34.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.344 -1.298 . . . . 1.67 108.872 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.42 -117.25 2.88 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.471 -0.871 . . . . 3.08 112.032 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.486 ' HG2' ' H ' ' A' ' 90' ' ' LEU . 56.7 tttp -91.93 135.0 34.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.733 -0.469 . . . . 7.26 109.733 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.9 pt -67.8 -10.25 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.93 0.345 . . . . 6.29 111.93 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.486 ' H ' ' HG2' ' A' ' 88' ' ' LYS . 29.4 tp -84.88 44.33 1.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.449 0.643 . . . . 7.27 110.229 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -117.66 156.02 28.92 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.958 -0.564 . . . . 5.18 110.529 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -78.57 135.45 37.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.012 0.434 . . . . 4.81 110.756 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 167' ' ' ARG . 37.8 p -61.01 122.76 71.67 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.805 -0.634 . . . . 2.11 110.118 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -86.0 18.03 1.65 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.572 2.181 . . . . 3.21 113.746 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.1 p 49.17 37.79 11.79 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.217 0.607 . . . . 3.59 111.091 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.44 94.25 1.84 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.565 -0.743 . . . . 2.1 112.63 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.59 117.01 24.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.7 -0.852 . . . . 2.3 108.7 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 118' ' ' LEU . 33.5 m-85 -134.62 179.24 6.41 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.736 -0.665 . . . . 1.93 110.445 -171.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.673 ' HA ' ' O ' ' A' ' 161' ' ' THR . 37.1 m-85 -124.5 143.64 50.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.506 -0.77 . . . . 0.58 109.716 170.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.681 HD11 HD12 ' A' ' 125' ' ' ILE . 13.3 mm -59.35 121.77 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.393 -1.336 . . . . 0.41 107.393 164.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.611 HG13 ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -109.49 -45.7 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.024 -0.67 . . . . 0.37 111.275 -173.436 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 101' ' ' ILE . 5.6 t-20 -153.32 173.39 15.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 118.665 -1.214 . . . . 1.99 113.975 -170.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.751 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -139.18 128.18 23.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 111.948 -2.387 . . . . 1.19 109.194 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -100.2 149.11 23.89 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.237 1.018 . . . . 1.67 111.46 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -52.6 151.2 4.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.859 -1.973 . . . . 3.06 112.765 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -45.67 107.14 0.62 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 113.694 -1.594 . . . . 2.61 111.589 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -53.08 -50.19 14.92 Favored 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 124.416 3.411 . . . . 0.98 112.727 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.12 -20.31 12.88 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.164 -0.925 . . . . 1.08 112.46 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.41 -170.01 13.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.053 -0.594 . . . . 1.05 112.085 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.95 33.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 124.578 3.519 . . . . 1.3 114.093 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.413 ' H ' ' C ' ' A' ' 109' ' ' GLY . 4.4 t80 -86.31 -8.07 58.01 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.17 0.51 . . . . 1.38 110.12 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.604 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 100.89 32.57 5.3 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 115.517 0.967 . . . . 1.11 115.517 168.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 70.09 -21.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.207 1.188 . . . . 0.81 114.207 168.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -157.2 128.73 6.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.119 -0.697 . . . . 1.12 109.119 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -101.76 100.07 10.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.526 -0.916 . . . . 2.19 108.526 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.751 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.4 mp -101.78 136.31 41.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.615 0.722 . . . . 0.61 109.756 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 101' ' ' ILE . 68.8 m -106.5 152.05 24.17 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.239 -0.891 . . . . 0.94 111.626 -171.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.642 HD11 HG11 ' A' ' 163' ' ' VAL . 1.5 tp -101.39 165.03 11.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.86 -1.064 . . . . 1.08 108.729 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.56 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 30.5 t -53.25 -32.05 46.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.401 . . . . 1.5 111.975 -175.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 122' ' ' HIS . 16.6 tptm -126.99 160.01 32.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.506 -0.554 . . . . 2.97 109.506 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -73.11 45.94 0.17 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.623 0.725 . . . . 5.06 110.861 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 123' ' ' TYR . 23.6 m-70 -138.66 119.79 14.57 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.287 -1.005 . . . . 5.95 108.287 175.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 122' ' ' HIS . 61.1 m-85 67.44 147.11 0.05 OUTLIER 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.968 0.792 . . . . 4.83 110.969 -171.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.2 126.8 1.99 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.469 -0.653 . . . . 0.95 111.469 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 55.4 mt -91.3 113.36 26.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.181 0.515 . . . . 0.48 109.646 -175.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.478 ' CE1' ' HD3' ' A' ' 144' ' ' ARG . 44.2 p-80 -152.11 -162.34 1.49 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.191 0.519 . . . . 1.25 110.718 -177.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.604 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.4 171.12 14.52 Favored Glycine 0 C--N 1.311 -0.843 0 C-N-CA 119.838 -1.172 . . . . 0.46 112.98 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -129.66 173.03 11.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.724 0.773 . . . . 0.5 111.809 -168.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -108.92 -20.65 12.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.382 -1.281 . . . . 1.86 109.078 165.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -124.79 103.6 30.99 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.261 -0.881 . . . . 1.77 109.696 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.8 3.77 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.294 2.662 . . . . 0.59 113.926 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.65 -13.16 59.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.58 0.705 . . . . 0.78 110.211 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.465 ' HB3' ' OG ' ' A' ' 139' ' ' SER . 21.7 m -96.26 6.97 47.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.185 -0.916 . . . . 1.45 109.943 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 83' ' ' PRO . 23.8 mm -97.55 116.4 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.394 -0.821 . . . . 0.7 110.376 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.92 -55.91 1.86 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.796 -0.716 . . . . 1.68 112.45 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -102.0 43.86 1.04 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.718 0.294 . . . . 4.39 110.958 -177.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -173.0 146.03 1.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 3.94 110.178 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.95 -34.45 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.236 0.541 . . . . 4.68 110.831 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 133' ' ' SER . 26.2 m 52.81 27.47 5.42 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.813 -1.085 . . . . 5.68 113.462 171.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.1 mttp 62.04 19.46 10.81 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.447 0.467 . . . . 8.3 111.879 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 142' ' ' CYS . . . 103.58 -158.36 17.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.541 -0.838 . . . . 3.85 112.38 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 141' ' ' GLY . 70.0 m 80.56 171.4 0.14 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.557 0.743 . . . . 2.51 110.664 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 8.1 tt -153.96 92.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.775 0.798 . . . . 1.44 110.534 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.478 ' HD3' ' CE1' ' A' ' 126' ' ' HIS . 34.2 ptt180 -142.87 163.1 33.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.887 -0.597 . . . . 3.36 111.864 -172.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -144.35 -161.12 1.22 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.779 -0.646 . . . . 1.13 109.669 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.489 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 48.8 m80 -70.53 166.14 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.983 -0.377 . . . . 2.51 109.983 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.594 ' O ' HG12 ' A' ' 150' ' ' VAL . 21.1 p-10 -54.26 -69.04 0.14 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 111.893 0.331 . . . . 1.77 111.893 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.01 -27.3 66.77 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.564 -0.71 . . . . 2.13 111.236 -176.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.489 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 3.1 m-20 -63.67 -46.82 83.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.923 -0.58 . . . . 1.05 110.545 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.1 p -77.35 -17.44 14.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-N 115.754 -0.657 . . . . 0.32 111.078 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.445 HD12 HG13 ' A' ' 150' ' ' VAL . 2.4 mp -85.46 -39.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 118.969 -0.538 . . . . 0.37 110.443 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -44.45 -69.97 0.12 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.705 1.139 . . . . 1.38 112.244 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.705 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.5 tp -49.82 -43.79 48.87 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.469 -0.787 . . . . 0.74 110.287 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.54 -48.36 69.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.256 -1.338 . . . . 0.22 111.819 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 35.0 t -79.63 -19.98 47.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.579 -1.191 . . . . 1.33 110.85 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 -48.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.782 -0.451 . . . . 0.23 109.782 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.4 m -77.45 116.47 58.14 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-O 121.802 0.811 . . . . 0.21 109.93 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.831 ' HG2' HD13 ' A' ' 57' ' ' ILE . 32.3 Cg_endo -84.46 -178.35 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.099 2.533 . . . . 0.34 112.442 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.644 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.4 m120 -63.27 5.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.743 -1.117 . . . . 1.02 113.349 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.19 58.2 0.47 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.89 -0.671 . . . . 0.28 112.56 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -92.75 136.71 33.0 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.447 -0.443 . . . . 0.3 110.671 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -83.85 129.52 34.93 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.642 -0.423 . . . . 1.96 110.301 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.642 HG11 HD11 ' A' ' 118' ' ' LEU . 4.4 p -136.37 127.3 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.23 0.538 . . . . 0.46 111.19 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.4 ' O ' HG13 ' A' ' 63' ' ' VAL . 10.4 m -119.23 134.64 55.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.768 -0.651 . . . . 0.56 111.689 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -121.82 108.68 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 119.32 -0.952 . . . . 0.96 110.673 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -143.2 136.27 27.95 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.061 -0.972 . . . . 1.19 111.177 -168.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.616 ' H ' HG22 ' A' ' 93' ' ' THR . 5.1 mpt_? -70.35 -32.52 70.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.091 -1.413 . . . . 3.42 111.348 176.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.11 -129.48 7.22 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.161 -0.775 . . . . 3.65 111.161 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.251 1.148 0 C-N-CA 122.749 0.419 . . . . 5.97 111.114 177.323 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.462 ' N26' ' NH1' ' A' ' 144' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.671 -0.572 . . . . 2.92 111.671 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -94.53 135.76 35.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.011 -0.366 . . . . 4.1 110.011 179.409 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.8 mptt -62.22 153.43 30.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.983 -0.553 . . . . 2.1 110.135 175.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.5 mt -89.15 168.9 11.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.092 -0.504 . . . . 0.26 110.629 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.617 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.3 tp -77.39 150.08 35.12 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 122.988 0.515 . . . . 0.23 112.119 -169.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.12 150.43 36.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.891 0.853 . . . . 0.26 111.67 167.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' SER . 69.2 t80 -135.48 151.82 50.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.717 -1.583 . . . . 0.39 108.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -131.67 118.74 20.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.61 -1.256 . . . . 1.07 107.61 174.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.532 HG11 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -80.53 159.34 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 123.333 0.653 . . . . 0.38 112.011 -169.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.409 ' N ' HG23 ' A' ' 9' ' ' VAL . 89.3 mttt -108.37 152.07 25.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.711 -0.677 . . . . 2.59 109.198 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.664 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 19.6 tm0? -50.54 119.4 3.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 1.74 112.175 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.67 -4.2 42.8 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.028 -0.987 . . . . 0.57 113.144 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.624 ' HB3' HD11 ' A' ' 18' ' ' ILE . 7.3 m-20 -65.62 156.81 31.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.535 0.668 . . . . 2.17 112.529 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.523 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -131.96 148.16 52.5 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.829 0.677 . . . . 0.5 112.829 -176.105 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.609 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.0 tp -46.5 -58.91 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.771 1.026 . . . . 0.27 113.771 -173.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.654 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 20.3 t-20 -64.73 -40.28 95.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.583 1.183 . . . . 1.21 110.328 -170.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.781 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 10.9 m -60.87 -42.75 98.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 112.602 -2.09 . . . . 1.24 110.398 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -73.38 -39.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 O-C-N 123.831 0.707 . . . . 0.3 112.332 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.689 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.1 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.396 -0.365 . . . . 0.23 111.522 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.75 52.31 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.902 -1.119 . . . . 0.39 111.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.781 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.2 t0 -60.7 -42.63 97.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.461 -1.311 . . . . 1.63 107.461 157.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.7 m-85 -93.55 16.78 12.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.5 0.556 . . . . 0.24 112.5 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HG2' HD13 ' A' ' 101' ' ' ILE . 7.0 mmm180 53.82 51.86 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 3.55 111.002 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.689 HG12 ' O ' ' A' ' 19' ' ' ALA . 35.7 pt -147.26 -172.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.928 -0.768 . . . . 0.27 108.928 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.97 148.01 23.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 0.81 109.682 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.654 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 23.3 p -63.39 -35.74 81.4 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.683 -0.858 . . . . 0.27 108.683 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.14 -32.58 74.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.303 -1.317 . . . . 0.26 111.38 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.05 -37.58 38.62 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.273 0.559 . . . . 0.23 109.634 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 46' ' ' ILE . 12.6 tp -74.18 -18.8 60.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.401 -0.818 . . . . 0.17 109.027 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.743 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.28 34.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.462 0.649 . . . . 0.19 111.424 172.437 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 60.3 mt-30 -57.08 -46.26 82.67 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 122.248 1.023 . . . . 1.07 109.458 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.0 47.97 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.18 -1.827 . . . . 0.17 112.202 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.1 m120 -142.96 72.71 18.67 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-O 121.153 0.502 . . . . 0.19 109.903 -173.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.492 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 17.8 Cg_endo -57.24 -11.42 8.03 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 123.7 2.933 . . . . 0.3 114.187 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 t -62.86 -34.19 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.049 0.928 . . . . 1.17 109.915 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.7 mt -78.27 -4.99 50.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.438 -1.255 . . . . 0.53 114.372 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.743 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -51.08 -39.44 56.08 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 122.342 1.068 . . . . 1.23 110.049 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.98 -46.47 12.02 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.987 -1.915 . . . . 0.4 111.437 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.28 -164.09 34.4 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.502 -0.856 . . . . 0.3 114.008 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.532 HD23 HG11 ' A' ' 9' ' ' VAL . 6.0 mp -118.16 157.41 26.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.401 -1.4 . . . . 0.31 110.088 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.582 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -134.15 136.8 44.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.704 -0.68 . . . . 0.39 110.428 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.02 126.89 7.92 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.282 0.845 . . . . 0.47 113.282 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' HA2' ' OE1' ' A' ' 8' ' ' GLN . . . 82.52 -11.78 49.78 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.528 -1.215 . . . . 0.36 112.002 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -63.09 150.25 43.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.766 0.793 . . . . 1.19 110.466 175.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 22.9 m -118.45 134.51 55.01 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.231 -1.35 . . . . 0.89 109.13 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 29' ' ' LEU . 18.0 pt -137.14 151.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.445 0.64 . . . . 0.22 110.513 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.445 ' H ' HD22 ' A' ' 33' ' ' ASN . 16.7 t -96.75 149.21 4.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.013 -0.994 . . . . 0.21 110.074 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.603 ' CG1' HD23 ' A' ' 5' ' ' LEU . 20.1 mm -117.65 88.84 31.05 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 108.309 -0.997 . . . . 0.17 108.309 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.742 ' HA ' HD13 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.83 142.14 98.05 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.014 2.476 . . . . 0.23 112.717 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.48 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.06 -6.91 65.08 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.525 -0.761 . . . . 0.3 112.995 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.681 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.9 127.74 26.44 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 108.737 -0.838 . . . . 0.25 108.737 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.5 Cg_endo -68.56 174.31 8.59 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.819 3.013 . . . . 0.31 113.93 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.6 t70 -89.57 142.48 29.47 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.881 -1.054 . . . . 0.72 110.185 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HD3' HD12 ' A' ' 5' ' ' LEU . 84.2 Cg_endo -80.96 -6.2 13.13 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.225 2.617 . . . . 0.27 111.973 -174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -95.85 -25.62 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 2.11 111.099 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 53' ' ' ASP . 28.6 p -70.49 -27.06 63.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.495 1.14 . . . . 1.47 108.028 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.9 mt -81.98 129.23 65.32 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 112.936 -1.938 . . . . 0.26 110.66 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -102.75 95.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 121.112 1.208 . . . . 0.2 110.761 165.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' SER . 86.8 m-85 -158.3 129.3 6.39 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.869 -1.53 . . . . 0.26 106.869 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 31.4 m-70 -136.69 105.13 5.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.983 -1.488 . . . . 2.84 106.983 -165.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 80.6 mt -94.15 113.42 28.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.282 -0.872 . . . . 0.32 110.703 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.6 95.19 5.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.366 -0.834 . . . . 0.34 110.752 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -110.18 112.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.431 -1.259 . . . . 0.68 109.479 177.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.626 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 49.5 m -107.38 135.63 48.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.836 -0.62 . . . . 1.05 110.629 -175.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.535 HG23 ' HB ' ' A' ' 86' ' ' VAL . 1.2 mt -57.32 -38.96 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.772 0.796 . . . . 1.29 110.269 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' H ' ' HA ' ' A' ' 167' ' ' ARG . . . -68.21 -45.73 69.06 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.32 -1.309 . . . . 0.88 111.717 177.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -74.41 -24.65 59.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.347 0.594 . . . . 0.74 112.052 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HG2' HG11 ' A' ' 86' ' ' VAL . 32.7 mttt 53.41 24.53 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.283 1.033 . . . . 2.51 111.732 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.472 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.5 OUTLIER -141.63 143.78 33.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.93 0.872 . . . . 0.45 110.934 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.8 tt -98.6 117.94 34.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.82 -1.536 . . . . 0.33 109.147 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -100.16 125.37 46.28 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.378 -0.529 . . . . 0.4 110.67 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.01 147.88 27.91 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.789 -1.56 . . . . 0.33 106.789 177.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 25.5 m -151.4 129.39 11.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 120.316 1.416 . . . . 0.75 112.729 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 tp -117.3 129.39 55.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.917 -1.038 . . . . 0.35 110.755 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 63.4 35.56 12.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.377 0.608 . . . . 0.52 109.679 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 77.48 2.75 3.09 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.595 -1.184 . . . . 1.84 111.784 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -129.95 138.74 51.03 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.41 -1.316 . . . . 3.19 114.032 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.53 149.36 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 113.162 -1.835 . . . . 0.41 112.822 -173.074 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -99.48 -45.57 5.77 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 112.675 -2.057 . . . . 0.35 108.38 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 179.53 157.61 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 112.805 -1.998 . . . . 2.07 110.388 -175.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.472 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.3 m -116.44 136.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.788 0.327 . . . . 0.37 111.661 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -116.89 153.27 49.35 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.088 -0.505 . . . . 0.97 110.192 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.11 143.09 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.59 2.193 . . . . 0.6 111.424 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.52 ' HB ' ' CG1' ' A' ' 143' ' ' ILE . 0.1 OUTLIER -145.96 179.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.672 -0.24 . . . . 0.64 110.59 -178.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' HG12 ' A' ' 84' ' ' ILE . . . -87.01 158.88 19.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.485 0.66 . . . . 0.83 111.64 177.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 65' ' ' ILE . 18.6 m -134.72 141.79 42.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.87 -1.059 . . . . 1.67 108.796 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.93 176.59 19.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.821 -1.18 . . . . 3.08 113.43 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.4 tttp 59.32 62.12 1.88 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.158 0.504 . . . . 7.26 110.237 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.425 HG13 HG22 ' A' ' 138' ' ' VAL . 23.8 mm -81.09 64.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.314 0.578 . . . . 6.29 111.106 -174.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.2 mt -141.65 -62.42 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.597 -0.729 . . . . 7.27 109.884 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.419 ' O ' ' HB3' ' A' ' 92' ' ' GLN . 15.0 t -178.68 -175.17 0.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.602 -0.726 . . . . 5.18 109.14 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' O ' ' HD2' ' A' ' 167' ' ' ARG . 57.2 tp60 74.1 126.27 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.83 0.706 . . . . 4.81 111.983 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.701 HG22 ' H ' ' A' ' 167' ' ' ARG . 18.3 p -81.88 109.94 17.61 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.349 -0.841 . . . . 2.11 109.462 172.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 92' ' ' GLN . 32.9 Cg_exo -60.84 134.44 53.64 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.741 1.627 . . . . 3.21 110.863 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.2 m -77.23 62.94 2.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.63 0.729 . . . . 3.59 109.686 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.01 66.52 0.42 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.487 -0.779 . . . . 2.1 112.345 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -94.43 121.54 36.08 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.336 -0.616 . . . . 2.3 109.336 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.596 ' HB3' ' H ' ' A' ' 119' ' ' SER . 33.4 m-85 -132.3 177.84 7.27 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.067 -0.97 . . . . 1.93 111.185 -174.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' A' ' 161' ' ' THR . 48.9 m-85 -128.62 138.52 52.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.476 -0.784 . . . . 0.58 109.897 171.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 125' ' ' ILE . 21.7 mm -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.926 -1.139 . . . . 0.41 107.926 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.593 HD12 ' CD1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -111.55 -33.54 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.897 -0.721 . . . . 0.37 112.666 -177.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 28.5 p-10 -166.47 -167.77 1.07 Allowed 'General case' 0 N--CA 1.46 0.062 0 CA-C-O 122.383 1.087 . . . . 1.99 113.846 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -156.84 141.6 16.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 112.391 -2.186 . . . . 1.19 111.501 178.101 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 23.5 tp60 -109.92 142.18 41.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.142 -0.936 . . . . 1.67 110.957 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -53.25 150.0 6.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.645 -1.616 . . . . 3.06 112.115 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -45.81 103.17 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 114.448 -1.251 . . . . 2.61 111.434 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.42 -49.77 15.77 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.151 3.234 . . . . 0.98 112.362 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.29 -16.01 20.1 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.995 -1.002 . . . . 1.08 112.393 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.97 -170.38 14.35 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.012 -0.613 . . . . 1.05 112.675 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.28 16.17 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.633 3.556 . . . . 1.3 114.99 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -66.66 -24.6 66.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.597 . . . . 1.38 109.933 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 127' ' ' GLY . . . 99.63 60.52 0.85 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.331 -0.849 . . . . 1.11 114.934 168.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.54 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 72.96 -57.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.941 1.089 . . . . 0.81 113.941 166.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -146.79 137.31 23.76 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.59 -0.522 . . . . 1.12 109.59 -173.104 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 76.2 t-105 -103.74 101.04 10.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.272 -0.64 . . . . 2.19 109.272 169.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.4 mp -104.51 109.23 21.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.585 0.707 . . . . 0.61 109.769 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.506 ' HB3' ' CG2' ' A' ' 101' ' ' ILE . 3.5 t -79.01 146.3 33.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 0.94 111.069 -168.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -92.88 177.02 6.21 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.591 -1.262 . . . . 1.08 107.591 171.223 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 36.0 t -79.89 8.74 6.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.869 0.322 . . . . 1.5 111.869 -172.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -130.57 128.8 41.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.847 -0.427 . . . . 2.97 109.847 170.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -71.26 52.65 0.18 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.373 0.606 . . . . 5.06 111.272 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -149.79 -27.8 0.25 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.763 -0.653 . . . . 5.95 109.643 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 99.6 m-85 -123.96 143.71 50.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 4.83 109.64 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.62 ' O ' HG22 ' A' ' 143' ' ' ILE . . . -154.57 151.67 23.31 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.358 -0.925 . . . . 0.95 112.248 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.754 HD12 HD11 ' A' ' 100' ' ' ILE . 21.1 mt -91.67 116.6 33.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.075 -0.713 . . . . 0.48 109.075 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.508 ' CE1' ' HG3' ' A' ' 144' ' ' ARG . 7.1 p80 -152.09 -164.99 2.1 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.399 0.618 . . . . 1.25 111.341 -175.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.443 ' O ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.07 -178.62 15.74 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.666 -1.152 . . . . 0.46 112.873 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.6 t -145.48 178.23 8.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.139 -0.531 . . . . 0.5 110.927 -165.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -108.98 -16.82 14.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.983 -1.008 . . . . 1.86 109.255 165.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -124.98 100.71 33.13 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 115.744 -0.662 . . . . 1.77 109.854 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.54 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 44.8 Cg_endo -92.78 4.64 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.584 2.856 . . . . 0.59 113.166 175.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.22 -20.99 50.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.976 0.417 . . . . 0.78 110.437 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 p -93.95 -4.83 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.598 0.714 . . . . 1.45 110.11 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 9.0 mm -76.91 111.91 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.239 -0.891 . . . . 0.7 110.461 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.83 7.35 74.76 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.695 -0.684 . . . . 1.68 111.549 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 136' ' ' LYS . 35.9 ttmt -123.83 127.31 47.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.691 0.281 . . . . 4.39 110.659 -174.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 64.65 -97.44 0.06 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.504 -0.771 . . . . 3.94 111.8 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 89' ' ' ILE . 22.9 t -137.42 -78.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.495 -0.187 . . . . 4.68 110.495 -175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.8 t 58.06 37.73 26.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.231 0.538 . . . . 5.68 111.02 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.407 ' H ' ' HG3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -64.35 162.33 15.15 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.365 0.506 . . . . 8.3 112.365 -176.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.36 -67.44 0.22 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.019 -0.61 . . . . 3.85 111.974 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 59.9 m -108.19 146.37 32.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.268 -0.641 . . . . 2.51 109.268 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 124' ' ' GLY . 20.3 tt -84.71 -60.01 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 119.169 -0.443 . . . . 1.44 110.478 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.508 ' HG3' ' CE1' ' A' ' 126' ' ' HIS . 37.1 mtt180 59.6 147.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.251 1.575 . . . . 3.36 115.251 170.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 144' ' ' ARG . 29.1 mtp -151.44 -166.93 2.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.786 -1.097 . . . . 1.13 109.964 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -79.0 153.27 30.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.919 -0.771 . . . . 2.51 108.919 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.64 ' O ' HG12 ' A' ' 150' ' ' VAL . 21.7 p-10 -52.08 -65.0 0.63 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.504 0.187 . . . . 1.77 111.504 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -60.74 -30.44 69.99 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.703 -0.623 . . . . 2.13 111.342 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -64.38 -43.54 94.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.179 0.514 . . . . 1.05 110.25 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.4 p -77.59 -17.42 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.509 -0.769 . . . . 0.32 110.993 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.54 HD11 ' HB1' ' A' ' 113' ' ' ALA . 3.0 mp -88.98 -40.86 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 119.022 -0.513 . . . . 0.37 110.649 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -44.03 -69.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.633 1.106 . . . . 1.38 112.027 162.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.744 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.8 OUTLIER -48.31 -42.52 31.26 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 123.813 0.695 . . . . 0.74 110.232 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.6 -57.02 12.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.427 -1.26 . . . . 0.22 112.465 -171.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 t -77.05 -14.99 59.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.825 -1.079 . . . . 1.33 110.487 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.48 -50.28 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 109.976 -0.379 . . . . 0.23 109.976 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 153' ' ' LEU . 28.3 m -75.96 116.71 58.1 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 121.939 0.876 . . . . 0.21 110.379 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.788 ' HG2' HD13 ' A' ' 57' ' ' ILE . 40.2 Cg_endo -81.97 -177.43 3.53 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.199 2.599 . . . . 0.34 112.581 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.681 ' O ' HD21 ' A' ' 51' ' ' LEU . 16.5 m120 -59.11 0.65 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.58 -1.191 . . . . 1.02 113.839 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.18 58.41 0.45 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.738 -0.744 . . . . 0.28 112.677 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.6 m -90.32 136.83 32.81 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.376 -0.484 . . . . 0.3 110.53 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -84.76 131.92 34.5 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.55 -0.46 . . . . 1.96 109.983 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.4 p -138.91 124.81 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.363 -0.835 . . . . 0.46 110.858 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.412 ' C ' HD12 ' A' ' 165' ' ' ILE . 89.8 m -116.92 140.5 49.38 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.682 -0.69 . . . . 0.56 111.636 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.1 mp -120.4 110.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.811 -1.156 . . . . 0.96 110.593 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' SER . 3.7 p30 -143.78 146.96 33.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.372 -1.285 . . . . 1.19 109.071 -172.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.701 ' H ' HG22 ' A' ' 93' ' ' THR . 7.9 ptm180 -92.85 -31.8 14.86 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.558 0.577 . . . . 3.42 112.558 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -160.29 -132.38 1.34 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.037 -0.601 . . . . 3.65 111.77 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.25 1.088 0 C-N-CA 122.929 0.491 . . . . 5.97 111.057 -179.513 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.595 ' H11' ' O62' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 111.582 -0.607 . . . . 2.92 111.582 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 63.78 177.84 0.17 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.91 0.862 . . . . 4.1 112.303 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -77.8 153.95 32.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.821 -1.081 . . . . 2.1 109.276 172.252 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.8 mt -91.79 168.86 11.15 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.382 0.426 . . . . 0.26 111.05 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.556 HD23 ' CG1' ' A' ' 48' ' ' ILE . 3.8 tp -76.42 150.31 36.76 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 123.42 0.688 . . . . 0.23 112.297 -168.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.551 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.57 150.05 35.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.137 0.97 . . . . 0.26 111.92 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 45' ' ' SER . 70.0 t80 -136.63 149.8 48.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.448 -1.705 . . . . 0.39 108.083 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.82 121.7 28.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.194 -1.41 . . . . 1.07 107.194 176.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -82.46 158.65 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.181 0.515 . . . . 0.38 112.119 -170.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -106.18 150.28 26.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.843 -0.799 . . . . 2.59 108.843 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.647 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 15.0 tt0 -53.97 112.73 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.541 0.526 . . . . 1.74 111.967 -175.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.0 -8.67 18.72 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.673 -0.775 . . . . 0.57 112.837 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.567 ' HB3' HD11 ' A' ' 18' ' ' ILE . 55.7 m-20 -62.26 154.84 26.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.067 0.433 . . . . 2.17 111.946 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.562 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 p -132.11 152.95 50.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.5 111.892 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.0 tp -49.86 -58.5 5.26 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.99 1.107 . . . . 0.27 113.99 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.6 t-20 -65.07 -42.01 94.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.569 1.176 . . . . 1.21 109.979 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.755 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 5.8 m -60.34 -39.45 87.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 112.51 -2.132 . . . . 1.24 110.769 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.567 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.8 -41.18 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 123.296 0.638 . . . . 0.3 112.176 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.62 -61.94 2.08 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.511 -0.313 . . . . 0.23 111.284 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.12 54.38 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.798 -1.161 . . . . 0.39 112.136 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.755 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.9 t70 -61.89 -34.84 76.75 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.654 -1.239 . . . . 1.63 107.654 156.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.4 m-85 -99.35 17.81 19.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.248 0.462 . . . . 0.24 112.248 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 52.11 51.92 15.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.356 -0.838 . . . . 3.55 110.954 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 19' ' ' ALA . 35.5 pt -146.86 -174.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.644 -0.872 . . . . 0.27 108.644 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -100.81 144.7 29.46 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.429 -0.805 . . . . 0.81 109.258 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.644 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 25.3 p -61.77 -34.81 76.54 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.48 0.657 . . . . 0.27 109.251 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.86 -29.4 70.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.34 -1.3 . . . . 0.26 111.511 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.82 -38.11 26.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.391 0.615 . . . . 0.23 109.791 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.672 HD11 HD12 ' A' ' 46' ' ' ILE . 16.7 tp -73.31 -16.93 61.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.214 -0.903 . . . . 0.17 108.958 174.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.769 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -82.1 -38.52 24.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.37 0.605 . . . . 0.19 111.578 173.077 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.4 mt-30 -57.92 -43.42 86.25 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.169 0.985 . . . . 1.07 109.636 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.59 -19.77 41.23 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.354 -1.748 . . . . 0.17 112.402 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 15.3 m120 -143.34 72.66 17.85 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.148 0.499 . . . . 0.19 109.922 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.663 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.8 Cg_endo -57.36 -11.32 8.11 Favored 'Trans proline' 0 C--N 1.333 -0.283 0 C-N-CA 123.649 2.9 . . . . 0.3 114.478 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -63.31 -34.43 77.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.913 0.864 . . . . 1.17 109.573 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -78.35 -6.62 55.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.332 -1.303 . . . . 0.53 114.415 -170.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.769 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.94 -42.56 48.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 119.78 1.173 . . . . 1.23 110.22 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.28 -45.95 12.31 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 112.881 -1.963 . . . . 0.4 111.439 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -164.81 36.16 Favored Glycine 0 CA--C 1.492 -1.355 0 C-N-CA 120.265 -0.969 . . . . 0.3 114.358 176.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.5 mp -115.43 157.86 23.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.966 -1.617 . . . . 0.31 110.447 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.62 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 96.3 m -133.89 133.86 42.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.641 -0.709 . . . . 0.39 110.519 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.647 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -44.61 126.49 5.54 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.416 0.895 . . . . 0.47 113.416 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.568 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.31 -10.66 53.65 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.391 -1.277 . . . . 0.36 112.129 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.62 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -63.99 150.91 44.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.776 0.798 . . . . 1.19 110.315 175.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 44.7 m -118.2 133.86 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.212 -1.358 . . . . 0.89 109.049 -171.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.672 HD12 HD11 ' A' ' 29' ' ' LEU . 15.0 pt -135.89 151.14 28.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.244 0.545 . . . . 0.22 110.312 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.49 ' H ' HD22 ' A' ' 33' ' ' ASN . 11.1 t -96.03 149.09 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.121 -0.945 . . . . 0.21 110.119 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.556 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.4 mm -117.24 87.31 23.51 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.84 -1.073 . . . . 0.17 108.386 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.699 ' HA ' HD13 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.59 140.26 92.97 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.119 2.546 . . . . 0.23 112.626 -173.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.554 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 85.3 -8.24 72.07 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.323 -0.853 . . . . 0.3 113.015 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.606 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.9 tt -117.55 127.43 26.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.585 -0.894 . . . . 0.25 108.585 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD23 ' A' ' 51' ' ' LEU . 62.0 Cg_endo -67.78 173.58 8.89 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.725 2.95 . . . . 0.31 113.818 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.785 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.9 t70 -90.3 142.05 28.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.034 -0.985 . . . . 0.72 110.576 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.548 ' HD3' HD12 ' A' ' 5' ' ' LEU . 60.3 Cg_endo -86.21 -8.31 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.73 2.953 . . . . 0.27 112.444 -174.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -92.01 -13.52 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 2.11 109.486 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 53' ' ' ASP . 12.3 p -84.92 -29.5 25.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.944 -1.132 . . . . 1.47 107.944 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.662 HD13 ' HG2' ' A' ' 158' ' ' PRO . 43.5 mt -83.02 131.74 52.94 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 113.496 -1.684 . . . . 0.26 110.887 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.68 96.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 121.046 1.164 . . . . 0.2 110.525 167.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.499 ' HD2' ' CG2' ' A' ' 57' ' ' ILE . 84.1 m-85 -157.3 132.49 8.97 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.604 -1.258 . . . . 0.26 107.604 171.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.646 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 0.9 OUTLIER -135.96 103.73 5.47 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.487 -1.672 . . . . 2.84 106.487 -167.183 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 64.5 mt -94.71 112.43 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 120.237 -0.585 . . . . 0.32 110.521 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.33 95.8 5.35 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.378 -0.828 . . . . 0.34 110.811 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 165' ' ' ILE . 0.3 OUTLIER -115.75 104.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.503 -1.226 . . . . 0.68 110.645 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -98.96 113.52 25.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.213 -1.032 . . . . 1.05 108.213 174.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.59 HG23 HG13 ' A' ' 86' ' ' VAL . 2.1 mt -54.62 -32.43 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-O 120.905 0.383 . . . . 1.29 111.779 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.446 ' HA2' ' HG3' ' A' ' 88' ' ' LYS . . . -59.09 -45.62 95.0 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.071 -1.061 . . . . 0.88 111.305 170.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.43 -23.45 62.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.461 0.648 . . . . 0.74 111.959 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.68 ' HA ' HG21 ' A' ' 86' ' ' VAL . 35.7 mttt 62.35 18.93 10.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.734 1.214 . . . . 2.51 112.999 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.441 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.94 140.17 31.0 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.284 1.04 . . . . 0.45 112.63 177.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.572 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -97.19 118.7 34.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.028 -1.897 . . . . 0.33 109.269 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -100.86 125.14 47.36 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.349 -0.54 . . . . 0.4 110.489 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.604 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.8 143.92 29.64 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.966 -1.864 . . . . 0.33 105.966 176.333 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 47.7 m -148.65 129.52 14.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 120.189 1.359 . . . . 0.75 112.895 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -114.46 126.53 55.06 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.608 -1.178 . . . . 0.35 110.438 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.5 t-20 63.7 36.31 10.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.52 109.54 172.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.1 m-20 76.81 2.73 3.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.591 -1.186 . . . . 1.84 112.409 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -130.42 137.79 50.01 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 118.081 -1.448 . . . . 3.19 114.269 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.17 149.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-N 113.122 -1.854 . . . . 0.41 113.59 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.553 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -103.3 -40.35 6.44 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.407 -2.179 . . . . 0.35 108.732 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.52 165.87 2.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.677 -2.056 . . . . 2.07 110.723 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.441 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 8.6 m -125.49 130.52 51.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.419 0.152 . . . . 0.37 110.947 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.473 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 15.7 m-85 -120.68 134.35 24.23 Favored Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.759 0.314 . . . . 0.97 110.966 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.69 143.53 74.78 Favored 'Trans proline' 0 N--CA 1.472 0.213 0 C-N-CA 123.168 2.579 . . . . 0.6 112.76 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.24 179.36 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.329 -0.396 . . . . 0.64 110.782 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.94 150.68 25.51 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 110.091 -0.337 . . . . 0.83 110.091 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 68' ' ' LYS . 2.1 t -149.28 145.15 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 114.261 1.208 . . . . 1.67 114.261 -159.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.524 ' H ' ' CG2' ' A' ' 65' ' ' ILE . . . -127.28 82.32 0.35 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.695 -1.362 . . . . 3.08 109.695 163.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.481 ' HD2' ' HE3' ' A' ' 68' ' ' LYS . 51.7 tttp -80.01 153.99 28.49 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.717 0.636 . . . . 7.26 112.717 -167.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.8 tp -168.39 -43.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.694 -0.685 . . . . 6.29 110.855 168.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.485 ' H ' ' HA3' ' A' ' 168' ' ' GLY . 0.2 OUTLIER -160.24 -95.34 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.153 -0.342 . . . . 7.27 111.242 175.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.666 ' N ' ' HA2' ' A' ' 168' ' ' GLY . 15.1 t -153.05 161.51 42.42 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.128 -0.358 . . . . 5.18 111.158 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' THR . 44.3 mt-30 76.95 127.9 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.084 0.953 . . . . 4.81 112.655 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.625 ' HB ' ' CD ' ' A' ' 94' ' ' PRO . 0.6 OUTLIER -84.7 -160.84 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 107.954 -1.128 . . . . 2.11 107.954 169.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.625 ' CD ' ' HB ' ' A' ' 93' ' ' THR . 22.7 Cg_exo -71.33 30.91 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 CA-C-N 120.631 1.261 . . . . 3.21 111.797 161.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.508 ' H ' ' C ' ' A' ' 93' ' ' THR . 28.7 m 65.56 83.42 0.17 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.454 0.702 . . . . 3.59 111.196 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -138.64 114.81 1.08 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.432 -0.889 . . . . 2.1 112.924 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' ' 164' ' ' THR . 32.1 mt-10 -119.39 140.08 50.96 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.33 -0.618 . . . . 2.3 109.33 174.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.506 ' HB3' ' H ' ' A' ' 119' ' ' SER . 7.2 m-85 -126.64 178.55 5.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.416 -0.356 . . . . 1.93 110.505 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 161' ' ' THR . 66.5 m-85 -131.17 139.83 49.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.58 110.252 172.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.596 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 34.0 mm -63.22 116.68 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 N-CA-C 108.752 -0.833 . . . . 0.41 108.752 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 3.7 tt -108.32 -19.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 119.237 -0.985 . . . . 0.37 112.507 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 6.2 t-20 179.0 -168.39 0.09 Allowed 'General case' 0 C--N 1.351 0.669 0 CA-C-O 122.73 1.252 . . . . 1.99 114.096 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.6 ptp180 -156.78 144.17 18.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.621 -2.536 . . . . 1.19 110.021 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.98 157.21 22.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 122.067 0.937 . . . . 1.67 111.172 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -52.32 150.21 4.9 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.521 -2.127 . . . . 3.06 112.05 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -48.33 110.3 1.4 Allowed Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 115.118 -0.946 . . . . 2.61 111.039 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.17 -48.25 22.63 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 123.762 2.975 . . . . 0.98 111.858 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 111.3 -20.39 23.42 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.849 -1.069 . . . . 1.08 112.625 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -105.93 -170.07 23.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.971 -0.633 . . . . 1.05 111.946 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.82 35.51 0.1 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.188 3.259 . . . . 1.3 113.561 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 109' ' ' GLY . 11.4 t80 -86.89 -16.89 34.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.21 0.529 . . . . 1.38 109.804 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.563 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.89 38.0 3.75 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.653 -0.703 . . . . 1.11 114.071 173.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB2' ' ND2' ' A' ' 147' ' ' ASN . . . 74.38 -36.71 0.34 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.121 1.156 . . . . 0.81 114.121 168.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.545 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -148.37 144.55 27.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.975 0.417 . . . . 1.12 110.949 -173.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -115.49 100.21 7.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.661 . . . . 2.19 109.373 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -101.72 145.72 28.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.206 0.527 . . . . 0.61 110.535 176.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.479 ' HB2' HG23 ' A' ' 101' ' ' ILE . 74.4 m -106.71 137.12 45.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.662 -0.699 . . . . 0.94 112.412 -170.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.564 HD11 HG11 ' A' ' 163' ' ' VAL . 2.2 tp -107.68 -171.29 1.84 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.086 -0.961 . . . . 1.08 108.987 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.506 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.7 t -87.57 -98.02 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.675 0.67 . . . . 1.5 111.18 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -89.34 159.7 17.23 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.908 0.707 . . . . 2.97 112.908 -171.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 57.92 -88.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.753 -1.112 . . . . 5.06 112.545 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -82.38 63.64 6.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.72 -1.215 . . . . 5.95 107.72 176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -71.9 22.04 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.202 0.816 . . . . 4.83 113.202 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 143' ' ' ILE . . . -154.89 122.4 1.22 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 119.654 -1.26 . . . . 0.95 113.951 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.637 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 12.0 mt -92.99 107.36 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.363 -1.347 . . . . 0.48 107.363 165.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.568 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 12.6 p80 -137.96 -163.92 1.53 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.697 -0.801 . . . . 1.25 112.463 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.563 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.9 -177.0 15.31 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.377 -1.283 . . . . 0.46 112.479 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -141.07 175.88 9.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.494 0.664 . . . . 0.5 111.594 -166.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -111.04 -17.78 13.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.827 -1.079 . . . . 1.86 109.311 166.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -125.45 102.94 29.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.296 -0.866 . . . . 1.77 109.727 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.412 ' HA ' HG12 ' A' ' 134' ' ' ILE . 44.3 Cg_endo -91.79 3.48 4.07 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.171 2.581 . . . . 0.59 113.564 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.86 57.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.869 0.366 . . . . 0.78 111.117 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 -3.02 50.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 1.45 110.152 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 131' ' ' PRO . 10.9 mm -79.48 118.41 26.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.7 111.255 -175.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.46 3.09 56.51 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.484 -0.78 . . . . 1.68 111.548 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -121.56 149.36 43.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.994 -0.373 . . . . 4.39 109.994 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.24 62.04 5.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.176 0.512 . . . . 3.94 110.517 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 95.9 t -82.6 -54.63 9.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.872 -0.604 . . . . 4.68 110.875 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.5 m -152.93 153.03 32.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.195 -0.457 . . . . 5.68 110.325 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -89.65 67.73 7.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.101 -0.499 . . . . 8.3 110.3 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -95.48 -130.57 6.24 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.919 -0.658 . . . . 3.85 112.642 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 47.3 m -103.22 -164.59 1.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.644 -0.502 . . . . 2.51 109.644 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 124' ' ' GLY . 2.5 tt -116.34 119.85 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.692 0.758 . . . . 1.44 110.151 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 34.8 ptt180 -150.51 153.65 36.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.937 -0.574 . . . . 3.36 110.273 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 10.8 mtm -145.71 -165.03 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.769 0.319 . . . . 1.13 110.679 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -67.73 150.51 48.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 2.51 110.046 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.595 ' O ' HG12 ' A' ' 150' ' ' VAL . 3.4 m-20 -51.63 -67.77 0.22 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 123.412 0.445 . . . . 1.77 111.589 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.43 -24.5 67.86 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.862 -0.524 . . . . 2.13 111.963 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.59 -38.41 74.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.731 0.3 . . . . 1.05 110.975 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.0 p -80.26 -14.9 13.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 116.587 -0.279 . . . . 0.32 110.521 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.545 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.5 mp -89.16 -38.96 12.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 118.851 -0.595 . . . . 0.37 110.911 173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -44.09 -68.6 0.18 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.854 1.206 . . . . 1.38 111.601 163.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.701 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -49.83 -42.47 47.33 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.589 -0.732 . . . . 0.74 110.059 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.64 -57.66 10.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.237 -1.347 . . . . 0.22 112.107 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.0 t -75.32 -14.57 60.5 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.475 -1.239 . . . . 1.33 110.63 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.438 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 80.9 mt -93.06 -47.77 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.32 -0.4 . . . . 0.23 110.365 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.9 m -76.88 110.61 12.37 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 122.038 0.923 . . . . 0.21 111.073 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.662 ' HG2' HD13 ' A' ' 57' ' ' ILE . 13.9 Cg_endo -82.16 -179.31 4.62 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.698 2.265 . . . . 0.34 113.254 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.425 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 8.7 m120 -66.73 110.54 3.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.74 -1.118 . . . . 1.02 108.254 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.89 2.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.284 -0.96 . . . . 0.28 113.314 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.596 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 18.9 m -93.2 136.29 33.6 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.839 -0.8 . . . . 0.3 109.819 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -84.72 134.16 34.35 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.952 -0.388 . . . . 1.96 109.952 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.564 HG11 HD11 ' A' ' 118' ' ' LEU . 3.2 p -140.51 125.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.421 -0.809 . . . . 0.46 111.424 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 97' ' ' GLU . 52.4 m -114.01 129.7 56.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.303 -0.862 . . . . 0.56 111.557 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.608 HG13 HG13 ' A' ' 63' ' ' VAL . 2.8 mp -119.25 122.3 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 118.135 -1.426 . . . . 0.96 109.578 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.582 ' HA ' HG23 ' A' ' 93' ' ' THR . 0.3 OUTLIER -142.54 122.51 13.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.087 0.946 . . . . 1.19 109.932 177.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.474 ' HD3' HG22 ' A' ' 93' ' ' THR . 31.6 ptt180 -98.18 -48.85 4.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.323 -1.762 . . . . 3.42 114.301 -165.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.666 ' HA2' ' N ' ' A' ' 91' ' ' THR . . . 138.84 101.38 0.52 Allowed Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.968 -0.853 . . . . 3.65 110.968 -163.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 64.7 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.954 -0.546 . . . . 5.97 109.777 177.911 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.516 H622 ' H41' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.99 -0.444 . . . . 2.92 111.99 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.41 175.5 9.87 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.12 -0.326 . . . . 4.1 110.12 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -70.32 151.7 44.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.754 -0.461 . . . . 2.1 109.754 176.112 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.779 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.2 mt -100.69 169.15 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 0.26 111.948 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.693 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.4 tp -79.62 153.02 29.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 123.643 0.777 . . . . 0.23 112.206 -169.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.571 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -116.58 153.05 32.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.866 0.841 . . . . 0.26 111.858 166.204 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.2 t80 -136.6 150.5 48.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.029 -1.441 . . . . 0.39 108.07 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.654 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.47 119.42 24.87 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.714 -1.587 . . . . 1.07 106.714 174.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -81.08 158.88 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 112.782 0.66 . . . . 0.38 112.782 -167.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' N ' HG23 ' A' ' 9' ' ' VAL . 8.5 mtmp? -99.26 150.14 22.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.019 -0.992 . . . . 2.59 109.43 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.791 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.1 tt0 -53.84 109.17 0.43 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.258 -0.883 . . . . 1.74 111.618 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -9.82 22.43 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.64 -0.79 . . . . 0.57 112.748 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 18' ' ' ILE . 82.4 m-20 -59.7 154.21 18.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.021 0.41 . . . . 2.17 111.545 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.556 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.7 p -133.39 153.63 51.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.102 0.477 . . . . 0.5 112.115 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.5 tp -49.44 -59.9 3.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.795 1.035 . . . . 0.27 113.795 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.681 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.6 t-20 -65.02 -40.13 94.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.22 1.009 . . . . 1.21 110.456 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.0 t -59.72 -51.46 69.66 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 113.221 -1.809 . . . . 1.24 109.358 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.64 -39.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.924 -0.58 . . . . 0.3 111.433 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.666 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.98 -65.2 0.66 Allowed 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.23 111.635 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.12 -5.3 55.74 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 118.84 -1.144 . . . . 0.39 112.269 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.094 -0.706 . . . . 1.63 109.094 158.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.618 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.4 m-85 -97.05 13.94 27.36 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.089 0.403 . . . . 0.24 112.089 173.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 58.15 49.19 11.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 3.55 110.096 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 19' ' ' ALA . 42.0 pt -147.7 -175.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.691 -0.855 . . . . 0.27 108.691 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 m -99.52 146.0 26.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.538 -0.755 . . . . 0.81 109.337 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.681 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.1 p -60.66 -38.08 83.68 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.01 -0.737 . . . . 0.27 109.01 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.55 69.0 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.47 -1.241 . . . . 0.26 111.654 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 49' ' ' PRO . . . -80.72 -38.13 29.36 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.078 -0.712 . . . . 0.23 109.078 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.712 HD11 HD12 ' A' ' 46' ' ' ILE . 12.8 tp -73.69 -18.54 61.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.333 -0.849 . . . . 0.17 109.044 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.737 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.9 -39.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.484 0.659 . . . . 0.19 111.563 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -57.92 -42.9 85.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 122.372 1.082 . . . . 1.07 109.648 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.43 -17.25 49.51 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.512 -1.676 . . . . 0.17 112.016 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.8 m120 -144.45 72.22 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.102 0.477 . . . . 0.19 110.115 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.53 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.9 Cg_endo -55.06 -10.54 2.92 Favored 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 124.216 3.277 . . . . 0.3 114.387 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.38 -37.77 87.99 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.894 0.854 . . . . 1.17 110.78 173.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 6.3 mt -76.55 -6.09 50.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.749 1.389 . . . . 0.53 114.749 -169.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.737 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -50.7 -39.72 52.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.527 1.156 . . . . 1.23 109.942 -177.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.95 -45.26 12.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.694 -2.048 . . . . 0.4 111.453 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.64 -165.28 35.98 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.576 -0.821 . . . . 0.3 114.187 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.8 mp -117.33 158.13 24.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.501 -1.35 . . . . 0.31 110.593 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.672 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 68.3 m -134.25 134.12 41.6 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.756 -0.656 . . . . 0.39 111.101 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.791 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.5 129.06 13.17 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.446 0.906 . . . . 0.47 113.446 175.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.654 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 81.84 -12.77 40.39 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 114.38 -1.282 . . . . 0.36 111.865 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.672 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.6 tt0 -64.7 151.63 44.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.715 0.769 . . . . 1.19 110.307 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 41.1 m -118.0 133.68 55.69 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.257 -1.338 . . . . 0.89 109.277 -172.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 29' ' ' LEU . 19.2 pt -136.28 148.05 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.389 0.614 . . . . 0.22 110.503 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 t -93.1 149.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.087 -0.96 . . . . 0.21 110.342 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.602 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.1 mm -118.01 88.94 33.06 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 0.17 108.61 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.779 ' HA ' HD13 ' A' ' 4' ' ' LEU . 31.1 Cg_endo -61.73 140.64 87.13 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.0 2.466 . . . . 0.23 112.468 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.483 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.76 -7.26 66.36 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.45 -0.796 . . . . 0.3 112.692 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -115.24 125.33 29.01 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.777 -0.823 . . . . 0.25 108.777 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.586 ' CD ' HD23 ' A' ' 51' ' ' LEU . 57.1 Cg_endo -65.39 174.2 5.47 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 124.064 3.176 . . . . 0.31 114.129 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.479 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 6.9 t70 -95.74 137.16 21.93 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.776 -1.102 . . . . 0.72 111.877 -170.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.693 ' HD3' HD12 ' A' ' 5' ' ' LEU . 71.3 Cg_endo -82.25 -8.36 11.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.496 2.797 . . . . 0.27 113.552 -174.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -95.21 -22.25 17.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.089 0.471 . . . . 2.11 110.942 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -85.5 -6.8 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.069 0.938 . . . . 1.47 108.942 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.808 HD13 ' HG2' ' A' ' 158' ' ' PRO . 87.1 mt -95.8 127.46 41.19 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.446 -1.252 . . . . 0.26 110.226 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -102.12 96.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.147 1.231 . . . . 0.2 110.698 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.52 ' HB2' HG23 ' A' ' 161' ' ' THR . 89.2 m-85 -157.4 131.49 8.26 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.241 -1.392 . . . . 0.26 107.241 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.541 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 0.3 OUTLIER -136.08 103.21 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.706 -1.59 . . . . 2.84 106.706 -165.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 55.6 mt -94.53 112.32 26.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.569 -0.742 . . . . 0.32 110.537 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.97 96.83 6.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.102 -0.954 . . . . 0.34 110.361 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.548 HG13 HG13 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -119.09 106.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.543 -1.208 . . . . 0.68 110.361 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.536 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 24.1 m -101.06 125.94 47.71 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.542 -0.754 . . . . 1.05 109.805 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.568 HG23 ' HB ' ' A' ' 86' ' ' VAL . 16.3 mt -47.01 -35.64 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.137 0.494 . . . . 1.29 110.83 166.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.47 -49.16 46.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.469 -0.872 . . . . 0.88 111.514 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -68.92 -24.65 64.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 0.74 112.186 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.64 ' HA ' HG11 ' A' ' 86' ' ' VAL . 2.9 tppt? 55.67 18.69 2.95 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.489 1.138 . . . . 2.51 112.055 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.69 140.25 34.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.968 0.889 . . . . 0.45 111.15 173.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -96.89 118.57 33.61 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.9 -1.5 . . . . 0.33 109.275 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.0 m -101.13 123.82 45.88 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.194 -0.602 . . . . 0.4 111.17 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.95 131.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.767 -1.938 . . . . 0.33 105.767 176.436 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 12.0 m -136.86 130.72 32.18 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 120.735 1.607 . . . . 0.75 112.761 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.15 126.89 55.14 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.278 -0.874 . . . . 0.35 110.322 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.0 t-20 63.7 35.65 11.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.383 0.611 . . . . 0.52 109.463 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.3 m-20 78.52 -0.04 2.53 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.548 -1.206 . . . . 1.84 112.613 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -129.99 139.42 51.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.082 -1.447 . . . . 3.19 113.793 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -51.89 149.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 112.891 -1.959 . . . . 0.41 113.737 -172.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.536 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.6 mtp -101.56 -42.04 6.38 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.234 -2.257 . . . . 0.35 108.22 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -176.64 160.78 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.508 -2.133 . . . . 2.07 110.373 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 9.5 m -122.78 132.6 54.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.527 -0.175 . . . . 0.37 110.527 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.57 156.04 53.85 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 110.346 -0.242 . . . . 0.97 110.346 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HB2' HG22 ' A' ' 134' ' ' ILE . 9.7 Cg_endo -83.36 143.45 11.11 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.7 2.267 . . . . 0.6 111.842 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.37 173.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.482 -0.326 . . . . 0.64 110.148 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.5 149.86 24.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.352 . . . . 0.83 110.804 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 68' ' ' LYS . 16.9 m -136.06 6.32 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.99 -0.55 . . . . 1.67 110.75 -170.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.25 71.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.746 . . . . 3.08 113.151 -173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -162.04 154.05 19.11 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.44 -0.948 . . . . 7.26 108.44 175.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt 67.23 95.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 O-C-N 123.557 0.536 . . . . 6.29 110.025 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.56 7.08 46.58 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.21 -0.306 . . . . 7.27 111.284 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.1 p -73.77 -72.71 0.25 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.079 0.466 . . . . 5.18 110.778 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -151.79 -159.05 0.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.661 . . . . 4.81 109.565 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.799 HG22 ' H ' ' A' ' 167' ' ' ARG . 28.9 p -60.23 122.51 67.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 109.064 -0.717 . . . . 2.11 109.064 169.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HG2' HG22 ' A' ' 165' ' ' ILE . 68.6 Cg_exo -42.02 -65.77 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.586 2.857 . . . . 3.21 113.8 -172.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.457 ' HB ' ' CE1' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -153.0 -170.85 3.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.105 -0.702 . . . . 3.59 109.105 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' H ' HG22 ' A' ' 95' ' ' THR . . . -86.79 -104.92 0.81 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.423 -0.894 . . . . 2.1 111.982 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.64 149.83 34.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.507 0.67 . . . . 2.3 111.442 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.579 ' HB2' HG13 ' A' ' 163' ' ' VAL . 6.7 m-85 -125.27 178.25 5.68 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.998 -1.112 . . . . 1.93 107.998 175.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.717 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.7 m-85 -132.56 137.96 47.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.719 0.295 . . . . 0.58 110.499 172.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.737 HD11 HD12 ' A' ' 125' ' ' ILE . 17.2 mm -58.73 116.5 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.562 -1.273 . . . . 0.41 107.562 165.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.629 HG13 HD11 ' A' ' 51' ' ' LEU . 1.2 tt -102.09 -34.39 3.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.042 -0.663 . . . . 0.37 111.985 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.547 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 59.1 t30 -166.21 -177.83 4.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 122.819 1.295 . . . . 1.99 113.846 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.547 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.7 ptt180 -155.65 131.27 9.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 111.476 -2.602 . . . . 1.19 110.187 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -104.2 153.7 20.66 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 121.925 0.869 . . . . 1.67 110.76 -173.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -51.47 152.71 2.51 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.352 -1.749 . . . . 3.06 113.25 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -44.69 110.84 1.12 Allowed Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 112.331 -2.213 . . . . 2.61 110.69 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -54.15 -50.34 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.499 2.799 . . . . 0.98 111.827 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.65 -20.35 20.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.088 -0.96 . . . . 1.08 112.683 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -132.94 -169.53 12.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.082 -0.58 . . . . 1.05 112.123 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.77 37.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.906 3.737 . . . . 1.3 114.487 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' O ' ' HE1' ' A' ' 126' ' ' HIS . 52.1 t80 -82.06 -18.04 44.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.695 -0.483 . . . . 1.38 109.695 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.56 52.3 0.99 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.599 -0.728 . . . . 1.11 114.415 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 71.71 -63.08 0.44 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.258 1.207 . . . . 0.81 114.258 164.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -142.41 138.28 30.99 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.541 -0.299 . . . . 1.12 110.204 -172.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 51.4 t-105 -98.35 99.35 10.54 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.976 -0.75 . . . . 2.19 108.976 169.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.5 mp -109.34 135.28 50.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.628 0.727 . . . . 0.61 110.659 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 101' ' ' ILE . 29.5 m -107.58 149.17 28.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.278 -0.874 . . . . 0.94 112.047 -175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.639 HD11 HG11 ' A' ' 163' ' ' VAL . 1.5 tp -102.17 -173.78 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.916 -1.038 . . . . 1.08 108.573 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.556 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 48.0 t -86.3 -79.89 0.25 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.627 -0.429 . . . . 1.5 112.101 -175.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.401 ' HD2' ' HE3' ' A' ' 10' ' ' LYS . 25.5 pttm -128.29 159.49 35.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.791 0.293 . . . . 2.97 111.791 -171.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.87 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.272 0.983 . . . . 5.06 112.633 169.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.6 t60 62.26 57.36 1.99 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.853 0.835 . . . . 5.95 108.862 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' A' ' 118' ' ' LEU . 5.0 p90 -97.9 95.72 7.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.069 -0.969 . . . . 4.83 112.178 -169.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.479 ' N ' ' HB2' ' A' ' 118' ' ' LEU . . . -156.32 148.04 17.45 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.271 -0.966 . . . . 0.95 114.235 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.737 HD12 HD11 ' A' ' 100' ' ' ILE . 7.4 mt -147.74 107.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.522 -1.659 . . . . 0.48 106.522 163.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.511 ' HB3' ' HG2' ' A' ' 144' ' ' ARG . 7.1 t-80 -134.9 179.31 6.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.883 -0.727 . . . . 1.25 111.715 -166.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -123.54 176.46 16.73 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.775 -1.102 . . . . 0.46 111.537 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.8 t -148.07 171.77 15.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.154 0.502 . . . . 0.5 111.07 -168.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -101.38 -15.41 17.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.209 -0.905 . . . . 1.86 109.523 166.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -125.33 101.34 31.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.673 -0.694 . . . . 1.77 109.873 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -90.65 4.88 4.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.171 2.581 . . . . 0.59 112.762 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.66 0.54 42.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.038 0.447 . . . . 0.78 110.849 -170.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.6 p -111.22 -2.31 15.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.661 0.743 . . . . 1.45 109.711 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 83' ' ' PRO . 20.9 mm -92.57 126.67 45.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.967 -1.015 . . . . 0.7 110.772 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.37 -134.87 13.22 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.502 -0.856 . . . . 1.68 112.171 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -76.02 87.72 2.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.269 0.557 . . . . 4.39 110.345 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -160.76 -63.12 0.06 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.372 -0.831 . . . . 3.94 109.942 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.83 172.41 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.749 -0.659 . . . . 4.68 110.113 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.422 ' OG ' ' HD2' ' A' ' 140' ' ' LYS . 7.7 p -91.05 -58.72 2.37 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.669 -0.241 . . . . 5.68 110.942 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.422 ' HD2' ' OG ' ' A' ' 139' ' ' SER . 11.4 mptt -72.03 141.05 49.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 8.3 110.982 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.29 174.76 26.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.048 -0.596 . . . . 3.85 111.701 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.0 t -99.32 159.8 14.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.8 0.3 . . . . 2.51 110.537 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.3 tt -75.24 80.64 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 122.267 1.032 . . . . 1.44 110.902 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.511 ' HG2' ' HB3' ' A' ' 126' ' ' HIS . 54.0 mtt180 -118.39 172.02 7.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.898 -1.046 . . . . 3.36 109.742 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.4 mtp -147.85 179.75 7.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.452 . . . . 1.13 110.599 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -71.38 146.22 48.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.457 -0.942 . . . . 2.51 108.457 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.554 ' O ' HG12 ' A' ' 150' ' ' VAL . 27.3 p-10 -50.21 -67.78 0.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 112.508 0.558 . . . . 1.77 112.508 -171.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -23.13 65.58 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.441 -0.787 . . . . 2.13 112.018 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.81 -40.57 63.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.865 -0.607 . . . . 1.05 111.055 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 8.9 p -75.77 -17.94 15.58 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 110.285 -0.265 . . . . 0.32 110.285 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.6 mp -87.12 -39.46 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 118.985 -0.531 . . . . 0.37 110.61 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -43.7 -70.15 0.11 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.534 1.061 . . . . 1.38 111.964 162.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.732 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -48.8 -44.79 39.47 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.626 -0.716 . . . . 0.74 110.139 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.88 -55.2 28.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.244 -1.344 . . . . 0.22 112.337 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.481 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 33.1 t -77.42 -14.72 59.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.592 -1.186 . . . . 1.33 110.9 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.54 -47.16 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.863 -0.421 . . . . 0.23 109.863 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 153' ' ' LEU . 32.6 m -76.12 120.11 80.23 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.885 0.85 . . . . 0.21 110.595 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.808 ' HG2' HD13 ' A' ' 57' ' ' ILE . 41.2 Cg_endo -83.43 -178.69 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.955 2.437 . . . . 0.34 112.538 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.739 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.9 m120 -62.3 4.25 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.503 -1.226 . . . . 1.02 113.366 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.3 54.84 0.52 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.28 112.446 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.717 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -89.72 131.17 35.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.438 -0.448 . . . . 0.3 110.837 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.37 138.9 31.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.472 -0.491 . . . . 1.96 110.342 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 118' ' ' LEU . 3.8 p -146.71 127.7 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.377 -0.829 . . . . 0.46 111.13 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.407 ' C ' HD12 ' A' ' 165' ' ' ILE . 7.1 m -111.67 133.38 53.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 0.56 111.1 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.548 HG13 HG13 ' A' ' 63' ' ' VAL . 2.7 mp -119.18 110.13 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 117.832 -1.547 . . . . 0.96 110.558 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 64' ' ' SER . 37.2 p-10 -143.17 141.74 31.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.896 -1.047 . . . . 1.19 110.312 -171.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.799 ' H ' HG22 ' A' ' 93' ' ' THR . 7.5 ptm180 -92.38 -32.68 14.86 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.43 -0.805 . . . . 3.42 111.922 -175.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.93 -59.58 3.06 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 121.18 -0.533 . . . . 3.65 113.54 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.375 -0.821 . . . . 5.97 110.453 -178.355 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.518 ' S21' ' O31' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.887 -0.485 . . . . 2.92 111.887 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -137.77 179.57 6.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.677 0.275 . . . . 4.1 110.74 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.6 mptt -61.31 154.9 22.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.714 -0.676 . . . . 2.1 109.864 172.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -93.49 167.22 11.84 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.367 0.417 . . . . 0.26 111.332 175.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.653 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.5 tp -77.11 151.2 35.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.488 0.715 . . . . 0.23 111.902 -170.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.8 150.14 38.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 122.1 0.952 . . . . 0.26 112.168 169.081 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' SER . 62.8 t80 -133.67 150.29 51.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.754 -1.567 . . . . 0.39 107.86 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -129.93 114.97 16.52 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.071 -1.455 . . . . 1.07 107.071 175.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.41 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.32 157.15 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.342 0.591 . . . . 0.38 112.359 -166.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -102.8 149.04 24.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.001 -0.999 . . . . 2.59 108.978 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.679 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.5 tm0? -52.53 117.94 3.24 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.874 -0.603 . . . . 1.74 111.369 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.67 -10.26 32.56 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.516 -0.766 . . . . 0.57 112.446 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.58 ' HB3' HD11 ' A' ' 18' ' ' ILE . 54.6 m-20 -62.24 147.55 47.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.997 0.427 . . . . 2.17 111.827 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.534 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -128.19 149.38 50.47 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.892 -0.594 . . . . 0.5 111.908 -178.033 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.605 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.2 tp -46.16 -60.42 2.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.868 1.062 . . . . 0.27 113.868 -173.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.652 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.7 t-20 -64.41 -38.96 92.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.751 1.262 . . . . 1.21 110.15 -171.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.78 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 19.3 m -62.07 -40.93 97.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.636 -2.075 . . . . 1.24 111.002 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.28 -39.74 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.013 0.925 . . . . 0.3 112.736 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.7 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.81 -62.1 1.98 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.61 -0.268 . . . . 0.23 111.203 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.38 -4.65 52.01 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.814 -1.155 . . . . 0.39 111.789 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.78 ' HB2' ' O ' ' A' ' 17' ' ' SER . 12.1 t70 -63.68 -32.42 73.9 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.135 -1.061 . . . . 1.63 108.135 158.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.653 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.0 m-85 -102.53 16.49 26.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 112.354 0.502 . . . . 0.24 112.354 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 54.46 52.02 13.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.206 -0.906 . . . . 3.55 110.644 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.7 HG12 ' O ' ' A' ' 19' ' ' ALA . 34.9 pt -147.99 -171.35 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.971 -0.752 . . . . 0.27 108.971 -172.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.85 147.47 24.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.668 -0.697 . . . . 0.81 109.917 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.652 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 15.8 p -63.0 -35.88 81.68 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.725 -0.843 . . . . 0.27 108.725 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.9 68.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.196 -1.366 . . . . 0.26 111.619 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.79 -38.43 25.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.368 0.604 . . . . 0.23 109.551 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.646 HD11 HD12 ' A' ' 46' ' ' ILE . 13.6 tp -73.88 -18.82 60.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 0.17 109.084 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.716 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.25 -39.34 33.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.616 0.722 . . . . 0.19 111.444 171.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -61.03 -40.3 93.06 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.128 -0.942 . . . . 1.07 110.009 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.74 36.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.881 -1.509 . . . . 0.17 112.085 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.0 m120 -142.02 71.57 23.43 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.039 0.447 . . . . 0.19 109.825 -173.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.519 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.33 -10.26 6.21 Favored 'Trans proline' 0 C--O 1.218 -0.475 0 C-N-CA 123.484 2.789 . . . . 0.3 114.07 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -62.63 -33.83 75.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.09 0.947 . . . . 1.17 109.75 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -78.78 -4.51 49.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.262 -1.335 . . . . 0.53 114.233 -172.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.716 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.64 -40.11 26.6 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 122.414 1.102 . . . . 1.23 110.249 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.46 -46.51 10.82 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.997 -1.911 . . . . 0.4 111.565 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.52 -164.52 34.89 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.978 -1.106 . . . . 0.3 114.264 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 18' ' ' ILE . 5.5 mp -116.38 159.56 21.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.262 -1.469 . . . . 0.31 110.396 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.1 m -138.44 135.09 34.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.916 -0.584 . . . . 0.39 110.871 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.0 129.32 14.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.662 0.744 . . . . 0.47 112.857 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.5 -13.64 39.88 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.46 -1.246 . . . . 0.36 112.179 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.617 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -64.59 151.3 45.04 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.628 0.728 . . . . 1.19 110.272 174.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 46.1 m -117.91 133.18 56.18 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.495 -1.23 . . . . 0.89 109.276 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.646 HD12 HD11 ' A' ' 29' ' ' LEU . 19.7 pt -135.22 148.97 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.277 0.561 . . . . 0.22 110.511 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.476 ' H ' HD22 ' A' ' 33' ' ' ASN . 14.2 t -93.41 149.61 4.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.136 -0.938 . . . . 0.21 110.099 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.518 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.7 mm -117.64 88.58 30.08 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.05 -0.977 . . . . 0.17 108.584 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.756 ' HA ' HD13 ' A' ' 4' ' ' LEU . 23.7 Cg_endo -59.06 143.28 99.86 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.053 2.502 . . . . 0.23 112.585 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.484 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.22 -6.59 59.67 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.694 -0.685 . . . . 0.3 112.996 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.718 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -116.73 126.39 27.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.752 -0.833 . . . . 0.25 108.752 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.648 ' HD2' HD23 ' A' ' 51' ' ' LEU . 61.6 Cg_endo -66.86 171.01 11.7 Favored 'Trans proline' 0 N--CA 1.477 0.517 0 C-N-CA 123.644 2.896 . . . . 0.31 114.029 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 2.0 t70 -90.95 138.89 25.9 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.573 -1.194 . . . . 0.72 111.82 -171.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HD3' HD12 ' A' ' 5' ' ' LEU . 66.3 Cg_endo -83.17 -4.94 11.19 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.529 2.819 . . . . 0.27 113.771 -173.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.34 -29.3 14.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.613 0.244 . . . . 2.11 111.235 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -80.38 -17.53 51.62 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.825 -0.805 . . . . 1.47 108.825 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.725 HD13 ' HG2' ' A' ' 158' ' ' PRO . 87.2 mt -81.44 123.31 81.2 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.974 -1.012 . . . . 0.26 109.224 169.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -100.83 94.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 120.023 1.044 . . . . 0.2 110.13 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' HD2' HG23 ' A' ' 57' ' ' ILE . 86.5 m-85 -158.78 129.79 6.23 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.558 -1.645 . . . . 0.26 106.558 172.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.682 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 2.5 m-70 -134.02 106.56 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.198 -1.779 . . . . 2.84 106.198 -165.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -95.06 110.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.908 -0.717 . . . . 0.32 110.904 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.13 94.21 4.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.277 -0.874 . . . . 0.34 110.442 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.555 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -119.36 97.76 5.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.317 -1.31 . . . . 0.68 110.432 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.9 m -89.33 112.26 23.31 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.529 -1.286 . . . . 1.05 107.529 173.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 1.4 mm -42.34 -43.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.901 -0.59 . . . . 1.29 110.03 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 89' ' ' ILE . . . -56.94 -46.33 91.07 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.661 -1.257 . . . . 0.88 111.746 175.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -66.83 -23.87 66.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.629 0.603 . . . . 0.74 112.629 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.703 ' HA ' HG21 ' A' ' 86' ' ' VAL . 81.6 mttt 62.63 13.08 6.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.034 0.753 . . . . 2.51 113.034 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.25 138.89 33.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.225 1.012 . . . . 0.45 111.796 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.555 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -98.45 120.63 39.21 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.241 -1.8 . . . . 0.33 109.282 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -102.1 124.23 47.34 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.593 -0.843 . . . . 0.4 110.826 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -85.21 129.92 34.71 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.728 -1.953 . . . . 0.33 105.728 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.682 ' OG ' ' HB2' ' A' ' 60' ' ' HIS . 13.7 p -139.23 128.88 24.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 121.37 1.895 . . . . 0.75 114.03 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 tp -113.97 127.49 55.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.346 -1.297 . . . . 0.35 110.338 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 11.5 t-20 63.44 35.9 11.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.217 0.532 . . . . 0.52 109.675 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.6 m-20 79.96 -1.02 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.835 -1.075 . . . . 1.84 112.697 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -131.2 138.78 49.55 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.391 -1.324 . . . . 3.19 113.832 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -50.31 149.31 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 113.004 -1.907 . . . . 0.41 113.298 -176.346 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.579 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.6 mtp -97.95 -46.03 6.06 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 112.116 -2.311 . . . . 0.35 107.525 174.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -177.87 157.56 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.576 -2.102 . . . . 2.07 110.479 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -115.69 132.15 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.508 0.195 . . . . 0.37 110.886 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.46 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 69.5 m-85 -115.63 147.27 38.54 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.617 -0.265 . . . . 0.97 110.398 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -86.92 141.71 6.32 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.489 2.126 . . . . 0.6 111.793 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.44 -177.51 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.332 -0.395 . . . . 0.64 110.807 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.06 133.49 34.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.842 0.353 . . . . 0.83 111.168 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 68' ' ' LYS . 21.1 t -150.31 157.4 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.575 -0.739 . . . . 1.67 110.984 -175.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.417 ' N ' ' CG1' ' A' ' 86' ' ' VAL . . . -77.49 -108.28 0.16 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.363 -0.446 . . . . 3.08 112.273 170.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -144.19 -32.31 0.43 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.751 0.649 . . . . 7.26 112.751 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.436 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 1.1 pp -63.53 170.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.977 0.732 . . . . 6.29 112.977 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 51.8 tp -149.39 79.05 1.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.106 -0.497 . . . . 7.27 112.088 -173.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.619 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 6.3 m -158.29 -97.56 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 O-C-N 122.367 -0.208 . . . . 5.18 111.028 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.512 ' HA ' ' HB2' ' A' ' 166' ' ' ASN . 48.5 mt-30 -138.71 154.61 48.58 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.956 -0.465 . . . . 4.81 111.852 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.687 HG22 ' HD2' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -71.59 176.4 2.22 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 109.608 -0.516 . . . . 2.11 109.608 174.07 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.81 -68.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 120.855 1.037 . . . . 3.21 109.886 163.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 p -155.73 121.36 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.834 -0.802 . . . . 3.59 108.834 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.52 87.41 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 119.195 -1.479 . . . . 2.1 114.754 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' HG2' HG23 ' A' ' 164' ' ' THR . 42.1 mt-10 -124.75 130.87 53.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.1 0.476 . . . . 2.3 109.76 168.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.556 ' HB3' ' H ' ' A' ' 119' ' ' SER . 13.6 m-85 -128.79 -175.65 3.61 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.478 -0.783 . . . . 1.93 110.452 -178.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 161' ' ' THR . 69.0 m-85 -136.84 139.27 41.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.58 109.838 171.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 125' ' ' ILE . 26.0 mm -60.23 118.79 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.997 -1.112 . . . . 0.41 107.997 167.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.8 tt -114.46 -22.68 4.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 119.814 -0.754 . . . . 0.37 112.287 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 66.0 t30 -167.67 178.62 5.23 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 122.86 1.314 . . . . 1.99 114.325 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 114' ' ' TYR . 2.1 ptt180 -151.18 131.8 13.94 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 111.387 -2.642 . . . . 1.19 110.447 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 5.5 tp60 -109.45 145.37 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.981 0.896 . . . . 1.67 111.623 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.586 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 61.3 ttt180 -54.92 150.24 10.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.431 -1.713 . . . . 3.06 111.487 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -46.04 106.22 0.54 Allowed Pre-proline 0 CA--C 1.511 -0.52 0 CA-C-N 115.602 -0.726 . . . . 2.61 111.624 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.01 -48.84 20.01 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.781 2.988 . . . . 0.98 111.69 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.87 -21.1 14.07 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.961 -1.018 . . . . 1.08 112.624 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -101.75 -169.89 27.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.956 -0.64 . . . . 1.05 112.13 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.44 31.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.231 3.288 . . . . 1.3 113.533 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.606 ' CE1' ' HB2' ' A' ' 115' ' ' TRP . 1.1 t80 -72.51 -33.45 66.93 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.308 -0.627 . . . . 1.38 109.308 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.28 60.64 0.78 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.119 -0.946 . . . . 1.11 114.485 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.51 -45.09 0.57 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.182 1.178 . . . . 0.81 114.182 166.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -150.41 145.79 26.28 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.21 -0.293 . . . . 1.12 110.21 -176.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.606 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 24.1 t-105 -116.01 101.06 8.42 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.258 -0.645 . . . . 2.19 109.258 166.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.5 mp -100.66 127.79 46.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.792 0.806 . . . . 0.61 110.536 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.421 ' HB2' HG23 ' A' ' 101' ' ' ILE . 62.4 m -87.44 133.72 33.7 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.22 -0.9 . . . . 0.94 111.672 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -88.55 -179.42 6.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.233 -1.395 . . . . 1.08 107.233 168.294 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.556 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 40.8 t -68.31 -85.24 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.392 -0.523 . . . . 1.5 110.037 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.622 ' HA ' ' OD1' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -66.05 119.42 11.37 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.937 -0.394 . . . . 2.97 109.937 -176.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.512 ' HG3' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -68.61 43.5 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.293 1.22 . . . . 5.06 114.293 -172.429 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -114.45 -15.38 12.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.469 -0.567 . . . . 5.95 109.469 171.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -136.19 151.93 50.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.329 -0.851 . . . . 4.83 109.834 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -153.16 145.96 13.93 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.974 -0.85 . . . . 0.95 110.974 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 100' ' ' ILE . 17.2 mt -93.4 120.76 43.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.477 -0.564 . . . . 0.48 109.477 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 7.9 p80 -155.43 -163.97 1.65 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.507 0.67 . . . . 1.25 111.729 -176.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -121.91 179.25 16.27 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.014 -1.089 . . . . 0.46 113.123 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 t -136.09 173.29 11.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.215 -0.493 . . . . 0.5 110.797 -168.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -104.22 -18.45 14.48 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.358 -0.837 . . . . 1.86 108.873 166.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -128.01 103.68 20.95 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 1.77 110.366 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.405 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 53.4 Cg_endo -91.21 4.07 4.25 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.143 2.562 . . . . 0.59 112.928 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.23 -18.67 33.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.284 0.564 . . . . 0.78 110.337 -172.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 m -89.26 -12.92 39.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 1.45 109.922 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 134' ' ' ILE . 5.3 mm -65.8 116.55 5.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.238 -0.892 . . . . 0.7 111.373 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.54 -38.99 2.99 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.417 -0.811 . . . . 1.68 113.516 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -125.22 3.91 7.83 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.719 0.637 . . . . 4.39 112.719 -171.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -150.78 167.37 27.64 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.052 -0.259 . . . . 3.94 111.321 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.0 t 50.93 69.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 123.955 0.784 . . . . 4.68 110.985 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.1 m -81.18 21.09 0.76 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.681 -0.691 . . . . 5.68 111.759 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.08 -44.81 71.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.215 0.531 . . . . 8.3 110.05 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 142' ' ' CYS . . . 146.6 -151.16 23.46 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.33 -0.708 . . . . 3.85 111.33 -176.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 141' ' ' GLY . 1.2 m 75.98 104.15 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.261 0.624 . . . . 2.51 109.666 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 38.7 mt -85.71 64.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.945 0.879 . . . . 1.44 109.599 -176.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 29.7 ptt180 -102.7 149.96 23.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.884 -1.053 . . . . 3.36 110.437 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 8.3 mtm -140.74 -166.27 2.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.759 0.314 . . . . 1.13 110.198 -177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 10.8 t-80 -67.58 145.33 54.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.155 -0.683 . . . . 2.51 109.155 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.519 ' O ' HG12 ' A' ' 150' ' ' VAL . 30.5 p-10 -49.33 -66.43 0.4 Allowed 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.296 0.48 . . . . 1.77 112.296 -174.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -62.95 -23.35 67.36 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.834 -0.541 . . . . 2.13 111.603 -174.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 1.5 m-20 -69.19 -43.14 74.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 1.05 110.9 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 14.3 p -77.68 -20.53 13.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 CA-C-N 116.555 -0.293 . . . . 0.32 111.036 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.497 HD11 ' HB1' ' A' ' 113' ' ' ALA . 3.1 mp -84.79 -40.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 118.907 -0.568 . . . . 0.37 110.437 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -43.63 -68.7 0.17 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.608 1.095 . . . . 1.38 111.931 163.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.678 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -50.55 -44.03 56.38 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.726 -0.67 . . . . 0.74 110.375 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.69 -54.28 40.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.377 -1.283 . . . . 0.22 112.157 -171.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.6 p -77.76 -13.73 59.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.223 -1.353 . . . . 1.33 111.443 -172.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -93.51 -46.82 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.907 0.384 . . . . 0.23 110.227 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 153' ' ' LEU . 24.4 m -76.61 122.64 86.96 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-O 121.586 0.708 . . . . 0.21 110.077 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.725 ' HG2' HD13 ' A' ' 57' ' ' ILE . 34.8 Cg_endo -84.08 -178.51 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.89 2.394 . . . . 0.34 112.557 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.718 ' O ' HD21 ' A' ' 51' ' ' LEU . 11.7 m120 -59.73 -0.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.021 . . . . 1.02 113.604 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.46 56.3 0.53 Allowed Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.822 -0.704 . . . . 0.28 112.734 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 2.5 m -92.68 139.43 30.57 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 122.29 -0.535 . . . . 0.3 110.733 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -85.1 134.6 34.19 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.151 -0.314 . . . . 1.96 110.151 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.95 128.03 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.544 0.687 . . . . 0.46 111.646 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.418 HG23 ' HG2' ' A' ' 97' ' ' GLU . 30.1 m -113.37 132.56 55.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.526 -0.761 . . . . 0.56 111.167 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.581 HG23 ' CG1' ' A' ' 65' ' ' ILE . 1.9 mp -120.27 116.67 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 118.788 -1.165 . . . . 0.96 110.184 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.563 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 21.0 p-10 -143.3 122.56 13.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.185 0.993 . . . . 1.19 111.171 -175.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.687 ' HD2' HG22 ' A' ' 93' ' ' THR . 6.1 ptm180 -100.52 -62.86 1.19 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 116.275 1.954 . . . . 3.42 116.275 -165.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.619 ' HA2' ' HB ' ' A' ' 91' ' ' THR . . . 141.98 -6.6 2.33 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 119.64 -1.266 . . . . 3.65 112.318 -169.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.496 ' H ' ' HG3' ' A' ' 167' ' ' ARG . 58.3 p . . . . . 0 C--O 1.253 1.266 0 CA-C-O 118.015 -0.993 . . . . 5.97 109.543 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.731 ' S21' ' H25' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.145 -0.382 . . . . 2.92 112.145 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -93.58 -172.32 2.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.823 -0.436 . . . . 4.1 109.823 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.664 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 5.8 mtmt -58.51 141.41 51.96 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.586 -0.734 . . . . 2.1 109.734 166.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -100.26 164.55 11.9 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.783 -0.644 . . . . 0.26 111.389 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.82 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.7 tp -75.51 149.77 38.33 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.906 -0.588 . . . . 0.23 111.973 -169.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.39 149.91 38.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.015 0.912 . . . . 0.26 112.148 169.619 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -134.98 148.34 49.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.671 -1.604 . . . . 0.39 107.661 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.75 115.72 17.71 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.175 -1.417 . . . . 1.07 107.175 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -77.82 158.47 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.886 -0.597 . . . . 0.38 111.843 -166.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.416 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.6 ptmt -104.66 153.58 21.06 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.859 -0.793 . . . . 2.59 108.859 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.77 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 16.8 tt0 -54.42 109.11 0.45 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.855 -0.611 . . . . 1.74 112.243 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.56 -7.01 18.16 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.397 -0.82 . . . . 0.57 112.723 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.602 ' HB3' HD11 ' A' ' 18' ' ' ILE . 87.5 m-20 -63.01 152.93 35.48 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.101 0.451 . . . . 2.17 111.973 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.557 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.9 p -132.27 155.05 49.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.01 0.433 . . . . 0.5 111.982 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.605 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 50.1 tp -49.12 -59.16 3.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.009 1.114 . . . . 0.27 114.009 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.657 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 13.3 t-20 -64.54 -43.21 94.7 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 122.452 1.12 . . . . 1.21 110.481 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 21.1 t -57.45 -42.31 82.23 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 112.467 -2.151 . . . . 1.24 110.289 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.94 -41.31 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 123.528 0.731 . . . . 0.3 112.488 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.683 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.86 -64.83 0.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.529 -0.305 . . . . 0.23 111.665 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.36 -3.89 48.38 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.067 -1.053 . . . . 0.39 111.826 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.741 ' HB2' ' O ' ' A' ' 17' ' ' SER . 53.6 t0 -62.18 -42.76 99.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.971 -1.122 . . . . 1.63 107.971 156.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.633 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.2 m-85 -89.93 16.28 8.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.123 0.416 . . . . 0.24 112.123 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 54.47 51.29 14.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.288 -0.869 . . . . 3.55 110.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 19' ' ' ALA . 38.6 pt -147.82 -173.62 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.826 -0.805 . . . . 0.27 108.826 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -100.87 146.09 27.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.48 -0.782 . . . . 0.81 109.759 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.657 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -62.34 -35.78 80.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.452 0.644 . . . . 0.27 109.435 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.67 67.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.57 -1.195 . . . . 0.26 111.673 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.25 -38.7 24.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.302 0.572 . . . . 0.23 109.472 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.48 -19.47 60.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.334 -0.848 . . . . 0.17 109.162 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.718 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.36 34.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.618 0.723 . . . . 0.19 111.45 173.327 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.2 -39.32 94.31 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.002 0.906 . . . . 1.07 110.047 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 -19.65 38.28 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.052 -1.431 . . . . 0.17 111.861 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.5 m120 -142.55 72.31 20.62 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 0.19 109.709 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.611 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.2 Cg_endo -54.52 -19.42 17.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 123.545 2.83 . . . . 0.3 113.9 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -59.85 -30.82 69.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.925 0.869 . . . . 1.17 110.431 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.8 mt -79.78 -3.72 48.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.309 -1.314 . . . . 0.53 114.238 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.718 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.67 -39.62 37.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.442 1.115 . . . . 1.23 110.082 -177.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.22 -45.94 11.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.875 -1.966 . . . . 0.4 111.733 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.33 -165.06 35.81 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.393 -0.908 . . . . 0.3 113.963 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.476 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.2 mp -115.08 158.22 22.45 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.232 -1.484 . . . . 0.31 109.977 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.1 m -134.67 136.39 42.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.893 -0.594 . . . . 0.39 110.553 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.77 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.75 127.64 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.272 0.841 . . . . 0.47 113.272 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.33 -10.93 46.94 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.33 -1.305 . . . . 0.36 112.265 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -64.23 151.81 42.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.477 0.656 . . . . 1.19 110.455 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 55.4 p -115.48 136.71 52.8 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.882 -1.054 . . . . 0.89 109.484 -173.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 29' ' ' LEU . 19.6 pt -137.36 149.37 25.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.414 0.626 . . . . 0.22 110.382 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.528 ' H ' HD22 ' A' ' 33' ' ' ASN . 12.8 t -96.48 149.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.973 -1.012 . . . . 0.21 110.121 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.574 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.2 mm -117.9 87.47 27.85 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.155 -0.929 . . . . 0.17 108.702 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.748 ' HA ' HD13 ' A' ' 4' ' ' LEU . 23.8 Cg_endo -59.14 141.41 98.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.248 2.632 . . . . 0.23 113.018 -173.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.52 -7.89 67.14 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.557 -0.747 . . . . 0.3 112.855 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -116.34 127.44 26.75 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.719 -0.845 . . . . 0.25 108.719 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.6 Cg_endo -65.91 171.87 9.27 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.674 2.916 . . . . 0.31 113.8 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.515 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 9.5 t70 -94.94 138.0 22.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.063 -0.971 . . . . 0.72 111.522 -170.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.82 ' HD3' HD12 ' A' ' 5' ' ' LEU . 77.6 Cg_endo -75.32 -7.95 19.29 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 123.296 2.664 . . . . 0.27 113.288 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -33.5 16.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.063 -0.255 . . . . 2.11 110.618 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.423 HG21 ' HG3' ' A' ' 3' ' ' LYS . 23.5 p -63.4 -31.82 73.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.426 1.107 . . . . 1.47 108.31 172.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.759 HD13 ' HG2' ' A' ' 158' ' ' PRO . 95.1 mt -77.27 126.02 85.65 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.082 -1.872 . . . . 0.26 110.857 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -100.97 95.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.946 0 C-N-CA 120.753 0.969 . . . . 0.2 110.257 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 73' ' ' SER . 94.3 m-85 -157.68 138.08 12.8 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.909 -1.515 . . . . 0.26 106.909 171.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 55.5 t-80 -144.56 104.07 4.01 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.429 -1.323 . . . . 2.84 107.429 -170.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 68.8 mt -94.8 109.25 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.037 -1.438 . . . . 0.32 110.176 -174.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.05 102.74 11.17 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.19 -0.913 . . . . 0.34 110.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.692 HG13 HG13 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -122.14 102.57 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.005 -1.452 . . . . 0.68 109.988 178.48 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.522 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 30.2 t -95.0 135.67 36.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.183 -0.917 . . . . 1.05 108.9 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.674 ' HB ' ' CB ' ' A' ' 167' ' ' ARG . 1.0 OUTLIER -59.64 -33.61 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.491 0.662 . . . . 1.29 109.95 170.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.04 -48.1 74.69 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 114.95 -1.023 . . . . 0.88 111.368 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -69.08 -25.12 64.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.873 0.694 . . . . 0.74 112.873 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 57.18 12.71 1.39 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.871 0.869 . . . . 2.51 112.982 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.43 142.27 35.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.575 0.702 . . . . 0.45 111.349 177.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.517 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -98.07 118.42 34.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.499 -1.228 . . . . 0.33 109.936 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 m -101.51 125.4 48.15 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.438 -0.505 . . . . 0.4 111.35 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.16 134.89 34.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.47 -1.678 . . . . 0.33 106.47 177.316 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.4 m -138.32 129.33 27.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.716 1.598 . . . . 0.75 112.346 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.14 124.25 49.86 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.079 -0.964 . . . . 0.35 110.01 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.57 37.51 3.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.843 -1.169 . . . . 0.52 107.843 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 83.92 -14.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.679 -1.601 . . . . 1.84 111.569 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -127.23 141.27 51.77 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 117.675 -1.61 . . . . 3.19 114.613 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -56.55 148.75 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 112.291 -2.232 . . . . 0.41 113.957 -165.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.0 mtp -100.49 -43.73 6.11 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.721 -2.49 . . . . 0.35 107.804 175.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 33.3 tptt -179.92 161.34 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.497 -2.138 . . . . 2.07 111.102 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.485 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 15.2 m -118.39 137.43 53.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 122.422 -0.174 . . . . 0.37 110.908 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -126.03 137.81 30.88 Favored Pre-proline 0 N--CA 1.457 -0.107 0 CA-C-O 120.702 0.287 . . . . 0.97 110.267 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HB2' HG22 ' A' ' 134' ' ' ILE . 27.8 Cg_endo -63.39 146.09 93.09 Favored 'Trans proline' 0 N--CA 1.471 0.184 0 C-N-CA 123.187 2.592 . . . . 0.6 112.772 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -139.58 179.75 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.67 -0.493 . . . . 0.64 109.67 176.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.34 141.67 29.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.55 0.691 . . . . 0.83 111.411 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.656 HG13 HG23 ' A' ' 65' ' ' ILE . 2.5 t -153.73 -35.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.112 -1.404 . . . . 1.67 108.585 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.11 -134.94 13.17 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.392 -1.083 . . . . 3.08 110.392 -175.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.642 ' HG3' ' H ' ' A' ' 89' ' ' ILE . 51.6 pttt -82.06 -62.98 1.48 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.089 -0.708 . . . . 7.26 109.089 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.642 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 71.0 mt -157.29 96.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.437 -0.949 . . . . 6.29 108.437 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.82 94.39 0.82 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.089 0.471 . . . . 7.27 110.156 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.9 p -77.89 56.43 1.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.723 -0.671 . . . . 5.18 112.222 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -127.47 -21.19 3.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.253 -0.431 . . . . 4.81 110.962 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.505 ' CG2' ' H ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER 43.21 67.6 3.55 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 109.513 -0.551 . . . . 2.11 109.513 -170.294 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.409 ' HG2' ' CG2' ' A' ' 165' ' ' ILE . 18.7 Cg_exo -18.01 -72.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.073 1 C-N-CA 125.496 4.131 . . . . 3.21 115.437 -162.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.4 p -146.73 -76.82 0.19 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.418 0.628 . . . . 3.59 110.246 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.9 -85.68 0.07 OUTLIER Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.243 -0.89 . . . . 2.1 111.362 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -124.97 140.54 52.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.276 0.56 . . . . 2.3 111.605 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.522 ' HB2' HG13 ' A' ' 163' ' ' VAL . 29.7 m-85 -125.87 177.1 6.5 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.939 -1.028 . . . . 1.93 108.518 171.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.639 ' HA ' ' O ' ' A' ' 161' ' ' THR . 42.4 m-85 -129.86 139.71 51.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.766 0.317 . . . . 0.58 110.19 169.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.828 HD11 HD12 ' A' ' 125' ' ' ILE . 18.6 mm -59.4 115.58 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.681 -1.229 . . . . 0.41 107.681 166.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.557 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.6 tt -99.31 -30.03 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.622 -0.831 . . . . 0.37 112.068 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -178.8 -165.06 0.08 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.599 1.19 . . . . 1.99 113.775 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.781 ' HG2' HD23 ' A' ' 116' ' ' LEU . 9.9 mtt180 -148.2 132.86 17.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 111.969 -2.378 . . . . 1.19 108.871 -173.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -101.76 158.91 15.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.274 1.035 . . . . 1.67 111.423 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.712 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 2.5 ttt180 -49.74 152.93 1.35 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 112.865 -1.971 . . . . 3.06 112.003 169.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.712 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.03 112.93 1.9 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 114.062 -1.426 . . . . 2.61 110.861 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -57.44 -50.75 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.141 2.56 . . . . 0.98 111.559 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.08 45.57 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.777 -1.101 . . . . 1.08 112.469 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.32 -169.21 22.05 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.328 -0.463 . . . . 1.05 112.09 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.6 36.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 124.576 3.517 . . . . 1.3 114.402 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -93.1 -12.05 31.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.76 0.314 . . . . 1.38 110.977 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.614 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.51 33.4 5.37 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.408 -0.901 . . . . 1.11 114.497 171.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.39 -22.5 0.25 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.943 1.09 . . . . 0.81 113.943 168.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -152.98 143.99 23.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.011 -0.366 . . . . 1.12 110.011 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -109.94 100.77 9.67 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.799 -0.815 . . . . 2.19 108.799 166.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.804 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.1 mp -104.82 137.1 43.12 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.42 0.629 . . . . 0.61 109.549 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.9 m -106.16 143.45 34.26 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.231 -0.895 . . . . 0.94 112.064 -170.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.6 OUTLIER -94.83 -174.79 3.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.702 -1.222 . . . . 1.08 107.702 171.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.516 ' O ' ' HE2' ' A' ' 120' ' ' LYS . 20.1 m -95.33 18.91 11.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.218 0.451 . . . . 1.5 112.218 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 119' ' ' SER . 0.0 OUTLIER -130.56 97.61 4.43 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 119.914 -0.714 . . . . 2.97 112.398 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.4 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 2.0 mp0 54.05 -103.09 0.16 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.566 0.746 . . . . 5.06 112.868 169.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -110.88 5.65 20.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.415 -0.357 . . . . 5.95 111.068 -174.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 78.4 m-85 -79.63 131.3 35.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.975 -0.38 . . . . 4.83 109.975 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.507 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -155.93 160.43 30.03 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.854 -0.689 . . . . 0.95 112.035 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 100' ' ' ILE . 41.7 mt -92.56 107.39 18.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.476 -0.935 . . . . 0.48 108.476 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.541 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 9.2 p80 -140.9 -162.71 1.41 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.045 -0.662 . . . . 1.25 111.463 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.614 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.3 175.89 16.22 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.087 -1.054 . . . . 0.46 113.449 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 144' ' ' ARG . 6.1 t -141.1 177.9 7.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.946 -0.627 . . . . 0.5 109.849 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 -4.71 9.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.317 -0.856 . . . . 1.86 110.116 167.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -126.31 101.69 27.82 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 109.178 -0.675 . . . . 1.77 109.178 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -92.5 3.57 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.636 2.89 . . . . 0.59 114.015 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.11 -19.34 59.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.131 0.491 . . . . 0.78 111.693 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.2 m -91.66 -18.24 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.116 0.484 . . . . 1.45 110.456 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 83' ' ' PRO . 25.3 mm -68.44 110.2 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.637 -0.71 . . . . 0.7 111.12 -176.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 84' ' ' ILE . . . 105.32 1.63 41.1 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.791 -0.718 . . . . 1.68 112.983 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -150.03 -54.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.229 0.514 . . . . 4.39 112.309 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.64 158.11 17.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.275 0.559 . . . . 3.94 111.874 -171.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.9 m -93.34 1.8 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.485 -0.779 . . . . 4.68 109.984 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.3 m -67.86 95.28 0.51 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.189 -0.914 . . . . 5.68 112.275 -173.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 56.02 58.33 4.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.64 -0.709 . . . . 8.3 111.649 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.3 133.23 2.27 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.27 -0.967 . . . . 3.85 112.749 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 63.9 m -120.66 -75.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.015 0.436 . . . . 2.51 109.875 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 10.1 mt -122.09 76.17 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.518 . . . . 1.44 109.822 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 89.2 mtt180 -129.85 147.33 51.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.838 -0.619 . . . . 3.36 110.124 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.553 ' H ' ' HA2' ' A' ' 127' ' ' GLY . 10.5 mtp -139.36 -166.39 2.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.451 -0.34 . . . . 1.13 110.196 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -79.13 158.89 27.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.597 -0.52 . . . . 2.51 109.597 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.556 ' O ' HG12 ' A' ' 150' ' ' VAL . 23.1 p-10 -52.05 -68.13 0.19 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 123.333 0.396 . . . . 1.77 111.73 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -62.55 -24.54 67.58 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.728 -0.607 . . . . 2.13 111.821 -175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.27 -43.05 71.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.331 -0.395 . . . . 1.05 110.704 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 7.3 p -77.3 -19.8 14.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.374 -0.375 . . . . 0.32 111.047 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.402 HD12 HG13 ' A' ' 150' ' ' VAL . 2.6 mp -84.61 -39.53 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 118.987 -0.53 . . . . 0.37 109.849 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -43.35 -70.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.257 0.935 . . . . 1.38 112.107 163.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.671 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -49.81 -42.96 48.21 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 123.853 0.721 . . . . 0.74 110.323 178.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.12 -56.68 15.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.3 -1.318 . . . . 0.22 111.884 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.2 t -76.41 -11.53 59.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.803 -1.09 . . . . 1.33 110.626 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 92.9 mt -93.03 -47.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.751 -0.463 . . . . 0.23 109.751 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 153' ' ' LEU . 27.0 m -77.17 119.16 76.36 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 121.996 0.903 . . . . 0.21 110.81 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.759 ' HG2' HD13 ' A' ' 57' ' ' ILE . 33.1 Cg_endo -84.09 -177.71 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.017 2.478 . . . . 0.34 113.013 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.692 ' O ' HD21 ' A' ' 51' ' ' LEU . 17.5 m120 -59.11 1.21 0.07 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.568 -1.196 . . . . 1.02 113.978 -176.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.08 55.92 0.47 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.729 . . . . 0.28 112.173 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.1 m -84.83 137.03 33.41 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.543 -0.386 . . . . 0.3 110.657 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HG2' ' HE1' ' A' ' 99' ' ' TYR . 64.0 mtm180 -83.06 125.87 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.097 -0.335 . . . . 1.96 110.097 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.7 p -139.49 123.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.401 0.62 . . . . 0.46 111.103 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.444 ' C ' HD12 ' A' ' 165' ' ' ILE . 62.5 m -113.44 137.12 51.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.699 -0.682 . . . . 0.56 111.813 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.692 HG13 HG13 ' A' ' 63' ' ' VAL . 3.2 mp -126.35 113.34 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 118.387 -1.325 . . . . 0.96 111.08 172.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 64' ' ' SER . 3.2 p30 -144.5 135.91 25.51 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 113.468 -1.697 . . . . 1.19 109.618 -174.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.674 ' CB ' ' HB ' ' A' ' 65' ' ' ILE . 3.9 ptt180 -92.47 -30.81 15.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.619 0.723 . . . . 3.42 109.893 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -133.77 137.81 9.61 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.738 -1.119 . . . . 3.65 111.093 170.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.72 -0.657 . . . . 5.97 110.04 179.305 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.548 ' S21' ' O31' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.907 -0.477 . . . . 2.92 111.907 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 67.04 175.89 0.25 Allowed 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.304 0.641 . . . . 4.1 111.687 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.9 mptp? -69.4 154.19 42.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.349 -0.841 . . . . 2.1 109.777 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.5 mt -97.05 168.16 10.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.017 -0.538 . . . . 0.26 111.147 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.551 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.8 tp -75.88 150.23 37.64 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 123.336 0.654 . . . . 0.23 111.886 -169.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.46 149.13 36.78 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.17 0.986 . . . . 0.26 111.978 167.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' SER . 77.9 t80 -135.18 150.84 50.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.277 -1.783 . . . . 0.39 108.068 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -129.41 120.96 26.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.359 -1.349 . . . . 1.07 107.359 174.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -81.41 159.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 123.327 0.651 . . . . 0.38 111.968 -171.159 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.1 ptmt -107.84 151.14 26.15 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.071 -0.715 . . . . 2.59 109.071 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.701 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 4.9 tt0 -54.3 113.76 1.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.339 -0.846 . . . . 1.74 111.949 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.75 -5.79 25.97 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.679 -0.772 . . . . 0.57 112.797 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.695 ' HB3' HD11 ' A' ' 18' ' ' ILE . 32.7 m-20 -66.6 156.26 35.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.661 0.615 . . . . 2.17 112.661 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.564 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -133.86 154.64 50.9 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 116.048 -0.524 . . . . 0.5 112.273 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.592 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.54 -58.68 4.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.767 1.025 . . . . 0.27 113.767 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.2 p30 -63.19 -41.83 99.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.794 1.283 . . . . 1.21 110.941 -171.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.794 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 3.2 m -61.83 -39.76 92.95 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.162 -2.29 . . . . 1.24 110.878 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.45 -38.99 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 123.638 0.775 . . . . 0.3 112.694 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.679 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.15 -61.29 2.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.465 -0.334 . . . . 0.23 111.2 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.32 -4.79 54.81 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.677 -1.209 . . . . 0.39 111.774 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.794 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.0 t70 -61.95 -35.43 78.41 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.609 -1.256 . . . . 1.63 107.609 157.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.665 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.9 m-85 -100.73 17.29 22.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.854 0.687 . . . . 0.24 112.854 176.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' NH2' ' HA ' ' A' ' 121' ' ' GLN . 2.5 mpt_? 53.95 52.49 12.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.563 -0.744 . . . . 3.55 110.856 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 19' ' ' ALA . 34.0 pt -149.85 -173.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.984 -0.747 . . . . 0.27 108.984 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 146.97 24.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.589 -0.732 . . . . 0.81 109.71 173.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 17.9 p -60.89 -36.6 79.64 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.503 -0.925 . . . . 0.27 108.503 175.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.64 70.55 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.441 -1.254 . . . . 0.26 111.733 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.21 -37.57 28.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.888 -0.507 . . . . 0.23 109.761 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.62 HD11 HD12 ' A' ' 46' ' ' ILE . 14.0 tp -74.47 -19.66 60.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.382 -0.826 . . . . 0.17 109.188 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.753 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.28 -39.02 41.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.723 0.773 . . . . 0.19 111.608 173.099 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -60.62 -41.39 94.76 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.971 -1.013 . . . . 1.07 109.745 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.54 -20.53 39.81 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.717 -1.583 . . . . 0.17 112.169 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 13.2 m120 -141.88 72.3 23.77 Favored Pre-proline 0 CA--C 1.513 -0.447 0 CA-C-O 121.132 0.492 . . . . 0.19 109.836 -173.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.708 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.6 Cg_endo -57.51 -11.94 9.9 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.415 2.743 . . . . 0.3 113.887 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -61.9 -32.77 73.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.965 0.888 . . . . 1.17 109.375 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.68 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.75 -6.87 59.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.785 1.402 . . . . 0.53 114.785 -171.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.753 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -50.58 -40.91 53.6 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 120.08 1.309 . . . . 1.23 110.241 179.254 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.81 -46.29 12.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.965 -1.925 . . . . 0.4 111.437 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.68 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.43 -163.5 34.15 Favored Glycine 0 CA--C 1.495 -1.214 0 C-N-CA 120.402 -0.904 . . . . 0.3 114.029 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 9' ' ' VAL . 6.6 mp -117.89 158.31 25.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.215 -1.493 . . . . 0.31 110.436 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.616 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.7 m -131.74 135.58 46.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.713 -0.676 . . . . 0.39 110.339 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.701 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.13 127.71 8.83 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.994 0.739 . . . . 0.47 112.994 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.458 ' HA2' ' OE1' ' A' ' 8' ' ' GLN . . . 81.79 -10.43 51.83 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.815 -1.084 . . . . 0.36 112.174 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.616 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.0 tt0 -64.25 151.33 43.91 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.771 0.796 . . . . 1.19 110.188 175.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 39.5 m -117.79 134.14 55.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.235 -1.348 . . . . 0.89 109.023 -171.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 29' ' ' LEU . 22.8 pt -135.88 149.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.319 0.581 . . . . 0.22 110.584 -175.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.553 ' H ' HD22 ' A' ' 33' ' ' ASN . 13.5 t -94.64 149.37 4.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.998 -1.001 . . . . 0.21 110.249 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.527 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.4 mm -117.58 88.36 29.09 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.993 -1.003 . . . . 0.17 108.434 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.766 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.45 143.4 97.88 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.248 2.632 . . . . 0.23 112.723 -173.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.451 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 79.14 -8.29 46.59 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.496 -0.775 . . . . 0.3 112.882 -176.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.727 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -113.54 124.82 30.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.551 -0.907 . . . . 0.25 108.551 177.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.659 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.2 Cg_endo -66.17 174.35 6.11 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.6 2.867 . . . . 0.31 113.631 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.6 t70 -89.12 142.0 29.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.043 -0.98 . . . . 0.72 109.967 -173.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 83.2 Cg_endo -81.19 -13.58 11.19 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.223 2.615 . . . . 0.27 112.087 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -96.91 -10.33 26.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.08 0.467 . . . . 2.11 111.182 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -81.22 -22.37 38.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.076 -1.453 . . . . 1.47 107.076 166.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.62 HD13 ' HG2' ' A' ' 158' ' ' PRO . 64.4 mt -87.68 132.56 40.16 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 113.005 -1.907 . . . . 0.26 110.219 173.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -103.89 96.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 121.208 1.272 . . . . 0.2 110.546 165.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.464 ' HD2' ' CG2' ' A' ' 57' ' ' ILE . 84.0 m-85 -157.97 130.99 7.45 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.5 -1.296 . . . . 0.26 107.5 172.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 0.3 OUTLIER -135.75 103.68 5.5 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.981 -1.489 . . . . 2.84 106.981 -166.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 76.2 mt -94.3 109.39 22.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.458 -0.792 . . . . 0.32 110.541 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.11 97.01 6.24 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.385 -0.825 . . . . 0.34 110.579 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.496 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -113.43 98.56 7.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.319 -1.309 . . . . 0.68 109.808 178.125 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 43.0 m -94.59 121.1 35.8 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.615 -1.175 . . . . 1.05 108.752 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.611 ' HA ' HG12 ' A' ' 86' ' ' VAL . 8.2 mt -57.82 -26.79 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.352 0.596 . . . . 1.29 111.601 175.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.49 70.53 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.722 -0.752 . . . . 0.88 111.269 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.19 -24.46 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.14 0.495 . . . . 0.74 112.335 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.506 ' HG2' HG11 ' A' ' 86' ' ' VAL . 35.9 mttt 58.26 18.38 5.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.367 1.067 . . . . 2.51 112.318 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.67 141.27 31.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.92 0.866 . . . . 0.45 111.516 176.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.496 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.96 118.52 31.94 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.895 -1.502 . . . . 0.33 109.318 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -99.68 124.28 44.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.39 -0.524 . . . . 0.4 111.095 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.494 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.07 133.52 35.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.804 -1.924 . . . . 0.33 105.804 175.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.6 m -138.76 130.78 28.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 120.544 1.52 . . . . 0.75 112.743 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.77 126.61 53.36 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.14 -0.936 . . . . 0.35 110.432 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 64.61 37.91 7.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.453 0.644 . . . . 0.52 109.357 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 73.98 2.34 4.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.562 -1.199 . . . . 1.84 112.567 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -130.8 138.0 49.7 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.618 -1.233 . . . . 3.19 113.703 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -52.04 148.64 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-N 113.292 -1.776 . . . . 0.41 113.587 -172.085 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.494 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.7 mtp -96.98 -46.12 6.32 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.191 -2.277 . . . . 0.35 107.576 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 6.5 tptp 179.2 159.01 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.474 -2.148 . . . . 2.07 109.767 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.536 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 18.5 m -117.03 136.22 53.12 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.379 -0.2 . . . . 0.37 110.946 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.54 133.42 24.04 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 109.986 -0.376 . . . . 0.97 109.986 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.76 146.57 92.15 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.868 2.378 . . . . 0.6 112.447 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 177.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.056 -0.72 . . . . 0.64 109.056 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.716 ' HB3' ' HA ' ' A' ' 142' ' ' CYS . . . -88.19 153.45 21.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.118 0.485 . . . . 0.83 110.072 173.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 65' ' ' ILE . 3.3 m -122.55 98.27 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.717 -0.674 . . . . 1.67 111.982 -171.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.03 84.36 0.92 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.726 -0.67 . . . . 3.08 111.904 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -82.72 2.96 31.18 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.803 0.297 . . . . 7.26 111.803 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.2 tp -81.8 -35.11 13.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.771 0.32 . . . . 6.29 111.13 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.99 123.26 28.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.302 . . . . 7.27 110.777 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -89.63 64.63 6.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.387 0.613 . . . . 5.18 110.773 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -123.72 84.56 2.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.165 -0.47 . . . . 4.81 110.326 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -80.75 -62.7 0.36 Allowed Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 112.885 0.698 . . . . 2.11 112.885 -175.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.592 ' HD3' ' OG1' ' A' ' 93' ' ' THR . 74.9 Cg_endo -91.0 -6.83 3.89 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.957 1.771 . . . . 3.21 113.707 -173.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.9 t -102.65 13.47 34.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.976 0.417 . . . . 3.59 111.239 -176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -105.33 52.8 0.69 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.451 -0.881 . . . . 2.1 112.465 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.39 128.18 53.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.366 0.603 . . . . 2.3 110.598 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 163' ' ' VAL . 13.1 m-85 -127.0 178.78 5.77 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.033 -0.985 . . . . 1.93 110.017 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' THR . 72.3 m-85 -134.06 140.42 46.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.923 -0.58 . . . . 0.58 110.09 172.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 125' ' ' ILE . 27.2 mm -60.46 126.61 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.239 -1.022 . . . . 0.41 108.239 167.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.7 tt -124.7 -21.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.047 -0.661 . . . . 0.37 112.41 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 21.9 t-20 -159.65 160.86 34.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.635 1.207 . . . . 1.99 114.088 -173.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 127.49 15.37 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 111.632 -2.531 . . . . 1.19 108.806 172.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.64 158.54 16.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.446 1.117 . . . . 1.67 111.821 -171.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.593 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 21.9 ttm180 -52.42 155.59 2.05 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.175 -2.284 . . . . 3.06 111.793 167.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.593 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 6.6 p30 -45.13 109.89 0.99 Allowed Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.163 -1.38 . . . . 2.61 111.519 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.37 -51.51 5.24 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.4 2.733 . . . . 0.98 112.12 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.61 -10.31 70.87 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.096 -0.957 . . . . 1.08 111.959 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -107.78 -168.72 21.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.412 -0.423 . . . . 1.05 112.085 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.54 18.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 124.073 3.182 . . . . 1.3 113.945 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.499 ' CZ ' ' H25' ' A' 1142 ' ' IM2 . 0.1 OUTLIER -69.26 -18.56 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 1.38 111.385 -177.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.591 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 94.19 41.38 4.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 1.11 113.4 174.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 77.08 -27.58 0.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.237 0.828 . . . . 0.81 113.237 171.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.551 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -152.64 146.5 25.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.95 0.405 . . . . 1.12 110.769 -178.178 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -115.88 101.58 8.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 2.19 109.545 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -103.63 141.69 35.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.406 0.622 . . . . 0.61 110.462 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 101' ' ' ILE . 50.7 m -106.15 140.3 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.488 -0.778 . . . . 0.94 111.818 -171.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -95.56 -178.41 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.676 -1.231 . . . . 1.08 107.676 172.436 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 58.9 m -56.93 -58.04 9.89 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 118.439 0.563 . . . . 1.5 111.037 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.407 ' HA ' ' OD1' ' A' ' 21' ' ' ASP . 25.5 mmmt -70.12 127.0 31.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.067 0.461 . . . . 2.97 109.884 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 21' ' ' ASP . 23.3 tm0? -56.4 -30.12 62.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.148 -0.933 . . . . 5.06 112.071 -174.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -90.13 11.47 20.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.853 0.316 . . . . 5.95 111.853 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -133.02 135.79 45.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.945 0.402 . . . . 4.83 110.464 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.2 158.0 28.07 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.007 -1.092 . . . . 0.95 112.882 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 100' ' ' ILE . 7.3 mt -92.73 109.43 21.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.499 -0.926 . . . . 0.48 108.499 172.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.486 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 54.1 p-80 -140.13 -164.44 1.71 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.505 -0.878 . . . . 1.25 111.796 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.591 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.04 179.52 16.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.724 -1.125 . . . . 0.46 113.968 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -139.39 174.22 10.73 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.293 0.568 . . . . 0.5 111.068 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -104.38 -21.29 13.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.971 -1.013 . . . . 1.86 108.9 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -127.22 104.36 22.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.755 -1.111 . . . . 1.77 109.672 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.69 5.41 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.499 2.799 . . . . 0.59 112.794 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.46 59.57 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.258 0.552 . . . . 0.78 110.363 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 m -85.33 -17.32 37.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 1.45 109.576 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 36.6 mm -81.5 115.55 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.407 -0.815 . . . . 0.7 111.017 -175.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.29 29.76 59.72 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.577 -0.738 . . . . 1.68 111.571 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -154.56 -38.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.772 0.32 . . . . 4.39 110.57 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -85.38 154.11 22.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.944 0.402 . . . . 3.94 110.865 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.57 -12.45 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.66 -0.7 . . . . 4.68 110.476 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.0 p -152.55 38.13 0.54 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.128 0.49 . . . . 5.68 111.271 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -151.96 133.71 14.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.414 -0.357 . . . . 8.3 110.65 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 144' ' ' ARG . . . 89.99 -33.8 4.33 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.112 -0.566 . . . . 3.85 113.371 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 29.9 p 39.05 -91.85 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.848 0.859 . . . . 2.51 113.088 -171.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.404 ' N ' ' SG ' ' A' ' 142' ' ' CYS . 15.6 mt -124.11 65.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 121.493 -0.755 . . . . 1.44 111.345 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 10.3 ptm180 -132.49 90.98 2.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.961 0.886 . . . . 3.36 110.475 175.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.7 ptm -100.29 -165.44 1.22 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.951 -1.022 . . . . 1.13 112.719 -168.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -64.58 133.81 53.07 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.669 -0.696 . . . . 2.51 111.051 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.623 ' O ' HG12 ' A' ' 150' ' ' VAL . 10.9 p30 -52.64 -63.54 1.11 Allowed 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 113.038 0.755 . . . . 1.77 113.038 -172.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -23.76 67.6 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.321 -0.862 . . . . 2.13 112.115 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.03 -33.8 57.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 1.05 111.193 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 14.8 p -79.71 -16.3 13.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 110.016 -0.365 . . . . 0.32 110.016 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.571 HD12 HG13 ' A' ' 150' ' ' VAL . 2.8 mp -88.38 -37.14 10.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.897 -0.409 . . . . 0.37 109.897 171.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -43.46 -70.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.878 0.763 . . . . 1.38 111.784 159.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.712 ' O ' HG22 ' A' ' 157' ' ' VAL . 2.9 pp -54.7 -36.0 64.22 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.474 0.484 . . . . 0.74 110.479 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.22 -51.92 65.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.6 0.714 . . . . 0.22 112.059 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 p -77.52 -15.57 59.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.77 -1.104 . . . . 1.33 110.91 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.2 mt -93.86 -49.01 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.06 -0.518 . . . . 0.23 110.5 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.2 m -76.83 111.97 19.53 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-O 121.776 0.798 . . . . 0.21 110.253 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.62 ' HG2' HD13 ' A' ' 57' ' ' ILE . 6.8 Cg_endo -77.85 -179.89 5.87 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.467 2.111 . . . . 0.34 112.804 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.727 ' O ' HD21 ' A' ' 51' ' ' LEU . 12.2 m120 -62.03 1.54 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.153 -1.385 . . . . 1.02 113.611 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.408 ' O ' HD12 ' A' ' 57' ' ' ILE . . . -145.1 58.4 0.51 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.145 -0.55 . . . . 0.28 112.133 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.465 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 9.4 m -96.34 136.72 36.44 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.514 -0.403 . . . . 0.3 110.27 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 135.36 33.8 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.365 -0.534 . . . . 1.96 110.386 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.2 p -139.0 122.75 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.022 -0.99 . . . . 0.46 110.788 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.409 ' C ' HD12 ' A' ' 165' ' ' ILE . 87.1 m -113.75 138.39 50.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.716 -0.674 . . . . 0.56 111.426 -177.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.489 HG13 HG13 ' A' ' 63' ' ' VAL . 2.9 mp -119.8 110.98 30.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 118.751 -1.18 . . . . 0.96 109.999 172.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -141.25 139.06 33.67 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.425 -1.261 . . . . 1.19 109.568 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.685 ' H ' HG22 ' A' ' 93' ' ' THR . 12.2 mpt_? -81.27 -9.72 59.72 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.236 -1.347 . . . . 3.42 110.568 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 175.71 -81.56 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.313 -0.858 . . . . 3.65 111.371 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.529 -0.748 . . . . 5.97 109.799 177.859 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.578 ' O32' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.718 -0.553 . . . . 2.92 111.718 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -79.1 169.38 18.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.064 0.459 . . . . 4.1 110.853 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.6 OUTLIER -72.93 153.62 40.9 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.984 -0.747 . . . . 2.1 108.984 172.189 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.789 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.5 mt -99.94 171.66 7.71 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.164 0.431 . . . . 0.26 112.164 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.594 HD12 ' HD3' ' A' ' 54' ' ' PRO . 4.7 tp -76.15 152.89 36.58 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.59 0.756 . . . . 0.23 112.512 -168.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.29 148.14 39.55 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.21 1.005 . . . . 0.26 111.88 165.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 45' ' ' SER . 71.7 t80 -134.34 149.14 50.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.096 -1.865 . . . . 0.39 107.612 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -130.03 114.41 15.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.208 -1.404 . . . . 1.07 107.208 175.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.2 m -72.76 155.92 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 121.203 0.525 . . . . 0.38 112.031 -166.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -98.53 151.35 20.72 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.096 -0.956 . . . . 2.59 109.593 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.798 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -52.17 116.41 2.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 1.74 111.398 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.05 -7.16 35.22 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.09 -0.959 . . . . 0.57 112.956 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.55 ' CB ' HD11 ' A' ' 18' ' ' ILE . 71.6 m-20 -61.29 149.11 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.362 0.505 . . . . 2.17 112.362 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.575 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -130.83 152.33 50.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.916 -0.583 . . . . 0.5 111.719 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.586 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.3 tp -48.43 -59.9 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 0.27 113.896 -170.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.694 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 7.1 t-20 -65.39 -39.85 92.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.132 0.968 . . . . 1.21 110.211 -170.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.737 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 23.3 m -59.59 -41.74 90.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.928 -1.942 . . . . 1.24 110.728 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -74.95 -40.36 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.515 0.726 . . . . 0.3 112.589 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -55.84 -63.65 1.11 Allowed 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.533 -0.303 . . . . 0.23 111.188 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -79.95 -3.56 48.72 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.818 -1.153 . . . . 0.39 112.035 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 17' ' ' SER . 13.6 t70 -64.47 -33.41 75.81 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.348 -0.982 . . . . 1.63 108.348 157.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.679 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.9 m-85 -100.19 17.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.96 0.41 . . . . 0.24 111.998 173.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 2.3 mpt_? 53.79 52.18 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.407 -0.815 . . . . 3.55 110.764 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 38.5 pt -148.2 -173.27 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.059 -0.719 . . . . 0.27 109.059 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -98.91 144.39 28.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.522 -0.763 . . . . 0.81 109.665 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.694 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 7.1 p -62.55 -37.97 88.2 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.618 0.723 . . . . 0.27 109.221 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.19 -27.41 68.67 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.164 -1.38 . . . . 0.26 111.284 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -38.71 26.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.467 0.651 . . . . 0.23 109.589 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.702 HD11 HD12 ' A' ' 46' ' ' ILE . 14.7 tp -72.06 -19.44 61.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 0.17 108.911 174.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.789 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.51 -37.23 32.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.307 0.575 . . . . 0.19 111.243 172.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.0 mt-30 -56.57 -43.26 79.82 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.353 1.073 . . . . 1.07 109.808 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.97 -18.93 35.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.404 -1.725 . . . . 0.17 112.801 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.6 m120 -143.82 73.76 16.71 Favored Pre-proline 0 CA--C 1.513 -0.479 0 CA-C-O 121.137 0.494 . . . . 0.19 109.961 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.679 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.1 Cg_endo -57.18 -14.02 14.04 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 123.568 2.845 . . . . 0.3 114.098 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.99 -33.56 74.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.104 0.954 . . . . 1.17 109.672 175.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -79.18 -6.0 55.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.225 -1.352 . . . . 0.53 114.375 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.789 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -49.25 -41.11 36.66 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 119.778 1.172 . . . . 1.23 110.295 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.1 -46.53 11.85 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.766 -2.016 . . . . 0.4 111.733 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.39 -163.89 34.73 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 120.369 -0.919 . . . . 0.3 114.383 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.8 mp -118.65 157.38 27.53 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 112.945 -1.627 . . . . 0.31 110.686 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 84.8 m -135.17 132.32 37.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.464 -0.789 . . . . 0.39 110.18 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.61 128.64 15.43 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.313 0.577 . . . . 0.47 112.339 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.09 -13.5 54.15 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 114.734 -1.121 . . . . 0.36 112.432 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.617 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -65.85 151.98 45.46 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.426 0.632 . . . . 1.19 110.358 173.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.5 m -117.92 134.35 55.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.589 -1.187 . . . . 0.89 109.463 -171.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 29' ' ' LEU . 16.4 pt -136.84 149.79 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.423 0.63 . . . . 0.22 110.576 -175.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.505 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 16.9 t -95.65 148.94 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.08 -0.964 . . . . 0.21 110.333 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.504 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.9 mm -117.25 89.33 30.66 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 114.835 -1.075 . . . . 0.17 108.812 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.789 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.9 Cg_endo -59.3 140.48 94.78 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.277 2.652 . . . . 0.23 112.767 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.77 -6.87 67.9 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.701 -0.681 . . . . 0.3 113.033 -176.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.7 tt -116.49 124.87 28.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.444 -0.947 . . . . 0.25 108.444 175.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD23 ' A' ' 51' ' ' LEU . 58.9 Cg_endo -65.86 174.22 5.95 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.728 2.952 . . . . 0.31 113.898 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.493 ' O ' HG13 ' A' ' 57' ' ' ILE . 3.8 t70 -90.56 137.55 27.21 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 114.743 -1.117 . . . . 0.72 111.604 -171.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.594 ' HD3' HD12 ' A' ' 5' ' ' LEU . 62.3 Cg_endo -83.94 -9.7 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.457 2.771 . . . . 0.27 113.344 -174.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -95.67 -15.42 22.71 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.994 0.426 . . . . 2.11 110.729 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -91.62 -5.31 54.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.623 0.725 . . . . 1.47 109.174 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.799 HD13 ' HG2' ' A' ' 158' ' ' PRO . 45.0 mt -98.28 137.73 20.8 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 115.24 -0.891 . . . . 0.26 109.605 171.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' O ' ' CG ' ' A' ' 59' ' ' TYR . 10.6 Cg_endo -104.13 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.243 0 CA-C-N 120.153 1.09 . . . . 0.2 110.038 163.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 58' ' ' PRO . 70.7 m-85 -156.94 133.47 9.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.142 -1.429 . . . . 0.26 107.142 169.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -148.18 111.26 4.86 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.555 -0.905 . . . . 2.84 108.555 -160.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 50.1 mt -98.63 118.25 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.798 -1.092 . . . . 0.32 111.019 -175.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.59 92.98 4.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.797 0.808 . . . . 0.34 110.07 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 70' ' ' LEU . 1.1 p -111.36 101.78 13.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.438 -1.256 . . . . 0.68 108.94 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.464 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.2 m -96.0 116.08 28.4 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.466 -0.939 . . . . 1.05 108.466 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.529 HG23 HG13 ' A' ' 86' ' ' VAL . 1.2 mm -45.47 -36.5 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 1.29 110.876 170.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . -63.9 -43.83 96.96 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.372 -0.918 . . . . 0.88 111.683 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -71.17 -23.2 62.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.872 -0.664 . . . . 0.74 112.73 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.446 ' HA ' HG21 ' A' ' 86' ' ' VAL . 6.2 mptt 58.71 14.98 3.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.882 0.873 . . . . 2.51 112.583 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.484 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.21 139.56 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.897 0.856 . . . . 0.45 111.442 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.459 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -93.67 114.01 26.22 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.744 -1.571 . . . . 0.33 108.737 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -98.5 122.19 41.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.06 -0.656 . . . . 0.4 110.432 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.595 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -81.87 127.14 32.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.823 -1.917 . . . . 0.33 105.823 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.1 m -131.8 127.34 36.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 120.341 1.428 . . . . 0.75 111.976 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -113.17 122.69 48.27 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.004 -0.998 . . . . 0.35 109.559 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 68.51 36.75 2.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.772 -0.825 . . . . 0.52 108.772 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 73.75 1.87 4.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.275 -1.329 . . . . 1.84 112.295 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -130.38 138.14 50.23 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 118.148 -1.421 . . . . 3.19 113.805 173.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.25 148.21 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 112.84 -1.982 . . . . 0.41 113.585 -171.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -98.96 -44.43 6.33 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 111.921 -2.4 . . . . 0.35 107.998 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 4.3 tppt? -178.96 160.77 1.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.235 -2.257 . . . . 2.07 109.491 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.484 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.7 m -118.93 131.07 56.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.518 0.199 . . . . 0.37 110.662 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.769 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 30.6 m-85 -118.11 141.2 29.0 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 109.294 -0.632 . . . . 0.97 109.294 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HB2' HG22 ' A' ' 134' ' ' ILE . 11.4 Cg_endo -80.94 144.13 14.9 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.196 1.93 . . . . 0.6 111.783 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.66 178.07 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.89 -0.411 . . . . 0.64 109.89 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.95 119.01 24.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.199 0.524 . . . . 0.83 111.367 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.529 HG13 HG23 ' A' ' 65' ' ' ILE . 22.1 t -133.1 112.89 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.027 -0.988 . . . . 1.67 109.619 175.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.93 138.35 9.95 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.206 -0.758 . . . . 3.08 111.206 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -93.85 64.73 3.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.481 0.658 . . . . 7.26 111.84 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.0 pt -101.15 -139.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.63 -0.714 . . . . 6.29 109.626 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.79 76.6 0.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.302 -0.629 . . . . 7.27 109.302 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.47 ' HB ' ' O32' ' A' 1142 ' ' IM2 . 5.1 t -170.48 152.36 3.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.386 -0.824 . . . . 5.18 109.405 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.561 ' HG2' ' H ' ' A' ' 93' ' ' THR . 6.2 tt0 -136.44 -148.31 0.28 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.36 -0.607 . . . . 4.81 109.36 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.561 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 13.0 p -66.08 117.68 45.11 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 122.793 0.437 . . . . 2.11 109.826 174.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.1 107.77 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.263 1.975 . . . . 3.21 111.627 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.9 t -85.0 43.51 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.677 0.751 . . . . 3.59 111.474 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.02 122.51 0.93 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.471 -0.871 . . . . 2.1 112.582 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -76.73 153.55 34.94 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.119 -0.326 . . . . 2.3 110.119 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.854 ' CE1' HG11 ' A' ' 163' ' ' VAL . 0.6 OUTLIER -113.29 176.99 4.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.092 -0.504 . . . . 1.93 109.803 176.362 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.487 ' HE2' ' HG3' ' A' ' 162' ' ' ARG . 37.0 m-85 -137.13 138.56 40.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.179 -0.675 . . . . 0.58 109.179 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.493 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 26.8 mm -60.64 107.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.994 -0.743 . . . . 0.41 108.994 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.626 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.4 tt -104.36 -31.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.629 -0.714 . . . . 0.37 112.401 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 66.5 t30 -168.65 175.52 6.09 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 123.028 1.394 . . . . 1.99 114.224 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.699 ' HB3' ' CE1' ' A' ' 114' ' ' TYR . 5.6 mtt180 -137.0 126.98 25.89 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.07 -2.787 . . . . 1.19 107.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.74 150.45 20.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.179 0.99 . . . . 1.67 111.081 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.578 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 27.0 ttm180 -51.78 156.81 1.33 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.95 -1.932 . . . . 3.06 111.863 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.578 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 8.4 p30 -43.23 105.12 0.41 Allowed Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 122.745 1.259 . . . . 2.61 111.312 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -58.3 -54.68 2.8 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.775 2.983 . . . . 0.98 112.949 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.96 72.38 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.445 -0.798 . . . . 1.08 111.848 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.89 -169.87 13.67 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.973 -0.451 . . . . 1.05 111.973 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.5 32.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 124.419 3.413 . . . . 1.3 114.369 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -88.11 -12.18 44.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.19 0.519 . . . . 1.38 110.938 178.059 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 72.31 51.99 11.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.146 -0.934 . . . . 1.11 114.018 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.81 -13.6 0.92 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.958 1.096 . . . . 0.81 113.958 167.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.699 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -161.99 142.57 10.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.656 0.265 . . . . 1.12 110.553 175.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.72 ' CZ3' ' HA3' ' A' ' 124' ' ' GLY . 24.5 t-105 -113.37 101.27 9.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.81 . . . . 2.19 108.814 168.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.645 HD12 ' HG2' ' A' ' 103' ' ' ARG . 1.6 mm? -92.71 110.3 21.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.447 0.641 . . . . 0.61 109.806 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.509 ' HB2' HG23 ' A' ' 101' ' ' ILE . 68.5 m -65.86 140.98 58.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.945 -1.025 . . . . 0.94 111.983 -174.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.654 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 1.4 tp -109.43 161.46 15.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.452 -0.573 . . . . 1.08 109.452 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.49 ' H ' ' HB2' ' A' ' 98' ' ' PHE . 5.6 m -93.92 29.55 2.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.303 0.573 . . . . 1.5 109.877 174.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 96.65 4.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.882 -0.599 . . . . 2.97 109.899 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 53.97 -131.49 2.02 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.36 0.412 . . . . 5.06 110.986 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -104.67 18.24 22.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.678 0.275 . . . . 5.95 110.777 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 94.1 m-85 -72.88 154.7 40.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.141 -0.688 . . . . 4.83 109.141 173.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.72 ' HA3' ' CZ3' ' A' ' 115' ' ' TRP . . . -156.91 162.65 31.83 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.259 -0.972 . . . . 0.95 113.065 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.616 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 47.7 mt -92.87 108.84 20.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 107.555 -1.276 . . . . 0.48 107.555 169.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.609 ' CE1' ' HB3' ' A' ' 144' ' ' ARG . 12.7 p80 -143.69 -163.4 1.65 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.825 -0.75 . . . . 1.25 111.846 -175.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.39 168.45 14.33 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.697 -1.138 . . . . 0.46 112.68 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 6.9 t -127.65 177.54 6.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.53 0.681 . . . . 0.5 111.888 -165.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -106.98 -18.45 13.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.614 -1.175 . . . . 1.86 109.456 166.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -125.3 103.88 29.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.401 -0.818 . . . . 1.77 109.732 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -87.78 4.2 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.979 2.453 . . . . 0.59 112.892 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.74 -21.59 23.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.086 0.47 . . . . 0.78 110.132 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.8 m -90.23 13.21 15.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 1.45 110.357 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' PRO . 20.4 mm -99.24 113.53 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.7 110.387 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.79 -83.31 0.35 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.574 -0.739 . . . . 1.68 111.594 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -108.43 72.66 0.84 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.321 0.582 . . . . 4.39 110.602 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -163.21 146.16 10.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.762 -0.654 . . . . 3.94 110.194 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.1 t -101.44 69.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.453 0.644 . . . . 4.68 110.314 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.0 m -90.91 138.53 31.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.517 -0.765 . . . . 5.68 110.751 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.99 -40.99 97.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.771 -0.65 . . . . 8.3 109.566 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -78.8 111.03 3.16 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.71 -0.956 . . . . 3.85 110.71 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 84.3 m -106.04 168.2 9.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.624 0.25 . . . . 2.51 111.518 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 125' ' ' ILE . 7.8 mt 49.36 54.54 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.453 -0.794 . . . . 1.44 111.944 171.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.609 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 15.5 ptt180 -131.26 96.8 4.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 3.36 110.176 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.769 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 36.0 mtm -99.58 -165.45 1.23 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.429 0.633 . . . . 1.13 112.241 -170.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.523 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 14.6 t-80 -72.77 148.19 44.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.125 -0.943 . . . . 2.51 109.212 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.549 ' O ' HG12 ' A' ' 150' ' ' VAL . 31.9 p-10 -50.31 -63.29 1.16 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 112.672 0.619 . . . . 1.77 112.672 -172.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -64.53 -21.06 66.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.429 -0.794 . . . . 2.13 111.945 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.1 m-20 -73.27 -39.51 65.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.207 -0.451 . . . . 1.05 110.659 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 10.4 p -80.99 -17.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.005 -0.543 . . . . 0.32 110.79 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.443 HD12 HG13 ' A' ' 150' ' ' VAL . 2.5 mp -86.02 -40.54 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.871 -0.585 . . . . 0.37 110.24 171.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -44.11 -69.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.411 1.005 . . . . 1.38 112.093 165.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.656 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.4 tp -52.07 -42.76 63.42 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.647 -0.706 . . . . 0.74 110.581 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.98 -51.55 61.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.475 -1.238 . . . . 0.22 111.605 -173.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 -18.04 53.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.739 -1.119 . . . . 1.33 111.244 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.417 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 62.2 mt -90.8 -50.35 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.924 -0.399 . . . . 0.23 109.924 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 153' ' ' LEU . 16.1 m -78.13 110.7 14.32 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-O 122.192 0.996 . . . . 0.21 110.226 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.799 ' HG2' HD13 ' A' ' 57' ' ' ILE . 24.4 Cg_endo -88.22 -179.08 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.386 2.724 . . . . 0.34 112.669 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 8.6 m120 -65.17 108.92 2.02 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.27 -1.011 . . . . 1.02 108.27 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.455 ' O ' HD12 ' A' ' 57' ' ' ILE . . . 108.11 37.37 2.16 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.375 -0.917 . . . . 0.28 113.496 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.494 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 26.1 m -90.61 131.69 36.18 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.65 -0.912 . . . . 0.3 110.394 172.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -85.98 136.62 33.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.251 -0.431 . . . . 1.96 109.892 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 98' ' ' PHE . 1.9 p -148.71 137.19 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.716 -0.674 . . . . 0.46 111.515 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.8 m -119.02 141.49 48.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 0.56 112.055 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.43 HG12 HG13 ' A' ' 63' ' ' VAL . 1.2 mt -125.94 116.32 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 C-N-CA 118.539 -1.264 . . . . 0.96 111.715 173.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -145.35 145.18 31.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.255 -1.339 . . . . 1.19 110.799 -170.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.548 ' H ' HG22 ' A' ' 93' ' ' THR . 4.9 ttt180 -93.11 -35.1 13.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.867 -1.06 . . . . 3.42 110.578 -174.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 162.24 108.07 0.22 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.458 -0.877 . . . . 3.65 112.228 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.652 -0.69 . . . . 5.97 110.095 179.223 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.511 ' S21' ' O31' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.661 -0.575 . . . . 2.92 111.661 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.72 160.51 30.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.649 -0.501 . . . . 4.1 109.649 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 4.0 mptp? -66.63 148.51 51.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.735 -0.469 . . . . 2.1 109.735 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.8 mt -97.43 170.04 9.33 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.524 0.515 . . . . 0.26 111.634 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.672 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.3 tp -77.69 150.31 34.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.376 0.67 . . . . 0.23 112.144 -170.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.547 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -114.84 149.39 37.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.093 0.949 . . . . 0.26 111.879 168.285 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.495 ' CE2' ' HA ' ' A' ' 9' ' ' VAL . 70.8 t80 -135.19 151.11 50.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.546 -1.661 . . . . 0.39 107.844 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -128.74 113.85 15.85 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.944 -1.502 . . . . 1.07 106.944 173.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.543 HG11 HD23 ' A' ' 40' ' ' LEU . 1.3 m -71.83 158.04 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 121.141 0.496 . . . . 0.38 111.771 -166.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HE2' ' HA3' ' A' ' 96' ' ' GLY . 79.1 mttt -111.17 145.09 39.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.328 -0.851 . . . . 2.59 109.487 -174.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 7.2 tt0 -54.82 121.45 8.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.067 -0.97 . . . . 1.74 111.82 -173.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.77 -8.21 17.01 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.149 -0.78 . . . . 0.57 111.149 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -40.42 142.37 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.198 1.555 . . . . 2.17 115.198 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 134.72 45.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.013 -0.994 . . . . 0.5 111.342 163.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.8 tp -41.37 -56.34 2.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.195 -0.911 . . . . 0.27 113.457 -174.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.675 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.6 -38.11 88.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.432 1.11 . . . . 1.21 110.322 -171.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -64.41 -42.35 96.13 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 112.953 -1.93 . . . . 1.24 110.263 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -70.26 -41.07 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.045 0.45 . . . . 0.3 111.228 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.5 -59.56 4.98 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.995 -0.548 . . . . 0.23 111.396 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.78 -3.86 57.19 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 118.936 -1.106 . . . . 0.39 112.153 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 5.2 m-20 -61.1 -37.8 84.02 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.987 -1.116 . . . . 1.63 107.987 155.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.79 ' O ' HG23 ' A' ' 24' ' ' ILE . 3.7 m-85 -98.06 27.91 4.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.404 0.52 . . . . 0.24 112.404 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.765 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.2 67.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.902 1.281 . . . . 3.55 113.729 -169.1 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 22' ' ' PHE . 33.0 pt -146.92 -172.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.094 -1.076 . . . . 0.27 108.094 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 m -101.72 145.0 29.72 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.732 -0.667 . . . . 0.81 109.38 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.675 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.3 p -61.4 -35.61 77.99 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.679 -0.692 . . . . 0.27 109.256 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.52 67.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.344 -1.298 . . . . 0.26 111.646 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.25 -39.15 19.62 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.463 -0.569 . . . . 0.23 109.463 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 46' ' ' ILE . 12.9 tp -72.88 -17.53 61.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.228 -0.896 . . . . 0.17 108.738 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.78 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -81.13 -37.89 28.1 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.484 0.659 . . . . 0.19 111.557 172.394 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -58.52 -43.13 89.05 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.306 1.051 . . . . 1.07 109.59 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.91 -20.96 41.0 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.64 -1.618 . . . . 0.17 111.995 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.568 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 14.8 m120 -142.52 72.77 20.68 Favored Pre-proline 0 CA--C 1.514 -0.414 0 CA-C-O 121.237 0.542 . . . . 0.19 109.993 -172.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.652 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.2 Cg_endo -56.62 -13.11 10.01 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 123.649 2.899 . . . . 0.3 114.122 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 t -62.24 -32.37 73.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.047 0.927 . . . . 1.17 109.754 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.2 mt -81.34 -6.65 59.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.345 -1.298 . . . . 0.53 114.402 -171.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.78 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -49.85 -44.45 49.59 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.471 1.129 . . . . 1.23 110.274 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.11 -45.85 15.83 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.937 -1.938 . . . . 0.4 110.551 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.42 -170.33 43.33 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.491 -0.862 . . . . 0.3 113.809 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 18' ' ' ILE . 6.7 mp -111.79 159.58 18.16 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.373 -1.414 . . . . 0.31 109.764 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.653 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 77.1 m -128.43 132.27 48.45 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.859 -0.61 . . . . 0.39 109.887 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.56 129.38 16.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.406 0.622 . . . . 0.47 112.241 174.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.35 -11.81 53.77 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.853 -1.067 . . . . 0.36 112.704 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.1 tt0 -66.08 153.66 41.68 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.537 0.684 . . . . 1.19 110.378 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 49.8 m -115.3 135.42 54.17 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.5 -1.227 . . . . 0.89 109.029 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.677 HD12 HD11 ' A' ' 29' ' ' LEU . 18.6 pt -137.28 151.16 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.358 0.599 . . . . 0.22 110.504 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.444 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 15.4 t -96.89 149.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.07 -0.968 . . . . 0.21 110.028 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.549 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.8 mm -117.64 88.41 29.54 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.024 -0.989 . . . . 0.17 108.529 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.776 ' HA ' HD13 ' A' ' 4' ' ' LEU . 26.3 Cg_endo -59.68 142.8 99.4 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.199 2.599 . . . . 0.23 112.564 -174.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.45 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.57 -6.95 59.64 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.874 -0.603 . . . . 0.3 112.621 -176.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.75 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.18 125.27 28.71 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 108.54 -0.911 . . . . 0.25 108.54 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD23 ' A' ' 51' ' ' LEU . 60.2 Cg_endo -66.38 172.62 8.76 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.715 2.943 . . . . 0.31 114.017 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 4.9 t70 -91.19 136.66 26.95 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.665 -1.152 . . . . 0.72 111.721 -170.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.672 ' HD3' HD12 ' A' ' 5' ' ' LEU . 68.8 Cg_endo -81.97 -6.94 12.28 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.332 2.688 . . . . 0.27 113.381 -174.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -28.06 16.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.015 0.436 . . . . 2.11 110.297 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -84.37 -12.93 53.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.985 -0.746 . . . . 1.47 108.985 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.764 HD13 ' HG2' ' A' ' 158' ' ' PRO . 84.0 mt -86.21 125.95 66.49 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.989 -1.005 . . . . 0.26 109.295 169.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -101.47 95.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.14 0 CA-C-N 119.876 0.991 . . . . 0.2 110.225 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 73' ' ' SER . 82.1 m-85 -158.55 129.45 6.26 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.016 -1.476 . . . . 0.26 107.016 172.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 0.3 OUTLIER -137.84 104.18 5.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.756 -1.572 . . . . 2.84 106.756 -164.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -94.34 108.4 20.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.584 -0.734 . . . . 0.32 110.331 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.6 97.35 6.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.14 -0.936 . . . . 0.34 110.67 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 164' ' ' THR . 0.6 OUTLIER -112.22 98.38 6.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.964 -1.471 . . . . 0.68 109.304 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.8 m -94.43 123.16 37.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.734 -1.121 . . . . 1.05 108.843 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.619 ' HB ' ' CB ' ' A' ' 167' ' ' ARG . 1.2 mt -59.75 -31.87 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.064 -0.517 . . . . 1.29 111.802 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.91 -40.54 97.3 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.715 -0.755 . . . . 0.88 111.301 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.35 -23.96 59.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.941 -0.63 . . . . 0.74 112.342 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.59 ' HA ' HG21 ' A' ' 86' ' ' VAL . 37.9 mttt 55.7 19.47 3.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.157 0.983 . . . . 2.51 112.776 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.27 140.85 35.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.716 0.77 . . . . 0.45 111.308 177.349 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.444 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.5 tt -94.31 119.27 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.157 -1.383 . . . . 0.33 109.367 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -101.97 124.8 48.2 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.443 -0.503 . . . . 0.4 111.093 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.558 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.62 139.52 33.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.237 -1.764 . . . . 0.33 106.237 176.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 19.4 m -143.05 128.91 19.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 120.508 1.503 . . . . 0.75 112.672 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.89 125.4 50.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.906 -1.043 . . . . 0.35 110.457 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 61.84 40.68 12.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.029 0.443 . . . . 0.52 109.867 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 81.68 -7.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.798 -1.092 . . . . 1.84 112.21 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -128.52 139.22 52.42 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 118.282 -1.367 . . . . 3.19 114.025 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.71 149.85 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 112.873 -1.967 . . . . 0.41 112.891 -174.564 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.558 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.0 mtp -100.16 -44.06 6.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.5 -2.137 . . . . 0.35 108.43 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 179.7 159.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.54 -2.118 . . . . 2.07 110.156 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.479 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.4 m -121.06 137.6 54.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.526 0.203 . . . . 0.37 111.309 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -127.82 135.94 28.24 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.905 0.383 . . . . 0.97 111.374 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.22 143.86 90.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.935 2.424 . . . . 0.6 112.181 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.7 -175.58 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 0.64 110.028 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.46 141.74 28.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.71 -0.478 . . . . 0.83 109.71 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.61 HG13 HG23 ' A' ' 65' ' ' ILE . 1.1 t -130.6 137.66 55.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.713 -0.676 . . . . 1.67 110.582 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' HA2' HG13 ' A' ' 138' ' ' VAL . . . -74.3 83.19 0.76 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.588 -0.733 . . . . 3.08 113.253 -175.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -67.5 -34.2 76.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.189 0.519 . . . . 7.26 109.663 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -85.36 -27.17 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.571 -0.74 . . . . 6.29 110.247 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.9 mt -75.58 94.32 3.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.789 -0.641 . . . . 7.27 110.443 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -81.68 61.76 5.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.536 0.684 . . . . 5.18 109.926 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -165.77 139.4 4.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.227 -0.897 . . . . 4.81 109.883 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.674 HG22 ' H ' ' A' ' 167' ' ' ARG . 11.0 p -85.62 110.01 26.45 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.008 -0.738 . . . . 2.11 109.008 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -47.89 100.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.865 2.377 . . . . 3.21 112.19 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.2 m -72.65 127.63 33.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.933 -0.576 . . . . 3.59 111.407 -173.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.475 ' HA3' ' HE2' ' A' ' 10' ' ' LYS . . . 93.6 133.81 6.86 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.834 -0.621 . . . . 2.1 112.406 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.39 169.5 18.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.339 0.59 . . . . 2.3 111.393 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.544 ' HB2' HG13 ' A' ' 163' ' ' VAL . 29.1 m-85 -123.79 175.5 6.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.186 -0.916 . . . . 1.93 108.643 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 161' ' ' THR . 80.7 m-85 -134.14 138.07 44.96 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.931 0.396 . . . . 0.58 110.738 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 125' ' ' ILE . 26.5 mm -59.55 124.77 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 107.428 -1.323 . . . . 0.41 107.428 166.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.765 HD11 ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -118.09 -22.09 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.893 -0.723 . . . . 0.37 112.174 -176.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.455 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 65.9 t30 -167.81 177.11 5.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 123.081 1.42 . . . . 1.99 114.122 -175.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.566 ' NH1' ' HA ' ' A' ' 155' ' ' SER . 4.3 ptt180 -152.19 123.93 7.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 110.824 -2.898 . . . . 1.19 108.684 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -106.07 161.25 14.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.382 1.087 . . . . 1.67 111.666 -168.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -52.56 155.08 2.31 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 112.626 -2.079 . . . . 3.06 112.662 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -44.0 110.3 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 113.119 -1.855 . . . . 2.61 111.02 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -54.56 -47.88 24.39 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.386 2.724 . . . . 0.98 111.668 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.71 -21.34 38.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.641 -1.163 . . . . 1.08 112.74 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -112.81 -170.27 17.86 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.999 -0.619 . . . . 1.05 112.199 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.9 34.24 0.1 Allowed 'Trans proline' 0 N--CA 1.478 0.578 0 C-N-CA 124.473 3.449 . . . . 1.3 113.888 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 109' ' ' GLY . 50.1 t80 -83.15 -18.03 40.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.08 0.467 . . . . 1.38 110.244 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.62 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.18 57.44 0.96 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.768 -0.73 . . . . 1.11 114.856 170.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.27 -45.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.262 1.208 . . . . 0.81 114.262 165.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.68 162.87 34.37 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.903 -0.406 . . . . 1.12 109.903 -176.106 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 1.8 t90 -127.27 99.63 5.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 2.19 108.433 172.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.653 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.3 mp -108.99 139.05 44.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.777 0.799 . . . . 0.61 110.89 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.514 ' HB2' HG23 ' A' ' 101' ' ' ILE . 72.1 m -107.7 148.62 29.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.822 -1.081 . . . . 0.94 113.115 -169.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.522 HD22 HG11 ' A' ' 163' ' ' VAL . 67.9 mt -104.86 -174.35 2.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.533 -1.212 . . . . 1.08 108.441 173.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.0 m -72.34 -69.39 0.4 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.555 0.576 . . . . 1.5 112.555 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -124.36 149.77 46.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.869 0.322 . . . . 2.97 111.869 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' A' ' 122' ' ' HIS . 1.5 tp-100 77.15 173.85 0.21 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 114.98 -1.009 . . . . 5.06 111.068 173.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.418 ' H ' ' HG3' ' A' ' 121' ' ' GLN . 23.4 m-70 -82.09 42.29 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 5.95 111.653 -173.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -110.63 128.66 55.78 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.861 -0.792 . . . . 4.83 108.861 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.458 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -147.64 152.22 24.36 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.616 -0.802 . . . . 0.95 111.609 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 100' ' ' ILE . 25.5 mt -92.97 116.07 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.271 -0.64 . . . . 0.48 109.271 175.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.529 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 8.1 p80 -155.21 -161.46 1.19 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.337 0.589 . . . . 1.25 110.578 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.62 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -119.31 177.1 16.31 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 119.612 -1.28 . . . . 0.46 112.877 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 144' ' ' ARG . 5.9 t -137.07 172.84 12.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.135 0.493 . . . . 0.5 110.254 -170.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -102.68 -19.66 14.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 1.86 109.0 165.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -125.39 104.41 28.46 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.339 -0.846 . . . . 1.77 110.124 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.49 4.98 4.41 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.259 2.639 . . . . 0.59 112.887 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.28 -22.8 28.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.039 0.447 . . . . 0.78 110.651 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.2 p -85.32 -16.94 38.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.538 0.685 . . . . 1.45 110.047 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 134' ' ' ILE . 11.9 mm -64.97 117.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.168 -0.923 . . . . 0.7 110.672 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.68 -5.11 47.16 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.724 -0.671 . . . . 1.68 111.944 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -132.74 -49.41 0.89 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.765 0.317 . . . . 4.39 111.647 -175.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.21 140.89 48.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.293 -0.412 . . . . 3.94 111.334 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 86' ' ' VAL . 47.4 t -117.2 -58.61 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 4.68 111.135 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.7 p -70.33 -43.99 69.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.287 -0.415 . . . . 5.68 110.591 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.81 -31.82 22.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.43 0.633 . . . . 8.3 109.807 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.6 129.61 19.58 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.256 -0.884 . . . . 3.85 113.22 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 64.6 m -122.65 -176.67 3.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.318 -0.623 . . . . 2.51 109.318 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 27.7 mt -81.02 73.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.482 0.658 . . . . 1.44 109.906 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 95.9 mtt180 -116.22 154.05 30.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.515 -0.766 . . . . 3.36 110.432 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.44 ' H ' ' HA2' ' A' ' 127' ' ' GLY . 35.8 mtp -136.96 -173.34 3.42 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.926 -0.579 . . . . 1.13 109.783 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.558 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 4.0 t-80 -78.57 154.71 30.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.265 -1.013 . . . . 2.51 108.265 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.557 ' O ' HG12 ' A' ' 150' ' ' VAL . 22.7 p-10 -48.87 -67.39 0.27 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.428 0.529 . . . . 1.77 112.428 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 149' ' ' ASP . 3.8 ptpp? -59.7 -28.2 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.72 -0.612 . . . . 2.13 111.582 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.558 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 6.7 m-20 -72.44 -40.15 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 1.05 110.714 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.4 p -74.83 -18.52 16.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.524 -0.307 . . . . 0.32 110.246 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.49 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.8 mp -86.82 -39.84 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.947 -0.549 . . . . 0.37 110.435 174.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -44.39 -69.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.688 1.131 . . . . 1.38 112.834 162.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.675 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -50.52 -42.35 54.89 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.74 110.242 179.088 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.74 -53.82 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.348 -1.296 . . . . 0.22 112.038 -172.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.566 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 12.1 p -76.55 -13.57 60.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.407 -1.269 . . . . 1.33 111.093 -172.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.65 -49.16 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.15 -0.477 . . . . 0.23 110.053 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.1 m -77.55 117.14 63.61 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-O 122.059 0.933 . . . . 0.21 110.81 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.764 ' HG2' HD13 ' A' ' 57' ' ' ILE . 42.2 Cg_endo -83.05 -178.52 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.876 2.384 . . . . 0.34 112.785 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.75 ' O ' HD21 ' A' ' 51' ' ' LEU . 16.9 m120 -58.32 -2.63 0.2 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.509 -1.223 . . . . 1.02 113.53 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.01 55.91 0.56 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.813 -0.708 . . . . 0.28 112.568 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.546 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 4.9 m -93.91 136.59 34.04 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.565 -0.374 . . . . 0.3 110.305 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.79 142.2 29.12 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.462 -0.495 . . . . 1.96 110.291 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.2 p -143.66 123.75 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 0.46 110.846 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.466 ' O ' HG13 ' A' ' 63' ' ' VAL . 23.3 m -112.7 139.63 48.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.56 112.007 -176.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -125.65 114.17 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 118.542 -1.263 . . . . 0.96 111.194 171.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -144.0 127.41 16.85 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.886 -1.506 . . . . 1.19 109.848 -175.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.674 ' H ' HG22 ' A' ' 93' ' ' THR . 5.4 ptt180 -92.91 -29.78 15.73 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.694 -0.685 . . . . 3.42 111.556 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -128.33 86.84 0.32 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.679 -0.772 . . . . 3.65 112.007 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.337 -0.84 . . . . 5.97 109.31 179.033 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.48 ' S21' ' O32' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.693 -0.563 . . . . 2.92 111.693 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -77.62 165.76 23.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.988 -0.375 . . . . 4.1 109.988 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.1 mptt -65.38 150.95 47.43 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.01 -0.737 . . . . 2.1 109.01 173.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.765 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.5 mt -92.38 167.87 11.69 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.269 0.356 . . . . 0.26 111.163 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.58 ' HB2' HD22 ' A' ' 51' ' ' LEU . 4.0 tp -75.89 149.05 37.84 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 122.929 0.492 . . . . 0.23 111.851 -169.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.04 150.04 34.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.969 0.89 . . . . 0.26 111.365 167.56 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' SER . 57.5 t80 -134.64 150.36 50.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.727 -1.579 . . . . 0.39 108.0 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.41 120.93 27.9 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.001 -1.481 . . . . 1.07 107.001 175.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -82.51 158.79 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 112.579 0.585 . . . . 0.38 112.579 -169.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -103.37 150.82 23.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.409 -0.814 . . . . 2.59 109.261 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -52.61 109.44 0.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.336 0.589 . . . . 1.74 112.005 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.23 -9.68 15.26 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.338 -0.846 . . . . 0.57 112.766 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.652 ' HB3' HD11 ' A' ' 18' ' ' ILE . 67.1 m-20 -61.43 152.55 29.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.844 0.322 . . . . 2.17 110.814 176.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.56 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -133.49 155.99 48.57 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.253 0.464 . . . . 0.5 112.253 -177.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.595 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -50.3 -58.33 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.545 0.943 . . . . 0.27 113.545 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.668 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.9 t-20 -66.08 -41.81 90.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.27 1.033 . . . . 1.21 110.687 -169.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 26.3 m -55.89 -52.29 64.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 112.958 -1.928 . . . . 1.24 109.754 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -66.48 -40.01 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.373 -0.831 . . . . 0.3 111.942 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.683 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.98 -66.06 0.51 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.087 -0.506 . . . . 0.23 112.108 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.35 -4.87 56.99 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 118.996 -1.081 . . . . 0.39 112.133 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.1 m-20 -66.21 -31.52 72.4 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.99 -0.745 . . . . 1.63 108.99 156.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD1' HD12 ' A' ' 101' ' ' ILE . 1.6 m-85 -96.48 15.21 22.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.033 -0.417 . . . . 0.24 112.068 173.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.57 51.48 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.607 -0.724 . . . . 3.55 110.609 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.4 pt -149.4 -172.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.721 -0.844 . . . . 0.27 108.721 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.96 147.49 24.94 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.678 -0.692 . . . . 0.81 109.909 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.668 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.7 p -61.5 -36.41 80.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.539 -0.911 . . . . 0.27 108.539 175.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.29 -28.64 69.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.478 -1.237 . . . . 0.26 111.664 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.72 -38.7 25.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.513 -0.551 . . . . 0.23 109.513 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 46' ' ' ILE . 14.0 tp -73.3 -19.44 61.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.412 -0.813 . . . . 0.17 109.081 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.702 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -39.69 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.657 0.742 . . . . 0.19 111.549 172.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.12 -40.6 96.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 114.994 -1.003 . . . . 1.07 110.03 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.24 -19.25 43.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.998 -1.455 . . . . 0.17 111.819 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 33.0 m-80 -142.13 71.57 22.89 Favored Pre-proline 0 CA--C 1.515 -0.374 0 CA-C-O 121.025 0.441 . . . . 0.19 109.903 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.712 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.23 -12.54 10.42 Favored 'Trans proline' 0 C--O 1.22 -0.4 0 C-N-CA 123.301 2.667 . . . . 0.3 113.946 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -61.69 -32.31 72.5 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.061 0.934 . . . . 1.17 110.035 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.1 mt -81.1 -6.36 58.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.206 -1.361 . . . . 0.53 114.551 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.712 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -51.69 -40.66 60.51 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.77 1.272 . . . . 1.23 109.503 177.766 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.97 -46.69 14.72 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 112.763 -2.017 . . . . 0.4 111.562 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.54 -162.69 33.76 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.271 -0.966 . . . . 0.3 114.364 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.1 mp -116.88 158.21 24.37 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.188 -1.506 . . . . 0.31 109.881 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 89.2 m -137.31 135.47 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 0.39 110.792 -177.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.646 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.48 126.66 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.404 0.89 . . . . 0.47 113.404 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.591 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.4 -12.48 45.47 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 114.613 -1.176 . . . . 0.36 112.083 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.597 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 4.1 tt0 -63.47 151.81 40.16 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.817 0.817 . . . . 1.19 110.263 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.9 m -117.41 135.51 53.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.133 -1.394 . . . . 0.89 109.096 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 29' ' ' LEU . 16.8 pt -136.71 146.42 28.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.296 0.57 . . . . 0.22 110.533 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.519 ' H ' HD21 ' A' ' 33' ' ' ASN . 7.2 t -91.61 149.1 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.051 -0.977 . . . . 0.21 110.409 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.579 HG13 HD23 ' A' ' 5' ' ' LEU . 19.2 mm -118.07 87.54 29.03 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-N 114.959 -1.019 . . . . 0.17 108.701 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.765 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.8 Cg_endo -59.08 139.78 92.16 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.209 2.606 . . . . 0.23 112.709 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.518 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.18 -7.59 70.91 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.3 112.93 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.75 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.81 128.78 25.78 Favored Pre-proline 0 C--O 1.218 -0.566 0 N-CA-C 108.566 -0.902 . . . . 0.25 108.566 177.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.697 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.4 Cg_endo -68.92 171.72 13.04 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.75 2.967 . . . . 0.31 114.167 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.745 ' HB3' HG22 ' A' ' 56' ' ' THR . 9.1 t70 -90.08 141.76 28.17 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.72 110.232 -172.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD3' HD12 ' A' ' 5' ' ' LEU . 62.9 Cg_endo -85.27 -7.13 9.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.323 2.682 . . . . 0.27 111.992 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -95.67 -24.52 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.11 110.239 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.745 HG22 ' HB3' ' A' ' 53' ' ' ASP . 13.1 t -87.25 -15.41 38.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.678 -0.86 . . . . 1.47 108.678 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.747 HD13 ' HG2' ' A' ' 158' ' ' PRO . 61.7 mt -87.21 126.2 63.44 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 114.503 -1.226 . . . . 0.26 108.964 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -101.16 93.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.175 0 CA-C-N 120.52 1.221 . . . . 0.2 110.106 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.414 ' HD2' HG23 ' A' ' 57' ' ' ILE . 78.0 m-85 -159.03 131.52 6.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.238 -1.764 . . . . 0.26 106.238 173.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 23.3 m-70 -140.33 107.8 5.57 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.095 -1.446 . . . . 2.84 107.095 -164.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.5 mt -94.61 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.054 -0.975 . . . . 0.32 110.398 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.39 94.59 5.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.0 0.905 . . . . 0.34 110.337 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -115.6 100.02 9.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.039 -1.437 . . . . 0.68 110.291 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.523 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 38.6 t -90.32 121.58 32.44 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.239 -1.393 . . . . 1.05 107.239 173.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.587 ' HB ' ' CB ' ' A' ' 167' ' ' ARG . 33.3 mm -62.26 -26.88 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.957 0.884 . . . . 1.29 108.936 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.89 -46.0 84.72 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.297 -0.954 . . . . 0.88 111.377 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -67.27 -23.99 65.74 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.606 0.595 . . . . 0.74 112.606 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.787 ' HA ' HG21 ' A' ' 86' ' ' VAL . 40.7 mttt 61.54 13.17 4.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.885 0.874 . . . . 2.51 112.544 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.506 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -141.13 137.35 32.7 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.1 0.953 . . . . 0.45 112.118 177.339 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.5 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.3 tt -93.96 118.93 32.16 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.346 -1.752 . . . . 0.33 109.121 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 m -102.6 125.08 49.2 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.055 -0.658 . . . . 0.4 111.233 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.595 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -84.6 129.75 34.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.509 -1.663 . . . . 0.33 106.509 177.18 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 15.6 m -135.58 126.45 27.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 120.905 1.684 . . . . 0.75 112.81 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.0 tp -113.03 126.5 55.56 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.774 -1.103 . . . . 0.35 109.876 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 63.05 40.05 9.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.088 -0.708 . . . . 0.52 109.088 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 83.35 -21.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.725 1.21 . . . . 1.84 111.949 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -121.92 139.06 54.12 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 117.295 -1.762 . . . . 3.19 114.779 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.92 149.53 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 112.546 -2.115 . . . . 0.41 113.882 -167.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.5 mtp -100.74 -42.97 6.28 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 112.076 -2.329 . . . . 0.35 108.18 175.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 2.6 tppt? -178.37 164.69 1.74 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 112.464 -2.153 . . . . 2.07 109.931 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.506 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 12.1 m -126.24 134.39 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.514 0.197 . . . . 0.37 110.798 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 19.5 m-85 -123.31 145.87 47.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 109.534 -0.543 . . . . 0.97 109.534 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 27.3 Cg_endo -83.86 148.31 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.44 2.093 . . . . 0.6 112.037 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.69 179.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.296 -0.411 . . . . 0.64 110.192 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.2 139.87 31.33 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.86 0.362 . . . . 0.83 110.251 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' A' ' 68' ' ' LYS . 2.1 t -135.69 149.45 28.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.948 -0.569 . . . . 1.67 112.506 -169.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.16 -91.46 1.25 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.933 -0.576 . . . . 3.08 113.099 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.55 ' HG3' ' H ' ' A' ' 89' ' ' ILE . 17.7 tptm -158.47 179.85 8.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.07 0.435 . . . . 7.26 110.428 -173.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.55 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 31.3 pt -131.88 132.67 61.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.132 0.419 . . . . 6.29 112.132 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.562 ' N ' ' HA ' ' A' ' 169' ' ' SER . 21.5 mt -156.66 -82.53 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.554 0.742 . . . . 7.27 110.593 173.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -173.86 77.65 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.753 0.649 . . . . 5.18 112.753 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.701 ' HB2' ' O ' ' A' ' 169' ' ' SER . 19.9 mm-40 -150.34 -81.63 0.11 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.761 0.652 . . . . 4.81 112.761 176.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.685 HG22 ' N ' ' A' ' 167' ' ' ARG . 60.6 p 61.81 127.55 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 124.446 1.098 . . . . 2.11 112.159 -174.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.77 152.82 37.71 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.264 1.976 . . . . 3.21 112.075 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.4 m -98.46 134.78 40.96 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.57 -0.529 . . . . 3.59 109.57 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.66 91.4 0.19 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.107 -1.044 . . . . 2.1 111.723 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -77.63 148.99 34.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.869 -0.419 . . . . 2.3 109.869 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.599 ' HB2' HG13 ' A' ' 163' ' ' VAL . 21.4 m-85 -113.33 174.31 5.97 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.189 -0.46 . . . . 1.93 109.857 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.7 m-85 -140.03 141.7 36.27 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.061 -0.348 . . . . 0.58 110.061 174.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.721 HD11 HD12 ' A' ' 125' ' ' ILE . 23.9 mm -60.16 121.17 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.9 -1.148 . . . . 0.41 107.9 167.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.652 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.8 tt -122.92 -25.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.094 -0.642 . . . . 0.37 112.161 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 9.1 t-20 -150.69 154.22 37.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.478 1.288 . . . . 1.99 114.478 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.56 119.85 11.55 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 111.487 -2.597 . . . . 1.19 108.904 172.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 105' ' ' ARG . 1.3 tt0 -97.59 159.87 14.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.386 1.088 . . . . 1.67 112.042 -168.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 18.3 ttm180 -50.69 149.73 3.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 112.352 -2.204 . . . . 3.06 111.646 168.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 19.3 m-80 -48.21 106.32 0.59 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 114.976 -1.011 . . . . 2.61 112.233 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.7 -49.9 13.32 Favored 'Trans proline' 0 CA--C 1.519 -0.261 0 C-N-CA 123.723 2.949 . . . . 0.98 112.43 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 16.75 49.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.237 -0.892 . . . . 1.08 112.394 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -138.67 -168.95 11.43 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.085 -0.579 . . . . 1.05 112.15 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.96 16.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.938 3.092 . . . . 1.3 113.115 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -70.57 -21.38 62.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.079 -0.509 . . . . 1.38 110.503 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.32 37.01 4.19 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.584 -0.735 . . . . 1.11 113.874 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.36 -19.0 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.762 0.653 . . . . 0.81 112.762 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.498 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -159.21 152.47 22.41 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 122.86 0.464 . . . . 1.12 110.02 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.401 ' CE3' ' HE1' ' A' ' 111' ' ' PHE . 33.7 t-105 -120.24 105.48 10.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.19 109.634 170.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.3 mp -107.84 138.52 43.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.6 0.714 . . . . 0.61 111.101 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.9 m -106.76 146.25 31.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.326 -0.852 . . . . 0.94 112.347 -171.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.88 -173.49 3.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.85 -0.796 . . . . 1.08 108.85 169.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.496 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.9 t -60.88 -80.08 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.42 0.526 . . . . 1.5 112.42 -172.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 21.8 pttm -125.39 160.44 29.4 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.191 -0.318 . . . . 2.97 111.086 -177.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 6.6 tp-100 75.28 156.56 0.18 Allowed 'General case' 0 N--CA 1.461 0.09 0 O-C-N 124.296 0.997 . . . . 5.06 109.179 -175.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.544 ' ND1' ' N26' ' A' 1142 ' ' IM2 . 84.2 m-70 -74.52 58.67 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.2 0.524 . . . . 5.95 111.49 -175.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -116.55 139.48 50.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.296 -0.865 . . . . 4.83 108.709 172.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.66 161.06 30.01 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.118 -1.039 . . . . 0.95 112.368 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.721 HD12 HD11 ' A' ' 100' ' ' ILE . 40.3 mt -93.26 107.35 19.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.213 -1.032 . . . . 0.48 108.213 173.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.468 ' O ' ' HG2' ' A' ' 145' ' ' MET . 12.6 p80 -138.95 -166.96 2.12 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.306 -0.957 . . . . 1.25 111.954 -176.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.468 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.72 161.54 14.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.356 -1.293 . . . . 0.46 112.988 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.7 t -127.25 178.22 6.18 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.951 -0.625 . . . . 0.5 110.569 -170.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -105.21 -16.64 14.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.318 -0.856 . . . . 1.86 109.662 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -126.92 100.69 27.23 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.842 -0.617 . . . . 1.77 110.152 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -91.6 4.31 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.197 2.598 . . . . 0.59 113.267 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.97 27.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.253 0.549 . . . . 0.78 110.251 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.483 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 28.1 t -82.19 -26.98 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.736 . . . . 1.45 109.732 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 144' ' ' ARG . 6.6 mm -60.35 107.94 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.18 -0.918 . . . . 0.7 111.552 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.65 32.75 85.24 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 114.9 -1.045 . . . . 1.68 112.771 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -153.19 -36.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.16 0.43 . . . . 4.39 112.16 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 133' ' ' SER . . . -142.56 160.81 39.57 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.242 -0.286 . . . . 3.94 111.52 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.9 t 72.57 -60.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 123.859 0.724 . . . . 4.68 111.2 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.1 m 66.01 170.43 0.23 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.882 0.473 . . . . 5.68 111.663 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 53.63 77.99 0.16 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.799 -0.637 . . . . 8.3 111.414 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.37 -152.97 6.35 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 3.85 112.109 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 56.7 m -111.34 177.09 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.393 0.616 . . . . 2.51 111.161 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.566 HG21 HG12 ' A' ' 125' ' ' ILE . 65.8 mt -86.04 94.49 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.386 -0.825 . . . . 1.44 111.428 -170.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.53 ' HB2' HD11 ' A' ' 134' ' ' ILE . 35.4 mtm180 -119.04 151.64 37.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.404 -0.816 . . . . 3.36 109.339 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.54 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 15.4 ptm -152.42 -167.18 2.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.506 0.193 . . . . 1.13 111.094 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -77.06 145.5 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.505 -0.316 . . . . 2.51 110.493 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.653 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.4 m-20 -49.89 -67.15 0.28 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.336 0.398 . . . . 1.77 111.898 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -26.32 65.45 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.572 -0.705 . . . . 2.13 111.853 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.44 -36.72 63.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.745 -0.207 . . . . 1.05 110.812 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.4 p -75.44 -18.65 15.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 116.61 -0.268 . . . . 0.32 110.377 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.568 HD12 HG13 ' A' ' 150' ' ' VAL . 3.2 mp -88.83 -41.44 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 119.27 -0.395 . . . . 0.37 110.243 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -41.03 -69.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 119.019 0.827 . . . . 1.38 112.191 162.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.703 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.1 tp -50.55 -43.11 56.04 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.859 -0.61 . . . . 0.74 110.334 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.02 -52.52 60.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.703 -1.135 . . . . 0.22 112.366 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.5 t -78.47 -14.67 59.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.668 -1.151 . . . . 1.33 110.961 -172.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.01 -48.78 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.028 0.442 . . . . 0.23 109.815 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.2 m -76.91 119.51 77.77 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-O 121.714 0.769 . . . . 0.21 109.819 178.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.747 ' HG2' HD13 ' A' ' 57' ' ' ILE . 46.3 Cg_endo -82.3 -178.89 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.664 2.243 . . . . 0.34 112.257 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.75 ' O ' HD21 ' A' ' 51' ' ' LEU . 9.6 m120 -59.67 -0.66 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.682 -1.144 . . . . 1.02 113.52 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.95 56.2 0.54 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.02 -0.61 . . . . 0.28 112.237 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.492 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 3.1 m -94.01 133.99 36.88 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.524 -0.398 . . . . 0.3 110.075 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -86.64 142.49 28.21 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.186 -0.605 . . . . 1.96 110.849 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.599 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.1 p -147.31 127.42 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.025 -0.989 . . . . 0.46 110.917 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.4 m -113.3 142.13 46.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.516 -0.766 . . . . 0.56 111.38 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.583 HG23 HG12 ' A' ' 65' ' ' ILE . 2.0 mp -125.34 119.34 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 118.791 -1.164 . . . . 0.96 111.148 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.79 120.56 11.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.952 -1.476 . . . . 1.19 107.768 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.685 ' N ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -96.55 -50.94 4.53 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 114.165 1.172 . . . . 3.42 114.165 -169.676 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.601 ' N ' ' HG2' ' A' ' 167' ' ' ARG . . . 125.42 -61.74 0.61 Allowed Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 109.993 -1.243 . . . . 3.65 109.993 -170.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.701 ' O ' ' HB2' ' A' ' 92' ' ' GLN . 12.9 t . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.343 -0.837 . . . . 5.97 112.643 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.544 ' N26' ' ND1' ' A' ' 122' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.763 -0.535 . . . . 2.92 111.763 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -107.66 170.47 7.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.947 -0.39 . . . . 4.1 109.947 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -71.39 148.66 46.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.538 -0.542 . . . . 2.1 109.538 176.407 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.4 mt -99.35 172.92 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.21 -0.45 . . . . 0.26 111.338 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.605 HD12 ' HD3' ' A' ' 54' ' ' PRO . 4.5 tp -77.67 152.33 33.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.201 0.6 . . . . 0.23 111.748 -170.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.17 150.13 36.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.115 0.959 . . . . 0.26 111.847 166.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' SER . 87.1 t80 -133.6 142.77 48.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.611 -1.631 . . . . 0.39 107.719 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -125.79 113.53 17.4 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.862 -1.533 . . . . 1.07 106.862 178.631 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -76.81 158.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 113.193 0.812 . . . . 0.38 113.193 -164.499 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' HD2' ' HD3' ' A' ' 120' ' ' LYS . 9.9 mtpm? -95.44 148.11 22.81 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.105 -0.952 . . . . 2.59 109.599 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.831 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 6.4 tt0 -52.19 109.38 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 1.74 111.554 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.9 -9.44 23.31 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.692 -0.766 . . . . 0.57 112.957 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.582 ' HB3' HD11 ' A' ' 18' ' ' ILE . 71.4 m-20 -59.75 154.44 18.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.294 0.547 . . . . 2.17 111.757 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.4 p -133.04 152.91 51.92 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.439 0.533 . . . . 0.5 112.439 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.99 -59.04 3.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.776 1.028 . . . . 0.27 113.776 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.66 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 16.5 t-20 -64.84 -41.2 95.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.615 1.198 . . . . 1.21 110.578 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 43.9 t -59.22 -48.51 81.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.353 -2.203 . . . . 1.24 109.991 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.582 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -68.01 -40.71 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.064 -0.516 . . . . 0.3 111.936 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.671 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.57 -63.9 1.05 Allowed 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.18 -0.464 . . . . 0.23 111.559 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.56 -4.64 54.78 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.877 -1.129 . . . . 0.39 112.181 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -68.29 -30.25 69.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.947 -0.76 . . . . 1.63 108.947 157.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.658 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.4 m-85 -96.44 15.61 20.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.996 0.369 . . . . 0.24 111.996 172.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 55.43 49.62 16.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.661 -0.699 . . . . 3.55 110.579 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.671 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.4 pt -148.2 -173.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.858 -0.793 . . . . 0.27 108.858 -173.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -100.6 146.19 27.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.167 -0.924 . . . . 0.81 109.737 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.66 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.3 p -61.37 -37.14 82.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.983 -0.747 . . . . 0.27 108.983 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -28.91 70.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.389 -1.278 . . . . 0.26 111.543 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.22 -38.06 27.59 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.492 -0.559 . . . . 0.23 109.492 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 46' ' ' ILE . 14.3 tp -74.32 -17.84 60.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.317 -0.856 . . . . 0.17 109.201 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.742 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.94 -39.1 26.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.681 0.753 . . . . 0.19 111.825 173.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -60.57 -40.95 93.56 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.947 -1.024 . . . . 1.07 109.764 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.35 -21.14 39.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.633 -1.622 . . . . 0.17 111.985 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 13.6 m120 -142.36 72.87 21.37 Favored Pre-proline 0 CA--C 1.513 -0.46 0 CA-C-O 121.163 0.506 . . . . 0.19 109.89 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.668 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 19.1 Cg_endo -58.36 -9.04 5.99 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.592 2.861 . . . . 0.3 114.157 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -63.34 -34.89 78.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.949 0.881 . . . . 1.17 109.478 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.21 -6.72 57.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.205 -1.361 . . . . 0.53 114.521 -170.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.742 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -49.13 -40.73 33.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.575 1.179 . . . . 1.23 110.181 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.06 -46.85 10.78 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 112.747 -2.024 . . . . 0.4 111.624 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.64 -164.08 34.81 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.43 -0.89 . . . . 0.3 114.172 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.459 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.6 mp -118.4 157.74 26.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.474 -1.363 . . . . 0.31 110.624 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.657 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 81.5 m -135.09 135.48 41.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.694 -0.684 . . . . 0.39 110.912 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.37 128.9 12.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.576 0.954 . . . . 0.47 113.576 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.49 -11.62 37.83 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.386 -1.279 . . . . 0.36 112.26 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.657 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.9 tt0 -63.74 152.22 39.87 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.555 0.693 . . . . 1.19 110.237 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 30.8 m -119.5 133.37 55.71 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.41 -1.268 . . . . 0.89 109.436 -171.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.718 HD12 HD11 ' A' ' 29' ' ' LEU . 19.5 pt -135.37 155.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.157 0.504 . . . . 0.22 110.397 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.476 ' H ' HD22 ' A' ' 33' ' ' ASN . 14.8 t -99.68 149.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.283 -0.871 . . . . 0.21 110.398 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.552 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.5 mm -117.57 88.72 30.26 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.118 -0.946 . . . . 0.17 108.516 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.778 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.1 Cg_endo -59.67 139.49 89.07 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.188 2.592 . . . . 0.23 112.876 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.495 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.38 -7.29 68.76 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.172 -0.922 . . . . 0.3 112.812 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.08 124.98 29.46 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.902 -0.777 . . . . 0.25 108.902 177.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.611 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.9 Cg_endo -66.23 174.19 6.39 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.729 2.953 . . . . 0.31 114.028 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 2.5 t70 -90.82 138.33 26.4 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.72 111.699 -171.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HD3' HD12 ' A' ' 5' ' ' LEU . 92.7 Cg_endo -81.17 -5.84 12.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.219 2.613 . . . . 0.27 113.429 -174.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -95.15 -28.51 15.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.65 0.262 . . . . 2.11 111.038 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t -78.99 -24.42 43.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.667 -0.864 . . . . 1.47 108.667 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.751 HD13 ' HG2' ' A' ' 158' ' ' PRO . 77.5 mt -74.24 123.59 89.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 114.859 -1.064 . . . . 0.26 109.711 170.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -101.06 94.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 119.839 0.978 . . . . 0.2 110.148 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HD2' HG23 ' A' ' 57' ' ' ILE . 84.1 m-85 -159.1 139.45 12.25 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.546 -1.65 . . . . 0.26 106.546 172.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.523 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 35.1 t60 -147.43 118.73 7.82 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.878 -1.156 . . . . 2.84 107.878 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 67.8 mt -106.51 113.02 42.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.032 -0.985 . . . . 0.32 111.087 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.89 106.87 16.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.107 -0.951 . . . . 0.34 110.106 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -113.37 119.85 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 114.59 -1.186 . . . . 0.68 110.017 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.619 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 16.5 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.015 -1.074 . . . . 1.05 109.937 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.697 HG23 ' HB ' ' A' ' 86' ' ' VAL . 17.2 mt -61.43 -28.78 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.808 0.813 . . . . 1.29 109.798 172.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.32 -47.25 59.26 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.658 -1.156 . . . . 0.88 111.615 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -74.94 -26.11 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.237 0.828 . . . . 0.74 113.237 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.573 ' HA ' HG11 ' A' ' 86' ' ' VAL . 59.0 tttt 49.35 29.27 2.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.112 0.958 . . . . 2.51 112.179 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.514 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -143.98 139.61 29.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.381 -0.827 . . . . 0.45 110.989 170.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 tt -97.03 120.06 36.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.907 -1.497 . . . . 0.33 109.495 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -100.45 123.18 44.34 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.003 -0.679 . . . . 0.4 110.711 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.573 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.73 143.57 30.8 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.449 -1.685 . . . . 0.33 106.449 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 31.2 p -149.72 127.47 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 120.499 1.499 . . . . 0.75 113.147 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 tp -112.19 125.91 54.64 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.151 -1.386 . . . . 0.35 110.076 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 8.9 t-20 68.87 31.02 4.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.513 -0.921 . . . . 0.52 108.513 172.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 17.3 m120 79.14 2.1 2.37 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.167 -1.378 . . . . 1.84 111.763 176.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -129.76 142.09 50.76 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 118.874 -1.13 . . . . 3.19 113.987 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -58.45 150.06 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 113.219 -1.81 . . . . 0.41 113.314 -168.223 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.573 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -100.47 -43.73 6.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.464 -2.153 . . . . 0.35 108.4 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 4.7 tppt? 179.5 161.05 0.81 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.746 -2.025 . . . . 2.07 110.451 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.514 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 22.8 m -118.05 132.0 56.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.675 0.274 . . . . 0.37 110.957 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 79.7 m-85 -113.22 152.01 44.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 0.97 110.297 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HB2' HG22 ' A' ' 134' ' ' ILE . 12.3 Cg_endo -83.86 138.84 8.31 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.508 2.139 . . . . 0.6 111.943 177.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.35 172.74 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.325 -0.62 . . . . 0.64 109.325 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.85 158.95 17.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 0.83 111.478 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.697 ' HB ' HG23 ' A' ' 65' ' ' ILE . 26.7 m -142.25 170.33 12.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.309 -0.859 . . . . 1.67 109.362 -174.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.95 -130.87 0.44 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.737 -0.744 . . . . 3.08 112.354 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -100.68 -93.33 0.28 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.745 -0.268 . . . . 7.26 110.706 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.567 HG13 ' H ' ' A' ' 90' ' ' LEU . 2.3 pt -136.5 -78.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.439 0.533 . . . . 6.29 112.439 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.567 ' H ' HG13 ' A' ' 89' ' ' ILE . 9.9 tt -116.16 139.05 50.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 7.27 111.212 -172.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.441 HG22 ' HG2' ' A' ' 92' ' ' GLN . 47.3 m -157.07 -86.27 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.518 . . . . 5.18 110.121 174.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.441 ' HG2' HG22 ' A' ' 91' ' ' THR . 14.0 pt20 -168.4 18.84 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.04 0.385 . . . . 4.81 112.04 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.737 HG22 ' H ' ' A' ' 167' ' ' ARG . 79.7 p 56.14 130.29 0.01 OUTLIER Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 124.08 0.952 . . . . 2.11 111.76 -172.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.79 27.69 0.43 Allowed 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.574 2.183 . . . . 3.21 114.235 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.7 p 45.51 48.62 10.96 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.474 0.654 . . . . 3.59 110.645 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -85.27 52.86 4.71 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.294 -0.866 . . . . 2.1 113.938 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -92.18 103.76 16.21 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.228 -0.656 . . . . 2.3 109.228 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 120' ' ' LYS . 7.1 m-85 -124.57 -178.6 4.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.517 -0.765 . . . . 1.93 109.72 -176.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.513 ' CE2' ' HG2' ' A' ' 162' ' ' ARG . 62.2 m-85 -139.26 138.64 36.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.781 -0.645 . . . . 0.58 110.315 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 125' ' ' ILE . 27.7 mm -60.51 127.63 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 107.987 -1.116 . . . . 0.41 107.987 167.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.619 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -118.17 -31.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.512 -0.875 . . . . 0.37 112.341 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -166.78 -175.07 2.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 118.084 -1.447 . . . . 1.99 114.289 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 103' ' ' ARG . 4.9 ptp180 -156.81 133.86 10.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 111.211 -2.722 . . . . 1.19 110.125 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -112.8 155.36 24.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.275 1.036 . . . . 1.67 111.708 -172.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.27 155.35 3.81 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 112.291 -2.231 . . . . 3.06 112.92 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -43.58 102.93 0.3 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 112.947 -1.933 . . . . 2.61 111.674 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.83 -54.04 2.71 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 124.114 3.209 . . . . 0.98 113.0 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.73 -20.6 26.87 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.543 -0.753 . . . . 1.08 111.907 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -87.82 -169.59 45.49 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.375 -0.44 . . . . 1.05 112.493 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.03 6.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.167 3.245 . . . . 1.3 113.949 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.41 ' H ' ' C ' ' A' ' 109' ' ' GLY . 32.6 m-85 -53.42 -35.95 60.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.138 0.494 . . . . 1.38 109.749 171.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.9 -2.58 16.76 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.337 -0.847 . . . . 1.11 114.697 168.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB1' ' CD1' ' A' ' 151' ' ' ILE . . . -175.57 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.828 0.814 . . . . 0.81 112.628 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.532 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -151.63 158.32 43.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.344 -0.389 . . . . 1.12 111.514 -171.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CE3' ' HD2' ' A' ' 126' ' ' HIS . 9.7 t-105 -117.77 100.44 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.359 -0.608 . . . . 2.19 109.359 171.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.46 ' CD1' HG22 ' A' ' 150' ' ' VAL . 3.8 mp -105.3 141.12 37.38 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.727 0.775 . . . . 0.61 111.351 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.513 ' HB2' HG23 ' A' ' 101' ' ' ILE . 56.3 m -105.83 142.79 34.95 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.934 -1.03 . . . . 0.94 111.979 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -102.87 -174.49 2.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.468 -0.938 . . . . 1.08 108.468 173.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.3 p -100.71 -44.75 5.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.973 0.806 . . . . 1.5 112.788 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.587 ' HB2' ' CD1' ' A' ' 98' ' ' PHE . 87.7 mttt -122.34 160.69 24.84 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.362 -0.211 . . . . 2.97 111.329 -173.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 67.5 179.3 0.23 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.698 0.761 . . . . 5.06 112.545 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -84.09 40.46 0.76 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.253 -0.885 . . . . 5.95 110.779 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -116.69 141.07 48.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.12 -0.491 . . . . 4.83 110.583 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -155.64 154.46 25.54 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 109.978 -1.249 . . . . 0.95 109.978 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 100' ' ' ILE . 30.8 mt -92.94 112.05 25.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.918 0.866 . . . . 0.48 109.441 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.428 ' HD2' ' CE3' ' A' ' 115' ' ' TRP . 14.9 t-80 -130.26 173.09 11.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.635 -1.166 . . . . 1.25 111.527 -160.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.2 -171.7 14.63 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 0.46 111.311 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 t -159.48 174.52 14.55 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.933 -1.107 . . . . 0.5 112.679 -163.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -104.18 -20.57 13.76 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.914 -1.494 . . . . 1.86 108.884 167.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.78 103.21 21.76 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.152 -0.931 . . . . 1.77 110.232 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.521 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 64.8 Cg_endo -90.63 4.94 4.35 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.975 2.45 . . . . 0.59 112.553 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.5 40.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.248 0.547 . . . . 0.78 109.977 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.0 m -91.25 13.8 16.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.324 -0.853 . . . . 1.45 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 18.8 mm -108.08 115.48 49.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 0.7 110.711 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.52 -36.66 3.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.775 . . . . 1.68 112.953 176.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' HD2' ' C ' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -121.22 116.68 25.37 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.536 -0.542 . . . . 4.39 109.536 179.3 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 66.18 170.59 0.23 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.01 0.819 . . . . 3.94 111.645 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t 67.15 138.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.696 0.76 . . . . 4.68 111.814 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 12.4 t -109.49 -145.73 0.4 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.53 -0.759 . . . . 5.68 110.223 -176.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 139' ' ' SER . 0.1 OUTLIER 72.66 108.78 0.07 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.542 0.687 . . . . 8.3 111.078 -178.456 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.47 89.62 1.03 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.554 -0.748 . . . . 3.85 112.629 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.842 ' SG ' ' H11' ' A' 1142 ' ' IM2 . 50.5 t -118.54 -33.9 4.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.952 -0.388 . . . . 2.51 109.952 174.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 68.0 mt 75.38 81.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.846 0.832 . . . . 1.44 111.442 173.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.503 ' NH2' ' N26' ' A' 1142 ' ' IM2 . 39.4 mtt180 -118.97 162.56 18.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.413 -0.958 . . . . 3.36 108.413 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.405 ' HA ' HG21 ' A' ' 134' ' ' ILE . 38.9 mtp -145.4 -169.28 3.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.096 0.474 . . . . 1.13 111.362 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 149' ' ' ASP . 37.6 m80 -66.45 176.11 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.167 -0.924 . . . . 2.51 109.143 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 150' ' ' VAL . 3.8 m120 -82.4 -63.5 1.36 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.017 -1.105 . . . . 1.77 108.017 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -66.69 -22.15 66.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.616 . . . . 2.13 111.323 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 146' ' ' HIS . 31.2 m-20 -67.93 -41.83 81.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.893 0.378 . . . . 1.05 110.831 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 8.5 p -79.52 -13.01 13.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.32 110.521 -177.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.581 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 3.3 mp -92.34 -40.52 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 119.254 -0.403 . . . . 0.37 110.849 168.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -42.32 -70.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.356 0.98 . . . . 1.38 111.912 162.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.0 OUTLIER -50.07 -41.96 48.99 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.738 0.649 . . . . 0.74 110.181 177.623 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.23 -55.47 20.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.622 -1.172 . . . . 0.22 111.727 -172.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 28.7 t -77.01 -16.66 59.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.686 -1.143 . . . . 1.33 110.863 -172.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.24 -50.07 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 0.23 109.969 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.3 m -77.51 115.78 52.43 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 122.046 0.927 . . . . 0.21 110.38 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.751 ' HG2' HD13 ' A' ' 57' ' ' ILE . 45.6 Cg_endo -80.82 -178.28 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.834 2.356 . . . . 0.34 112.578 -172.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.694 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.2 m120 -55.91 -5.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.669 -1.151 . . . . 1.02 113.57 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.18 57.26 0.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.937 -0.649 . . . . 0.28 112.168 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.528 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 3.8 m -90.72 140.32 29.89 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.405 -0.467 . . . . 0.3 110.608 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.513 ' HG2' ' CE2' ' A' ' 99' ' ' TYR . 60.4 mtm180 -83.53 125.15 31.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.51 . . . . 1.96 109.86 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -136.16 126.65 41.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.389 0.614 . . . . 0.46 111.419 -177.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.5 m -117.29 140.49 49.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.384 -0.826 . . . . 0.56 111.975 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.7 mp -129.14 115.82 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 122.342 1.067 . . . . 0.96 111.397 172.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.8 OUTLIER -143.78 137.77 28.29 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.527 -1.67 . . . . 1.19 110.26 -173.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.737 ' H ' HG22 ' A' ' 93' ' ' THR . 8.6 ptm180 -91.99 -11.56 35.71 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.098 -0.956 . . . . 3.42 111.342 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.66 -57.24 0.52 Allowed Glycine 0 C--N 1.308 -1.022 0 CA-C-N 114.459 -1.246 . . . . 3.65 110.949 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.248 0.98 0 N-CA-C 109.123 -0.695 . . . . 5.97 109.123 173.194 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.842 ' H11' ' SG ' ' A' ' 142' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.908 -0.477 . . . . 2.92 111.908 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.484 ' HD3' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -110.97 178.15 4.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.214 0.531 . . . . 4.1 110.756 178.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.645 ' HE2' ' H ' ' A' ' 3' ' ' LYS . 1.8 mppt? -73.27 143.01 47.2 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.288 -0.869 . . . . 2.1 108.845 174.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -95.91 170.89 8.98 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.071 0.232 . . . . 0.26 111.15 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.544 HD23 ' CG1' ' A' ' 48' ' ' ILE . 4.0 tp -77.62 150.11 34.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 123.215 0.606 . . . . 0.23 112.173 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.541 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -115.07 149.25 37.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.012 0.911 . . . . 0.26 111.754 168.006 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.5 t80 -133.72 150.3 51.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.61 -1.632 . . . . 0.39 107.911 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -131.59 117.13 18.3 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.151 -1.426 . . . . 1.07 107.151 174.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG11 HD23 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -78.58 158.83 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 123.234 0.614 . . . . 0.38 111.226 -169.473 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 10' ' ' LYS . 8.5 mtpm? -110.27 156.72 20.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.111 -0.7 . . . . 2.59 109.111 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.849 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 19.7 tm0? -49.82 117.94 2.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.826 -0.625 . . . . 1.74 112.571 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.54 -6.44 35.94 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.57 113.428 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.704 ' HB3' HD11 ' A' ' 18' ' ' ILE . 20.9 m-20 -70.66 157.09 38.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.473 0.637 . . . . 2.17 112.436 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.615 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -134.7 162.29 32.76 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.549 0.574 . . . . 0.5 112.549 -176.337 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.9 tp -51.75 -60.73 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.937 1.088 . . . . 0.27 113.937 -173.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.647 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.8 t-20 -63.75 -43.37 96.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.614 1.197 . . . . 1.21 110.403 -169.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.768 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 31.3 m -60.46 -39.17 86.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 112.494 -2.139 . . . . 1.24 110.989 -177.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.35 -40.87 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 123.012 0.525 . . . . 0.3 112.327 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.682 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.55 -61.66 2.27 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.487 -0.324 . . . . 0.23 111.242 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.14 -3.33 54.62 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.01 -1.076 . . . . 0.39 112.136 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' SER . 4.0 t70 -62.13 -39.64 93.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.85 -1.167 . . . . 1.63 107.85 155.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.766 ' O ' HG23 ' A' ' 24' ' ' ILE . 4.6 m-85 -93.13 24.9 3.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.087 -0.506 . . . . 0.24 111.969 174.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.647 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 23.74 69.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.96 1.304 . . . . 3.55 113.515 -168.41 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 22' ' ' PHE . 29.8 pt -147.66 -169.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.066 -1.087 . . . . 0.27 108.066 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.22 146.88 25.18 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.943 -0.571 . . . . 0.81 109.736 171.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.647 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.6 p -61.25 -35.56 77.58 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.499 -0.926 . . . . 0.27 108.499 174.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.66 71.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.604 -1.18 . . . . 0.26 111.77 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.03 -38.24 32.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.874 -0.516 . . . . 0.23 109.725 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.68 -19.08 60.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.423 -0.808 . . . . 0.17 109.133 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.764 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -78.83 -40.37 32.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 0.19 111.832 173.396 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -59.68 -40.59 88.33 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.072 -0.967 . . . . 1.07 109.746 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.11 -20.29 41.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.673 -1.603 . . . . 0.17 112.214 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 11.1 m120 -143.52 73.12 17.46 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.165 0.507 . . . . 0.19 109.941 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.724 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.8 Cg_endo -57.08 -11.32 7.42 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 123.574 2.849 . . . . 0.3 113.809 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.6 t -62.67 -32.83 73.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.988 0.899 . . . . 1.17 109.392 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.82 -7.08 59.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.568 1.321 . . . . 0.53 114.568 -172.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.764 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -53.06 -39.84 63.56 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 120.19 1.359 . . . . 1.23 109.599 177.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.78 -47.4 12.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.769 -2.014 . . . . 0.4 111.334 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.03 -166.54 38.68 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.91 -1.138 . . . . 0.3 114.567 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.577 ' CD2' HG12 ' A' ' 18' ' ' ILE . 5.6 mp -114.88 158.91 21.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.335 -1.432 . . . . 0.31 110.152 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.605 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.84 136.2 38.57 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.797 -0.638 . . . . 0.39 110.499 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.849 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.93 127.46 10.08 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 113.115 0.783 . . . . 0.47 113.115 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.22 -11.13 51.23 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.607 -1.179 . . . . 0.36 112.312 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -63.31 151.11 41.63 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.697 0.76 . . . . 1.19 110.298 175.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 35.6 m -118.88 131.59 56.07 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.32 -1.309 . . . . 0.89 109.265 -171.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 29' ' ' LEU . 21.2 pt -132.81 159.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.095 0.474 . . . . 0.22 110.345 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.1 t -106.63 148.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.292 -0.867 . . . . 0.21 109.808 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.544 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.9 mm -116.97 88.69 27.19 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.31 -0.996 . . . . 0.17 108.31 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.709 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.3 Cg_endo -59.05 142.32 99.23 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.129 2.553 . . . . 0.23 112.617 -173.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.514 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.37 -7.08 61.93 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.492 -0.776 . . . . 0.3 112.811 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.712 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -114.62 126.07 28.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.742 -0.836 . . . . 0.25 108.742 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 51' ' ' LEU . 57.5 Cg_endo -65.58 174.3 5.55 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.849 3.033 . . . . 0.31 113.656 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.1 t70 -91.31 141.73 26.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.158 -0.928 . . . . 0.72 110.9 -169.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 96.5 Cg_endo -83.57 -7.11 10.73 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.616 2.877 . . . . 0.27 112.17 -175.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 62.1 m-85 -94.84 -27.31 15.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.831 -0.433 . . . . 2.11 109.831 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -70.23 -35.06 73.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.497 -1.298 . . . . 1.47 107.497 170.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.8 HD13 ' HG2' ' A' ' 158' ' ' PRO . 85.0 mt -74.34 126.43 88.96 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 113.327 -1.761 . . . . 0.26 110.524 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -102.94 95.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.905 1.07 . . . . 0.2 110.257 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.451 ' HD2' HG23 ' A' ' 57' ' ' ILE . 77.2 m-85 -158.33 129.57 6.49 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.403 -1.332 . . . . 0.26 107.403 172.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m-70 -137.7 110.13 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.158 -1.423 . . . . 2.84 107.158 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.0 mt -94.94 111.4 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.383 0.611 . . . . 0.32 110.539 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.27 93.06 4.23 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.857 0.837 . . . . 0.34 110.399 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -112.88 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.414 -1.266 . . . . 0.68 109.647 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 35.4 t -92.77 124.96 37.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.849 -1.167 . . . . 1.05 107.849 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.703 HG23 HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -58.98 -28.59 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.345 0.593 . . . . 1.29 110.796 172.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.45 -45.05 88.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.881 -0.888 . . . . 0.88 110.881 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.481 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -70.25 -24.08 63.01 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.644 0.609 . . . . 0.74 112.644 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.593 ' HA ' HG21 ' A' ' 86' ' ' VAL . 55.5 mttt 58.57 14.26 2.97 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.818 0.847 . . . . 2.51 112.894 -177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.458 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.42 138.9 35.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.973 0.892 . . . . 0.45 111.249 177.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.445 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -92.74 117.9 30.49 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.881 -1.509 . . . . 0.33 108.881 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.61 125.4 48.26 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.938 -0.705 . . . . 0.4 110.925 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.43 142.62 31.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.095 -1.817 . . . . 0.33 106.095 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 26.1 m -147.48 128.2 14.28 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 120.445 1.475 . . . . 0.75 112.969 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -111.41 126.88 55.41 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.588 -1.187 . . . . 0.35 110.147 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.1 t-20 61.89 35.45 16.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 0.52 110.285 173.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.2 m-20 78.35 1.59 2.68 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.112 -0.949 . . . . 1.84 112.404 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 77' ' ' ARG . 5.5 ttt180 -128.51 137.36 51.73 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 118.283 -1.367 . . . . 3.19 113.446 172.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.19 147.93 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 112.987 -1.915 . . . . 0.41 113.17 -171.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.533 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -97.8 -44.72 6.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.25 -2.25 . . . . 0.35 107.943 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 26.0 tptt -179.04 160.21 1.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.325 -2.216 . . . . 2.07 110.484 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.458 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.5 m -116.11 131.44 56.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.689 -0.232 . . . . 0.37 111.403 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -113.71 146.86 36.37 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 110.487 -0.19 . . . . 0.97 110.487 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.95 143.19 12.88 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.506 2.137 . . . . 0.6 111.305 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.75 172.23 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.768 -0.456 . . . . 0.64 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.56 127.65 34.51 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.92 0.391 . . . . 0.83 110.08 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.703 HG13 HG23 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -114.02 -57.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.572 -0.74 . . . . 1.67 111.55 -177.751 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.444 ' N ' HG12 ' A' ' 86' ' ' VAL . . . 74.63 -56.08 2.52 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.347 -0.454 . . . . 3.08 113.0 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt 58.04 82.69 0.13 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.462 0.705 . . . . 7.26 110.729 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 tp -76.22 -24.27 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.985 -0.552 . . . . 6.29 110.34 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 91' ' ' THR . 34.0 tp -176.25 172.92 2.23 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.867 -0.79 . . . . 7.27 108.867 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 15.0 p -52.13 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.528 0.518 . . . . 5.18 111.114 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 65.26 -66.66 0.14 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.88 0.696 . . . . 4.81 112.88 172.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 167' ' ' ARG . 22.1 p 49.26 83.58 0.22 Allowed Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 123.917 0.887 . . . . 2.11 111.965 -174.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.98 103.83 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.892 2.395 . . . . 3.21 112.142 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.5 p -82.56 73.25 9.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.753 -0.658 . . . . 3.59 111.659 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.88 153.04 21.54 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.05 -0.595 . . . . 2.1 111.664 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.84 147.48 34.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.303 0.573 . . . . 2.3 111.133 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.648 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 2.7 m-85 -121.56 172.5 8.05 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.301 -1.0 . . . . 1.93 108.301 -177.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 161' ' ' THR . 89.4 m-85 -135.9 139.1 43.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.464 -0.495 . . . . 0.58 111.685 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.73 HD11 HD12 ' A' ' 125' ' ' ILE . 26.6 mm -60.62 126.19 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 107.578 -1.267 . . . . 0.41 107.578 164.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -125.46 -27.93 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 120.118 -0.633 . . . . 0.37 112.51 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 3.6 t30 -151.61 158.8 43.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.82 1.045 . . . . 1.99 113.82 -168.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.69 133.91 20.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.397 -2.183 . . . . 1.19 110.198 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 13.3 tp60 -111.92 142.57 44.14 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.806 0.813 . . . . 1.67 110.709 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -54.23 151.44 7.26 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 112.937 -1.938 . . . . 3.06 113.254 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -45.36 101.98 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 114.121 -1.399 . . . . 2.61 111.998 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.402 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 85.7 Cg_exo -56.79 -51.39 9.11 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 124.242 3.294 . . . . 0.98 112.839 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.39 -0.86 29.46 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.353 -0.839 . . . . 1.08 112.436 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.16 -170.34 11.99 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.939 -0.648 . . . . 1.05 112.098 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.29 49.14 0.16 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.465 3.443 . . . . 1.3 113.945 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.402 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 1.6 t80 -107.42 -15.56 14.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.392 -0.596 . . . . 1.38 109.392 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.427 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.92 35.37 4.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.806 -0.712 . . . . 1.11 114.516 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.406 ' O ' ' HD1' ' A' ' 114' ' ' TYR . . . 72.72 -36.42 0.36 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.468 0.914 . . . . 0.81 113.468 172.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -152.83 137.57 16.99 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.366 -0.605 . . . . 1.12 109.366 -176.043 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 61.9 t-105 -110.34 102.35 11.01 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.485 -0.561 . . . . 2.19 109.485 171.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.2 mp -102.03 144.41 30.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.763 0.792 . . . . 0.61 110.54 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.588 ' HB2' HG23 ' A' ' 101' ' ' ILE . 34.8 m -107.84 144.32 35.21 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.08 -0.964 . . . . 0.94 112.794 -169.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.716 HD11 HG11 ' A' ' 163' ' ' VAL . 6.8 tp -106.81 -171.78 1.95 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.836 -1.529 . . . . 1.08 107.899 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.1 t -129.29 41.87 3.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.772 0.715 . . . . 1.5 111.836 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.648 ' HD2' ' CZ ' ' A' ' 98' ' ' PHE . 57.6 tttp -129.73 95.91 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.045 -0.41 . . . . 2.97 111.012 172.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 42.07 -93.52 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.135 0.897 . . . . 5.06 112.55 174.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -83.12 69.66 9.92 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.555 -0.906 . . . . 5.95 108.555 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.439 ' HB2' ' CB ' ' A' ' 118' ' ' LEU . 33.3 p90 -71.57 137.42 48.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.703 -1.135 . . . . 4.83 112.114 -172.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.413 ' O ' HG21 ' A' ' 143' ' ' ILE . . . -157.32 138.96 6.12 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.253 -1.451 . . . . 0.95 116.015 176.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 100' ' ' ILE . 4.0 mt -151.49 107.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.338 -1.727 . . . . 0.48 106.338 159.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.497 ' NE2' ' HB3' ' A' ' 144' ' ' ARG . 53.1 p-80 -149.48 -165.06 2.17 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.467 -0.893 . . . . 1.25 112.272 -172.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.427 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.17 175.39 16.35 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.636 -1.165 . . . . 0.46 113.01 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 5.0 t -136.69 171.68 14.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.464 0.649 . . . . 0.5 111.986 -165.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.57 ' H ' ' C25' ' A' 1142 ' ' IM2 . 4.3 m-20 -104.81 -18.17 14.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.877 -1.056 . . . . 1.86 108.702 165.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -124.21 102.8 33.45 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.268 -0.878 . . . . 1.77 109.661 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -90.07 4.29 4.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.165 2.577 . . . . 0.59 112.846 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.48 -12.37 58.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.338 0.59 . . . . 0.78 109.805 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.6 m -93.53 5.9 50.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.298 -0.865 . . . . 1.45 109.271 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 145' ' ' MET . 31.2 mm -98.56 115.57 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.095 -0.957 . . . . 0.7 110.487 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 106.45 -56.81 0.49 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.076 -1.21 . . . . 1.68 110.076 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -100.56 97.63 8.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.244 -0.651 . . . . 4.39 109.244 172.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.29 109.4 4.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.199 0.523 . . . . 3.94 111.612 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.3 86.2 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.49 -0.777 . . . . 4.68 110.49 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 t 66.08 -83.46 0.03 OUTLIER 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.346 -0.843 . . . . 5.68 111.502 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -76.39 104.45 6.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.039 0.447 . . . . 8.3 111.007 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.21 99.81 0.74 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.698 -0.763 . . . . 3.85 112.049 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 3.9 t -121.22 130.5 53.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.209 -0.293 . . . . 2.51 110.209 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.577 HD13 HG12 ' A' ' 125' ' ' ILE . 16.9 tt -86.24 64.53 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 122.436 1.112 . . . . 1.44 111.003 -173.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.604 ' O ' ' HB ' ' A' ' 128' ' ' THR . 16.4 ptt180 -107.62 88.04 2.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.631 -1.168 . . . . 3.36 110.075 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 126' ' ' HIS . 20.4 ptm -92.94 -166.75 1.59 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.588 -0.733 . . . . 1.13 112.253 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.439 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 14.3 m80 -67.54 138.61 56.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 2.51 109.826 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.643 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.4 m-20 -52.3 -64.67 0.74 Allowed 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.18 0.3 . . . . 1.77 111.401 -175.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -59.57 -27.29 66.12 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.91 -0.494 . . . . 2.13 111.809 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.439 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 2.3 m-20 -70.31 -43.68 69.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 1.05 110.68 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 11.2 p -73.68 -15.79 16.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.32 110.37 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -90.18 -40.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 119.181 -0.438 . . . . 0.37 110.551 172.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -43.16 -67.75 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.348 0.976 . . . . 1.38 112.014 163.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.694 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.6 tp -49.35 -43.79 44.14 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.592 -0.731 . . . . 0.74 109.894 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.66 -50.85 64.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.118 -1.401 . . . . 0.22 112.421 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 17.1 t -78.74 -18.64 53.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.758 -1.11 . . . . 1.33 110.71 -173.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.16 -50.46 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.838 -0.43 . . . . 0.23 109.838 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.8 m -77.12 114.88 43.96 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 122.057 0.932 . . . . 0.21 109.985 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.8 ' HG2' HD13 ' A' ' 57' ' ' ILE . 46.4 Cg_endo -82.12 -178.11 3.89 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.169 2.579 . . . . 0.34 112.609 -174.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.712 ' O ' HD21 ' A' ' 51' ' ' LEU . 20.6 m120 -59.2 -1.71 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.591 -1.186 . . . . 1.02 113.364 -174.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.42 59.08 0.5 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.947 -0.644 . . . . 0.28 112.414 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.2 m -95.69 134.85 38.12 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.535 -0.391 . . . . 0.3 110.393 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -84.88 140.24 31.29 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.098 -0.334 . . . . 1.96 110.098 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.716 HG11 HD11 ' A' ' 118' ' ' LEU . 3.7 p -145.55 130.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.811 -0.631 . . . . 0.46 111.271 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.404 ' C ' HD12 ' A' ' 165' ' ' ILE . 20.0 m -116.82 138.18 51.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.811 -0.631 . . . . 0.56 111.789 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.465 HG23 HG13 ' A' ' 65' ' ' ILE . 2.9 mp -122.18 109.84 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 118.997 -1.081 . . . . 0.96 110.619 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -143.72 156.7 44.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.526 -1.215 . . . . 1.19 109.358 -170.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.61 ' H ' HG22 ' A' ' 93' ' ' THR . 3.1 mpt_? -91.37 -8.32 48.34 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.017 -0.538 . . . . 3.42 110.84 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.21 -69.24 1.84 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.677 -0.692 . . . . 3.65 112.617 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.714 -0.66 . . . . 5.97 110.126 -177.358 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.57 ' C25' ' H ' ' A' ' 129' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.727 -0.549 . . . . 2.92 111.727 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -97.72 160.8 14.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.823 0.311 . . . . 4.1 110.503 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt -65.3 153.45 41.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.417 -0.586 . . . . 2.1 109.417 172.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.784 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.9 mt -91.96 170.63 9.7 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.94 -0.573 . . . . 0.26 110.854 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD23 ' CG1' ' A' ' 48' ' ' ILE . 3.6 tp -76.49 149.07 36.81 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 122.983 0.513 . . . . 0.23 111.866 -170.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.51 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.59 149.18 36.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.166 0.984 . . . . 0.26 111.67 168.125 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 45' ' ' SER . 77.3 t80 -134.54 147.53 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.304 -1.771 . . . . 0.39 107.521 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.56 112.01 14.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.288 -1.745 . . . . 1.07 106.288 174.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 40' ' ' LEU . 1.6 m -71.42 157.68 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 115.714 -0.675 . . . . 0.38 111.961 -165.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -108.27 147.77 30.94 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.113 -0.948 . . . . 2.59 109.387 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.5 tm0? -51.58 131.22 29.42 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.888 0.742 . . . . 1.74 112.349 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -4.59 39.69 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.371 -0.831 . . . . 0.57 111.44 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -45.11 143.63 1.53 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.915 1.45 . . . . 2.17 114.915 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.23 140.1 46.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.978 -1.01 . . . . 0.5 111.674 164.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.5 tp -42.31 -55.28 3.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.315 -0.857 . . . . 0.27 113.174 -175.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 17.3 t-20 -65.43 -42.97 91.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.584 1.183 . . . . 1.21 110.375 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.786 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 15.1 m -62.95 -38.06 89.54 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 112.477 -2.147 . . . . 1.24 110.878 -176.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -76.08 -39.62 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 O-C-N 123.713 0.633 . . . . 0.3 112.2 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.718 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.02 -59.59 4.85 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.611 -0.268 . . . . 0.23 110.998 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 -4.65 56.83 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.527 -1.269 . . . . 0.39 111.848 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.786 ' HB2' ' O ' ' A' ' 17' ' ' SER . 8.3 t70 -61.3 -29.24 69.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.567 -1.272 . . . . 1.63 107.567 157.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.692 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.8 m-85 -109.06 19.13 19.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.999 0.74 . . . . 0.24 112.999 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? 49.57 54.95 10.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.486 -0.779 . . . . 3.55 111.266 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 19' ' ' ALA . 33.5 pt -148.18 -172.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.721 -0.844 . . . . 0.27 108.721 -173.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.58 146.78 24.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.66 -0.7 . . . . 0.81 109.684 173.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.644 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.1 p -62.69 -35.19 78.89 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.793 -0.818 . . . . 0.27 108.793 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.16 -28.88 68.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.362 -1.29 . . . . 0.26 111.665 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.38 26.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.241 -0.651 . . . . 0.23 109.241 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 16.5 tp -72.46 -17.85 61.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.144 -0.935 . . . . 0.17 108.772 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.757 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.05 -37.51 33.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.393 0.616 . . . . 0.19 111.16 171.234 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -56.39 -46.28 80.18 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.636 1.208 . . . . 1.07 110.278 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.69 43.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 112.998 -1.91 . . . . 0.17 112.317 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 15.7 m120 -142.51 73.1 20.59 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.19 110.108 -172.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.747 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.6 Cg_endo -57.24 -13.55 12.95 Favored 'Trans proline' 0 C--O 1.22 -0.419 0 C-N-CA 123.437 2.758 . . . . 0.3 114.325 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.48 -31.59 71.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.932 0.872 . . . . 1.17 109.718 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.675 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -81.0 -6.69 59.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.469 1.285 . . . . 0.53 114.469 -171.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.757 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -50.86 -41.48 58.03 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.806 1.185 . . . . 1.23 110.147 179.538 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.62 -46.32 13.44 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.829 -1.987 . . . . 0.4 111.136 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.01 -170.32 43.4 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.49 -0.862 . . . . 0.3 113.952 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 9' ' ' VAL . 5.3 mp -110.03 161.71 15.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.558 -1.321 . . . . 0.31 109.724 177.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.3 m -135.61 134.12 38.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.872 -0.603 . . . . 0.39 110.428 176.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.44 129.25 18.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.314 0.578 . . . . 0.47 112.281 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.18 -12.9 57.11 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.802 -1.09 . . . . 0.36 112.647 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.6 tt0 -65.88 152.7 43.88 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.641 0.734 . . . . 1.19 110.306 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.498 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 50.7 m -117.02 130.68 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.501 -1.227 . . . . 0.89 109.603 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 29' ' ' LEU . 20.6 pt -134.46 145.51 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.516 0.674 . . . . 0.22 110.526 -174.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.558 ' H ' HD22 ' A' ' 33' ' ' ASN . 12.5 t -91.02 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.866 -1.061 . . . . 0.21 110.192 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.8 mm -117.47 88.53 29.09 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-N 115.083 -0.962 . . . . 0.17 108.425 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.784 ' HA ' HD13 ' A' ' 4' ' ' LEU . 22.8 Cg_endo -58.74 141.36 97.71 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.221 2.614 . . . . 0.23 112.967 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.495 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.6 -7.6 72.58 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.381 -0.827 . . . . 0.3 113.115 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.636 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.7 tt -118.53 128.39 26.0 Favored Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.641 -0.874 . . . . 0.25 108.641 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.636 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.8 Cg_endo -67.33 175.12 6.22 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.563 2.842 . . . . 0.31 113.825 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.771 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.9 t70 -89.46 142.11 29.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.72 110.56 -171.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.503 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 75.0 Cg_endo -84.28 -4.58 10.26 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.576 2.851 . . . . 0.27 112.363 -174.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -94.79 -26.53 16.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.741 -0.466 . . . . 2.11 109.741 174.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.771 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.1 p -72.99 -28.76 62.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.561 1.172 . . . . 1.47 107.844 171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.755 HD13 ' HG2' ' A' ' 158' ' ' PRO . 93.0 mt -80.68 124.35 81.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 113.065 -1.88 . . . . 0.26 109.868 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -101.8 96.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 120.779 0.986 . . . . 0.2 110.235 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.489 ' HB2' HG23 ' A' ' 161' ' ' THR . 89.9 m-85 -157.74 133.23 9.01 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.387 -1.338 . . . . 0.26 107.387 172.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 9.7 m-70 -137.08 103.82 5.25 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.259 -1.756 . . . . 2.84 106.259 -167.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.1 mt -92.96 106.43 17.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.705 0.764 . . . . 0.32 109.595 -177.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.86 96.1 5.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.716 -1.129 . . . . 0.34 110.623 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.557 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -114.82 96.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 113.743 -1.571 . . . . 0.68 108.712 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.51 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.1 m -95.18 122.57 38.0 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.209 -1.36 . . . . 1.05 108.383 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 3.1 mm -47.3 -34.48 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.428 0.632 . . . . 1.29 110.117 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.55 -47.33 35.05 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.17 -0.923 . . . . 0.88 112.336 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.51 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -64.37 -24.25 67.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.317 0.58 . . . . 0.74 112.392 174.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.609 ' HA ' HG11 ' A' ' 86' ' ' VAL . 17.9 mttt 54.97 17.63 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.773 1.229 . . . . 2.51 113.414 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.414 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -143.32 142.46 31.32 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.318 0.58 . . . . 0.45 111.02 171.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.557 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.5 tt -90.98 118.21 30.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.169 -0.923 . . . . 0.33 109.411 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -105.0 125.77 51.33 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.392 -0.523 . . . . 0.4 111.691 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.543 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.76 136.82 34.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.129 -1.804 . . . . 0.33 106.129 176.055 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.648 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 13.3 m -141.78 129.35 21.44 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 120.493 1.497 . . . . 0.75 112.758 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.26 126.59 53.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.045 -0.98 . . . . 0.35 110.539 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.9 t-20 63.74 37.79 9.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.423 0.63 . . . . 0.52 109.827 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.4 m-20 76.25 0.57 3.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.672 -1.149 . . . . 1.84 112.525 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.49 138.54 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.279 -1.368 . . . . 3.19 113.751 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -53.89 147.23 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 113.053 -1.885 . . . . 0.41 112.863 -172.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.52 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -96.47 -45.66 6.67 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.338 -2.21 . . . . 0.35 107.565 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 30.2 tptt -176.77 159.33 1.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.216 -2.265 . . . . 2.07 110.298 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.414 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 3.6 m -119.43 134.81 55.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.397 -0.121 . . . . 0.37 111.051 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.421 ' HB3' ' HA2' ' A' ' 141' ' ' GLY . 25.7 m-85 -120.22 127.14 26.48 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 120.924 0.392 . . . . 0.97 110.876 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.454 ' HB2' HG21 ' A' ' 138' ' ' VAL . 7.7 Cg_endo -57.46 137.82 83.25 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 124.16 3.24 . . . . 0.6 113.813 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 142' ' ' CYS . 0.2 OUTLIER -138.12 168.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.818 -0.353 . . . . 0.64 110.371 177.394 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.542 ' HB3' ' H51' ' A' 1142 ' ' IM2 . . . -85.98 137.43 32.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.549 0.69 . . . . 0.83 111.39 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -131.13 19.66 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.571 -1.195 . . . . 1.67 110.104 -175.697 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.1 69.39 3.11 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.438 -0.801 . . . . 3.08 112.102 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -147.38 138.71 23.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.33 -0.989 . . . . 7.26 108.33 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.6 tp -52.44 129.05 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.211 0.529 . . . . 6.29 111.151 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.0 mt -83.41 58.44 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.986 -0.552 . . . . 7.27 110.592 -175.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.8 m -68.55 -54.74 14.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.51 -0.768 . . . . 5.18 111.693 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -151.18 150.49 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.865 0.364 . . . . 4.81 110.644 -175.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 167' ' ' ARG . 10.6 p -78.21 117.35 65.61 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.894 -0.593 . . . . 2.11 110.583 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 166' ' ' ASN . 46.4 Cg_exo -57.87 129.82 35.28 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.39 2.06 . . . . 3.21 111.904 175.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.3 p -87.26 156.98 19.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.98 -0.555 . . . . 3.59 111.779 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.03 -168.31 48.73 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.098 -0.573 . . . . 2.1 112.669 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.9 168.24 20.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.789 -0.448 . . . . 2.3 109.789 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.642 ' HB2' HG13 ' A' ' 163' ' ' VAL . 13.3 m-85 -116.59 167.68 10.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.205 -1.405 . . . . 1.93 107.205 171.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 161' ' ' THR . 84.6 m-85 -130.37 135.9 48.52 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.277 -0.569 . . . . 0.58 111.021 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.804 HD11 HD12 ' A' ' 125' ' ' ILE . 26.8 mm -60.26 121.06 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 107.346 -1.353 . . . . 0.41 107.346 164.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.629 HD12 ' HD1' ' A' ' 22' ' ' PHE . 3.1 tt -109.04 -22.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.487 -0.885 . . . . 0.37 112.099 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 21.1 p-10 -178.5 -165.7 0.09 Allowed 'General case' 0 C--N 1.348 0.531 0 N-CA-C 114.024 1.12 . . . . 1.99 114.024 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 103' ' ' ARG . 5.3 ptp180 -150.73 139.66 20.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 112.683 -2.053 . . . . 1.19 111.68 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 24.7 tp60 -107.12 145.0 33.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.604 -1.18 . . . . 1.67 111.407 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.707 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 34.3 ttm180 -56.64 150.15 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.167 -1.833 . . . . 3.06 111.506 170.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -46.07 104.01 0.38 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 123.89 0.744 . . . . 2.61 111.736 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.425 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 87.9 Cg_exo -56.35 -51.64 8.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.815 3.01 . . . . 0.98 111.874 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.75 -21.59 13.83 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.02 -0.991 . . . . 1.08 112.578 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -100.27 -169.49 29.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.96 -0.638 . . . . 1.05 112.311 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.52 32.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.256 3.304 . . . . 1.3 113.754 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -85.92 -20.92 28.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.142 0.496 . . . . 1.38 109.933 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.439 ' HA3' ' CA ' ' A' ' 127' ' ' GLY . . . 96.33 42.55 3.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.519 -0.764 . . . . 1.11 114.019 170.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.69 -33.62 0.23 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.419 0.896 . . . . 0.81 113.419 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.559 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -150.17 127.0 11.04 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.816 -0.439 . . . . 1.12 109.816 -174.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 34.0 t-105 -100.48 100.39 11.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.158 -0.682 . . . . 2.19 109.158 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.2 mp -101.09 141.27 34.22 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 0.61 109.016 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.1 m -106.93 144.09 34.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.644 0.609 . . . . 0.94 112.644 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.598 HD11 HG11 ' A' ' 163' ' ' VAL . 2.3 tp -97.97 -174.19 2.8 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.786 -1.191 . . . . 1.08 107.786 172.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t -75.04 -67.61 0.63 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.586 -0.445 . . . . 1.5 110.741 175.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.54 ' HA ' ' NZ ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -64.91 110.66 2.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.937 0.718 . . . . 2.97 112.937 -165.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 55.89 -136.96 1.14 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.146 -0.934 . . . . 5.06 111.998 173.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -90.27 15.74 9.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.949 0.404 . . . . 5.95 110.539 -176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 120' ' ' LYS . 29.6 m-85 -66.07 134.26 52.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.751 -0.462 . . . . 4.83 109.751 174.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.32 158.43 28.66 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.782 -0.723 . . . . 0.95 111.881 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.804 HD12 HD11 ' A' ' 100' ' ' ILE . 9.2 mt -93.59 106.0 17.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 108.541 -0.911 . . . . 0.48 108.541 174.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' NE2' ' HG2' ' A' ' 144' ' ' ARG . 18.4 p80 -136.95 -161.76 1.2 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.527 0.68 . . . . 1.25 111.27 -172.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.439 ' CA ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.1 155.8 16.08 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.815 -1.183 . . . . 0.46 113.569 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 3.8 t -98.37 172.5 7.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.028 -1.086 . . . . 0.5 110.592 -171.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.93 -13.35 13.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.351 -0.841 . . . . 1.86 109.075 160.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 133' ' ' SER . 24.1 t30 -124.75 101.12 33.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.185 -0.916 . . . . 1.77 109.414 171.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.464 ' O ' ' HA ' ' A' ' 139' ' ' SER . 81.1 Cg_endo -90.49 3.29 4.82 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.785 2.323 . . . . 0.59 113.039 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -94.8 -2.02 51.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.383 0.611 . . . . 0.78 109.546 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.468 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 33.3 t -90.23 -12.69 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.262 -0.881 . . . . 1.45 109.555 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.669 HD12 ' HB3' ' A' ' 142' ' ' CYS . 14.6 mm -60.11 130.65 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.672 -0.695 . . . . 0.7 109.963 177.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.25 -121.3 15.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.778 -0.725 . . . . 1.68 111.596 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -107.65 -63.83 1.27 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.142 -0.688 . . . . 4.39 109.142 170.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -134.13 29.0 3.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.648 -0.706 . . . . 3.94 110.332 176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 134' ' ' ILE . 3.4 m -95.19 -176.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.932 -0.766 . . . . 4.68 108.932 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 131' ' ' PRO . 64.1 m -147.63 170.1 18.22 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.564 -0.455 . . . . 5.68 112.021 -177.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.4 pttm 42.78 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.589 1.156 . . . . 8.3 112.908 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 142' ' ' CYS . . . 173.25 -177.65 45.57 Favored Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 115.27 -0.877 . . . . 3.85 111.329 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.686 ' HA ' HG22 ' A' ' 84' ' ' ILE . 42.2 t 79.73 167.87 0.18 Allowed 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.461 -0.57 . . . . 2.51 109.461 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 125' ' ' ILE . 22.4 pt -76.06 24.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.496 0.665 . . . . 1.44 110.397 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.544 ' H ' ' C ' ' A' ' 142' ' ' CYS . 98.9 mtt180 -153.83 66.25 0.73 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.876 1.271 . . . . 3.36 108.494 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.528 ' CG ' ' HB ' ' A' ' 150' ' ' VAL . 5.1 ptm -107.48 -167.44 1.26 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.279 0.844 . . . . 1.13 113.279 -166.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -71.12 153.93 42.14 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.851 -0.796 . . . . 2.51 108.851 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.573 ' O ' HG12 ' A' ' 150' ' ' VAL . 29.8 p-10 -54.21 -69.91 0.11 Allowed 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.268 0.47 . . . . 1.77 112.268 -172.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -61.39 -20.35 62.95 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.567 -0.708 . . . . 2.13 111.405 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -74.26 -45.3 48.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.667 -0.697 . . . . 1.05 110.354 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.601 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.2 p -72.05 -18.37 19.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.32 110.945 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.583 HD12 HG13 ' A' ' 150' ' ' VAL . 1.9 mp -84.68 -36.68 11.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 119.116 -0.469 . . . . 0.37 110.297 177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -45.05 -70.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 119.441 1.018 . . . . 1.38 112.337 162.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.677 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -49.45 -40.88 38.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.74 110.316 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.99 -55.6 30.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.169 -1.378 . . . . 0.22 111.997 -172.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.9 p -75.08 -12.91 60.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.7 -1.136 . . . . 1.33 110.919 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.89 -49.87 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.881 -0.6 . . . . 0.23 110.098 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.2 m -77.15 115.69 51.05 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 122.096 0.95 . . . . 0.21 110.541 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.755 ' HG2' HD13 ' A' ' 57' ' ' ILE . 38.4 Cg_endo -82.78 -177.34 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.184 2.589 . . . . 0.34 112.971 -173.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.631 ' O ' HD21 ' A' ' 51' ' ' LEU . 12.0 m120 -57.63 -2.13 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.708 -1.133 . . . . 1.02 113.898 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.57 57.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.28 112.537 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.2 m -92.69 134.62 34.85 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.612 -0.346 . . . . 0.3 110.479 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 138.81 31.73 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.904 0.383 . . . . 1.96 110.389 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -145.63 127.39 8.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.339 -0.846 . . . . 0.46 110.911 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 63' ' ' VAL . 3.3 m -116.34 143.0 46.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.854 -0.612 . . . . 0.56 111.652 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.465 HG13 HG13 ' A' ' 63' ' ' VAL . 3.1 mp -124.34 107.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 119.252 -0.979 . . . . 0.96 109.77 172.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 94' ' ' PRO . 29.0 p-10 -143.46 145.21 32.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 1.19 111.148 -168.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 93' ' ' THR . 4.5 mpt_? -81.36 -10.24 59.58 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.007 -0.997 . . . . 3.42 111.274 177.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.02 -62.58 4.52 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.98 -0.629 . . . . 3.65 111.964 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.726 -0.654 . . . . 5.97 110.384 179.415 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.542 ' H51' ' HB3' ' A' ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 112.39 -0.284 . . . . 2.92 112.39 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.18 167.86 27.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.9 -0.407 . . . . 4.1 109.9 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.533 ' HE2' ' CG2' ' A' ' 56' ' ' THR . 4.1 mppt? -78.9 150.14 32.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.89 -0.411 . . . . 2.1 109.89 174.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.1 mt -95.21 172.6 8.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.855 -0.611 . . . . 0.26 111.192 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.548 HD23 ' CG1' ' A' ' 48' ' ' ILE . 4.2 tp -75.49 149.2 38.51 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.103 0.478 . . . . 0.23 111.77 -170.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.529 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.29 147.82 38.47 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.143 0.973 . . . . 0.26 111.6 167.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' SER . 81.1 t80 -133.91 146.7 50.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.205 -1.816 . . . . 0.39 107.571 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.6 tt0 -127.33 111.35 13.8 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 1.07 106.66 176.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.549 HG11 HD23 ' A' ' 40' ' ' LEU . 1.2 m -70.64 157.44 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 121.37 0.605 . . . . 0.38 111.856 -165.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.31 147.09 33.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.128 -0.942 . . . . 2.59 109.44 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.658 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 3.8 tt0 -53.13 130.82 35.5 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.838 0.712 . . . . 1.74 112.15 -173.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.81 -4.85 39.51 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.491 -0.777 . . . . 0.57 111.672 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -43.5 146.17 0.53 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.004 1.483 . . . . 2.17 115.004 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.35 139.9 45.97 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.014 -0.994 . . . . 0.5 111.928 162.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.582 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.5 tp -43.11 -55.76 3.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.499 -0.773 . . . . 0.27 113.031 -175.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.679 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.2 -40.06 93.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.261 1.029 . . . . 1.21 110.268 -171.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -59.81 -49.88 75.97 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 112.924 -1.944 . . . . 1.24 109.534 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -65.84 -39.35 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 O-C-N 123.522 0.514 . . . . 0.3 111.35 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.68 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.41 -62.67 1.61 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.887 -0.597 . . . . 0.23 111.612 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.27 -4.27 56.84 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.996 -1.081 . . . . 0.39 112.292 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.56 -33.58 74.11 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.285 -1.005 . . . . 1.63 108.285 155.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.6 m-85 -101.47 27.39 6.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.099 0.407 . . . . 0.24 112.099 175.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.694 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.13 68.62 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.836 1.255 . . . . 3.55 113.805 -168.406 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.772 HG23 ' O ' ' A' ' 22' ' ' PHE . 34.6 pt -147.42 -173.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.856 -1.164 . . . . 0.27 107.856 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -101.09 145.68 28.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.764 -0.653 . . . . 0.81 109.409 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.679 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.7 p -61.93 -35.24 77.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.54 0.686 . . . . 0.27 109.208 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.1 -30.18 71.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.282 -1.326 . . . . 0.26 111.334 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.14 -38.54 27.01 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.394 0.616 . . . . 0.23 109.692 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.693 HD11 HD12 ' A' ' 46' ' ' ILE . 13.9 tp -72.74 -18.22 61.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.432 -0.804 . . . . 0.17 108.963 175.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.738 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.58 -37.58 35.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.19 111.223 171.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.0 mt-30 -56.96 -47.43 80.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.285 1.04 . . . . 1.07 109.501 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.56 -18.37 51.91 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.361 -1.745 . . . . 0.17 112.178 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 15.1 m120 -143.15 72.52 18.22 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.153 0.501 . . . . 0.19 109.903 -173.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.774 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.68 -13.0 12.85 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 123.322 2.681 . . . . 0.3 113.781 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -31.78 70.67 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 122.045 0.926 . . . . 1.17 109.897 174.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.668 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -82.67 -6.45 59.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.159 -1.382 . . . . 0.53 114.527 -172.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.774 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -50.6 -42.28 55.71 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 119.778 1.172 . . . . 1.23 109.907 178.04 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.19 -47.04 15.29 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 112.99 -1.914 . . . . 0.4 111.172 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.668 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.12 -166.82 39.04 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-O 122.162 0.868 . . . . 0.3 113.989 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.549 HD23 HG11 ' A' ' 9' ' ' VAL . 5.1 mp -113.76 160.34 18.78 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.392 -1.404 . . . . 0.31 109.871 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.0 m -136.02 135.36 39.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.901 -0.591 . . . . 0.39 110.231 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.12 129.98 18.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.438 0.637 . . . . 0.47 112.451 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.99 -13.03 46.54 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.804 -1.089 . . . . 0.36 112.534 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.613 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -64.34 152.71 40.53 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.507 0.67 . . . . 1.19 110.288 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 45.8 m -117.81 132.32 56.46 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.741 -1.118 . . . . 0.89 109.512 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.693 HD12 HD11 ' A' ' 29' ' ' LEU . 17.4 pt -135.77 155.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.354 0.597 . . . . 0.22 110.633 -175.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.5 t -100.08 149.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.0 -1.0 . . . . 0.21 110.189 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.548 ' CG1' HD23 ' A' ' 5' ' ' LEU . 18.0 mm -117.57 87.8 27.1 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 0.17 108.257 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.742 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.4 Cg_endo -57.89 143.45 95.83 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.303 2.669 . . . . 0.23 112.937 -173.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.485 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.2 -7.22 60.96 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.667 -0.697 . . . . 0.3 113.07 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.9 tt -116.15 126.47 27.6 Favored Pre-proline 0 C--O 1.219 -0.539 0 N-CA-C 108.457 -0.942 . . . . 0.25 108.457 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD2' HD23 ' A' ' 51' ' ' LEU . 60.1 Cg_endo -66.45 174.88 5.67 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.72 2.947 . . . . 0.31 113.618 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.753 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.9 t70 -89.63 141.75 28.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.72 110.355 -172.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.511 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 90.2 Cg_endo -82.49 -3.88 11.48 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.423 2.749 . . . . 0.27 112.169 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.68 -25.44 16.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 2.11 110.14 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.753 HG23 ' HB3' ' A' ' 53' ' ' ASP . 22.7 p -74.05 -28.32 61.35 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.737 -1.208 . . . . 1.47 107.737 171.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.798 HD13 ' HG2' ' A' ' 158' ' ' PRO . 97.0 mt -80.93 128.6 70.78 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 113.234 -1.803 . . . . 0.26 109.659 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -103.6 96.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.942 0 CA-C-N 120.1 1.071 . . . . 0.2 110.681 166.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HD2' HG23 ' A' ' 57' ' ' ILE . 80.3 m-85 -157.7 132.81 8.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.587 -1.264 . . . . 0.26 107.587 172.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.585 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 2.7 m-70 -139.08 104.98 5.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.483 -1.302 . . . . 2.84 107.483 -164.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.7 mt -96.35 114.4 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.722 -0.672 . . . . 0.32 111.169 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.84 97.01 6.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.202 -0.908 . . . . 0.34 110.808 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -120.79 100.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.396 -1.275 . . . . 0.68 110.253 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.537 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.9 m -94.76 134.51 37.28 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.23 -0.895 . . . . 1.05 109.298 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.692 ' HA ' HG12 ' A' ' 86' ' ' VAL . 6.0 mm -59.39 -33.44 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.867 0.842 . . . . 1.29 109.433 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.33 40.97 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.314 -1.312 . . . . 0.88 112.068 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -68.16 -24.86 65.03 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.177 0.513 . . . . 0.74 112.18 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.81 ' HA ' HG11 ' A' ' 86' ' ' VAL . 26.8 mttt 55.74 16.94 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.295 1.038 . . . . 2.51 113.544 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.98 142.37 31.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 0.45 110.839 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.516 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.2 tt -96.37 120.25 36.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.467 -1.242 . . . . 0.33 109.658 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 m -101.12 122.34 43.42 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.078 -0.649 . . . . 0.4 111.019 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.549 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.44 131.76 35.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 106.22 -1.77 . . . . 0.33 106.22 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -137.28 126.89 25.24 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.677 1.581 . . . . 0.75 112.703 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -113.06 126.22 55.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.089 -0.959 . . . . 0.35 110.288 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 66.86 35.31 4.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.499 0.666 . . . . 0.52 109.326 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.4 t30 75.7 -0.28 3.23 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.215 -1.357 . . . . 1.84 112.21 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -128.93 140.6 51.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.125 -1.43 . . . . 3.19 113.944 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -56.14 148.09 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 113.41 -1.723 . . . . 0.41 113.371 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.549 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -96.94 -46.42 6.22 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.013 -2.358 . . . . 0.35 107.594 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 21.0 tptp -178.77 155.68 0.81 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.397 -2.183 . . . . 2.07 110.462 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -111.48 131.57 55.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.483 -0.192 . . . . 0.37 110.483 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.85 135.85 24.5 Favored Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.97 111.6 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -64.04 140.96 74.88 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.272 2.648 . . . . 0.6 112.613 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 -179.64 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.803 -0.814 . . . . 0.64 108.803 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.96 147.35 26.27 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.083 0.468 . . . . 0.83 110.662 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -143.5 120.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.438 -0.801 . . . . 1.67 110.948 -176.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.36 -148.47 9.22 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.621 -0.718 . . . . 3.08 112.535 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -68.24 139.18 56.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.798 0.332 . . . . 7.26 110.62 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.4 pt -94.06 55.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.414 0.626 . . . . 6.29 110.858 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 91' ' ' THR . 31.1 tp -89.2 176.56 6.91 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.127 -0.694 . . . . 7.27 109.127 176.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.502 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 6.5 t -72.63 17.41 0.11 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.25 0.548 . . . . 5.18 111.665 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 90' ' ' LEU . 43.2 mt-30 -84.39 55.64 3.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.226 0.536 . . . . 4.81 109.609 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.58 HG22 ' HB2' ' A' ' 167' ' ' ARG . 21.2 p -75.93 112.69 21.55 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.937 -0.574 . . . . 2.11 110.587 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 92' ' ' GLN . 33.8 Cg_exo -60.97 118.27 5.12 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.282 1.988 . . . . 3.21 111.431 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.0 p -81.84 158.23 24.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.098 -0.501 . . . . 3.59 110.793 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.47 164.93 39.65 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.678 -0.772 . . . . 2.1 112.087 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -111.07 157.8 19.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.226 0.536 . . . . 2.3 110.932 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 163' ' ' VAL . 2.4 m-85 -119.52 171.22 8.51 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.181 -1.044 . . . . 1.93 108.181 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.5 m-85 -136.31 138.68 41.96 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.213 -0.595 . . . . 0.58 111.639 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.73 HD11 HD12 ' A' ' 125' ' ' ILE . 26.8 mm -59.93 106.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.19 -1.411 . . . . 0.41 107.19 163.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.694 HD11 ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -94.87 -24.03 4.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.829 -0.749 . . . . 0.37 111.587 -176.28 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -172.01 -174.75 1.35 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 122.784 1.278 . . . . 1.99 114.227 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.504 ' NH1' ' HA ' ' A' ' 155' ' ' SER . 2.8 ptt180 -149.9 137.7 20.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 111.374 -2.648 . . . . 1.19 110.575 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.642 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 29.2 tp60 -105.83 144.37 32.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.842 -1.072 . . . . 1.67 110.386 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.576 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 23.8 ttm180 -53.37 155.28 2.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.748 -2.024 . . . . 3.06 112.085 172.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.576 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.4 109.87 1.1 Allowed Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 114.955 -1.021 . . . . 2.61 110.498 175.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.15 -52.07 5.58 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.325 2.683 . . . . 0.98 111.958 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.33 -20.24 25.89 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.197 -0.91 . . . . 1.08 112.168 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -115.27 -169.94 16.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.94 -0.648 . . . . 1.05 112.621 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.31 9.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 124.598 3.532 . . . . 1.3 114.557 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 115' ' ' TRP . 3.8 t80 -62.27 -27.37 68.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.421 0.629 . . . . 1.38 109.959 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.78 55.36 0.94 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.11 114.427 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 73.38 -46.98 0.65 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.389 1.255 . . . . 0.81 114.389 166.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.567 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -151.84 147.06 26.17 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 122.638 0.375 . . . . 1.12 110.445 -174.586 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.642 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 47.0 t-105 -118.56 102.58 9.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.975 -0.38 . . . . 2.19 109.975 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -107.45 139.78 41.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.561 0.696 . . . . 0.61 110.222 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 101' ' ' ILE . 58.3 m -107.66 148.52 29.26 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.51 0.93 . . . . 0.94 113.51 -168.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.48 HD22 HG11 ' A' ' 163' ' ' VAL . 70.4 mt -103.09 -172.62 2.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.416 -1.266 . . . . 1.08 107.981 173.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 p -78.65 -94.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.422 -0.911 . . . . 1.5 110.244 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -131.08 113.6 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.195 0.443 . . . . 2.97 112.195 176.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -156.89 3.12 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 5.06 110.832 172.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.2 t60 62.46 24.96 14.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.036 0.922 . . . . 5.95 108.983 -169.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -136.0 156.63 48.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.821 -1.081 . . . . 4.83 110.355 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.524 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -149.25 157.13 27.12 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.106 -1.198 . . . . 0.95 110.106 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 100' ' ' ILE . 20.4 mt -92.67 107.52 19.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.085 -0.709 . . . . 0.48 109.085 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.599 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 45.6 p-80 -145.45 -163.15 1.66 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.283 -0.567 . . . . 1.25 111.117 -176.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.55 173.76 16.1 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.171 -1.014 . . . . 0.46 113.016 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -137.21 174.68 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.432 0.634 . . . . 0.5 111.375 -167.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -104.44 -17.87 14.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.199 -0.909 . . . . 1.86 109.604 165.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -125.39 103.08 29.36 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.827 -0.624 . . . . 1.77 110.238 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.53 4.43 4.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.203 2.602 . . . . 0.59 113.545 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.49 -22.66 54.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.189 0.519 . . . . 0.78 110.818 -171.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -88.28 -6.56 57.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 1.45 110.303 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 134' ' ' ILE . 30.4 mm -81.49 104.69 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 121.663 0.744 . . . . 0.7 110.176 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.89 -153.79 25.07 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 114.785 -1.098 . . . . 1.68 110.676 -176.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -77.74 73.46 4.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.104 0.478 . . . . 4.39 110.638 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -143.33 137.79 29.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.661 -0.7 . . . . 3.94 110.482 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.0 p -116.85 73.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 122.251 1.024 . . . . 4.68 110.339 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.3 m -153.07 110.07 3.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.295 -0.866 . . . . 5.68 109.636 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt 58.02 42.4 22.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.271 0.558 . . . . 8.3 109.587 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.58 114.93 7.04 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.229 -0.896 . . . . 3.85 113.665 -172.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.426 ' HA ' ' O7 ' ' A' 1142 ' ' IM2 . 90.4 m -128.0 149.72 50.24 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.789 -0.449 . . . . 2.51 109.789 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 40.7 mt -90.23 62.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.724 0.773 . . . . 1.44 109.307 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 6.3 ptm180 -124.28 94.3 4.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.793 0.806 . . . . 3.36 111.35 -176.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.467 ' H ' ' HG2' ' A' ' 145' ' ' MET . 7.8 ptm -90.86 -166.51 1.6 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.874 -1.057 . . . . 1.13 111.858 -171.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -61.43 144.23 54.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.474 -0.33 . . . . 2.51 110.156 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.563 ' O ' HG12 ' A' ' 150' ' ' VAL . 25.3 p-10 -51.98 -64.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.025 0.203 . . . . 1.77 111.536 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -62.68 -26.66 68.77 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.747 -0.596 . . . . 2.13 111.462 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.47 -42.23 71.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.451 -0.341 . . . . 1.05 110.526 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.625 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.8 p -75.8 -17.44 15.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.32 110.577 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.567 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -88.33 -37.99 11.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 119.289 -0.386 . . . . 0.37 110.306 174.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -43.64 -70.23 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.078 0.854 . . . . 1.38 111.954 161.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.664 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.0 OUTLIER -50.03 -41.2 47.01 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.465 -0.789 . . . . 0.74 110.29 178.248 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.41 -51.57 64.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.662 -1.154 . . . . 0.22 111.719 -173.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.504 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 14.9 m -77.94 -13.42 59.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.393 -1.276 . . . . 1.33 111.387 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.48 -50.85 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.156 -0.474 . . . . 0.23 110.08 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 153' ' ' LEU . 18.9 m -78.59 115.37 51.1 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-O 121.943 0.878 . . . . 0.21 110.536 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.798 ' HG2' HD13 ' A' ' 57' ' ' ILE . 33.5 Cg_endo -84.6 -177.17 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.375 2.717 . . . . 0.34 112.935 -174.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.616 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.5 m120 -56.09 -2.35 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.636 -1.165 . . . . 1.02 114.016 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.2 57.2 0.5 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.633 -0.794 . . . . 0.28 112.477 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.4 m -92.16 133.14 36.06 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.018 -0.364 . . . . 0.3 110.018 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.22 133.9 34.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.469 -0.492 . . . . 1.96 110.089 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -143.84 130.78 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 0.46 111.234 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.402 ' C ' HD12 ' A' ' 165' ' ' ILE . 29.6 m -115.55 140.45 49.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.855 -0.612 . . . . 0.56 111.647 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 164' ' ' THR . 2.9 mp -123.82 110.29 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 118.957 -1.097 . . . . 0.96 110.217 171.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -142.81 140.01 31.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.897 -1.047 . . . . 1.19 110.566 -172.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.58 ' HB2' HG22 ' A' ' 93' ' ' THR . 5.1 mpt_? -72.88 -16.31 61.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.114 -0.948 . . . . 3.42 111.584 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.78 89.2 0.54 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.663 -0.779 . . . . 3.65 111.758 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.262 -0.875 . . . . 5.97 109.913 179.322 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1142 ' ' IM2 . . . . . 0.528 ' S21' ' O31' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 3.1 mppt? . . . . . 0 CA--C 1.512 -0.495 0 CA-C-O 120.28 0.086 . . . . 2.1000000000000001 111.114 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 49' ' ' PRO . 20.0 mt -85.2 168.26 14.94 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.721 0.638 . . . . 0.26000000000000001 110.958 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.869 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -76.87 149.48 36.11 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 123.273 0.629 . . . . 0.23000000000000001 112.57 -167.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.528 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.2 148.94 36.52 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.091 -0.959 . . . . 0.26000000000000001 111.427 167.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 45' ' ' SER . 74.3 t80 -134.42 148.43 50.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.705 -1.589 . . . . 0.39000000000000001 107.753 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.89 114.46 15.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.152 -1.425 . . . . 1.0700000000000001 107.152 175.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.442 HG11 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -77.51 158.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.801 -0.636 . . . . 0.38 111.262 -168.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -112.44 153.1 27.89 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.846 -0.798 . . . . 2.5899999999999999 108.846 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.676 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.24 116.18 1.91 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.64 -0.709 . . . . 1.74 112.396 -172.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.93 -11.57 20.51 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.476 -0.783 . . . . 0.56999999999999995 113.013 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.584 ' HB3' HD11 ' A' ' 18' ' ' ILE . 78.9 m-20 -63.13 153.97 32.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.633 0.605 . . . . 2.1699999999999999 112.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.551 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.4 p -134.05 155.0 50.79 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.858 -0.61 . . . . 0.5 112.385 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.3 tp -48.64 -58.99 3.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.68 0.992 . . . . 0.27000000000000002 113.68 -173.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.656 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.9 t-20 -65.25 -43.13 92.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.533 1.159 . . . . 1.21 110.164 -169.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.83 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 13.9 m -57.98 -43.13 86.36 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 112.381 -2.19 . . . . 1.24 110.484 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.584 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.51 -41.1 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 123.738 0.815 . . . . 0.29999999999999999 112.566 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.678 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.29 -64.41 0.87 Allowed 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.588 -0.278 . . . . 0.23000000000000001 111.388 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.27 -4.46 50.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.875 -1.13 . . . . 0.39000000000000001 111.843 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.83 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.8 t0 -65.54 -34.31 77.95 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.618 -0.882 . . . . 1.6299999999999999 108.618 157.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.673 ' CD1' HD12 ' A' ' 101' ' ' ILE . 1.9 m-85 -95.15 16.92 15.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.777 0.322 . . . . 0.23999999999999999 111.83 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 55.14 48.41 19.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.619 -0.719 . . . . 3.5499999999999998 110.552 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.678 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.1 pt -147.22 -176.34 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.526 -0.916 . . . . 0.27000000000000002 108.526 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -100.07 145.04 28.41 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.297 -0.865 . . . . 0.81000000000000005 109.374 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.656 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 13.5 p -60.75 -35.85 77.44 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.41 0.624 . . . . 0.27000000000000002 109.331 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.569 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.02 -32.71 74.14 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.488 -1.233 . . . . 0.26000000000000001 111.514 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -37.51 42.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.095 0.474 . . . . 0.23000000000000001 109.749 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 46' ' ' ILE . 18.3 tp -73.63 -19.25 60.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.499 -0.773 . . . . 0.17000000000000001 109.077 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.737 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.79 35.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.3 0.571 . . . . 0.19 111.419 172.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 64.9 mt-30 -57.04 -44.33 82.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.511 1.148 . . . . 1.0700000000000001 109.598 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.39 42.18 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.327 -1.76 . . . . 0.17000000000000001 112.37 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.614 HD21 ' H ' ' A' ' 47' ' ' VAL . 30.7 m-80 -143.28 72.56 17.97 Favored Pre-proline 0 CA--C 1.513 -0.466 0 CA-C-O 121.075 0.464 . . . . 0.19 110.014 -171.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.691 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.6 Cg_endo -57.87 -9.05 5.21 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.289 2.659 . . . . 0.29999999999999999 113.876 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -63.62 -33.54 75.83 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.073 0.939 . . . . 1.1699999999999999 109.363 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.646 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -80.97 -6.53 58.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.059 -1.428 . . . . 0.53000000000000003 114.508 -171.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.737 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.73 -40.64 41.39 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.634 1.207 . . . . 1.23 109.919 177.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.61 -46.36 11.61 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 112.755 -2.02 . . . . 0.40000000000000002 111.815 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -166.89 39.11 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.439 -0.886 . . . . 0.29999999999999999 114.163 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 18' ' ' ILE . 5.3 mp -113.98 158.97 20.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.67 -1.265 . . . . 0.31 110.214 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.623 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.05 135.32 39.31 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.905 -0.589 . . . . 0.39000000000000001 110.923 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.676 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.91 126.69 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.338 0.866 . . . . 0.46999999999999997 113.338 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.8 -10.52 51.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 114.539 -1.21 . . . . 0.35999999999999999 112.192 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.5 tt0 -64.28 152.31 41.4 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.572 0.701 . . . . 1.1899999999999999 110.552 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.7 m -118.47 134.74 54.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.452 -1.249 . . . . 0.89000000000000001 109.113 -172.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 HD11 ' A' ' 29' ' ' LEU . 22.2 pt -137.08 153.93 30.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.213 0.53 . . . . 0.22 110.508 -175.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.614 ' H ' HD21 ' A' ' 33' ' ' ASN . 11.4 t -98.81 148.99 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.292 -0.867 . . . . 0.20999999999999999 110.407 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.5 mm -118.16 88.09 31.2 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 114.903 -1.044 . . . . 0.17000000000000001 108.356 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.703 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.7 Cg_endo -60.04 140.59 93.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.095 2.53 . . . . 0.23000000000000001 112.43 -174.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.534 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.01 -7.79 69.43 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.636 -0.711 . . . . 0.29999999999999999 112.528 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.759 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.63 128.67 25.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.487 -0.931 . . . . 0.25 108.487 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.655 ' HD2' HD23 ' A' ' 51' ' ' LEU . 71.8 Cg_endo -69.36 169.24 18.86 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.695 2.93 . . . . 0.31 114.241 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 3.2 t70 -90.91 136.88 27.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.621 -1.172 . . . . 0.71999999999999997 111.603 -172.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.869 ' HD3' HD12 ' A' ' 5' ' ' LEU . 73.2 Cg_endo -76.74 -1.9 12.07 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.02 2.48 . . . . 0.27000000000000002 112.893 -173.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -96.13 -28.75 14.44 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 120.714 0.292 . . . . 2.1099999999999999 111.031 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.7 p -65.19 -34.6 78.76 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.606 -1.257 . . . . 1.47 107.606 168.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.752 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.4 mt -78.15 126.37 83.65 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 113.053 -1.885 . . . . 0.26000000000000001 111.016 176.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.47 96.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 120.92 1.08 . . . . 0.20000000000000001 110.248 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.435 ' HD2' HG23 ' A' ' 57' ' ' ILE . 82.9 m-85 -158.87 136.77 10.39 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.463 -1.31 . . . . 0.26000000000000001 107.463 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 26.2 t-80 -141.75 108.18 5.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.603 -1.258 . . . . 2.8399999999999999 107.603 -169.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.0 mt -95.11 109.83 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.974 -1.012 . . . . 0.32000000000000001 110.317 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.53 95.42 5.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.181 -0.918 . . . . 0.34000000000000002 110.013 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.479 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -114.34 97.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.362 -1.29 . . . . 0.68000000000000005 109.325 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 32.0 m -92.05 130.37 37.8 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.898 -1.046 . . . . 1.05 108.584 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.9 mm -60.2 -34.96 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.768 0.794 . . . . 1.29 109.042 177.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.38 91.24 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.475 -1.238 . . . . 0.88 111.337 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.489 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.11 -24.35 64.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.265 0.555 . . . . 0.73999999999999999 112.217 176.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 30.4 mttt 55.39 18.06 2.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.159 0.984 . . . . 2.5099999999999998 112.798 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.518 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -141.26 140.58 33.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.78 0.8 . . . . 0.45000000000000001 110.982 175.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.479 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -94.06 117.58 30.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.267 -1.333 . . . . 0.33000000000000002 109.516 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 m -101.05 126.27 47.72 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.439 -0.504 . . . . 0.40000000000000002 111.189 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.559 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -82.74 147.73 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.126 -1.805 . . . . 0.33000000000000002 106.126 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 20.0 m -150.94 130.82 13.28 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 120.238 1.381 . . . . 0.75 112.329 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.9 tp -122.02 125.2 45.75 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.921 -1.036 . . . . 0.34999999999999998 110.697 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 66.06 35.14 6.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.539 0.685 . . . . 0.52000000000000002 109.321 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.3 m120 82.19 2.0 1.33 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.183 -1.371 . . . . 1.8400000000000001 111.719 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -131.52 140.46 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 118.756 -1.178 . . . . 3.1899999999999999 113.623 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.4 148.28 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 113.017 -1.901 . . . . 0.40999999999999998 112.788 -177.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.55 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.3 mtp -98.51 -42.74 7.17 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 112.734 -2.03 . . . . 0.34999999999999998 108.275 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 179.32 159.47 0.67 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.226 -2.261 . . . . 2.0699999999999998 110.135 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.518 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 11.8 m -119.14 133.26 55.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.588 0.232 . . . . 0.37 111.238 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 48.6 m-85 -117.38 145.44 36.09 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.541 . . . . 0.96999999999999997 109.538 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.44 ' HB2' HG22 ' A' ' 134' ' ' ILE . 10.2 Cg_endo -82.09 144.34 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.308 2.005 . . . . 0.59999999999999998 111.722 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.45 173.27 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.675 -0.491 . . . . 0.64000000000000001 109.675 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 121.38 0.61 . . . . 0.82999999999999996 110.966 177.502 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.566 ' HB2' HG13 ' A' ' 163' ' ' VAL . 4.4 m-85 . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 107.841 -1.17 . . . . 1.9299999999999999 107.841 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 161' ' ' THR . 60.6 m-85 -130.67 140.49 50.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.113 0.482 . . . . 0.57999999999999996 110.879 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.837 HD11 HD12 ' A' ' 125' ' ' ILE . 19.0 mm -59.76 104.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.194 -1.039 . . . . 0.40999999999999998 108.194 166.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.673 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.5 tt -103.01 -24.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 120.221 -0.592 . . . . 0.37 112.191 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 6.5 t-20 -155.23 157.73 37.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.133 1.16 . . . . 1.99 114.133 -172.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.31 133.73 26.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 111.767 -2.47 . . . . 1.1899999999999999 110.262 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 33.5 tp60 -106.27 141.79 37.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.069 -0.969 . . . . 1.6699999999999999 111.386 -173.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.515 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 17.7 ttt180 -54.69 150.76 9.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.075 -1.875 . . . . 3.0600000000000001 112.434 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -45.19 100.36 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.507 0 O-C-N 124.931 1.395 . . . . 2.6099999999999999 111.58 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -55.37 -50.02 14.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.886 3.058 . . . . 0.97999999999999998 112.242 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.26 -13.16 23.71 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.02 -0.991 . . . . 1.0800000000000001 112.256 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.75 -170.44 13.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.829 -0.7 . . . . 1.05 112.773 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.64 18.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 124.69 3.593 . . . . 1.3 114.61 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 115' ' ' TRP . 1.4 t80 -72.36 -16.13 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.256 0.55 . . . . 1.3799999999999999 109.655 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.88 42.71 2.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 1.1100000000000001 114.061 170.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 114' ' ' TYR . . . 73.59 -39.05 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.307 0.854 . . . . 0.81000000000000005 113.307 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -151.55 144.79 24.69 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 122.719 0.408 . . . . 1.1200000000000001 109.93 -174.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 47.8 t-105 -117.07 104.44 11.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.873 -0.417 . . . . 2.1899999999999999 109.873 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.3 mp -105.95 137.1 44.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.546 0.688 . . . . 0.60999999999999999 110.707 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.1 m -105.09 145.18 30.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.334 -0.848 . . . . 0.93999999999999995 112.266 -170.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.517 HD11 HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -96.53 -174.67 3.1 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.907 -1.146 . . . . 1.0800000000000001 107.907 171.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.556 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 33.7 m . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 113.764 1.024 . . . . 1.5 113.764 -172.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 HD11 ' A' ' 100' ' ' ILE . 40.0 mt . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 108.976 -0.75 . . . . 0.47999999999999998 108.976 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -140.93 -167.65 2.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.752 0.787 . . . . 1.25 112.65 -172.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.469 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.62 179.86 16.05 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.586 -1.188 . . . . 0.46000000000000002 113.221 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -144.65 174.6 10.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.49 0.662 . . . . 0.5 111.563 -165.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -110.85 -13.23 14.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.923 -1.035 . . . . 1.8600000000000001 109.557 162.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -124.39 101.6 34.13 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.72 -0.673 . . . . 1.77 109.633 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -92.22 3.6 3.82 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.213 2.609 . . . . 0.58999999999999997 113.682 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.07 -19.24 40.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.33 0.586 . . . . 0.78000000000000003 110.458 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -87.7 -7.12 57.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.57 -0.741 . . . . 1.45 110.223 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.44 HG22 ' HB2' ' A' ' 83' ' ' PRO . 13.4 mm . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.238 -0.892 . . . . 0.69999999999999996 111.369 -174.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.273 0 N-CA-C 109.784 -0.45 . . . . 1.1299999999999999 109.784 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.555 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 30.4 m-70 -66.84 152.69 45.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.251 -0.648 . . . . 2.5099999999999998 109.251 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.554 ' O ' HG12 ' A' ' 150' ' ' VAL . 1.9 m-20 -50.5 -61.55 2.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.302 0.376 . . . . 1.77 111.101 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.19 -28.54 70.12 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.89 -0.506 . . . . 2.1299999999999999 111.63 -175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 1.5 m-20 -67.12 -41.96 85.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 1.05 110.777 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.5 p -77.03 -16.38 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.32000000000000001 110.716 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -89.15 -39.68 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 119.109 -0.472 . . . . 0.37 110.679 173.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -43.69 -68.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.402 1.001 . . . . 1.3799999999999999 111.825 163.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -49.96 -43.11 49.9 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.638 -0.71 . . . . 0.73999999999999999 110.271 177.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.16 -52.8 60.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.406 -1.27 . . . . 0.22 112.25 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.8 p -77.44 -15.94 59.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.548 -1.206 . . . . 1.3300000000000001 111.214 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.5 -48.62 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.731 -0.47 . . . . 0.23000000000000001 109.731 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.8 m -77.48 118.87 74.85 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-O 121.946 0.879 . . . . 0.20999999999999999 110.559 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.752 ' HG2' HD13 ' A' ' 57' ' ' ILE . 35.3 Cg_endo -83.6 -177.85 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.177 2.585 . . . . 0.34000000000000002 112.533 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.759 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.0 m120 -61.56 3.84 0.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.977 -1.01 . . . . 1.02 113.52 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.94 58.13 0.46 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.28000000000000003 112.379 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.78 135.92 33.41 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 122.547 -0.384 . . . . 0.29999999999999999 110.452 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -83.88 125.51 32.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.79 -0.187 . . . . 1.96 110.546 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 98' ' ' PHE . 4.2 p -138.15 127.43 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.439 0.637 . . . . 0.46000000000000002 111.28 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.4 ' C ' HD12 ' A' ' 165' ' ' ILE . 31.7 m -118.22 140.36 49.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.654 -0.703 . . . . 0.56000000000000005 111.721 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.422 HG13 HG13 ' A' ' 63' ' ' VAL . 2.7 mp -122.17 110.25 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 118.919 -1.112 . . . . 0.95999999999999996 110.524 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.649 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.476 -0.784 . . . . 1.1899999999999999 111.354 -170.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.5 mptp? . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.632 -0.507 . . . . 2.1000000000000001 109.632 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -99.4 170.81 8.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.425 -0.352 . . . . 0.26000000000000001 111.458 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.568 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.2 tp -77.86 150.95 34.1 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.334 0.654 . . . . 0.23000000000000001 112.358 -170.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.552 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.86 149.47 40.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.055 0.931 . . . . 0.26000000000000001 112.295 169.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.7 t80 -133.1 147.73 52.15 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 113.595 -1.639 . . . . 0.39000000000000001 107.596 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.68 113.65 16.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.036 -1.468 . . . . 1.0700000000000001 107.036 175.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -73.48 156.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.066 0.46 . . . . 0.38 111.89 -166.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -104.96 146.71 28.66 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.491 -0.777 . . . . 2.5899999999999999 109.23 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.931 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 3.2 tt0 -50.55 106.18 0.12 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.846 -1.07 . . . . 1.74 112.894 -173.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.15 15.17 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.407 -0.815 . . . . 0.56999999999999995 112.812 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.591 ' HB3' HD11 ' A' ' 18' ' ' ILE . 17.3 m-20 -62.36 154.57 27.64 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.345 0.498 . . . . 2.1699999999999999 112.345 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.611 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -131.64 155.37 47.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.008 0.433 . . . . 0.5 111.989 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.7 tp -49.03 -60.12 3.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.098 1.147 . . . . 0.27000000000000002 114.098 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.727 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 3.1 t-20 -65.21 -38.72 91.3 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.011 0.91 . . . . 1.21 110.572 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 t -58.61 -50.36 74.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 113.154 -1.839 . . . . 1.24 109.19 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -67.72 -38.48 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 O-C-N 123.584 0.553 . . . . 0.29999999999999999 111.975 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.48 -60.16 4.07 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 110.994 175.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.79 58.57 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.67 -1.212 . . . . 0.39000000000000001 112.15 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 11.3 m-20 -62.61 -34.33 76.81 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.859 -1.163 . . . . 1.6299999999999999 107.859 156.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.694 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.3 m-85 -99.98 17.54 20.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.396 0.517 . . . . 0.23999999999999999 112.396 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 50.44 53.77 12.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 3.5499999999999998 111.13 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.1 pt -147.77 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.045 -0.724 . . . . 0.27000000000000002 109.045 -173.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -98.78 144.17 28.31 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.333 -0.849 . . . . 0.81000000000000005 109.57 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.727 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.9 p -62.89 -37.15 85.79 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.564 0.697 . . . . 0.27000000000000002 109.21 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.14 -27.89 69.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.104 -1.407 . . . . 0.26000000000000001 111.343 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.89 -37.52 26.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.231 0.538 . . . . 0.23000000000000001 109.862 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 HD12 ' A' ' 46' ' ' ILE . 14.3 tp -73.8 -19.83 60.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.205 -0.907 . . . . 0.17000000000000001 109.009 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.747 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.98 -37.74 38.65 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.332 0.586 . . . . 0.19 111.235 172.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.5 mt-30 -56.89 -42.85 80.62 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.25 1.024 . . . . 1.0700000000000001 109.686 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.65 -20.58 35.99 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.536 -1.666 . . . . 0.17000000000000001 112.523 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 31.7 m-80 -142.04 72.16 23.09 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.009 0.433 . . . . 0.19 109.994 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.6 -9.36 5.27 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.586 2.857 . . . . 0.29999999999999999 113.954 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -63.78 -33.63 76.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.028 0.918 . . . . 1.1699999999999999 109.845 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -80.6 -4.75 55.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.206 -1.361 . . . . 0.53000000000000003 114.46 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.747 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -50.52 -39.41 48.69 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 122.561 1.172 . . . . 1.23 110.035 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.535 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -86.57 -45.87 10.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 112.921 -1.945 . . . . 0.40000000000000002 111.523 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 176.08 -167.55 39.3 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.155 -1.021 . . . . 0.29999999999999999 114.295 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 18' ' ' ILE . 6.3 mp -115.86 157.92 23.73 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.511 -1.345 . . . . 0.31 110.571 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 48.8 m -130.34 134.74 47.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.74 -0.664 . . . . 0.39000000000000001 110.394 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.931 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.99 129.95 17.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.98 0.733 . . . . 0.46999999999999997 112.98 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 -13.82 35.89 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 114.792 -1.095 . . . . 0.35999999999999999 112.054 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.64 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.2 tt0 -63.02 152.38 37.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.744 0.783 . . . . 1.1899999999999999 110.323 175.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 31.1 m -119.42 131.88 55.72 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.365 -1.289 . . . . 0.89000000000000001 109.403 -171.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.691 HD12 HD11 ' A' ' 29' ' ' LEU . 23.0 pt -133.46 155.82 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.248 0.547 . . . . 0.22 110.522 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.584 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.4 t -101.38 148.73 6.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.239 -0.891 . . . . 0.20999999999999999 110.176 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.528 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.8 mm -117.17 87.69 24.52 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.767 -1.106 . . . . 0.17000000000000001 108.099 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.692 ' HA ' HD13 ' A' ' 4' ' ' LEU . 21.7 Cg_endo -58.63 145.82 93.94 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.387 2.725 . . . . 0.23000000000000001 112.627 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 78.61 -6.16 54.33 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.911 -0.586 . . . . 0.29999999999999999 112.831 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.72 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -116.06 125.41 28.62 Favored Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.707 -0.849 . . . . 0.25 108.707 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HD2' HD23 ' A' ' 51' ' ' LEU . 55.6 Cg_endo -64.92 174.2 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.616 2.878 . . . . 0.31 113.752 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 1.8 t70 -91.13 140.43 25.87 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 114.88 -1.054 . . . . 0.71999999999999997 111.686 -170.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.568 ' HD3' HD12 ' A' ' 5' ' ' LEU . 63.0 Cg_endo -84.09 -7.58 10.12 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.316 2.677 . . . . 0.27000000000000002 113.474 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.65 -29.27 17.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.924 0.392 . . . . 2.1099999999999999 110.437 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -80.69 -13.73 58.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.749 0.785 . . . . 1.47 109.02 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.794 HD13 ' HG2' ' A' ' 158' ' ' PRO . 66.8 mt -85.91 126.95 64.18 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 114.679 -1.146 . . . . 0.26000000000000001 109.839 171.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -101.61 94.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.948 0 CA-C-N 119.972 1.026 . . . . 0.20000000000000001 110.659 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.803 ' HA ' ' O ' ' A' ' 73' ' ' SER . 92.6 m-85 -158.56 139.65 13.09 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.981 -1.463 . . . . 0.26000000000000001 107.236 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 55.9 m-70 -139.19 117.77 12.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.916 -1.513 . . . . 2.8399999999999999 106.916 -176.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 79.6 mt -98.88 109.34 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.085 -0.646 . . . . 0.32000000000000001 110.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.65 98.94 7.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.918 0.865 . . . . 0.34000000000000002 110.896 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.3 p -121.01 98.44 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.012 -1.449 . . . . 0.68000000000000005 110.606 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 68' ' ' LYS . 68.8 m -92.03 115.49 28.12 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.419 -1.326 . . . . 1.05 107.419 170.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 mt -54.05 -26.0 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 121.122 0.487 . . . . 1.29 110.167 172.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.58 -48.43 62.64 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.795 -0.717 . . . . 0.88 112.237 169.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.34 -22.48 66.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.451 0.643 . . . . 0.73999999999999999 110.849 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 64' ' ' SER . 9.0 tmtt? 64.35 11.03 6.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.6 -1.182 . . . . 2.5099999999999998 112.603 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.471 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -145.12 143.43 30.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.591 0.71 . . . . 0.45000000000000001 112.183 176.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.526 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.8 tt -95.72 122.27 38.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.197 -1.365 . . . . 0.33000000000000002 109.952 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.26 125.74 50.07 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.487 -0.485 . . . . 0.40000000000000002 111.61 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.555 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.21 150.62 26.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.426 -1.694 . . . . 0.33000000000000002 106.426 175.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.803 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 1.4 m -150.84 128.5 11.55 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.335 1.425 . . . . 0.75 111.786 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.0 tp -115.01 126.91 55.29 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.496 -0.775 . . . . 0.34999999999999998 110.222 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.58 35.29 11.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.392 0.615 . . . . 0.52000000000000002 109.666 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.39 7.77 5.17 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.02 -0.991 . . . . 1.8400000000000001 112.367 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -129.89 138.26 50.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.755 -1.178 . . . . 3.1899999999999999 113.649 170.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.71 150.06 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 113.551 -1.659 . . . . 0.40999999999999998 112.963 -172.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.531 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 3.6 mtp -103.36 -41.15 6.11 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.745 -2.025 . . . . 0.34999999999999998 108.476 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 2.8 tppt? -175.29 170.28 3.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 112.868 -1.969 . . . . 2.0699999999999998 111.1 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.471 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 16.0 m -131.02 129.42 42.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.684 -0.235 . . . . 0.37 110.93 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.77 150.43 44.86 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 122.32 0.248 . . . . 0.96999999999999997 110.948 -175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -84.92 141.07 8.23 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.838 2.359 . . . . 0.59999999999999998 112.1 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.46 -177.12 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.057 -0.519 . . . . 0.64000000000000001 110.412 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.82999999999999996 109.617 176.295 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 163' ' ' VAL . 19.6 m-85 . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.269 0.557 . . . . 1.9299999999999999 110.531 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' THR . 65.2 m-85 -131.46 141.26 49.76 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.255 -0.884 . . . . 0.57999999999999996 109.969 172.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 125' ' ' ILE . 24.0 mm -59.87 114.36 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 N-CA-C 107.47 -1.307 . . . . 0.40999999999999998 107.47 165.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.59 HD12 ' HD1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -106.91 -27.41 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.551 -0.86 . . . . 0.37 112.018 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.578 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 60.0 t30 -172.41 -172.64 0.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.663 1.22 . . . . 1.99 113.481 -175.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.578 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.3 ptt180 -155.45 131.71 10.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 111.693 -2.503 . . . . 1.1899999999999999 109.711 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.74 157.34 17.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.58 1.181 . . . . 1.6699999999999999 112.227 -171.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 106' ' ' ASN . 37.0 ttt180 -53.93 154.78 3.81 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 112.485 -2.143 . . . . 3.0600000000000001 112.473 170.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 105' ' ' ARG . 9.3 p30 -44.03 105.72 0.46 Allowed Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 112.925 -1.943 . . . . 2.6099999999999999 111.346 175.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 88.7 Cg_exo -56.75 -53.31 5.26 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.653 2.902 . . . . 0.97999999999999998 112.309 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.62 37.68 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.206 -0.906 . . . . 1.0800000000000001 112.599 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.85 -170.37 24.36 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.915 -0.66 . . . . 1.05 111.89 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.15 49.56 0.34 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.992 3.128 . . . . 1.3 113.127 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.441 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -93.85 -21.1 19.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.059 0.456 . . . . 1.3799999999999999 110.026 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.54 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 46.62 2.04 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.53 -0.759 . . . . 1.1100000000000001 113.986 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.62 -24.53 0.21 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.192 0.812 . . . . 0.81000000000000005 113.192 170.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -154.43 151.33 28.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.261 -0.274 . . . . 1.1200000000000001 110.261 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -118.02 100.25 7.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.788 -0.819 . . . . 2.1899999999999999 108.788 165.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.5 mp -101.85 139.24 37.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.801 0.81 . . . . 0.60999999999999999 110.32 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.401 ' HB2' HG23 ' A' ' 101' ' ' ILE . 68.0 m -106.68 144.96 32.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.916 -1.038 . . . . 0.93999999999999995 112.378 -168.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.574 HD22 HG11 ' A' ' 163' ' ' VAL . 73.0 mt -102.24 -176.84 3.23 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.648 -1.16 . . . . 1.0800000000000001 108.464 173.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 49.6 m . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 111.803 0.297 . . . . 1.5 111.803 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.789 HD12 HD11 ' A' ' 100' ' ' ILE . 23.1 mt . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.254 -0.647 . . . . 0.47999999999999998 109.254 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -153.51 -162.22 1.42 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.405 0.621 . . . . 1.25 111.498 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.54 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.63 179.57 16.38 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.158 -1.02 . . . . 0.46000000000000002 112.779 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -135.13 174.83 10.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.453 0.644 . . . . 0.5 111.185 -167.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -107.74 -23.0 12.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.92 -1.036 . . . . 1.8600000000000001 108.994 168.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.41 104.63 28.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 114.756 -1.111 . . . . 1.77 109.616 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.418 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.8 Cg_endo -89.97 4.5 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.213 2.609 . . . . 0.58999999999999997 113.185 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.84 -21.91 29.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.389 0.614 . . . . 0.78000000000000003 109.453 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.2 t -76.76 -18.18 58.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.079 -0.964 . . . . 1.45 109.317 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 23.4 mm . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.096 -0.957 . . . . 0.69999999999999996 110.275 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.9 mtp . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.79 0.329 . . . . 1.1299999999999999 110.581 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -78.4 161.46 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.106 -0.701 . . . . 2.5099999999999998 109.106 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.633 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.5 m-20 -52.42 -68.13 0.19 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.398 0.436 . . . . 1.77 110.987 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -58.12 -30.89 66.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.098 0.407 . . . . 2.1299999999999999 112.098 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -67.07 -41.5 86.31 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.906 0.384 . . . . 1.05 110.975 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 7.3 p -78.38 -15.27 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 0.32000000000000001 110.637 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.467 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.7 mp -87.39 -41.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 118.749 -0.643 . . . . 0.37 110.414 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -44.36 -68.72 0.17 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.543 1.065 . . . . 1.3799999999999999 112.244 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.687 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.8 OUTLIER -49.94 -43.46 49.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.927 -0.579 . . . . 0.73999999999999999 110.169 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.17 -54.66 32.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.074 -1.421 . . . . 0.22 111.929 -171.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -79.95 -14.4 58.63 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.574 -1.194 . . . . 1.3300000000000001 110.779 -170.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.65 -48.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.987 -0.375 . . . . 0.23000000000000001 109.987 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 153' ' ' LEU . 23.1 m -76.33 119.35 76.93 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-O 121.672 0.748 . . . . 0.20999999999999999 110.294 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.794 ' HG2' HD13 ' A' ' 57' ' ' ILE . 43.8 Cg_endo -83.1 -178.07 3.63 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.154 2.569 . . . . 0.34000000000000002 112.872 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.72 ' O ' HD21 ' A' ' 51' ' ' LEU . 21.6 m120 -61.44 0.06 0.34 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.104 -0.953 . . . . 1.02 113.142 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.84 58.02 0.52 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.767 -0.73 . . . . 0.28000000000000003 112.519 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.5 m -95.26 133.98 38.54 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.327 -0.513 . . . . 0.29999999999999999 110.206 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 162' ' ' ARG . 0.0 OUTLIER -84.7 134.17 34.36 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 1.96 110.353 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.574 HG11 HD22 ' A' ' 118' ' ' LEU . 2.4 p -140.57 123.73 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.024 -0.989 . . . . 0.46000000000000002 110.79 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.463 ' C ' HD12 ' A' ' 165' ' ' ILE . 93.0 m -118.09 141.57 48.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.494 -0.775 . . . . 0.56000000000000005 111.782 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.506 HG13 HG13 ' A' ' 63' ' ' VAL . 2.9 mp -125.13 123.31 65.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 118.845 -1.142 . . . . 0.95999999999999996 112.258 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 107.989 -1.115 . . . . 1.1899999999999999 107.989 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.6 mptp? . . . . . 0 CA--C 1.52 -0.207 0 N-CA-C 109.929 -0.397 . . . . 2.1000000000000001 109.929 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -100.11 169.92 8.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.188 0.305 . . . . 0.26000000000000001 111.439 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.587 HD23 HG13 ' A' ' 48' ' ' ILE . 4.6 tp -75.86 150.23 37.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 123.076 0.55 . . . . 0.23000000000000001 112.17 -170.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.515 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.38 149.26 38.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 122.11 0.957 . . . . 0.26000000000000001 111.921 167.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 45' ' ' SER . 67.8 t80 -132.84 149.41 52.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.538 -1.665 . . . . 0.39000000000000001 107.863 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.592 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.1 119.67 25.81 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.628 -1.619 . . . . 1.0700000000000001 106.628 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.448 HG11 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -79.99 158.56 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-O 121.227 0.537 . . . . 0.38 111.554 -170.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -110.16 155.44 21.95 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.554 -0.906 . . . . 2.5899999999999999 108.554 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.628 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 47.7 tt0 -52.53 122.34 8.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 1.74 112.14 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.99 -9.08 36.68 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.99 -1.004 . . . . 0.56999999999999995 112.724 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.68 ' HB3' HD11 ' A' ' 18' ' ' ILE . 94.7 m-20 -67.42 151.23 47.77 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.935 0.398 . . . . 2.1699999999999999 112.058 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.563 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 p -132.6 157.33 45.05 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 112.282 0.475 . . . . 0.5 112.282 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.579 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.9 tp -49.96 -59.75 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.95 1.092 . . . . 0.27000000000000002 113.95 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.4 t-20 -65.83 -38.3 88.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.298 1.047 . . . . 1.21 110.476 -168.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 t -57.09 -54.93 41.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 113.143 -1.844 . . . . 1.24 109.233 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.68 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.72 -38.76 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 115.531 -0.759 . . . . 0.29999999999999999 112.086 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.86 -63.73 1.11 Allowed 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 116.048 -0.523 . . . . 0.23000000000000001 111.279 177.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.66 -3.93 54.83 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.803 -1.159 . . . . 0.39000000000000001 112.011 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 23.6 m-20 -66.97 -27.34 67.37 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.81 -0.811 . . . . 1.6299999999999999 108.81 156.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.1 m-85 -103.07 18.31 21.99 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.861 -0.524 . . . . 0.23999999999999999 111.968 171.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 50.34 54.81 10.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.195 -0.911 . . . . 3.5499999999999998 110.918 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.1 pt -148.26 -173.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.597 -0.89 . . . . 0.27000000000000002 108.597 -173.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -100.96 143.63 30.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.29 -0.868 . . . . 0.81000000000000005 109.319 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.71 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.8 p -61.05 -35.27 76.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.453 0.645 . . . . 0.27000000000000002 109.503 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.94 -30.69 71.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.482 -1.236 . . . . 0.26000000000000001 111.396 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.78 30.5 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.224 0.535 . . . . 0.23000000000000001 109.631 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.674 HD11 HD12 ' A' ' 46' ' ' ILE . 15.0 tp -73.17 -19.3 61.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.417 -0.81 . . . . 0.17000000000000001 109.022 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.748 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.61 36.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.315 0.578 . . . . 0.19 111.237 172.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 51.6 mt-30 -58.01 -42.52 85.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.227 1.013 . . . . 1.0700000000000001 109.727 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.69 -20.71 38.94 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 113.478 -1.692 . . . . 0.17000000000000001 112.489 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.708 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 30.9 m-80 -143.43 73.48 17.5 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.19 109.949 -172.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.751 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.7 Cg_endo -57.36 -12.05 9.73 Favored 'Trans proline' 0 C--O 1.221 -0.372 0 C-N-CA 123.573 2.849 . . . . 0.29999999999999999 114.003 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -62.47 -34.23 76.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.106 0.955 . . . . 1.1699999999999999 109.119 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.3 mt -78.44 -6.7 56.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.117 -1.402 . . . . 0.53000000000000003 114.448 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -50.99 -42.55 60.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 120.019 1.281 . . . . 1.23 109.478 176.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.84 15.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 112.894 -1.957 . . . . 0.40000000000000002 111.601 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.86 -164.4 35.81 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.264 -0.969 . . . . 0.29999999999999999 114.243 176.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' CD2' HG12 ' A' ' 18' ' ' ILE . 5.6 mp -116.85 158.96 23.11 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.274 -1.463 . . . . 0.31 109.905 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.597 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 93.2 m -136.53 135.63 38.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.912 -0.585 . . . . 0.39000000000000001 110.77 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.27 126.61 6.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.267 0.84 . . . . 0.46999999999999997 113.267 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.592 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.57 -12.52 46.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.588 -1.187 . . . . 0.35999999999999999 112.388 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.597 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.7 tt0 -63.2 152.08 38.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.597 0.713 . . . . 1.1899999999999999 110.455 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 49.9 m -119.87 132.27 55.51 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.668 -1.151 . . . . 0.89000000000000001 109.612 -171.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.674 HD12 HD11 ' A' ' 29' ' ' LEU . 18.9 pt -132.91 160.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.156 0.503 . . . . 0.22 110.319 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.708 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 21.7 t -107.05 148.45 11.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.221 -0.899 . . . . 0.20999999999999999 109.943 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.587 HG13 HD23 ' A' ' 5' ' ' LEU . 15.0 mm -116.66 88.5 25.02 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.957 -1.019 . . . . 0.17000000000000001 108.277 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.725 ' HA ' HD13 ' A' ' 4' ' ' LEU . 27.5 Cg_endo -59.3 142.66 99.43 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.304 2.669 . . . . 0.23000000000000001 113.02 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.479 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.29 -7.56 60.43 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.447 -0.797 . . . . 0.29999999999999999 112.9 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.722 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.48 126.15 28.06 Favored Pre-proline 0 C--O 1.218 -0.567 0 N-CA-C 108.936 -0.764 . . . . 0.25 108.936 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD23 ' A' ' 51' ' ' LEU . 48.8 Cg_endo -64.48 176.56 2.67 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.939 3.093 . . . . 0.31 114.198 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.761 ' HB3' HG22 ' A' ' 56' ' ' THR . 4.3 t70 -90.74 141.99 27.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.84 -1.073 . . . . 0.71999999999999997 110.646 -170.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.484 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 63.1 Cg_endo -86.81 -4.61 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.352 2.702 . . . . 0.27000000000000002 112.158 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -95.06 -28.67 14.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 2.1099999999999999 110.59 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.761 HG22 ' HB3' ' A' ' 53' ' ' ASP . 14.9 t -79.43 -14.1 59.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.024 -1.102 . . . . 1.47 108.024 172.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.8 HD13 ' HG2' ' A' ' 158' ' ' PRO . 71.8 mt -91.54 126.22 55.03 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.118 -1.401 . . . . 0.26000000000000001 109.77 170.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -103.13 95.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.146 0 CA-C-N 120.036 1.048 . . . . 0.20000000000000001 110.117 166.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.424 ' HD2' HG23 ' A' ' 57' ' ' ILE . 74.8 m-85 -158.96 138.66 11.78 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.645 -1.613 . . . . 0.26000000000000001 106.645 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.571 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 12.6 t60 -147.69 121.83 9.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 2.8399999999999999 108.147 -169.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.4 mt -103.39 111.13 31.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 114.643 -1.162 . . . . 0.32000000000000001 110.853 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.27 94.29 4.86 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.077 0.941 . . . . 0.34000000000000002 110.14 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -116.95 98.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 113.82 -1.537 . . . . 0.68000000000000005 109.819 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.507 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 38.7 m -90.19 113.13 24.86 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.672 -1.233 . . . . 1.05 107.672 175.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.571 ' CG1' HG23 ' A' ' 165' ' ' ILE . 2.6 mm -46.46 -37.49 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.845 170.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.31 -42.05 99.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.076 -1.059 . . . . 0.88 112.247 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.507 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.97 -23.96 62.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.051 1.13 . . . . 0.73999999999999999 114.051 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.6 mptt 61.83 11.4 4.06 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.819 0.848 . . . . 2.5099999999999998 112.866 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.407 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -141.62 137.42 31.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.143 0.973 . . . . 0.45000000000000001 112.232 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.523 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.97 119.87 34.23 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.455 -1.702 . . . . 0.33000000000000002 109.621 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.96 124.53 47.74 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.104 -0.639 . . . . 0.40000000000000002 111.538 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.602 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -83.26 134.73 34.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.168 -1.79 . . . . 0.33000000000000002 106.168 175.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 33.6 p -143.39 125.75 15.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 120.943 1.701 . . . . 0.75 113.334 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 tp -110.48 124.42 51.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.351 -1.295 . . . . 0.34999999999999998 110.116 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.46 33.12 7.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.602 0.715 . . . . 0.52000000000000002 109.077 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 m120 77.5 4.48 3.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.23 -1.35 . . . . 1.8400000000000001 111.6 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -129.27 138.08 51.43 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.689 -1.205 . . . . 3.1899999999999999 113.504 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -57.22 148.66 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 113.054 -1.884 . . . . 0.40999999999999998 112.975 -172.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.602 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.2 mtp -100.4 -41.91 6.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.581 -2.099 . . . . 0.34999999999999998 108.393 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? 179.98 160.19 0.85 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.442 -2.163 . . . . 2.0699999999999998 110.39 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.407 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.0 m -121.65 133.23 54.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.385 0.136 . . . . 0.37 110.789 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.447 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 73.0 m-85 -118.81 149.13 45.92 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 120.831 0.348 . . . . 0.96999999999999997 111.623 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 9.9 Cg_endo -80.36 141.49 14.3 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.752 2.301 . . . . 0.59999999999999998 111.738 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.48 173.82 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.442 -0.577 . . . . 0.64000000000000001 109.442 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.135 0.493 . . . . 0.82999999999999996 111.653 -177.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.517 ' HB3' ' H ' ' A' ' 119' ' ' SER . 15.7 m-85 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.734 -0.469 . . . . 1.9299999999999999 109.734 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 161' ' ' THR . 65.8 m-85 -135.69 141.07 44.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.592 -0.731 . . . . 0.57999999999999996 109.75 172.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 125' ' ' ILE . 23.7 mm -59.56 116.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 107.469 -1.308 . . . . 0.40999999999999998 107.469 167.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.574 HD12 ' HD1' ' A' ' 22' ' ' PHE . 2.9 tt -103.18 -28.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.361 -0.936 . . . . 0.37 112.026 -175.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -172.36 -169.96 0.67 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 114.923 1.453 . . . . 1.99 114.923 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.538 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.3 ptp180 -151.92 131.12 12.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 111.634 -2.53 . . . . 1.1899999999999999 109.378 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.27 156.81 17.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.245 1.021 . . . . 1.6699999999999999 111.531 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -53.18 152.26 4.48 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.562 -2.108 . . . . 3.0600000000000001 112.42 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -44.98 104.85 0.41 Allowed Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 113.854 -1.521 . . . . 2.6099999999999999 111.48 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -55.19 -51.19 10.72 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.971 3.114 . . . . 0.97999999999999998 112.291 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.76 -20.2 34.5 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.999 -1.0 . . . . 1.0800000000000001 112.181 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -103.43 -169.84 25.74 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.193 -0.527 . . . . 1.05 112.174 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.98 15.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 124.434 3.423 . . . . 1.3 114.094 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -67.93 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.949 0.404 . . . . 1.3799999999999999 110.64 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 45.58 2.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 1.1100000000000001 114.186 170.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.06 -22.57 0.26 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.305 0.854 . . . . 0.81000000000000005 113.305 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.462 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -157.84 151.95 24.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.732 0.301 . . . . 1.1200000000000001 110.373 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -120.92 102.43 8.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 2.1899999999999999 109.583 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -106.59 137.28 44.88 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.236 0.541 . . . . 0.60999999999999999 110.413 176.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.2 m -106.15 145.17 31.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.507 -0.77 . . . . 0.93999999999999995 112.726 -170.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -92.37 -174.19 3.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.703 -1.221 . . . . 1.0800000000000001 107.703 170.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.517 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 52.9 m . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 118.806 0.73 . . . . 1.5 112.08 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 100' ' ' ILE . 47.2 mt . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 107.905 -1.146 . . . . 0.47999999999999998 107.905 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.434 ' HA ' HG21 ' A' ' 150' ' ' VAL . 9.2 p80 -138.98 -162.83 1.37 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.35 0.595 . . . . 1.25 111.542 -173.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.453 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.92 178.28 16.39 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.844 -1.17 . . . . 0.46000000000000002 113.654 -175.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.4 t -144.54 176.41 9.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.487 0.661 . . . . 0.5 111.263 -167.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -108.06 -15.15 14.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.72 -1.127 . . . . 1.8600000000000001 109.715 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.13 103.73 29.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.555 -0.748 . . . . 1.77 109.976 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -90.52 4.58 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.168 2.579 . . . . 0.58999999999999997 112.9 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.46 -16.25 46.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.322 0.582 . . . . 0.78000000000000003 110.324 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -98.19 7.15 46.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.652 -0.704 . . . . 1.45 109.912 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 26.2 mm . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.384 -0.825 . . . . 0.69999999999999996 111.244 -176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.473 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 10.8 ptm . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.082 -0.34 . . . . 1.1299999999999999 110.082 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.529 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 22.1 m170 -73.52 154.53 39.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.939 -0.393 . . . . 2.5099999999999998 109.939 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HG12 ' A' ' 150' ' ' VAL . 13.0 m120 -50.31 -68.05 0.2 Allowed 'General case' 0 C--O 1.221 -0.412 0 O-C-N 123.318 0.386 . . . . 1.77 111.43 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -60.41 -29.41 68.96 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.782 -0.574 . . . . 2.1299999999999999 111.699 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.529 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 2.2 m-20 -66.72 -41.95 87.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.732 0.301 . . . . 1.05 110.956 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.3 p -75.86 -18.93 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 116.311 -0.404 . . . . 0.32000000000000001 110.615 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.534 HD12 HG13 ' A' ' 150' ' ' VAL . 2.8 mp -86.89 -39.94 13.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 119.014 -0.517 . . . . 0.37 110.154 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -45.33 -66.26 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.52 1.054 . . . . 1.3799999999999999 111.949 165.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.631 ' O ' HG22 ' A' ' 157' ' ' VAL . 2.2 tp -53.17 -42.69 66.44 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.838 -0.619 . . . . 0.73999999999999999 110.107 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.32 -54.84 26.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.384 -1.28 . . . . 0.22 111.735 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 32.8 t -75.46 -16.46 60.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.822 -1.081 . . . . 1.3300000000000001 110.491 -172.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.2 mt -90.94 -53.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.787 -0.449 . . . . 0.23000000000000001 109.787 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 153' ' ' LEU . 18.7 m -77.45 114.79 43.82 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 122.194 0.997 . . . . 0.20999999999999999 110.212 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.8 ' HG2' HD13 ' A' ' 57' ' ' ILE . 54.6 Cg_endo -81.13 -179.12 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.911 2.407 . . . . 0.34000000000000002 112.715 -173.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.722 ' O ' HD21 ' A' ' 51' ' ' LEU . 17.1 m120 -59.63 -0.24 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.827 -1.079 . . . . 1.02 113.404 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.23 59.02 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.834 -0.698 . . . . 0.28000000000000003 112.435 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -95.03 134.89 37.21 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.523 -0.398 . . . . 0.29999999999999999 110.219 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 131.83 34.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.859 0.362 . . . . 1.96 110.499 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.506 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.8 p -140.24 123.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.579 -0.737 . . . . 0.46000000000000002 111.471 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.2 m -111.6 138.53 48.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.805 -0.634 . . . . 0.56000000000000005 111.074 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.571 HG23 ' CG1' ' A' ' 65' ' ' ILE . 2.0 mp -122.37 117.2 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 118.461 -1.296 . . . . 0.95999999999999996 111.059 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.643 ' N ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 123.263 1.506 . . . . 1.1899999999999999 110.154 -175.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 121.037 0.446 . . . . 2.1000000000000001 111.223 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.4 mt -97.95 168.63 10.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.088 -0.96 . . . . 0.26000000000000001 110.886 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 48' ' ' ILE . 2.3 tp -80.71 151.42 28.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.411 0.684 . . . . 0.23000000000000001 112.407 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.519 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -117.3 151.33 37.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.997 0.903 . . . . 0.26000000000000001 112.364 169.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.4 t80 -134.56 148.74 50.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.701 -1.59 . . . . 0.39000000000000001 107.917 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.638 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -127.33 121.15 30.25 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.012 -1.477 . . . . 1.0700000000000001 107.012 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -83.06 158.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.243 0.544 . . . . 0.38 112.011 -170.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' N ' HG23 ' A' ' 9' ' ' VAL . 53.9 mtpt -109.43 150.37 28.18 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.838 -0.801 . . . . 2.5899999999999999 108.838 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.97 114.1 1.21 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.89 -0.595 . . . . 1.74 112.004 -174.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -10.07 21.65 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.677 -0.773 . . . . 0.56999999999999995 112.944 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.575 ' HB3' HD11 ' A' ' 18' ' ' ILE . 9.6 m-20 -62.62 154.51 28.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.028 0.414 . . . . 2.1699999999999999 111.82 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.555 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -132.53 152.0 51.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.5 112.153 -177.492 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.4 tp -48.04 -57.76 5.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.425 0.898 . . . . 0.27000000000000002 113.425 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.67 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.5 t-20 -66.05 -39.5 90.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 1.21 110.308 -169.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -59.4 -47.62 84.75 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 113.106 -1.861 . . . . 1.24 109.902 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -69.64 -39.36 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.513 -0.767 . . . . 0.29999999999999999 112.205 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.0 -57.79 11.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.23000000000000001 110.934 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.6 -4.35 57.54 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.683 -1.207 . . . . 0.39000000000000001 112.147 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 42.2 m-20 -61.85 -36.38 81.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.902 -1.148 . . . . 1.6299999999999999 107.902 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.669 ' CD1' HD12 ' A' ' 101' ' ' ILE . 2.2 m-85 -99.75 15.82 25.61 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.899 0.703 . . . . 0.23999999999999999 112.899 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.05 50.99 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 3.5499999999999998 110.684 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 19' ' ' ALA . 36.8 pt -146.65 -174.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.692 -0.855 . . . . 0.27000000000000002 108.692 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -100.2 143.76 30.01 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.231 -0.895 . . . . 0.81000000000000005 109.293 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.67 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.4 p -60.97 -35.09 75.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 121.4 0.619 . . . . 0.27000000000000002 109.399 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.95 -31.51 72.72 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.507 -1.224 . . . . 0.26000000000000001 111.657 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.85 -37.89 39.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.406 0.622 . . . . 0.23000000000000001 109.574 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.671 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.97 -20.47 60.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.042 -0.981 . . . . 0.17000000000000001 109.066 175.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.735 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.91 -39.13 43.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.431 0.634 . . . . 0.19 111.582 172.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 55.2 mt-30 -59.18 -42.23 90.34 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.163 0.983 . . . . 1.0700000000000001 109.649 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.53 -18.89 43.47 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.535 -1.666 . . . . 0.17000000000000001 112.32 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.637 HD21 ' H ' ' A' ' 47' ' ' VAL . 29.7 m-80 -143.77 71.9 17.11 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.19 109.881 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.643 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 12.2 Cg_endo -55.64 -13.56 8.4 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 123.696 2.931 . . . . 0.29999999999999999 114.318 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -61.9 -35.72 79.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.02 0.914 . . . . 1.1699999999999999 109.798 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -76.76 -6.64 53.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.341 -1.3 . . . . 0.53000000000000003 114.362 -170.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.735 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -49.23 -40.68 34.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.527 1.156 . . . . 1.23 110.485 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.41 -45.65 11.67 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.054 -1.885 . . . . 0.40000000000000002 111.627 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.651 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.3 -163.87 34.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.479 -0.867 . . . . 0.29999999999999999 114.238 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.3 mp -118.97 158.04 26.53 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.444 -1.378 . . . . 0.31 110.512 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 71.3 m -133.22 136.48 45.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.873 -0.603 . . . . 0.39000000000000001 110.964 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -44.73 126.17 5.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 0.46999999999999997 113.312 173.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.638 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.84 -12.49 48.23 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.558 -1.201 . . . . 0.35999999999999999 112.16 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.603 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.9 tt0 -62.75 150.81 40.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.741 0.781 . . . . 1.1899999999999999 110.294 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.8 m -120.42 130.85 54.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.328 -1.305 . . . . 0.89000000000000001 109.544 -170.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.671 HD12 HD11 ' A' ' 29' ' ' LEU . 21.3 pt -132.86 148.65 31.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.338 0.589 . . . . 0.22 110.697 -173.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.637 ' H ' HD21 ' A' ' 33' ' ' ASN . 13.2 t -94.1 149.02 4.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.078 -0.965 . . . . 0.20999999999999999 110.383 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 18.9 mm -117.44 87.72 26.06 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 114.771 -1.104 . . . . 0.17000000000000001 108.384 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.708 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.2 Cg_endo -59.38 143.82 99.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.214 2.609 . . . . 0.23000000000000001 112.737 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.502 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.46 -7.6 56.95 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.569 -0.741 . . . . 0.29999999999999999 112.977 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.758 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -115.92 127.1 27.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.711 -0.848 . . . . 0.25 108.711 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.2 Cg_endo -66.47 174.91 5.65 Favored 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 123.793 2.996 . . . . 0.31 114.005 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.703 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.6 t70 -90.45 141.53 27.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.263 -0.88 . . . . 0.71999999999999997 110.734 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HD3' HD12 ' A' ' 5' ' ' LEU . 90.5 Cg_endo -83.84 -9.51 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.27000000000000002 112.438 -175.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -95.09 -27.08 15.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 2.1099999999999999 110.25 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.6 p -68.14 -32.34 72.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.591 -1.263 . . . . 1.47 107.591 170.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.768 HD13 ' HG2' ' A' ' 158' ' ' PRO . 89.5 mt -76.27 127.86 83.93 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 113.242 -1.799 . . . . 0.26000000000000001 110.476 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -101.84 95.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.856 0 C-N-CA 120.846 1.031 . . . . 0.20000000000000001 110.479 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.4 m-85 -158.38 139.25 12.98 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.952 -1.499 . . . . 0.26000000000000001 106.952 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 34.2 t-80 -145.27 107.15 4.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.789 -1.189 . . . . 2.8399999999999999 107.789 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 69.9 mt -94.93 109.64 22.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.254 -1.339 . . . . 0.32000000000000001 110.302 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.94 94.73 5.09 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.987 0.898 . . . . 0.34000000000000002 110.175 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 p -110.35 97.3 5.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.183 -1.372 . . . . 0.68000000000000005 109.256 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 m -93.43 108.52 20.18 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.756 -1.111 . . . . 1.05 108.074 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.42 ' CG1' HG22 ' A' ' 165' ' ' ILE . 0.9 OUTLIER -46.38 -32.2 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.293 0.637 . . . . 1.29 112.613 174.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.16 -44.91 93.3 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.155 -1.022 . . . . 0.88 111.476 172.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.82 -23.28 63.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.768 -0.716 . . . . 0.73999999999999999 111.754 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttt 59.97 16.94 6.2 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.042 0.937 . . . . 2.5099999999999998 113.056 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.59 140.32 37.01 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.919 0.866 . . . . 0.45000000000000001 111.404 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.441 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.6 tt -95.67 120.17 35.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.029 -1.441 . . . . 0.33000000000000002 109.7 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -101.79 125.82 48.54 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.147 -0.621 . . . . 0.40000000000000002 111.289 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.604 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.37 147.45 27.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.559 -1.645 . . . . 0.33000000000000002 106.559 175.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.653 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 24.3 m -150.96 132.77 15.01 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 120.407 1.458 . . . . 0.75 112.712 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp -120.42 125.9 49.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.989 -1.005 . . . . 0.34999999999999998 110.731 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 65.7 34.53 7.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.52000000000000002 109.393 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.7 m120 79.87 3.46 2.06 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.377 -1.283 . . . . 1.8400000000000001 111.754 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -130.9 139.07 50.06 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 118.803 -1.159 . . . . 3.1899999999999999 113.75 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -52.76 149.69 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 113.112 -1.858 . . . . 0.40999999999999998 112.884 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.505 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.9 mtp -98.91 -43.98 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.643 -2.071 . . . . 0.34999999999999998 108.263 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? 179.26 154.71 0.47 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.33 -2.214 . . . . 2.0699999999999998 110.332 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.1 m -115.11 135.57 54.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.464 0.173 . . . . 0.37 110.754 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -125.34 131.97 24.19 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.96999999999999997 110.608 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.58 146.37 79.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.793 2.328 . . . . 0.59999999999999998 111.748 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.39 179.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.218 -0.66 . . . . 0.64000000000000001 109.218 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.816 0 C-N-CA 119.199 -1.0 . . . . 0.82999999999999996 109.877 174.702 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.57 ' HB2' HG13 ' A' ' 163' ' ' VAL . 17.8 m-85 . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 107.431 -1.322 . . . . 1.9299999999999999 107.431 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.769 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.3 m-85 -127.19 136.45 52.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.925 -0.31 . . . . 0.57999999999999996 110.477 175.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.85 HD11 HD12 ' A' ' 125' ' ' ILE . 11.7 mm -58.1 108.18 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 108.042 -1.096 . . . . 0.40999999999999998 108.042 169.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.669 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.0 tt -108.4 -27.31 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 112.813 0.672 . . . . 0.37 112.813 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 26.2 t-20 -156.33 161.2 40.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 122.675 1.226 . . . . 1.99 114.046 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.82 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 134.14 36.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 111.678 -2.51 . . . . 1.1899999999999999 109.177 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 16.0 tm0? -114.66 145.23 42.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.022 0.915 . . . . 1.6699999999999999 111.055 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -50.1 154.37 1.18 Allowed 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 112.828 -1.987 . . . . 3.0600000000000001 112.391 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -43.84 100.32 0.23 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 CA-C-O 121.557 0.694 . . . . 2.6099999999999999 111.185 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HG3' ' OE1' ' A' ' 104' ' ' GLN . 90.2 Cg_exo -55.99 -51.01 10.54 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.18 3.253 . . . . 0.97999999999999998 112.794 -173.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.89 16.87 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.146 -0.934 . . . . 1.0800000000000001 112.15 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -106.13 -171.15 23.22 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.697 -0.763 . . . . 1.05 112.347 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.93 33.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 124.621 3.547 . . . . 1.3 114.422 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -77.61 -32.19 53.35 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.068 0.461 . . . . 1.3799999999999999 110.695 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.488 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.82 42.78 2.79 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.598 -0.728 . . . . 1.1100000000000001 113.333 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.83 -17.07 0.54 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.53 0.937 . . . . 0.81000000000000005 113.53 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -156.87 131.38 8.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 110.042 -0.355 . . . . 1.1200000000000001 110.042 176.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.9 t-105 -99.23 101.17 12.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.743 -0.836 . . . . 2.1899999999999999 108.743 167.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.82 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.3 mp -106.95 135.64 48.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.281 0.562 . . . . 0.60999999999999999 110.168 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.3 m -106.36 144.42 33.07 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.625 -0.716 . . . . 0.93999999999999995 112.175 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.423 ' CD1' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -86.36 -177.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.415 -1.328 . . . . 1.0800000000000001 107.415 164.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 21.7 m . . . . . 0 C--N 1.318 -0.778 0 N-CA-C 112.445 0.535 . . . . 1.5 112.445 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.85 HD12 HD11 ' A' ' 100' ' ' ILE . 43.0 mt . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.687 -0.857 . . . . 0.47999999999999998 108.687 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -144.34 -163.81 1.76 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.789 -0.765 . . . . 1.25 112.148 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.488 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.05 -174.94 15.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.929 -1.129 . . . . 0.46000000000000002 113.541 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -141.9 173.66 11.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.454 0.645 . . . . 0.5 111.333 -165.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.88 -18.59 14.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.131 -0.941 . . . . 1.8600000000000001 108.645 164.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -127.26 101.66 24.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.891 -1.05 . . . . 1.77 110.3 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.1 Cg_endo -92.14 3.83 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.138 2.558 . . . . 0.58999999999999997 112.801 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.01 -30.29 24.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.01 0.433 . . . . 0.78000000000000003 110.254 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 m -85.52 -2.66 58.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 1.45 110.384 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 8.0 mm . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 115.476 -0.784 . . . . 0.69999999999999996 110.12 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.3 mtp . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.243 0.544 . . . . 1.1299999999999999 111.14 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -73.83 146.46 44.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.082 -0.963 . . . . 2.5099999999999998 108.739 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.617 ' O ' HG12 ' A' ' 150' ' ' VAL . 4.4 m-20 -52.16 -65.33 0.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.219 0.451 . . . . 1.77 112.219 -171.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -59.22 -25.05 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.65 -0.656 . . . . 2.1299999999999999 111.476 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.61 -35.78 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 1.05 110.765 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 10.8 p -77.94 -17.01 14.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.691 0 CA-C-N 116.529 -0.305 . . . . 0.32000000000000001 110.25 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.447 HD12 HG13 ' A' ' 150' ' ' VAL . 2.3 mp -85.9 -39.11 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 119.073 -0.489 . . . . 0.37 109.914 172.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -44.72 -69.48 0.13 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 119.148 0.885 . . . . 1.3799999999999999 112.178 163.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.706 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -50.36 -44.34 54.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.73999999999999999 110.303 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.65 -50.04 71.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.141 -1.39 . . . . 0.22 112.109 -171.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 p -77.58 -17.21 58.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.724 -1.126 . . . . 1.3300000000000001 111.111 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.42 -46.2 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.933 -0.576 . . . . 0.23000000000000001 109.528 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 153' ' ' LEU . 30.6 m -76.51 120.95 83.88 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-O 121.669 0.747 . . . . 0.20999999999999999 110.459 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.768 ' HG2' HD13 ' A' ' 57' ' ' ILE . 27.4 Cg_endo -85.59 -177.71 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.384 2.723 . . . . 0.34000000000000002 112.841 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.758 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.7 m120 -60.09 3.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.775 -1.102 . . . . 1.02 113.895 -175.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -149.65 57.8 0.46 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.635 -0.793 . . . . 0.28000000000000003 112.641 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.769 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.71 134.26 34.55 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.472 -0.428 . . . . 0.29999999999999999 111.173 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -84.39 128.5 34.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.055 -0.521 . . . . 1.96 110.622 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 98' ' ' PHE . 3.2 p -141.83 129.58 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.542 0.526 . . . . 0.46000000000000002 111.347 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.9 m -122.95 143.86 49.63 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.515 0.561 . . . . 0.56000000000000005 112.515 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.42 HG22 ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -125.92 115.86 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.19 -1.004 . . . . 0.95999999999999996 112.352 177.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.629 ' N ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 114.958 -1.019 . . . . 1.1899999999999999 109.73 -172.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.232 -0.655 . . . . 2.1000000000000001 109.232 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.767 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.1 mt -90.73 167.72 12.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.211 -0.449 . . . . 0.26000000000000001 111.069 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.671 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -74.19 148.57 41.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.216 0.531 . . . . 0.23000000000000001 111.65 -170.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.38 148.67 37.31 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.794 0.806 . . . . 0.26000000000000001 111.257 168.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.462 ' CE2' ' HA ' ' A' ' 9' ' ' VAL . 69.1 t80 -134.04 148.03 51.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.009 -1.45 . . . . 0.39000000000000001 107.61 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.8 tt0 -127.84 111.21 13.37 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.657 -1.609 . . . . 1.0700000000000001 106.657 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -72.18 157.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.219 0.533 . . . . 0.38 111.39 -165.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -107.64 148.43 29.35 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.461 -0.79 . . . . 2.5899999999999999 109.291 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.955 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -46.53 116.96 1.44 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 1.74 112.631 -173.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.35 -8.94 38.39 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.967 -1.015 . . . . 0.56999999999999995 113.514 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.546 ' HB3' HD11 ' A' ' 18' ' ' ILE . 83.1 m-20 -61.46 155.03 22.8 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.973 0.731 . . . . 2.1699999999999999 112.973 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.592 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -134.32 159.11 41.99 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.949 -0.569 . . . . 0.5 111.73 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 46.6 tp -52.68 -57.71 9.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.948 1.092 . . . . 0.27000000000000002 113.948 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.706 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 2.0 t30 -66.71 -43.19 84.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 122.309 1.052 . . . . 1.21 110.558 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.569 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 37.5 t -57.77 -47.96 81.03 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 112.988 -1.915 . . . . 1.24 109.797 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 14' ' ' THR . 1.6 mp -68.75 -40.65 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.795 -0.639 . . . . 0.29999999999999999 111.89 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.708 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.28 -65.55 0.59 Allowed 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.23000000000000001 111.541 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.89 -4.73 55.87 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.768 -1.173 . . . . 0.39000000000000001 112.273 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -67.62 -27.28 66.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.93 -0.767 . . . . 1.6299999999999999 108.93 157.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -99.6 15.37 26.87 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.804 -0.56 . . . . 0.23999999999999999 112.146 172.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 56.28 50.94 12.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.495 -0.775 . . . . 3.5499999999999998 110.662 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.708 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.3 pt -149.14 -173.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.909 -0.775 . . . . 0.27000000000000002 108.909 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.04 147.61 23.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.415 -0.811 . . . . 0.81000000000000005 110.017 172.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.706 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.4 p -62.56 -36.46 82.71 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.654 -0.869 . . . . 0.27000000000000002 108.654 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -28.83 68.74 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.665 -1.152 . . . . 0.26000000000000001 111.539 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 49' ' ' PRO . . . -80.37 -38.22 30.84 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.524 -0.547 . . . . 0.23000000000000001 109.524 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 46' ' ' ILE . 12.7 tp -71.98 -20.42 61.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.563 -0.744 . . . . 0.17000000000000001 109.007 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.684 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -38.36 40.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.47 0.652 . . . . 0.19 111.381 172.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -59.25 -42.46 91.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.998 0.904 . . . . 1.0700000000000001 109.84 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.95 -16.26 51.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.843 -1.526 . . . . 0.17000000000000001 112.01 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 33.2 m-80 -139.99 69.94 35.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.624 -0.51 . . . . 0.19 109.624 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.46 -21.9 19.77 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 124.533 3.489 . . . . 0.29999999999999999 115.422 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -69.64 -34.12 73.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 119.458 1.026 . . . . 1.1699999999999999 110.293 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.629 ' CD2' ' HB3' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -65.05 -6.7 9.42 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.422 -1.263 . . . . 0.53000000000000003 113.635 -172.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.684 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.12 -40.68 24.34 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.475 1.131 . . . . 1.23 110.351 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.579 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -82.37 -46.15 13.93 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.98 -1.918 . . . . 0.40000000000000002 111.642 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.41 -161.78 31.82 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.118 -1.039 . . . . 0.29999999999999999 114.396 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.5 mp -118.6 158.27 25.78 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.704 -1.748 . . . . 0.31 110.542 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 98.7 m -133.6 133.69 42.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.799 -0.637 . . . . 0.39000000000000001 110.55 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.955 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.22 127.15 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.789 0.662 . . . . 0.46999999999999997 112.789 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.47 52.9 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.796 -1.093 . . . . 0.35999999999999999 112.506 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.631 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.1 tt0 -65.28 152.66 43.2 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.643 0.735 . . . . 1.1899999999999999 110.219 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 42.0 m -119.24 131.76 55.84 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.61 -1.177 . . . . 0.89000000000000001 109.542 -171.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.718 HD12 HD11 ' A' ' 29' ' ' LEU . 25.2 pt -136.49 151.34 28.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.339 0.59 . . . . 0.22 110.698 -174.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.615 ' H ' HD21 ' A' ' 33' ' ' ASN . 5.3 t -94.56 148.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.156 -0.929 . . . . 0.20999999999999999 110.703 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.598 ' CG1' HD23 ' A' ' 5' ' ' LEU . 15.7 mm -117.44 88.74 29.63 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 114.599 -1.182 . . . . 0.17000000000000001 108.418 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.6 Cg_endo -59.02 143.8 99.65 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.186 2.591 . . . . 0.23000000000000001 112.769 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.46 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.83 -6.88 60.68 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.29999999999999999 113.035 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.752 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.9 tt -116.65 129.97 24.88 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.334 -0.987 . . . . 0.25 108.334 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.721 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.2 Cg_endo -69.45 171.08 14.76 Favored 'Trans proline' 0 N--CA 1.475 0.41 0 C-N-CA 123.583 2.855 . . . . 0.31 113.906 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 3.1 t70 -91.6 138.05 25.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 0.71999999999999997 112.297 -171.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.671 ' HD3' HD12 ' A' ' 5' ' ' LEU . 69.4 Cg_endo -84.4 -4.27 10.15 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 123.684 2.923 . . . . 0.27000000000000002 113.351 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -94.96 -25.15 16.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.853 0.359 . . . . 2.1099999999999999 110.9 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.7 t -86.06 -13.0 48.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.448 0.642 . . . . 1.47 109.42 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HG2' ' A' ' 158' ' ' PRO . 81.3 mt -85.61 124.42 71.3 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.198 -0.91 . . . . 0.26000000000000001 110.034 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -101.25 95.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.811 0.968 . . . . 0.20000000000000001 110.109 169.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -158.37 137.13 11.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.55 -1.648 . . . . 0.26000000000000001 106.55 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 71.8 t60 -144.19 109.89 5.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.851 -1.166 . . . . 2.8399999999999999 107.851 -167.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 70.2 mt -95.14 107.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.394 -1.276 . . . . 0.32000000000000001 109.864 -177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.5 94.24 4.9 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.048 0.927 . . . . 0.34000000000000002 110.244 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.492 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -113.95 98.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 113.825 -1.534 . . . . 0.68000000000000005 109.202 178.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.491 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 55.2 m -91.0 123.76 34.72 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.805 -1.183 . . . . 1.05 107.805 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 5.8 mt -60.6 -26.98 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.571 0.7 . . . . 1.29 110.214 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.53 -47.08 64.44 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 114.96 -1.018 . . . . 0.88 111.477 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -66.36 -23.92 66.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.114 0.483 . . . . 0.73999999999999999 111.908 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 2.7 mtpt 59.13 12.48 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.256 1.023 . . . . 2.5099999999999998 113.169 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.98 143.23 38.44 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.647 0.736 . . . . 0.45000000000000001 110.902 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.6 tt -96.8 119.1 34.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.319 -1.31 . . . . 0.33000000000000002 109.635 -177.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -102.59 126.51 49.69 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.244 -0.582 . . . . 0.40000000000000002 111.317 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.566 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.71 141.9 32.07 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.436 -1.69 . . . . 0.33000000000000002 106.436 175.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.5 m -145.98 128.81 16.33 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.481 1.491 . . . . 0.75 112.377 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -118.07 125.49 50.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.982 -1.008 . . . . 0.34999999999999998 110.291 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.49 33.36 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.13 -0.692 . . . . 0.52000000000000002 109.13 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.6 m120 77.57 3.88 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.374 -1.285 . . . . 1.8400000000000001 111.592 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -130.47 138.52 50.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 118.779 -1.168 . . . . 3.1899999999999999 113.368 170.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -53.2 150.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 113.107 -1.86 . . . . 0.40999999999999998 112.957 -174.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.566 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -99.03 -43.88 6.51 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.543 -2.117 . . . . 0.34999999999999998 108.21 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -177.52 157.6 1.29 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.427 -2.169 . . . . 2.0699999999999998 109.863 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -117.59 130.65 56.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.723 0.297 . . . . 0.37 110.8 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 74.9 m-85 -114.99 143.11 29.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.355 -0.384 . . . . 0.96999999999999997 110.337 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 18.8 Cg_endo -81.67 140.61 11.82 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.298 1.999 . . . . 0.59999999999999998 111.156 175.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.27 -172.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.323 -0.399 . . . . 0.64000000000000001 111.085 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 0.82999999999999996 110.03 175.394 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.516 ' HB2' HG13 ' A' ' 163' ' ' VAL . 19.1 m-85 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 107.61 -1.256 . . . . 1.9299999999999999 107.61 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 161' ' ' THR . 46.9 m-85 -128.78 139.07 52.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.761 0.315 . . . . 0.57999999999999996 110.221 173.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.69 HD11 HD12 ' A' ' 125' ' ' ILE . 16.3 mm -58.66 104.59 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.273 -1.01 . . . . 0.40999999999999998 108.273 169.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.558 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.5 tt -93.17 -25.86 4.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.009 -0.676 . . . . 0.37 112.337 -170.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.456 ' ND2' HG23 ' A' ' 101' ' ' ILE . 11.5 p30 -169.4 -179.51 3.49 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 114.936 1.458 . . . . 1.99 114.936 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.9 175.8 10.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 111.079 -2.782 . . . . 1.1899999999999999 108.517 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.78 155.27 39.84 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.462 1.125 . . . . 1.6699999999999999 113.311 -164.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -52.54 149.73 5.62 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.64 -2.073 . . . . 3.0600000000000001 111.109 166.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.14 107.03 0.71 Allowed Pre-proline 0 CA--C 1.514 -0.407 0 CA-C-N 115.825 -0.625 . . . . 2.6099999999999999 111.928 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -59.2 -51.62 6.29 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 123.627 2.885 . . . . 0.97999999999999998 112.896 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.45 -21.64 44.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.2 -0.909 . . . . 1.0800000000000001 111.575 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -93.79 -170.1 38.57 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.357 -0.449 . . . . 1.05 112.137 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.3 21.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 124.648 3.565 . . . . 1.3 114.69 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -75.73 -18.5 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.369 . . . . 1.3799999999999999 111.136 179.041 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 82.51 49.42 5.18 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.78 -0.646 . . . . 1.1100000000000001 113.326 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.93 -20.56 0.37 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.222 0.823 . . . . 0.81000000000000005 113.222 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.522 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -155.77 144.54 20.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 1.1200000000000001 110.861 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -111.87 102.16 10.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.342 -0.614 . . . . 2.1899999999999999 109.342 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -106.47 137.01 45.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.537 0.685 . . . . 0.60999999999999999 109.839 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.412 ' HB2' HG23 ' A' ' 101' ' ' ILE . 72.9 m -106.75 144.46 33.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.412 -0.813 . . . . 0.93999999999999995 112.272 -171.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -90.98 -175.04 4.21 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.19 -1.411 . . . . 1.0800000000000001 107.19 169.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.316 -0.871 0 C-N-CA 119.775 -0.77 . . . . 1.5 111.861 -178.323 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.69 HD12 HD11 ' A' ' 100' ' ' ILE . 27.8 mt . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 108.78 -0.822 . . . . 0.47999999999999998 108.78 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -139.68 -163.27 1.47 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.329 0.585 . . . . 1.25 111.441 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.03 163.51 14.47 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.058 -1.068 . . . . 0.46000000000000002 113.597 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.7 t -120.45 170.87 8.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.711 -0.745 . . . . 0.5 111.608 -168.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.98 -22.21 13.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.926 -1.034 . . . . 1.8600000000000001 108.586 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -124.88 104.56 30.05 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 114.837 -1.074 . . . . 1.77 109.642 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.58 4.22 7.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.96 2.44 . . . . 0.58999999999999997 112.783 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.21 -11.0 47.97 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.98 -0.748 . . . . 0.78000000000000003 108.98 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.7 m -78.52 -26.65 45.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.011 -0.995 . . . . 1.45 109.439 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 27.1 mm . . . . . 0 N--CA 1.451 -0.383 0 CA-C-N 115.354 -0.839 . . . . 0.69999999999999996 110.041 175.915 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.41 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 9.7 ptm . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 111.721 0.267 . . . . 1.1299999999999999 111.721 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -67.33 148.1 52.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.493 -0.188 . . . . 2.5099999999999998 110.493 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.619 ' O ' HG12 ' A' ' 150' ' ' VAL . 10.1 m120 -50.8 -68.09 0.2 Allowed 'General case' 0 C--O 1.221 -0.408 0 O-C-N 123.529 0.518 . . . . 1.77 110.962 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.383 0.512 . . . . 2.1299999999999999 112.383 -173.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.55 -37.99 62.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.579 0.228 . . . . 1.05 111.14 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.5 p -75.85 -15.2 15.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 110.11 -0.33 . . . . 0.32000000000000001 110.11 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.522 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -89.79 -39.65 12.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.101 -0.476 . . . . 0.37 110.582 172.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -44.44 -68.63 0.18 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.574 1.079 . . . . 1.3799999999999999 112.137 164.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.4 tp -50.0 -43.11 50.41 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.904 0.753 . . . . 0.73999999999999999 110.092 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.24 -53.67 47.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.296 -1.32 . . . . 0.22 112.464 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.2 t -76.74 -16.99 59.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.843 -1.072 . . . . 1.3300000000000001 110.618 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.7 mt -91.28 -49.58 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.768 -0.456 . . . . 0.23000000000000001 109.768 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 22.5 m -77.98 116.27 57.26 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-O 121.855 0.835 . . . . 0.20999999999999999 110.119 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.788 ' HG2' HD13 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -83.01 -178.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.052 2.501 . . . . 0.34000000000000002 112.327 -175.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.752 ' O ' HD21 ' A' ' 51' ' ' LEU . 14.2 m120 -64.93 7.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.905 -1.043 . . . . 1.02 113.337 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -146.64 53.98 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.941 -0.647 . . . . 0.28000000000000003 112.156 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.0 m -88.17 135.8 33.27 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.47 -0.429 . . . . 0.29999999999999999 110.863 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 162' ' ' ARG . 9.0 mtm180 -84.75 122.08 28.6 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.783 -0.644 . . . . 1.96 110.351 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 98' ' ' PHE . 3.6 p -134.74 127.74 49.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.46000000000000002 111.594 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 m -118.67 140.06 50.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.474 -0.785 . . . . 0.56000000000000005 111.902 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -124.65 114.71 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 118.887 -1.125 . . . . 0.95999999999999996 110.75 174.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.678 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.878 0 CA-C-N 114.917 -1.038 . . . . 1.1899999999999999 110.268 -173.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 108.428 -0.953 . . . . 2.1000000000000001 108.428 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.803 HD13 ' HA ' ' A' ' 49' ' ' PRO . 19.8 mt -99.2 172.37 7.41 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.396 0.435 . . . . 0.26000000000000001 111.756 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD23 HG13 ' A' ' 48' ' ' ILE . 4.3 tp -75.86 150.73 37.57 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.176 0.59 . . . . 0.23000000000000001 111.84 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.539 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.06 150.58 35.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.978 0.894 . . . . 0.26000000000000001 111.927 167.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.1 t80 -133.16 149.62 52.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.656 -1.611 . . . . 0.39000000000000001 108.014 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.647 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.88 116.38 19.33 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 106.405 -1.702 . . . . 1.0700000000000001 106.405 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.48 158.03 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.446 0.641 . . . . 0.38 111.786 -169.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.63 152.04 26.07 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.145 -0.934 . . . . 2.5899999999999999 108.804 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.796 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.6 111.3 0.57 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 1.74 111.795 -174.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -9.17 20.56 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.141 -0.936 . . . . 0.56999999999999995 113.015 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.608 ' HB3' HD11 ' A' ' 18' ' ' ILE . 74.8 m-20 -66.48 147.13 53.73 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.327 0.563 . . . . 2.1699999999999999 112.25 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.643 ' O ' HD13 ' A' ' 18' ' ' ILE . 2.0 p -134.44 163.75 28.99 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.257 0.466 . . . . 0.5 112.257 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.597 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -49.94 -62.06 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.367 1.247 . . . . 0.27000000000000002 114.367 -171.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.697 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.2 t-20 -64.99 -41.14 95.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.49 1.138 . . . . 1.21 110.305 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.768 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.9 t -57.42 -48.15 79.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.472 -2.149 . . . . 1.24 109.858 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -70.15 -40.4 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 123.668 0.787 . . . . 0.29999999999999999 112.456 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.687 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.33 -65.07 0.67 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.397 -0.365 . . . . 0.23000000000000001 111.535 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.85 -5.06 54.73 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.743 -1.183 . . . . 0.39000000000000001 111.83 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' SER . 17.3 t70 -65.19 -32.88 74.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.329 -0.989 . . . . 1.6299999999999999 108.329 158.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.599 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.4 m-85 -97.83 14.96 25.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.196 0.443 . . . . 0.23999999999999999 112.196 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 58.46 47.93 12.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 3.5499999999999998 110.741 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.1 pt -147.89 -175.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.918 -0.771 . . . . 0.27000000000000002 108.918 -173.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 146.22 26.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.362 -0.835 . . . . 0.81000000000000005 109.467 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.697 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 10.3 p -62.17 -37.39 85.09 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.933 -0.766 . . . . 0.27000000000000002 108.933 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.556 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.75 -30.29 71.4 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.192 -1.367 . . . . 0.26000000000000001 111.281 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.93 -37.94 33.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 0.23000000000000001 109.778 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.742 HD11 HD12 ' A' ' 46' ' ' ILE . 14.1 tp -73.69 -20.09 60.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 0.17000000000000001 109.206 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.744 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.93 -38.82 44.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.65 0.738 . . . . 0.19 111.435 172.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 57.4 mt-30 -59.53 -41.9 91.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.288 1.042 . . . . 1.0700000000000001 109.744 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.42 -20.74 39.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.565 -1.652 . . . . 0.17000000000000001 112.315 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.657 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 26.8 m-80 -142.34 73.25 21.25 Favored Pre-proline 0 CA--C 1.513 -0.449 0 CA-C-O 121.196 0.522 . . . . 0.19 110.099 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.726 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.3 Cg_endo -58.37 -10.03 7.9 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 123.239 2.626 . . . . 0.29999999999999999 113.926 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -62.59 -31.06 71.81 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.972 0.892 . . . . 1.1699999999999999 109.564 173.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 3.2 mt -83.14 -7.01 59.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.679 1.363 . . . . 0.53000000000000003 114.679 -172.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.744 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -49.54 -40.92 39.86 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 120.03 1.286 . . . . 1.23 110.151 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 -46.64 12.84 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.886 -1.961 . . . . 0.40000000000000002 111.511 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.42 -165.93 37.61 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.295 -0.955 . . . . 0.29999999999999999 114.472 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.466 HD23 HG11 ' A' ' 9' ' ' VAL . 4.5 mp -113.71 158.47 20.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.412 -1.394 . . . . 0.31 110.252 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.687 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -136.97 134.16 36.39 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.786 -0.643 . . . . 0.39000000000000001 110.65 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.796 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.05 129.36 17.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.475 0.655 . . . . 0.46999999999999997 112.736 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.594 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 83.2 -11.49 54.76 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.561 -1.199 . . . . 0.35999999999999999 112.766 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.888 ' OE1' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -61.48 158.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.194 0.521 . . . . 1.1899999999999999 110.134 172.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.492 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 58.7 p -123.24 137.85 54.77 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.96 -1.018 . . . . 0.89000000000000001 110.468 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.888 HG23 ' OE1' ' A' ' 44' ' ' GLN . 12.3 pt -135.13 171.6 17.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.287 0.565 . . . . 0.22 111.266 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.657 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 19.1 t -114.2 149.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.731 -1.122 . . . . 0.20999999999999999 109.533 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.55 HG13 HD23 ' A' ' 5' ' ' LEU . 18.4 mm -118.27 88.29 32.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.183 -0.917 . . . . 0.17000000000000001 108.711 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.803 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.47 139.88 92.38 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.387 2.725 . . . . 0.23000000000000001 113.203 -173.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.469 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.22 -7.37 67.8 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.424 -0.807 . . . . 0.29999999999999999 112.867 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.691 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.57 124.27 30.22 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.578 -0.897 . . . . 0.25 108.578 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD23 ' A' ' 51' ' ' LEU . 57.0 Cg_endo -65.31 176.34 3.36 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.75 2.967 . . . . 0.31 113.939 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.638 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.2 t70 -89.6 140.97 28.26 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.801 -1.091 . . . . 0.71999999999999997 110.139 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.598 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 88.0 Cg_endo -81.86 -1.16 10.74 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.367 2.711 . . . . 0.27000000000000002 111.725 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -28.83 14.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.898 -0.592 . . . . 2.1099999999999999 110.772 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 53' ' ' ASP . 34.1 p -69.41 -28.4 66.12 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 122.617 1.199 . . . . 1.47 107.905 170.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.804 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.8 mt -84.16 124.75 73.81 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.899 -1.955 . . . . 0.26000000000000001 110.648 175.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -101.57 95.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 CA-C-N 119.841 0.979 . . . . 0.20000000000000001 109.847 166.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' HD2' HG23 ' A' ' 57' ' ' ILE . 80.8 m-85 -157.74 131.75 8.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.925 -1.509 . . . . 0.26000000000000001 106.925 172.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 3.5 m-70 -140.48 113.55 8.38 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.436 -1.32 . . . . 2.8399999999999999 107.436 -164.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.7 mt -102.23 111.22 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.723 -0.671 . . . . 0.32000000000000001 111.307 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.96 98.86 7.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.227 -0.897 . . . . 0.34000000000000002 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 165' ' ' ILE . 0.4 OUTLIER -116.55 99.71 8.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.174 -1.375 . . . . 0.68000000000000005 109.559 177.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 54.2 m -94.46 133.08 38.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.071 -0.968 . . . . 1.05 109.199 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -35.63 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.595 0.712 . . . . 1.29 110.676 176.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.85 -43.4 97.67 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.905 -1.043 . . . . 0.88 110.956 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -71.32 -25.27 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.825 0.676 . . . . 0.73999999999999999 112.825 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 mttt 54.03 17.07 1.28 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.913 0.885 . . . . 2.5099999999999998 112.961 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.42 141.59 35.5 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.525 0.678 . . . . 0.45000000000000001 111.051 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.486 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.2 tt -96.25 117.47 30.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.473 -1.239 . . . . 0.33000000000000002 109.675 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 m -100.73 127.51 47.12 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.17 -0.468 . . . . 0.40000000000000002 111.227 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.557 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -81.94 146.84 29.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.275 -1.75 . . . . 0.33000000000000002 106.275 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 36.5 m -150.31 127.02 10.95 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 120.351 1.432 . . . . 0.75 112.442 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.07 125.25 53.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.492 -1.231 . . . . 0.34999999999999998 110.088 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 4.7 t-20 60.73 42.25 13.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.152 0.501 . . . . 0.52000000000000002 110.166 174.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.7 m-20 74.64 -1.46 3.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.993 -1.003 . . . . 1.8400000000000001 112.731 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -128.69 135.76 49.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 117.845 -1.542 . . . . 3.1899999999999999 114.115 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -56.55 149.17 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 112.7 -2.045 . . . . 0.40999999999999998 113.027 -170.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.557 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.2 mtp -101.02 -43.03 6.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.581 -2.1 . . . . 0.34999999999999998 108.566 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 178.81 159.1 0.57 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.617 -2.083 . . . . 2.0699999999999998 110.342 -177.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.512 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.1 m -117.07 135.55 53.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.392 0.139 . . . . 0.37 111.165 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -124.08 135.03 25.88 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-O 120.792 0.329 . . . . 0.96999999999999997 110.778 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -62.49 145.27 95.53 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.385 2.723 . . . . 0.59999999999999998 113.268 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.94 169.38 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.091 -0.504 . . . . 0.64000000000000001 109.675 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.297 0.57 . . . . 0.82999999999999996 110.902 175.249 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.632 ' HB2' HG13 ' A' ' 163' ' ' VAL . 7.1 m-85 . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 109.76 -0.459 . . . . 1.9299999999999999 109.76 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 161' ' ' THR . 95.6 m-85 -139.02 143.33 38.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.57999999999999996 110.385 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.79 HD11 HD12 ' A' ' 125' ' ' ILE . 22.6 mm -59.96 126.08 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.54 -1.281 . . . . 0.40999999999999998 107.54 164.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -124.02 -23.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.653 -0.819 . . . . 0.37 112.808 -174.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 15.7 t-20 -161.3 161.34 30.56 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.328 1.233 . . . . 1.99 114.328 -173.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 1.0 OUTLIER -147.0 128.74 15.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 111.579 -2.555 . . . . 1.1899999999999999 109.515 174.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.686 ' HB3' ' CD1' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -109.26 161.54 15.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.562 1.172 . . . . 1.6699999999999999 111.542 -171.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.55 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 9.4 ttm180 -49.79 152.67 1.45 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.929 -2.396 . . . . 3.0600000000000001 112.544 171.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.55 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-20 -45.26 114.72 2.33 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-N 114.556 -1.202 . . . . 2.6099999999999999 111.628 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HG3' ' NE1' ' A' ' 115' ' ' TRP . 85.3 Cg_exo -51.19 -48.16 22.44 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 C-N-CA 124.082 3.188 . . . . 0.97999999999999998 112.441 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.59 -4.26 59.7 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.441 -1.254 . . . . 1.0800000000000001 112.025 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -139.52 -171.55 12.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.989 -0.624 . . . . 1.05 112.736 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.64 20.15 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.724 3.616 . . . . 1.3 114.973 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 109' ' ' GLY . 46.6 t80 -74.55 -11.2 60.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.216 0.531 . . . . 1.3799999999999999 110.21 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.89 38.16 3.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.705 -0.76 . . . . 1.1100000000000001 114.31 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 73.25 -23.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.541 1.311 . . . . 0.81000000000000005 114.541 166.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.542 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -152.16 148.96 28.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.832 0.349 . . . . 1.1200000000000001 111.175 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.686 ' CD1' ' HB3' ' A' ' 104' ' ' GLN . 0.1 OUTLIER -110.4 101.6 10.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.489 -0.93 . . . . 2.1899999999999999 108.489 171.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.782 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -111.44 138.18 48.27 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.073 -0.651 . . . . 0.60999999999999999 110.252 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 101' ' ' ILE . 10.0 t -107.32 151.34 25.61 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.717 -0.674 . . . . 0.93999999999999995 111.951 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.447 HD11 HG11 ' A' ' 163' ' ' VAL . 1.0 OUTLIER -101.8 -174.1 2.51 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.275 -1.38 . . . . 1.0800000000000001 107.275 172.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.575 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 32.4 t . . . . . 0 C--N 1.316 -0.856 0 C-N-CA 119.678 -0.809 . . . . 1.5 110.716 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.79 HD12 HD11 ' A' ' 100' ' ' ILE . 32.3 mt . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 108.051 -1.092 . . . . 0.47999999999999998 108.051 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -140.69 -162.13 1.31 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.978 -0.689 . . . . 1.25 111.443 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.62 -172.36 14.63 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.679 -1.248 . . . . 0.46000000000000002 113.13 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -154.7 178.15 10.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.209 0.528 . . . . 0.5 110.336 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -111.66 -12.79 13.85 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.425 -0.807 . . . . 1.8600000000000001 109.57 169.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -125.26 101.99 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.61 -0.723 . . . . 1.77 109.782 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.52 4.04 4.62 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.053 2.502 . . . . 0.58999999999999997 113.148 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.13 54.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.521 0.677 . . . . 0.78000000000000003 109.57 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -100.13 3.28 43.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.003 -0.999 . . . . 1.45 109.53 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 0.69999999999999996 110.256 -179.807 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' A' ' 149' ' ' ASP . 1.7 ttm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.778 0.323 . . . . 1.1299999999999999 111.063 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -71.73 154.19 41.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.306 -0.627 . . . . 2.5099999999999998 109.306 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.618 ' O ' HG12 ' A' ' 150' ' ' VAL . 5.4 p30 -51.52 -68.69 0.15 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.288 0.477 . . . . 1.77 112.288 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -60.15 -26.29 66.18 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 121.644 -0.66 . . . . 2.1299999999999999 112.315 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.453 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 62.9 m-20 -78.08 -34.33 50.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.523 -0.308 . . . . 1.05 111.639 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.649 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 11.6 p -74.97 -15.82 15.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.32000000000000001 109.651 175.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.542 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.5 mp -88.59 -37.34 10.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.178 -0.464 . . . . 0.37 110.33 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -43.43 -71.8 0.07 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.375 0.989 . . . . 1.3799999999999999 112.098 162.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.5 tp -49.03 -42.42 38.18 Favored 'General case' 0 C--O 1.222 -0.343 0 O-C-N 123.747 0.654 . . . . 0.73999999999999999 110.147 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.43 -54.66 29.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.298 -1.319 . . . . 0.22 112.033 -172.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.6 p -77.82 -14.81 59.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.313 -1.312 . . . . 1.3300000000000001 111.619 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.14 -51.83 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.82 -0.437 . . . . 0.23000000000000001 109.82 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.8 m -77.13 118.06 69.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-O 121.952 0.882 . . . . 0.20999999999999999 110.229 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.804 ' HG2' HD13 ' A' ' 57' ' ' ILE . 41.1 Cg_endo -83.88 -178.42 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.022 2.481 . . . . 0.34000000000000002 112.832 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.691 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.4 m120 -59.84 -0.46 0.2 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.621 -1.172 . . . . 1.02 113.641 -174.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.59 57.46 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.28000000000000003 112.235 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -94.46 132.78 38.75 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.441 -0.446 . . . . 0.29999999999999999 109.951 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -84.54 140.28 31.53 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.676 -0.41 . . . . 1.96 109.995 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.4 p -145.48 126.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.584 -0.735 . . . . 0.46000000000000002 110.744 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.453 ' C ' HD12 ' A' ' 165' ' ' ILE . 92.0 m -116.51 144.19 44.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.813 -0.63 . . . . 0.56000000000000005 111.646 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.507 HG13 HG13 ' A' ' 63' ' ' VAL . 3.3 mp -125.96 114.17 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 118.819 -1.152 . . . . 0.95999999999999996 110.58 173.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.155 -1.384 . . . . 1.1899999999999999 108.698 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 1.8 mppt? . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 109.64 -0.504 . . . . 2.1000000000000001 109.64 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -100.92 168.32 9.7 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.143 0.277 . . . . 0.26000000000000001 111.374 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.702 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.6 tp -78.16 149.81 33.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.303 0.641 . . . . 0.23000000000000001 112.189 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.565 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -116.18 149.46 39.06 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.953 0.882 . . . . 0.26000000000000001 112.123 169.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' SER . 65.3 t80 -133.9 149.86 51.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.761 -1.563 . . . . 0.39000000000000001 107.498 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -129.86 116.07 18.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.163 -1.421 . . . . 1.0700000000000001 107.163 174.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -77.17 158.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.203 0.525 . . . . 0.38 111.885 -166.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -104.94 152.66 22.4 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.417 -0.811 . . . . 2.5899999999999999 108.947 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.717 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -53.0 119.69 4.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.962 -0.563 . . . . 1.74 111.694 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.03 -10.42 37.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.56999999999999995 113.15 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.543 ' HB3' HD11 ' A' ' 18' ' ' ILE . 80.9 m-20 -59.33 154.52 16.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.814 0.672 . . . . 2.1699999999999999 112.814 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.521 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -133.95 150.79 51.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.972 -0.558 . . . . 0.5 112.071 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.598 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.1 tp -48.33 -58.7 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.674 0.99 . . . . 0.27000000000000002 113.674 -172.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.674 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.0 t-20 -64.69 -42.4 95.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.546 1.165 . . . . 1.21 110.233 -169.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -59.06 -45.65 90.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.428 -2.169 . . . . 1.24 110.031 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -70.43 -41.14 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.715 -0.675 . . . . 0.29999999999999999 111.867 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.684 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.58 -66.22 0.48 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 111.812 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -4.6 48.27 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.989 -1.084 . . . . 0.39000000000000001 112.352 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.51 -29.67 69.15 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.16 -0.682 . . . . 1.6299999999999999 109.16 158.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD1' HG13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -95.41 10.49 36.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.034 0.445 . . . . 0.23999999999999999 111.961 173.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 59.95 50.3 6.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.256 -0.883 . . . . 3.5499999999999998 110.513 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.684 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.6 pt -147.7 -174.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.608 -0.886 . . . . 0.27000000000000002 108.608 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.2 m -101.07 147.7 25.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.559 -0.746 . . . . 0.81000000000000005 109.755 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.674 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -61.74 -36.09 79.98 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.745 -0.661 . . . . 0.27000000000000002 109.251 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.39 71.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.502 -1.227 . . . . 0.26000000000000001 111.677 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -37.54 37.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.196 -0.602 . . . . 0.23000000000000001 109.451 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 46' ' ' ILE . 16.3 tp -74.17 -19.75 60.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.433 -0.803 . . . . 0.17000000000000001 109.115 176.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.711 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.08 -38.68 35.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.454 0.645 . . . . 0.19 111.652 173.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -58.89 -43.17 90.9 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 122.223 1.011 . . . . 1.0700000000000001 109.834 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.53 44.08 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.576 -1.647 . . . . 0.17000000000000001 111.929 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.617 HD21 ' H ' ' A' ' 47' ' ' VAL . 32.8 m-80 -142.6 72.85 20.27 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.19 109.75 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.46 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.3 Cg_endo -54.91 -16.53 11.97 Favored 'Trans proline' 0 C--N 1.333 -0.273 0 C-N-CA 123.598 2.865 . . . . 0.29999999999999999 113.991 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -61.12 -32.65 72.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.068 0.937 . . . . 1.1699999999999999 109.727 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.664 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.63 -4.47 51.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.295 -1.32 . . . . 0.53000000000000003 114.484 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.711 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.92 -41.24 45.68 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 119.883 1.219 . . . . 1.23 109.856 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.582 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.63 -45.3 11.85 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.946 -1.933 . . . . 0.40000000000000002 111.597 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.84 -166.31 37.49 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.324 -0.941 . . . . 0.29999999999999999 113.781 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.8 mp -115.92 158.23 23.33 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.591 -1.304 . . . . 0.31 110.364 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.626 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.6 m -131.27 133.68 45.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.994 -0.548 . . . . 0.39000000000000001 110.643 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.55 127.93 9.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.108 0.781 . . . . 0.46999999999999997 113.108 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.77 -11.04 48.98 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.33 -1.304 . . . . 0.35999999999999999 112.322 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.626 ' HB3' ' O ' ' A' ' 41' ' ' THR . 5.6 tt0 -65.06 152.12 44.3 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.526 0.679 . . . . 1.1899999999999999 110.355 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 69.1 p -116.04 133.71 55.74 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.691 -1.14 . . . . 0.89000000000000001 109.758 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 29' ' ' LEU . 21.7 pt -136.12 144.03 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.464 0.649 . . . . 0.22 110.54 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.617 ' H ' HD21 ' A' ' 33' ' ' ASN . 11.9 t -90.72 150.09 3.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.805 -1.089 . . . . 0.20999999999999999 110.39 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.607 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.2 mm -117.95 87.1 26.94 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 114.849 -1.069 . . . . 0.17000000000000001 108.245 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.699 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.4 Cg_endo -59.79 142.51 98.78 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.488 2.792 . . . . 0.23000000000000001 113.023 -172.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.534 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.44 -7.78 63.64 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.56 -0.746 . . . . 0.29999999999999999 112.69 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.644 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.2 tt -115.45 127.13 27.06 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.771 -0.826 . . . . 0.25 108.771 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 55.3 Cg_endo -64.97 174.04 5.2 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.817 3.011 . . . . 0.31 113.7 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 4.9 t70 -95.75 138.73 21.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.428 -0.805 . . . . 0.71999999999999997 111.996 -168.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HD3' HD12 ' A' ' 5' ' ' LEU . 97.3 Cg_endo -77.74 -9.76 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.388 2.725 . . . . 0.27000000000000002 113.271 -172.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -94.98 -25.32 16.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 2.1099999999999999 110.444 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 3' ' ' LYS . 21.9 p -68.4 -31.79 71.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.3 1.048 . . . . 1.47 108.233 169.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.831 HD13 ' HG2' ' A' ' 158' ' ' PRO . 95.5 mt -77.25 126.87 84.52 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 113.362 -1.745 . . . . 0.26000000000000001 110.854 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -102.15 95.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 121.084 1.19 . . . . 0.20000000000000001 110.53 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.3 m-85 -158.42 133.34 8.41 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.886 -1.524 . . . . 0.26000000000000001 106.886 172.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 10.8 m-70 -138.91 109.05 6.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.729 -1.582 . . . . 2.8399999999999999 106.729 -168.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -94.65 109.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.126 -0.943 . . . . 0.32000000000000001 110.135 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.73 96.42 5.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.046 0.927 . . . . 0.34000000000000002 110.396 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.0 OUTLIER -115.74 97.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.028 -1.442 . . . . 0.68000000000000005 109.741 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -89.29 128.13 35.84 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.994 -1.003 . . . . 1.05 108.494 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.5 mm -57.91 -35.26 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.611 -0.885 . . . . 1.29 108.611 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.54 -43.68 91.72 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 114.355 -1.293 . . . . 0.88 111.828 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.96 -23.91 63.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.404 0.52 . . . . 0.73999999999999999 112.404 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 58.14 15.32 3.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.07 0.948 . . . . 2.5099999999999998 112.857 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.49 143.26 33.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.556 0.694 . . . . 0.45000000000000001 111.462 175.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.434 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 4.7 tt -94.45 122.68 37.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.362 -1.29 . . . . 0.33000000000000002 109.766 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -103.36 123.77 47.43 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.041 -0.664 . . . . 0.40000000000000002 111.267 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.535 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.76 141.47 32.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.323 -1.732 . . . . 0.33000000000000002 106.323 176.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 2.4 m -144.6 125.91 14.77 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 120.456 1.48 . . . . 0.75 112.483 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.3 tp -112.53 127.81 56.17 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 0.34999999999999998 110.085 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 7.3 t-20 63.13 32.89 14.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.385 0.612 . . . . 0.52000000000000002 109.519 173.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.7 m-20 79.86 1.44 2.12 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.536 -1.211 . . . . 1.8400000000000001 112.493 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -129.15 138.73 51.95 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.707 -1.197 . . . . 3.1899999999999999 113.698 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.01 147.94 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 113.329 -1.76 . . . . 0.40999999999999998 113.553 -170.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.535 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -99.68 -44.45 6.11 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 112.087 -2.324 . . . . 0.34999999999999998 108.121 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 34.4 tptt -176.89 164.75 2.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 112.491 -2.14 . . . . 2.0699999999999998 110.661 -176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 m -124.16 134.41 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.893 -0.14 . . . . 0.37 111.304 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -124.51 134.62 25.71 Favored Pre-proline 0 CA--C 1.521 -0.154 0 CA-C-O 121.027 0.441 . . . . 0.96999999999999997 111.637 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.4 ' HB2' HG22 ' A' ' 134' ' ' ILE . 25.6 Cg_endo -63.78 146.64 92.18 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.985 2.456 . . . . 0.59999999999999998 111.967 174.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.52 -178.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.834 -0.432 . . . . 0.64000000000000001 109.834 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.666 0.746 . . . . 0.82999999999999996 111.575 -178.469 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 118' ' ' LEU . 33.5 m-85 . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 121.103 0.478 . . . . 1.9299999999999999 110.445 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.673 ' HA ' ' O ' ' A' ' 161' ' ' THR . 37.1 m-85 -124.5 143.64 50.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.506 -0.77 . . . . 0.57999999999999996 109.716 170.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.681 HD11 HD12 ' A' ' 125' ' ' ILE . 13.3 mm -59.35 121.77 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.393 -1.336 . . . . 0.40999999999999998 107.393 164.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.611 HG13 ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -109.49 -45.7 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.024 -0.67 . . . . 0.37 111.275 -173.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 101' ' ' ILE . 5.6 t-20 -153.32 173.39 15.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 118.665 -1.214 . . . . 1.99 113.975 -170.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.751 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -139.18 128.18 23.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 111.948 -2.387 . . . . 1.1899999999999999 109.194 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.2 149.11 23.89 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.237 1.018 . . . . 1.6699999999999999 111.46 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -52.6 151.2 4.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.859 -1.973 . . . . 3.0600000000000001 112.765 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.67 107.14 0.62 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 113.694 -1.594 . . . . 2.6099999999999999 111.589 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -53.08 -50.19 14.92 Favored 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 124.416 3.411 . . . . 0.97999999999999998 112.727 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.12 -20.31 12.88 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.164 -0.925 . . . . 1.0800000000000001 112.46 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.41 -170.01 13.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.053 -0.594 . . . . 1.05 112.085 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.95 33.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 124.578 3.519 . . . . 1.3 114.093 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.413 ' H ' ' C ' ' A' ' 109' ' ' GLY . 4.4 t80 -86.31 -8.07 58.01 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.17 0.51 . . . . 1.3799999999999999 110.12 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.604 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 100.89 32.57 5.3 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 115.517 0.967 . . . . 1.1100000000000001 115.517 168.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 70.09 -21.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.207 1.188 . . . . 0.81000000000000005 114.207 168.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -157.2 128.73 6.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.119 -0.697 . . . . 1.1200000000000001 109.119 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -101.76 100.07 10.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.526 -0.916 . . . . 2.1899999999999999 108.526 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.751 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.4 mp -101.78 136.31 41.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.615 0.722 . . . . 0.60999999999999999 109.756 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 101' ' ' ILE . 68.8 m -106.5 152.05 24.17 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.239 -0.891 . . . . 0.93999999999999995 111.626 -171.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.642 HD11 HG11 ' A' ' 163' ' ' VAL . 1.5 tp -101.39 165.03 11.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.86 -1.064 . . . . 1.0800000000000001 108.729 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.56 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 30.5 t . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.401 . . . . 1.5 111.975 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 55.4 mt . . . . . 0 CA--C 1.513 -0.449 0 CA-C-O 121.181 0.515 . . . . 0.47999999999999998 109.646 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -152.11 -162.34 1.49 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.191 0.519 . . . . 1.25 110.718 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.604 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.4 171.12 14.52 Favored Glycine 0 C--N 1.311 -0.843 0 C-N-CA 119.838 -1.172 . . . . 0.46000000000000002 112.98 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -129.66 173.03 11.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.724 0.773 . . . . 0.5 111.809 -168.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 129' ' ' ASN . 1.6 t-20 -108.92 -20.65 12.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.382 -1.281 . . . . 1.8600000000000001 109.078 165.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -124.79 103.6 30.99 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.261 -0.881 . . . . 1.77 109.696 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.8 3.77 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.294 2.662 . . . . 0.58999999999999997 113.926 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.65 -13.16 59.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.58 0.705 . . . . 0.78000000000000003 110.211 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.7 m -96.26 6.97 47.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.185 -0.916 . . . . 1.45 109.943 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 83' ' ' PRO . 23.8 mm . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.394 -0.821 . . . . 0.69999999999999996 110.376 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.2 mpp? . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 109.669 -0.493 . . . . 1.1299999999999999 109.669 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.489 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 48.8 m80 -70.53 166.14 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.983 -0.377 . . . . 2.5099999999999998 109.983 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.594 ' O ' HG12 ' A' ' 150' ' ' VAL . 21.1 p-10 -54.26 -69.04 0.14 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 111.893 0.331 . . . . 1.77 111.893 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.01 -27.3 66.77 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.564 -0.71 . . . . 2.1299999999999999 111.236 -176.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.489 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 3.1 m-20 -63.67 -46.82 83.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.923 -0.58 . . . . 1.05 110.545 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.1 p -77.35 -17.44 14.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-N 115.754 -0.657 . . . . 0.32000000000000001 111.078 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.445 HD12 HG13 ' A' ' 150' ' ' VAL . 2.4 mp -85.46 -39.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 118.969 -0.538 . . . . 0.37 110.443 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -44.45 -69.97 0.12 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.705 1.139 . . . . 1.3799999999999999 112.244 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.705 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.5 tp -49.82 -43.79 48.87 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.469 -0.787 . . . . 0.73999999999999999 110.287 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.54 -48.36 69.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.256 -1.338 . . . . 0.22 111.819 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 35.0 t -79.63 -19.98 47.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.579 -1.191 . . . . 1.3300000000000001 110.85 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 -48.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.782 -0.451 . . . . 0.23000000000000001 109.782 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.4 m -77.45 116.47 58.14 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-O 121.802 0.811 . . . . 0.20999999999999999 109.93 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.831 ' HG2' HD13 ' A' ' 57' ' ' ILE . 32.3 Cg_endo -84.46 -178.35 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.099 2.533 . . . . 0.34000000000000002 112.442 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.644 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.4 m120 -63.27 5.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.743 -1.117 . . . . 1.02 113.349 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.19 58.2 0.47 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.89 -0.671 . . . . 0.28000000000000003 112.56 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -92.75 136.71 33.0 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.447 -0.443 . . . . 0.29999999999999999 110.671 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -83.85 129.52 34.93 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.642 -0.423 . . . . 1.96 110.301 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.642 HG11 HD11 ' A' ' 118' ' ' LEU . 4.4 p -136.37 127.3 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.23 0.538 . . . . 0.46000000000000002 111.19 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.4 ' O ' HG13 ' A' ' 63' ' ' VAL . 10.4 m -119.23 134.64 55.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.768 -0.651 . . . . 0.56000000000000005 111.689 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -121.82 108.68 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 119.32 -0.952 . . . . 0.95999999999999996 110.673 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.652 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.662 0 CA-C-N 115.061 -0.972 . . . . 1.1899999999999999 111.177 -168.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.8 mptt . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 110.135 -0.32 . . . . 2.1000000000000001 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.5 mt -89.15 168.9 11.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.092 -0.504 . . . . 0.26000000000000001 110.629 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.617 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.3 tp -77.39 150.08 35.12 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 122.988 0.515 . . . . 0.23000000000000001 112.119 -169.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.12 150.43 36.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.891 0.853 . . . . 0.26000000000000001 111.67 167.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' SER . 69.2 t80 -135.48 151.82 50.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.717 -1.583 . . . . 0.39000000000000001 108.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.627 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -131.67 118.74 20.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.61 -1.256 . . . . 1.0700000000000001 107.61 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.532 HG11 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -80.53 159.34 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 123.333 0.653 . . . . 0.38 112.011 -169.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.409 ' N ' HG23 ' A' ' 9' ' ' VAL . 89.3 mttt -108.37 152.07 25.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.711 -0.677 . . . . 2.5899999999999999 109.198 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.664 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -50.54 119.4 3.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 1.74 112.175 -175.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.67 -4.2 42.8 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.028 -0.987 . . . . 0.56999999999999995 113.144 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.624 ' HB3' HD11 ' A' ' 18' ' ' ILE . 7.3 m-20 -65.62 156.81 31.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.535 0.668 . . . . 2.1699999999999999 112.529 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.523 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -131.96 148.16 52.5 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.829 0.677 . . . . 0.5 112.829 -176.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.609 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.0 tp -46.5 -58.91 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.771 1.026 . . . . 0.27000000000000002 113.771 -173.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.654 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 20.3 t-20 -64.73 -40.28 95.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.583 1.183 . . . . 1.21 110.328 -170.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.781 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 10.9 m -60.87 -42.75 98.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 112.602 -2.09 . . . . 1.24 110.398 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -73.38 -39.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 O-C-N 123.831 0.707 . . . . 0.29999999999999999 112.332 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.689 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.1 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.396 -0.365 . . . . 0.23000000000000001 111.522 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.75 52.31 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.902 -1.119 . . . . 0.39000000000000001 111.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.781 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.2 t0 -60.7 -42.63 97.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.461 -1.311 . . . . 1.6299999999999999 107.461 157.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.7 m-85 -93.55 16.78 12.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.5 0.556 . . . . 0.23999999999999999 112.5 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HG2' HD13 ' A' ' 101' ' ' ILE . 7.0 mmm180 53.82 51.86 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 3.5499999999999998 111.002 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.689 HG12 ' O ' ' A' ' 19' ' ' ALA . 35.7 pt -147.26 -172.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.928 -0.768 . . . . 0.27000000000000002 108.928 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.97 148.01 23.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 0.81000000000000005 109.682 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.654 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 23.3 p -63.39 -35.74 81.4 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.683 -0.858 . . . . 0.27000000000000002 108.683 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.14 -32.58 74.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.303 -1.317 . . . . 0.26000000000000001 111.38 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.05 -37.58 38.62 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.273 0.559 . . . . 0.23000000000000001 109.634 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 46' ' ' ILE . 12.6 tp -74.18 -18.8 60.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.401 -0.818 . . . . 0.17000000000000001 109.027 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.743 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.28 34.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.462 0.649 . . . . 0.19 111.424 172.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 60.3 mt-30 -57.08 -46.26 82.67 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 122.248 1.023 . . . . 1.0700000000000001 109.458 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.0 47.97 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.18 -1.827 . . . . 0.17000000000000001 112.202 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.612 HD21 ' H ' ' A' ' 47' ' ' VAL . 29.1 m-80 -142.96 72.71 18.67 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-O 121.153 0.502 . . . . 0.19 109.903 -173.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.492 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 17.8 Cg_endo -57.24 -11.42 8.03 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 123.7 2.933 . . . . 0.29999999999999999 114.187 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 t -62.86 -34.19 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.049 0.928 . . . . 1.1699999999999999 109.915 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.7 mt -78.27 -4.99 50.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.438 -1.255 . . . . 0.53000000000000003 114.372 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.743 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -51.08 -39.44 56.08 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 122.342 1.068 . . . . 1.23 110.049 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.592 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -83.98 -46.47 12.02 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.987 -1.915 . . . . 0.40000000000000002 111.437 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.28 -164.09 34.4 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.502 -0.856 . . . . 0.29999999999999999 114.008 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.532 HD23 HG11 ' A' ' 9' ' ' VAL . 6.0 mp -118.16 157.41 26.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.401 -1.4 . . . . 0.31 110.088 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.582 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -134.15 136.8 44.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.704 -0.68 . . . . 0.39000000000000001 110.428 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.02 126.89 7.92 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.282 0.845 . . . . 0.46999999999999997 113.282 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.627 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.52 -11.78 49.78 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.528 -1.215 . . . . 0.35999999999999999 112.002 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 3.7 tt0 -63.09 150.25 43.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.766 0.793 . . . . 1.1899999999999999 110.466 175.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 22.9 m -118.45 134.51 55.01 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.231 -1.35 . . . . 0.89000000000000001 109.13 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 29' ' ' LEU . 18.0 pt -137.14 151.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.445 0.64 . . . . 0.22 110.513 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.612 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.7 t -96.75 149.21 4.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.013 -0.994 . . . . 0.20999999999999999 110.074 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.603 ' CG1' HD23 ' A' ' 5' ' ' LEU . 20.1 mm -117.65 88.84 31.05 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 108.309 -0.997 . . . . 0.17000000000000001 108.309 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.742 ' HA ' HD13 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.83 142.14 98.05 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.014 2.476 . . . . 0.23000000000000001 112.717 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.48 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.06 -6.91 65.08 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.525 -0.761 . . . . 0.29999999999999999 112.995 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.681 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.9 127.74 26.44 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 108.737 -0.838 . . . . 0.25 108.737 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.5 Cg_endo -68.56 174.31 8.59 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.819 3.013 . . . . 0.31 113.93 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.6 t70 -89.57 142.48 29.47 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.881 -1.054 . . . . 0.71999999999999997 110.185 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HD3' HD12 ' A' ' 5' ' ' LEU . 84.2 Cg_endo -80.96 -6.2 13.13 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.225 2.617 . . . . 0.27000000000000002 111.973 -174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -95.85 -25.62 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 2.1099999999999999 111.099 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 53' ' ' ASP . 28.6 p -70.49 -27.06 63.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.495 1.14 . . . . 1.47 108.028 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.9 mt -81.98 129.23 65.32 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 112.936 -1.938 . . . . 0.26000000000000001 110.66 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -102.75 95.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 121.112 1.208 . . . . 0.20000000000000001 110.761 165.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' SER . 86.8 m-85 -158.3 129.3 6.39 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.869 -1.53 . . . . 0.26000000000000001 106.869 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 31.4 m-70 -136.69 105.13 5.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.983 -1.488 . . . . 2.8399999999999999 106.983 -165.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 80.6 mt -94.15 113.42 28.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.282 -0.872 . . . . 0.32000000000000001 110.703 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.6 95.19 5.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.366 -0.834 . . . . 0.34000000000000002 110.752 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -110.18 112.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.431 -1.259 . . . . 0.68000000000000005 109.479 177.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.626 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 49.5 m -107.38 135.63 48.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.836 -0.62 . . . . 1.05 110.629 -175.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 1.2 mt -57.32 -38.96 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.772 0.796 . . . . 1.29 110.269 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.21 -45.73 69.06 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.32 -1.309 . . . . 0.88 111.717 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -74.41 -24.65 59.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.347 0.594 . . . . 0.73999999999999999 112.052 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 32.7 mttt 53.41 24.53 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.283 1.033 . . . . 2.5099999999999998 111.732 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.472 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.5 OUTLIER -141.63 143.78 33.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.93 0.872 . . . . 0.45000000000000001 110.934 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.8 tt -98.6 117.94 34.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.82 -1.536 . . . . 0.33000000000000002 109.147 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -100.16 125.37 46.28 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.378 -0.529 . . . . 0.40000000000000002 110.67 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.01 147.88 27.91 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.789 -1.56 . . . . 0.33000000000000002 106.789 177.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 25.5 m -151.4 129.39 11.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 120.316 1.416 . . . . 0.75 112.729 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 tp -117.3 129.39 55.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.917 -1.038 . . . . 0.34999999999999998 110.755 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 63.4 35.56 12.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.377 0.608 . . . . 0.52000000000000002 109.679 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 77.48 2.75 3.09 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.595 -1.184 . . . . 1.8400000000000001 111.784 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -129.95 138.74 51.03 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.41 -1.316 . . . . 3.1899999999999999 114.032 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.53 149.36 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 113.162 -1.835 . . . . 0.40999999999999998 112.822 -173.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -99.48 -45.57 5.77 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 112.675 -2.057 . . . . 0.34999999999999998 108.38 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 179.53 157.61 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 112.805 -1.998 . . . . 2.0699999999999998 110.388 -175.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.472 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.3 m -116.44 136.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.788 0.327 . . . . 0.37 111.661 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -116.89 153.27 49.35 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.088 -0.505 . . . . 0.96999999999999997 110.192 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.11 143.09 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.59 2.193 . . . . 0.59999999999999998 111.424 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 85' ' ' ALA . 0.1 OUTLIER -145.96 179.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.672 -0.24 . . . . 0.64000000000000001 110.59 -178.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' HG12 ' A' ' 84' ' ' ILE . . . . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.485 0.66 . . . . 0.82999999999999996 111.64 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.596 ' HB3' ' H ' ' A' ' 119' ' ' SER . 33.4 m-85 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.085 0.469 . . . . 1.9299999999999999 111.185 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' A' ' 161' ' ' THR . 48.9 m-85 -128.62 138.52 52.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.476 -0.784 . . . . 0.57999999999999996 109.897 171.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 125' ' ' ILE . 21.7 mm -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.926 -1.139 . . . . 0.40999999999999998 107.926 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.593 HD12 ' CD1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -111.55 -33.54 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.897 -0.721 . . . . 0.37 112.666 -177.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 28.5 p-10 -166.47 -167.77 1.07 Allowed 'General case' 0 N--CA 1.46 0.062 0 CA-C-O 122.383 1.087 . . . . 1.99 113.846 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -156.84 141.6 16.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 112.391 -2.186 . . . . 1.1899999999999999 111.501 178.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 23.5 tp60 -109.92 142.18 41.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.142 -0.936 . . . . 1.6699999999999999 110.957 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -53.25 150.0 6.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.645 -1.616 . . . . 3.0600000000000001 112.115 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.81 103.17 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 114.448 -1.251 . . . . 2.6099999999999999 111.434 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.42 -49.77 15.77 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.151 3.234 . . . . 0.97999999999999998 112.362 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.29 -16.01 20.1 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.995 -1.002 . . . . 1.0800000000000001 112.393 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.97 -170.38 14.35 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.012 -0.613 . . . . 1.05 112.675 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.28 16.17 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.633 3.556 . . . . 1.3 114.99 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -66.66 -24.6 66.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.597 . . . . 1.3799999999999999 109.933 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 127' ' ' GLY . . . 99.63 60.52 0.85 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.331 -0.849 . . . . 1.1100000000000001 114.934 168.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.54 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 72.96 -57.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.941 1.089 . . . . 0.81000000000000005 113.941 166.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -146.79 137.31 23.76 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.59 -0.522 . . . . 1.1200000000000001 109.59 -173.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 76.2 t-105 -103.74 101.04 10.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.272 -0.64 . . . . 2.1899999999999999 109.272 169.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.4 mp -104.51 109.23 21.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.585 0.707 . . . . 0.60999999999999999 109.769 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.506 ' HB3' ' CG2' ' A' ' 101' ' ' ILE . 3.5 t -79.01 146.3 33.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 0.93999999999999995 111.069 -168.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -92.88 177.02 6.21 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.591 -1.262 . . . . 1.0800000000000001 107.591 171.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 36.0 t . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 111.869 0.322 . . . . 1.5 111.869 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.754 HD12 HD11 ' A' ' 100' ' ' ILE . 21.1 mt . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.075 -0.713 . . . . 0.47999999999999998 109.075 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -152.09 -164.99 2.1 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.399 0.618 . . . . 1.25 111.341 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.443 ' O ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.07 -178.62 15.74 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.666 -1.152 . . . . 0.46000000000000002 112.873 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.6 t -145.48 178.23 8.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.139 -0.531 . . . . 0.5 110.927 -165.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -108.98 -16.82 14.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.983 -1.008 . . . . 1.8600000000000001 109.255 165.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -124.98 100.71 33.13 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 115.744 -0.662 . . . . 1.77 109.854 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.54 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 44.8 Cg_endo -92.78 4.64 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.584 2.856 . . . . 0.58999999999999997 113.166 175.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.22 -20.99 50.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.976 0.417 . . . . 0.78000000000000003 110.437 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 p -93.95 -4.83 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.598 0.714 . . . . 1.45 110.11 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 9.0 mm . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.239 -0.891 . . . . 0.69999999999999996 110.461 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 29.1 mtp . . . . . 0 C--O 1.234 0.256 0 N-CA-C 109.964 -0.384 . . . . 1.1299999999999999 109.964 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -79.0 153.27 30.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.919 -0.771 . . . . 2.5099999999999998 108.919 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.64 ' O ' HG12 ' A' ' 150' ' ' VAL . 21.7 p-10 -52.08 -65.0 0.63 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.504 0.187 . . . . 1.77 111.504 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -60.74 -30.44 69.99 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.703 -0.623 . . . . 2.1299999999999999 111.342 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -64.38 -43.54 94.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.179 0.514 . . . . 1.05 110.25 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.4 p -77.59 -17.42 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.509 -0.769 . . . . 0.32000000000000001 110.993 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.54 HD11 ' HB1' ' A' ' 113' ' ' ALA . 3.0 mp -88.98 -40.86 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 119.022 -0.513 . . . . 0.37 110.649 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -44.03 -69.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.633 1.106 . . . . 1.3799999999999999 112.027 162.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.744 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.8 OUTLIER -48.31 -42.52 31.26 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 123.813 0.695 . . . . 0.73999999999999999 110.232 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.6 -57.02 12.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.427 -1.26 . . . . 0.22 112.465 -171.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 t -77.05 -14.99 59.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.825 -1.079 . . . . 1.3300000000000001 110.487 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.48 -50.28 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 109.976 -0.379 . . . . 0.23000000000000001 109.976 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 153' ' ' LEU . 28.3 m -75.96 116.71 58.1 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 121.939 0.876 . . . . 0.20999999999999999 110.379 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.788 ' HG2' HD13 ' A' ' 57' ' ' ILE . 40.2 Cg_endo -81.97 -177.43 3.53 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.199 2.599 . . . . 0.34000000000000002 112.581 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.681 ' O ' HD21 ' A' ' 51' ' ' LEU . 16.5 m120 -59.11 0.65 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.58 -1.191 . . . . 1.02 113.839 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.18 58.41 0.45 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.738 -0.744 . . . . 0.28000000000000003 112.677 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.6 m -90.32 136.83 32.81 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.376 -0.484 . . . . 0.29999999999999999 110.53 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -84.76 131.92 34.5 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.55 -0.46 . . . . 1.96 109.983 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.4 p -138.91 124.81 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.363 -0.835 . . . . 0.46000000000000002 110.858 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.412 ' C ' HD12 ' A' ' 165' ' ' ILE . 89.8 m -116.92 140.5 49.38 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.682 -0.69 . . . . 0.56000000000000005 111.636 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.1 mp -120.4 110.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.811 -1.156 . . . . 0.95999999999999996 110.593 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.321 -0.649 0 CA-C-N 114.372 -1.285 . . . . 1.1899999999999999 109.071 -172.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.276 -0.639 . . . . 2.1000000000000001 109.276 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.8 mt -91.79 168.86 11.15 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.382 0.426 . . . . 0.26000000000000001 111.05 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.556 HD23 ' CG1' ' A' ' 48' ' ' ILE . 3.8 tp -76.42 150.31 36.76 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 123.42 0.688 . . . . 0.23000000000000001 112.297 -168.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.551 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.57 150.05 35.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.137 0.97 . . . . 0.26000000000000001 111.92 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 45' ' ' SER . 70.0 t80 -136.63 149.8 48.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.448 -1.705 . . . . 0.39000000000000001 108.083 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.82 121.7 28.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.194 -1.41 . . . . 1.0700000000000001 107.194 176.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -82.46 158.65 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.181 0.515 . . . . 0.38 112.119 -170.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -106.18 150.28 26.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.843 -0.799 . . . . 2.5899999999999999 108.843 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.647 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.2 tt0 -53.97 112.73 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.541 0.526 . . . . 1.74 111.967 -175.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.0 -8.67 18.72 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.673 -0.775 . . . . 0.56999999999999995 112.837 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.567 ' HB3' HD11 ' A' ' 18' ' ' ILE . 55.7 m-20 -62.26 154.84 26.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.067 0.433 . . . . 2.1699999999999999 111.946 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.562 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 p -132.11 152.95 50.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.5 111.892 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.0 tp -49.86 -58.5 5.26 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.99 1.107 . . . . 0.27000000000000002 113.99 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.6 t-20 -65.07 -42.01 94.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.569 1.176 . . . . 1.21 109.979 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.755 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 5.8 m -60.34 -39.45 87.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 112.51 -2.132 . . . . 1.24 110.769 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.567 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.8 -41.18 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 123.296 0.638 . . . . 0.29999999999999999 112.176 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.62 -61.94 2.08 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.511 -0.313 . . . . 0.23000000000000001 111.284 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.12 54.38 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.798 -1.161 . . . . 0.39000000000000001 112.136 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.755 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.9 t70 -61.89 -34.84 76.75 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.654 -1.239 . . . . 1.6299999999999999 107.654 156.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.4 m-85 -99.35 17.81 19.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.248 0.462 . . . . 0.23999999999999999 112.248 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 52.11 51.92 15.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.356 -0.838 . . . . 3.5499999999999998 110.954 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 19' ' ' ALA . 35.5 pt -146.86 -174.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.644 -0.872 . . . . 0.27000000000000002 108.644 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -100.81 144.7 29.46 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.429 -0.805 . . . . 0.81000000000000005 109.258 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.644 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 25.3 p -61.77 -34.81 76.54 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.48 0.657 . . . . 0.27000000000000002 109.251 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.86 -29.4 70.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.34 -1.3 . . . . 0.26000000000000001 111.511 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.82 -38.11 26.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.391 0.615 . . . . 0.23000000000000001 109.791 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.672 HD11 HD12 ' A' ' 46' ' ' ILE . 16.7 tp -73.31 -16.93 61.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.214 -0.903 . . . . 0.17000000000000001 108.958 174.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.769 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -82.1 -38.52 24.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.37 0.605 . . . . 0.19 111.578 173.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.4 mt-30 -57.92 -43.42 86.25 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.169 0.985 . . . . 1.0700000000000001 109.636 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.59 -19.77 41.23 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.354 -1.748 . . . . 0.17000000000000001 112.402 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 32.7 m-80 -143.34 72.66 17.85 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.148 0.499 . . . . 0.19 109.922 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.663 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.8 Cg_endo -57.36 -11.32 8.11 Favored 'Trans proline' 0 C--N 1.333 -0.283 0 C-N-CA 123.649 2.9 . . . . 0.29999999999999999 114.478 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -63.31 -34.43 77.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.913 0.864 . . . . 1.1699999999999999 109.573 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -78.35 -6.62 55.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.332 -1.303 . . . . 0.53000000000000003 114.415 -170.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.769 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.94 -42.56 48.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 119.78 1.173 . . . . 1.23 110.22 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.28 -45.95 12.31 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 112.881 -1.963 . . . . 0.40000000000000002 111.439 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -164.81 36.16 Favored Glycine 0 CA--C 1.492 -1.355 0 C-N-CA 120.265 -0.969 . . . . 0.29999999999999999 114.358 176.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.5 mp -115.43 157.86 23.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.966 -1.617 . . . . 0.31 110.447 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.62 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 96.3 m -133.89 133.86 42.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.641 -0.709 . . . . 0.39000000000000001 110.519 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.647 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -44.61 126.49 5.54 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.416 0.895 . . . . 0.46999999999999997 113.416 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.568 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.31 -10.66 53.65 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.391 -1.277 . . . . 0.35999999999999999 112.129 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.62 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -63.99 150.91 44.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.776 0.798 . . . . 1.1899999999999999 110.315 175.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 44.7 m -118.2 133.86 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.212 -1.358 . . . . 0.89000000000000001 109.049 -171.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.672 HD12 HD11 ' A' ' 29' ' ' LEU . 15.0 pt -135.89 151.14 28.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.244 0.545 . . . . 0.22 110.312 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.573 ' H ' HD21 ' A' ' 33' ' ' ASN . 11.1 t -96.03 149.09 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.121 -0.945 . . . . 0.20999999999999999 110.119 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.556 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.4 mm -117.24 87.31 23.51 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.84 -1.073 . . . . 0.17000000000000001 108.386 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.699 ' HA ' HD13 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.59 140.26 92.97 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.119 2.546 . . . . 0.23000000000000001 112.626 -173.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.554 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 85.3 -8.24 72.07 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.323 -0.853 . . . . 0.29999999999999999 113.015 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.606 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.9 tt -117.55 127.43 26.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.585 -0.894 . . . . 0.25 108.585 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD23 ' A' ' 51' ' ' LEU . 62.0 Cg_endo -67.78 173.58 8.89 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.725 2.95 . . . . 0.31 113.818 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.785 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.9 t70 -90.3 142.05 28.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.034 -0.985 . . . . 0.71999999999999997 110.576 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.548 ' HD3' HD12 ' A' ' 5' ' ' LEU . 60.3 Cg_endo -86.21 -8.31 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.73 2.953 . . . . 0.27000000000000002 112.444 -174.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -92.01 -13.52 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 2.1099999999999999 109.486 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 53' ' ' ASP . 12.3 p -84.92 -29.5 25.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.944 -1.132 . . . . 1.47 107.944 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.662 HD13 ' HG2' ' A' ' 158' ' ' PRO . 43.5 mt -83.02 131.74 52.94 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 113.496 -1.684 . . . . 0.26000000000000001 110.887 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.68 96.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 121.046 1.164 . . . . 0.20000000000000001 110.525 167.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.499 ' HD2' ' CG2' ' A' ' 57' ' ' ILE . 84.1 m-85 -157.3 132.49 8.97 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.604 -1.258 . . . . 0.26000000000000001 107.604 171.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.646 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 29.1 m170 -135.96 103.73 5.47 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.487 -1.672 . . . . 2.8399999999999999 106.487 -167.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 64.5 mt -94.71 112.43 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 120.237 -0.585 . . . . 0.32000000000000001 110.521 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.33 95.8 5.35 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.378 -0.828 . . . . 0.34000000000000002 110.811 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 165' ' ' ILE . 0.3 OUTLIER -115.75 104.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.503 -1.226 . . . . 0.68000000000000005 110.645 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -98.96 113.52 25.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.213 -1.032 . . . . 1.05 108.213 174.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 mt -54.62 -32.43 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-O 120.905 0.383 . . . . 1.29 111.779 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.09 -45.62 95.0 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.071 -1.061 . . . . 0.88 111.305 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.43 -23.45 62.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.461 0.648 . . . . 0.73999999999999999 111.959 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.7 mttt 62.35 18.93 10.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.734 1.214 . . . . 2.5099999999999998 112.999 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.441 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.94 140.17 31.0 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.284 1.04 . . . . 0.45000000000000001 112.63 177.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.572 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -97.19 118.7 34.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.028 -1.897 . . . . 0.33000000000000002 109.269 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -100.86 125.14 47.36 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.349 -0.54 . . . . 0.40000000000000002 110.489 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.604 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.8 143.92 29.64 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.966 -1.864 . . . . 0.33000000000000002 105.966 176.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 47.7 m -148.65 129.52 14.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 120.189 1.359 . . . . 0.75 112.895 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -114.46 126.53 55.06 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.608 -1.178 . . . . 0.34999999999999998 110.438 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.5 t-20 63.7 36.31 10.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.52000000000000002 109.54 172.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.1 m-20 76.81 2.73 3.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.591 -1.186 . . . . 1.8400000000000001 112.409 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -130.42 137.79 50.01 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 118.081 -1.448 . . . . 3.1899999999999999 114.269 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.17 149.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-N 113.122 -1.854 . . . . 0.40999999999999998 113.59 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.553 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -103.3 -40.35 6.44 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.407 -2.179 . . . . 0.34999999999999998 108.732 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.52 165.87 2.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.677 -2.056 . . . . 2.0699999999999998 110.723 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.441 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 8.6 m -125.49 130.52 51.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.419 0.152 . . . . 0.37 110.947 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.473 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 15.7 m-85 -120.68 134.35 24.23 Favored Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.759 0.314 . . . . 0.96999999999999997 110.966 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.69 143.53 74.78 Favored 'Trans proline' 0 N--CA 1.472 0.213 0 C-N-CA 123.168 2.579 . . . . 0.59999999999999998 112.76 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.24 179.36 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.329 -0.396 . . . . 0.64000000000000001 110.782 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 110.091 -0.337 . . . . 0.82999999999999996 110.091 179.555 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.506 ' HB3' ' H ' ' A' ' 119' ' ' SER . 7.2 m-85 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.71 0.291 . . . . 1.9299999999999999 110.505 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 161' ' ' THR . 66.5 m-85 -131.17 139.83 49.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.57999999999999996 110.252 172.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.596 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 34.0 mm -63.22 116.68 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 N-CA-C 108.752 -0.833 . . . . 0.40999999999999998 108.752 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 3.7 tt -108.32 -19.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 119.237 -0.985 . . . . 0.37 112.507 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 6.2 t-20 179.0 -168.39 0.09 Allowed 'General case' 0 C--N 1.351 0.669 0 CA-C-O 122.73 1.252 . . . . 1.99 114.096 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.6 ptp180 -156.78 144.17 18.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.621 -2.536 . . . . 1.1899999999999999 110.021 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.98 157.21 22.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 122.067 0.937 . . . . 1.6699999999999999 111.172 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -52.32 150.21 4.9 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.521 -2.127 . . . . 3.0600000000000001 112.05 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -48.33 110.3 1.4 Allowed Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 115.118 -0.946 . . . . 2.6099999999999999 111.039 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.17 -48.25 22.63 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 123.762 2.975 . . . . 0.97999999999999998 111.858 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 111.3 -20.39 23.42 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.849 -1.069 . . . . 1.0800000000000001 112.625 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -105.93 -170.07 23.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.971 -0.633 . . . . 1.05 111.946 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.82 35.51 0.1 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.188 3.259 . . . . 1.3 113.561 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 109' ' ' GLY . 11.4 t80 -86.89 -16.89 34.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.21 0.529 . . . . 1.3799999999999999 109.804 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.563 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.89 38.0 3.75 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.653 -0.703 . . . . 1.1100000000000001 114.071 173.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB2' ' ND2' ' A' ' 147' ' ' ASN . . . 74.38 -36.71 0.34 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.121 1.156 . . . . 0.81000000000000005 114.121 168.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.545 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -148.37 144.55 27.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.975 0.417 . . . . 1.1200000000000001 110.949 -173.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -115.49 100.21 7.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.661 . . . . 2.1899999999999999 109.373 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -101.72 145.72 28.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.206 0.527 . . . . 0.60999999999999999 110.535 176.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.479 ' HB2' HG23 ' A' ' 101' ' ' ILE . 74.4 m -106.71 137.12 45.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.662 -0.699 . . . . 0.93999999999999995 112.412 -170.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.564 HD11 HG11 ' A' ' 163' ' ' VAL . 2.2 tp -107.68 -171.29 1.84 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.086 -0.961 . . . . 1.0800000000000001 108.987 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.506 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.7 t . . . . . 0 CA--C 1.543 0.685 0 CA-C-N 118.675 0.67 . . . . 1.5 111.18 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.637 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 12.0 mt . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 107.363 -1.347 . . . . 0.47999999999999998 107.363 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -137.96 -163.92 1.53 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.697 -0.801 . . . . 1.25 112.463 -173.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.563 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.9 -177.0 15.31 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.377 -1.283 . . . . 0.46000000000000002 112.479 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -141.07 175.88 9.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.494 0.664 . . . . 0.5 111.594 -166.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -111.04 -17.78 13.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.827 -1.079 . . . . 1.8600000000000001 109.311 166.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -125.45 102.94 29.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.296 -0.866 . . . . 1.77 109.727 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.412 ' HA ' HG12 ' A' ' 134' ' ' ILE . 44.3 Cg_endo -91.79 3.48 4.07 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.171 2.581 . . . . 0.58999999999999997 113.564 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.86 57.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.869 0.366 . . . . 0.78000000000000003 111.117 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 -3.02 50.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 1.45 110.152 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 131' ' ' PRO . 10.9 mm . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.69999999999999996 111.255 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 10.8 mtm . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.769 0.319 . . . . 1.1299999999999999 110.679 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -67.73 150.51 48.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 2.5099999999999998 110.046 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.595 ' O ' HG12 ' A' ' 150' ' ' VAL . 3.4 m-20 -51.63 -67.77 0.22 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 123.412 0.445 . . . . 1.77 111.589 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.43 -24.5 67.86 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.862 -0.524 . . . . 2.1299999999999999 111.963 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.59 -38.41 74.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.731 0.3 . . . . 1.05 110.975 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.0 p -80.26 -14.9 13.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 116.587 -0.279 . . . . 0.32000000000000001 110.521 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.545 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.5 mp -89.16 -38.96 12.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 118.851 -0.595 . . . . 0.37 110.911 173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -44.09 -68.6 0.18 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.854 1.206 . . . . 1.3799999999999999 111.601 163.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.701 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -49.83 -42.47 47.33 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.589 -0.732 . . . . 0.73999999999999999 110.059 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.64 -57.66 10.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.237 -1.347 . . . . 0.22 112.107 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.0 t -75.32 -14.57 60.5 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.475 -1.239 . . . . 1.3300000000000001 110.63 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.438 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 80.9 mt -93.06 -47.77 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.32 -0.4 . . . . 0.23000000000000001 110.365 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.9 m -76.88 110.61 12.37 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 122.038 0.923 . . . . 0.20999999999999999 111.073 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.662 ' HG2' HD13 ' A' ' 57' ' ' ILE . 13.9 Cg_endo -82.16 -179.31 4.62 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.698 2.265 . . . . 0.34000000000000002 113.254 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.425 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 8.7 m120 -66.73 110.54 3.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.74 -1.118 . . . . 1.02 108.254 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.89 2.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.284 -0.96 . . . . 0.28000000000000003 113.314 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.596 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 18.9 m -93.2 136.29 33.6 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.839 -0.8 . . . . 0.29999999999999999 109.819 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -84.72 134.16 34.35 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.952 -0.388 . . . . 1.96 109.952 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.564 HG11 HD11 ' A' ' 118' ' ' LEU . 3.2 p -140.51 125.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.421 -0.809 . . . . 0.46000000000000002 111.424 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.4 m -114.01 129.7 56.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.303 -0.862 . . . . 0.56000000000000005 111.557 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.608 HG13 HG13 ' A' ' 63' ' ' VAL . 2.8 mp -119.25 122.3 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 118.135 -1.426 . . . . 0.95999999999999996 109.578 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 122.087 0.946 . . . . 1.1899999999999999 109.932 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.157 0 N-CA-C 109.754 -0.461 . . . . 2.1000000000000001 109.754 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.779 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.2 mt -100.69 169.15 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 0.26000000000000001 111.948 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.693 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.4 tp -79.62 153.02 29.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 123.643 0.777 . . . . 0.23000000000000001 112.206 -169.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.571 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -116.58 153.05 32.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.866 0.841 . . . . 0.26000000000000001 111.858 166.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.2 t80 -136.6 150.5 48.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.029 -1.441 . . . . 0.39000000000000001 108.07 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.654 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.47 119.42 24.87 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.714 -1.587 . . . . 1.0700000000000001 106.714 174.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -81.08 158.88 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 112.782 0.66 . . . . 0.38 112.782 -167.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.407 ' N ' HG23 ' A' ' 9' ' ' VAL . 8.5 mtmp? -99.26 150.14 22.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.019 -0.992 . . . . 2.5899999999999999 109.43 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.791 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.1 tt0 -53.84 109.17 0.43 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.258 -0.883 . . . . 1.74 111.618 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -9.82 22.43 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.64 -0.79 . . . . 0.56999999999999995 112.748 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 18' ' ' ILE . 82.4 m-20 -59.7 154.21 18.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.021 0.41 . . . . 2.1699999999999999 111.545 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.556 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.7 p -133.39 153.63 51.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.102 0.477 . . . . 0.5 112.115 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.5 tp -49.44 -59.9 3.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.795 1.035 . . . . 0.27000000000000002 113.795 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.681 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.6 t-20 -65.02 -40.13 94.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.22 1.009 . . . . 1.21 110.456 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.0 t -59.72 -51.46 69.66 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 113.221 -1.809 . . . . 1.24 109.358 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.64 -39.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.924 -0.58 . . . . 0.29999999999999999 111.433 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.666 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.98 -65.2 0.66 Allowed 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.23000000000000001 111.635 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.12 -5.3 55.74 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 118.84 -1.144 . . . . 0.39000000000000001 112.269 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.094 -0.706 . . . . 1.6299999999999999 109.094 158.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.618 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.4 m-85 -97.05 13.94 27.36 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.089 0.403 . . . . 0.23999999999999999 112.089 173.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 58.15 49.19 11.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 3.5499999999999998 110.096 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 19' ' ' ALA . 42.0 pt -147.7 -175.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.691 -0.855 . . . . 0.27000000000000002 108.691 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 m -99.52 146.0 26.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.538 -0.755 . . . . 0.81000000000000005 109.337 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.681 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.1 p -60.66 -38.08 83.68 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.01 -0.737 . . . . 0.27000000000000002 109.01 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.55 69.0 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.47 -1.241 . . . . 0.26000000000000001 111.654 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 49' ' ' PRO . . . -80.72 -38.13 29.36 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.078 -0.712 . . . . 0.23000000000000001 109.078 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.712 HD11 HD12 ' A' ' 46' ' ' ILE . 12.8 tp -73.69 -18.54 61.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.333 -0.849 . . . . 0.17000000000000001 109.044 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.737 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.9 -39.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.484 0.659 . . . . 0.19 111.563 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -57.92 -42.9 85.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 122.372 1.082 . . . . 1.0700000000000001 109.648 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.43 -17.25 49.51 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.512 -1.676 . . . . 0.17000000000000001 112.016 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.695 HD21 ' H ' ' A' ' 47' ' ' VAL . 33.6 m-80 -144.45 72.22 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.102 0.477 . . . . 0.19 110.115 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.53 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.9 Cg_endo -55.06 -10.54 2.92 Favored 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 124.216 3.277 . . . . 0.29999999999999999 114.387 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.38 -37.77 87.99 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.894 0.854 . . . . 1.1699999999999999 110.78 173.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 6.3 mt -76.55 -6.09 50.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.749 1.389 . . . . 0.53000000000000003 114.749 -169.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.737 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -50.7 -39.72 52.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.527 1.156 . . . . 1.23 109.942 -177.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.95 -45.26 12.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.694 -2.048 . . . . 0.40000000000000002 111.453 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.64 -165.28 35.98 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.576 -0.821 . . . . 0.29999999999999999 114.187 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.8 mp -117.33 158.13 24.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.501 -1.35 . . . . 0.31 110.593 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.672 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 68.3 m -134.25 134.12 41.6 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.756 -0.656 . . . . 0.39000000000000001 111.101 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.791 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.5 129.06 13.17 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.446 0.906 . . . . 0.46999999999999997 113.446 175.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.654 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 81.84 -12.77 40.39 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 114.38 -1.282 . . . . 0.35999999999999999 111.865 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.672 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.6 tt0 -64.7 151.63 44.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.715 0.769 . . . . 1.1899999999999999 110.307 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 41.1 m -118.0 133.68 55.69 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.257 -1.338 . . . . 0.89000000000000001 109.277 -172.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 29' ' ' LEU . 19.2 pt -136.28 148.05 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.389 0.614 . . . . 0.22 110.503 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.695 ' H ' HD21 ' A' ' 33' ' ' ASN . 14.8 t -93.1 149.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.087 -0.96 . . . . 0.20999999999999999 110.342 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.602 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.1 mm -118.01 88.94 33.06 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 0.17000000000000001 108.61 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.779 ' HA ' HD13 ' A' ' 4' ' ' LEU . 31.1 Cg_endo -61.73 140.64 87.13 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.0 2.466 . . . . 0.23000000000000001 112.468 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.483 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.76 -7.26 66.36 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.45 -0.796 . . . . 0.29999999999999999 112.692 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -115.24 125.33 29.01 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.777 -0.823 . . . . 0.25 108.777 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.586 ' CD ' HD23 ' A' ' 51' ' ' LEU . 57.1 Cg_endo -65.39 174.2 5.47 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 124.064 3.176 . . . . 0.31 114.129 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.479 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 6.9 t70 -95.74 137.16 21.93 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.776 -1.102 . . . . 0.71999999999999997 111.877 -170.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.693 ' HD3' HD12 ' A' ' 5' ' ' LEU . 71.3 Cg_endo -82.25 -8.36 11.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.496 2.797 . . . . 0.27000000000000002 113.552 -174.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -95.21 -22.25 17.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.089 0.471 . . . . 2.1099999999999999 110.942 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -85.5 -6.8 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.069 0.938 . . . . 1.47 108.942 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.808 HD13 ' HG2' ' A' ' 158' ' ' PRO . 87.1 mt -95.8 127.46 41.19 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.446 -1.252 . . . . 0.26000000000000001 110.226 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -102.12 96.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.147 1.231 . . . . 0.20000000000000001 110.698 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.52 ' HB2' HG23 ' A' ' 161' ' ' THR . 89.2 m-85 -157.4 131.49 8.26 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.241 -1.392 . . . . 0.26000000000000001 107.241 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.541 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 18.3 m170 -136.08 103.21 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.706 -1.59 . . . . 2.8399999999999999 106.706 -165.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 55.6 mt -94.53 112.32 26.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.569 -0.742 . . . . 0.32000000000000001 110.537 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.97 96.83 6.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.102 -0.954 . . . . 0.34000000000000002 110.361 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.548 HG13 HG13 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -119.09 106.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.543 -1.208 . . . . 0.68000000000000005 110.361 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.536 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 24.1 m -101.06 125.94 47.71 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.542 -0.754 . . . . 1.05 109.805 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 mt -47.01 -35.64 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.137 0.494 . . . . 1.29 110.83 166.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.47 -49.16 46.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.469 -0.872 . . . . 0.88 111.514 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -68.92 -24.65 64.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 0.73999999999999999 112.186 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.58 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 2.9 tppt? 55.67 18.69 2.95 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.489 1.138 . . . . 2.5099999999999998 112.055 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.69 140.25 34.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.968 0.889 . . . . 0.45000000000000001 111.15 173.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -96.89 118.57 33.61 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.9 -1.5 . . . . 0.33000000000000002 109.275 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.0 m -101.13 123.82 45.88 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.194 -0.602 . . . . 0.40000000000000002 111.17 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.95 131.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.767 -1.938 . . . . 0.33000000000000002 105.767 176.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 12.0 m -136.86 130.72 32.18 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 120.735 1.607 . . . . 0.75 112.761 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.15 126.89 55.14 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.278 -0.874 . . . . 0.34999999999999998 110.322 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.0 t-20 63.7 35.65 11.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.383 0.611 . . . . 0.52000000000000002 109.463 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.3 m-20 78.52 -0.04 2.53 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.548 -1.206 . . . . 1.8400000000000001 112.613 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -129.99 139.42 51.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.082 -1.447 . . . . 3.1899999999999999 113.793 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -51.89 149.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 112.891 -1.959 . . . . 0.40999999999999998 113.737 -172.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.536 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.6 mtp -101.56 -42.04 6.38 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.234 -2.257 . . . . 0.34999999999999998 108.22 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -176.64 160.78 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.508 -2.133 . . . . 2.0699999999999998 110.373 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 9.5 m -122.78 132.6 54.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.527 -0.175 . . . . 0.37 110.527 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.57 156.04 53.85 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 110.346 -0.242 . . . . 0.96999999999999997 110.346 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HB2' HG22 ' A' ' 134' ' ' ILE . 9.7 Cg_endo -83.36 143.45 11.11 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.7 2.267 . . . . 0.59999999999999998 111.842 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.37 173.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.482 -0.326 . . . . 0.64000000000000001 110.148 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.352 . . . . 0.82999999999999996 110.804 176.262 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.579 ' HB2' HG13 ' A' ' 163' ' ' VAL . 6.7 m-85 . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 107.998 -1.112 . . . . 1.9299999999999999 107.998 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.717 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.7 m-85 -132.56 137.96 47.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.719 0.295 . . . . 0.57999999999999996 110.499 172.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.737 HD11 HD12 ' A' ' 125' ' ' ILE . 17.2 mm -58.73 116.5 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.562 -1.273 . . . . 0.40999999999999998 107.562 165.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.629 HG13 HD11 ' A' ' 51' ' ' LEU . 1.2 tt -102.09 -34.39 3.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.042 -0.663 . . . . 0.37 111.985 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.547 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 59.1 t30 -166.21 -177.83 4.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 122.819 1.295 . . . . 1.99 113.846 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.547 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.7 ptt180 -155.65 131.27 9.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 111.476 -2.602 . . . . 1.1899999999999999 110.187 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.2 153.7 20.66 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 121.925 0.869 . . . . 1.6699999999999999 110.76 -173.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -51.47 152.71 2.51 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.352 -1.749 . . . . 3.0600000000000001 113.25 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -44.69 110.84 1.12 Allowed Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 112.331 -2.213 . . . . 2.6099999999999999 110.69 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -54.15 -50.34 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.499 2.799 . . . . 0.97999999999999998 111.827 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.65 -20.35 20.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.088 -0.96 . . . . 1.0800000000000001 112.683 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -132.94 -169.53 12.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.082 -0.58 . . . . 1.05 112.123 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.77 37.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.906 3.737 . . . . 1.3 114.487 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.481 ' O ' ' HE1' ' A' ' 126' ' ' HIS . 52.1 t80 -82.06 -18.04 44.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.695 -0.483 . . . . 1.3799999999999999 109.695 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.56 52.3 0.99 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.599 -0.728 . . . . 1.1100000000000001 114.415 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 71.71 -63.08 0.44 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.258 1.207 . . . . 0.81000000000000005 114.258 164.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -142.41 138.28 30.99 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.541 -0.299 . . . . 1.1200000000000001 110.204 -172.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 51.4 t-105 -98.35 99.35 10.54 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.976 -0.75 . . . . 2.1899999999999999 108.976 169.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.5 mp -109.34 135.28 50.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.628 0.727 . . . . 0.60999999999999999 110.659 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 101' ' ' ILE . 29.5 m -107.58 149.17 28.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.278 -0.874 . . . . 0.93999999999999995 112.047 -175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.639 HD11 HG11 ' A' ' 163' ' ' VAL . 1.5 tp -102.17 -173.78 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.916 -1.038 . . . . 1.0800000000000001 108.573 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.556 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 48.0 t . . . . . 0 C--N 1.323 -0.57 0 C-N-CA 120.627 -0.429 . . . . 1.5 112.101 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.737 HD12 HD11 ' A' ' 100' ' ' ILE . 7.4 mt . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 106.522 -1.659 . . . . 0.47999999999999998 106.522 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.481 ' HE1' ' O ' ' A' ' 111' ' ' PHE . 7.1 t-80 -134.9 179.31 6.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.883 -0.727 . . . . 1.25 111.715 -166.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -123.54 176.46 16.73 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.775 -1.102 . . . . 0.46000000000000002 111.537 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.8 t -148.07 171.77 15.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.154 0.502 . . . . 0.5 111.07 -168.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -101.38 -15.41 17.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.209 -0.905 . . . . 1.8600000000000001 109.523 166.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -125.33 101.34 31.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.673 -0.694 . . . . 1.77 109.873 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -90.65 4.88 4.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.171 2.581 . . . . 0.58999999999999997 112.762 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.66 0.54 42.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.038 0.447 . . . . 0.78000000000000003 110.849 -170.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.6 p -111.22 -2.31 15.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.661 0.743 . . . . 1.45 109.711 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 83' ' ' PRO . 20.9 mm . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.967 -1.015 . . . . 0.69999999999999996 110.772 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.4 mtp . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.05 0.452 . . . . 1.1299999999999999 110.599 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -71.38 146.22 48.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.457 -0.942 . . . . 2.5099999999999998 108.457 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.554 ' O ' HG12 ' A' ' 150' ' ' VAL . 27.3 p-10 -50.21 -67.78 0.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 112.508 0.558 . . . . 1.77 112.508 -171.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -23.13 65.58 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.441 -0.787 . . . . 2.1299999999999999 112.018 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.81 -40.57 63.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.865 -0.607 . . . . 1.05 111.055 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 8.9 p -75.77 -17.94 15.58 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 110.285 -0.265 . . . . 0.32000000000000001 110.285 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.6 mp -87.12 -39.46 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 118.985 -0.531 . . . . 0.37 110.61 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -43.7 -70.15 0.11 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.534 1.061 . . . . 1.3799999999999999 111.964 162.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.732 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -48.8 -44.79 39.47 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.626 -0.716 . . . . 0.73999999999999999 110.139 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.88 -55.2 28.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.244 -1.344 . . . . 0.22 112.337 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.481 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 33.1 t -77.42 -14.72 59.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.592 -1.186 . . . . 1.3300000000000001 110.9 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.54 -47.16 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.863 -0.421 . . . . 0.23000000000000001 109.863 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 153' ' ' LEU . 32.6 m -76.12 120.11 80.23 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.885 0.85 . . . . 0.20999999999999999 110.595 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.808 ' HG2' HD13 ' A' ' 57' ' ' ILE . 41.2 Cg_endo -83.43 -178.69 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.955 2.437 . . . . 0.34000000000000002 112.538 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.739 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.9 m120 -62.3 4.25 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.503 -1.226 . . . . 1.02 113.366 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.3 54.84 0.52 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.28000000000000003 112.446 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.717 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -89.72 131.17 35.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.438 -0.448 . . . . 0.29999999999999999 110.837 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.37 138.9 31.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.472 -0.491 . . . . 1.96 110.342 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 118' ' ' LEU . 3.8 p -146.71 127.7 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.377 -0.829 . . . . 0.46000000000000002 111.13 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.407 ' C ' HD12 ' A' ' 165' ' ' ILE . 7.1 m -111.67 133.38 53.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 0.56000000000000005 111.1 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.548 HG13 HG13 ' A' ' 63' ' ' VAL . 2.7 mp -119.18 110.13 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 117.832 -1.547 . . . . 0.95999999999999996 110.558 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.7 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.747 0 CA-C-N 114.896 -1.047 . . . . 1.1899999999999999 110.312 -171.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.6 mptt . . . . . 0 CA--C 1.518 -0.286 0 N-CA-C 109.864 -0.421 . . . . 2.1000000000000001 109.864 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -93.49 167.22 11.84 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.367 0.417 . . . . 0.26000000000000001 111.332 175.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.653 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.5 tp -77.11 151.2 35.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.488 0.715 . . . . 0.23000000000000001 111.902 -170.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.8 150.14 38.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 122.1 0.952 . . . . 0.26000000000000001 112.168 169.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' SER . 62.8 t80 -133.67 150.29 51.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.754 -1.567 . . . . 0.39000000000000001 107.86 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -129.93 114.97 16.52 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.071 -1.455 . . . . 1.0700000000000001 107.071 175.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.41 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.32 157.15 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.342 0.591 . . . . 0.38 112.359 -166.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -102.8 149.04 24.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.001 -0.999 . . . . 2.5899999999999999 108.978 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.679 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -52.53 117.94 3.24 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.874 -0.603 . . . . 1.74 111.369 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.67 -10.26 32.56 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.516 -0.766 . . . . 0.56999999999999995 112.446 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.58 ' HB3' HD11 ' A' ' 18' ' ' ILE . 54.6 m-20 -62.24 147.55 47.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.997 0.427 . . . . 2.1699999999999999 111.827 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.534 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -128.19 149.38 50.47 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.892 -0.594 . . . . 0.5 111.908 -178.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.605 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.2 tp -46.16 -60.42 2.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.868 1.062 . . . . 0.27000000000000002 113.868 -173.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.652 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.7 t-20 -64.41 -38.96 92.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.751 1.262 . . . . 1.21 110.15 -171.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.78 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 19.3 m -62.07 -40.93 97.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.636 -2.075 . . . . 1.24 111.002 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.28 -39.74 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.013 0.925 . . . . 0.29999999999999999 112.736 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.7 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.81 -62.1 1.98 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.61 -0.268 . . . . 0.23000000000000001 111.203 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.38 -4.65 52.01 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.814 -1.155 . . . . 0.39000000000000001 111.789 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.78 ' HB2' ' O ' ' A' ' 17' ' ' SER . 12.1 t70 -63.68 -32.42 73.9 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.135 -1.061 . . . . 1.6299999999999999 108.135 158.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.653 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.0 m-85 -102.53 16.49 26.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 112.354 0.502 . . . . 0.23999999999999999 112.354 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 54.46 52.02 13.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.206 -0.906 . . . . 3.5499999999999998 110.644 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.7 HG12 ' O ' ' A' ' 19' ' ' ALA . 34.9 pt -147.99 -171.35 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.971 -0.752 . . . . 0.27000000000000002 108.971 -172.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.85 147.47 24.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.668 -0.697 . . . . 0.81000000000000005 109.917 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.652 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 15.8 p -63.0 -35.88 81.68 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.725 -0.843 . . . . 0.27000000000000002 108.725 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.9 68.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.196 -1.366 . . . . 0.26000000000000001 111.619 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.79 -38.43 25.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.368 0.604 . . . . 0.23000000000000001 109.551 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.646 HD11 HD12 ' A' ' 46' ' ' ILE . 13.6 tp -73.88 -18.82 60.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 0.17000000000000001 109.084 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.716 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.25 -39.34 33.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.616 0.722 . . . . 0.19 111.444 171.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -61.03 -40.3 93.06 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.128 -0.942 . . . . 1.0700000000000001 110.009 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.74 36.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.881 -1.509 . . . . 0.17000000000000001 112.085 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 29.7 m-80 -142.02 71.57 23.43 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.039 0.447 . . . . 0.19 109.825 -173.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.519 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.33 -10.26 6.21 Favored 'Trans proline' 0 C--O 1.218 -0.475 0 C-N-CA 123.484 2.789 . . . . 0.29999999999999999 114.07 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -62.63 -33.83 75.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.09 0.947 . . . . 1.1699999999999999 109.75 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -78.78 -4.51 49.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.262 -1.335 . . . . 0.53000000000000003 114.233 -172.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.716 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.64 -40.11 26.6 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 122.414 1.102 . . . . 1.23 110.249 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.586 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.46 -46.51 10.82 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.997 -1.911 . . . . 0.40000000000000002 111.565 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.52 -164.52 34.89 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.978 -1.106 . . . . 0.29999999999999999 114.264 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 18' ' ' ILE . 5.5 mp -116.38 159.56 21.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.262 -1.469 . . . . 0.31 110.396 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.1 m -138.44 135.09 34.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.916 -0.584 . . . . 0.39000000000000001 110.871 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.0 129.32 14.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.662 0.744 . . . . 0.46999999999999997 112.857 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.5 -13.64 39.88 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.46 -1.246 . . . . 0.35999999999999999 112.179 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.617 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.8 tt0 -64.59 151.3 45.04 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.628 0.728 . . . . 1.1899999999999999 110.272 174.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 46.1 m -117.91 133.18 56.18 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.495 -1.23 . . . . 0.89000000000000001 109.276 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.646 HD12 HD11 ' A' ' 29' ' ' LEU . 19.7 pt -135.22 148.97 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.277 0.561 . . . . 0.22 110.511 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.552 ' H ' HD21 ' A' ' 33' ' ' ASN . 14.2 t -93.41 149.61 4.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.136 -0.938 . . . . 0.20999999999999999 110.099 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.518 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.7 mm -117.64 88.58 30.08 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.05 -0.977 . . . . 0.17000000000000001 108.584 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.756 ' HA ' HD13 ' A' ' 4' ' ' LEU . 23.7 Cg_endo -59.06 143.28 99.86 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.053 2.502 . . . . 0.23000000000000001 112.585 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.484 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.22 -6.59 59.67 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.694 -0.685 . . . . 0.29999999999999999 112.996 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.718 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -116.73 126.39 27.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.752 -0.833 . . . . 0.25 108.752 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.648 ' HD2' HD23 ' A' ' 51' ' ' LEU . 61.6 Cg_endo -66.86 171.01 11.7 Favored 'Trans proline' 0 N--CA 1.477 0.517 0 C-N-CA 123.644 2.896 . . . . 0.31 114.029 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 2.0 t70 -90.95 138.89 25.9 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.573 -1.194 . . . . 0.71999999999999997 111.82 -171.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HD3' HD12 ' A' ' 5' ' ' LEU . 66.3 Cg_endo -83.17 -4.94 11.19 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.529 2.819 . . . . 0.27000000000000002 113.771 -173.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.34 -29.3 14.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.613 0.244 . . . . 2.1099999999999999 111.235 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -80.38 -17.53 51.62 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.825 -0.805 . . . . 1.47 108.825 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.725 HD13 ' HG2' ' A' ' 158' ' ' PRO . 87.2 mt -81.44 123.31 81.2 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.974 -1.012 . . . . 0.26000000000000001 109.224 169.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -100.83 94.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 120.023 1.044 . . . . 0.20000000000000001 110.13 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' HD2' HG23 ' A' ' 57' ' ' ILE . 86.5 m-85 -158.78 129.79 6.23 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.558 -1.645 . . . . 0.26000000000000001 106.558 172.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.682 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 42.9 m170 -134.02 106.56 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.198 -1.779 . . . . 2.8399999999999999 106.198 -165.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -95.06 110.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.908 -0.717 . . . . 0.32000000000000001 110.904 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.13 94.21 4.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.277 -0.874 . . . . 0.34000000000000002 110.442 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.555 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -119.36 97.76 5.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.317 -1.31 . . . . 0.68000000000000005 110.432 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.9 m -89.33 112.26 23.31 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.529 -1.286 . . . . 1.05 107.529 173.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.581 ' CG1' HG23 ' A' ' 165' ' ' ILE . 1.4 mm -42.34 -43.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.901 -0.59 . . . . 1.29 110.03 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.94 -46.33 91.07 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.661 -1.257 . . . . 0.88 111.746 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -66.83 -23.87 66.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.629 0.603 . . . . 0.73999999999999999 112.629 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.6 mttt 62.63 13.08 6.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.034 0.753 . . . . 2.5099999999999998 113.034 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.25 138.89 33.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.225 1.012 . . . . 0.45000000000000001 111.796 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.555 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -98.45 120.63 39.21 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.241 -1.8 . . . . 0.33000000000000002 109.282 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -102.1 124.23 47.34 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.593 -0.843 . . . . 0.40000000000000002 110.826 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -85.21 129.92 34.71 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.728 -1.953 . . . . 0.33000000000000002 105.728 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.682 ' OG ' ' HB2' ' A' ' 60' ' ' HIS . 13.7 p -139.23 128.88 24.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 121.37 1.895 . . . . 0.75 114.03 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 tp -113.97 127.49 55.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.346 -1.297 . . . . 0.34999999999999998 110.338 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 11.5 t-20 63.44 35.9 11.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.217 0.532 . . . . 0.52000000000000002 109.675 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.6 m-20 79.96 -1.02 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.835 -1.075 . . . . 1.8400000000000001 112.697 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -131.2 138.78 49.55 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.391 -1.324 . . . . 3.1899999999999999 113.832 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -50.31 149.31 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 113.004 -1.907 . . . . 0.40999999999999998 113.298 -176.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.579 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.6 mtp -97.95 -46.03 6.06 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 112.116 -2.311 . . . . 0.34999999999999998 107.525 174.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -177.87 157.56 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.576 -2.102 . . . . 2.0699999999999998 110.479 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -115.69 132.15 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.508 0.195 . . . . 0.37 110.886 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.46 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 69.5 m-85 -115.63 147.27 38.54 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.617 -0.265 . . . . 0.96999999999999997 110.398 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -86.92 141.71 6.32 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.489 2.126 . . . . 0.59999999999999998 111.793 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.44 -177.51 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.332 -0.395 . . . . 0.64000000000000001 110.807 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 CA-C-O 120.842 0.353 . . . . 0.82999999999999996 111.168 -178.269 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.556 ' HB3' ' H ' ' A' ' 119' ' ' SER . 13.6 m-85 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.085 0.469 . . . . 1.9299999999999999 110.452 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 161' ' ' THR . 69.0 m-85 -136.84 139.27 41.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.57999999999999996 109.838 171.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 125' ' ' ILE . 26.0 mm -60.23 118.79 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.997 -1.112 . . . . 0.40999999999999998 107.997 167.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.8 tt -114.46 -22.68 4.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 119.814 -0.754 . . . . 0.37 112.287 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 66.0 t30 -167.67 178.62 5.23 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 122.86 1.314 . . . . 1.99 114.325 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 114' ' ' TYR . 2.1 ptt180 -151.18 131.8 13.94 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 111.387 -2.642 . . . . 1.1899999999999999 110.447 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 5.5 tp60 -109.45 145.37 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.981 0.896 . . . . 1.6699999999999999 111.623 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.586 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 61.3 ttt180 -54.92 150.24 10.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.431 -1.713 . . . . 3.0600000000000001 111.487 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.04 106.22 0.54 Allowed Pre-proline 0 CA--C 1.511 -0.52 0 CA-C-N 115.602 -0.726 . . . . 2.6099999999999999 111.624 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.01 -48.84 20.01 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.781 2.988 . . . . 0.97999999999999998 111.69 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.87 -21.1 14.07 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.961 -1.018 . . . . 1.0800000000000001 112.624 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -101.75 -169.89 27.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.956 -0.64 . . . . 1.05 112.13 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.44 31.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.231 3.288 . . . . 1.3 113.533 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.606 ' CE1' ' HB2' ' A' ' 115' ' ' TRP . 1.1 t80 -72.51 -33.45 66.93 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.308 -0.627 . . . . 1.3799999999999999 109.308 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.28 60.64 0.78 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.119 -0.946 . . . . 1.1100000000000001 114.485 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.51 -45.09 0.57 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.182 1.178 . . . . 0.81000000000000005 114.182 166.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -150.41 145.79 26.28 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.21 -0.293 . . . . 1.1200000000000001 110.21 -176.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.606 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 24.1 t-105 -116.01 101.06 8.42 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.258 -0.645 . . . . 2.1899999999999999 109.258 166.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.5 mp -100.66 127.79 46.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.792 0.806 . . . . 0.60999999999999999 110.536 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.421 ' HB2' HG23 ' A' ' 101' ' ' ILE . 62.4 m -87.44 133.72 33.7 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.22 -0.9 . . . . 0.93999999999999995 111.672 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -88.55 -179.42 6.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.233 -1.395 . . . . 1.0800000000000001 107.233 168.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.556 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 40.8 t . . . . . 0 C--N 1.321 -0.642 0 C-N-CA 120.392 -0.523 . . . . 1.5 110.037 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 100' ' ' ILE . 17.2 mt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.477 -0.564 . . . . 0.47999999999999998 109.477 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -155.43 -163.97 1.65 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.507 0.67 . . . . 1.25 111.729 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -121.91 179.25 16.27 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.014 -1.089 . . . . 0.46000000000000002 113.123 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 t -136.09 173.29 11.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.215 -0.493 . . . . 0.5 110.797 -168.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -104.22 -18.45 14.48 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.358 -0.837 . . . . 1.8600000000000001 108.873 166.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -128.01 103.68 20.95 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 1.77 110.366 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.405 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 53.4 Cg_endo -91.21 4.07 4.25 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.143 2.562 . . . . 0.58999999999999997 112.928 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.23 -18.67 33.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.284 0.564 . . . . 0.78000000000000003 110.337 -172.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 m -89.26 -12.92 39.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 1.45 109.922 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 134' ' ' ILE . 5.3 mm . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.238 -0.892 . . . . 0.69999999999999996 111.373 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 8.3 mtm . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.759 0.314 . . . . 1.1299999999999999 110.198 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 1.9 t60 -67.58 145.33 54.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.155 -0.683 . . . . 2.5099999999999998 109.155 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.519 ' O ' HG12 ' A' ' 150' ' ' VAL . 30.5 p-10 -49.33 -66.43 0.4 Allowed 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.296 0.48 . . . . 1.77 112.296 -174.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -62.95 -23.35 67.36 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.834 -0.541 . . . . 2.1299999999999999 111.603 -174.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 1.5 m-20 -69.19 -43.14 74.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 1.05 110.9 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 14.3 p -77.68 -20.53 13.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 CA-C-N 116.555 -0.293 . . . . 0.32000000000000001 111.036 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.497 HD11 ' HB1' ' A' ' 113' ' ' ALA . 3.1 mp -84.79 -40.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 118.907 -0.568 . . . . 0.37 110.437 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -43.63 -68.7 0.17 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.608 1.095 . . . . 1.3799999999999999 111.931 163.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.678 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -50.55 -44.03 56.38 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.726 -0.67 . . . . 0.73999999999999999 110.375 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.69 -54.28 40.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.377 -1.283 . . . . 0.22 112.157 -171.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.6 p -77.76 -13.73 59.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.223 -1.353 . . . . 1.3300000000000001 111.443 -172.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -93.51 -46.82 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.907 0.384 . . . . 0.23000000000000001 110.227 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 153' ' ' LEU . 24.4 m -76.61 122.64 86.96 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-O 121.586 0.708 . . . . 0.20999999999999999 110.077 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.725 ' HG2' HD13 ' A' ' 57' ' ' ILE . 34.8 Cg_endo -84.08 -178.51 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.89 2.394 . . . . 0.34000000000000002 112.557 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.718 ' O ' HD21 ' A' ' 51' ' ' LEU . 11.7 m120 -59.73 -0.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.021 . . . . 1.02 113.604 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.46 56.3 0.53 Allowed Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.822 -0.704 . . . . 0.28000000000000003 112.734 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 2.5 m -92.68 139.43 30.57 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 122.29 -0.535 . . . . 0.29999999999999999 110.733 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -85.1 134.6 34.19 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.151 -0.314 . . . . 1.96 110.151 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.95 128.03 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.544 0.687 . . . . 0.46000000000000002 111.646 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.1 m -113.37 132.56 55.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.526 -0.761 . . . . 0.56000000000000005 111.167 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.581 HG23 ' CG1' ' A' ' 65' ' ' ILE . 1.9 mp -120.27 116.67 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 118.788 -1.165 . . . . 0.95999999999999996 110.184 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.669 ' N ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 122.185 0.993 . . . . 1.1899999999999999 111.171 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.664 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 5.8 mtmt . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.734 -0.469 . . . . 2.1000000000000001 109.734 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -100.26 164.55 11.9 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.783 -0.644 . . . . 0.26000000000000001 111.389 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.82 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.7 tp -75.51 149.77 38.33 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.906 -0.588 . . . . 0.23000000000000001 111.973 -169.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.39 149.91 38.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.015 0.912 . . . . 0.26000000000000001 112.148 169.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -134.98 148.34 49.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.671 -1.604 . . . . 0.39000000000000001 107.661 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.75 115.72 17.71 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.175 -1.417 . . . . 1.0700000000000001 107.175 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -77.82 158.47 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.886 -0.597 . . . . 0.38 111.843 -166.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.416 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.6 ptmt -104.66 153.58 21.06 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.859 -0.793 . . . . 2.5899999999999999 108.859 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.77 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 16.8 tt0 -54.42 109.11 0.45 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.855 -0.611 . . . . 1.74 112.243 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.56 -7.01 18.16 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.397 -0.82 . . . . 0.56999999999999995 112.723 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.602 ' HB3' HD11 ' A' ' 18' ' ' ILE . 87.5 m-20 -63.01 152.93 35.48 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.101 0.451 . . . . 2.1699999999999999 111.973 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.557 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.9 p -132.27 155.05 49.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.01 0.433 . . . . 0.5 111.982 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.605 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 50.1 tp -49.12 -59.16 3.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.009 1.114 . . . . 0.27000000000000002 114.009 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.657 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 13.3 t-20 -64.54 -43.21 94.7 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 122.452 1.12 . . . . 1.21 110.481 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 21.1 t -57.45 -42.31 82.23 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 112.467 -2.151 . . . . 1.24 110.289 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.94 -41.31 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 123.528 0.731 . . . . 0.29999999999999999 112.488 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.683 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.86 -64.83 0.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.529 -0.305 . . . . 0.23000000000000001 111.665 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.36 -3.89 48.38 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.067 -1.053 . . . . 0.39000000000000001 111.826 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.741 ' HB2' ' O ' ' A' ' 17' ' ' SER . 53.6 t0 -62.18 -42.76 99.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.971 -1.122 . . . . 1.6299999999999999 107.971 156.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.633 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.2 m-85 -89.93 16.28 8.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.123 0.416 . . . . 0.23999999999999999 112.123 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 54.47 51.29 14.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.288 -0.869 . . . . 3.5499999999999998 110.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 19' ' ' ALA . 38.6 pt -147.82 -173.62 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.826 -0.805 . . . . 0.27000000000000002 108.826 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -100.87 146.09 27.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.48 -0.782 . . . . 0.81000000000000005 109.759 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.657 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -62.34 -35.78 80.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.452 0.644 . . . . 0.27000000000000002 109.435 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.67 67.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.57 -1.195 . . . . 0.26000000000000001 111.673 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.25 -38.7 24.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.302 0.572 . . . . 0.23000000000000001 109.472 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.48 -19.47 60.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.334 -0.848 . . . . 0.17000000000000001 109.162 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.718 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.36 34.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.618 0.723 . . . . 0.19 111.45 173.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.2 -39.32 94.31 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.002 0.906 . . . . 1.0700000000000001 110.047 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 -19.65 38.28 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.052 -1.431 . . . . 0.17000000000000001 111.861 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.563 HD21 ' H ' ' A' ' 47' ' ' VAL . 29.9 m-80 -142.55 72.31 20.62 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 0.19 109.709 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.611 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.2 Cg_endo -54.52 -19.42 17.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 123.545 2.83 . . . . 0.29999999999999999 113.9 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -59.85 -30.82 69.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.925 0.869 . . . . 1.1699999999999999 110.431 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.8 mt -79.78 -3.72 48.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.309 -1.314 . . . . 0.53000000000000003 114.238 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.718 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.67 -39.62 37.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.442 1.115 . . . . 1.23 110.082 -177.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.585 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.22 -45.94 11.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.875 -1.966 . . . . 0.40000000000000002 111.733 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.33 -165.06 35.81 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.393 -0.908 . . . . 0.29999999999999999 113.963 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.476 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.2 mp -115.08 158.22 22.45 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.232 -1.484 . . . . 0.31 109.977 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.1 m -134.67 136.39 42.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.893 -0.594 . . . . 0.39000000000000001 110.553 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.77 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.75 127.64 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.272 0.841 . . . . 0.46999999999999997 113.272 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.33 -10.93 46.94 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.33 -1.305 . . . . 0.35999999999999999 112.265 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -64.23 151.81 42.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.477 0.656 . . . . 1.1899999999999999 110.455 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 55.4 p -115.48 136.71 52.8 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.882 -1.054 . . . . 0.89000000000000001 109.484 -173.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 29' ' ' LEU . 19.6 pt -137.36 149.37 25.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.414 0.626 . . . . 0.22 110.382 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.563 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.8 t -96.48 149.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.973 -1.012 . . . . 0.20999999999999999 110.121 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.574 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.2 mm -117.9 87.47 27.85 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.155 -0.929 . . . . 0.17000000000000001 108.702 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.748 ' HA ' HD13 ' A' ' 4' ' ' LEU . 23.8 Cg_endo -59.14 141.41 98.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.248 2.632 . . . . 0.23000000000000001 113.018 -173.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.52 -7.89 67.14 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.557 -0.747 . . . . 0.29999999999999999 112.855 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -116.34 127.44 26.75 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.719 -0.845 . . . . 0.25 108.719 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.6 Cg_endo -65.91 171.87 9.27 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.674 2.916 . . . . 0.31 113.8 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.515 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 9.5 t70 -94.94 138.0 22.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.063 -0.971 . . . . 0.71999999999999997 111.522 -170.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.82 ' HD3' HD12 ' A' ' 5' ' ' LEU . 77.6 Cg_endo -75.32 -7.95 19.29 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 123.296 2.664 . . . . 0.27000000000000002 113.288 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -33.5 16.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.063 -0.255 . . . . 2.1099999999999999 110.618 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.423 HG21 ' HG3' ' A' ' 3' ' ' LYS . 23.5 p -63.4 -31.82 73.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.426 1.107 . . . . 1.47 108.31 172.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.759 HD13 ' HG2' ' A' ' 158' ' ' PRO . 95.1 mt -77.27 126.02 85.65 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.082 -1.872 . . . . 0.26000000000000001 110.857 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -100.97 95.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.946 0 C-N-CA 120.753 0.969 . . . . 0.20000000000000001 110.257 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 73' ' ' SER . 94.3 m-85 -157.68 138.08 12.8 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.909 -1.515 . . . . 0.26000000000000001 106.909 171.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 55.5 t-80 -144.56 104.07 4.01 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.429 -1.323 . . . . 2.8399999999999999 107.429 -170.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 68.8 mt -94.8 109.25 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.037 -1.438 . . . . 0.32000000000000001 110.176 -174.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.05 102.74 11.17 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.19 -0.913 . . . . 0.34000000000000002 110.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.692 HG13 HG13 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -122.14 102.57 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.005 -1.452 . . . . 0.68000000000000005 109.988 178.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.522 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 30.2 t -95.0 135.67 36.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.183 -0.917 . . . . 1.05 108.9 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -33.61 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.491 0.662 . . . . 1.29 109.95 170.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.04 -48.1 74.69 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 114.95 -1.023 . . . . 0.88 111.368 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -69.08 -25.12 64.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.873 0.694 . . . . 0.73999999999999999 112.873 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 57.18 12.71 1.39 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.871 0.869 . . . . 2.5099999999999998 112.982 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.43 142.27 35.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.575 0.702 . . . . 0.45000000000000001 111.349 177.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.517 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -98.07 118.42 34.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.499 -1.228 . . . . 0.33000000000000002 109.936 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 m -101.51 125.4 48.15 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.438 -0.505 . . . . 0.40000000000000002 111.35 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.16 134.89 34.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.47 -1.678 . . . . 0.33000000000000002 106.47 177.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.4 m -138.32 129.33 27.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.716 1.598 . . . . 0.75 112.346 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.14 124.25 49.86 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.079 -0.964 . . . . 0.34999999999999998 110.01 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.57 37.51 3.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.843 -1.169 . . . . 0.52000000000000002 107.843 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m120 83.92 -14.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.679 -1.601 . . . . 1.8400000000000001 111.569 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -127.23 141.27 51.77 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 117.675 -1.61 . . . . 3.1899999999999999 114.613 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -56.55 148.75 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 112.291 -2.232 . . . . 0.40999999999999998 113.957 -165.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.0 mtp -100.49 -43.73 6.11 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.721 -2.49 . . . . 0.34999999999999998 107.804 175.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 33.3 tptt -179.92 161.34 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.497 -2.138 . . . . 2.0699999999999998 111.102 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.485 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 15.2 m -118.39 137.43 53.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 122.422 -0.174 . . . . 0.37 110.908 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -126.03 137.81 30.88 Favored Pre-proline 0 N--CA 1.457 -0.107 0 CA-C-O 120.702 0.287 . . . . 0.96999999999999997 110.267 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HB2' HG22 ' A' ' 134' ' ' ILE . 27.8 Cg_endo -63.39 146.09 93.09 Favored 'Trans proline' 0 N--CA 1.471 0.184 0 C-N-CA 123.187 2.592 . . . . 0.59999999999999998 112.772 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.58 179.75 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.67 -0.493 . . . . 0.64000000000000001 109.67 176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.55 0.691 . . . . 0.82999999999999996 111.411 179.376 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.522 ' HB2' HG13 ' A' ' 163' ' ' VAL . 29.7 m-85 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.518 -0.919 . . . . 1.9299999999999999 108.518 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.639 ' HA ' ' O ' ' A' ' 161' ' ' THR . 42.4 m-85 -129.86 139.71 51.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.766 0.317 . . . . 0.57999999999999996 110.19 169.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.828 HD11 HD12 ' A' ' 125' ' ' ILE . 18.6 mm -59.4 115.58 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.681 -1.229 . . . . 0.40999999999999998 107.681 166.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.557 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.6 tt -99.31 -30.03 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.622 -0.831 . . . . 0.37 112.068 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -178.8 -165.06 0.08 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.599 1.19 . . . . 1.99 113.775 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.781 ' HG2' HD23 ' A' ' 116' ' ' LEU . 9.9 mtt180 -148.2 132.86 17.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 111.969 -2.378 . . . . 1.1899999999999999 108.871 -173.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -101.76 158.91 15.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.274 1.035 . . . . 1.6699999999999999 111.423 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.712 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 2.5 ttt180 -49.74 152.93 1.35 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 112.865 -1.971 . . . . 3.0600000000000001 112.003 169.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.712 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.03 112.93 1.9 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 114.062 -1.426 . . . . 2.6099999999999999 110.861 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -57.44 -50.75 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.141 2.56 . . . . 0.97999999999999998 111.559 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.08 45.57 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.777 -1.101 . . . . 1.0800000000000001 112.469 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.32 -169.21 22.05 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.328 -0.463 . . . . 1.05 112.09 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.6 36.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 124.576 3.517 . . . . 1.3 114.402 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -93.1 -12.05 31.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.76 0.314 . . . . 1.3799999999999999 110.977 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.614 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.51 33.4 5.37 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.408 -0.901 . . . . 1.1100000000000001 114.497 171.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.39 -22.5 0.25 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.943 1.09 . . . . 0.81000000000000005 113.943 168.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -152.98 143.99 23.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.011 -0.366 . . . . 1.1200000000000001 110.011 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -109.94 100.77 9.67 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.799 -0.815 . . . . 2.1899999999999999 108.799 166.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.804 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.1 mp -104.82 137.1 43.12 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.42 0.629 . . . . 0.60999999999999999 109.549 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.9 m -106.16 143.45 34.26 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.231 -0.895 . . . . 0.93999999999999995 112.064 -170.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.6 OUTLIER -94.83 -174.79 3.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.702 -1.222 . . . . 1.0800000000000001 107.702 171.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.318 -0.802 0 N-CA-C 112.218 0.451 . . . . 1.5 112.218 -177.772 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 100' ' ' ILE . 41.7 mt . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 108.476 -0.935 . . . . 0.47999999999999998 108.476 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -140.9 -162.71 1.41 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.045 -0.662 . . . . 1.25 111.463 -175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.614 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.3 175.89 16.22 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.087 -1.054 . . . . 0.46000000000000002 113.449 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -141.1 177.9 7.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.946 -0.627 . . . . 0.5 109.849 -172.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 -4.71 9.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.317 -0.856 . . . . 1.8600000000000001 110.116 167.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -126.31 101.69 27.82 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 109.178 -0.675 . . . . 1.77 109.178 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -92.5 3.57 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.636 2.89 . . . . 0.58999999999999997 114.015 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.11 -19.34 59.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.131 0.491 . . . . 0.78000000000000003 111.693 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.2 m -91.66 -18.24 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.116 0.484 . . . . 1.45 110.456 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 83' ' ' PRO . 25.3 mm . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.637 -0.71 . . . . 0.69999999999999996 111.12 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.5 mtp . . . . . 0 C--O 1.232 0.172 0 N-CA-C 110.196 -0.298 . . . . 1.1299999999999999 110.196 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -79.13 158.89 27.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.597 -0.52 . . . . 2.5099999999999998 109.597 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.556 ' O ' HG12 ' A' ' 150' ' ' VAL . 23.1 p-10 -52.05 -68.13 0.19 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 123.333 0.396 . . . . 1.77 111.73 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -62.55 -24.54 67.58 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.728 -0.607 . . . . 2.1299999999999999 111.821 -175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.27 -43.05 71.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.331 -0.395 . . . . 1.05 110.704 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 7.3 p -77.3 -19.8 14.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.374 -0.375 . . . . 0.32000000000000001 111.047 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.402 HD12 HG13 ' A' ' 150' ' ' VAL . 2.6 mp -84.61 -39.53 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 118.987 -0.53 . . . . 0.37 109.849 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -43.35 -70.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.257 0.935 . . . . 1.3799999999999999 112.107 163.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.671 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -49.81 -42.96 48.21 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 123.853 0.721 . . . . 0.73999999999999999 110.323 178.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.12 -56.68 15.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.3 -1.318 . . . . 0.22 111.884 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.2 t -76.41 -11.53 59.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.803 -1.09 . . . . 1.3300000000000001 110.626 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 92.9 mt -93.03 -47.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.751 -0.463 . . . . 0.23000000000000001 109.751 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 153' ' ' LEU . 27.0 m -77.17 119.16 76.36 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 121.996 0.903 . . . . 0.20999999999999999 110.81 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.759 ' HG2' HD13 ' A' ' 57' ' ' ILE . 33.1 Cg_endo -84.09 -177.71 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.017 2.478 . . . . 0.34000000000000002 113.013 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.692 ' O ' HD21 ' A' ' 51' ' ' LEU . 17.5 m120 -59.11 1.21 0.07 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.568 -1.196 . . . . 1.02 113.978 -176.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.08 55.92 0.47 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.729 . . . . 0.28000000000000003 112.173 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.1 m -84.83 137.03 33.41 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.543 -0.386 . . . . 0.29999999999999999 110.657 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HG2' ' HE1' ' A' ' 99' ' ' TYR . 64.0 mtm180 -83.06 125.87 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.097 -0.335 . . . . 1.96 110.097 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.7 p -139.49 123.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.401 0.62 . . . . 0.46000000000000002 111.103 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.444 ' C ' HD12 ' A' ' 165' ' ' ILE . 62.5 m -113.44 137.12 51.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.699 -0.682 . . . . 0.56000000000000005 111.813 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.692 HG13 HG13 ' A' ' 63' ' ' VAL . 3.2 mp -126.35 113.34 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 118.387 -1.325 . . . . 0.95999999999999996 111.08 172.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 113.468 -1.697 . . . . 1.1899999999999999 109.618 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.9 mptp? . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.777 -0.453 . . . . 2.1000000000000001 109.777 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.5 mt -97.05 168.16 10.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.017 -0.538 . . . . 0.26000000000000001 111.147 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.551 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.8 tp -75.88 150.23 37.64 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 123.336 0.654 . . . . 0.23000000000000001 111.886 -169.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.46 149.13 36.78 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.17 0.986 . . . . 0.26000000000000001 111.978 167.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' SER . 77.9 t80 -135.18 150.84 50.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.277 -1.783 . . . . 0.39000000000000001 108.068 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.615 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.1 tm0? -129.41 120.96 26.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.359 -1.349 . . . . 1.0700000000000001 107.359 174.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -81.41 159.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 123.327 0.651 . . . . 0.38 111.968 -171.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.1 ptmt -107.84 151.14 26.15 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.071 -0.715 . . . . 2.5899999999999999 109.071 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.701 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 4.9 tt0 -54.3 113.76 1.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.339 -0.846 . . . . 1.74 111.949 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.75 -5.79 25.97 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.679 -0.772 . . . . 0.56999999999999995 112.797 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.695 ' HB3' HD11 ' A' ' 18' ' ' ILE . 32.7 m-20 -66.6 156.26 35.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.661 0.615 . . . . 2.1699999999999999 112.661 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.564 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -133.86 154.64 50.9 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 116.048 -0.524 . . . . 0.5 112.273 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.592 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.54 -58.68 4.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.767 1.025 . . . . 0.27000000000000002 113.767 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.2 p30 -63.19 -41.83 99.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.794 1.283 . . . . 1.21 110.941 -171.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.794 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 3.2 m -61.83 -39.76 92.95 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.162 -2.29 . . . . 1.24 110.878 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.45 -38.99 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 123.638 0.775 . . . . 0.29999999999999999 112.694 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.679 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.15 -61.29 2.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.465 -0.334 . . . . 0.23000000000000001 111.2 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.32 -4.79 54.81 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.677 -1.209 . . . . 0.39000000000000001 111.774 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.794 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.0 t70 -61.95 -35.43 78.41 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.609 -1.256 . . . . 1.6299999999999999 107.609 157.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.665 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.9 m-85 -100.73 17.29 22.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.854 0.687 . . . . 0.23999999999999999 112.854 176.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 53.95 52.49 12.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.563 -0.744 . . . . 3.5499999999999998 110.856 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 19' ' ' ALA . 34.0 pt -149.85 -173.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.984 -0.747 . . . . 0.27000000000000002 108.984 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 146.97 24.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.589 -0.732 . . . . 0.81000000000000005 109.71 173.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 17.9 p -60.89 -36.6 79.64 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.503 -0.925 . . . . 0.27000000000000002 108.503 175.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.64 70.55 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.441 -1.254 . . . . 0.26000000000000001 111.733 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.21 -37.57 28.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.888 -0.507 . . . . 0.23000000000000001 109.761 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.62 HD11 HD12 ' A' ' 46' ' ' ILE . 14.0 tp -74.47 -19.66 60.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.382 -0.826 . . . . 0.17000000000000001 109.188 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.753 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.28 -39.02 41.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.723 0.773 . . . . 0.19 111.608 173.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -60.62 -41.39 94.76 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.971 -1.013 . . . . 1.0700000000000001 109.745 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.54 -20.53 39.81 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.717 -1.583 . . . . 0.17000000000000001 112.169 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 25.4 m-80 -141.88 72.3 23.77 Favored Pre-proline 0 CA--C 1.513 -0.447 0 CA-C-O 121.132 0.492 . . . . 0.19 109.836 -173.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.708 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.6 Cg_endo -57.51 -11.94 9.9 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.415 2.743 . . . . 0.29999999999999999 113.887 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -61.9 -32.77 73.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.965 0.888 . . . . 1.1699999999999999 109.375 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.68 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.75 -6.87 59.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.785 1.402 . . . . 0.53000000000000003 114.785 -171.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.753 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -50.58 -40.91 53.6 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 120.08 1.309 . . . . 1.23 110.241 179.254 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.81 -46.29 12.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.965 -1.925 . . . . 0.40000000000000002 111.437 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.68 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.43 -163.5 34.15 Favored Glycine 0 CA--C 1.495 -1.214 0 C-N-CA 120.402 -0.904 . . . . 0.29999999999999999 114.029 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 9' ' ' VAL . 6.6 mp -117.89 158.31 25.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.215 -1.493 . . . . 0.31 110.436 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.616 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.7 m -131.74 135.58 46.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.713 -0.676 . . . . 0.39000000000000001 110.339 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.701 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.13 127.71 8.83 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.994 0.739 . . . . 0.46999999999999997 112.994 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.615 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 81.79 -10.43 51.83 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.815 -1.084 . . . . 0.35999999999999999 112.174 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.616 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.0 tt0 -64.25 151.33 43.91 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.771 0.796 . . . . 1.1899999999999999 110.188 175.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 39.5 m -117.79 134.14 55.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.235 -1.348 . . . . 0.89000000000000001 109.023 -171.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 29' ' ' LEU . 22.8 pt -135.88 149.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.319 0.581 . . . . 0.22 110.584 -175.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.557 ' H ' HD21 ' A' ' 33' ' ' ASN . 13.5 t -94.64 149.37 4.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.998 -1.001 . . . . 0.20999999999999999 110.249 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.527 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.4 mm -117.58 88.36 29.09 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.993 -1.003 . . . . 0.17000000000000001 108.434 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.766 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.45 143.4 97.88 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.248 2.632 . . . . 0.23000000000000001 112.723 -173.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.451 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 79.14 -8.29 46.59 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.496 -0.775 . . . . 0.29999999999999999 112.882 -176.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.727 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -113.54 124.82 30.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.551 -0.907 . . . . 0.25 108.551 177.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.659 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.2 Cg_endo -66.17 174.35 6.11 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.6 2.867 . . . . 0.31 113.631 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.6 t70 -89.12 142.0 29.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.043 -0.98 . . . . 0.71999999999999997 109.967 -173.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 83.2 Cg_endo -81.19 -13.58 11.19 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.223 2.615 . . . . 0.27000000000000002 112.087 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -96.91 -10.33 26.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.08 0.467 . . . . 2.1099999999999999 111.182 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -81.22 -22.37 38.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.076 -1.453 . . . . 1.47 107.076 166.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.62 HD13 ' HG2' ' A' ' 158' ' ' PRO . 64.4 mt -87.68 132.56 40.16 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 113.005 -1.907 . . . . 0.26000000000000001 110.219 173.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -103.89 96.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 121.208 1.272 . . . . 0.20000000000000001 110.546 165.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.464 ' HD2' ' CG2' ' A' ' 57' ' ' ILE . 84.0 m-85 -157.97 130.99 7.45 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.5 -1.296 . . . . 0.26000000000000001 107.5 172.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 13.0 m170 -135.75 103.68 5.5 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.981 -1.489 . . . . 2.8399999999999999 106.981 -166.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 76.2 mt -94.3 109.39 22.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.458 -0.792 . . . . 0.32000000000000001 110.541 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.11 97.01 6.24 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.385 -0.825 . . . . 0.34000000000000002 110.579 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.496 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -113.43 98.56 7.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.319 -1.309 . . . . 0.68000000000000005 109.808 178.125 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 43.0 m -94.59 121.1 35.8 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.615 -1.175 . . . . 1.05 108.752 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.2 mt -57.82 -26.79 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.352 0.596 . . . . 1.29 111.601 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.49 70.53 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.722 -0.752 . . . . 0.88 111.269 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.19 -24.46 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.14 0.495 . . . . 0.73999999999999999 112.335 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.9 mttt 58.26 18.38 5.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.367 1.067 . . . . 2.5099999999999998 112.318 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.67 141.27 31.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.92 0.866 . . . . 0.45000000000000001 111.516 176.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.496 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.96 118.52 31.94 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.895 -1.502 . . . . 0.33000000000000002 109.318 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -99.68 124.28 44.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.39 -0.524 . . . . 0.40000000000000002 111.095 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.494 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.07 133.52 35.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.804 -1.924 . . . . 0.33000000000000002 105.804 175.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.6 m -138.76 130.78 28.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 120.544 1.52 . . . . 0.75 112.743 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.77 126.61 53.36 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.14 -0.936 . . . . 0.34999999999999998 110.432 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 64.61 37.91 7.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.453 0.644 . . . . 0.52000000000000002 109.357 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 73.98 2.34 4.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.562 -1.199 . . . . 1.8400000000000001 112.567 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -130.8 138.0 49.7 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.618 -1.233 . . . . 3.1899999999999999 113.703 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -52.04 148.64 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-N 113.292 -1.776 . . . . 0.40999999999999998 113.587 -172.085 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.494 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.7 mtp -96.98 -46.12 6.32 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.191 -2.277 . . . . 0.34999999999999998 107.576 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 6.5 tptp 179.2 159.01 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.474 -2.148 . . . . 2.0699999999999998 109.767 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.536 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 18.5 m -117.03 136.22 53.12 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.379 -0.2 . . . . 0.37 110.946 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.54 133.42 24.04 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 109.986 -0.376 . . . . 0.96999999999999997 109.986 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.76 146.57 92.15 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.868 2.378 . . . . 0.59999999999999998 112.447 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 177.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.056 -0.72 . . . . 0.64000000000000001 109.056 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.118 0.485 . . . . 0.82999999999999996 110.072 173.433 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 163' ' ' VAL . 13.1 m-85 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.973 0.416 . . . . 1.9299999999999999 110.017 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' THR . 72.3 m-85 -134.06 140.42 46.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.923 -0.58 . . . . 0.57999999999999996 110.09 172.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 125' ' ' ILE . 27.2 mm -60.46 126.61 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.239 -1.022 . . . . 0.40999999999999998 108.239 167.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.7 tt -124.7 -21.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.047 -0.661 . . . . 0.37 112.41 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 21.9 t-20 -159.65 160.86 34.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.635 1.207 . . . . 1.99 114.088 -173.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 127.49 15.37 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 111.632 -2.531 . . . . 1.1899999999999999 108.806 172.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.64 158.54 16.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.446 1.117 . . . . 1.6699999999999999 111.821 -171.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.593 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 21.9 ttm180 -52.42 155.59 2.05 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.175 -2.284 . . . . 3.0600000000000001 111.793 167.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.593 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 6.6 p30 -45.13 109.89 0.99 Allowed Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.163 -1.38 . . . . 2.6099999999999999 111.519 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.37 -51.51 5.24 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.4 2.733 . . . . 0.97999999999999998 112.12 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.61 -10.31 70.87 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.096 -0.957 . . . . 1.0800000000000001 111.959 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -107.78 -168.72 21.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.412 -0.423 . . . . 1.05 112.085 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.54 18.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 124.073 3.182 . . . . 1.3 113.945 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -69.26 -18.56 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 1.3799999999999999 111.385 -177.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.591 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 94.19 41.38 4.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 1.1100000000000001 113.4 174.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 77.08 -27.58 0.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.237 0.828 . . . . 0.81000000000000005 113.237 171.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.551 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -152.64 146.5 25.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.95 0.405 . . . . 1.1200000000000001 110.769 -178.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -115.88 101.58 8.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 2.1899999999999999 109.545 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -103.63 141.69 35.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.406 0.622 . . . . 0.60999999999999999 110.462 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 101' ' ' ILE . 50.7 m -106.15 140.3 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.488 -0.778 . . . . 0.93999999999999995 111.818 -171.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -95.56 -178.41 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.676 -1.231 . . . . 1.0800000000000001 107.676 172.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 58.9 m . . . . . 0 C--O 1.221 -0.421 0 CA-C-N 118.439 0.563 . . . . 1.5 111.037 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 100' ' ' ILE . 7.3 mt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 108.499 -0.926 . . . . 0.47999999999999998 108.499 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -140.13 -164.44 1.71 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.505 -0.878 . . . . 1.25 111.796 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.591 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.04 179.52 16.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.724 -1.125 . . . . 0.46000000000000002 113.968 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -139.39 174.22 10.73 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.293 0.568 . . . . 0.5 111.068 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -104.38 -21.29 13.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.971 -1.013 . . . . 1.8600000000000001 108.9 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -127.22 104.36 22.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.755 -1.111 . . . . 1.77 109.672 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.69 5.41 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.499 2.799 . . . . 0.58999999999999997 112.794 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.46 59.57 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.258 0.552 . . . . 0.78000000000000003 110.363 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 m -85.33 -17.32 37.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 1.45 109.576 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.407 -0.815 . . . . 0.69999999999999996 111.017 -175.101 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.7 ptm . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 112.719 0.637 . . . . 1.1299999999999999 112.719 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -64.58 133.81 53.07 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.669 -0.696 . . . . 2.5099999999999998 111.051 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.623 ' O ' HG12 ' A' ' 150' ' ' VAL . 10.9 p30 -52.64 -63.54 1.11 Allowed 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 113.038 0.755 . . . . 1.77 113.038 -172.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -23.76 67.6 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.321 -0.862 . . . . 2.1299999999999999 112.115 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.03 -33.8 57.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 1.05 111.193 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 14.8 p -79.71 -16.3 13.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 110.016 -0.365 . . . . 0.32000000000000001 110.016 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.571 HD12 HG13 ' A' ' 150' ' ' VAL . 2.8 mp -88.38 -37.14 10.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.897 -0.409 . . . . 0.37 109.897 171.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -43.46 -70.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.878 0.763 . . . . 1.3799999999999999 111.784 159.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.712 ' O ' HG22 ' A' ' 157' ' ' VAL . 2.9 pp -54.7 -36.0 64.22 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.474 0.484 . . . . 0.73999999999999999 110.479 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.22 -51.92 65.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.6 0.714 . . . . 0.22 112.059 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 p -77.52 -15.57 59.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.77 -1.104 . . . . 1.3300000000000001 110.91 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.2 mt -93.86 -49.01 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.06 -0.518 . . . . 0.23000000000000001 110.5 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.2 m -76.83 111.97 19.53 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-O 121.776 0.798 . . . . 0.20999999999999999 110.253 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.62 ' HG2' HD13 ' A' ' 57' ' ' ILE . 6.8 Cg_endo -77.85 -179.89 5.87 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.467 2.111 . . . . 0.34000000000000002 112.804 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.727 ' O ' HD21 ' A' ' 51' ' ' LEU . 12.2 m120 -62.03 1.54 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.153 -1.385 . . . . 1.02 113.611 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.408 ' O ' HD12 ' A' ' 57' ' ' ILE . . . -145.1 58.4 0.51 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.145 -0.55 . . . . 0.28000000000000003 112.133 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.465 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 9.4 m -96.34 136.72 36.44 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.514 -0.403 . . . . 0.29999999999999999 110.27 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 135.36 33.8 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.365 -0.534 . . . . 1.96 110.386 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.2 p -139.0 122.75 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.022 -0.99 . . . . 0.46000000000000002 110.788 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.409 ' C ' HD12 ' A' ' 165' ' ' ILE . 87.1 m -113.75 138.39 50.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.716 -0.674 . . . . 0.56000000000000005 111.426 -177.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.489 HG13 HG13 ' A' ' 63' ' ' VAL . 2.9 mp -119.8 110.98 30.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 118.751 -1.18 . . . . 0.95999999999999996 109.999 172.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.861 0 CA-C-N 114.425 -1.261 . . . . 1.1899999999999999 109.568 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.6 OUTLIER . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 108.984 -0.747 . . . . 2.1000000000000001 108.984 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.789 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.5 mt -99.94 171.66 7.71 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.164 0.431 . . . . 0.26000000000000001 112.164 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.594 HD12 ' HD3' ' A' ' 54' ' ' PRO . 4.7 tp -76.15 152.89 36.58 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.59 0.756 . . . . 0.23000000000000001 112.512 -168.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.29 148.14 39.55 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.21 1.005 . . . . 0.26000000000000001 111.88 165.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 45' ' ' SER . 71.7 t80 -134.34 149.14 50.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.096 -1.865 . . . . 0.39000000000000001 107.612 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -130.03 114.41 15.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.208 -1.404 . . . . 1.0700000000000001 107.208 175.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.2 m -72.76 155.92 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 121.203 0.525 . . . . 0.38 112.031 -166.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -98.53 151.35 20.72 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.096 -0.956 . . . . 2.5899999999999999 109.593 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.798 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -52.17 116.41 2.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 1.74 111.398 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.05 -7.16 35.22 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.09 -0.959 . . . . 0.56999999999999995 112.956 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.55 ' CB ' HD11 ' A' ' 18' ' ' ILE . 71.6 m-20 -61.29 149.11 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.362 0.505 . . . . 2.1699999999999999 112.362 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.575 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -130.83 152.33 50.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.916 -0.583 . . . . 0.5 111.719 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.586 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.3 tp -48.43 -59.9 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 0.27000000000000002 113.896 -170.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.694 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 7.1 t-20 -65.39 -39.85 92.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.132 0.968 . . . . 1.21 110.211 -170.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.737 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 23.3 m -59.59 -41.74 90.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.928 -1.942 . . . . 1.24 110.728 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -74.95 -40.36 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.515 0.726 . . . . 0.29999999999999999 112.589 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -55.84 -63.65 1.11 Allowed 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.533 -0.303 . . . . 0.23000000000000001 111.188 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -79.95 -3.56 48.72 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.818 -1.153 . . . . 0.39000000000000001 112.035 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 17' ' ' SER . 13.6 t70 -64.47 -33.41 75.81 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.348 -0.982 . . . . 1.6299999999999999 108.348 157.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.679 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.9 m-85 -100.19 17.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.96 0.41 . . . . 0.23999999999999999 111.998 173.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 2.3 mpt_? 53.79 52.18 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.407 -0.815 . . . . 3.5499999999999998 110.764 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 38.5 pt -148.2 -173.27 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.059 -0.719 . . . . 0.27000000000000002 109.059 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -98.91 144.39 28.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.522 -0.763 . . . . 0.81000000000000005 109.665 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.694 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 7.1 p -62.55 -37.97 88.2 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.618 0.723 . . . . 0.27000000000000002 109.221 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.19 -27.41 68.67 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.164 -1.38 . . . . 0.26000000000000001 111.284 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -38.71 26.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.467 0.651 . . . . 0.23000000000000001 109.589 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.702 HD11 HD12 ' A' ' 46' ' ' ILE . 14.7 tp -72.06 -19.44 61.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 0.17000000000000001 108.911 174.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.789 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.51 -37.23 32.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.307 0.575 . . . . 0.19 111.243 172.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.0 mt-30 -56.57 -43.26 79.82 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.353 1.073 . . . . 1.0700000000000001 109.808 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.97 -18.93 35.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.404 -1.725 . . . . 0.17000000000000001 112.801 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 31.7 m-80 -143.82 73.76 16.71 Favored Pre-proline 0 CA--C 1.513 -0.479 0 CA-C-O 121.137 0.494 . . . . 0.19 109.961 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.679 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.1 Cg_endo -57.18 -14.02 14.04 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 123.568 2.845 . . . . 0.29999999999999999 114.098 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.99 -33.56 74.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.104 0.954 . . . . 1.1699999999999999 109.672 175.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -79.18 -6.0 55.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.225 -1.352 . . . . 0.53000000000000003 114.375 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.789 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -49.25 -41.11 36.66 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 119.778 1.172 . . . . 1.23 110.295 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.1 -46.53 11.85 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.766 -2.016 . . . . 0.40000000000000002 111.733 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.39 -163.89 34.73 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 120.369 -0.919 . . . . 0.29999999999999999 114.383 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.8 mp -118.65 157.38 27.53 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 112.945 -1.627 . . . . 0.31 110.686 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 84.8 m -135.17 132.32 37.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.464 -0.789 . . . . 0.39000000000000001 110.18 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.61 128.64 15.43 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.313 0.577 . . . . 0.46999999999999997 112.339 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.09 -13.5 54.15 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 114.734 -1.121 . . . . 0.35999999999999999 112.432 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.617 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.7 tt0 -65.85 151.98 45.46 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.426 0.632 . . . . 1.1899999999999999 110.358 173.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.5 m -117.92 134.35 55.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.589 -1.187 . . . . 0.89000000000000001 109.463 -171.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 29' ' ' LEU . 16.4 pt -136.84 149.79 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.423 0.63 . . . . 0.22 110.576 -175.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.576 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 16.9 t -95.65 148.94 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.08 -0.964 . . . . 0.20999999999999999 110.333 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.504 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.9 mm -117.25 89.33 30.66 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 114.835 -1.075 . . . . 0.17000000000000001 108.812 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.789 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.9 Cg_endo -59.3 140.48 94.78 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.277 2.652 . . . . 0.23000000000000001 112.767 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.77 -6.87 67.9 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.701 -0.681 . . . . 0.29999999999999999 113.033 -176.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.7 tt -116.49 124.87 28.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.444 -0.947 . . . . 0.25 108.444 175.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD23 ' A' ' 51' ' ' LEU . 58.9 Cg_endo -65.86 174.22 5.95 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.728 2.952 . . . . 0.31 113.898 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.493 ' O ' HG13 ' A' ' 57' ' ' ILE . 3.8 t70 -90.56 137.55 27.21 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 114.743 -1.117 . . . . 0.71999999999999997 111.604 -171.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.594 ' HD3' HD12 ' A' ' 5' ' ' LEU . 62.3 Cg_endo -83.94 -9.7 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.457 2.771 . . . . 0.27000000000000002 113.344 -174.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -95.67 -15.42 22.71 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.994 0.426 . . . . 2.1099999999999999 110.729 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -91.62 -5.31 54.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.623 0.725 . . . . 1.47 109.174 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.799 HD13 ' HG2' ' A' ' 158' ' ' PRO . 45.0 mt -98.28 137.73 20.8 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 115.24 -0.891 . . . . 0.26000000000000001 109.605 171.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' O ' ' CG ' ' A' ' 59' ' ' TYR . 10.6 Cg_endo -104.13 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.243 0 CA-C-N 120.153 1.09 . . . . 0.20000000000000001 110.038 163.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 58' ' ' PRO . 70.7 m-85 -156.94 133.47 9.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.142 -1.429 . . . . 0.26000000000000001 107.142 169.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.406 ' CD2' ' HB2' ' A' ' 73' ' ' SER . 1.2 t60 -148.18 111.26 4.86 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.555 -0.905 . . . . 2.8399999999999999 108.555 -160.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 50.1 mt -98.63 118.25 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.798 -1.092 . . . . 0.32000000000000001 111.019 -175.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.59 92.98 4.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.797 0.808 . . . . 0.34000000000000002 110.07 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 70' ' ' LEU . 1.1 p -111.36 101.78 13.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.438 -1.256 . . . . 0.68000000000000005 108.94 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.464 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.2 m -96.0 116.08 28.4 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.466 -0.939 . . . . 1.05 108.466 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mm -45.47 -36.5 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 1.29 110.876 170.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . -63.9 -43.83 96.96 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.372 -0.918 . . . . 0.88 111.683 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -71.17 -23.2 62.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.872 -0.664 . . . . 0.73999999999999999 112.73 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 66' ' ' GLY . 6.2 mptt 58.71 14.98 3.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.882 0.873 . . . . 2.5099999999999998 112.583 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.484 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.21 139.56 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.897 0.856 . . . . 0.45000000000000001 111.442 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.459 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -93.67 114.01 26.22 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.744 -1.571 . . . . 0.33000000000000002 108.737 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -98.5 122.19 41.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.06 -0.656 . . . . 0.40000000000000002 110.432 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.595 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -81.87 127.14 32.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.823 -1.917 . . . . 0.33000000000000002 105.823 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.1 m -131.8 127.34 36.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 120.341 1.428 . . . . 0.75 111.976 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -113.17 122.69 48.27 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.004 -0.998 . . . . 0.34999999999999998 109.559 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 68.51 36.75 2.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.772 -0.825 . . . . 0.52000000000000002 108.772 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 73.75 1.87 4.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.275 -1.329 . . . . 1.8400000000000001 112.295 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -130.38 138.14 50.23 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 118.148 -1.421 . . . . 3.1899999999999999 113.805 173.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.25 148.21 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 112.84 -1.982 . . . . 0.40999999999999998 113.585 -171.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -98.96 -44.43 6.33 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 111.921 -2.4 . . . . 0.34999999999999998 107.998 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 4.3 tppt? -178.96 160.77 1.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.235 -2.257 . . . . 2.0699999999999998 109.491 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.484 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.7 m -118.93 131.07 56.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.518 0.199 . . . . 0.37 110.662 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.769 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 30.6 m-85 -118.11 141.2 29.0 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 109.294 -0.632 . . . . 0.96999999999999997 109.294 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HB2' HG22 ' A' ' 134' ' ' ILE . 11.4 Cg_endo -80.94 144.13 14.9 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.196 1.93 . . . . 0.59999999999999998 111.783 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.66 178.07 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.89 -0.411 . . . . 0.64000000000000001 109.89 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.199 0.524 . . . . 0.82999999999999996 111.367 -178.845 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.854 ' CE1' HG11 ' A' ' 163' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 109.803 -0.443 . . . . 1.9299999999999999 109.803 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.487 ' HE2' ' HG3' ' A' ' 162' ' ' ARG . 37.0 m-85 -137.13 138.56 40.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.179 -0.675 . . . . 0.57999999999999996 109.179 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.493 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 26.8 mm -60.64 107.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.994 -0.743 . . . . 0.40999999999999998 108.994 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.626 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.4 tt -104.36 -31.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.629 -0.714 . . . . 0.37 112.401 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.625 ' ND2' ' H ' ' A' ' 103' ' ' ARG . 4.0 t-20 -168.65 175.52 6.09 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 123.028 1.394 . . . . 1.99 114.224 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.699 ' HB3' ' CE1' ' A' ' 114' ' ' TYR . 5.6 mtt180 -137.0 126.98 25.89 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.07 -2.787 . . . . 1.1899999999999999 107.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.74 150.45 20.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.179 0.99 . . . . 1.6699999999999999 111.081 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.578 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 27.0 ttm180 -51.78 156.81 1.33 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.95 -1.932 . . . . 3.0600000000000001 111.863 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.578 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 8.4 p30 -43.23 105.12 0.41 Allowed Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 122.745 1.259 . . . . 2.6099999999999999 111.312 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -58.3 -54.68 2.8 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.775 2.983 . . . . 0.97999999999999998 112.949 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.96 72.38 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.445 -0.798 . . . . 1.0800000000000001 111.848 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.89 -169.87 13.67 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.973 -0.451 . . . . 1.05 111.973 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.5 32.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 124.419 3.413 . . . . 1.3 114.369 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -88.11 -12.18 44.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.19 0.519 . . . . 1.3799999999999999 110.938 178.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 72.31 51.99 11.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.146 -0.934 . . . . 1.1100000000000001 114.018 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.81 -13.6 0.92 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.958 1.096 . . . . 0.81000000000000005 113.958 167.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.699 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -161.99 142.57 10.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.656 0.265 . . . . 1.1200000000000001 110.553 175.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -113.37 101.27 9.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.81 . . . . 2.1899999999999999 108.814 168.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.645 HD12 ' HG2' ' A' ' 103' ' ' ARG . 1.6 mm? -92.71 110.3 21.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.447 0.641 . . . . 0.60999999999999999 109.806 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.509 ' HB2' HG23 ' A' ' 101' ' ' ILE . 68.5 m -65.86 140.98 58.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.945 -1.025 . . . . 0.93999999999999995 111.983 -174.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.654 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 1.4 tp -109.43 161.46 15.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.452 -0.573 . . . . 1.0800000000000001 109.452 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.49 ' H ' ' HB2' ' A' ' 98' ' ' PHE . 5.6 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.303 0.573 . . . . 1.5 109.877 174.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.616 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 47.7 mt . . . . . 0 N--CA 1.442 -0.864 0 N-CA-C 107.555 -1.276 . . . . 0.47999999999999998 107.555 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -143.69 -163.4 1.65 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.825 -0.75 . . . . 1.25 111.846 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.39 168.45 14.33 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.697 -1.138 . . . . 0.46000000000000002 112.68 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.9 t -127.65 177.54 6.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.53 0.681 . . . . 0.5 111.888 -165.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -106.98 -18.45 13.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.614 -1.175 . . . . 1.8600000000000001 109.456 166.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -125.3 103.88 29.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.401 -0.818 . . . . 1.77 109.732 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -87.78 4.2 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.979 2.453 . . . . 0.58999999999999997 112.892 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.74 -21.59 23.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.086 0.47 . . . . 0.78000000000000003 110.132 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.8 m -90.23 13.21 15.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 1.45 110.357 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' PRO . 20.4 mm . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.69999999999999996 110.387 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.769 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 36.0 mtm . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.429 0.633 . . . . 1.1299999999999999 112.241 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.523 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 14.6 t-80 -72.77 148.19 44.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.125 -0.943 . . . . 2.5099999999999998 109.212 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.549 ' O ' HG12 ' A' ' 150' ' ' VAL . 31.9 p-10 -50.31 -63.29 1.16 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 112.672 0.619 . . . . 1.77 112.672 -172.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -64.53 -21.06 66.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.429 -0.794 . . . . 2.1299999999999999 111.945 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.1 m-20 -73.27 -39.51 65.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.207 -0.451 . . . . 1.05 110.659 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 10.4 p -80.99 -17.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.005 -0.543 . . . . 0.32000000000000001 110.79 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.443 HD12 HG13 ' A' ' 150' ' ' VAL . 2.5 mp -86.02 -40.54 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.871 -0.585 . . . . 0.37 110.24 171.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -44.11 -69.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.411 1.005 . . . . 1.3799999999999999 112.093 165.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.656 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.4 tp -52.07 -42.76 63.42 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.647 -0.706 . . . . 0.73999999999999999 110.581 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.98 -51.55 61.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.475 -1.238 . . . . 0.22 111.605 -173.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 -18.04 53.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.739 -1.119 . . . . 1.3300000000000001 111.244 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.417 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 62.2 mt -90.8 -50.35 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.924 -0.399 . . . . 0.23000000000000001 109.924 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 153' ' ' LEU . 16.1 m -78.13 110.7 14.32 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-O 122.192 0.996 . . . . 0.20999999999999999 110.226 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.799 ' HG2' HD13 ' A' ' 57' ' ' ILE . 24.4 Cg_endo -88.22 -179.08 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.386 2.724 . . . . 0.34000000000000002 112.669 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 8.6 m120 -65.17 108.92 2.02 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.27 -1.011 . . . . 1.02 108.27 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.455 ' O ' HD12 ' A' ' 57' ' ' ILE . . . 108.11 37.37 2.16 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.375 -0.917 . . . . 0.28000000000000003 113.496 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.494 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 26.1 m -90.61 131.69 36.18 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.65 -0.912 . . . . 0.29999999999999999 110.394 172.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -85.98 136.62 33.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.251 -0.431 . . . . 1.96 109.892 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 98' ' ' PHE . 1.9 p -148.71 137.19 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.716 -0.674 . . . . 0.46000000000000002 111.515 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.8 m -119.02 141.49 48.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 0.56000000000000005 112.055 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.43 HG12 HG13 ' A' ' 63' ' ' VAL . 1.2 mt -125.94 116.32 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 C-N-CA 118.539 -1.264 . . . . 0.95999999999999996 111.715 173.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.666 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 114.255 -1.339 . . . . 1.1899999999999999 110.799 -170.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 4.0 mptp? . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 109.735 -0.469 . . . . 2.1000000000000001 109.735 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.8 mt -97.43 170.04 9.33 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.524 0.515 . . . . 0.26000000000000001 111.634 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.672 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.3 tp -77.69 150.31 34.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.376 0.67 . . . . 0.23000000000000001 112.144 -170.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.547 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -114.84 149.39 37.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.093 0.949 . . . . 0.26000000000000001 111.879 168.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.495 ' CE2' ' HA ' ' A' ' 9' ' ' VAL . 70.8 t80 -135.19 151.11 50.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.546 -1.661 . . . . 0.39000000000000001 107.844 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -128.74 113.85 15.85 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.944 -1.502 . . . . 1.0700000000000001 106.944 173.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.543 HG11 HD23 ' A' ' 40' ' ' LEU . 1.3 m -71.83 158.04 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 121.141 0.496 . . . . 0.38 111.771 -166.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' N ' HG23 ' A' ' 9' ' ' VAL . 79.1 mttt -111.17 145.09 39.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.328 -0.851 . . . . 2.5899999999999999 109.487 -174.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -54.82 121.45 8.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.067 -0.97 . . . . 1.74 111.82 -173.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.77 -8.21 17.01 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.149 -0.78 . . . . 0.56999999999999995 111.149 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -40.42 142.37 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.198 1.555 . . . . 2.1699999999999999 115.198 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 134.72 45.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.013 -0.994 . . . . 0.5 111.342 163.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.8 tp -41.37 -56.34 2.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.195 -0.911 . . . . 0.27000000000000002 113.457 -174.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.675 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.6 -38.11 88.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.432 1.11 . . . . 1.21 110.322 -171.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -64.41 -42.35 96.13 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 112.953 -1.93 . . . . 1.24 110.263 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -70.26 -41.07 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.045 0.45 . . . . 0.29999999999999999 111.228 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.5 -59.56 4.98 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.995 -0.548 . . . . 0.23000000000000001 111.396 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.78 -3.86 57.19 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 118.936 -1.106 . . . . 0.39000000000000001 112.153 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 5.2 m-20 -61.1 -37.8 84.02 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.987 -1.116 . . . . 1.6299999999999999 107.987 155.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.79 ' O ' HG23 ' A' ' 24' ' ' ILE . 3.7 m-85 -98.06 27.91 4.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.404 0.52 . . . . 0.23999999999999999 112.404 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.765 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.2 67.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.902 1.281 . . . . 3.5499999999999998 113.729 -169.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 22' ' ' PHE . 33.0 pt -146.92 -172.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.094 -1.076 . . . . 0.27000000000000002 108.094 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 m -101.72 145.0 29.72 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.732 -0.667 . . . . 0.81000000000000005 109.38 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.675 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.3 p -61.4 -35.61 77.99 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.679 -0.692 . . . . 0.27000000000000002 109.256 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.52 67.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.344 -1.298 . . . . 0.26000000000000001 111.646 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.25 -39.15 19.62 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.463 -0.569 . . . . 0.23000000000000001 109.463 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 46' ' ' ILE . 12.9 tp -72.88 -17.53 61.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.228 -0.896 . . . . 0.17000000000000001 108.738 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.78 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -81.13 -37.89 28.1 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.484 0.659 . . . . 0.19 111.557 172.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -58.52 -43.13 89.05 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.306 1.051 . . . . 1.0700000000000001 109.59 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.91 -20.96 41.0 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.64 -1.618 . . . . 0.17000000000000001 111.995 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.568 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 31.9 m-80 -142.52 72.77 20.68 Favored Pre-proline 0 CA--C 1.514 -0.414 0 CA-C-O 121.237 0.542 . . . . 0.19 109.993 -172.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.652 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.2 Cg_endo -56.62 -13.11 10.01 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 123.649 2.899 . . . . 0.29999999999999999 114.122 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 t -62.24 -32.37 73.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.047 0.927 . . . . 1.1699999999999999 109.754 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.2 mt -81.34 -6.65 59.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.345 -1.298 . . . . 0.53000000000000003 114.402 -171.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.78 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -49.85 -44.45 49.59 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.471 1.129 . . . . 1.23 110.274 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.11 -45.85 15.83 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.937 -1.938 . . . . 0.40000000000000002 110.551 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.42 -170.33 43.33 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.491 -0.862 . . . . 0.29999999999999999 113.809 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 18' ' ' ILE . 6.7 mp -111.79 159.58 18.16 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.373 -1.414 . . . . 0.31 109.764 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.653 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 77.1 m -128.43 132.27 48.45 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.859 -0.61 . . . . 0.39000000000000001 109.887 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.56 129.38 16.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.406 0.622 . . . . 0.46999999999999997 112.241 174.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.35 -11.81 53.77 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.853 -1.067 . . . . 0.35999999999999999 112.704 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.1 tt0 -66.08 153.66 41.68 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.537 0.684 . . . . 1.1899999999999999 110.378 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 49.8 m -115.3 135.42 54.17 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.5 -1.227 . . . . 0.89000000000000001 109.029 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.677 HD12 HD11 ' A' ' 29' ' ' LEU . 18.6 pt -137.28 151.16 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.358 0.599 . . . . 0.22 110.504 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.567 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 15.4 t -96.89 149.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.07 -0.968 . . . . 0.20999999999999999 110.028 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.549 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.8 mm -117.64 88.41 29.54 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.024 -0.989 . . . . 0.17000000000000001 108.529 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.776 ' HA ' HD13 ' A' ' 4' ' ' LEU . 26.3 Cg_endo -59.68 142.8 99.4 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.199 2.599 . . . . 0.23000000000000001 112.564 -174.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.45 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.57 -6.95 59.64 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.874 -0.603 . . . . 0.29999999999999999 112.621 -176.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.75 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.18 125.27 28.71 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 108.54 -0.911 . . . . 0.25 108.54 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD23 ' A' ' 51' ' ' LEU . 60.2 Cg_endo -66.38 172.62 8.76 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.715 2.943 . . . . 0.31 114.017 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 4.9 t70 -91.19 136.66 26.95 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.665 -1.152 . . . . 0.71999999999999997 111.721 -170.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.672 ' HD3' HD12 ' A' ' 5' ' ' LEU . 68.8 Cg_endo -81.97 -6.94 12.28 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.332 2.688 . . . . 0.27000000000000002 113.381 -174.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -28.06 16.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.015 0.436 . . . . 2.1099999999999999 110.297 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -84.37 -12.93 53.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.985 -0.746 . . . . 1.47 108.985 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.764 HD13 ' HG2' ' A' ' 158' ' ' PRO . 84.0 mt -86.21 125.95 66.49 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.989 -1.005 . . . . 0.26000000000000001 109.295 169.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -101.47 95.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.14 0 CA-C-N 119.876 0.991 . . . . 0.20000000000000001 110.225 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 73' ' ' SER . 82.1 m-85 -158.55 129.45 6.26 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.016 -1.476 . . . . 0.26000000000000001 107.016 172.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 14.8 m170 -137.84 104.18 5.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.756 -1.572 . . . . 2.8399999999999999 106.756 -164.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -94.34 108.4 20.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.584 -0.734 . . . . 0.32000000000000001 110.331 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.6 97.35 6.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.14 -0.936 . . . . 0.34000000000000002 110.67 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 164' ' ' THR . 0.6 OUTLIER -112.22 98.38 6.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.964 -1.471 . . . . 0.68000000000000005 109.304 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.8 m -94.43 123.16 37.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.734 -1.121 . . . . 1.05 108.843 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mt -59.75 -31.87 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.064 -0.517 . . . . 1.29 111.802 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.91 -40.54 97.3 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.715 -0.755 . . . . 0.88 111.301 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.35 -23.96 59.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.941 -0.63 . . . . 0.73999999999999999 112.342 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.9 mttt 55.7 19.47 3.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.157 0.983 . . . . 2.5099999999999998 112.776 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.27 140.85 35.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.716 0.77 . . . . 0.45000000000000001 111.308 177.349 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.444 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.5 tt -94.31 119.27 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.157 -1.383 . . . . 0.33000000000000002 109.367 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -101.97 124.8 48.2 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.443 -0.503 . . . . 0.40000000000000002 111.093 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.558 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.62 139.52 33.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.237 -1.764 . . . . 0.33000000000000002 106.237 176.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 19.4 m -143.05 128.91 19.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 120.508 1.503 . . . . 0.75 112.672 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.89 125.4 50.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.906 -1.043 . . . . 0.34999999999999998 110.457 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 61.84 40.68 12.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.029 0.443 . . . . 0.52000000000000002 109.867 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 81.68 -7.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.798 -1.092 . . . . 1.8400000000000001 112.21 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -128.52 139.22 52.42 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 118.282 -1.367 . . . . 3.1899999999999999 114.025 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.71 149.85 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 112.873 -1.967 . . . . 0.40999999999999998 112.891 -174.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.558 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.0 mtp -100.16 -44.06 6.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.5 -2.137 . . . . 0.34999999999999998 108.43 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 179.7 159.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.54 -2.118 . . . . 2.0699999999999998 110.156 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.479 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.4 m -121.06 137.6 54.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.526 0.203 . . . . 0.37 111.309 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -127.82 135.94 28.24 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.905 0.383 . . . . 0.96999999999999997 111.374 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.22 143.86 90.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.935 2.424 . . . . 0.59999999999999998 112.181 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.7 -175.58 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 0.64000000000000001 110.028 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.399 0 N-CA-C 109.71 -0.478 . . . . 0.82999999999999996 109.71 173.611 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.544 ' HB2' HG13 ' A' ' 163' ' ' VAL . 29.1 m-85 . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.643 -0.873 . . . . 1.9299999999999999 108.643 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 161' ' ' THR . 80.7 m-85 -134.14 138.07 44.96 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.931 0.396 . . . . 0.57999999999999996 110.738 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 125' ' ' ILE . 26.5 mm -59.55 124.77 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 107.428 -1.323 . . . . 0.40999999999999998 107.428 166.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.765 HD11 ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -118.09 -22.09 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.893 -0.723 . . . . 0.37 112.174 -176.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 103' ' ' ARG . 3.1 t-20 -167.81 177.11 5.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 123.081 1.42 . . . . 1.99 114.122 -175.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.612 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 4.3 ptt180 -152.19 123.93 7.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 110.824 -2.898 . . . . 1.1899999999999999 108.684 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 161.25 14.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.382 1.087 . . . . 1.6699999999999999 111.666 -168.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -52.56 155.08 2.31 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 112.626 -2.079 . . . . 3.0600000000000001 112.662 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -44.0 110.3 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 113.119 -1.855 . . . . 2.6099999999999999 111.02 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -54.56 -47.88 24.39 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.386 2.724 . . . . 0.97999999999999998 111.668 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.71 -21.34 38.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.641 -1.163 . . . . 1.0800000000000001 112.74 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -112.81 -170.27 17.86 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.999 -0.619 . . . . 1.05 112.199 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.9 34.24 0.1 Allowed 'Trans proline' 0 N--CA 1.478 0.578 0 C-N-CA 124.473 3.449 . . . . 1.3 113.888 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 109' ' ' GLY . 50.1 t80 -83.15 -18.03 40.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.08 0.467 . . . . 1.3799999999999999 110.244 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.62 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.18 57.44 0.96 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.768 -0.73 . . . . 1.1100000000000001 114.856 170.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.27 -45.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.262 1.208 . . . . 0.81000000000000005 114.262 165.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.68 162.87 34.37 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.903 -0.406 . . . . 1.1200000000000001 109.903 -176.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 1.8 t90 -127.27 99.63 5.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 2.1899999999999999 108.433 172.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.653 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.3 mp -108.99 139.05 44.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.777 0.799 . . . . 0.60999999999999999 110.89 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.514 ' HB2' HG23 ' A' ' 101' ' ' ILE . 72.1 m -107.7 148.62 29.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.822 -1.081 . . . . 0.93999999999999995 113.115 -169.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.522 HD22 HG11 ' A' ' 163' ' ' VAL . 67.9 mt -104.86 -174.35 2.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.533 -1.212 . . . . 1.0800000000000001 108.441 173.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.0 m . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 112.555 0.576 . . . . 1.5 112.555 -176.859 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 100' ' ' ILE . 25.5 mt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.271 -0.64 . . . . 0.47999999999999998 109.271 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -155.21 -161.46 1.19 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.337 0.589 . . . . 1.25 110.578 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.62 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -119.31 177.1 16.31 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 119.612 -1.28 . . . . 0.46000000000000002 112.877 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.9 t -137.07 172.84 12.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.135 0.493 . . . . 0.5 110.254 -170.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.68 -19.66 14.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 1.8600000000000001 109.0 165.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -125.39 104.41 28.46 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.339 -0.846 . . . . 1.77 110.124 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.49 4.98 4.41 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.259 2.639 . . . . 0.58999999999999997 112.887 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.28 -22.8 28.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.039 0.447 . . . . 0.78000000000000003 110.651 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.2 p -85.32 -16.94 38.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.538 0.685 . . . . 1.45 110.047 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 134' ' ' ILE . 11.9 mm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.168 -0.923 . . . . 0.69999999999999996 110.672 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 35.8 mtp . . . . . 0 CA--C 1.519 -0.242 0 N-CA-C 109.783 -0.451 . . . . 1.1299999999999999 109.783 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.558 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 4.0 t-80 -78.57 154.71 30.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.265 -1.013 . . . . 2.5099999999999998 108.265 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.557 ' O ' HG12 ' A' ' 150' ' ' VAL . 22.7 p-10 -48.87 -67.39 0.27 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.428 0.529 . . . . 1.77 112.428 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 149' ' ' ASP . 3.8 ptpp? -59.7 -28.2 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.72 -0.612 . . . . 2.1299999999999999 111.582 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.558 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 6.7 m-20 -72.44 -40.15 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 1.05 110.714 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.4 p -74.83 -18.52 16.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.524 -0.307 . . . . 0.32000000000000001 110.246 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.49 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.8 mp -86.82 -39.84 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.947 -0.549 . . . . 0.37 110.435 174.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -44.39 -69.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.688 1.131 . . . . 1.3799999999999999 112.834 162.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.675 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -50.52 -42.35 54.89 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.73999999999999999 110.242 179.088 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.74 -53.82 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.348 -1.296 . . . . 0.22 112.038 -172.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.566 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 12.1 p -76.55 -13.57 60.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.407 -1.269 . . . . 1.3300000000000001 111.093 -172.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.65 -49.16 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.15 -0.477 . . . . 0.23000000000000001 110.053 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.1 m -77.55 117.14 63.61 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-O 122.059 0.933 . . . . 0.20999999999999999 110.81 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.764 ' HG2' HD13 ' A' ' 57' ' ' ILE . 42.2 Cg_endo -83.05 -178.52 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.876 2.384 . . . . 0.34000000000000002 112.785 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.75 ' O ' HD21 ' A' ' 51' ' ' LEU . 16.9 m120 -58.32 -2.63 0.2 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.509 -1.223 . . . . 1.02 113.53 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.01 55.91 0.56 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.813 -0.708 . . . . 0.28000000000000003 112.568 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.546 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 4.9 m -93.91 136.59 34.04 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.565 -0.374 . . . . 0.29999999999999999 110.305 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.79 142.2 29.12 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.462 -0.495 . . . . 1.96 110.291 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.2 p -143.66 123.75 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 0.46000000000000002 110.846 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.466 ' O ' HG13 ' A' ' 63' ' ' VAL . 23.3 m -112.7 139.63 48.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.56000000000000005 112.007 -176.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -125.65 114.17 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 118.542 -1.263 . . . . 0.95999999999999996 111.194 171.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.992 0 CA-C-N 113.886 -1.506 . . . . 1.1899999999999999 109.848 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.1 mptt . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.01 -0.737 . . . . 2.1000000000000001 109.01 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.765 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.5 mt -92.38 167.87 11.69 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.269 0.356 . . . . 0.26000000000000001 111.163 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.58 ' HB2' HD22 ' A' ' 51' ' ' LEU . 4.0 tp -75.89 149.05 37.84 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 122.929 0.492 . . . . 0.23000000000000001 111.851 -169.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.04 150.04 34.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.969 0.89 . . . . 0.26000000000000001 111.365 167.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' SER . 57.5 t80 -134.64 150.36 50.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.727 -1.579 . . . . 0.39000000000000001 108.0 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.41 120.93 27.9 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.001 -1.481 . . . . 1.0700000000000001 107.001 175.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -82.51 158.79 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 112.579 0.585 . . . . 0.38 112.579 -169.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -103.37 150.82 23.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.409 -0.814 . . . . 2.5899999999999999 109.261 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -52.61 109.44 0.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.336 0.589 . . . . 1.74 112.005 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.23 -9.68 15.26 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.338 -0.846 . . . . 0.56999999999999995 112.766 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.652 ' HB3' HD11 ' A' ' 18' ' ' ILE . 67.1 m-20 -61.43 152.55 29.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.844 0.322 . . . . 2.1699999999999999 110.814 176.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.56 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -133.49 155.99 48.57 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.253 0.464 . . . . 0.5 112.253 -177.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.595 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -50.3 -58.33 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.545 0.943 . . . . 0.27000000000000002 113.545 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.668 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.9 t-20 -66.08 -41.81 90.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.27 1.033 . . . . 1.21 110.687 -169.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 26.3 m -55.89 -52.29 64.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 112.958 -1.928 . . . . 1.24 109.754 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -66.48 -40.01 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.373 -0.831 . . . . 0.29999999999999999 111.942 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.683 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.98 -66.06 0.51 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.087 -0.506 . . . . 0.23000000000000001 112.108 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.35 -4.87 56.99 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 118.996 -1.081 . . . . 0.39000000000000001 112.133 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.1 m-20 -66.21 -31.52 72.4 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.99 -0.745 . . . . 1.6299999999999999 108.99 156.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD1' HD12 ' A' ' 101' ' ' ILE . 1.6 m-85 -96.48 15.21 22.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.033 -0.417 . . . . 0.23999999999999999 112.068 173.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.57 51.48 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.607 -0.724 . . . . 3.5499999999999998 110.609 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.4 pt -149.4 -172.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.721 -0.844 . . . . 0.27000000000000002 108.721 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.96 147.49 24.94 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.678 -0.692 . . . . 0.81000000000000005 109.909 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.668 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.7 p -61.5 -36.41 80.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.539 -0.911 . . . . 0.27000000000000002 108.539 175.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.29 -28.64 69.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.478 -1.237 . . . . 0.26000000000000001 111.664 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.72 -38.7 25.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.513 -0.551 . . . . 0.23000000000000001 109.513 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 46' ' ' ILE . 14.0 tp -73.3 -19.44 61.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.412 -0.813 . . . . 0.17000000000000001 109.081 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.702 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -39.69 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.657 0.742 . . . . 0.19 111.549 172.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.12 -40.6 96.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 114.994 -1.003 . . . . 1.0700000000000001 110.03 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.24 -19.25 43.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.998 -1.455 . . . . 0.17000000000000001 111.819 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 33.0 m-80 -142.13 71.57 22.89 Favored Pre-proline 0 CA--C 1.515 -0.374 0 CA-C-O 121.025 0.441 . . . . 0.19 109.903 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.712 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.23 -12.54 10.42 Favored 'Trans proline' 0 C--O 1.22 -0.4 0 C-N-CA 123.301 2.667 . . . . 0.29999999999999999 113.946 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -61.69 -32.31 72.5 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.061 0.934 . . . . 1.1699999999999999 110.035 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.1 mt -81.1 -6.36 58.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.206 -1.361 . . . . 0.53000000000000003 114.551 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.712 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -51.69 -40.66 60.51 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.77 1.272 . . . . 1.23 109.503 177.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.97 -46.69 14.72 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 112.763 -2.017 . . . . 0.40000000000000002 111.562 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.54 -162.69 33.76 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.271 -0.966 . . . . 0.29999999999999999 114.364 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.1 mp -116.88 158.21 24.37 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.188 -1.506 . . . . 0.31 109.881 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 89.2 m -137.31 135.47 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 0.39000000000000001 110.792 -177.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.646 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.48 126.66 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.404 0.89 . . . . 0.46999999999999997 113.404 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.591 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.4 -12.48 45.47 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 114.613 -1.176 . . . . 0.35999999999999999 112.083 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.597 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 4.1 tt0 -63.47 151.81 40.16 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.817 0.817 . . . . 1.1899999999999999 110.263 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.9 m -117.41 135.51 53.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.133 -1.394 . . . . 0.89000000000000001 109.096 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 29' ' ' LEU . 16.8 pt -136.71 146.42 28.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.296 0.57 . . . . 0.22 110.533 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.519 ' H ' HD21 ' A' ' 33' ' ' ASN . 7.2 t -91.61 149.1 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.051 -0.977 . . . . 0.20999999999999999 110.409 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.579 HG13 HD23 ' A' ' 5' ' ' LEU . 19.2 mm -118.07 87.54 29.03 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-N 114.959 -1.019 . . . . 0.17000000000000001 108.701 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.765 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.8 Cg_endo -59.08 139.78 92.16 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.209 2.606 . . . . 0.23000000000000001 112.709 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.518 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.18 -7.59 70.91 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.29999999999999999 112.93 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.75 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.81 128.78 25.78 Favored Pre-proline 0 C--O 1.218 -0.566 0 N-CA-C 108.566 -0.902 . . . . 0.25 108.566 177.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.697 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.4 Cg_endo -68.92 171.72 13.04 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.75 2.967 . . . . 0.31 114.167 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.745 ' HB3' HG22 ' A' ' 56' ' ' THR . 9.1 t70 -90.08 141.76 28.17 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.71999999999999997 110.232 -172.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD3' HD12 ' A' ' 5' ' ' LEU . 62.9 Cg_endo -85.27 -7.13 9.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.323 2.682 . . . . 0.27000000000000002 111.992 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -95.67 -24.52 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.1099999999999999 110.239 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.745 HG22 ' HB3' ' A' ' 53' ' ' ASP . 13.1 t -87.25 -15.41 38.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.678 -0.86 . . . . 1.47 108.678 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.747 HD13 ' HG2' ' A' ' 158' ' ' PRO . 61.7 mt -87.21 126.2 63.44 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 114.503 -1.226 . . . . 0.26000000000000001 108.964 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -101.16 93.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.175 0 CA-C-N 120.52 1.221 . . . . 0.20000000000000001 110.106 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.414 ' HD2' HG23 ' A' ' 57' ' ' ILE . 78.0 m-85 -159.03 131.52 6.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.238 -1.764 . . . . 0.26000000000000001 106.238 173.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 23.3 m-70 -140.33 107.8 5.57 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.095 -1.446 . . . . 2.8399999999999999 107.095 -164.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.5 mt -94.61 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.054 -0.975 . . . . 0.32000000000000001 110.398 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.39 94.59 5.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.0 0.905 . . . . 0.34000000000000002 110.337 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -115.6 100.02 9.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.039 -1.437 . . . . 0.68000000000000005 110.291 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.523 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 38.6 t -90.32 121.58 32.44 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.239 -1.393 . . . . 1.05 107.239 173.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 165' ' ' ILE . 33.3 mm -62.26 -26.88 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.957 0.884 . . . . 1.29 108.936 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.89 -46.0 84.72 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.297 -0.954 . . . . 0.88 111.377 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -67.27 -23.99 65.74 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.606 0.595 . . . . 0.73999999999999999 112.606 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.7 mttt 61.54 13.17 4.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.885 0.874 . . . . 2.5099999999999998 112.544 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.506 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -141.13 137.35 32.7 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.1 0.953 . . . . 0.45000000000000001 112.118 177.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.5 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.3 tt -93.96 118.93 32.16 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.346 -1.752 . . . . 0.33000000000000002 109.121 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 m -102.6 125.08 49.2 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.055 -0.658 . . . . 0.40000000000000002 111.233 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.595 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -84.6 129.75 34.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.509 -1.663 . . . . 0.33000000000000002 106.509 177.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 15.6 m -135.58 126.45 27.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 120.905 1.684 . . . . 0.75 112.81 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.0 tp -113.03 126.5 55.56 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.774 -1.103 . . . . 0.34999999999999998 109.876 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 63.05 40.05 9.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.088 -0.708 . . . . 0.52000000000000002 109.088 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 83.35 -21.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.725 1.21 . . . . 1.8400000000000001 111.949 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -121.92 139.06 54.12 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 117.295 -1.762 . . . . 3.1899999999999999 114.779 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.92 149.53 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 112.546 -2.115 . . . . 0.40999999999999998 113.882 -167.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.5 mtp -100.74 -42.97 6.28 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 112.076 -2.329 . . . . 0.34999999999999998 108.18 175.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 2.6 tppt? -178.37 164.69 1.74 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 112.464 -2.153 . . . . 2.0699999999999998 109.931 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.506 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 12.1 m -126.24 134.39 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.514 0.197 . . . . 0.37 110.798 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 19.5 m-85 -123.31 145.87 47.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 109.534 -0.543 . . . . 0.96999999999999997 109.534 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 27.3 Cg_endo -83.86 148.31 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.44 2.093 . . . . 0.59999999999999998 112.037 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.69 179.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.296 -0.411 . . . . 0.64000000000000001 110.192 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.86 0.362 . . . . 0.82999999999999996 110.251 179.035 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.599 ' HB2' HG13 ' A' ' 163' ' ' VAL . 21.4 m-85 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.857 -0.423 . . . . 1.9299999999999999 109.857 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.7 m-85 -140.03 141.7 36.27 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.061 -0.348 . . . . 0.57999999999999996 110.061 174.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.721 HD11 HD12 ' A' ' 125' ' ' ILE . 23.9 mm -60.16 121.17 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.9 -1.148 . . . . 0.40999999999999998 107.9 167.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.652 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.8 tt -122.92 -25.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.094 -0.642 . . . . 0.37 112.161 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 9.1 t-20 -150.69 154.22 37.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.478 1.288 . . . . 1.99 114.478 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.56 119.85 11.55 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 111.487 -2.597 . . . . 1.1899999999999999 108.904 172.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -97.59 159.87 14.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.386 1.088 . . . . 1.6699999999999999 112.042 -168.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 18.3 ttm180 -50.69 149.73 3.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 112.352 -2.204 . . . . 3.0600000000000001 111.646 168.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.403 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 19.3 m-80 -48.21 106.32 0.59 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 114.976 -1.011 . . . . 2.6099999999999999 112.233 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.7 -49.9 13.32 Favored 'Trans proline' 0 CA--C 1.519 -0.261 0 C-N-CA 123.723 2.949 . . . . 0.97999999999999998 112.43 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 16.75 49.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.237 -0.892 . . . . 1.0800000000000001 112.394 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -138.67 -168.95 11.43 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.085 -0.579 . . . . 1.05 112.15 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.96 16.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.938 3.092 . . . . 1.3 113.115 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -70.57 -21.38 62.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.079 -0.509 . . . . 1.3799999999999999 110.503 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.32 37.01 4.19 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.584 -0.735 . . . . 1.1100000000000001 113.874 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.36 -19.0 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.762 0.653 . . . . 0.81000000000000005 112.762 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.498 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -159.21 152.47 22.41 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 122.86 0.464 . . . . 1.1200000000000001 110.02 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.401 ' CE3' ' HE1' ' A' ' 111' ' ' PHE . 33.7 t-105 -120.24 105.48 10.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.1899999999999999 109.634 170.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.3 mp -107.84 138.52 43.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.6 0.714 . . . . 0.60999999999999999 111.101 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.9 m -106.76 146.25 31.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.326 -0.852 . . . . 0.93999999999999995 112.347 -171.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.88 -173.49 3.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.85 -0.796 . . . . 1.0800000000000001 108.85 169.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.496 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.9 t . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.42 0.526 . . . . 1.5 112.42 -172.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.721 HD12 HD11 ' A' ' 100' ' ' ILE . 40.3 mt . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 108.213 -1.032 . . . . 0.47999999999999998 108.213 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.468 ' O ' ' HG2' ' A' ' 145' ' ' MET . 12.6 p80 -138.95 -166.96 2.12 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.306 -0.957 . . . . 1.25 111.954 -176.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.468 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.72 161.54 14.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.356 -1.293 . . . . 0.46000000000000002 112.988 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.7 t -127.25 178.22 6.18 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.951 -0.625 . . . . 0.5 110.569 -170.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -105.21 -16.64 14.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.318 -0.856 . . . . 1.8600000000000001 109.662 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -126.92 100.69 27.23 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.842 -0.617 . . . . 1.77 110.152 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -91.6 4.31 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.197 2.598 . . . . 0.58999999999999997 113.267 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.97 27.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.253 0.549 . . . . 0.78000000000000003 110.251 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.1 t -82.19 -26.98 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.736 . . . . 1.45 109.732 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.455 HD13 ' HA ' ' A' ' 134' ' ' ILE . 6.6 mm . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.18 -0.918 . . . . 0.69999999999999996 111.552 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.54 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 15.4 ptm . . . . . 0 C--O 1.234 0.243 0 CA-C-O 120.506 0.193 . . . . 1.1299999999999999 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -77.06 145.5 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.505 -0.316 . . . . 2.5099999999999998 110.493 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.653 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.4 m-20 -49.89 -67.15 0.28 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.336 0.398 . . . . 1.77 111.898 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -26.32 65.45 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.572 -0.705 . . . . 2.1299999999999999 111.853 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.44 -36.72 63.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.745 -0.207 . . . . 1.05 110.812 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.4 p -75.44 -18.65 15.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 116.61 -0.268 . . . . 0.32000000000000001 110.377 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.568 HD12 HG13 ' A' ' 150' ' ' VAL . 3.2 mp -88.83 -41.44 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 119.27 -0.395 . . . . 0.37 110.243 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -41.03 -69.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 119.019 0.827 . . . . 1.3799999999999999 112.191 162.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.703 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.1 tp -50.55 -43.11 56.04 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.859 -0.61 . . . . 0.73999999999999999 110.334 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.02 -52.52 60.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.703 -1.135 . . . . 0.22 112.366 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.5 t -78.47 -14.67 59.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.668 -1.151 . . . . 1.3300000000000001 110.961 -172.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.01 -48.78 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.028 0.442 . . . . 0.23000000000000001 109.815 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.2 m -76.91 119.51 77.77 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-O 121.714 0.769 . . . . 0.20999999999999999 109.819 178.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.747 ' HG2' HD13 ' A' ' 57' ' ' ILE . 46.3 Cg_endo -82.3 -178.89 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.664 2.243 . . . . 0.34000000000000002 112.257 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.75 ' O ' HD21 ' A' ' 51' ' ' LEU . 9.6 m120 -59.67 -0.66 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.682 -1.144 . . . . 1.02 113.52 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.95 56.2 0.54 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.02 -0.61 . . . . 0.28000000000000003 112.237 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.492 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 3.1 m -94.01 133.99 36.88 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.524 -0.398 . . . . 0.29999999999999999 110.075 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -86.64 142.49 28.21 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.186 -0.605 . . . . 1.96 110.849 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.599 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.1 p -147.31 127.42 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.025 -0.989 . . . . 0.46000000000000002 110.917 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.4 m -113.3 142.13 46.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.516 -0.766 . . . . 0.56000000000000005 111.38 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.583 HG23 HG12 ' A' ' 65' ' ' ILE . 2.0 mp -125.34 119.34 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 118.791 -1.164 . . . . 0.95999999999999996 111.148 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.44 -0.936 0 CA-C-N 113.952 -1.476 . . . . 1.1899999999999999 107.768 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 109.538 -0.542 . . . . 2.1000000000000001 109.538 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.4 mt -99.35 172.92 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.21 -0.45 . . . . 0.26000000000000001 111.338 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.605 HD12 ' HD3' ' A' ' 54' ' ' PRO . 4.5 tp -77.67 152.33 33.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.201 0.6 . . . . 0.23000000000000001 111.748 -170.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.17 150.13 36.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.115 0.959 . . . . 0.26000000000000001 111.847 166.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' SER . 87.1 t80 -133.6 142.77 48.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.611 -1.631 . . . . 0.39000000000000001 107.719 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.3 tm0? -125.79 113.53 17.4 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.862 -1.533 . . . . 1.0700000000000001 106.862 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -76.81 158.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 113.193 0.812 . . . . 0.38 113.193 -164.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -95.44 148.11 22.81 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.105 -0.952 . . . . 2.5899999999999999 109.599 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.831 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 6.4 tt0 -52.19 109.38 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 1.74 111.554 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.9 -9.44 23.31 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.692 -0.766 . . . . 0.56999999999999995 112.957 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.582 ' HB3' HD11 ' A' ' 18' ' ' ILE . 71.4 m-20 -59.75 154.44 18.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.294 0.547 . . . . 2.1699999999999999 111.757 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.4 p -133.04 152.91 51.92 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.439 0.533 . . . . 0.5 112.439 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.99 -59.04 3.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.776 1.028 . . . . 0.27000000000000002 113.776 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.66 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 16.5 t-20 -64.84 -41.2 95.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.615 1.198 . . . . 1.21 110.578 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 43.9 t -59.22 -48.51 81.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.353 -2.203 . . . . 1.24 109.991 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.582 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -68.01 -40.71 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.064 -0.516 . . . . 0.29999999999999999 111.936 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.671 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.57 -63.9 1.05 Allowed 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.559 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.56 -4.64 54.78 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.877 -1.129 . . . . 0.39000000000000001 112.181 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -68.29 -30.25 69.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.947 -0.76 . . . . 1.6299999999999999 108.947 157.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.658 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.4 m-85 -96.44 15.61 20.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.996 0.369 . . . . 0.23999999999999999 111.996 172.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 55.43 49.62 16.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.661 -0.699 . . . . 3.5499999999999998 110.579 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.671 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.4 pt -148.2 -173.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.858 -0.793 . . . . 0.27000000000000002 108.858 -173.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -100.6 146.19 27.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.167 -0.924 . . . . 0.81000000000000005 109.737 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.66 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.3 p -61.37 -37.14 82.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.983 -0.747 . . . . 0.27000000000000002 108.983 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -28.91 70.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.389 -1.278 . . . . 0.26000000000000001 111.543 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.22 -38.06 27.59 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.492 -0.559 . . . . 0.23000000000000001 109.492 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 46' ' ' ILE . 14.3 tp -74.32 -17.84 60.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.317 -0.856 . . . . 0.17000000000000001 109.201 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.742 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.94 -39.1 26.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.681 0.753 . . . . 0.19 111.825 173.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -60.57 -40.95 93.56 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.947 -1.024 . . . . 1.0700000000000001 109.764 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.35 -21.14 39.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.633 -1.622 . . . . 0.17000000000000001 111.985 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.584 HD21 ' H ' ' A' ' 47' ' ' VAL . 28.3 m-80 -142.36 72.87 21.37 Favored Pre-proline 0 CA--C 1.513 -0.46 0 CA-C-O 121.163 0.506 . . . . 0.19 109.89 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.668 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 19.1 Cg_endo -58.36 -9.04 5.99 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.592 2.861 . . . . 0.29999999999999999 114.157 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -63.34 -34.89 78.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.949 0.881 . . . . 1.1699999999999999 109.478 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.21 -6.72 57.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.205 -1.361 . . . . 0.53000000000000003 114.521 -170.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.742 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -49.13 -40.73 33.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.575 1.179 . . . . 1.23 110.181 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.06 -46.85 10.78 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 112.747 -2.024 . . . . 0.40000000000000002 111.624 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.64 -164.08 34.81 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.43 -0.89 . . . . 0.29999999999999999 114.172 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.459 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.6 mp -118.4 157.74 26.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.474 -1.363 . . . . 0.31 110.624 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.657 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 81.5 m -135.09 135.48 41.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.694 -0.684 . . . . 0.39000000000000001 110.912 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.37 128.9 12.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.576 0.954 . . . . 0.46999999999999997 113.576 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.509 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 80.49 -11.62 37.83 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.386 -1.279 . . . . 0.35999999999999999 112.26 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.657 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.9 tt0 -63.74 152.22 39.87 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.555 0.693 . . . . 1.1899999999999999 110.237 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 30.8 m -119.5 133.37 55.71 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.41 -1.268 . . . . 0.89000000000000001 109.436 -171.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.718 HD12 HD11 ' A' ' 29' ' ' LEU . 19.5 pt -135.37 155.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.157 0.504 . . . . 0.22 110.397 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.584 ' H ' HD21 ' A' ' 33' ' ' ASN . 14.8 t -99.68 149.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.283 -0.871 . . . . 0.20999999999999999 110.398 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.552 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.5 mm -117.57 88.72 30.26 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.118 -0.946 . . . . 0.17000000000000001 108.516 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.778 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.1 Cg_endo -59.67 139.49 89.07 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.188 2.592 . . . . 0.23000000000000001 112.876 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.495 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.38 -7.29 68.76 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.172 -0.922 . . . . 0.29999999999999999 112.812 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.08 124.98 29.46 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.902 -0.777 . . . . 0.25 108.902 177.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.611 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.9 Cg_endo -66.23 174.19 6.39 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.729 2.953 . . . . 0.31 114.028 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 2.5 t70 -90.82 138.33 26.4 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.71999999999999997 111.699 -171.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HD3' HD12 ' A' ' 5' ' ' LEU . 92.7 Cg_endo -81.17 -5.84 12.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.219 2.613 . . . . 0.27000000000000002 113.429 -174.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -95.15 -28.51 15.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.65 0.262 . . . . 2.1099999999999999 111.038 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t -78.99 -24.42 43.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.667 -0.864 . . . . 1.47 108.667 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.751 HD13 ' HG2' ' A' ' 158' ' ' PRO . 77.5 mt -74.24 123.59 89.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 114.859 -1.064 . . . . 0.26000000000000001 109.711 170.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -101.06 94.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 119.839 0.978 . . . . 0.20000000000000001 110.148 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HD2' HG23 ' A' ' 57' ' ' ILE . 84.1 m-85 -159.1 139.45 12.25 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.546 -1.65 . . . . 0.26000000000000001 106.546 172.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.523 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 35.1 t60 -147.43 118.73 7.82 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.878 -1.156 . . . . 2.8399999999999999 107.878 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 67.8 mt -106.51 113.02 42.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.032 -0.985 . . . . 0.32000000000000001 111.087 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.89 106.87 16.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.107 -0.951 . . . . 0.34000000000000002 110.106 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -113.37 119.85 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 114.59 -1.186 . . . . 0.68000000000000005 110.017 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.619 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 16.5 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.015 -1.074 . . . . 1.05 109.937 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.2 mt -61.43 -28.78 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.808 0.813 . . . . 1.29 109.798 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.32 -47.25 59.26 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.658 -1.156 . . . . 0.88 111.615 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -74.94 -26.11 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.237 0.828 . . . . 0.73999999999999999 113.237 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 tttt 49.35 29.27 2.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.112 0.958 . . . . 2.5099999999999998 112.179 -175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.514 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -143.98 139.61 29.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.381 -0.827 . . . . 0.45000000000000001 110.989 170.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 tt -97.03 120.06 36.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.907 -1.497 . . . . 0.33000000000000002 109.495 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -100.45 123.18 44.34 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.003 -0.679 . . . . 0.40000000000000002 110.711 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.573 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.73 143.57 30.8 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.449 -1.685 . . . . 0.33000000000000002 106.449 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 31.2 p -149.72 127.47 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 120.499 1.499 . . . . 0.75 113.147 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 tp -112.19 125.91 54.64 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.151 -1.386 . . . . 0.34999999999999998 110.076 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 8.9 t-20 68.87 31.02 4.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.513 -0.921 . . . . 0.52000000000000002 108.513 172.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 34.9 m-80 79.14 2.1 2.37 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.167 -1.378 . . . . 1.8400000000000001 111.763 176.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -129.76 142.09 50.76 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 118.874 -1.13 . . . . 3.1899999999999999 113.987 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -58.45 150.06 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 113.219 -1.81 . . . . 0.40999999999999998 113.314 -168.223 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.573 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -100.47 -43.73 6.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.464 -2.153 . . . . 0.34999999999999998 108.4 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 4.7 tppt? 179.5 161.05 0.81 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.746 -2.025 . . . . 2.0699999999999998 110.451 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.514 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 22.8 m -118.05 132.0 56.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.675 0.274 . . . . 0.37 110.957 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 79.7 m-85 -113.22 152.01 44.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 0.96999999999999997 110.297 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HB2' HG22 ' A' ' 134' ' ' ILE . 12.3 Cg_endo -83.86 138.84 8.31 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.508 2.139 . . . . 0.59999999999999998 111.943 177.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.35 172.74 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.325 -0.62 . . . . 0.64000000000000001 109.325 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 0.82999999999999996 111.478 176.209 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.512 ' HB2' HG13 ' A' ' 163' ' ' VAL . 7.1 m-85 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.72 -0.474 . . . . 1.9299999999999999 109.72 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.513 ' CE2' ' HG2' ' A' ' 162' ' ' ARG . 62.2 m-85 -139.26 138.64 36.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.781 -0.645 . . . . 0.57999999999999996 110.315 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 125' ' ' ILE . 27.7 mm -60.51 127.63 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 107.987 -1.116 . . . . 0.40999999999999998 107.987 167.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.619 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -118.17 -31.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.512 -0.875 . . . . 0.37 112.341 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -166.78 -175.07 2.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 118.084 -1.447 . . . . 1.99 114.289 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 103' ' ' ARG . 4.9 ptp180 -156.81 133.86 10.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 111.211 -2.722 . . . . 1.1899999999999999 110.125 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.8 155.36 24.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.275 1.036 . . . . 1.6699999999999999 111.708 -172.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.27 155.35 3.81 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 112.291 -2.231 . . . . 3.0600000000000001 112.92 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -43.58 102.93 0.3 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 112.947 -1.933 . . . . 2.6099999999999999 111.674 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.83 -54.04 2.71 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 124.114 3.209 . . . . 0.97999999999999998 113.0 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.73 -20.6 26.87 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.543 -0.753 . . . . 1.0800000000000001 111.907 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -87.82 -169.59 45.49 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.375 -0.44 . . . . 1.05 112.493 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.03 6.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.167 3.245 . . . . 1.3 113.949 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.41 ' H ' ' C ' ' A' ' 109' ' ' GLY . 32.6 m-85 -53.42 -35.95 60.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.138 0.494 . . . . 1.3799999999999999 109.749 171.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.9 -2.58 16.76 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.337 -0.847 . . . . 1.1100000000000001 114.697 168.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB1' ' CD1' ' A' ' 151' ' ' ILE . . . -175.57 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.828 0.814 . . . . 0.81000000000000005 112.628 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.532 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -151.63 158.32 43.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.344 -0.389 . . . . 1.1200000000000001 111.514 -171.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CE3' ' HD2' ' A' ' 126' ' ' HIS . 9.7 t-105 -117.77 100.44 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.359 -0.608 . . . . 2.1899999999999999 109.359 171.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.46 ' CD1' HG22 ' A' ' 150' ' ' VAL . 3.8 mp -105.3 141.12 37.38 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.727 0.775 . . . . 0.60999999999999999 111.351 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.513 ' HB2' HG23 ' A' ' 101' ' ' ILE . 56.3 m -105.83 142.79 34.95 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.934 -1.03 . . . . 0.93999999999999995 111.979 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -102.87 -174.49 2.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.468 -0.938 . . . . 1.0800000000000001 108.468 173.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 118.973 0.806 . . . . 1.5 112.788 -176.792 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 100' ' ' ILE . 30.8 mt . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 121.918 0.866 . . . . 0.47999999999999998 109.441 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.428 ' HD2' ' CE3' ' A' ' 115' ' ' TRP . 14.9 t-80 -130.26 173.09 11.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.635 -1.166 . . . . 1.25 111.527 -160.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.2 -171.7 14.63 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 0.46000000000000002 111.311 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 t -159.48 174.52 14.55 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.933 -1.107 . . . . 0.5 112.679 -163.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.18 -20.57 13.76 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.914 -1.494 . . . . 1.8600000000000001 108.884 167.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.78 103.21 21.76 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.152 -0.931 . . . . 1.77 110.232 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.521 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 64.8 Cg_endo -90.63 4.94 4.35 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.975 2.45 . . . . 0.58999999999999997 112.553 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.5 40.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.248 0.547 . . . . 0.78000000000000003 109.977 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.0 m -91.25 13.8 16.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.324 -0.853 . . . . 1.45 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 18.8 mm . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 0.69999999999999996 110.711 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.405 ' HA ' HG21 ' A' ' 134' ' ' ILE . 38.9 mtp . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 121.096 0.474 . . . . 1.1299999999999999 111.362 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 149' ' ' ASP . 37.6 m80 -66.45 176.11 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.167 -0.924 . . . . 2.5099999999999998 109.143 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 150' ' ' VAL . 3.8 m120 -82.4 -63.5 1.36 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.017 -1.105 . . . . 1.77 108.017 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -66.69 -22.15 66.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.616 . . . . 2.1299999999999999 111.323 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 146' ' ' HIS . 31.2 m-20 -67.93 -41.83 81.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.893 0.378 . . . . 1.05 110.831 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 8.5 p -79.52 -13.01 13.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.32000000000000001 110.521 -177.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.581 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 3.3 mp -92.34 -40.52 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 119.254 -0.403 . . . . 0.37 110.849 168.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -42.32 -70.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.356 0.98 . . . . 1.3799999999999999 111.912 162.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.0 OUTLIER -50.07 -41.96 48.99 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.738 0.649 . . . . 0.73999999999999999 110.181 177.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.23 -55.47 20.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.622 -1.172 . . . . 0.22 111.727 -172.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 28.7 t -77.01 -16.66 59.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.686 -1.143 . . . . 1.3300000000000001 110.863 -172.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.24 -50.07 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 0.23000000000000001 109.969 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.3 m -77.51 115.78 52.43 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 122.046 0.927 . . . . 0.20999999999999999 110.38 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.751 ' HG2' HD13 ' A' ' 57' ' ' ILE . 45.6 Cg_endo -80.82 -178.28 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.834 2.356 . . . . 0.34000000000000002 112.578 -172.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.694 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.2 m120 -55.91 -5.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.669 -1.151 . . . . 1.02 113.57 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.18 57.26 0.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.937 -0.649 . . . . 0.28000000000000003 112.168 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.528 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 3.8 m -90.72 140.32 29.89 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.405 -0.467 . . . . 0.29999999999999999 110.608 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.513 ' HG2' ' CE2' ' A' ' 99' ' ' TYR . 60.4 mtm180 -83.53 125.15 31.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.51 . . . . 1.96 109.86 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -136.16 126.65 41.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.389 0.614 . . . . 0.46000000000000002 111.419 -177.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.5 m -117.29 140.49 49.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.384 -0.826 . . . . 0.56000000000000005 111.975 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.7 mp -129.14 115.82 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 122.342 1.067 . . . . 0.95999999999999996 111.397 172.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.948 0 CA-C-N 113.527 -1.67 . . . . 1.1899999999999999 110.26 -173.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 1.8 mppt? . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 108.845 -0.798 . . . . 2.1000000000000001 108.845 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -95.91 170.89 8.98 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.071 0.232 . . . . 0.26000000000000001 111.15 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.544 HD23 ' CG1' ' A' ' 48' ' ' ILE . 4.0 tp -77.62 150.11 34.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 123.215 0.606 . . . . 0.23000000000000001 112.173 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.541 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -115.07 149.25 37.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.012 0.911 . . . . 0.26000000000000001 111.754 168.006 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.5 t80 -133.72 150.3 51.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.61 -1.632 . . . . 0.39000000000000001 107.911 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.3 tm0? -131.59 117.13 18.3 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.151 -1.426 . . . . 1.0700000000000001 107.151 174.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG11 HD23 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -78.58 158.83 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 123.234 0.614 . . . . 0.38 111.226 -169.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 10' ' ' LYS . 8.5 mtpm? -110.27 156.72 20.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.111 -0.7 . . . . 2.5899999999999999 109.111 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.849 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 19.7 tm0? -49.82 117.94 2.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.826 -0.625 . . . . 1.74 112.571 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.54 -6.44 35.94 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.56999999999999995 113.428 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.704 ' HB3' HD11 ' A' ' 18' ' ' ILE . 20.9 m-20 -70.66 157.09 38.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.473 0.637 . . . . 2.1699999999999999 112.436 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.615 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -134.7 162.29 32.76 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.549 0.574 . . . . 0.5 112.549 -176.337 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.9 tp -51.75 -60.73 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.937 1.088 . . . . 0.27000000000000002 113.937 -173.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.647 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.8 t-20 -63.75 -43.37 96.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.614 1.197 . . . . 1.21 110.403 -169.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.768 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 31.3 m -60.46 -39.17 86.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 112.494 -2.139 . . . . 1.24 110.989 -177.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.35 -40.87 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 123.012 0.525 . . . . 0.29999999999999999 112.327 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.682 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.55 -61.66 2.27 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.487 -0.324 . . . . 0.23000000000000001 111.242 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.14 -3.33 54.62 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.01 -1.076 . . . . 0.39000000000000001 112.136 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' SER . 4.0 t70 -62.13 -39.64 93.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.85 -1.167 . . . . 1.6299999999999999 107.85 155.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.766 ' O ' HG23 ' A' ' 24' ' ' ILE . 4.6 m-85 -93.13 24.9 3.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.087 -0.506 . . . . 0.23999999999999999 111.969 174.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.647 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 23.74 69.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.96 1.304 . . . . 3.5499999999999998 113.515 -168.41 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 22' ' ' PHE . 29.8 pt -147.66 -169.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.066 -1.087 . . . . 0.27000000000000002 108.066 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.22 146.88 25.18 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.943 -0.571 . . . . 0.81000000000000005 109.736 171.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.647 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.6 p -61.25 -35.56 77.58 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.499 -0.926 . . . . 0.27000000000000002 108.499 174.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.66 71.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.604 -1.18 . . . . 0.26000000000000001 111.77 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.03 -38.24 32.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.874 -0.516 . . . . 0.23000000000000001 109.725 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.68 -19.08 60.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.423 -0.808 . . . . 0.17000000000000001 109.133 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.764 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -78.83 -40.37 32.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 0.19 111.832 173.396 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -59.68 -40.59 88.33 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.072 -0.967 . . . . 1.0700000000000001 109.746 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.11 -20.29 41.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.673 -1.603 . . . . 0.17000000000000001 112.214 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.693 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 23.8 m-80 -143.52 73.12 17.46 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.165 0.507 . . . . 0.19 109.941 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.724 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.8 Cg_endo -57.08 -11.32 7.42 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 123.574 2.849 . . . . 0.29999999999999999 113.809 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.6 t -62.67 -32.83 73.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.988 0.899 . . . . 1.1699999999999999 109.392 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.82 -7.08 59.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.568 1.321 . . . . 0.53000000000000003 114.568 -172.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.764 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -53.06 -39.84 63.56 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 120.19 1.359 . . . . 1.23 109.599 177.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.78 -47.4 12.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.769 -2.014 . . . . 0.40000000000000002 111.334 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.03 -166.54 38.68 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.91 -1.138 . . . . 0.29999999999999999 114.567 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.577 ' CD2' HG12 ' A' ' 18' ' ' ILE . 5.6 mp -114.88 158.91 21.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.335 -1.432 . . . . 0.31 110.152 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.605 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.84 136.2 38.57 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.797 -0.638 . . . . 0.39000000000000001 110.499 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.849 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.93 127.46 10.08 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 113.115 0.783 . . . . 0.46999999999999997 113.115 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.22 -11.13 51.23 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.607 -1.179 . . . . 0.35999999999999999 112.312 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -63.31 151.11 41.63 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.697 0.76 . . . . 1.1899999999999999 110.298 175.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 35.6 m -118.88 131.59 56.07 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.32 -1.309 . . . . 0.89000000000000001 109.265 -171.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 29' ' ' LEU . 21.2 pt -132.81 159.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.095 0.474 . . . . 0.22 110.345 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.693 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 26.1 t -106.63 148.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.292 -0.867 . . . . 0.20999999999999999 109.808 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.544 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.9 mm -116.97 88.69 27.19 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.31 -0.996 . . . . 0.17000000000000001 108.31 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.709 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.3 Cg_endo -59.05 142.32 99.23 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.129 2.553 . . . . 0.23000000000000001 112.617 -173.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.514 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.37 -7.08 61.93 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.492 -0.776 . . . . 0.29999999999999999 112.811 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.712 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -114.62 126.07 28.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.742 -0.836 . . . . 0.25 108.742 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 51' ' ' LEU . 57.5 Cg_endo -65.58 174.3 5.55 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.849 3.033 . . . . 0.31 113.656 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.1 t70 -91.31 141.73 26.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.158 -0.928 . . . . 0.71999999999999997 110.9 -169.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 96.5 Cg_endo -83.57 -7.11 10.73 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.616 2.877 . . . . 0.27000000000000002 112.17 -175.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 62.1 m-85 -94.84 -27.31 15.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.831 -0.433 . . . . 2.1099999999999999 109.831 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -70.23 -35.06 73.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.497 -1.298 . . . . 1.47 107.497 170.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.8 HD13 ' HG2' ' A' ' 158' ' ' PRO . 85.0 mt -74.34 126.43 88.96 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 113.327 -1.761 . . . . 0.26000000000000001 110.524 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -102.94 95.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.905 1.07 . . . . 0.20000000000000001 110.257 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.451 ' HD2' HG23 ' A' ' 57' ' ' ILE . 77.2 m-85 -158.33 129.57 6.49 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.403 -1.332 . . . . 0.26000000000000001 107.403 172.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m-70 -137.7 110.13 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.158 -1.423 . . . . 2.8399999999999999 107.158 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.0 mt -94.94 111.4 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.383 0.611 . . . . 0.32000000000000001 110.539 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.27 93.06 4.23 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.857 0.837 . . . . 0.34000000000000002 110.399 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -112.88 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.414 -1.266 . . . . 0.68000000000000005 109.647 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 35.4 t -92.77 124.96 37.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.849 -1.167 . . . . 1.05 107.849 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.465 HG13 HG23 ' A' ' 165' ' ' ILE . 1.0 OUTLIER -58.98 -28.59 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.345 0.593 . . . . 1.29 110.796 172.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.45 -45.05 88.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.881 -0.888 . . . . 0.88 110.881 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.481 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -70.25 -24.08 63.01 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.644 0.609 . . . . 0.73999999999999999 112.644 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.5 mttt 58.57 14.26 2.97 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.818 0.847 . . . . 2.5099999999999998 112.894 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.458 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.42 138.9 35.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.973 0.892 . . . . 0.45000000000000001 111.249 177.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.445 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -92.74 117.9 30.49 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.881 -1.509 . . . . 0.33000000000000002 108.881 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.61 125.4 48.26 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.938 -0.705 . . . . 0.40000000000000002 110.925 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.43 142.62 31.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.095 -1.817 . . . . 0.33000000000000002 106.095 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 26.1 m -147.48 128.2 14.28 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 120.445 1.475 . . . . 0.75 112.969 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -111.41 126.88 55.41 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.588 -1.187 . . . . 0.34999999999999998 110.147 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.1 t-20 61.89 35.45 16.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 0.52000000000000002 110.285 173.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.2 m-20 78.35 1.59 2.68 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.112 -0.949 . . . . 1.8400000000000001 112.404 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 77' ' ' ARG . 5.5 ttt180 -128.51 137.36 51.73 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 118.283 -1.367 . . . . 3.1899999999999999 113.446 172.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.19 147.93 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 112.987 -1.915 . . . . 0.40999999999999998 113.17 -171.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.533 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -97.8 -44.72 6.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.25 -2.25 . . . . 0.34999999999999998 107.943 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 26.0 tptt -179.04 160.21 1.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.325 -2.216 . . . . 2.0699999999999998 110.484 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.458 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.5 m -116.11 131.44 56.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.689 -0.232 . . . . 0.37 111.403 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -113.71 146.86 36.37 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 110.487 -0.19 . . . . 0.96999999999999997 110.487 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.95 143.19 12.88 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.506 2.137 . . . . 0.59999999999999998 111.305 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.75 172.23 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.768 -0.456 . . . . 0.64000000000000001 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.92 0.391 . . . . 0.82999999999999996 110.08 175.666 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.506 ' HB2' HG13 ' A' ' 163' ' ' VAL . 2.7 m-85 . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 108.301 -1.0 . . . . 1.9299999999999999 108.301 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 161' ' ' THR . 89.4 m-85 -135.9 139.1 43.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.464 -0.495 . . . . 0.57999999999999996 111.685 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.73 HD11 HD12 ' A' ' 125' ' ' ILE . 26.6 mm -60.62 126.19 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 107.578 -1.267 . . . . 0.40999999999999998 107.578 164.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -125.46 -27.93 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 120.118 -0.633 . . . . 0.37 112.51 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 3.6 t30 -151.61 158.8 43.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.82 1.045 . . . . 1.99 113.82 -168.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.69 133.91 20.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.397 -2.183 . . . . 1.1899999999999999 110.198 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 13.3 tp60 -111.92 142.57 44.14 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.806 0.813 . . . . 1.6699999999999999 110.709 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -54.23 151.44 7.26 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 112.937 -1.938 . . . . 3.0600000000000001 113.254 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -45.36 101.98 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 114.121 -1.399 . . . . 2.6099999999999999 111.998 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.402 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 85.7 Cg_exo -56.79 -51.39 9.11 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 124.242 3.294 . . . . 0.97999999999999998 112.839 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.39 -0.86 29.46 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.353 -0.839 . . . . 1.0800000000000001 112.436 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.16 -170.34 11.99 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.939 -0.648 . . . . 1.05 112.098 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.29 49.14 0.16 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.465 3.443 . . . . 1.3 113.945 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.402 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 1.6 t80 -107.42 -15.56 14.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.392 -0.596 . . . . 1.3799999999999999 109.392 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.427 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.92 35.37 4.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.806 -0.712 . . . . 1.1100000000000001 114.516 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.406 ' O ' ' HD1' ' A' ' 114' ' ' TYR . . . 72.72 -36.42 0.36 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.468 0.914 . . . . 0.81000000000000005 113.468 172.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -152.83 137.57 16.99 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.366 -0.605 . . . . 1.1200000000000001 109.366 -176.043 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 61.9 t-105 -110.34 102.35 11.01 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.485 -0.561 . . . . 2.1899999999999999 109.485 171.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.2 mp -102.03 144.41 30.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.763 0.792 . . . . 0.60999999999999999 110.54 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.588 ' HB2' HG23 ' A' ' 101' ' ' ILE . 34.8 m -107.84 144.32 35.21 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.08 -0.964 . . . . 0.93999999999999995 112.794 -169.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.716 HD11 HG11 ' A' ' 163' ' ' VAL . 6.8 tp -106.81 -171.78 1.95 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.836 -1.529 . . . . 1.0800000000000001 107.899 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 118.772 0.715 . . . . 1.5 111.836 178.388 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 100' ' ' ILE . 4.0 mt . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 106.338 -1.727 . . . . 0.47999999999999998 106.338 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' A' ' 145' ' ' MET . 10.3 p80 -149.48 -165.06 2.17 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.467 -0.893 . . . . 1.25 112.272 -172.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.427 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.17 175.39 16.35 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.636 -1.165 . . . . 0.46000000000000002 113.01 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.0 t -136.69 171.68 14.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.464 0.649 . . . . 0.5 111.986 -165.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -104.81 -18.17 14.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.877 -1.056 . . . . 1.8600000000000001 108.702 165.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -124.21 102.8 33.45 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.268 -0.878 . . . . 1.77 109.661 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -90.07 4.29 4.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.165 2.577 . . . . 0.58999999999999997 112.846 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.48 -12.37 58.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.338 0.59 . . . . 0.78000000000000003 109.805 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.6 m -93.53 5.9 50.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.298 -0.865 . . . . 1.45 109.271 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 145' ' ' MET . 31.2 mm . . . . . 0 N--CA 1.45 -0.473 0 CA-C-N 115.095 -0.957 . . . . 0.69999999999999996 110.487 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 126' ' ' HIS . 20.4 ptm . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 112.253 0.464 . . . . 1.1299999999999999 112.253 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.439 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 14.3 m80 -67.54 138.61 56.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 2.5099999999999998 109.826 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.643 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.4 m-20 -52.3 -64.67 0.74 Allowed 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.18 0.3 . . . . 1.77 111.401 -175.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -59.57 -27.29 66.12 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.91 -0.494 . . . . 2.1299999999999999 111.809 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.439 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 2.3 m-20 -70.31 -43.68 69.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 1.05 110.68 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 11.2 p -73.68 -15.79 16.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.32000000000000001 110.37 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -90.18 -40.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 119.181 -0.438 . . . . 0.37 110.551 172.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -43.16 -67.75 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.348 0.976 . . . . 1.3799999999999999 112.014 163.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.694 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.6 tp -49.35 -43.79 44.14 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.592 -0.731 . . . . 0.73999999999999999 109.894 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.66 -50.85 64.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.118 -1.401 . . . . 0.22 112.421 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 17.1 t -78.74 -18.64 53.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.758 -1.11 . . . . 1.3300000000000001 110.71 -173.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.16 -50.46 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.838 -0.43 . . . . 0.23000000000000001 109.838 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.8 m -77.12 114.88 43.96 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 122.057 0.932 . . . . 0.20999999999999999 109.985 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.8 ' HG2' HD13 ' A' ' 57' ' ' ILE . 46.4 Cg_endo -82.12 -178.11 3.89 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.169 2.579 . . . . 0.34000000000000002 112.609 -174.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.712 ' O ' HD21 ' A' ' 51' ' ' LEU . 20.6 m120 -59.2 -1.71 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.591 -1.186 . . . . 1.02 113.364 -174.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.42 59.08 0.5 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.947 -0.644 . . . . 0.28000000000000003 112.414 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.2 m -95.69 134.85 38.12 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.535 -0.391 . . . . 0.29999999999999999 110.393 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -84.88 140.24 31.29 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.098 -0.334 . . . . 1.96 110.098 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.716 HG11 HD11 ' A' ' 118' ' ' LEU . 3.7 p -145.55 130.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.811 -0.631 . . . . 0.46000000000000002 111.271 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.404 ' C ' HD12 ' A' ' 165' ' ' ILE . 20.0 m -116.82 138.18 51.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.811 -0.631 . . . . 0.56000000000000005 111.789 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.465 HG23 HG13 ' A' ' 65' ' ' ILE . 2.9 mp -122.18 109.84 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 118.997 -1.081 . . . . 0.95999999999999996 110.619 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.631 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 114.526 -1.215 . . . . 1.1899999999999999 109.358 -170.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.417 -0.586 . . . . 2.1000000000000001 109.417 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.784 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.9 mt -91.96 170.63 9.7 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.94 -0.573 . . . . 0.26000000000000001 110.854 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.539 HD23 ' CG1' ' A' ' 48' ' ' ILE . 3.6 tp -76.49 149.07 36.81 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 122.983 0.513 . . . . 0.23000000000000001 111.866 -170.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.51 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.59 149.18 36.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.166 0.984 . . . . 0.26000000000000001 111.67 168.125 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 45' ' ' SER . 77.3 t80 -134.54 147.53 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.304 -1.771 . . . . 0.39000000000000001 107.521 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.56 112.01 14.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.288 -1.745 . . . . 1.0700000000000001 106.288 174.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 40' ' ' LEU . 1.6 m -71.42 157.68 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 115.714 -0.675 . . . . 0.38 111.961 -165.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -108.27 147.77 30.94 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.113 -0.948 . . . . 2.5899999999999999 109.387 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.58 131.22 29.42 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.888 0.742 . . . . 1.74 112.349 -174.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -4.59 39.69 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.371 -0.831 . . . . 0.56999999999999995 111.44 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -45.11 143.63 1.53 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.915 1.45 . . . . 2.1699999999999999 114.915 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.23 140.1 46.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.978 -1.01 . . . . 0.5 111.674 164.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.5 tp -42.31 -55.28 3.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.315 -0.857 . . . . 0.27000000000000002 113.174 -175.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 17.3 t-20 -65.43 -42.97 91.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.584 1.183 . . . . 1.21 110.375 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.786 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 15.1 m -62.95 -38.06 89.54 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 112.477 -2.147 . . . . 1.24 110.878 -176.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -76.08 -39.62 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 O-C-N 123.713 0.633 . . . . 0.29999999999999999 112.2 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.718 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.02 -59.59 4.85 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.611 -0.268 . . . . 0.23000000000000001 110.998 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 -4.65 56.83 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.527 -1.269 . . . . 0.39000000000000001 111.848 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.786 ' HB2' ' O ' ' A' ' 17' ' ' SER . 8.3 t70 -61.3 -29.24 69.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.567 -1.272 . . . . 1.6299999999999999 107.567 157.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.692 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.8 m-85 -109.06 19.13 19.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.999 0.74 . . . . 0.23999999999999999 112.999 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? 49.57 54.95 10.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.486 -0.779 . . . . 3.5499999999999998 111.266 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 19' ' ' ALA . 33.5 pt -148.18 -172.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.721 -0.844 . . . . 0.27000000000000002 108.721 -173.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.58 146.78 24.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.66 -0.7 . . . . 0.81000000000000005 109.684 173.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.644 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.1 p -62.69 -35.19 78.89 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.793 -0.818 . . . . 0.27000000000000002 108.793 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.16 -28.88 68.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.362 -1.29 . . . . 0.26000000000000001 111.665 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.38 26.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.241 -0.651 . . . . 0.23000000000000001 109.241 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 16.5 tp -72.46 -17.85 61.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.144 -0.935 . . . . 0.17000000000000001 108.772 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.757 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.05 -37.51 33.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.393 0.616 . . . . 0.19 111.16 171.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -56.39 -46.28 80.18 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.636 1.208 . . . . 1.0700000000000001 110.278 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.69 43.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 112.998 -1.91 . . . . 0.17000000000000001 112.317 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 34.3 m-80 -142.51 73.1 20.59 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.19 110.108 -172.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.747 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.6 Cg_endo -57.24 -13.55 12.95 Favored 'Trans proline' 0 C--O 1.22 -0.419 0 C-N-CA 123.437 2.758 . . . . 0.29999999999999999 114.325 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.48 -31.59 71.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.932 0.872 . . . . 1.1699999999999999 109.718 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.675 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -81.0 -6.69 59.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.469 1.285 . . . . 0.53000000000000003 114.469 -171.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.757 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -50.86 -41.48 58.03 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.806 1.185 . . . . 1.23 110.147 179.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.62 -46.32 13.44 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.829 -1.987 . . . . 0.40000000000000002 111.136 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.01 -170.32 43.4 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.49 -0.862 . . . . 0.29999999999999999 113.952 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 9' ' ' VAL . 5.3 mp -110.03 161.71 15.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.558 -1.321 . . . . 0.31 109.724 177.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.3 m -135.61 134.12 38.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.872 -0.603 . . . . 0.39000000000000001 110.428 176.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.44 129.25 18.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.314 0.578 . . . . 0.46999999999999997 112.281 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.18 -12.9 57.11 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.802 -1.09 . . . . 0.35999999999999999 112.647 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.6 tt0 -65.88 152.7 43.88 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.641 0.734 . . . . 1.1899999999999999 110.306 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.498 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 50.7 m -117.02 130.68 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.501 -1.227 . . . . 0.89000000000000001 109.603 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 29' ' ' LEU . 20.6 pt -134.46 145.51 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.516 0.674 . . . . 0.22 110.526 -174.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.57 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.5 t -91.02 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.866 -1.061 . . . . 0.20999999999999999 110.192 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.8 mm -117.47 88.53 29.09 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-N 115.083 -0.962 . . . . 0.17000000000000001 108.425 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.784 ' HA ' HD13 ' A' ' 4' ' ' LEU . 22.8 Cg_endo -58.74 141.36 97.71 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.221 2.614 . . . . 0.23000000000000001 112.967 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.495 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.6 -7.6 72.58 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.381 -0.827 . . . . 0.29999999999999999 113.115 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.636 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.7 tt -118.53 128.39 26.0 Favored Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.641 -0.874 . . . . 0.25 108.641 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.636 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.8 Cg_endo -67.33 175.12 6.22 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.563 2.842 . . . . 0.31 113.825 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.771 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.9 t70 -89.46 142.11 29.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.71999999999999997 110.56 -171.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.503 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 75.0 Cg_endo -84.28 -4.58 10.26 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.576 2.851 . . . . 0.27000000000000002 112.363 -174.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -94.79 -26.53 16.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.741 -0.466 . . . . 2.1099999999999999 109.741 174.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.771 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.1 p -72.99 -28.76 62.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.561 1.172 . . . . 1.47 107.844 171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.755 HD13 ' HG2' ' A' ' 158' ' ' PRO . 93.0 mt -80.68 124.35 81.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 113.065 -1.88 . . . . 0.26000000000000001 109.868 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -101.8 96.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 120.779 0.986 . . . . 0.20000000000000001 110.235 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.489 ' HB2' HG23 ' A' ' 161' ' ' THR . 89.9 m-85 -157.74 133.23 9.01 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.387 -1.338 . . . . 0.26000000000000001 107.387 172.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 9.7 m-70 -137.08 103.82 5.25 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.259 -1.756 . . . . 2.8399999999999999 106.259 -167.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.1 mt -92.96 106.43 17.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.705 0.764 . . . . 0.32000000000000001 109.595 -177.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.86 96.1 5.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.716 -1.129 . . . . 0.34000000000000002 110.623 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.557 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -114.82 96.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 113.743 -1.571 . . . . 0.68000000000000005 108.712 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.51 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.1 m -95.18 122.57 38.0 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.209 -1.36 . . . . 1.05 108.383 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 3.1 mm -47.3 -34.48 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.428 0.632 . . . . 1.29 110.117 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.55 -47.33 35.05 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.17 -0.923 . . . . 0.88 112.336 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.51 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -64.37 -24.25 67.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.317 0.58 . . . . 0.73999999999999999 112.392 174.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 17.9 mttt 54.97 17.63 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.773 1.229 . . . . 2.5099999999999998 113.414 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.414 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -143.32 142.46 31.32 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.318 0.58 . . . . 0.45000000000000001 111.02 171.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.557 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.5 tt -90.98 118.21 30.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.169 -0.923 . . . . 0.33000000000000002 109.411 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -105.0 125.77 51.33 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.392 -0.523 . . . . 0.40000000000000002 111.691 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.543 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.76 136.82 34.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.129 -1.804 . . . . 0.33000000000000002 106.129 176.055 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.648 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 13.3 m -141.78 129.35 21.44 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 120.493 1.497 . . . . 0.75 112.758 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.26 126.59 53.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.045 -0.98 . . . . 0.34999999999999998 110.539 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.9 t-20 63.74 37.79 9.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.423 0.63 . . . . 0.52000000000000002 109.827 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.4 m-20 76.25 0.57 3.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.672 -1.149 . . . . 1.8400000000000001 112.525 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.49 138.54 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.279 -1.368 . . . . 3.1899999999999999 113.751 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -53.89 147.23 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 113.053 -1.885 . . . . 0.40999999999999998 112.863 -172.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.52 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -96.47 -45.66 6.67 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.338 -2.21 . . . . 0.34999999999999998 107.565 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 30.2 tptt -176.77 159.33 1.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.216 -2.265 . . . . 2.0699999999999998 110.298 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.414 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 3.6 m -119.43 134.81 55.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.397 -0.121 . . . . 0.37 111.051 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -120.22 127.14 26.48 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 120.924 0.392 . . . . 0.96999999999999997 110.876 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 69' ' ' THR . 7.7 Cg_endo -57.46 137.82 83.25 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 124.16 3.24 . . . . 0.59999999999999998 113.813 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 168.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.818 -0.353 . . . . 0.64000000000000001 110.371 177.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.314 0 CA-C-O 121.549 0.69 . . . . 0.82999999999999996 111.39 179.025 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.642 ' HB2' HG13 ' A' ' 163' ' ' VAL . 13.3 m-85 . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 107.205 -1.405 . . . . 1.9299999999999999 107.205 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 161' ' ' THR . 84.6 m-85 -130.37 135.9 48.52 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.277 -0.569 . . . . 0.57999999999999996 111.021 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.804 HD11 HD12 ' A' ' 125' ' ' ILE . 26.8 mm -60.26 121.06 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 107.346 -1.353 . . . . 0.40999999999999998 107.346 164.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.629 HD12 ' HD1' ' A' ' 22' ' ' PHE . 3.1 tt -109.04 -22.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.487 -0.885 . . . . 0.37 112.099 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 21.1 p-10 -178.5 -165.7 0.09 Allowed 'General case' 0 C--N 1.348 0.531 0 N-CA-C 114.024 1.12 . . . . 1.99 114.024 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 103' ' ' ARG . 5.3 ptp180 -150.73 139.66 20.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 112.683 -2.053 . . . . 1.1899999999999999 111.68 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 24.7 tp60 -107.12 145.0 33.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.604 -1.18 . . . . 1.6699999999999999 111.407 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.707 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 34.3 ttm180 -56.64 150.15 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.167 -1.833 . . . . 3.0600000000000001 111.506 170.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -46.07 104.01 0.38 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 123.89 0.744 . . . . 2.6099999999999999 111.736 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.425 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 87.9 Cg_exo -56.35 -51.64 8.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.815 3.01 . . . . 0.97999999999999998 111.874 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.75 -21.59 13.83 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.02 -0.991 . . . . 1.0800000000000001 112.578 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -100.27 -169.49 29.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.96 -0.638 . . . . 1.05 112.311 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.52 32.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.256 3.304 . . . . 1.3 113.754 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -85.92 -20.92 28.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.142 0.496 . . . . 1.3799999999999999 109.933 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.439 ' HA3' ' CA ' ' A' ' 127' ' ' GLY . . . 96.33 42.55 3.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.519 -0.764 . . . . 1.1100000000000001 114.019 170.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.69 -33.62 0.23 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.419 0.896 . . . . 0.81000000000000005 113.419 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.559 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -150.17 127.0 11.04 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.816 -0.439 . . . . 1.1200000000000001 109.816 -174.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 34.0 t-105 -100.48 100.39 11.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.158 -0.682 . . . . 2.1899999999999999 109.158 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.2 mp -101.09 141.27 34.22 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 0.60999999999999999 109.016 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.1 m -106.93 144.09 34.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.644 0.609 . . . . 0.93999999999999995 112.644 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.598 HD11 HG11 ' A' ' 163' ' ' VAL . 2.3 tp -97.97 -174.19 2.8 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.786 -1.191 . . . . 1.0800000000000001 107.786 172.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--N 1.314 -0.951 0 C-N-CA 120.586 -0.445 . . . . 1.5 110.741 175.35 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.804 HD12 HD11 ' A' ' 100' ' ' ILE . 9.2 mt . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.541 -0.911 . . . . 0.47999999999999998 108.541 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -136.95 -161.76 1.2 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.527 0.68 . . . . 1.25 111.27 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.439 ' CA ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.1 155.8 16.08 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.815 -1.183 . . . . 0.46000000000000002 113.569 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.441 HG21 ' CA ' ' A' ' 131' ' ' PRO . 3.8 t -98.37 172.5 7.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.028 -1.086 . . . . 0.5 110.592 -171.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.93 -13.35 13.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.351 -0.841 . . . . 1.8600000000000001 109.075 160.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 133' ' ' SER . 24.1 t30 -124.75 101.12 33.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.185 -0.916 . . . . 1.77 109.414 171.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.441 ' CA ' HG21 ' A' ' 128' ' ' THR . 81.1 Cg_endo -90.49 3.29 4.82 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.785 2.323 . . . . 0.58999999999999997 113.039 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -94.8 -2.02 51.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.383 0.611 . . . . 0.78000000000000003 109.546 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.468 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 33.3 t -90.23 -12.69 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.262 -0.881 . . . . 1.45 109.555 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.6 mm . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.672 -0.695 . . . . 0.69999999999999996 109.963 177.831 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.528 ' CG ' ' HB ' ' A' ' 150' ' ' VAL . 5.1 ptm . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 113.279 0.844 . . . . 1.1299999999999999 113.279 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.434 ' HD2' ' OD1' ' A' ' 147' ' ' ASN . 2.6 t60 -71.12 153.93 42.14 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.851 -0.796 . . . . 2.5099999999999998 108.851 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.573 ' O ' HG12 ' A' ' 150' ' ' VAL . 29.8 p-10 -54.21 -69.91 0.11 Allowed 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.268 0.47 . . . . 1.77 112.268 -172.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -61.39 -20.35 62.95 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.567 -0.708 . . . . 2.1299999999999999 111.405 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -74.26 -45.3 48.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.667 -0.697 . . . . 1.05 110.354 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.601 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.2 p -72.05 -18.37 19.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.32000000000000001 110.945 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.583 HD12 HG13 ' A' ' 150' ' ' VAL . 1.9 mp -84.68 -36.68 11.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 119.116 -0.469 . . . . 0.37 110.297 177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -45.05 -70.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 119.441 1.018 . . . . 1.3799999999999999 112.337 162.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.677 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -49.45 -40.88 38.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.73999999999999999 110.316 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.99 -55.6 30.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.169 -1.378 . . . . 0.22 111.997 -172.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.9 p -75.08 -12.91 60.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.7 -1.136 . . . . 1.3300000000000001 110.919 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.89 -49.87 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.881 -0.6 . . . . 0.23000000000000001 110.098 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.2 m -77.15 115.69 51.05 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 122.096 0.95 . . . . 0.20999999999999999 110.541 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.755 ' HG2' HD13 ' A' ' 57' ' ' ILE . 38.4 Cg_endo -82.78 -177.34 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.184 2.589 . . . . 0.34000000000000002 112.971 -173.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.631 ' O ' HD21 ' A' ' 51' ' ' LEU . 12.0 m120 -57.63 -2.13 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.708 -1.133 . . . . 1.02 113.898 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.57 57.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.28000000000000003 112.537 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.2 m -92.69 134.62 34.85 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.612 -0.346 . . . . 0.29999999999999999 110.479 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 138.81 31.73 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.904 0.383 . . . . 1.96 110.389 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -145.63 127.39 8.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.339 -0.846 . . . . 0.46000000000000002 110.911 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 63' ' ' VAL . 3.3 m -116.34 143.0 46.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.854 -0.612 . . . . 0.56000000000000005 111.652 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.465 HG13 HG13 ' A' ' 63' ' ' VAL . 3.1 mp -124.34 107.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 119.252 -0.979 . . . . 0.95999999999999996 109.77 172.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.643 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 1.1899999999999999 111.148 -168.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.533 ' HE2' ' CG2' ' A' ' 56' ' ' THR . 4.1 mppt? . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 109.89 -0.411 . . . . 2.1000000000000001 109.89 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.1 mt -95.21 172.6 8.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.855 -0.611 . . . . 0.26000000000000001 111.192 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.548 HD23 ' CG1' ' A' ' 48' ' ' ILE . 4.2 tp -75.49 149.2 38.51 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.103 0.478 . . . . 0.23000000000000001 111.77 -170.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.529 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.29 147.82 38.47 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.143 0.973 . . . . 0.26000000000000001 111.6 167.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' SER . 81.1 t80 -133.91 146.7 50.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.205 -1.816 . . . . 0.39000000000000001 107.571 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.6 tt0 -127.33 111.35 13.8 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 1.0700000000000001 106.66 176.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.549 HG11 HD23 ' A' ' 40' ' ' LEU . 1.2 m -70.64 157.44 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 121.37 0.605 . . . . 0.38 111.856 -165.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.31 147.09 33.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.128 -0.942 . . . . 2.5899999999999999 109.44 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.658 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -53.13 130.82 35.5 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.838 0.712 . . . . 1.74 112.15 -173.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.81 -4.85 39.51 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.491 -0.777 . . . . 0.56999999999999995 111.672 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -43.5 146.17 0.53 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.004 1.483 . . . . 2.1699999999999999 115.004 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.35 139.9 45.97 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.014 -0.994 . . . . 0.5 111.928 162.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.582 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.5 tp -43.11 -55.76 3.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.499 -0.773 . . . . 0.27000000000000002 113.031 -175.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.679 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.2 -40.06 93.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.261 1.029 . . . . 1.21 110.268 -171.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -59.81 -49.88 75.97 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 112.924 -1.944 . . . . 1.24 109.534 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -65.84 -39.35 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 O-C-N 123.522 0.514 . . . . 0.29999999999999999 111.35 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.68 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.41 -62.67 1.61 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.887 -0.597 . . . . 0.23000000000000001 111.612 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.27 -4.27 56.84 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.996 -1.081 . . . . 0.39000000000000001 112.292 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.56 -33.58 74.11 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.285 -1.005 . . . . 1.6299999999999999 108.285 155.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.6 m-85 -101.47 27.39 6.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.099 0.407 . . . . 0.23999999999999999 112.099 175.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.694 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.13 68.62 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.836 1.255 . . . . 3.5499999999999998 113.805 -168.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.772 HG23 ' O ' ' A' ' 22' ' ' PHE . 34.6 pt -147.42 -173.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.856 -1.164 . . . . 0.27000000000000002 107.856 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -101.09 145.68 28.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.764 -0.653 . . . . 0.81000000000000005 109.409 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.679 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.7 p -61.93 -35.24 77.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.54 0.686 . . . . 0.27000000000000002 109.208 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.1 -30.18 71.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.282 -1.326 . . . . 0.26000000000000001 111.334 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.14 -38.54 27.01 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.394 0.616 . . . . 0.23000000000000001 109.692 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.693 HD11 HD12 ' A' ' 46' ' ' ILE . 13.9 tp -72.74 -18.22 61.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.432 -0.804 . . . . 0.17000000000000001 108.963 175.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.738 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.58 -37.58 35.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.19 111.223 171.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.0 mt-30 -56.96 -47.43 80.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.285 1.04 . . . . 1.0700000000000001 109.501 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.56 -18.37 51.91 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.361 -1.745 . . . . 0.17000000000000001 112.178 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.594 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 31.3 m-80 -143.15 72.52 18.22 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.153 0.501 . . . . 0.19 109.903 -173.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.774 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.68 -13.0 12.85 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 123.322 2.681 . . . . 0.29999999999999999 113.781 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -31.78 70.67 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 122.045 0.926 . . . . 1.1699999999999999 109.897 174.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.668 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -82.67 -6.45 59.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.159 -1.382 . . . . 0.53000000000000003 114.527 -172.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.774 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -50.6 -42.28 55.71 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 119.778 1.172 . . . . 1.23 109.907 178.04 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.19 -47.04 15.29 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 112.99 -1.914 . . . . 0.40000000000000002 111.172 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.668 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.12 -166.82 39.04 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-O 122.162 0.868 . . . . 0.29999999999999999 113.989 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.549 HD23 HG11 ' A' ' 9' ' ' VAL . 5.1 mp -113.76 160.34 18.78 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.392 -1.404 . . . . 0.31 109.871 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.0 m -136.02 135.36 39.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.901 -0.591 . . . . 0.39000000000000001 110.231 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.12 129.98 18.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.438 0.637 . . . . 0.46999999999999997 112.451 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.99 -13.03 46.54 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.804 -1.089 . . . . 0.35999999999999999 112.534 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.613 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -64.34 152.71 40.53 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.507 0.67 . . . . 1.1899999999999999 110.288 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 45.8 m -117.81 132.32 56.46 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.741 -1.118 . . . . 0.89000000000000001 109.512 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.693 HD12 HD11 ' A' ' 29' ' ' LEU . 17.4 pt -135.77 155.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.354 0.597 . . . . 0.22 110.633 -175.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.594 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.5 t -100.08 149.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.0 -1.0 . . . . 0.20999999999999999 110.189 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.548 ' CG1' HD23 ' A' ' 5' ' ' LEU . 18.0 mm -117.57 87.8 27.1 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 0.17000000000000001 108.257 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.742 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.4 Cg_endo -57.89 143.45 95.83 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.303 2.669 . . . . 0.23000000000000001 112.937 -173.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.485 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.2 -7.22 60.96 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.667 -0.697 . . . . 0.29999999999999999 113.07 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.9 tt -116.15 126.47 27.6 Favored Pre-proline 0 C--O 1.219 -0.539 0 N-CA-C 108.457 -0.942 . . . . 0.25 108.457 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD2' HD23 ' A' ' 51' ' ' LEU . 60.1 Cg_endo -66.45 174.88 5.67 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.72 2.947 . . . . 0.31 113.618 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.753 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.9 t70 -89.63 141.75 28.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.71999999999999997 110.355 -172.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.511 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 90.2 Cg_endo -82.49 -3.88 11.48 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.423 2.749 . . . . 0.27000000000000002 112.169 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.68 -25.44 16.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 2.1099999999999999 110.14 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.753 HG23 ' HB3' ' A' ' 53' ' ' ASP . 22.7 p -74.05 -28.32 61.35 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.737 -1.208 . . . . 1.47 107.737 171.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.798 HD13 ' HG2' ' A' ' 158' ' ' PRO . 97.0 mt -80.93 128.6 70.78 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 113.234 -1.803 . . . . 0.26000000000000001 109.659 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -103.6 96.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.942 0 CA-C-N 120.1 1.071 . . . . 0.20000000000000001 110.681 166.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HD2' HG23 ' A' ' 57' ' ' ILE . 80.3 m-85 -157.7 132.81 8.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.587 -1.264 . . . . 0.26000000000000001 107.587 172.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.585 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 2.7 m-70 -139.08 104.98 5.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.483 -1.302 . . . . 2.8399999999999999 107.483 -164.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.7 mt -96.35 114.4 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.722 -0.672 . . . . 0.32000000000000001 111.169 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.84 97.01 6.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.202 -0.908 . . . . 0.34000000000000002 110.808 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -120.79 100.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.396 -1.275 . . . . 0.68000000000000005 110.253 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.537 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.9 m -94.76 134.51 37.28 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.23 -0.895 . . . . 1.05 109.298 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.557 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 6.0 mm -59.39 -33.44 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.867 0.842 . . . . 1.29 109.433 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.33 40.97 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.314 -1.312 . . . . 0.88 112.068 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -68.16 -24.86 65.03 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.177 0.513 . . . . 0.73999999999999999 112.18 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 65' ' ' ILE . 26.8 mttt 55.74 16.94 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.295 1.038 . . . . 2.5099999999999998 113.544 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.98 142.37 31.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 0.45000000000000001 110.839 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.516 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.2 tt -96.37 120.25 36.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.467 -1.242 . . . . 0.33000000000000002 109.658 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 m -101.12 122.34 43.42 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.078 -0.649 . . . . 0.40000000000000002 111.019 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.549 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.44 131.76 35.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 106.22 -1.77 . . . . 0.33000000000000002 106.22 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -137.28 126.89 25.24 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.677 1.581 . . . . 0.75 112.703 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -113.06 126.22 55.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.089 -0.959 . . . . 0.34999999999999998 110.288 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 66.86 35.31 4.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.499 0.666 . . . . 0.52000000000000002 109.326 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.4 t30 75.7 -0.28 3.23 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.215 -1.357 . . . . 1.8400000000000001 112.21 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -128.93 140.6 51.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.125 -1.43 . . . . 3.1899999999999999 113.944 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -56.14 148.09 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 113.41 -1.723 . . . . 0.40999999999999998 113.371 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.549 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -96.94 -46.42 6.22 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.013 -2.358 . . . . 0.34999999999999998 107.594 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 21.0 tptp -178.77 155.68 0.81 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.397 -2.183 . . . . 2.0699999999999998 110.462 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -111.48 131.57 55.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.483 -0.192 . . . . 0.37 110.483 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.85 135.85 24.5 Favored Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.96999999999999997 111.6 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -64.04 140.96 74.88 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.272 2.648 . . . . 0.59999999999999998 112.613 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 -179.64 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.803 -0.814 . . . . 0.64000000000000001 108.803 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.083 0.468 . . . . 0.82999999999999996 110.662 175.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 163' ' ' VAL . 2.4 m-85 . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 108.181 -1.044 . . . . 1.9299999999999999 108.181 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.5 m-85 -136.31 138.68 41.96 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.213 -0.595 . . . . 0.57999999999999996 111.639 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.73 HD11 HD12 ' A' ' 125' ' ' ILE . 26.8 mm -59.93 106.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.19 -1.411 . . . . 0.40999999999999998 107.19 163.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.694 HD11 ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -94.87 -24.03 4.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.829 -0.749 . . . . 0.37 111.587 -176.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -172.01 -174.75 1.35 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 122.784 1.278 . . . . 1.99 114.227 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.504 ' NH1' ' HA ' ' A' ' 155' ' ' SER . 2.8 ptt180 -149.9 137.7 20.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 111.374 -2.648 . . . . 1.1899999999999999 110.575 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.642 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 29.2 tp60 -105.83 144.37 32.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.842 -1.072 . . . . 1.6699999999999999 110.386 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.576 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 23.8 ttm180 -53.37 155.28 2.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.748 -2.024 . . . . 3.0600000000000001 112.085 172.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.576 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.4 109.87 1.1 Allowed Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 114.955 -1.021 . . . . 2.6099999999999999 110.498 175.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.15 -52.07 5.58 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.325 2.683 . . . . 0.97999999999999998 111.958 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.33 -20.24 25.89 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.197 -0.91 . . . . 1.0800000000000001 112.168 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -115.27 -169.94 16.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.94 -0.648 . . . . 1.05 112.621 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.31 9.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 124.598 3.532 . . . . 1.3 114.557 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 115' ' ' TRP . 3.8 t80 -62.27 -27.37 68.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.421 0.629 . . . . 1.3799999999999999 109.959 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.78 55.36 0.94 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.1100000000000001 114.427 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 73.38 -46.98 0.65 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.389 1.255 . . . . 0.81000000000000005 114.389 166.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.567 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -151.84 147.06 26.17 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 122.638 0.375 . . . . 1.1200000000000001 110.445 -174.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.642 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 47.0 t-105 -118.56 102.58 9.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.975 -0.38 . . . . 2.1899999999999999 109.975 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -107.45 139.78 41.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.561 0.696 . . . . 0.60999999999999999 110.222 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 101' ' ' ILE . 58.3 m -107.66 148.52 29.26 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.51 0.93 . . . . 0.93999999999999995 113.51 -168.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.48 HD22 HG11 ' A' ' 163' ' ' VAL . 70.4 mt -103.09 -172.62 2.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.416 -1.266 . . . . 1.0800000000000001 107.981 173.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 p . . . . . 0 C--N 1.324 -0.521 0 C-N-CA 119.422 -0.911 . . . . 1.5 110.244 173.347 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 100' ' ' ILE . 20.4 mt . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.085 -0.709 . . . . 0.47999999999999998 109.085 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -145.45 -163.15 1.66 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.283 -0.567 . . . . 1.25 111.117 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.55 173.76 16.1 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.171 -1.014 . . . . 0.46000000000000002 113.016 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -137.21 174.68 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.432 0.634 . . . . 0.5 111.375 -167.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -104.44 -17.87 14.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.199 -0.909 . . . . 1.8600000000000001 109.604 165.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -125.39 103.08 29.36 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.827 -0.624 . . . . 1.77 110.238 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.53 4.43 4.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.203 2.602 . . . . 0.58999999999999997 113.545 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.49 -22.66 54.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.189 0.519 . . . . 0.78000000000000003 110.818 -171.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -88.28 -6.56 57.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 1.45 110.303 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 134' ' ' ILE . 30.4 mm . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.663 0.744 . . . . 0.69999999999999996 110.176 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.428 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 7.8 ptm . . . . . 0 C--O 1.232 0.177 0 N-CA-C 111.858 0.318 . . . . 1.1299999999999999 111.858 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -61.43 144.23 54.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.474 -0.33 . . . . 2.5099999999999998 110.156 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.563 ' O ' HG12 ' A' ' 150' ' ' VAL . 25.3 p-10 -51.98 -64.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.025 0.203 . . . . 1.77 111.536 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -62.68 -26.66 68.77 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.747 -0.596 . . . . 2.1299999999999999 111.462 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.47 -42.23 71.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.451 -0.341 . . . . 1.05 110.526 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.625 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.8 p -75.8 -17.44 15.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.32000000000000001 110.577 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.567 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -88.33 -37.99 11.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 119.289 -0.386 . . . . 0.37 110.306 174.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -43.64 -70.23 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.078 0.854 . . . . 1.3799999999999999 111.954 161.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.664 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.0 OUTLIER -50.03 -41.2 47.01 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.465 -0.789 . . . . 0.73999999999999999 110.29 178.248 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.41 -51.57 64.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.662 -1.154 . . . . 0.22 111.719 -173.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.504 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 14.9 m -77.94 -13.42 59.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.393 -1.276 . . . . 1.3300000000000001 111.387 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.48 -50.85 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.156 -0.474 . . . . 0.23000000000000001 110.08 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 153' ' ' LEU . 18.9 m -78.59 115.37 51.1 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-O 121.943 0.878 . . . . 0.20999999999999999 110.536 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.798 ' HG2' HD13 ' A' ' 57' ' ' ILE . 33.5 Cg_endo -84.6 -177.17 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.375 2.717 . . . . 0.34000000000000002 112.935 -174.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.616 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.5 m120 -56.09 -2.35 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.636 -1.165 . . . . 1.02 114.016 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.2 57.2 0.5 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.633 -0.794 . . . . 0.28000000000000003 112.477 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.4 m -92.16 133.14 36.06 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.018 -0.364 . . . . 0.29999999999999999 110.018 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.22 133.9 34.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.469 -0.492 . . . . 1.96 110.089 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -143.84 130.78 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 0.46000000000000002 111.234 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.402 ' C ' HD12 ' A' ' 165' ' ' ILE . 29.6 m -115.55 140.45 49.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.855 -0.612 . . . . 0.56000000000000005 111.647 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 164' ' ' THR . 2.9 mp -123.82 110.29 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 118.957 -1.097 . . . . 0.95999999999999996 110.217 171.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 114.897 -1.047 . . . . 1.1899999999999999 110.566 -172.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.543 -0.623 . . . . 2.9199999999999999 111.543 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -87.36 134.86 33.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.216 0.531 . . . . 4.0999999999999996 110.475 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' HD3' ' H ' ' A' ' 3' ' ' LYS . 3.1 mppt? -74.25 157.31 36.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.95 -1.023 . . . . 2.1000000000000001 111.114 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 49' ' ' PRO . 20.0 mt -85.2 168.26 14.94 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.721 0.638 . . . . 0.26000000000000001 110.958 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.869 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -76.87 149.48 36.11 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 123.273 0.629 . . . . 0.23000000000000001 112.57 -167.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.528 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.2 148.94 36.52 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.091 -0.959 . . . . 0.26000000000000001 111.427 167.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 45' ' ' SER . 74.3 t80 -134.42 148.43 50.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.705 -1.589 . . . . 0.39000000000000001 107.753 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.89 114.46 15.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.152 -1.425 . . . . 1.0700000000000001 107.152 175.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.442 HG11 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -77.51 158.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.801 -0.636 . . . . 0.38 111.262 -168.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -112.44 153.1 27.89 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.846 -0.798 . . . . 2.5899999999999999 108.846 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.676 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.24 116.18 1.91 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.64 -0.709 . . . . 1.74 112.396 -172.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.93 -11.57 20.51 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.476 -0.783 . . . . 0.56999999999999995 113.013 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.584 ' HB3' HD11 ' A' ' 18' ' ' ILE . 78.9 m-20 -63.13 153.97 32.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.633 0.605 . . . . 2.1699999999999999 112.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.551 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.4 p -134.05 155.0 50.79 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-N 115.858 -0.61 . . . . 0.5 112.385 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.585 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.3 tp -48.64 -58.99 3.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.68 0.992 . . . . 0.27000000000000002 113.68 -173.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.656 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.9 t-20 -65.25 -43.13 92.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.533 1.159 . . . . 1.21 110.164 -169.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.83 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 13.9 m -57.98 -43.13 86.36 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 112.381 -2.19 . . . . 1.24 110.484 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.584 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.51 -41.1 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 123.738 0.815 . . . . 0.29999999999999999 112.566 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.678 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.29 -64.41 0.87 Allowed 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.588 -0.278 . . . . 0.23000000000000001 111.388 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.27 -4.46 50.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.875 -1.13 . . . . 0.39000000000000001 111.843 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.83 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.8 t0 -65.54 -34.31 77.95 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.618 -0.882 . . . . 1.6299999999999999 108.618 157.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.673 ' CD1' HD12 ' A' ' 101' ' ' ILE . 1.9 m-85 -95.15 16.92 15.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.777 0.322 . . . . 0.23999999999999999 111.83 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 55.14 48.41 19.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.619 -0.719 . . . . 3.5499999999999998 110.552 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.678 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.1 pt -147.22 -176.34 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.526 -0.916 . . . . 0.27000000000000002 108.526 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -100.07 145.04 28.41 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.297 -0.865 . . . . 0.81000000000000005 109.374 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.656 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 13.5 p -60.75 -35.85 77.44 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.41 0.624 . . . . 0.27000000000000002 109.331 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.569 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.02 -32.71 74.14 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.488 -1.233 . . . . 0.26000000000000001 111.514 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -37.51 42.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.095 0.474 . . . . 0.23000000000000001 109.749 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 46' ' ' ILE . 18.3 tp -73.63 -19.25 60.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.499 -0.773 . . . . 0.17000000000000001 109.077 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.737 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.79 35.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.3 0.571 . . . . 0.19 111.419 172.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 64.9 mt-30 -57.04 -44.33 82.83 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.511 1.148 . . . . 1.0700000000000001 109.598 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.39 42.18 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.327 -1.76 . . . . 0.17000000000000001 112.37 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.614 HD21 ' H ' ' A' ' 47' ' ' VAL . 30.7 m-80 -143.28 72.56 17.97 Favored Pre-proline 0 CA--C 1.513 -0.466 0 CA-C-O 121.075 0.464 . . . . 0.19 110.014 -171.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.691 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.6 Cg_endo -57.87 -9.05 5.21 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.289 2.659 . . . . 0.29999999999999999 113.876 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -63.62 -33.54 75.83 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.073 0.939 . . . . 1.1699999999999999 109.363 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.646 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -80.97 -6.53 58.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.059 -1.428 . . . . 0.53000000000000003 114.508 -171.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.737 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.73 -40.64 41.39 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.634 1.207 . . . . 1.23 109.919 177.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.61 -46.36 11.61 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 112.755 -2.02 . . . . 0.40000000000000002 111.815 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -166.89 39.11 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.439 -0.886 . . . . 0.29999999999999999 114.163 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 18' ' ' ILE . 5.3 mp -113.98 158.97 20.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.67 -1.265 . . . . 0.31 110.214 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.623 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.05 135.32 39.31 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.905 -0.589 . . . . 0.39000000000000001 110.923 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.676 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.91 126.69 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.338 0.866 . . . . 0.46999999999999997 113.338 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.8 -10.52 51.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 114.539 -1.21 . . . . 0.35999999999999999 112.192 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.5 tt0 -64.28 152.31 41.4 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.572 0.701 . . . . 1.1899999999999999 110.552 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.7 m -118.47 134.74 54.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.452 -1.249 . . . . 0.89000000000000001 109.113 -172.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 HD11 ' A' ' 29' ' ' LEU . 22.2 pt -137.08 153.93 30.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.213 0.53 . . . . 0.22 110.508 -175.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.614 ' H ' HD21 ' A' ' 33' ' ' ASN . 11.4 t -98.81 148.99 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.292 -0.867 . . . . 0.20999999999999999 110.407 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.5 mm -118.16 88.09 31.2 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 114.903 -1.044 . . . . 0.17000000000000001 108.356 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.703 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.7 Cg_endo -60.04 140.59 93.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.095 2.53 . . . . 0.23000000000000001 112.43 -174.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.534 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.01 -7.79 69.43 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.636 -0.711 . . . . 0.29999999999999999 112.528 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.759 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.63 128.67 25.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.487 -0.931 . . . . 0.25 108.487 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.655 ' HD2' HD23 ' A' ' 51' ' ' LEU . 71.8 Cg_endo -69.36 169.24 18.86 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.695 2.93 . . . . 0.31 114.241 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 3.2 t70 -90.91 136.88 27.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.621 -1.172 . . . . 0.71999999999999997 111.603 -172.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.869 ' HD3' HD12 ' A' ' 5' ' ' LEU . 73.2 Cg_endo -76.74 -1.9 12.07 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.02 2.48 . . . . 0.27000000000000002 112.893 -173.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -96.13 -28.75 14.44 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 120.714 0.292 . . . . 2.1099999999999999 111.031 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 3' ' ' LYS . 34.7 p -65.19 -34.6 78.76 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.606 -1.257 . . . . 1.47 107.606 168.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.752 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.4 mt -78.15 126.37 83.65 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 113.053 -1.885 . . . . 0.26000000000000001 111.016 176.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.47 96.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 120.92 1.08 . . . . 0.20000000000000001 110.248 166.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.435 ' HD2' HG23 ' A' ' 57' ' ' ILE . 82.9 m-85 -158.87 136.77 10.39 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.463 -1.31 . . . . 0.26000000000000001 107.463 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 26.2 t-80 -141.75 108.18 5.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.603 -1.258 . . . . 2.8399999999999999 107.603 -169.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.0 mt -95.11 109.83 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.974 -1.012 . . . . 0.32000000000000001 110.317 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.53 95.42 5.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.181 -0.918 . . . . 0.34000000000000002 110.013 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.479 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -114.34 97.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.362 -1.29 . . . . 0.68000000000000005 109.325 177.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 32.0 m -92.05 130.37 37.8 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.898 -1.046 . . . . 1.05 108.584 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.558 HG21 ' NE ' ' A' ' 167' ' ' ARG . 9.9 mm -60.2 -34.96 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.768 0.794 . . . . 1.29 109.042 177.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.38 91.24 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.475 -1.238 . . . . 0.88 111.337 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.489 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.11 -24.35 64.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.265 0.555 . . . . 0.73999999999999999 112.217 176.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.643 ' HA ' HG21 ' A' ' 86' ' ' VAL . 30.4 mttt 55.39 18.06 2.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.159 0.984 . . . . 2.5099999999999998 112.798 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.518 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -141.26 140.58 33.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.78 0.8 . . . . 0.45000000000000001 110.982 175.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.479 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -94.06 117.58 30.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.267 -1.333 . . . . 0.33000000000000002 109.516 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 m -101.05 126.27 47.72 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.439 -0.504 . . . . 0.40000000000000002 111.189 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.559 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -82.74 147.73 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.126 -1.805 . . . . 0.33000000000000002 106.126 176.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 20.0 m -150.94 130.82 13.28 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 120.238 1.381 . . . . 0.75 112.329 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.9 tp -122.02 125.2 45.75 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.921 -1.036 . . . . 0.34999999999999998 110.697 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 66.06 35.14 6.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.539 0.685 . . . . 0.52000000000000002 109.321 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.3 m120 82.19 2.0 1.33 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.183 -1.371 . . . . 1.8400000000000001 111.719 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -131.52 140.46 49.52 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 118.756 -1.178 . . . . 3.1899999999999999 113.623 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.4 148.28 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-N 113.017 -1.901 . . . . 0.40999999999999998 112.788 -177.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.55 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.3 mtp -98.51 -42.74 7.17 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 112.734 -2.03 . . . . 0.34999999999999998 108.275 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 179.32 159.47 0.67 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.226 -2.261 . . . . 2.0699999999999998 110.135 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.518 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 11.8 m -119.14 133.26 55.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.588 0.232 . . . . 0.37 111.238 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 48.6 m-85 -117.38 145.44 36.09 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.538 -0.541 . . . . 0.96999999999999997 109.538 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.44 ' HB2' HG22 ' A' ' 134' ' ' ILE . 10.2 Cg_endo -82.09 144.34 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.308 2.005 . . . . 0.59999999999999998 111.722 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.45 173.27 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.675 -0.491 . . . . 0.64000000000000001 109.675 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.541 ' HB3' ' H ' ' A' ' 142' ' ' CYS . . . -86.3 118.63 25.86 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.38 0.61 . . . . 0.82999999999999996 110.966 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 68' ' ' LYS . 1.3 t -111.18 -47.34 6.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.735 -1.121 . . . . 1.6699999999999999 110.444 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.34 -173.42 15.31 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.663 -0.699 . . . . 3.0800000000000001 111.471 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -118.12 -18.2 9.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.01 0.433 . . . . 7.2599999999999998 110.118 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.4 tt -158.19 71.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 122.192 0.996 . . . . 6.29 109.674 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.4 tp -134.57 100.85 4.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.442 -0.799 . . . . 7.2699999999999996 110.2 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' A' ' 92' ' ' GLN . 17.3 p -96.99 -154.96 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.057 -0.52 . . . . 5.1799999999999997 111.451 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' H ' ' HB ' ' A' ' 91' ' ' THR . 0.0 OUTLIER 73.01 98.32 0.07 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.328 0.651 . . . . 4.8099999999999996 109.778 -178.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 167' ' ' ARG . 16.5 p -75.39 113.11 22.65 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.22 -0.446 . . . . 2.1099999999999999 111.129 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HD3' HH11 ' A' ' 167' ' ' ARG . 6.2 Cg_exo -74.46 91.48 0.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.283 1.988 . . . . 3.21 110.923 175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 p -76.05 70.3 2.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.584 0.707 . . . . 3.5899999999999999 111.576 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.09 165.39 30.28 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.44 -0.8 . . . . 2.1000000000000001 111.323 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.82 145.87 44.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.058 0.456 . . . . 2.2999999999999998 110.329 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.566 ' HB2' HG13 ' A' ' 163' ' ' VAL . 4.4 m-85 -120.67 170.48 9.39 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.841 -1.17 . . . . 1.9299999999999999 107.841 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 161' ' ' THR . 60.6 m-85 -130.67 140.49 50.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.113 0.482 . . . . 0.57999999999999996 110.879 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.837 HD11 HD12 ' A' ' 125' ' ' ILE . 19.0 mm -59.76 104.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.194 -1.039 . . . . 0.40999999999999998 108.194 166.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.673 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.5 tt -103.01 -24.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 C-N-CA 120.221 -0.592 . . . . 0.37 112.191 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 6.5 t-20 -155.23 157.73 37.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 114.133 1.16 . . . . 1.99 114.133 -172.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.31 133.73 26.47 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 111.767 -2.47 . . . . 1.1899999999999999 110.262 173.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 33.5 tp60 -106.27 141.79 37.02 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.069 -0.969 . . . . 1.6699999999999999 111.386 -173.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.515 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 17.7 ttt180 -54.69 150.76 9.11 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.075 -1.875 . . . . 3.0600000000000001 112.434 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -45.19 100.36 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.507 0 O-C-N 124.931 1.395 . . . . 2.6099999999999999 111.58 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -55.37 -50.02 14.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.886 3.058 . . . . 0.97999999999999998 112.242 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.26 -13.16 23.71 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.02 -0.991 . . . . 1.0800000000000001 112.256 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.75 -170.44 13.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.829 -0.7 . . . . 1.05 112.773 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.64 18.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 124.69 3.593 . . . . 1.3 114.61 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 115' ' ' TRP . 1.4 t80 -72.36 -16.13 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.256 0.55 . . . . 1.3799999999999999 109.655 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.88 42.71 2.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 1.1100000000000001 114.061 170.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 114' ' ' TYR . . . 73.59 -39.05 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.307 0.854 . . . . 0.81000000000000005 113.307 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -151.55 144.79 24.69 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 122.719 0.408 . . . . 1.1200000000000001 109.93 -174.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 47.8 t-105 -117.07 104.44 11.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.873 -0.417 . . . . 2.1899999999999999 109.873 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.3 mp -105.95 137.1 44.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.546 0.688 . . . . 0.60999999999999999 110.707 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.1 m -105.09 145.18 30.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.334 -0.848 . . . . 0.93999999999999995 112.266 -170.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.517 HD11 HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -96.53 -174.67 3.1 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.907 -1.146 . . . . 1.0800000000000001 107.907 171.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.556 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 33.7 m -106.66 3.38 26.73 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.764 1.024 . . . . 1.5 113.764 -172.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -130.93 98.7 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.127 -1.029 . . . . 2.9700000000000002 112.908 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.483 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 96.9 mt-30 45.08 -107.04 0.12 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.444 1.276 . . . . 5.0599999999999996 114.444 171.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -91.8 49.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.349 0.595 . . . . 5.9500000000000002 111.438 -167.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.499 ' HB3' HD23 ' A' ' 118' ' ' LEU . 68.8 m-85 -136.54 130.93 33.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.854 -0.612 . . . . 4.8300000000000001 110.107 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -155.09 156.73 27.13 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.971 -0.633 . . . . 0.94999999999999996 111.724 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 HD11 ' A' ' 100' ' ' ILE . 40.0 mt -109.0 112.32 39.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.976 -0.75 . . . . 0.47999999999999998 108.976 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 8.9 p80 -140.93 -167.65 2.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.752 0.787 . . . . 1.25 112.65 -172.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.469 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.62 179.86 16.05 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.586 -1.188 . . . . 0.46000000000000002 113.221 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.1 t -144.65 174.6 10.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.49 0.662 . . . . 0.5 111.563 -165.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -110.85 -13.23 14.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.923 -1.035 . . . . 1.8600000000000001 109.557 162.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -124.39 101.6 34.13 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.72 -0.673 . . . . 1.77 109.633 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -92.22 3.6 3.82 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.213 2.609 . . . . 0.58999999999999997 113.682 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.07 -19.24 40.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.33 0.586 . . . . 0.78000000000000003 110.458 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -87.7 -7.12 57.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.57 -0.741 . . . . 1.45 110.223 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.539 HD11 ' HE ' ' A' ' 144' ' ' ARG . 13.4 mm -79.74 104.85 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.238 -0.892 . . . . 0.69999999999999996 111.369 -174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.41 -11.02 71.17 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.726 -1.125 . . . . 1.6799999999999999 112.153 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -127.52 12.25 6.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.134 0.42 . . . . 4.3899999999999997 112.134 -172.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.08 164.83 36.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.057 0.456 . . . . 3.9399999999999999 111.375 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.5 m -92.22 63.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 4.6799999999999997 111.016 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.3 m -79.98 50.7 1.24 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.96 -0.564 . . . . 5.6799999999999997 111.886 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt 37.26 47.02 0.64 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.507 1.123 . . . . 8.3000000000000007 113.415 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 57.48 63.7 5.06 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.995 -0.548 . . . . 3.8500000000000001 114.024 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.541 ' H ' ' HB3' ' A' ' 85' ' ' ALA . 89.3 m -108.48 126.64 53.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 2.5099999999999998 109.906 174.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 29.3 mt -96.21 73.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.6 0.714 . . . . 1.4399999999999999 109.565 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.539 ' HE ' HD11 ' A' ' 134' ' ' ILE . 40.1 ptt180 -129.59 151.88 49.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.482 -0.781 . . . . 3.3599999999999999 110.448 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.56 -162.32 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.784 -0.45 . . . . 1.1299999999999999 109.784 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.555 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 30.4 m-70 -66.84 152.69 45.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.251 -0.648 . . . . 2.5099999999999998 109.251 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.554 ' O ' HG12 ' A' ' 150' ' ' VAL . 1.9 m-20 -50.5 -61.55 2.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.302 0.376 . . . . 1.77 111.101 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.19 -28.54 70.12 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.89 -0.506 . . . . 2.1299999999999999 111.63 -175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 1.5 m-20 -67.12 -41.96 85.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 1.05 110.777 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.5 p -77.03 -16.38 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.32000000000000001 110.716 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -89.15 -39.68 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 119.109 -0.472 . . . . 0.37 110.679 173.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -43.69 -68.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.402 1.001 . . . . 1.3799999999999999 111.825 163.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -49.96 -43.11 49.9 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 115.638 -0.71 . . . . 0.73999999999999999 110.271 177.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.16 -52.8 60.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.406 -1.27 . . . . 0.22 112.25 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.8 p -77.44 -15.94 59.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.548 -1.206 . . . . 1.3300000000000001 111.214 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.5 -48.62 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.731 -0.47 . . . . 0.23000000000000001 109.731 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.8 m -77.48 118.87 74.85 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-O 121.946 0.879 . . . . 0.20999999999999999 110.559 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.752 ' HG2' HD13 ' A' ' 57' ' ' ILE . 35.3 Cg_endo -83.6 -177.85 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.177 2.585 . . . . 0.34000000000000002 112.533 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.759 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.0 m120 -61.56 3.84 0.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.977 -1.01 . . . . 1.02 113.52 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.94 58.13 0.46 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.28000000000000003 112.379 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.78 135.92 33.41 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 122.547 -0.384 . . . . 0.29999999999999999 110.452 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -83.88 125.51 32.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.79 -0.187 . . . . 1.96 110.546 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 98' ' ' PHE . 4.2 p -138.15 127.43 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.439 0.637 . . . . 0.46000000000000002 111.28 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.4 ' C ' HD12 ' A' ' 165' ' ' ILE . 31.7 m -118.22 140.36 49.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.654 -0.703 . . . . 0.56000000000000005 111.721 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.422 HG13 HG13 ' A' ' 63' ' ' VAL . 2.7 mp -122.17 110.25 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 118.919 -1.112 . . . . 0.95999999999999996 110.524 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.649 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.51 139.93 30.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.476 -0.784 . . . . 1.1899999999999999 111.354 -170.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.579 ' HB2' HG22 ' A' ' 93' ' ' THR . 5.4 mpt_? -77.81 -16.07 58.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.939 -1.028 . . . . 3.4199999999999999 110.912 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.69 -96.32 0.84 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.004 -0.617 . . . . 3.6499999999999999 112.377 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.478 -0.773 . . . . 5.9699999999999998 110.397 -177.341 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.596 ' H25' ' CH2' ' A' ' 115' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 111.912 -0.475 . . . . 2.9199999999999999 111.912 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 63.64 -173.63 0.16 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.462 0.649 . . . . 4.0999999999999996 111.46 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.5 mptp? -71.04 148.19 47.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.38 -0.827 . . . . 2.1000000000000001 109.632 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -99.4 170.81 8.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.425 -0.352 . . . . 0.26000000000000001 111.458 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.568 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.2 tp -77.86 150.95 34.1 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.334 0.654 . . . . 0.23000000000000001 112.358 -170.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.552 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.86 149.47 40.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.055 0.931 . . . . 0.26000000000000001 112.295 169.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.7 t80 -133.1 147.73 52.15 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 113.595 -1.639 . . . . 0.39000000000000001 107.596 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.68 113.65 16.3 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.036 -1.468 . . . . 1.0700000000000001 107.036 175.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -73.48 156.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.066 0.46 . . . . 0.38 111.89 -166.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -104.96 146.71 28.66 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.491 -0.777 . . . . 2.5899999999999999 109.23 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.931 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 3.2 tt0 -50.55 106.18 0.12 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.846 -1.07 . . . . 1.74 112.894 -173.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.15 15.17 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.407 -0.815 . . . . 0.56999999999999995 112.812 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.591 ' HB3' HD11 ' A' ' 18' ' ' ILE . 17.3 m-20 -62.36 154.57 27.64 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.345 0.498 . . . . 2.1699999999999999 112.345 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.611 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -131.64 155.37 47.69 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.008 0.433 . . . . 0.5 111.989 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.7 tp -49.03 -60.12 3.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.098 1.147 . . . . 0.27000000000000002 114.098 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.727 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 3.1 t-20 -65.21 -38.72 91.3 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 122.011 0.91 . . . . 1.21 110.572 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 t -58.61 -50.36 74.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 113.154 -1.839 . . . . 1.24 109.19 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -67.72 -38.48 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 O-C-N 123.584 0.553 . . . . 0.29999999999999999 111.975 -173.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.48 -60.16 4.07 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 110.994 175.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.79 58.57 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.67 -1.212 . . . . 0.39000000000000001 112.15 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 11.3 m-20 -62.61 -34.33 76.81 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.859 -1.163 . . . . 1.6299999999999999 107.859 156.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.694 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.3 m-85 -99.98 17.54 20.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.396 0.517 . . . . 0.23999999999999999 112.396 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 50.44 53.77 12.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 3.5499999999999998 111.13 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.1 pt -147.77 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.045 -0.724 . . . . 0.27000000000000002 109.045 -173.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -98.78 144.17 28.31 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.333 -0.849 . . . . 0.81000000000000005 109.57 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.727 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.9 p -62.89 -37.15 85.79 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.564 0.697 . . . . 0.27000000000000002 109.21 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.14 -27.89 69.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.104 -1.407 . . . . 0.26000000000000001 111.343 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.89 -37.52 26.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.231 0.538 . . . . 0.23000000000000001 109.862 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 HD12 ' A' ' 46' ' ' ILE . 14.3 tp -73.8 -19.83 60.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.205 -0.907 . . . . 0.17000000000000001 109.009 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.747 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.98 -37.74 38.65 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.332 0.586 . . . . 0.19 111.235 172.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.5 mt-30 -56.89 -42.85 80.62 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.25 1.024 . . . . 1.0700000000000001 109.686 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.65 -20.58 35.99 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.536 -1.666 . . . . 0.17000000000000001 112.523 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 31.7 m-80 -142.04 72.16 23.09 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.009 0.433 . . . . 0.19 109.994 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.6 -9.36 5.27 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 123.586 2.857 . . . . 0.29999999999999999 113.954 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -63.78 -33.63 76.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.028 0.918 . . . . 1.1699999999999999 109.845 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -80.6 -4.75 55.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.206 -1.361 . . . . 0.53000000000000003 114.46 -171.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.747 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -50.52 -39.41 48.69 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 122.561 1.172 . . . . 1.23 110.035 -177.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.535 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -86.57 -45.87 10.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 112.921 -1.945 . . . . 0.40000000000000002 111.523 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 176.08 -167.55 39.3 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.155 -1.021 . . . . 0.29999999999999999 114.295 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 18' ' ' ILE . 6.3 mp -115.86 157.92 23.73 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.511 -1.345 . . . . 0.31 110.571 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 48.8 m -130.34 134.74 47.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.74 -0.664 . . . . 0.39000000000000001 110.394 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.931 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.99 129.95 17.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.98 0.733 . . . . 0.46999999999999997 112.98 173.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 -13.82 35.89 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 114.792 -1.095 . . . . 0.35999999999999999 112.054 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.64 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.2 tt0 -63.02 152.38 37.07 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.744 0.783 . . . . 1.1899999999999999 110.323 175.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 31.1 m -119.42 131.88 55.72 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.365 -1.289 . . . . 0.89000000000000001 109.403 -171.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.691 HD12 HD11 ' A' ' 29' ' ' LEU . 23.0 pt -133.46 155.82 40.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.248 0.547 . . . . 0.22 110.522 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.584 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.4 t -101.38 148.73 6.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.239 -0.891 . . . . 0.20999999999999999 110.176 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.528 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.8 mm -117.17 87.69 24.52 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.767 -1.106 . . . . 0.17000000000000001 108.099 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.692 ' HA ' HD13 ' A' ' 4' ' ' LEU . 21.7 Cg_endo -58.63 145.82 93.94 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.387 2.725 . . . . 0.23000000000000001 112.627 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.475 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 78.61 -6.16 54.33 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.911 -0.586 . . . . 0.29999999999999999 112.831 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.72 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -116.06 125.41 28.62 Favored Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 108.707 -0.849 . . . . 0.25 108.707 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HD2' HD23 ' A' ' 51' ' ' LEU . 55.6 Cg_endo -64.92 174.2 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.616 2.878 . . . . 0.31 113.752 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 1.8 t70 -91.13 140.43 25.87 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 114.88 -1.054 . . . . 0.71999999999999997 111.686 -170.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.568 ' HD3' HD12 ' A' ' 5' ' ' LEU . 63.0 Cg_endo -84.09 -7.58 10.12 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.316 2.677 . . . . 0.27000000000000002 113.474 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.65 -29.27 17.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.924 0.392 . . . . 2.1099999999999999 110.437 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -80.69 -13.73 58.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.749 0.785 . . . . 1.47 109.02 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.794 HD13 ' HG2' ' A' ' 158' ' ' PRO . 66.8 mt -85.91 126.95 64.18 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 114.679 -1.146 . . . . 0.26000000000000001 109.839 171.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -101.61 94.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.948 0 CA-C-N 119.972 1.026 . . . . 0.20000000000000001 110.659 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.803 ' HA ' ' O ' ' A' ' 73' ' ' SER . 92.6 m-85 -158.56 139.65 13.09 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.981 -1.463 . . . . 0.26000000000000001 107.236 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 55.9 m-70 -139.19 117.77 12.18 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.916 -1.513 . . . . 2.8399999999999999 106.916 -176.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 79.6 mt -98.88 109.34 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.085 -0.646 . . . . 0.32000000000000001 110.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.65 98.94 7.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.918 0.865 . . . . 0.34000000000000002 110.896 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.3 p -121.01 98.44 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.012 -1.449 . . . . 0.68000000000000005 110.606 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 68' ' ' LYS . 68.8 m -92.03 115.49 28.12 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.419 -1.326 . . . . 1.05 107.419 170.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.807 ' CG2' ' HB2' ' A' ' 167' ' ' ARG . 16.4 mt -54.05 -26.0 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-O 121.122 0.487 . . . . 1.29 110.167 172.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' CA ' ' HD3' ' A' ' 88' ' ' LYS . . . -66.58 -48.43 62.64 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.795 -0.717 . . . . 0.88 112.237 169.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.34 -22.48 66.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.451 0.643 . . . . 0.73999999999999999 110.849 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.839 ' HA ' HG11 ' A' ' 86' ' ' VAL . 9.0 tmtt? 64.35 11.03 6.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.6 -1.182 . . . . 2.5099999999999998 112.603 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.471 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -145.12 143.43 30.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.591 0.71 . . . . 0.45000000000000001 112.183 176.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.526 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.8 tt -95.72 122.27 38.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.197 -1.365 . . . . 0.33000000000000002 109.952 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.26 125.74 50.07 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.487 -0.485 . . . . 0.40000000000000002 111.61 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.555 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.21 150.62 26.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.426 -1.694 . . . . 0.33000000000000002 106.426 175.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.803 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 1.4 m -150.84 128.5 11.55 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 120.335 1.425 . . . . 0.75 111.786 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.0 tp -115.01 126.91 55.29 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.496 -0.775 . . . . 0.34999999999999998 110.222 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.58 35.29 11.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.392 0.615 . . . . 0.52000000000000002 109.666 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.39 7.77 5.17 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.02 -0.991 . . . . 1.8400000000000001 112.367 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -129.89 138.26 50.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.755 -1.178 . . . . 3.1899999999999999 113.649 170.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.71 150.06 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 113.551 -1.659 . . . . 0.40999999999999998 112.963 -172.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.531 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 3.6 mtp -103.36 -41.15 6.11 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.745 -2.025 . . . . 0.34999999999999998 108.476 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 2.8 tppt? -175.29 170.28 3.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 112.868 -1.969 . . . . 2.0699999999999998 111.1 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.471 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 16.0 m -131.02 129.42 42.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.684 -0.235 . . . . 0.37 110.93 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.77 150.43 44.86 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 122.32 0.248 . . . . 0.96999999999999997 110.948 -175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -84.92 141.07 8.23 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.838 2.359 . . . . 0.59999999999999998 112.1 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.46 -177.12 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.057 -0.519 . . . . 0.64000000000000001 110.412 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.66 ' HB3' ' H ' ' A' ' 142' ' ' CYS . . . -84.66 138.9 32.41 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.82999999999999996 109.617 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.839 HG11 ' HA ' ' A' ' 68' ' ' LYS . 17.0 m -143.7 -163.8 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.844 0.683 . . . . 1.6699999999999999 112.844 -165.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 86' ' ' VAL . . . 146.3 92.76 0.12 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.81 -0.916 . . . . 3.0800000000000001 110.81 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.51 ' HD3' ' CA ' ' A' ' 66' ' ' GLY . 32.3 ttpt -98.26 -72.46 0.65 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.134 0.42 . . . . 7.2599999999999998 112.134 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.475 HG22 ' HG ' ' A' ' 90' ' ' LEU . 3.8 mp 65.2 -84.63 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.219 0.608 . . . . 6.29 111.921 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 89' ' ' ILE . 71.5 mt -126.77 -106.3 0.32 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.289 0.848 . . . . 7.2699999999999996 113.289 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 91.4 m -147.46 134.62 20.48 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.503 0.557 . . . . 5.1799999999999997 112.503 -171.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -178.13 -66.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.172 0.589 . . . . 4.8099999999999996 110.183 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.758 HG22 ' H ' ' A' ' 167' ' ' ARG . 45.5 p 51.76 89.47 0.1 OUTLIER Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 123.869 0.867 . . . . 2.1099999999999999 113.295 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -72.2 63.25 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.523 2.149 . . . . 3.21 109.846 167.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.5 m -58.01 109.29 0.71 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.002 -0.999 . . . . 3.5899999999999999 112.247 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.07 108.08 2.65 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.308 -1.117 . . . . 2.1000000000000001 110.308 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -77.02 124.74 28.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.397 0.618 . . . . 2.2999999999999998 109.917 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 163' ' ' VAL . 19.6 m-85 -124.44 172.47 9.14 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.989 -1.005 . . . . 1.9299999999999999 110.531 -176.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' THR . 65.2 m-85 -131.46 141.26 49.76 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.255 -0.884 . . . . 0.57999999999999996 109.969 172.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 125' ' ' ILE . 24.0 mm -59.87 114.36 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 N-CA-C 107.47 -1.307 . . . . 0.40999999999999998 107.47 165.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.59 HD12 ' HD1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -106.91 -27.41 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.551 -0.86 . . . . 0.37 112.018 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.578 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 60.0 t30 -172.41 -172.64 0.95 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 122.663 1.22 . . . . 1.99 113.481 -175.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.578 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.3 ptt180 -155.45 131.71 10.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 111.693 -2.503 . . . . 1.1899999999999999 109.711 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.74 157.34 17.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 122.58 1.181 . . . . 1.6699999999999999 112.227 -171.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.412 ' CG ' ' N ' ' A' ' 106' ' ' ASN . 37.0 ttt180 -53.93 154.78 3.81 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 112.485 -2.143 . . . . 3.0600000000000001 112.473 170.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 105' ' ' ARG . 9.3 p30 -44.03 105.72 0.46 Allowed Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 112.925 -1.943 . . . . 2.6099999999999999 111.346 175.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 88.7 Cg_exo -56.75 -53.31 5.26 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.653 2.902 . . . . 0.97999999999999998 112.309 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.62 37.68 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.206 -0.906 . . . . 1.0800000000000001 112.599 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.85 -170.37 24.36 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.915 -0.66 . . . . 1.05 111.89 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.15 49.56 0.34 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.992 3.128 . . . . 1.3 113.127 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.441 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -93.85 -21.1 19.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.059 0.456 . . . . 1.3799999999999999 110.026 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.54 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 46.62 2.04 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.53 -0.759 . . . . 1.1100000000000001 113.986 170.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.62 -24.53 0.21 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.192 0.812 . . . . 0.81000000000000005 113.192 170.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -154.43 151.33 28.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.261 -0.274 . . . . 1.1200000000000001 110.261 179.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -118.02 100.25 7.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.788 -0.819 . . . . 2.1899999999999999 108.788 165.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.5 mp -101.85 139.24 37.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.801 0.81 . . . . 0.60999999999999999 110.32 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.401 ' HB2' HG23 ' A' ' 101' ' ' ILE . 68.0 m -106.68 144.96 32.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.916 -1.038 . . . . 0.93999999999999995 112.378 -168.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.574 HD22 HG11 ' A' ' 163' ' ' VAL . 73.0 mt -102.24 -176.84 3.23 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.648 -1.16 . . . . 1.0800000000000001 108.464 173.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 49.6 m -76.61 2.58 13.64 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.803 0.297 . . . . 1.5 111.803 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 11.9 tptt -128.36 146.89 50.64 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.599 -0.519 . . . . 2.9700000000000002 109.599 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.409 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 12.0 pt20 -84.53 2.33 41.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.679 0.276 . . . . 5.0599999999999996 111.013 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -89.15 -29.31 19.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.783 0.325 . . . . 5.9500000000000002 110.887 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -128.85 146.71 50.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.406 -0.361 . . . . 4.8300000000000001 110.736 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.36 150.77 22.45 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.095 -0.574 . . . . 0.94999999999999996 111.69 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.789 HD12 HD11 ' A' ' 100' ' ' ILE . 23.1 mt -93.19 115.07 31.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.254 -0.647 . . . . 0.47999999999999998 109.254 176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.532 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 7.9 p80 -153.51 -162.22 1.42 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.405 0.621 . . . . 1.25 111.498 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.54 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.63 179.57 16.38 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.158 -1.02 . . . . 0.46000000000000002 112.779 -175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -135.13 174.83 10.18 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.453 0.644 . . . . 0.5 111.185 -167.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -107.74 -23.0 12.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.92 -1.036 . . . . 1.8600000000000001 108.994 168.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.41 104.63 28.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 114.756 -1.111 . . . . 1.77 109.616 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.418 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.8 Cg_endo -89.97 4.5 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.213 2.609 . . . . 0.58999999999999997 113.185 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.84 -21.91 29.65 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.389 0.614 . . . . 0.78000000000000003 109.453 -175.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.2 t -76.76 -18.18 58.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.079 -0.964 . . . . 1.45 109.317 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 144' ' ' ARG . 23.4 mm -70.92 106.17 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.096 -0.957 . . . . 0.69999999999999996 110.275 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 135.18 -135.29 7.8 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.667 -0.778 . . . . 1.6799999999999999 112.464 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -86.46 4.33 40.14 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.728 0.27 . . . . 4.3899999999999997 111.728 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.7 -55.5 26.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.702 0.287 . . . . 3.9399999999999999 111.272 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.52 155.37 8.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.181 -0.463 . . . . 4.6799999999999997 109.932 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 14.7 p -84.0 -143.49 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.199 -0.455 . . . . 5.6799999999999997 111.02 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 139' ' ' SER . 4.2 mptp? 69.44 114.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.167 0.587 . . . . 8.3000000000000007 110.416 -174.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.54 96.85 0.03 OUTLIER Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.934 -0.576 . . . . 3.8500000000000001 113.457 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.66 ' H ' ' HB3' ' A' ' 85' ' ' ALA . 77.7 m -128.53 105.48 8.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.109 0.48 . . . . 2.5099999999999998 110.388 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.491 HG21 HG12 ' A' ' 125' ' ' ILE . 13.8 mt -95.13 79.91 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.416 0.627 . . . . 1.4399999999999999 110.08 -175.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 81.7 mtm180 -128.67 150.29 50.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.407 -0.815 . . . . 3.3599999999999999 110.523 -175.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.9 mtp -145.26 -165.68 2.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.37 -0.377 . . . . 1.1299999999999999 110.581 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -78.4 161.46 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.106 -0.701 . . . . 2.5099999999999998 109.106 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.633 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.5 m-20 -52.42 -68.13 0.19 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.398 0.436 . . . . 1.77 110.987 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -58.12 -30.89 66.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.098 0.407 . . . . 2.1299999999999999 112.098 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -67.07 -41.5 86.31 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.906 0.384 . . . . 1.05 110.975 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 7.3 p -78.38 -15.27 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 0.32000000000000001 110.637 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.467 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.7 mp -87.39 -41.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 118.749 -0.643 . . . . 0.37 110.414 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -44.36 -68.72 0.17 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.543 1.065 . . . . 1.3799999999999999 112.244 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.687 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.8 OUTLIER -49.94 -43.46 49.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.927 -0.579 . . . . 0.73999999999999999 110.169 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.17 -54.66 32.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.074 -1.421 . . . . 0.22 111.929 -171.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -79.95 -14.4 58.63 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.574 -1.194 . . . . 1.3300000000000001 110.779 -170.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.65 -48.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.987 -0.375 . . . . 0.23000000000000001 109.987 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 153' ' ' LEU . 23.1 m -76.33 119.35 76.93 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-O 121.672 0.748 . . . . 0.20999999999999999 110.294 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.794 ' HG2' HD13 ' A' ' 57' ' ' ILE . 43.8 Cg_endo -83.1 -178.07 3.63 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.154 2.569 . . . . 0.34000000000000002 112.872 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.72 ' O ' HD21 ' A' ' 51' ' ' LEU . 21.6 m120 -61.44 0.06 0.34 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.104 -0.953 . . . . 1.02 113.142 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.84 58.02 0.52 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.767 -0.73 . . . . 0.28000000000000003 112.519 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.5 m -95.26 133.98 38.54 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.327 -0.513 . . . . 0.29999999999999999 110.206 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 162' ' ' ARG . 0.0 OUTLIER -84.7 134.17 34.36 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 1.96 110.353 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.574 HG11 HD22 ' A' ' 118' ' ' LEU . 2.4 p -140.57 123.73 16.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.024 -0.989 . . . . 0.46000000000000002 110.79 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.463 ' C ' HD12 ' A' ' 165' ' ' ILE . 93.0 m -118.09 141.57 48.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.494 -0.775 . . . . 0.56000000000000005 111.782 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.506 HG13 HG13 ' A' ' 63' ' ' VAL . 2.9 mp -125.13 123.31 65.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 118.845 -1.142 . . . . 0.95999999999999996 112.258 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.17 118.41 10.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.989 -1.115 . . . . 1.1899999999999999 107.989 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.807 ' HB2' ' CG2' ' A' ' 65' ' ' ILE . 2.0 ptt180 -99.0 -49.74 4.42 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 115.602 1.704 . . . . 3.4199999999999999 115.602 -169.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.674 ' N ' ' HG2' ' A' ' 167' ' ' ARG . . . 132.45 -141.65 13.03 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 108.589 -1.804 . . . . 3.6499999999999999 108.589 -161.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 89' ' ' ILE . 24.1 p . . . . . 0 C--O 1.252 1.19 0 CA-C-N 118.7 1.25 . . . . 5.9699999999999998 110.885 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.701 ' H41' H622 ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.975 -0.45 . . . . 2.9199999999999999 111.975 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.9 OUTLIER 63.81 -177.18 0.16 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.317 0.579 . . . . 4.0999999999999996 111.539 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.6 mptp? -71.87 142.87 49.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.532 -0.758 . . . . 2.1000000000000001 109.929 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -100.11 169.92 8.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.188 0.305 . . . . 0.26000000000000001 111.439 177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.587 HD23 HG13 ' A' ' 48' ' ' ILE . 4.6 tp -75.86 150.23 37.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 123.076 0.55 . . . . 0.23000000000000001 112.17 -170.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.515 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.38 149.26 38.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 122.11 0.957 . . . . 0.26000000000000001 111.921 167.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 45' ' ' SER . 67.8 t80 -132.84 149.41 52.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.538 -1.665 . . . . 0.39000000000000001 107.863 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.592 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.1 119.67 25.81 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.628 -1.619 . . . . 1.0700000000000001 106.628 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.448 HG11 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -79.99 158.56 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-O 121.227 0.537 . . . . 0.38 111.554 -170.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -110.16 155.44 21.95 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.554 -0.906 . . . . 2.5899999999999999 108.554 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.628 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 47.7 tt0 -52.53 122.34 8.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 1.74 112.14 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.99 -9.08 36.68 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.99 -1.004 . . . . 0.56999999999999995 112.724 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.68 ' HB3' HD11 ' A' ' 18' ' ' ILE . 94.7 m-20 -67.42 151.23 47.77 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.935 0.398 . . . . 2.1699999999999999 112.058 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.563 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 p -132.6 157.33 45.05 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 112.282 0.475 . . . . 0.5 112.282 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.579 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.9 tp -49.96 -59.75 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.95 1.092 . . . . 0.27000000000000002 113.95 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.4 t-20 -65.83 -38.3 88.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.298 1.047 . . . . 1.21 110.476 -168.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 t -57.09 -54.93 41.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 113.143 -1.844 . . . . 1.24 109.233 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.68 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.72 -38.76 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 115.531 -0.759 . . . . 0.29999999999999999 112.086 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.86 -63.73 1.11 Allowed 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 116.048 -0.523 . . . . 0.23000000000000001 111.279 177.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.66 -3.93 54.83 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.803 -1.159 . . . . 0.39000000000000001 112.011 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 23.6 m-20 -66.97 -27.34 67.37 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.81 -0.811 . . . . 1.6299999999999999 108.81 156.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.1 m-85 -103.07 18.31 21.99 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.861 -0.524 . . . . 0.23999999999999999 111.968 171.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 50.34 54.81 10.48 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.195 -0.911 . . . . 3.5499999999999998 110.918 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.1 pt -148.26 -173.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.597 -0.89 . . . . 0.27000000000000002 108.597 -173.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -100.96 143.63 30.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.29 -0.868 . . . . 0.81000000000000005 109.319 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.71 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 3.8 p -61.05 -35.27 76.48 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.453 0.645 . . . . 0.27000000000000002 109.503 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.94 -30.69 71.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.482 -1.236 . . . . 0.26000000000000001 111.396 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.78 30.5 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.224 0.535 . . . . 0.23000000000000001 109.631 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.674 HD11 HD12 ' A' ' 46' ' ' ILE . 15.0 tp -73.17 -19.3 61.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.417 -0.81 . . . . 0.17000000000000001 109.022 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.748 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.02 -38.61 36.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.315 0.578 . . . . 0.19 111.237 172.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 51.6 mt-30 -58.01 -42.52 85.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.227 1.013 . . . . 1.0700000000000001 109.727 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.69 -20.71 38.94 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 113.478 -1.692 . . . . 0.17000000000000001 112.489 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.708 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 30.9 m-80 -143.43 73.48 17.5 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.257 0.551 . . . . 0.19 109.949 -172.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.751 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.7 Cg_endo -57.36 -12.05 9.73 Favored 'Trans proline' 0 C--O 1.221 -0.372 0 C-N-CA 123.573 2.849 . . . . 0.29999999999999999 114.003 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -62.47 -34.23 76.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.106 0.955 . . . . 1.1699999999999999 109.119 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.3 mt -78.44 -6.7 56.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.117 -1.402 . . . . 0.53000000000000003 114.448 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -50.99 -42.55 60.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 120.019 1.281 . . . . 1.23 109.478 176.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.53 -46.84 15.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 112.894 -1.957 . . . . 0.40000000000000002 111.601 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.86 -164.4 35.81 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.264 -0.969 . . . . 0.29999999999999999 114.243 176.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' CD2' HG12 ' A' ' 18' ' ' ILE . 5.6 mp -116.85 158.96 23.11 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.274 -1.463 . . . . 0.31 109.905 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.597 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 93.2 m -136.53 135.63 38.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.912 -0.585 . . . . 0.39000000000000001 110.77 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.27 126.61 6.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.267 0.84 . . . . 0.46999999999999997 113.267 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.592 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.57 -12.52 46.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.588 -1.187 . . . . 0.35999999999999999 112.388 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.597 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.7 tt0 -63.2 152.08 38.54 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.597 0.713 . . . . 1.1899999999999999 110.455 175.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 49.9 m -119.87 132.27 55.51 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.668 -1.151 . . . . 0.89000000000000001 109.612 -171.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.674 HD12 HD11 ' A' ' 29' ' ' LEU . 18.9 pt -132.91 160.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.156 0.503 . . . . 0.22 110.319 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.708 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 21.7 t -107.05 148.45 11.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.221 -0.899 . . . . 0.20999999999999999 109.943 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.587 HG13 HD23 ' A' ' 5' ' ' LEU . 15.0 mm -116.66 88.5 25.02 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.957 -1.019 . . . . 0.17000000000000001 108.277 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.725 ' HA ' HD13 ' A' ' 4' ' ' LEU . 27.5 Cg_endo -59.3 142.66 99.43 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.304 2.669 . . . . 0.23000000000000001 113.02 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.479 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.29 -7.56 60.43 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.447 -0.797 . . . . 0.29999999999999999 112.9 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.722 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.48 126.15 28.06 Favored Pre-proline 0 C--O 1.218 -0.567 0 N-CA-C 108.936 -0.764 . . . . 0.25 108.936 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD23 ' A' ' 51' ' ' LEU . 48.8 Cg_endo -64.48 176.56 2.67 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.939 3.093 . . . . 0.31 114.198 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.761 ' HB3' HG22 ' A' ' 56' ' ' THR . 4.3 t70 -90.74 141.99 27.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.84 -1.073 . . . . 0.71999999999999997 110.646 -170.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.484 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 63.1 Cg_endo -86.81 -4.61 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.352 2.702 . . . . 0.27000000000000002 112.158 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -95.06 -28.67 14.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 2.1099999999999999 110.59 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.761 HG22 ' HB3' ' A' ' 53' ' ' ASP . 14.9 t -79.43 -14.1 59.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.024 -1.102 . . . . 1.47 108.024 172.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.8 HD13 ' HG2' ' A' ' 158' ' ' PRO . 71.8 mt -91.54 126.22 55.03 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.118 -1.401 . . . . 0.26000000000000001 109.77 170.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -103.13 95.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.146 0 CA-C-N 120.036 1.048 . . . . 0.20000000000000001 110.117 166.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.424 ' HD2' HG23 ' A' ' 57' ' ' ILE . 74.8 m-85 -158.96 138.66 11.78 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.645 -1.613 . . . . 0.26000000000000001 106.645 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.571 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 12.6 t60 -147.69 121.83 9.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 2.8399999999999999 108.147 -169.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.4 mt -103.39 111.13 31.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 114.643 -1.162 . . . . 0.32000000000000001 110.853 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.27 94.29 4.86 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.077 0.941 . . . . 0.34000000000000002 110.14 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -116.95 98.26 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 113.82 -1.537 . . . . 0.68000000000000005 109.819 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.507 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 38.7 m -90.19 113.13 24.86 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.672 -1.233 . . . . 1.05 107.672 175.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.67 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 2.6 mm -46.46 -37.49 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.845 170.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.31 -42.05 99.67 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.076 -1.059 . . . . 0.88 112.247 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.507 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.97 -23.96 62.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.051 1.13 . . . . 0.73999999999999999 114.051 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.637 ' HA ' HG21 ' A' ' 86' ' ' VAL . 7.6 mptt 61.83 11.4 4.06 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.819 0.848 . . . . 2.5099999999999998 112.866 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.407 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -141.62 137.42 31.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.143 0.973 . . . . 0.45000000000000001 112.232 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.523 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.97 119.87 34.23 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.455 -1.702 . . . . 0.33000000000000002 109.621 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.96 124.53 47.74 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.104 -0.639 . . . . 0.40000000000000002 111.538 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.602 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -83.26 134.73 34.93 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.168 -1.79 . . . . 0.33000000000000002 106.168 175.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 33.6 p -143.39 125.75 15.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 120.943 1.701 . . . . 0.75 113.334 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 tp -110.48 124.42 51.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.351 -1.295 . . . . 0.34999999999999998 110.116 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.46 33.12 7.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.602 0.715 . . . . 0.52000000000000002 109.077 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 m120 77.5 4.48 3.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.23 -1.35 . . . . 1.8400000000000001 111.6 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -129.27 138.08 51.43 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 118.689 -1.205 . . . . 3.1899999999999999 113.504 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -57.22 148.66 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 113.054 -1.884 . . . . 0.40999999999999998 112.975 -172.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.602 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.2 mtp -100.4 -41.91 6.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.581 -2.099 . . . . 0.34999999999999998 108.393 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? 179.98 160.19 0.85 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.442 -2.163 . . . . 2.0699999999999998 110.39 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.407 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.0 m -121.65 133.23 54.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.385 0.136 . . . . 0.37 110.789 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.447 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 73.0 m-85 -118.81 149.13 45.92 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 120.831 0.348 . . . . 0.96999999999999997 111.623 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 9.9 Cg_endo -80.36 141.49 14.3 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.752 2.301 . . . . 0.59999999999999998 111.738 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.48 173.82 11.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.442 -0.577 . . . . 0.64000000000000001 109.442 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.71 132.94 34.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.135 0.493 . . . . 0.82999999999999996 111.653 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.652 HG22 HG23 ' A' ' 65' ' ' ILE . 10.8 t -146.81 152.3 13.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.996 -1.002 . . . . 1.6699999999999999 110.326 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.99 57.06 0.23 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.013 -0.613 . . . . 3.0800000000000001 112.094 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -150.67 158.29 43.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.857 0.329 . . . . 7.2599999999999998 111.482 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.488 ' O ' ' HA3' ' A' ' 168' ' ' GLY . 4.6 mp -119.11 -85.48 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 116.29 -0.414 . . . . 6.29 111.943 -174.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.516 ' HA ' ' C ' ' A' ' 168' ' ' GLY . 61.3 tp -155.38 115.28 3.72 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.436 0.532 . . . . 7.2699999999999996 112.436 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.588 ' N ' ' HA ' ' A' ' 169' ' ' SER . 17.2 m -165.68 -61.62 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.335 0.654 . . . . 5.1799999999999997 111.011 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.602 ' H ' ' HA ' ' A' ' 169' ' ' SER . 16.7 mm100 -125.71 -68.17 0.84 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.958 1.095 . . . . 4.8099999999999996 113.958 -169.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.841 HG23 ' H ' ' A' ' 167' ' ' ARG . 2.9 m 61.47 67.52 1.35 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 117.879 0.309 . . . . 2.1099999999999999 110.513 -165.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.18 -11.37 10.96 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.938 2.425 . . . . 3.21 112.251 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.8 m -65.85 127.62 32.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.668 -0.697 . . . . 3.5899999999999999 111.103 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.77 173.61 49.28 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.805 -0.712 . . . . 2.1000000000000001 111.96 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -82.39 143.06 31.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.786 -0.45 . . . . 2.2999999999999998 109.786 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.517 ' HB3' ' H ' ' A' ' 119' ' ' SER . 15.7 m-85 -123.6 -178.94 4.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.125 -0.488 . . . . 1.9299999999999999 109.734 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 161' ' ' THR . 65.8 m-85 -135.69 141.07 44.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.592 -0.731 . . . . 0.57999999999999996 109.75 172.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 125' ' ' ILE . 23.7 mm -59.56 116.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 107.469 -1.308 . . . . 0.40999999999999998 107.469 167.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.574 HD12 ' HD1' ' A' ' 22' ' ' PHE . 2.9 tt -103.18 -28.15 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.361 -0.936 . . . . 0.37 112.026 -175.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -172.36 -169.96 0.67 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 114.923 1.453 . . . . 1.99 114.923 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.538 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.3 ptp180 -151.92 131.12 12.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 111.634 -2.53 . . . . 1.1899999999999999 109.378 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.27 156.81 17.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.245 1.021 . . . . 1.6699999999999999 111.531 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -53.18 152.26 4.48 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.562 -2.108 . . . . 3.0600000000000001 112.42 171.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -44.98 104.85 0.41 Allowed Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 113.854 -1.521 . . . . 2.6099999999999999 111.48 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -55.19 -51.19 10.72 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.971 3.114 . . . . 0.97999999999999998 112.291 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.76 -20.2 34.5 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.999 -1.0 . . . . 1.0800000000000001 112.181 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -103.43 -169.84 25.74 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.193 -0.527 . . . . 1.05 112.174 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.98 15.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 124.434 3.423 . . . . 1.3 114.094 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -67.93 -19.81 65.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.949 0.404 . . . . 1.3799999999999999 110.64 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.94 45.58 2.21 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 1.1100000000000001 114.186 170.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.06 -22.57 0.26 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.305 0.854 . . . . 0.81000000000000005 113.305 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.462 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -157.84 151.95 24.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.732 0.301 . . . . 1.1200000000000001 110.373 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -120.92 102.43 8.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.032 -0.531 . . . . 2.1899999999999999 109.583 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -106.59 137.28 44.88 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.236 0.541 . . . . 0.60999999999999999 110.413 176.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.2 m -106.15 145.17 31.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.507 -0.77 . . . . 0.93999999999999995 112.726 -170.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -92.37 -174.19 3.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.703 -1.221 . . . . 1.0800000000000001 107.703 170.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.517 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 52.9 m -85.61 -101.9 0.06 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.806 0.73 . . . . 1.5 112.08 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 121' ' ' GLN . 36.2 ttpt -72.13 142.69 49.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.087 -0.338 . . . . 2.9700000000000002 110.087 -174.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 120' ' ' LYS . 2.3 mp0 71.0 125.43 0.03 OUTLIER 'General case' 0 C--O 1.233 0.184 0 O-C-N 124.093 0.871 . . . . 5.0599999999999996 109.044 -170.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -74.1 64.43 1.04 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.45 0.643 . . . . 5.9500000000000002 112.048 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -113.88 163.88 14.51 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.554 -0.906 . . . . 4.8300000000000001 108.554 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -155.64 163.88 31.88 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.958 -1.115 . . . . 0.94999999999999996 112.935 -176.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 100' ' ' ILE . 47.2 mt -91.97 107.12 18.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.905 -1.146 . . . . 0.47999999999999998 107.905 172.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 9.2 p80 -138.98 -162.83 1.37 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.35 0.595 . . . . 1.25 111.542 -173.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.453 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.92 178.28 16.39 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.844 -1.17 . . . . 0.46000000000000002 113.654 -175.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.455 ' HA ' ' NH2' ' A' ' 144' ' ' ARG . 7.4 t -144.54 176.41 9.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.487 0.661 . . . . 0.5 111.263 -167.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -108.06 -15.15 14.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.72 -1.127 . . . . 1.8600000000000001 109.715 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.13 103.73 29.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.555 -0.748 . . . . 1.77 109.976 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -90.52 4.58 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.168 2.579 . . . . 0.58999999999999997 112.9 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.46 -16.25 46.46 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.322 0.582 . . . . 0.78000000000000003 110.324 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -98.19 7.15 46.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.652 -0.704 . . . . 1.45 109.912 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 26.2 mm -102.83 119.67 51.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.384 -0.825 . . . . 0.69999999999999996 111.244 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.64 53.76 2.21 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.416 -0.897 . . . . 1.6799999999999999 113.004 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.53 149.45 16.95 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.035 -0.357 . . . . 4.3899999999999997 110.035 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.421 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . . . -87.11 102.8 14.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.031 -0.531 . . . . 3.9399999999999999 110.497 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.1 p -154.78 -47.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.167 -0.47 . . . . 4.6799999999999997 110.948 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 65.5 m -158.87 147.67 18.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.05 -0.352 . . . . 5.6799999999999997 110.05 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -80.89 77.92 7.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.441 -0.578 . . . . 8.3000000000000007 109.441 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.47 -139.84 0.77 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.969 -0.634 . . . . 3.8500000000000001 111.805 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 64.4 m -110.43 168.31 9.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.22 0.534 . . . . 2.5099999999999998 111.363 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 31.7 mt -89.44 80.14 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.378 -0.828 . . . . 1.4399999999999999 110.123 -174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 46.9 mtp180 -118.4 156.3 29.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 3.3599999999999999 110.58 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.473 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 10.8 ptm -151.95 -168.22 3.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.204 -0.453 . . . . 1.1299999999999999 110.082 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.529 ' HB2' ' OD1' ' A' ' 149' ' ' ASP . 22.1 m170 -73.52 154.53 39.83 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.939 -0.393 . . . . 2.5099999999999998 109.939 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HG12 ' A' ' 150' ' ' VAL . 13.0 m120 -50.31 -68.05 0.2 Allowed 'General case' 0 C--O 1.221 -0.412 0 O-C-N 123.318 0.386 . . . . 1.77 111.43 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -60.41 -29.41 68.96 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.782 -0.574 . . . . 2.1299999999999999 111.699 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.529 ' OD1' ' HB2' ' A' ' 146' ' ' HIS . 2.2 m-20 -66.72 -41.95 87.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.732 0.301 . . . . 1.05 110.956 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.3 p -75.86 -18.93 15.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 116.311 -0.404 . . . . 0.32000000000000001 110.615 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.534 HD12 HG13 ' A' ' 150' ' ' VAL . 2.8 mp -86.89 -39.94 13.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 119.014 -0.517 . . . . 0.37 110.154 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -45.33 -66.26 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.52 1.054 . . . . 1.3799999999999999 111.949 165.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.631 ' O ' HG22 ' A' ' 157' ' ' VAL . 2.2 tp -53.17 -42.69 66.44 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.838 -0.619 . . . . 0.73999999999999999 110.107 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.32 -54.84 26.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.384 -1.28 . . . . 0.22 111.735 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 32.8 t -75.46 -16.46 60.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.822 -1.081 . . . . 1.3300000000000001 110.491 -172.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.2 mt -90.94 -53.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.787 -0.449 . . . . 0.23000000000000001 109.787 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 153' ' ' LEU . 18.7 m -77.45 114.79 43.82 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 122.194 0.997 . . . . 0.20999999999999999 110.212 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.8 ' HG2' HD13 ' A' ' 57' ' ' ILE . 54.6 Cg_endo -81.13 -179.12 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.911 2.407 . . . . 0.34000000000000002 112.715 -173.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.722 ' O ' HD21 ' A' ' 51' ' ' LEU . 17.1 m120 -59.63 -0.24 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.827 -1.079 . . . . 1.02 113.404 -176.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.23 59.02 0.51 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.834 -0.698 . . . . 0.28000000000000003 112.435 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -95.03 134.89 37.21 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.523 -0.398 . . . . 0.29999999999999999 110.219 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 131.83 34.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.859 0.362 . . . . 1.96 110.499 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.506 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 2.8 p -140.24 123.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.579 -0.737 . . . . 0.46000000000000002 111.471 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.2 m -111.6 138.53 48.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.805 -0.634 . . . . 0.56000000000000005 111.074 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.571 HG23 ' CG1' ' A' ' 65' ' ' ILE . 2.0 mp -122.37 117.2 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 118.461 -1.296 . . . . 0.95999999999999996 111.059 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.742 ' HA ' ' CG2' ' A' ' 93' ' ' THR . 0.0 OUTLIER -141.3 121.26 13.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 123.263 1.506 . . . . 1.1899999999999999 110.154 -175.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.841 ' H ' HG23 ' A' ' 93' ' ' THR . 3.4 ptm180 -101.53 -47.46 4.65 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 111.751 -2.477 . . . . 3.4199999999999999 114.162 -166.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.516 ' C ' ' HA ' ' A' ' 90' ' ' LEU . . . 117.3 -77.3 0.29 Allowed Glycine 0 N--CA 1.418 -2.506 0 N-CA-C 109.196 -1.561 . . . . 3.6499999999999999 109.196 -163.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.602 ' HA ' ' H ' ' A' ' 92' ' ' GLN . 80.2 p . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.562 -0.733 . . . . 5.9699999999999998 110.747 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.545 ' O31' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.387 -0.285 . . . . 2.9199999999999999 112.387 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 3' ' ' LYS . 9.3 ptp180 -135.73 -169.2 2.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.557 -0.534 . . . . 4.0999999999999996 109.557 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.33 147.17 21.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.92 -0.582 . . . . 2.1000000000000001 111.223 173.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.4 mt -97.95 168.63 10.17 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.088 -0.96 . . . . 0.26000000000000001 110.886 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 48' ' ' ILE . 2.3 tp -80.71 151.42 28.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.411 0.684 . . . . 0.23000000000000001 112.407 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.519 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -117.3 151.33 37.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.997 0.903 . . . . 0.26000000000000001 112.364 169.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.4 t80 -134.56 148.74 50.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 113.701 -1.59 . . . . 0.39000000000000001 107.917 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.638 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -127.33 121.15 30.25 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.012 -1.477 . . . . 1.0700000000000001 107.012 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -83.06 158.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.243 0.544 . . . . 0.38 112.011 -170.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' N ' HG23 ' A' ' 9' ' ' VAL . 53.9 mtpt -109.43 150.37 28.18 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.838 -0.801 . . . . 2.5899999999999999 108.838 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.97 114.1 1.21 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.89 -0.595 . . . . 1.74 112.004 -174.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.61 -10.07 21.65 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.677 -0.773 . . . . 0.56999999999999995 112.944 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.575 ' HB3' HD11 ' A' ' 18' ' ' ILE . 9.6 m-20 -62.62 154.51 28.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.028 0.414 . . . . 2.1699999999999999 111.82 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.555 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -132.53 152.0 51.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.5 112.153 -177.492 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.4 tp -48.04 -57.76 5.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.425 0.898 . . . . 0.27000000000000002 113.425 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.67 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.5 t-20 -66.05 -39.5 90.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.236 1.017 . . . . 1.21 110.308 -169.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -59.4 -47.62 84.75 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 113.106 -1.861 . . . . 1.24 109.902 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -69.64 -39.36 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 115.513 -0.767 . . . . 0.29999999999999999 112.205 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.676 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.0 -57.79 11.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 0.23000000000000001 110.934 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.6 -4.35 57.54 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.683 -1.207 . . . . 0.39000000000000001 112.147 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 42.2 m-20 -61.85 -36.38 81.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.902 -1.148 . . . . 1.6299999999999999 107.902 156.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.669 ' CD1' HD12 ' A' ' 101' ' ' ILE . 2.2 m-85 -99.75 15.82 25.61 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.899 0.703 . . . . 0.23999999999999999 112.899 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 54.05 50.99 15.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 3.5499999999999998 110.684 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 19' ' ' ALA . 36.8 pt -146.65 -174.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.692 -0.855 . . . . 0.27000000000000002 108.692 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -100.2 143.76 30.01 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.231 -0.895 . . . . 0.81000000000000005 109.293 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.67 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.4 p -60.97 -35.09 75.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 121.4 0.619 . . . . 0.27000000000000002 109.399 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.95 -31.51 72.72 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.507 -1.224 . . . . 0.26000000000000001 111.657 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.85 -37.89 39.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.406 0.622 . . . . 0.23000000000000001 109.574 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.671 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.97 -20.47 60.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.042 -0.981 . . . . 0.17000000000000001 109.066 175.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.735 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.91 -39.13 43.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.431 0.634 . . . . 0.19 111.582 172.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 55.2 mt-30 -59.18 -42.23 90.34 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.163 0.983 . . . . 1.0700000000000001 109.649 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.53 -18.89 43.47 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.535 -1.666 . . . . 0.17000000000000001 112.32 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.637 HD21 ' H ' ' A' ' 47' ' ' VAL . 29.7 m-80 -143.77 71.9 17.11 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-O 121.081 0.467 . . . . 0.19 109.881 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.643 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 12.2 Cg_endo -55.64 -13.56 8.4 Favored 'Trans proline' 0 C--N 1.333 -0.284 0 C-N-CA 123.696 2.931 . . . . 0.29999999999999999 114.318 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -61.9 -35.72 79.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.02 0.914 . . . . 1.1699999999999999 109.798 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.3 mt -76.76 -6.64 53.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.341 -1.3 . . . . 0.53000000000000003 114.362 -170.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.735 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -49.23 -40.68 34.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-O 122.527 1.156 . . . . 1.23 110.485 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.41 -45.65 11.67 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.054 -1.885 . . . . 0.40000000000000002 111.627 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.651 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.3 -163.87 34.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.479 -0.867 . . . . 0.29999999999999999 114.238 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.3 mp -118.97 158.04 26.53 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.444 -1.378 . . . . 0.31 110.512 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 71.3 m -133.22 136.48 45.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.873 -0.603 . . . . 0.39000000000000001 110.964 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -44.73 126.17 5.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.312 0.856 . . . . 0.46999999999999997 113.312 173.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.638 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.84 -12.49 48.23 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.558 -1.201 . . . . 0.35999999999999999 112.16 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.603 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.9 tt0 -62.75 150.81 40.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.741 0.781 . . . . 1.1899999999999999 110.294 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 27.8 m -120.42 130.85 54.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.328 -1.305 . . . . 0.89000000000000001 109.544 -170.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.671 HD12 HD11 ' A' ' 29' ' ' LEU . 21.3 pt -132.86 148.65 31.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.338 0.589 . . . . 0.22 110.697 -173.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.637 ' H ' HD21 ' A' ' 33' ' ' ASN . 13.2 t -94.1 149.02 4.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.078 -0.965 . . . . 0.20999999999999999 110.383 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 5' ' ' LEU . 18.9 mm -117.44 87.72 26.06 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 114.771 -1.104 . . . . 0.17000000000000001 108.384 -177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.708 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.2 Cg_endo -59.38 143.82 99.6 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.214 2.609 . . . . 0.23000000000000001 112.737 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.502 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.46 -7.6 56.95 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.569 -0.741 . . . . 0.29999999999999999 112.977 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.758 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -115.92 127.1 27.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.711 -0.848 . . . . 0.25 108.711 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.2 Cg_endo -66.47 174.91 5.65 Favored 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 123.793 2.996 . . . . 0.31 114.005 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.703 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.6 t70 -90.45 141.53 27.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.263 -0.88 . . . . 0.71999999999999997 110.734 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HD3' HD12 ' A' ' 5' ' ' LEU . 90.5 Cg_endo -83.84 -9.51 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.27000000000000002 112.438 -175.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -95.09 -27.08 15.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 2.1099999999999999 110.25 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.6 p -68.14 -32.34 72.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.591 -1.263 . . . . 1.47 107.591 170.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.768 HD13 ' HG2' ' A' ' 158' ' ' PRO . 89.5 mt -76.27 127.86 83.93 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 113.242 -1.799 . . . . 0.26000000000000001 110.476 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -101.84 95.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.856 0 C-N-CA 120.846 1.031 . . . . 0.20000000000000001 110.479 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.4 m-85 -158.38 139.25 12.98 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.952 -1.499 . . . . 0.26000000000000001 106.952 171.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 34.2 t-80 -145.27 107.15 4.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.789 -1.189 . . . . 2.8399999999999999 107.789 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 69.9 mt -94.93 109.64 22.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.254 -1.339 . . . . 0.32000000000000001 110.302 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.94 94.73 5.09 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.987 0.898 . . . . 0.34000000000000002 110.175 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 p -110.35 97.3 5.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 114.183 -1.372 . . . . 0.68000000000000005 109.256 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.1 m -93.43 108.52 20.18 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 114.756 -1.111 . . . . 1.05 108.074 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.653 HG23 HG13 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -46.38 -32.2 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.293 0.637 . . . . 1.29 112.613 174.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.16 -44.91 93.3 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.155 -1.022 . . . . 0.88 111.476 172.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.82 -23.28 63.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.768 -0.716 . . . . 0.73999999999999999 111.754 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HA ' HG21 ' A' ' 86' ' ' VAL . 52.4 mttt 59.97 16.94 6.2 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.042 0.937 . . . . 2.5099999999999998 113.056 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.59 140.32 37.01 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.919 0.866 . . . . 0.45000000000000001 111.404 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.441 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.6 tt -95.67 120.17 35.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.029 -1.441 . . . . 0.33000000000000002 109.7 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -101.79 125.82 48.54 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.147 -0.621 . . . . 0.40000000000000002 111.289 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.604 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.37 147.45 27.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.559 -1.645 . . . . 0.33000000000000002 106.559 175.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.653 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 24.3 m -150.96 132.77 15.01 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 120.407 1.458 . . . . 0.75 112.712 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 tp -120.42 125.9 49.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.989 -1.005 . . . . 0.34999999999999998 110.731 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 65.7 34.53 7.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.42 0.629 . . . . 0.52000000000000002 109.393 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.7 m120 79.87 3.46 2.06 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.377 -1.283 . . . . 1.8400000000000001 111.754 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -130.9 139.07 50.06 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 118.803 -1.159 . . . . 3.1899999999999999 113.75 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -52.76 149.69 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 113.112 -1.858 . . . . 0.40999999999999998 112.884 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.505 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.9 mtp -98.91 -43.98 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.643 -2.071 . . . . 0.34999999999999998 108.263 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? 179.26 154.71 0.47 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.33 -2.214 . . . . 2.0699999999999998 110.332 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.1 m -115.11 135.57 54.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.464 0.173 . . . . 0.37 110.754 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -125.34 131.97 24.19 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.96999999999999997 110.608 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.58 146.37 79.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.793 2.328 . . . . 0.59999999999999998 111.748 174.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.39 179.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.218 -0.66 . . . . 0.64000000000000001 109.218 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.481 ' HB3' ' H ' ' A' ' 142' ' ' CYS . . . -86.27 114.64 23.24 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 119.199 -1.0 . . . . 0.82999999999999996 109.877 174.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.653 HG13 HG23 ' A' ' 65' ' ' ILE . 8.5 t -102.67 92.46 2.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.532 -1.655 . . . . 1.6699999999999999 106.532 164.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.468 ' HA3' ' HB ' ' A' ' 138' ' ' VAL . . . 152.85 107.4 0.32 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.179 -1.01 . . . . 3.0800000000000001 113.478 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 140' ' ' LYS . 17.4 tppt? -171.18 -53.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.831 0.348 . . . . 7.2599999999999998 110.068 173.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.429 ' C ' HD22 ' A' ' 90' ' ' LEU . 18.7 mm -105.03 -108.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.344 -0.389 . . . . 6.29 110.562 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.429 HD22 ' C ' ' A' ' 89' ' ' ILE . 2.5 mm? -136.03 174.56 10.48 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.02 0.438 . . . . 7.2699999999999996 110.881 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 m -80.46 85.29 5.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.696 -0.684 . . . . 5.1799999999999997 109.897 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.628 ' C ' ' HD2' ' A' ' 94' ' ' PRO . 47.8 tt0 -74.0 -94.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.792 -0.64 . . . . 4.8099999999999996 111.184 -176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.571 HG22 ' HB2' ' A' ' 167' ' ' ARG 0.272 60.5 p 107.9 -48.21 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 127.089 2.155 . . . . 2.1099999999999999 112.834 -178.144 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.628 ' HD2' ' C ' ' A' ' 92' ' ' GLN . 30.5 Cg_endo -65.49 74.73 0.28 Allowed 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 121.528 1.485 . . . . 3.21 111.755 173.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 165' ' ' ILE . 23.9 m -128.71 112.93 14.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.341 -0.845 . . . . 3.5899999999999999 109.412 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.86 -178.4 34.15 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.662 -0.78 . . . . 2.1000000000000001 112.128 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.59 145.82 38.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.107 0.48 . . . . 2.2999999999999998 110.164 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.57 ' HB2' HG13 ' A' ' 163' ' ' VAL . 17.8 m-85 -119.33 167.61 11.73 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.431 -1.322 . . . . 1.9299999999999999 107.431 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.769 ' HA ' ' O ' ' A' ' 161' ' ' THR . 38.3 m-85 -127.19 136.45 52.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.925 -0.31 . . . . 0.57999999999999996 110.477 175.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.85 HD11 HD12 ' A' ' 125' ' ' ILE . 11.7 mm -58.1 108.18 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.897 0 N-CA-C 108.042 -1.096 . . . . 0.40999999999999998 108.042 169.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.669 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.0 tt -108.4 -27.31 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 112.813 0.672 . . . . 0.37 112.813 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 26.2 t-20 -156.33 161.2 40.2 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 122.675 1.226 . . . . 1.99 114.046 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.82 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 134.14 36.0 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 111.678 -2.51 . . . . 1.1899999999999999 109.177 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 16.0 tm0? -114.66 145.23 42.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.022 0.915 . . . . 1.6699999999999999 111.055 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -50.1 154.37 1.18 Allowed 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 112.828 -1.987 . . . . 3.0600000000000001 112.391 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -43.84 100.32 0.23 Allowed Pre-proline 0 CA--C 1.513 -0.478 0 CA-C-O 121.557 0.694 . . . . 2.6099999999999999 111.185 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HG3' ' OE1' ' A' ' 104' ' ' GLN . 90.2 Cg_exo -55.99 -51.01 10.54 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.18 3.253 . . . . 0.97999999999999998 112.794 -173.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.86 -20.89 16.87 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.146 -0.934 . . . . 1.0800000000000001 112.15 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -106.13 -171.15 23.22 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.697 -0.763 . . . . 1.05 112.347 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.93 33.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 124.621 3.547 . . . . 1.3 114.422 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -77.61 -32.19 53.35 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.068 0.461 . . . . 1.3799999999999999 110.695 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 98.82 42.78 2.79 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.598 -0.728 . . . . 1.1100000000000001 113.333 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.83 -17.07 0.54 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.53 0.937 . . . . 0.81000000000000005 113.53 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -156.87 131.38 8.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 110.042 -0.355 . . . . 1.1200000000000001 110.042 176.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.9 t-105 -99.23 101.17 12.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.743 -0.836 . . . . 2.1899999999999999 108.743 167.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.82 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.3 mp -106.95 135.64 48.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.281 0.562 . . . . 0.60999999999999999 110.168 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.3 m -106.36 144.42 33.07 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.625 -0.716 . . . . 0.93999999999999995 112.175 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 123' ' ' TYR . 0.1 OUTLIER -86.36 -177.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.415 -1.328 . . . . 1.0800000000000001 107.415 164.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 21.7 m -88.62 4.65 46.27 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.445 0.535 . . . . 1.5 112.445 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.47 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 33.2 tptt -129.15 115.59 17.92 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 119.766 -0.773 . . . . 2.9700000000000002 112.295 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 51.42 -144.12 0.6 Allowed 'General case' 0 C--N 1.332 -0.184 0 O-C-N 124.088 0.868 . . . . 5.0599999999999996 112.202 174.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -86.69 9.52 18.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.739 0.274 . . . . 5.9500000000000002 111.739 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 78.8 m-85 -70.41 123.77 22.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.081 -0.711 . . . . 4.8300000000000001 109.081 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.414 ' HA2' HD22 ' A' ' 118' ' ' LEU . . . -154.0 162.03 30.28 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.245 -0.979 . . . . 0.94999999999999996 112.76 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.85 HD12 HD11 ' A' ' 100' ' ' ILE . 43.0 mt -95.14 117.01 38.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.687 -0.857 . . . . 0.47999999999999998 108.687 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.559 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 8.8 p80 -144.34 -163.81 1.76 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.789 -0.765 . . . . 1.25 112.148 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.488 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.05 -174.94 15.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.929 -1.129 . . . . 0.46000000000000002 113.541 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.457 ' HA ' ' NH2' ' A' ' 144' ' ' ARG . 5.2 t -141.9 173.66 11.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.454 0.645 . . . . 0.5 111.333 -165.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.88 -18.59 14.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.131 -0.941 . . . . 1.8600000000000001 108.645 164.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -127.26 101.66 24.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.891 -1.05 . . . . 1.77 110.3 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 59.1 Cg_endo -92.14 3.83 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.138 2.558 . . . . 0.58999999999999997 112.801 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.01 -30.29 24.29 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.01 0.433 . . . . 0.78000000000000003 110.254 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 m -85.52 -2.66 58.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.884 -0.598 . . . . 1.45 110.384 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 8.0 mm -67.37 114.76 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.476 -0.784 . . . . 0.69999999999999996 110.12 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.18 96.25 1.7 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.102 -0.799 . . . . 1.6799999999999999 111.102 -172.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -151.58 -170.77 3.74 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.634 -0.333 . . . . 4.3899999999999997 110.995 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 138' ' ' VAL . . . -84.61 -174.81 5.48 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.189 -0.301 . . . . 3.9399999999999999 110.189 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.468 ' HB ' ' HA3' ' A' ' 87' ' ' GLY . 40.6 t 76.79 168.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.588 -0.893 . . . . 4.6799999999999997 108.588 -172.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 138' ' ' VAL . 8.1 t -124.76 156.1 38.25 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.677 -0.64 . . . . 5.6799999999999997 111.041 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 88.9 tttt 57.02 85.75 0.08 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.404 -0.816 . . . . 8.3000000000000007 111.63 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 88' ' ' LYS . . . -113.55 -148.3 10.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.747 -0.739 . . . . 3.8500000000000001 112.244 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.481 ' H ' ' HB3' ' A' ' 85' ' ' ALA . 95.7 m -102.54 146.25 28.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.504 . . . . 2.5099999999999998 110.114 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.505 ' CG2' HG12 ' A' ' 125' ' ' ILE . 23.8 mt -96.82 73.15 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.438 0.637 . . . . 1.4399999999999999 109.869 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 9.7 ptm180 -123.89 148.97 46.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 3.3599999999999999 110.558 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.3 mtp -136.39 -167.31 2.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.243 0.544 . . . . 1.1299999999999999 111.14 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -73.83 146.46 44.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.082 -0.963 . . . . 2.5099999999999998 108.739 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.617 ' O ' HG12 ' A' ' 150' ' ' VAL . 4.4 m-20 -52.16 -65.33 0.58 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.219 0.451 . . . . 1.77 112.219 -171.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -59.22 -25.05 63.68 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.65 -0.656 . . . . 2.1299999999999999 111.476 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.61 -35.78 57.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 1.05 110.765 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 10.8 p -77.94 -17.01 14.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.691 0 CA-C-N 116.529 -0.305 . . . . 0.32000000000000001 110.25 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.447 HD12 HG13 ' A' ' 150' ' ' VAL . 2.3 mp -85.9 -39.11 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 119.073 -0.489 . . . . 0.37 109.914 172.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -44.72 -69.48 0.13 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 119.148 0.885 . . . . 1.3799999999999999 112.178 163.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.706 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -50.36 -44.34 54.62 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.73999999999999999 110.303 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.65 -50.04 71.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.141 -1.39 . . . . 0.22 112.109 -171.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 p -77.58 -17.21 58.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.724 -1.126 . . . . 1.3300000000000001 111.111 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.42 -46.2 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 115.933 -0.576 . . . . 0.23000000000000001 109.528 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 153' ' ' LEU . 30.6 m -76.51 120.95 83.88 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-O 121.669 0.747 . . . . 0.20999999999999999 110.459 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.768 ' HG2' HD13 ' A' ' 57' ' ' ILE . 27.4 Cg_endo -85.59 -177.71 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.384 2.723 . . . . 0.34000000000000002 112.841 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.758 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.7 m120 -60.09 3.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.775 -1.102 . . . . 1.02 113.895 -175.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -149.65 57.8 0.46 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.635 -0.793 . . . . 0.28000000000000003 112.641 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.769 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.1 m -90.71 134.26 34.55 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.472 -0.428 . . . . 0.29999999999999999 111.173 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -84.39 128.5 34.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.055 -0.521 . . . . 1.96 110.622 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 98' ' ' PHE . 3.2 p -141.83 129.58 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 O-C-N 123.542 0.526 . . . . 0.46000000000000002 111.347 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.9 m -122.95 143.86 49.63 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.515 0.561 . . . . 0.56000000000000005 112.515 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.42 HG22 ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -125.92 115.86 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.19 -1.004 . . . . 0.95999999999999996 112.352 177.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.629 ' N ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.46 141.01 30.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.958 -1.019 . . . . 1.1899999999999999 109.73 -172.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.571 ' HB2' HG22 ' A' ' 93' ' ' THR . 5.5 mpt_? -93.34 -39.26 11.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.848 -1.069 . . . . 3.4199999999999999 111.586 -172.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.37 -57.46 4.42 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.891 -0.595 . . . . 3.6499999999999999 112.271 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.38 -0.819 . . . . 5.9699999999999998 109.718 178.502 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.69 H623 ' N4 ' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 111.698 -0.561 . . . . 2.9199999999999999 111.698 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 61.25 -175.54 0.12 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.601 0.715 . . . . 4.0999999999999996 111.705 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt -66.87 155.12 39.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.234 -0.894 . . . . 2.1000000000000001 109.232 169.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.767 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.1 mt -90.73 167.72 12.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.211 -0.449 . . . . 0.26000000000000001 111.069 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.671 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.7 tp -74.19 148.57 41.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.216 0.531 . . . . 0.23000000000000001 111.65 -170.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.38 148.67 37.31 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.794 0.806 . . . . 0.26000000000000001 111.257 168.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.462 ' CE2' ' HA ' ' A' ' 9' ' ' VAL . 69.1 t80 -134.04 148.03 51.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.009 -1.45 . . . . 0.39000000000000001 107.61 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.8 tt0 -127.84 111.21 13.37 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.657 -1.609 . . . . 1.0700000000000001 106.657 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -72.18 157.47 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-O 121.219 0.533 . . . . 0.38 111.39 -165.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HE2' ' HA3' ' A' ' 96' ' ' GLY . 87.7 mttt -107.64 148.43 29.35 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.461 -0.79 . . . . 2.5899999999999999 109.291 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.955 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -46.53 116.96 1.44 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 1.74 112.631 -173.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.35 -8.94 38.39 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.967 -1.015 . . . . 0.56999999999999995 113.514 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.546 ' HB3' HD11 ' A' ' 18' ' ' ILE . 83.1 m-20 -61.46 155.03 22.8 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.973 0.731 . . . . 2.1699999999999999 112.973 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.592 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -134.32 159.11 41.99 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 115.949 -0.569 . . . . 0.5 111.73 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 46.6 tp -52.68 -57.71 9.19 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.948 1.092 . . . . 0.27000000000000002 113.948 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.706 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 2.0 t30 -66.71 -43.19 84.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 122.309 1.052 . . . . 1.21 110.558 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.569 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 37.5 t -57.77 -47.96 81.03 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 112.988 -1.915 . . . . 1.24 109.797 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 14' ' ' THR . 1.6 mp -68.75 -40.65 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.795 -0.639 . . . . 0.29999999999999999 111.89 -176.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.708 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.28 -65.55 0.59 Allowed 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.23000000000000001 111.541 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.89 -4.73 55.87 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.768 -1.173 . . . . 0.39000000000000001 112.273 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -67.62 -27.28 66.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.93 -0.767 . . . . 1.6299999999999999 108.93 157.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -99.6 15.37 26.87 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.804 -0.56 . . . . 0.23999999999999999 112.146 172.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 56.28 50.94 12.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.495 -0.775 . . . . 3.5499999999999998 110.662 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.708 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.3 pt -149.14 -173.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.909 -0.775 . . . . 0.27000000000000002 108.909 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.04 147.61 23.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.415 -0.811 . . . . 0.81000000000000005 110.017 172.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.706 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.4 p -62.56 -36.46 82.71 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.654 -0.869 . . . . 0.27000000000000002 108.654 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -28.83 68.74 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 114.665 -1.152 . . . . 0.26000000000000001 111.539 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 49' ' ' PRO . . . -80.37 -38.22 30.84 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.524 -0.547 . . . . 0.23000000000000001 109.524 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 46' ' ' ILE . 12.7 tp -71.98 -20.42 61.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.563 -0.744 . . . . 0.17000000000000001 109.007 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.684 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -38.36 40.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.47 0.652 . . . . 0.19 111.381 172.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -59.25 -42.46 91.18 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.998 0.904 . . . . 1.0700000000000001 109.84 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.95 -16.26 51.06 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.843 -1.526 . . . . 0.17000000000000001 112.01 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 33.2 m-80 -139.99 69.94 35.56 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.624 -0.51 . . . . 0.19 109.624 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.46 -21.9 19.77 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 124.533 3.489 . . . . 0.29999999999999999 115.422 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -69.64 -34.12 73.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 119.458 1.026 . . . . 1.1699999999999999 110.293 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.629 ' CD2' ' HB3' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -65.05 -6.7 9.42 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.422 -1.263 . . . . 0.53000000000000003 113.635 -172.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.684 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.12 -40.68 24.34 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.475 1.131 . . . . 1.23 110.351 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.579 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -82.37 -46.15 13.93 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.98 -1.918 . . . . 0.40000000000000002 111.642 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.41 -161.78 31.82 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.118 -1.039 . . . . 0.29999999999999999 114.396 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.5 mp -118.6 158.27 25.78 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.704 -1.748 . . . . 0.31 110.542 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 98.7 m -133.6 133.69 42.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.799 -0.637 . . . . 0.39000000000000001 110.55 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.955 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.22 127.15 10.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.789 0.662 . . . . 0.46999999999999997 112.789 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.84 -12.47 52.9 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.796 -1.093 . . . . 0.35999999999999999 112.506 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.631 ' HB3' ' O ' ' A' ' 41' ' ' THR . 7.1 tt0 -65.28 152.66 43.2 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.643 0.735 . . . . 1.1899999999999999 110.219 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 42.0 m -119.24 131.76 55.84 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.61 -1.177 . . . . 0.89000000000000001 109.542 -171.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.718 HD12 HD11 ' A' ' 29' ' ' LEU . 25.2 pt -136.49 151.34 28.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.339 0.59 . . . . 0.22 110.698 -174.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.615 ' H ' HD21 ' A' ' 33' ' ' ASN . 5.3 t -94.56 148.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.156 -0.929 . . . . 0.20999999999999999 110.703 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.598 ' CG1' HD23 ' A' ' 5' ' ' LEU . 15.7 mm -117.44 88.74 29.63 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 114.599 -1.182 . . . . 0.17000000000000001 108.418 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.6 Cg_endo -59.02 143.8 99.65 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.186 2.591 . . . . 0.23000000000000001 112.769 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.46 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.83 -6.88 60.68 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.29999999999999999 113.035 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.752 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.9 tt -116.65 129.97 24.88 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.334 -0.987 . . . . 0.25 108.334 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.721 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.2 Cg_endo -69.45 171.08 14.76 Favored 'Trans proline' 0 N--CA 1.475 0.41 0 C-N-CA 123.583 2.855 . . . . 0.31 113.906 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 3.1 t70 -91.6 138.05 25.43 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.865 -1.061 . . . . 0.71999999999999997 112.297 -171.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.671 ' HD3' HD12 ' A' ' 5' ' ' LEU . 69.4 Cg_endo -84.4 -4.27 10.15 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 123.684 2.923 . . . . 0.27000000000000002 113.351 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -94.96 -25.15 16.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.853 0.359 . . . . 2.1099999999999999 110.9 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.7 t -86.06 -13.0 48.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.448 0.642 . . . . 1.47 109.42 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HG2' ' A' ' 158' ' ' PRO . 81.3 mt -85.61 124.42 71.3 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.198 -0.91 . . . . 0.26000000000000001 110.034 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -101.25 95.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.811 0.968 . . . . 0.20000000000000001 110.109 169.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -158.37 137.13 11.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.55 -1.648 . . . . 0.26000000000000001 106.55 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 71.8 t60 -144.19 109.89 5.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.851 -1.166 . . . . 2.8399999999999999 107.851 -167.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 70.2 mt -95.14 107.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.394 -1.276 . . . . 0.32000000000000001 109.864 -177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.5 94.24 4.9 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.048 0.927 . . . . 0.34000000000000002 110.244 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.492 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -113.95 98.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 113.825 -1.534 . . . . 0.68000000000000005 109.202 178.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.491 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 55.2 m -91.0 123.76 34.72 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.805 -1.183 . . . . 1.05 107.805 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 167' ' ' ARG . 5.8 mt -60.6 -26.98 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.571 0.7 . . . . 1.29 110.214 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.53 -47.08 64.44 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 114.96 -1.018 . . . . 0.88 111.477 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -66.36 -23.92 66.42 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.114 0.483 . . . . 0.73999999999999999 111.908 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.609 ' HA ' HG11 ' A' ' 86' ' ' VAL . 2.7 mtpt 59.13 12.48 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.256 1.023 . . . . 2.5099999999999998 113.169 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.98 143.23 38.44 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.647 0.736 . . . . 0.45000000000000001 110.902 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.6 tt -96.8 119.1 34.64 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.319 -1.31 . . . . 0.33000000000000002 109.635 -177.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -102.59 126.51 49.69 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.244 -0.582 . . . . 0.40000000000000002 111.317 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.566 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.71 141.9 32.07 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.436 -1.69 . . . . 0.33000000000000002 106.436 175.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.5 m -145.98 128.81 16.33 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.481 1.491 . . . . 0.75 112.377 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -118.07 125.49 50.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.982 -1.008 . . . . 0.34999999999999998 110.291 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.49 33.36 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.13 -0.692 . . . . 0.52000000000000002 109.13 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.6 m120 77.57 3.88 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.374 -1.285 . . . . 1.8400000000000001 111.592 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -130.47 138.52 50.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 118.779 -1.168 . . . . 3.1899999999999999 113.368 170.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -53.2 150.22 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 113.107 -1.86 . . . . 0.40999999999999998 112.957 -174.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.566 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -99.03 -43.88 6.51 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 112.543 -2.117 . . . . 0.34999999999999998 108.21 175.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -177.52 157.6 1.29 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.427 -2.169 . . . . 2.0699999999999998 109.863 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -117.59 130.65 56.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.723 0.297 . . . . 0.37 110.8 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 74.9 m-85 -114.99 143.11 29.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.355 -0.384 . . . . 0.96999999999999997 110.337 -177.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 18.8 Cg_endo -81.67 140.61 11.82 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.298 1.999 . . . . 0.59999999999999998 111.156 175.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.27 -172.78 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.323 -0.399 . . . . 0.64000000000000001 111.085 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.05 130.34 34.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 0.82999999999999996 110.03 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -152.85 32.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 1.6699999999999999 111.173 -172.147 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.86 -170.68 38.63 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.702 -0.761 . . . . 3.0800000000000001 112.869 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HG2' ' CB ' ' A' ' 137' ' ' ALA . 74.0 mmtt 60.43 87.03 0.09 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.214 0.606 . . . . 7.2599999999999998 111.221 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 tp -74.61 80.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 122.053 0.93 . . . . 6.29 110.432 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.1 mt -90.63 -6.18 54.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.581 -0.736 . . . . 7.2699999999999996 110.46 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.448 ' C ' ' HD3' ' A' ' 167' ' ' ARG . 23.4 m 74.52 -20.22 0.33 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.689 -0.687 . . . . 5.1799999999999997 111.807 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -68.36 119.73 13.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.041 0.448 . . . . 4.8099999999999996 111.108 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.558 HG23 ' HG2' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -88.13 118.2 69.31 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.75 -0.659 . . . . 2.1099999999999999 110.126 173.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.51 113.74 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.333 2.022 . . . . 3.21 111.087 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.3 m -92.95 128.5 38.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.911 -0.586 . . . . 3.5899999999999999 111.004 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.418 ' HA3' ' HE2' ' A' ' 10' ' ' LYS . . . 90.9 142.41 10.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.975 -0.631 . . . . 2.1000000000000001 111.982 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.11 169.29 18.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.344 0.592 . . . . 2.2999999999999998 111.355 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.516 ' HB2' HG13 ' A' ' 163' ' ' VAL . 19.1 m-85 -123.98 172.38 9.0 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.61 -1.256 . . . . 1.9299999999999999 107.61 169.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 161' ' ' THR . 46.9 m-85 -128.78 139.07 52.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.761 0.315 . . . . 0.57999999999999996 110.221 173.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.69 HD11 HD12 ' A' ' 125' ' ' ILE . 16.3 mm -58.66 104.59 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.273 -1.01 . . . . 0.40999999999999998 108.273 169.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.558 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.5 tt -93.17 -25.86 4.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.009 -0.676 . . . . 0.37 112.337 -170.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.456 ' ND2' HG23 ' A' ' 101' ' ' ILE . 11.5 p30 -169.4 -179.51 3.49 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 114.936 1.458 . . . . 1.99 114.936 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.9 175.8 10.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 111.079 -2.782 . . . . 1.1899999999999999 108.517 176.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.78 155.27 39.84 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.462 1.125 . . . . 1.6699999999999999 113.311 -164.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -52.54 149.73 5.62 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 112.64 -2.073 . . . . 3.0600000000000001 111.109 166.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -50.14 107.03 0.71 Allowed Pre-proline 0 CA--C 1.514 -0.407 0 CA-C-N 115.825 -0.625 . . . . 2.6099999999999999 111.928 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -59.2 -51.62 6.29 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 123.627 2.885 . . . . 0.97999999999999998 112.896 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.45 -21.64 44.93 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.2 -0.909 . . . . 1.0800000000000001 111.575 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -93.79 -170.1 38.57 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.357 -0.449 . . . . 1.05 112.137 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.3 21.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 124.648 3.565 . . . . 1.3 114.69 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -75.73 -18.5 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.369 . . . . 1.3799999999999999 111.136 179.041 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 82.51 49.42 5.18 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.78 -0.646 . . . . 1.1100000000000001 113.326 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.93 -20.56 0.37 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.222 0.823 . . . . 0.81000000000000005 113.222 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.522 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -155.77 144.54 20.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 1.1200000000000001 110.861 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -111.87 102.16 10.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.342 -0.614 . . . . 2.1899999999999999 109.342 169.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -106.47 137.01 45.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.537 0.685 . . . . 0.60999999999999999 109.839 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.412 ' HB2' HG23 ' A' ' 101' ' ' ILE . 72.9 m -106.75 144.46 33.37 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.412 -0.813 . . . . 0.93999999999999995 112.272 -171.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -90.98 -175.04 4.21 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.19 -1.411 . . . . 1.0800000000000001 107.19 169.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.2 m -80.23 -67.61 0.75 Allowed 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.775 -0.77 . . . . 1.5 111.861 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -86.79 151.37 23.42 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.092 0.775 . . . . 2.9700000000000002 113.092 -170.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 64.3 -169.93 0.19 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.571 -1.195 . . . . 5.0599999999999996 111.412 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -96.3 44.92 1.07 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.149 0.499 . . . . 5.9500000000000002 109.711 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -115.74 140.61 49.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.772 -0.649 . . . . 4.8300000000000001 109.993 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -154.64 163.41 31.21 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.704 -0.76 . . . . 0.94999999999999996 112.209 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.69 HD12 HD11 ' A' ' 100' ' ' ILE . 27.8 mt -91.72 107.19 18.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.78 -0.822 . . . . 0.47999999999999998 108.78 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.679 ' CE1' ' HB3' ' A' ' 144' ' ' ARG . 10.0 p80 -139.68 -163.27 1.47 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.329 0.585 . . . . 1.25 111.441 -174.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.03 163.51 14.47 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.058 -1.068 . . . . 0.46000000000000002 113.597 -175.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 5.7 t -120.45 170.87 8.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.711 -0.745 . . . . 0.5 111.608 -168.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.98 -22.21 13.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.926 -1.034 . . . . 1.8600000000000001 108.586 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -124.88 104.56 30.05 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 114.837 -1.074 . . . . 1.77 109.642 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.58 4.22 7.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.96 2.44 . . . . 0.58999999999999997 112.783 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.21 -11.0 47.97 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.98 -0.748 . . . . 0.78000000000000003 108.98 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.404 ' HB3' HG21 ' A' ' 138' ' ' VAL . 15.7 m -78.52 -26.65 45.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.011 -0.995 . . . . 1.45 109.439 175.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 144' ' ' ARG . 27.1 mm -60.84 117.36 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.354 -0.839 . . . . 0.69999999999999996 110.041 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 122.88 -29.79 5.27 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.051 -0.819 . . . . 1.6799999999999999 111.051 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -104.7 -156.7 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.289 -0.263 . . . . 4.3899999999999997 110.289 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.447 ' CB ' ' HG2' ' A' ' 88' ' ' LYS . . . -99.44 -74.08 0.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.218 0.451 . . . . 3.9399999999999999 112.218 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 137' ' ' ALA . 93.7 t 70.45 103.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 123.615 0.572 . . . . 4.6799999999999997 109.564 -170.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m 65.94 -89.81 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.271 -0.877 . . . . 5.6799999999999997 110.289 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.58 -0.34 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.257 0.551 . . . . 8.3000000000000007 109.774 174.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 135.35 115.46 1.5 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.593 -0.731 . . . . 3.8500000000000001 111.513 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.601 ' SG ' ' HD2' ' A' ' 144' ' ' ARG . 0.5 OUTLIER -113.1 110.1 19.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 2.5099999999999998 111.42 -178.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 19.9 mt -86.11 66.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.08 0.467 . . . . 1.4399999999999999 110.156 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.679 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 1.7 ptm180 -127.6 104.79 8.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.569 0.699 . . . . 3.3599999999999999 111.844 -176.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.41 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 9.7 ptm -107.83 -165.16 1.02 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.211 -0.904 . . . . 1.1299999999999999 111.721 -172.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -67.33 148.1 52.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.493 -0.188 . . . . 2.5099999999999998 110.493 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.619 ' O ' HG12 ' A' ' 150' ' ' VAL . 10.1 m120 -50.8 -68.09 0.2 Allowed 'General case' 0 C--O 1.221 -0.408 0 O-C-N 123.529 0.518 . . . . 1.77 110.962 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.383 0.512 . . . . 2.1299999999999999 112.383 -173.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.55 -37.99 62.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.579 0.228 . . . . 1.05 111.14 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.5 p -75.85 -15.2 15.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 110.11 -0.33 . . . . 0.32000000000000001 110.11 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.522 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -89.79 -39.65 12.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.101 -0.476 . . . . 0.37 110.582 172.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -44.44 -68.63 0.18 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.574 1.079 . . . . 1.3799999999999999 112.137 164.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.4 tp -50.0 -43.11 50.41 Favored 'General case' 0 C--O 1.22 -0.474 0 O-C-N 123.904 0.753 . . . . 0.73999999999999999 110.092 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.24 -53.67 47.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.296 -1.32 . . . . 0.22 112.464 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.2 t -76.74 -16.99 59.33 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.843 -1.072 . . . . 1.3300000000000001 110.618 -172.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.7 mt -91.28 -49.58 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.768 -0.456 . . . . 0.23000000000000001 109.768 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 22.5 m -77.98 116.27 57.26 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-O 121.855 0.835 . . . . 0.20999999999999999 110.119 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.788 ' HG2' HD13 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -83.01 -178.61 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.052 2.501 . . . . 0.34000000000000002 112.327 -175.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.752 ' O ' HD21 ' A' ' 51' ' ' LEU . 14.2 m120 -64.93 7.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.905 -1.043 . . . . 1.02 113.337 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -146.64 53.98 0.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.941 -0.647 . . . . 0.28000000000000003 112.156 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.0 m -88.17 135.8 33.27 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.47 -0.429 . . . . 0.29999999999999999 110.863 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 162' ' ' ARG . 9.0 mtm180 -84.75 122.08 28.6 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.783 -0.644 . . . . 1.96 110.351 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 98' ' ' PHE . 3.6 p -134.74 127.74 49.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.422 0.629 . . . . 0.46000000000000002 111.594 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 m -118.67 140.06 50.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.474 -0.785 . . . . 0.56000000000000005 111.902 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -124.65 114.71 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 118.887 -1.125 . . . . 0.95999999999999996 110.75 174.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.678 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.65 127.85 17.66 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.917 -1.038 . . . . 1.1899999999999999 110.268 -173.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.558 ' HG2' HG23 ' A' ' 93' ' ' THR . 6.0 ptm180 -94.24 -22.86 18.14 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.811 -1.086 . . . . 3.4199999999999999 111.856 -175.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.5 -128.4 8.47 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.248 -0.887 . . . . 3.6499999999999999 110.999 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.769 -0.634 . . . . 5.9699999999999998 109.906 177.764 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.729 ' O62' ' H11' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.737 -0.545 . . . . 2.9199999999999999 111.737 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -142.16 174.31 10.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.049 0.452 . . . . 4.0999999999999996 110.114 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.21 143.75 27.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.428 -0.953 . . . . 2.1000000000000001 108.428 167.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.803 HD13 ' HA ' ' A' ' 49' ' ' PRO . 19.8 mt -99.2 172.37 7.41 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.396 0.435 . . . . 0.26000000000000001 111.756 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD23 HG13 ' A' ' 48' ' ' ILE . 4.3 tp -75.86 150.73 37.57 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.176 0.59 . . . . 0.23000000000000001 111.84 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.539 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.06 150.58 35.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.978 0.894 . . . . 0.26000000000000001 111.927 167.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.1 t80 -133.16 149.62 52.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.656 -1.611 . . . . 0.39000000000000001 108.014 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.647 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.88 116.38 19.33 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 106.405 -1.702 . . . . 1.0700000000000001 106.405 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.48 158.03 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-O 121.446 0.641 . . . . 0.38 111.786 -169.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.63 152.04 26.07 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.145 -0.934 . . . . 2.5899999999999999 108.804 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.796 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.6 111.3 0.57 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.735 -0.666 . . . . 1.74 111.795 -174.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -9.17 20.56 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.141 -0.936 . . . . 0.56999999999999995 113.015 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.608 ' HB3' HD11 ' A' ' 18' ' ' ILE . 74.8 m-20 -66.48 147.13 53.73 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.327 0.563 . . . . 2.1699999999999999 112.25 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.643 ' O ' HD13 ' A' ' 18' ' ' ILE . 2.0 p -134.44 163.75 28.99 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.257 0.466 . . . . 0.5 112.257 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.597 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -49.94 -62.06 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.367 1.247 . . . . 0.27000000000000002 114.367 -171.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.697 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.2 t-20 -64.99 -41.14 95.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 122.49 1.138 . . . . 1.21 110.305 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.768 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.9 t -57.42 -48.15 79.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 112.472 -2.149 . . . . 1.24 109.858 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -70.15 -40.4 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 123.668 0.787 . . . . 0.29999999999999999 112.456 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.687 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.33 -65.07 0.67 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.397 -0.365 . . . . 0.23000000000000001 111.535 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.85 -5.06 54.73 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.743 -1.183 . . . . 0.39000000000000001 111.83 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' SER . 17.3 t70 -65.19 -32.88 74.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.329 -0.989 . . . . 1.6299999999999999 108.329 158.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.599 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.4 m-85 -97.83 14.96 25.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.196 0.443 . . . . 0.23999999999999999 112.196 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? 58.46 47.93 12.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.01 -0.541 . . . . 3.5499999999999998 110.741 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.1 pt -147.89 -175.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.918 -0.771 . . . . 0.27000000000000002 108.918 -173.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 146.22 26.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.362 -0.835 . . . . 0.81000000000000005 109.467 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.697 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 10.3 p -62.17 -37.39 85.09 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.933 -0.766 . . . . 0.27000000000000002 108.933 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.556 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.75 -30.29 71.4 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.192 -1.367 . . . . 0.26000000000000001 111.281 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.93 -37.94 33.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.104 0.478 . . . . 0.23000000000000001 109.778 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.742 HD11 HD12 ' A' ' 46' ' ' ILE . 14.1 tp -73.69 -20.09 60.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 0.17000000000000001 109.206 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.744 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -77.93 -38.82 44.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.65 0.738 . . . . 0.19 111.435 172.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 57.4 mt-30 -59.53 -41.9 91.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.288 1.042 . . . . 1.0700000000000001 109.744 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.42 -20.74 39.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.565 -1.652 . . . . 0.17000000000000001 112.315 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.657 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 26.8 m-80 -142.34 73.25 21.25 Favored Pre-proline 0 CA--C 1.513 -0.449 0 CA-C-O 121.196 0.522 . . . . 0.19 110.099 -172.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.726 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.3 Cg_endo -58.37 -10.03 7.9 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 123.239 2.626 . . . . 0.29999999999999999 113.926 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -62.59 -31.06 71.81 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.972 0.892 . . . . 1.1699999999999999 109.564 173.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 3.2 mt -83.14 -7.01 59.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.679 1.363 . . . . 0.53000000000000003 114.679 -172.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.744 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -49.54 -40.92 39.86 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 120.03 1.286 . . . . 1.23 110.151 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 -46.64 12.84 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.886 -1.961 . . . . 0.40000000000000002 111.511 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.42 -165.93 37.61 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.295 -0.955 . . . . 0.29999999999999999 114.472 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.466 HD23 HG11 ' A' ' 9' ' ' VAL . 4.5 mp -113.71 158.47 20.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.412 -1.394 . . . . 0.31 110.252 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.687 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -136.97 134.16 36.39 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.786 -0.643 . . . . 0.39000000000000001 110.65 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.796 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.05 129.36 17.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.475 0.655 . . . . 0.46999999999999997 112.736 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.594 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 83.2 -11.49 54.76 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.561 -1.199 . . . . 0.35999999999999999 112.766 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.888 ' OE1' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -61.48 158.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.194 0.521 . . . . 1.1899999999999999 110.134 172.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.492 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 58.7 p -123.24 137.85 54.77 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.96 -1.018 . . . . 0.89000000000000001 110.468 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.888 HG23 ' OE1' ' A' ' 44' ' ' GLN . 12.3 pt -135.13 171.6 17.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.287 0.565 . . . . 0.22 111.266 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.657 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 19.1 t -114.2 149.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.731 -1.122 . . . . 0.20999999999999999 109.533 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.55 HG13 HD23 ' A' ' 5' ' ' LEU . 18.4 mm -118.27 88.29 32.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.183 -0.917 . . . . 0.17000000000000001 108.711 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.803 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.47 139.88 92.38 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.387 2.725 . . . . 0.23000000000000001 113.203 -173.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.469 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.22 -7.37 67.8 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.424 -0.807 . . . . 0.29999999999999999 112.867 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.691 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.57 124.27 30.22 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.578 -0.897 . . . . 0.25 108.578 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD23 ' A' ' 51' ' ' LEU . 57.0 Cg_endo -65.31 176.34 3.36 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.75 2.967 . . . . 0.31 113.939 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.638 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.2 t70 -89.6 140.97 28.26 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.801 -1.091 . . . . 0.71999999999999997 110.139 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.598 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 88.0 Cg_endo -81.86 -1.16 10.74 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.367 2.711 . . . . 0.27000000000000002 111.725 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -28.83 14.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.898 -0.592 . . . . 2.1099999999999999 110.772 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 53' ' ' ASP . 34.1 p -69.41 -28.4 66.12 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 122.617 1.199 . . . . 1.47 107.905 170.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.804 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.8 mt -84.16 124.75 73.81 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 112.899 -1.955 . . . . 0.26000000000000001 110.648 175.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -101.57 95.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 CA-C-N 119.841 0.979 . . . . 0.20000000000000001 109.847 166.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' HD2' HG23 ' A' ' 57' ' ' ILE . 80.8 m-85 -157.74 131.75 8.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.925 -1.509 . . . . 0.26000000000000001 106.925 172.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 3.5 m-70 -140.48 113.55 8.38 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.436 -1.32 . . . . 2.8399999999999999 107.436 -164.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.7 mt -102.23 111.22 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 115.723 -0.671 . . . . 0.32000000000000001 111.307 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.96 98.86 7.65 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.227 -0.897 . . . . 0.34000000000000002 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 165' ' ' ILE . 0.4 OUTLIER -116.55 99.71 8.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.174 -1.375 . . . . 0.68000000000000005 109.559 177.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.432 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 54.2 m -94.46 133.08 38.44 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.071 -0.968 . . . . 1.05 109.199 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.658 HG23 HG13 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -59.87 -35.63 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.595 0.712 . . . . 1.29 110.676 176.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' H ' ' HA ' ' A' ' 167' ' ' ARG . . . -63.85 -43.4 97.67 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.905 -1.043 . . . . 0.88 110.956 175.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -71.32 -25.27 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.825 0.676 . . . . 0.73999999999999999 112.825 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.2 mttt 54.03 17.07 1.28 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.913 0.885 . . . . 2.5099999999999998 112.961 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.42 141.59 35.5 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.525 0.678 . . . . 0.45000000000000001 111.051 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.486 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.2 tt -96.25 117.47 30.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.473 -1.239 . . . . 0.33000000000000002 109.675 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 m -100.73 127.51 47.12 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.17 -0.468 . . . . 0.40000000000000002 111.227 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.557 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -81.94 146.84 29.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.275 -1.75 . . . . 0.33000000000000002 106.275 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 36.5 m -150.31 127.02 10.95 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 120.351 1.432 . . . . 0.75 112.442 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.07 125.25 53.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.492 -1.231 . . . . 0.34999999999999998 110.088 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 4.7 t-20 60.73 42.25 13.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.152 0.501 . . . . 0.52000000000000002 110.166 174.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.7 m-20 74.64 -1.46 3.08 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.993 -1.003 . . . . 1.8400000000000001 112.731 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -128.69 135.76 49.68 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 117.845 -1.542 . . . . 3.1899999999999999 114.115 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -56.55 149.17 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 112.7 -2.045 . . . . 0.40999999999999998 113.027 -170.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.557 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.2 mtp -101.02 -43.03 6.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.581 -2.1 . . . . 0.34999999999999998 108.566 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 178.81 159.1 0.57 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.617 -2.083 . . . . 2.0699999999999998 110.342 -177.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.512 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.1 m -117.07 135.55 53.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.392 0.139 . . . . 0.37 111.165 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -124.08 135.03 25.88 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-O 120.792 0.329 . . . . 0.96999999999999997 110.778 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -62.49 145.27 95.53 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.385 2.723 . . . . 0.59999999999999998 113.268 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.94 169.38 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.091 -0.504 . . . . 0.64000000000000001 109.675 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.537 ' HB3' ' H ' ' A' ' 142' ' ' CYS . . . -88.27 127.75 35.47 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.297 0.57 . . . . 0.82999999999999996 110.902 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.658 HG13 HG23 ' A' ' 65' ' ' ILE . 1.2 t -109.06 -28.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.774 -1.103 . . . . 1.6699999999999999 111.781 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 138' ' ' VAL . . . 84.47 -126.93 7.87 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.375 -0.917 . . . . 3.0800000000000001 111.246 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -176.16 -35.09 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.457 0.169 . . . . 7.2599999999999998 111.457 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 tp -143.82 -24.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.163 -0.615 . . . . 6.29 112.26 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 20.4 tp -83.13 21.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.45 0.643 . . . . 7.2699999999999996 111.036 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.9 m -152.71 114.42 4.32 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.136 -0.691 . . . . 5.1799999999999997 109.136 175.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -84.61 171.33 12.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.97 -0.559 . . . . 4.8099999999999996 110.492 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.659 HG23 ' H ' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -54.16 -56.53 25.18 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 111.663 0.246 . . . . 2.1099999999999999 111.663 177.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' A' ' 93' ' ' THR . 2.7 Cg_exo -76.32 75.79 4.15 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.486 2.124 . . . . 3.21 111.928 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 m -80.96 -26.45 36.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.347 -0.612 . . . . 3.5899999999999999 109.347 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.95 156.74 14.51 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.386 -0.825 . . . . 2.1000000000000001 111.928 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -88.93 129.6 35.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 2.2999999999999998 109.688 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.632 ' HB2' HG13 ' A' ' 163' ' ' VAL . 7.1 m-85 -118.74 177.55 4.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.535 -0.757 . . . . 1.9299999999999999 109.76 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 161' ' ' THR . 95.6 m-85 -139.02 143.33 38.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.57999999999999996 110.385 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.79 HD11 HD12 ' A' ' 125' ' ' ILE . 22.6 mm -59.96 126.08 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.54 -1.281 . . . . 0.40999999999999998 107.54 164.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -124.02 -23.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.653 -0.819 . . . . 0.37 112.808 -174.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 15.7 t-20 -161.3 161.34 30.56 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.328 1.233 . . . . 1.99 114.328 -173.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 1.0 OUTLIER -147.0 128.74 15.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 111.579 -2.555 . . . . 1.1899999999999999 109.515 174.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.686 ' HB3' ' CD1' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -109.26 161.54 15.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.562 1.172 . . . . 1.6699999999999999 111.542 -171.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.55 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 9.4 ttm180 -49.79 152.67 1.45 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 111.929 -2.396 . . . . 3.0600000000000001 112.544 171.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.55 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-20 -45.26 114.72 2.33 Favored Pre-proline 0 CA--C 1.515 -0.387 0 CA-C-N 114.556 -1.202 . . . . 2.6099999999999999 111.628 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HG3' ' NE1' ' A' ' 115' ' ' TRP . 85.3 Cg_exo -51.19 -48.16 22.44 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 C-N-CA 124.082 3.188 . . . . 0.97999999999999998 112.441 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.59 -4.26 59.7 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.441 -1.254 . . . . 1.0800000000000001 112.025 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -139.52 -171.55 12.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.989 -0.624 . . . . 1.05 112.736 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.64 20.15 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.724 3.616 . . . . 1.3 114.973 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 109' ' ' GLY . 46.6 t80 -74.55 -11.2 60.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.216 0.531 . . . . 1.3799999999999999 110.21 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.89 38.16 3.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.705 -0.76 . . . . 1.1100000000000001 114.31 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 73.25 -23.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.541 1.311 . . . . 0.81000000000000005 114.541 166.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.542 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -152.16 148.96 28.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.832 0.349 . . . . 1.1200000000000001 111.175 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.686 ' CD1' ' HB3' ' A' ' 104' ' ' GLN . 0.1 OUTLIER -110.4 101.6 10.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.489 -0.93 . . . . 2.1899999999999999 108.489 171.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.782 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.4 mp -111.44 138.18 48.27 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.073 -0.651 . . . . 0.60999999999999999 110.252 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 101' ' ' ILE . 10.0 t -107.32 151.34 25.61 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.717 -0.674 . . . . 0.93999999999999995 111.951 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.48 ' N ' ' HA2' ' A' ' 124' ' ' GLY . 1.0 OUTLIER -101.8 -174.1 2.51 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.275 -1.38 . . . . 1.0800000000000001 107.275 172.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.575 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 32.4 t -80.78 -76.78 0.22 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.678 -0.809 . . . . 1.5 110.716 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.464 ' HE2' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -126.56 149.2 49.56 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.113 0.412 . . . . 2.9700000000000002 112.113 -170.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 72.16 -60.96 0.51 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.179 0.992 . . . . 5.0599999999999996 113.404 169.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -79.67 10.97 3.45 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.83 0.307 . . . . 5.9500000000000002 111.83 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 64.03 -87.33 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.944 0.777 . . . . 4.8300000000000001 112.377 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.48 ' HA2' ' N ' ' A' ' 118' ' ' LEU . . . -156.24 162.33 31.35 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.258 -0.972 . . . . 0.94999999999999996 113.574 -175.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.79 HD12 HD11 ' A' ' 100' ' ' ILE . 32.3 mt -93.26 106.39 17.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.051 -1.092 . . . . 0.47999999999999998 108.051 169.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.577 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 9.9 p80 -140.69 -162.13 1.31 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.978 -0.689 . . . . 1.25 111.443 -172.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.62 -172.36 14.63 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.679 -1.248 . . . . 0.46000000000000002 113.13 -175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -154.7 178.15 10.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.209 0.528 . . . . 0.5 110.336 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -111.66 -12.79 13.85 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.425 -0.807 . . . . 1.8600000000000001 109.57 169.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -125.26 101.99 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.61 -0.723 . . . . 1.77 109.782 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.52 4.04 4.62 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.053 2.502 . . . . 0.58999999999999997 113.148 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.13 54.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.521 0.677 . . . . 0.78000000000000003 109.57 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -100.13 3.28 43.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.003 -0.999 . . . . 1.45 109.53 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 144' ' ' ARG . 16.7 mm -95.71 122.88 47.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 0.69999999999999996 110.256 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.53 -8.55 74.55 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.544 -1.022 . . . . 1.6799999999999999 110.544 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -151.38 80.98 1.3 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.904 -0.406 . . . . 4.3899999999999997 109.904 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.07 147.02 25.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.435 -0.348 . . . . 3.9399999999999999 110.646 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 33.4 m -111.75 148.42 14.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.448 -0.342 . . . . 4.6799999999999997 111.187 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.5 m 67.7 159.5 0.15 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.646 -0.707 . . . . 5.6799999999999997 111.744 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.611 ' HB2' ' N26' ' A' 1142 ' ' IM2 . 0.4 OUTLIER 71.82 -61.57 0.49 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.571 -0.741 . . . . 8.3000000000000007 112.04 175.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.18 82.74 0.24 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.79 -0.719 . . . . 3.8500000000000001 112.733 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.537 ' H ' ' HB3' ' A' ' 85' ' ' ALA . 69.0 m -110.13 165.3 11.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 2.5099999999999998 110.489 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.559 ' CG2' HG12 ' A' ' 125' ' ' ILE . 52.0 mt -124.44 83.83 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.587 0.708 . . . . 1.4399999999999999 110.014 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 21.6 mtp180 -119.03 161.35 20.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.484 -0.78 . . . . 3.3599999999999999 109.248 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' A' ' 149' ' ' ASP . 1.7 ttm -152.83 -165.35 2.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.778 0.323 . . . . 1.1299999999999999 111.063 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -71.73 154.19 41.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.306 -0.627 . . . . 2.5099999999999998 109.306 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.618 ' O ' HG12 ' A' ' 150' ' ' VAL . 5.4 p30 -51.52 -68.69 0.15 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.288 0.477 . . . . 1.77 112.288 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -60.15 -26.29 66.18 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 121.644 -0.66 . . . . 2.1299999999999999 112.315 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.453 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 62.9 m-20 -78.08 -34.33 50.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.523 -0.308 . . . . 1.05 111.639 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.649 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 11.6 p -74.97 -15.82 15.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.32000000000000001 109.651 175.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.542 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.5 mp -88.59 -37.34 10.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.178 -0.464 . . . . 0.37 110.33 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -43.43 -71.8 0.07 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.375 0.989 . . . . 1.3799999999999999 112.098 162.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.5 tp -49.03 -42.42 38.18 Favored 'General case' 0 C--O 1.222 -0.343 0 O-C-N 123.747 0.654 . . . . 0.73999999999999999 110.147 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.43 -54.66 29.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.298 -1.319 . . . . 0.22 112.033 -172.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.6 p -77.82 -14.81 59.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.313 -1.312 . . . . 1.3300000000000001 111.619 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.14 -51.83 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.82 -0.437 . . . . 0.23000000000000001 109.82 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.8 m -77.13 118.06 69.39 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-O 121.952 0.882 . . . . 0.20999999999999999 110.229 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.804 ' HG2' HD13 ' A' ' 57' ' ' ILE . 41.1 Cg_endo -83.88 -178.42 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.022 2.481 . . . . 0.34000000000000002 112.832 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.691 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.4 m120 -59.84 -0.46 0.2 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.621 -1.172 . . . . 1.02 113.641 -174.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.59 57.46 0.53 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.28000000000000003 112.235 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -94.46 132.78 38.75 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.441 -0.446 . . . . 0.29999999999999999 109.951 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -84.54 140.28 31.53 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.676 -0.41 . . . . 1.96 109.995 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.4 p -145.48 126.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.584 -0.735 . . . . 0.46000000000000002 110.744 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.453 ' C ' HD12 ' A' ' 165' ' ' ILE . 92.0 m -116.51 144.19 44.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.813 -0.63 . . . . 0.56000000000000005 111.646 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.507 HG13 HG13 ' A' ' 63' ' ' VAL . 3.3 mp -125.96 114.17 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 118.819 -1.152 . . . . 0.95999999999999996 110.58 173.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.31 135.82 25.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.155 -1.384 . . . . 1.1899999999999999 108.698 -175.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.659 ' H ' HG23 ' A' ' 93' ' ' THR . 8.0 ptm180 -92.37 -24.99 18.72 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.143 0.423 . . . . 3.4199999999999999 112.143 -177.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.538 ' H ' HG23 ' A' ' 93' ' ' THR . . . -177.47 -127.97 1.11 Allowed Glycine 0 C--N 1.309 -0.935 0 N-CA-C 111.464 -0.654 . . . . 3.6499999999999999 111.464 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.249 1.052 0 N-CA-C 109.507 -0.553 . . . . 5.9699999999999998 109.507 177.463 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.611 ' N26' ' HB2' ' A' ' 140' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.613 -0.595 . . . . 2.9199999999999999 111.613 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 9.9 mpt_? -101.0 177.96 4.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.099 0.476 . . . . 4.0999999999999996 110.672 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.62 ' HE2' ' H ' ' A' ' 3' ' ' LYS . 1.8 mppt? -62.43 147.08 49.72 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.326 -0.852 . . . . 2.1000000000000001 109.64 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -100.92 168.32 9.7 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.143 0.277 . . . . 0.26000000000000001 111.374 176.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.702 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.6 tp -78.16 149.81 33.7 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.303 0.641 . . . . 0.23000000000000001 112.189 -169.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.565 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -116.18 149.46 39.06 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.953 0.882 . . . . 0.26000000000000001 112.123 169.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' SER . 65.3 t80 -133.9 149.86 51.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.761 -1.563 . . . . 0.39000000000000001 107.498 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -129.86 116.07 18.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.163 -1.421 . . . . 1.0700000000000001 107.163 174.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -77.17 158.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.203 0.525 . . . . 0.38 111.885 -166.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -104.94 152.66 22.4 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.417 -0.811 . . . . 2.5899999999999999 108.947 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.717 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -53.0 119.69 4.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.962 -0.563 . . . . 1.74 111.694 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.03 -10.42 37.2 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.56999999999999995 113.15 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.543 ' HB3' HD11 ' A' ' 18' ' ' ILE . 80.9 m-20 -59.33 154.52 16.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.814 0.672 . . . . 2.1699999999999999 112.814 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.521 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -133.95 150.79 51.31 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.972 -0.558 . . . . 0.5 112.071 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.598 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.1 tp -48.33 -58.7 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.674 0.99 . . . . 0.27000000000000002 113.674 -172.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.674 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 11.0 t-20 -64.69 -42.4 95.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.546 1.165 . . . . 1.21 110.233 -169.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -59.06 -45.65 90.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.428 -2.169 . . . . 1.24 110.031 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -70.43 -41.14 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.715 -0.675 . . . . 0.29999999999999999 111.867 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.684 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.58 -66.22 0.48 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 111.812 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -4.6 48.27 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.989 -1.084 . . . . 0.39000000000000001 112.352 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.51 -29.67 69.15 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.16 -0.682 . . . . 1.6299999999999999 109.16 158.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD1' HG13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -95.41 10.49 36.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.034 0.445 . . . . 0.23999999999999999 111.961 173.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 59.95 50.3 6.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.256 -0.883 . . . . 3.5499999999999998 110.513 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.684 HG12 ' O ' ' A' ' 19' ' ' ALA . 39.6 pt -147.7 -174.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.608 -0.886 . . . . 0.27000000000000002 108.608 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.2 m -101.07 147.7 25.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.559 -0.746 . . . . 0.81000000000000005 109.755 173.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.674 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -61.74 -36.09 79.98 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.745 -0.661 . . . . 0.27000000000000002 109.251 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.39 71.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.502 -1.227 . . . . 0.26000000000000001 111.677 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.28 -37.54 37.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.196 -0.602 . . . . 0.23000000000000001 109.451 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 46' ' ' ILE . 16.3 tp -74.17 -19.75 60.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.433 -0.803 . . . . 0.17000000000000001 109.115 176.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.711 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.08 -38.68 35.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.454 0.645 . . . . 0.19 111.652 173.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -58.89 -43.17 90.9 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 122.223 1.011 . . . . 1.0700000000000001 109.834 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.53 44.08 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.576 -1.647 . . . . 0.17000000000000001 111.929 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.617 HD21 ' H ' ' A' ' 47' ' ' VAL . 32.8 m-80 -142.6 72.85 20.27 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.19 109.75 -172.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.3 Cg_endo -54.91 -16.53 11.97 Favored 'Trans proline' 0 C--N 1.333 -0.273 0 C-N-CA 123.598 2.865 . . . . 0.29999999999999999 113.991 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 t -61.12 -32.65 72.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.068 0.937 . . . . 1.1699999999999999 109.727 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.664 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.63 -4.47 51.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.295 -1.32 . . . . 0.53000000000000003 114.484 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.711 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.92 -41.24 45.68 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 119.883 1.219 . . . . 1.23 109.856 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.582 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.63 -45.3 11.85 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.946 -1.933 . . . . 0.40000000000000002 111.597 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.84 -166.31 37.49 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.324 -0.941 . . . . 0.29999999999999999 113.781 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.8 mp -115.92 158.23 23.33 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.591 -1.304 . . . . 0.31 110.364 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.626 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.6 m -131.27 133.68 45.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.994 -0.548 . . . . 0.39000000000000001 110.643 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.55 127.93 9.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.108 0.781 . . . . 0.46999999999999997 113.108 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.77 -11.04 48.98 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.33 -1.304 . . . . 0.35999999999999999 112.322 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.626 ' HB3' ' O ' ' A' ' 41' ' ' THR . 5.6 tt0 -65.06 152.12 44.3 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.526 0.679 . . . . 1.1899999999999999 110.355 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 69.1 p -116.04 133.71 55.74 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.691 -1.14 . . . . 0.89000000000000001 109.758 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 29' ' ' LEU . 21.7 pt -136.12 144.03 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.464 0.649 . . . . 0.22 110.54 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.617 ' H ' HD21 ' A' ' 33' ' ' ASN . 11.9 t -90.72 150.09 3.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.805 -1.089 . . . . 0.20999999999999999 110.39 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.607 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.2 mm -117.95 87.1 26.94 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 114.849 -1.069 . . . . 0.17000000000000001 108.245 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.699 ' HA ' HD13 ' A' ' 4' ' ' LEU . 28.4 Cg_endo -59.79 142.51 98.78 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.488 2.792 . . . . 0.23000000000000001 113.023 -172.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.534 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.44 -7.78 63.64 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.56 -0.746 . . . . 0.29999999999999999 112.69 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.644 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.2 tt -115.45 127.13 27.06 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.771 -0.826 . . . . 0.25 108.771 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 55.3 Cg_endo -64.97 174.04 5.2 Favored 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.817 3.011 . . . . 0.31 113.7 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 4.9 t70 -95.75 138.73 21.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.428 -0.805 . . . . 0.71999999999999997 111.996 -168.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HD3' HD12 ' A' ' 5' ' ' LEU . 97.3 Cg_endo -77.74 -9.76 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.388 2.725 . . . . 0.27000000000000002 113.271 -172.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -94.98 -25.32 16.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 2.1099999999999999 110.444 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 3' ' ' LYS . 21.9 p -68.4 -31.79 71.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 122.3 1.048 . . . . 1.47 108.233 169.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.831 HD13 ' HG2' ' A' ' 158' ' ' PRO . 95.5 mt -77.25 126.87 84.52 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 113.362 -1.745 . . . . 0.26000000000000001 110.854 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -102.15 95.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 121.084 1.19 . . . . 0.20000000000000001 110.53 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' SER . 89.3 m-85 -158.42 133.34 8.41 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.886 -1.524 . . . . 0.26000000000000001 106.886 172.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 10.8 m-70 -138.91 109.05 6.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.729 -1.582 . . . . 2.8399999999999999 106.729 -168.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -94.65 109.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.126 -0.943 . . . . 0.32000000000000001 110.135 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.73 96.42 5.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.046 0.927 . . . . 0.34000000000000002 110.396 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.0 OUTLIER -115.74 97.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.028 -1.442 . . . . 0.68000000000000005 109.741 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -89.29 128.13 35.84 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.994 -1.003 . . . . 1.05 108.494 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.598 HG21 ' HE ' ' A' ' 167' ' ' ARG . 15.5 mm -57.91 -35.26 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.611 -0.885 . . . . 1.29 108.611 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.54 -43.68 91.72 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 114.355 -1.293 . . . . 0.88 111.828 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -69.96 -23.91 63.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.404 0.52 . . . . 0.73999999999999999 112.404 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HE2' ' CG1' ' A' ' 86' ' ' VAL . 32.4 mttt 58.14 15.32 3.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.07 0.948 . . . . 2.5099999999999998 112.857 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.49 143.26 33.73 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.556 0.694 . . . . 0.45000000000000001 111.462 175.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.509 ' CD1' HD11 ' A' ' 143' ' ' ILE . 4.7 tt -94.45 122.68 37.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.362 -1.29 . . . . 0.33000000000000002 109.766 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -103.36 123.77 47.43 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.041 -0.664 . . . . 0.40000000000000002 111.267 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.535 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.76 141.47 32.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.323 -1.732 . . . . 0.33000000000000002 106.323 176.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 2.4 m -144.6 125.91 14.77 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 120.456 1.48 . . . . 0.75 112.483 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.3 tp -112.53 127.81 56.17 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 0.34999999999999998 110.085 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 7.3 t-20 63.13 32.89 14.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.385 0.612 . . . . 0.52000000000000002 109.519 173.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.7 m-20 79.86 1.44 2.12 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.536 -1.211 . . . . 1.8400000000000001 112.493 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -129.15 138.73 51.95 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.707 -1.197 . . . . 3.1899999999999999 113.698 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.01 147.94 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-N 113.329 -1.76 . . . . 0.40999999999999998 113.553 -170.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.535 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -99.68 -44.45 6.11 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 112.087 -2.324 . . . . 0.34999999999999998 108.121 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 34.4 tptt -176.89 164.75 2.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 112.491 -2.14 . . . . 2.0699999999999998 110.661 -176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 m -124.16 134.41 53.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.893 -0.14 . . . . 0.37 111.304 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -124.51 134.62 25.71 Favored Pre-proline 0 CA--C 1.521 -0.154 0 CA-C-O 121.027 0.441 . . . . 0.96999999999999997 111.637 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.4 ' HB2' HG22 ' A' ' 134' ' ' ILE . 25.6 Cg_endo -63.78 146.64 92.18 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.985 2.456 . . . . 0.59999999999999998 111.967 174.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.52 -178.2 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.834 -0.432 . . . . 0.64000000000000001 109.834 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.84 119.04 24.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.666 0.746 . . . . 0.82999999999999996 111.575 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.598 ' CG1' ' HE2' ' A' ' 68' ' ' LYS . 8.8 t -140.98 137.43 34.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.344 -1.298 . . . . 1.6699999999999999 108.872 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.42 -117.25 2.88 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.471 -0.871 . . . . 3.0800000000000001 112.032 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.486 ' HG2' ' H ' ' A' ' 90' ' ' LEU . 56.7 tttp -91.93 135.0 34.28 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.733 -0.469 . . . . 7.2599999999999998 109.733 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.9 pt -67.8 -10.25 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.93 0.345 . . . . 6.29 111.93 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.486 ' H ' ' HG2' ' A' ' 88' ' ' LYS . 29.4 tp -84.88 44.33 1.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.449 0.643 . . . . 7.2699999999999996 110.229 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -117.66 156.02 28.92 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.958 -0.564 . . . . 5.1799999999999997 110.529 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -78.57 135.45 37.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.012 0.434 . . . . 4.8099999999999996 110.756 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.616 HG22 ' H ' ' A' ' 167' ' ' ARG . 37.8 p -61.01 122.76 71.67 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.805 -0.634 . . . . 2.1099999999999999 110.118 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -86.0 18.03 1.65 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.572 2.181 . . . . 3.21 113.746 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.1 p 49.17 37.79 11.79 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.217 0.607 . . . . 3.5899999999999999 111.091 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.44 94.25 1.84 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.565 -0.743 . . . . 2.1000000000000001 112.63 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.59 117.01 24.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.7 -0.852 . . . . 2.2999999999999998 108.7 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 118' ' ' LEU . 33.5 m-85 -134.62 179.24 6.41 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.736 -0.665 . . . . 1.9299999999999999 110.445 -171.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.673 ' HA ' ' O ' ' A' ' 161' ' ' THR . 37.1 m-85 -124.5 143.64 50.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.506 -0.77 . . . . 0.57999999999999996 109.716 170.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.681 HD11 HD12 ' A' ' 125' ' ' ILE . 13.3 mm -59.35 121.77 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.393 -1.336 . . . . 0.40999999999999998 107.393 164.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.611 HG13 ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -109.49 -45.7 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 120.024 -0.67 . . . . 0.37 111.275 -173.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 101' ' ' ILE . 5.6 t-20 -153.32 173.39 15.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 118.665 -1.214 . . . . 1.99 113.975 -170.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.751 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -139.18 128.18 23.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 111.948 -2.387 . . . . 1.1899999999999999 109.194 -179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.2 149.11 23.89 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.237 1.018 . . . . 1.6699999999999999 111.46 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -52.6 151.2 4.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.859 -1.973 . . . . 3.0600000000000001 112.765 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.67 107.14 0.62 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 113.694 -1.594 . . . . 2.6099999999999999 111.589 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -53.08 -50.19 14.92 Favored 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 124.416 3.411 . . . . 0.97999999999999998 112.727 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.12 -20.31 12.88 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.164 -0.925 . . . . 1.0800000000000001 112.46 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.41 -170.01 13.83 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.053 -0.594 . . . . 1.05 112.085 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.95 33.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 124.578 3.519 . . . . 1.3 114.093 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.413 ' H ' ' C ' ' A' ' 109' ' ' GLY . 4.4 t80 -86.31 -8.07 58.01 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.17 0.51 . . . . 1.3799999999999999 110.12 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.604 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 100.89 32.57 5.3 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 115.517 0.967 . . . . 1.1100000000000001 115.517 168.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 70.09 -21.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.207 1.188 . . . . 0.81000000000000005 114.207 168.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -157.2 128.73 6.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.119 -0.697 . . . . 1.1200000000000001 109.119 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -101.76 100.07 10.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.526 -0.916 . . . . 2.1899999999999999 108.526 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.751 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.4 mp -101.78 136.31 41.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.615 0.722 . . . . 0.60999999999999999 109.756 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 101' ' ' ILE . 68.8 m -106.5 152.05 24.17 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.239 -0.891 . . . . 0.93999999999999995 111.626 -171.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.642 HD11 HG11 ' A' ' 163' ' ' VAL . 1.5 tp -101.39 165.03 11.48 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.86 -1.064 . . . . 1.0800000000000001 108.729 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.56 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 30.5 t -53.25 -32.05 46.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.401 . . . . 1.5 111.975 -175.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 122' ' ' HIS . 16.6 tptm -126.99 160.01 32.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.506 -0.554 . . . . 2.9700000000000002 109.506 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -73.11 45.94 0.17 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.623 0.725 . . . . 5.0599999999999996 110.861 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 123' ' ' TYR . 23.6 m-70 -138.66 119.79 14.57 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.287 -1.005 . . . . 5.9500000000000002 108.287 175.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 122' ' ' HIS . 61.1 m-85 67.44 147.11 0.05 OUTLIER 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.968 0.792 . . . . 4.8300000000000001 110.969 -171.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.2 126.8 1.99 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.469 -0.653 . . . . 0.94999999999999996 111.469 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 55.4 mt -91.3 113.36 26.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.181 0.515 . . . . 0.47999999999999998 109.646 -175.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.584 ' CE1' ' HD3' ' A' ' 144' ' ' ARG . 7.4 p80 -152.11 -162.34 1.49 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.191 0.519 . . . . 1.25 110.718 -177.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.604 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.4 171.12 14.52 Favored Glycine 0 C--N 1.311 -0.843 0 C-N-CA 119.838 -1.172 . . . . 0.46000000000000002 112.98 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -129.66 173.03 11.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.724 0.773 . . . . 0.5 111.809 -168.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 129' ' ' ASN . 1.6 t-20 -108.92 -20.65 12.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.382 -1.281 . . . . 1.8600000000000001 109.078 165.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -124.79 103.6 30.99 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.261 -0.881 . . . . 1.77 109.696 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.8 3.77 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.294 2.662 . . . . 0.58999999999999997 113.926 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.65 -13.16 59.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.58 0.705 . . . . 0.78000000000000003 110.211 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.465 ' HB3' ' OG ' ' A' ' 139' ' ' SER . 21.7 m -96.26 6.97 47.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.185 -0.916 . . . . 1.45 109.943 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 83' ' ' PRO . 23.8 mm -97.55 116.4 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.394 -0.821 . . . . 0.69999999999999996 110.376 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.92 -55.91 1.86 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.796 -0.716 . . . . 1.6799999999999999 112.45 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -102.0 43.86 1.04 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.718 0.294 . . . . 4.3899999999999997 110.958 -177.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -173.0 146.03 1.45 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 3.9399999999999999 110.178 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.95 -34.45 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.236 0.541 . . . . 4.6799999999999997 110.831 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 133' ' ' SER . 26.2 m 52.81 27.47 5.42 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.813 -1.085 . . . . 5.6799999999999997 113.462 171.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.1 mttp 62.04 19.46 10.81 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.447 0.467 . . . . 8.3000000000000007 111.879 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 142' ' ' CYS . . . 103.58 -158.36 17.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.541 -0.838 . . . . 3.8500000000000001 112.38 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 141' ' ' GLY . 70.0 m 80.56 171.4 0.14 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.557 0.743 . . . . 2.5099999999999998 110.664 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 8.1 tt -153.96 92.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.775 0.798 . . . . 1.4399999999999999 110.534 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.584 ' HD3' ' CE1' ' A' ' 126' ' ' HIS . 34.2 ptt180 -142.87 163.1 33.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.887 -0.597 . . . . 3.3599999999999999 111.864 -172.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -144.35 -161.12 1.22 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.779 -0.646 . . . . 1.1299999999999999 109.669 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.489 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 48.8 m80 -70.53 166.14 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.983 -0.377 . . . . 2.5099999999999998 109.983 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.594 ' O ' HG12 ' A' ' 150' ' ' VAL . 21.1 p-10 -54.26 -69.04 0.14 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 111.893 0.331 . . . . 1.77 111.893 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.01 -27.3 66.77 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.564 -0.71 . . . . 2.1299999999999999 111.236 -176.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.489 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 3.1 m-20 -63.67 -46.82 83.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.923 -0.58 . . . . 1.05 110.545 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.1 p -77.35 -17.44 14.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-N 115.754 -0.657 . . . . 0.32000000000000001 111.078 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.445 HD12 HG13 ' A' ' 150' ' ' VAL . 2.4 mp -85.46 -39.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 118.969 -0.538 . . . . 0.37 110.443 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -44.45 -69.97 0.12 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.705 1.139 . . . . 1.3799999999999999 112.244 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.705 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.5 tp -49.82 -43.79 48.87 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.469 -0.787 . . . . 0.73999999999999999 110.287 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.54 -48.36 69.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.256 -1.338 . . . . 0.22 111.819 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 35.0 t -79.63 -19.98 47.89 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.579 -1.191 . . . . 1.3300000000000001 110.85 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 -48.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.782 -0.451 . . . . 0.23000000000000001 109.782 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.4 m -77.45 116.47 58.14 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-O 121.802 0.811 . . . . 0.20999999999999999 109.93 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.831 ' HG2' HD13 ' A' ' 57' ' ' ILE . 32.3 Cg_endo -84.46 -178.35 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.099 2.533 . . . . 0.34000000000000002 112.442 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.644 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.4 m120 -63.27 5.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.743 -1.117 . . . . 1.02 113.349 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -148.19 58.2 0.47 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.89 -0.671 . . . . 0.28000000000000003 112.56 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.3 m -92.75 136.71 33.0 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 122.447 -0.443 . . . . 0.29999999999999999 110.671 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -83.85 129.52 34.93 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.642 -0.423 . . . . 1.96 110.301 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.642 HG11 HD11 ' A' ' 118' ' ' LEU . 4.4 p -136.37 127.3 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.23 0.538 . . . . 0.46000000000000002 111.19 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.4 ' O ' HG13 ' A' ' 63' ' ' VAL . 10.4 m -119.23 134.64 55.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.768 -0.651 . . . . 0.56000000000000005 111.689 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -121.82 108.68 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 119.32 -0.952 . . . . 0.95999999999999996 110.673 175.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.652 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.2 136.27 27.95 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.061 -0.972 . . . . 1.1899999999999999 111.177 -168.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.616 ' H ' HG22 ' A' ' 93' ' ' THR . 5.1 mpt_? -70.35 -32.52 70.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.091 -1.413 . . . . 3.4199999999999999 111.348 176.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.11 -129.48 7.22 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.161 -0.775 . . . . 3.6499999999999999 111.161 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.251 1.148 0 C-N-CA 122.749 0.419 . . . . 5.9699999999999998 111.114 177.323 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.462 ' N26' ' NH1' ' A' ' 144' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.671 -0.572 . . . . 2.9199999999999999 111.671 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -94.53 135.76 35.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.011 -0.366 . . . . 4.0999999999999996 110.011 179.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.8 mptt -62.22 153.43 30.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.983 -0.553 . . . . 2.1000000000000001 110.135 175.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.5 mt -89.15 168.9 11.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.092 -0.504 . . . . 0.26000000000000001 110.629 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.617 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.3 tp -77.39 150.08 35.12 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 122.988 0.515 . . . . 0.23000000000000001 112.119 -169.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.12 150.43 36.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.891 0.853 . . . . 0.26000000000000001 111.67 167.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' SER . 69.2 t80 -135.48 151.82 50.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.717 -1.583 . . . . 0.39000000000000001 108.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.627 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -131.67 118.74 20.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.61 -1.256 . . . . 1.0700000000000001 107.61 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.532 HG11 HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -80.53 159.34 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 123.333 0.653 . . . . 0.38 112.011 -169.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.409 ' N ' HG23 ' A' ' 9' ' ' VAL . 89.3 mttt -108.37 152.07 25.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.711 -0.677 . . . . 2.5899999999999999 109.198 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.664 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -50.54 119.4 3.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 1.74 112.175 -175.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.67 -4.2 42.8 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.028 -0.987 . . . . 0.56999999999999995 113.144 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.624 ' HB3' HD11 ' A' ' 18' ' ' ILE . 7.3 m-20 -65.62 156.81 31.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.535 0.668 . . . . 2.1699999999999999 112.529 177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.523 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -131.96 148.16 52.5 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 112.829 0.677 . . . . 0.5 112.829 -176.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.609 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.0 tp -46.5 -58.91 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.771 1.026 . . . . 0.27000000000000002 113.771 -173.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.654 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 20.3 t-20 -64.73 -40.28 95.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.583 1.183 . . . . 1.21 110.328 -170.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.781 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 10.9 m -60.87 -42.75 98.49 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 112.602 -2.09 . . . . 1.24 110.398 -178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -73.38 -39.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 O-C-N 123.831 0.707 . . . . 0.29999999999999999 112.332 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.689 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.1 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.396 -0.365 . . . . 0.23000000000000001 111.522 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -4.75 52.31 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 118.902 -1.119 . . . . 0.39000000000000001 111.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.781 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.2 t0 -60.7 -42.63 97.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.461 -1.311 . . . . 1.6299999999999999 107.461 157.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.7 m-85 -93.55 16.78 12.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.5 0.556 . . . . 0.23999999999999999 112.5 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HG2' HD13 ' A' ' 101' ' ' ILE . 7.0 mmm180 53.82 51.86 14.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 3.5499999999999998 111.002 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.689 HG12 ' O ' ' A' ' 19' ' ' ALA . 35.7 pt -147.26 -172.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.928 -0.768 . . . . 0.27000000000000002 108.928 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.97 148.01 23.91 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 0.81000000000000005 109.682 172.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.654 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 23.3 p -63.39 -35.74 81.4 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.683 -0.858 . . . . 0.27000000000000002 108.683 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.14 -32.58 74.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.303 -1.317 . . . . 0.26000000000000001 111.38 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.05 -37.58 38.62 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.273 0.559 . . . . 0.23000000000000001 109.634 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 46' ' ' ILE . 12.6 tp -74.18 -18.8 60.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.401 -0.818 . . . . 0.17000000000000001 109.027 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.743 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.28 34.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.462 0.649 . . . . 0.19 111.424 172.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 60.3 mt-30 -57.08 -46.26 82.67 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 122.248 1.023 . . . . 1.0700000000000001 109.458 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.0 47.97 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.18 -1.827 . . . . 0.17000000000000001 112.202 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.612 HD21 ' H ' ' A' ' 47' ' ' VAL . 29.1 m-80 -142.96 72.71 18.67 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-O 121.153 0.502 . . . . 0.19 109.903 -173.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.492 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 17.8 Cg_endo -57.24 -11.42 8.03 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 123.7 2.933 . . . . 0.29999999999999999 114.187 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 t -62.86 -34.19 76.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.049 0.928 . . . . 1.1699999999999999 109.915 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.7 mt -78.27 -4.99 50.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.438 -1.255 . . . . 0.53000000000000003 114.372 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.743 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -51.08 -39.44 56.08 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 122.342 1.068 . . . . 1.23 110.049 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.592 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -83.98 -46.47 12.02 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 112.987 -1.915 . . . . 0.40000000000000002 111.437 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.28 -164.09 34.4 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.502 -0.856 . . . . 0.29999999999999999 114.008 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.532 HD23 HG11 ' A' ' 9' ' ' VAL . 6.0 mp -118.16 157.41 26.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.401 -1.4 . . . . 0.31 110.088 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.582 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 92.6 m -134.15 136.8 44.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.704 -0.68 . . . . 0.39000000000000001 110.428 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.02 126.89 7.92 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.282 0.845 . . . . 0.46999999999999997 113.282 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.627 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.52 -11.78 49.78 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.528 -1.215 . . . . 0.35999999999999999 112.002 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 3.7 tt0 -63.09 150.25 43.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.766 0.793 . . . . 1.1899999999999999 110.466 175.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 22.9 m -118.45 134.51 55.01 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.231 -1.35 . . . . 0.89000000000000001 109.13 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 29' ' ' LEU . 18.0 pt -137.14 151.91 27.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.445 0.64 . . . . 0.22 110.513 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.612 ' H ' HD21 ' A' ' 33' ' ' ASN . 16.7 t -96.75 149.21 4.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.013 -0.994 . . . . 0.20999999999999999 110.074 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.603 ' CG1' HD23 ' A' ' 5' ' ' LEU . 20.1 mm -117.65 88.84 31.05 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 108.309 -0.997 . . . . 0.17000000000000001 108.309 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.742 ' HA ' HD13 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.83 142.14 98.05 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.014 2.476 . . . . 0.23000000000000001 112.717 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.48 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.06 -6.91 65.08 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.525 -0.761 . . . . 0.29999999999999999 112.995 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.681 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -117.9 127.74 26.44 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 108.737 -0.838 . . . . 0.25 108.737 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.5 Cg_endo -68.56 174.31 8.59 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.819 3.013 . . . . 0.31 113.93 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.6 t70 -89.57 142.48 29.47 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.881 -1.054 . . . . 0.71999999999999997 110.185 -173.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HD3' HD12 ' A' ' 5' ' ' LEU . 84.2 Cg_endo -80.96 -6.2 13.13 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.225 2.617 . . . . 0.27000000000000002 111.973 -174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -95.85 -25.62 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.256 -0.429 . . . . 2.1099999999999999 111.099 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 53' ' ' ASP . 28.6 p -70.49 -27.06 63.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.495 1.14 . . . . 1.47 108.028 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HG2' ' A' ' 158' ' ' PRO . 96.9 mt -81.98 129.23 65.32 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 112.936 -1.938 . . . . 0.26000000000000001 110.66 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -102.75 95.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 121.112 1.208 . . . . 0.20000000000000001 110.761 165.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' SER . 86.8 m-85 -158.3 129.3 6.39 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.869 -1.53 . . . . 0.26000000000000001 106.869 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 31.4 m-70 -136.69 105.13 5.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.983 -1.488 . . . . 2.8399999999999999 106.983 -165.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 80.6 mt -94.15 113.42 28.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.282 -0.872 . . . . 0.32000000000000001 110.703 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.6 95.19 5.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.366 -0.834 . . . . 0.34000000000000002 110.752 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -110.18 112.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.431 -1.259 . . . . 0.68000000000000005 109.479 177.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.626 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 49.5 m -107.38 135.63 48.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.836 -0.62 . . . . 1.05 110.629 -175.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.535 HG23 ' HB ' ' A' ' 86' ' ' VAL . 1.2 mt -57.32 -38.96 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.772 0.796 . . . . 1.29 110.269 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' H ' ' HA ' ' A' ' 167' ' ' ARG . . . -68.21 -45.73 69.06 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.32 -1.309 . . . . 0.88 111.717 177.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -74.41 -24.65 59.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.347 0.594 . . . . 0.73999999999999999 112.052 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HG2' HG11 ' A' ' 86' ' ' VAL . 32.7 mttt 53.41 24.53 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.283 1.033 . . . . 2.5099999999999998 111.732 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.472 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.5 OUTLIER -141.63 143.78 33.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.93 0.872 . . . . 0.45000000000000001 110.934 177.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.8 tt -98.6 117.94 34.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.82 -1.536 . . . . 0.33000000000000002 109.147 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -100.16 125.37 46.28 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.378 -0.529 . . . . 0.40000000000000002 110.67 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.01 147.88 27.91 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.789 -1.56 . . . . 0.33000000000000002 106.789 177.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 25.5 m -151.4 129.39 11.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 120.316 1.416 . . . . 0.75 112.729 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 tp -117.3 129.39 55.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.917 -1.038 . . . . 0.34999999999999998 110.755 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 63.4 35.56 12.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.377 0.608 . . . . 0.52000000000000002 109.679 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 77.48 2.75 3.09 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.595 -1.184 . . . . 1.8400000000000001 111.784 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -129.95 138.74 51.03 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.41 -1.316 . . . . 3.1899999999999999 114.032 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -54.53 149.36 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 113.162 -1.835 . . . . 0.40999999999999998 112.822 -173.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -99.48 -45.57 5.77 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 112.675 -2.057 . . . . 0.34999999999999998 108.38 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 179.53 157.61 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 112.805 -1.998 . . . . 2.0699999999999998 110.388 -175.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.472 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.3 m -116.44 136.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.788 0.327 . . . . 0.37 111.661 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -116.89 153.27 49.35 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.088 -0.505 . . . . 0.96999999999999997 110.192 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -86.11 143.09 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.59 2.193 . . . . 0.59999999999999998 111.424 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.52 ' HB ' ' CG1' ' A' ' 143' ' ' ILE . 0.1 OUTLIER -145.96 179.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.672 -0.24 . . . . 0.64000000000000001 110.59 -178.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' HG12 ' A' ' 84' ' ' ILE . . . -87.01 158.88 19.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.485 0.66 . . . . 0.82999999999999996 111.64 177.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 65' ' ' ILE . 18.6 m -134.72 141.79 42.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.87 -1.059 . . . . 1.6699999999999999 108.796 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.93 176.59 19.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.821 -1.18 . . . . 3.0800000000000001 113.43 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.4 tttp 59.32 62.12 1.88 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.158 0.504 . . . . 7.2599999999999998 110.237 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.425 HG13 HG22 ' A' ' 138' ' ' VAL . 23.8 mm -81.09 64.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.314 0.578 . . . . 6.29 111.106 -174.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.2 mt -141.65 -62.42 0.46 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.597 -0.729 . . . . 7.2699999999999996 109.884 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.419 ' O ' ' HB3' ' A' ' 92' ' ' GLN . 15.0 t -178.68 -175.17 0.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.602 -0.726 . . . . 5.1799999999999997 109.14 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' O ' ' HD2' ' A' ' 167' ' ' ARG . 57.2 tp60 74.1 126.27 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.83 0.706 . . . . 4.8099999999999996 111.983 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.701 HG22 ' H ' ' A' ' 167' ' ' ARG . 18.3 p -81.88 109.94 17.61 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.349 -0.841 . . . . 2.1099999999999999 109.462 172.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 92' ' ' GLN . 32.9 Cg_exo -60.84 134.44 53.64 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.741 1.627 . . . . 3.21 110.863 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.2 m -77.23 62.94 2.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.63 0.729 . . . . 3.5899999999999999 109.686 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.01 66.52 0.42 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.487 -0.779 . . . . 2.1000000000000001 112.345 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -94.43 121.54 36.08 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.336 -0.616 . . . . 2.2999999999999998 109.336 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.596 ' HB3' ' H ' ' A' ' 119' ' ' SER . 33.4 m-85 -132.3 177.84 7.27 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.067 -0.97 . . . . 1.9299999999999999 111.185 -174.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' A' ' 161' ' ' THR . 48.9 m-85 -128.62 138.52 52.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.476 -0.784 . . . . 0.57999999999999996 109.897 171.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 125' ' ' ILE . 21.7 mm -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.926 -1.139 . . . . 0.40999999999999998 107.926 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.593 HD12 ' CD1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -111.55 -33.54 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 119.897 -0.721 . . . . 0.37 112.666 -177.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 28.5 p-10 -166.47 -167.77 1.07 Allowed 'General case' 0 N--CA 1.46 0.062 0 CA-C-O 122.383 1.087 . . . . 1.99 113.846 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -156.84 141.6 16.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 112.391 -2.186 . . . . 1.1899999999999999 111.501 178.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 23.5 tp60 -109.92 142.18 41.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.142 -0.936 . . . . 1.6699999999999999 110.957 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -53.25 150.0 6.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.645 -1.616 . . . . 3.0600000000000001 112.115 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.81 103.17 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 114.448 -1.251 . . . . 2.6099999999999999 111.434 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -54.42 -49.77 15.77 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 124.151 3.234 . . . . 0.97999999999999998 112.362 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.29 -16.01 20.1 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.995 -1.002 . . . . 1.0800000000000001 112.393 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.97 -170.38 14.35 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.012 -0.613 . . . . 1.05 112.675 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.28 16.17 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.633 3.556 . . . . 1.3 114.99 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -66.66 -24.6 66.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.597 . . . . 1.3799999999999999 109.933 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 127' ' ' GLY . . . 99.63 60.52 0.85 Allowed Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.331 -0.849 . . . . 1.1100000000000001 114.934 168.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.54 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 72.96 -57.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.941 1.089 . . . . 0.81000000000000005 113.941 166.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -146.79 137.31 23.76 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.59 -0.522 . . . . 1.1200000000000001 109.59 -173.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.679 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 76.2 t-105 -103.74 101.04 10.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.272 -0.64 . . . . 2.1899999999999999 109.272 169.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.4 mp -104.51 109.23 21.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.585 0.707 . . . . 0.60999999999999999 109.769 175.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.506 ' HB3' ' CG2' ' A' ' 101' ' ' ILE . 3.5 t -79.01 146.3 33.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 0.93999999999999995 111.069 -168.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -92.88 177.02 6.21 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.591 -1.262 . . . . 1.0800000000000001 107.591 171.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 36.0 t -79.89 8.74 6.3 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.869 0.322 . . . . 1.5 111.869 -172.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -130.57 128.8 41.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.847 -0.427 . . . . 2.9700000000000002 109.847 170.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -71.26 52.65 0.18 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.373 0.606 . . . . 5.0599999999999996 111.272 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -149.79 -27.8 0.25 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.763 -0.653 . . . . 5.9500000000000002 109.643 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 99.6 m-85 -123.96 143.71 50.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 4.8300000000000001 109.64 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.62 ' O ' HG22 ' A' ' 143' ' ' ILE . . . -154.57 151.67 23.31 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.358 -0.925 . . . . 0.94999999999999996 112.248 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.754 HD12 HD11 ' A' ' 100' ' ' ILE . 21.1 mt -91.67 116.6 33.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.075 -0.713 . . . . 0.47999999999999998 109.075 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.508 ' CE1' ' HG3' ' A' ' 144' ' ' ARG . 7.1 p80 -152.09 -164.99 2.1 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.399 0.618 . . . . 1.25 111.341 -175.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.443 ' O ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.07 -178.62 15.74 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.666 -1.152 . . . . 0.46000000000000002 112.873 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.6 t -145.48 178.23 8.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.139 -0.531 . . . . 0.5 110.927 -165.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -108.98 -16.82 14.06 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.983 -1.008 . . . . 1.8600000000000001 109.255 165.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -124.98 100.71 33.13 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 115.744 -0.662 . . . . 1.77 109.854 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.54 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 44.8 Cg_endo -92.78 4.64 3.38 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.584 2.856 . . . . 0.58999999999999997 113.166 175.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.22 -20.99 50.66 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 120.976 0.417 . . . . 0.78000000000000003 110.437 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 p -93.95 -4.83 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.598 0.714 . . . . 1.45 110.11 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 9.0 mm -76.91 111.91 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.239 -0.891 . . . . 0.69999999999999996 110.461 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.83 7.35 74.76 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.695 -0.684 . . . . 1.6799999999999999 111.549 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 136' ' ' LYS . 35.9 ttmt -123.83 127.31 47.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.691 0.281 . . . . 4.3899999999999997 110.659 -174.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 64.65 -97.44 0.06 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.504 -0.771 . . . . 3.9399999999999999 111.8 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 89' ' ' ILE . 22.9 t -137.42 -78.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.495 -0.187 . . . . 4.6799999999999997 110.495 -175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.8 t 58.06 37.73 26.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.231 0.538 . . . . 5.6799999999999997 111.02 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.407 ' H ' ' HG3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -64.35 162.33 15.15 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.365 0.506 . . . . 8.3000000000000007 112.365 -176.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.36 -67.44 0.22 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.019 -0.61 . . . . 3.8500000000000001 111.974 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 59.9 m -108.19 146.37 32.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.268 -0.641 . . . . 2.5099999999999998 109.268 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 124' ' ' GLY . 20.3 tt -84.71 -60.01 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 119.169 -0.443 . . . . 1.4399999999999999 110.478 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.508 ' HG3' ' CE1' ' A' ' 126' ' ' HIS . 37.1 mtt180 59.6 147.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.251 1.575 . . . . 3.3599999999999999 115.251 170.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 144' ' ' ARG . 29.1 mtp -151.44 -166.93 2.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.786 -1.097 . . . . 1.1299999999999999 109.964 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -79.0 153.27 30.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.919 -0.771 . . . . 2.5099999999999998 108.919 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.64 ' O ' HG12 ' A' ' 150' ' ' VAL . 21.7 p-10 -52.08 -65.0 0.63 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.504 0.187 . . . . 1.77 111.504 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -60.74 -30.44 69.99 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.703 -0.623 . . . . 2.1299999999999999 111.342 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -64.38 -43.54 94.16 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.179 0.514 . . . . 1.05 110.25 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.4 p -77.59 -17.42 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.509 -0.769 . . . . 0.32000000000000001 110.993 -176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.54 HD11 ' HB1' ' A' ' 113' ' ' ALA . 3.0 mp -88.98 -40.86 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 119.022 -0.513 . . . . 0.37 110.649 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -44.03 -69.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 119.633 1.106 . . . . 1.3799999999999999 112.027 162.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.744 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.8 OUTLIER -48.31 -42.52 31.26 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 123.813 0.695 . . . . 0.73999999999999999 110.232 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.6 -57.02 12.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.427 -1.26 . . . . 0.22 112.465 -171.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 t -77.05 -14.99 59.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.825 -1.079 . . . . 1.3300000000000001 110.487 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.48 -50.28 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 109.976 -0.379 . . . . 0.23000000000000001 109.976 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 153' ' ' LEU . 28.3 m -75.96 116.71 58.1 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 121.939 0.876 . . . . 0.20999999999999999 110.379 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.788 ' HG2' HD13 ' A' ' 57' ' ' ILE . 40.2 Cg_endo -81.97 -177.43 3.53 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.199 2.599 . . . . 0.34000000000000002 112.581 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.681 ' O ' HD21 ' A' ' 51' ' ' LEU . 16.5 m120 -59.11 0.65 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.58 -1.191 . . . . 1.02 113.839 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.18 58.41 0.45 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.738 -0.744 . . . . 0.28000000000000003 112.677 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.6 m -90.32 136.83 32.81 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.376 -0.484 . . . . 0.29999999999999999 110.53 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -84.76 131.92 34.5 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.55 -0.46 . . . . 1.96 109.983 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.4 p -138.91 124.81 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.363 -0.835 . . . . 0.46000000000000002 110.858 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.412 ' C ' HD12 ' A' ' 165' ' ' ILE . 89.8 m -116.92 140.5 49.38 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.682 -0.69 . . . . 0.56000000000000005 111.636 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.1 mp -120.4 110.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.811 -1.156 . . . . 0.95999999999999996 110.593 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -143.78 146.96 33.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.372 -1.285 . . . . 1.1899999999999999 109.071 -172.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.701 ' H ' HG22 ' A' ' 93' ' ' THR . 7.9 ptm180 -92.85 -31.8 14.86 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.558 0.577 . . . . 3.4199999999999999 112.558 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -160.29 -132.38 1.34 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.037 -0.601 . . . . 3.6499999999999999 111.77 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.25 1.088 0 C-N-CA 122.929 0.491 . . . . 5.9699999999999998 111.057 -179.513 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.595 ' O62' ' H11' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 111.582 -0.607 . . . . 2.9199999999999999 111.582 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 63.78 177.84 0.17 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.91 0.862 . . . . 4.0999999999999996 112.303 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -77.8 153.95 32.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.821 -1.081 . . . . 2.1000000000000001 109.276 172.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.699 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.8 mt -91.79 168.86 11.15 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.382 0.426 . . . . 0.26000000000000001 111.05 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.556 HD23 ' CG1' ' A' ' 48' ' ' ILE . 3.8 tp -76.42 150.31 36.76 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 123.42 0.688 . . . . 0.23000000000000001 112.297 -168.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.551 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.57 150.05 35.6 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.137 0.97 . . . . 0.26000000000000001 111.92 167.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 45' ' ' SER . 70.0 t80 -136.63 149.8 48.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.448 -1.705 . . . . 0.39000000000000001 108.083 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.82 121.7 28.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.194 -1.41 . . . . 1.0700000000000001 107.194 176.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -82.46 158.65 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.181 0.515 . . . . 0.38 112.119 -170.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -106.18 150.28 26.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.843 -0.799 . . . . 2.5899999999999999 108.843 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.647 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.2 tt0 -53.97 112.73 1.01 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.541 0.526 . . . . 1.74 111.967 -175.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.0 -8.67 18.72 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.673 -0.775 . . . . 0.56999999999999995 112.837 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.567 ' HB3' HD11 ' A' ' 18' ' ' ILE . 55.7 m-20 -62.26 154.84 26.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.067 0.433 . . . . 2.1699999999999999 111.946 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.562 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 p -132.11 152.95 50.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.5 111.892 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.0 tp -49.86 -58.5 5.26 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.99 1.107 . . . . 0.27000000000000002 113.99 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.6 t-20 -65.07 -42.01 94.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.569 1.176 . . . . 1.21 109.979 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.755 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 5.8 m -60.34 -39.45 87.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 112.51 -2.132 . . . . 1.24 110.769 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.567 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.8 -41.18 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 123.296 0.638 . . . . 0.29999999999999999 112.176 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.62 -61.94 2.08 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.511 -0.313 . . . . 0.23000000000000001 111.284 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.17 -4.12 54.38 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.798 -1.161 . . . . 0.39000000000000001 112.136 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.755 ' HB2' ' O ' ' A' ' 17' ' ' SER . 6.9 t70 -61.89 -34.84 76.75 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.654 -1.239 . . . . 1.6299999999999999 107.654 156.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.4 m-85 -99.35 17.81 19.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.248 0.462 . . . . 0.23999999999999999 112.248 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 52.11 51.92 15.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.356 -0.838 . . . . 3.5499999999999998 110.954 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 19' ' ' ALA . 35.5 pt -146.86 -174.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.644 -0.872 . . . . 0.27000000000000002 108.644 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -100.81 144.7 29.46 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.429 -0.805 . . . . 0.81000000000000005 109.258 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.644 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 25.3 p -61.77 -34.81 76.54 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.48 0.657 . . . . 0.27000000000000002 109.251 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -63.86 -29.4 70.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.34 -1.3 . . . . 0.26000000000000001 111.511 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.82 -38.11 26.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.391 0.615 . . . . 0.23000000000000001 109.791 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.672 HD11 HD12 ' A' ' 46' ' ' ILE . 16.7 tp -73.31 -16.93 61.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.214 -0.903 . . . . 0.17000000000000001 108.958 174.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.769 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -82.1 -38.52 24.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.37 0.605 . . . . 0.19 111.578 173.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.4 mt-30 -57.92 -43.42 86.25 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 122.169 0.985 . . . . 1.0700000000000001 109.636 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.59 -19.77 41.23 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.354 -1.748 . . . . 0.17000000000000001 112.402 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 32.7 m-80 -143.34 72.66 17.85 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.148 0.499 . . . . 0.19 109.922 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.663 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 15.8 Cg_endo -57.36 -11.32 8.11 Favored 'Trans proline' 0 C--N 1.333 -0.283 0 C-N-CA 123.649 2.9 . . . . 0.29999999999999999 114.478 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -63.31 -34.43 77.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.913 0.864 . . . . 1.1699999999999999 109.573 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -78.35 -6.62 55.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.332 -1.303 . . . . 0.53000000000000003 114.415 -170.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.769 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.94 -42.56 48.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 CA-C-N 119.78 1.173 . . . . 1.23 110.22 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.28 -45.95 12.31 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 112.881 -1.963 . . . . 0.40000000000000002 111.439 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.18 -164.81 36.16 Favored Glycine 0 CA--C 1.492 -1.355 0 C-N-CA 120.265 -0.969 . . . . 0.29999999999999999 114.358 176.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.5 mp -115.43 157.86 23.34 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.966 -1.617 . . . . 0.31 110.447 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.62 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 96.3 m -133.89 133.86 42.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.641 -0.709 . . . . 0.39000000000000001 110.519 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.647 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -44.61 126.49 5.54 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.416 0.895 . . . . 0.46999999999999997 113.416 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.568 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.31 -10.66 53.65 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.391 -1.277 . . . . 0.35999999999999999 112.129 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.62 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -63.99 150.91 44.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.776 0.798 . . . . 1.1899999999999999 110.315 175.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 44.7 m -118.2 133.86 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.212 -1.358 . . . . 0.89000000000000001 109.049 -171.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.672 HD12 HD11 ' A' ' 29' ' ' LEU . 15.0 pt -135.89 151.14 28.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.244 0.545 . . . . 0.22 110.312 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.573 ' H ' HD21 ' A' ' 33' ' ' ASN . 11.1 t -96.03 149.09 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.121 -0.945 . . . . 0.20999999999999999 110.119 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.556 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.4 mm -117.24 87.31 23.51 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.84 -1.073 . . . . 0.17000000000000001 108.386 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.699 ' HA ' HD13 ' A' ' 4' ' ' LEU . 29.0 Cg_endo -59.59 140.26 92.97 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.119 2.546 . . . . 0.23000000000000001 112.626 -173.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.554 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 85.3 -8.24 72.07 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.323 -0.853 . . . . 0.29999999999999999 113.015 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.606 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.9 tt -117.55 127.43 26.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.585 -0.894 . . . . 0.25 108.585 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD23 ' A' ' 51' ' ' LEU . 62.0 Cg_endo -67.78 173.58 8.89 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.725 2.95 . . . . 0.31 113.818 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.785 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.9 t70 -90.3 142.05 28.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.034 -0.985 . . . . 0.71999999999999997 110.576 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.548 ' HD3' HD12 ' A' ' 5' ' ' LEU . 60.3 Cg_endo -86.21 -8.31 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.73 2.953 . . . . 0.27000000000000002 112.444 -174.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -92.01 -13.52 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.307 0.575 . . . . 2.1099999999999999 109.486 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.785 HG23 ' HB3' ' A' ' 53' ' ' ASP . 12.3 p -84.92 -29.5 25.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.944 -1.132 . . . . 1.47 107.944 172.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.662 HD13 ' HG2' ' A' ' 158' ' ' PRO . 43.5 mt -83.02 131.74 52.94 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 113.496 -1.684 . . . . 0.26000000000000001 110.887 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -102.68 96.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 121.046 1.164 . . . . 0.20000000000000001 110.525 167.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.499 ' HD2' ' CG2' ' A' ' 57' ' ' ILE . 84.1 m-85 -157.3 132.49 8.97 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.604 -1.258 . . . . 0.26000000000000001 107.604 171.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.646 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 29.1 m170 -135.96 103.73 5.47 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.487 -1.672 . . . . 2.8399999999999999 106.487 -167.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 64.5 mt -94.71 112.43 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 120.237 -0.585 . . . . 0.32000000000000001 110.521 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.33 95.8 5.35 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.378 -0.828 . . . . 0.34000000000000002 110.811 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.608 HG13 HG13 ' A' ' 165' ' ' ILE . 0.3 OUTLIER -115.75 104.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.503 -1.226 . . . . 0.68000000000000005 110.645 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -98.96 113.52 25.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.213 -1.032 . . . . 1.05 108.213 174.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.59 HG23 HG13 ' A' ' 86' ' ' VAL . 2.1 mt -54.62 -32.43 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-O 120.905 0.383 . . . . 1.29 111.779 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.446 ' HA2' ' HG3' ' A' ' 88' ' ' LYS . . . -59.09 -45.62 95.0 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.071 -1.061 . . . . 0.88 111.305 170.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.43 -23.45 62.74 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.461 0.648 . . . . 0.73999999999999999 111.959 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.68 ' HA ' HG21 ' A' ' 86' ' ' VAL . 35.7 mttt 62.35 18.93 10.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.734 1.214 . . . . 2.5099999999999998 112.999 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.441 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.94 140.17 31.0 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.284 1.04 . . . . 0.45000000000000001 112.63 177.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.572 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -97.19 118.7 34.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.028 -1.897 . . . . 0.33000000000000002 109.269 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -100.86 125.14 47.36 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.349 -0.54 . . . . 0.40000000000000002 110.489 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.604 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.8 143.92 29.64 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.966 -1.864 . . . . 0.33000000000000002 105.966 176.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 47.7 m -148.65 129.52 14.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 120.189 1.359 . . . . 0.75 112.895 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -114.46 126.53 55.06 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.608 -1.178 . . . . 0.34999999999999998 110.438 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.5 t-20 63.7 36.31 10.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.52000000000000002 109.54 172.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.1 m-20 76.81 2.73 3.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.591 -1.186 . . . . 1.8400000000000001 112.409 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -130.42 137.79 50.01 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 118.081 -1.448 . . . . 3.1899999999999999 114.269 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.62 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.17 149.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-N 113.122 -1.854 . . . . 0.40999999999999998 113.59 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.553 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.8 mtp -103.3 -40.35 6.44 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.407 -2.179 . . . . 0.34999999999999998 108.732 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.52 165.87 2.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.677 -2.056 . . . . 2.0699999999999998 110.723 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.441 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 8.6 m -125.49 130.52 51.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.419 0.152 . . . . 0.37 110.947 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.473 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 15.7 m-85 -120.68 134.35 24.23 Favored Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.759 0.314 . . . . 0.96999999999999997 110.966 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.69 143.53 74.78 Favored 'Trans proline' 0 N--CA 1.472 0.213 0 C-N-CA 123.168 2.579 . . . . 0.59999999999999998 112.76 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.24 179.36 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.329 -0.396 . . . . 0.64000000000000001 110.782 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.94 150.68 25.51 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 110.091 -0.337 . . . . 0.82999999999999996 110.091 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 68' ' ' LYS . 2.1 t -149.28 145.15 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 114.261 1.208 . . . . 1.6699999999999999 114.261 -159.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.524 ' H ' ' CG2' ' A' ' 65' ' ' ILE . . . -127.28 82.32 0.35 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.695 -1.362 . . . . 3.0800000000000001 109.695 163.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.481 ' HD2' ' HE3' ' A' ' 68' ' ' LYS . 51.7 tttp -80.01 153.99 28.49 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.717 0.636 . . . . 7.2599999999999998 112.717 -167.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.8 tp -168.39 -43.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.694 -0.685 . . . . 6.29 110.855 168.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.485 ' H ' ' HA3' ' A' ' 168' ' ' GLY . 0.2 OUTLIER -160.24 -95.34 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.153 -0.342 . . . . 7.2699999999999996 111.242 175.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.666 ' N ' ' HA2' ' A' ' 168' ' ' GLY . 15.1 t -153.05 161.51 42.42 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 122.128 -0.358 . . . . 5.1799999999999997 111.158 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' THR . 44.3 mt-30 76.95 127.9 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.084 0.953 . . . . 4.8099999999999996 112.655 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.625 ' HB ' ' CD ' ' A' ' 94' ' ' PRO . 0.6 OUTLIER -84.7 -160.84 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 107.954 -1.128 . . . . 2.1099999999999999 107.954 169.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.625 ' CD ' ' HB ' ' A' ' 93' ' ' THR . 22.7 Cg_exo -71.33 30.91 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 CA-C-N 120.631 1.261 . . . . 3.21 111.797 161.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.508 ' H ' ' C ' ' A' ' 93' ' ' THR . 28.7 m 65.56 83.42 0.17 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.454 0.702 . . . . 3.5899999999999999 111.196 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -138.64 114.81 1.08 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.432 -0.889 . . . . 2.1000000000000001 112.924 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' ' 164' ' ' THR . 32.1 mt-10 -119.39 140.08 50.96 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.33 -0.618 . . . . 2.2999999999999998 109.33 174.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.506 ' HB3' ' H ' ' A' ' 119' ' ' SER . 7.2 m-85 -126.64 178.55 5.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.416 -0.356 . . . . 1.9299999999999999 110.505 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 161' ' ' THR . 66.5 m-85 -131.17 139.83 49.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.57999999999999996 110.252 172.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.596 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 34.0 mm -63.22 116.68 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.87 0 N-CA-C 108.752 -0.833 . . . . 0.40999999999999998 108.752 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 3.7 tt -108.32 -19.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 119.237 -0.985 . . . . 0.37 112.507 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 6.2 t-20 179.0 -168.39 0.09 Allowed 'General case' 0 C--N 1.351 0.669 0 CA-C-O 122.73 1.252 . . . . 1.99 114.096 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.6 ptp180 -156.78 144.17 18.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.621 -2.536 . . . . 1.1899999999999999 110.021 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.98 157.21 22.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 122.067 0.937 . . . . 1.6699999999999999 111.172 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -52.32 150.21 4.9 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.521 -2.127 . . . . 3.0600000000000001 112.05 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -48.33 110.3 1.4 Allowed Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 115.118 -0.946 . . . . 2.6099999999999999 111.039 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -52.17 -48.25 22.63 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 123.762 2.975 . . . . 0.97999999999999998 111.858 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 111.3 -20.39 23.42 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.849 -1.069 . . . . 1.0800000000000001 112.625 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -105.93 -170.07 23.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.971 -0.633 . . . . 1.05 111.946 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.82 35.51 0.1 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.188 3.259 . . . . 1.3 113.561 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 109' ' ' GLY . 11.4 t80 -86.89 -16.89 34.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.21 0.529 . . . . 1.3799999999999999 109.804 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.563 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.89 38.0 3.75 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.653 -0.703 . . . . 1.1100000000000001 114.071 173.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB2' ' ND2' ' A' ' 147' ' ' ASN . . . 74.38 -36.71 0.34 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.121 1.156 . . . . 0.81000000000000005 114.121 168.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.545 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -148.37 144.55 27.58 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.975 0.417 . . . . 1.1200000000000001 110.949 -173.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -115.49 100.21 7.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.661 . . . . 2.1899999999999999 109.373 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -101.72 145.72 28.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.206 0.527 . . . . 0.60999999999999999 110.535 176.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.479 ' HB2' HG23 ' A' ' 101' ' ' ILE . 74.4 m -106.71 137.12 45.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.662 -0.699 . . . . 0.93999999999999995 112.412 -170.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.564 HD11 HG11 ' A' ' 163' ' ' VAL . 2.2 tp -107.68 -171.29 1.84 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.086 -0.961 . . . . 1.0800000000000001 108.987 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.506 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.7 t -87.57 -98.02 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.675 0.67 . . . . 1.5 111.18 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -89.34 159.7 17.23 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.908 0.707 . . . . 2.9700000000000002 112.908 -171.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 57.92 -88.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.753 -1.112 . . . . 5.0599999999999996 112.545 169.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -82.38 63.64 6.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.72 -1.215 . . . . 5.9500000000000002 107.72 176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -71.9 22.04 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.202 0.816 . . . . 4.8300000000000001 113.202 -168.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 143' ' ' ILE . . . -154.89 122.4 1.22 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 119.654 -1.26 . . . . 0.94999999999999996 113.951 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.637 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 12.0 mt -92.99 107.36 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.363 -1.347 . . . . 0.47999999999999998 107.363 165.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.568 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 12.6 p80 -137.96 -163.92 1.53 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.697 -0.801 . . . . 1.25 112.463 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.563 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.9 -177.0 15.31 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.377 -1.283 . . . . 0.46000000000000002 112.479 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.8 t -141.07 175.88 9.27 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.494 0.664 . . . . 0.5 111.594 -166.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -111.04 -17.78 13.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.827 -1.079 . . . . 1.8600000000000001 109.311 166.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -125.45 102.94 29.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.296 -0.866 . . . . 1.77 109.727 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.412 ' HA ' HG12 ' A' ' 134' ' ' ILE . 44.3 Cg_endo -91.79 3.48 4.07 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.171 2.581 . . . . 0.58999999999999997 113.564 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.86 57.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.869 0.366 . . . . 0.78000000000000003 111.117 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 -3.02 50.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 1.45 110.152 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 131' ' ' PRO . 10.9 mm -79.48 118.41 26.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.69999999999999996 111.255 -175.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.46 3.09 56.51 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.484 -0.78 . . . . 1.6799999999999999 111.548 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -121.56 149.36 43.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.994 -0.373 . . . . 4.3899999999999997 109.994 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.24 62.04 5.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.176 0.512 . . . . 3.9399999999999999 110.517 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 95.9 t -82.6 -54.63 9.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.872 -0.604 . . . . 4.6799999999999997 110.875 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.5 m -152.93 153.03 32.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.195 -0.457 . . . . 5.6799999999999997 110.325 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -89.65 67.73 7.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.101 -0.499 . . . . 8.3000000000000007 110.3 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -95.48 -130.57 6.24 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.919 -0.658 . . . . 3.8500000000000001 112.642 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 47.3 m -103.22 -164.59 1.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.644 -0.502 . . . . 2.5099999999999998 109.644 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 124' ' ' GLY . 2.5 tt -116.34 119.85 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.692 0.758 . . . . 1.4399999999999999 110.151 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 34.8 ptt180 -150.51 153.65 36.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.937 -0.574 . . . . 3.3599999999999999 110.273 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 10.8 mtm -145.71 -165.03 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.769 0.319 . . . . 1.1299999999999999 110.679 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -67.73 150.51 48.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 2.5099999999999998 110.046 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.595 ' O ' HG12 ' A' ' 150' ' ' VAL . 3.4 m-20 -51.63 -67.77 0.22 Allowed 'General case' 0 C--O 1.22 -0.467 0 O-C-N 123.412 0.445 . . . . 1.77 111.589 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.43 -24.5 67.86 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.862 -0.524 . . . . 2.1299999999999999 111.963 -172.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.59 -38.41 74.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.731 0.3 . . . . 1.05 110.975 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.0 p -80.26 -14.9 13.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 116.587 -0.279 . . . . 0.32000000000000001 110.521 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.545 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.5 mp -89.16 -38.96 12.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 118.851 -0.595 . . . . 0.37 110.911 173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -44.09 -68.6 0.18 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.854 1.206 . . . . 1.3799999999999999 111.601 163.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.701 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -49.83 -42.47 47.33 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.589 -0.732 . . . . 0.73999999999999999 110.059 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.64 -57.66 10.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.237 -1.347 . . . . 0.22 112.107 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.0 t -75.32 -14.57 60.5 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.475 -1.239 . . . . 1.3300000000000001 110.63 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.438 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 80.9 mt -93.06 -47.77 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.32 -0.4 . . . . 0.23000000000000001 110.365 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.9 m -76.88 110.61 12.37 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-O 122.038 0.923 . . . . 0.20999999999999999 111.073 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.662 ' HG2' HD13 ' A' ' 57' ' ' ILE . 13.9 Cg_endo -82.16 -179.31 4.62 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.698 2.265 . . . . 0.34000000000000002 113.254 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.425 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 8.7 m120 -66.73 110.54 3.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.74 -1.118 . . . . 1.02 108.254 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 108.03 33.89 2.9 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.284 -0.96 . . . . 0.28000000000000003 113.314 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.596 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 18.9 m -93.2 136.29 33.6 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.839 -0.8 . . . . 0.29999999999999999 109.819 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -84.72 134.16 34.35 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.952 -0.388 . . . . 1.96 109.952 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.564 HG11 HD11 ' A' ' 118' ' ' LEU . 3.2 p -140.51 125.51 19.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.421 -0.809 . . . . 0.46000000000000002 111.424 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 97' ' ' GLU . 52.4 m -114.01 129.7 56.59 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.303 -0.862 . . . . 0.56000000000000005 111.557 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.608 HG13 HG13 ' A' ' 63' ' ' VAL . 2.8 mp -119.25 122.3 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 118.135 -1.426 . . . . 0.95999999999999996 109.578 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.582 ' HA ' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -142.54 122.51 13.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.087 0.946 . . . . 1.1899999999999999 109.932 177.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.474 ' HD3' HG22 ' A' ' 93' ' ' THR . 31.6 ptt180 -98.18 -48.85 4.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.323 -1.762 . . . . 3.4199999999999999 114.301 -165.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.666 ' HA2' ' N ' ' A' ' 91' ' ' THR . . . 138.84 101.38 0.52 Allowed Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.968 -0.853 . . . . 3.6499999999999999 110.968 -163.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 64.7 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.954 -0.546 . . . . 5.9699999999999998 109.777 177.911 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.516 ' H41' H622 ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.99 -0.444 . . . . 2.9199999999999999 111.99 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.41 175.5 9.87 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.12 -0.326 . . . . 4.0999999999999996 110.12 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -70.32 151.7 44.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.754 -0.461 . . . . 2.1000000000000001 109.754 176.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.779 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.2 mt -100.69 169.15 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.918 0.39 . . . . 0.26000000000000001 111.948 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.693 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.4 tp -79.62 153.02 29.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 123.643 0.777 . . . . 0.23000000000000001 112.206 -169.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.571 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -116.58 153.05 32.92 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.866 0.841 . . . . 0.26000000000000001 111.858 166.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.2 t80 -136.6 150.5 48.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.029 -1.441 . . . . 0.39000000000000001 108.07 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.654 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.2 tm0? -128.47 119.42 24.87 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.714 -1.587 . . . . 1.0700000000000001 106.714 174.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -81.08 158.88 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 112.782 0.66 . . . . 0.38 112.782 -167.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' N ' HG23 ' A' ' 9' ' ' VAL . 8.5 mtmp? -99.26 150.14 22.39 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.019 -0.992 . . . . 2.5899999999999999 109.43 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.791 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.1 tt0 -53.84 109.17 0.43 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.258 -0.883 . . . . 1.74 111.618 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -9.82 22.43 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.64 -0.79 . . . . 0.56999999999999995 112.748 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 18' ' ' ILE . 82.4 m-20 -59.7 154.21 18.48 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.021 0.41 . . . . 2.1699999999999999 111.545 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.556 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.7 p -133.39 153.63 51.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.102 0.477 . . . . 0.5 112.115 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 51.5 tp -49.44 -59.9 3.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.795 1.035 . . . . 0.27000000000000002 113.795 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.681 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.6 t-20 -65.02 -40.13 94.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.22 1.009 . . . . 1.21 110.456 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.0 t -59.72 -51.46 69.66 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 113.221 -1.809 . . . . 1.24 109.358 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -64.64 -39.56 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 115.924 -0.58 . . . . 0.29999999999999999 111.433 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.666 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.98 -65.2 0.66 Allowed 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.23000000000000001 111.635 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.12 -5.3 55.74 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 118.84 -1.144 . . . . 0.39000000000000001 112.269 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.094 -0.706 . . . . 1.6299999999999999 109.094 158.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.618 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.4 m-85 -97.05 13.94 27.36 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.089 0.403 . . . . 0.23999999999999999 112.089 173.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 58.15 49.19 11.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.708 -0.678 . . . . 3.5499999999999998 110.096 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 19' ' ' ALA . 42.0 pt -147.7 -175.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.691 -0.855 . . . . 0.27000000000000002 108.691 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 m -99.52 146.0 26.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.538 -0.755 . . . . 0.81000000000000005 109.337 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.681 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.1 p -60.66 -38.08 83.68 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.01 -0.737 . . . . 0.27000000000000002 109.01 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.55 69.0 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.47 -1.241 . . . . 0.26000000000000001 111.654 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 49' ' ' PRO . . . -80.72 -38.13 29.36 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.078 -0.712 . . . . 0.23000000000000001 109.078 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.712 HD11 HD12 ' A' ' 46' ' ' ILE . 12.8 tp -73.69 -18.54 61.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.333 -0.849 . . . . 0.17000000000000001 109.044 176.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.737 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.9 -39.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.484 0.659 . . . . 0.19 111.563 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -57.92 -42.9 85.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 122.372 1.082 . . . . 1.0700000000000001 109.648 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.43 -17.25 49.51 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.512 -1.676 . . . . 0.17000000000000001 112.016 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.695 HD21 ' H ' ' A' ' 47' ' ' VAL . 33.6 m-80 -144.45 72.22 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.102 0.477 . . . . 0.19 110.115 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.53 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.9 Cg_endo -55.06 -10.54 2.92 Favored 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 124.216 3.277 . . . . 0.29999999999999999 114.387 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.38 -37.77 87.99 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.894 0.854 . . . . 1.1699999999999999 110.78 173.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 6.3 mt -76.55 -6.09 50.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.749 1.389 . . . . 0.53000000000000003 114.749 -169.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.737 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -50.7 -39.72 52.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.527 1.156 . . . . 1.23 109.942 -177.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.95 -45.26 12.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.694 -2.048 . . . . 0.40000000000000002 111.453 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.64 -165.28 35.98 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.576 -0.821 . . . . 0.29999999999999999 114.187 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.8 mp -117.33 158.13 24.93 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.501 -1.35 . . . . 0.31 110.593 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.672 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 68.3 m -134.25 134.12 41.6 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.756 -0.656 . . . . 0.39000000000000001 111.101 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.791 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.5 129.06 13.17 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.446 0.906 . . . . 0.46999999999999997 113.446 175.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.654 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 81.84 -12.77 40.39 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 114.38 -1.282 . . . . 0.35999999999999999 111.865 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.672 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.6 tt0 -64.7 151.63 44.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.715 0.769 . . . . 1.1899999999999999 110.307 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 41.1 m -118.0 133.68 55.69 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.257 -1.338 . . . . 0.89000000000000001 109.277 -172.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 29' ' ' LEU . 19.2 pt -136.28 148.05 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.389 0.614 . . . . 0.22 110.503 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.695 ' H ' HD21 ' A' ' 33' ' ' ASN . 14.8 t -93.1 149.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.087 -0.96 . . . . 0.20999999999999999 110.342 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.602 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.1 mm -118.01 88.94 33.06 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 0.17000000000000001 108.61 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.779 ' HA ' HD13 ' A' ' 4' ' ' LEU . 31.1 Cg_endo -61.73 140.64 87.13 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.0 2.466 . . . . 0.23000000000000001 112.468 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.483 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.76 -7.26 66.36 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.45 -0.796 . . . . 0.29999999999999999 112.692 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.0 tt -115.24 125.33 29.01 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.777 -0.823 . . . . 0.25 108.777 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.586 ' CD ' HD23 ' A' ' 51' ' ' LEU . 57.1 Cg_endo -65.39 174.2 5.47 Favored 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 124.064 3.176 . . . . 0.31 114.129 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.479 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 6.9 t70 -95.74 137.16 21.93 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.776 -1.102 . . . . 0.71999999999999997 111.877 -170.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.693 ' HD3' HD12 ' A' ' 5' ' ' LEU . 71.3 Cg_endo -82.25 -8.36 11.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.496 2.797 . . . . 0.27000000000000002 113.552 -174.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -95.21 -22.25 17.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.089 0.471 . . . . 2.1099999999999999 110.942 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -85.5 -6.8 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.069 0.938 . . . . 1.47 108.942 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.808 HD13 ' HG2' ' A' ' 158' ' ' PRO . 87.1 mt -95.8 127.46 41.19 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.446 -1.252 . . . . 0.26000000000000001 110.226 174.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -102.12 96.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.147 1.231 . . . . 0.20000000000000001 110.698 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.52 ' HB2' HG23 ' A' ' 161' ' ' THR . 89.2 m-85 -157.4 131.49 8.26 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.241 -1.392 . . . . 0.26000000000000001 107.241 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.541 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 18.3 m170 -136.08 103.21 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.706 -1.59 . . . . 2.8399999999999999 106.706 -165.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 55.6 mt -94.53 112.32 26.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.569 -0.742 . . . . 0.32000000000000001 110.537 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.97 96.83 6.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.102 -0.954 . . . . 0.34000000000000002 110.361 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.548 HG13 HG13 ' A' ' 165' ' ' ILE . 0.7 OUTLIER -119.09 106.16 18.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.543 -1.208 . . . . 0.68000000000000005 110.361 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.536 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 24.1 m -101.06 125.94 47.71 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.542 -0.754 . . . . 1.05 109.805 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.568 HG23 ' HB ' ' A' ' 86' ' ' VAL . 16.3 mt -47.01 -35.64 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.137 0.494 . . . . 1.29 110.83 166.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.47 -49.16 46.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.469 -0.872 . . . . 0.88 111.514 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -68.92 -24.65 64.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.091 0.472 . . . . 0.73999999999999999 112.186 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.64 ' HA ' HG11 ' A' ' 86' ' ' VAL . 2.9 tppt? 55.67 18.69 2.95 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.489 1.138 . . . . 2.5099999999999998 112.055 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.69 140.25 34.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.968 0.889 . . . . 0.45000000000000001 111.15 173.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -96.89 118.57 33.61 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.9 -1.5 . . . . 0.33000000000000002 109.275 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.0 m -101.13 123.82 45.88 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.194 -0.602 . . . . 0.40000000000000002 111.17 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.95 131.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.767 -1.938 . . . . 0.33000000000000002 105.767 176.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 12.0 m -136.86 130.72 32.18 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 120.735 1.607 . . . . 0.75 112.761 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.15 126.89 55.14 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.278 -0.874 . . . . 0.34999999999999998 110.322 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 9.0 t-20 63.7 35.65 11.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.383 0.611 . . . . 0.52000000000000002 109.463 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.3 m-20 78.52 -0.04 2.53 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.548 -1.206 . . . . 1.8400000000000001 112.613 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -129.99 139.42 51.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.082 -1.447 . . . . 3.1899999999999999 113.793 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -51.89 149.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 112.891 -1.959 . . . . 0.40999999999999998 113.737 -172.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.536 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.6 mtp -101.56 -42.04 6.38 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.234 -2.257 . . . . 0.34999999999999998 108.22 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -176.64 160.78 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.508 -2.133 . . . . 2.0699999999999998 110.373 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 9.5 m -122.78 132.6 54.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.527 -0.175 . . . . 0.37 110.527 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.57 156.04 53.85 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 110.346 -0.242 . . . . 0.96999999999999997 110.346 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HB2' HG22 ' A' ' 134' ' ' ILE . 9.7 Cg_endo -83.36 143.45 11.11 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.7 2.267 . . . . 0.59999999999999998 111.842 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.37 173.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.482 -0.326 . . . . 0.64000000000000001 110.148 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.5 149.86 24.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.352 . . . . 0.82999999999999996 110.804 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 68' ' ' LYS . 16.9 m -136.06 6.32 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.99 -0.55 . . . . 1.6699999999999999 110.75 -170.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.25 71.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.746 . . . . 3.0800000000000001 113.151 -173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -162.04 154.05 19.11 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.44 -0.948 . . . . 7.2599999999999998 108.44 175.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt 67.23 95.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 O-C-N 123.557 0.536 . . . . 6.29 110.025 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.56 7.08 46.58 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.21 -0.306 . . . . 7.2699999999999996 111.284 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.1 p -73.77 -72.71 0.25 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.079 0.466 . . . . 5.1799999999999997 110.778 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -151.79 -159.05 0.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.661 . . . . 4.8099999999999996 109.565 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.799 HG22 ' H ' ' A' ' 167' ' ' ARG . 28.9 p -60.23 122.51 67.32 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 109.064 -0.717 . . . . 2.1099999999999999 109.064 169.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HG2' HG22 ' A' ' 165' ' ' ILE . 68.6 Cg_exo -42.02 -65.77 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.586 2.857 . . . . 3.21 113.8 -172.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.457 ' HB ' ' CE1' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -153.0 -170.85 3.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.105 -0.702 . . . . 3.5899999999999999 109.105 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' H ' HG22 ' A' ' 95' ' ' THR . . . -86.79 -104.92 0.81 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.423 -0.894 . . . . 2.1000000000000001 111.982 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.64 149.83 34.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.507 0.67 . . . . 2.2999999999999998 111.442 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.579 ' HB2' HG13 ' A' ' 163' ' ' VAL . 6.7 m-85 -125.27 178.25 5.68 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.998 -1.112 . . . . 1.9299999999999999 107.998 175.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.717 ' HA ' ' O ' ' A' ' 161' ' ' THR . 56.7 m-85 -132.56 137.96 47.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.719 0.295 . . . . 0.57999999999999996 110.499 172.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.737 HD11 HD12 ' A' ' 125' ' ' ILE . 17.2 mm -58.73 116.5 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.562 -1.273 . . . . 0.40999999999999998 107.562 165.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.629 HG13 HD11 ' A' ' 51' ' ' LEU . 1.2 tt -102.09 -34.39 3.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.042 -0.663 . . . . 0.37 111.985 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.547 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 59.1 t30 -166.21 -177.83 4.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 122.819 1.295 . . . . 1.99 113.846 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.547 ' H ' ' CG ' ' A' ' 102' ' ' ASN . 4.7 ptt180 -155.65 131.27 9.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 111.476 -2.602 . . . . 1.1899999999999999 110.187 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.2 153.7 20.66 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 121.925 0.869 . . . . 1.6699999999999999 110.76 -173.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -51.47 152.71 2.51 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.352 -1.749 . . . . 3.0600000000000001 113.25 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -44.69 110.84 1.12 Allowed Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 112.331 -2.213 . . . . 2.6099999999999999 110.69 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -54.15 -50.34 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.499 2.799 . . . . 0.97999999999999998 111.827 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.65 -20.35 20.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.088 -0.96 . . . . 1.0800000000000001 112.683 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -132.94 -169.53 12.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.082 -0.58 . . . . 1.05 112.123 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.77 37.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 124.906 3.737 . . . . 1.3 114.487 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' O ' ' HE1' ' A' ' 126' ' ' HIS . 52.1 t80 -82.06 -18.04 44.53 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.695 -0.483 . . . . 1.3799999999999999 109.695 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.56 52.3 0.99 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.599 -0.728 . . . . 1.1100000000000001 114.415 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 71.71 -63.08 0.44 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.258 1.207 . . . . 0.81000000000000005 114.258 164.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -142.41 138.28 30.99 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.541 -0.299 . . . . 1.1200000000000001 110.204 -172.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 51.4 t-105 -98.35 99.35 10.54 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.976 -0.75 . . . . 2.1899999999999999 108.976 169.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 1.5 mp -109.34 135.28 50.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.628 0.727 . . . . 0.60999999999999999 110.659 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 101' ' ' ILE . 29.5 m -107.58 149.17 28.35 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.278 -0.874 . . . . 0.93999999999999995 112.047 -175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.639 HD11 HG11 ' A' ' 163' ' ' VAL . 1.5 tp -102.17 -173.78 2.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.916 -1.038 . . . . 1.0800000000000001 108.573 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.556 ' HB2' ' H ' ' A' ' 99' ' ' TYR . 48.0 t -86.3 -79.89 0.25 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.627 -0.429 . . . . 1.5 112.101 -175.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.401 ' HD2' ' HE3' ' A' ' 10' ' ' LYS . 25.5 pttm -128.29 159.49 35.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.791 0.293 . . . . 2.9700000000000002 111.791 -171.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.87 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.272 0.983 . . . . 5.0599999999999996 112.633 169.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.6 t60 62.26 57.36 1.99 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.853 0.835 . . . . 5.9500000000000002 108.862 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' A' ' 118' ' ' LEU . 5.0 p90 -97.9 95.72 7.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.069 -0.969 . . . . 4.8300000000000001 112.178 -169.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.479 ' N ' ' HB2' ' A' ' 118' ' ' LEU . . . -156.32 148.04 17.45 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.271 -0.966 . . . . 0.94999999999999996 114.235 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.737 HD12 HD11 ' A' ' 100' ' ' ILE . 7.4 mt -147.74 107.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.522 -1.659 . . . . 0.47999999999999998 106.522 163.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.511 ' HB3' ' HG2' ' A' ' 144' ' ' ARG . 7.1 t-80 -134.9 179.31 6.39 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.883 -0.727 . . . . 1.25 111.715 -166.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -123.54 176.46 16.73 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.775 -1.102 . . . . 0.46000000000000002 111.537 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.8 t -148.07 171.77 15.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.154 0.502 . . . . 0.5 111.07 -168.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -101.38 -15.41 17.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.209 -0.905 . . . . 1.8600000000000001 109.523 166.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -125.33 101.34 31.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.673 -0.694 . . . . 1.77 109.873 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -90.65 4.88 4.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.171 2.581 . . . . 0.58999999999999997 112.762 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.66 0.54 42.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.038 0.447 . . . . 0.78000000000000003 110.849 -170.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.6 p -111.22 -2.31 15.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.661 0.743 . . . . 1.45 109.711 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 83' ' ' PRO . 20.9 mm -92.57 126.67 45.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.967 -1.015 . . . . 0.69999999999999996 110.772 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.37 -134.87 13.22 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.502 -0.856 . . . . 1.6799999999999999 112.171 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -76.02 87.72 2.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.269 0.557 . . . . 4.3899999999999997 110.345 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -160.76 -63.12 0.06 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.372 -0.831 . . . . 3.9399999999999999 109.942 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.83 172.41 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.749 -0.659 . . . . 4.6799999999999997 110.113 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.422 ' OG ' ' HD2' ' A' ' 140' ' ' LYS . 7.7 p -91.05 -58.72 2.37 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.669 -0.241 . . . . 5.6799999999999997 110.942 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.422 ' HD2' ' OG ' ' A' ' 139' ' ' SER . 11.4 mptt -72.03 141.05 49.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 8.3000000000000007 110.982 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.29 174.76 26.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.048 -0.596 . . . . 3.8500000000000001 111.701 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 5.0 t -99.32 159.8 14.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.8 0.3 . . . . 2.5099999999999998 110.537 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 13.3 tt -75.24 80.64 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 122.267 1.032 . . . . 1.4399999999999999 110.902 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.511 ' HG2' ' HB3' ' A' ' 126' ' ' HIS . 54.0 mtt180 -118.39 172.02 7.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.898 -1.046 . . . . 3.3599999999999999 109.742 176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.4 mtp -147.85 179.75 7.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.05 0.452 . . . . 1.1299999999999999 110.599 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -71.38 146.22 48.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.457 -0.942 . . . . 2.5099999999999998 108.457 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.554 ' O ' HG12 ' A' ' 150' ' ' VAL . 27.3 p-10 -50.21 -67.78 0.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 112.508 0.558 . . . . 1.77 112.508 -171.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -23.13 65.58 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.441 -0.787 . . . . 2.1299999999999999 112.018 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.81 -40.57 63.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.865 -0.607 . . . . 1.05 111.055 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 8.9 p -75.77 -17.94 15.58 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 110.285 -0.265 . . . . 0.32000000000000001 110.285 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.6 mp -87.12 -39.46 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 118.985 -0.531 . . . . 0.37 110.61 174.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -43.7 -70.15 0.11 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.534 1.061 . . . . 1.3799999999999999 111.964 162.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.732 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -48.8 -44.79 39.47 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.626 -0.716 . . . . 0.73999999999999999 110.139 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.88 -55.2 28.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.244 -1.344 . . . . 0.22 112.337 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.481 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 33.1 t -77.42 -14.72 59.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.592 -1.186 . . . . 1.3300000000000001 110.9 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.54 -47.16 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.863 -0.421 . . . . 0.23000000000000001 109.863 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 153' ' ' LEU . 32.6 m -76.12 120.11 80.23 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.885 0.85 . . . . 0.20999999999999999 110.595 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.808 ' HG2' HD13 ' A' ' 57' ' ' ILE . 41.2 Cg_endo -83.43 -178.69 3.83 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.955 2.437 . . . . 0.34000000000000002 112.538 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.739 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.9 m120 -62.3 4.25 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.503 -1.226 . . . . 1.02 113.366 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.3 54.84 0.52 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.28000000000000003 112.446 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.717 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.2 m -89.72 131.17 35.83 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.438 -0.448 . . . . 0.29999999999999999 110.837 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.37 138.9 31.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.472 -0.491 . . . . 1.96 110.342 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 118' ' ' LEU . 3.8 p -146.71 127.7 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.377 -0.829 . . . . 0.46000000000000002 111.13 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.407 ' C ' HD12 ' A' ' 165' ' ' ILE . 7.1 m -111.67 133.38 53.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.217 -0.447 . . . . 0.56000000000000005 111.1 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.548 HG13 HG13 ' A' ' 63' ' ' VAL . 2.7 mp -119.18 110.13 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 117.832 -1.547 . . . . 0.95999999999999996 110.558 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.7 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.17 141.74 31.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.896 -1.047 . . . . 1.1899999999999999 110.312 -171.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.799 ' H ' HG22 ' A' ' 93' ' ' THR . 7.5 ptm180 -92.38 -32.68 14.86 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.43 -0.805 . . . . 3.4199999999999999 111.922 -175.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.93 -59.58 3.06 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 121.18 -0.533 . . . . 3.6499999999999999 113.54 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.375 -0.821 . . . . 5.9699999999999998 110.453 -178.355 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.518 ' O31' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.887 -0.485 . . . . 2.9199999999999999 111.887 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -137.77 179.57 6.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.677 0.275 . . . . 4.0999999999999996 110.74 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.6 mptt -61.31 154.9 22.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.714 -0.676 . . . . 2.1000000000000001 109.864 172.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -93.49 167.22 11.84 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.367 0.417 . . . . 0.26000000000000001 111.332 175.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.653 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.5 tp -77.11 151.2 35.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.488 0.715 . . . . 0.23000000000000001 111.902 -170.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.8 150.14 38.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 122.1 0.952 . . . . 0.26000000000000001 112.168 169.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 45' ' ' SER . 62.8 t80 -133.67 150.29 51.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.754 -1.567 . . . . 0.39000000000000001 107.86 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -129.93 114.97 16.52 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.071 -1.455 . . . . 1.0700000000000001 107.071 175.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.41 HG23 ' HB2' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.32 157.15 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.342 0.591 . . . . 0.38 112.359 -166.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -102.8 149.04 24.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.001 -0.999 . . . . 2.5899999999999999 108.978 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.679 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -52.53 117.94 3.24 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.874 -0.603 . . . . 1.74 111.369 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.67 -10.26 32.56 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.516 -0.766 . . . . 0.56999999999999995 112.446 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.58 ' HB3' HD11 ' A' ' 18' ' ' ILE . 54.6 m-20 -62.24 147.55 47.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.997 0.427 . . . . 2.1699999999999999 111.827 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.534 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -128.19 149.38 50.47 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.892 -0.594 . . . . 0.5 111.908 -178.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.605 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.2 tp -46.16 -60.42 2.3 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.868 1.062 . . . . 0.27000000000000002 113.868 -173.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.652 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.7 t-20 -64.41 -38.96 92.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.751 1.262 . . . . 1.21 110.15 -171.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.78 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 19.3 m -62.07 -40.93 97.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.636 -2.075 . . . . 1.24 111.002 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.28 -39.74 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 124.013 0.925 . . . . 0.29999999999999999 112.736 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.7 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.81 -62.1 1.98 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.61 -0.268 . . . . 0.23000000000000001 111.203 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.38 -4.65 52.01 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.814 -1.155 . . . . 0.39000000000000001 111.789 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.78 ' HB2' ' O ' ' A' ' 17' ' ' SER . 12.1 t70 -63.68 -32.42 73.9 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.135 -1.061 . . . . 1.6299999999999999 108.135 158.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.653 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.0 m-85 -102.53 16.49 26.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 112.354 0.502 . . . . 0.23999999999999999 112.354 174.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 54.46 52.02 13.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.206 -0.906 . . . . 3.5499999999999998 110.644 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.7 HG12 ' O ' ' A' ' 19' ' ' ALA . 34.9 pt -147.99 -171.35 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.971 -0.752 . . . . 0.27000000000000002 108.971 -172.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.85 147.47 24.39 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.668 -0.697 . . . . 0.81000000000000005 109.917 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.652 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 15.8 p -63.0 -35.88 81.68 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.725 -0.843 . . . . 0.27000000000000002 108.725 175.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.9 68.6 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.196 -1.366 . . . . 0.26000000000000001 111.619 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.79 -38.43 25.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.368 0.604 . . . . 0.23000000000000001 109.551 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.646 HD11 HD12 ' A' ' 46' ' ' ILE . 13.6 tp -73.88 -18.82 60.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 0.17000000000000001 109.084 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.716 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.25 -39.34 33.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.616 0.722 . . . . 0.19 111.444 171.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -61.03 -40.3 93.06 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.128 -0.942 . . . . 1.0700000000000001 110.009 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.74 36.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.881 -1.509 . . . . 0.17000000000000001 112.085 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 29.7 m-80 -142.02 71.57 23.43 Favored Pre-proline 0 CA--C 1.514 -0.411 0 CA-C-O 121.039 0.447 . . . . 0.19 109.825 -173.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.519 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.9 Cg_endo -57.33 -10.26 6.21 Favored 'Trans proline' 0 C--O 1.218 -0.475 0 C-N-CA 123.484 2.789 . . . . 0.29999999999999999 114.07 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -62.63 -33.83 75.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.09 0.947 . . . . 1.1699999999999999 109.75 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -78.78 -4.51 49.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.262 -1.335 . . . . 0.53000000000000003 114.233 -172.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.716 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.64 -40.11 26.6 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 122.414 1.102 . . . . 1.23 110.249 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.586 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.46 -46.51 10.82 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.997 -1.911 . . . . 0.40000000000000002 111.565 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.52 -164.52 34.89 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.978 -1.106 . . . . 0.29999999999999999 114.264 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 18' ' ' ILE . 5.5 mp -116.38 159.56 21.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.262 -1.469 . . . . 0.31 110.396 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 85.1 m -138.44 135.09 34.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.916 -0.584 . . . . 0.39000000000000001 110.871 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.0 129.32 14.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.662 0.744 . . . . 0.46999999999999997 112.857 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.5 -13.64 39.88 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.46 -1.246 . . . . 0.35999999999999999 112.179 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.617 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.8 tt0 -64.59 151.3 45.04 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.628 0.728 . . . . 1.1899999999999999 110.272 174.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 46.1 m -117.91 133.18 56.18 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.495 -1.23 . . . . 0.89000000000000001 109.276 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.646 HD12 HD11 ' A' ' 29' ' ' LEU . 19.7 pt -135.22 148.97 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.277 0.561 . . . . 0.22 110.511 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.552 ' H ' HD21 ' A' ' 33' ' ' ASN . 14.2 t -93.41 149.61 4.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.136 -0.938 . . . . 0.20999999999999999 110.099 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.518 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.7 mm -117.64 88.58 30.08 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.05 -0.977 . . . . 0.17000000000000001 108.584 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.756 ' HA ' HD13 ' A' ' 4' ' ' LEU . 23.7 Cg_endo -59.06 143.28 99.86 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.053 2.502 . . . . 0.23000000000000001 112.585 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.484 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.22 -6.59 59.67 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.694 -0.685 . . . . 0.29999999999999999 112.996 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.718 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -116.73 126.39 27.56 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.752 -0.833 . . . . 0.25 108.752 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.648 ' HD2' HD23 ' A' ' 51' ' ' LEU . 61.6 Cg_endo -66.86 171.01 11.7 Favored 'Trans proline' 0 N--CA 1.477 0.517 0 C-N-CA 123.644 2.896 . . . . 0.31 114.029 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 2.0 t70 -90.95 138.89 25.9 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.573 -1.194 . . . . 0.71999999999999997 111.82 -171.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HD3' HD12 ' A' ' 5' ' ' LEU . 66.3 Cg_endo -83.17 -4.94 11.19 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.529 2.819 . . . . 0.27000000000000002 113.771 -173.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -95.34 -29.3 14.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.613 0.244 . . . . 2.1099999999999999 111.235 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -80.38 -17.53 51.62 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.825 -0.805 . . . . 1.47 108.825 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.725 HD13 ' HG2' ' A' ' 158' ' ' PRO . 87.2 mt -81.44 123.31 81.2 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.974 -1.012 . . . . 0.26000000000000001 109.224 169.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -100.83 94.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 120.023 1.044 . . . . 0.20000000000000001 110.13 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' HD2' HG23 ' A' ' 57' ' ' ILE . 86.5 m-85 -158.78 129.79 6.23 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.558 -1.645 . . . . 0.26000000000000001 106.558 172.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.682 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 42.9 m170 -134.02 106.56 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.198 -1.779 . . . . 2.8399999999999999 106.198 -165.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -95.06 110.24 23.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.908 -0.717 . . . . 0.32000000000000001 110.904 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.13 94.21 4.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.277 -0.874 . . . . 0.34000000000000002 110.442 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.555 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -119.36 97.76 5.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.317 -1.31 . . . . 0.68000000000000005 110.432 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.9 m -89.33 112.26 23.31 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.529 -1.286 . . . . 1.05 107.529 173.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 1.4 mm -42.34 -43.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.901 -0.59 . . . . 1.29 110.03 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 89' ' ' ILE . . . -56.94 -46.33 91.07 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.661 -1.257 . . . . 0.88 111.746 175.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -66.83 -23.87 66.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.629 0.603 . . . . 0.73999999999999999 112.629 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.703 ' HA ' HG21 ' A' ' 86' ' ' VAL . 81.6 mttt 62.63 13.08 6.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.034 0.753 . . . . 2.5099999999999998 113.034 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.25 138.89 33.57 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.225 1.012 . . . . 0.45000000000000001 111.796 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.555 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.7 tt -98.45 120.63 39.21 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.241 -1.8 . . . . 0.33000000000000002 109.282 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 m -102.1 124.23 47.34 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.593 -0.843 . . . . 0.40000000000000002 110.826 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -85.21 129.92 34.71 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.728 -1.953 . . . . 0.33000000000000002 105.728 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.682 ' OG ' ' HB2' ' A' ' 60' ' ' HIS . 13.7 p -139.23 128.88 24.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 121.37 1.895 . . . . 0.75 114.03 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 tp -113.97 127.49 55.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.346 -1.297 . . . . 0.34999999999999998 110.338 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 11.5 t-20 63.44 35.9 11.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.217 0.532 . . . . 0.52000000000000002 109.675 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.6 m-20 79.96 -1.02 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.835 -1.075 . . . . 1.8400000000000001 112.697 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -131.2 138.78 49.55 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.391 -1.324 . . . . 3.1899999999999999 113.832 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -50.31 149.31 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 113.004 -1.907 . . . . 0.40999999999999998 113.298 -176.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.579 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.6 mtp -97.95 -46.03 6.06 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 112.116 -2.311 . . . . 0.34999999999999998 107.525 174.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -177.87 157.56 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.576 -2.102 . . . . 2.0699999999999998 110.479 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 m -115.69 132.15 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.508 0.195 . . . . 0.37 110.886 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.46 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 69.5 m-85 -115.63 147.27 38.54 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.617 -0.265 . . . . 0.96999999999999997 110.398 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -86.92 141.71 6.32 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.489 2.126 . . . . 0.59999999999999998 111.793 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.44 -177.51 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.332 -0.395 . . . . 0.64000000000000001 110.807 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.06 133.49 34.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.842 0.353 . . . . 0.82999999999999996 111.168 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 68' ' ' LYS . 21.1 t -150.31 157.4 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.575 -0.739 . . . . 1.6699999999999999 110.984 -175.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.417 ' N ' ' CG1' ' A' ' 86' ' ' VAL . . . -77.49 -108.28 0.16 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.363 -0.446 . . . . 3.0800000000000001 112.273 170.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -144.19 -32.31 0.43 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.751 0.649 . . . . 7.2599999999999998 112.751 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.436 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 1.1 pp -63.53 170.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.977 0.732 . . . . 6.29 112.977 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 90' ' ' LEU . 51.8 tp -149.39 79.05 1.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.106 -0.497 . . . . 7.2699999999999996 112.088 -173.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.619 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 6.3 m -158.29 -97.56 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 O-C-N 122.367 -0.208 . . . . 5.1799999999999997 111.028 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.512 ' HA ' ' HB2' ' A' ' 166' ' ' ASN . 48.5 mt-30 -138.71 154.61 48.58 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.956 -0.465 . . . . 4.8099999999999996 111.852 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.687 HG22 ' HD2' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -71.59 176.4 2.22 Favored Pre-proline 0 C--O 1.233 0.235 0 N-CA-C 109.608 -0.516 . . . . 2.1099999999999999 109.608 174.07 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.81 -68.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 120.855 1.037 . . . . 3.21 109.886 163.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.7 p -155.73 121.36 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.834 -0.802 . . . . 3.5899999999999999 108.834 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.52 87.41 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 119.195 -1.479 . . . . 2.1000000000000001 114.754 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' HG2' HG23 ' A' ' 164' ' ' THR . 42.1 mt-10 -124.75 130.87 53.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.1 0.476 . . . . 2.2999999999999998 109.76 168.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.556 ' HB3' ' H ' ' A' ' 119' ' ' SER . 13.6 m-85 -128.79 -175.65 3.61 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.478 -0.783 . . . . 1.9299999999999999 110.452 -178.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 161' ' ' THR . 69.0 m-85 -136.84 139.27 41.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.611 -0.722 . . . . 0.57999999999999996 109.838 171.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 125' ' ' ILE . 26.0 mm -60.23 118.79 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.997 -1.112 . . . . 0.40999999999999998 107.997 167.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.8 tt -114.46 -22.68 4.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 119.814 -0.754 . . . . 0.37 112.287 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 103' ' ' ARG . 66.0 t30 -167.67 178.62 5.23 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-O 122.86 1.314 . . . . 1.99 114.325 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 114' ' ' TYR . 2.1 ptt180 -151.18 131.8 13.94 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 111.387 -2.642 . . . . 1.1899999999999999 110.447 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 5.5 tp60 -109.45 145.37 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.981 0.896 . . . . 1.6699999999999999 111.623 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.586 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 61.3 ttt180 -54.92 150.24 10.41 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.431 -1.713 . . . . 3.0600000000000001 111.487 175.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.04 106.22 0.54 Allowed Pre-proline 0 CA--C 1.511 -0.52 0 CA-C-N 115.602 -0.726 . . . . 2.6099999999999999 111.624 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.01 -48.84 20.01 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.781 2.988 . . . . 0.97999999999999998 111.69 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.87 -21.1 14.07 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.961 -1.018 . . . . 1.0800000000000001 112.624 176.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -101.75 -169.89 27.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.956 -0.64 . . . . 1.05 112.13 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.44 31.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.231 3.288 . . . . 1.3 113.533 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.606 ' CE1' ' HB2' ' A' ' 115' ' ' TRP . 1.1 t80 -72.51 -33.45 66.93 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.308 -0.627 . . . . 1.3799999999999999 109.308 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.28 60.64 0.78 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.119 -0.946 . . . . 1.1100000000000001 114.485 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.51 -45.09 0.57 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.182 1.178 . . . . 0.81000000000000005 114.182 166.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -150.41 145.79 26.28 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.21 -0.293 . . . . 1.1200000000000001 110.21 -176.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.606 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 24.1 t-105 -116.01 101.06 8.42 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.258 -0.645 . . . . 2.1899999999999999 109.258 166.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.5 mp -100.66 127.79 46.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.792 0.806 . . . . 0.60999999999999999 110.536 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.421 ' HB2' HG23 ' A' ' 101' ' ' ILE . 62.4 m -87.44 133.72 33.7 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.22 -0.9 . . . . 0.93999999999999995 111.672 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -88.55 -179.42 6.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.233 -1.395 . . . . 1.0800000000000001 107.233 168.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.556 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 40.8 t -68.31 -85.24 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.392 -0.523 . . . . 1.5 110.037 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.622 ' HA ' ' OD1' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -66.05 119.42 11.37 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.937 -0.394 . . . . 2.9700000000000002 109.937 -176.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.512 ' HG3' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -68.61 43.5 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.293 1.22 . . . . 5.0599999999999996 114.293 -172.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -114.45 -15.38 12.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.469 -0.567 . . . . 5.9500000000000002 109.469 171.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -136.19 151.93 50.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.329 -0.851 . . . . 4.8300000000000001 109.834 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -153.16 145.96 13.93 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.974 -0.85 . . . . 0.94999999999999996 110.974 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 100' ' ' ILE . 17.2 mt -93.4 120.76 43.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.477 -0.564 . . . . 0.47999999999999998 109.477 176.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 7.9 p80 -155.43 -163.97 1.65 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.507 0.67 . . . . 1.25 111.729 -176.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -121.91 179.25 16.27 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.014 -1.089 . . . . 0.46000000000000002 113.123 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 t -136.09 173.29 11.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.215 -0.493 . . . . 0.5 110.797 -168.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -104.22 -18.45 14.48 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.358 -0.837 . . . . 1.8600000000000001 108.873 166.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -128.01 103.68 20.95 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 1.77 110.366 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.405 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 53.4 Cg_endo -91.21 4.07 4.25 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.143 2.562 . . . . 0.58999999999999997 112.928 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.23 -18.67 33.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.284 0.564 . . . . 0.78000000000000003 110.337 -172.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 m -89.26 -12.92 39.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 1.45 109.922 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 134' ' ' ILE . 5.3 mm -65.8 116.55 5.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.238 -0.892 . . . . 0.69999999999999996 111.373 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.54 -38.99 2.99 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.417 -0.811 . . . . 1.6799999999999999 113.516 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -125.22 3.91 7.83 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.719 0.637 . . . . 4.3899999999999997 112.719 -171.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -150.78 167.37 27.64 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.052 -0.259 . . . . 3.9399999999999999 111.321 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.0 t 50.93 69.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 123.955 0.784 . . . . 4.6799999999999997 110.985 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.1 m -81.18 21.09 0.76 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.681 -0.691 . . . . 5.6799999999999997 111.759 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.08 -44.81 71.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.215 0.531 . . . . 8.3000000000000007 110.05 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 142' ' ' CYS . . . 146.6 -151.16 23.46 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.33 -0.708 . . . . 3.8500000000000001 111.33 -176.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 141' ' ' GLY . 1.2 m 75.98 104.15 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.261 0.624 . . . . 2.5099999999999998 109.666 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 38.7 mt -85.71 64.06 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.945 0.879 . . . . 1.4399999999999999 109.599 -176.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 29.7 ptt180 -102.7 149.96 23.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.884 -1.053 . . . . 3.3599999999999999 110.437 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 8.3 mtm -140.74 -166.27 2.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.759 0.314 . . . . 1.1299999999999999 110.198 -177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 1.9 t60 -67.58 145.33 54.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.155 -0.683 . . . . 2.5099999999999998 109.155 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.519 ' O ' HG12 ' A' ' 150' ' ' VAL . 30.5 p-10 -49.33 -66.43 0.4 Allowed 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 112.296 0.48 . . . . 1.77 112.296 -174.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -62.95 -23.35 67.36 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.834 -0.541 . . . . 2.1299999999999999 111.603 -174.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 1.5 m-20 -69.19 -43.14 74.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 1.05 110.9 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 14.3 p -77.68 -20.53 13.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 CA-C-N 116.555 -0.293 . . . . 0.32000000000000001 111.036 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.497 HD11 ' HB1' ' A' ' 113' ' ' ALA . 3.1 mp -84.79 -40.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 118.907 -0.568 . . . . 0.37 110.437 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -43.63 -68.7 0.17 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.608 1.095 . . . . 1.3799999999999999 111.931 163.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.678 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.5 OUTLIER -50.55 -44.03 56.38 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.726 -0.67 . . . . 0.73999999999999999 110.375 179.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.69 -54.28 40.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.377 -1.283 . . . . 0.22 112.157 -171.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.6 p -77.76 -13.73 59.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.223 -1.353 . . . . 1.3300000000000001 111.443 -172.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -93.51 -46.82 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.907 0.384 . . . . 0.23000000000000001 110.227 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 153' ' ' LEU . 24.4 m -76.61 122.64 86.96 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-O 121.586 0.708 . . . . 0.20999999999999999 110.077 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.725 ' HG2' HD13 ' A' ' 57' ' ' ILE . 34.8 Cg_endo -84.08 -178.51 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.89 2.394 . . . . 0.34000000000000002 112.557 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.718 ' O ' HD21 ' A' ' 51' ' ' LEU . 11.7 m120 -59.73 -0.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.021 . . . . 1.02 113.604 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.46 56.3 0.53 Allowed Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.822 -0.704 . . . . 0.28000000000000003 112.734 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 2.5 m -92.68 139.43 30.57 Favored 'General case' 0 C--N 1.317 -0.822 0 O-C-N 122.29 -0.535 . . . . 0.29999999999999999 110.733 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -85.1 134.6 34.19 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.151 -0.314 . . . . 1.96 110.151 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.95 128.03 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.544 0.687 . . . . 0.46000000000000002 111.646 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.418 HG23 ' HG2' ' A' ' 97' ' ' GLU . 30.1 m -113.37 132.56 55.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.526 -0.761 . . . . 0.56000000000000005 111.167 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.581 HG23 ' CG1' ' A' ' 65' ' ' ILE . 1.9 mp -120.27 116.67 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 118.788 -1.165 . . . . 0.95999999999999996 110.184 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.669 ' N ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.3 122.56 13.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.185 0.993 . . . . 1.1899999999999999 111.171 -175.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.687 ' HD2' HG22 ' A' ' 93' ' ' THR . 6.1 ptm180 -100.52 -62.86 1.19 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 116.275 1.954 . . . . 3.4199999999999999 116.275 -165.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.619 ' HA2' ' HB ' ' A' ' 91' ' ' THR . . . 141.98 -6.6 2.33 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 119.64 -1.266 . . . . 3.6499999999999999 112.318 -169.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.496 ' H ' ' HG3' ' A' ' 167' ' ' ARG . 58.3 p . . . . . 0 C--O 1.253 1.266 0 CA-C-O 118.015 -0.993 . . . . 5.9699999999999998 109.543 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.731 ' S21' ' H25' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.145 -0.382 . . . . 2.9199999999999999 112.145 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -93.58 -172.32 2.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.823 -0.436 . . . . 4.0999999999999996 109.823 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.664 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 5.8 mtmt -58.51 141.41 51.96 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.586 -0.734 . . . . 2.1000000000000001 109.734 166.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.7 mt -100.26 164.55 11.9 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.783 -0.644 . . . . 0.26000000000000001 111.389 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.82 HD12 ' HD3' ' A' ' 54' ' ' PRO . 2.7 tp -75.51 149.77 38.33 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.906 -0.588 . . . . 0.23000000000000001 111.973 -169.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -116.39 149.91 38.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.015 0.912 . . . . 0.26000000000000001 112.148 169.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -134.98 148.34 49.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.671 -1.604 . . . . 0.39000000000000001 107.661 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.8 OUTLIER -129.75 115.72 17.71 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.175 -1.417 . . . . 1.0700000000000001 107.175 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -77.82 158.47 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.886 -0.597 . . . . 0.38 111.843 -166.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.416 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.6 ptmt -104.66 153.58 21.06 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.859 -0.793 . . . . 2.5899999999999999 108.859 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.77 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 16.8 tt0 -54.42 109.11 0.45 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.855 -0.611 . . . . 1.74 112.243 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.56 -7.01 18.16 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.397 -0.82 . . . . 0.56999999999999995 112.723 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.602 ' HB3' HD11 ' A' ' 18' ' ' ILE . 87.5 m-20 -63.01 152.93 35.48 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 117.101 0.451 . . . . 2.1699999999999999 111.973 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.557 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.9 p -132.27 155.05 49.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.01 0.433 . . . . 0.5 111.982 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.605 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 50.1 tp -49.12 -59.16 3.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.009 1.114 . . . . 0.27000000000000002 114.009 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.657 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 13.3 t-20 -64.54 -43.21 94.7 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 122.452 1.12 . . . . 1.21 110.481 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 21.1 t -57.45 -42.31 82.23 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 112.467 -2.151 . . . . 1.24 110.289 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -74.94 -41.31 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 123.528 0.731 . . . . 0.29999999999999999 112.488 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.683 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.86 -64.83 0.75 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.529 -0.305 . . . . 0.23000000000000001 111.665 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.36 -3.89 48.38 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.067 -1.053 . . . . 0.39000000000000001 111.826 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.741 ' HB2' ' O ' ' A' ' 17' ' ' SER . 53.6 t0 -62.18 -42.76 99.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.971 -1.122 . . . . 1.6299999999999999 107.971 156.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.633 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.2 m-85 -89.93 16.28 8.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.123 0.416 . . . . 0.23999999999999999 112.123 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? 54.47 51.29 14.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.288 -0.869 . . . . 3.5499999999999998 110.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 19' ' ' ALA . 38.6 pt -147.82 -173.62 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.826 -0.805 . . . . 0.27000000000000002 108.826 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 m -100.87 146.09 27.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.48 -0.782 . . . . 0.81000000000000005 109.759 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.657 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 14.7 p -62.34 -35.78 80.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.452 0.644 . . . . 0.27000000000000002 109.435 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.67 67.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.57 -1.195 . . . . 0.26000000000000001 111.673 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.25 -38.7 24.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.302 0.572 . . . . 0.23000000000000001 109.472 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.48 -19.47 60.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.334 -0.848 . . . . 0.17000000000000001 109.162 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.718 HD11 ' CA ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.95 -37.36 34.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.618 0.723 . . . . 0.19 111.45 173.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.2 -39.32 94.31 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.002 0.906 . . . . 1.0700000000000001 110.047 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 -19.65 38.28 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.052 -1.431 . . . . 0.17000000000000001 111.861 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.563 HD21 ' H ' ' A' ' 47' ' ' VAL . 29.9 m-80 -142.55 72.31 20.62 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.499 . . . . 0.19 109.709 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.611 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 11.2 Cg_endo -54.52 -19.42 17.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 123.545 2.83 . . . . 0.29999999999999999 113.9 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -59.85 -30.82 69.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.925 0.869 . . . . 1.1699999999999999 110.431 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.8 mt -79.78 -3.72 48.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.309 -1.314 . . . . 0.53000000000000003 114.238 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.718 ' CA ' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -49.67 -39.62 37.11 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.442 1.115 . . . . 1.23 110.082 -177.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.585 ' N ' HE21 ' A' ' 37' ' ' GLN . . . -85.22 -45.94 11.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 112.875 -1.966 . . . . 0.40000000000000002 111.733 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.33 -165.06 35.81 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.393 -0.908 . . . . 0.29999999999999999 113.963 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.476 ' HB3' HG21 ' A' ' 9' ' ' VAL . 6.2 mp -115.08 158.22 22.45 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.232 -1.484 . . . . 0.31 109.977 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.587 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.1 m -134.67 136.39 42.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.893 -0.594 . . . . 0.39000000000000001 110.553 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.77 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.75 127.64 8.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.272 0.841 . . . . 0.46999999999999997 113.272 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.33 -10.93 46.94 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.33 -1.305 . . . . 0.35999999999999999 112.265 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -64.23 151.81 42.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.477 0.656 . . . . 1.1899999999999999 110.455 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 55.4 p -115.48 136.71 52.8 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.882 -1.054 . . . . 0.89000000000000001 109.484 -173.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.644 HD12 HD11 ' A' ' 29' ' ' LEU . 19.6 pt -137.36 149.37 25.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.414 0.626 . . . . 0.22 110.382 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.563 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.8 t -96.48 149.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.973 -1.012 . . . . 0.20999999999999999 110.121 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.574 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.2 mm -117.9 87.47 27.85 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.155 -0.929 . . . . 0.17000000000000001 108.702 -177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.748 ' HA ' HD13 ' A' ' 4' ' ' LEU . 23.8 Cg_endo -59.14 141.41 98.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.248 2.632 . . . . 0.23000000000000001 113.018 -173.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.52 -7.89 67.14 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.557 -0.747 . . . . 0.29999999999999999 112.855 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 159' ' ' ASN . 3.1 tt -116.34 127.44 26.75 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.719 -0.845 . . . . 0.25 108.719 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 58.6 Cg_endo -65.91 171.87 9.27 Favored 'Trans proline' 0 N--CA 1.476 0.446 0 C-N-CA 123.674 2.916 . . . . 0.31 113.8 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.515 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 9.5 t70 -94.94 138.0 22.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.063 -0.971 . . . . 0.71999999999999997 111.522 -170.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.82 ' HD3' HD12 ' A' ' 5' ' ' LEU . 77.6 Cg_endo -75.32 -7.95 19.29 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 123.296 2.664 . . . . 0.27000000000000002 113.288 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.1 -33.5 16.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.063 -0.255 . . . . 2.1099999999999999 110.618 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.423 HG21 ' HG3' ' A' ' 3' ' ' LYS . 23.5 p -63.4 -31.82 73.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.426 1.107 . . . . 1.47 108.31 172.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.759 HD13 ' HG2' ' A' ' 158' ' ' PRO . 95.1 mt -77.27 126.02 85.65 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.082 -1.872 . . . . 0.26000000000000001 110.857 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -100.97 95.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.946 0 C-N-CA 120.753 0.969 . . . . 0.20000000000000001 110.257 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 73' ' ' SER . 94.3 m-85 -157.68 138.08 12.8 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.909 -1.515 . . . . 0.26000000000000001 106.909 171.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 55.5 t-80 -144.56 104.07 4.01 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.429 -1.323 . . . . 2.8399999999999999 107.429 -170.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 163' ' ' VAL . 68.8 mt -94.8 109.25 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.037 -1.438 . . . . 0.32000000000000001 110.176 -174.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.05 102.74 11.17 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.19 -0.913 . . . . 0.34000000000000002 110.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.692 HG13 HG13 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -122.14 102.57 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.005 -1.452 . . . . 0.68000000000000005 109.988 178.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.522 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 30.2 t -95.0 135.67 36.25 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.183 -0.917 . . . . 1.05 108.9 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.674 ' HB ' ' CB ' ' A' ' 167' ' ' ARG . 1.0 OUTLIER -59.64 -33.61 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.491 0.662 . . . . 1.29 109.95 170.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.04 -48.1 74.69 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 114.95 -1.023 . . . . 0.88 111.368 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -69.08 -25.12 64.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.873 0.694 . . . . 0.73999999999999999 112.873 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 57.18 12.71 1.39 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.871 0.869 . . . . 2.5099999999999998 112.982 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.43 142.27 35.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.575 0.702 . . . . 0.45000000000000001 111.349 177.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.517 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.0 tt -98.07 118.42 34.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.499 -1.228 . . . . 0.33000000000000002 109.936 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 m -101.51 125.4 48.15 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.438 -0.505 . . . . 0.40000000000000002 111.35 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.16 134.89 34.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.47 -1.678 . . . . 0.33000000000000002 106.47 177.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.4 m -138.32 129.33 27.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.716 1.598 . . . . 0.75 112.346 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.14 124.25 49.86 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.079 -0.964 . . . . 0.34999999999999998 110.01 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.57 37.51 3.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.843 -1.169 . . . . 0.52000000000000002 107.843 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m120 83.92 -14.18 0.69 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.679 -1.601 . . . . 1.8400000000000001 111.569 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -127.23 141.27 51.77 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 117.675 -1.61 . . . . 3.1899999999999999 114.613 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -56.55 148.75 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 112.291 -2.232 . . . . 0.40999999999999998 113.957 -165.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.541 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.0 mtp -100.49 -43.73 6.11 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.721 -2.49 . . . . 0.34999999999999998 107.804 175.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 33.3 tptt -179.92 161.34 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.497 -2.138 . . . . 2.0699999999999998 111.102 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.485 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 15.2 m -118.39 137.43 53.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 122.422 -0.174 . . . . 0.37 110.908 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -126.03 137.81 30.88 Favored Pre-proline 0 N--CA 1.457 -0.107 0 CA-C-O 120.702 0.287 . . . . 0.96999999999999997 110.267 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HB2' HG22 ' A' ' 134' ' ' ILE . 27.8 Cg_endo -63.39 146.09 93.09 Favored 'Trans proline' 0 N--CA 1.471 0.184 0 C-N-CA 123.187 2.592 . . . . 0.59999999999999998 112.772 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 0.2 OUTLIER -139.58 179.75 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.67 -0.493 . . . . 0.64000000000000001 109.67 176.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.34 141.67 29.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.55 0.691 . . . . 0.82999999999999996 111.411 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.656 HG13 HG23 ' A' ' 65' ' ' ILE . 2.5 t -153.73 -35.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.112 -1.404 . . . . 1.6699999999999999 108.585 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.11 -134.94 13.17 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.392 -1.083 . . . . 3.0800000000000001 110.392 -175.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.642 ' HG3' ' H ' ' A' ' 89' ' ' ILE . 51.6 pttt -82.06 -62.98 1.48 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.089 -0.708 . . . . 7.2599999999999998 109.089 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.642 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 71.0 mt -157.29 96.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.437 -0.949 . . . . 6.29 108.437 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.82 94.39 0.82 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.089 0.471 . . . . 7.2699999999999996 110.156 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.9 p -77.89 56.43 1.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.723 -0.671 . . . . 5.1799999999999997 112.222 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -127.47 -21.19 3.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.253 -0.431 . . . . 4.8099999999999996 110.962 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.505 ' CG2' ' H ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER 43.21 67.6 3.55 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 109.513 -0.551 . . . . 2.1099999999999999 109.513 -170.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.409 ' HG2' ' CG2' ' A' ' 165' ' ' ILE . 18.7 Cg_exo -18.01 -72.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.073 1 C-N-CA 125.496 4.131 . . . . 3.21 115.437 -162.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.4 p -146.73 -76.82 0.19 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.418 0.628 . . . . 3.5899999999999999 110.246 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.9 -85.68 0.07 OUTLIER Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.243 -0.89 . . . . 2.1000000000000001 111.362 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -124.97 140.54 52.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.276 0.56 . . . . 2.2999999999999998 111.605 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.522 ' HB2' HG13 ' A' ' 163' ' ' VAL . 29.7 m-85 -125.87 177.1 6.5 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.939 -1.028 . . . . 1.9299999999999999 108.518 171.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.639 ' HA ' ' O ' ' A' ' 161' ' ' THR . 42.4 m-85 -129.86 139.71 51.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.766 0.317 . . . . 0.57999999999999996 110.19 169.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.828 HD11 HD12 ' A' ' 125' ' ' ILE . 18.6 mm -59.4 115.58 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 107.681 -1.229 . . . . 0.40999999999999998 107.681 166.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.557 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.6 tt -99.31 -30.03 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.622 -0.831 . . . . 0.37 112.068 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -178.8 -165.06 0.08 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.599 1.19 . . . . 1.99 113.775 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.781 ' HG2' HD23 ' A' ' 116' ' ' LEU . 9.9 mtt180 -148.2 132.86 17.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 111.969 -2.378 . . . . 1.1899999999999999 108.871 -173.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -101.76 158.91 15.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.274 1.035 . . . . 1.6699999999999999 111.423 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.712 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 2.5 ttt180 -49.74 152.93 1.35 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 112.865 -1.971 . . . . 3.0600000000000001 112.003 169.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.712 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.03 112.93 1.9 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 114.062 -1.426 . . . . 2.6099999999999999 110.861 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -57.44 -50.75 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.141 2.56 . . . . 0.97999999999999998 111.559 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.08 45.57 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.777 -1.101 . . . . 1.0800000000000001 112.469 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.32 -169.21 22.05 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.328 -0.463 . . . . 1.05 112.09 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.6 36.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 124.576 3.517 . . . . 1.3 114.402 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -93.1 -12.05 31.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.76 0.314 . . . . 1.3799999999999999 110.977 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.614 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.51 33.4 5.37 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.408 -0.901 . . . . 1.1100000000000001 114.497 171.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.39 -22.5 0.25 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.943 1.09 . . . . 0.81000000000000005 113.943 168.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -152.98 143.99 23.01 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.011 -0.366 . . . . 1.1200000000000001 110.011 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -109.94 100.77 9.67 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.799 -0.815 . . . . 2.1899999999999999 108.799 166.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.804 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 2.1 mp -104.82 137.1 43.12 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.42 0.629 . . . . 0.60999999999999999 109.549 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.9 m -106.16 143.45 34.26 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.231 -0.895 . . . . 0.93999999999999995 112.064 -170.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.6 OUTLIER -94.83 -174.79 3.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.702 -1.222 . . . . 1.0800000000000001 107.702 171.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.516 ' O ' ' HE2' ' A' ' 120' ' ' LYS . 20.1 m -95.33 18.91 11.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.218 0.451 . . . . 1.5 112.218 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 119' ' ' SER . 0.0 OUTLIER -130.56 97.61 4.43 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 119.914 -0.714 . . . . 2.9700000000000002 112.398 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.4 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 2.0 mp0 54.05 -103.09 0.16 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.566 0.746 . . . . 5.0599999999999996 112.868 169.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -110.88 5.65 20.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.415 -0.357 . . . . 5.9500000000000002 111.068 -174.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 78.4 m-85 -79.63 131.3 35.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.975 -0.38 . . . . 4.8300000000000001 109.975 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.507 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -155.93 160.43 30.03 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.854 -0.689 . . . . 0.94999999999999996 112.035 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 100' ' ' ILE . 41.7 mt -92.56 107.39 18.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.476 -0.935 . . . . 0.47999999999999998 108.476 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.541 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 9.2 p80 -140.9 -162.71 1.41 Allowed 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.045 -0.662 . . . . 1.25 111.463 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.614 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -121.3 175.89 16.22 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.087 -1.054 . . . . 0.46000000000000002 113.449 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 144' ' ' ARG . 6.1 t -141.1 177.9 7.75 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.946 -0.627 . . . . 0.5 109.849 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 -4.71 9.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.317 -0.856 . . . . 1.8600000000000001 110.116 167.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -126.31 101.69 27.82 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 109.178 -0.675 . . . . 1.77 109.178 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -92.5 3.57 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.636 2.89 . . . . 0.58999999999999997 114.015 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.11 -19.34 59.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.131 0.491 . . . . 0.78000000000000003 111.693 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.2 m -91.66 -18.24 24.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.116 0.484 . . . . 1.45 110.456 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 83' ' ' PRO . 25.3 mm -68.44 110.2 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.637 -0.71 . . . . 0.69999999999999996 111.12 -176.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 84' ' ' ILE . . . 105.32 1.63 41.1 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.791 -0.718 . . . . 1.6799999999999999 112.983 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -150.03 -54.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.229 0.514 . . . . 4.3899999999999997 112.309 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.64 158.11 17.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.275 0.559 . . . . 3.9399999999999999 111.874 -171.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.9 m -93.34 1.8 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.485 -0.779 . . . . 4.6799999999999997 109.984 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.3 m -67.86 95.28 0.51 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.189 -0.914 . . . . 5.6799999999999997 112.275 -173.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 56.02 58.33 4.45 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.64 -0.709 . . . . 8.3000000000000007 111.649 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.3 133.23 2.27 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.27 -0.967 . . . . 3.8500000000000001 112.749 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 63.9 m -120.66 -75.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.015 0.436 . . . . 2.5099999999999998 109.875 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 10.1 mt -122.09 76.17 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.518 . . . . 1.4399999999999999 109.822 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 89.2 mtt180 -129.85 147.33 51.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.838 -0.619 . . . . 3.3599999999999999 110.124 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.553 ' H ' ' HA2' ' A' ' 127' ' ' GLY . 10.5 mtp -139.36 -166.39 2.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.451 -0.34 . . . . 1.1299999999999999 110.196 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -79.13 158.89 27.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.597 -0.52 . . . . 2.5099999999999998 109.597 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.556 ' O ' HG12 ' A' ' 150' ' ' VAL . 23.1 p-10 -52.05 -68.13 0.19 Allowed 'General case' 0 C--O 1.221 -0.438 0 O-C-N 123.333 0.396 . . . . 1.77 111.73 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -62.55 -24.54 67.58 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.728 -0.607 . . . . 2.1299999999999999 111.821 -175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.27 -43.05 71.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.331 -0.395 . . . . 1.05 110.704 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 7.3 p -77.3 -19.8 14.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.374 -0.375 . . . . 0.32000000000000001 111.047 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.402 HD12 HG13 ' A' ' 150' ' ' VAL . 2.6 mp -84.61 -39.53 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 118.987 -0.53 . . . . 0.37 109.849 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -43.35 -70.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.257 0.935 . . . . 1.3799999999999999 112.107 163.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.671 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -49.81 -42.96 48.21 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 123.853 0.721 . . . . 0.73999999999999999 110.323 178.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.12 -56.68 15.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.3 -1.318 . . . . 0.22 111.884 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.2 t -76.41 -11.53 59.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.803 -1.09 . . . . 1.3300000000000001 110.626 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 92.9 mt -93.03 -47.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.751 -0.463 . . . . 0.23000000000000001 109.751 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 153' ' ' LEU . 27.0 m -77.17 119.16 76.36 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 121.996 0.903 . . . . 0.20999999999999999 110.81 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.759 ' HG2' HD13 ' A' ' 57' ' ' ILE . 33.1 Cg_endo -84.09 -177.71 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.017 2.478 . . . . 0.34000000000000002 113.013 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.692 ' O ' HD21 ' A' ' 51' ' ' LEU . 17.5 m120 -59.11 1.21 0.07 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.568 -1.196 . . . . 1.02 113.978 -176.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -150.08 55.92 0.47 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.729 . . . . 0.28000000000000003 112.173 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 5.1 m -84.83 137.03 33.41 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.543 -0.386 . . . . 0.29999999999999999 110.657 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HG2' ' HE1' ' A' ' 99' ' ' TYR . 64.0 mtm180 -83.06 125.87 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.097 -0.335 . . . . 1.96 110.097 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.7 p -139.49 123.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.401 0.62 . . . . 0.46000000000000002 111.103 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.444 ' C ' HD12 ' A' ' 165' ' ' ILE . 62.5 m -113.44 137.12 51.99 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.699 -0.682 . . . . 0.56000000000000005 111.813 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.692 HG13 HG13 ' A' ' 63' ' ' VAL . 3.2 mp -126.35 113.34 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 118.387 -1.325 . . . . 0.95999999999999996 111.08 172.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -144.5 135.91 25.51 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 113.468 -1.697 . . . . 1.1899999999999999 109.618 -174.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.674 ' CB ' ' HB ' ' A' ' 65' ' ' ILE . 3.9 ptt180 -92.47 -30.81 15.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.619 0.723 . . . . 3.4199999999999999 109.893 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -133.77 137.81 9.61 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.738 -1.119 . . . . 3.6499999999999999 111.093 170.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.72 -0.657 . . . . 5.9699999999999998 110.04 179.305 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.548 ' O31' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.907 -0.477 . . . . 2.9199999999999999 111.907 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 67.04 175.89 0.25 Allowed 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.304 0.641 . . . . 4.0999999999999996 111.687 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 3.9 mptp? -69.4 154.19 42.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.349 -0.841 . . . . 2.1000000000000001 109.777 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 49' ' ' PRO . 15.5 mt -97.05 168.16 10.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.017 -0.538 . . . . 0.26000000000000001 111.147 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.551 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.8 tp -75.88 150.23 37.64 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 123.336 0.654 . . . . 0.23000000000000001 111.886 -169.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.46 149.13 36.78 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.17 0.986 . . . . 0.26000000000000001 111.978 167.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' SER . 77.9 t80 -135.18 150.84 50.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.277 -1.783 . . . . 0.39000000000000001 108.068 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.615 ' NE2' ' HA2' ' A' ' 43' ' ' GLY . 1.1 tm0? -129.41 120.96 26.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.359 -1.349 . . . . 1.0700000000000001 107.359 174.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -81.41 159.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 123.327 0.651 . . . . 0.38 111.968 -171.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' N ' HG23 ' A' ' 9' ' ' VAL . 1.1 ptmt -107.84 151.14 26.15 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.071 -0.715 . . . . 2.5899999999999999 109.071 -176.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.701 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 4.9 tt0 -54.3 113.76 1.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.339 -0.846 . . . . 1.74 111.949 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.75 -5.79 25.97 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.679 -0.772 . . . . 0.56999999999999995 112.797 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.695 ' HB3' HD11 ' A' ' 18' ' ' ILE . 32.7 m-20 -66.6 156.26 35.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.661 0.615 . . . . 2.1699999999999999 112.661 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.564 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -133.86 154.64 50.9 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 116.048 -0.524 . . . . 0.5 112.273 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.592 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.54 -58.68 4.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.767 1.025 . . . . 0.27000000000000002 113.767 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.2 p30 -63.19 -41.83 99.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.794 1.283 . . . . 1.21 110.941 -171.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.794 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 3.2 m -61.83 -39.76 92.95 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.162 -2.29 . . . . 1.24 110.878 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -76.45 -38.99 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 123.638 0.775 . . . . 0.29999999999999999 112.694 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.679 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.15 -61.29 2.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.465 -0.334 . . . . 0.23000000000000001 111.2 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.32 -4.79 54.81 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.677 -1.209 . . . . 0.39000000000000001 111.774 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.794 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.0 t70 -61.95 -35.43 78.41 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.609 -1.256 . . . . 1.6299999999999999 107.609 157.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.665 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.9 m-85 -100.73 17.29 22.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 112.854 0.687 . . . . 0.23999999999999999 112.854 176.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' NH2' ' HA ' ' A' ' 121' ' ' GLN . 2.5 mpt_? 53.95 52.49 12.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.563 -0.744 . . . . 3.5499999999999998 110.856 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 19' ' ' ALA . 34.0 pt -149.85 -173.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.984 -0.747 . . . . 0.27000000000000002 108.984 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 146.97 24.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.589 -0.732 . . . . 0.81000000000000005 109.71 173.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 17.9 p -60.89 -36.6 79.64 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.503 -0.925 . . . . 0.27000000000000002 108.503 175.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.64 70.55 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.441 -1.254 . . . . 0.26000000000000001 111.733 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.21 -37.57 28.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.888 -0.507 . . . . 0.23000000000000001 109.761 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.62 HD11 HD12 ' A' ' 46' ' ' ILE . 14.0 tp -74.47 -19.66 60.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.382 -0.826 . . . . 0.17000000000000001 109.188 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.753 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.28 -39.02 41.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.723 0.773 . . . . 0.19 111.608 173.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -60.62 -41.39 94.76 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.971 -1.013 . . . . 1.0700000000000001 109.745 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.54 -20.53 39.81 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.717 -1.583 . . . . 0.17000000000000001 112.169 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 25.4 m-80 -141.88 72.3 23.77 Favored Pre-proline 0 CA--C 1.513 -0.447 0 CA-C-O 121.132 0.492 . . . . 0.19 109.836 -173.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.708 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.6 Cg_endo -57.51 -11.94 9.9 Favored 'Trans proline' 0 C--N 1.331 -0.356 0 C-N-CA 123.415 2.743 . . . . 0.29999999999999999 113.887 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -61.9 -32.77 73.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.965 0.888 . . . . 1.1699999999999999 109.375 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.68 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.75 -6.87 59.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.785 1.402 . . . . 0.53000000000000003 114.785 -171.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.753 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -50.58 -40.91 53.6 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 120.08 1.309 . . . . 1.23 110.241 179.254 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.81 -46.29 12.36 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.965 -1.925 . . . . 0.40000000000000002 111.437 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.68 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.43 -163.5 34.15 Favored Glycine 0 CA--C 1.495 -1.214 0 C-N-CA 120.402 -0.904 . . . . 0.29999999999999999 114.029 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 9' ' ' VAL . 6.6 mp -117.89 158.31 25.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.215 -1.493 . . . . 0.31 110.436 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.616 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.7 m -131.74 135.58 46.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.713 -0.676 . . . . 0.39000000000000001 110.339 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.701 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.13 127.71 8.83 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.994 0.739 . . . . 0.46999999999999997 112.994 172.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.615 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 81.79 -10.43 51.83 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.815 -1.084 . . . . 0.35999999999999999 112.174 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.616 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.0 tt0 -64.25 151.33 43.91 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.771 0.796 . . . . 1.1899999999999999 110.188 175.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 39.5 m -117.79 134.14 55.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.235 -1.348 . . . . 0.89000000000000001 109.023 -171.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 29' ' ' LEU . 22.8 pt -135.88 149.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.319 0.581 . . . . 0.22 110.584 -175.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.557 ' H ' HD21 ' A' ' 33' ' ' ASN . 13.5 t -94.64 149.37 4.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 114.998 -1.001 . . . . 0.20999999999999999 110.249 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.527 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.4 mm -117.58 88.36 29.09 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 114.993 -1.003 . . . . 0.17000000000000001 108.434 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.766 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.5 Cg_endo -58.45 143.4 97.88 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.248 2.632 . . . . 0.23000000000000001 112.723 -173.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.451 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 79.14 -8.29 46.59 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.496 -0.775 . . . . 0.29999999999999999 112.882 -176.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.727 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.2 tt -113.54 124.82 30.54 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.551 -0.907 . . . . 0.25 108.551 177.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.659 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.2 Cg_endo -66.17 174.35 6.11 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.6 2.867 . . . . 0.31 113.631 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.6 t70 -89.12 142.0 29.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.043 -0.98 . . . . 0.71999999999999997 109.967 -173.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 83.2 Cg_endo -81.19 -13.58 11.19 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.223 2.615 . . . . 0.27000000000000002 112.087 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -96.91 -10.33 26.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.08 0.467 . . . . 2.1099999999999999 111.182 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -81.22 -22.37 38.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.076 -1.453 . . . . 1.47 107.076 166.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.62 HD13 ' HG2' ' A' ' 158' ' ' PRO . 64.4 mt -87.68 132.56 40.16 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 113.005 -1.907 . . . . 0.26000000000000001 110.219 173.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -103.89 96.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 121.208 1.272 . . . . 0.20000000000000001 110.546 165.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.464 ' HD2' ' CG2' ' A' ' 57' ' ' ILE . 84.0 m-85 -157.97 130.99 7.45 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.5 -1.296 . . . . 0.26000000000000001 107.5 172.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 13.0 m170 -135.75 103.68 5.5 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.981 -1.489 . . . . 2.8399999999999999 106.981 -166.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 76.2 mt -94.3 109.39 22.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.458 -0.792 . . . . 0.32000000000000001 110.541 -175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.11 97.01 6.24 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.385 -0.825 . . . . 0.34000000000000002 110.579 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.496 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -113.43 98.56 7.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.319 -1.309 . . . . 0.68000000000000005 109.808 178.125 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 43.0 m -94.59 121.1 35.8 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.615 -1.175 . . . . 1.05 108.752 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.611 ' HA ' HG12 ' A' ' 86' ' ' VAL . 8.2 mt -57.82 -26.79 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.352 0.596 . . . . 1.29 111.601 175.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.49 70.53 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.722 -0.752 . . . . 0.88 111.269 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -70.19 -24.46 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.14 0.495 . . . . 0.73999999999999999 112.335 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.506 ' HG2' HG11 ' A' ' 86' ' ' VAL . 35.9 mttt 58.26 18.38 5.37 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.367 1.067 . . . . 2.5099999999999998 112.318 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -142.67 141.27 31.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.92 0.866 . . . . 0.45000000000000001 111.516 176.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.496 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -94.96 118.52 31.94 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.895 -1.502 . . . . 0.33000000000000002 109.318 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -99.68 124.28 44.76 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.39 -0.524 . . . . 0.40000000000000002 111.095 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.494 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.07 133.52 35.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.804 -1.924 . . . . 0.33000000000000002 105.804 175.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.6 m -138.76 130.78 28.1 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 120.544 1.52 . . . . 0.75 112.743 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.77 126.61 53.36 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.14 -0.936 . . . . 0.34999999999999998 110.432 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 64.61 37.91 7.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.453 0.644 . . . . 0.52000000000000002 109.357 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 73.98 2.34 4.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.562 -1.199 . . . . 1.8400000000000001 112.567 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -130.8 138.0 49.7 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.618 -1.233 . . . . 3.1899999999999999 113.703 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -52.04 148.64 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-N 113.292 -1.776 . . . . 0.40999999999999998 113.587 -172.085 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.494 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.7 mtp -96.98 -46.12 6.32 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.191 -2.277 . . . . 0.34999999999999998 107.576 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 6.5 tptp 179.2 159.01 0.62 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.474 -2.148 . . . . 2.0699999999999998 109.767 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.536 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 18.5 m -117.03 136.22 53.12 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.379 -0.2 . . . . 0.37 110.946 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.54 133.42 24.04 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 109.986 -0.376 . . . . 0.96999999999999997 109.986 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.76 146.57 92.15 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.868 2.378 . . . . 0.59999999999999998 112.447 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 177.15 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.056 -0.72 . . . . 0.64000000000000001 109.056 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.716 ' HB3' ' HA ' ' A' ' 142' ' ' CYS . . . -88.19 153.45 21.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.118 0.485 . . . . 0.82999999999999996 110.072 173.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 65' ' ' ILE . 3.3 m -122.55 98.27 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.717 -0.674 . . . . 1.6699999999999999 111.982 -171.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.03 84.36 0.92 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.726 -0.67 . . . . 3.0800000000000001 111.904 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -82.72 2.96 31.18 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.803 0.297 . . . . 7.2599999999999998 111.803 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.2 tp -81.8 -35.11 13.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.771 0.32 . . . . 6.29 111.13 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.99 123.26 28.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.302 . . . . 7.2699999999999996 110.777 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -89.63 64.63 6.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.387 0.613 . . . . 5.1799999999999997 110.773 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -123.72 84.56 2.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.165 -0.47 . . . . 4.8099999999999996 110.326 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -80.75 -62.7 0.36 Allowed Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 112.885 0.698 . . . . 2.1099999999999999 112.885 -175.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.592 ' HD3' ' OG1' ' A' ' 93' ' ' THR . 74.9 Cg_endo -91.0 -6.83 3.89 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.957 1.771 . . . . 3.21 113.707 -173.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.9 t -102.65 13.47 34.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.976 0.417 . . . . 3.5899999999999999 111.239 -176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -105.33 52.8 0.69 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.451 -0.881 . . . . 2.1000000000000001 112.465 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.39 128.18 53.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.366 0.603 . . . . 2.2999999999999998 110.598 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 163' ' ' VAL . 13.1 m-85 -127.0 178.78 5.77 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.033 -0.985 . . . . 1.9299999999999999 110.017 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' THR . 72.3 m-85 -134.06 140.42 46.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.923 -0.58 . . . . 0.57999999999999996 110.09 172.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 125' ' ' ILE . 27.2 mm -60.46 126.61 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.239 -1.022 . . . . 0.40999999999999998 108.239 167.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.7 tt -124.7 -21.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.047 -0.661 . . . . 0.37 112.41 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 21.9 t-20 -159.65 160.86 34.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.635 1.207 . . . . 1.99 114.088 -173.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.66 127.49 15.37 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 111.632 -2.531 . . . . 1.1899999999999999 108.806 172.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.64 158.54 16.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.446 1.117 . . . . 1.6699999999999999 111.821 -171.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.593 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 21.9 ttm180 -52.42 155.59 2.05 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.175 -2.284 . . . . 3.0600000000000001 111.793 167.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.593 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 6.6 p30 -45.13 109.89 0.99 Allowed Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.163 -1.38 . . . . 2.6099999999999999 111.519 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.37 -51.51 5.24 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.4 2.733 . . . . 0.97999999999999998 112.12 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.61 -10.31 70.87 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.096 -0.957 . . . . 1.0800000000000001 111.959 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -107.78 -168.72 21.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.412 -0.423 . . . . 1.05 112.085 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.54 18.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 124.073 3.182 . . . . 1.3 113.945 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.499 ' CZ ' ' H25' ' A' 1142 ' ' IM2 . 0.1 OUTLIER -69.26 -18.56 63.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 1.3799999999999999 111.385 -177.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.591 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 94.19 41.38 4.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 1.1100000000000001 113.4 174.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 77.08 -27.58 0.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.237 0.828 . . . . 0.81000000000000005 113.237 171.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.551 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -152.64 146.5 25.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.95 0.405 . . . . 1.1200000000000001 110.769 -178.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -115.88 101.58 8.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 2.1899999999999999 109.545 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.1 mp -103.63 141.69 35.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.406 0.622 . . . . 0.60999999999999999 110.462 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 101' ' ' ILE . 50.7 m -106.15 140.3 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.488 -0.778 . . . . 0.93999999999999995 111.818 -171.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -95.56 -178.41 4.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.676 -1.231 . . . . 1.0800000000000001 107.676 172.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 58.9 m -56.93 -58.04 9.89 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 118.439 0.563 . . . . 1.5 111.037 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.407 ' HA ' ' OD1' ' A' ' 21' ' ' ASP . 25.5 mmmt -70.12 127.0 31.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.067 0.461 . . . . 2.9700000000000002 109.884 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 21' ' ' ASP . 23.3 tm0? -56.4 -30.12 62.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.148 -0.933 . . . . 5.0599999999999996 112.071 -174.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -90.13 11.47 20.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.853 0.316 . . . . 5.9500000000000002 111.853 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -133.02 135.79 45.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.945 0.402 . . . . 4.8300000000000001 110.464 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.2 158.0 28.07 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.007 -1.092 . . . . 0.94999999999999996 112.882 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 100' ' ' ILE . 7.3 mt -92.73 109.43 21.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.499 -0.926 . . . . 0.47999999999999998 108.499 172.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 144' ' ' ARG . 9.9 p80 -140.13 -164.44 1.71 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.505 -0.878 . . . . 1.25 111.796 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.591 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.04 179.52 16.2 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.724 -1.125 . . . . 0.46000000000000002 113.968 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -139.39 174.22 10.73 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.293 0.568 . . . . 0.5 111.068 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -104.38 -21.29 13.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.971 -1.013 . . . . 1.8600000000000001 108.9 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -127.22 104.36 22.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.755 -1.111 . . . . 1.77 109.672 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.69 5.41 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.499 2.799 . . . . 0.58999999999999997 112.794 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.46 59.57 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.258 0.552 . . . . 0.78000000000000003 110.363 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 m -85.33 -17.32 37.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 1.45 109.576 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 36.6 mm -81.5 115.55 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.407 -0.815 . . . . 0.69999999999999996 111.017 -175.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.29 29.76 59.72 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.577 -0.738 . . . . 1.6799999999999999 111.571 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -154.56 -38.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.772 0.32 . . . . 4.3899999999999997 110.57 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -85.38 154.11 22.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.944 0.402 . . . . 3.9399999999999999 110.865 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.57 -12.45 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.66 -0.7 . . . . 4.6799999999999997 110.476 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.0 p -152.55 38.13 0.54 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.128 0.49 . . . . 5.6799999999999997 111.271 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -151.96 133.71 14.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.414 -0.357 . . . . 8.3000000000000007 110.65 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 144' ' ' ARG . . . 89.99 -33.8 4.33 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.112 -0.566 . . . . 3.8500000000000001 113.371 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 85' ' ' ALA . 29.9 p 39.05 -91.85 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.848 0.859 . . . . 2.5099999999999998 113.088 -171.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.404 ' N ' ' SG ' ' A' ' 142' ' ' CYS . 15.6 mt -124.11 65.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 121.493 -0.755 . . . . 1.4399999999999999 111.345 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.569 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 10.3 ptm180 -132.49 90.98 2.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.961 0.886 . . . . 3.3599999999999999 110.475 175.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.7 ptm -100.29 -165.44 1.22 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.951 -1.022 . . . . 1.1299999999999999 112.719 -168.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -64.58 133.81 53.07 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.669 -0.696 . . . . 2.5099999999999998 111.051 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.623 ' O ' HG12 ' A' ' 150' ' ' VAL . 10.9 p30 -52.64 -63.54 1.11 Allowed 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 113.038 0.755 . . . . 1.77 113.038 -172.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -23.76 67.6 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.321 -0.862 . . . . 2.1299999999999999 112.115 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.03 -33.8 57.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 1.05 111.193 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 14.8 p -79.71 -16.3 13.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 110.016 -0.365 . . . . 0.32000000000000001 110.016 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.571 HD12 HG13 ' A' ' 150' ' ' VAL . 2.8 mp -88.38 -37.14 10.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.897 -0.409 . . . . 0.37 109.897 171.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -43.46 -70.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.878 0.763 . . . . 1.3799999999999999 111.784 159.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.712 ' O ' HG22 ' A' ' 157' ' ' VAL . 2.9 pp -54.7 -36.0 64.22 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.474 0.484 . . . . 0.73999999999999999 110.479 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.22 -51.92 65.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.6 0.714 . . . . 0.22 112.059 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.0 p -77.52 -15.57 59.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.77 -1.104 . . . . 1.3300000000000001 110.91 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.2 mt -93.86 -49.01 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.06 -0.518 . . . . 0.23000000000000001 110.5 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.2 m -76.83 111.97 19.53 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-O 121.776 0.798 . . . . 0.20999999999999999 110.253 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.62 ' HG2' HD13 ' A' ' 57' ' ' ILE . 6.8 Cg_endo -77.85 -179.89 5.87 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.467 2.111 . . . . 0.34000000000000002 112.804 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.727 ' O ' HD21 ' A' ' 51' ' ' LEU . 12.2 m120 -62.03 1.54 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.153 -1.385 . . . . 1.02 113.611 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.408 ' O ' HD12 ' A' ' 57' ' ' ILE . . . -145.1 58.4 0.51 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.145 -0.55 . . . . 0.28000000000000003 112.133 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.465 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 9.4 m -96.34 136.72 36.44 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.514 -0.403 . . . . 0.29999999999999999 110.27 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 135.36 33.8 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.365 -0.534 . . . . 1.96 110.386 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.2 p -139.0 122.75 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.022 -0.99 . . . . 0.46000000000000002 110.788 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.409 ' C ' HD12 ' A' ' 165' ' ' ILE . 87.1 m -113.75 138.39 50.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.716 -0.674 . . . . 0.56000000000000005 111.426 -177.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.489 HG13 HG13 ' A' ' 63' ' ' VAL . 2.9 mp -119.8 110.98 30.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 118.751 -1.18 . . . . 0.95999999999999996 109.999 172.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.25 139.06 33.67 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.425 -1.261 . . . . 1.1899999999999999 109.568 -173.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.685 ' H ' HG22 ' A' ' 93' ' ' THR . 12.2 mpt_? -81.27 -9.72 59.72 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.236 -1.347 . . . . 3.4199999999999999 110.568 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 175.71 -81.56 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.313 -0.858 . . . . 3.6499999999999999 111.371 177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.529 -0.748 . . . . 5.9699999999999998 109.799 177.859 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.578 ' O32' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.718 -0.553 . . . . 2.9199999999999999 111.718 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -79.1 169.38 18.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.064 0.459 . . . . 4.0999999999999996 110.853 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.6 OUTLIER -72.93 153.62 40.9 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.984 -0.747 . . . . 2.1000000000000001 108.984 172.189 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.789 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.5 mt -99.94 171.66 7.71 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.164 0.431 . . . . 0.26000000000000001 112.164 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.594 HD12 ' HD3' ' A' ' 54' ' ' PRO . 4.7 tp -76.15 152.89 36.58 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.59 0.756 . . . . 0.23000000000000001 112.512 -168.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -115.29 148.14 39.55 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.21 1.005 . . . . 0.26000000000000001 111.88 165.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 45' ' ' SER . 71.7 t80 -134.34 149.14 50.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.096 -1.865 . . . . 0.39000000000000001 107.612 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -130.03 114.41 15.76 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.208 -1.404 . . . . 1.0700000000000001 107.208 175.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.2 m -72.76 155.92 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 121.203 0.525 . . . . 0.38 112.031 -166.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -98.53 151.35 20.72 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.096 -0.956 . . . . 2.5899999999999999 109.593 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.798 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -52.17 116.41 2.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 1.74 111.398 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.05 -7.16 35.22 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 115.09 -0.959 . . . . 0.56999999999999995 112.956 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.55 ' CB ' HD11 ' A' ' 18' ' ' ILE . 71.6 m-20 -61.29 149.11 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.362 0.505 . . . . 2.1699999999999999 112.362 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.575 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -130.83 152.33 50.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.916 -0.583 . . . . 0.5 111.719 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.586 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 54.3 tp -48.43 -59.9 3.1 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 0.27000000000000002 113.896 -170.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.694 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 7.1 t-20 -65.39 -39.85 92.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.132 0.968 . . . . 1.21 110.211 -170.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.737 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 23.3 m -59.59 -41.74 90.97 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.928 -1.942 . . . . 1.24 110.728 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 14' ' ' THR . 1.7 mp -74.95 -40.36 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.515 0.726 . . . . 0.29999999999999999 112.589 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -55.84 -63.65 1.11 Allowed 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.533 -0.303 . . . . 0.23000000000000001 111.188 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -79.95 -3.56 48.72 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.818 -1.153 . . . . 0.39000000000000001 112.035 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 17' ' ' SER . 13.6 t70 -64.47 -33.41 75.81 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.348 -0.982 . . . . 1.6299999999999999 108.348 157.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.679 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.9 m-85 -100.19 17.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.96 0.41 . . . . 0.23999999999999999 111.998 173.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 2.3 mpt_? 53.79 52.18 13.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.407 -0.815 . . . . 3.5499999999999998 110.764 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.707 HG12 ' O ' ' A' ' 19' ' ' ALA . 38.5 pt -148.2 -173.27 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.059 -0.719 . . . . 0.27000000000000002 109.059 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -98.91 144.39 28.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.522 -0.763 . . . . 0.81000000000000005 109.665 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.694 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 7.1 p -62.55 -37.97 88.2 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.618 0.723 . . . . 0.27000000000000002 109.221 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -65.19 -27.41 68.67 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.164 -1.38 . . . . 0.26000000000000001 111.284 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.41 -38.71 26.09 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.467 0.651 . . . . 0.23000000000000001 109.589 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.702 HD11 HD12 ' A' ' 46' ' ' ILE . 14.7 tp -72.06 -19.44 61.82 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 0.17000000000000001 108.911 174.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.789 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.51 -37.23 32.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.307 0.575 . . . . 0.19 111.243 172.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 49.0 mt-30 -56.57 -43.26 79.82 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.353 1.073 . . . . 1.0700000000000001 109.808 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.97 -18.93 35.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.404 -1.725 . . . . 0.17000000000000001 112.801 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 31.7 m-80 -143.82 73.76 16.71 Favored Pre-proline 0 CA--C 1.513 -0.479 0 CA-C-O 121.137 0.494 . . . . 0.19 109.961 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.679 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.1 Cg_endo -57.18 -14.02 14.04 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 123.568 2.845 . . . . 0.29999999999999999 114.098 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.99 -33.56 74.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.104 0.954 . . . . 1.1699999999999999 109.672 175.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.1 mt -79.18 -6.0 55.55 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.225 -1.352 . . . . 0.53000000000000003 114.375 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.789 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -49.25 -41.11 36.66 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 119.778 1.172 . . . . 1.23 110.295 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.1 -46.53 11.85 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 112.766 -2.016 . . . . 0.40000000000000002 111.733 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.39 -163.89 34.73 Favored Glycine 0 CA--C 1.493 -1.314 0 C-N-CA 120.369 -0.919 . . . . 0.29999999999999999 114.383 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.8 mp -118.65 157.38 27.53 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 112.945 -1.627 . . . . 0.31 110.686 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 84.8 m -135.17 132.32 37.85 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.464 -0.789 . . . . 0.39000000000000001 110.18 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.61 128.64 15.43 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.313 0.577 . . . . 0.46999999999999997 112.339 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.09 -13.5 54.15 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 114.734 -1.121 . . . . 0.35999999999999999 112.432 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.617 ' HB3' ' O ' ' A' ' 41' ' ' THR . 4.7 tt0 -65.85 151.98 45.46 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.426 0.632 . . . . 1.1899999999999999 110.358 173.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 50.5 m -117.92 134.35 55.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.589 -1.187 . . . . 0.89000000000000001 109.463 -171.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 29' ' ' LEU . 16.4 pt -136.84 149.79 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.423 0.63 . . . . 0.22 110.576 -175.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.576 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 16.9 t -95.65 148.94 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.08 -0.964 . . . . 0.20999999999999999 110.333 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.504 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.9 mm -117.25 89.33 30.66 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 114.835 -1.075 . . . . 0.17000000000000001 108.812 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.789 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.9 Cg_endo -59.3 140.48 94.78 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.277 2.652 . . . . 0.23000000000000001 112.767 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 82.77 -6.87 67.9 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.701 -0.681 . . . . 0.29999999999999999 113.033 -176.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.7 tt -116.49 124.87 28.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.444 -0.947 . . . . 0.25 108.444 175.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD23 ' A' ' 51' ' ' LEU . 58.9 Cg_endo -65.86 174.22 5.95 Favored 'Trans proline' 0 N--CA 1.473 0.28 0 C-N-CA 123.728 2.952 . . . . 0.31 113.898 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.493 ' O ' HG13 ' A' ' 57' ' ' ILE . 3.8 t70 -90.56 137.55 27.21 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 114.743 -1.117 . . . . 0.71999999999999997 111.604 -171.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.594 ' HD3' HD12 ' A' ' 5' ' ' LEU . 62.3 Cg_endo -83.94 -9.7 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.457 2.771 . . . . 0.27000000000000002 113.344 -174.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -95.67 -15.42 22.71 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.994 0.426 . . . . 2.1099999999999999 110.729 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -91.62 -5.31 54.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.623 0.725 . . . . 1.47 109.174 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.799 HD13 ' HG2' ' A' ' 158' ' ' PRO . 45.0 mt -98.28 137.73 20.8 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 115.24 -0.891 . . . . 0.26000000000000001 109.605 171.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' O ' ' CG ' ' A' ' 59' ' ' TYR . 10.6 Cg_endo -104.13 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.243 0 CA-C-N 120.153 1.09 . . . . 0.20000000000000001 110.038 163.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 58' ' ' PRO . 70.7 m-85 -156.94 133.47 9.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.142 -1.429 . . . . 0.26000000000000001 107.142 169.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.406 ' CD2' ' HB2' ' A' ' 73' ' ' SER . 1.2 t60 -148.18 111.26 4.86 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.555 -0.905 . . . . 2.8399999999999999 108.555 -160.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 50.1 mt -98.63 118.25 44.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.798 -1.092 . . . . 0.32000000000000001 111.019 -175.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.59 92.98 4.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.797 0.808 . . . . 0.34000000000000002 110.07 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 70' ' ' LEU . 1.1 p -111.36 101.78 13.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 114.438 -1.256 . . . . 0.68000000000000005 108.94 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.464 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.2 m -96.0 116.08 28.4 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.466 -0.939 . . . . 1.05 108.466 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.529 HG23 HG13 ' A' ' 86' ' ' VAL . 1.2 mm -45.47 -36.5 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.119 0.485 . . . . 1.29 110.876 170.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . -63.9 -43.83 96.96 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.372 -0.918 . . . . 0.88 111.683 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -71.17 -23.2 62.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.872 -0.664 . . . . 0.73999999999999999 112.73 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.446 ' HA ' HG21 ' A' ' 86' ' ' VAL . 6.2 mptt 58.71 14.98 3.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.882 0.873 . . . . 2.5099999999999998 112.583 -176.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.484 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -140.21 139.56 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.897 0.856 . . . . 0.45000000000000001 111.442 177.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.459 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 7.1 tt -93.67 114.01 26.22 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.744 -1.571 . . . . 0.33000000000000002 108.737 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -98.5 122.19 41.38 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.06 -0.656 . . . . 0.40000000000000002 110.432 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.595 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -81.87 127.14 32.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.823 -1.917 . . . . 0.33000000000000002 105.823 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.1 m -131.8 127.34 36.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 120.341 1.428 . . . . 0.75 111.976 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -113.17 122.69 48.27 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.004 -0.998 . . . . 0.34999999999999998 109.559 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 68.51 36.75 2.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.772 -0.825 . . . . 0.52000000000000002 108.772 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 73.75 1.87 4.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.275 -1.329 . . . . 1.8400000000000001 112.295 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -130.38 138.14 50.23 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 118.148 -1.421 . . . . 3.1899999999999999 113.805 173.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.25 148.21 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 112.84 -1.982 . . . . 0.40999999999999998 113.585 -171.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -98.96 -44.43 6.33 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 111.921 -2.4 . . . . 0.34999999999999998 107.998 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 4.3 tppt? -178.96 160.77 1.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 112.235 -2.257 . . . . 2.0699999999999998 109.491 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.484 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 6.7 m -118.93 131.07 56.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.518 0.199 . . . . 0.37 110.662 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.769 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 30.6 m-85 -118.11 141.2 29.0 Favored Pre-proline 0 N--CA 1.447 -0.609 0 N-CA-C 109.294 -0.632 . . . . 0.96999999999999997 109.294 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HB2' HG22 ' A' ' 134' ' ' ILE . 11.4 Cg_endo -80.94 144.13 14.9 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.196 1.93 . . . . 0.59999999999999998 111.783 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.66 178.07 6.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.89 -0.411 . . . . 0.64000000000000001 109.89 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.95 119.01 24.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.199 0.524 . . . . 0.82999999999999996 111.367 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.529 HG13 HG23 ' A' ' 65' ' ' ILE . 22.1 t -133.1 112.89 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.027 -0.988 . . . . 1.6699999999999999 109.619 175.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.93 138.35 9.95 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.206 -0.758 . . . . 3.0800000000000001 111.206 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -93.85 64.73 3.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.481 0.658 . . . . 7.2599999999999998 111.84 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.0 pt -101.15 -139.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.63 -0.714 . . . . 6.29 109.626 174.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.79 76.6 0.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.302 -0.629 . . . . 7.2699999999999996 109.302 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.47 ' HB ' ' O32' ' A' 1142 ' ' IM2 . 5.1 t -170.48 152.36 3.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.386 -0.824 . . . . 5.1799999999999997 109.405 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.561 ' HG2' ' H ' ' A' ' 93' ' ' THR . 6.2 tt0 -136.44 -148.31 0.28 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.36 -0.607 . . . . 4.8099999999999996 109.36 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.561 ' H ' ' HG2' ' A' ' 92' ' ' GLN . 13.0 p -66.08 117.68 45.11 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 122.793 0.437 . . . . 2.1099999999999999 109.826 174.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.1 107.77 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.263 1.975 . . . . 3.21 111.627 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.9 t -85.0 43.51 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.677 0.751 . . . . 3.5899999999999999 111.474 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.02 122.51 0.93 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.471 -0.871 . . . . 2.1000000000000001 112.582 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -76.73 153.55 34.94 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.119 -0.326 . . . . 2.2999999999999998 110.119 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.854 ' CE1' HG11 ' A' ' 163' ' ' VAL . 0.6 OUTLIER -113.29 176.99 4.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.092 -0.504 . . . . 1.9299999999999999 109.803 176.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.487 ' HE2' ' HG3' ' A' ' 162' ' ' ARG . 37.0 m-85 -137.13 138.56 40.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.179 -0.675 . . . . 0.57999999999999996 109.179 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.493 ' CG1' ' HB ' ' A' ' 161' ' ' THR . 26.8 mm -60.64 107.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.994 -0.743 . . . . 0.40999999999999998 108.994 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.626 HD12 ' CD1' ' A' ' 22' ' ' PHE . 2.4 tt -104.36 -31.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.629 -0.714 . . . . 0.37 112.401 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.625 ' ND2' ' H ' ' A' ' 103' ' ' ARG . 4.0 t-20 -168.65 175.52 6.09 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 123.028 1.394 . . . . 1.99 114.224 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.699 ' HB3' ' CE1' ' A' ' 114' ' ' TYR . 5.6 mtt180 -137.0 126.98 25.89 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 111.07 -2.787 . . . . 1.1899999999999999 107.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.74 150.45 20.2 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.179 0.99 . . . . 1.6699999999999999 111.081 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.578 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 27.0 ttm180 -51.78 156.81 1.33 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.95 -1.932 . . . . 3.0600000000000001 111.863 170.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.578 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 8.4 p30 -43.23 105.12 0.41 Allowed Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 122.745 1.259 . . . . 2.6099999999999999 111.312 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -58.3 -54.68 2.8 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.775 2.983 . . . . 0.97999999999999998 112.949 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.96 72.38 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.445 -0.798 . . . . 1.0800000000000001 111.848 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -121.89 -169.87 13.67 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.973 -0.451 . . . . 1.05 111.973 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.5 32.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 124.419 3.413 . . . . 1.3 114.369 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -88.11 -12.18 44.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.19 0.519 . . . . 1.3799999999999999 110.938 178.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 127' ' ' GLY . . . 72.31 51.99 11.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.146 -0.934 . . . . 1.1100000000000001 114.018 173.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 76.81 -13.6 0.92 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.958 1.096 . . . . 0.81000000000000005 113.958 167.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.699 ' CE1' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -161.99 142.57 10.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.656 0.265 . . . . 1.1200000000000001 110.553 175.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.72 ' CZ3' ' HA3' ' A' ' 124' ' ' GLY . 24.5 t-105 -113.37 101.27 9.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.81 . . . . 2.1899999999999999 108.814 168.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.645 HD12 ' HG2' ' A' ' 103' ' ' ARG . 1.6 mm? -92.71 110.3 21.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.447 0.641 . . . . 0.60999999999999999 109.806 177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.509 ' HB2' HG23 ' A' ' 101' ' ' ILE . 68.5 m -65.86 140.98 58.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.945 -1.025 . . . . 0.93999999999999995 111.983 -174.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.654 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 1.4 tp -109.43 161.46 15.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.452 -0.573 . . . . 1.0800000000000001 109.452 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.49 ' H ' ' HB2' ' A' ' 98' ' ' PHE . 5.6 m -93.92 29.55 2.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.303 0.573 . . . . 1.5 109.877 174.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.65 96.65 4.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.882 -0.599 . . . . 2.9700000000000002 109.899 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 53.97 -131.49 2.02 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.36 0.412 . . . . 5.0599999999999996 110.986 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -104.67 18.24 22.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.678 0.275 . . . . 5.9500000000000002 110.777 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 94.1 m-85 -72.88 154.7 40.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.141 -0.688 . . . . 4.8300000000000001 109.141 173.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.72 ' HA3' ' CZ3' ' A' ' 115' ' ' TRP . . . -156.91 162.65 31.83 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.259 -0.972 . . . . 0.94999999999999996 113.065 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.616 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 47.7 mt -92.87 108.84 20.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 107.555 -1.276 . . . . 0.47999999999999998 107.555 169.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.609 ' CE1' ' HB3' ' A' ' 144' ' ' ARG . 12.7 p80 -143.69 -163.4 1.65 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.825 -0.75 . . . . 1.25 111.846 -175.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 112' ' ' GLY . . . -121.39 168.45 14.33 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.697 -1.138 . . . . 0.46000000000000002 112.68 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 6.9 t -127.65 177.54 6.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.53 0.681 . . . . 0.5 111.888 -165.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -106.98 -18.45 13.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.614 -1.175 . . . . 1.8600000000000001 109.456 166.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -125.3 103.88 29.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.401 -0.818 . . . . 1.77 109.732 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -87.78 4.2 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.979 2.453 . . . . 0.58999999999999997 112.892 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.74 -21.59 23.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.086 0.47 . . . . 0.78000000000000003 110.132 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.8 m -90.23 13.21 15.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.783 -0.644 . . . . 1.45 110.357 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' PRO . 20.4 mm -99.24 113.53 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.82 -0.627 . . . . 0.69999999999999996 110.387 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.79 -83.31 0.35 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.574 -0.739 . . . . 1.6799999999999999 111.594 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -108.43 72.66 0.84 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.321 0.582 . . . . 4.3899999999999997 110.602 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -163.21 146.16 10.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.762 -0.654 . . . . 3.9399999999999999 110.194 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.1 t -101.44 69.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.453 0.644 . . . . 4.6799999999999997 110.314 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.0 m -90.91 138.53 31.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.517 -0.765 . . . . 5.6799999999999997 110.751 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.99 -40.99 97.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.771 -0.65 . . . . 8.3000000000000007 109.566 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -78.8 111.03 3.16 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.71 -0.956 . . . . 3.8500000000000001 110.71 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 84.3 m -106.04 168.2 9.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.624 0.25 . . . . 2.5099999999999998 111.518 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 125' ' ' ILE . 7.8 mt 49.36 54.54 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.453 -0.794 . . . . 1.4399999999999999 111.944 171.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.609 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 15.5 ptt180 -131.26 96.8 4.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 3.3599999999999999 110.176 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.769 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 36.0 mtm -99.58 -165.45 1.23 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.429 0.633 . . . . 1.1299999999999999 112.241 -170.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.523 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 14.6 t-80 -72.77 148.19 44.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.125 -0.943 . . . . 2.5099999999999998 109.212 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.549 ' O ' HG12 ' A' ' 150' ' ' VAL . 31.9 p-10 -50.31 -63.29 1.16 Allowed 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 112.672 0.619 . . . . 1.77 112.672 -172.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -64.53 -21.06 66.58 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.429 -0.794 . . . . 2.1299999999999999 111.945 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.1 m-20 -73.27 -39.51 65.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.207 -0.451 . . . . 1.05 110.659 177.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 10.4 p -80.99 -17.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.005 -0.543 . . . . 0.32000000000000001 110.79 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.443 HD12 HG13 ' A' ' 150' ' ' VAL . 2.5 mp -86.02 -40.54 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.871 -0.585 . . . . 0.37 110.24 171.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -44.11 -69.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 119.411 1.005 . . . . 1.3799999999999999 112.093 165.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.656 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.4 tp -52.07 -42.76 63.42 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.647 -0.706 . . . . 0.73999999999999999 110.581 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.98 -51.55 61.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.475 -1.238 . . . . 0.22 111.605 -173.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 -18.04 53.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.739 -1.119 . . . . 1.3300000000000001 111.244 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.417 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 62.2 mt -90.8 -50.35 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.924 -0.399 . . . . 0.23000000000000001 109.924 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 153' ' ' LEU . 16.1 m -78.13 110.7 14.32 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-O 122.192 0.996 . . . . 0.20999999999999999 110.226 176.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.799 ' HG2' HD13 ' A' ' 57' ' ' ILE . 24.4 Cg_endo -88.22 -179.08 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.386 2.724 . . . . 0.34000000000000002 112.669 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' A' ' 52' ' ' PRO . 8.6 m120 -65.17 108.92 2.02 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.27 -1.011 . . . . 1.02 108.27 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.455 ' O ' HD12 ' A' ' 57' ' ' ILE . . . 108.11 37.37 2.16 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.375 -0.917 . . . . 0.28000000000000003 113.496 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.494 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 26.1 m -90.61 131.69 36.18 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.65 -0.912 . . . . 0.29999999999999999 110.394 172.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.509 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -85.98 136.62 33.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.251 -0.431 . . . . 1.96 109.892 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 98' ' ' PHE . 1.9 p -148.71 137.19 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.716 -0.674 . . . . 0.46000000000000002 111.515 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.8 m -119.02 141.49 48.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 0.56000000000000005 112.055 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.43 HG12 HG13 ' A' ' 63' ' ' VAL . 1.2 mt -125.94 116.32 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 C-N-CA 118.539 -1.264 . . . . 0.95999999999999996 111.715 173.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.666 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER -145.35 145.18 31.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.255 -1.339 . . . . 1.1899999999999999 110.799 -170.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.548 ' H ' HG22 ' A' ' 93' ' ' THR . 4.9 ttt180 -93.11 -35.1 13.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.867 -1.06 . . . . 3.4199999999999999 110.578 -174.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 162.24 108.07 0.22 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.458 -0.877 . . . . 3.6499999999999999 112.228 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.652 -0.69 . . . . 5.9699999999999998 110.095 179.223 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.511 ' O31' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 111.661 -0.575 . . . . 2.9199999999999999 111.661 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.72 160.51 30.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.649 -0.501 . . . . 4.0999999999999996 109.649 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 4.0 mptp? -66.63 148.51 51.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.735 -0.469 . . . . 2.1000000000000001 109.735 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.8 mt -97.43 170.04 9.33 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.524 0.515 . . . . 0.26000000000000001 111.634 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.672 HD12 ' HD3' ' A' ' 54' ' ' PRO . 3.3 tp -77.69 150.31 34.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 123.376 0.67 . . . . 0.23000000000000001 112.144 -170.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.547 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -114.84 149.39 37.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.093 0.949 . . . . 0.26000000000000001 111.879 168.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.495 ' CE2' ' HA ' ' A' ' 9' ' ' VAL . 70.8 t80 -135.19 151.11 50.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 113.546 -1.661 . . . . 0.39000000000000001 107.844 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -128.74 113.85 15.85 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 106.944 -1.502 . . . . 1.0700000000000001 106.944 173.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.543 HG11 HD23 ' A' ' 40' ' ' LEU . 1.3 m -71.83 158.04 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-O 121.141 0.496 . . . . 0.38 111.771 -166.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HE2' ' HA3' ' A' ' 96' ' ' GLY . 79.1 mttt -111.17 145.09 39.27 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.328 -0.851 . . . . 2.5899999999999999 109.487 -174.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -54.82 121.45 8.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.067 -0.97 . . . . 1.74 111.82 -173.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.77 -8.21 17.01 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.149 -0.78 . . . . 0.56999999999999995 111.149 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -40.42 142.37 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.198 1.555 . . . . 2.1699999999999999 115.198 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 134.72 45.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.013 -0.994 . . . . 0.5 111.342 163.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 56.8 tp -41.37 -56.34 2.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.195 -0.911 . . . . 0.27000000000000002 113.457 -174.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.675 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.6 -38.11 88.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.432 1.11 . . . . 1.21 110.322 -171.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -64.41 -42.35 96.13 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 112.953 -1.93 . . . . 1.24 110.263 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -70.26 -41.07 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.045 0.45 . . . . 0.29999999999999999 111.228 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.5 -59.56 4.98 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 115.995 -0.548 . . . . 0.23000000000000001 111.396 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.78 -3.86 57.19 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 118.936 -1.106 . . . . 0.39000000000000001 112.153 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 5.2 m-20 -61.1 -37.8 84.02 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.987 -1.116 . . . . 1.6299999999999999 107.987 155.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.79 ' O ' HG23 ' A' ' 24' ' ' ILE . 3.7 m-85 -98.06 27.91 4.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 112.404 0.52 . . . . 0.23999999999999999 112.404 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.765 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.2 67.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.902 1.281 . . . . 3.5499999999999998 113.729 -169.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 22' ' ' PHE . 33.0 pt -146.92 -172.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.094 -1.076 . . . . 0.27000000000000002 108.094 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 m -101.72 145.0 29.72 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.732 -0.667 . . . . 0.81000000000000005 109.38 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.675 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 11.3 p -61.4 -35.61 77.99 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.679 -0.692 . . . . 0.27000000000000002 109.256 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.52 67.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.344 -1.298 . . . . 0.26000000000000001 111.646 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.25 -39.15 19.62 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.463 -0.569 . . . . 0.23000000000000001 109.463 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 46' ' ' ILE . 12.9 tp -72.88 -17.53 61.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.228 -0.896 . . . . 0.17000000000000001 108.738 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.78 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -81.13 -37.89 28.1 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.484 0.659 . . . . 0.19 111.557 172.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -58.52 -43.13 89.05 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.306 1.051 . . . . 1.0700000000000001 109.59 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.91 -20.96 41.0 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.64 -1.618 . . . . 0.17000000000000001 111.995 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.568 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 31.9 m-80 -142.52 72.77 20.68 Favored Pre-proline 0 CA--C 1.514 -0.414 0 CA-C-O 121.237 0.542 . . . . 0.19 109.993 -172.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.652 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 13.2 Cg_endo -56.62 -13.11 10.01 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 123.649 2.899 . . . . 0.29999999999999999 114.122 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.5 t -62.24 -32.37 73.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.047 0.927 . . . . 1.1699999999999999 109.754 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.2 mt -81.34 -6.65 59.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.345 -1.298 . . . . 0.53000000000000003 114.402 -171.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.78 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -49.85 -44.45 49.59 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.471 1.129 . . . . 1.23 110.274 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.11 -45.85 15.83 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.937 -1.938 . . . . 0.40000000000000002 110.551 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.42 -170.33 43.33 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.491 -0.862 . . . . 0.29999999999999999 113.809 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 18' ' ' ILE . 6.7 mp -111.79 159.58 18.16 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.373 -1.414 . . . . 0.31 109.764 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.653 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 77.1 m -128.43 132.27 48.45 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.859 -0.61 . . . . 0.39000000000000001 109.887 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -48.56 129.38 16.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.406 0.622 . . . . 0.46999999999999997 112.241 174.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.35 -11.81 53.77 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.853 -1.067 . . . . 0.35999999999999999 112.704 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.1 tt0 -66.08 153.66 41.68 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.537 0.684 . . . . 1.1899999999999999 110.378 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 49.8 m -115.3 135.42 54.17 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.5 -1.227 . . . . 0.89000000000000001 109.029 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.677 HD12 HD11 ' A' ' 29' ' ' LEU . 18.6 pt -137.28 151.16 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.358 0.599 . . . . 0.22 110.504 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.567 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 15.4 t -96.89 149.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.07 -0.968 . . . . 0.20999999999999999 110.028 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.549 ' CG1' HD23 ' A' ' 5' ' ' LEU . 19.8 mm -117.64 88.41 29.54 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.024 -0.989 . . . . 0.17000000000000001 108.529 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.776 ' HA ' HD13 ' A' ' 4' ' ' LEU . 26.3 Cg_endo -59.68 142.8 99.4 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.199 2.599 . . . . 0.23000000000000001 112.564 -174.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.45 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 80.57 -6.95 59.64 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.874 -0.603 . . . . 0.29999999999999999 112.621 -176.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.75 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.18 125.27 28.71 Favored Pre-proline 0 N--CA 1.448 -0.532 0 N-CA-C 108.54 -0.911 . . . . 0.25 108.54 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD23 ' A' ' 51' ' ' LEU . 60.2 Cg_endo -66.38 172.62 8.76 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.715 2.943 . . . . 0.31 114.017 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 4.9 t70 -91.19 136.66 26.95 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.665 -1.152 . . . . 0.71999999999999997 111.721 -170.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.672 ' HD3' HD12 ' A' ' 5' ' ' LEU . 68.8 Cg_endo -81.97 -6.94 12.28 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.332 2.688 . . . . 0.27000000000000002 113.381 -174.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -28.06 16.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.015 0.436 . . . . 2.1099999999999999 110.297 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -84.37 -12.93 53.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.985 -0.746 . . . . 1.47 108.985 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.764 HD13 ' HG2' ' A' ' 158' ' ' PRO . 84.0 mt -86.21 125.95 66.49 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 114.989 -1.005 . . . . 0.26000000000000001 109.295 169.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -101.47 95.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.14 0 CA-C-N 119.876 0.991 . . . . 0.20000000000000001 110.225 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 73' ' ' SER . 82.1 m-85 -158.55 129.45 6.26 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.016 -1.476 . . . . 0.26000000000000001 107.016 172.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 14.8 m170 -137.84 104.18 5.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.756 -1.572 . . . . 2.8399999999999999 106.756 -164.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -94.34 108.4 20.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.584 -0.734 . . . . 0.32000000000000001 110.331 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.6 97.35 6.52 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.14 -0.936 . . . . 0.34000000000000002 110.67 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 164' ' ' THR . 0.6 OUTLIER -112.22 98.38 6.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.964 -1.471 . . . . 0.68000000000000005 109.304 177.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.8 m -94.43 123.16 37.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.734 -1.121 . . . . 1.05 108.843 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.619 ' HB ' ' CB ' ' A' ' 167' ' ' ARG . 1.2 mt -59.75 -31.87 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.064 -0.517 . . . . 1.29 111.802 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.91 -40.54 97.3 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.715 -0.755 . . . . 0.88 111.301 171.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.35 -23.96 59.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.941 -0.63 . . . . 0.73999999999999999 112.342 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.59 ' HA ' HG21 ' A' ' 86' ' ' VAL . 37.9 mttt 55.7 19.47 3.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.157 0.983 . . . . 2.5099999999999998 112.776 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.27 140.85 35.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.716 0.77 . . . . 0.45000000000000001 111.308 177.349 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.444 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 7.5 tt -94.31 119.27 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.157 -1.383 . . . . 0.33000000000000002 109.367 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -101.97 124.8 48.2 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.443 -0.503 . . . . 0.40000000000000002 111.093 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.558 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.62 139.52 33.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.237 -1.764 . . . . 0.33000000000000002 106.237 176.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 19.4 m -143.05 128.91 19.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 120.508 1.503 . . . . 0.75 112.672 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.89 125.4 50.41 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.906 -1.043 . . . . 0.34999999999999998 110.457 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 61.84 40.68 12.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.029 0.443 . . . . 0.52000000000000002 109.867 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 81.68 -7.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.798 -1.092 . . . . 1.8400000000000001 112.21 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -128.52 139.22 52.42 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 118.282 -1.367 . . . . 3.1899999999999999 114.025 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.71 149.85 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 112.873 -1.967 . . . . 0.40999999999999998 112.891 -174.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.558 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.0 mtp -100.16 -44.06 6.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 112.5 -2.137 . . . . 0.34999999999999998 108.43 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? 179.7 159.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.54 -2.118 . . . . 2.0699999999999998 110.156 -176.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.479 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.4 m -121.06 137.6 54.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.526 0.203 . . . . 0.37 111.309 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -127.82 135.94 28.24 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 120.905 0.383 . . . . 0.96999999999999997 111.374 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -63.22 143.86 90.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.935 2.424 . . . . 0.59999999999999998 112.181 173.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.7 -175.58 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.116 -0.493 . . . . 0.64000000000000001 110.028 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.46 141.74 28.89 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.71 -0.478 . . . . 0.82999999999999996 109.71 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.61 HG13 HG23 ' A' ' 65' ' ' ILE . 1.1 t -130.6 137.66 55.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.713 -0.676 . . . . 1.6699999999999999 110.582 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' HA2' HG13 ' A' ' 138' ' ' VAL . . . -74.3 83.19 0.76 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.588 -0.733 . . . . 3.0800000000000001 113.253 -175.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -67.5 -34.2 76.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.189 0.519 . . . . 7.2599999999999998 109.663 173.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.2 mt -85.36 -27.17 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.571 -0.74 . . . . 6.29 110.247 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.9 mt -75.58 94.32 3.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.789 -0.641 . . . . 7.2699999999999996 110.443 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -81.68 61.76 5.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.536 0.684 . . . . 5.1799999999999997 109.926 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -165.77 139.4 4.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.227 -0.897 . . . . 4.8099999999999996 109.883 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.674 HG22 ' H ' ' A' ' 167' ' ' ARG . 11.0 p -85.62 110.01 26.45 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.008 -0.738 . . . . 2.1099999999999999 109.008 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -47.89 100.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.865 2.377 . . . . 3.21 112.19 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.2 m -72.65 127.63 33.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.933 -0.576 . . . . 3.5899999999999999 111.407 -173.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.475 ' HA3' ' HE2' ' A' ' 10' ' ' LYS . . . 93.6 133.81 6.86 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.834 -0.621 . . . . 2.1000000000000001 112.406 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.39 169.5 18.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.339 0.59 . . . . 2.2999999999999998 111.393 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.544 ' HB2' HG13 ' A' ' 163' ' ' VAL . 29.1 m-85 -123.79 175.5 6.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.186 -0.916 . . . . 1.9299999999999999 108.643 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 161' ' ' THR . 80.7 m-85 -134.14 138.07 44.96 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.931 0.396 . . . . 0.57999999999999996 110.738 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 125' ' ' ILE . 26.5 mm -59.55 124.77 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 107.428 -1.323 . . . . 0.40999999999999998 107.428 166.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.765 HD11 ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -118.09 -22.09 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.893 -0.723 . . . . 0.37 112.174 -176.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 103' ' ' ARG . 3.1 t-20 -167.81 177.11 5.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 123.081 1.42 . . . . 1.99 114.122 -175.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.612 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 4.3 ptt180 -152.19 123.93 7.92 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 110.824 -2.898 . . . . 1.1899999999999999 108.684 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 161.25 14.66 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.382 1.087 . . . . 1.6699999999999999 111.666 -168.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -52.56 155.08 2.31 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 112.626 -2.079 . . . . 3.0600000000000001 112.662 172.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -44.0 110.3 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 113.119 -1.855 . . . . 2.6099999999999999 111.02 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -54.56 -47.88 24.39 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.386 2.724 . . . . 0.97999999999999998 111.668 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.71 -21.34 38.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.641 -1.163 . . . . 1.0800000000000001 112.74 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -112.81 -170.27 17.86 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.999 -0.619 . . . . 1.05 112.199 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.9 34.24 0.1 Allowed 'Trans proline' 0 N--CA 1.478 0.578 0 C-N-CA 124.473 3.449 . . . . 1.3 113.888 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 109' ' ' GLY . 50.1 t80 -83.15 -18.03 40.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.08 0.467 . . . . 1.3799999999999999 110.244 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.62 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.18 57.44 0.96 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.768 -0.73 . . . . 1.1100000000000001 114.856 170.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 74.27 -45.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.262 1.208 . . . . 0.81000000000000005 114.262 165.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.68 162.87 34.37 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.903 -0.406 . . . . 1.1200000000000001 109.903 -176.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 1.8 t90 -127.27 99.63 5.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.433 -0.951 . . . . 2.1899999999999999 108.433 172.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.653 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.3 mp -108.99 139.05 44.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.777 0.799 . . . . 0.60999999999999999 110.89 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.514 ' HB2' HG23 ' A' ' 101' ' ' ILE . 72.1 m -107.7 148.62 29.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.822 -1.081 . . . . 0.93999999999999995 113.115 -169.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.522 HD22 HG11 ' A' ' 163' ' ' VAL . 67.9 mt -104.86 -174.35 2.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.533 -1.212 . . . . 1.0800000000000001 108.441 173.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.0 m -72.34 -69.39 0.4 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.555 0.576 . . . . 1.5 112.555 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -124.36 149.77 46.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.869 0.322 . . . . 2.9700000000000002 111.869 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' A' ' 122' ' ' HIS . 3.1 tp60 77.15 173.85 0.21 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 114.98 -1.009 . . . . 5.0599999999999996 111.068 173.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.418 ' H ' ' HG3' ' A' ' 121' ' ' GLN . 23.4 m-70 -82.09 42.29 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 5.9500000000000002 111.653 -173.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -110.63 128.66 55.78 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.861 -0.792 . . . . 4.8300000000000001 108.861 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.458 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -147.64 152.22 24.36 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.616 -0.802 . . . . 0.94999999999999996 111.609 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.713 HD12 HD11 ' A' ' 100' ' ' ILE . 25.5 mt -92.97 116.07 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.271 -0.64 . . . . 0.47999999999999998 109.271 175.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.529 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 8.1 p80 -155.21 -161.46 1.19 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.337 0.589 . . . . 1.25 110.578 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.62 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -119.31 177.1 16.31 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 119.612 -1.28 . . . . 0.46000000000000002 112.877 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 144' ' ' ARG . 5.9 t -137.07 172.84 12.41 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.135 0.493 . . . . 0.5 110.254 -170.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.68 -19.66 14.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 1.8600000000000001 109.0 165.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -125.39 104.41 28.46 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.339 -0.846 . . . . 1.77 110.124 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.49 4.98 4.41 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.259 2.639 . . . . 0.58999999999999997 112.887 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.28 -22.8 28.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.039 0.447 . . . . 0.78000000000000003 110.651 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.2 p -85.32 -16.94 38.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.538 0.685 . . . . 1.45 110.047 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 134' ' ' ILE . 11.9 mm -64.97 117.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.168 -0.923 . . . . 0.69999999999999996 110.672 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.68 -5.11 47.16 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.724 -0.671 . . . . 1.6799999999999999 111.944 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -132.74 -49.41 0.89 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.765 0.317 . . . . 4.3899999999999997 111.647 -175.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.21 140.89 48.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.293 -0.412 . . . . 3.9399999999999999 111.334 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 86' ' ' VAL . 47.4 t -117.2 -58.61 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 4.6799999999999997 111.135 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.7 p -70.33 -43.99 69.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.287 -0.415 . . . . 5.6799999999999997 110.591 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.81 -31.82 22.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.43 0.633 . . . . 8.3000000000000007 109.807 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.6 129.61 19.58 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.256 -0.884 . . . . 3.8500000000000001 113.22 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 64.6 m -122.65 -176.67 3.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.318 -0.623 . . . . 2.5099999999999998 109.318 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 27.7 mt -81.02 73.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.482 0.658 . . . . 1.4399999999999999 109.906 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 126' ' ' HIS . 95.9 mtt180 -116.22 154.05 30.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.515 -0.766 . . . . 3.3599999999999999 110.432 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.44 ' H ' ' HA2' ' A' ' 127' ' ' GLY . 35.8 mtp -136.96 -173.34 3.42 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.926 -0.579 . . . . 1.1299999999999999 109.783 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.558 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 4.0 t-80 -78.57 154.71 30.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.265 -1.013 . . . . 2.5099999999999998 108.265 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.557 ' O ' HG12 ' A' ' 150' ' ' VAL . 22.7 p-10 -48.87 -67.39 0.27 Allowed 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 112.428 0.529 . . . . 1.77 112.428 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 149' ' ' ASP . 3.8 ptpp? -59.7 -28.2 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.72 -0.612 . . . . 2.1299999999999999 111.582 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.558 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 6.7 m-20 -72.44 -40.15 67.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 1.05 110.714 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 9.4 p -74.83 -18.52 16.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.524 -0.307 . . . . 0.32000000000000001 110.246 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.49 HD11 ' HB1' ' A' ' 113' ' ' ALA . 2.8 mp -86.82 -39.84 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.947 -0.549 . . . . 0.37 110.435 174.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -44.39 -69.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.688 1.131 . . . . 1.3799999999999999 112.834 162.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.675 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -50.52 -42.35 54.89 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.73999999999999999 110.242 179.088 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.74 -53.82 51.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.348 -1.296 . . . . 0.22 112.038 -172.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.566 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 12.1 p -76.55 -13.57 60.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.407 -1.269 . . . . 1.3300000000000001 111.093 -172.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.65 -49.16 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.15 -0.477 . . . . 0.23000000000000001 110.053 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.1 m -77.55 117.14 63.61 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-O 122.059 0.933 . . . . 0.20999999999999999 110.81 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.764 ' HG2' HD13 ' A' ' 57' ' ' ILE . 42.2 Cg_endo -83.05 -178.52 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.876 2.384 . . . . 0.34000000000000002 112.785 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.75 ' O ' HD21 ' A' ' 51' ' ' LEU . 16.9 m120 -58.32 -2.63 0.2 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.509 -1.223 . . . . 1.02 113.53 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.01 55.91 0.56 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.813 -0.708 . . . . 0.28000000000000003 112.568 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.546 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 4.9 m -93.91 136.59 34.04 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.565 -0.374 . . . . 0.29999999999999999 110.305 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.79 142.2 29.12 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.462 -0.495 . . . . 1.96 110.291 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.2 p -143.66 123.75 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.75 -0.659 . . . . 0.46000000000000002 110.846 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.466 ' O ' HG13 ' A' ' 63' ' ' VAL . 23.3 m -112.7 139.63 48.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.56000000000000005 112.007 -176.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -125.65 114.17 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 C-N-CA 118.542 -1.263 . . . . 0.95999999999999996 111.194 171.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.0 127.41 16.85 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.886 -1.506 . . . . 1.1899999999999999 109.848 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.674 ' H ' HG22 ' A' ' 93' ' ' THR . 5.4 ptt180 -92.91 -29.78 15.73 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.694 -0.685 . . . . 3.4199999999999999 111.556 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -128.33 86.84 0.32 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.679 -0.772 . . . . 3.6499999999999999 112.007 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.337 -0.84 . . . . 5.9699999999999998 109.31 179.033 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.48 ' S21' ' O32' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.693 -0.563 . . . . 2.9199999999999999 111.693 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -77.62 165.76 23.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.988 -0.375 . . . . 4.0999999999999996 109.988 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.1 mptt -65.38 150.95 47.43 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.01 -0.737 . . . . 2.1000000000000001 109.01 173.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.765 HD13 ' HA ' ' A' ' 49' ' ' PRO . 17.5 mt -92.38 167.87 11.69 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.269 0.356 . . . . 0.26000000000000001 111.163 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.58 ' HB2' HD22 ' A' ' 51' ' ' LEU . 4.0 tp -75.89 149.05 37.84 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 122.929 0.492 . . . . 0.23000000000000001 111.851 -169.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.04 150.04 34.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.969 0.89 . . . . 0.26000000000000001 111.365 167.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' SER . 57.5 t80 -134.64 150.36 50.65 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.727 -1.579 . . . . 0.39000000000000001 108.0 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.2 tm0? -128.41 120.93 27.9 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.001 -1.481 . . . . 1.0700000000000001 107.001 175.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -82.51 158.79 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 112.579 0.585 . . . . 0.38 112.579 -169.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -103.37 150.82 23.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.409 -0.814 . . . . 2.5899999999999999 109.261 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -52.61 109.44 0.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.336 0.589 . . . . 1.74 112.005 -178.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.23 -9.68 15.26 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.338 -0.846 . . . . 0.56999999999999995 112.766 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.652 ' HB3' HD11 ' A' ' 18' ' ' ILE . 67.1 m-20 -61.43 152.55 29.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.844 0.322 . . . . 2.1699999999999999 110.814 176.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.56 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.2 p -133.49 155.99 48.57 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.253 0.464 . . . . 0.5 112.253 -177.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.595 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.1 tp -50.3 -58.33 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.545 0.943 . . . . 0.27000000000000002 113.545 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.668 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 10.9 t-20 -66.08 -41.81 90.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.27 1.033 . . . . 1.21 110.687 -169.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 26.3 m -55.89 -52.29 64.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 112.958 -1.928 . . . . 1.24 109.754 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -66.48 -40.01 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 115.373 -0.831 . . . . 0.29999999999999999 111.942 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.683 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.98 -66.06 0.51 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.087 -0.506 . . . . 0.23000000000000001 112.108 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.35 -4.87 56.99 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 118.996 -1.081 . . . . 0.39000000000000001 112.133 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.1 m-20 -66.21 -31.52 72.4 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.99 -0.745 . . . . 1.6299999999999999 108.99 156.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD1' HD12 ' A' ' 101' ' ' ILE . 1.6 m-85 -96.48 15.21 22.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.033 -0.417 . . . . 0.23999999999999999 112.068 173.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.57 51.48 12.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.607 -0.724 . . . . 3.5499999999999998 110.609 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.4 pt -149.4 -172.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.721 -0.844 . . . . 0.27000000000000002 108.721 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.96 147.49 24.94 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.678 -0.692 . . . . 0.81000000000000005 109.909 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.668 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.7 p -61.5 -36.41 80.42 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.539 -0.911 . . . . 0.27000000000000002 108.539 175.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.29 -28.64 69.46 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.478 -1.237 . . . . 0.26000000000000001 111.664 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.72 -38.7 25.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.513 -0.551 . . . . 0.23000000000000001 109.513 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.665 HD11 HD12 ' A' ' 46' ' ' ILE . 14.0 tp -73.3 -19.44 61.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.412 -0.813 . . . . 0.17000000000000001 109.081 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.702 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -78.51 -39.69 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.657 0.742 . . . . 0.19 111.549 172.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.12 -40.6 96.45 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 114.994 -1.003 . . . . 1.0700000000000001 110.03 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.24 -19.25 43.55 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.998 -1.455 . . . . 0.17000000000000001 111.819 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 33.0 m-80 -142.13 71.57 22.89 Favored Pre-proline 0 CA--C 1.515 -0.374 0 CA-C-O 121.025 0.441 . . . . 0.19 109.903 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.712 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.23 -12.54 10.42 Favored 'Trans proline' 0 C--O 1.22 -0.4 0 C-N-CA 123.301 2.667 . . . . 0.29999999999999999 113.946 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -61.69 -32.31 72.5 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 122.061 0.934 . . . . 1.1699999999999999 110.035 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 5.1 mt -81.1 -6.36 58.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.206 -1.361 . . . . 0.53000000000000003 114.551 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.712 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -51.69 -40.66 60.51 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 122.77 1.272 . . . . 1.23 109.503 177.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.97 -46.69 14.72 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 112.763 -2.017 . . . . 0.40000000000000002 111.562 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 173.54 -162.69 33.76 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.271 -0.966 . . . . 0.29999999999999999 114.364 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.1 mp -116.88 158.21 24.37 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.188 -1.506 . . . . 0.31 109.881 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 89.2 m -137.31 135.47 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 0.39000000000000001 110.792 -177.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.646 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -45.48 126.66 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.404 0.89 . . . . 0.46999999999999997 113.404 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.591 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.4 -12.48 45.47 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 114.613 -1.176 . . . . 0.35999999999999999 112.083 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.597 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 4.1 tt0 -63.47 151.81 40.16 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.817 0.817 . . . . 1.1899999999999999 110.263 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.9 m -117.41 135.51 53.83 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.133 -1.394 . . . . 0.89000000000000001 109.096 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 29' ' ' LEU . 16.8 pt -136.71 146.42 28.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.296 0.57 . . . . 0.22 110.533 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.519 ' H ' HD21 ' A' ' 33' ' ' ASN . 7.2 t -91.61 149.1 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.051 -0.977 . . . . 0.20999999999999999 110.409 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.579 HG13 HD23 ' A' ' 5' ' ' LEU . 19.2 mm -118.07 87.54 29.03 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-N 114.959 -1.019 . . . . 0.17000000000000001 108.701 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.765 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.8 Cg_endo -59.08 139.78 92.16 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.209 2.606 . . . . 0.23000000000000001 112.709 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.518 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.18 -7.59 70.91 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.29999999999999999 112.93 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.75 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.8 tt -116.81 128.78 25.78 Favored Pre-proline 0 C--O 1.218 -0.566 0 N-CA-C 108.566 -0.902 . . . . 0.25 108.566 177.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.697 ' HD2' HD23 ' A' ' 51' ' ' LEU . 73.4 Cg_endo -68.92 171.72 13.04 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.75 2.967 . . . . 0.31 114.167 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.745 ' HB3' HG22 ' A' ' 56' ' ' THR . 9.1 t70 -90.08 141.76 28.17 Favored Pre-proline 0 CA--C 1.514 -0.433 0 CA-C-N 114.908 -1.042 . . . . 0.71999999999999997 110.232 -172.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD3' HD12 ' A' ' 5' ' ' LEU . 62.9 Cg_endo -85.27 -7.13 9.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.323 2.682 . . . . 0.27000000000000002 111.992 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -95.67 -24.52 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.1099999999999999 110.239 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.745 HG22 ' HB3' ' A' ' 53' ' ' ASP . 13.1 t -87.25 -15.41 38.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.678 -0.86 . . . . 1.47 108.678 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.747 HD13 ' HG2' ' A' ' 158' ' ' PRO . 61.7 mt -87.21 126.2 63.44 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 114.503 -1.226 . . . . 0.26000000000000001 108.964 169.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -101.16 93.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.175 0 CA-C-N 120.52 1.221 . . . . 0.20000000000000001 110.106 170.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.414 ' HD2' HG23 ' A' ' 57' ' ' ILE . 78.0 m-85 -159.03 131.52 6.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.238 -1.764 . . . . 0.26000000000000001 106.238 173.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 23.3 m-70 -140.33 107.8 5.57 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.095 -1.446 . . . . 2.8399999999999999 107.095 -164.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.5 mt -94.61 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.054 -0.975 . . . . 0.32000000000000001 110.398 -175.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.39 94.59 5.0 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.0 0.905 . . . . 0.34000000000000002 110.337 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -115.6 100.02 9.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.039 -1.437 . . . . 0.68000000000000005 110.291 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.523 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 38.6 t -90.32 121.58 32.44 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.239 -1.393 . . . . 1.05 107.239 173.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.587 ' HB ' ' CB ' ' A' ' 167' ' ' ARG . 33.3 mm -62.26 -26.88 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.957 0.884 . . . . 1.29 108.936 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.89 -46.0 84.72 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.297 -0.954 . . . . 0.88 111.377 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -67.27 -23.99 65.74 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.606 0.595 . . . . 0.73999999999999999 112.606 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.787 ' HA ' HG21 ' A' ' 86' ' ' VAL . 40.7 mttt 61.54 13.17 4.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.885 0.874 . . . . 2.5099999999999998 112.544 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.506 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -141.13 137.35 32.7 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.1 0.953 . . . . 0.45000000000000001 112.118 177.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.5 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.3 tt -93.96 118.93 32.16 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.346 -1.752 . . . . 0.33000000000000002 109.121 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 m -102.6 125.08 49.2 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.055 -0.658 . . . . 0.40000000000000002 111.233 -173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.595 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -84.6 129.75 34.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.509 -1.663 . . . . 0.33000000000000002 106.509 177.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 15.6 m -135.58 126.45 27.55 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 120.905 1.684 . . . . 0.75 112.81 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.0 tp -113.03 126.5 55.56 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.774 -1.103 . . . . 0.34999999999999998 109.876 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 63.05 40.05 9.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.088 -0.708 . . . . 0.52000000000000002 109.088 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 83.35 -21.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.725 1.21 . . . . 1.8400000000000001 111.949 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -121.92 139.06 54.12 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 117.295 -1.762 . . . . 3.1899999999999999 114.779 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -53.92 149.53 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-N 112.546 -2.115 . . . . 0.40999999999999998 113.882 -167.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.5 mtp -100.74 -42.97 6.28 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 112.076 -2.329 . . . . 0.34999999999999998 108.18 175.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 2.6 tppt? -178.37 164.69 1.74 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 112.464 -2.153 . . . . 2.0699999999999998 109.931 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.506 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 12.1 m -126.24 134.39 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.514 0.197 . . . . 0.37 110.798 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 19.5 m-85 -123.31 145.87 47.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 109.534 -0.543 . . . . 0.96999999999999997 109.534 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' TYR . 27.3 Cg_endo -83.86 148.31 12.22 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.44 2.093 . . . . 0.59999999999999998 112.037 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.69 179.47 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.296 -0.411 . . . . 0.64000000000000001 110.192 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.2 139.87 31.33 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.86 0.362 . . . . 0.82999999999999996 110.251 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' A' ' 68' ' ' LYS . 2.1 t -135.69 149.45 28.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.948 -0.569 . . . . 1.6699999999999999 112.506 -169.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.16 -91.46 1.25 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.933 -0.576 . . . . 3.0800000000000001 113.099 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.55 ' HG3' ' H ' ' A' ' 89' ' ' ILE . 17.7 tptm -158.47 179.85 8.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.07 0.435 . . . . 7.2599999999999998 110.428 -173.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.55 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 31.3 pt -131.88 132.67 61.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 112.132 0.419 . . . . 6.29 112.132 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.562 ' N ' ' HA ' ' A' ' 169' ' ' SER . 21.5 mt -156.66 -82.53 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.554 0.742 . . . . 7.2699999999999996 110.593 173.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 t -173.86 77.65 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.753 0.649 . . . . 5.1799999999999997 112.753 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.701 ' HB2' ' O ' ' A' ' 169' ' ' SER . 19.9 mm-40 -150.34 -81.63 0.11 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.761 0.652 . . . . 4.8099999999999996 112.761 176.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.685 HG22 ' N ' ' A' ' 167' ' ' ARG . 60.6 p 61.81 127.55 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 124.446 1.098 . . . . 2.1099999999999999 112.159 -174.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.77 152.82 37.71 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.264 1.976 . . . . 3.21 112.075 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.4 m -98.46 134.78 40.96 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.57 -0.529 . . . . 3.5899999999999999 109.57 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.66 91.4 0.19 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.107 -1.044 . . . . 2.1000000000000001 111.723 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -77.63 148.99 34.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.869 -0.419 . . . . 2.2999999999999998 109.869 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.599 ' HB2' HG13 ' A' ' 163' ' ' VAL . 21.4 m-85 -113.33 174.31 5.97 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.189 -0.46 . . . . 1.9299999999999999 109.857 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.7 m-85 -140.03 141.7 36.27 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.061 -0.348 . . . . 0.57999999999999996 110.061 174.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.721 HD11 HD12 ' A' ' 125' ' ' ILE . 23.9 mm -60.16 121.17 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.9 -1.148 . . . . 0.40999999999999998 107.9 167.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.652 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.8 tt -122.92 -25.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.094 -0.642 . . . . 0.37 112.161 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 9.1 t-20 -150.69 154.22 37.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.478 1.288 . . . . 1.99 114.478 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.56 119.85 11.55 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 111.487 -2.597 . . . . 1.1899999999999999 108.904 172.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -97.59 159.87 14.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.386 1.088 . . . . 1.6699999999999999 112.042 -168.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 18.3 ttm180 -50.69 149.73 3.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 112.352 -2.204 . . . . 3.0600000000000001 111.646 168.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 19.3 m-80 -48.21 106.32 0.59 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 114.976 -1.011 . . . . 2.6099999999999999 112.233 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.7 -49.9 13.32 Favored 'Trans proline' 0 CA--C 1.519 -0.261 0 C-N-CA 123.723 2.949 . . . . 0.97999999999999998 112.43 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.09 16.75 49.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.237 -0.892 . . . . 1.0800000000000001 112.394 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -138.67 -168.95 11.43 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.085 -0.579 . . . . 1.05 112.15 -176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.96 16.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.938 3.092 . . . . 1.3 113.115 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -70.57 -21.38 62.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.079 -0.509 . . . . 1.3799999999999999 110.503 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.32 37.01 4.19 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.584 -0.735 . . . . 1.1100000000000001 113.874 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 74.36 -19.0 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.762 0.653 . . . . 0.81000000000000005 112.762 172.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.498 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -159.21 152.47 22.41 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 122.86 0.464 . . . . 1.1200000000000001 110.02 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.401 ' CE3' ' HE1' ' A' ' 111' ' ' PHE . 33.7 t-105 -120.24 105.48 10.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.1899999999999999 109.634 170.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.3 mp -107.84 138.52 43.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.6 0.714 . . . . 0.60999999999999999 111.101 175.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.9 m -106.76 146.25 31.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.326 -0.852 . . . . 0.93999999999999995 112.347 -171.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.88 -173.49 3.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.85 -0.796 . . . . 1.0800000000000001 108.85 169.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.496 ' H ' ' HB3' ' A' ' 98' ' ' PHE . 30.9 t -60.88 -80.08 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.42 0.526 . . . . 1.5 112.42 -172.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 21.8 pttm -125.39 160.44 29.4 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.191 -0.318 . . . . 2.9700000000000002 111.086 -177.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 6.6 tp-100 75.28 156.56 0.18 Allowed 'General case' 0 N--CA 1.461 0.09 0 O-C-N 124.296 0.997 . . . . 5.0599999999999996 109.179 -175.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.544 ' ND1' ' N26' ' A' 1142 ' ' IM2 . 84.2 m-70 -74.52 58.67 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.2 0.524 . . . . 5.9500000000000002 111.49 -175.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -116.55 139.48 50.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.296 -0.865 . . . . 4.8300000000000001 108.709 172.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.66 161.06 30.01 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.118 -1.039 . . . . 0.94999999999999996 112.368 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.721 HD12 HD11 ' A' ' 100' ' ' ILE . 40.3 mt -93.26 107.35 19.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.213 -1.032 . . . . 0.47999999999999998 108.213 173.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.468 ' O ' ' HG2' ' A' ' 145' ' ' MET . 12.6 p80 -138.95 -166.96 2.12 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.306 -0.957 . . . . 1.25 111.954 -176.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.468 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.72 161.54 14.83 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.356 -1.293 . . . . 0.46000000000000002 112.988 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.7 t -127.25 178.22 6.18 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.951 -0.625 . . . . 0.5 110.569 -170.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -105.21 -16.64 14.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.318 -0.856 . . . . 1.8600000000000001 109.662 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -126.92 100.69 27.23 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.842 -0.617 . . . . 1.77 110.152 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -91.6 4.31 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.197 2.598 . . . . 0.58999999999999997 113.267 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.97 27.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.253 0.549 . . . . 0.78000000000000003 110.251 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.483 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 28.1 t -82.19 -26.98 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.736 . . . . 1.45 109.732 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 144' ' ' ARG . 6.6 mm -60.35 107.94 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.18 -0.918 . . . . 0.69999999999999996 111.552 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.65 32.75 85.24 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 114.9 -1.045 . . . . 1.6799999999999999 112.771 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -153.19 -36.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.16 0.43 . . . . 4.3899999999999997 112.16 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 133' ' ' SER . . . -142.56 160.81 39.57 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.242 -0.286 . . . . 3.9399999999999999 111.52 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.9 t 72.57 -60.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 123.859 0.724 . . . . 4.6799999999999997 111.2 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.1 m 66.01 170.43 0.23 Allowed 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.882 0.473 . . . . 5.6799999999999997 111.663 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 53.63 77.99 0.16 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.799 -0.637 . . . . 8.3000000000000007 111.414 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.37 -152.97 6.35 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 3.8500000000000001 112.109 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 56.7 m -111.34 177.09 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.393 0.616 . . . . 2.5099999999999998 111.161 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.566 HG21 HG12 ' A' ' 125' ' ' ILE . 65.8 mt -86.04 94.49 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.386 -0.825 . . . . 1.4399999999999999 111.428 -170.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.53 ' HB2' HD11 ' A' ' 134' ' ' ILE . 35.4 mtm180 -119.04 151.64 37.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.404 -0.816 . . . . 3.3599999999999999 109.339 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.54 ' HG3' ' HB ' ' A' ' 150' ' ' VAL . 15.4 ptm -152.42 -167.18 2.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.506 0.193 . . . . 1.1299999999999999 111.094 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -77.06 145.5 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.505 -0.316 . . . . 2.5099999999999998 110.493 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.653 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.4 m-20 -49.89 -67.15 0.28 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.336 0.398 . . . . 1.77 111.898 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -26.32 65.45 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.572 -0.705 . . . . 2.1299999999999999 111.853 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.44 -36.72 63.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.745 -0.207 . . . . 1.05 110.812 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.4 p -75.44 -18.65 15.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.505 0 CA-C-N 116.61 -0.268 . . . . 0.32000000000000001 110.377 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.568 HD12 HG13 ' A' ' 150' ' ' VAL . 3.2 mp -88.83 -41.44 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 119.27 -0.395 . . . . 0.37 110.243 172.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -41.03 -69.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 119.019 0.827 . . . . 1.3799999999999999 112.191 162.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.703 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.1 tp -50.55 -43.11 56.04 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.859 -0.61 . . . . 0.73999999999999999 110.334 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.02 -52.52 60.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.703 -1.135 . . . . 0.22 112.366 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.5 t -78.47 -14.67 59.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.668 -1.151 . . . . 1.3300000000000001 110.961 -172.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.01 -48.78 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.028 0.442 . . . . 0.23000000000000001 109.815 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 153' ' ' LEU . 25.2 m -76.91 119.51 77.77 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-O 121.714 0.769 . . . . 0.20999999999999999 109.819 178.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.747 ' HG2' HD13 ' A' ' 57' ' ' ILE . 46.3 Cg_endo -82.3 -178.89 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.664 2.243 . . . . 0.34000000000000002 112.257 -176.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.75 ' O ' HD21 ' A' ' 51' ' ' LEU . 9.6 m120 -59.67 -0.66 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.682 -1.144 . . . . 1.02 113.52 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.95 56.2 0.54 Allowed Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.02 -0.61 . . . . 0.28000000000000003 112.237 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.492 ' OG1' ' HD2' ' A' ' 158' ' ' PRO . 3.1 m -94.01 133.99 36.88 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.524 -0.398 . . . . 0.29999999999999999 110.075 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -86.64 142.49 28.21 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.186 -0.605 . . . . 1.96 110.849 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.599 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.1 p -147.31 127.42 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.025 -0.989 . . . . 0.46000000000000002 110.917 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 91.4 m -113.3 142.13 46.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.516 -0.766 . . . . 0.56000000000000005 111.38 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.583 HG23 HG12 ' A' ' 65' ' ' ILE . 2.0 mp -125.34 119.34 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 118.791 -1.164 . . . . 0.95999999999999996 111.148 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.79 120.56 11.91 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.952 -1.476 . . . . 1.1899999999999999 107.768 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.685 ' N ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -96.55 -50.94 4.53 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 114.165 1.172 . . . . 3.4199999999999999 114.165 -169.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.601 ' N ' ' HG2' ' A' ' 167' ' ' ARG . . . 125.42 -61.74 0.61 Allowed Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 109.993 -1.243 . . . . 3.6499999999999999 109.993 -170.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.701 ' O ' ' HB2' ' A' ' 92' ' ' GLN . 12.9 t . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.343 -0.837 . . . . 5.9699999999999998 112.643 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.544 ' N26' ' ND1' ' A' ' 122' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.763 -0.535 . . . . 2.9199999999999999 111.763 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -107.66 170.47 7.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.947 -0.39 . . . . 4.0999999999999996 109.947 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -71.39 148.66 46.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.538 -0.542 . . . . 2.1000000000000001 109.538 176.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.4 mt -99.35 172.92 7.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.21 -0.45 . . . . 0.26000000000000001 111.338 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.605 HD12 ' HD3' ' A' ' 54' ' ' PRO . 4.5 tp -77.67 152.33 33.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 123.201 0.6 . . . . 0.23000000000000001 111.748 -170.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -115.17 150.13 36.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.115 0.959 . . . . 0.26000000000000001 111.847 166.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' SER . 87.1 t80 -133.6 142.77 48.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.611 -1.631 . . . . 0.39000000000000001 107.719 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.3 tm0? -125.79 113.53 17.4 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 106.862 -1.533 . . . . 1.0700000000000001 106.862 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -76.81 158.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 113.193 0.812 . . . . 0.38 113.193 -164.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' HD2' ' HD3' ' A' ' 120' ' ' LYS . 9.9 mtpm? -95.44 148.11 22.81 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.105 -0.952 . . . . 2.5899999999999999 109.599 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.831 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 6.4 tt0 -52.19 109.38 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 1.74 111.554 177.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.9 -9.44 23.31 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.692 -0.766 . . . . 0.56999999999999995 112.957 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.582 ' HB3' HD11 ' A' ' 18' ' ' ILE . 71.4 m-20 -59.75 154.44 18.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.294 0.547 . . . . 2.1699999999999999 111.757 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.4 p -133.04 152.91 51.92 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.439 0.533 . . . . 0.5 112.439 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.8 tp -48.99 -59.04 3.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.776 1.028 . . . . 0.27000000000000002 113.776 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.66 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 16.5 t-20 -64.84 -41.2 95.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.615 1.198 . . . . 1.21 110.578 -169.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 43.9 t -59.22 -48.51 81.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 112.353 -2.203 . . . . 1.24 109.991 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.582 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.6 mp -68.01 -40.71 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-N 116.064 -0.516 . . . . 0.29999999999999999 111.936 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.671 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.57 -63.9 1.05 Allowed 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.559 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.56 -4.64 54.78 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.877 -1.129 . . . . 0.39000000000000001 112.181 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -68.29 -30.25 69.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.947 -0.76 . . . . 1.6299999999999999 108.947 157.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.658 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.4 m-85 -96.44 15.61 20.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.996 0.369 . . . . 0.23999999999999999 111.996 172.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 55.43 49.62 16.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.661 -0.699 . . . . 3.5499999999999998 110.579 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.671 HG12 ' O ' ' A' ' 19' ' ' ALA . 37.4 pt -148.2 -173.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.858 -0.793 . . . . 0.27000000000000002 108.858 -173.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -100.6 146.19 27.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.167 -0.924 . . . . 0.81000000000000005 109.737 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.66 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.3 p -61.37 -37.14 82.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.983 -0.747 . . . . 0.27000000000000002 108.983 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -28.91 70.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.389 -1.278 . . . . 0.26000000000000001 111.543 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.22 -38.06 27.59 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.492 -0.559 . . . . 0.23000000000000001 109.492 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.718 HD11 HD12 ' A' ' 46' ' ' ILE . 14.3 tp -74.32 -17.84 60.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.317 -0.856 . . . . 0.17000000000000001 109.201 175.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.742 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.94 -39.1 26.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.681 0.753 . . . . 0.19 111.825 173.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -60.57 -40.95 93.56 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.947 -1.024 . . . . 1.0700000000000001 109.764 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.35 -21.14 39.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.633 -1.622 . . . . 0.17000000000000001 111.985 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.584 HD21 ' H ' ' A' ' 47' ' ' VAL . 28.3 m-80 -142.36 72.87 21.37 Favored Pre-proline 0 CA--C 1.513 -0.46 0 CA-C-O 121.163 0.506 . . . . 0.19 109.89 -172.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.668 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 19.1 Cg_endo -58.36 -9.04 5.99 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.592 2.861 . . . . 0.29999999999999999 114.157 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -63.34 -34.89 78.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.949 0.881 . . . . 1.1699999999999999 109.478 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.9 mt -79.21 -6.72 57.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.205 -1.361 . . . . 0.53000000000000003 114.521 -170.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.742 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -49.13 -40.73 33.69 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 122.575 1.179 . . . . 1.23 110.181 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.06 -46.85 10.78 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 112.747 -2.024 . . . . 0.40000000000000002 111.624 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.64 -164.08 34.81 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.43 -0.89 . . . . 0.29999999999999999 114.172 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.459 ' HB3' HG21 ' A' ' 9' ' ' VAL . 5.6 mp -118.4 157.74 26.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.474 -1.363 . . . . 0.31 110.624 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.657 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 81.5 m -135.09 135.48 41.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.694 -0.684 . . . . 0.39000000000000001 110.912 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -47.37 128.9 12.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.576 0.954 . . . . 0.46999999999999997 113.576 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.509 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 80.49 -11.62 37.83 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.386 -1.279 . . . . 0.35999999999999999 112.26 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.657 ' HB3' ' O ' ' A' ' 41' ' ' THR . 6.9 tt0 -63.74 152.22 39.87 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.555 0.693 . . . . 1.1899999999999999 110.237 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 30.8 m -119.5 133.37 55.71 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.41 -1.268 . . . . 0.89000000000000001 109.436 -171.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.718 HD12 HD11 ' A' ' 29' ' ' LEU . 19.5 pt -135.37 155.22 36.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.157 0.504 . . . . 0.22 110.397 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.584 ' H ' HD21 ' A' ' 33' ' ' ASN . 14.8 t -99.68 149.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.283 -0.871 . . . . 0.20999999999999999 110.398 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.552 ' CG1' HD23 ' A' ' 5' ' ' LEU . 17.5 mm -117.57 88.72 30.26 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.118 -0.946 . . . . 0.17000000000000001 108.516 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.778 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.1 Cg_endo -59.67 139.49 89.07 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.188 2.592 . . . . 0.23000000000000001 112.876 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.495 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 83.38 -7.29 68.76 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.172 -0.922 . . . . 0.29999999999999999 112.812 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.7 tt -115.08 124.98 29.46 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.902 -0.777 . . . . 0.25 108.902 177.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.611 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.9 Cg_endo -66.23 174.19 6.39 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.729 2.953 . . . . 0.31 114.028 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD1' ' HD2' ' A' ' 54' ' ' PRO . 2.5 t70 -90.82 138.33 26.4 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.71999999999999997 111.699 -171.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HD3' HD12 ' A' ' 5' ' ' LEU . 92.7 Cg_endo -81.17 -5.84 12.89 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.219 2.613 . . . . 0.27000000000000002 113.429 -174.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -95.15 -28.51 15.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.65 0.262 . . . . 2.1099999999999999 111.038 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t -78.99 -24.42 43.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.667 -0.864 . . . . 1.47 108.667 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.751 HD13 ' HG2' ' A' ' 158' ' ' PRO . 77.5 mt -74.24 123.59 89.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 114.859 -1.064 . . . . 0.26000000000000001 109.711 170.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -101.06 94.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 119.839 0.978 . . . . 0.20000000000000001 110.148 169.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HD2' HG23 ' A' ' 57' ' ' ILE . 84.1 m-85 -159.1 139.45 12.25 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.546 -1.65 . . . . 0.26000000000000001 106.546 172.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.523 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 35.1 t60 -147.43 118.73 7.82 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.878 -1.156 . . . . 2.8399999999999999 107.878 -170.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 67.8 mt -106.51 113.02 42.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.032 -0.985 . . . . 0.32000000000000001 111.087 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.89 106.87 16.14 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.107 -0.951 . . . . 0.34000000000000002 110.106 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -113.37 119.85 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 114.59 -1.186 . . . . 0.68000000000000005 110.017 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.619 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 16.5 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.015 -1.074 . . . . 1.05 109.937 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.697 HG23 ' HB ' ' A' ' 86' ' ' VAL . 17.2 mt -61.43 -28.78 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.808 0.813 . . . . 1.29 109.798 172.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.32 -47.25 59.26 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.658 -1.156 . . . . 0.88 111.615 172.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -74.94 -26.11 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.237 0.828 . . . . 0.73999999999999999 113.237 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.573 ' HA ' HG11 ' A' ' 86' ' ' VAL . 59.0 tttt 49.35 29.27 2.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.112 0.958 . . . . 2.5099999999999998 112.179 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.514 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -143.98 139.61 29.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.381 -0.827 . . . . 0.45000000000000001 110.989 170.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 tt -97.03 120.06 36.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.907 -1.497 . . . . 0.33000000000000002 109.495 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -100.45 123.18 44.34 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.003 -0.679 . . . . 0.40000000000000002 110.711 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.573 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.73 143.57 30.8 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.449 -1.685 . . . . 0.33000000000000002 106.449 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 31.2 p -149.72 127.47 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 120.499 1.499 . . . . 0.75 113.147 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 tp -112.19 125.91 54.64 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.151 -1.386 . . . . 0.34999999999999998 110.076 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 8.9 t-20 68.87 31.02 4.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.513 -0.921 . . . . 0.52000000000000002 108.513 172.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 34.9 m-80 79.14 2.1 2.37 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.167 -1.378 . . . . 1.8400000000000001 111.763 176.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -129.76 142.09 50.76 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 118.874 -1.13 . . . . 3.1899999999999999 113.987 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -58.45 150.06 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 113.219 -1.81 . . . . 0.40999999999999998 113.314 -168.223 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.573 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -100.47 -43.73 6.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.464 -2.153 . . . . 0.34999999999999998 108.4 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 4.7 tppt? 179.5 161.05 0.81 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 112.746 -2.025 . . . . 2.0699999999999998 110.451 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.514 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 22.8 m -118.05 132.0 56.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.675 0.274 . . . . 0.37 110.957 178.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 79.7 m-85 -113.22 152.01 44.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 0.96999999999999997 110.297 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HB2' HG22 ' A' ' 134' ' ' ILE . 12.3 Cg_endo -83.86 138.84 8.31 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.508 2.139 . . . . 0.59999999999999998 111.943 177.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.35 172.74 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.325 -0.62 . . . . 0.64000000000000001 109.325 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.85 158.95 17.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 0.82999999999999996 111.478 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.697 ' HB ' HG23 ' A' ' 65' ' ' ILE . 26.7 m -142.25 170.33 12.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.309 -0.859 . . . . 1.6699999999999999 109.362 -174.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.95 -130.87 0.44 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.737 -0.744 . . . . 3.0800000000000001 112.354 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -100.68 -93.33 0.28 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.745 -0.268 . . . . 7.2599999999999998 110.706 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.567 HG13 ' H ' ' A' ' 90' ' ' LEU . 2.3 pt -136.5 -78.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.439 0.533 . . . . 6.29 112.439 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.567 ' H ' HG13 ' A' ' 89' ' ' ILE . 9.9 tt -116.16 139.05 50.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 7.2699999999999996 111.212 -172.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.441 HG22 ' HG2' ' A' ' 92' ' ' GLN . 47.3 m -157.07 -86.27 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.518 . . . . 5.1799999999999997 110.121 174.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.441 ' HG2' HG22 ' A' ' 91' ' ' THR . 3.6 pt20 -168.4 18.84 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.04 0.385 . . . . 4.8099999999999996 112.04 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.737 HG22 ' H ' ' A' ' 167' ' ' ARG . 79.7 p 56.14 130.29 0.01 OUTLIER Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 124.08 0.952 . . . . 2.1099999999999999 111.76 -172.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.79 27.69 0.43 Allowed 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.574 2.183 . . . . 3.21 114.235 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.7 p 45.51 48.62 10.96 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.474 0.654 . . . . 3.5899999999999999 110.645 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -85.27 52.86 4.71 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.294 -0.866 . . . . 2.1000000000000001 113.938 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -92.18 103.76 16.21 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.228 -0.656 . . . . 2.2999999999999998 109.228 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 120' ' ' LYS . 7.1 m-85 -124.57 -178.6 4.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.517 -0.765 . . . . 1.9299999999999999 109.72 -176.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.513 ' CE2' ' HG2' ' A' ' 162' ' ' ARG . 62.2 m-85 -139.26 138.64 36.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.781 -0.645 . . . . 0.57999999999999996 110.315 173.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.712 HD11 HD12 ' A' ' 125' ' ' ILE . 27.7 mm -60.51 127.63 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 107.987 -1.116 . . . . 0.40999999999999998 107.987 167.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.619 HD12 ' CD1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -118.17 -31.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.512 -0.875 . . . . 0.37 112.341 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -166.78 -175.07 2.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 118.084 -1.447 . . . . 1.99 114.289 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 103' ' ' ARG . 4.9 ptp180 -156.81 133.86 10.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 111.211 -2.722 . . . . 1.1899999999999999 110.125 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.8 155.36 24.74 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.275 1.036 . . . . 1.6699999999999999 111.708 -172.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.27 155.35 3.81 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 112.291 -2.231 . . . . 3.0600000000000001 112.92 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -43.58 102.93 0.3 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-N 112.947 -1.933 . . . . 2.6099999999999999 111.674 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.83 -54.04 2.71 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 124.114 3.209 . . . . 0.97999999999999998 113.0 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.73 -20.6 26.87 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.543 -0.753 . . . . 1.0800000000000001 111.907 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -87.82 -169.59 45.49 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.375 -0.44 . . . . 1.05 112.493 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.03 6.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.167 3.245 . . . . 1.3 113.949 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.41 ' H ' ' C ' ' A' ' 109' ' ' GLY . 32.6 m-85 -53.42 -35.95 60.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.138 0.494 . . . . 1.3799999999999999 109.749 171.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.9 -2.58 16.76 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.337 -0.847 . . . . 1.1100000000000001 114.697 168.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB1' ' CD1' ' A' ' 151' ' ' ILE . . . -175.57 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.828 0.814 . . . . 0.81000000000000005 112.628 -174.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.532 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -151.63 158.32 43.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.344 -0.389 . . . . 1.1200000000000001 111.514 -171.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CE3' ' HD2' ' A' ' 126' ' ' HIS . 9.7 t-105 -117.77 100.44 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.359 -0.608 . . . . 2.1899999999999999 109.359 171.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.46 ' CD1' HG22 ' A' ' 150' ' ' VAL . 3.8 mp -105.3 141.12 37.38 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.727 0.775 . . . . 0.60999999999999999 111.351 175.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.513 ' HB2' HG23 ' A' ' 101' ' ' ILE . 56.3 m -105.83 142.79 34.95 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.934 -1.03 . . . . 0.93999999999999995 111.979 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -102.87 -174.49 2.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.468 -0.938 . . . . 1.0800000000000001 108.468 173.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.3 p -100.71 -44.75 5.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.973 0.806 . . . . 1.5 112.788 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.587 ' HB2' ' CD1' ' A' ' 98' ' ' PHE . 87.7 mttt -122.34 160.69 24.84 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.362 -0.211 . . . . 2.9700000000000002 111.329 -173.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 67.5 179.3 0.23 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.698 0.761 . . . . 5.0599999999999996 112.545 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -84.09 40.46 0.76 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.253 -0.885 . . . . 5.9500000000000002 110.779 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -116.69 141.07 48.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.12 -0.491 . . . . 4.8300000000000001 110.583 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -155.64 154.46 25.54 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 109.978 -1.249 . . . . 0.94999999999999996 109.978 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.712 HD12 HD11 ' A' ' 100' ' ' ILE . 30.8 mt -92.94 112.05 25.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.918 0.866 . . . . 0.47999999999999998 109.441 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.428 ' HD2' ' CE3' ' A' ' 115' ' ' TRP . 14.9 t-80 -130.26 173.09 11.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.635 -1.166 . . . . 1.25 111.527 -160.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.2 -171.7 14.63 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 0.46000000000000002 111.311 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 t -159.48 174.52 14.55 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.933 -1.107 . . . . 0.5 112.679 -163.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.18 -20.57 13.76 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.914 -1.494 . . . . 1.8600000000000001 108.884 167.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.78 103.21 21.76 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.152 -0.931 . . . . 1.77 110.232 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.521 ' O ' ' HB ' ' A' ' 134' ' ' ILE . 64.8 Cg_endo -90.63 4.94 4.35 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.975 2.45 . . . . 0.58999999999999997 112.553 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.5 40.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.248 0.547 . . . . 0.78000000000000003 109.977 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.0 m -91.25 13.8 16.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.324 -0.853 . . . . 1.45 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 18.8 mm -108.08 115.48 49.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 0.69999999999999996 110.711 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.52 -36.66 3.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.775 . . . . 1.6799999999999999 112.953 176.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' HD2' ' C ' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -121.22 116.68 25.37 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.536 -0.542 . . . . 4.3899999999999997 109.536 179.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 66.18 170.59 0.23 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 124.01 0.819 . . . . 3.9399999999999999 111.645 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t 67.15 138.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.696 0.76 . . . . 4.6799999999999997 111.814 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 12.4 t -109.49 -145.73 0.4 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.53 -0.759 . . . . 5.6799999999999997 110.223 -176.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 139' ' ' SER . 0.1 OUTLIER 72.66 108.78 0.07 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.542 0.687 . . . . 8.3000000000000007 111.078 -178.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.47 89.62 1.03 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.554 -0.748 . . . . 3.8500000000000001 112.629 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.842 ' SG ' ' H11' ' A' 1142 ' ' IM2 . 50.5 t -118.54 -33.9 4.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.952 -0.388 . . . . 2.5099999999999998 109.952 174.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 68.0 mt 75.38 81.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.846 0.832 . . . . 1.4399999999999999 111.442 173.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.503 ' NH2' ' N26' ' A' 1142 ' ' IM2 . 39.4 mtt180 -118.97 162.56 18.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.413 -0.958 . . . . 3.3599999999999999 108.413 174.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.405 ' HA ' HG21 ' A' ' 134' ' ' ILE . 38.9 mtp -145.4 -169.28 3.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.096 0.474 . . . . 1.1299999999999999 111.362 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 149' ' ' ASP . 37.6 m80 -66.45 176.11 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.167 -0.924 . . . . 2.5099999999999998 109.143 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 150' ' ' VAL . 3.8 m120 -82.4 -63.5 1.36 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.017 -1.105 . . . . 1.77 108.017 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -66.69 -22.15 66.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.616 . . . . 2.1299999999999999 111.323 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 146' ' ' HIS . 31.2 m-20 -67.93 -41.83 81.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.893 0.378 . . . . 1.05 110.831 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.7 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 8.5 p -79.52 -13.01 13.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 116.232 -0.44 . . . . 0.32000000000000001 110.521 -177.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.581 ' CD1' ' HB1' ' A' ' 113' ' ' ALA . 3.3 mp -92.34 -40.52 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 119.254 -0.403 . . . . 0.37 110.849 168.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -42.32 -70.6 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 119.356 0.98 . . . . 1.3799999999999999 111.912 162.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.71 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.0 OUTLIER -50.07 -41.96 48.99 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.738 0.649 . . . . 0.73999999999999999 110.181 177.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -52.23 -55.47 20.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.622 -1.172 . . . . 0.22 111.727 -172.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 28.7 t -77.01 -16.66 59.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.686 -1.143 . . . . 1.3300000000000001 110.863 -172.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 67.6 mt -91.24 -50.07 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.969 -0.382 . . . . 0.23000000000000001 109.969 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.3 m -77.51 115.78 52.43 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 122.046 0.927 . . . . 0.20999999999999999 110.38 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.751 ' HG2' HD13 ' A' ' 57' ' ' ILE . 45.6 Cg_endo -80.82 -178.28 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.834 2.356 . . . . 0.34000000000000002 112.578 -172.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.694 ' O ' HD21 ' A' ' 51' ' ' LEU . 19.2 m120 -55.91 -5.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.669 -1.151 . . . . 1.02 113.57 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -144.18 57.26 0.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.937 -0.649 . . . . 0.28000000000000003 112.168 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.528 ' HB ' ' CG1' ' A' ' 100' ' ' ILE . 3.8 m -90.72 140.32 29.89 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.405 -0.467 . . . . 0.29999999999999999 110.608 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.513 ' HG2' ' CE2' ' A' ' 99' ' ' TYR . 60.4 mtm180 -83.53 125.15 31.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.51 . . . . 1.96 109.86 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -136.16 126.65 41.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.389 0.614 . . . . 0.46000000000000002 111.419 -177.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 90.5 m -117.29 140.49 49.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.384 -0.826 . . . . 0.56000000000000005 111.975 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 3.7 mp -129.14 115.82 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 122.342 1.067 . . . . 0.95999999999999996 111.397 172.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -143.78 137.77 28.29 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.527 -1.67 . . . . 1.1899999999999999 110.26 -173.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.737 ' H ' HG22 ' A' ' 93' ' ' THR . 8.6 ptm180 -91.99 -11.56 35.71 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.098 -0.956 . . . . 3.4199999999999999 111.342 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.66 -57.24 0.52 Allowed Glycine 0 C--N 1.308 -1.022 0 CA-C-N 114.459 -1.246 . . . . 3.6499999999999999 110.949 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.248 0.98 0 N-CA-C 109.123 -0.695 . . . . 5.9699999999999998 109.123 173.194 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.842 ' H11' ' SG ' ' A' ' 142' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 111.908 -0.477 . . . . 2.9199999999999999 111.908 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.484 ' HD3' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -110.97 178.15 4.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.214 0.531 . . . . 4.0999999999999996 110.756 178.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.645 ' HE2' ' H ' ' A' ' 3' ' ' LYS . 1.8 mppt? -73.27 143.01 47.2 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.288 -0.869 . . . . 2.1000000000000001 108.845 174.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 49' ' ' PRO . 16.6 mt -95.91 170.89 8.98 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.071 0.232 . . . . 0.26000000000000001 111.15 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.544 HD23 ' CG1' ' A' ' 48' ' ' ILE . 4.0 tp -77.62 150.11 34.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 123.215 0.606 . . . . 0.23000000000000001 112.173 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.541 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -115.07 149.25 37.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.012 0.911 . . . . 0.26000000000000001 111.754 168.006 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' SER . 68.5 t80 -133.72 150.3 51.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.61 -1.632 . . . . 0.39000000000000001 107.911 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.3 tm0? -131.59 117.13 18.3 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.151 -1.426 . . . . 1.0700000000000001 107.151 174.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG11 HD23 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -78.58 158.83 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 123.234 0.614 . . . . 0.38 111.226 -169.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 10' ' ' LYS . 8.5 mtpm? -110.27 156.72 20.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.111 -0.7 . . . . 2.5899999999999999 109.111 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.849 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 19.7 tm0? -49.82 117.94 2.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.826 -0.625 . . . . 1.74 112.571 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.54 -6.44 35.94 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.56999999999999995 113.428 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.704 ' HB3' HD11 ' A' ' 18' ' ' ILE . 20.9 m-20 -70.66 157.09 38.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 117.473 0.637 . . . . 2.1699999999999999 112.436 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.615 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -134.7 162.29 32.76 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.549 0.574 . . . . 0.5 112.549 -176.337 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 52.9 tp -51.75 -60.73 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.937 1.088 . . . . 0.27000000000000002 113.937 -173.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.647 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 14.8 t-20 -63.75 -43.37 96.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.614 1.197 . . . . 1.21 110.403 -169.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.768 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 31.3 m -60.46 -39.17 86.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 112.494 -2.139 . . . . 1.24 110.989 -177.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 13' ' ' ASP . 1.7 mp -75.35 -40.87 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 123.012 0.525 . . . . 0.29999999999999999 112.327 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.682 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -56.55 -61.66 2.27 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.487 -0.324 . . . . 0.23000000000000001 111.242 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.14 -3.33 54.62 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.01 -1.076 . . . . 0.39000000000000001 112.136 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' SER . 4.0 t70 -62.13 -39.64 93.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.85 -1.167 . . . . 1.6299999999999999 107.85 155.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.766 ' O ' HG23 ' A' ' 24' ' ' ILE . 4.6 m-85 -93.13 24.9 3.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.087 -0.506 . . . . 0.23999999999999999 111.969 174.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.647 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 23.74 69.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.96 1.304 . . . . 3.5499999999999998 113.515 -168.41 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 22' ' ' PHE . 29.8 pt -147.66 -169.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.066 -1.087 . . . . 0.27000000000000002 108.066 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.22 146.88 25.18 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.943 -0.571 . . . . 0.81000000000000005 109.736 171.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.647 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 16.6 p -61.25 -35.56 77.58 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.499 -0.926 . . . . 0.27000000000000002 108.499 174.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.75 -30.66 71.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.604 -1.18 . . . . 0.26000000000000001 111.77 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.03 -38.24 32.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 O-C-N 121.874 -0.516 . . . . 0.23000000000000001 109.725 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 46' ' ' ILE . 14.4 tp -73.68 -19.08 60.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.423 -0.808 . . . . 0.17000000000000001 109.133 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.764 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -78.83 -40.37 32.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 0.19 111.832 173.396 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -59.68 -40.59 88.33 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.072 -0.967 . . . . 1.0700000000000001 109.746 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.11 -20.29 41.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.673 -1.603 . . . . 0.17000000000000001 112.214 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.693 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 23.8 m-80 -143.52 73.12 17.46 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 121.165 0.507 . . . . 0.19 109.941 -173.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.724 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.8 Cg_endo -57.08 -11.32 7.42 Favored 'Trans proline' 0 C--N 1.331 -0.392 0 C-N-CA 123.574 2.849 . . . . 0.29999999999999999 113.809 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.6 t -62.67 -32.83 73.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.988 0.899 . . . . 1.1699999999999999 109.392 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -80.82 -7.08 59.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.568 1.321 . . . . 0.53000000000000003 114.568 -172.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.764 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -53.06 -39.84 63.56 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 120.19 1.359 . . . . 1.23 109.599 177.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.78 -47.4 12.91 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.769 -2.014 . . . . 0.40000000000000002 111.334 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.03 -166.54 38.68 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.91 -1.138 . . . . 0.29999999999999999 114.567 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.577 ' CD2' HG12 ' A' ' 18' ' ' ILE . 5.6 mp -114.88 158.91 21.32 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.335 -1.432 . . . . 0.31 110.152 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.605 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 87.5 m -136.84 136.2 38.57 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.797 -0.638 . . . . 0.39000000000000001 110.499 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.849 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -46.93 127.46 10.08 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 113.115 0.783 . . . . 0.46999999999999997 113.115 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.22 -11.13 51.23 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.607 -1.179 . . . . 0.35999999999999999 112.312 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.3 tt0 -63.31 151.11 41.63 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.697 0.76 . . . . 1.1899999999999999 110.298 175.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 35.6 m -118.88 131.59 56.07 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.32 -1.309 . . . . 0.89000000000000001 109.265 -171.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 29' ' ' LEU . 21.2 pt -132.81 159.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.095 0.474 . . . . 0.22 110.345 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.693 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 26.1 t -106.63 148.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.292 -0.867 . . . . 0.20999999999999999 109.808 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.544 ' CG1' HD23 ' A' ' 5' ' ' LEU . 16.9 mm -116.97 88.69 27.19 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.31 -0.996 . . . . 0.17000000000000001 108.31 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.709 ' HA ' HD13 ' A' ' 4' ' ' LEU . 24.3 Cg_endo -59.05 142.32 99.23 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.129 2.553 . . . . 0.23000000000000001 112.617 -173.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.514 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.37 -7.08 61.93 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.492 -0.776 . . . . 0.29999999999999999 112.811 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.712 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.5 tt -114.62 126.07 28.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.742 -0.836 . . . . 0.25 108.742 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 51' ' ' LEU . 57.5 Cg_endo -65.58 174.3 5.55 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.849 3.033 . . . . 0.31 113.656 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.1 t70 -91.31 141.73 26.43 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.158 -0.928 . . . . 0.71999999999999997 110.9 -169.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 96.5 Cg_endo -83.57 -7.11 10.73 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.616 2.877 . . . . 0.27000000000000002 112.17 -175.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 62.1 m-85 -94.84 -27.31 15.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.831 -0.433 . . . . 2.1099999999999999 109.831 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -70.23 -35.06 73.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.497 -1.298 . . . . 1.47 107.497 170.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.8 HD13 ' HG2' ' A' ' 158' ' ' PRO . 85.0 mt -74.34 126.43 88.96 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 113.327 -1.761 . . . . 0.26000000000000001 110.524 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -102.94 95.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.905 1.07 . . . . 0.20000000000000001 110.257 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.451 ' HD2' HG23 ' A' ' 57' ' ' ILE . 77.2 m-85 -158.33 129.57 6.49 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.403 -1.332 . . . . 0.26000000000000001 107.403 172.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m-70 -137.7 110.13 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.158 -1.423 . . . . 2.8399999999999999 107.158 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 73.0 mt -94.94 111.4 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.383 0.611 . . . . 0.32000000000000001 110.539 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.27 93.06 4.23 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.857 0.837 . . . . 0.34000000000000002 110.399 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -112.88 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.414 -1.266 . . . . 0.68000000000000005 109.647 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB3' ' CB ' ' A' ' 67' ' ' ALA . 35.4 t -92.77 124.96 37.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.849 -1.167 . . . . 1.05 107.849 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.703 HG23 HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -58.98 -28.59 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.345 0.593 . . . . 1.29 110.796 172.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.45 -45.05 88.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.881 -0.888 . . . . 0.88 110.881 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.481 ' CB ' ' HB3' ' A' ' 64' ' ' SER . . . -70.25 -24.08 63.01 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.644 0.609 . . . . 0.73999999999999999 112.644 176.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.593 ' HA ' HG21 ' A' ' 86' ' ' VAL . 55.5 mttt 58.57 14.26 2.97 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.818 0.847 . . . . 2.5099999999999998 112.894 -177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.458 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -140.42 138.9 35.08 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.973 0.892 . . . . 0.45000000000000001 111.249 177.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.445 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.0 tt -92.74 117.9 30.49 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.881 -1.509 . . . . 0.33000000000000002 108.881 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 m -101.61 125.4 48.26 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.938 -0.705 . . . . 0.40000000000000002 110.925 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.43 142.62 31.78 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.095 -1.817 . . . . 0.33000000000000002 106.095 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 26.1 m -147.48 128.2 14.28 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 120.445 1.475 . . . . 0.75 112.969 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -111.41 126.88 55.41 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.588 -1.187 . . . . 0.34999999999999998 110.147 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.1 t-20 61.89 35.45 16.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 0.52000000000000002 110.285 173.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 3.2 m-20 78.35 1.59 2.68 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.112 -0.949 . . . . 1.8400000000000001 112.404 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 77' ' ' ARG . 5.5 ttt180 -128.51 137.36 51.73 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 118.283 -1.367 . . . . 3.1899999999999999 113.446 172.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -54.19 147.93 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 112.987 -1.915 . . . . 0.40999999999999998 113.17 -171.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.533 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -97.8 -44.72 6.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.25 -2.25 . . . . 0.34999999999999998 107.943 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 26.0 tptt -179.04 160.21 1.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.325 -2.216 . . . . 2.0699999999999998 110.484 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.458 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 5.5 m -116.11 131.44 56.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.689 -0.232 . . . . 0.37 111.403 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -113.71 146.86 36.37 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 110.487 -0.19 . . . . 0.96999999999999997 110.487 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -81.95 143.19 12.88 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.506 2.137 . . . . 0.59999999999999998 111.305 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.75 172.23 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.768 -0.456 . . . . 0.64000000000000001 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.56 127.65 34.51 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.92 0.391 . . . . 0.82999999999999996 110.08 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.703 HG13 HG23 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -114.02 -57.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.572 -0.74 . . . . 1.6699999999999999 111.55 -177.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.444 ' N ' HG12 ' A' ' 86' ' ' VAL . . . 74.63 -56.08 2.52 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.347 -0.454 . . . . 3.0800000000000001 113.0 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt 58.04 82.69 0.13 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.462 0.705 . . . . 7.2599999999999998 110.729 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 tp -76.22 -24.27 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.985 -0.552 . . . . 6.29 110.34 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 91' ' ' THR . 34.0 tp -176.25 172.92 2.23 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.867 -0.79 . . . . 7.2699999999999996 108.867 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 15.0 p -52.13 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.528 0.518 . . . . 5.1799999999999997 111.114 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 65.26 -66.66 0.14 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.88 0.696 . . . . 4.8099999999999996 112.88 172.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 167' ' ' ARG . 22.1 p 49.26 83.58 0.22 Allowed Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 123.917 0.887 . . . . 2.1099999999999999 111.965 -174.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.98 103.83 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.892 2.395 . . . . 3.21 112.142 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.5 p -82.56 73.25 9.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.753 -0.658 . . . . 3.5899999999999999 111.659 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.88 153.04 21.54 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.05 -0.595 . . . . 2.1000000000000001 111.664 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -110.84 147.48 34.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.303 0.573 . . . . 2.2999999999999998 111.133 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.648 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 2.7 m-85 -121.56 172.5 8.05 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.301 -1.0 . . . . 1.9299999999999999 108.301 -177.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 161' ' ' THR . 89.4 m-85 -135.9 139.1 43.05 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.464 -0.495 . . . . 0.57999999999999996 111.685 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.73 HD11 HD12 ' A' ' 125' ' ' ILE . 26.6 mm -60.62 126.19 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 107.578 -1.267 . . . . 0.40999999999999998 107.578 164.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -125.46 -27.93 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 120.118 -0.633 . . . . 0.37 112.51 -177.324 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' LEU . 3.6 t30 -151.61 158.8 43.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.82 1.045 . . . . 1.99 113.82 -168.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.69 133.91 20.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.397 -2.183 . . . . 1.1899999999999999 110.198 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 13.3 tp60 -111.92 142.57 44.14 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.806 0.813 . . . . 1.6699999999999999 110.709 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -54.23 151.44 7.26 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 112.937 -1.938 . . . . 3.0600000000000001 113.254 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -45.36 101.98 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 114.121 -1.399 . . . . 2.6099999999999999 111.998 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.402 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 85.7 Cg_exo -56.79 -51.39 9.11 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 124.242 3.294 . . . . 0.97999999999999998 112.839 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.39 -0.86 29.46 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.353 -0.839 . . . . 1.0800000000000001 112.436 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.16 -170.34 11.99 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.939 -0.648 . . . . 1.05 112.098 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.29 49.14 0.16 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.465 3.443 . . . . 1.3 113.945 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.402 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 1.6 t80 -107.42 -15.56 14.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.392 -0.596 . . . . 1.3799999999999999 109.392 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.427 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 99.92 35.37 4.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.806 -0.712 . . . . 1.1100000000000001 114.516 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.406 ' O ' ' HD1' ' A' ' 114' ' ' TYR . . . 72.72 -36.42 0.36 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.468 0.914 . . . . 0.81000000000000005 113.468 172.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -152.83 137.57 16.99 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.366 -0.605 . . . . 1.1200000000000001 109.366 -176.043 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 61.9 t-105 -110.34 102.35 11.01 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.485 -0.561 . . . . 2.1899999999999999 109.485 171.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 102' ' ' ASN . 4.2 mp -102.03 144.41 30.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.763 0.792 . . . . 0.60999999999999999 110.54 176.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.588 ' HB2' HG23 ' A' ' 101' ' ' ILE . 34.8 m -107.84 144.32 35.21 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.08 -0.964 . . . . 0.93999999999999995 112.794 -169.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.716 HD11 HG11 ' A' ' 163' ' ' VAL . 6.8 tp -106.81 -171.78 1.95 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.836 -1.529 . . . . 1.0800000000000001 107.899 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.1 t -129.29 41.87 3.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.772 0.715 . . . . 1.5 111.836 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.648 ' HD2' ' CZ ' ' A' ' 98' ' ' PHE . 57.6 tttp -129.73 95.91 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.045 -0.41 . . . . 2.9700000000000002 111.012 172.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 42.07 -93.52 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.135 0.897 . . . . 5.0599999999999996 112.55 174.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -83.12 69.66 9.92 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.555 -0.906 . . . . 5.9500000000000002 108.555 172.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.439 ' HB2' ' CB ' ' A' ' 118' ' ' LEU . 33.3 p90 -71.57 137.42 48.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.703 -1.135 . . . . 4.8300000000000001 112.114 -172.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.413 ' O ' HG21 ' A' ' 143' ' ' ILE . . . -157.32 138.96 6.12 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.253 -1.451 . . . . 0.94999999999999996 116.015 176.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 100' ' ' ILE . 4.0 mt -151.49 107.02 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.338 -1.727 . . . . 0.47999999999999998 106.338 159.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.704 ' CE1' ' HB3' ' A' ' 144' ' ' ARG . 10.3 p80 -149.48 -165.06 2.17 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.467 -0.893 . . . . 1.25 112.272 -172.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.427 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -122.17 175.39 16.35 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.636 -1.165 . . . . 0.46000000000000002 113.01 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 5.0 t -136.69 171.68 14.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.464 0.649 . . . . 0.5 111.986 -165.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.57 ' H ' ' C25' ' A' 1142 ' ' IM2 . 4.3 m-20 -104.81 -18.17 14.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.877 -1.056 . . . . 1.8600000000000001 108.702 165.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -124.21 102.8 33.45 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.268 -0.878 . . . . 1.77 109.661 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -90.07 4.29 4.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.165 2.577 . . . . 0.58999999999999997 112.846 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.48 -12.37 58.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.338 0.59 . . . . 0.78000000000000003 109.805 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.6 m -93.53 5.9 50.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.298 -0.865 . . . . 1.45 109.271 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 145' ' ' MET . 31.2 mm -98.56 115.57 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.095 -0.957 . . . . 0.69999999999999996 110.487 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 106.45 -56.81 0.49 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.076 -1.21 . . . . 1.6799999999999999 110.076 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -100.56 97.63 8.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.244 -0.651 . . . . 4.3899999999999997 109.244 172.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.29 109.4 4.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.199 0.523 . . . . 3.9399999999999999 111.612 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.3 86.2 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.49 -0.777 . . . . 4.6799999999999997 110.49 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 t 66.08 -83.46 0.03 OUTLIER 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.346 -0.843 . . . . 5.6799999999999997 111.502 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -76.39 104.45 6.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.039 0.447 . . . . 8.3000000000000007 111.007 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.21 99.81 0.74 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.698 -0.763 . . . . 3.8500000000000001 112.049 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 3.9 t -121.22 130.5 53.72 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.209 -0.293 . . . . 2.5099999999999998 110.209 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.577 HD13 HG12 ' A' ' 125' ' ' ILE . 16.9 tt -86.24 64.53 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 122.436 1.112 . . . . 1.4399999999999999 111.003 -173.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.704 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 16.4 ptt180 -107.62 88.04 2.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.631 -1.168 . . . . 3.3599999999999999 110.075 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 126' ' ' HIS . 20.4 ptm -92.94 -166.75 1.59 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.588 -0.733 . . . . 1.1299999999999999 112.253 -170.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.439 ' HB2' ' CG ' ' A' ' 149' ' ' ASP . 14.3 m80 -67.54 138.61 56.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 2.5099999999999998 109.826 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.643 ' O ' HG12 ' A' ' 150' ' ' VAL . 2.4 m-20 -52.3 -64.67 0.74 Allowed 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.18 0.3 . . . . 1.77 111.401 -175.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -59.57 -27.29 66.12 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.91 -0.494 . . . . 2.1299999999999999 111.809 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.439 ' CG ' ' HB2' ' A' ' 146' ' ' HIS . 2.3 m-20 -70.31 -43.68 69.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.925 0.393 . . . . 1.05 110.68 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.687 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 11.2 p -73.68 -15.79 16.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.32000000000000001 110.37 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -90.18 -40.93 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 119.181 -0.438 . . . . 0.37 110.551 172.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -43.16 -67.75 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.348 0.976 . . . . 1.3799999999999999 112.014 163.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.694 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.6 tp -49.35 -43.79 44.14 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.592 -0.731 . . . . 0.73999999999999999 109.894 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -53.66 -50.85 64.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.118 -1.401 . . . . 0.22 112.421 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 17.1 t -78.74 -18.64 53.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.758 -1.11 . . . . 1.3300000000000001 110.71 -173.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.16 -50.46 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.838 -0.43 . . . . 0.23000000000000001 109.838 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 153' ' ' LEU . 20.8 m -77.12 114.88 43.96 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 122.057 0.932 . . . . 0.20999999999999999 109.985 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.8 ' HG2' HD13 ' A' ' 57' ' ' ILE . 46.4 Cg_endo -82.12 -178.11 3.89 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.169 2.579 . . . . 0.34000000000000002 112.609 -174.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.712 ' O ' HD21 ' A' ' 51' ' ' LEU . 20.6 m120 -59.2 -1.71 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.591 -1.186 . . . . 1.02 113.364 -174.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -145.42 59.08 0.5 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.947 -0.644 . . . . 0.28000000000000003 112.414 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.2 m -95.69 134.85 38.12 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.535 -0.391 . . . . 0.29999999999999999 110.393 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -84.88 140.24 31.29 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.098 -0.334 . . . . 1.96 110.098 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.716 HG11 HD11 ' A' ' 118' ' ' LEU . 3.7 p -145.55 130.16 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.811 -0.631 . . . . 0.46000000000000002 111.271 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.404 ' C ' HD12 ' A' ' 165' ' ' ILE . 20.0 m -116.82 138.18 51.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.811 -0.631 . . . . 0.56000000000000005 111.789 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.465 HG23 HG13 ' A' ' 65' ' ' ILE . 2.9 mp -122.18 109.84 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 118.997 -1.081 . . . . 0.95999999999999996 110.619 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.631 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.72 156.7 44.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.526 -1.215 . . . . 1.1899999999999999 109.358 -170.187 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.61 ' H ' HG22 ' A' ' 93' ' ' THR . 3.1 mpt_? -91.37 -8.32 48.34 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.017 -0.538 . . . . 3.4199999999999999 110.84 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.21 -69.24 1.84 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.677 -0.692 . . . . 3.6499999999999999 112.617 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.714 -0.66 . . . . 5.9699999999999998 110.126 -177.358 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.57 ' C25' ' H ' ' A' ' 129' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.727 -0.549 . . . . 2.9199999999999999 111.727 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -97.72 160.8 14.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.823 0.311 . . . . 4.0999999999999996 110.503 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 13.5 mptt -65.3 153.45 41.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.417 -0.586 . . . . 2.1000000000000001 109.417 172.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.784 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.9 mt -91.96 170.63 9.7 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.94 -0.573 . . . . 0.26000000000000001 110.854 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD23 ' CG1' ' A' ' 48' ' ' ILE . 3.6 tp -76.49 149.07 36.81 Favored 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 122.983 0.513 . . . . 0.23000000000000001 111.866 -170.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.51 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.59 149.18 36.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 122.166 0.984 . . . . 0.26000000000000001 111.67 168.125 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 45' ' ' SER . 77.3 t80 -134.54 147.53 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.304 -1.771 . . . . 0.39000000000000001 107.521 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.7 OUTLIER -127.56 112.01 14.43 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.288 -1.745 . . . . 1.0700000000000001 106.288 174.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 40' ' ' LEU . 1.6 m -71.42 157.68 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 115.714 -0.675 . . . . 0.38 111.961 -165.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -108.27 147.77 30.94 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.113 -0.948 . . . . 2.5899999999999999 109.387 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -51.58 131.22 29.42 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.888 0.742 . . . . 1.74 112.349 -174.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.71 -4.59 39.69 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.371 -0.831 . . . . 0.56999999999999995 111.44 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -45.11 143.63 1.53 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.915 1.45 . . . . 2.1699999999999999 114.915 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.23 140.1 46.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.978 -1.01 . . . . 0.5 111.674 164.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 53.5 tp -42.31 -55.28 3.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.315 -0.857 . . . . 0.27000000000000002 113.174 -175.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 17.3 t-20 -65.43 -42.97 91.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.584 1.183 . . . . 1.21 110.375 -172.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.786 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 15.1 m -62.95 -38.06 89.54 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 112.477 -2.147 . . . . 1.24 110.878 -176.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -76.08 -39.62 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 O-C-N 123.713 0.633 . . . . 0.29999999999999999 112.2 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.718 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.02 -59.59 4.85 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.611 -0.268 . . . . 0.23000000000000001 110.998 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 -4.65 56.83 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 118.527 -1.269 . . . . 0.39000000000000001 111.848 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.786 ' HB2' ' O ' ' A' ' 17' ' ' SER . 8.3 t70 -61.3 -29.24 69.75 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.567 -1.272 . . . . 1.6299999999999999 107.567 157.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.692 ' O ' HG23 ' A' ' 24' ' ' ILE . 1.8 m-85 -109.06 19.13 19.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.999 0.74 . . . . 0.23999999999999999 112.999 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? 49.57 54.95 10.12 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.486 -0.779 . . . . 3.5499999999999998 111.266 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 19' ' ' ALA . 33.5 pt -148.18 -172.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.721 -0.844 . . . . 0.27000000000000002 108.721 -173.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.58 146.78 24.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.66 -0.7 . . . . 0.81000000000000005 109.684 173.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.644 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 18.1 p -62.69 -35.19 78.89 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.793 -0.818 . . . . 0.27000000000000002 108.793 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.16 -28.88 68.48 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.362 -1.29 . . . . 0.26000000000000001 111.665 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.38 26.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.241 -0.651 . . . . 0.23000000000000001 109.241 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 16.5 tp -72.46 -17.85 61.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.144 -0.935 . . . . 0.17000000000000001 108.772 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.757 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -80.05 -37.51 33.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.393 0.616 . . . . 0.19 111.16 171.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -56.39 -46.28 80.18 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 122.636 1.208 . . . . 1.0700000000000001 110.278 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.69 43.09 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 112.998 -1.91 . . . . 0.17000000000000001 112.317 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 34.3 m-80 -142.51 73.1 20.59 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.19 110.108 -172.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.747 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.6 Cg_endo -57.24 -13.55 12.95 Favored 'Trans proline' 0 C--O 1.22 -0.419 0 C-N-CA 123.437 2.758 . . . . 0.29999999999999999 114.325 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.9 t -61.48 -31.59 71.57 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.932 0.872 . . . . 1.1699999999999999 109.718 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.675 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mt -81.0 -6.69 59.09 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.469 1.285 . . . . 0.53000000000000003 114.469 -171.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.757 ' N ' HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -50.86 -41.48 58.03 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.806 1.185 . . . . 1.23 110.147 179.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.62 -46.32 13.44 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.829 -1.987 . . . . 0.40000000000000002 111.136 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 175.01 -170.32 43.4 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.49 -0.862 . . . . 0.29999999999999999 113.952 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 9' ' ' VAL . 5.3 mp -110.03 161.71 15.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 113.558 -1.321 . . . . 0.31 109.724 177.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 86.3 m -135.61 134.12 38.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.872 -0.603 . . . . 0.39000000000000001 110.428 176.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.44 129.25 18.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.314 0.578 . . . . 0.46999999999999997 112.281 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.18 -12.9 57.11 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.802 -1.09 . . . . 0.35999999999999999 112.647 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.6 tt0 -65.88 152.7 43.88 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.641 0.734 . . . . 1.1899999999999999 110.306 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.498 ' N ' ' HG3' ' A' ' 44' ' ' GLN . 50.7 m -117.02 130.68 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.501 -1.227 . . . . 0.89000000000000001 109.603 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 29' ' ' LEU . 20.6 pt -134.46 145.51 32.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.516 0.674 . . . . 0.22 110.526 -174.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.57 ' H ' HD21 ' A' ' 33' ' ' ASN . 12.5 t -91.02 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.866 -1.061 . . . . 0.20999999999999999 110.192 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CG1' HD23 ' A' ' 5' ' ' LEU . 21.8 mm -117.47 88.53 29.09 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-N 115.083 -0.962 . . . . 0.17000000000000001 108.425 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.784 ' HA ' HD13 ' A' ' 4' ' ' LEU . 22.8 Cg_endo -58.74 141.36 97.71 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.221 2.614 . . . . 0.23000000000000001 112.967 -173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.495 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 84.6 -7.6 72.58 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.381 -0.827 . . . . 0.29999999999999999 113.115 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.636 HD23 ' HD2' ' A' ' 52' ' ' PRO . 2.7 tt -118.53 128.39 26.0 Favored Pre-proline 0 C--O 1.217 -0.637 0 N-CA-C 108.641 -0.874 . . . . 0.25 108.641 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.636 ' HD2' HD23 ' A' ' 51' ' ' LEU . 59.8 Cg_endo -67.33 175.12 6.22 Favored 'Trans proline' 0 N--CA 1.48 0.692 0 C-N-CA 123.563 2.842 . . . . 0.31 113.825 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.771 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.9 t70 -89.46 142.11 29.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.268 -0.878 . . . . 0.71999999999999997 110.56 -171.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.503 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 75.0 Cg_endo -84.28 -4.58 10.26 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.576 2.851 . . . . 0.27000000000000002 112.363 -174.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -94.79 -26.53 16.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.741 -0.466 . . . . 2.1099999999999999 109.741 174.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.771 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.1 p -72.99 -28.76 62.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.561 1.172 . . . . 1.47 107.844 171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.755 HD13 ' HG2' ' A' ' 158' ' ' PRO . 93.0 mt -80.68 124.35 81.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 113.065 -1.88 . . . . 0.26000000000000001 109.868 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -101.8 96.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 120.779 0.986 . . . . 0.20000000000000001 110.235 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.489 ' HB2' HG23 ' A' ' 161' ' ' THR . 89.9 m-85 -157.74 133.23 9.01 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.387 -1.338 . . . . 0.26000000000000001 107.387 172.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 9.7 m-70 -137.08 103.82 5.25 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 106.259 -1.756 . . . . 2.8399999999999999 106.259 -167.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 68.1 mt -92.96 106.43 17.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.705 0.764 . . . . 0.32000000000000001 109.595 -177.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.86 96.1 5.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.716 -1.129 . . . . 0.34000000000000002 110.623 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.557 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.2 p -114.82 96.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 113.743 -1.571 . . . . 0.68000000000000005 108.712 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.51 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 51.1 m -95.18 122.57 38.0 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.209 -1.36 . . . . 1.05 108.383 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 3.1 mm -47.3 -34.48 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.428 0.632 . . . . 1.29 110.117 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.55 -47.33 35.05 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.17 -0.923 . . . . 0.88 112.336 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.51 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -64.37 -24.25 67.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.317 0.58 . . . . 0.73999999999999999 112.392 174.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.609 ' HA ' HG11 ' A' ' 86' ' ' VAL . 17.9 mttt 54.97 17.63 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.773 1.229 . . . . 2.5099999999999998 113.414 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.414 ' HB ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -143.32 142.46 31.32 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.318 0.58 . . . . 0.45000000000000001 111.02 171.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.557 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 6.5 tt -90.98 118.21 30.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.169 -0.923 . . . . 0.33000000000000002 109.411 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m -105.0 125.77 51.33 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.392 -0.523 . . . . 0.40000000000000002 111.691 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.543 ' HG ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.76 136.82 34.58 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.129 -1.804 . . . . 0.33000000000000002 106.129 176.055 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.648 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 13.3 m -141.78 129.35 21.44 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 120.493 1.497 . . . . 0.75 112.758 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -116.26 126.59 53.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.045 -0.98 . . . . 0.34999999999999998 110.539 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 5.9 t-20 63.74 37.79 9.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.423 0.63 . . . . 0.52000000000000002 109.827 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 5.4 m-20 76.25 0.57 3.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.672 -1.149 . . . . 1.8400000000000001 112.525 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -129.49 138.54 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.279 -1.368 . . . . 3.1899999999999999 113.751 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -53.89 147.23 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 113.053 -1.885 . . . . 0.40999999999999998 112.863 -172.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.52 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -96.47 -45.66 6.67 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.338 -2.21 . . . . 0.34999999999999998 107.565 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 30.2 tptt -176.77 159.33 1.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 112.216 -2.265 . . . . 2.0699999999999998 110.298 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.414 ' CG2' ' HB ' ' A' ' 69' ' ' THR . 3.6 m -119.43 134.81 55.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.397 -0.121 . . . . 0.37 111.051 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.421 ' HB3' ' HA2' ' A' ' 141' ' ' GLY . 25.7 m-85 -120.22 127.14 26.48 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 120.924 0.392 . . . . 0.96999999999999997 110.876 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.454 ' HB2' HG21 ' A' ' 138' ' ' VAL . 7.7 Cg_endo -57.46 137.82 83.25 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 124.16 3.24 . . . . 0.59999999999999998 113.813 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 142' ' ' CYS . 0.2 OUTLIER -138.12 168.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.818 -0.353 . . . . 0.64000000000000001 110.371 177.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.542 ' HB3' ' H51' ' A' 1142 ' ' IM2 . . . -85.98 137.43 32.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.549 0.69 . . . . 0.82999999999999996 111.39 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -131.13 19.66 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.571 -1.195 . . . . 1.6699999999999999 110.104 -175.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.1 69.39 3.11 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.438 -0.801 . . . . 3.0800000000000001 112.102 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -147.38 138.71 23.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.33 -0.989 . . . . 7.2599999999999998 108.33 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.6 tp -52.44 129.05 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.211 0.529 . . . . 6.29 111.151 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.0 mt -83.41 58.44 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.986 -0.552 . . . . 7.2699999999999996 110.592 -175.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.8 m -68.55 -54.74 14.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.51 -0.768 . . . . 5.1799999999999997 111.693 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -151.18 150.49 30.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.865 0.364 . . . . 4.8099999999999996 110.644 -175.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 167' ' ' ARG . 10.6 p -78.21 117.35 65.61 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.894 -0.593 . . . . 2.1099999999999999 110.583 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 166' ' ' ASN . 46.4 Cg_exo -57.87 129.82 35.28 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.39 2.06 . . . . 3.21 111.904 175.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.3 p -87.26 156.98 19.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.98 -0.555 . . . . 3.5899999999999999 111.779 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.03 -168.31 48.73 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.098 -0.573 . . . . 2.1000000000000001 112.669 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.9 168.24 20.1 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.789 -0.448 . . . . 2.2999999999999998 109.789 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.642 ' HB2' HG13 ' A' ' 163' ' ' VAL . 13.3 m-85 -116.59 167.68 10.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.205 -1.405 . . . . 1.9299999999999999 107.205 171.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 161' ' ' THR . 84.6 m-85 -130.37 135.9 48.52 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.277 -0.569 . . . . 0.57999999999999996 111.021 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.804 HD11 HD12 ' A' ' 125' ' ' ILE . 26.8 mm -60.26 121.06 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 N-CA-C 107.346 -1.353 . . . . 0.40999999999999998 107.346 164.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.629 HD12 ' HD1' ' A' ' 22' ' ' PHE . 3.1 tt -109.04 -22.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.487 -0.885 . . . . 0.37 112.099 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 21.1 p-10 -178.5 -165.7 0.09 Allowed 'General case' 0 C--N 1.348 0.531 0 N-CA-C 114.024 1.12 . . . . 1.99 114.024 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 103' ' ' ARG . 5.3 ptp180 -150.73 139.66 20.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 112.683 -2.053 . . . . 1.1899999999999999 111.68 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 24.7 tp60 -107.12 145.0 33.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.604 -1.18 . . . . 1.6699999999999999 111.407 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.707 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 34.3 ttm180 -56.64 150.15 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.167 -1.833 . . . . 3.0600000000000001 111.506 170.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -46.07 104.01 0.38 Allowed Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 123.89 0.744 . . . . 2.6099999999999999 111.736 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.425 ' HG2' ' HB3' ' A' ' 111' ' ' PHE . 87.9 Cg_exo -56.35 -51.64 8.87 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.815 3.01 . . . . 0.97999999999999998 111.874 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.75 -21.59 13.83 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.02 -0.991 . . . . 1.0800000000000001 112.578 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -100.27 -169.49 29.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.96 -0.638 . . . . 1.05 112.311 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.52 32.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.256 3.304 . . . . 1.3 113.754 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -85.92 -20.92 28.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.142 0.496 . . . . 1.3799999999999999 109.933 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.439 ' HA3' ' CA ' ' A' ' 127' ' ' GLY . . . 96.33 42.55 3.43 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.519 -0.764 . . . . 1.1100000000000001 114.019 170.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 75.69 -33.62 0.23 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.419 0.896 . . . . 0.81000000000000005 113.419 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.559 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -150.17 127.0 11.04 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.816 -0.439 . . . . 1.1200000000000001 109.816 -174.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 34.0 t-105 -100.48 100.39 11.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.158 -0.682 . . . . 2.1899999999999999 109.158 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.2 mp -101.09 141.27 34.22 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 0.60999999999999999 109.016 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.1 m -106.93 144.09 34.07 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.644 0.609 . . . . 0.93999999999999995 112.644 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.598 HD11 HG11 ' A' ' 163' ' ' VAL . 2.3 tp -97.97 -174.19 2.8 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.786 -1.191 . . . . 1.0800000000000001 107.786 172.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t -75.04 -67.61 0.63 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.586 -0.445 . . . . 1.5 110.741 175.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.54 ' NZ ' ' HA ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -64.91 110.66 2.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.937 0.718 . . . . 2.9700000000000002 112.937 -165.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 55.89 -136.96 1.14 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.146 -0.934 . . . . 5.0599999999999996 111.998 173.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -90.27 15.74 9.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.949 0.404 . . . . 5.9500000000000002 110.539 -176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 120' ' ' LYS . 29.6 m-85 -66.07 134.26 52.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.751 -0.462 . . . . 4.8300000000000001 109.751 174.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.32 158.43 28.66 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.782 -0.723 . . . . 0.94999999999999996 111.881 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.804 HD12 HD11 ' A' ' 100' ' ' ILE . 9.2 mt -93.59 106.0 17.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 108.541 -0.911 . . . . 0.47999999999999998 108.541 174.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' NE2' ' HG2' ' A' ' 144' ' ' ARG . 18.4 p80 -136.95 -161.76 1.2 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.527 0.68 . . . . 1.25 111.27 -172.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.439 ' CA ' ' HA3' ' A' ' 112' ' ' GLY . . . -120.1 155.8 16.08 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 119.815 -1.183 . . . . 0.46000000000000002 113.569 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 3.8 t -98.37 172.5 7.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.028 -1.086 . . . . 0.5 110.592 -171.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.93 -13.35 13.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.351 -0.841 . . . . 1.8600000000000001 109.075 160.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 133' ' ' SER . 24.1 t30 -124.75 101.12 33.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.185 -0.916 . . . . 1.77 109.414 171.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.464 ' O ' ' HA ' ' A' ' 139' ' ' SER . 81.1 Cg_endo -90.49 3.29 4.82 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.785 2.323 . . . . 0.58999999999999997 113.039 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -94.8 -2.02 51.69 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.383 0.611 . . . . 0.78000000000000003 109.546 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.468 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 33.3 t -90.23 -12.69 37.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.262 -0.881 . . . . 1.45 109.555 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.669 HD12 ' HB3' ' A' ' 142' ' ' CYS . 14.6 mm -60.11 130.65 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.672 -0.695 . . . . 0.69999999999999996 109.963 177.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.25 -121.3 15.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.778 -0.725 . . . . 1.6799999999999999 111.596 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -107.65 -63.83 1.27 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.142 -0.688 . . . . 4.3899999999999997 109.142 170.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -134.13 29.0 3.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.648 -0.706 . . . . 3.9399999999999999 110.332 176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 134' ' ' ILE . 3.4 m -95.19 -176.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.932 -0.766 . . . . 4.6799999999999997 108.932 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 131' ' ' PRO . 64.1 m -147.63 170.1 18.22 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.564 -0.455 . . . . 5.6799999999999997 112.021 -177.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.4 pttm 42.78 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.589 1.156 . . . . 8.3000000000000007 112.908 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 142' ' ' CYS . . . 173.25 -177.65 45.57 Favored Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 115.27 -0.877 . . . . 3.8500000000000001 111.329 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.686 ' HA ' HG22 ' A' ' 84' ' ' ILE . 42.2 t 79.73 167.87 0.18 Allowed 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.461 -0.57 . . . . 2.5099999999999998 109.461 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 125' ' ' ILE . 22.4 pt -76.06 24.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.496 0.665 . . . . 1.4399999999999999 110.397 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.544 ' H ' ' C ' ' A' ' 142' ' ' CYS . 98.9 mtt180 -153.83 66.25 0.73 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.876 1.271 . . . . 3.3599999999999999 108.494 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.528 ' CG ' ' HB ' ' A' ' 150' ' ' VAL . 5.1 ptm -107.48 -167.44 1.26 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.279 0.844 . . . . 1.1299999999999999 113.279 -166.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.434 ' HD2' ' OD1' ' A' ' 147' ' ' ASN . 2.6 t60 -71.12 153.93 42.14 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.851 -0.796 . . . . 2.5099999999999998 108.851 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.573 ' O ' HG12 ' A' ' 150' ' ' VAL . 29.8 p-10 -54.21 -69.91 0.11 Allowed 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 112.268 0.47 . . . . 1.77 112.268 -172.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -61.39 -20.35 62.95 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.567 -0.708 . . . . 2.1299999999999999 111.405 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -74.26 -45.3 48.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.667 -0.697 . . . . 1.05 110.354 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.601 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 13.2 p -72.05 -18.37 19.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.32000000000000001 110.945 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.583 HD12 HG13 ' A' ' 150' ' ' VAL . 1.9 mp -84.68 -36.68 11.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 119.116 -0.469 . . . . 0.37 110.297 177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -45.05 -70.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 119.441 1.018 . . . . 1.3799999999999999 112.337 162.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.677 ' O ' HG22 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -49.45 -40.88 38.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.73999999999999999 110.316 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -55.99 -55.6 30.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.169 -1.378 . . . . 0.22 111.997 -172.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.9 p -75.08 -12.91 60.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.7 -1.136 . . . . 1.3300000000000001 110.919 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.89 -49.87 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.881 -0.6 . . . . 0.23000000000000001 110.098 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 153' ' ' LEU . 21.2 m -77.15 115.69 51.05 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 122.096 0.95 . . . . 0.20999999999999999 110.541 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.755 ' HG2' HD13 ' A' ' 57' ' ' ILE . 38.4 Cg_endo -82.78 -177.34 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.184 2.589 . . . . 0.34000000000000002 112.971 -173.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.631 ' O ' HD21 ' A' ' 51' ' ' LEU . 12.0 m120 -57.63 -2.13 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.708 -1.133 . . . . 1.02 113.898 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.57 57.92 0.48 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.28000000000000003 112.537 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 3.2 m -92.69 134.62 34.85 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.612 -0.346 . . . . 0.29999999999999999 110.479 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 138.81 31.73 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.904 0.383 . . . . 1.96 110.389 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -145.63 127.39 8.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.339 -0.846 . . . . 0.46000000000000002 110.911 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 63' ' ' VAL . 3.3 m -116.34 143.0 46.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.854 -0.612 . . . . 0.56000000000000005 111.652 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.465 HG13 HG13 ' A' ' 63' ' ' VAL . 3.1 mp -124.34 107.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 119.252 -0.979 . . . . 0.95999999999999996 109.77 172.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.643 ' H ' HD22 ' A' ' 166' ' ' ASN . 0.0 OUTLIER -143.46 145.21 32.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 1.1899999999999999 111.148 -168.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 93' ' ' THR . 4.5 mpt_? -81.36 -10.24 59.58 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.007 -0.997 . . . . 3.4199999999999999 111.274 177.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.02 -62.58 4.52 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.98 -0.629 . . . . 3.6499999999999999 111.964 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.726 -0.654 . . . . 5.9699999999999998 110.384 179.415 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.542 ' H51' ' HB3' ' A' ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 112.39 -0.284 . . . . 2.9199999999999999 112.39 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.18 167.86 27.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.9 -0.407 . . . . 4.0999999999999996 109.9 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.533 ' HE2' ' CG2' ' A' ' 56' ' ' THR . 4.1 mppt? -78.9 150.14 32.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.89 -0.411 . . . . 2.1000000000000001 109.89 174.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 49' ' ' PRO . 18.1 mt -95.21 172.6 8.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.855 -0.611 . . . . 0.26000000000000001 111.192 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.548 HD23 ' CG1' ' A' ' 48' ' ' ILE . 4.2 tp -75.49 149.2 38.51 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.103 0.478 . . . . 0.23000000000000001 111.77 -170.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.529 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -114.29 147.82 38.47 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.143 0.973 . . . . 0.26000000000000001 111.6 167.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' SER . 81.1 t80 -133.91 146.7 50.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.205 -1.816 . . . . 0.39000000000000001 107.571 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 1.6 tt0 -127.33 111.35 13.8 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 1.0700000000000001 106.66 176.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.549 HG11 HD23 ' A' ' 40' ' ' LEU . 1.2 m -70.64 157.44 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 121.37 0.605 . . . . 0.38 111.856 -165.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.31 147.09 33.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.128 -0.942 . . . . 2.5899999999999999 109.44 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.658 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -53.13 130.82 35.5 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.838 0.712 . . . . 1.74 112.15 -173.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.81 -4.85 39.51 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.491 -0.777 . . . . 0.56999999999999995 111.672 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -43.5 146.17 0.53 Allowed 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.004 1.483 . . . . 2.1699999999999999 115.004 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.35 139.9 45.97 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.014 -0.994 . . . . 0.5 111.928 162.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.582 ' HG ' ' CG2' ' A' ' 26' ' ' THR . 55.5 tp -43.11 -55.76 3.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.499 -0.773 . . . . 0.27000000000000002 113.031 -175.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.679 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 8.0 t-20 -65.2 -40.06 93.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.261 1.029 . . . . 1.21 110.268 -171.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -59.81 -49.88 75.97 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 112.924 -1.944 . . . . 1.24 109.534 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 HD21 ' A' ' 40' ' ' LEU . 1.5 mp -65.84 -39.35 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 O-C-N 123.522 0.514 . . . . 0.29999999999999999 111.35 -175.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.68 ' O ' HG12 ' A' ' 24' ' ' ILE . . . -57.41 -62.67 1.61 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.887 -0.597 . . . . 0.23000000000000001 111.612 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.27 -4.27 56.84 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.996 -1.081 . . . . 0.39000000000000001 112.292 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.56 -33.58 74.11 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.285 -1.005 . . . . 1.6299999999999999 108.285 155.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.6 m-85 -101.47 27.39 6.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.099 0.407 . . . . 0.23999999999999999 112.099 175.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.694 ' HD2' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER 24.13 68.62 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.836 1.255 . . . . 3.5499999999999998 113.805 -168.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.772 HG23 ' O ' ' A' ' 22' ' ' PHE . 34.6 pt -147.42 -173.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.856 -1.164 . . . . 0.27000000000000002 107.856 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -101.09 145.68 28.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.764 -0.653 . . . . 0.81000000000000005 109.409 173.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.679 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 12.7 p -61.93 -35.24 77.82 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.54 0.686 . . . . 0.27000000000000002 109.208 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . -64.1 -30.18 71.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.282 -1.326 . . . . 0.26000000000000001 111.334 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.14 -38.54 27.01 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.394 0.616 . . . . 0.23000000000000001 109.692 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.693 HD11 HD12 ' A' ' 46' ' ' ILE . 13.9 tp -72.74 -18.22 61.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.432 -0.804 . . . . 0.17000000000000001 108.963 175.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.738 HD11 ' N ' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.58 -37.58 35.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.35 0.595 . . . . 0.19 111.223 171.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 27' ' ' ALA . 53.0 mt-30 -56.96 -47.43 80.75 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.285 1.04 . . . . 1.0700000000000001 109.501 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.56 -18.37 51.91 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.361 -1.745 . . . . 0.17000000000000001 112.178 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.594 ' ND2' ' H ' ' A' ' 47' ' ' VAL . 31.3 m-80 -143.15 72.52 18.22 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.153 0.501 . . . . 0.19 109.903 -173.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.774 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 16.4 Cg_endo -57.68 -13.0 12.85 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 123.322 2.681 . . . . 0.29999999999999999 113.781 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -31.78 70.67 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 122.045 0.926 . . . . 1.1699999999999999 109.897 174.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.668 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 4.6 mt -82.67 -6.45 59.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.159 -1.382 . . . . 0.53000000000000003 114.527 -172.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.774 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -50.6 -42.28 55.71 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 119.778 1.172 . . . . 1.23 109.907 178.04 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.19 -47.04 15.29 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 112.99 -1.914 . . . . 0.40000000000000002 111.172 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.668 ' O ' ' HA ' ' A' ' 36' ' ' LEU . . . 174.12 -166.82 39.04 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-O 122.162 0.868 . . . . 0.29999999999999999 113.989 175.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.549 HD23 HG11 ' A' ' 9' ' ' VAL . 5.1 mp -113.76 160.34 18.78 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.392 -1.404 . . . . 0.31 109.871 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 88.0 m -136.02 135.36 39.39 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.901 -0.591 . . . . 0.39000000000000001 110.231 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -49.12 129.98 18.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.438 0.637 . . . . 0.46999999999999997 112.451 174.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA2' ' NE2' ' A' ' 8' ' ' GLN . . . 82.99 -13.03 46.54 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.804 -1.089 . . . . 0.35999999999999999 112.534 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.613 ' HB3' ' O ' ' A' ' 41' ' ' THR . 3.4 tt0 -64.34 152.71 40.53 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.507 0.67 . . . . 1.1899999999999999 110.288 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 45.8 m -117.81 132.32 56.46 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.741 -1.118 . . . . 0.89000000000000001 109.512 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.693 HD12 HD11 ' A' ' 29' ' ' LEU . 17.4 pt -135.77 155.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 121.354 0.597 . . . . 0.22 110.633 -175.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.594 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 14.5 t -100.08 149.43 5.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.0 -1.0 . . . . 0.20999999999999999 110.189 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.548 ' CG1' HD23 ' A' ' 5' ' ' LEU . 18.0 mm -117.57 87.8 27.1 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 114.923 -1.035 . . . . 0.17000000000000001 108.257 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.742 ' HA ' HD13 ' A' ' 4' ' ' LEU . 20.4 Cg_endo -57.89 143.45 95.83 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.303 2.669 . . . . 0.23000000000000001 112.937 -173.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.485 ' H ' HD13 ' A' ' 4' ' ' LEU . . . 81.2 -7.22 60.96 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.667 -0.697 . . . . 0.29999999999999999 113.07 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD21 ' O ' ' A' ' 159' ' ' ASN . 2.9 tt -116.15 126.47 27.6 Favored Pre-proline 0 C--O 1.219 -0.539 0 N-CA-C 108.457 -0.942 . . . . 0.25 108.457 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD2' HD23 ' A' ' 51' ' ' LEU . 60.1 Cg_endo -66.45 174.88 5.67 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.72 2.947 . . . . 0.31 113.618 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.753 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.9 t70 -89.63 141.75 28.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.71999999999999997 110.355 -172.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.511 ' HD2' ' CG ' ' A' ' 53' ' ' ASP . 90.2 Cg_endo -82.49 -3.88 11.48 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.423 2.749 . . . . 0.27000000000000002 112.169 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.68 -25.44 16.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 2.1099999999999999 110.14 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.753 HG23 ' HB3' ' A' ' 53' ' ' ASP . 22.7 p -74.05 -28.32 61.35 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.737 -1.208 . . . . 1.47 107.737 171.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.798 HD13 ' HG2' ' A' ' 158' ' ' PRO . 97.0 mt -80.93 128.6 70.78 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 113.234 -1.803 . . . . 0.26000000000000001 109.659 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -103.6 96.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.942 0 CA-C-N 120.1 1.071 . . . . 0.20000000000000001 110.681 166.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HD2' HG23 ' A' ' 57' ' ' ILE . 80.3 m-85 -157.7 132.81 8.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.587 -1.264 . . . . 0.26000000000000001 107.587 172.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.585 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 2.7 m-70 -139.08 104.98 5.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.483 -1.302 . . . . 2.8399999999999999 107.483 -164.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 163' ' ' VAL . 75.7 mt -96.35 114.4 33.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.722 -0.672 . . . . 0.32000000000000001 111.169 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.84 97.01 6.0 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.202 -0.908 . . . . 0.34000000000000002 110.808 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HB ' ' CB ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -120.79 100.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.396 -1.275 . . . . 0.68000000000000005 110.253 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.537 ' HB2' ' CB ' ' A' ' 67' ' ' ALA . 48.9 m -94.76 134.51 37.28 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.23 -0.895 . . . . 1.05 109.298 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.692 ' HA ' HG12 ' A' ' 86' ' ' VAL . 6.0 mm -59.39 -33.44 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 121.867 0.842 . . . . 1.29 109.433 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.33 40.97 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.314 -1.312 . . . . 0.88 112.068 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 64' ' ' SER . . . -68.16 -24.86 65.03 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.177 0.513 . . . . 0.73999999999999999 112.18 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.81 ' HA ' HG11 ' A' ' 86' ' ' VAL . 26.8 mttt 55.74 16.94 2.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.295 1.038 . . . . 2.5099999999999998 113.544 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.98 142.37 31.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 0.45000000000000001 110.839 173.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.516 ' CB ' ' HB ' ' A' ' 63' ' ' VAL . 8.2 tt -96.37 120.25 36.34 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.467 -1.242 . . . . 0.33000000000000002 109.658 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 m -101.12 122.34 43.42 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.078 -0.649 . . . . 0.40000000000000002 111.019 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.549 HD22 ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -82.44 131.76 35.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 106.22 -1.77 . . . . 0.33000000000000002 106.22 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -137.28 126.89 25.24 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 120.677 1.581 . . . . 0.75 112.703 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -113.06 126.22 55.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.089 -0.959 . . . . 0.34999999999999998 110.288 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 66.86 35.31 4.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.499 0.666 . . . . 0.52000000000000002 109.326 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.4 t30 75.7 -0.28 3.23 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.215 -1.357 . . . . 1.8400000000000001 112.21 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -128.93 140.6 51.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 118.125 -1.43 . . . . 3.1899999999999999 113.944 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -56.14 148.09 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 113.41 -1.723 . . . . 0.40999999999999998 113.371 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.549 ' SD ' HD22 ' A' ' 72' ' ' LEU . 4.1 mtp -96.94 -46.42 6.22 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.013 -2.358 . . . . 0.34999999999999998 107.594 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 21.0 tptp -178.77 155.68 0.81 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.397 -2.183 . . . . 2.0699999999999998 110.462 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -111.48 131.57 55.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.483 -0.192 . . . . 0.37 110.483 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.85 135.85 24.5 Favored Pre-proline 0 N--CA 1.453 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.96999999999999997 111.6 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -64.04 140.96 74.88 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.272 2.648 . . . . 0.59999999999999998 112.613 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 -179.64 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.803 -0.814 . . . . 0.64000000000000001 108.803 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.96 147.35 26.27 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.083 0.468 . . . . 0.82999999999999996 110.662 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -143.5 120.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.438 -0.801 . . . . 1.6699999999999999 110.948 -176.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.36 -148.47 9.22 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.621 -0.718 . . . . 3.0800000000000001 112.535 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -68.24 139.18 56.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.798 0.332 . . . . 7.2599999999999998 110.62 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.4 pt -94.06 55.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.414 0.626 . . . . 6.29 110.858 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 91' ' ' THR . 31.1 tp -89.2 176.56 6.91 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.127 -0.694 . . . . 7.2699999999999996 109.127 176.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.502 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 6.5 t -72.63 17.41 0.11 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.25 0.548 . . . . 5.1799999999999997 111.665 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 90' ' ' LEU . 43.2 mt-30 -84.39 55.64 3.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.226 0.536 . . . . 4.8099999999999996 109.609 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.58 HG22 ' HB2' ' A' ' 167' ' ' ARG . 21.2 p -75.93 112.69 21.55 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.937 -0.574 . . . . 2.1099999999999999 110.587 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 92' ' ' GLN . 33.8 Cg_exo -60.97 118.27 5.12 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.282 1.988 . . . . 3.21 111.431 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.0 p -81.84 158.23 24.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.098 -0.501 . . . . 3.5899999999999999 110.793 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.47 164.93 39.65 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.678 -0.772 . . . . 2.1000000000000001 112.087 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -111.07 157.8 19.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.226 0.536 . . . . 2.2999999999999998 110.932 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.532 ' HB2' HG13 ' A' ' 163' ' ' VAL . 2.4 m-85 -119.52 171.22 8.51 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.181 -1.044 . . . . 1.9299999999999999 108.181 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 161' ' ' THR . 96.5 m-85 -136.31 138.68 41.96 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.213 -0.595 . . . . 0.57999999999999996 111.639 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.73 HD11 HD12 ' A' ' 125' ' ' ILE . 26.8 mm -59.93 106.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.19 -1.411 . . . . 0.40999999999999998 107.19 163.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.694 HD11 ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -94.87 -24.03 4.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.829 -0.749 . . . . 0.37 111.587 -176.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -172.01 -174.75 1.35 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 122.784 1.278 . . . . 1.99 114.227 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.504 ' NH1' ' HA ' ' A' ' 155' ' ' SER . 2.8 ptt180 -149.9 137.7 20.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 111.374 -2.648 . . . . 1.1899999999999999 110.575 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.642 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 29.2 tp60 -105.83 144.37 32.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.842 -1.072 . . . . 1.6699999999999999 110.386 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.576 ' HG2' ' N ' ' A' ' 106' ' ' ASN . 23.8 ttm180 -53.37 155.28 2.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 112.748 -2.024 . . . . 3.0600000000000001 112.085 172.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.576 ' N ' ' HG2' ' A' ' 105' ' ' ARG . 3.7 p30 -46.4 109.87 1.1 Allowed Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 114.955 -1.021 . . . . 2.6099999999999999 110.498 175.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.15 -52.07 5.58 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.325 2.683 . . . . 0.97999999999999998 111.958 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.33 -20.24 25.89 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.197 -0.91 . . . . 1.0800000000000001 112.168 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -115.27 -169.94 16.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.94 -0.648 . . . . 1.05 112.621 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.31 9.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 124.598 3.532 . . . . 1.3 114.557 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 115' ' ' TRP . 3.8 t80 -62.27 -27.37 68.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.421 0.629 . . . . 1.3799999999999999 109.959 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.78 55.36 0.94 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.1100000000000001 114.427 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 73.38 -46.98 0.65 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.389 1.255 . . . . 0.81000000000000005 114.389 166.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.567 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -151.84 147.06 26.17 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 122.638 0.375 . . . . 1.1200000000000001 110.445 -174.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.642 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 47.0 t-105 -118.56 102.58 9.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.975 -0.38 . . . . 2.1899999999999999 109.975 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 4.3 mp -107.45 139.78 41.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.561 0.696 . . . . 0.60999999999999999 110.222 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 101' ' ' ILE . 58.3 m -107.66 148.52 29.26 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.51 0.93 . . . . 0.93999999999999995 113.51 -168.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.48 HD22 HG11 ' A' ' 163' ' ' VAL . 70.4 mt -103.09 -172.62 2.15 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.416 -1.266 . . . . 1.0800000000000001 107.981 173.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 p -78.65 -94.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.422 -0.911 . . . . 1.5 110.244 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -131.08 113.6 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.195 0.443 . . . . 2.9700000000000002 112.195 176.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -156.89 3.12 0.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.946 -0.57 . . . . 5.0599999999999996 110.832 172.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.426 ' CE1' ' H41' ' A' 1142 ' ' IM2 . 19.5 t-80 62.46 24.96 14.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.036 0.922 . . . . 5.9500000000000002 108.983 -169.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -136.0 156.63 48.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.821 -1.081 . . . . 4.8300000000000001 110.355 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.524 ' O ' ' HB ' ' A' ' 143' ' ' ILE . . . -149.25 157.13 27.12 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.106 -1.198 . . . . 0.94999999999999996 110.106 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.73 HD12 HD11 ' A' ' 100' ' ' ILE . 20.4 mt -92.67 107.52 19.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.085 -0.709 . . . . 0.47999999999999998 109.085 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.609 ' CE1' ' HB3' ' A' ' 144' ' ' ARG . 7.7 p80 -145.45 -163.15 1.66 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.283 -0.567 . . . . 1.25 111.117 -176.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.55 173.76 16.1 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.171 -1.014 . . . . 0.46000000000000002 113.016 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -137.21 174.68 10.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.432 0.634 . . . . 0.5 111.375 -167.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -104.44 -17.87 14.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.199 -0.909 . . . . 1.8600000000000001 109.604 165.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -125.39 103.08 29.36 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.827 -0.624 . . . . 1.77 110.238 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.53 4.43 4.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.203 2.602 . . . . 0.58999999999999997 113.545 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.49 -22.66 54.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.189 0.519 . . . . 0.78000000000000003 110.818 -171.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -88.28 -6.56 57.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 1.45 110.303 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 134' ' ' ILE . 30.4 mm -81.49 104.69 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 121.663 0.744 . . . . 0.69999999999999996 110.176 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.89 -153.79 25.07 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 114.785 -1.098 . . . . 1.6799999999999999 110.676 -176.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -77.74 73.46 4.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.104 0.478 . . . . 4.3899999999999997 110.638 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -143.33 137.79 29.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.661 -0.7 . . . . 3.9399999999999999 110.482 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.0 p -116.85 73.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 122.251 1.024 . . . . 4.6799999999999997 110.339 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.3 m -153.07 110.07 3.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.295 -0.866 . . . . 5.6799999999999997 109.636 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt 58.02 42.4 22.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.271 0.558 . . . . 8.3000000000000007 109.587 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.58 114.93 7.04 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.229 -0.896 . . . . 3.8500000000000001 113.665 -172.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.426 ' HA ' ' O7 ' ' A' 1142 ' ' IM2 . 90.4 m -128.0 149.72 50.24 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.789 -0.449 . . . . 2.5099999999999998 109.789 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 124' ' ' GLY . 40.7 mt -90.23 62.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.724 0.773 . . . . 1.4399999999999999 109.307 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.609 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 6.3 ptm180 -124.28 94.3 4.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.793 0.806 . . . . 3.3599999999999999 111.35 -176.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.467 ' H ' ' HG2' ' A' ' 145' ' ' MET . 7.8 ptm -90.86 -166.51 1.6 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.874 -1.057 . . . . 1.1299999999999999 111.858 -171.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -61.43 144.23 54.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.474 -0.33 . . . . 2.5099999999999998 110.156 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.563 ' O ' HG12 ' A' ' 150' ' ' VAL . 25.3 p-10 -51.98 -64.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.025 0.203 . . . . 1.77 111.536 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -62.68 -26.66 68.77 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.747 -0.596 . . . . 2.1299999999999999 111.462 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.47 -42.23 71.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.451 -0.341 . . . . 1.05 110.526 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.625 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 12.8 p -75.8 -17.44 15.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.32000000000000001 110.577 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.567 HG13 ' CD2' ' A' ' 114' ' ' TYR . 2.7 mp -88.33 -37.99 11.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 119.289 -0.386 . . . . 0.37 110.306 174.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -43.64 -70.23 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.078 0.854 . . . . 1.3799999999999999 111.954 161.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.664 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.0 OUTLIER -50.03 -41.2 47.01 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.465 -0.789 . . . . 0.73999999999999999 110.29 178.248 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 150' ' ' VAL . . . -54.41 -51.57 64.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.662 -1.154 . . . . 0.22 111.719 -173.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.504 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . 14.9 m -77.94 -13.42 59.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.393 -1.276 . . . . 1.3300000000000001 111.387 -173.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.48 -50.85 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 116.156 -0.474 . . . . 0.23000000000000001 110.08 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 153' ' ' LEU . 18.9 m -78.59 115.37 51.1 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-O 121.943 0.878 . . . . 0.20999999999999999 110.536 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.798 ' HG2' HD13 ' A' ' 57' ' ' ILE . 33.5 Cg_endo -84.6 -177.17 2.79 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.375 2.717 . . . . 0.34000000000000002 112.935 -174.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.616 ' O ' HD21 ' A' ' 51' ' ' LEU . 15.5 m120 -56.09 -2.35 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.636 -1.165 . . . . 1.02 114.016 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.2 57.2 0.5 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.633 -0.794 . . . . 0.28000000000000003 112.477 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 4.4 m -92.16 133.14 36.06 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 110.018 -0.364 . . . . 0.29999999999999999 110.018 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.22 133.9 34.17 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.469 -0.492 . . . . 1.96 110.089 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 98' ' ' PHE . 2.5 p -143.84 130.78 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.184 -0.916 . . . . 0.46000000000000002 111.234 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.402 ' C ' HD12 ' A' ' 165' ' ' ILE . 29.6 m -115.55 140.45 49.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.855 -0.612 . . . . 0.56000000000000005 111.647 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 164' ' ' THR . 2.9 mp -123.82 110.29 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 118.957 -1.097 . . . . 0.95999999999999996 110.217 171.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.81 140.01 31.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.897 -1.047 . . . . 1.1899999999999999 110.566 -172.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.58 ' HB2' HG22 ' A' ' 93' ' ' THR . 5.1 mpt_? -72.88 -16.31 61.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.114 -0.948 . . . . 3.4199999999999999 111.584 177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.78 89.2 0.54 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.663 -0.779 . . . . 3.6499999999999999 111.758 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.262 -0.875 . . . . 5.9699999999999998 109.913 179.322 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1142 ' ' IM2 . . . . . 0.528 ' O31' ' S21' ' A' 1142 ' ' IM2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_